data_2mbt_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2mbt _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 . . . . . 0 N--CA 1.464 0.245 0 CA-C-O 121.732 0.777 . . . . 75.04 110.504 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -128.33 4.91 5.73 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 113.883 1.068 . . . . 74.15 113.883 -161.647 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 16.1 m-85 -140.95 161.86 36.83 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 125.332 1.453 . . . . 71.33 108.234 -170.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 24.6 m -133.73 141.94 47.74 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.123 0.569 . . . . 74.01 109.564 -177.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -70.37 152.96 43.53 Favored 'General case' 0 C--O 1.235 0.316 0 O-C-N 121.477 -0.764 . . . . 75.21 109.423 173.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 73.28 -41.35 0.92 Allowed Glycine 0 CA--C 1.531 1.049 0 C-N-CA 125.877 1.703 . . . . 51.23 111.626 -164.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 17.6 tptt -74.89 -85.16 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 126.631 1.972 . . . . 74.2 110.612 -174.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.7 mp0 -77.82 -25.03 48.58 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 125.343 1.457 . . . . 73.5 110.075 -174.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 41.2 p90 -161.17 178.01 9.69 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 123.885 0.874 . . . . 73.03 109.719 -173.121 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 79.2 t -132.47 109.28 14.58 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 C-N-CA 125.074 1.35 . . . . 74.11 108.179 -179.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.22 162.63 24.56 Favored 'General case' 0 C--O 1.235 0.317 0 O-C-N 120.815 -1.178 . . . . 73.34 108.24 158.327 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -140.88 118.34 11.49 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 124.049 0.94 . . . . 74.22 109.584 -172.069 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.2 m -71.11 7.9 1.11 Allowed 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.99 1.316 . . . . 64.54 113.025 -174.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 33.0 m -134.47 82.13 46.85 Favored Pre-proline 0 N--CA 1.449 -0.505 0 C-N-CA 125.592 1.557 . . . . 74.23 109.224 173.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -75.16 -174.85 2.11 Favored 'Trans proline' 0 CA--C 1.544 1.005 0 C-N-CA 124.966 3.778 . . . . 62.22 114.011 -174.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 10.8 t -141.92 143.27 27.82 Favored Pre-proline 0 CA--C 1.545 0.788 0 C-N-CA 125.872 1.669 . . . . 74.54 109.339 168.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -90.05 178.87 2.14 Favored 'Trans proline' 0 CA--C 1.543 0.956 1 C-N-CA 125.777 4.318 . . . . 74.21 113.068 170.025 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 4.6 m -112.85 -177.7 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 C-N-CA 126.085 1.754 . . . . 74.35 110.327 171.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 12.6 t -63.12 -38.29 90.57 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 125.941 1.696 . . . . 72.21 112.05 172.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -153.53 143.49 15.34 Favored Pre-proline 0 N--CA 1.45 -0.457 0 CA-C-O 117.532 -1.223 . . . . 72.03 107.72 -179.424 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -72.62 178.0 6.82 Favored 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 122.437 2.091 . . . . 71.21 111.118 173.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 133.46 -95.85 0.29 Allowed Glycine 0 C--N 1.332 0.318 0 N-CA-C 108.456 -1.858 . . . . 73.43 108.456 174.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.28 137.73 50.97 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 107.461 -1.311 . . . . 75.11 107.461 176.592 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 33.6 mm -67.69 133.32 31.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 106.79 -1.559 . . . . 75.42 106.79 175.021 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -83.95 143.65 29.69 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.283 -0.636 . . . . 73.05 109.283 176.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 25.7 t -133.68 109.53 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.225 0 N-CA-C 106.381 -1.711 . . . . 74.13 106.381 171.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 58.6 t -96.56 115.06 34.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 N-CA-C 106.104 -1.813 . . . . 71.02 106.104 179.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -76.45 134.99 39.4 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 107.937 -1.134 . . . . 75.24 107.937 157.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.3 mp -125.95 123.23 38.09 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 125.661 1.584 . . . . 73.31 108.011 170.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 15.9 p90 -138.94 176.71 8.46 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.376 1.071 . . . . 64.34 110.816 -170.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 25.0 t90 -147.1 172.12 14.25 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.997 1.319 . . . . 75.51 107.857 177.054 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 19.7 t80 -56.01 -41.0 74.22 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 126.374 1.869 . . . . 55.5 113.129 173.115 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -92.99 -106.87 1.76 Allowed Glycine 0 N--CA 1.449 -0.483 0 N-CA-C 107.965 -2.054 . . . . 74.01 107.965 -168.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 21.1 p 44.22 72.34 1.23 Allowed Pre-proline 0 C--O 1.221 -0.419 0 C-N-CA 125.373 1.469 . . . . 74.21 112.03 175.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -58.93 -24.9 75.02 Favored 'Trans proline' 0 CA--C 1.539 0.739 0 CA-C-N 121.596 1.606 . . . . 71.53 113.419 -171.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 19.7 m170 -71.98 -33.03 67.82 Favored 'General case' 0 CA--C 1.549 0.926 0 CA-C-O 118.059 -0.972 . . . . 73.45 112.512 172.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 15.9 p -65.85 -38.33 88.57 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 120.746 1.612 . . . . 75.13 110.793 -179.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 34.8 t80 -64.56 -31.32 72.49 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 123.199 0.6 . . . . 72.25 111.657 176.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.9 -3.99 25.64 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 112.597 0.591 . . . . 71.42 112.597 174.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 26.1 t80 -117.45 -21.33 8.69 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 125.358 1.463 . . . . 74.22 111.982 -176.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -46.33 -63.52 1.29 Allowed Pre-proline 0 N--CA 1.474 0.762 0 CA-C-N 120.446 1.475 . . . . 73.43 112.432 178.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -71.93 -6.77 19.78 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 CA-C-N 121.856 1.698 . . . . 72.35 114.084 -175.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.0 m -78.95 -42.83 25.92 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.172 1.389 . . . . 73.31 108.535 169.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 20.2 tt -89.84 -36.48 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 O-C-N 121.5 -0.75 . . . . 73.21 112.035 -171.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 54.2 t -50.69 -54.24 38.12 Favored Pre-proline 0 CA--C 1.54 0.565 0 C-N-CA 124.787 1.235 . . . . 73.1 111.591 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -68.73 -36.34 14.3 Favored 'Trans proline' 0 N--CA 1.454 -0.852 0 CA-C-N 121.098 1.428 . . . . 74.34 111.416 178.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 79.2 t90 -54.75 -51.05 66.9 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 118.801 0.728 . . . . 73.31 109.486 177.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -63.16 -37.39 87.04 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 117.857 0.299 . . . . 61.45 111.292 -175.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -62.59 -48.69 78.31 Favored 'General case' 0 N--CA 1.453 -0.299 0 O-C-N 121.58 -0.7 . . . . 75.14 109.255 179.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.54 18.24 2.37 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.84 0.856 . . . . 71.41 113.087 -173.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 19.7 mt -65.02 156.34 80.88 Favored Pre-proline 0 N--CA 1.451 -0.381 0 C-N-CA 123.483 0.713 . . . . 74.42 110.355 174.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -76.06 177.13 9.14 Favored 'Trans proline' 0 N--CA 1.452 -0.917 0 C-N-CA 124.648 3.566 . . . . 71.14 111.164 177.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -67.32 -7.99 28.87 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.535 1.134 . . . . 54.3 113.371 -178.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -107.29 1.77 24.09 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 119.804 1.184 . . . . 74.5 112.369 -168.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 40.7 t -125.66 137.52 57.41 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 N-CA-C 107.835 -1.172 . . . . 74.4 107.835 -172.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 67.2 t60 -127.5 99.94 5.81 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 124.687 1.195 . . . . 72.13 109.227 -177.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 35.0 t80 -80.51 142.15 34.47 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 114.389 -1.278 . . . . 71.42 110.863 176.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 32.6 t -135.08 154.57 36.41 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 C-N-CA 126.573 1.949 . . . . 73.24 106.85 178.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 9.6 mtm180 -132.11 120.18 21.98 Favored 'General case' 0 CA--C 1.516 -0.341 0 C-N-CA 124.364 1.066 . . . . 65.25 108.479 175.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 28.9 mt -132.33 153.28 81.18 Favored Pre-proline 0 C--N 1.33 -0.279 0 O-C-N 121.903 -0.498 . . . . 75.51 110.614 -177.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -81.71 144.97 14.22 Favored 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 123.455 2.77 . . . . 73.32 112.149 -178.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -90.91 74.42 6.47 Favored 'General case' 0 CA--C 1.528 0.122 0 C-N-CA 124.221 1.008 . . . . 73.01 109.338 -171.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 15.7 mt -74.32 86.84 1.99 Allowed 'General case' 0 CA--C 1.543 0.683 0 O-C-N 121.226 -0.921 . . . . 64.14 110.96 -170.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -105.87 24.76 11.82 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.495 1.118 . . . . 70.43 112.414 -178.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 89.14 171.28 45.53 Favored Glycine 0 CA--C 1.528 0.854 0 N-CA-C 110.215 -1.154 . . . . 64.22 110.215 -175.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 46.5 -146.49 3.27 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 124.117 0.865 . . . . 73.24 113.249 177.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 6.7 tp -63.92 -18.57 22.77 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 C-N-CA 123.288 0.635 . . . . 72.54 112.544 -172.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 9.4 m95 -62.16 -44.36 96.79 Favored 'General case' 0 C--N 1.344 0.362 0 CA-C-N 119.537 1.062 . . . . 72.41 109.537 176.316 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 4.3 p30 -77.08 -39.44 49.74 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 117.858 -1.067 . . . . 72.15 111.884 178.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 56.1 t -55.83 -52.03 53.47 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-N 119.153 0.888 . . . . 72.53 109.811 -178.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 34.0 m170 -63.64 -31.94 73.26 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 118.691 -0.671 . . . . 65.23 112.808 -176.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -87.98 -12.08 66.59 Favored Glycine 0 C--N 1.335 0.515 0 CA-C-N 119.701 1.137 . . . . 64.42 111.706 -175.143 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -60.97 -43.77 98.31 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 123.662 0.785 . . . . 75.04 110.667 -173.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 3.7 ppp? -50.22 -32.96 17.9 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 125.318 1.447 . . . . 71.14 114.155 177.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -59.92 -49.52 77.37 Favored 'General case' 0 N--CA 1.458 -0.072 0 C-N-CA 125.181 1.392 . . . . 74.43 108.421 -175.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 29.2 mt -66.26 -36.54 83.27 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 124.486 1.114 . . . . 74.31 109.732 179.244 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.02 -46.86 82.6 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 120.006 1.275 . . . . 74.03 110.801 176.71 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.31 -50.79 64.22 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 125.878 1.671 . . . . 71.41 107.961 -175.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -62.12 -46.31 89.61 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.516 1.126 . . . . 73.22 111.52 174.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 7.1 t -53.3 -32.89 50.98 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 126.102 1.761 . . . . 65.41 113.941 -172.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' MET . . . . . 0.433 ' HE3' ' H ' ' A' ' 121' ' ' ASP . 8.1 ptp . . . . . 0 N--CA 1.467 0.416 0 N-CA-C 114.16 1.17 . . . . 72.35 114.16 179.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.342 0 N-CA-C 113.059 0.763 . . . . 60.44 113.059 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 66.9 t -51.61 -70.6 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 C-N-CA 128.369 2.668 . . . . 64.02 111.063 160.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -54.27 -43.07 70.7 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 125.948 1.699 . . . . 72.43 110.977 176.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -83.63 14.86 3.5 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 126.018 1.727 . . . . 73.15 110.846 -174.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -114.76 -19.85 10.87 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 126.081 1.752 . . . . 72.5 114.604 157.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 36.9 mt -80.5 -66.71 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 N-CA-C 108.373 -0.973 . . . . 73.32 108.373 175.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -78.45 -66.96 0.79 Allowed 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 114.038 1.125 . . . . 71.13 114.038 -163.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 29.8 mtpt -50.3 -53.19 30.47 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 125.36 1.464 . . . . 73.45 109.996 177.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 22.4 mm-40 -75.68 -28.11 58.54 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 125.609 1.563 . . . . 64.34 109.426 -168.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 22.3 t-160 64.86 26.57 12.89 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 126.217 1.807 . . . . 63.31 111.358 174.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 28.2 mmtp -70.61 140.23 51.59 Favored 'General case' 0 C--N 1.342 0.251 0 O-C-N 121.1 -1.0 . . . . 75.01 109.665 177.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 19.8 tttt -56.97 -51.03 70.84 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 125.277 1.431 . . . . 73.32 111.313 -171.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 50.2 mt 47.86 35.14 4.5 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.363 1.465 . . . . 74.33 112.496 173.082 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -94.11 -7.16 43.25 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 113.941 1.089 . . . . 64.45 113.941 -169.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 17.3 p -135.98 155.23 77.86 Favored Pre-proline 0 C--O 1.235 0.308 0 CA-C-N 119.242 0.928 . . . . 71.11 109.639 -177.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -63.14 -33.61 72.03 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 122.088 1.858 . . . . 72.3 111.843 -178.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -66.32 -23.88 66.44 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 118.467 0.576 . . . . 74.5 111.974 176.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -81.77 -44.79 16.53 Favored 'General case' 0 CA--C 1.528 0.111 0 C-N-CA 123.57 0.748 . . . . 73.33 109.851 175.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 44.4 mtt -66.11 -54.55 24.24 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 123.628 0.771 . . . . 72.03 109.162 -175.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.403 ' HB3' ' HE2' ' A' ' 122' ' ' LYS . . . -68.18 -29.91 68.89 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 119.073 -0.489 . . . . 64.42 111.518 -173.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -62.21 -48.61 79.25 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 123.524 0.73 . . . . 72.24 110.464 169.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 86.8 t80 -62.4 -42.52 99.49 Favored 'General case' 0 N--CA 1.447 -0.592 0 O-C-N 122.21 -0.306 . . . . 75.41 111.725 -179.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 35.3 mt -80.89 -11.59 59.56 Favored 'General case' 0 N--CA 1.451 -0.408 0 O-C-N 121.339 -0.851 . . . . 73.02 111.071 -172.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -54.51 -37.65 65.59 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 118.082 0.401 . . . . 61.35 110.506 178.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -84.53 8.97 66.25 Favored Glycine 0 CA--C 1.528 0.857 0 C-N-CA 124.928 1.251 . . . . 63.15 114.818 175.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 52.4 mmtt -133.74 45.01 2.7 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-N 119.485 1.643 . . . . 65.13 110.256 -169.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 63.25 22.84 65.72 Favored Glycine 0 CA--C 1.53 1.022 0 CA-C-O 118.6 -1.111 . . . . 62.24 113.503 170.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 41.9 t -114.17 151.89 15.91 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 C-N-CA 127.528 2.331 . . . . 75.41 106.335 173.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . 0.433 ' H ' ' HE3' ' A' ' 84' ' ' MET . 8.0 t70 -115.67 140.56 49.08 Favored 'General case' 0 C--O 1.235 0.33 0 O-C-N 121.963 -0.461 . . . . 74.43 110.322 172.566 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . 0.403 ' HE2' ' HB3' ' A' ' 112' ' ' ALA . 10.8 mttt -62.69 -39.97 95.67 Favored 'General case' 0 CA--C 1.527 0.061 0 CA-C-O 118.42 -0.8 . . . . 75.54 110.519 178.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 59.2 mt-10 -50.99 -52.39 43.25 Favored 'General case' 0 N--CA 1.457 -0.124 0 CA-C-N 118.888 0.767 . . . . 74.34 109.954 176.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 88.1 mttt -79.53 -42.14 25.8 Favored 'General case' 0 CA--C 1.515 -0.399 0 N-CA-C 107.075 -1.454 . . . . 74.23 107.075 -166.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 62.4 t80 -55.78 -60.32 3.62 Favored 'General case' 0 N--CA 1.443 -0.821 0 C-N-CA 123.798 0.839 . . . . 73.2 109.357 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 47.8 mt -67.2 -37.81 84.28 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-O 118.953 -0.546 . . . . 73.03 110.799 -172.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 2.9 t -64.73 -41.77 95.7 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 119.42 1.009 . . . . 72.53 110.127 -176.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 3.4 t -80.23 -31.77 38.53 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 118.839 0.745 . . . . 71.01 111.069 -179.011 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 91.0 t80 -53.45 -52.93 57.87 Favored 'General case' 0 C--O 1.234 0.268 0 O-C-N 121.294 -0.879 . . . . 73.13 109.369 170.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -86.58 56.5 4.03 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 125.205 1.402 . . . . 74.44 109.033 176.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 14.9 t -136.26 168.5 19.29 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 124.037 0.935 . . . . 74.25 110.549 176.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -69.34 -27.16 65.11 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.249 0.62 . . . . 65.11 110.053 167.288 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -51.73 -53.73 36.14 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 124.209 1.003 . . . . 71.21 111.005 -178.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 14.3 mm -65.17 -36.56 78.05 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 CA-C-O 118.763 -0.637 . . . . 74.44 110.853 177.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 22.4 mttt -57.88 -38.3 75.52 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 119.511 1.05 . . . . 75.42 110.369 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -72.2 -17.73 77.57 Favored Glycine 0 CA--C 1.528 0.86 0 N-CA-C 111.842 -0.503 . . . . 73.4 111.842 -177.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 6.9 mt-30 -88.98 -42.77 11.58 Favored 'General case' 0 N--CA 1.453 -0.276 0 O-C-N 121.542 -0.975 . . . . 71.3 110.514 174.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 91.7 mmm -58.37 -52.58 65.01 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 108.636 -0.876 . . . . 74.2 108.636 -178.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -65.85 -30.46 71.08 Favored 'General case' 0 CA--C 1.535 0.365 0 CA-C-N 119.112 0.869 . . . . 71.13 112.509 -172.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 13.5 mmtt -63.3 -68.54 0.33 Allowed 'General case' 0 C--O 1.227 -0.083 0 C-N-CA 126.081 1.752 . . . . 73.32 109.606 171.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -54.73 -36.27 64.59 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 119.218 0.917 . . . . 62.23 111.208 -174.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -54.57 -66.14 0.45 Allowed 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 126.374 1.87 . . . . 70.21 110.949 172.176 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.69 -31.51 72.23 Favored 'General case' 0 N--CA 1.466 0.33 0 O-C-N 121.433 -0.792 . . . . 74.33 111.142 -174.233 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 49.2 mt -60.11 -54.29 47.67 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 123.968 0.907 . . . . 65.21 109.778 178.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -54.13 -42.14 69.17 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 118.842 0.746 . . . . 74.22 111.341 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -64.25 -43.51 94.68 Favored 'General case' 0 C--O 1.235 0.336 0 O-C-N 121.499 -0.751 . . . . 73.33 111.229 178.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -63.35 -40.17 96.55 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 123.72 0.808 . . . . 73.43 110.383 -179.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 52.8 m-85 -72.78 11.92 0.59 Allowed 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 114.181 1.178 . . . . 74.53 114.181 -178.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 55.59 27.81 11.0 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.295 1.438 . . . . 75.15 113.347 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 40.8 t -64.02 -47.78 88.89 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 C-N-CA 124.995 1.318 . . . . 74.51 112.791 -168.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 82.0 p 55.0 -54.51 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 128.713 2.805 . . . . 74.43 114.82 -166.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -146.94 -166.76 12.55 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 127.161 2.315 . . . . 53.44 110.506 -173.28 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 29.1 m -143.83 155.12 59.54 Favored Pre-proline 0 C--O 1.239 0.551 0 C-N-CA 125.47 1.508 . . . . 73.31 108.779 -172.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -68.81 145.38 77.12 Favored 'Cis proline' 0 C--N 1.345 0.359 0 C-N-CA 125.055 -0.81 . . . . 74.02 113.918 0.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 37.8 m -149.43 127.94 12.31 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 125.431 1.493 . . . . 74.45 107.533 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 20.2 mmm -115.26 148.46 39.13 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 125.561 1.544 . . . . 74.23 107.916 172.126 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 49.9 t -138.96 115.38 10.09 Favored 'Isoleucine or valine' 0 C--O 1.238 0.482 0 N-CA-C 109.571 -0.529 . . . . 75.04 109.571 -177.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 95.2 t -84.48 127.23 40.03 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 N-CA-C 107.764 -1.198 . . . . 73.41 107.764 170.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 6.1 t30 49.34 26.15 1.5 Allowed 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 130.128 3.371 . . . . 74.1 115.243 165.306 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 56.8 28.77 57.71 Favored Glycine 0 CA--C 1.527 0.825 0 C-N-CA 126.311 1.91 . . . . 52.1 114.172 -172.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 6.1 mtpt -131.72 -22.33 2.4 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 120.08 1.94 . . . . 73.11 112.916 -179.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -128.08 126.75 41.81 Favored 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 107.954 -1.128 . . . . 75.44 107.954 179.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 9.2 ttp85 -109.27 134.29 51.96 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 127.187 2.195 . . . . 71.15 105.643 176.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 11.8 p90 -152.26 167.55 28.25 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.675 -0.861 . . . . 74.33 108.675 -178.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -175.9 177.8 1.59 Allowed 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.655 1.182 . . . . 73.23 109.903 -179.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 10.8 mt -47.1 -47.7 8.72 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.131 0 C-N-CA 127.145 2.178 . . . . 64.15 109.394 176.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -80.86 -8.89 86.97 Favored Glycine 0 N--CA 1.448 -0.556 0 CA-C-O 118.092 -1.393 . . . . 52.45 113.715 -177.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 1.2 m -82.94 -65.79 0.97 Allowed 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 119.743 1.771 . . . . 73.21 107.504 164.032 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -59.51 -54.85 41.8 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 124.388 1.075 . . . . 71.3 109.774 -168.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 140.58 -8.45 2.84 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 124.764 1.173 . . . . 72.01 114.106 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 171.38 167.08 31.13 Favored Glycine 0 CA--C 1.526 0.73 0 CA-C-N 119.598 1.699 . . . . 72.11 109.401 -174.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_endo -64.5 -45.36 9.28 Favored 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 122.902 2.401 . . . . 72.12 111.518 -173.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -65.12 -25.55 67.81 Favored 'General case' 0 CA--C 1.537 0.445 0 O-C-N 121.32 -0.862 . . . . 74.3 111.536 174.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -77.07 -28.28 54.6 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.745 0.818 . . . . 72.01 111.021 177.147 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 93.4 m -60.12 -45.51 92.75 Favored 'General case' 0 N--CA 1.464 0.235 0 O-C-N 120.581 -1.324 . . . . 63.22 109.854 178.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 52.5 mt -62.09 -31.83 72.31 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 118.028 0.376 . . . . 75.12 110.622 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 14.2 ttpt -55.8 -40.16 72.31 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 124.131 0.973 . . . . 75.42 110.07 174.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -75.05 -44.82 45.47 Favored 'General case' 0 CA--C 1.509 -0.614 0 CA-C-O 117.876 -1.059 . . . . 73.3 111.196 173.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -51.66 -47.45 63.8 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 119.048 0.84 . . . . 72.31 111.75 -172.019 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -68.91 -47.48 65.71 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.209 1.004 . . . . 73.53 110.524 -175.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -55.17 -49.35 72.08 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 125.301 1.441 . . . . 73.41 111.164 175.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 77.5 mt -66.11 -34.78 78.83 Favored 'General case' 0 C--O 1.232 0.14 0 C-N-CA 124.617 1.167 . . . . 74.45 111.583 -178.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 28.8 mt -60.5 -54.52 33.95 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.143 0 N-CA-C 107.845 -1.169 . . . . 64.44 107.845 173.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -53.36 -42.33 66.72 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 119.271 0.941 . . . . 73.33 111.042 -179.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 42.9 tptt -59.96 -37.0 78.32 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 126.296 1.838 . . . . 75.33 111.881 -177.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 34.7 mm-40 -90.44 -31.34 16.85 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.562 1.145 . . . . 75.21 111.784 177.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . 0.505 ' HA ' ' HE ' ' A' ' 187' ' ' ARG . 1.4 tpm_? -61.18 -37.96 84.81 Favored 'General case' 0 CA--C 1.514 -0.419 0 O-C-N 120.439 -1.413 . . . . 74.42 110.071 178.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.273 0 C-N-CA 127.856 2.462 . . . . 65.43 110.975 173.477 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 . . . . . 0 N--CA 1.456 -0.153 0 CA-C-O 122.606 1.193 . . . . 75.31 111.234 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -131.66 6.86 4.41 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.455 1.102 . . . . 73.21 111.866 -177.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 34.0 m-85 -130.35 160.62 33.42 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 124.104 0.962 . . . . 71.21 110.006 -169.104 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 59.7 m -137.07 133.27 35.22 Favored 'General case' 0 C--O 1.239 0.541 0 N-CA-C 107.04 -1.467 . . . . 75.24 107.04 179.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.26 146.62 54.71 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 109.101 -0.703 . . . . 74.32 109.101 174.003 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 79.92 -35.13 2.11 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 126.332 1.92 . . . . 75.11 112.081 -170.023 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 21.4 tptt -77.54 -63.92 1.27 Allowed 'General case' 0 CA--C 1.518 -0.279 0 C-N-CA 124.687 1.195 . . . . 74.24 110.456 -176.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -98.16 -26.15 14.66 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 125.002 1.321 . . . . 61.33 109.362 -171.171 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 45.0 p90 -157.96 174.96 14.46 Favored 'General case' 0 N--CA 1.468 0.429 0 O-C-N 121.55 -0.719 . . . . 72.53 110.625 -172.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 48.7 t -132.72 106.9 11.25 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 N-CA-C 107.548 -1.279 . . . . 71.14 107.548 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 13.4 tt0 -64.81 147.94 52.24 Favored 'General case' 0 N--CA 1.445 -0.693 0 O-C-N 120.111 -1.618 . . . . 72.42 109.209 165.419 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -110.55 103.96 12.62 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.252 -1.34 . . . . 75.13 110.005 -178.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 79.6 p -65.0 5.85 0.3 Allowed 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 114.521 1.304 . . . . 64.23 114.521 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 8.8 t -128.37 85.28 60.85 Favored Pre-proline 0 N--CA 1.449 -0.479 0 N-CA-C 105.975 -1.861 . . . . 71.45 105.975 159.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -72.34 178.91 5.55 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 123.608 2.872 . . . . 73.51 111.097 -176.157 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 10.9 t -142.99 137.47 14.95 Favored Pre-proline 0 CA--C 1.539 0.521 0 C-N-CA 124.029 0.932 . . . . 64.35 109.186 -176.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -79.37 -178.52 4.66 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 C-N-CA 124.53 3.487 . . . . 75.22 111.703 175.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 29.6 m -132.29 166.23 29.77 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 125.798 1.639 . . . . 74.15 109.009 168.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 5.2 m -44.92 -49.66 10.91 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 127.138 2.175 . . . . 62.33 113.304 178.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 36.4 tt0 -145.62 144.38 22.45 Favored Pre-proline 0 CA--C 1.539 0.521 0 C-N-CA 124.588 1.155 . . . . 72.44 108.766 176.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -70.55 -167.49 0.26 Allowed 'Trans proline' 0 CA--C 1.544 0.976 0 C-N-CA 123.452 2.768 . . . . 74.24 110.455 164.142 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 120.26 -65.35 0.44 Allowed Glycine 0 C--N 1.333 0.395 0 N-CA-C 109.007 -1.637 . . . . 64.12 109.007 177.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -103.55 146.7 28.16 Favored 'General case' 0 C--O 1.232 0.132 0 C-N-CA 125.352 1.461 . . . . 74.22 108.899 170.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 49.5 mm -68.69 139.68 20.18 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 N-CA-C 106.247 -1.76 . . . . 74.43 106.247 173.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -94.81 104.14 16.04 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 106.913 -1.514 . . . . 54.13 106.913 175.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 55.2 t -102.99 128.53 55.82 Favored 'Isoleucine or valine' 0 C--O 1.231 0.089 0 N-CA-C 106.482 -1.673 . . . . 73.14 106.482 173.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 17.6 t -133.73 118.99 31.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 N-CA-C 107.717 -1.216 . . . . 73.14 107.717 -173.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -87.86 144.77 26.41 Favored 'General case' 0 C--O 1.238 0.478 0 N-CA-C 107.737 -1.208 . . . . 74.32 107.737 160.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.9 mp -124.34 125.06 43.71 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 125.042 1.337 . . . . 73.54 108.235 174.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -115.11 175.95 5.28 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.564 0.746 . . . . 72.42 112.717 -169.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 25.3 t90 -148.29 -178.54 6.36 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 126.526 1.93 . . . . 73.22 108.235 168.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 4.0 m-30 -104.86 4.3 31.92 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 126.912 2.085 . . . . 72.11 112.377 179.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -129.6 18.74 5.39 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 124.689 1.137 . . . . 63.22 111.242 -178.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 21.9 p -105.03 85.59 1.3 Allowed Pre-proline 0 N--CA 1.449 -0.511 0 C-N-CA 125.11 1.364 . . . . 72.54 108.587 -177.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -59.82 -24.93 77.76 Favored 'Trans proline' 0 CA--C 1.535 0.558 0 CA-C-N 120.833 1.333 . . . . 64.24 112.291 -175.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 14.1 m170 -74.57 -15.31 60.85 Favored 'General case' 0 CA--C 1.538 0.489 0 O-C-N 121.233 -0.917 . . . . 75.52 112.403 178.039 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 71.5 m -62.25 -43.61 98.43 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 119.356 0.98 . . . . 72.21 108.815 167.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -57.28 -44.84 84.38 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 125.125 1.37 . . . . 74.25 111.013 175.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.37 -10.49 11.46 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 114.005 1.113 . . . . 62.32 114.005 -179.269 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 6.2 t80 -119.51 -25.54 5.99 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-O 117.221 -1.371 . . . . 74.22 112.537 -169.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -37.86 -67.5 0.25 Allowed Pre-proline 0 N--CA 1.472 0.659 0 C-N-CA 125.902 1.681 . . . . 74.11 113.378 179.078 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -70.84 -5.48 16.99 Favored 'Trans proline' 0 CA--C 1.537 0.639 0 CA-C-N 121.249 1.482 . . . . 74.13 114.067 -173.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.9 m -103.75 4.47 35.27 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 128.501 2.72 . . . . 74.43 110.647 177.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 16.8 tt -131.32 -30.52 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-N 120.406 1.457 . . . . 75.12 111.74 171.271 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 18.3 t -45.69 -64.87 0.77 Allowed Pre-proline 0 CA--C 1.537 0.464 0 C-N-CA 125.096 1.358 . . . . 74.52 110.168 173.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -69.33 -28.86 26.82 Favored 'Trans proline' 0 N--CA 1.451 -0.972 0 CA-C-N 120.791 1.318 . . . . 73.13 111.029 -172.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 70.7 t90 -59.2 -53.29 60.0 Favored 'General case' 0 C--N 1.341 0.198 0 CA-C-N 119.093 0.861 . . . . 74.11 109.581 174.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 90.6 p -58.77 -39.75 81.95 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 122.244 0.218 . . . . 61.12 111.07 -176.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -70.93 -12.94 61.83 Favored 'General case' 0 CA--C 1.54 0.587 0 O-C-N 121.154 -0.966 . . . . 73.25 112.874 178.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 68.4 mmtt -103.76 -2.03 27.05 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 125.771 1.628 . . . . 64.34 114.154 175.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 18.4 mt -54.93 147.68 31.74 Favored Pre-proline 0 N--CA 1.452 -0.327 0 CA-C-N 119.714 1.143 . . . . 63.12 110.997 -178.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -74.46 164.89 32.95 Favored 'Trans proline' 0 N--CA 1.439 -1.696 0 C-N-CA 123.346 2.698 . . . . 54.03 109.82 -176.161 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -65.43 1.02 1.26 Allowed 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.03 1.332 . . . . 64.33 114.009 178.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -98.73 0.09 43.83 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 127.965 2.506 . . . . 61.45 112.107 -179.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 57.5 t -131.81 157.09 43.08 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 C-N-CA 124.518 1.127 . . . . 75.52 108.569 -169.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 78.9 t60 -132.64 138.89 47.51 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 107.499 -1.297 . . . . 75.11 107.499 162.061 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 73.4 t80 -106.0 144.13 33.15 Favored 'General case' 0 CA--C 1.519 -0.224 0 N-CA-C 107.915 -1.143 . . . . 75.14 107.915 179.095 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 48.6 t -136.86 148.83 26.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 N-CA-C 108.239 -1.022 . . . . 73.12 108.239 178.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 23.1 mtt180 -115.47 128.08 55.77 Favored 'General case' 0 CA--C 1.513 -0.467 0 N-CA-C 105.867 -1.901 . . . . 73.25 105.867 165.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 23.5 mt -128.41 149.95 73.0 Favored Pre-proline 0 N--CA 1.467 0.391 0 CA-C-N 118.616 0.644 . . . . 73.43 111.173 170.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -78.29 129.62 9.62 Favored 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 122.482 2.122 . . . . 72.15 111.363 178.058 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -76.74 120.33 21.76 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.971 1.308 . . . . 72.13 110.179 174.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 47.7 mt -107.62 56.93 0.63 Allowed 'General case' 0 C--O 1.232 0.146 0 O-C-N 121.026 -1.046 . . . . 72.32 113.456 -167.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -77.33 53.26 1.01 Allowed 'General case' 0 CA--C 1.548 0.869 0 N-CA-C 113.456 0.91 . . . . 72.11 113.456 -176.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 80.29 -54.28 4.52 Favored Glycine 0 CA--C 1.53 1.02 0 C-N-CA 126.693 2.092 . . . . 63.41 114.486 155.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -82.52 -150.98 9.27 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 125.639 1.59 . . . . 62.21 110.377 172.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 9.7 tp -50.29 -19.88 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 C-N-CA 126.648 1.979 . . . . 72.22 113.604 -172.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 28.1 m95 -49.42 -52.93 25.53 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 125.484 1.513 . . . . 75.14 112.16 173.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 20.0 p30 -75.22 -29.58 60.31 Favored 'General case' 0 CA--C 1.522 -0.118 0 N-CA-C 112.288 0.477 . . . . 62.11 112.288 -178.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 81.5 t -61.32 -50.48 80.26 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.33 0 N-CA-C 107.809 -1.182 . . . . 73.55 107.809 174.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 60.8 m170 -70.44 14.63 0.12 Allowed 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 125.714 1.605 . . . . 72.22 113.004 173.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -129.58 -33.37 0.53 Allowed Glycine 0 CA--C 1.528 0.845 0 O-C-N 119.914 -1.741 . . . . 65.22 113.352 -173.086 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -64.71 -36.42 84.23 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 117.961 0.88 . . . . 72.53 111.073 -176.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -60.1 -45.04 94.28 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-O 116.37 -1.776 . . . . 71.22 112.126 179.644 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 25.9 t80 -52.22 -48.99 64.81 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 120.33 1.423 . . . . 71.42 109.935 -176.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 13.3 mt -67.04 -37.49 84.2 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 118.234 -0.889 . . . . 71.13 109.486 -178.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.3 m -63.74 -39.57 94.62 Favored 'General case' 0 C--N 1.342 0.253 0 CA-C-N 119.756 1.162 . . . . 72.22 111.407 174.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -60.4 -54.02 50.59 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 125.44 1.496 . . . . 74.13 107.035 -179.447 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -63.69 -31.41 72.57 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 112.592 0.59 . . . . 74.34 112.592 178.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.9 t -54.5 -19.15 5.25 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 118.003 -0.998 . . . . 71.33 112.288 171.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 9.1 mtp . . . . . 0 N--CA 1.453 -0.312 0 N-CA-C 115.33 1.604 . . . . 75.34 115.33 -174.818 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 0.351 0 N-CA-C 112.971 0.73 . . . . 54.41 112.971 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 70.2 t -54.58 -61.58 0.96 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.841 0 C-N-CA 123.925 0.89 . . . . 60.23 111.157 171.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -71.99 -35.23 69.41 Favored 'General case' 0 N--CA 1.473 0.693 0 O-C-N 119.966 -1.709 . . . . 75.53 111.785 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -67.73 -12.31 60.25 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.003 0.921 . . . . 72.41 111.46 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -84.46 -16.57 42.07 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.259 1.024 . . . . 73.11 111.547 173.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 10.0 mm -96.16 -37.14 7.04 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 C-N-CA 124.546 1.138 . . . . 72.32 110.243 -176.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 88.1 m-70 -103.74 -64.78 1.06 Allowed 'General case' 0 C--O 1.233 0.21 0 C-N-CA 122.838 0.455 . . . . 73.44 110.667 -169.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 21.3 mtpt -63.26 -15.94 58.72 Favored 'General case' 0 N--CA 1.464 0.27 0 O-C-N 121.876 -0.515 . . . . 75.42 111.309 177.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -123.83 -58.41 1.58 Allowed 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.565 1.146 . . . . 73.41 112.4 -173.015 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 2.4 t60 63.94 62.53 0.88 Allowed 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.749 1.62 . . . . 71.32 112.448 -176.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 7.8 mmmt -77.91 22.51 0.28 Allowed 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 127.628 2.371 . . . . 72.43 113.916 -178.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 18.0 ttpp 46.53 40.29 8.02 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 126.309 1.844 . . . . 62.11 111.669 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 40.3 mt -72.67 59.51 0.46 Allowed 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 129.61 3.164 . . . . 63.14 109.313 178.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -106.42 10.98 31.32 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 128.386 2.674 . . . . 75.43 111.429 -172.252 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -150.75 157.4 35.97 Favored Pre-proline 0 C--N 1.328 -0.335 0 C-N-CA 124.645 1.178 . . . . 74.41 109.497 -175.786 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -66.14 -42.43 10.8 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 121.905 1.737 . . . . 72.21 109.973 -175.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -55.98 -53.56 55.38 Favored 'General case' 0 N--CA 1.437 -1.098 0 C-N-CA 124.011 0.924 . . . . 74.52 111.86 173.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 24.0 tp10 -62.35 -41.19 98.39 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 118.206 0.457 . . . . 73.51 109.988 -175.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 38.5 mtt -60.65 -51.05 71.05 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 123.056 0.542 . . . . 64.15 110.335 175.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -61.71 -44.0 97.76 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 124.678 1.191 . . . . 74.43 110.329 -177.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -66.57 -4.93 9.66 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.624 1.57 . . . . 75.53 112.414 177.769 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -95.54 -54.76 3.26 Favored 'General case' 0 C--O 1.234 0.266 0 O-C-N 120.061 -1.649 . . . . 65.42 109.669 163.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 33.7 mt -65.37 -15.4 62.53 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 124.123 0.969 . . . . 74.21 112.066 -172.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -57.92 -16.81 13.35 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.078 0.951 . . . . 73.41 111.805 172.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -105.84 8.07 42.43 Favored Glycine 0 CA--C 1.531 1.043 0 C-N-CA 125.304 1.431 . . . . 71.12 114.43 171.013 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 30.1 mmtm -134.88 42.05 2.82 Favored 'General case' 0 C--O 1.225 -0.221 0 CA-C-N 119.751 1.776 . . . . 74.34 109.046 -172.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 70.49 42.09 64.85 Favored Glycine 0 C--N 1.336 0.541 0 N-CA-C 111.901 -0.48 . . . . 74.11 111.901 169.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 65.9 t -134.0 115.18 20.73 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 CA-C-O 122.601 1.191 . . . . 71.14 108.869 178.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 49.9 t0 -67.99 123.69 21.33 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 115.164 -0.926 . . . . 75.33 109.926 166.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 5.2 ttmt -62.51 -35.35 79.11 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 122.895 0.478 . . . . 75.15 110.233 175.088 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 61.7 mm-40 -64.76 -22.03 66.89 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 123.548 0.739 . . . . 75.32 111.69 179.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 67.9 mmtt -91.25 -53.28 4.42 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 107.937 -1.134 . . . . 75.41 107.937 176.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -47.39 -69.45 0.13 Allowed 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 126.348 1.859 . . . . 75.12 111.399 -175.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 15.5 mt -63.51 -41.45 98.51 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 118.655 0.661 . . . . 71.12 110.409 -167.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 35.3 t -59.87 -54.2 49.0 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 125.368 1.467 . . . . 74.14 109.549 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 30.2 m -64.57 -40.02 94.8 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.426 1.09 . . . . 62.24 109.72 -175.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -57.03 -47.48 80.81 Favored 'General case' 0 C--O 1.231 0.108 0 C-N-CA 124.293 1.037 . . . . 71.14 108.952 176.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -84.7 29.43 0.61 Allowed 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 126.685 1.994 . . . . 62.41 111.771 -177.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 3.2 t -115.14 165.92 12.39 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 124.573 1.149 . . . . 75.41 111.072 -171.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -59.77 -33.38 71.62 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.509 1.124 . . . . 65.41 110.769 170.294 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -52.84 -54.56 32.58 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 124.562 1.145 . . . . 75.45 111.258 -176.13 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 48.3 mm -74.92 -25.82 18.87 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 CA-C-O 119.226 -0.416 . . . . 73.21 110.393 -175.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 12.8 tttt -53.78 -41.42 67.2 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 124.386 1.074 . . . . 72.22 109.813 170.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -67.99 -22.33 74.0 Favored Glycine 0 CA--C 1.528 0.854 0 C-N-CA 124.205 0.907 . . . . 64.41 113.549 -178.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -88.85 -43.22 11.37 Favored 'General case' 0 N--CA 1.455 -0.182 0 O-C-N 121.421 -1.046 . . . . 72.34 109.357 174.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 4.2 mtp -57.38 -41.53 80.39 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 112.836 0.68 . . . . 72.42 112.836 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 22.9 pt-20 -60.28 -49.28 78.23 Favored 'General case' 0 C--O 1.233 0.205 0 O-C-N 121.95 -0.469 . . . . 73.35 111.171 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 76.1 mttt -60.64 -59.11 5.92 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 124.12 0.968 . . . . 61.24 108.603 178.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -53.13 -41.41 65.05 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 118.87 -0.586 . . . . 64.13 111.522 -174.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 26.8 ttmt -64.83 -59.9 3.68 Favored 'General case' 0 C--N 1.344 0.334 0 CA-C-N 119.015 0.825 . . . . 73.52 109.932 -179.365 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.39 -28.91 70.11 Favored 'General case' 0 C--N 1.343 0.308 0 CA-C-N 118.612 0.642 . . . . 71.23 110.746 -174.056 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 52.1 mt -68.52 -52.16 35.11 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-O 118.675 -0.679 . . . . 73.12 110.606 177.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -55.78 -50.42 70.51 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 118.97 0.804 . . . . 73.43 111.437 -175.093 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -59.13 -47.59 84.73 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 118.938 -0.554 . . . . 61.14 111.776 176.814 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -71.42 -21.25 62.01 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 119.303 0.956 . . . . 65.12 111.589 -174.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 21.5 m-85 -77.93 10.84 2.54 Favored 'General case' 0 CA--C 1.541 0.609 0 O-C-N 121.002 -1.061 . . . . 75.24 112.564 170.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 53.62 34.05 17.85 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 126.778 2.031 . . . . 72.42 112.534 -177.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 34.8 t -75.72 141.85 15.26 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 N-CA-C 107.415 -1.328 . . . . 74.31 107.415 174.184 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -135.69 -4.02 2.29 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 124.452 1.101 . . . . 65.43 112.621 170.619 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -160.48 177.54 36.86 Favored Glycine 0 N--CA 1.448 -0.501 0 N-CA-C 109.843 -1.303 . . . . 74.34 109.843 -176.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.425 ' HA ' ' C ' ' A' ' 154' ' ' PRO . 23.7 m -145.26 149.22 40.69 Favored Pre-proline 0 C--O 1.238 0.487 0 C-N-CA 124.336 1.054 . . . . 73.24 108.974 -179.439 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . 0.425 ' C ' ' HA ' ' A' ' 153' ' ' VAL . 41.0 Cg_endo -67.64 153.87 86.52 Favored 'Cis proline' 0 C--O 1.237 0.447 0 C-N-CA 125.195 -0.752 . . . . 73.22 112.728 0.325 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 55.0 m -150.7 127.54 11.0 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 125.305 1.442 . . . . 71.32 107.367 177.357 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 91.1 mtp -105.42 157.85 17.06 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-O 122.171 0.986 . . . . 73.53 109.161 168.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 21.4 t -141.01 149.64 20.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 106.858 -1.534 . . . . 73.24 106.858 177.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 41.4 t -122.62 123.56 68.69 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 C-N-CA 125.958 1.703 . . . . 65.22 106.648 172.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 56.48 16.51 2.52 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 127.37 2.268 . . . . 75.33 114.782 167.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 60.81 33.89 84.86 Favored Glycine 0 CA--C 1.528 0.889 0 CA-C-O 118.205 -1.331 . . . . 74.53 113.867 -169.117 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 61.9 mttt -132.04 -33.31 1.35 Allowed 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 119.457 1.629 . . . . 73.11 113.262 -177.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -122.63 122.61 39.23 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 107.444 -1.317 . . . . 73.41 107.444 -178.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 35.9 ttp180 -103.33 137.73 41.06 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 104.805 -2.295 . . . . 73.14 104.805 170.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 21.1 p90 -152.65 162.24 41.51 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 107.075 -1.454 . . . . 73.25 107.075 176.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -171.08 176.55 3.96 Favored 'General case' 0 CA--C 1.514 -0.426 0 N-CA-C 109.235 -0.654 . . . . 61.43 109.235 -178.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 40.5 mt -47.78 -49.45 10.55 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 C-N-CA 126.881 2.072 . . . . 75.23 110.34 -177.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -84.51 0.14 89.28 Favored Glycine 0 CA--C 1.522 0.525 0 CA-C-O 118.788 -1.007 . . . . 52.22 113.767 -177.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 10.5 m -90.85 -66.27 0.94 Allowed 'General case' 0 N--CA 1.456 -0.157 0 CA-C-N 119.872 1.836 . . . . 73.15 107.179 161.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -70.13 -30.5 67.7 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-O 117.446 -1.264 . . . . 72.42 113.154 -161.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 129.86 22.09 1.18 Allowed Glycine 0 CA--C 1.538 1.51 0 N-CA-C 116.247 1.259 . . . . 62.41 116.247 171.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 113.12 164.28 15.89 Favored Glycine 0 CA--C 1.532 1.113 0 CA-C-N 120.028 1.914 . . . . 72.32 110.249 -176.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -63.23 -32.06 73.89 Favored 'Trans proline' 0 CA--C 1.536 0.622 0 CA-C-N 120.53 2.165 . . . . 75.32 113.816 -156.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 80.9 mt-10 -71.64 -29.94 65.2 Favored 'General case' 0 C--O 1.232 0.184 0 O-C-N 121.004 -1.06 . . . . 61.31 111.559 176.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -72.99 -24.79 60.81 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 122.773 0.429 . . . . 64.33 110.613 173.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 3.1 m -65.24 -45.57 84.08 Favored 'General case' 0 C--O 1.233 0.217 0 O-C-N 121.014 -1.054 . . . . 72.15 109.296 -175.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 39.8 mt -60.56 -33.42 72.67 Favored 'General case' 0 C--O 1.225 -0.213 0 CA-C-N 118.235 0.47 . . . . 65.22 111.206 175.214 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 10.3 tttt -58.05 -35.14 70.9 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-O 118.091 -0.956 . . . . 73.53 110.207 179.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -78.94 -44.89 21.6 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-N 119.359 0.982 . . . . 75.32 110.299 171.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -55.38 -31.49 61.85 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 118.604 0.638 . . . . 65.41 112.649 -175.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -90.61 -44.41 9.55 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 124.699 1.199 . . . . 54.21 109.41 -171.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 25.5 t80 -61.18 -49.21 78.12 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 121.382 0.611 . . . . 73.11 110.604 175.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 89.7 mt -63.07 -21.29 66.07 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 123.879 0.871 . . . . 74.31 112.491 -174.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 28.4 mt -57.36 -59.32 3.37 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.306 0 N-CA-C 107.395 -1.335 . . . . 72.14 107.395 168.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -56.52 -38.55 71.98 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 120.083 1.311 . . . . 73.42 111.618 -177.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 2.7 tmtt? -59.39 -39.82 84.6 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.249 0.619 . . . . 73.34 110.457 -178.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -89.05 -31.14 18.2 Favored 'General case' 0 CA--C 1.517 -0.301 0 O-C-N 121.424 -0.798 . . . . 73.22 112.75 177.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -60.55 -35.89 77.14 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.741 0.781 . . . . 74.25 111.039 -177.537 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.491 0 C-N-CA 123.719 0.808 . . . . 52.41 112.636 176.761 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.449 -0.478 0 N-CA-C 107.3 -1.37 . . . . 61.45 107.3 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 27.3 t0 -141.9 15.41 2.11 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 125.991 1.716 . . . . 71.32 110.023 -178.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 -155.34 153.22 30.17 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 126.581 1.953 . . . . 74.41 108.086 -173.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 74.7 m -128.25 144.59 51.14 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 121.337 0.589 . . . . 74.2 110.02 -172.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -70.1 144.42 52.1 Favored 'General case' 0 N--CA 1.456 -0.127 0 O-C-N 121.375 -0.828 . . . . 61.42 109.196 -179.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 67.44 -15.17 0.44 Allowed Glycine 0 CA--C 1.532 1.14 0 C-N-CA 126.05 1.786 . . . . 63.14 113.45 -167.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -94.54 -60.25 1.75 Allowed 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 125.218 1.407 . . . . 74.52 107.594 -171.104 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -106.57 -25.59 11.75 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 126.423 1.889 . . . . 75.01 110.18 -177.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 41.1 p90 -153.48 170.15 21.45 Favored 'General case' 0 C--N 1.332 -0.164 0 O-C-N 120.895 -1.128 . . . . 75.12 110.266 -171.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 26.8 t -128.93 103.42 9.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 107.158 -1.423 . . . . 73.44 107.158 -176.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -80.78 169.85 17.06 Favored 'General case' 0 C--O 1.237 0.446 0 O-C-N 119.243 -2.161 . . . . 75.43 109.672 174.705 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -127.59 110.88 13.14 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 107.543 -1.28 . . . . 75.45 107.543 -177.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -60.33 -14.27 17.51 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.824 1.649 . . . . 72.41 112.814 175.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 4.0 p -109.52 85.06 3.44 Favored Pre-proline 0 N--CA 1.451 -0.39 0 N-CA-C 107.618 -1.253 . . . . 74.35 107.618 166.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -67.52 179.35 2.6 Favored 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 122.479 2.119 . . . . 74.23 111.038 178.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 31.0 t -134.47 139.57 33.1 Favored Pre-proline 0 CA--C 1.536 0.425 0 N-CA-C 107.55 -1.278 . . . . 73.33 107.55 -178.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -75.58 177.25 8.92 Favored 'Trans proline' 0 CA--C 1.536 0.588 0 C-N-CA 122.937 2.425 . . . . 73.41 110.577 173.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 35.4 m -139.86 166.85 20.01 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 C-N-CA 123.426 0.69 . . . . 61.11 110.859 179.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 3.4 t -54.43 -60.1 3.8 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 126.26 1.824 . . . . 71.43 110.027 172.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 4.1 tp-100 -120.71 84.97 38.23 Favored Pre-proline 0 N--CA 1.454 -0.243 0 C-N-CA 125.335 1.454 . . . . 74.25 108.316 -163.155 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -67.75 -8.71 23.22 Favored 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 122.18 1.92 . . . . 75.3 112.183 177.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -61.21 -25.59 64.83 Favored Glycine 0 CA--C 1.53 1.022 0 O-C-N 120.848 -1.157 . . . . 65.23 112.118 168.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 56.2 mttm -125.66 150.87 47.24 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-N 119.391 1.595 . . . . 73.03 109.39 -179.157 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 51.2 mm -78.09 127.62 38.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 106.28 -1.748 . . . . 75.15 106.28 177.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -91.24 118.71 30.71 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 107.716 -1.216 . . . . 64.03 107.716 -174.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 42.1 t -120.42 115.94 48.67 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 N-CA-C 106.985 -1.487 . . . . 65.43 106.985 -178.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 16.8 t -124.48 103.59 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 N-CA-C 107.642 -1.244 . . . . 71.14 107.642 -163.299 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -67.67 135.83 53.4 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 125.48 1.512 . . . . 74.31 108.594 164.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.0 mp -119.85 125.61 48.94 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 124.741 1.216 . . . . 75.25 107.72 160.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -130.77 164.27 25.49 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.086 0.954 . . . . 65.23 111.222 -174.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 25.9 t90 -143.27 142.58 31.41 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.163 0.985 . . . . 74.42 109.975 177.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 5.7 m-30 -61.57 -25.5 67.36 Favored 'General case' 0 CA--C 1.533 0.309 0 O-C-N 121.757 -0.59 . . . . 74.41 111.505 175.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -91.57 19.9 44.87 Favored Glycine 0 CA--C 1.53 1.026 0 CA-C-O 118.53 -1.15 . . . . 73.44 113.255 -179.349 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 46.1 t -104.46 85.66 1.18 Allowed Pre-proline 0 CA--C 1.541 0.606 0 C-N-CA 125.281 1.432 . . . . 64.14 110.719 -173.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_endo -67.17 5.28 0.89 Allowed 'Trans proline' 0 CA--C 1.536 0.619 0 C-N-CA 124.672 3.581 . . . . 73.25 114.606 179.164 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 22.9 m170 -107.11 -20.02 13.43 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 126.27 1.828 . . . . 64.51 111.546 175.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 94.4 m -78.82 -34.55 45.15 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.602 0.761 . . . . 74.54 110.901 -175.238 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 14.1 t80 -55.91 -41.4 74.49 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 124.917 1.287 . . . . 74.22 110.575 178.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -45.39 -51.7 10.94 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 125.766 1.626 . . . . 72.52 110.859 179.302 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -84.39 -21.23 30.89 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 125.791 1.636 . . . . 75.23 112.695 -167.075 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 59.0 mm-40 -45.15 -62.59 1.58 Allowed Pre-proline 0 N--CA 1.469 0.505 0 CA-C-N 120.001 1.273 . . . . 74.25 112.562 -176.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -71.11 -5.13 16.3 Favored 'Trans proline' 0 CA--C 1.538 0.724 0 C-N-CA 121.839 1.693 . . . . 60.34 114.455 -178.032 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 74.7 m -87.74 -34.69 18.26 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 119.643 1.11 . . . . 75.3 109.561 168.22 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 19.2 tt -92.78 -29.05 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 CA-C-N 119.708 1.14 . . . . 75.11 112.189 -174.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 38.6 t -49.19 -62.92 1.94 Allowed Pre-proline 0 CA--C 1.536 0.437 0 CA-C-O 117.797 -1.097 . . . . 75.51 109.943 170.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -66.3 -25.38 49.6 Favored 'Trans proline' 0 N--CA 1.451 -0.973 0 CA-C-N 120.737 1.299 . . . . 75.14 112.591 -173.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 58.4 t90 -65.88 -54.92 20.34 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 123.564 0.746 . . . . 74.13 110.406 173.345 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 88.8 p -57.61 -38.66 75.3 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.187 0.595 . . . . 71.0 112.24 -170.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 72.2 mt-10 -59.13 -36.84 75.9 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.796 1.238 . . . . 75.14 111.291 177.208 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 4.7 mmmm -92.51 2.82 56.46 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 125.35 1.46 . . . . 74.53 112.019 -167.094 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 33.7 mt -62.06 155.98 61.01 Favored Pre-proline 0 C--O 1.239 0.502 0 C-N-CA 125.558 1.543 . . . . 71.34 112.122 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -81.4 171.57 13.5 Favored 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 125.143 3.895 . . . . 72.44 112.452 -177.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -69.12 -2.34 9.99 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 126.513 1.925 . . . . 73.51 115.28 -177.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -115.79 0.24 13.11 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.756 1.222 . . . . 74.22 111.939 -178.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 86.1 t -96.71 150.6 4.36 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 N-CA-C 107.751 -1.203 . . . . 73.44 107.751 168.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 33.8 t60 -129.94 99.6 5.16 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 124.983 1.313 . . . . 71.45 107.829 165.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 51.4 t80 -77.21 145.23 37.73 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 114.9 -1.046 . . . . 75.25 109.606 178.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 21.6 t -142.09 157.04 19.93 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 C-N-CA 125.998 1.719 . . . . 74.22 107.695 -177.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 57.7 mtt180 -130.56 131.74 45.19 Favored 'General case' 0 N--CA 1.462 0.144 0 N-CA-C 107.793 -1.188 . . . . 74.03 107.793 163.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 37.3 mt -133.63 157.35 78.17 Favored Pre-proline 0 N--CA 1.468 0.438 0 C-N-CA 124.532 1.133 . . . . 73.25 108.935 176.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -74.85 164.72 32.94 Favored 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 121.381 1.388 . . . . 74.2 111.289 177.608 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -111.45 112.6 24.46 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 125.777 1.631 . . . . 75.11 107.53 -177.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 26.8 mt -115.68 60.29 0.71 Allowed 'General case' 0 C--O 1.234 0.274 0 O-C-N 121.489 -0.757 . . . . 73.14 112.602 -161.093 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -65.53 -14.83 61.89 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 114.613 1.338 . . . . 72.31 114.613 -171.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 122.65 -37.78 2.73 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 125.329 1.442 . . . . 64.25 111.763 175.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -77.96 -157.77 10.03 Favored Glycine 0 CA--C 1.527 0.787 0 C-N-CA 124.383 0.992 . . . . 75.53 110.844 172.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 6.3 tp -45.11 -24.28 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 127.996 2.519 . . . . 74.11 113.396 179.288 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 37.6 m95 -44.19 -50.72 8.62 Favored 'General case' 0 N--CA 1.441 -0.899 0 C-N-CA 126.657 1.983 . . . . 73.12 111.277 172.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 26.4 p30 -77.71 -29.27 51.21 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 113.852 1.056 . . . . 73.03 113.852 -179.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 73.8 t -60.89 -50.0 82.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 108.757 -0.831 . . . . 72.31 108.757 174.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 55.9 m170 -72.29 -0.65 12.78 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.034 1.734 . . . . 73.24 112.538 171.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -100.51 -14.56 32.14 Favored Glycine 0 CA--C 1.525 0.661 0 CA-C-N 120.205 1.366 . . . . 72.14 112.309 -175.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -96.63 -27.13 14.94 Favored 'General case' 0 N--CA 1.45 -0.473 0 O-C-N 121.792 -0.828 . . . . 72.3 112.102 -159.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -65.11 -42.37 94.02 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-O 116.833 -1.556 . . . . 73.03 111.244 -177.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 7.7 t80 -52.21 -56.13 16.66 Favored 'General case' 0 C--N 1.34 0.194 0 CA-C-N 119.466 1.03 . . . . 74.24 109.01 -176.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 44.5 mt -64.89 -32.07 73.61 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 116.497 -1.716 . . . . 74.44 111.247 -177.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.3 m -70.3 -38.18 74.93 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 120.77 1.623 . . . . 75.32 111.356 177.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.7 -54.25 47.56 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 124.395 1.078 . . . . 73.13 109.211 175.338 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -56.21 -37.69 70.0 Favored 'General case' 0 C--O 1.226 -0.154 0 C-N-CA 125.139 1.375 . . . . 73.33 110.485 177.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -50.95 -20.31 1.3 Allowed 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.538 1.535 . . . . 73.12 113.769 176.443 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 53.6 mtm . . . . . 0 N--CA 1.466 0.368 0 CA-C-N 120.422 1.465 . . . . 73.32 113.992 176.593 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.187 0 CA-C-O 118.761 -0.638 . . . . 74.21 111.152 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 4.1 t -57.43 -51.27 71.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 CA-C-N 119.551 1.068 . . . . 70.1 110.83 -179.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -65.18 -52.84 52.48 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 123.686 0.794 . . . . 75.21 109.256 175.71 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -58.02 -26.89 62.99 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.605 1.562 . . . . 73.21 110.978 -172.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -72.91 -16.03 61.57 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 125.822 1.649 . . . . 75.32 113.572 -179.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 19.4 mt -92.61 -43.1 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 N-CA-C 107.353 -1.351 . . . . 64.43 107.353 174.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 30.5 p80 -102.86 -64.11 1.1 Allowed 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 113.54 0.941 . . . . 71.33 113.54 -166.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 29.6 mtpt -68.14 -16.06 63.84 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 119.916 1.235 . . . . 65.43 111.783 176.13 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -99.48 -23.32 15.14 Favored 'General case' 0 C--N 1.331 -0.212 0 O-C-N 120.834 -1.166 . . . . 70.51 111.92 171.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 7.2 t60 57.4 84.6 0.09 Allowed 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.629 1.572 . . . . 72.2 112.497 172.202 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 8.3 mmtp -136.71 152.23 50.13 Favored 'General case' 0 CA--C 1.52 -0.193 0 C-N-CA 124.187 0.995 . . . . 65.02 111.193 -169.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 9.3 ttmm -71.18 -51.19 26.23 Favored 'General case' 0 C--O 1.224 -0.253 0 N-CA-C 109.261 -0.644 . . . . 73.54 109.261 -177.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 77.9 mt 50.54 32.17 6.39 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.893 1.277 . . . . 63.13 113.514 179.053 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -86.81 8.67 21.82 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 114.768 1.395 . . . . 73.22 114.768 -167.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -143.34 157.84 58.97 Favored Pre-proline 0 N--CA 1.471 0.605 0 O-C-N 120.846 -1.159 . . . . 73.24 109.392 -172.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -58.77 -42.68 50.79 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 121.905 1.736 . . . . 74.14 111.738 -177.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -63.05 -53.45 53.62 Favored 'General case' 0 N--CA 1.442 -0.86 0 O-C-N 124.342 1.026 . . . . 74.21 110.486 -178.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 44.3 tp10 -58.11 -33.61 69.31 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.362 0.665 . . . . 70.24 111.04 -172.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 69.1 mtm -72.68 -56.86 4.66 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 118.149 -0.929 . . . . 72.41 111.595 169.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -59.63 -49.87 76.06 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 124.764 1.226 . . . . 74.45 112.529 -171.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -68.08 -36.7 80.25 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 124.62 1.168 . . . . 75.51 111.591 -170.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . 0.424 ' CZ ' ' HE3' ' A' ' 118' ' ' LYS . 84.8 t80 -58.06 -38.93 77.27 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.229 0.612 . . . . 70.22 110.878 171.416 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 14.0 mt -77.66 -19.18 55.84 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 123.924 0.89 . . . . 73.13 110.278 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.4 -20.06 58.26 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 121.149 -0.969 . . . . 71.44 111.249 173.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -97.06 -6.5 57.86 Favored Glycine 0 CA--C 1.528 0.888 0 CA-C-O 118.877 -0.957 . . . . 64.42 114.112 169.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.424 ' HE3' ' CZ ' ' A' ' 114' ' ' PHE . 48.2 mttm -125.27 61.91 1.19 Allowed 'General case' 0 N--CA 1.456 -0.134 0 CA-C-N 119.938 1.869 . . . . 74.2 108.406 -175.083 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 71.69 18.48 77.34 Favored Glycine 0 CA--C 1.525 0.661 0 CA-C-O 119.021 -0.877 . . . . 65.44 114.646 161.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 28.3 t -125.89 139.88 50.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 C-N-CA 125.707 1.603 . . . . 73.45 108.04 -176.608 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 65.5 t0 -85.68 121.2 28.01 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 107.712 -1.218 . . . . 54.31 107.712 167.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 15.3 ttpt -57.32 -35.62 70.09 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 124.053 0.941 . . . . 75.33 110.394 176.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -65.68 -39.6 91.47 Favored 'General case' 0 N--CA 1.454 -0.26 0 O-C-N 121.491 -0.756 . . . . 64.32 111.566 178.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 46.0 mttm -75.68 -44.25 43.2 Favored 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 106.819 -1.548 . . . . 75.04 106.819 -173.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -49.02 -68.06 0.21 Allowed 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 125.605 1.562 . . . . 72.45 110.579 174.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 18.3 mt -65.33 -32.59 74.32 Favored 'General case' 0 C--O 1.234 0.253 0 O-C-N 121.379 -0.825 . . . . 72.2 111.155 -170.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 35.7 t -56.98 -58.26 8.92 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 107.637 -1.245 . . . . 75.1 107.637 177.017 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . 0.341 10.1 t -71.79 -30.13 65.2 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 119.919 -0.712 . . . . 74.12 110.864 -175.32 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 31.1 t80 -54.65 -35.36 63.4 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 120.646 -1.283 . . . . 74.45 111.085 174.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -102.72 18.14 22.12 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.618 1.167 . . . . 65.02 112.744 179.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 28.8 m -104.53 160.99 14.49 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 125.652 1.581 . . . . 73.3 111.926 176.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -59.9 -25.97 65.54 Favored 'General case' 0 CA--C 1.532 0.288 0 O-C-N 122.143 -0.348 . . . . 72.33 111.058 171.051 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -50.01 -28.75 7.42 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 125.386 1.474 . . . . 64.1 113.304 173.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 5.5 mm -101.64 -36.06 4.49 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 C-N-CA 125.159 1.384 . . . . 74.42 110.671 176.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 35.3 tttm -53.91 -39.06 65.47 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 124.073 0.949 . . . . 75.43 110.463 174.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -72.55 -16.05 77.57 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 125.152 1.358 . . . . 51.14 111.916 -170.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -99.1 -39.22 8.6 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 123.393 0.677 . . . . 73.03 109.494 176.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 75.6 mmm -58.47 -37.83 76.32 Favored 'General case' 0 C--N 1.342 0.257 0 N-CA-C 109.77 -0.456 . . . . 74.03 109.77 177.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -59.66 -51.53 69.41 Favored 'General case' 0 CA--C 1.535 0.374 0 O-C-N 121.303 -0.873 . . . . 71.4 110.737 173.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 4.3 mmtp -61.98 -58.14 9.01 Favored 'General case' 0 C--N 1.344 0.327 0 CA-C-O 117.987 -1.006 . . . . 73.21 111.47 -175.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -59.5 -30.75 68.79 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 119.474 1.034 . . . . 62.12 110.671 -176.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 2.2 tmpt? -66.16 -58.87 4.48 Favored 'General case' 0 C--N 1.344 0.357 0 O-C-N 121.035 -1.04 . . . . 73.21 109.99 176.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 15.2 ptpt -62.61 -37.82 87.78 Favored 'General case' 0 C--N 1.341 0.22 0 CA-C-O 118.611 -0.709 . . . . 73.44 109.499 -173.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 35.7 mt -57.89 -59.77 4.73 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.467 1.107 . . . . 71.34 110.984 175.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -56.01 -40.61 73.63 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 119.03 0.832 . . . . 75.23 111.765 -175.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -63.25 -50.52 69.84 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 109.918 -0.401 . . . . 74.33 109.918 175.503 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -69.67 -22.44 63.44 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-O 118.572 -0.727 . . . . 72.13 112.4 -172.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -73.98 -8.27 55.49 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 125.37 1.468 . . . . 74.14 113.864 171.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 52.61 72.66 0.39 Allowed 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 124.793 1.237 . . . . 75.31 110.919 -167.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 47.4 t -101.63 145.83 10.93 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 N-CA-C 107.457 -1.312 . . . . 75.41 107.457 166.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -123.27 -13.89 7.58 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 123.629 0.772 . . . . 70.5 112.787 172.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -159.35 -163.7 13.59 Favored Glycine 0 C--N 1.334 0.431 0 O-C-N 121.047 -1.033 . . . . 75.32 113.213 179.051 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.467 ' HA ' ' C ' ' A' ' 154' ' ' PRO . 15.4 m -144.11 146.78 35.1 Favored Pre-proline 0 C--N 1.328 -0.335 0 C-N-CA 126.102 1.761 . . . . 65.44 107.086 173.055 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . 0.467 ' C ' ' HA ' ' A' ' 153' ' ' VAL . 60.8 Cg_endo -67.31 150.95 83.68 Favored 'Cis proline' 0 N--CA 1.46 -0.479 0 C-N-CA 125.2 -0.75 . . . . 64.42 112.149 1.524 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 85.8 m -151.15 127.75 10.81 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 105.769 -1.937 . . . . 73.31 105.769 174.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 14.6 mmm -110.81 150.81 28.6 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 106.569 -1.641 . . . . 75.24 106.569 165.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 46.6 t -129.11 128.91 67.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 107.114 -1.439 . . . . 73.21 107.114 171.301 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 77.4 t -93.1 123.04 45.06 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 N-CA-C 107.48 -1.304 . . . . 74.44 107.48 164.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 2.7 t30 64.58 11.74 6.92 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 129.114 2.966 . . . . 63.54 115.52 159.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 71.19 23.33 78.19 Favored Glycine 0 CA--C 1.526 0.742 0 CA-C-O 117.711 -1.605 . . . . 74.42 112.973 -170.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 35.9 mttt -133.58 -30.18 1.3 Allowed 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 120.043 1.921 . . . . 71.22 112.402 -175.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 80.3 m-85 -124.34 115.01 20.31 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 118.943 -0.551 . . . . 74.5 110.864 -179.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 6.3 ptt180 -96.01 141.41 29.45 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 106.685 -1.598 . . . . 64.51 106.685 171.171 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 15.1 p90 -151.71 164.84 36.08 Favored 'General case' 0 C--N 1.309 -1.154 0 O-C-N 120.721 -1.237 . . . . 73.13 108.376 176.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -168.19 169.12 11.19 Favored 'General case' 0 CA--C 1.513 -0.445 0 CA-C-N 116.001 -0.545 . . . . 73.21 109.611 -174.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 42.0 mt -51.73 -47.79 38.57 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 C-N-CA 125.41 1.484 . . . . 73.2 109.702 -175.115 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -84.13 -4.65 88.16 Favored Glycine 0 CA--C 1.527 0.791 0 CA-C-O 117.701 -1.611 . . . . 64.44 113.38 -176.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 52.1 m -87.24 -56.31 3.42 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 121.224 2.512 . . . . 72.32 108.249 163.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -79.0 -28.02 43.36 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-O 116.9 -1.524 . . . . 71.34 113.969 -165.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 154.12 -46.7 0.54 Allowed Glycine 0 CA--C 1.527 0.793 0 CA-C-N 121.343 1.883 . . . . 65.3 115.457 176.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 154.26 167.13 15.83 Favored Glycine 0 CA--C 1.534 1.224 0 N-CA-C 108.159 -1.977 . . . . 74.01 108.159 -153.145 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -67.69 -23.48 42.35 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 CA-C-N 120.525 2.163 . . . . 63.41 113.294 -164.182 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -70.0 -46.4 65.22 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 123.013 1.387 . . . . 75.25 109.557 174.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -66.97 -21.51 65.96 Favored 'General case' 0 N--CA 1.445 -0.675 0 C-N-CA 126.622 1.969 . . . . 74.44 111.344 -175.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 3.2 m -70.6 -43.76 68.68 Favored 'General case' 0 CA--C 1.529 0.16 0 O-C-N 121.126 -0.984 . . . . 72.15 109.162 -177.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 53.4 mt -62.84 -33.27 74.9 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 118.288 0.495 . . . . 73.35 110.799 177.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 7.5 tttt -52.58 -51.42 59.88 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 125.099 1.36 . . . . 75.43 109.33 173.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -68.78 -39.89 79.96 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-O 118.287 -0.864 . . . . 73.11 110.846 175.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -55.8 -49.04 74.28 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 119.215 0.916 . . . . 75.44 111.201 -174.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -72.88 -43.13 62.9 Favored 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 122.76 0.424 . . . . 72.41 110.333 -172.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 15.9 t80 -60.45 -52.33 65.67 Favored 'General case' 0 N--CA 1.44 -0.946 0 C-N-CA 124.736 1.214 . . . . 74.33 110.048 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 95.9 mt -62.63 -34.8 77.78 Favored 'General case' 0 C--O 1.233 0.213 0 C-N-CA 123.206 0.602 . . . . 71.05 110.768 -178.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 38.1 mt -60.8 -61.96 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 N-CA-C 108.419 -0.956 . . . . 73.41 108.419 173.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -56.98 -32.79 66.44 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 124.491 1.117 . . . . 74.25 111.509 -173.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 79.3 tttt -58.51 -66.93 0.41 Allowed 'General case' 0 C--O 1.232 0.156 0 C-N-CA 125.425 1.49 . . . . 74.25 110.571 171.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 43.0 mm-40 -65.38 -19.34 65.9 Favored 'General case' 0 N--CA 1.446 -0.625 0 O-C-N 121.03 -1.044 . . . . 73.01 113.258 -177.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.94 -44.79 63.04 Favored 'General case' 0 CA--C 1.533 0.319 0 O-C-N 120.974 -1.079 . . . . 74.03 109.327 169.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.133 0 C-N-CA 124.214 1.005 . . . . 74.54 110.73 -177.648 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 . . . . . 0 CA--C 1.512 -0.483 0 N-CA-C 106.969 -1.493 . . . . 74.53 106.969 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -81.55 8.92 8.43 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-N 112.757 -2.02 . . . . 71.25 114.835 -161.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 42.7 m-85 -134.18 167.03 21.41 Favored 'General case' 0 N--CA 1.442 -0.854 0 C-N-CA 124.803 1.241 . . . . 75.35 108.641 -164.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 94.2 m -134.2 141.24 46.97 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 108.451 -0.944 . . . . 74.15 108.451 173.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -70.28 143.58 52.03 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-O 122.069 0.938 . . . . 73.22 110.055 175.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 61.46 16.0 48.28 Favored Glycine 0 CA--C 1.529 0.917 0 C-N-CA 124.898 1.237 . . . . 51.44 112.762 -166.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 8.1 ttmt -118.4 -85.23 0.65 Allowed 'General case' 0 CA--C 1.517 -0.31 0 N-CA-C 105.879 -1.897 . . . . 72.44 105.879 172.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 38.4 mp0 -75.6 -21.97 57.32 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 118.675 0.67 . . . . 75.2 112.462 -179.505 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 47.9 p90 -159.78 176.0 12.47 Favored 'General case' 0 CA--C 1.52 -0.179 0 O-C-N 121.477 -0.765 . . . . 73.43 110.726 -170.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 44.3 t -140.68 96.05 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 N-CA-C 108.534 -0.913 . . . . 70.01 108.534 -170.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.39 146.18 27.81 Favored 'General case' 0 C--O 1.237 0.402 0 O-C-N 121.089 -1.007 . . . . 61.21 110.677 177.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -100.68 146.46 27.17 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 114.467 -1.242 . . . . 75.12 108.192 -170.675 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.8 p -81.85 -23.77 36.2 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 125.569 1.547 . . . . 73.31 111.12 179.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 69.3 m -115.27 84.32 11.35 Favored Pre-proline 0 N--CA 1.455 -0.18 0 C-N-CA 124.783 1.233 . . . . 75.0 109.587 -178.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -75.01 174.75 12.25 Favored 'Trans proline' 0 N--CA 1.451 -0.995 0 C-N-CA 122.113 1.875 . . . . 75.4 112.288 -178.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 20.7 t -130.2 130.46 23.06 Favored Pre-proline 0 CA--C 1.534 0.342 0 CA-C-N 114.937 -1.029 . . . . 63.21 108.714 -173.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -76.73 175.91 10.78 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 124.277 3.318 . . . . 74.12 112.865 178.04 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 19.4 m -120.25 168.56 12.48 Favored 'Isoleucine or valine' 0 C--O 1.24 0.567 0 C-N-CA 126.366 1.866 . . . . 75.22 110.264 173.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 38.9 m -54.91 -53.01 61.02 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 126.664 1.986 . . . . 74.21 110.777 174.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 3.5 mm-40 -141.58 144.27 32.74 Favored Pre-proline 0 N--CA 1.451 -0.392 0 N-CA-C 106.564 -1.643 . . . . 74.23 106.564 178.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -71.51 165.01 33.81 Favored 'Trans proline' 0 N--CA 1.447 -1.224 0 C-N-CA 121.269 1.313 . . . . 71.22 109.156 162.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 159.57 -35.04 0.47 Allowed Glycine 0 CA--C 1.519 0.329 0 CA-C-O 119.547 -0.585 . . . . 64.04 112.784 167.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -129.71 163.58 25.85 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.581 1.553 . . . . 75.33 109.707 162.463 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 28.2 mm -66.31 126.34 25.46 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 N-CA-C 106.467 -1.679 . . . . 65.35 106.467 168.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -89.3 123.45 33.5 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 125.992 1.717 . . . . 72.53 106.762 -176.66 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 28.3 t -123.73 135.29 63.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 108.002 -1.11 . . . . 73.45 108.002 -179.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 40.3 t -126.76 125.9 67.72 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.177 0 N-CA-C 108.262 -1.014 . . . . 75.52 108.262 -175.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -87.46 134.91 33.53 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 125.164 1.386 . . . . 72.31 107.769 162.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.2 mp -122.23 123.5 41.61 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 124.715 1.206 . . . . 73.53 108.354 165.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -131.8 171.59 13.33 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.754 1.622 . . . . 72.01 110.979 -169.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 27.3 t90 -147.22 168.92 20.49 Favored 'General case' 0 CA--C 1.537 0.452 0 O-C-N 120.86 -1.15 . . . . 74.03 109.46 168.038 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 14.6 t80 -60.77 -53.51 56.5 Favored 'General case' 0 N--CA 1.461 0.076 0 C-N-CA 126.062 1.745 . . . . 74.12 111.425 174.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -68.66 -84.41 0.13 Allowed Glycine 0 C--N 1.336 0.575 0 N-CA-C 110.697 -0.961 . . . . 55.44 110.697 -159.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 14.5 t 42.54 71.93 1.27 Allowed Pre-proline 0 CA--C 1.533 0.289 0 C-N-CA 125.961 1.704 . . . . 54.55 113.415 149.163 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -67.3 3.42 1.7 Allowed 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 122.264 1.976 . . . . 73.34 113.71 -176.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 18.7 m170 -108.66 -28.98 8.96 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 119.857 1.208 . . . . 71.33 111.978 173.062 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 85.7 m -60.27 -46.32 90.24 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 119.545 1.066 . . . . 63.14 109.754 -175.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 32.7 t80 -66.62 -22.13 66.12 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 121.085 -1.009 . . . . 73.24 112.187 -178.329 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -74.64 -3.54 31.85 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 120.931 -1.106 . . . . 52.34 112.782 175.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 15.6 t80 -121.82 -25.14 5.08 Favored 'General case' 0 C--O 1.226 -0.171 0 C-N-CA 125.372 1.469 . . . . 65.0 112.511 -168.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 56.9 mm-40 -42.39 -63.23 0.96 Allowed Pre-proline 0 CA--C 1.539 0.553 0 C-N-CA 124.253 1.021 . . . . 73.04 112.403 -177.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -73.3 -8.73 22.34 Favored 'Trans proline' 0 N--CA 1.46 -0.445 0 CA-C-N 122.535 1.941 . . . . 74.1 114.966 -177.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.4 m -70.8 -44.91 65.63 Favored 'General case' 0 CA--C 1.543 0.708 0 O-C-N 121.034 -1.042 . . . . 74.33 108.525 166.293 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 12.9 tt -94.78 -36.02 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 C-N-CA 123.86 0.864 . . . . 74.42 112.418 -165.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 41.9 t -46.8 -58.85 6.09 Favored Pre-proline 0 CA--C 1.538 0.493 0 C-N-CA 125.691 1.596 . . . . 74.53 110.443 176.001 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -72.53 -25.51 17.72 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 121.646 1.564 . . . . 74.33 112.929 -178.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 79.6 t90 -60.24 -52.01 67.11 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 119.757 1.162 . . . . 74.4 109.014 173.315 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.2 t -55.88 -42.8 76.46 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.321 0.648 . . . . 71.3 110.522 177.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 90.0 mt-10 -64.05 -10.34 21.52 Favored 'General case' 0 N--CA 1.468 0.474 0 O-C-N 121.207 -0.933 . . . . 71.1 113.352 -179.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 19.3 mmmt -122.49 8.48 9.58 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 126.116 1.767 . . . . 74.13 112.277 -171.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 25.2 mt -64.73 153.59 87.39 Favored Pre-proline 0 C--O 1.24 0.566 0 C-N-CA 125.029 1.331 . . . . 74.41 111.177 177.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -74.54 167.25 27.56 Favored 'Trans proline' 0 N--CA 1.448 -1.154 0 C-N-CA 124.658 3.572 . . . . 73.05 110.494 179.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -73.12 -2.19 20.45 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.385 1.474 . . . . 74.31 113.349 -175.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -101.75 8.29 41.55 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.01 1.324 . . . . 75.04 111.15 177.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 60.8 t -124.58 155.13 32.47 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 C-N-CA 124.521 1.128 . . . . 74.04 108.766 -177.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 63.9 t60 -139.27 123.72 18.26 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 126.903 2.081 . . . . 73.43 106.333 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 47.4 t80 -107.97 139.4 42.65 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 108.079 -1.082 . . . . 64.44 108.079 -176.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 25.9 t -135.2 153.75 34.61 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 N-CA-C 105.511 -2.033 . . . . 75.23 105.511 -177.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -127.86 140.16 52.19 Favored 'General case' 0 CA--C 1.512 -0.512 0 N-CA-C 105.341 -2.096 . . . . 75.32 105.341 167.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 97.5 mt -138.54 144.46 42.45 Favored Pre-proline 0 C--N 1.326 -0.416 0 N-CA-C 108.829 -0.804 . . . . 71.42 108.829 174.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -71.6 148.25 53.05 Favored 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 121.526 1.484 . . . . 72.45 110.913 178.098 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -93.28 86.53 5.34 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 124.962 1.305 . . . . 75.14 108.362 -178.019 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 46.8 mt -80.86 65.45 6.01 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 121.006 -1.059 . . . . 65.13 112.601 -169.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 13.0 m-85 -80.02 27.2 0.32 Allowed 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 115.111 1.523 . . . . 64.12 115.111 -168.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 66.54 -168.32 35.48 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 109.217 -1.553 . . . . 63.2 109.217 -166.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 56.15 -151.03 23.03 Favored Glycine 0 CA--C 1.526 0.747 0 CA-C-N 117.848 0.824 . . . . 73.33 111.34 178.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 9.6 tp -70.45 -12.04 15.65 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 N-CA-C 112.471 0.545 . . . . 74.2 112.471 173.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 9.4 m95 -64.42 -36.16 83.24 Favored 'General case' 0 C--O 1.224 -0.266 0 O-C-N 120.004 -1.685 . . . . 72.23 112.178 -171.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 11.5 p30 -76.54 -28.34 56.27 Favored 'General case' 0 CA--C 1.518 -0.254 0 N-CA-C 113.051 0.76 . . . . 74.41 113.051 177.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 94.2 t -65.61 -51.69 59.79 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 N-CA-C 107.21 -1.404 . . . . 71.1 107.21 172.281 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 59.0 m170 -79.1 54.18 1.58 Allowed 'General case' 0 C--O 1.239 0.505 0 C-N-CA 125.493 1.517 . . . . 72.23 111.446 172.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -164.82 -29.28 0.02 OUTLIER Glycine 0 N--CA 1.445 -0.752 0 CA-C-N 115.485 -0.78 . . . . 74.52 112.717 156.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -62.32 -25.78 68.07 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 119.314 1.557 . . . . 75.22 114.045 -173.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 40.3 ttp -53.3 -40.12 64.53 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 124.358 1.063 . . . . 71.32 112.546 -177.404 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -58.47 -47.1 85.15 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 125.074 1.349 . . . . 74.12 108.523 178.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 15.5 mt -68.81 -34.69 75.93 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-O 116.487 -1.721 . . . . 72.23 111.095 -178.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -63.73 -45.12 91.33 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 121.761 2.073 . . . . 75.13 111.335 174.509 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -52.53 -60.6 3.04 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.454 1.102 . . . . 75.4 108.723 -176.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -67.19 -27.56 67.37 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.26 1.024 . . . . 74.21 110.043 -174.696 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.0 t -51.68 -39.86 59.04 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 124.52 1.128 . . . . 53.05 111.621 176.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 44.7 mtm . . . . . 0 CA--C 1.534 0.327 0 CA-C-N 118.761 0.71 . . . . 64.31 112.439 -176.979 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.545 0.752 0 N-CA-C 114.986 1.476 . . . . 71.25 114.986 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 25.6 t -73.36 -66.43 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 CA-C-N 119.895 1.225 . . . . 70.34 108.805 167.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -60.0 -36.98 78.35 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.261 1.025 . . . . 75.41 110.776 -175.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -60.15 -35.55 75.57 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 125.382 1.473 . . . . 72.34 110.745 176.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -65.22 -22.18 66.85 Favored 'General case' 0 CA--C 1.534 0.338 0 O-C-N 121.163 -0.961 . . . . 63.13 112.053 176.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 55.5 mt -87.34 -60.01 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.884 0 N-CA-C 105.883 -1.895 . . . . 73.3 105.883 178.106 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 31.6 p80 -92.55 -53.64 4.11 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 115.379 1.622 . . . . 72.15 115.379 -168.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 34.2 mmtt -62.64 -20.4 64.75 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.238 1.015 . . . . 75.51 111.742 175.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -117.19 -26.2 6.86 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 118.053 -0.975 . . . . 70.42 113.148 -171.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 1.9 t-160 53.46 42.97 31.91 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.275 1.43 . . . . 72.1 111.994 178.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 25.4 mmtp -74.79 157.52 35.03 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 120.941 -1.099 . . . . 75.33 110.218 175.353 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 11.0 tttt -80.17 36.47 0.35 Allowed 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 127.872 2.469 . . . . 74.23 111.748 -173.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 24.7 mt -64.54 32.82 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 130.452 3.501 . . . . 74.43 115.182 -174.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -79.8 13.09 2.29 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 129.636 3.174 . . . . 61.3 113.14 178.562 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -148.04 158.53 41.74 Favored Pre-proline 0 N--CA 1.463 0.221 0 CA-C-N 119.21 0.914 . . . . 75.4 111.852 -179.628 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -67.93 -19.55 46.09 Favored 'Trans proline' 0 N--CA 1.455 -0.773 0 C-N-CA 123.225 2.617 . . . . 62.31 112.106 174.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -60.39 -71.19 0.14 Allowed 'General case' 0 C--O 1.22 -0.497 0 N-CA-C 107.398 -1.334 . . . . 73.03 107.398 167.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -51.51 -42.61 61.83 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 124.289 1.036 . . . . 73.51 112.395 -176.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 48.0 mtt -58.72 -57.15 14.28 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 109.67 -0.493 . . . . 74.24 109.67 179.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -65.73 -37.33 86.1 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 119.536 -0.269 . . . . 65.15 111.111 -177.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -60.63 -48.77 80.31 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 127.533 2.333 . . . . 74.45 110.341 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -65.72 -47.81 74.06 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 123.666 0.787 . . . . 75.12 110.698 177.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 66.9 mt -75.15 -13.06 60.43 Favored 'General case' 0 N--CA 1.457 -0.101 0 CA-C-O 119.051 -0.5 . . . . 74.54 111.76 -173.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -49.11 -53.58 20.05 Favored 'General case' 0 CA--C 1.52 -0.178 0 C-N-CA 125.099 1.36 . . . . 70.25 109.882 -174.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -72.21 7.2 8.41 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 125.453 1.501 . . . . 74.43 115.571 178.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 20.3 mttm -125.43 25.94 6.94 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 120.788 2.294 . . . . 75.24 111.57 -170.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 74.46 40.82 38.53 Favored Glycine 0 C--N 1.334 0.448 0 N-CA-C 111.142 -0.783 . . . . 74.4 111.142 -179.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 58.4 t -131.0 111.61 20.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 N-CA-C 107.147 -1.427 . . . . 64.11 107.147 173.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -70.57 136.54 49.34 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 123.993 0.917 . . . . 71.52 111.47 173.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 26.9 tttt -64.74 -48.25 75.27 Favored 'General case' 0 CA--C 1.516 -0.362 0 N-CA-C 109.762 -0.458 . . . . 74.33 109.762 -176.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 60.1 mm-40 -63.85 -39.19 93.63 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 122.775 0.43 . . . . 71.24 110.237 -174.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 3.9 mtpm? -75.62 -38.77 58.71 Favored 'General case' 0 CA--C 1.515 -0.376 0 N-CA-C 108.282 -1.007 . . . . 73.31 108.282 -177.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 87.4 t80 -57.76 -60.5 3.6 Favored 'General case' 0 N--CA 1.44 -0.925 0 O-C-N 123.794 0.684 . . . . 72.52 110.294 178.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 15.7 mt -65.61 -37.27 86.13 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-O 118.937 -0.554 . . . . 74.41 109.754 -175.108 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 45.6 t -60.14 -51.85 67.86 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 108.582 -0.896 . . . . 72.52 108.582 177.094 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . 0.278 1.3 t -69.12 -33.12 72.97 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 119.454 1.025 . . . . 73.21 109.873 -173.792 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 53.2 t80 -51.1 -48.56 61.65 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.361 1.465 . . . . 73.51 110.664 170.14 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -95.14 17.63 13.77 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 113.213 0.82 . . . . 72.43 113.213 -179.074 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 58.0 m -107.67 172.47 6.81 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 119.772 1.169 . . . . 74.44 111.694 179.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -63.84 -23.84 67.51 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 115.92 -0.582 . . . . 75.5 112.338 -174.724 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -53.58 -59.87 4.04 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.671 1.189 . . . . 75.44 110.032 176.006 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 14.2 mm -67.1 -26.21 35.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 C-N-CA 123.032 0.533 . . . . 73.54 111.605 -179.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 6.8 tttp -55.48 -45.45 76.99 Favored 'General case' 0 N--CA 1.464 0.225 0 O-C-N 120.938 -1.101 . . . . 72.23 109.639 171.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -72.76 -10.91 77.45 Favored Glycine 0 CA--C 1.524 0.63 0 C-N-CA 123.475 0.559 . . . . 72.22 112.009 -172.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 7.5 mm100 -108.66 -38.52 5.63 Favored 'General case' 0 N--CA 1.44 -0.938 0 C-N-CA 126.332 1.853 . . . . 75.11 109.357 -171.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -62.98 -41.91 99.69 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 118.368 -0.825 . . . . 75.12 110.332 174.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -67.71 -44.66 77.17 Favored 'General case' 0 CA--C 1.535 0.365 0 CA-C-N 119.137 0.881 . . . . 73.35 110.266 178.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 3.1 ttmt -63.23 -56.13 19.15 Favored 'General case' 0 N--CA 1.449 -0.475 0 O-C-N 121.034 -1.041 . . . . 75.35 111.164 -174.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -59.64 -33.27 71.31 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 118.029 0.377 . . . . 65.31 110.661 -176.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 2.0 tmtm? -60.1 -60.54 3.66 Favored 'General case' 0 CA--C 1.531 0.245 0 O-C-N 121.269 -0.894 . . . . 75.03 110.925 172.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.44 -18.79 63.0 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 119.265 0.939 . . . . 73.45 112.039 -173.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 45.4 mt -69.5 -54.55 13.64 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 123.96 0.904 . . . . 73.45 110.338 172.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -53.58 -47.37 70.2 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 119.558 1.072 . . . . 73.41 112.588 -174.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -62.33 -45.13 94.6 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 112.704 0.631 . . . . 71.1 112.704 175.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -63.21 -35.65 81.01 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 118.496 0.589 . . . . 74.34 109.88 -179.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 -74.19 9.2 1.72 Allowed 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 114.014 1.116 . . . . 74.53 114.014 173.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 60.86 19.5 9.76 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 126.294 1.838 . . . . 74.34 112.649 176.063 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 25.8 t -75.16 141.14 16.31 Favored 'Isoleucine or valine' 0 C--O 1.24 0.58 0 N-CA-C 107.996 -1.113 . . . . 74.44 107.996 -177.042 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -141.49 0.5 1.48 Allowed 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 118.846 -0.597 . . . . 75.33 112.408 173.409 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -160.12 167.96 35.63 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 108.6 -1.8 . . . . 72.33 108.6 170.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.413 ' HA ' ' C ' ' A' ' 154' ' ' PRO . 30.0 m -123.88 156.03 66.08 Favored Pre-proline 0 C--O 1.238 0.473 0 C-N-CA 125.697 1.599 . . . . 71.35 107.614 176.515 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . 0.413 ' C ' ' HA ' ' A' ' 153' ' ' VAL . 94.8 Cg_endo -67.33 157.92 83.53 Favored 'Cis proline' 0 N--CA 1.46 -0.447 0 O-C-N 122.607 0.793 . . . . 73.41 113.323 -2.083 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 5.1 m -154.86 136.93 14.69 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 107.989 -1.115 . . . . 74.32 107.989 171.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 91.8 mtp -111.13 152.92 26.44 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 107.135 -1.432 . . . . 70.32 107.135 169.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 41.0 t -138.98 128.66 31.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 N-CA-C 107.92 -1.141 . . . . 73.43 107.92 178.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 42.7 t -104.03 130.71 54.23 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 C-N-CA 124.371 1.069 . . . . 71.41 108.634 173.013 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 45.29 23.53 0.12 Allowed 'General case' 0 N--CA 1.464 0.264 1 C-N-CA 131.728 4.011 . . . . 71.41 114.374 177.278 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 59.41 31.33 69.91 Favored Glycine 0 CA--C 1.531 1.091 0 CA-C-O 117.69 -1.616 . . . . 52.43 113.882 -170.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 10.5 mtpt -131.27 -30.56 1.72 Allowed 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 119.622 1.711 . . . . 72.32 113.386 -177.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -122.16 118.59 29.0 Favored 'General case' 0 CA--C 1.519 -0.235 0 N-CA-C 107.907 -1.146 . . . . 74.24 107.907 -174.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 36.2 ttp85 -100.49 135.8 41.36 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 105.04 -2.207 . . . . 72.03 105.04 175.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 18.1 p90 -154.07 166.5 32.84 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 108.346 -0.983 . . . . 73.13 108.346 172.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -170.94 178.56 3.39 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.998 0.428 . . . . 75.15 110.77 -175.346 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 43.3 mt -55.89 -45.06 79.74 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 C-N-CA 124.904 1.282 . . . . 75.51 108.799 -179.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -88.32 29.4 5.68 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 126.481 1.991 . . . . 75.13 113.155 174.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 19.0 p -119.99 -51.16 2.24 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 107.482 -1.303 . . . . 74.14 107.482 156.315 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -66.52 -39.55 88.7 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 125.097 1.359 . . . . 64.21 112.319 -175.042 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 110.61 11.56 19.05 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 124.103 0.859 . . . . 73.32 113.48 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 159.99 170.4 24.53 Favored Glycine 0 CA--C 1.524 0.598 0 CA-C-N 119.469 1.634 . . . . 62.04 110.525 175.02 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -66.44 -42.36 10.05 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 122.019 1.813 . . . . 74.14 110.762 -175.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -70.1 -34.33 73.0 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 109.166 -0.679 . . . . 63.32 109.166 -177.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 41.7 mm-40 -67.37 -28.9 68.33 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.544 1.538 . . . . 74.3 110.472 174.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 23.6 m -66.0 -40.72 91.39 Favored 'General case' 0 CA--C 1.531 0.212 0 O-C-N 120.467 -1.396 . . . . 73.13 108.844 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 61.1 mt -66.36 -24.48 66.51 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 119.343 0.974 . . . . 71.24 112.423 177.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 9.4 mttt -56.58 -54.25 48.09 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 108.564 -0.902 . . . . 74.14 108.564 168.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -68.14 -43.62 77.92 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 120.326 -0.549 . . . . 74.43 109.931 -178.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.42 -26.98 63.89 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 124.247 1.019 . . . . 70.24 112.864 -174.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -100.69 -32.57 10.66 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 123.769 0.827 . . . . 45.31 111.474 -173.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 33.7 t80 -62.45 -52.01 65.24 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 124.178 0.991 . . . . 73.42 109.906 170.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 48.9 mt -55.39 -32.54 62.72 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 124.304 1.042 . . . . 73.22 112.164 -176.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 81.3 mt -54.19 -62.73 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.309 0 N-CA-C 107.857 -1.164 . . . . 73.41 107.857 174.401 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 -61.53 -37.43 83.75 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 121.193 0.52 . . . . 73.12 111.56 -171.188 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -58.14 -52.21 66.5 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.106 0.963 . . . . 71.41 109.875 179.695 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -68.06 -42.53 80.34 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-O 121.603 0.716 . . . . 74.3 112.586 174.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 5.5 tpm_? -53.61 -46.72 70.53 Favored 'General case' 0 CA--C 1.516 -0.334 0 C-N-CA 125.188 1.395 . . . . 75.45 110.326 -175.09 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.286 0 C-N-CA 125.201 1.401 . . . . 63.01 112.159 -177.733 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . 0.414 ' C ' ' H ' ' A' ' 6' ' ' TYR . 1.6 m-20 . . . . . 0 N--CA 1.458 -0.055 0 CA-C-O 123.108 1.433 . . . . 74.31 110.049 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -69.33 8.33 0.62 Allowed 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 125.262 1.425 . . . . 72.14 113.524 177.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.414 ' H ' ' C ' ' A' ' 4' ' ' ASP . 36.8 m-85 -138.6 167.53 21.74 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 126.603 1.961 . . . . 71.54 108.944 -171.649 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 59.3 m -133.99 133.32 41.17 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 107.213 -1.402 . . . . 74.43 107.213 176.034 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -69.37 137.78 53.13 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 108.166 -1.05 . . . . 52.53 108.166 168.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 72.47 24.78 75.68 Favored Glycine 0 CA--C 1.528 0.867 0 N-CA-C 111.251 -0.74 . . . . 61.43 111.251 -167.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 18.4 tttm -140.4 -85.02 0.21 Allowed 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 106.81 -1.552 . . . . 74.45 106.81 171.044 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -72.92 -23.93 60.76 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 124.588 1.155 . . . . 73.42 111.044 -177.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 44.8 p90 -157.74 167.51 29.84 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 123.508 0.723 . . . . 71.42 109.468 -171.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 93.5 t -133.99 119.71 32.99 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 C-N-CA 124.321 1.048 . . . . 75.42 109.089 -179.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.91 161.42 30.15 Favored 'General case' 0 C--N 1.328 -0.351 0 O-C-N 120.19 -1.568 . . . . 63.2 109.633 172.307 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -119.53 108.12 14.13 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 124.022 0.929 . . . . 72.02 108.988 177.704 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.8 m -61.9 -5.64 2.23 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 124.864 1.266 . . . . 74.51 113.946 -178.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -121.02 84.6 39.54 Favored Pre-proline 0 N--CA 1.449 -0.483 0 N-CA-C 106.334 -1.728 . . . . 73.44 106.334 167.298 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -67.19 177.62 3.62 Favored 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 123.084 2.523 . . . . 74.33 111.129 179.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 36.4 t -136.8 139.67 29.61 Favored Pre-proline 0 C--N 1.327 -0.371 0 C-N-CA 124.552 1.141 . . . . 72.32 108.085 -166.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -76.14 177.78 8.32 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 123.0 2.466 . . . . 62.41 112.356 175.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 4.0 m -126.83 -174.61 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 C-N-CA 126.952 2.101 . . . . 73.12 108.301 177.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -66.18 -41.59 90.04 Favored 'General case' 0 CA--C 1.538 0.517 0 O-C-N 121.51 -0.744 . . . . 71.34 109.752 176.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 -168.12 166.04 7.52 Favored Pre-proline 0 CA--C 1.539 0.535 0 C-N-CA 127.63 2.372 . . . . 74.52 108.325 -179.127 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -61.25 167.25 9.64 Favored 'Trans proline' 0 CA--C 1.543 0.952 0 C-N-CA 122.051 1.834 . . . . 71.43 110.681 162.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 137.05 -64.08 0.57 Allowed Glycine 0 C--N 1.338 0.64 0 O-C-N 121.296 -0.877 . . . . 70.15 112.509 170.146 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.416 ' HE2' ' N ' ' A' ' 26' ' ' LYS . 0.2 OUTLIER -113.43 144.16 43.27 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 118.966 1.383 . . . . 74.25 107.756 176.389 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 45.4 mm -67.54 129.66 32.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 104.991 -2.226 . . . . 74.35 104.991 170.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -90.47 138.57 31.44 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 107.322 -1.362 . . . . 72.42 107.322 177.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 58.5 t -129.43 116.47 39.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 106.414 -1.699 . . . . 74.51 106.414 175.114 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 23.4 t -106.58 112.35 39.27 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 N-CA-C 107.891 -1.151 . . . . 73.53 107.891 -175.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -77.53 130.3 36.78 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 107.843 -1.169 . . . . 73.41 107.843 159.076 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 5.3 mp -114.68 130.75 56.86 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 124.236 1.014 . . . . 71.25 108.587 164.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 33.4 p90 -134.17 168.58 18.59 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.608 0.763 . . . . 75.1 111.255 -172.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 25.2 t90 -147.96 168.45 22.26 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 126.597 1.959 . . . . 75.05 107.691 173.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 2.1 m-30 -81.41 -41.13 22.36 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 109.181 -0.674 . . . . 74.25 109.181 179.301 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -76.5 21.64 2.35 Favored Glycine 0 CA--C 1.532 1.105 0 C-N-CA 124.81 1.195 . . . . 60.23 114.089 -175.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 51.8 t -105.0 87.23 1.79 Allowed Pre-proline 0 CA--C 1.537 0.475 0 C-N-CA 126.752 2.021 . . . . 73.03 110.391 -170.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -54.11 -42.61 65.59 Favored 'Trans proline' 0 CA--C 1.534 0.514 0 C-N-CA 122.387 2.058 . . . . 74.22 113.284 177.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 26.7 m170 -72.87 -24.16 60.82 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 119.227 0.922 . . . . 74.12 111.734 -172.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 99.6 m -62.57 -39.25 93.09 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.846 0.858 . . . . 61.33 110.56 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 21.8 t80 -62.67 -45.94 90.5 Favored 'General case' 0 C--N 1.341 0.229 0 C-N-CA 123.616 0.766 . . . . 74.45 111.061 -176.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.61 -9.97 31.61 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 112.695 0.628 . . . . 74.2 112.695 -176.056 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -97.97 -22.61 16.2 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 124.97 1.308 . . . . 72.52 111.267 178.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -44.81 -64.83 0.74 Allowed Pre-proline 0 CA--C 1.54 0.57 0 C-N-CA 125.007 1.323 . . . . 71.2 112.47 -172.069 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -69.96 -4.91 15.11 Favored 'Trans proline' 0 N--CA 1.459 -0.509 0 C-N-CA 122.1 1.867 . . . . 72.35 115.547 -176.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.8 m -87.12 -41.11 14.04 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 108.529 -0.915 . . . . 72.53 108.529 171.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 19.0 tt -84.62 -29.35 6.87 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 O-C-N 121.586 -0.696 . . . . 72.01 111.422 -174.011 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 34.8 t -48.88 -66.32 0.61 Allowed Pre-proline 0 CA--C 1.534 0.339 0 CA-C-O 117.428 -1.272 . . . . 71.43 110.84 172.126 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -58.86 -41.45 62.42 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 121.67 1.58 . . . . 75.05 110.125 -175.206 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 61.6 t90 -52.71 -57.33 10.45 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 118.519 0.599 . . . . 74.14 110.473 177.095 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 78.1 p -59.96 -34.61 73.49 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.272 0.629 . . . . 74.22 112.483 -177.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -78.67 -16.77 56.9 Favored 'General case' 0 CA--C 1.533 0.317 0 O-C-N 121.303 -0.873 . . . . 75.44 112.835 178.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 42.2 mmtm -106.04 2.16 27.04 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 126.089 1.756 . . . . 74.44 112.662 -178.078 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 37.2 mt -57.7 148.73 55.88 Favored Pre-proline 0 C--O 1.236 0.37 0 C-N-CA 124.397 1.079 . . . . 74.41 110.741 177.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -77.55 170.93 18.41 Favored 'Trans proline' 0 N--CA 1.443 -1.451 0 C-N-CA 124.015 3.143 . . . . 64.43 111.014 178.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -67.84 3.4 1.51 Allowed 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 115.075 1.509 . . . . 74.12 115.075 -170.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -118.56 1.42 11.7 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 126.94 2.096 . . . . 64.51 112.568 -177.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 23.1 t -120.19 123.29 70.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 CA-C-N 119.369 0.986 . . . . 54.31 109.569 -179.014 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 80.1 t60 -115.05 107.63 15.6 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 126.155 1.782 . . . . 75.43 109.663 -174.317 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 26.5 t80 -78.34 139.63 38.81 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.688 1.195 . . . . 74.22 110.762 179.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 88.8 t -131.51 146.61 33.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 C-N-CA 127.698 2.399 . . . . 75.55 106.681 -178.132 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 29.7 mtt-85 -131.63 120.03 22.25 Favored 'General case' 0 CA--C 1.508 -0.669 0 N-CA-C 106.929 -1.508 . . . . 71.41 106.929 -177.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 75.2 mt -129.93 148.68 70.57 Favored Pre-proline 0 C--N 1.325 -0.464 0 O-C-N 123.419 0.45 . . . . 75.24 112.187 179.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -75.87 134.77 16.77 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 122.8 2.333 . . . . 74.55 110.457 177.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -75.97 108.7 9.03 Favored 'General case' 0 CA--C 1.535 0.395 0 O-C-N 121.477 -0.764 . . . . 71.02 109.059 170.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 49.5 mt -103.03 94.19 5.42 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 127.165 2.186 . . . . 72.14 108.548 -179.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -130.8 43.53 3.09 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 119.221 0.918 . . . . 65.14 112.21 -175.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 74.63 164.23 11.35 Favored Glycine 0 CA--C 1.522 0.525 0 C-N-CA 124.767 1.175 . . . . 74.51 112.358 175.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 52.33 -144.11 20.45 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.416 -1.073 . . . . 73.32 110.416 -175.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 4.8 tp -64.4 -15.12 16.9 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 CA-C-O 118.093 -0.955 . . . . 73.52 111.431 -172.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 19.7 m95 -59.81 -33.59 71.93 Favored 'General case' 0 C--N 1.342 0.275 0 CA-C-N 120.732 1.605 . . . . 73.25 111.139 173.126 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 7.3 m-80 -80.52 -32.32 36.9 Favored 'General case' 0 C--N 1.339 0.147 0 CA-C-N 118.766 0.712 . . . . 73.32 111.708 177.137 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.404 ' C ' ' H ' ' A' ' 75' ' ' GLY . 70.5 t -68.44 -58.83 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 N-CA-C 108.512 -0.922 . . . . 72.35 108.512 178.159 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 52.1 m170 -72.14 47.21 0.15 Allowed 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 126.625 1.97 . . . . 74.24 109.578 167.113 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.404 ' H ' ' C ' ' A' ' 73' ' ' VAL . . . -164.49 1.24 0.05 OUTLIER Glycine 0 CA--C 1.527 0.818 0 C-N-CA 127.055 2.264 . . . . 55.53 113.28 -176.795 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -108.2 -24.13 11.65 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 120.78 2.29 . . . . 75.21 113.23 -174.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 3.0 ptt? -85.14 -23.45 28.41 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 114.361 1.245 . . . . 74.22 114.361 -170.194 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 29.5 t80 -56.58 -48.68 76.87 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 119.861 1.21 . . . . 74.4 107.94 176.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 35.1 mt -60.84 -46.85 88.95 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 114.846 -1.07 . . . . 72.35 109.672 178.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.72 -41.94 98.29 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 119.503 1.047 . . . . 72.33 111.525 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -54.53 -53.24 57.04 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 123.99 0.916 . . . . 74.42 108.993 -177.31 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -76.54 -24.85 53.64 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 124.645 1.178 . . . . 72.04 112.212 -176.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 7.7 t -55.11 -11.71 0.76 Allowed 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.629 1.572 . . . . 72.13 113.46 172.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 9.1 mtp . . . . . 0 C--O 1.225 -0.213 0 C-N-CA 124.165 0.986 . . . . 75.52 112.799 177.745 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.135 0 N-CA-C 111.53 0.196 . . . . 72.0 111.53 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 82.7 t -62.0 -35.19 67.03 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.379 0 N-CA-C 109.468 -0.567 . . . . 75.42 109.468 175.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -80.44 -46.97 15.07 Favored 'General case' 0 CA--C 1.527 0.062 0 CA-C-N 119.738 1.154 . . . . 75.44 109.908 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.405 ' OE1' ' HE3' ' A' ' 100' ' ' LYS . 13.4 mm-40 -50.99 -38.13 49.15 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.715 1.606 . . . . 73.31 110.251 178.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -75.56 -14.71 60.41 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.75 1.22 . . . . 64.33 113.826 -174.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 51.9 mt -121.01 -24.45 2.79 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 C-N-CA 125.123 1.369 . . . . 75.22 109.307 -169.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -100.16 -68.3 0.82 Allowed 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 124.977 1.311 . . . . 75.42 108.419 176.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.405 ' HE3' ' OE1' ' A' ' 96' ' ' GLU . 0.1 OUTLIER -65.96 -32.9 74.66 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 119.601 1.091 . . . . 74.41 110.985 -177.456 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -112.98 -21.11 11.28 Favored 'General case' 0 CA--C 1.528 0.101 0 N-CA-C 113.53 0.937 . . . . 75.41 113.53 -170.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 3.2 t60 45.08 62.98 1.9 Allowed 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 125.726 1.611 . . . . 63.53 114.644 175.06 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 19.3 mmtp -77.78 158.95 29.33 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.634 1.174 . . . . 72.52 111.794 174.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 28.7 tttt -93.27 45.87 1.19 Allowed 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 125.089 1.356 . . . . 75.52 112.381 -172.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 53.6 mt -69.0 51.76 0.08 Allowed 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 131.387 3.875 . . . . 73.21 111.475 -179.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -98.37 1.5 47.0 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 126.232 1.813 . . . . 71.4 111.924 -177.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -131.52 150.62 76.87 Favored Pre-proline 0 N--CA 1.467 0.388 0 C-N-CA 124.128 0.971 . . . . 65.41 109.936 -178.483 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_exo -59.62 -42.59 45.77 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 121.675 1.583 . . . . 74.25 110.782 -176.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 10.5 mp0 -61.35 -38.08 85.65 Favored 'General case' 0 N--CA 1.438 -1.065 0 C-N-CA 124.447 1.099 . . . . 74.14 110.623 -179.078 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -71.42 -47.05 58.37 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 125.591 1.557 . . . . 72.03 110.369 -176.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 58.2 mtt -58.56 -55.63 32.61 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 124.609 1.164 . . . . 72.44 109.154 174.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -64.28 -31.12 72.2 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.825 1.25 . . . . 74.42 111.559 -175.18 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -63.6 -46.68 84.7 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 119.478 1.036 . . . . 74.33 110.955 173.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 72.0 t80 -65.71 -44.32 86.45 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 121.866 0.841 . . . . 75.14 109.972 177.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 53.0 mt -69.27 -23.94 63.9 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 124.459 1.104 . . . . 75.45 111.481 -176.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.81 -13.92 18.4 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 122.902 0.481 . . . . 74.43 112.2 176.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -110.93 3.2 28.72 Favored Glycine 0 CA--C 1.526 0.755 0 C-N-CA 124.705 1.145 . . . . 63.23 114.046 170.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -135.42 51.31 2.08 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 119.383 1.592 . . . . 74.4 108.847 -171.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 92.56 13.85 56.35 Favored Glycine 0 CA--C 1.526 0.756 0 O-C-N 124.149 0.905 . . . . 63.41 114.395 162.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 99.1 t -129.99 165.06 31.07 Favored 'Isoleucine or valine' 0 C--O 1.231 0.116 0 CA-C-N 118.317 1.058 . . . . 74.12 109.35 -167.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 45.2 t0 -129.27 130.86 46.74 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 107.36 -1.348 . . . . 74.34 107.36 174.202 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 3.3 mttp -57.23 -36.98 71.59 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 119.075 0.852 . . . . 71.03 110.571 174.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -61.05 -24.16 65.99 Favored 'General case' 0 C--O 1.231 0.098 0 C-N-CA 124.173 0.989 . . . . 74.11 112.209 176.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 88.2 mttt -102.31 -49.37 3.91 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 119.97 1.259 . . . . 71.32 108.465 -177.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 68.4 t80 -48.92 -61.96 1.78 Allowed 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 126.331 1.852 . . . . 72.12 111.953 -178.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 15.9 mt -66.66 -31.63 72.42 Favored 'General case' 0 CA--C 1.534 0.352 0 O-C-N 121.486 -0.759 . . . . 75.2 110.475 -172.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 34.3 t -61.57 -50.4 72.79 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 124.299 1.04 . . . . 54.23 109.128 179.017 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . 0.272 0.0 OUTLIER -70.15 -34.76 73.43 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 119.164 0.893 . . . . 74.02 110.332 178.264 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 49.2 t80 -54.96 -55.29 32.36 Favored 'General case' 0 CA--C 1.529 0.17 0 O-C-N 121.592 -0.693 . . . . 74.42 110.422 179.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 -94.16 49.66 1.33 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.4 0.68 . . . . 75.24 109.294 176.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -123.2 164.15 19.26 Favored 'General case' 0 C--O 1.241 0.626 0 C-N-CA 125.626 1.57 . . . . 61.44 109.322 170.678 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.17 -30.96 70.72 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-O 119.293 -0.384 . . . . 74.05 110.464 178.446 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -45.3 -66.92 0.33 Allowed 'General case' 0 C--O 1.234 0.264 0 C-N-CA 124.97 1.308 . . . . 71.35 110.959 176.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 8.0 mm -64.54 -32.82 59.39 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 CA-C-O 118.56 -0.733 . . . . 75.03 111.21 -178.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 10.5 mttp -57.87 -35.35 70.84 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 119.1 0.863 . . . . 72.43 110.617 174.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -82.65 -31.78 29.09 Favored Glycine 0 C--N 1.339 0.695 0 CA-C-O 122.583 1.101 . . . . 72.44 110.696 -175.112 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 2.8 mm100 -74.51 -39.86 62.14 Favored 'General case' 0 N--CA 1.45 -0.46 0 O-C-N 121.539 -0.977 . . . . 75.54 109.835 -176.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 9.3 mtp -60.63 -51.26 70.15 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 119.069 -0.491 . . . . 75.21 110.379 174.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -63.64 -29.16 70.44 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 118.86 0.754 . . . . 73.41 112.435 -174.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 14.7 mtmt -61.47 -75.15 0.07 Allowed 'General case' 0 CA--C 1.522 -0.102 0 N-CA-C 107.86 -1.163 . . . . 74.11 107.86 165.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -49.12 -35.07 15.44 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.228 1.011 . . . . 74.43 112.619 -169.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 9.9 tmtt? -58.02 -46.94 84.48 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 126.301 1.84 . . . . 74.33 112.366 177.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 9.5 ptpp? -77.79 -33.44 52.59 Favored 'General case' 0 C--N 1.34 0.176 0 CA-C-N 120.824 1.647 . . . . 64.02 111.199 173.573 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 41.5 mt -59.35 -46.21 89.27 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 119.032 0.833 . . . . 71.24 109.973 -174.151 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -58.67 -37.03 75.12 Favored 'General case' 0 CA--C 1.534 0.349 0 O-C-N 121.814 -0.554 . . . . 60.53 111.592 -178.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 1.1 mtm -76.8 -31.85 57.25 Favored 'General case' 0 C--O 1.23 0.044 0 O-C-N 122.138 -0.352 . . . . 75.22 110.857 179.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -56.46 -46.24 80.47 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 108.82 -0.808 . . . . 75.45 108.82 172.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 35.8 m-85 -76.74 10.16 2.38 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 114.175 1.176 . . . . 75.24 114.175 177.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 59.1 23.47 11.69 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 127.562 2.345 . . . . 74.0 113.98 176.004 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 66.4 t -67.05 133.97 30.76 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 C-N-CA 124.031 0.932 . . . . 74.42 108.653 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -130.49 -5.65 4.21 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 125.244 1.418 . . . . 75.32 113.132 -177.641 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 170.98 139.51 2.78 Favored Glycine 0 N--CA 1.448 -0.541 0 N-CA-C 107.666 -2.173 . . . . 64.24 107.666 174.174 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.422 ' HA ' ' C ' ' A' ' 154' ' ' PRO . 17.2 m -83.37 152.72 64.84 Favored Pre-proline 0 CA--C 1.534 0.364 0 C-N-CA 124.559 1.144 . . . . 73.45 109.647 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . 0.422 ' C ' ' HA ' ' A' ' 153' ' ' VAL . 53.7 Cg_endo -70.74 157.71 94.59 Favored 'Cis proline' 0 CA--C 1.531 0.359 0 C-N-CA 125.15 -0.771 . . . . 75.35 113.623 3.405 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 36.5 m -157.13 115.17 3.19 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 107.461 -1.311 . . . . 72.3 107.461 175.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 93.7 mtp -96.3 158.24 15.53 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 108.705 -0.85 . . . . 75.53 108.705 164.01 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 5.2 t -136.48 138.47 46.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 106.586 -1.635 . . . . 75.24 106.586 174.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 51.2 t -103.18 125.22 57.66 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 N-CA-C 106.734 -1.58 . . . . 74.41 106.734 164.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 9.4 t30 52.98 21.54 2.08 Favored 'General case' 0 N--CA 1.462 0.153 0 C-N-CA 130.89 3.676 . . . . 72.15 115.521 162.112 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 73.34 22.62 78.57 Favored Glycine 0 CA--C 1.526 0.72 0 CA-C-O 117.69 -1.617 . . . . 64.42 114.068 -176.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 10.4 mtpt -134.18 -24.4 1.64 Allowed 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 120.248 2.024 . . . . 73.24 113.122 -174.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -128.2 120.2 26.78 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 124.179 0.991 . . . . 74.22 109.033 -173.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 41.5 ttp85 -102.56 126.83 49.76 Favored 'General case' 0 CA--C 1.52 -0.178 0 C-N-CA 126.117 1.767 . . . . 75.31 107.886 174.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 13.4 p90 -145.28 174.0 11.48 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 107.277 -1.379 . . . . 75.32 107.277 177.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 174.89 -175.25 0.08 Allowed 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 125.437 1.495 . . . . 64.41 108.595 176.423 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 6.5 mt -45.58 -52.27 2.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 C-N-CA 129.901 3.281 . . . . 75.43 108.574 172.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -75.61 19.28 2.6 Favored Glycine 0 CA--C 1.524 0.641 0 C-N-CA 128.062 2.744 . . . . 74.12 114.911 176.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 19.2 m -129.27 -50.1 1.19 Allowed 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 119.315 1.557 . . . . 62.1 110.847 157.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -71.16 -19.56 62.4 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.691 0.797 . . . . 74.43 111.944 -174.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 103.44 4.14 46.83 Favored Glycine 0 CA--C 1.525 0.66 0 O-C-N 120.624 -1.298 . . . . 62.35 113.296 175.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 154.03 177.06 27.07 Favored Glycine 0 CA--C 1.53 0.981 0 CA-C-N 119.239 1.52 . . . . 72.23 111.268 172.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -65.07 -37.51 32.55 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 122.851 2.367 . . . . 73.53 113.38 -169.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -69.37 -42.32 75.37 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 119.454 1.025 . . . . 74.51 108.413 -178.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 51.2 mm-40 -66.03 -26.89 67.73 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.685 1.194 . . . . 64.43 110.235 179.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 46.0 m -64.36 -41.34 96.77 Favored 'General case' 0 CA--C 1.534 0.354 0 O-C-N 120.075 -1.641 . . . . 65.34 110.638 -178.276 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 36.9 mt -65.88 -32.04 73.32 Favored 'General case' 0 C--N 1.341 0.203 0 CA-C-N 119.061 0.846 . . . . 75.43 110.532 175.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.03 -39.8 69.53 Favored 'General case' 0 CA--C 1.522 -0.127 0 C-N-CA 124.903 1.281 . . . . 73.4 109.535 174.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -78.21 -41.48 34.33 Favored 'General case' 0 CA--C 1.505 -0.763 0 CA-C-O 117.638 -1.172 . . . . 74.01 111.076 173.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -55.63 -45.97 77.49 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 119.52 1.055 . . . . 72.53 109.889 -172.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.93 -37.6 55.01 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 125.204 1.401 . . . . 55.53 109.519 -167.643 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 12.9 t80 -67.78 -47.8 68.13 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.512 1.125 . . . . 65.33 111.253 173.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 78.8 mt -63.33 -35.88 81.85 Favored 'General case' 0 C--O 1.232 0.169 0 C-N-CA 123.889 0.876 . . . . 73.52 110.83 -176.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 34.7 mt -53.31 -54.61 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 CA-C-O 118.338 -0.839 . . . . 73.32 109.181 170.275 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -55.92 -41.78 75.08 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 119.554 1.07 . . . . 73.15 111.553 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.86 -55.72 27.34 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 125.157 1.383 . . . . 74.45 108.267 -179.363 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 26.4 mm-40 -71.38 -32.74 68.82 Favored 'General case' 0 C--O 1.225 -0.186 0 C-N-CA 124.514 1.125 . . . . 73.34 113.094 -178.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.91 -24.52 62.46 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 120.762 -1.211 . . . . 71.54 111.719 -178.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 0.259 0 C-N-CA 123.302 0.641 . . . . 73.11 111.928 171.725 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 . . . . . 0 N--CA 1.445 -0.691 0 N-CA-C 103.341 -2.837 . . . . 65.51 103.341 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -143.03 6.87 1.58 Allowed 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.527 0.679 . . . . 61.43 111.723 -166.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 -132.87 178.96 6.47 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.561 1.144 . . . . 71.34 109.619 -168.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.0 m -148.05 141.93 25.78 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.588 1.555 . . . . 72.13 109.467 175.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.98 137.28 56.4 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 124.338 1.055 . . . . 72.43 110.043 178.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.7 -17.4 15.54 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 125.959 1.742 . . . . 74.53 112.76 -171.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 4.4 ttmt -92.86 -86.47 0.25 Allowed 'General case' 0 CA--C 1.519 -0.218 0 CA-C-N 119.028 1.414 . . . . 72.13 107.783 -176.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -77.53 -21.34 52.77 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.627 0.771 . . . . 63.21 110.364 -175.354 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 14.0 p90 -161.51 175.95 11.59 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.784 1.234 . . . . 71.13 109.296 -175.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 41.3 t -135.05 154.41 36.21 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.811 0 C-N-CA 126.377 1.871 . . . . 74.12 108.321 -175.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -103.88 170.59 7.84 Favored 'General case' 0 CA--C 1.521 -0.164 0 O-C-N 119.649 -1.907 . . . . 61.22 109.63 166.209 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -128.56 113.22 15.18 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 106.956 -1.498 . . . . 73.33 106.956 169.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.4 m -58.43 -15.06 9.27 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 117.129 -1.415 . . . . 74.22 113.744 176.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.6 m -107.96 75.91 0.56 Allowed Pre-proline 0 C--N 1.343 0.307 0 CA-C-N 120.526 1.512 . . . . 74.54 110.179 169.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -71.54 174.46 10.92 Favored 'Trans proline' 0 N--CA 1.444 -1.386 0 C-N-CA 123.19 2.594 . . . . 71.32 110.241 178.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 64.7 t -139.26 125.76 12.51 Favored Pre-proline 0 C--N 1.323 -0.583 0 N-CA-C 107.042 -1.466 . . . . 70.12 107.042 -165.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -73.78 174.84 11.62 Favored 'Trans proline' 0 N--CA 1.453 -0.892 0 C-N-CA 122.646 2.231 . . . . 75.54 110.897 178.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 34.0 m -139.39 -174.03 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 C-N-CA 124.645 1.178 . . . . 74.44 109.404 178.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 15.2 t -48.19 -68.89 0.14 Allowed 'General case' 0 N--CA 1.442 -0.852 0 C-N-CA 128.17 2.588 . . . . 73.35 110.458 172.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -152.94 163.47 23.4 Favored Pre-proline 0 CA--C 1.534 0.354 0 C-N-CA 124.399 1.08 . . . . 52.44 110.297 174.36 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -78.79 -7.1 15.51 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 124.058 3.172 . . . . 74.41 113.095 177.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -58.15 -37.29 85.85 Favored Glycine 0 C--N 1.338 0.667 0 C-N-CA 125.537 1.541 . . . . 71.11 113.605 -170.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 28.2 mttp -119.32 124.58 46.99 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 126.388 1.875 . . . . 74.01 106.087 165.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 44.7 mm -54.98 136.26 17.23 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 N-CA-C 106.931 -1.507 . . . . 70.13 106.931 168.2 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -104.4 93.12 4.63 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 106.425 -1.695 . . . . 75.24 106.425 -176.112 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 26.6 t -88.31 135.86 24.62 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 N-CA-C 106.624 -1.621 . . . . 74.51 106.624 174.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 33.6 t -129.31 135.84 60.83 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 N-CA-C 107.243 -1.392 . . . . 63.24 107.243 -176.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 15.9 tm-20 -114.0 140.57 48.32 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 125.133 1.373 . . . . 74.45 107.699 167.063 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.4 mp -130.76 114.72 15.7 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 124.615 1.166 . . . . 75.33 108.466 -179.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 18.9 p90 -107.36 174.85 5.7 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 124.603 1.161 . . . . 74.3 111.931 -176.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 22.6 t90 -145.34 162.01 38.27 Favored 'General case' 0 C--O 1.225 -0.219 0 C-N-CA 125.068 1.347 . . . . 74.54 107.999 162.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 59.8 t80 -56.7 -42.43 79.1 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 126.062 1.745 . . . . 75.52 112.121 172.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -95.39 29.73 9.2 Favored Glycine 0 CA--C 1.531 1.089 0 O-C-N 120.938 -1.101 . . . . 61.34 113.665 -168.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 23.3 t -106.03 81.87 0.82 Allowed Pre-proline 0 CA--C 1.537 0.472 0 C-N-CA 130.474 3.51 . . . . 75.13 111.528 -173.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -79.14 62.02 8.35 Favored 'Trans proline' 0 CA--C 1.544 1.023 0 C-N-CA 121.694 1.596 . . . . 74.24 111.482 -177.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 -160.35 -49.99 0.05 OUTLIER 'General case' 0 C--O 1.226 -0.182 0 C-N-CA 126.123 1.769 . . . . 74.42 109.095 -178.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 1.1 p -61.52 -37.36 83.45 Favored 'General case' 0 CA--C 1.548 0.872 0 CA-C-O 121.769 0.795 . . . . 74.13 110.339 -173.036 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -61.76 -29.15 69.94 Favored 'General case' 0 N--CA 1.468 0.465 0 O-C-N 120.084 -1.635 . . . . 73.22 112.87 176.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -78.01 3.61 14.34 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.903 1.281 . . . . 74.5 111.107 177.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 24.4 t80 -125.49 -27.78 3.39 Favored 'General case' 0 C--O 1.223 -0.308 0 C-N-CA 126.781 2.033 . . . . 74.2 111.0 178.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -39.51 -65.76 0.39 Allowed Pre-proline 0 CA--C 1.544 0.712 0 CA-C-N 120.286 1.403 . . . . 74.44 114.638 -177.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -75.89 -9.05 19.43 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 CA-C-N 122.17 1.811 . . . . 73.24 114.185 -178.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 4.2 m -68.44 -42.68 78.51 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 108.45 -0.944 . . . . 73.13 108.45 164.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 19.9 tt -88.21 -34.55 7.23 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 N-CA-C 112.762 0.652 . . . . 73.03 112.762 -172.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 16.2 t -44.73 -54.72 12.14 Favored Pre-proline 0 CA--C 1.549 0.936 0 C-N-CA 124.409 1.084 . . . . 73.55 113.464 176.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -74.07 -21.35 18.23 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 121.905 1.737 . . . . 72.43 112.356 -178.136 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 86.3 t90 -66.15 -51.61 56.21 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 118.679 0.672 . . . . 72.12 109.75 170.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 5.1 p -67.05 -24.14 65.96 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 119.075 0.852 . . . . 74.35 112.277 -175.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 73.6 mt-10 -59.9 -54.7 43.08 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 120.793 -1.192 . . . . 74.11 110.302 168.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 54.5 mmtt -76.68 6.73 5.49 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 125.316 1.446 . . . . 75.2 113.555 -168.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 36.6 mt -62.28 157.15 56.29 Favored Pre-proline 0 N--CA 1.448 -0.574 0 C-N-CA 122.986 0.514 . . . . 73.31 111.268 178.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -77.72 174.88 11.93 Favored 'Trans proline' 0 N--CA 1.449 -1.117 0 C-N-CA 124.809 3.673 . . . . 73.53 110.296 173.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -71.26 -5.74 34.47 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.636 0.774 . . . . 73.12 112.888 177.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -95.66 7.88 45.03 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 123.856 0.862 . . . . 74.45 109.847 -176.205 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 22.6 t -138.76 152.75 24.8 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 N-CA-C 107.628 -1.249 . . . . 73.51 107.628 -176.046 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 41.3 t60 -137.47 162.1 34.59 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 107.332 -1.359 . . . . 61.11 107.332 165.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 35.1 t80 -125.99 137.74 53.69 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 124.237 1.015 . . . . 74.45 108.493 -173.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 52.8 t -132.44 147.84 31.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 107.421 -1.325 . . . . 63.13 107.421 -175.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 44.0 mtm180 -124.21 136.0 53.85 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 107.236 -1.394 . . . . 71.52 107.236 163.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 92.8 mt -129.7 144.91 54.84 Favored Pre-proline 0 C--N 1.328 -0.361 0 O-C-N 123.654 0.596 . . . . 62.33 109.96 172.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -73.9 143.83 33.65 Favored 'Trans proline' 0 N--CA 1.451 -0.984 0 C-N-CA 120.756 0.971 . . . . 75.13 109.835 175.269 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -89.28 106.31 18.36 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 126.297 1.839 . . . . 72.14 107.841 174.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 57.8 mt -102.83 60.09 0.79 Allowed 'General case' 0 C--O 1.237 0.417 0 C-N-CA 125.343 1.457 . . . . 73.34 111.491 -168.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 -88.15 -6.54 57.82 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 114.569 1.322 . . . . 71.11 114.569 -164.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 106.58 -173.22 19.26 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 108.548 -1.821 . . . . 43.32 108.548 -175.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 44.39 64.79 1.91 Allowed Glycine 0 CA--C 1.528 0.904 0 CA-C-O 117.929 -1.484 . . . . 64.33 112.444 173.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . 0.276 2.8 tt 64.96 -15.97 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 131.153 3.781 . . . . 74.53 116.192 -176.486 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 10.4 m95 -57.01 -36.83 70.86 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 121.185 1.811 . . . . 73.15 112.311 -174.256 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -73.02 -40.25 65.31 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-O 118.693 -0.67 . . . . 63.2 112.4 -178.078 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 92.3 t -57.92 -51.67 67.71 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 C-N-CA 123.605 0.762 . . . . 74.53 109.474 -175.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 65.4 m170 -69.23 -0.69 6.45 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.541 1.136 . . . . 73.53 113.259 178.049 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -101.19 -47.85 1.52 Allowed Glycine 0 CA--C 1.526 0.761 0 N-CA-C 109.852 -1.299 . . . . 73.32 109.852 174.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -53.28 -34.02 55.56 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 127.383 2.273 . . . . 75.24 114.684 -164.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -57.98 -42.91 86.08 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-O 117.742 -1.123 . . . . 74.14 112.443 178.469 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -55.4 -54.1 47.9 Favored 'General case' 0 CA--C 1.526 0.042 0 N-CA-C 108.639 -0.875 . . . . 75.24 108.639 -175.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 15.7 mt -55.74 -37.56 68.64 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.664 1.186 . . . . 74.53 110.982 177.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.3 m -73.39 -39.76 64.86 Favored 'General case' 0 C--N 1.343 0.324 0 CA-C-N 119.498 1.044 . . . . 72.23 110.588 -177.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 1.2 tt -56.3 -51.1 69.46 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 125.219 1.407 . . . . 64.52 108.054 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -62.19 -29.66 70.53 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.694 1.198 . . . . 73.02 110.757 177.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 10.4 t -65.17 -30.66 71.59 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.873 0.869 . . . . 75.12 111.351 -171.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 16.6 mtm . . . . . 0 N--CA 1.468 0.443 0 CA-C-N 119.682 1.128 . . . . 70.31 112.861 173.344 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.321 0 N-CA-C 113.722 1.008 . . . . 74.23 113.722 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 74.9 t -60.81 -69.37 0.18 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.322 0 C-N-CA 124.897 1.279 . . . . 74.01 108.587 170.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -60.4 -47.7 84.94 Favored 'General case' 0 CA--C 1.521 -0.165 0 C-N-CA 123.666 0.786 . . . . 74.45 109.814 -175.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -59.61 -26.93 65.86 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 124.198 0.999 . . . . 71.43 111.038 -176.287 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -88.56 -8.96 53.87 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 112.928 0.714 . . . . 55.44 112.928 -179.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 14.7 mm -73.27 -60.65 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 N-CA-C 106.053 -1.832 . . . . 74.41 106.053 154.256 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 35.0 p80 -88.27 -70.41 0.64 Allowed 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 114.325 1.231 . . . . 74.12 114.325 -152.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 25.5 mttp -58.76 -31.3 68.23 Favored 'General case' 0 N--CA 1.463 0.19 0 C-N-CA 123.954 0.901 . . . . 73.21 110.74 177.008 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -69.58 -38.47 77.39 Favored 'General case' 0 N--CA 1.452 -0.34 0 O-C-N 121.814 -0.554 . . . . 64.31 110.602 176.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 3.4 t-160 48.77 92.45 0.02 OUTLIER 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 129.578 3.151 . . . . 74.21 110.891 -164.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.526 ' HE3' ' CE1' ' A' ' 114' ' ' PHE . 0.2 OUTLIER -132.85 147.28 52.3 Favored 'General case' 0 CA--C 1.515 -0.392 0 C-N-CA 123.374 0.67 . . . . 73.33 110.667 170.722 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 3.9 ttmt -79.48 95.47 5.82 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 106.249 -1.76 . . . . 75.53 106.249 -175.189 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 90.0 mt -121.07 46.18 2.1 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 126.379 1.872 . . . . 73.53 110.645 -177.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -80.05 8.08 7.83 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 115.025 1.491 . . . . 72.32 115.025 -174.617 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -153.13 153.86 30.13 Favored Pre-proline 0 C--N 1.326 -0.421 0 C-N-CA 124.737 1.215 . . . . 74.2 109.056 -163.201 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_endo -65.29 -42.84 12.27 Favored 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 122.421 2.081 . . . . 75.54 110.759 -170.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.424 ' HG2' ' H ' ' A' ' 109' ' ' GLU . 9.4 pt-20 -64.61 -36.79 85.4 Favored 'General case' 0 N--CA 1.444 -0.738 0 C-N-CA 124.209 1.004 . . . . 72.32 111.449 -177.674 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -65.74 -52.9 47.45 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 125.8 1.64 . . . . 74.44 110.192 175.065 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 49.6 mtm -59.3 -43.51 92.6 Favored 'General case' 0 CA--C 1.529 0.164 0 O-C-N 121.804 -0.56 . . . . 74.45 110.616 178.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -61.46 -52.24 65.36 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 124.195 0.998 . . . . 64.32 109.676 177.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -50.81 -46.48 59.86 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 125.371 1.469 . . . . 73.1 110.696 -179.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . 0.526 ' CE1' ' HE3' ' A' ' 103' ' ' LYS . 57.5 t80 -61.15 -41.75 97.32 Favored 'General case' 0 N--CA 1.449 -0.497 0 O-C-N 121.768 -0.582 . . . . 74.44 112.217 -178.001 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 36.7 mt -83.28 -16.53 45.94 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 123.782 0.833 . . . . 75.43 111.144 -174.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -72.53 66.61 0.71 Allowed 'General case' 0 C--O 1.234 0.267 0 C-N-CA 127.539 2.336 . . . . 64.23 110.891 -171.049 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -178.4 -37.81 0.06 OUTLIER Glycine 0 N--CA 1.442 -0.95 0 C-N-CA 127.557 2.503 . . . . 61.33 109.941 -177.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 1.7 ptpt -86.32 3.12 44.76 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 119.428 1.614 . . . . 74.0 114.111 -163.186 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 118.36 -2.77 16.1 Favored Glycine 0 N--CA 1.449 -0.499 0 CA-C-O 118.694 -1.059 . . . . 61.25 111.135 -167.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 42.5 t -96.7 149.48 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.948 0 N-CA-C 103.642 -2.725 . . . . 74.24 103.642 169.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -124.34 143.35 50.63 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 106.942 -1.503 . . . . 64.33 106.942 169.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 24.4 mtpt -55.8 -48.86 74.64 Favored 'General case' 0 CA--C 1.516 -0.327 0 CA-C-O 118.56 -0.733 . . . . 74.15 109.285 178.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -55.01 -35.91 64.9 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 118.71 0.687 . . . . 70.33 111.779 -177.108 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 27.8 mmmt -94.99 -29.54 14.58 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 123.537 0.735 . . . . 74.1 109.392 -165.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 82.1 t80 -66.55 -64.57 0.83 Allowed 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 127.2 2.2 . . . . 73.32 109.413 169.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 12.8 mt -58.27 -43.75 88.08 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.236 1.014 . . . . 73.55 109.939 -170.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 22.7 t -52.68 -26.49 14.03 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 126.294 1.838 . . . . 73.44 113.176 -179.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . 0.278 1.4 t -116.73 -23.55 8.09 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 119.363 0.983 . . . . 70.33 110.712 -176.262 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 27.9 t80 -53.59 -52.57 59.35 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.721 1.208 . . . . 73.11 108.84 166.2 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 18.0 m-80 -91.98 38.85 1.0 Allowed 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 124.551 1.141 . . . . 74.51 110.574 -177.016 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 3.2 t -140.06 169.95 16.75 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 114.627 1.343 . . . . 73.12 114.627 178.187 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -52.98 -30.6 35.93 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 126.802 2.041 . . . . 74.3 111.133 -179.458 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -52.33 -63.73 1.05 Allowed 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 125.351 1.461 . . . . 74.33 110.824 173.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 11.5 mm -63.55 -27.37 42.83 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.141 0 O-C-N 121.452 -0.78 . . . . 75.41 112.298 176.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.09 -40.44 73.64 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 119.604 1.093 . . . . 74.13 109.708 173.275 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -64.84 -26.63 71.31 Favored Glycine 0 CA--C 1.532 1.114 0 C-N-CA 124.569 1.08 . . . . 70.03 112.744 177.295 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 6.9 mt-30 -85.42 -45.31 11.98 Favored 'General case' 0 C--O 1.235 0.291 0 O-C-N 120.943 -1.328 . . . . 64.43 110.287 179.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 82.4 mmm -61.84 -31.45 71.7 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 123.645 0.778 . . . . 74.21 110.764 179.275 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -64.73 -51.84 60.25 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 119.502 1.046 . . . . 71.51 111.321 175.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 5.8 mttm -62.82 -57.57 10.42 Favored 'General case' 0 CA--C 1.512 -0.497 0 C-N-CA 123.761 0.824 . . . . 74.43 109.29 -175.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -52.95 -40.52 63.73 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 119.494 -0.289 . . . . 72.45 110.883 -176.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.68 -62.14 2.02 Favored 'General case' 0 C--N 1.343 0.292 0 CA-C-N 118.7 0.682 . . . . 74.35 110.007 174.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 8.0 ptmt -68.52 -16.55 63.92 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 113.019 0.748 . . . . 75.32 113.019 -169.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 65.9 mt -69.47 -59.65 2.84 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 123.687 0.795 . . . . 74.15 110.104 168.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -54.51 -43.72 72.1 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 118.736 0.698 . . . . 73.04 112.531 -173.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 2.1 ptm -63.21 -44.4 95.43 Favored 'General case' 0 N--CA 1.468 0.458 0 O-C-N 121.677 -0.639 . . . . 75.4 112.377 175.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -64.11 -40.82 97.03 Favored 'General case' 0 CA--C 1.536 0.433 0 O-C-N 121.893 -0.505 . . . . 75.43 109.739 -178.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 21.5 m-85 -70.42 9.0 0.68 Allowed 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 126.944 2.098 . . . . 74.35 113.426 173.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 58.3 mt-30 53.76 35.54 21.65 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 126.612 1.965 . . . . 75.12 114.046 178.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 43.4 t -77.68 89.21 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 O-C-N 120.698 -1.251 . . . . 72.2 108.602 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -82.34 -12.13 58.16 Favored 'General case' 0 N--CA 1.469 0.496 0 O-C-N 120.586 -1.321 . . . . 64.1 113.458 177.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -171.18 -171.64 36.59 Favored Glycine 0 CA--C 1.524 0.639 0 C-N-CA 125.216 1.389 . . . . 73.53 109.65 -173.066 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.429 ' HA ' ' C ' ' A' ' 154' ' ' PRO . 29.0 m -137.92 158.38 71.48 Favored Pre-proline 0 CA--C 1.544 0.72 0 C-N-CA 124.756 1.222 . . . . 64.04 109.155 178.667 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . 0.429 ' C ' ' HA ' ' A' ' 153' ' ' VAL . 31.4 Cg_endo -62.49 152.17 65.46 Favored 'Cis proline' 0 N--CA 1.452 -0.969 0 C-N-CA 123.569 -1.429 . . . . 74.0 112.788 -10.221 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 77.6 m -141.07 127.08 19.39 Favored 'General case' 0 N--CA 1.443 -0.805 0 C-N-CA 126.457 1.903 . . . . 74.44 107.013 170.041 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 33.1 mmm -107.08 160.27 15.68 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 124.908 1.283 . . . . 71.43 107.57 159.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 6.3 t -142.02 148.29 20.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 106.955 -1.498 . . . . 74.41 106.955 177.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 58.8 t -121.36 126.0 74.39 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 N-CA-C 106.314 -1.735 . . . . 73.34 106.314 168.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 55.25 17.82 2.21 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 127.339 2.256 . . . . 65.12 115.006 171.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 58.41 31.37 66.32 Favored Glycine 0 CA--C 1.53 0.969 0 CA-C-O 117.926 -1.485 . . . . 72.35 112.791 -168.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 1.2 mtpm? -126.38 -42.88 1.8 Allowed 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 119.656 1.728 . . . . 73.34 111.779 -177.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -111.65 147.34 35.73 Favored 'General case' 0 CA--C 1.511 -0.551 0 N-CA-C 106.941 -1.503 . . . . 74.2 106.941 179.11 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 41.4 ttp85 -125.01 135.87 53.18 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 105.601 -2.0 . . . . 73.1 105.601 175.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 7.4 p90 -153.54 171.41 18.78 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 107.295 -1.372 . . . . 72.22 107.295 -178.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 174.97 176.33 0.17 Allowed 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 123.726 0.81 . . . . 73.41 108.915 -178.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 38.7 mt -57.14 -35.2 47.41 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 C-N-CA 128.266 2.626 . . . . 72.41 110.268 -173.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -86.62 -3.55 83.73 Favored Glycine 0 CA--C 1.525 0.687 0 CA-C-O 117.617 -1.657 . . . . 64.31 113.278 -177.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 19.4 m -105.72 -54.59 2.46 Favored 'General case' 0 C--N 1.342 0.248 0 CA-C-N 119.04 1.42 . . . . 75.11 108.86 168.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -60.74 -29.14 69.2 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 125.234 1.414 . . . . 65.34 112.4 -179.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 98.43 8.59 54.65 Favored Glycine 0 CA--C 1.527 0.841 0 CA-C-O 119.115 -0.825 . . . . 73.05 113.712 175.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 163.68 171.42 29.9 Favored Glycine 0 CA--C 1.527 0.827 0 CA-C-N 119.543 1.671 . . . . 72.52 111.781 177.299 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -69.37 -44.34 2.41 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 122.097 1.864 . . . . 64.53 111.129 -175.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -68.6 -34.45 75.8 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 118.913 0.779 . . . . 73.53 109.473 179.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -62.8 -33.27 74.86 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 123.226 0.611 . . . . 75.02 109.828 176.181 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 37.1 m -65.41 -40.55 93.52 Favored 'General case' 0 CA--C 1.534 0.358 0 O-C-N 120.924 -1.11 . . . . 65.42 109.332 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 58.7 mt -64.55 -36.46 84.28 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 119.644 1.111 . . . . 75.23 110.647 175.009 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 27.0 tttt -50.93 -51.76 49.0 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.176 0.991 . . . . 63.41 108.904 172.344 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -67.67 -40.85 84.45 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-O 118.415 -0.803 . . . . 65.11 111.143 177.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -56.59 -41.59 77.24 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 119.05 0.841 . . . . 72.24 111.347 -174.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -85.93 -36.75 19.68 Favored 'General case' 0 CA--C 1.511 -0.532 0 N-CA-C 109.171 -0.677 . . . . 74.2 109.171 -168.271 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -59.3 -54.17 49.85 Favored 'General case' 0 N--CA 1.438 -1.059 0 N-CA-C 109.064 -0.717 . . . . 74.32 109.064 170.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 90.9 mt -61.93 -32.04 72.41 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-O 118.271 -0.871 . . . . 73.34 112.47 -175.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 26.6 mt -51.16 -65.97 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.212 0 CA-C-N 119.211 0.914 . . . . 75.12 109.352 166.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 9.8 tm-20 -69.76 -20.09 63.5 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.984 0.913 . . . . 75.11 112.101 -171.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.24 -52.95 60.09 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 124.962 1.305 . . . . 64.34 109.05 168.551 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 42.2 mm-40 -74.99 -39.7 61.1 Favored 'General case' 0 C--N 1.334 -0.104 0 C-N-CA 123.578 0.751 . . . . 72.44 111.891 -176.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.14 -36.03 74.53 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 124.023 0.929 . . . . 75.41 109.767 -177.69 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.381 0 C-N-CA 124.273 1.029 . . . . 61.34 112.417 177.981 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.234 0.288 0 N-CA-C 108.155 -1.054 . . . . 65.12 108.155 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -117.83 10.99 13.4 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 113.172 0.805 . . . . 71.31 113.172 -171.214 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -141.55 164.15 30.99 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 125.558 1.543 . . . . 75.52 107.705 -173.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 29.4 m -133.04 130.98 40.11 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.14 -0.689 . . . . 74.32 109.14 -176.046 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.36 124.18 21.57 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 108.061 -1.089 . . . . 63.13 108.061 176.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 101.1 -38.49 3.12 Favored Glycine 0 CA--C 1.527 0.832 0 C-N-CA 128.556 2.979 . . . . 71.12 111.393 -173.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 8.4 tptp -75.21 -67.3 0.67 Allowed 'General case' 0 C--O 1.226 -0.163 0 C-N-CA 126.364 1.866 . . . . 74.03 109.442 -175.15 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 5.3 mp0 -93.28 -28.65 16.09 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 126.229 1.812 . . . . 74.34 109.691 -173.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 55.2 p90 -152.54 167.26 29.41 Favored 'General case' 0 N--CA 1.469 0.523 0 O-C-N 121.012 -1.055 . . . . 74.41 110.73 -171.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 93.4 t -133.51 117.01 26.09 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-N 119.661 1.119 . . . . 74.33 109.716 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -71.71 166.75 21.3 Favored 'General case' 0 N--CA 1.447 -0.614 0 O-C-N 121.085 -1.009 . . . . 73.11 110.727 174.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -126.68 104.48 8.11 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 124.803 1.241 . . . . 73.42 108.207 173.055 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 44.2 p -67.52 -6.39 19.55 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 124.068 0.947 . . . . 70.01 112.425 176.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 70.0 m -104.86 80.51 0.49 Allowed Pre-proline 0 N--CA 1.451 -0.396 0 N-CA-C 107.006 -1.479 . . . . 74.01 107.006 160.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -70.95 -179.48 3.48 Favored 'Trans proline' 0 N--CA 1.452 -0.969 0 C-N-CA 123.224 2.616 . . . . 72.01 110.519 -177.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 11.8 t -140.21 136.18 16.76 Favored Pre-proline 0 CA--C 1.534 0.361 0 N-CA-C 108.365 -0.976 . . . . 72.42 108.365 178.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -76.53 174.68 12.43 Favored 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 122.603 2.202 . . . . 63.35 111.413 172.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.4 m -112.18 -174.91 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 125.906 1.682 . . . . 72.24 109.539 179.184 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 21.4 m -67.01 -51.84 49.99 Favored 'General case' 0 N--CA 1.45 -0.465 0 O-C-N 121.318 -0.864 . . . . 75.2 109.484 170.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -146.41 161.03 40.26 Favored Pre-proline 0 N--CA 1.446 -0.63 0 C-N-CA 124.176 0.99 . . . . 73.4 109.636 177.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -69.28 -164.58 0.12 Allowed 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 124.358 3.372 . . . . 74.12 111.726 170.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.74 -110.11 3.96 Favored Glycine 0 N--CA 1.448 -0.531 0 N-CA-C 107.457 -2.257 . . . . 64.41 107.457 179.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 8.3 mttp -63.53 135.33 56.78 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 109.639 -0.504 . . . . 73.14 109.639 -178.258 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 38.6 mm -62.3 144.08 14.63 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 N-CA-C 107.423 -1.325 . . . . 73.14 107.423 170.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -101.75 118.62 37.31 Favored 'General case' 0 N--CA 1.458 -0.038 0 N-CA-C 107.564 -1.272 . . . . 74.1 107.564 -177.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 48.8 t -108.77 134.82 49.51 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 N-CA-C 107.716 -1.216 . . . . 75.01 107.716 171.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 6.8 t -132.83 111.05 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 C-N-CA 123.842 0.857 . . . . 72.44 109.814 -174.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 -65.82 127.98 34.16 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 125.255 1.422 . . . . 72.02 108.916 162.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.6 mp -102.45 148.68 25.21 Favored 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 107.596 -1.261 . . . . 73.11 107.596 155.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 37.7 p90 -141.94 170.76 15.12 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 118.848 0.749 . . . . 71.0 111.554 173.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 28.1 t90 -156.41 158.43 37.31 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.889 1.276 . . . . 72.3 110.041 172.323 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 7.4 t80 -70.68 -15.52 62.72 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 113.444 0.905 . . . . 74.41 113.444 -177.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -104.84 12.58 49.83 Favored Glycine 0 CA--C 1.522 0.47 0 CA-C-O 117.554 -1.692 . . . . 74.15 113.067 -175.002 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 24.8 p -112.95 85.3 7.7 Favored Pre-proline 0 CA--C 1.538 0.486 0 CA-C-N 119.938 1.869 . . . . 72.1 108.53 -178.122 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_endo -59.38 -26.31 81.48 Favored 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 121.735 1.623 . . . . 72.15 113.187 -177.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 29.1 m170 -68.27 -23.16 64.74 Favored 'General case' 0 CA--C 1.535 0.379 0 O-C-N 121.346 -0.846 . . . . 71.04 110.89 178.063 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 73.4 m -60.04 -48.06 83.26 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.022 0.929 . . . . 74.53 108.499 171.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 27.1 t80 -63.38 -46.05 88.29 Favored 'General case' 0 N--CA 1.467 0.419 0 O-C-N 120.892 -1.13 . . . . 74.24 111.46 175.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -55.99 -34.9 66.19 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 118.416 0.553 . . . . 74.32 111.737 -176.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -71.23 -23.04 61.93 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 127.174 2.19 . . . . 74.23 113.697 178.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -48.75 -67.05 0.46 Allowed Pre-proline 0 CA--C 1.541 0.614 0 C-N-CA 124.222 1.009 . . . . 64.34 113.21 -165.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -70.93 -6.82 20.03 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 CA-C-N 122.081 1.779 . . . . 75.34 114.636 -177.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.4 m -69.38 -47.4 64.35 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 119.432 1.014 . . . . 74.53 108.318 164.316 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 16.7 tt -94.5 -32.64 4.69 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 C-N-CA 123.814 0.846 . . . . 73.14 112.733 -165.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 22.8 t -49.54 -61.85 3.09 Favored Pre-proline 0 CA--C 1.542 0.646 0 C-N-CA 124.849 1.26 . . . . 75.44 110.551 178.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -64.08 -34.37 58.41 Favored 'Trans proline' 0 N--CA 1.454 -0.795 0 CA-C-N 120.454 1.198 . . . . 75.42 112.329 179.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 72.7 t90 -59.73 -50.57 73.33 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 119.768 1.167 . . . . 73.43 110.679 177.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 42.0 t -59.57 -44.9 93.16 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 123.947 0.899 . . . . 74.2 108.97 -176.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 57.5 mt-10 -61.99 -35.61 79.02 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 121.162 -0.961 . . . . 72.53 110.737 178.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 70.4 mmtt -77.19 -2.96 37.15 Favored 'General case' 0 C--O 1.237 0.432 0 O-C-N 120.42 -1.425 . . . . 74.2 114.482 177.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 26.8 mt -54.57 147.21 30.81 Favored Pre-proline 0 C--O 1.237 0.414 0 CA-C-N 120.405 1.457 . . . . 74.43 111.588 -177.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -74.28 164.95 33.0 Favored 'Trans proline' 0 N--CA 1.445 -1.34 0 C-N-CA 124.035 3.157 . . . . 70.31 110.602 -176.062 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -66.23 -4.65 8.13 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 125.753 1.621 . . . . 50.31 115.025 -171.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 -118.52 22.71 11.93 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.646 1.579 . . . . 72.44 110.744 179.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 57.8 t -121.61 160.18 23.34 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 N-CA-C 107.531 -1.285 . . . . 73.44 107.531 167.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 75.3 t60 -137.27 152.7 50.09 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 125.766 1.626 . . . . 74.22 107.3 167.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 57.5 t80 -130.79 137.37 49.41 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 123.787 0.835 . . . . 73.45 108.849 -171.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 47.4 t -134.07 155.35 39.42 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 C-N-CA 126.426 1.89 . . . . 75.22 106.906 -173.056 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 4.0 mpt_? -127.07 134.89 50.19 Favored 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 104.364 -2.458 . . . . 74.54 104.364 166.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 68.0 mt -131.85 148.79 71.33 Favored Pre-proline 0 N--CA 1.465 0.293 0 CA-C-N 119.51 1.05 . . . . 74.54 108.629 170.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -69.11 141.78 48.9 Favored 'Trans proline' 0 N--CA 1.451 -1.016 0 C-N-CA 121.421 1.414 . . . . 71.21 110.409 171.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -91.46 67.32 5.6 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 124.535 1.134 . . . . 72.11 108.44 -176.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 54.9 mt -64.8 65.94 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 127.538 2.335 . . . . 74.24 112.724 -171.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -98.2 48.66 1.0 Allowed 'General case' 0 C--O 1.237 0.416 0 C-N-CA 125.229 1.412 . . . . 73.35 111.437 -170.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 67.48 167.83 3.62 Favored Glycine 0 CA--C 1.531 1.034 0 C-N-CA 124.218 0.913 . . . . 74.14 112.11 -177.27 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 50.94 -143.22 14.85 Favored Glycine 0 CA--C 1.526 0.736 0 O-C-N 122.091 -0.653 . . . . 44.2 113.121 176.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 4.9 tp -63.63 -11.77 9.58 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 C-N-CA 123.955 0.902 . . . . 73.31 111.547 -173.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 18.4 m95 -73.81 -33.45 64.18 Favored 'General case' 0 CA--C 1.531 0.243 0 O-C-N 120.661 -1.274 . . . . 72.24 110.909 175.2 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -64.78 -44.06 91.22 Favored 'General case' 0 C--O 1.236 0.382 0 O-C-N 121.33 -0.856 . . . . 65.34 109.834 168.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 91.5 t -62.78 -53.99 39.66 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 N-CA-C 109.169 -0.678 . . . . 75.33 109.169 -173.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 19.3 m170 -88.96 51.15 2.09 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.864 1.266 . . . . 74.55 109.455 173.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -140.71 -55.53 0.04 OUTLIER Glycine 0 N--CA 1.443 -0.891 0 C-N-CA 124.75 1.167 . . . . 71.01 110.224 167.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.94 -28.75 58.36 Favored 'General case' 0 CA--C 1.554 1.109 0 N-CA-C 114.617 1.34 . . . . 70.54 114.617 -166.223 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 34.8 ttp -58.22 -38.14 76.23 Favored 'General case' 0 N--CA 1.469 0.489 0 O-C-N 119.299 -2.126 . . . . 74.3 112.119 -176.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 27.9 t80 -56.12 -50.28 71.55 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 123.774 0.83 . . . . 71.41 109.5 -179.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 42.3 mt -66.1 -42.43 89.28 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-O 117.495 -1.241 . . . . 74.53 109.825 179.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.39 -42.36 86.93 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 120.317 1.417 . . . . 73.42 110.623 -178.192 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -54.94 -52.13 63.95 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 125.131 1.372 . . . . 74.35 108.813 -174.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -78.79 -25.37 44.29 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.415 0.686 . . . . 74.32 111.505 -177.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 12.6 t -62.49 -33.42 74.84 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 125.124 1.37 . . . . 74.11 111.387 176.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' MET . . . . . 0.415 ' SD ' ' HA ' ' A' ' 125' ' ' PHE . 30.6 mtp . . . . . 0 C--O 1.236 0.382 0 C-N-CA 125.718 1.607 . . . . 74.23 111.616 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 0.262 0 CA-C-O 117.748 -1.12 . . . . 75.45 112.869 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 57.9 t -45.06 -65.32 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 124.845 1.258 . . . . 74.41 110.987 166.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -57.87 -46.34 85.01 Favored 'General case' 0 C--O 1.226 -0.146 0 CA-C-N 118.583 0.629 . . . . 75.32 110.722 178.289 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -59.27 -37.54 77.89 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.499 0.72 . . . . 73.25 110.637 -174.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -68.51 -31.72 71.17 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 124.791 1.236 . . . . 60.52 113.016 178.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 55.9 mt -78.75 -57.25 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 N-CA-C 105.897 -1.89 . . . . 74.15 105.897 -179.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 85.2 m-70 -74.13 -72.26 0.29 Allowed 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 127.032 2.133 . . . . 73.44 112.031 -172.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 43.5 mttt -65.68 -30.68 71.4 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 119.396 0.998 . . . . 74.32 112.063 -173.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -93.58 -26.76 16.97 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 118.427 0.558 . . . . 72.24 110.788 -173.481 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 49.29 53.2 13.05 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 126.029 1.732 . . . . 74.44 113.766 175.671 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 2.5 mmpt? -85.23 22.33 1.5 Allowed 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.955 1.302 . . . . 73.53 114.401 -173.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 12.2 ttmt 70.29 -69.66 0.17 Allowed 'General case' 0 C--O 1.222 -0.342 0 C-N-CA 128.151 2.58 . . . . 74.25 109.873 -179.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 39.3 mt 63.08 28.93 16.25 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 127.176 2.19 . . . . 75.23 112.342 175.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -79.3 -10.08 59.73 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 115.142 1.534 . . . . 65.33 115.142 -175.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 24.8 p -137.13 159.43 69.86 Favored Pre-proline 0 C--O 1.236 0.39 0 O-C-N 120.932 -1.105 . . . . 74.53 109.08 -177.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -61.55 -34.84 84.34 Favored 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 122.04 1.827 . . . . 73.23 110.607 177.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -63.83 -40.28 96.23 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 123.404 0.681 . . . . 74.22 112.216 176.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -65.01 -48.37 74.19 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.696 0.798 . . . . 74.42 110.123 177.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 57.8 mtt -63.54 -50.46 69.47 Favored 'General case' 0 C--O 1.231 0.09 0 C-N-CA 123.893 0.877 . . . . 75.13 110.773 -179.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -71.46 -39.46 70.94 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-O 118.414 -0.803 . . . . 62.34 110.234 -170.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -61.62 -28.46 69.38 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 119.288 0.949 . . . . 64.43 112.293 176.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -75.25 -58.76 3.08 Favored 'General case' 0 N--CA 1.443 -0.806 0 O-C-N 121.827 -0.546 . . . . 73.12 110.176 175.047 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 53.8 mt -66.59 -22.48 66.13 Favored 'General case' 0 CA--C 1.532 0.261 0 O-C-N 121.748 -0.595 . . . . 72.11 110.756 -173.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -55.93 -17.53 6.78 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 125.215 1.406 . . . . 64.41 112.719 175.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -90.98 -5.83 67.65 Favored Glycine 0 CA--C 1.524 0.625 0 CA-C-O 118.079 -1.4 . . . . 71.44 114.51 174.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 17.2 mmtt -134.79 29.92 3.45 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 120.217 2.009 . . . . 72.45 111.749 -156.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 83.82 29.86 30.81 Favored Glycine 0 CA--C 1.52 0.405 0 N-CA-C 111.558 -0.617 . . . . 64.3 111.558 175.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 87.7 t -123.87 119.15 56.21 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 N-CA-C 107.126 -1.435 . . . . 74.14 107.126 175.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 66.3 t0 -70.25 124.37 23.96 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-O 121.185 0.517 . . . . 74.33 109.745 172.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 9.5 ttpt -60.15 -40.3 89.41 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 124.128 0.971 . . . . 73.05 110.206 176.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -68.07 -27.25 66.33 Favored 'General case' 0 C--O 1.236 0.347 0 O-C-N 121.489 -0.757 . . . . 71.35 111.325 -177.103 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 52.2 mttm -77.71 -48.13 17.44 Favored 'General case' 0 CA--C 1.509 -0.611 0 N-CA-C 107.217 -1.401 . . . . 72.11 107.217 177.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.415 ' HA ' ' SD ' ' A' ' 84' ' ' MET . 34.0 t80 -44.81 -64.87 0.61 Allowed 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 124.751 1.22 . . . . 74.33 110.592 177.26 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 22.3 mt -68.69 -40.57 79.98 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 119.22 -0.419 . . . . 71.23 110.552 -170.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 46.6 t -58.33 -56.73 18.28 Favored 'General case' 0 C--N 1.341 0.209 0 N-CA-C 108.059 -1.089 . . . . 75.25 108.059 -179.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 55.2 m -62.03 -43.3 99.13 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 123.808 0.843 . . . . 74.31 110.325 -176.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 45.5 t80 -51.46 -45.86 62.86 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 123.838 0.855 . . . . 74.35 110.591 177.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -98.05 35.06 1.8 Allowed 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.456 1.102 . . . . 70.31 111.155 178.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -120.03 155.84 32.1 Favored 'General case' 0 C--O 1.235 0.316 0 O-C-N 120.929 -1.107 . . . . 74.01 109.807 174.617 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -64.79 -22.3 66.96 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.654 0.782 . . . . 74.41 111.293 174.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -53.95 -29.11 41.27 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 125.173 1.389 . . . . 75.25 113.17 173.333 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 11.2 mm -77.23 -39.4 28.48 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.484 0 C-N-CA 123.829 0.852 . . . . 74.32 113.149 169.263 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 9.9 tttp -58.89 -34.61 71.86 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 118.309 -0.853 . . . . 74.44 110.002 -170.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -67.81 -23.4 74.12 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 123.915 0.769 . . . . 53.32 112.952 -178.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -91.28 -45.51 8.57 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 121.923 0.868 . . . . 72.02 108.974 178.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 5.2 ttm -62.17 -40.27 95.46 Favored 'General case' 0 N--CA 1.426 -1.647 0 C-N-CA 126.293 1.837 . . . . 75.52 110.142 -177.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 21.8 pt-20 -69.44 -37.51 77.42 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 120.042 1.292 . . . . 73.2 112.531 -177.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 10.2 mmtt -62.59 -59.4 4.98 Favored 'General case' 0 C--O 1.225 -0.23 0 N-CA-C 107.402 -1.333 . . . . 74.42 107.402 171.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -54.78 -43.3 72.68 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 119.56 1.073 . . . . 73.31 111.707 -175.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 11.6 tmtt? -49.77 -64.25 0.87 Allowed 'General case' 0 CA--C 1.518 -0.283 0 C-N-CA 125.167 1.387 . . . . 74.45 110.272 174.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.2 -29.82 64.34 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 120.031 -0.668 . . . . 72.22 110.972 -170.616 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 38.0 mt -61.5 -53.3 58.23 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 123.843 0.857 . . . . 74.44 110.383 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -57.67 -40.76 80.11 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 118.823 0.738 . . . . 64.11 110.814 -175.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -64.97 -48.11 75.18 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.769 0.828 . . . . 74.4 110.635 177.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -68.91 -28.97 67.15 Favored 'General case' 0 CA--C 1.533 0.297 0 O-C-N 121.791 -0.568 . . . . 54.02 111.27 -175.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -71.57 7.88 1.29 Allowed 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 125.057 1.343 . . . . 73.22 112.976 171.03 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 57.53 28.42 15.54 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 127.522 2.329 . . . . 74.15 113.335 177.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 15.5 t -77.31 141.55 15.43 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 O-C-N 120.865 -1.147 . . . . 75.33 108.057 -179.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -142.14 10.87 1.95 Allowed 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 121.618 0.723 . . . . 72.23 112.248 179.636 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -171.64 178.98 43.66 Favored Glycine 0 N--CA 1.442 -0.933 0 N-CA-C 108.301 -1.92 . . . . 62.22 108.301 172.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.463 ' HA ' ' C ' ' A' ' 154' ' ' PRO . 0.8 OUTLIER -145.51 147.2 32.51 Favored Pre-proline 0 C--N 1.32 -0.681 0 C-N-CA 126.66 1.984 . . . . 71.22 106.082 -175.155 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . 0.463 ' C ' ' HA ' ' A' ' 153' ' ' VAL . 37.6 Cg_endo -65.59 157.67 77.33 Favored 'Cis proline' 0 CA--C 1.531 0.351 0 N-CA-C 114.74 1.015 . . . . 74.33 114.74 3.217 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 18.1 m -158.92 141.05 13.82 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 124.758 1.223 . . . . 73.22 109.227 172.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 98.5 mtp -113.38 156.04 24.15 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 126.529 1.932 . . . . 73.43 107.947 165.192 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 40.6 t -135.42 144.19 34.72 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.36 0 N-CA-C 106.898 -1.519 . . . . 72.43 106.898 172.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 6.0 t -113.81 124.1 70.12 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 N-CA-C 105.828 -1.916 . . . . 74.31 105.828 172.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 48.9 22.58 0.58 Allowed 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 129.948 3.299 . . . . 71.24 115.927 165.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 59.67 36.21 88.84 Favored Glycine 0 CA--C 1.527 0.835 0 CA-C-O 118.335 -1.258 . . . . 64.11 114.223 -169.018 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 32.1 mttm -128.37 -44.39 1.4 Allowed 'General case' 0 C--O 1.233 0.222 0 CA-C-N 119.269 1.534 . . . . 64.23 111.887 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -116.84 120.29 38.05 Favored 'General case' 0 C--N 1.332 -0.174 0 O-C-N 122.194 -0.316 . . . . 60.05 110.767 -174.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 35.8 ttp85 -98.75 126.58 44.41 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 106.752 -1.573 . . . . 64.23 106.752 171.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 7.8 p90 -145.36 163.42 34.63 Favored 'General case' 0 C--N 1.316 -0.872 0 O-C-N 120.829 -1.169 . . . . 74.2 108.438 177.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -173.33 173.1 3.61 Favored 'General case' 0 CA--C 1.516 -0.357 0 N-CA-C 109.786 -0.45 . . . . 74.31 109.786 -172.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 9.1 mt -52.48 -47.99 46.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 C-N-CA 127.648 2.379 . . . . 74.44 109.959 -175.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -83.54 3.98 83.31 Favored Glycine 0 CA--C 1.526 0.752 0 CA-C-O 117.9 -1.5 . . . . 74.23 114.027 179.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -102.39 -53.73 2.83 Favored 'General case' 0 C--O 1.226 -0.174 0 CA-C-N 120.518 2.159 . . . . 72.03 107.771 166.634 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -60.0 -52.62 64.6 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 123.872 0.869 . . . . 73.21 110.75 -178.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 129.76 8.59 3.41 Favored Glycine 0 CA--C 1.526 0.724 0 CA-C-O 119.092 -0.838 . . . . 61.14 113.882 -176.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 154.96 174.38 24.82 Favored Glycine 0 CA--C 1.528 0.895 0 CA-C-N 119.192 1.496 . . . . 64.33 110.496 178.208 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -62.48 -49.39 5.89 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 122.67 2.247 . . . . 73.42 111.136 -175.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -67.96 -37.34 81.45 Favored 'General case' 0 CA--C 1.53 0.182 0 O-C-N 121.305 -0.872 . . . . 74.22 110.013 -177.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -59.35 -29.93 68.02 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.204 0.601 . . . . 71.41 110.862 175.491 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 30.5 m -66.74 -41.91 87.1 Favored 'General case' 0 CA--C 1.529 0.172 0 O-C-N 120.698 -1.251 . . . . 74.21 109.361 178.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 44.6 mt -63.87 -36.33 83.58 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 118.928 0.786 . . . . 65.53 110.458 174.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -54.39 -44.74 72.55 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 118.219 -0.896 . . . . 75.22 109.585 173.779 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -68.66 -43.39 76.29 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-O 117.711 -1.138 . . . . 73.51 111.867 173.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -52.46 -49.81 63.92 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 119.458 1.026 . . . . 75.23 111.367 -170.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -70.68 -36.95 73.58 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 124.103 0.961 . . . . 72.31 111.055 -171.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -68.07 -48.22 66.15 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 126.213 1.805 . . . . 75.34 111.412 177.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 85.1 mt -61.92 -44.03 97.62 Favored 'General case' 0 CA--C 1.527 0.076 0 C-N-CA 123.673 0.789 . . . . 74.01 110.225 -176.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 56.8 mt -51.78 -51.16 29.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 C-N-CA 124.479 1.112 . . . . 72.15 109.387 174.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 14.9 tm-20 -61.18 -27.23 68.27 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 124.512 1.125 . . . . 74.43 112.419 -178.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . 0.434 ' HA ' ' HE3' ' A' ' 185' ' ' LYS . 0.3 OUTLIER -61.7 -60.73 3.23 Favored 'General case' 0 C--O 1.232 0.162 0 N-CA-C 107.833 -1.173 . . . . 74.02 107.833 176.602 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 66.8 mt-10 -67.41 -34.82 78.04 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 125.781 1.632 . . . . 74.3 111.594 -173.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.93 -21.43 64.76 Favored 'General case' 0 N--CA 1.462 0.173 0 O-C-N 120.776 -1.202 . . . . 73.11 111.911 -177.59 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.357 0 C-N-CA 122.979 0.511 . . . . 74.03 111.955 173.535 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 . . . . . 0 CA--C 1.524 -0.035 0 N-CA-C 109.234 -0.654 . . . . 74.11 109.234 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -142.28 9.37 1.86 Allowed 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.029 0.932 . . . . 75.52 112.593 -175.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.458 ' CD2' HD13 ' A' ' 178' ' ' LEU . 34.7 m-85 -142.02 167.16 22.79 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 124.755 1.222 . . . . 75.51 109.687 -170.754 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 18.9 m -130.87 133.63 46.07 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.697 1.199 . . . . 73.14 109.691 175.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.03 128.7 36.84 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 124.709 1.204 . . . . 70.13 109.98 173.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 71.52 24.33 76.96 Favored Glycine 0 CA--C 1.531 1.037 0 CA-C-O 118.721 -1.044 . . . . 75.44 111.946 -170.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 3.9 ttmt -127.39 -85.77 0.59 Allowed 'General case' 0 CA--C 1.518 -0.263 0 C-N-CA 125.119 1.368 . . . . 65.03 107.866 165.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 36.9 mp0 -64.31 -23.24 67.23 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 123.484 0.713 . . . . 74.11 110.824 -179.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 46.0 p90 -162.98 -178.53 6.14 Favored 'General case' 0 N--CA 1.462 0.174 0 O-C-N 121.731 -0.606 . . . . 75.14 111.88 -169.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 85.1 t -140.0 111.95 4.91 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 C-N-CA 125.428 1.491 . . . . 74.0 109.116 -178.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -75.7 163.42 27.31 Favored 'General case' 0 C--O 1.234 0.289 0 O-C-N 119.997 -1.689 . . . . 72.54 109.162 162.498 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -123.77 129.76 51.57 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 124.958 1.303 . . . . 74.53 108.657 -176.514 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 57.1 p -59.79 -27.54 66.65 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-O 118.228 -0.891 . . . . 74.0 112.363 -178.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 9.3 p -114.65 84.19 9.8 Favored Pre-proline 0 N--CA 1.452 -0.345 0 CA-C-N 119.068 0.849 . . . . 72.51 110.507 -175.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -70.75 175.19 9.27 Favored 'Trans proline' 0 N--CA 1.451 -1.01 0 C-N-CA 122.897 2.398 . . . . 64.15 110.915 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 24.6 t -139.18 136.46 18.12 Favored Pre-proline 0 CA--C 1.542 0.644 0 C-N-CA 123.674 0.79 . . . . 74.22 109.122 -167.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -73.05 176.93 8.42 Favored 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 123.917 3.078 . . . . 75.51 112.949 175.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 15.4 m -137.02 164.71 29.53 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 C-N-CA 124.601 1.16 . . . . 75.43 112.63 -167.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 13.4 t -58.49 -30.4 66.98 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 126.769 2.028 . . . . 73.11 112.965 175.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -155.58 86.06 3.29 Favored Pre-proline 0 N--CA 1.446 -0.657 0 CA-C-N 119.636 1.107 . . . . 74.32 109.425 -170.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -65.28 86.8 0.19 Allowed 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 122.224 1.949 . . . . 74.21 108.991 172.186 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -174.25 -41.8 0.05 OUTLIER Glycine 0 CA--C 1.525 0.714 0 CA-C-O 118.846 -0.975 . . . . 73.11 112.296 -165.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 9.5 mptt -108.06 152.19 24.84 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 106.759 -1.571 . . . . 74.15 106.759 160.011 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 32.6 mm -57.81 148.39 5.53 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 N-CA-C 105.868 -1.901 . . . . 64.23 105.868 162.121 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -117.55 117.47 29.51 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 106.958 -1.497 . . . . 72.21 106.958 -178.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 43.1 t -116.61 129.79 72.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 N-CA-C 107.327 -1.361 . . . . 74.12 107.327 179.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 4.8 t -118.9 134.37 62.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 106.143 -1.799 . . . . 74.53 106.143 179.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -107.89 101.8 11.04 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 104.631 -2.359 . . . . 60.51 104.631 162.031 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 5.4 mp -82.98 118.67 23.65 Favored 'General case' 0 CA--C 1.522 -0.114 0 N-CA-C 106.917 -1.512 . . . . 73.51 106.917 177.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 49.4 p90 -124.22 168.39 13.0 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.163 0.585 . . . . 71.22 112.045 -171.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 22.6 t90 -146.14 143.43 29.32 Favored 'General case' 0 C--N 1.343 0.312 0 C-N-CA 125.142 1.377 . . . . 75.2 109.238 174.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 5.4 t80 -49.15 -42.15 38.7 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 126.739 2.016 . . . . 75.21 112.571 171.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -83.57 15.61 34.9 Favored Glycine 0 CA--C 1.525 0.7 0 CA-C-O 119.163 -0.799 . . . . 64.12 113.017 -171.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 53.5 t -105.12 85.62 1.34 Allowed Pre-proline 0 N--CA 1.447 -0.613 0 C-N-CA 126.322 1.849 . . . . 71.53 108.148 178.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -61.44 -32.68 88.92 Favored 'Trans proline' 0 CA--C 1.534 0.5 0 C-N-CA 122.085 1.856 . . . . 70.12 110.279 177.198 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 5.4 m170 -53.44 -48.72 68.55 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 126.201 1.8 . . . . 75.13 110.134 175.258 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 84.1 m -59.57 -38.07 80.17 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.008 0.923 . . . . 73.42 109.555 -168.102 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 38.5 t80 -62.74 -23.45 67.19 Favored 'General case' 0 N--CA 1.47 0.55 0 O-C-N 120.892 -1.13 . . . . 75.02 112.559 179.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -55.96 -40.32 73.07 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 118.983 0.81 . . . . 74.41 110.043 172.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -85.44 -21.66 28.65 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 125.833 1.653 . . . . 73.11 112.681 -168.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -38.93 -67.08 0.28 Allowed Pre-proline 0 N--CA 1.478 0.937 0 C-N-CA 125.348 1.459 . . . . 73.02 112.662 -176.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -73.95 -10.29 22.88 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 CA-C-N 121.803 1.68 . . . . 71.15 114.406 -174.351 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.8 m -72.32 -45.21 60.92 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 107.975 -1.12 . . . . 75.11 107.975 166.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 20.2 tt -92.28 -36.54 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 N-CA-C 113.207 0.817 . . . . 74.5 113.207 -167.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 29.3 t -43.5 -60.48 2.51 Favored Pre-proline 0 CA--C 1.543 0.686 0 C-N-CA 125.31 1.444 . . . . 73.01 110.962 175.135 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -69.62 -29.93 23.73 Favored 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 121.725 1.617 . . . . 74.42 112.011 -177.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 72.5 t90 -57.44 -49.75 75.23 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 119.074 0.852 . . . . 75.22 109.209 175.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 44.2 t -61.73 -37.08 82.9 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 122.942 0.497 . . . . 71.04 110.636 178.099 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -59.6 -44.66 93.32 Favored 'General case' 0 CA--C 1.533 0.324 0 O-C-N 120.757 -1.214 . . . . 65.0 110.979 176.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -85.99 4.99 35.37 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 119.197 0.908 . . . . 74.04 113.179 -173.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 60.7 mt -58.6 148.72 65.34 Favored Pre-proline 0 N--CA 1.447 -0.612 0 N-CA-C 109.785 -0.45 . . . . 73.43 109.785 173.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -70.69 174.45 10.3 Favored 'Trans proline' 0 N--CA 1.447 -1.252 0 C-N-CA 123.982 3.121 . . . . 74.34 110.623 -178.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -67.68 0.95 2.76 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.986 1.314 . . . . 62.23 114.093 178.253 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -117.88 4.08 12.19 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 125.598 1.559 . . . . 73.33 111.916 -170.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 59.5 t -126.4 138.03 55.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 N-CA-C 105.721 -1.955 . . . . 74.22 105.721 179.243 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 3.2 p-80 -126.74 147.14 50.0 Favored 'General case' 0 N--CA 1.444 -0.768 0 C-N-CA 123.827 0.851 . . . . 74.03 109.13 179.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 28.1 t80 -110.96 140.5 45.41 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 124.199 1.0 . . . . 74.44 108.661 -173.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 82.4 t -133.71 113.54 18.66 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.441 0 N-CA-C 108.283 -1.006 . . . . 75.43 108.283 -170.011 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 29.1 mtm180 -101.07 114.96 29.39 Favored 'General case' 0 CA--C 1.506 -0.716 0 N-CA-C 105.84 -1.911 . . . . 72.55 105.84 -175.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 79.1 mt -130.36 145.58 58.02 Favored Pre-proline 0 C--N 1.328 -0.365 0 C-N-CA 123.177 0.591 . . . . 74.43 109.679 175.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -76.65 134.92 15.61 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 122.829 2.353 . . . . 74.2 110.474 172.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -77.11 95.03 4.14 Favored 'General case' 0 CA--C 1.539 0.533 0 O-C-N 121.55 -0.719 . . . . 64.31 110.035 178.058 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 29.6 mt -88.63 75.09 8.33 Favored 'General case' 0 CA--C 1.539 0.553 0 O-C-N 120.057 -1.652 . . . . 75.23 111.372 -172.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -87.0 30.28 0.77 Allowed 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 113.947 1.091 . . . . 75.12 113.947 -175.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 72.31 -165.01 54.42 Favored Glycine 0 CA--C 1.527 0.826 0 N-CA-C 108.341 -1.904 . . . . 55.11 108.341 -168.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 56.34 -156.47 11.64 Favored Glycine 0 CA--C 1.529 0.95 0 CA-C-N 117.891 0.846 . . . . 75.03 113.601 172.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 9.5 tp -61.67 -20.98 24.49 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 C-N-CA 123.481 0.712 . . . . 74.51 112.219 172.182 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 11.9 m95 -59.3 -42.07 90.49 Favored 'General case' 0 C--N 1.343 0.313 0 CA-C-N 120.097 1.317 . . . . 73.35 110.798 -171.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 12.1 p30 -79.93 -28.15 39.75 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 112.979 0.733 . . . . 72.34 112.979 178.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 92.4 t -63.12 -45.99 97.18 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 N-CA-C 108.089 -1.078 . . . . 75.12 108.089 175.055 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 64.2 m170 -76.61 15.13 0.67 Allowed 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 124.759 1.224 . . . . 71.44 112.644 169.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -123.73 -22.48 2.23 Favored Glycine 0 CA--C 1.532 1.141 0 CA-C-N 120.358 1.436 . . . . 55.42 114.182 178.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 33.7 tt0 -72.92 -28.98 62.78 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 118.286 1.043 . . . . 65.21 111.553 -172.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 6.5 ttp -61.52 -47.79 83.99 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-O 117.512 -1.232 . . . . 73.23 111.724 -177.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 13.7 t80 -52.62 -52.91 53.28 Favored 'General case' 0 N--CA 1.462 0.138 0 N-CA-C 108.813 -0.81 . . . . 74.25 108.813 -176.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 47.3 mt -56.61 -44.22 80.93 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 114.829 -1.078 . . . . 71.53 109.993 177.014 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 2.5 m -62.94 -40.92 99.1 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 120.353 1.433 . . . . 75.11 112.087 -174.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -55.88 -54.14 48.26 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.897 0.879 . . . . 61.53 108.76 176.584 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -74.36 -10.71 59.85 Favored 'General case' 0 CA--C 1.543 0.68 0 O-C-N 121.407 -0.808 . . . . 75.44 111.5 -176.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 9.3 t -88.29 -20.03 25.97 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 126.496 1.918 . . . . 71.41 113.578 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 8.5 ptp . . . . . 0 N--CA 1.466 0.334 0 O-C-N 120.89 -1.132 . . . . 74.21 110.072 157.904 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.297 0 N-CA-C 111.65 0.241 . . . . 74.1 111.65 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 48.5 t -53.42 -61.98 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 C-N-CA 124.159 0.983 . . . . 75.44 108.552 171.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.403 ' CD2' ' CD2' ' A' ' 99' ' ' HIS . 4.8 t80 -69.1 -41.95 76.76 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 119.174 -0.441 . . . . 55.13 110.716 -175.142 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -52.86 -39.66 62.75 Favored 'General case' 0 C--O 1.233 0.21 0 C-N-CA 124.671 1.188 . . . . 75.44 111.024 -178.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -63.76 -27.53 69.26 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 124.022 0.929 . . . . 72.42 111.055 -176.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 52.2 mt -85.45 -60.51 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.933 0 C-N-CA 125.97 1.708 . . . . 75.15 107.299 176.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . 0.403 ' CD2' ' CD2' ' A' ' 95' ' ' PHE . 20.7 p80 -76.18 -57.17 4.02 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 119.719 1.145 . . . . 72.43 113.256 -169.016 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -83.07 -33.15 26.48 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-N 118.404 0.547 . . . . 71.12 110.989 -171.187 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -97.51 -30.77 12.69 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 124.145 0.978 . . . . 75.31 111.091 -171.06 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 5.2 t-160 45.08 88.53 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 127.901 2.48 . . . . 74.1 112.885 176.056 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.463 ' HE2' ' CE1' ' A' ' 114' ' ' PHE . 0.0 OUTLIER -106.38 155.31 19.68 Favored 'General case' 0 CA--C 1.507 -0.7 0 CA-C-O 121.579 0.704 . . . . 73.52 111.128 164.429 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 5.2 ttmt -58.03 101.97 0.09 Allowed 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 106.698 -1.593 . . . . 74.44 106.698 165.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 93.0 mt -130.42 70.1 1.45 Allowed 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 126.934 2.094 . . . . 73.52 108.701 178.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -114.86 1.67 14.13 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.463 1.105 . . . . 74.45 112.619 -175.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -138.63 152.57 71.11 Favored Pre-proline 0 CA--C 1.531 0.249 0 C-N-CA 125.342 1.457 . . . . 75.24 109.209 -175.197 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -65.15 -34.02 47.56 Favored 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 121.395 1.396 . . . . 71.44 110.473 -179.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -64.37 -21.02 66.5 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 118.536 0.607 . . . . 73.54 112.343 174.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -84.06 -55.06 4.41 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 107.894 -1.15 . . . . 74.45 107.894 177.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 3.9 mpp? -58.21 -51.78 68.33 Favored 'General case' 0 C--N 1.34 0.187 0 C-N-CA 123.213 0.605 . . . . 75.23 111.135 179.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -67.28 -41.45 85.45 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 118.3 -0.857 . . . . 60.23 110.319 -173.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -57.8 -46.98 83.88 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 118.831 0.741 . . . . 74.34 110.006 174.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . 0.463 ' CE1' ' HE2' ' A' ' 103' ' ' LYS . 84.7 t80 -60.48 -46.9 88.39 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 118.015 0.37 . . . . 64.14 110.817 -176.561 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 46.0 mt -75.62 -17.98 59.84 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 119.356 -0.354 . . . . 74.1 111.007 -176.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.18 -9.85 2.41 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.481 1.512 . . . . 53.35 114.115 -179.096 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -121.34 15.37 9.29 Favored Glycine 0 CA--C 1.533 1.194 0 C-N-CA 126.666 2.079 . . . . 75.22 112.808 176.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 2.8 mmpt? -135.01 25.87 3.59 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.905 1.282 . . . . 75.21 110.891 -172.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 94.13 20.69 29.73 Favored Glycine 0 CA--C 1.524 0.617 0 C-N-CA 124.08 0.848 . . . . 70.51 113.529 172.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 94.0 t -132.98 130.01 58.13 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 C-N-CA 124.675 1.19 . . . . 74.22 107.817 -169.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -98.98 134.06 42.36 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 112.251 0.463 . . . . 74.03 112.251 -176.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 39.6 mtpt -60.74 -35.07 75.45 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 118.491 -0.766 . . . . 74.34 110.017 176.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -55.87 -46.51 78.24 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 119.086 0.857 . . . . 75.22 110.479 176.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 25.8 mmtt -78.27 -46.27 20.68 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 106.724 -1.584 . . . . 72.23 106.724 -174.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 47.6 t80 -54.06 -65.15 0.62 Allowed 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 125.455 1.502 . . . . 74.15 111.391 -176.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 9.3 mt -70.45 -33.76 71.68 Favored 'General case' 0 N--CA 1.467 0.418 0 O-C-N 121.146 -0.971 . . . . 72.11 111.06 -166.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 17.1 t -58.02 -57.8 11.21 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 107.198 -1.408 . . . . 63.25 107.198 172.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 38.4 m -62.85 -39.81 95.52 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-O 118.987 -0.53 . . . . 74.31 110.238 -175.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 54.7 t80 -56.42 -41.79 76.97 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 119.975 1.262 . . . . 73.54 110.064 -179.046 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 33.7 m-80 -84.43 -10.78 57.22 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 124.367 1.067 . . . . 74.21 113.745 -179.382 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 4.3 m -86.73 154.93 20.58 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 126.125 1.77 . . . . 71.43 112.645 -169.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -63.01 -29.83 71.13 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 114.171 1.174 . . . . 75.31 114.171 -171.541 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -57.21 -43.99 83.26 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 120.297 1.408 . . . . 75.24 111.231 -177.287 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 4.6 mm -58.48 -43.86 87.73 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.496 0 C-N-CA 126.394 1.878 . . . . 73.02 110.721 174.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 17.3 tttm -51.82 -37.49 51.99 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.941 0.896 . . . . 71.34 109.161 174.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -71.95 -40.13 57.78 Favored Glycine 0 CA--C 1.527 0.787 0 C-N-CA 124.634 1.111 . . . . 73.13 111.599 179.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -72.22 -34.37 68.29 Favored 'General case' 0 C--N 1.329 -0.311 0 O-C-N 120.906 -1.349 . . . . 73.23 110.551 -179.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 55.1 mtp -65.06 -51.29 62.33 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 124.599 1.16 . . . . 73.43 109.395 176.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -55.88 -38.78 70.62 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 119.298 0.953 . . . . 74.42 110.926 -172.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 21.6 mtmt -66.67 -61.6 1.88 Allowed 'General case' 0 C--N 1.342 0.255 0 CA-C-O 117.703 -1.141 . . . . 75.25 110.911 176.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -52.31 -39.13 60.16 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 120.834 1.652 . . . . 73.32 111.298 -177.226 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 11.0 tttt -62.49 -54.46 39.68 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 125.514 1.526 . . . . 73.3 112.454 178.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.01 -30.61 67.97 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 119.824 1.193 . . . . 74.21 110.623 179.166 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 40.3 mt -60.2 -47.25 86.76 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-O 118.932 -0.556 . . . . 72.1 110.558 -177.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -54.76 -45.93 74.28 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 118.016 0.371 . . . . 72.04 111.56 -177.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 13.2 ptp -70.57 -42.05 71.6 Favored 'General case' 0 CA--C 1.523 -0.079 0 N-CA-C 112.117 0.414 . . . . 72.22 112.117 -179.172 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -60.59 -38.53 84.96 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 123.747 0.819 . . . . 55.21 109.126 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 23.4 m-85 -76.47 6.16 6.17 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 114.12 1.155 . . . . 74.44 114.12 175.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 54.2 mt-30 57.63 36.19 26.46 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 127.073 2.149 . . . . 74.55 112.829 -179.22 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 36.1 t -82.94 145.87 7.85 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 N-CA-C 108.072 -1.084 . . . . 73.52 108.072 171.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -140.18 -7.79 1.18 Allowed 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 124.53 1.132 . . . . 64.23 112.642 173.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -154.43 -176.77 27.1 Favored Glycine 0 CA--C 1.52 0.396 0 N-CA-C 108.601 -1.8 . . . . 73.13 108.601 -178.209 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.41 ' HA ' ' C ' ' A' ' 154' ' ' PRO . 31.4 m -137.49 158.37 72.18 Favored Pre-proline 0 CA--C 1.54 0.563 0 N-CA-C 108.628 -0.879 . . . . 71.44 108.628 174.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . 0.41 ' C ' ' HA ' ' A' ' 153' ' ' VAL . 61.5 Cg_endo -63.05 160.56 59.06 Favored 'Cis proline' 0 N--CA 1.455 -0.771 0 C-N-CA 123.252 -1.562 . . . . 75.51 112.055 -12.026 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 9.4 m -159.04 111.05 2.16 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 105.537 -2.023 . . . . 74.12 105.537 174.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 92.7 mtp -84.39 155.61 22.21 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 108.579 -0.897 . . . . 74.42 108.579 165.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 10.0 t -138.48 150.71 24.16 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 N-CA-C 106.82 -1.548 . . . . 75.24 106.82 174.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 55.2 t -134.98 123.79 41.49 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 N-CA-C 105.908 -1.886 . . . . 74.43 105.908 -178.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 9.3 m-20 52.33 13.1 0.27 Allowed 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 129.814 3.246 . . . . 74.2 114.598 178.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 59.17 42.31 97.09 Favored Glycine 0 CA--C 1.527 0.785 0 CA-C-O 118.612 -1.105 . . . . 75.44 111.826 -166.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 13.5 mtpp -133.19 -38.85 0.94 Allowed 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 125.119 1.367 . . . . 72.54 111.219 -177.23 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -116.29 154.2 30.59 Favored 'General case' 0 CA--C 1.502 -0.901 0 N-CA-C 108.409 -0.96 . . . . 71.54 108.409 177.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 28.4 ttp85 -132.7 135.11 45.58 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 105.034 -2.21 . . . . 65.24 105.034 174.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 45.5 p90 -149.77 173.26 13.92 Favored 'General case' 0 C--N 1.324 -0.543 0 O-C-N 121.465 -0.772 . . . . 74.32 109.123 169.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -167.5 174.24 8.03 Favored 'General case' 0 CA--C 1.515 -0.367 0 N-CA-C 109.76 -0.459 . . . . 43.3 109.76 178.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 14.7 mt -51.77 -51.27 28.47 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 C-N-CA 125.917 1.687 . . . . 71.5 110.33 -179.183 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -76.09 -20.7 77.23 Favored Glycine 0 CA--C 1.527 0.8 0 CA-C-O 118.096 -1.391 . . . . 70.31 113.467 -178.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 66.6 m -70.18 -64.25 0.93 Allowed 'General case' 0 C--O 1.235 0.33 0 CA-C-N 120.011 1.906 . . . . 74.23 108.407 168.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -55.76 -48.74 74.76 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 127.354 2.261 . . . . 71.43 111.943 -174.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 130.89 -6.49 5.78 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 124.532 1.063 . . . . 74.3 114.303 178.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 165.59 169.67 29.51 Favored Glycine 0 CA--C 1.526 0.758 0 CA-C-N 119.218 1.509 . . . . 71.21 110.413 178.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -61.07 -43.43 29.89 Favored 'Trans proline' 0 N--CA 1.461 -0.439 0 C-N-CA 123.047 2.498 . . . . 74.21 111.351 -174.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 -60.32 -44.43 95.48 Favored 'General case' 0 CA--C 1.536 0.424 0 O-C-N 121.468 -0.77 . . . . 73.33 110.474 176.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -66.5 -23.94 66.33 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.511 1.125 . . . . 74.44 110.648 -177.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 28.3 m -66.58 -44.31 82.6 Favored 'General case' 0 N--CA 1.455 -0.19 0 O-C-N 121.056 -1.027 . . . . 74.52 109.668 179.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 54.9 mt -68.15 -23.51 64.88 Favored 'General case' 0 C--N 1.341 0.217 0 CA-C-N 118.702 0.683 . . . . 74.15 111.938 179.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.12 -54.9 37.36 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 108.245 -1.02 . . . . 75.52 108.245 168.577 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.458 HD13 ' CD2' ' A' ' 6' ' ' TYR . 3.0 mm? -64.74 -44.69 89.33 Favored 'General case' 0 CA--C 1.515 -0.383 0 N-CA-C 110.016 -0.365 . . . . 73.42 110.016 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -54.86 -34.38 62.86 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 112.538 0.57 . . . . 73.12 112.538 -175.018 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -94.61 -36.55 11.74 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 123.475 0.71 . . . . 70.23 110.929 -170.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 37.9 t80 -57.25 -53.45 57.99 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.757 0.823 . . . . 74.21 109.65 171.156 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 26.5 mt -55.75 -46.8 77.75 Favored 'General case' 0 CA--C 1.516 -0.329 0 C-N-CA 124.43 1.092 . . . . 72.43 111.403 -177.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 46.2 mt -48.46 -58.65 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.139 0 N-CA-C 109.025 -0.731 . . . . 74.33 109.025 176.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 6.9 tm-20 -65.1 -26.64 68.3 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 119.254 0.934 . . . . 73.31 111.882 -176.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 3.7 tmtm? -64.9 -58.28 6.59 Favored 'General case' 0 C--O 1.234 0.282 0 O-C-N 120.645 -1.284 . . . . 73.35 109.634 172.018 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -60.54 -40.8 92.85 Favored 'General case' 0 N--CA 1.438 -1.04 0 C-N-CA 125.525 1.53 . . . . 75.22 112.077 -177.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.68 -43.37 80.31 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 125.859 1.664 . . . . 72.13 110.299 179.428 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.451 0 CA-C-N 119.884 1.22 . . . . 72.43 111.202 -174.708 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . 0.27 0.0 OUTLIER . . . . . 0 N--CA 1.471 0.59 0 CA-C-O 120.561 0.22 . . . . 63.34 110.598 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -152.93 14.48 0.54 Allowed 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.123 0.969 . . . . 74.23 112.127 175.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 25.5 m-85 -146.6 160.72 41.81 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 123.932 0.893 . . . . 74.41 110.275 -167.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 31.5 m -128.78 136.59 50.74 Favored 'General case' 0 C--O 1.238 0.461 0 O-C-N 121.418 -0.801 . . . . 62.31 108.846 -177.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -70.99 149.99 46.1 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 122.119 0.961 . . . . 60.54 109.1 174.229 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 62.32 12.04 36.6 Favored Glycine 0 CA--C 1.533 1.208 0 CA-C-O 118.556 -1.136 . . . . 73.54 112.582 -167.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.8 tptt -126.97 -84.24 0.61 Allowed 'General case' 0 C--N 1.339 0.131 0 CA-C-N 119.885 1.842 . . . . 74.42 107.346 -178.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.6 mp0 -74.52 -26.82 60.23 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 125.477 1.511 . . . . 75.44 110.372 179.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 34.3 p90 -158.61 174.86 14.41 Favored 'General case' 0 N--CA 1.456 -0.131 0 O-C-N 121.18 -0.95 . . . . 75.41 109.451 -175.223 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 24.7 t -135.76 128.56 47.07 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.107 0 C-N-CA 124.418 1.087 . . . . 64.12 108.196 -179.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -87.74 169.28 12.23 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.211 1.404 . . . . 74.53 110.782 165.204 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -136.38 122.48 20.29 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 124.641 1.176 . . . . 74.11 111.054 177.037 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.6 p -63.13 -0.07 0.69 Allowed 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 128.657 2.783 . . . . 74.14 114.693 179.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 74.1 m -137.7 78.87 35.82 Favored Pre-proline 0 N--CA 1.447 -0.592 0 N-CA-C 107.546 -1.279 . . . . 73.25 107.546 173.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -68.97 179.6 3.17 Favored 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 123.339 2.692 . . . . 74.52 111.818 -176.39 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 40.4 t -126.84 136.97 29.57 Favored Pre-proline 0 CA--C 1.536 0.407 0 N-CA-C 108.503 -0.925 . . . . 75.43 108.503 -169.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -78.18 -179.09 5.13 Favored 'Trans proline' 0 CA--C 1.537 0.635 0 C-N-CA 122.882 2.388 . . . . 73.33 111.861 178.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 3.7 m -131.96 179.78 4.07 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 C-N-CA 127.294 2.237 . . . . 73.44 109.504 176.306 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 47.3 t -64.15 -70.58 0.21 Allowed 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 124.879 1.272 . . . . 53.25 108.324 168.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 57.2 tp60 -116.54 143.03 30.49 Favored Pre-proline 0 N--CA 1.45 -0.443 0 N-CA-C 105.543 -2.021 . . . . 73.33 105.543 -176.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -86.21 -164.13 0.21 Allowed 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 123.699 2.932 . . . . 73.42 110.306 176.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 94.3 -77.84 0.97 Allowed Glycine 0 N--CA 1.444 -0.771 0 N-CA-C 108.889 -1.684 . . . . 74.3 108.889 174.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 87.2 mttt -62.98 136.56 57.91 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 107.919 -1.141 . . . . 65.41 107.919 178.271 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 25.8 mm -73.78 124.66 31.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 106.134 -1.802 . . . . 74.45 106.134 176.117 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -73.76 146.93 43.94 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.104 -1.073 . . . . 75.31 108.104 175.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 60.1 t -133.35 135.6 55.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 106.382 -1.71 . . . . 72.23 106.382 164.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 60.9 t -130.38 101.28 5.65 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 N-CA-C 106.4 -1.704 . . . . 62.12 106.4 -169.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -72.04 133.64 45.39 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 107.679 -1.23 . . . . 71.53 107.679 164.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.1 mp -119.71 126.87 52.13 Favored 'General case' 0 C--O 1.231 0.109 0 N-CA-C 108.536 -0.912 . . . . 74.43 108.536 167.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 21.6 p90 -135.3 163.59 29.66 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 124.649 1.18 . . . . 70.04 111.131 -171.007 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 34.2 t90 -143.44 157.75 44.2 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 124.647 1.179 . . . . 73.24 107.948 173.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 31.3 t80 -46.23 -57.88 4.16 Favored 'General case' 0 N--CA 1.444 -0.745 0 C-N-CA 128.063 2.545 . . . . 75.34 113.707 -177.11 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -75.46 -83.68 0.41 Allowed Glycine 0 N--CA 1.444 -0.767 0 N-CA-C 108.548 -1.821 . . . . 72.1 108.548 -170.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 9.1 t 42.63 65.53 5.1 Favored Pre-proline 0 CA--C 1.541 0.62 0 C-N-CA 126.032 1.733 . . . . 63.41 112.752 164.128 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -62.57 -20.12 69.81 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 122.413 2.076 . . . . 74.35 112.471 -175.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 15.1 m-70 -83.95 -21.4 31.8 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 117.732 -1.128 . . . . 74.41 113.938 172.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 99.0 m -68.16 -41.87 80.9 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 119.931 1.241 . . . . 74.52 109.56 175.141 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 19.1 t80 -54.06 -42.81 69.68 Favored 'General case' 0 C--N 1.341 0.202 0 C-N-CA 124.155 0.982 . . . . 75.14 110.804 -174.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -51.68 -43.87 62.88 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.815 0.846 . . . . 71.51 111.909 -179.094 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -76.84 -24.59 52.7 Favored 'General case' 0 C--O 1.225 -0.231 0 CA-C-O 117.061 -1.447 . . . . 71.35 112.725 -171.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -44.45 -67.79 0.33 Allowed Pre-proline 0 CA--C 1.543 0.68 0 CA-C-N 120.421 1.464 . . . . 75.13 113.677 -170.037 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -70.92 -4.62 15.17 Favored 'Trans proline' 0 CA--C 1.536 0.611 0 C-N-CA 121.801 1.667 . . . . 74.11 112.815 -175.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -96.52 -0.8 48.38 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 127.181 2.192 . . . . 61.04 111.151 173.461 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 20.6 tt -126.93 -28.38 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 CA-C-N 120.885 1.675 . . . . 74.15 112.978 171.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 54.6 t -50.92 -60.14 6.14 Favored Pre-proline 0 CA--C 1.538 0.493 0 CA-C-N 119.612 1.096 . . . . 73.51 110.974 178.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -69.16 -32.51 20.93 Favored 'Trans proline' 0 N--CA 1.451 -0.998 0 CA-C-N 121.07 1.418 . . . . 70.24 111.067 -175.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 83.4 t90 -53.38 -53.41 51.51 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 119.842 1.201 . . . . 73.34 110.242 173.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 21.5 t -60.48 -37.42 81.0 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.676 0.79 . . . . 73.55 111.288 -177.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -61.66 -45.82 92.41 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 119.32 0.963 . . . . 73.02 110.88 173.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 2.6 mptp? -83.49 7.93 15.51 Favored 'General case' 0 C--O 1.234 0.261 0 O-C-N 120.625 -1.297 . . . . 74.44 113.544 -169.081 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 35.2 mt -61.59 157.49 47.01 Favored Pre-proline 0 CA--C 1.537 0.471 0 C-N-CA 125.198 1.399 . . . . 72.35 111.784 179.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -74.85 167.98 25.87 Favored 'Trans proline' 0 N--CA 1.451 -0.993 0 C-N-CA 124.752 3.635 . . . . 73.13 110.548 172.123 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -77.69 -4.95 48.75 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.755 0.822 . . . . 55.33 113.133 178.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -94.43 7.04 46.91 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 119.272 0.942 . . . . 72.42 110.647 177.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 96.8 t -126.55 138.0 56.06 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 N-CA-C 106.715 -1.587 . . . . 75.12 106.715 -177.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 68.5 t60 -123.48 108.84 13.11 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 124.9 1.28 . . . . 74.13 108.747 -178.004 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 51.8 t80 -87.81 137.55 32.24 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 123.788 0.835 . . . . 74.21 109.528 -178.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 47.7 t -136.28 150.18 27.66 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 C-N-CA 126.215 1.806 . . . . 74.02 107.409 -174.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 30.4 mtp180 -132.72 126.08 31.69 Favored 'General case' 0 C--O 1.232 0.166 0 N-CA-C 106.885 -1.524 . . . . 72.22 106.885 -176.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 86.8 mt -138.47 144.82 44.11 Favored Pre-proline 0 N--CA 1.467 0.402 0 C-N-CA 124.141 0.976 . . . . 63.34 109.587 -178.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -74.79 152.82 42.37 Favored 'Trans proline' 0 N--CA 1.456 -0.735 0 C-N-CA 122.14 1.893 . . . . 73.44 111.672 177.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -89.48 107.21 18.94 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 125.237 1.415 . . . . 61.04 109.09 177.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 39.8 mt -105.71 78.59 1.36 Allowed 'General case' 0 C--O 1.236 0.356 0 C-N-CA 125.151 1.381 . . . . 72.24 108.103 -173.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -121.96 59.95 0.99 Allowed 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 124.706 1.202 . . . . 72.43 110.197 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 68.85 164.74 3.58 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 125.983 1.754 . . . . 71.32 114.174 167.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 48.72 -142.7 8.6 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 124.252 0.929 . . . . 74.11 111.276 -175.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -56.7 -17.29 4.83 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 C-N-CA 124.71 1.204 . . . . 73.21 113.524 -175.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 13.3 m95 -60.97 -42.85 99.1 Favored 'General case' 0 C--N 1.341 0.211 0 O-C-N 120.442 -1.411 . . . . 75.24 109.959 178.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 7.5 m-80 -72.21 -17.97 61.88 Favored 'General case' 0 CA--C 1.527 0.095 0 O-C-N 121.566 -0.709 . . . . 74.31 112.512 176.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 64.8 t -92.53 -13.25 8.76 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 C-N-CA 123.786 0.834 . . . . 74.4 111.605 -173.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 52.0 m170 -115.45 4.49 14.3 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.342 1.057 . . . . 74.14 111.924 172.141 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -102.93 -41.73 2.22 Favored Glycine 0 N--CA 1.448 -0.526 0 N-CA-C 109.518 -1.433 . . . . 53.23 109.518 -176.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . 0.268 1.3 pm0 -49.12 -43.86 41.85 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 125.16 1.384 . . . . 75.13 113.027 -179.689 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 5.1 ppp? -54.35 -37.16 64.61 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 114.154 1.168 . . . . 75.55 114.154 -172.276 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 39.4 t80 -56.49 -43.07 79.34 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 122.835 1.302 . . . . 74.14 109.049 -172.2 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 12.9 mt -68.87 -34.8 76.05 Favored 'General case' 0 N--CA 1.442 -0.867 0 C-N-CA 125.991 1.716 . . . . 75.41 110.729 -177.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -68.53 -50.99 47.8 Favored 'General case' 0 C--N 1.344 0.356 0 CA-C-N 121.125 1.784 . . . . 71.5 110.182 176.026 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -51.09 -52.96 38.42 Favored 'General case' 0 CA--C 1.535 0.376 0 O-C-N 123.968 0.793 . . . . 75.13 109.459 -177.543 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -65.12 -28.14 69.22 Favored 'General case' 0 N--CA 1.465 0.289 0 O-C-N 121.517 -0.739 . . . . 73.55 112.866 -179.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 8.5 t -69.63 -19.76 63.62 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 118.09 -0.957 . . . . 64.51 111.682 -175.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 4.9 ptp . . . . . 0 N--CA 1.471 0.617 0 CA-C-N 121.116 1.78 . . . . 74.22 112.364 170.794 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.478 0 CA-C-O 118.65 -0.691 . . . . 62.4 111.663 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 57.3 t -60.05 -65.08 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 CA-C-N 119.997 1.271 . . . . 65.34 108.258 164.182 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -51.4 -49.36 61.72 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 125.114 1.366 . . . . 75.13 112.086 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.409 ' OE1' ' HE3' ' A' ' 100' ' ' LYS . 3.5 mm-40 -62.04 -13.8 29.64 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 126.825 2.05 . . . . 71.55 112.442 -178.272 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -108.0 1.51 22.55 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 125.638 1.575 . . . . 74.33 111.024 178.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 28.3 mt -110.74 -58.1 3.78 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.286 0 N-CA-C 107.741 -1.207 . . . . 74.0 107.741 172.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 80.3 m-70 -66.37 -60.7 2.51 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 119.051 0.841 . . . . 73.24 111.09 -177.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.409 ' HE3' ' OE1' ' A' ' 96' ' ' GLU . 0.6 OUTLIER -68.17 -30.0 69.01 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 118.999 0.818 . . . . 75.54 110.646 -174.06 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -98.38 -36.89 9.83 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 123.84 0.856 . . . . 74.32 111.715 -168.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 5.0 t-160 44.26 57.31 4.37 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 128.713 2.805 . . . . 72.22 112.778 178.004 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -64.88 -173.37 0.11 Allowed 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.897 1.679 . . . . 73.54 111.756 170.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 18.8 ttmm -109.49 54.3 0.66 Allowed 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 126.447 1.899 . . . . 74.43 110.415 175.09 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 24.8 mt -75.39 58.32 0.98 Allowed 'General case' 0 C--N 1.322 -0.587 0 C-N-CA 127.479 2.311 . . . . 75.22 108.452 179.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -114.6 -2.36 13.12 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 127.832 2.453 . . . . 74.15 111.346 -171.307 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 45.1 p -135.4 151.28 74.5 Favored Pre-proline 0 C--O 1.232 0.14 0 C-N-CA 124.729 1.212 . . . . 72.33 108.715 179.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -66.59 -23.83 49.17 Favored 'Trans proline' 0 N--CA 1.459 -0.5 0 C-N-CA 121.888 1.725 . . . . 73.44 111.955 179.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -58.27 -60.32 3.94 Favored 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 124.71 1.204 . . . . 75.11 110.479 167.034 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 19.5 tp10 -66.49 -40.07 89.09 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 120.978 -0.289 . . . . 74.24 110.842 -174.06 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 3.6 mtt -67.01 -47.06 72.62 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 120.722 -0.391 . . . . 74.45 111.447 -175.007 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -63.28 -48.35 78.49 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 118.94 -0.552 . . . . 72.22 110.59 -177.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -70.96 -5.42 30.83 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 118.847 0.748 . . . . 64.11 112.928 -178.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 87.0 t80 -100.18 -35.22 9.73 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 124.626 1.17 . . . . 73.44 112.38 176.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 76.9 mt -83.22 -17.75 41.66 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 123.134 0.574 . . . . 72.33 111.166 175.502 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -52.17 -30.31 26.33 Favored 'General case' 0 CA--C 1.528 0.115 0 C-N-CA 125.765 1.626 . . . . 74.22 112.657 -175.375 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -93.28 -2.0 66.3 Favored Glycine 0 N--CA 1.441 -1.01 0 CA-C-O 118.473 -1.182 . . . . 73.05 112.312 -175.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.12 39.46 3.11 Favored 'General case' 0 C--N 1.342 0.242 0 CA-C-N 119.134 1.467 . . . . 73.54 111.273 -163.569 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 90.45 11.57 62.32 Favored Glycine 0 CA--C 1.527 0.785 0 CA-C-O 118.541 -1.144 . . . . 55.22 113.849 169.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 30.7 t -113.36 128.92 69.94 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 C-N-CA 125.643 1.577 . . . . 73.03 107.237 175.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -99.16 141.13 32.32 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 122.884 0.474 . . . . 64.31 111.811 173.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 5.1 mtmt -66.15 -33.82 76.64 Favored 'General case' 0 CA--C 1.537 0.449 0 O-C-N 121.501 -0.749 . . . . 74.24 111.423 178.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -64.9 -33.61 76.43 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 125.116 1.367 . . . . 75.05 111.323 178.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 7.2 mmtp -79.55 -50.77 10.22 Favored 'General case' 0 C--O 1.23 0.066 0 N-CA-C 107.888 -1.153 . . . . 72.43 107.888 172.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 52.0 t80 -53.39 -67.47 0.25 Allowed 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.831 1.252 . . . . 74.24 113.332 -165.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 25.4 mt -62.79 -38.84 92.25 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 122.738 0.415 . . . . 75.21 111.228 -165.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 22.5 t -57.43 -46.5 83.48 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 124.16 0.984 . . . . 73.31 111.295 -176.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 9.9 t -80.73 -33.66 35.02 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 110.355 -0.239 . . . . 73.24 110.355 178.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 76.8 t80 -55.62 -38.28 69.29 Favored 'General case' 0 C--O 1.237 0.396 0 O-C-N 121.266 -0.896 . . . . 70.21 111.138 176.091 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -91.99 16.83 10.31 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.428 1.491 . . . . 75.04 112.082 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 2.2 p -106.48 171.89 7.11 Favored 'General case' 0 C--O 1.24 0.589 0 CA-C-N 119.804 1.183 . . . . 74.01 111.895 -175.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -67.2 -17.78 64.97 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 123.883 0.873 . . . . 74.0 112.081 172.34 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -57.9 -56.31 23.62 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 119.106 0.866 . . . . 74.21 109.29 178.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 13.7 mm -59.39 -41.33 84.07 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.134 0 CA-C-O 119.169 -0.443 . . . . 74.3 110.583 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 13.0 mttt -57.31 -35.14 69.46 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 119.31 0.959 . . . . 71.4 111.637 175.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -81.61 -22.38 60.21 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 125.071 1.32 . . . . 64.35 113.009 -178.183 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -82.39 -39.6 22.46 Favored 'General case' 0 CA--C 1.535 0.399 0 O-C-N 121.382 -1.069 . . . . 74.12 110.097 173.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 92.8 mmm -61.26 -41.19 96.5 Favored 'General case' 0 C--O 1.231 0.099 0 C-N-CA 124.105 0.962 . . . . 62.3 111.169 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -57.13 -43.13 82.12 Favored 'General case' 0 CA--C 1.535 0.4 0 O-C-N 121.032 -1.043 . . . . 74.35 111.375 178.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 13.3 mtmt -60.29 -66.06 0.58 Allowed 'General case' 0 C--N 1.342 0.272 0 CA-C-N 118.549 0.613 . . . . 75.04 110.518 176.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -59.94 -26.97 66.39 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 119.027 0.83 . . . . 75.3 111.64 -170.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.55 -56.11 8.26 Favored 'General case' 0 C--N 1.34 0.158 0 O-C-N 121.368 -0.832 . . . . 74.3 110.509 176.411 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.55 -32.7 73.66 Favored 'General case' 0 C--N 1.342 0.26 0 CA-C-N 119.172 0.896 . . . . 75.3 110.365 -177.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 42.1 mt -59.67 -54.97 40.17 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 118.007 -0.997 . . . . 73.42 110.288 179.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -54.66 -37.44 65.72 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 119.616 1.098 . . . . 74.21 112.166 -178.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -73.25 -42.7 62.23 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 122.903 0.481 . . . . 74.44 110.777 -179.808 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -59.83 -44.95 93.8 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 123.605 0.762 . . . . 64.54 109.099 175.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 15.9 m-85 -63.0 -7.35 5.12 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.242 1.417 . . . . 73.41 113.337 177.151 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 61.7 mt-30 56.21 47.56 19.13 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 127.208 2.203 . . . . 75.23 111.01 -174.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 95.3 t -82.72 141.54 14.82 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 O-C-N 120.665 -1.272 . . . . 73.54 108.196 178.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 11.7 p -104.93 -19.75 13.76 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 124.178 0.991 . . . . 73.42 113.092 -174.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 179.12 -148.08 8.04 Favored Glycine 0 N--CA 1.452 -0.275 0 N-CA-C 108.81 -1.716 . . . . 73.31 108.81 -170.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.426 ' HA ' ' C ' ' A' ' 154' ' ' PRO . 22.3 m -147.09 153.93 45.81 Favored Pre-proline 0 C--O 1.243 0.738 0 C-N-CA 127.115 2.166 . . . . 74.23 106.717 167.46 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . 0.426 ' C ' ' HA ' ' A' ' 153' ' ' VAL . 98.2 Cg_endo -66.9 158.24 81.64 Favored 'Cis proline' 0 N--CA 1.458 -0.587 0 C-N-CA 124.132 -1.195 . . . . 71.21 112.154 -3.633 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 97.8 m -156.82 146.46 20.69 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 106.391 -1.707 . . . . 70.01 106.391 172.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 28.7 mmm -114.78 165.48 12.78 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 106.689 -1.596 . . . . 60.33 106.689 161.096 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 78.0 t -137.41 143.9 33.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 106.383 -1.71 . . . . 75.41 106.383 160.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 20.0 t -105.21 134.48 46.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 N-CA-C 105.915 -1.883 . . . . 70.4 105.915 162.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 4.0 t30 50.77 17.02 0.36 Allowed 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 130.197 3.399 . . . . 72.11 116.359 166.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 70.23 25.23 75.92 Favored Glycine 0 CA--C 1.527 0.836 0 CA-C-O 117.231 -1.872 . . . . 73.5 113.659 -171.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 21.6 mtpt -128.72 -37.05 1.79 Allowed 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 119.878 1.839 . . . . 75.14 114.032 179.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 -121.4 108.79 14.1 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 119.708 1.14 . . . . 72.42 111.557 -168.126 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 18.9 ptt180 -90.56 32.79 0.94 Allowed 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 126.96 2.104 . . . . 74.24 115.532 -171.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 4.0 p90 -52.06 155.51 1.86 Allowed 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 122.154 0.978 . . . . 63.23 110.085 -177.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -160.96 174.66 13.47 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 107.811 -1.181 . . . . 73.01 107.811 -175.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 3.5 mt -46.3 -52.67 3.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 C-N-CA 126.108 1.763 . . . . 74.44 108.163 161.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -78.28 19.72 4.46 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 126.828 2.156 . . . . 65.2 114.621 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 18.8 m -125.27 -48.89 1.7 Allowed 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 119.37 1.585 . . . . 74.51 109.12 154.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -63.2 -34.84 78.52 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-O 118.166 -0.921 . . . . 53.44 112.909 -170.276 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 117.75 5.5 13.87 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 123.586 0.612 . . . . 72.42 113.547 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 153.35 174.39 23.6 Favored Glycine 0 CA--C 1.527 0.805 0 CA-C-N 119.22 1.51 . . . . 45.21 110.543 177.03 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -64.05 -45.18 10.72 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 122.308 2.005 . . . . 75.3 110.826 -173.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -66.41 -39.46 89.02 Favored 'General case' 0 N--CA 1.453 -0.304 0 O-C-N 121.269 -0.895 . . . . 75.32 110.173 177.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -62.58 -27.45 69.2 Favored 'General case' 0 CA--C 1.537 0.466 0 O-C-N 122.306 -0.246 . . . . 74.11 110.932 175.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 24.9 m -61.84 -45.9 91.79 Favored 'General case' 0 CA--C 1.534 0.354 0 O-C-N 120.469 -1.394 . . . . 74.52 109.537 179.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 33.2 mt -65.51 -24.38 67.12 Favored 'General case' 0 N--CA 1.466 0.366 0 O-C-N 121.365 -0.834 . . . . 72.52 112.043 177.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.74 -46.18 74.24 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-O 118.796 -0.621 . . . . 74.14 109.427 169.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -76.51 -39.35 53.29 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-O 117.27 -1.348 . . . . 75.53 110.565 -178.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -52.65 -49.88 64.32 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 120.015 1.28 . . . . 75.52 111.754 -172.088 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -66.1 -45.33 81.57 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 125.235 1.414 . . . . 74.03 110.786 -173.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -62.45 -46.88 86.51 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 126.003 1.721 . . . . 74.32 111.448 176.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 83.0 mt -64.32 -38.83 92.44 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 118.487 -0.768 . . . . 75.42 110.118 -176.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 39.5 mt -55.6 -51.5 57.66 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 CA-C-N 119.369 0.986 . . . . 74.3 108.655 172.333 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -67.97 7.4 0.54 Allowed 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 127.378 2.271 . . . . 75.43 114.414 174.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -110.73 -45.29 3.51 Favored 'General case' 0 N--CA 1.454 -0.252 0 O-C-N 120.841 -1.162 . . . . 73.24 108.823 165.74 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 26.9 mm-40 -54.66 -38.49 67.0 Favored 'General case' 0 CA--C 1.512 -0.495 0 C-N-CA 126.326 1.85 . . . . 75.23 115.403 -173.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.73 -23.41 29.01 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 118.624 -1.23 . . . . 72.11 114.14 -176.586 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.238 0.463 0 C-N-CA 126.484 1.914 . . . . 74.51 113.084 175.126 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . 0.466 ' C ' ' H ' ' A' ' 6' ' ' TYR . 1.3 m-20 . . . . . 0 CA--C 1.53 0.189 0 N-CA-C 110.159 -0.312 . . . . 70.41 110.159 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -75.04 25.18 0.09 Allowed 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.517 1.127 . . . . 74.01 113.161 -172.386 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.466 ' H ' ' C ' ' A' ' 4' ' ' ASP . 33.1 m-85 -140.53 170.3 16.05 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 128.19 2.596 . . . . 75.34 108.838 -176.418 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 95.0 m -141.69 137.48 31.76 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 124.932 1.293 . . . . 75.24 108.269 176.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.66 130.62 43.93 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 108.729 -0.841 . . . . 73.33 108.729 172.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 80.07 15.92 77.83 Favored Glycine 0 CA--C 1.525 0.681 0 CA-C-O 119.33 -0.705 . . . . 63.1 112.966 -174.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.1 tpmt? -133.25 -55.99 0.91 Allowed 'General case' 0 CA--C 1.519 -0.242 0 CA-C-N 118.384 1.092 . . . . 73.13 109.345 -177.146 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 8.1 mp0 -105.42 -21.2 13.27 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 124.388 1.075 . . . . 74.52 110.642 179.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 42.6 p90 -159.44 168.16 26.95 Favored 'General case' 0 C--O 1.234 0.253 0 O-C-N 121.119 -0.988 . . . . 74.24 110.641 -171.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 84.0 t -126.13 111.47 26.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 C-N-CA 124.894 1.277 . . . . 72.42 108.504 178.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -78.08 165.61 23.79 Favored 'General case' 0 C--O 1.239 0.5 0 O-C-N 120.871 -1.143 . . . . 64.55 109.246 169.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -133.87 111.41 10.46 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 126.011 1.725 . . . . 73.31 107.333 -175.728 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 76.3 p -65.24 0.24 1.48 Allowed 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 125.985 1.714 . . . . 63.04 113.26 179.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 38.6 m -128.92 73.74 81.4 Favored Pre-proline 0 N--CA 1.439 -1.001 0 N-CA-C 105.397 -2.075 . . . . 55.35 105.397 -176.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -72.93 177.86 7.18 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 124.211 3.274 . . . . 74.32 110.922 -170.209 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 6.1 t -140.61 116.67 7.67 Favored Pre-proline 0 CA--C 1.537 0.46 0 C-N-CA 123.321 0.648 . . . . 75.41 109.442 176.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -72.79 -176.36 2.3 Favored 'Trans proline' 0 CA--C 1.537 0.672 0 C-N-CA 123.858 3.038 . . . . 70.22 110.854 171.011 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 3.5 m -133.85 160.61 41.89 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 N-CA-C 106.016 -1.846 . . . . 74.41 106.016 176.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 3.4 m -47.75 -66.88 0.33 Allowed 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 125.392 1.477 . . . . 72.44 113.766 166.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 11.8 tp60 -128.71 81.25 71.12 Favored Pre-proline 0 N--CA 1.469 0.48 0 C-N-CA 123.9 0.88 . . . . 73.33 108.718 -169.003 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.565 ' C ' ' H ' ' A' ' 26' ' ' LYS . 36.2 Cg_endo -73.05 -57.51 0.07 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.095 0 CA-C-N 119.122 0.722 . . . . 71.35 110.314 179.236 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 51.35 -23.34 0.01 OUTLIER Glycine 0 CA--C 1.53 1.019 0 C-N-CA 127.831 2.634 . . . . 31.43 115.243 -159.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.565 ' H ' ' C ' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -140.05 -167.06 2.22 Favored 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 129.548 3.139 . . . . 74.45 105.483 -161.931 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 30.4 mm -87.75 130.65 37.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 N-CA-C 106.207 -1.775 . . . . 74.34 106.207 168.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -69.71 140.04 53.48 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 105.608 -1.997 . . . . 74.41 105.608 173.131 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 54.8 t -128.2 134.32 65.21 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 N-CA-C 105.769 -1.937 . . . . 71.5 105.769 160.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 30.1 t -123.14 112.71 34.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 105.95 -1.87 . . . . 74.21 105.95 172.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 62.6 tt0 -72.26 122.01 20.36 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 106.347 -1.723 . . . . 74.54 106.347 156.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.5 mp -109.65 137.91 46.78 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-N 119.212 0.914 . . . . 75.12 108.919 166.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 9.5 p90 -145.66 171.26 14.98 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 122.986 0.514 . . . . 75.24 110.487 -168.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 42.2 t90 -156.7 151.57 25.97 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.38 1.472 . . . . 75.33 109.9 171.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 19.4 t80 -45.58 -48.49 14.5 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 127.789 2.436 . . . . 71.21 114.408 -174.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -75.14 -88.59 0.23 Allowed Glycine 0 C--N 1.341 0.806 0 N-CA-C 109.75 -1.34 . . . . 73.24 109.75 -169.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 12.7 t 42.76 72.49 1.13 Allowed Pre-proline 0 CA--C 1.538 0.483 0 C-N-CA 126.44 1.896 . . . . 74.34 112.955 160.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -59.16 -38.83 84.13 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 121.191 1.261 . . . . 72.3 112.199 -178.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 17.8 m170 -65.79 -30.38 71.02 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 119.142 0.883 . . . . 73.33 111.031 -179.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 82.1 m -62.67 -38.11 89.06 Favored 'General case' 0 C--N 1.343 0.32 0 CA-C-N 118.407 0.549 . . . . 64.13 110.158 177.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 38.6 t80 -62.0 -44.28 97.06 Favored 'General case' 0 C--N 1.339 0.139 0 O-C-N 121.614 -0.679 . . . . 72.55 110.828 -175.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -56.52 -34.45 67.02 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 118.285 0.493 . . . . 73.52 111.333 178.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -82.52 -16.0 50.28 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.837 1.655 . . . . 75.32 113.445 -178.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -43.26 -63.48 0.99 Allowed Pre-proline 0 CA--C 1.539 0.554 0 CA-C-N 120.042 1.292 . . . . 75.33 112.422 -173.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -85.79 -7.36 8.46 Favored 'Trans proline' 0 N--CA 1.452 -0.921 0 C-N-CA 121.645 1.563 . . . . 73.14 114.687 -174.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 26.0 m -66.01 -46.84 76.49 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 107.355 -1.35 . . . . 75.04 107.355 166.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 20.5 tt -84.2 -35.31 10.72 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 N-CA-C 113.528 0.936 . . . . 74.3 113.528 -166.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 42.9 t -48.16 -61.18 3.34 Favored Pre-proline 0 CA--C 1.545 0.779 0 O-C-N 121.237 -0.914 . . . . 73.43 111.803 178.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -72.5 -6.59 19.33 Favored 'Trans proline' 0 N--CA 1.454 -0.794 0 C-N-CA 122.007 1.805 . . . . 75.34 113.708 -177.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 79.8 t90 -72.25 -62.48 1.42 Allowed 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 120.085 1.312 . . . . 74.32 107.691 161.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 22.4 p -53.79 -33.3 55.55 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 115.035 1.494 . . . . 64.22 115.035 -169.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 58.4 mt-10 -80.45 -24.84 39.29 Favored 'General case' 0 CA--C 1.54 0.572 0 O-C-N 120.663 -1.273 . . . . 70.03 112.007 -179.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 11.1 mptt -96.2 9.26 41.57 Favored 'General case' 0 C--O 1.225 -0.196 0 C-N-CA 124.97 1.308 . . . . 74.54 112.009 -168.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 35.2 mt -62.15 160.14 33.26 Favored Pre-proline 0 C--O 1.242 0.661 0 C-N-CA 129.327 3.051 . . . . 74.43 113.41 -177.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -80.09 170.18 16.75 Favored 'Trans proline' 0 N--CA 1.448 -1.164 0 C-N-CA 124.752 3.634 . . . . 73.52 110.273 176.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -70.1 -5.06 24.24 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 124.112 0.965 . . . . 72.21 112.919 -179.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -104.38 9.61 35.69 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.428 1.091 . . . . 72.34 111.988 -171.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 93.1 t -120.46 149.52 23.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 N-CA-C 108.166 -1.05 . . . . 73.15 108.166 -177.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 21.9 t-160 -124.88 84.75 2.32 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 128.092 2.557 . . . . 72.42 105.931 -179.127 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 45.5 t80 -68.26 129.43 39.9 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 108.794 -0.817 . . . . 75.42 108.794 174.045 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 40.7 t -136.21 155.13 34.41 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.651 0 C-N-CA 126.461 1.904 . . . . 72.33 106.351 175.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 34.6 mtp180 -133.28 123.35 25.34 Favored 'General case' 0 CA--C 1.515 -0.375 0 N-CA-C 105.371 -2.085 . . . . 75.22 105.371 -176.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 78.0 mt -134.62 144.58 51.4 Favored Pre-proline 0 CA--C 1.533 0.307 0 CA-C-N 119.461 1.028 . . . . 75.32 110.716 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -77.1 129.32 10.42 Favored 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 122.589 2.192 . . . . 65.14 111.36 177.178 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -69.69 114.53 7.98 Favored 'General case' 0 CA--C 1.537 0.465 0 O-C-N 121.519 -0.738 . . . . 73.0 110.245 174.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 14.6 mt -106.62 103.15 12.52 Favored 'General case' 0 N--CA 1.466 0.351 0 O-C-N 121.059 -1.026 . . . . 75.22 110.247 -178.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -133.03 13.35 4.29 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 114.901 1.445 . . . . 73.52 114.901 -174.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -169.47 -116.9 0.39 Allowed Glycine 0 C--N 1.333 0.385 0 CA-C-N 119.603 1.092 . . . . 74.15 112.382 176.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -114.52 -73.6 0.58 Allowed Glycine 0 C--N 1.334 0.438 0 C-N-CA 126.225 1.869 . . . . 71.44 108.448 171.048 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 6.4 tp -58.84 -24.77 27.22 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-N 118.248 1.024 . . . . 72.11 112.164 -174.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 10.5 m95 -59.47 -48.8 80.26 Favored 'General case' 0 N--CA 1.455 -0.201 0 O-C-N 121.444 -0.785 . . . . 71.42 111.547 172.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 11.7 p30 -77.94 -30.64 50.57 Favored 'General case' 0 CA--C 1.509 -0.601 0 CA-C-O 117.663 -1.161 . . . . 75.15 113.599 177.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 74.5 t -57.15 -58.22 6.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 108.824 -0.806 . . . . 73.51 108.824 172.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 37.4 m170 -65.58 -24.18 67.02 Favored 'General case' 0 CA--C 1.528 0.109 0 N-CA-C 112.416 0.525 . . . . 75.22 112.416 178.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -78.96 -18.99 73.77 Favored Glycine 0 N--CA 1.444 -0.804 0 CA-C-O 118.966 -0.908 . . . . 73.3 111.302 178.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.71 -55.77 13.6 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 118.275 1.037 . . . . 73.4 109.606 -160.427 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 3.7 ptm -55.21 -28.78 55.54 Favored 'General case' 0 N--CA 1.454 -0.273 0 O-C-N 124.129 0.893 . . . . 75.44 113.294 -166.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 29.7 t80 -55.22 -52.06 64.59 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 124.007 0.923 . . . . 74.22 109.981 176.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 37.9 mt -66.54 -43.1 86.03 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 117.979 -1.01 . . . . 75.05 109.821 179.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.6 -41.67 90.86 Favored 'General case' 0 C--N 1.344 0.354 0 CA-C-N 120.3 1.409 . . . . 65.03 110.906 -179.31 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.4 -55.45 33.38 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 123.882 0.873 . . . . 71.31 109.077 -178.484 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -74.74 -14.53 60.73 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 112.505 0.558 . . . . 75.34 112.505 -177.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 3.2 t -70.44 -10.22 58.53 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.821 1.249 . . . . 72.32 112.222 171.384 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 43.4 mtm . . . . . 0 CA--C 1.535 0.386 0 C-N-CA 124.423 1.089 . . . . 75.33 112.887 168.165 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.445 0 CA-C-O 118.872 -0.585 . . . . 74.0 112.003 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.9 t -62.26 -76.8 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 N-CA-C 108.515 -0.92 . . . . 72.22 108.515 164.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -51.26 -46.92 62.54 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 126.018 1.727 . . . . 73.04 112.103 -176.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 22.2 mm-40 -60.9 -44.17 97.52 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.514 1.526 . . . . 71.2 109.242 -175.38 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -74.91 -3.49 32.39 Favored 'General case' 0 CA--C 1.531 0.245 0 O-C-N 120.62 -1.3 . . . . 73.22 113.158 -179.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 72.8 mt -104.18 -54.78 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 N-CA-C 106.554 -1.647 . . . . 74.04 106.554 177.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 90.7 m-70 -80.54 -56.13 4.38 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 123.495 0.718 . . . . 73.22 112.014 -173.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 2.2 mmtp -71.87 -12.95 61.52 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 123.753 0.821 . . . . 74.21 112.05 -178.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -117.07 -31.32 5.4 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.963 0.905 . . . . 74.31 112.494 -174.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 5.2 t60 45.15 61.04 2.7 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 125.903 1.681 . . . . 73.3 111.209 -176.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 7.8 mtpp -76.94 159.45 29.97 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.727 -1.124 . . . . 74.31 108.454 170.082 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 46.5 tttt -85.82 38.35 0.75 Allowed 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 125.726 1.61 . . . . 64.14 111.735 -173.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 43.3 mt -72.61 51.07 0.26 Allowed 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 128.815 2.846 . . . . 73.42 112.053 -167.146 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -103.12 3.66 36.14 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 129.463 3.105 . . . . 74.11 112.21 -177.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -134.39 156.03 79.26 Favored Pre-proline 0 N--CA 1.467 0.413 0 CA-C-N 118.556 0.616 . . . . 73.14 110.66 171.073 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -70.89 -19.84 30.25 Favored 'Trans proline' 0 N--CA 1.449 -1.108 0 C-N-CA 121.658 1.572 . . . . 72.31 111.889 -177.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.7 -62.95 1.48 Allowed 'General case' 0 C--O 1.224 -0.255 0 CA-C-N 119.859 1.209 . . . . 74.14 108.961 168.11 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -45.79 -56.55 5.2 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 127.229 2.211 . . . . 72.45 110.413 178.358 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 57.4 mtt -54.91 -50.45 68.77 Favored 'General case' 0 N--CA 1.458 -0.065 0 C-N-CA 123.7 0.8 . . . . 71.13 111.354 -178.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -77.1 -40.63 45.21 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-O 119.043 -0.504 . . . . 75.33 111.013 -170.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -56.43 -35.61 68.04 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 125.12 1.368 . . . . 73.1 110.525 174.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 82.8 t80 -71.81 -54.08 11.28 Favored 'General case' 0 N--CA 1.44 -0.952 0 C-N-CA 122.969 0.508 . . . . 73.53 110.2 176.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 73.5 mt -69.64 -18.31 63.58 Favored 'General case' 0 CA--C 1.52 -0.178 0 C-N-CA 123.454 0.702 . . . . 73.11 112.428 -173.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -57.17 -16.71 8.54 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.226 1.41 . . . . 64.34 112.32 -176.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -110.38 8.12 30.58 Favored Glycine 0 CA--C 1.526 0.74 0 C-N-CA 124.94 1.257 . . . . 53.25 113.588 177.073 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 30.9 mmtt -129.09 27.6 5.37 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 119.608 1.704 . . . . 73.25 111.398 -169.096 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 85.56 41.54 7.27 Favored Glycine 0 N--CA 1.447 -0.579 0 CA-C-O 119.199 -0.778 . . . . 75.12 111.245 178.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 95.0 t -135.83 141.91 40.59 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 106.968 -1.493 . . . . 70.43 106.968 173.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 66.2 t0 -97.12 123.62 40.92 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 108.231 -1.025 . . . . 54.33 108.231 167.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -57.88 -38.97 76.73 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.789 0.835 . . . . 73.33 109.245 177.071 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -61.87 -41.46 97.88 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 123.638 0.775 . . . . 74.42 111.225 -177.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 21.1 mmtt -79.59 -47.28 15.75 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 108.074 -1.084 . . . . 71.32 108.074 -176.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 80.2 t80 -44.98 -59.3 2.64 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 126.322 1.849 . . . . 73.02 110.126 -177.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 32.4 mt -69.38 -36.32 76.69 Favored 'General case' 0 C--O 1.234 0.245 0 O-C-N 122.107 -0.371 . . . . 73.21 111.217 -176.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 23.2 t -56.05 -47.8 77.22 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 109.442 -0.577 . . . . 72.0 109.442 178.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . 0.259 15.0 t -77.28 -31.62 54.94 Favored 'General case' 0 CA--C 1.543 0.712 0 C-N-CA 123.116 0.567 . . . . 75.44 111.543 -179.089 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 76.4 t80 -56.19 -36.49 68.45 Favored 'General case' 0 N--CA 1.471 0.621 0 O-C-N 120.357 -1.465 . . . . 75.3 111.893 172.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 48.0 m-20 -102.97 13.39 34.43 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.085 0.954 . . . . 73.12 111.216 176.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 40.0 t -88.81 163.65 15.58 Favored 'General case' 0 C--O 1.235 0.298 0 O-C-N 120.469 -1.395 . . . . 75.55 109.263 174.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -59.11 -24.96 63.41 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 114.92 -1.036 . . . . 64.41 110.85 170.328 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -48.91 -63.48 1.08 Allowed 'General case' 0 C--O 1.236 0.387 0 C-N-CA 124.568 1.147 . . . . 72.33 110.955 176.089 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 7.1 mm -58.36 -32.58 45.49 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 N-CA-C 113.532 0.938 . . . . 74.23 113.532 176.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 2.7 tttp -57.7 -35.05 70.1 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 118.844 0.747 . . . . 71.11 110.151 -178.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -80.13 -37.24 22.3 Favored Glycine 0 C--N 1.34 0.798 0 C-N-CA 124.864 1.221 . . . . 64.22 111.969 -178.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 2.4 mm100 -70.74 -39.8 73.1 Favored 'General case' 0 C--N 1.331 -0.238 0 O-C-N 121.582 -0.952 . . . . 72.03 109.312 -178.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -62.23 -50.09 73.15 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 123.668 0.787 . . . . 75.12 110.191 176.475 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -63.42 -43.23 98.08 Favored 'General case' 0 CA--C 1.521 -0.151 0 CA-C-O 117.744 -1.122 . . . . 73.51 111.095 -177.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 44.7 mtmt -59.29 -59.67 5.09 Favored 'General case' 0 C--N 1.343 0.31 0 CA-C-O 117.991 -1.004 . . . . 73.33 108.748 177.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -54.35 -35.73 63.07 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 119.852 1.206 . . . . 71.13 112.012 -179.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 35.8 tttt -65.97 -66.44 0.55 Allowed 'General case' 0 C--N 1.342 0.278 0 N-CA-C 108.467 -0.938 . . . . 71.25 108.467 177.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 17.7 ptmt -60.02 -28.14 67.48 Favored 'General case' 0 C--O 1.227 -0.106 0 C-N-CA 123.476 0.71 . . . . 73.25 111.187 -171.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 36.2 mt -68.75 -58.58 4.01 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 124.816 1.246 . . . . 65.04 111.976 173.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -55.6 -50.6 69.69 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 118.957 0.799 . . . . 72.31 110.244 -169.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -58.87 -42.74 90.18 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 113.007 0.743 . . . . 73.22 113.007 174.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -65.84 -26.37 67.63 Favored 'General case' 0 N--CA 1.462 0.155 0 C-N-CA 123.33 0.652 . . . . 75.45 111.622 -178.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 36.2 m-85 -84.17 20.13 1.67 Allowed 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.3 1.44 . . . . 71.32 112.125 172.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 11.5 mm100 64.35 6.44 3.05 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 127.399 2.279 . . . . 74.54 115.536 173.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 42.9 t -51.7 -57.27 3.63 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.985 0 C-N-CA 127.639 2.376 . . . . 72.23 113.858 -164.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . 0.281 73.5 p 54.97 -40.05 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 128.912 2.885 . . . . 75.35 117.365 -165.341 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -150.45 -177.87 24.79 Favored Glycine 0 CA--C 1.521 0.422 0 C-N-CA 125.951 1.739 . . . . 64.14 110.285 -171.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.437 ' HA ' ' C ' ' A' ' 154' ' ' PRO . 17.3 m -133.26 157.33 78.47 Favored Pre-proline 0 C--O 1.239 0.545 0 N-CA-C 108.801 -0.815 . . . . 74.53 108.801 -178.186 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . 0.437 ' C ' ' HA ' ' A' ' 153' ' ' VAL . 37.4 Cg_endo -66.74 154.07 83.43 Favored 'Cis proline' 0 N--CA 1.46 -0.489 0 C-N-CA 124.478 -1.051 . . . . 71.42 112.494 -4.265 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 35.3 m -155.06 110.61 3.1 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 105.194 -2.15 . . . . 73.44 105.194 172.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 95.9 mtp -89.5 152.12 21.61 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 107.5 -1.296 . . . . 71.42 107.5 164.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 15.0 t -138.97 139.41 40.48 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.288 0 N-CA-C 108.113 -1.069 . . . . 71.31 108.113 175.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 11.4 t -112.34 124.09 68.7 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 C-N-CA 126.395 1.878 . . . . 75.21 106.516 176.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 1.4 t30 51.0 17.13 0.4 Allowed 'General case' 0 C--O 1.223 -0.308 0 C-N-CA 128.836 2.854 . . . . 72.21 114.813 170.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 58.71 38.99 92.97 Favored Glycine 0 CA--C 1.525 0.66 0 C-N-CA 125.69 1.614 . . . . 71.52 112.829 -168.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 37.6 mttt -132.95 -38.27 0.98 Allowed 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 124.51 1.124 . . . . 74.22 112.29 178.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -116.6 118.24 32.07 Favored 'General case' 0 CA--C 1.517 -0.311 0 N-CA-C 108.284 -1.006 . . . . 71.34 108.284 -178.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 37.3 ttp85 -105.43 123.33 47.7 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 126.536 1.934 . . . . 75.42 106.972 174.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 13.5 p90 -150.23 170.97 17.72 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 107.529 -1.286 . . . . 75.15 107.529 -176.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -178.84 178.77 0.75 Allowed 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.166 -0.679 . . . . 75.3 109.166 -173.197 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 23.7 mt -47.96 -55.95 2.28 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 C-N-CA 127.733 2.413 . . . . 73.24 109.044 174.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -75.67 8.01 23.15 Favored Glycine 0 CA--C 1.526 0.727 0 C-N-CA 127.028 2.251 . . . . 74.1 114.794 178.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 4.7 m -110.72 -52.25 2.8 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-N 119.507 1.653 . . . . 74.41 109.886 168.038 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -65.39 -53.11 47.97 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 125.652 1.581 . . . . 62.43 111.598 -178.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 142.59 -7.16 2.21 Favored Glycine 0 CA--C 1.528 0.846 0 CA-C-O 119.056 -0.858 . . . . 70.33 114.41 -174.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 155.7 175.72 27.04 Favored Glycine 0 CA--C 1.53 0.983 0 CA-C-N 119.514 1.657 . . . . 50.11 110.149 -175.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -61.21 -53.67 2.31 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 122.918 2.412 . . . . 65.22 111.247 -175.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 8.2 mp0 -62.85 -32.89 74.2 Favored 'General case' 0 CA--C 1.536 0.411 0 O-C-N 121.434 -0.791 . . . . 71.43 110.924 179.134 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -66.17 -30.76 71.3 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.218 0.607 . . . . 74.5 110.131 178.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 37.7 m -65.59 -46.21 80.24 Favored 'General case' 0 N--CA 1.455 -0.221 0 O-C-N 121.364 -0.835 . . . . 72.21 110.453 -173.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 64.0 mt -62.89 -28.08 69.8 Favored 'General case' 0 C--O 1.223 -0.306 0 CA-C-N 118.559 0.618 . . . . 75.31 111.447 -177.027 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 2.6 tttt -53.58 -49.41 67.8 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 124.819 1.248 . . . . 74.21 109.338 172.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -67.12 -44.51 79.72 Favored 'General case' 0 CA--C 1.515 -0.392 0 N-CA-C 109.329 -0.619 . . . . 73.4 109.329 175.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -56.78 -31.73 64.94 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 118.34 -0.838 . . . . 71.33 112.71 -174.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -84.16 -52.0 6.61 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 126.357 1.863 . . . . 73.34 108.666 -176.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 16.6 t80 -60.84 -45.61 93.8 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 123.896 0.878 . . . . 72.12 110.998 -175.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 93.1 mt -61.22 -28.66 69.32 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.06 0.944 . . . . 73.14 112.527 -178.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 44.0 mt -60.3 -52.78 57.36 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 CA-C-N 119.931 1.241 . . . . 75.14 108.357 173.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -66.71 -5.72 12.98 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 126.802 2.041 . . . . 74.04 112.901 177.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -98.12 -23.74 15.6 Favored 'General case' 0 N--CA 1.463 0.21 0 O-C-N 120.868 -1.145 . . . . 74.44 111.525 173.187 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 30.5 mm-40 -96.54 -33.57 11.78 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 123.785 0.834 . . . . 70.33 112.734 -176.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.12 -32.55 23.07 Favored 'General case' 0 N--CA 1.476 0.841 0 O-C-N 120.847 -1.158 . . . . 74.43 110.522 168.748 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.478 0 C-N-CA 126.713 2.005 . . . . 73.41 111.883 179.773 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 . . . . . 0 CA--C 1.532 0.28 0 CA-C-O 121.083 0.468 . . . . 75.53 110.857 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -153.23 15.88 0.54 Allowed 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 114.058 1.133 . . . . 72.22 114.058 -175.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 38.5 m-85 -135.49 160.2 39.2 Favored 'General case' 0 C--O 1.24 0.589 0 C-N-CA 125.1 1.36 . . . . 73.31 108.884 -173.299 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 88.6 m -125.89 134.78 51.49 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 109.217 -0.66 . . . . 72.54 109.217 178.062 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.03 144.36 57.33 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 121.837 0.827 . . . . 74.24 111.077 176.003 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 76.85 -19.61 3.28 Favored Glycine 0 CA--C 1.527 0.807 0 CA-C-O 118.674 -1.07 . . . . 61.42 112.366 -172.324 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 20.3 ttmt -97.43 -84.3 0.38 Allowed 'General case' 0 CA--C 1.511 -0.55 0 CA-C-N 119.116 1.458 . . . . 75.45 108.007 -177.101 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -64.61 -26.31 68.34 Favored 'General case' 0 N--CA 1.442 -0.854 0 C-N-CA 124.748 1.219 . . . . 64.43 110.145 -175.19 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 12.7 p90 -163.91 171.8 14.85 Favored 'General case' 0 C--O 1.233 0.206 0 O-C-N 121.091 -1.006 . . . . 71.43 108.58 -172.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 24.4 t -132.34 110.83 16.8 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 C-N-CA 123.614 0.765 . . . . 74.34 110.035 -177.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -68.75 159.77 31.65 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 124.793 1.237 . . . . 70.42 109.112 166.514 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -134.08 116.36 15.37 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 124.214 1.005 . . . . 64.11 108.425 -174.454 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -61.6 -1.1 0.51 Allowed 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 125.805 1.642 . . . . 75.25 113.908 -177.539 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 48.9 m -133.82 85.57 40.94 Favored Pre-proline 0 CA--C 1.541 0.598 0 C-N-CA 127.583 2.353 . . . . 71.12 108.284 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -77.54 -178.73 4.81 Favored 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 124.647 3.564 . . . . 75.14 113.388 -178.372 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 25.9 t -136.55 148.21 62.88 Favored Pre-proline 0 CA--C 1.548 0.875 0 C-N-CA 126.525 1.93 . . . . 73.22 109.005 -178.115 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -82.19 -178.68 4.2 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 124.567 3.511 . . . . 73.53 112.572 173.493 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.9 m -131.36 172.18 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 124.975 1.31 . . . . 75.13 109.513 172.003 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 66.4 m -48.89 -56.15 9.62 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 125.614 1.565 . . . . 73.22 112.142 176.273 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -144.35 152.08 52.85 Favored Pre-proline 0 C--O 1.239 0.529 0 C-N-CA 125.363 1.465 . . . . 72.31 108.072 -172.604 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -69.45 178.33 4.49 Favored 'Trans proline' 0 N--CA 1.451 -0.982 0 C-N-CA 122.492 2.128 . . . . 74.54 109.251 165.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.26 -118.87 6.2 Favored Glycine 0 N--CA 1.45 -0.402 0 N-CA-C 106.951 -2.46 . . . . 72.05 106.951 -166.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -61.01 137.55 58.23 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 119.519 1.66 . . . . 74.34 110.916 -163.225 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 42.1 mm -62.72 138.88 22.02 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 N-CA-C 107.12 -1.437 . . . . 71.2 107.12 168.113 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.7 124.41 36.69 Favored 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 127.138 2.175 . . . . 73.12 106.851 -178.668 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.7 t -128.82 102.29 7.8 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.174 0 N-CA-C 106.438 -1.69 . . . . 72.23 106.438 176.173 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 52.3 t -97.33 114.25 33.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 107.278 -1.378 . . . . 74.15 107.278 -177.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 67.7 tt0 -72.28 134.27 45.47 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 107.6 -1.259 . . . . 54.14 107.6 152.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 5.0 mp -111.36 136.02 51.08 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 107.061 -1.459 . . . . 75.41 107.061 160.035 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 28.9 p90 -134.28 166.71 22.18 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.229 1.011 . . . . 75.03 110.642 -177.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 26.6 t90 -150.36 158.95 44.72 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.724 1.21 . . . . 74.24 108.888 176.101 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 5.3 m-30 -83.59 51.29 1.97 Allowed 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.427 0.691 . . . . 75.23 111.302 178.171 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -174.91 18.84 0.05 OUTLIER Glycine 0 N--CA 1.463 0.446 0 O-C-N 120.287 -1.508 . . . . 74.51 114.273 -174.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 20.6 p -118.41 86.28 27.76 Favored Pre-proline 0 N--CA 1.449 -0.513 0 C-N-CA 124.907 1.283 . . . . 74.12 108.252 -172.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -63.15 -11.79 26.86 Favored 'Trans proline' 0 CA--C 1.541 0.874 0 C-N-CA 122.279 1.986 . . . . 74.22 114.03 -170.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 35.3 m170 -73.74 -22.73 59.78 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 119.209 0.913 . . . . 72.42 112.625 168.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 79.1 m -67.53 -65.85 0.64 Allowed 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.564 1.545 . . . . 74.43 110.67 -173.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 14.2 t80 -59.32 -29.23 67.47 Favored 'General case' 0 N--CA 1.467 0.419 0 O-C-N 121.415 -0.803 . . . . 74.11 112.036 -179.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.47 -26.22 68.62 Favored 'General case' 0 CA--C 1.542 0.652 0 O-C-N 121.452 -0.78 . . . . 75.53 112.615 176.04 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 20.8 t80 -93.97 -18.03 22.32 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 124.999 1.319 . . . . 75.44 112.426 -173.066 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -38.22 -63.04 0.59 Allowed Pre-proline 0 N--CA 1.472 0.631 0 C-N-CA 125.451 1.5 . . . . 74.55 112.767 175.079 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -77.23 -11.44 17.6 Favored 'Trans proline' 0 CA--C 1.534 0.524 0 CA-C-N 121.775 1.67 . . . . 72.15 114.533 -171.103 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.8 m -72.15 -44.97 62.27 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 107.786 -1.19 . . . . 73.4 107.786 166.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 14.3 tt -94.15 -28.65 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 N-CA-C 113.47 0.915 . . . . 75.04 113.47 -165.339 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 14.1 t -47.88 -60.94 3.5 Favored Pre-proline 0 CA--C 1.544 0.724 0 C-N-CA 124.87 1.268 . . . . 73.43 110.027 171.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_endo -72.28 -7.77 21.54 Favored 'Trans proline' 0 C--N 1.348 0.538 0 CA-C-N 121.555 1.591 . . . . 63.35 113.34 -175.247 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 82.6 t90 -77.57 -61.11 2.1 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 119.591 1.087 . . . . 73.12 108.297 165.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 47.9 t -60.23 -36.55 77.98 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.156 1.382 . . . . 72.31 112.593 -169.483 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -75.04 -10.76 59.77 Favored 'General case' 0 CA--C 1.54 0.566 0 O-C-N 120.78 -1.2 . . . . 65.52 111.922 -177.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -111.86 18.82 18.52 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 127.736 2.414 . . . . 74.5 113.228 -176.212 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 39.1 mt -75.22 156.18 85.8 Favored Pre-proline 0 N--CA 1.448 -0.565 0 C-N-CA 125.044 1.338 . . . . 64.42 111.424 -177.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -77.78 172.35 15.83 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 124.964 3.776 . . . . 75.42 111.096 179.045 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -66.12 -2.83 4.57 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 114.501 1.297 . . . . 71.02 114.501 -178.577 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -102.74 1.69 34.69 Favored 'General case' 0 C--O 1.223 -0.335 0 C-N-CA 125.05 1.34 . . . . 74.35 112.453 -177.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 39.1 t -125.99 131.52 71.67 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 CA-C-N 120.161 1.346 . . . . 70.32 108.381 -170.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 86.5 t60 -131.67 101.69 5.59 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 125.096 1.358 . . . . 74.31 109.214 -176.169 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 10.4 t80 -82.66 138.55 34.1 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 126.579 1.951 . . . . 73.55 109.476 -176.111 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 23.6 t -130.08 154.32 40.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 106.974 -1.491 . . . . 73.51 106.974 178.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 66.5 mtt85 -123.86 129.7 51.42 Favored 'General case' 0 CA--C 1.513 -0.448 0 N-CA-C 105.279 -2.119 . . . . 75.31 105.279 168.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 47.5 mt -134.24 148.92 69.8 Favored Pre-proline 0 C--N 1.33 -0.256 0 N-CA-C 108.921 -0.77 . . . . 75.31 108.921 175.354 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -73.8 140.24 28.78 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 122.347 2.031 . . . . 74.4 110.287 178.024 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -79.1 88.42 4.83 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.883 0.873 . . . . 73.24 110.549 178.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 10.1 mt -87.68 96.73 10.54 Favored 'General case' 0 C--N 1.331 -0.214 0 O-C-N 120.188 -1.57 . . . . 73.42 109.858 -177.336 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 48.0 m-85 -115.84 36.36 4.05 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 123.929 0.892 . . . . 74.41 110.958 179.34 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 78.66 -161.47 48.12 Favored Glycine 0 C--N 1.336 0.555 0 N-CA-C 110.004 -1.239 . . . . 73.52 110.004 -179.307 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 44.82 -131.79 7.78 Favored Glycine 0 CA--C 1.532 1.106 0 C-N-CA 125.355 1.455 . . . . 45.43 113.106 172.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 7.7 tp -80.76 -18.47 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 123.73 0.812 . . . . 74.04 110.962 174.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 8.6 m95 -58.52 -38.4 77.64 Favored 'General case' 0 C--N 1.338 0.097 0 O-C-N 121.226 -0.921 . . . . 72.44 111.664 -171.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -83.04 -28.24 29.74 Favored 'General case' 0 C--O 1.232 0.134 0 N-CA-C 113.647 0.98 . . . . 71.25 113.647 177.044 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 33.3 t -59.66 -52.4 61.49 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 N-CA-C 107.336 -1.357 . . . . 75.12 107.336 174.613 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 65.6 m170 -75.01 47.82 0.36 Allowed 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 126.968 2.107 . . . . 75.42 111.261 170.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -153.46 -42.17 0.02 OUTLIER Glycine 0 CA--C 1.526 0.734 0 C-N-CA 124.93 1.252 . . . . 75.44 111.775 177.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 37.9 tt0 -61.95 -26.31 68.12 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.421 1.088 . . . . 75.33 113.783 -168.003 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 1.7 ptt? -71.6 -34.05 69.55 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 120.121 1.328 . . . . 64.31 112.718 -177.395 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 45.1 t80 -54.81 -51.9 64.36 Favored 'General case' 0 N--CA 1.463 0.209 0 C-N-CA 124.067 0.947 . . . . 74.11 109.459 -176.034 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 36.7 mt -57.62 -40.47 79.23 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 124.66 1.184 . . . . 55.23 110.338 178.091 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.8 m -70.36 -35.02 73.28 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 118.717 0.689 . . . . 72.25 111.247 -178.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -57.52 -56.22 24.66 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 125.073 1.349 . . . . 74.2 108.452 178.694 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -73.33 -21.16 60.62 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.907 0.883 . . . . 63.5 112.098 -178.308 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 27.8 t -66.1 -3.51 5.64 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 117.621 -1.181 . . . . 73.35 113.102 175.242 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 44.2 mtm . . . . . 0 N--CA 1.464 0.235 0 CA-C-N 120.933 1.697 . . . . 73.14 113.599 169.517 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.109 0 CA-C-O 118.946 -0.549 . . . . 73.23 112.382 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 58.4 t -58.32 -57.94 8.69 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 C-N-CA 124.091 0.957 . . . . 74.33 108.921 177.051 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -69.39 -37.98 77.77 Favored 'General case' 0 C--N 1.335 -0.058 0 C-N-CA 123.132 0.573 . . . . 74.53 112.36 -176.823 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -58.75 -32.61 69.4 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.608 1.563 . . . . 71.23 110.042 176.367 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -79.61 -20.83 45.91 Favored 'General case' 0 N--CA 1.448 -0.565 0 O-C-N 120.848 -1.157 . . . . 74.03 111.318 178.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 31.8 mt -94.45 -35.72 6.45 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 O-C-N 120.555 -1.341 . . . . 74.11 109.241 -179.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 57.8 m-70 -90.42 -63.64 1.25 Allowed 'General case' 0 C--O 1.233 0.232 0 C-N-CA 124.489 1.116 . . . . 64.32 110.954 -174.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 7.5 mtmt -68.07 -35.61 78.48 Favored 'General case' 0 N--CA 1.463 0.223 0 O-C-N 121.929 -0.482 . . . . 74.24 110.583 -176.163 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -99.87 -70.29 0.74 Allowed 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 108.51 -0.922 . . . . 74.23 108.51 -172.467 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 7.5 t-80 74.6 64.01 0.07 Allowed 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 128.618 2.767 . . . . 73.11 113.301 -177.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 65.2 mttt -76.53 28.97 0.12 Allowed 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 114.755 1.391 . . . . 73.43 114.755 179.515 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 10.0 tmtt? 46.52 57.91 5.05 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 125.958 1.703 . . . . 72.52 112.509 176.189 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 44.7 mt -67.46 42.4 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 130.16 3.384 . . . . 72.03 112.197 179.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -88.36 6.44 37.26 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 128.679 2.792 . . . . 71.2 113.14 -178.563 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -139.7 156.49 71.03 Favored Pre-proline 0 CA--C 1.537 0.479 0 C-N-CA 123.809 0.844 . . . . 74.43 111.335 178.614 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -64.69 -39.4 26.96 Favored 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 122.579 2.186 . . . . 72.23 112.386 -179.243 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -59.2 -42.89 92.0 Favored 'General case' 0 C--O 1.225 -0.187 0 CA-C-N 118.09 0.404 . . . . 71.22 110.177 176.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -60.52 -38.31 83.99 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 123.109 0.564 . . . . 64.45 110.615 -177.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 54.2 mtt -68.45 -49.91 56.44 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 123.908 0.883 . . . . 73.12 110.467 175.173 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -64.75 -47.14 79.29 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 124.811 1.244 . . . . 74.02 110.783 -171.188 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -62.2 -29.13 70.16 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 126.061 1.744 . . . . 73.34 112.836 176.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 73.0 t80 -76.85 -54.86 6.04 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 109.933 -0.395 . . . . 74.21 109.933 174.177 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 56.4 mt -68.07 -21.19 65.0 Favored 'General case' 0 CA--C 1.516 -0.345 0 O-C-N 121.809 -0.557 . . . . 75.4 110.584 -168.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -55.03 -13.65 1.23 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.402 0.681 . . . . 72.15 112.236 169.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -88.06 -9.69 70.23 Favored Glycine 0 N--CA 1.433 -1.51 0 CA-C-O 116.97 -2.017 . . . . 53.4 110.235 179.216 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -130.35 10.94 5.34 Favored 'General case' 0 C--N 1.347 0.466 0 CA-C-N 120.985 2.393 . . . . 72.45 112.947 -170.137 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 86.83 70.68 1.3 Allowed Glycine 0 N--CA 1.445 -0.731 0 N-CA-C 109.454 -1.458 . . . . 73.24 109.454 -179.198 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 25.7 t -141.4 129.71 22.83 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.816 0 C-N-CA 127.168 2.187 . . . . 74.12 107.271 172.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 41.2 t0 -89.45 123.16 33.33 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 124.185 0.994 . . . . 73.21 110.639 178.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 11.2 mtmt -59.07 -38.7 80.06 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 124.194 0.998 . . . . 61.13 111.02 171.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 75.7 mm-40 -65.17 -15.22 62.19 Favored 'General case' 0 C--N 1.329 -0.318 0 O-C-N 120.983 -1.073 . . . . 74.31 112.889 -177.403 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 9.7 mmtm -117.95 -42.33 2.83 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-O 117.585 -1.198 . . . . 74.12 110.777 -178.189 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 81.3 t80 -46.65 -65.71 0.52 Allowed 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 125.238 1.415 . . . . 74.43 111.12 171.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 18.0 mt -62.3 -38.38 89.15 Favored 'General case' 0 N--CA 1.465 0.279 0 O-C-N 122.055 -0.403 . . . . 72.34 110.827 -173.459 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 31.8 t -54.17 -61.76 2.09 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 107.883 -1.154 . . . . 73.13 107.883 177.178 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . 0.281 4.8 t -69.41 -30.2 68.1 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 118.268 -0.873 . . . . 73.43 110.699 -173.541 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 60.8 t80 -56.49 -42.1 77.73 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 119.87 1.214 . . . . 74.2 111.212 176.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -94.7 13.72 23.5 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.906 1.282 . . . . 73.34 111.854 179.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 50.5 m -103.56 161.98 13.43 Favored 'General case' 0 N--CA 1.469 0.504 0 O-C-N 120.618 -1.302 . . . . 54.24 111.167 176.406 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -63.52 -33.88 76.57 Favored 'General case' 0 C--O 1.225 -0.215 0 C-N-CA 122.628 0.371 . . . . 72.41 111.944 -171.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -50.99 -46.95 61.55 Favored 'General case' 0 CA--C 1.534 0.339 0 O-C-N 121.705 -0.622 . . . . 74.23 111.98 -175.636 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 48.2 mm -68.53 -33.6 60.89 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-O 118.912 -0.566 . . . . 74.53 110.01 179.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 12.3 tttt -55.05 -38.47 68.04 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 119.453 1.024 . . . . 71.11 110.45 171.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -70.96 -42.44 59.76 Favored Glycine 0 C--N 1.335 0.503 0 N-CA-C 110.603 -0.999 . . . . 64.22 110.603 -175.117 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -67.11 -43.82 81.48 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 123.946 0.898 . . . . 75.31 109.833 -179.51 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 86.7 mmm -58.54 -52.59 65.0 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 125.397 1.479 . . . . 64.43 109.665 175.272 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -63.26 -39.16 93.82 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 120.001 1.273 . . . . 72.53 112.004 -173.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 7.2 mmtt -56.29 -59.77 4.47 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 119.057 0.844 . . . . 75.12 109.227 170.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -53.62 -42.58 67.9 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 118.308 0.504 . . . . 71.32 110.948 -175.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 7.7 tttt -57.99 -60.8 3.16 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 125.532 1.533 . . . . 75.45 109.872 177.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 2.2 pttt -71.03 -17.62 62.61 Favored 'General case' 0 CA--C 1.529 0.169 0 N-CA-C 112.313 0.486 . . . . 74.15 112.313 -174.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 32.6 mt -73.81 -56.12 5.36 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 124.021 0.928 . . . . 74.54 111.01 170.305 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -57.16 -43.19 82.29 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 119.049 0.84 . . . . 73.24 111.577 -171.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 3.8 ppp? -60.62 -44.29 96.49 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 113.146 0.795 . . . . 74.24 113.146 174.289 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -62.92 -35.75 81.12 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 124.247 1.019 . . . . 75.13 111.096 179.263 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 31.0 m-85 -74.54 14.37 0.48 Allowed 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.11 1.364 . . . . 74.1 113.317 177.458 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 57.32 18.65 4.47 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 126.023 1.729 . . . . 71.25 114.112 178.212 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 20.6 t -75.0 137.05 23.8 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 CA-C-N 119.177 0.898 . . . . 74.03 109.309 -174.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -132.42 2.97 3.88 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.524 0.73 . . . . 54.31 112.191 -172.345 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -173.54 -168.91 35.27 Favored Glycine 0 CA--C 1.527 0.83 0 C-N-CA 127.278 2.371 . . . . 73.34 110.054 178.228 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.415 ' HA ' ' C ' ' A' ' 154' ' ' PRO . 3.5 m -149.04 157.37 40.05 Favored Pre-proline 0 CA--C 1.537 0.476 0 C-N-CA 125.943 1.697 . . . . 61.5 109.092 -175.798 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . 0.415 ' C ' ' HA ' ' A' ' 153' ' ' VAL . 18.7 Cg_endo -62.31 159.79 56.17 Favored 'Cis proline' 0 N--CA 1.454 -0.848 0 C-N-CA 124.527 -1.031 . . . . 75.32 111.571 -9.837 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 7.7 m -155.56 139.71 16.52 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 107.695 -1.224 . . . . 74.11 107.695 176.174 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 98.8 mtp -119.11 160.26 22.41 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-N 114.666 -1.152 . . . . 75.13 108.17 170.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 39.6 t -139.89 156.01 25.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 106.188 -1.782 . . . . 74.44 106.188 178.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 48.2 t -126.18 120.39 56.67 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 N-CA-C 107.242 -1.392 . . . . 72.21 107.242 171.033 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 23.2 m-20 51.64 21.87 1.45 Allowed 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 127.794 2.437 . . . . 72.14 114.405 175.199 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 57.02 32.89 63.15 Favored Glycine 0 CA--C 1.528 0.854 0 CA-C-O 118.239 -1.312 . . . . 62.33 113.996 -168.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 8.0 mtpt -126.79 -29.94 2.81 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 119.491 1.646 . . . . 73.43 111.467 -178.437 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -126.07 128.91 48.12 Favored 'General case' 0 CA--C 1.519 -0.225 0 N-CA-C 108.553 -0.906 . . . . 75.34 108.553 179.221 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 3.7 ttp85 -101.04 132.45 46.46 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 105.673 -1.973 . . . . 74.42 105.673 171.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 13.9 p90 -147.9 161.93 40.32 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.65 -0.871 . . . . 73.11 108.65 173.276 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -170.47 -171.87 1.15 Allowed 'General case' 0 N--CA 1.474 0.762 0 O-C-N 121.741 -0.6 . . . . 75.24 111.162 -174.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 12.2 mt -71.72 -26.02 25.29 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 C-N-CA 126.137 1.775 . . . . 73.34 110.263 -179.168 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -66.16 -54.78 22.16 Favored Glycine 0 N--CA 1.444 -0.811 0 N-CA-C 110.196 -1.161 . . . . 60.42 110.196 168.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 11.4 m -69.06 -59.17 3.22 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 117.398 0.599 . . . . 64.12 111.036 -163.219 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -67.35 -35.79 80.09 Favored 'General case' 0 CA--C 1.537 0.462 0 O-C-N 122.034 -0.416 . . . . 73.03 111.862 -167.482 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 140.64 4.09 1.25 Allowed Glycine 0 CA--C 1.531 1.049 0 C-N-CA 125.59 1.567 . . . . 74.23 115.744 175.362 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 137.36 178.18 15.71 Favored Glycine 0 CA--C 1.531 1.078 0 CA-C-N 119.797 1.798 . . . . 74.42 109.59 -168.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -64.68 -44.48 10.66 Favored 'Trans proline' 0 N--CA 1.459 -0.553 0 C-N-CA 123.243 2.629 . . . . 75.51 112.006 -166.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -56.13 -44.75 79.49 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.363 0.665 . . . . 73.04 109.968 178.377 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -71.68 -27.53 63.11 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 116.012 -0.54 . . . . 74.43 110.36 -173.554 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 90.0 m -59.13 -43.56 92.0 Favored 'General case' 0 CA--C 1.533 0.319 0 O-C-N 120.612 -1.305 . . . . 74.13 110.636 177.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 52.0 mt -64.46 -35.46 81.0 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 119.228 0.922 . . . . 75.53 110.852 177.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 21.2 tttt -55.3 -36.02 65.73 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 124.423 1.089 . . . . 73.43 110.121 176.196 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -79.57 -43.9 22.1 Favored 'General case' 0 CA--C 1.513 -0.47 0 CA-C-O 117.67 -1.157 . . . . 73.12 110.294 173.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -51.33 -43.2 61.68 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 119.459 1.027 . . . . 71.34 111.979 -177.017 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -82.39 -38.5 24.02 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 123.954 0.902 . . . . 72.23 109.274 -167.268 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 30.8 t80 -61.07 -55.96 26.52 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 124.442 1.097 . . . . 72.42 110.535 171.27 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 91.2 mt -61.72 -29.83 70.36 Favored 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 124.09 0.956 . . . . 74.13 111.83 -173.274 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 30.2 mt -56.47 -60.97 1.37 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.151 0 N-CA-C 108.151 -1.055 . . . . 72.53 108.151 168.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 10.9 tm-20 -52.31 -40.74 62.26 Favored 'General case' 0 N--CA 1.457 -0.113 0 C-N-CA 124.28 1.032 . . . . 74.22 111.554 -177.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 12.7 tptp -58.09 -47.92 81.75 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 123.047 0.539 . . . . 74.4 111.254 -179.434 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 41.5 mm-40 -74.53 -39.47 62.35 Favored 'General case' 0 C--O 1.223 -0.312 0 C-N-CA 123.082 0.553 . . . . 74.4 110.865 178.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.65 -37.89 89.14 Favored 'General case' 0 C--N 1.331 -0.216 0 O-C-N 120.269 -1.519 . . . . 72.31 109.253 -175.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.255 0 C-N-CA 125.267 1.427 . . . . 73.35 111.808 177.288 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 . . . . . 0 C--O 1.232 0.148 0 CA-C-O 122.509 1.147 . . . . 74.42 109.45 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -82.69 16.29 2.26 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 126.366 1.866 . . . . 74.23 114.187 -177.355 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 42.1 m-85 -143.63 164.32 30.75 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 124.431 1.093 . . . . 74.12 110.5 -165.176 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 57.3 m -133.67 130.53 38.34 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.754 1.221 . . . . 75.0 108.609 -176.024 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.91 140.89 58.91 Favored 'General case' 0 C--O 1.232 0.162 0 O-C-N 121.636 -0.665 . . . . 72.23 109.732 175.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 82.52 -23.19 5.74 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 125.877 1.703 . . . . 44.53 112.297 -170.461 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 75.1 tttt -96.64 -72.77 0.62 Allowed 'General case' 0 CA--C 1.508 -0.642 0 CA-C-N 118.405 1.103 . . . . 73.0 110.517 -169.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 16.5 mp0 -76.3 -23.89 54.36 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 124.639 1.175 . . . . 75.44 109.702 178.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 41.3 p90 -162.19 174.46 12.87 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.699 0.8 . . . . 74.4 110.717 -171.265 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 59.8 t -131.95 113.74 22.89 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 N-CA-C 108.123 -1.066 . . . . 74.12 108.123 178.28 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.68 160.51 32.11 Favored 'General case' 0 C--O 1.234 0.283 0 O-C-N 120.602 -1.311 . . . . 73.12 108.736 163.418 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -134.75 116.75 15.23 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 124.43 1.092 . . . . 73.24 110.133 -178.312 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 4.3 p -67.39 6.3 0.62 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 127.274 2.23 . . . . 73.35 113.918 176.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 18.6 m -127.12 71.43 75.96 Favored Pre-proline 0 N--CA 1.45 -0.447 0 C-N-CA 126.023 1.729 . . . . 73.2 108.205 174.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -76.69 179.81 6.09 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 124.125 3.216 . . . . 73.33 112.533 -170.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 88.3 t -140.8 128.2 12.15 Favored Pre-proline 0 CA--C 1.544 0.73 0 C-N-CA 124.284 1.034 . . . . 72.31 110.448 -167.393 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -82.65 178.73 5.87 Favored 'Trans proline' 0 CA--C 1.542 0.897 0 C-N-CA 124.794 3.663 . . . . 71.5 112.326 176.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 28.2 m -134.07 167.29 26.55 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 C-N-CA 124.202 1.001 . . . . 73.42 112.077 -179.268 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 11.2 t -64.42 -49.29 72.11 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 127.427 2.291 . . . . 62.13 109.568 170.163 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 30.9 tt0 -113.74 80.99 5.39 Favored Pre-proline 0 CA--C 1.541 0.601 0 C-N-CA 124.264 1.026 . . . . 75.51 110.451 -173.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -68.97 97.18 0.56 Allowed 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 123.928 3.086 . . . . 74.15 108.216 174.434 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -175.5 -58.97 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.378 0 N-CA-C 110.715 -0.954 . . . . 54.14 110.715 -175.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.46 145.04 28.36 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 107.172 -1.418 . . . . 75.42 107.172 166.634 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 36.9 mm -66.11 131.74 31.79 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 N-CA-C 105.721 -1.955 . . . . 64.24 105.721 167.298 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -80.65 142.58 33.84 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 108.699 -0.852 . . . . 74.51 108.699 171.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 47.1 t -131.57 114.38 25.29 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 N-CA-C 106.391 -1.707 . . . . 71.13 106.391 161.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 4.7 t -92.89 141.85 14.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 106.81 -1.552 . . . . 74.32 106.81 171.256 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 79.4 tt0 -107.64 106.25 16.51 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 105.217 -2.142 . . . . 74.34 105.217 156.286 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.0 mp -74.93 155.43 37.45 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 108.624 -0.88 . . . . 74.31 108.624 165.087 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -140.71 164.02 31.32 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 115.777 -0.647 . . . . 75.41 112.207 -163.849 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 23.6 t90 -159.63 129.76 5.58 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 121.559 0.695 . . . . 75.24 110.642 158.403 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 11.2 m-30 -45.24 -27.3 0.62 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 126.392 1.877 . . . . 75.11 114.611 165.045 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -80.77 2.42 79.6 Favored Glycine 0 CA--C 1.531 1.067 0 CA-C-N 119.63 1.105 . . . . 73.04 114.161 -178.151 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 54.1 t -105.44 86.89 1.86 Allowed Pre-proline 0 CA--C 1.539 0.543 0 C-N-CA 125.71 1.604 . . . . 71.02 112.72 -165.304 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -63.81 -25.13 68.05 Favored 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 121.862 1.708 . . . . 72.12 112.95 177.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 13.7 m-70 -61.76 -46.39 89.78 Favored 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 108.365 -0.976 . . . . 75.1 108.365 173.337 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 87.7 m -60.09 -39.03 84.7 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.83 0.852 . . . . 52.1 109.037 -170.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 45.7 t80 -51.96 -40.46 60.88 Favored 'General case' 0 C--N 1.344 0.344 0 C-N-CA 125.3 1.44 . . . . 72.12 110.763 178.316 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.74 -26.25 68.28 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 118.817 -0.611 . . . . 75.14 112.546 -178.337 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -79.3 -25.73 42.37 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-O 117.558 -1.21 . . . . 75.04 111.741 -176.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 28.8 mm-40 -37.64 -69.39 0.19 Allowed Pre-proline 0 N--CA 1.471 0.606 0 C-N-CA 125.379 1.472 . . . . 74.45 112.829 -171.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -68.68 -6.67 18.45 Favored 'Trans proline' 0 CA--C 1.536 0.62 0 CA-C-N 121.98 1.743 . . . . 72.2 115.696 -172.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 60.1 m -85.26 -40.25 16.82 Favored 'General case' 0 CA--C 1.537 0.464 0 O-C-N 121.019 -1.051 . . . . 64.44 109.293 168.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 21.0 tt -93.51 -26.16 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 CA-C-N 118.575 0.625 . . . . 74.55 112.467 -171.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 19.3 t -53.18 -64.73 1.46 Allowed Pre-proline 0 C--O 1.236 0.385 0 C-N-CA 125.728 1.611 . . . . 74.43 110.059 172.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -63.11 -34.6 68.83 Favored 'Trans proline' 0 N--CA 1.451 -0.971 0 CA-C-N 120.898 1.356 . . . . 75.1 111.396 -174.142 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 86.7 t90 -54.54 -51.92 63.69 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 124.195 0.998 . . . . 73.33 110.521 174.242 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 98.7 p -59.25 -38.07 79.15 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 118.428 0.558 . . . . 74.44 111.84 -176.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -71.49 -18.71 62.27 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.691 0.796 . . . . 64.22 112.116 179.281 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 67.7 mmtt -94.72 -1.89 52.15 Favored 'General case' 0 C--O 1.232 0.164 0 C-N-CA 124.98 1.312 . . . . 74.14 112.983 179.101 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 36.9 mt -61.16 149.73 81.4 Favored Pre-proline 0 N--CA 1.45 -0.438 0 CA-C-N 119.846 1.203 . . . . 72.14 111.927 -175.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -77.48 165.06 27.87 Favored 'Trans proline' 0 N--CA 1.447 -1.221 0 C-N-CA 123.82 3.013 . . . . 73.41 111.547 -175.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -66.77 12.46 0.07 Allowed 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 127.421 2.288 . . . . 62.1 115.072 -176.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -128.36 14.76 6.65 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.449 1.499 . . . . 74.0 111.211 175.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 90.2 t -116.28 155.98 17.56 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 O-C-N 120.64 -1.288 . . . . 71.13 109.445 177.347 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 16.9 t-160 -132.43 102.84 5.89 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 125.955 1.702 . . . . 72.12 106.905 168.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -89.21 139.04 30.89 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 109.228 -0.656 . . . . 75.22 109.228 172.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 78.2 t -143.8 145.74 21.74 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.102 0 C-N-CA 124.675 1.19 . . . . 72.32 108.616 -176.317 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 22.2 mtp180 -111.21 119.28 38.39 Favored 'General case' 0 N--CA 1.463 0.193 0 N-CA-C 105.838 -1.912 . . . . 74.43 105.838 174.156 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 21.0 mt -128.18 147.02 61.74 Favored Pre-proline 0 N--CA 1.473 0.721 0 C-N-CA 123.543 0.737 . . . . 71.03 111.406 176.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -77.38 149.04 27.25 Favored 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 122.639 2.226 . . . . 73.01 112.206 -178.216 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -95.21 126.03 40.25 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 122.232 1.015 . . . . 73.03 108.671 174.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 60.9 mt -113.03 52.26 0.8 Allowed 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 125.927 1.691 . . . . 74.02 111.583 -165.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 50.4 m-85 -83.42 63.89 7.55 Favored 'General case' 0 CA--C 1.54 0.57 0 O-C-N 121.332 -0.855 . . . . 71.23 111.784 -177.015 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 61.77 6.77 9.73 Favored Glycine 0 N--CA 1.476 1.366 0 N-CA-C 117.428 1.731 . . . . 63.42 117.428 142.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -170.47 103.85 0.2 Allowed Glycine 0 C--O 1.226 -0.406 0 N-CA-C 106.851 -2.5 . . . . 73.22 106.851 -176.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . 0.308 3.6 tp 58.34 -40.38 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 C-N-CA 130.501 3.52 . . . . 70.12 115.637 -171.063 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 12.5 m95 -49.26 -42.33 40.54 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 126.282 1.833 . . . . 75.24 111.606 -176.049 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 12.6 p30 -76.74 -28.69 55.87 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 114.284 1.216 . . . . 73.34 114.284 -178.323 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 86.0 t -70.28 -53.42 23.17 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 N-CA-C 106.347 -1.723 . . . . 74.33 106.347 174.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 40.5 m170 -68.03 39.42 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 128.905 2.882 . . . . 73.33 113.263 169.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -156.47 -46.66 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.424 0 O-C-N 121.204 -0.935 . . . . 72.21 111.378 177.397 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -50.66 -41.57 55.66 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.136 0.975 . . . . 75.52 112.144 -176.049 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 4.1 ttt -54.1 -35.39 62.07 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.387 1.075 . . . . 75.25 113.462 -175.547 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 39.3 t80 -59.94 -42.38 93.87 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 118.918 0.781 . . . . 74.43 109.844 -179.102 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 16.3 mt -66.0 -40.51 91.22 Favored 'General case' 0 C--O 1.227 -0.102 0 C-N-CA 125.094 1.358 . . . . 74.33 109.427 179.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.78 -37.02 85.81 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.666 0.786 . . . . 74.55 110.833 175.673 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.35 -56.33 15.13 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 124.092 0.957 . . . . 73.32 109.266 -178.422 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -72.06 -15.51 62.02 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 112.534 0.568 . . . . 61.21 112.534 -178.36 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 38.5 t -60.39 -18.99 54.22 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.521 1.129 . . . . 74.44 111.409 170.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 45.9 mtm . . . . . 0 N--CA 1.47 0.537 0 CA-C-N 120.282 1.401 . . . . 72.25 114.421 173.565 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 0.532 0 N-CA-C 113.189 0.811 . . . . 71.45 113.189 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 17.6 t -71.57 -62.18 1.4 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 N-CA-C 108.375 -0.972 . . . . 75.42 108.375 172.383 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 41.3 m-85 -64.42 -35.88 82.35 Favored 'General case' 0 C--N 1.338 0.082 0 C-N-CA 124.267 1.027 . . . . 75.31 111.89 -174.561 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 34.8 mm-40 -57.93 -45.19 86.97 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 125.553 1.541 . . . . 65.53 109.435 175.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -64.28 -19.67 65.56 Favored 'General case' 0 CA--C 1.542 0.645 0 O-C-N 121.574 -0.704 . . . . 74.11 112.195 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 64.4 mt -101.74 -25.93 3.66 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 C-N-CA 125.679 1.592 . . . . 71.03 110.298 -173.239 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 83.8 m-70 -117.58 -53.71 2.4 Favored 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 124.323 1.049 . . . . 73.24 111.835 -174.391 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -72.1 -32.66 67.2 Favored 'General case' 0 N--CA 1.468 0.45 0 O-C-N 121.309 -0.869 . . . . 71.34 110.949 176.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -101.71 -36.32 8.76 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 119.425 1.011 . . . . 75.41 112.597 177.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 22.7 t-160 44.5 63.62 1.61 Allowed 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.901 1.68 . . . . 74.2 112.07 -171.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 37.7 mmtt -64.19 170.71 3.49 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.208 1.403 . . . . 74.22 110.96 171.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 63.3 tttt -81.38 30.02 0.35 Allowed 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 125.985 1.714 . . . . 71.05 112.622 -173.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 31.0 mt -71.89 32.08 0.05 Allowed 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 128.8 2.84 . . . . 73.31 114.452 -165.112 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -78.85 8.37 5.61 Favored 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 126.864 2.066 . . . . 74.11 114.303 -178.333 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -150.75 156.77 36.15 Favored Pre-proline 0 CA--C 1.534 0.332 0 C-N-CA 124.25 1.02 . . . . 75.21 109.566 -174.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -65.42 -30.23 53.21 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 121.818 1.678 . . . . 61.32 114.0 -170.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -66.26 -53.69 33.86 Favored 'General case' 0 C--O 1.223 -0.31 0 CA-C-O 118.13 -0.938 . . . . 75.44 109.563 178.004 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -50.89 -48.19 60.5 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 119.353 0.979 . . . . 75.02 111.286 178.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 59.7 mtt -54.96 -55.19 33.48 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 123.937 0.895 . . . . 70.42 110.173 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -66.73 -42.61 86.0 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.565 1.146 . . . . 75.45 110.989 -172.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -61.0 -40.06 92.08 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 126.192 1.797 . . . . 74.43 109.853 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 38.7 t80 -68.81 -50.86 46.65 Favored 'General case' 0 N--CA 1.454 -0.243 0 O-C-N 121.807 -0.558 . . . . 75.42 109.644 178.193 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 50.7 mt -68.45 -15.94 63.73 Favored 'General case' 0 N--CA 1.452 -0.341 0 O-C-N 121.988 -0.445 . . . . 71.22 110.323 -172.561 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -54.19 -31.41 52.87 Favored 'General case' 0 CA--C 1.534 0.329 0 O-C-N 121.88 -0.513 . . . . 72.35 111.987 169.4 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -83.65 1.92 88.07 Favored Glycine 0 CA--C 1.534 1.22 0 CA-C-O 119.113 -0.826 . . . . 74.33 113.988 173.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 13.5 mmtp -131.62 27.31 4.68 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 120.036 1.918 . . . . 73.24 111.292 -166.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 73.33 36.1 55.77 Favored Glycine 0 CA--C 1.521 0.453 0 CA-C-O 119.825 -0.431 . . . . 71.13 112.295 173.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 31.8 t -126.51 123.11 62.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 N-CA-C 106.704 -1.591 . . . . 71.54 106.704 178.389 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -69.75 153.56 43.19 Favored 'General case' 0 CA--C 1.537 0.454 0 O-C-N 122.021 -0.424 . . . . 63.13 111.533 173.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 6.1 ttpt -83.48 -36.84 23.82 Favored 'General case' 0 N--CA 1.465 0.299 0 O-C-N 120.419 -1.426 . . . . 72.25 110.46 175.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 58.0 mt-10 -57.83 -52.86 63.72 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 118.859 0.754 . . . . 74.23 109.693 -176.504 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 7.6 mmmt -73.32 -38.52 65.78 Favored 'General case' 0 CA--C 1.508 -0.639 0 N-CA-C 108.353 -0.98 . . . . 75.44 108.353 -167.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 61.4 t80 -57.88 -62.49 1.77 Allowed 'General case' 0 N--CA 1.436 -1.174 0 O-C-N 124.732 1.27 . . . . 74.3 109.13 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 16.0 mt -68.05 -31.15 70.6 Favored 'General case' 0 C--O 1.238 0.485 0 O-C-N 121.985 -0.447 . . . . 75.11 111.305 -176.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 33.2 t -56.15 -59.8 4.41 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 107.4 -1.333 . . . . 63.13 107.4 175.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 4.5 t -71.86 -36.18 70.04 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 118.963 -0.541 . . . . 73.24 109.934 -171.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 61.6 t80 -51.62 -43.98 62.74 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.93 1.292 . . . . 73.41 111.733 176.394 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 54.4 m-20 -104.39 33.61 3.45 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 121.779 -0.576 . . . . 73.4 110.667 -179.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 22.6 t -122.95 165.76 16.18 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.178 1.391 . . . . 62.22 110.926 177.182 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -57.19 -29.42 63.67 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.168 1.387 . . . . 64.03 111.517 177.746 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -53.57 -58.89 5.57 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 123.918 0.887 . . . . 65.3 110.849 177.586 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 38.6 mm -74.17 -28.28 23.07 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-O 118.421 -0.8 . . . . 74.41 109.89 -176.099 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 7.4 mmtt -53.97 -43.12 69.65 Favored 'General case' 0 C--N 1.34 0.169 0 CA-C-N 119.639 1.108 . . . . 64.31 110.002 170.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -66.76 -20.47 70.35 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 124.389 0.995 . . . . 63.21 112.944 -177.516 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -90.13 -41.31 11.71 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 117.954 0.877 . . . . 71.14 110.1 174.342 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 87.8 mmm -64.39 -35.93 82.48 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 124.825 1.25 . . . . 73.45 112.3 -179.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -61.31 -51.29 69.48 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 119.039 0.836 . . . . 74.41 109.804 177.248 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 2.7 mmtt -65.04 -55.45 18.82 Favored 'General case' 0 CA--C 1.514 -0.419 0 C-N-CA 123.932 0.893 . . . . 74.52 109.275 -176.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -55.02 -34.5 63.54 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 119.681 1.128 . . . . 54.22 111.688 -178.086 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 5.7 tmtt? -77.87 -51.31 10.65 Favored 'General case' 0 C--N 1.346 0.437 0 CA-C-N 119.884 1.22 . . . . 75.5 111.344 -179.244 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 18.3 ptmt -60.54 -30.63 69.89 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 119.558 1.072 . . . . 74.34 110.527 178.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 48.4 mt -68.86 -56.91 6.46 Favored 'General case' 0 N--CA 1.443 -0.802 0 C-N-CA 123.442 0.697 . . . . 74.11 110.232 177.384 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -53.93 -41.5 67.77 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 119.887 1.221 . . . . 54.21 113.32 -173.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -65.22 -46.74 79.43 Favored 'General case' 0 N--CA 1.464 0.25 0 O-C-N 122.049 -0.407 . . . . 71.22 111.932 175.149 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -69.73 -35.04 74.66 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 118.733 0.697 . . . . 73.13 111.557 -176.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -69.48 9.29 0.49 Allowed 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 125.536 1.534 . . . . 71.34 113.763 171.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 10.9 mm100 59.04 24.72 13.02 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 126.005 1.722 . . . . 73.43 113.16 177.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 39.3 t -69.18 150.57 10.51 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 O-C-N 120.643 -1.286 . . . . 62.04 108.475 -178.197 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -145.98 6.27 1.02 Allowed 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.311 0.644 . . . . 52.22 111.947 -166.02 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 159.52 -171.99 36.05 Favored Glycine 0 N--CA 1.446 -0.688 0 N-CA-C 109.127 -1.589 . . . . 64.53 109.127 -166.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.461 ' HA ' ' C ' ' A' ' 154' ' ' PRO . 15.3 m -139.72 161.93 53.77 Favored Pre-proline 0 CA--C 1.539 0.531 0 C-N-CA 124.064 0.945 . . . . 74.42 110.261 176.615 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . 0.461 ' C ' ' HA ' ' A' ' 153' ' ' VAL . 20.6 Cg_endo -58.37 156.63 36.13 Favored 'Cis proline' 0 CA--C 1.532 0.384 0 C-N-CA 123.928 -1.28 . . . . 73.3 111.065 -14.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' THR . . . . . 0.42 ' HA ' ' HB3' ' A' ' 165' ' ' ASP . 11.0 m -147.95 109.96 4.53 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.066 -1.087 . . . . 74.42 108.066 171.255 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 36.2 mmm -89.27 158.73 17.73 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 108.337 -0.986 . . . . 71.35 108.337 170.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 11.5 t -145.19 121.56 3.97 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 N-CA-C 108.575 -0.898 . . . . 75.25 108.575 174.128 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 77.2 t -91.83 131.51 38.73 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 N-CA-C 108.524 -0.917 . . . . 70.45 108.524 169.367 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 44.1 t30 48.88 19.45 0.27 Allowed 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 130.082 3.353 . . . . 73.11 115.323 168.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 69.62 23.75 76.54 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 125.357 1.456 . . . . 71.35 112.852 -175.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 55.9 mttt -131.55 -31.45 1.59 Allowed 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 118.596 1.198 . . . . 74.23 113.111 -171.285 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -125.68 108.08 11.19 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 123.529 0.732 . . . . 73.2 109.12 -175.532 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 41.7 ttt-85 -90.36 124.12 34.67 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 126.985 2.114 . . . . 72.51 106.039 174.475 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 18.1 p90 -149.42 166.95 27.54 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 107.67 -1.233 . . . . 73.52 107.67 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . 0.42 ' HB3' ' HA ' ' A' ' 155' ' ' THR . 10.4 p-10 178.24 178.07 0.4 Allowed 'General case' 0 CA--C 1.51 -0.562 0 C-N-CA 124.86 1.264 . . . . 75.53 109.205 -178.666 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 18.2 mt -54.35 -38.49 40.54 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.673 0 C-N-CA 126.405 1.882 . . . . 72.42 109.834 178.204 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -65.27 -30.96 79.03 Favored Glycine 0 CA--C 1.526 0.764 0 C-N-CA 124.321 0.963 . . . . 61.14 113.266 175.499 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 51.0 m -84.61 -62.19 1.61 Allowed 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.898 0.879 . . . . 65.52 110.064 178.148 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -59.0 -32.87 70.08 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 126.583 1.953 . . . . 73.25 112.071 -173.274 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 102.07 2.58 51.7 Favored Glycine 0 CA--C 1.526 0.727 0 CA-C-O 118.656 -1.08 . . . . 63.11 112.453 178.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 169.24 172.66 36.17 Favored Glycine 0 CA--C 1.531 1.041 0 CA-C-N 119.256 1.528 . . . . 63.41 111.556 175.579 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -66.44 -49.37 1.82 Allowed 'Trans proline' 0 CA--C 1.534 0.502 0 C-N-CA 123.046 2.497 . . . . 74.3 112.459 -175.357 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -57.09 -43.67 82.43 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 119.406 1.003 . . . . 74.1 109.865 175.429 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -57.79 -34.88 70.08 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.21 -0.905 . . . . 71.4 109.958 -178.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 48.8 m -67.4 -41.51 84.81 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-O 118.179 -0.915 . . . . 74.25 110.689 -178.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 49.7 mt -66.45 -35.64 80.81 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 119.836 1.198 . . . . 64.14 111.039 176.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 10.3 mttt -51.39 -48.56 62.54 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.244 1.418 . . . . 64.21 110.09 170.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -67.58 -48.85 65.68 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-O 118.346 -0.835 . . . . 75.44 110.478 173.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -52.91 -37.55 60.86 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 123.375 0.67 . . . . 73.03 111.977 -172.576 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -81.36 -47.55 13.12 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.659 1.184 . . . . 74.3 110.657 -173.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -56.56 -47.79 78.72 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 108.82 -0.807 . . . . 74.02 108.82 176.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 29.4 mt -63.57 -32.44 73.9 Favored 'General case' 0 CA--C 1.514 -0.438 0 C-N-CA 125.3 1.44 . . . . 64.12 112.205 -170.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 30.0 mt -58.38 -61.49 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 N-CA-C 107.046 -1.465 . . . . 73.33 107.046 174.058 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -53.05 -37.19 61.38 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 123.869 0.867 . . . . 64.12 111.691 -179.339 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.72 -39.09 67.88 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.547 0.739 . . . . 75.12 111.046 -176.063 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 63.8 mm-40 -95.14 -33.85 12.49 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 124.133 0.973 . . . . 71.53 112.135 175.126 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.05 -34.45 74.89 Favored 'General case' 0 CA--C 1.529 0.17 0 O-C-N 120.598 -1.314 . . . . 74.52 109.908 -179.022 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.237 0.427 0 C-N-CA 124.914 1.286 . . . . 70.34 112.174 179.385 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 . . . . . 0 CA--C 1.514 -0.43 0 CA-C-O 120.788 0.327 . . . . 70.22 110.977 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -134.21 11.37 3.86 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 126.278 1.831 . . . . 72.51 111.546 -170.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 -140.02 158.18 44.47 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 124.697 1.199 . . . . 71.44 108.485 -169.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 24.4 m -134.76 138.94 44.77 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 108.777 -0.823 . . . . 75.32 108.777 -178.577 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -71.14 143.74 50.47 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 109.146 -0.687 . . . . 75.42 109.146 174.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 68.1 14.28 65.78 Favored Glycine 0 CA--C 1.523 0.577 0 CA-C-O 119.315 -0.714 . . . . 72.42 112.515 -168.054 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 6.7 tttm -130.92 -82.56 0.53 Allowed 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 107.532 -1.285 . . . . 72.41 107.532 179.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 7.5 mp0 -79.44 -24.59 42.35 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 124.587 1.155 . . . . 70.4 111.361 -178.392 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 41.3 p90 -155.89 174.57 15.13 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 107.329 -1.36 . . . . 71.42 107.329 -177.075 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 23.0 t -132.29 146.82 32.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 108.474 -0.935 . . . . 74.23 108.474 -175.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -109.22 156.52 19.8 Favored 'General case' 0 N--CA 1.451 -0.409 0 O-C-N 120.894 -1.129 . . . . 75.43 109.161 166.398 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -126.02 120.22 29.72 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 125.747 1.619 . . . . 72.33 108.695 -169.338 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.8 m -55.13 -15.53 2.31 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.616 1.567 . . . . 72.02 114.223 -177.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 10.4 p -128.59 84.99 61.51 Favored Pre-proline 0 N--CA 1.445 -0.688 0 CA-C-N 119.164 0.893 . . . . 54.2 111.55 -179.552 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -73.08 179.79 5.07 Favored 'Trans proline' 0 CA--C 1.542 0.923 0 C-N-CA 124.449 3.432 . . . . 74.52 113.822 178.19 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 6.7 t -128.94 142.3 44.66 Favored Pre-proline 0 N--CA 1.47 0.564 0 C-N-CA 125.347 1.459 . . . . 70.24 108.102 173.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -76.73 176.52 10.01 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 123.608 2.872 . . . . 73.42 111.216 172.042 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.7 m -115.99 179.4 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 C-N-CA 124.017 0.927 . . . . 74.33 109.418 170.095 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 34.7 t -56.15 -64.03 0.99 Allowed 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 123.82 0.848 . . . . 75.21 108.906 169.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 19.1 mt-30 -150.38 161.23 31.27 Favored Pre-proline 0 C--O 1.237 0.442 0 O-C-N 121.68 -0.638 . . . . 74.51 110.761 -174.172 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -70.82 166.38 29.11 Favored 'Trans proline' 0 N--CA 1.45 -1.049 0 C-N-CA 122.747 2.298 . . . . 74.04 109.333 171.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 143.04 -86.57 0.18 Allowed Glycine 0 N--CA 1.449 -0.495 0 N-CA-C 108.894 -1.683 . . . . 65.43 108.894 -175.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.29 158.0 15.64 Favored 'General case' 0 N--CA 1.462 0.161 0 N-CA-C 108.616 -0.883 . . . . 74.42 108.616 -176.616 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 48.0 mm -66.63 154.91 7.61 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 N-CA-C 106.585 -1.635 . . . . 75.35 106.585 166.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -108.59 90.32 3.26 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 107.449 -1.315 . . . . 75.4 107.449 172.466 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 41.4 t -94.61 119.8 43.11 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.175 0 N-CA-C 106.654 -1.61 . . . . 74.11 106.654 176.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 25.4 t -119.45 110.99 31.2 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 N-CA-C 108.507 -0.923 . . . . 70.54 108.507 -174.291 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -72.61 126.94 31.1 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 108.046 -1.094 . . . . 73.53 108.046 154.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.5 mp -109.7 139.9 44.2 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 106.634 -1.617 . . . . 75.35 106.634 151.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 9.3 p90 -146.07 168.06 21.85 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 125.323 1.449 . . . . 74.12 107.974 -173.116 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 24.1 t90 -142.18 151.75 42.49 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 107.664 -1.236 . . . . 75.34 107.664 -177.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -47.15 -31.28 3.42 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.882 1.273 . . . . 74.42 112.085 166.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -109.5 17.9 30.52 Favored Glycine 0 CA--C 1.527 0.809 0 CA-C-O 117.577 -1.68 . . . . 74.42 115.138 -159.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 23.0 p -104.83 86.33 1.45 Allowed Pre-proline 0 CA--C 1.538 0.516 0 CA-C-N 119.644 1.722 . . . . 71.1 110.723 -170.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -58.51 -27.24 81.58 Favored 'Trans proline' 0 CA--C 1.54 0.776 0 CA-C-N 121.778 1.671 . . . . 54.11 114.232 -174.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 10.9 m170 -59.84 -19.63 52.14 Favored 'General case' 0 CA--C 1.537 0.449 0 O-C-N 121.365 -0.835 . . . . 72.44 112.592 174.067 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 98.8 m -71.01 -36.07 72.28 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.922 1.289 . . . . 65.13 110.632 -176.156 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 38.4 m-85 -61.68 -36.48 80.97 Favored 'General case' 0 N--CA 1.471 0.595 0 O-C-N 120.794 -1.191 . . . . 74.12 111.711 -177.462 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.74 -12.09 43.41 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 124.505 1.122 . . . . 71.33 112.209 179.299 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 27.1 t80 -126.41 -25.28 3.49 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-O 116.353 -1.784 . . . . 74.21 112.701 -172.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -45.37 -62.77 1.51 Allowed Pre-proline 0 N--CA 1.473 0.722 0 CA-C-N 121.619 2.009 . . . . 65.3 113.107 -177.517 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -70.38 -7.81 22.12 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 CA-C-N 121.179 1.457 . . . . 74.23 114.932 -178.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 25.4 m -80.84 -37.53 29.83 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.093 0.957 . . . . 64.11 110.061 170.295 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 20.6 tt -91.65 -31.62 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 C-N-CA 123.147 0.579 . . . . 75.12 111.617 -174.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 12.5 t -46.93 -62.8 1.71 Allowed Pre-proline 0 CA--C 1.539 0.533 0 CA-C-O 117.975 -1.012 . . . . 61.41 111.027 174.256 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -66.83 -34.91 29.13 Favored 'Trans proline' 0 N--CA 1.452 -0.939 0 CA-C-N 121.222 1.472 . . . . 75.4 111.027 -176.194 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 91.2 t90 -55.09 -47.32 75.08 Favored 'General case' 0 C--N 1.341 0.217 0 CA-C-N 119.778 1.172 . . . . 74.2 109.929 174.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 49.7 p -59.51 -38.1 80.06 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 122.783 0.433 . . . . 71.15 111.604 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.4 mt-10 -75.32 -10.55 59.55 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.34 1.456 . . . . 74.15 112.483 177.506 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 9.7 mmmm -119.44 9.8 11.69 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 126.447 1.899 . . . . 72.35 112.772 -174.571 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 27.5 mt -65.02 160.6 55.05 Favored Pre-proline 0 CA--C 1.538 0.506 0 C-N-CA 124.402 1.081 . . . . 75.34 111.661 172.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -82.66 169.7 13.39 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 124.913 3.742 . . . . 73.22 111.409 175.088 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -71.83 16.64 0.11 Allowed 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 126.755 2.022 . . . . 74.45 114.062 -175.304 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -127.09 -4.96 6.19 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 126.601 1.961 . . . . 73.4 113.074 -179.09 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 48.5 t -113.68 113.98 45.49 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.307 0 N-CA-C 106.689 -1.597 . . . . 74.3 106.689 -178.011 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 79.5 t60 -101.3 112.71 25.3 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 107.045 -1.465 . . . . 73.23 107.045 174.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 27.6 t80 -84.6 143.99 28.91 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 114.855 -1.066 . . . . 74.2 109.16 176.153 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 48.8 t -136.24 141.09 42.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 N-CA-C 106.387 -1.708 . . . . 73.4 106.387 -177.316 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 60.1 mtm-85 -123.43 113.33 18.65 Favored 'General case' 0 CA--C 1.508 -0.635 0 N-CA-C 104.613 -2.366 . . . . 74.34 104.613 176.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 5.8 mt -124.67 149.23 61.61 Favored Pre-proline 0 N--CA 1.466 0.326 0 CA-C-N 120.443 1.474 . . . . 73.11 110.043 174.294 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -67.53 143.43 62.85 Favored 'Trans proline' 0 N--CA 1.45 -1.051 0 C-N-CA 121.123 1.215 . . . . 63.14 110.743 -177.305 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -79.17 59.19 2.69 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.684 1.594 . . . . 70.25 111.49 -179.665 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 10.6 mt -74.1 88.13 1.91 Allowed 'General case' 0 C--N 1.328 -0.356 0 O-C-N 120.382 -1.449 . . . . 62.32 108.502 -176.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -141.61 1.98 1.57 Allowed 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 114.352 1.241 . . . . 75.55 114.352 175.649 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -153.04 179.0 29.82 Favored Glycine 0 C--N 1.333 0.401 0 O-C-N 121.078 -1.014 . . . . 72.31 113.814 -163.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -51.81 -53.56 29.18 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 128.589 2.995 . . . . 65.4 113.117 -164.289 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 9.8 tp -106.39 -6.85 10.24 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 C-N-CA 124.886 1.274 . . . . 73.1 110.884 173.39 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 8.9 m95 -73.76 -24.7 59.9 Favored 'General case' 0 N--CA 1.448 -0.568 0 O-C-N 120.876 -1.14 . . . . 74.31 111.495 -171.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -70.38 -46.94 63.04 Favored 'General case' 0 C--O 1.234 0.244 0 O-C-N 121.321 -0.862 . . . . 75.51 109.299 169.457 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 25.7 t -63.31 -53.13 49.65 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 C-N-CA 122.774 0.43 . . . . 72.04 110.189 -173.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 38.6 m170 -67.31 1.88 1.95 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.225 1.01 . . . . 70.02 113.185 178.457 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -109.19 -43.5 1.17 Allowed Glycine 0 C--N 1.338 0.669 0 CA-C-N 120.702 1.592 . . . . 63.21 110.697 -176.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -54.37 -36.62 64.07 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 113.391 0.886 . . . . 74.43 113.391 -170.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 5.9 ttt -45.21 -45.79 11.94 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 125.849 1.659 . . . . 64.25 114.434 -179.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 34.8 t80 -56.85 -42.34 79.53 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 121.52 0.676 . . . . 71.44 109.775 -173.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 18.2 mt -68.75 -42.11 77.97 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 117.082 -1.437 . . . . 73.21 109.291 178.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -56.51 -40.61 75.31 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 121.046 1.748 . . . . 74.53 110.944 178.255 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.07 -59.79 4.32 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 123.686 0.794 . . . . 71.11 110.219 179.243 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -65.24 -16.37 63.47 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 118.806 0.73 . . . . 73.32 112.208 -178.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -53.25 -25.74 15.52 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.208 1.003 . . . . 74.41 111.724 174.355 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 11.6 mtp . . . . . 0 CA--C 1.531 0.243 0 C-N-CA 125.429 1.492 . . . . 64.42 112.05 -172.464 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.119 0 CA-C-O 117.96 -1.019 . . . . 74.52 113.029 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 39.0 t -59.19 -62.67 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.339 0.14 0 N-CA-C 107.683 -1.229 . . . . 72.03 107.683 178.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -61.95 -49.57 75.59 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 123.874 0.87 . . . . 74.1 110.343 -179.387 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -57.29 -38.36 73.86 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.922 0.889 . . . . 72.1 110.488 -173.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -67.88 -43.79 78.55 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-O 122.46 1.124 . . . . 71.51 111.12 -178.452 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 45.2 mt -71.57 -36.29 59.48 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 N-CA-C 108.207 -1.034 . . . . 75.45 108.207 -175.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 81.1 m-70 -95.68 -74.03 0.57 Allowed 'General case' 0 N--CA 1.446 -0.66 0 O-C-N 121.46 -0.775 . . . . 75.32 109.936 -171.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 22.5 mmtt -64.12 -18.53 64.51 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 125.099 1.36 . . . . 75.21 112.097 -176.359 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -108.82 -19.83 13.27 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 113.516 0.932 . . . . 74.2 113.516 179.243 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 3.9 t60 44.02 57.64 4.08 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 126.389 1.876 . . . . 75.22 112.059 173.325 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 12.6 mmtm -75.51 160.65 29.95 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.668 1.187 . . . . 70.01 109.992 178.308 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 32.7 tttt -77.61 29.83 0.16 Allowed 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 127.466 2.307 . . . . 74.24 113.892 -178.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 27.6 mt -74.62 49.88 0.41 Allowed 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 127.489 2.316 . . . . 74.15 111.734 -169.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -90.37 -0.26 57.56 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 128.093 2.557 . . . . 72.3 112.333 -178.535 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 23.8 p -141.01 153.41 67.18 Favored Pre-proline 0 C--O 1.233 0.23 0 C-N-CA 123.424 0.69 . . . . 73.54 110.135 173.439 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -63.89 -28.4 67.21 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 122.528 2.152 . . . . 63.51 112.642 -176.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 27.8 mp0 -70.35 -36.71 74.36 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 119.594 1.088 . . . . 72.13 110.31 177.286 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -73.37 -40.36 64.44 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.847 0.859 . . . . 74.14 109.544 178.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 45.1 mtt -58.47 -61.29 2.7 Favored 'General case' 0 C--N 1.343 0.286 0 C-N-CA 126.044 1.738 . . . . 65.2 109.935 174.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -62.91 -41.26 99.38 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 123.888 0.875 . . . . 71.35 111.476 -170.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -56.65 -41.91 78.04 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.049 0.452 . . . . 72.05 111.212 176.199 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 80.8 t80 -70.57 -40.69 73.17 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 123.614 0.766 . . . . 71.44 112.061 -179.173 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 56.1 mt -75.97 -17.02 59.88 Favored 'General case' 0 C--N 1.332 -0.181 0 O-C-N 121.378 -0.826 . . . . 75.12 111.445 -177.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -54.06 -28.33 38.18 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.981 0.912 . . . . 64.24 111.832 -178.075 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -89.54 -1.68 77.45 Favored Glycine 0 CA--C 1.529 0.94 0 CA-C-O 117.741 -1.589 . . . . 72.24 115.151 177.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 39.5 mttt -129.33 26.42 5.41 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 120.791 2.295 . . . . 74.15 112.647 -166.313 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 104.7 3.93 42.91 Favored Glycine 0 CA--C 1.527 0.812 0 C-N-CA 123.542 0.591 . . . . 71.13 113.463 173.101 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 77.0 t -106.3 165.09 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 C-N-CA 125.277 1.431 . . . . 75.2 107.899 179.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 60.8 t0 -132.87 132.24 41.87 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 105.711 -1.959 . . . . 61.02 105.711 176.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 21.3 mtpt -55.72 -36.03 66.77 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 123.523 0.729 . . . . 73.0 110.885 176.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -60.2 -50.87 71.96 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 118.875 0.761 . . . . 74.43 109.874 174.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -78.04 -28.03 48.91 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 108.979 -0.749 . . . . 75.44 108.979 -167.452 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 32.8 t80 -68.66 -69.73 0.31 Allowed 'General case' 0 N--CA 1.437 -1.09 0 C-N-CA 125.434 1.493 . . . . 74.35 108.845 173.627 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 8.1 mt -68.04 -37.99 81.99 Favored 'General case' 0 CA--C 1.531 0.24 0 O-C-N 121.244 -0.91 . . . . 73.31 110.348 -163.164 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 3.9 t -66.61 -21.13 66.13 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 118.781 -0.628 . . . . 73.05 112.232 -175.167 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 3.1 t -98.42 -35.11 10.39 Favored 'General case' 0 C--N 1.342 0.27 0 CA-C-N 119.196 0.907 . . . . 73.02 110.448 171.113 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 80.2 t80 -49.31 -55.69 11.95 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 119.184 0.902 . . . . 61.41 110.533 177.344 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 -86.08 55.61 3.61 Favored 'General case' 0 C--O 1.231 0.105 0 N-CA-C 108.714 -0.847 . . . . 71.04 108.714 174.356 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -157.91 166.53 32.4 Favored 'General case' 0 C--O 1.237 0.396 0 O-C-N 120.93 -1.106 . . . . 75.33 111.33 -177.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -74.6 -29.61 61.37 Favored 'General case' 0 N--CA 1.456 -0.14 0 CA-C-N 115.613 -0.721 . . . . 73.02 112.836 -162.551 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -56.73 -49.48 75.05 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 119.658 1.117 . . . . 73.34 110.258 -177.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 35.5 mm -63.02 -39.44 85.23 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.345 0 C-N-CA 125.161 1.384 . . . . 75.23 109.493 177.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 28.0 tttm -55.83 -42.67 76.08 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 118.585 -0.721 . . . . 75.21 109.562 175.305 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -71.18 -24.95 76.48 Favored Glycine 0 CA--C 1.523 0.559 0 C-N-CA 124.796 1.189 . . . . 74.15 111.958 -171.525 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -87.61 -50.4 6.53 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 124.347 1.059 . . . . 73.4 108.39 179.114 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 1.2 ppp? -58.49 -43.11 88.87 Favored 'General case' 0 C--N 1.34 0.161 0 C-N-CA 123.627 0.771 . . . . 74.25 109.737 -176.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -60.13 -40.01 88.27 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-O 118.464 -0.779 . . . . 64.23 112.133 -176.024 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -59.85 -59.38 5.52 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 123.906 0.883 . . . . 70.41 109.855 173.813 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -54.01 -34.0 58.7 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 118.038 0.381 . . . . 72.21 111.175 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 49.6 tttt -67.55 -59.67 3.17 Favored 'General case' 0 C--O 1.232 0.149 0 O-C-N 121.322 -0.861 . . . . 75.43 110.852 177.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.45 -24.28 64.7 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 118.452 0.569 . . . . 74.43 111.566 -174.686 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 32.6 mt -67.33 -53.16 32.05 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 118.52 -0.752 . . . . 75.34 110.203 170.543 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -53.92 -44.86 70.94 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 118.957 0.799 . . . . 71.42 112.291 -174.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 13.5 ptp -63.48 -46.9 84.03 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 119.423 -0.323 . . . . 63.12 111.551 176.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -58.87 -43.31 90.86 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 118.354 -0.831 . . . . 63.23 109.481 -179.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 18.1 m-85 -66.28 5.4 0.55 Allowed 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 115.078 1.511 . . . . 73.24 115.078 -175.096 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 59.2 mm-40 62.46 34.31 15.5 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 121.143 1.792 . . . . 71.54 113.198 176.39 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 57.5 t -80.5 -76.97 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 CA-C-O 118.415 -0.803 . . . . 73.35 111.18 -165.072 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . 0.26 1.6 p 54.59 -22.45 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 129.293 3.037 . . . . 72.44 118.18 -179.731 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -99.45 -179.84 30.89 Favored Glycine 0 CA--C 1.532 1.102 0 CA-C-N 121.6 2.0 . . . . 72.45 111.807 168.467 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 3.1 m -165.2 148.06 6.94 Favored Pre-proline 0 CA--C 1.547 0.865 0 C-N-CA 129.351 3.06 . . . . 75.33 108.033 167.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -67.34 142.35 62.2 Favored 'Cis proline' 0 N--CA 1.452 -0.923 0 CA-C-N 120.006 1.038 . . . . 71.32 110.543 -5.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' THR . . . . . 0.529 ' CG2' ' HE ' ' A' ' 163' ' ' ARG . 25.3 m -147.07 133.4 19.56 Favored 'General case' 0 N--CA 1.447 -0.575 0 N-CA-C 107.979 -1.119 . . . . 75.34 107.979 -174.253 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 42.6 mmm -111.81 163.69 13.89 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.324 1.45 . . . . 64.44 109.434 176.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 38.7 t -142.32 151.67 18.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 C-N-CA 125.154 1.382 . . . . 71.15 107.528 168.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 60.5 t -118.61 125.46 74.41 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 C-N-CA 125.802 1.641 . . . . 74.15 106.966 166.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 14.9 m-20 55.15 10.99 0.47 Allowed 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 128.016 2.526 . . . . 71.42 115.926 172.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 82.59 12.57 79.99 Favored Glycine 0 CA--C 1.522 0.524 0 CA-C-O 117.921 -1.488 . . . . 73.02 113.45 -174.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 45.1 mttt -121.67 -52.34 2.02 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-N 119.083 1.441 . . . . 70.2 111.227 -166.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 74.6 m-85 -99.68 122.65 43.0 Favored 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 108.086 -1.079 . . . . 75.34 108.086 -179.52 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . 0.529 ' HE ' ' CG2' ' A' ' 155' ' ' THR . 0.1 OUTLIER -92.46 133.42 35.93 Favored 'General case' 0 N--CA 1.446 -0.675 0 C-N-CA 126.888 2.075 . . . . 72.45 105.496 169.256 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 20.6 p90 -147.93 167.96 23.49 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.062 -1.088 . . . . 63.23 108.062 168.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -174.65 -179.41 1.49 Allowed 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 123.957 0.903 . . . . 74.42 108.921 178.191 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 13.5 mt -55.61 -45.07 78.75 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 C-N-CA 126.99 2.116 . . . . 75.22 108.408 176.022 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -61.69 -39.54 97.56 Favored Glycine 0 C--N 1.338 0.667 0 C-N-CA 124.154 0.883 . . . . 73.5 112.415 178.323 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 16.2 m -74.36 -56.79 4.47 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 118.678 1.239 . . . . 71.05 110.273 178.565 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -74.15 -33.19 63.43 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 125.201 1.401 . . . . 72.31 113.626 -163.127 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 147.4 -46.77 0.7 Allowed Glycine 0 CA--C 1.521 0.424 0 O-C-N 123.648 0.593 . . . . 62.3 112.259 -178.047 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 168.16 -174.19 43.0 Favored Glycine 0 CA--C 1.53 0.972 0 N-CA-C 109.209 -1.557 . . . . 75.22 109.209 -156.31 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -66.76 -55.59 0.32 Allowed 'Trans proline' 0 N--CA 1.452 -0.958 0 C-N-CA 122.618 2.212 . . . . 73.14 111.003 -170.319 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -60.46 -41.85 95.0 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 121.838 0.827 . . . . 75.23 109.58 179.35 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -56.48 -29.87 62.27 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 124.971 1.308 . . . . 71.32 111.864 179.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 89.5 m -67.04 -44.49 80.06 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-O 118.358 -0.829 . . . . 65.33 109.817 179.411 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 55.9 mt -60.52 -37.82 82.4 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 118.945 0.793 . . . . 74.23 109.682 175.264 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 8.7 ttpp -52.25 -39.89 60.95 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 117.626 -1.178 . . . . 74.42 110.326 175.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -79.16 -43.38 24.08 Favored 'General case' 0 C--N 1.346 0.454 0 CA-C-N 120.601 1.546 . . . . 75.41 111.869 172.071 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -51.54 -41.86 61.38 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 119.287 0.949 . . . . 72.32 111.818 -175.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -78.37 -38.91 40.74 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 124.801 1.24 . . . . 60.54 110.613 -172.286 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 24.1 t80 -64.46 -54.6 29.94 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 125.091 1.356 . . . . 73.45 110.444 174.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 87.6 mt -60.98 -23.24 65.2 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.251 1.02 . . . . 72.5 113.294 -174.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 23.7 mt -57.02 -59.89 2.63 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 CA-C-N 119.275 0.943 . . . . 73.52 108.816 170.339 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 10.6 tm-20 -56.87 -37.58 71.54 Favored 'General case' 0 C--O 1.227 -0.108 0 C-N-CA 124.581 1.152 . . . . 71.53 110.356 -177.519 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 12.8 tptt -53.14 -41.06 64.73 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 124.292 1.037 . . . . 72.42 111.863 -179.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 32.5 mm-40 -91.67 -41.76 10.55 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.036 0.934 . . . . 74.34 111.242 178.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.38 -35.68 78.16 Favored 'General case' 0 C--O 1.234 0.268 0 O-C-N 120.645 -1.284 . . . . 73.42 109.952 -175.852 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.237 0.423 0 C-N-CA 125.275 1.43 . . . . 74.43 112.045 -179.927 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 . . . . . 0 CA--C 1.503 -0.829 0 CA-C-O 119.552 -0.261 . . . . 53.41 110.909 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . 0.336 13.8 m-20 75.99 11.31 3.04 Favored 'General case' 0 N--CA 1.435 -1.21 0 C-N-CA 128.43 2.692 . . . . 73.13 116.222 168.378 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -142.82 172.2 13.02 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 126.758 2.023 . . . . 74.14 107.73 173.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 61.5 m -140.78 138.0 33.77 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.887 0.875 . . . . 64.42 109.462 178.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.04 144.75 57.07 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 122.132 0.968 . . . . 72.34 110.272 175.425 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 80.5 -36.75 2.24 Favored Glycine 0 CA--C 1.526 0.776 0 C-N-CA 126.64 2.067 . . . . 63.42 111.787 -167.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -84.0 -76.5 0.29 Allowed 'General case' 0 CA--C 1.515 -0.372 0 C-N-CA 124.774 1.23 . . . . 73.4 110.134 -165.452 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 15.8 mp0 -78.87 -24.87 44.02 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 124.929 1.292 . . . . 74.0 110.452 178.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 37.9 p90 -160.32 174.41 14.22 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 123.806 0.842 . . . . 74.42 109.726 -172.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 32.8 t -132.48 112.49 19.27 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 C-N-CA 123.797 0.839 . . . . 74.22 109.13 178.418 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -71.0 154.44 41.81 Favored 'General case' 0 C--O 1.235 0.33 0 O-C-N 120.89 -1.131 . . . . 73.24 109.155 162.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -124.31 113.85 18.78 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 124.476 1.11 . . . . 74.34 110.292 -173.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 59.3 p -69.66 13.34 0.14 Allowed 'General case' 0 C--O 1.236 0.379 0 C-N-CA 127.177 2.191 . . . . 71.4 114.278 -175.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 32.1 t -143.28 78.77 14.67 Favored Pre-proline 0 N--CA 1.454 -0.239 0 N-CA-C 108.085 -1.08 . . . . 74.41 108.085 165.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -67.22 -179.92 2.07 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 122.867 2.378 . . . . 74.21 111.922 -173.239 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 40.6 t -130.71 136.66 29.28 Favored Pre-proline 0 C--O 1.233 0.212 0 N-CA-C 107.073 -1.454 . . . . 72.12 107.073 179.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -79.27 173.71 12.93 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 121.836 1.69 . . . . 72.14 110.939 176.204 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 20.7 m -122.4 169.49 13.69 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 C-N-CA 125.09 1.356 . . . . 73.33 109.622 -178.183 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.1 t -47.74 -64.25 0.84 Allowed 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 126.406 1.882 . . . . 63.01 109.808 176.314 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -147.07 164.58 22.59 Favored Pre-proline 0 C--O 1.237 0.401 0 C-N-CA 123.931 0.893 . . . . 74.31 109.86 178.168 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_endo -66.3 176.07 4.35 Favored 'Trans proline' 0 N--CA 1.45 -1.04 0 C-N-CA 122.081 1.854 . . . . 72.22 111.066 163.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 129.39 -89.42 0.31 Allowed Glycine 0 N--CA 1.448 -0.559 0 N-CA-C 108.059 -2.016 . . . . 74.25 108.059 -178.029 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -85.21 163.53 18.64 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 117.919 0.86 . . . . 74.14 109.322 -179.085 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 46.9 mm -77.13 137.51 22.3 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 N-CA-C 105.204 -2.147 . . . . 74.43 105.204 158.125 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -99.3 118.0 35.0 Favored 'General case' 0 N--CA 1.445 -0.725 0 N-CA-C 105.859 -1.904 . . . . 73.54 105.859 -179.442 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 60.2 t -121.64 131.81 72.22 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 N-CA-C 106.723 -1.584 . . . . 74.22 106.723 -179.091 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 43.2 t -127.09 138.72 54.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 106.241 -1.763 . . . . 73.02 106.241 -175.22 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -106.32 137.74 43.74 Favored 'General case' 0 C--O 1.239 0.525 0 N-CA-C 106.655 -1.609 . . . . 74.52 106.655 158.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 5.3 mp -115.69 137.21 52.31 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 107.455 -1.313 . . . . 75.1 107.455 163.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 31.3 p90 -141.44 169.01 18.41 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 124.122 0.969 . . . . 74.04 110.034 -172.101 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 29.7 t90 -155.11 153.21 30.49 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 123.663 0.785 . . . . 72.54 109.464 179.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 56.2 t80 -44.08 -51.26 8.08 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 129.366 3.067 . . . . 75.44 113.84 -172.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -72.05 -90.49 0.11 Allowed Glycine 0 C--N 1.339 0.705 0 N-CA-C 110.944 -0.862 . . . . 71.24 110.944 -171.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 34.4 t 43.51 68.92 2.63 Favored Pre-proline 0 CA--C 1.546 0.797 0 C-N-CA 125.283 1.433 . . . . 74.54 113.824 163.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -63.53 -14.87 45.1 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 122.743 2.295 . . . . 74.41 114.126 -176.415 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 20.3 m170 -84.24 -22.85 30.68 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 119.856 1.207 . . . . 75.24 112.537 172.07 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 60.4 m -62.65 -48.73 78.06 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 120.284 1.402 . . . . 72.13 110.619 -174.105 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 45.4 t80 -61.75 -27.55 68.81 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 120.554 -1.341 . . . . 73.4 112.23 -175.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.26 -6.58 40.81 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.558 0.743 . . . . 73.15 112.73 177.285 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 26.8 t80 -123.64 -13.93 7.39 Favored 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 126.387 1.875 . . . . 73.13 111.594 -175.52 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 67.0 tt0 -50.73 -64.64 1.22 Allowed Pre-proline 0 CA--C 1.536 0.433 0 CA-C-N 119.813 1.188 . . . . 74.13 111.512 -178.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -74.96 -4.77 15.91 Favored 'Trans proline' 0 N--CA 1.453 -0.881 0 CA-C-N 120.831 1.333 . . . . 72.34 114.294 -175.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.5 m -70.15 -47.25 62.49 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 107.892 -1.151 . . . . 73.53 107.892 163.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 19.3 tt -96.8 -28.5 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 N-CA-C 113.704 1.001 . . . . 74.33 113.704 -165.627 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 74.0 t -54.19 -55.97 31.08 Favored Pre-proline 0 CA--C 1.545 0.772 0 CA-C-N 119.64 1.109 . . . . 75.3 111.314 173.457 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -68.14 -24.93 37.88 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 CA-C-N 120.85 1.339 . . . . 71.23 111.794 -179.006 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 77.8 t90 -62.38 -55.18 30.39 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 119.274 0.943 . . . . 75.04 109.008 170.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.5 p -61.01 -41.95 97.52 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 123.704 0.802 . . . . 64.2 112.555 -173.248 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -62.63 -39.86 95.14 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 119.282 0.946 . . . . 75.03 110.886 175.619 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 8.0 mptt -90.88 20.06 5.1 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 113.543 0.942 . . . . 75.24 113.543 -170.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 32.1 mt -65.71 164.85 23.23 Favored Pre-proline 0 CA--C 1.543 0.674 0 C-N-CA 126.421 1.888 . . . . 70.31 111.75 175.081 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -83.7 174.45 8.65 Favored 'Trans proline' 0 N--CA 1.454 -0.838 1 C-N-CA 125.64 4.226 . . . . 74.51 110.933 174.203 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -71.24 -10.26 59.47 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 113.829 1.048 . . . . 72.41 113.829 -176.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -103.61 5.79 36.76 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 119.364 0.984 . . . . 72.11 112.074 -170.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 87.6 t -117.42 152.61 19.29 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 C-N-CA 124.9 1.28 . . . . 74.32 107.793 -178.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 22.6 t-160 -136.78 92.91 2.79 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 126.486 1.914 . . . . 71.23 106.651 178.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -79.78 132.67 36.21 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 124.488 1.115 . . . . 74.34 109.692 173.466 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 23.4 t -136.51 158.62 37.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 C-N-CA 125.453 1.501 . . . . 74.34 107.76 -179.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 55.7 mtp180 -131.41 128.42 39.51 Favored 'General case' 0 CA--C 1.506 -0.718 0 N-CA-C 106.897 -1.52 . . . . 73.41 106.897 179.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 70.1 mt -127.44 153.2 77.29 Favored Pre-proline 0 N--CA 1.464 0.267 0 O-C-N 123.379 0.425 . . . . 73.51 111.082 173.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -75.42 134.14 16.79 Favored 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 122.371 2.047 . . . . 71.32 111.209 179.019 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -75.0 95.78 3.07 Favored 'General case' 0 CA--C 1.54 0.562 0 O-C-N 121.038 -1.039 . . . . 73.21 111.598 176.241 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 20.0 mt -88.6 95.38 10.22 Favored 'General case' 0 CA--C 1.541 0.62 0 O-C-N 120.42 -1.425 . . . . 73.53 111.188 -177.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -133.83 5.33 3.63 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 116.027 1.862 . . . . 74.02 116.027 -173.342 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -154.33 -143.62 3.72 Favored Glycine 0 C--N 1.336 0.573 0 CA-C-N 119.039 0.836 . . . . 65.43 114.269 -166.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -89.96 -85.58 1.34 Allowed Glycine 0 CA--C 1.524 0.607 0 N-CA-C 106.887 -2.485 . . . . 73.04 106.887 155.242 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.2 tt -58.61 -25.23 27.73 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 N-CA-C 113.133 0.79 . . . . 73.13 113.133 -168.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 10.8 m95 -54.55 -40.7 68.96 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 123.891 0.876 . . . . 74.23 112.214 175.137 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 17.2 p30 -91.73 -27.32 18.12 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 112.892 0.701 . . . . 75.41 112.892 179.034 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 39.4 t -64.71 -41.59 92.64 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-N 118.536 0.607 . . . . 73.15 109.578 174.095 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 66.6 m170 -79.14 7.08 8.12 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.821 1.248 . . . . 73.2 112.327 170.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -103.08 -37.55 3.1 Favored Glycine 0 CA--C 1.525 0.69 0 O-C-N 120.989 -1.069 . . . . 75.14 111.594 -179.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -65.12 -25.6 67.83 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 114.456 1.28 . . . . 74.5 114.456 -165.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 6.6 ttt -62.95 -43.02 99.94 Favored 'General case' 0 N--CA 1.463 0.191 0 O-C-N 120.926 -1.109 . . . . 74.04 112.055 -175.262 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -51.29 -52.85 41.38 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 125.011 1.324 . . . . 75.3 108.367 -176.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 13.7 mt -63.37 -39.56 94.87 Favored 'General case' 0 C--O 1.226 -0.182 0 C-N-CA 124.451 1.1 . . . . 71.44 110.122 -178.296 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.4 m -66.71 -38.38 86.6 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 118.873 0.761 . . . . 73.2 109.775 -178.048 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.48 -60.13 4.11 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 124.063 0.945 . . . . 75.05 108.535 177.478 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -60.84 -25.03 66.34 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 124.166 0.986 . . . . 75.11 112.686 -177.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -62.98 -5.62 3.11 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.885 1.674 . . . . 75.52 114.566 176.406 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 29.5 mtm . . . . . 0 N--CA 1.473 0.685 0 N-CA-C 115.047 1.499 . . . . 63.51 115.047 165.843 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.294 0 N-CA-C 114.384 1.253 . . . . 72.03 114.384 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 56.2 t -62.93 -61.45 1.65 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.189 0 N-CA-C 108.079 -1.082 . . . . 74.34 108.079 172.02 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -62.84 -42.2 99.64 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 125.29 1.436 . . . . 74.12 110.636 -178.361 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -71.66 3.66 3.85 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 124.828 1.251 . . . . 65.54 112.351 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -115.52 5.08 14.35 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 115.658 1.725 . . . . 52.3 115.658 164.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 13.6 mt -117.21 -51.13 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 CA-C-N 120.476 1.489 . . . . 73.32 108.732 177.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 88.2 m-70 -63.97 -83.04 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 126.025 1.73 . . . . 72.22 113.231 -179.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.64 -16.71 64.3 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 126.711 2.004 . . . . 75.22 114.606 -177.452 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -97.17 -32.91 11.7 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 124.572 1.149 . . . . 74.43 111.64 178.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 1.8 t-160 50.38 36.37 12.97 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 125.572 1.549 . . . . 75.51 112.924 173.424 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.35 164.76 25.12 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 124.039 0.936 . . . . 73.41 108.784 168.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 10.2 mtpt -61.82 -72.11 0.13 Allowed 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 124.94 1.296 . . . . 73.12 109.433 172.602 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 77.2 mt 50.91 54.52 11.09 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 124.707 1.203 . . . . 73.22 111.455 -172.316 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -109.81 1.36 19.27 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.666 1.586 . . . . 74.34 113.326 -170.231 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -147.22 156.49 46.49 Favored Pre-proline 0 C--O 1.234 0.287 0 C-N-CA 126.948 2.099 . . . . 73.32 109.63 -167.448 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -70.99 -38.19 5.4 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 122.759 2.306 . . . . 75.24 110.927 -170.119 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -62.2 -48.93 77.81 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 109.022 -0.732 . . . . 75.01 109.022 172.037 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -58.45 -39.74 80.7 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 124.853 1.261 . . . . 74.24 111.737 -171.227 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 59.3 mtm -78.0 -50.23 12.53 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 124.523 1.129 . . . . 72.12 111.336 174.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -64.42 -39.53 94.02 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 119.05 0.841 . . . . 74.33 110.93 -173.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -71.03 -22.5 62.14 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 123.764 0.826 . . . . 73.33 111.509 -179.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 91.4 t80 -73.29 -51.46 17.51 Favored 'General case' 0 N--CA 1.45 -0.473 0 O-C-N 121.495 -0.753 . . . . 64.13 109.631 170.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 68.2 mt -69.83 -17.7 63.4 Favored 'General case' 0 N--CA 1.452 -0.351 0 O-C-N 121.728 -0.608 . . . . 72.43 111.337 -175.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -55.9 -18.09 8.1 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.91 0.884 . . . . 72.13 111.563 167.468 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -98.51 3.75 59.59 Favored Glycine 0 CA--C 1.527 0.803 0 CA-C-O 117.416 -1.769 . . . . 54.31 114.835 171.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.498 ' HA ' ' HE2' ' A' ' 118' ' ' LYS . 7.7 mmpt? -125.85 13.66 7.96 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 120.654 2.227 . . . . 72.32 113.123 -169.375 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 87.23 26.62 30.34 Favored Glycine 0 CA--C 1.522 0.517 0 CA-C-N 118.836 0.744 . . . . 61.52 112.526 -179.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 76.2 t -112.07 136.76 47.25 Favored 'Isoleucine or valine' 0 C--O 1.24 0.605 0 C-N-CA 125.648 1.579 . . . . 75.02 107.186 175.276 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 32.0 t0 -85.53 116.28 23.74 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 108.551 -0.907 . . . . 61.22 108.551 171.422 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 3.1 tttm -52.77 -48.08 67.06 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 125.638 1.575 . . . . 71.51 109.437 177.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -65.6 -22.72 66.7 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 113.078 0.77 . . . . 73.31 113.078 -175.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 49.4 mmtt -82.9 -50.74 8.29 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 107.673 -1.232 . . . . 74.01 107.673 175.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -49.08 -62.0 1.77 Allowed 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 125.648 1.579 . . . . 74.51 109.729 -179.14 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 20.5 mt -62.93 -39.27 94.09 Favored 'General case' 0 C--O 1.233 0.213 0 C-N-CA 122.744 0.417 . . . . 73.23 110.889 -174.419 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 39.5 t -57.17 -50.95 71.23 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 123.145 0.578 . . . . 73.12 109.919 -177.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 2.6 t -81.35 -33.14 32.61 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 119.184 -0.436 . . . . 73.43 110.761 -175.453 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 82.3 t80 -50.35 -52.39 37.51 Favored 'General case' 0 C--N 1.344 0.34 0 C-N-CA 124.719 1.207 . . . . 72.22 109.467 172.199 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -90.39 55.56 3.08 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 124.265 1.026 . . . . 75.4 109.495 174.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 22.7 t -140.64 162.2 35.94 Favored 'General case' 0 C--O 1.234 0.258 0 O-C-N 121.083 -1.011 . . . . 71.13 110.795 172.613 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -58.08 -26.97 63.22 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.733 1.213 . . . . 71.44 110.673 168.506 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -53.31 -59.27 4.79 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 124.492 1.117 . . . . 74.42 111.218 179.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 41.7 mm -69.06 -26.3 31.89 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 C-N-CA 123.266 0.626 . . . . 74.44 110.355 178.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 17.7 tttt -58.37 -36.32 73.31 Favored 'General case' 0 CA--C 1.522 -0.1 0 O-C-N 121.35 -0.844 . . . . 73.1 111.008 175.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -63.3 -46.1 93.64 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 110.665 -0.974 . . . . 72.34 110.665 178.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -66.04 -44.84 83.47 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 123.196 0.599 . . . . 72.41 110.008 -179.16 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 94.9 mmm -57.32 -47.84 80.5 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 118.595 -0.717 . . . . 75.33 109.948 176.231 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -65.87 -40.92 92.07 Favored 'General case' 0 N--CA 1.457 -0.098 0 CA-C-N 119.573 1.079 . . . . 74.03 112.126 -175.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 11.2 mtpt -60.13 -58.13 9.87 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-O 118.242 -0.885 . . . . 75.43 109.579 176.27 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -53.64 -39.8 65.29 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 119.137 0.88 . . . . 75.43 110.762 178.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 25.7 ttmt -60.97 -63.07 1.42 Allowed 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.128 0.971 . . . . 71.35 110.481 178.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 16.6 ptmt -64.89 -24.01 67.4 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 123.463 0.705 . . . . 70.32 111.0 -176.041 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 41.7 mt -75.77 -53.76 8.0 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 118.637 -0.697 . . . . 74.04 111.055 175.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -52.57 -54.28 35.02 Favored 'General case' 0 C--O 1.228 -0.04 0 C-N-CA 123.865 0.866 . . . . 65.34 110.52 -173.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 3.9 ppp? -55.37 -47.06 76.38 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 113.23 0.826 . . . . 72.33 113.23 177.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -69.11 -29.85 68.01 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-O 118.093 -0.956 . . . . 64.51 110.291 -176.157 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 23.5 m-85 -71.81 16.29 0.12 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.241 1.416 . . . . 75.42 113.431 173.355 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 16.8 mm-40 63.31 17.54 10.33 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.062 1.345 . . . . 74.11 112.724 174.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 59.1 t -65.84 90.88 0.11 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.376 0 C-N-CA 125.712 1.605 . . . . 73.1 109.379 -174.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -95.97 88.59 4.94 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-O 123.137 1.446 . . . . 75.21 108.237 161.843 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 104.65 -162.5 14.85 Favored Glycine 0 N--CA 1.445 -0.712 0 CA-C-N 112.645 -2.07 . . . . 73.3 111.818 164.404 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 16.6 m -144.38 155.48 57.5 Favored Pre-proline 0 CA--C 1.539 0.524 0 C-N-CA 126.314 1.846 . . . . 75.32 107.37 178.092 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_endo -64.76 160.15 70.4 Favored 'Cis proline' 0 CA--C 1.54 0.823 0 C-N-CA 124.195 -1.169 . . . . 75.44 110.465 -12.093 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 5.4 m -153.42 108.12 3.14 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 123.686 0.795 . . . . 73.21 109.575 -179.616 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 50.7 mmm -93.87 153.44 18.25 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 124.288 1.035 . . . . 74.23 109.946 169.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 94.2 t -145.21 155.04 13.73 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 C-N-CA 125.102 1.361 . . . . 74.5 107.393 175.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 50.6 t -126.25 123.95 64.7 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 C-N-CA 127.783 2.433 . . . . 73.44 107.164 177.288 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 15.9 m-20 52.23 18.44 0.88 Allowed 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 129.294 3.038 . . . . 70.51 114.685 174.286 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 62.89 31.34 80.16 Favored Glycine 0 CA--C 1.532 1.152 0 CA-C-O 118.025 -1.431 . . . . 73.24 113.92 -169.288 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 9.2 mtpt -133.87 -28.15 1.41 Allowed 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 119.863 1.831 . . . . 75.15 113.334 -175.506 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -125.83 129.05 48.63 Favored 'General case' 0 CA--C 1.512 -0.5 0 N-CA-C 107.7 -1.222 . . . . 73.44 107.7 177.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 2.4 ttp85 -114.73 134.96 54.68 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 127.124 2.169 . . . . 75.21 105.787 179.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 28.2 p90 -151.22 167.26 28.34 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.988 -0.745 . . . . 72.01 108.988 -179.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -176.03 178.25 1.48 Allowed 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.269 1.028 . . . . 74.11 109.896 -178.175 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 38.1 mt -52.18 -42.23 35.51 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 C-N-CA 126.482 1.913 . . . . 73.23 110.459 178.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -80.25 -21.58 64.68 Favored Glycine 0 CA--C 1.526 0.722 0 CA-C-O 118.646 -1.086 . . . . 73.41 112.56 -179.407 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 1.1 m -72.83 -63.91 1.07 Allowed 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 119.716 1.758 . . . . 70.43 107.484 170.359 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -64.33 -38.59 91.56 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 123.907 0.883 . . . . 74.5 111.065 -168.568 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 121.06 -3.87 11.46 Favored Glycine 0 CA--C 1.525 0.674 0 CA-C-O 118.268 -1.295 . . . . 61.23 112.872 175.061 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 175.74 172.65 40.75 Favored Glycine 0 CA--C 1.528 0.852 0 CA-C-N 119.364 1.582 . . . . 71.03 110.231 -175.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -65.74 -44.68 7.69 Favored 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 122.524 2.149 . . . . 72.42 109.82 -177.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -63.64 -38.28 90.52 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-O 122.228 1.013 . . . . 74.41 110.467 -176.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -68.0 -29.18 68.13 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 126.291 1.836 . . . . 75.44 109.433 -176.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 35.9 m -64.85 -45.09 87.57 Favored 'General case' 0 CA--C 1.533 0.325 0 O-C-N 121.082 -1.011 . . . . 75.31 110.069 -176.229 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 46.0 mt -63.97 -32.05 73.45 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 118.799 0.727 . . . . 73.54 110.784 177.542 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 1.9 ttmt -55.41 -38.89 69.53 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 124.31 1.044 . . . . 64.33 110.148 175.258 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -76.47 -41.58 46.71 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-O 118.136 -0.935 . . . . 74.32 110.552 174.174 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -52.67 -50.36 63.4 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 119.325 0.966 . . . . 70.31 112.025 -175.442 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -72.12 -42.19 66.33 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 123.323 0.649 . . . . 55.34 109.347 -173.144 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 10.9 t80 -63.0 -46.38 87.94 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 124.468 1.107 . . . . 74.42 111.158 178.255 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 81.3 mt -67.69 -34.17 76.38 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 123.649 0.78 . . . . 73.22 111.024 -178.381 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 29.5 mt -53.75 -55.82 11.86 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 N-CA-C 107.995 -1.113 . . . . 71.53 107.995 166.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -56.63 -31.91 64.8 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.979 0.912 . . . . 74.14 112.863 -177.689 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 9.3 tptm -68.83 -48.21 64.1 Favored 'General case' 0 N--CA 1.463 0.209 0 O-C-N 121.401 -0.812 . . . . 63.41 110.535 -179.305 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 35.6 mm-40 -74.75 -42.47 58.18 Favored 'General case' 0 C--O 1.222 -0.367 0 O-C-N 121.955 -0.466 . . . . 63.21 111.228 178.508 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.05 -34.28 74.64 Favored 'General case' 0 N--CA 1.465 0.288 0 O-C-N 121.073 -1.017 . . . . 74.43 110.739 -176.874 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.368 0 C-N-CA 123.56 0.744 . . . . 65.05 112.378 175.355 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.515 -0.391 0 CA-C-O 123.479 1.609 . . . . 65.31 110.316 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -73.26 11.95 0.66 Allowed 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 127.096 2.158 . . . . 72.12 113.025 -179.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 14.4 m-85 -146.43 157.74 43.8 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 126.01 1.724 . . . . 75.02 108.056 -175.19 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.9 m -131.23 132.8 44.89 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 107.671 -1.233 . . . . 73.51 107.671 -174.328 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -69.61 148.45 49.34 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 108.158 -1.052 . . . . 73.44 108.158 175.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 63.69 13.61 52.04 Favored Glycine 0 CA--C 1.535 1.308 0 C-N-CA 124.68 1.134 . . . . 65.34 113.445 -167.02 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.94 -63.06 0.98 Allowed 'General case' 0 CA--C 1.52 -0.208 0 CA-C-N 119.775 1.788 . . . . 74.44 107.804 -177.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.4 mp0 -98.44 -25.91 14.63 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.342 1.457 . . . . 73.53 110.505 178.109 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 50.6 p90 -154.56 167.12 31.16 Favored 'General case' 0 N--CA 1.467 0.41 0 O-C-N 121.238 -0.914 . . . . 74.42 111.697 -171.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 59.2 t -132.9 115.91 25.37 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 C-N-CA 124.859 1.263 . . . . 74.14 109.058 -171.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -80.43 167.3 20.35 Favored 'General case' 0 C--O 1.236 0.392 0 O-C-N 119.972 -1.705 . . . . 72.32 110.478 174.301 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -126.16 124.64 40.96 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 124.237 1.015 . . . . 72.2 108.88 172.694 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 8.2 m -67.34 -9.45 41.32 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.838 0.855 . . . . 74.4 113.163 179.296 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 30.2 m -129.32 74.47 80.96 Favored Pre-proline 0 CA--C 1.537 0.454 0 C-N-CA 124.224 1.01 . . . . 63.54 108.625 -177.009 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -69.56 -179.01 2.53 Favored 'Trans proline' 0 N--CA 1.46 -0.459 0 C-N-CA 125.056 3.837 . . . . 73.3 112.281 -172.12 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.2 t -128.68 138.93 34.18 Favored Pre-proline 0 CA--C 1.532 0.27 0 C-N-CA 124.672 1.189 . . . . 75.24 107.93 -174.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_endo -73.13 179.1 5.74 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 122.42 2.08 . . . . 74.03 112.613 176.286 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.4 m -127.46 168.25 20.9 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 C-N-CA 126.826 2.051 . . . . 75.23 108.945 174.028 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 70.9 m -47.01 -61.84 1.69 Allowed 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 126.795 2.038 . . . . 62.4 110.508 176.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -145.82 165.38 21.17 Favored Pre-proline 0 C--O 1.238 0.492 0 C-N-CA 127.347 2.259 . . . . 73.03 105.375 163.079 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -70.88 -164.66 0.15 Allowed 'Trans proline' 0 CA--C 1.541 0.862 0 C-N-CA 122.62 2.213 . . . . 73.22 110.222 173.325 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 118.1 -112.68 2.45 Favored Glycine 0 N--CA 1.447 -0.627 0 N-CA-C 106.301 -2.72 . . . . 72.45 106.301 -179.388 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 33.4 mttm -54.46 133.69 45.81 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 124.136 0.974 . . . . 65.45 108.721 172.177 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 31.8 mm -64.59 140.72 19.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 106.377 -1.712 . . . . 75.05 106.377 169.541 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -99.21 139.17 35.26 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 107.559 -1.274 . . . . 74.32 107.559 -177.65 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 56.1 t -128.54 130.43 69.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 105.895 -1.891 . . . . 75.15 105.895 176.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 11.3 t -131.2 108.05 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 N-CA-C 107.417 -1.327 . . . . 63.32 107.417 -172.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -69.0 143.34 54.38 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 124.27 1.028 . . . . 64.31 108.556 162.26 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 5.0 mp -121.75 131.08 53.88 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 108.881 -0.785 . . . . 73.2 108.881 158.416 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 23.9 p90 -127.33 176.77 7.18 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.477 1.111 . . . . 71.12 110.469 179.249 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . 0.435 ' HE1' ' HA ' ' A' ' 71' ' ' TRP . 27.1 t90 -151.0 175.8 11.73 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.082 1.353 . . . . 75.02 109.559 174.551 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.465 ' HH ' ' CE1' ' A' ' 102' ' ' HIS . 40.2 t80 -61.5 -73.18 0.1 Allowed 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.616 1.166 . . . . 74.24 112.876 172.741 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -81.86 52.03 4.53 Favored Glycine 0 C--N 1.339 0.705 0 C-N-CA 124.823 1.201 . . . . 44.4 110.358 -171.123 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 35.8 t -113.5 84.81 8.25 Favored Pre-proline 0 CA--C 1.538 0.487 0 C-N-CA 127.462 2.305 . . . . 72.44 106.051 -163.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -72.57 168.56 24.08 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 123.314 2.676 . . . . 74.12 109.217 171.228 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 5.2 m170 63.98 -45.7 0.27 Allowed 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 126.476 1.91 . . . . 73.42 112.116 -165.007 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 3.8 m -46.74 -53.14 12.43 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 126.745 2.018 . . . . 75.15 110.604 176.425 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 11.7 t80 -58.92 -49.92 75.99 Favored 'General case' 0 C--N 1.341 0.229 0 C-N-CA 125.361 1.464 . . . . 73.03 110.894 176.51 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.76 -13.52 61.51 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 112.742 0.645 . . . . 60.14 112.742 -171.356 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 7.0 t80 -90.71 -16.85 27.76 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 125.714 1.605 . . . . 71.51 112.073 179.262 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -46.68 -67.27 0.4 Allowed Pre-proline 0 N--CA 1.469 0.485 0 CA-C-N 120.059 1.299 . . . . 73.24 112.566 -172.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -69.02 -9.13 25.52 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 CA-C-N 122.033 1.762 . . . . 75.33 114.496 -177.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.9 m -70.91 -43.18 68.83 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 119.758 1.163 . . . . 74.42 108.798 167.167 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 21.1 tt -105.2 -28.51 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 N-CA-C 113.825 1.046 . . . . 72.44 113.825 -164.504 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 27.5 t -46.37 -60.4 3.72 Favored Pre-proline 0 CA--C 1.54 0.559 0 C-N-CA 124.794 1.238 . . . . 73.2 109.434 173.438 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -61.85 -35.31 79.16 Favored 'Trans proline' 0 N--CA 1.453 -0.883 0 CA-C-N 120.31 1.146 . . . . 75.35 112.974 -177.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 72.8 t90 -57.24 -51.62 68.61 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.367 0.667 . . . . 74.3 110.402 179.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 29.5 t -58.89 -39.18 80.69 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 121.132 0.491 . . . . 72.02 110.269 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -68.92 -25.55 64.64 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 121.173 -0.954 . . . . 72.51 111.407 -177.429 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 14.3 mmtp -96.72 10.08 39.79 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.576 1.15 . . . . 75.43 112.879 177.477 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 34.9 mt -60.88 151.23 74.44 Favored Pre-proline 0 C--O 1.237 0.395 0 CA-C-N 119.532 1.06 . . . . 75.23 110.964 174.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -76.07 169.69 21.58 Favored 'Trans proline' 0 N--CA 1.445 -1.378 0 C-N-CA 124.065 3.177 . . . . 71.55 110.485 177.533 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -65.13 -4.19 4.64 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 125.044 1.338 . . . . 74.52 113.391 173.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -100.68 8.4 43.36 Favored 'General case' 0 N--CA 1.463 0.182 0 C-N-CA 125.709 1.603 . . . . 75.21 110.597 -177.056 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 61.0 t -129.53 160.03 40.93 Favored 'Isoleucine or valine' 0 C--O 1.239 0.542 0 O-C-N 121.214 -0.929 . . . . 51.45 108.798 -179.651 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 29.2 t60 -132.93 155.39 49.17 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 126.268 1.827 . . . . 61.41 107.249 165.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 55.7 t80 -132.5 134.01 44.49 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 108.102 -1.073 . . . . 71.22 108.102 -175.104 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 47.6 t -135.31 155.38 37.2 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 C-N-CA 126.551 1.941 . . . . 71.13 107.264 -172.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 16.4 mtt85 -133.2 130.32 38.94 Favored 'General case' 0 CA--C 1.513 -0.46 0 N-CA-C 105.197 -2.149 . . . . 74.04 105.197 176.284 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 37.6 mt -135.58 144.74 50.45 Favored Pre-proline 0 N--CA 1.469 0.514 0 CA-C-N 120.113 1.324 . . . . 74.34 110.082 175.502 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -74.89 157.45 43.21 Favored 'Trans proline' 0 N--CA 1.462 -0.353 0 C-N-CA 122.379 2.053 . . . . 74.11 110.728 -179.414 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -101.04 94.55 6.05 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 123.984 0.914 . . . . 64.24 110.12 -175.463 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 22.5 mt -86.43 76.75 9.58 Favored 'General case' 0 CA--C 1.539 0.54 0 O-C-N 120.612 -1.305 . . . . 73.1 111.869 -172.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -82.49 20.2 1.14 Allowed 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 115.129 1.529 . . . . 75.44 115.129 -176.156 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 89.01 -48.09 3.43 Favored Glycine 0 CA--C 1.525 0.704 0 O-C-N 119.924 -1.735 . . . . 62.43 112.834 168.214 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -72.55 -152.11 1.58 Allowed Glycine 0 CA--C 1.529 0.958 0 C-N-CA 124.337 0.97 . . . . 71.31 110.737 174.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 7.1 tp -46.75 -30.88 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 C-N-CA 124.1 0.96 . . . . 75.33 112.055 177.371 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . 0.435 ' HA ' ' HE1' ' A' ' 34' ' ' TRP . 19.4 m95 -50.31 -27.47 6.23 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 126.069 1.748 . . . . 73.03 113.391 177.757 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 20.2 m-20 -73.91 -36.42 64.72 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-N 119.576 1.08 . . . . 75.04 110.496 177.153 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.417 ' C ' ' H ' ' A' ' 75' ' ' GLY . 40.7 t -73.82 -55.19 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 N-CA-C 107.966 -1.124 . . . . 75.2 107.966 174.839 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 34.9 m170 -65.95 31.92 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 129.534 3.134 . . . . 74.34 112.175 170.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.417 ' H ' ' C ' ' A' ' 73' ' ' VAL . . . -149.21 -42.55 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 125.353 1.454 . . . . 61.13 111.191 173.122 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -54.6 -41.84 70.42 Favored 'General case' 0 C--O 1.223 -0.328 0 CA-C-O 117.753 -1.118 . . . . 74.11 112.439 -175.06 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -44.47 -44.34 8.47 Favored 'General case' 0 CA--C 1.514 -0.407 0 N-CA-C 114.123 1.157 . . . . 71.22 114.123 -173.303 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 28.8 t80 -61.88 -45.76 92.34 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 118.525 0.602 . . . . 73.5 110.236 -176.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 50.0 mt -61.35 -45.24 95.22 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-O 116.726 -1.606 . . . . 64.33 109.251 175.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -62.41 -45.68 92.03 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 120.652 1.569 . . . . 72.21 110.776 -176.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.82 -60.6 2.99 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 125.998 1.719 . . . . 72.1 109.469 178.495 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -69.75 -28.92 66.18 Favored 'General case' 0 C--O 1.231 0.095 0 CA-C-O 118.927 -0.558 . . . . 64.23 111.76 -175.21 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 6.2 t -51.67 -37.16 49.33 Favored 'General case' 0 CA--C 1.52 -0.184 0 C-N-CA 124.343 1.057 . . . . 71.52 110.712 178.091 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 30.8 mtp . . . . . 0 N--CA 1.448 -0.562 0 CA-C-O 118.762 -0.637 . . . . 75.13 111.696 -170.913 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.387 0 N-CA-C 114.533 1.308 . . . . 75.34 114.533 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 55.8 t -71.49 -65.63 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 CA-C-O 117.575 -1.203 . . . . 73.4 108.614 166.241 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -54.61 -46.78 73.89 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 120.387 1.449 . . . . 73.23 111.98 -179.58 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -58.45 -40.49 82.77 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.427 1.491 . . . . 75.43 110.196 -178.705 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.411 ' HB1' ' CE1' ' A' ' 114' ' ' PHE . . . -74.2 4.53 5.53 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 125.798 1.639 . . . . 64.11 112.84 -178.641 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 61.7 mt -115.25 -57.12 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.891 0 N-CA-C 104.975 -2.232 . . . . 74.13 104.975 177.129 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 88.0 m-70 -80.67 -61.24 2.03 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 123.664 0.786 . . . . 75.41 112.616 -173.178 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -68.34 -21.16 64.75 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 119.063 0.847 . . . . 73.24 112.209 -177.756 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -94.45 -53.56 3.86 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 124.548 1.139 . . . . 73.44 108.771 -175.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . 0.465 ' CE1' ' HH ' ' A' ' 35' ' ' TYR . 6.9 t60 58.49 88.0 0.07 Allowed 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.513 1.525 . . . . 70.34 110.65 -169.792 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 3.3 mmpt? -116.33 13.79 15.62 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.389 1.076 . . . . 72.11 113.302 -176.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 30.4 tttm 69.87 -64.23 0.36 Allowed 'General case' 0 C--O 1.221 -0.418 0 C-N-CA 128.2 2.6 . . . . 73.32 109.558 -174.333 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 40.6 mt 54.47 44.66 28.48 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.813 1.645 . . . . 73.43 112.508 177.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -94.63 14.54 20.72 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.283 1.433 . . . . 72.33 114.189 -173.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -156.13 155.35 29.01 Favored Pre-proline 0 CA--C 1.535 0.395 0 C-N-CA 127.97 2.508 . . . . 75.22 107.662 -178.078 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -64.21 -44.99 10.71 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.546 2.164 . . . . 71.41 109.959 -173.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -69.01 -29.38 67.55 Favored 'General case' 0 N--CA 1.438 -1.039 0 C-N-CA 124.189 0.995 . . . . 72.43 111.15 -174.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -54.47 -42.15 70.34 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.95 1.3 . . . . 72.4 110.356 173.039 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 2.5 mtt -76.85 -48.53 18.14 Favored 'General case' 0 CA--C 1.512 -0.514 0 C-N-CA 124.193 0.997 . . . . 75.45 108.92 -178.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -62.29 -37.16 84.46 Favored 'General case' 0 N--CA 1.447 -0.619 0 O-C-N 123.408 0.443 . . . . 73.44 111.337 -172.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -56.07 -46.85 78.83 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 125.287 1.435 . . . . 53.44 112.61 172.075 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . 0.411 ' CE1' ' HB1' ' A' ' 97' ' ' ALA . 19.0 t80 -74.27 -41.68 60.85 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 123.548 0.739 . . . . 74.32 111.45 -177.401 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 18.2 mt -76.94 -14.71 59.83 Favored 'General case' 0 C--N 1.332 -0.172 0 O-C-N 121.33 -0.856 . . . . 73.24 110.4 -176.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -48.48 -41.71 30.58 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.805 0.842 . . . . 74.51 110.127 172.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -82.09 10.09 54.67 Favored Glycine 0 CA--C 1.529 0.965 0 CA-C-O 117.975 -1.458 . . . . 75.43 114.805 177.265 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 23.8 mmtt -127.34 8.77 6.58 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 121.338 2.569 . . . . 72.43 112.615 -174.412 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 86.87 49.31 4.11 Favored Glycine 0 C--N 1.333 0.392 0 N-CA-C 109.669 -1.372 . . . . 65.22 109.669 -177.416 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 39.0 t -134.58 132.89 54.72 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 N-CA-C 105.18 -2.156 . . . . 73.14 105.18 169.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -92.27 133.65 35.63 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 123.68 0.792 . . . . 75.24 110.002 173.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 17.6 mtpt -64.58 -37.0 86.05 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 118.747 -0.644 . . . . 75.11 110.386 174.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -67.02 -26.82 66.97 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 118.707 0.685 . . . . 71.24 111.72 178.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 13.0 mttm -77.61 -57.06 4.02 Favored 'General case' 0 CA--C 1.518 -0.27 0 N-CA-C 106.402 -1.703 . . . . 75.42 106.402 171.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 41.3 t80 -51.86 -59.49 4.26 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 124.808 1.243 . . . . 73.03 112.174 -166.46 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 19.7 mt -73.54 -33.74 64.86 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 110.275 -0.268 . . . . 52.35 110.275 -170.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 29.7 m -62.26 -49.44 75.7 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 109.315 -0.624 . . . . 74.33 109.315 179.122 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 23.9 m -65.71 -41.33 92.44 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 124.553 1.141 . . . . 75.01 110.22 178.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 42.2 t80 -49.19 -48.69 45.05 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 119.691 1.132 . . . . 73.31 110.82 173.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 14.5 m-20 -92.64 38.89 1.02 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.647 0.779 . . . . 72.23 111.16 -178.121 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 7.7 t -122.86 172.26 8.6 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.403 1.481 . . . . 73.24 111.653 -177.334 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -67.09 -40.39 86.92 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.824 1.25 . . . . 75.44 110.52 178.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -50.58 -49.85 55.25 Favored 'General case' 0 C--N 1.34 0.166 0 C-N-CA 123.725 0.81 . . . . 63.13 110.463 -177.503 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 21.5 mm -69.51 -38.85 77.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 C-N-CA 124.218 1.007 . . . . 64.15 111.269 -178.305 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 1.7 mtmt -55.53 -33.26 63.65 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 124.066 0.947 . . . . 73.54 110.964 177.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -73.23 -48.42 19.44 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 110.831 -0.907 . . . . 65.25 110.831 178.357 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -63.34 -36.2 82.92 Favored 'General case' 0 CA--C 1.532 0.255 0 O-C-N 121.715 -0.874 . . . . 74.54 109.587 -177.502 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.32 -34.9 78.71 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-O 117.755 -1.116 . . . . 73.52 111.483 178.605 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -80.48 -39.84 27.3 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 120.588 1.54 . . . . 74.1 111.634 175.021 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.92 -59.02 5.67 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 118.864 -0.589 . . . . 74.32 110.763 179.116 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -58.85 -44.45 91.01 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 118.882 0.765 . . . . 75.41 109.056 -176.315 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 1.9 tmtt? -50.38 -57.73 7.3 Favored 'General case' 0 CA--C 1.528 0.11 0 C-N-CA 123.996 0.918 . . . . 73.12 111.139 -179.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.94 -35.06 69.51 Favored 'General case' 0 C--O 1.231 0.099 0 CA-C-N 118.834 0.743 . . . . 74.23 111.384 -175.28 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 37.8 mt -59.0 -49.56 77.44 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 123.577 0.751 . . . . 74.12 110.646 -177.477 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -54.47 -48.0 72.32 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 119.154 0.888 . . . . 73.12 111.722 -179.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 1.5 mtm -66.63 -34.8 78.68 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 120.332 -0.547 . . . . 72.22 109.774 -177.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -59.91 -43.86 94.62 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 118.426 0.557 . . . . 70.44 109.66 176.348 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -70.01 4.98 1.77 Allowed 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 126.183 1.793 . . . . 74.51 113.492 177.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 54.37 36.78 26.2 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 126.936 2.094 . . . . 75.43 112.124 -175.1 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 89.8 t -69.36 135.05 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 107.674 -1.232 . . . . 71.32 107.674 172.161 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 5.7 p -129.23 -16.12 4.04 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 126.787 2.035 . . . . 74.34 110.343 -176.132 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -168.36 -170.88 33.62 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 125.944 1.735 . . . . 65.12 112.825 -175.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.412 ' HA ' ' C ' ' A' ' 154' ' ' PRO . 14.8 m -142.46 153.04 61.82 Favored Pre-proline 0 CA--C 1.546 0.819 0 C-N-CA 127.323 2.249 . . . . 75.32 108.316 175.613 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . 0.412 ' C ' ' HA ' ' A' ' 153' ' ' VAL . 56.2 Cg_endo -63.52 152.71 71.36 Favored 'Cis proline' 0 CA--C 1.537 0.673 0 C-N-CA 124.578 -1.009 . . . . 64.44 113.145 -6.884 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 59.2 m -145.91 144.26 30.07 Favored 'General case' 0 C--O 1.239 0.547 0 C-N-CA 125.31 1.444 . . . . 73.44 108.529 175.251 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 19.8 mmm -123.97 158.41 32.12 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 125.774 1.63 . . . . 75.41 108.209 163.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 21.5 t -142.1 136.47 29.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 106.939 -1.504 . . . . 73.24 106.939 174.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 28.9 t -104.01 135.2 42.8 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 N-CA-C 107.098 -1.445 . . . . 72.12 107.098 168.726 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 1.4 t30 47.12 10.8 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.688 1 C-N-CA 133.111 4.565 . . . . 73.43 117.541 171.153 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 83.69 20.11 60.48 Favored Glycine 0 CA--C 1.526 0.777 0 CA-C-O 117.806 -1.552 . . . . 52.04 115.559 -169.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 48.0 mttt -131.81 -41.39 1.04 Allowed 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 119.971 1.885 . . . . 74.51 114.358 -170.302 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 -112.74 107.51 16.19 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 108.293 -1.003 . . . . 75.33 108.293 -171.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 63.2 ttp85 -88.92 113.41 24.43 Favored 'General case' 0 C--O 1.231 0.109 0 C-N-CA 126.5 1.92 . . . . 73.13 106.797 175.023 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 5.3 p90 -136.51 169.59 17.45 Favored 'General case' 0 C--N 1.319 -0.75 0 O-C-N 120.343 -1.473 . . . . 63.13 107.186 177.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . 0.41 ' CG ' ' H ' ' A' ' 166' ' ' ILE . 3.9 t70 -174.97 -178.78 1.28 Allowed 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 122.548 0.339 . . . . 74.12 110.129 177.333 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . 0.41 ' H ' ' CG ' ' A' ' 165' ' ' ASP . 21.5 mt -46.33 -50.05 5.23 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 C-N-CA 128.555 2.742 . . . . 75.03 107.728 160.378 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -76.16 16.57 4.51 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 125.847 1.689 . . . . 70.41 114.392 178.012 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 17.8 m -128.3 -51.13 1.29 Allowed 'General case' 0 C--O 1.224 -0.239 0 CA-C-N 118.795 1.298 . . . . 75.33 109.705 168.565 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -70.32 -34.65 72.94 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 125.12 1.368 . . . . 73.54 112.266 -175.253 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 122.58 -5.96 9.87 Favored Glycine 0 C--N 1.341 0.83 0 CA-C-O 118.512 -1.16 . . . . 64.45 114.793 175.089 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 165.84 174.31 35.21 Favored Glycine 0 CA--C 1.532 1.097 0 CA-C-N 119.745 1.772 . . . . 74.51 110.003 -175.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -64.9 -52.61 1.18 Allowed 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 122.408 2.072 . . . . 71.31 111.772 -169.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -62.29 -28.68 69.9 Favored 'General case' 0 N--CA 1.463 0.223 0 O-C-N 120.965 -1.084 . . . . 73.42 111.547 178.491 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -67.4 -27.21 66.89 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.141 0.576 . . . . 74.32 110.366 177.527 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 19.7 m -77.66 -42.9 33.07 Favored 'General case' 0 CA--C 1.53 0.177 0 O-C-N 121.052 -1.03 . . . . 73.43 110.915 -169.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 35.8 mt -63.88 -31.77 73.07 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 118.918 0.781 . . . . 74.22 111.013 178.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 4.8 tttt -48.48 -56.48 8.17 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 126.602 1.961 . . . . 71.53 108.041 168.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -65.48 -41.37 93.38 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-O 116.941 -1.504 . . . . 74.53 111.554 176.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -53.82 -48.68 69.67 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 120.917 1.689 . . . . 70.41 111.699 -175.395 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -69.52 -47.09 64.92 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 122.943 0.497 . . . . 63.54 110.577 -176.072 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -60.47 -42.61 96.59 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 123.565 0.746 . . . . 73.41 111.285 178.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 90.6 mt -67.09 -37.4 83.9 Favored 'General case' 0 C--N 1.332 -0.171 0 O-C-N 120.949 -1.094 . . . . 74.21 111.221 178.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 31.6 mt -58.25 -51.94 65.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 CA-C-N 119.259 0.936 . . . . 70.11 108.582 172.059 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -52.06 -43.07 63.62 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 124.59 1.156 . . . . 73.23 109.976 175.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 71.3 tttt -79.66 -0.32 33.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 117.124 -1.417 . . . . 74.14 113.161 -175.486 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -103.11 -33.33 9.27 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 125.662 1.585 . . . . 73.12 114.43 178.435 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.39 -55.76 4.98 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 107.372 -1.344 . . . . 73.04 107.372 -179.222 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.403 0 CA-C-N 115.172 -0.922 . . . . 75.43 111.795 -176.444 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 . . . . . 0 N--CA 1.471 0.576 0 CA-C-O 123.399 1.571 . . . . 71.2 111.895 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -75.55 5.6 5.77 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 112.954 -1.93 . . . . 74.32 114.234 -171.48 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 30.1 m-85 -135.0 165.02 26.31 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 126.066 1.746 . . . . 73.2 108.04 -171.472 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 13.6 m -130.05 131.66 45.89 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 108.001 -1.111 . . . . 74.44 108.001 -178.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.89 154.02 42.03 Favored 'General case' 0 C--O 1.232 0.158 0 O-C-N 121.093 -1.005 . . . . 73.22 109.265 173.597 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 71.02 -36.17 0.51 Allowed Glycine 0 CA--C 1.53 1.001 0 C-N-CA 125.723 1.63 . . . . 64.01 112.859 -163.398 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 4.7 tptt -83.38 -83.37 0.14 Allowed 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 124.783 1.233 . . . . 72.14 108.993 -173.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 23.6 mp0 -73.41 -24.61 60.3 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 125.596 1.558 . . . . 73.23 110.47 -177.294 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 43.6 p90 -158.7 176.03 12.89 Favored 'General case' 0 N--CA 1.468 0.466 0 O-C-N 121.165 -0.959 . . . . 62.03 110.728 -173.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 62.0 t -134.55 107.63 9.33 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 124.921 1.288 . . . . 75.31 109.344 -177.283 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -73.23 147.14 44.94 Favored 'General case' 0 N--CA 1.444 -0.744 0 O-C-N 120.942 -1.099 . . . . 72.11 109.963 166.123 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -111.68 134.67 53.09 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 125.29 1.436 . . . . 74.31 109.92 -178.579 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 5.4 p -80.69 4.11 19.88 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 125.33 1.452 . . . . 53.13 114.137 -176.356 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -141.7 83.91 12.62 Favored Pre-proline 0 N--CA 1.45 -0.471 0 N-CA-C 106.781 -1.562 . . . . 71.54 106.781 173.342 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -70.92 -176.25 1.74 Allowed 'Trans proline' 0 CA--C 1.536 0.598 0 C-N-CA 124.086 3.191 . . . . 73.11 111.799 -175.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 22.1 t -131.65 137.5 30.52 Favored Pre-proline 0 CA--C 1.536 0.431 0 C-N-CA 123.942 0.897 . . . . 75.22 108.788 -174.186 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -78.95 176.39 9.89 Favored 'Trans proline' 0 CA--C 1.536 0.584 0 C-N-CA 123.67 2.914 . . . . 71.42 111.607 176.07 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.6 m -125.29 178.91 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 C-N-CA 125.307 1.443 . . . . 72.43 109.529 171.575 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 51.3 m -59.11 -58.18 9.79 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 124.537 1.135 . . . . 71.31 111.276 174.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -143.89 154.15 58.28 Favored Pre-proline 0 CA--C 1.536 0.428 0 C-N-CA 123.954 0.902 . . . . 73.12 109.509 173.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -70.29 167.04 26.29 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 123.37 2.713 . . . . 72.41 111.009 177.136 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 131.72 -96.39 0.33 Allowed Glycine 0 N--CA 1.449 -0.471 0 N-CA-C 109.412 -1.475 . . . . 63.04 109.412 178.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.39 126.11 29.03 Favored 'General case' 0 CA--C 1.518 -0.268 0 N-CA-C 108.53 -0.915 . . . . 75.43 108.53 -175.364 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 34.2 mm -61.68 140.17 19.51 Favored 'Isoleucine or valine' 0 C--O 1.24 0.581 0 N-CA-C 107.111 -1.44 . . . . 75.24 107.111 176.459 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -93.87 153.39 18.28 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 118.296 -1.361 . . . . 73.41 108.558 -177.135 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 16.1 t -146.31 121.81 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 N-CA-C 105.106 -2.183 . . . . 75.43 105.106 -177.567 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 57.3 t -123.07 119.47 57.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 106.898 -1.519 . . . . 73.33 106.898 -175.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -80.24 124.01 28.45 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 106.489 -1.671 . . . . 74.42 106.489 157.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.7 mp -110.47 145.24 38.02 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 107.031 -1.47 . . . . 74.32 107.031 160.022 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 18.5 p90 -154.23 176.93 11.68 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 124.138 0.975 . . . . 71.22 110.07 -172.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 30.4 t90 -146.9 176.61 9.77 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 126.445 1.898 . . . . 72.44 108.268 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 23.7 t80 -56.22 -57.9 10.24 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 125.818 1.647 . . . . 73.22 111.467 178.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -93.4 -76.68 1.34 Allowed Glycine 0 C--N 1.338 0.677 0 N-CA-C 111.125 -0.79 . . . . 71.23 111.125 -155.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . 0.289 10.7 p 42.68 74.97 0.68 Allowed Pre-proline 0 CA--C 1.534 0.352 0 C-N-CA 126.409 1.884 . . . . 64.42 112.45 165.828 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -54.95 -27.43 54.08 Favored 'Trans proline' 0 CA--C 1.537 0.668 0 CA-C-N 121.078 1.421 . . . . 64.51 113.023 -175.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 10.6 m170 -70.34 -37.45 74.67 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.598 1.159 . . . . 73.15 111.861 175.001 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 18.7 p -67.37 -31.58 71.92 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 119.833 1.197 . . . . 74.54 111.087 -178.451 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 89.9 t80 -65.97 -26.02 67.37 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.314 1.046 . . . . 74.31 111.733 176.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -74.35 -7.76 53.94 Favored 'General case' 0 CA--C 1.536 0.424 0 O-C-N 120.879 -1.138 . . . . 42.15 112.15 172.196 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -126.76 -20.34 4.3 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-O 118.023 -0.989 . . . . 63.14 113.125 -163.511 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . 0.253 0.0 OUTLIER -50.44 -64.28 1.38 Allowed Pre-proline 0 N--CA 1.475 0.794 0 CA-C-N 120.689 1.586 . . . . 72.34 113.893 -175.551 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -70.52 -9.29 25.52 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 CA-C-N 122.099 1.785 . . . . 72.35 114.015 -176.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 85.4 m -79.87 -36.44 36.61 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 119.564 1.074 . . . . 74.44 109.671 169.398 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 15.8 tt -85.14 -35.49 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 CA-C-N 119.367 0.985 . . . . 72.13 111.617 -177.125 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 55.8 t -48.29 -62.65 2.05 Favored Pre-proline 0 CA--C 1.538 0.504 0 CA-C-O 117.413 -1.28 . . . . 73.3 112.088 -177.094 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -68.11 -29.53 33.15 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 121.428 1.418 . . . . 64.21 111.32 -176.041 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 77.2 t90 -54.23 -57.79 9.83 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 119.322 0.965 . . . . 75.51 109.973 177.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.2 -23.39 62.94 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 112.587 0.588 . . . . 73.24 112.587 -172.572 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 78.0 mt-10 -66.42 -48.19 70.8 Favored 'General case' 0 C--O 1.235 0.301 0 O-C-N 120.926 -1.109 . . . . 71.12 109.716 169.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 30.0 mmmt -74.57 3.6 7.46 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.524 1.53 . . . . 73.35 112.817 -169.678 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 37.7 mt -59.09 159.45 14.31 Favored Pre-proline 0 CA--C 1.543 0.674 0 C-N-CA 125.363 1.465 . . . . 74.11 112.129 177.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -87.27 174.0 5.39 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 125.204 3.936 . . . . 74.21 112.265 178.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -66.83 -21.26 66.03 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 114.307 1.225 . . . . 61.02 114.307 -175.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 40.9 m-20 -86.81 6.89 29.4 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.722 1.209 . . . . 71.5 111.146 -175.292 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 46.8 t -129.0 151.76 36.22 Favored 'Isoleucine or valine' 0 C--O 1.24 0.589 0 C-N-CA 125.194 1.398 . . . . 73.23 108.412 -173.245 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 79.6 t60 -133.96 144.5 48.81 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 125.498 1.519 . . . . 73.3 107.852 173.574 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 24.7 t80 -128.42 136.82 51.4 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 123.763 0.825 . . . . 74.4 110.535 -172.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 70.9 t -133.64 148.96 30.52 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 C-N-CA 126.253 1.821 . . . . 71.23 107.935 -174.532 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -123.79 125.31 44.47 Favored 'General case' 0 CA--C 1.512 -0.515 0 N-CA-C 105.615 -1.995 . . . . 74.14 105.615 172.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 20.7 mt -133.43 150.93 76.44 Favored Pre-proline 0 N--CA 1.47 0.539 0 CA-C-N 119.474 1.033 . . . . 70.22 111.092 176.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -73.63 139.29 27.96 Favored 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 121.64 1.56 . . . . 75.34 110.578 179.13 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -79.93 79.06 6.51 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.225 1.01 . . . . 53.42 109.382 173.216 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 48.8 mt -72.76 106.02 4.57 Favored 'General case' 0 C--N 1.329 -0.304 0 O-C-N 120.99 -1.069 . . . . 72.13 109.363 175.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -128.8 28.06 5.4 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.424 1.489 . . . . 74.43 112.376 178.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 76.9 169.78 31.54 Favored Glycine 0 CA--C 1.523 0.589 0 C-N-CA 125.454 1.502 . . . . 72.44 111.166 -178.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 56.77 -151.04 26.15 Favored Glycine 0 CA--C 1.529 0.937 0 N-CA-C 111.083 -0.807 . . . . 72.04 111.083 -175.129 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.2 tt -60.47 -21.33 22.84 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 C-N-CA 124.183 0.993 . . . . 72.35 112.658 -174.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 23.9 m95 -63.31 -32.1 73.43 Favored 'General case' 0 CA--C 1.53 0.178 0 O-C-N 121.725 -0.609 . . . . 75.51 110.715 173.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -77.49 -43.57 31.74 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-N 118.676 0.671 . . . . 75.51 110.46 173.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 58.7 t -55.29 -58.21 5.12 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 C-N-CA 124.077 0.951 . . . . 74.51 109.916 -175.258 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 61.5 m170 -69.89 -7.61 41.73 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 118.568 -0.729 . . . . 74.11 112.042 -178.425 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -93.45 -18.55 38.27 Favored Glycine 0 C--N 1.338 0.652 0 CA-C-N 120.288 1.404 . . . . 73.21 110.242 -177.449 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -74.76 -36.6 62.57 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 118.58 1.19 . . . . 75.31 110.97 -173.452 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 34.2 ttp -53.82 -45.28 70.78 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.659 1.583 . . . . 74.42 113.436 179.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 10.7 t80 -57.5 -44.21 84.82 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 109.172 -0.677 . . . . 75.24 109.172 -177.115 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 24.4 mt -65.94 -44.9 83.71 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-O 117.092 -1.432 . . . . 75.12 109.53 178.331 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -56.42 -41.71 76.83 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 121.165 1.802 . . . . 65.25 112.318 178.501 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.0 -59.43 4.92 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 124.853 1.261 . . . . 75.12 109.154 -174.675 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -72.46 -24.37 61.19 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 111.442 0.164 . . . . 73.22 111.442 -174.382 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.4 t -58.92 -8.5 1.41 Allowed 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.597 1.559 . . . . 73.2 113.516 176.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 6.8 mtp . . . . . 0 C--O 1.233 0.22 0 C-N-CA 125.453 1.501 . . . . 72.11 113.963 -179.415 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.102 0 N-CA-C 113.421 0.897 . . . . 74.13 113.421 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 60.0 t -58.45 -58.69 5.51 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 N-CA-C 108.393 -0.965 . . . . 75.51 108.393 172.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 -58.84 -49.9 76.0 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 124.296 1.038 . . . . 74.04 110.873 179.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -71.27 -2.97 17.94 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 126.184 1.793 . . . . 73.44 112.64 -173.529 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -96.37 -28.33 14.52 Favored 'General case' 0 N--CA 1.453 -0.28 0 O-C-N 120.84 -1.162 . . . . 73.35 112.405 169.646 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 12.1 mt -84.65 -58.49 3.46 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.513 0 N-CA-C 106.799 -1.556 . . . . 74.33 106.799 178.027 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 58.0 m-70 -73.61 -61.43 1.84 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 118.8 0.727 . . . . 73.04 112.734 -163.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.6 -12.1 60.0 Favored 'General case' 0 N--CA 1.473 0.7 0 O-C-N 120.614 -1.304 . . . . 75.41 114.18 179.42 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -114.46 -27.82 7.41 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 113.888 1.07 . . . . 75.15 113.888 -171.045 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . 0.41 ' C ' ' H ' ' A' ' 104' ' ' LYS 0.272 5.1 m170 43.72 46.63 6.41 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 127.632 2.373 . . . . 73.33 112.868 169.387 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.457 ' HE2' ' HA ' ' A' ' 103' ' ' LYS . 7.9 mmpt? -68.37 12.12 0.14 Allowed 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 125.109 1.364 . . . . 72.03 114.614 178.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.41 ' H ' ' C ' ' A' ' 102' ' ' HIS . 4.2 ttpm? 68.14 -52.27 0.53 Allowed 'General case' 0 C--O 1.223 -0.293 0 C-N-CA 129.384 3.074 . . . . 75.23 111.057 -177.771 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 64.8 mt 51.84 43.96 29.72 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 125.957 1.703 . . . . 75.21 110.295 171.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -84.76 -24.97 28.56 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 124.369 1.067 . . . . 54.11 112.536 -175.371 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 44.4 p -124.06 160.08 53.71 Favored Pre-proline 0 N--CA 1.463 0.193 0 CA-C-N 119.767 1.167 . . . . 75.53 111.474 -169.423 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -71.15 -15.91 31.92 Favored 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 121.344 1.363 . . . . 73.12 112.809 178.273 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.43 -59.91 2.58 Favored 'General case' 0 N--CA 1.462 0.153 0 N-CA-C 107.064 -1.458 . . . . 63.0 107.064 166.458 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -58.52 -42.03 86.79 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 123.928 0.891 . . . . 71.33 112.09 -170.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 41.1 mtt -65.57 -55.75 16.01 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 122.963 0.505 . . . . 73.41 111.099 175.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -70.86 -40.08 72.54 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 119.45 -0.31 . . . . 75.32 110.721 -166.121 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -60.79 -38.35 85.03 Favored 'General case' 0 C--N 1.338 0.103 0 C-N-CA 122.84 0.456 . . . . 73.3 110.638 175.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 82.9 t80 -72.0 -48.19 46.53 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 122.848 0.459 . . . . 72.12 111.206 -177.359 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 55.7 mt -68.29 -16.79 64.09 Favored 'General case' 0 C--O 1.23 0.049 0 O-C-N 121.49 -0.756 . . . . 65.14 111.219 -174.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -52.09 -18.03 1.29 Allowed 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.762 1.225 . . . . 63.44 112.867 172.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -86.37 -12.4 70.16 Favored Glycine 0 CA--C 1.529 0.938 0 O-C-N 120.927 -1.108 . . . . 72.13 113.148 177.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -116.84 6.04 13.09 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 119.485 1.643 . . . . 73.42 113.544 -161.587 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 87.65 48.92 4.04 Favored Glycine 0 C--N 1.334 0.439 0 N-CA-C 109.754 -1.338 . . . . 72.43 109.754 -169.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 55.9 t -129.81 155.08 41.19 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 N-CA-C 104.794 -2.299 . . . . 65.43 104.794 165.7 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -127.31 135.3 50.36 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 106.538 -1.653 . . . . 65.44 106.538 -176.27 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 2.5 mtmt -67.39 -42.43 83.35 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 118.817 0.735 . . . . 72.25 111.431 -175.238 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -62.48 -36.22 81.81 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 123.859 0.864 . . . . 74.51 110.1 -178.563 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 40.8 mttm -73.08 -53.48 10.97 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 106.042 -1.836 . . . . 75.1 106.042 176.264 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 33.1 t80 -51.98 -60.67 2.92 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 125.246 1.418 . . . . 73.22 110.874 -172.21 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 11.8 mt -68.67 -37.29 79.51 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 123.063 0.545 . . . . 74.04 110.191 -170.21 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 11.2 t -65.1 -37.07 86.29 Favored 'General case' 0 CA--C 1.534 0.335 0 O-C-N 122.05 -0.406 . . . . 71.54 109.999 179.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 51.6 m -70.02 -40.87 74.97 Favored 'General case' 0 N--CA 1.455 -0.209 0 O-C-N 121.87 -0.519 . . . . 63.11 111.003 171.664 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 77.5 t80 -54.23 -48.93 70.55 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 119.3 0.954 . . . . 74.44 109.269 179.454 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 55.3 m-20 -91.46 59.09 3.75 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.905 1.282 . . . . 74.31 109.74 171.657 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 68.3 p -123.64 163.33 21.26 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-O 121.951 0.881 . . . . 63.33 111.702 168.197 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -68.44 -32.13 71.94 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.675 0.79 . . . . 60.33 110.21 172.303 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -56.54 -50.46 71.79 Favored 'General case' 0 C--O 1.234 0.26 0 O-C-N 121.796 -0.565 . . . . 64.52 110.045 -179.187 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 26.5 mm -63.94 -34.18 66.77 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-O 118.407 -0.806 . . . . 74.04 110.983 177.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 54.2 tttt -53.53 -41.76 66.72 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 118.898 0.772 . . . . 65.53 109.394 174.507 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -71.91 -33.81 62.56 Favored Glycine 0 C--N 1.337 0.61 0 C-N-CA 125.015 1.293 . . . . 73.25 111.75 -178.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 -73.3 -36.58 66.3 Favored 'General case' 0 N--CA 1.452 -0.36 0 O-C-N 121.824 -0.809 . . . . 71.21 110.503 -178.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 14.7 mtp -62.17 -52.01 65.51 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 118.119 0.418 . . . . 74.14 110.458 173.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -65.84 -37.01 85.06 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-O 118.696 -0.669 . . . . 74.4 111.913 -168.529 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 3.0 mtmt -56.52 -64.09 0.98 Allowed 'General case' 0 C--N 1.341 0.222 0 CA-C-O 118.357 -0.83 . . . . 75.01 109.041 172.448 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -55.99 -37.91 69.74 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 118.567 0.621 . . . . 73.13 111.437 -173.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 9.5 tmtt? -55.41 -59.82 4.28 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 124.228 1.011 . . . . 75.14 110.3 178.092 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 8.6 ptmt -69.67 -31.2 69.13 Favored 'General case' 0 C--N 1.343 0.307 0 CA-C-N 120.158 1.345 . . . . 75.54 111.974 179.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 21.9 mt -60.63 -54.41 45.68 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 118.624 0.647 . . . . 75.5 109.376 -174.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -54.4 -41.07 68.85 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 122.503 0.321 . . . . 74.24 111.237 -178.244 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -63.65 -45.71 88.94 Favored 'General case' 0 N--CA 1.461 0.11 0 C-N-CA 123.08 0.552 . . . . 70.23 111.3 178.239 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -62.33 -39.45 93.11 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 123.442 0.697 . . . . 71.42 110.11 -178.508 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 34.9 m-85 -75.67 8.0 3.32 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.662 1.185 . . . . 72.21 113.441 177.405 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 13.3 mt-30 49.93 39.06 17.73 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 126.998 2.119 . . . . 74.22 112.729 -175.678 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 46.6 t -74.2 138.27 21.49 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 N-CA-C 106.276 -1.75 . . . . 74.31 106.276 168.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -141.68 4.48 1.73 Allowed 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.873 0.869 . . . . 73.1 111.607 -178.449 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 177.28 -177.22 48.29 Favored Glycine 0 CA--C 1.524 0.631 0 C-N-CA 126.243 1.877 . . . . 74.13 108.709 -174.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 12.9 m -149.15 149.99 30.89 Favored Pre-proline 0 C--O 1.24 0.586 0 C-N-CA 125.378 1.471 . . . . 75.53 108.91 -175.471 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -68.98 147.89 83.87 Favored 'Cis proline' 0 CA--C 1.537 0.648 0 O-C-N 122.532 0.754 . . . . 73.4 112.148 -1.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 62.9 m -150.53 131.57 14.34 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 126.559 1.944 . . . . 73.42 107.442 179.27 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 93.3 mtp -116.36 163.12 16.49 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 124.153 0.981 . . . . 73.03 109.615 172.022 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 6.3 t -139.75 143.71 29.89 Favored 'Isoleucine or valine' 0 C--O 1.24 0.595 0 N-CA-C 106.522 -1.659 . . . . 71.31 106.522 179.041 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 96.8 t -113.29 134.7 55.16 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 C-N-CA 124.929 1.291 . . . . 74.21 107.545 167.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 7.8 t30 49.24 9.34 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 131.63 3.972 . . . . 74.34 116.344 172.361 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 81.48 19.81 65.53 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 126.124 1.821 . . . . 64.2 114.306 -171.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 24.1 mtpt -137.78 -30.19 0.83 Allowed 'General case' 0 N--CA 1.479 1.002 0 CA-C-N 120.292 2.046 . . . . 71.22 113.498 -167.541 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -118.7 142.41 47.69 Favored 'General case' 0 CA--C 1.508 -0.662 0 N-CA-C 107.318 -1.364 . . . . 75.4 107.318 174.524 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 21.7 ttp180 -123.48 144.34 49.59 Favored 'General case' 0 N--CA 1.44 -0.955 0 N-CA-C 104.877 -2.268 . . . . 72.44 104.877 178.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 14.1 p90 -154.22 173.32 16.27 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 107.596 -1.261 . . . . 75.4 107.596 178.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -173.42 175.65 3.01 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 107.681 -1.229 . . . . 75.42 107.681 -177.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 23.6 mt -56.23 -44.93 80.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 C-N-CA 126.493 1.917 . . . . 75.43 108.746 -177.498 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -72.46 -34.92 60.02 Favored Glycine 0 N--CA 1.442 -0.927 0 CA-C-O 117.996 -1.446 . . . . 62.34 112.093 -175.252 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 72.9 m -69.03 -57.3 5.63 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 118.924 1.362 . . . . 73.14 109.36 172.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -63.21 -44.84 94.19 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 123.1 0.56 . . . . 72.41 111.322 -169.187 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 141.28 -18.32 2.68 Favored Glycine 0 CA--C 1.523 0.573 0 C-N-CA 123.768 0.699 . . . . 74.0 114.197 173.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 169.82 169.23 32.8 Favored Glycine 0 CA--C 1.527 0.814 0 N-CA-C 107.19 -2.364 . . . . 41.33 107.19 -172.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -64.34 -36.11 46.99 Favored 'Trans proline' 0 N--CA 1.459 -0.543 0 C-N-CA 122.643 2.229 . . . . 75.0 111.984 -168.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -56.62 -48.96 76.34 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 123.453 0.701 . . . . 75.1 110.331 171.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -67.15 -27.6 67.43 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 123.797 0.839 . . . . 75.23 109.909 -169.078 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -51.29 -48.36 62.29 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 124.143 0.977 . . . . 70.12 110.197 173.75 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 55.9 mt -65.91 -34.02 77.16 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 117.851 0.296 . . . . 71.3 111.261 -179.318 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.78 -48.4 75.4 Favored 'General case' 0 N--CA 1.456 -0.165 0 N-CA-C 108.652 -0.87 . . . . 75.35 108.652 174.662 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -66.88 -44.7 80.23 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-O 117.848 -1.072 . . . . 73.53 110.843 175.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -50.38 -50.3 51.91 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 118.967 0.803 . . . . 74.24 110.329 -178.078 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -72.92 -44.37 61.31 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 123.625 0.77 . . . . 72.21 109.663 -170.133 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 5.5 t80 -59.76 -47.95 83.63 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 124.312 1.045 . . . . 75.54 111.894 176.063 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 82.7 mt -63.28 -44.63 94.52 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 108.967 -0.753 . . . . 74.14 108.967 -174.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 65.2 mt -58.14 -45.68 88.53 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 123.236 0.614 . . . . 73.22 109.43 174.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -65.84 -17.57 64.73 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 123.694 0.798 . . . . 75.31 112.571 179.492 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 13.5 tptp -84.23 -57.29 3.23 Favored 'General case' 0 N--CA 1.441 -0.917 0 N-CA-C 106.911 -1.514 . . . . 75.2 106.911 173.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -55.88 -20.19 14.77 Favored 'General case' 0 CA--C 1.513 -0.465 0 C-N-CA 129.856 3.262 . . . . 74.0 116.245 -167.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 2.6 mtm180 -71.88 -68.85 0.43 Allowed 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 117.784 -1.566 . . . . 74.4 110.629 168.336 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.471 0 CA-C-O 124.02 1.866 . . . . 72.03 111.076 -173.061 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 . . . . . 0 CA--C 1.519 -0.217 0 N-CA-C 109.205 -0.665 . . . . 74.14 109.205 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -117.1 11.49 14.21 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 123.968 0.907 . . . . 72.41 112.631 178.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 -135.89 159.87 40.35 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 125.381 1.472 . . . . 73.2 109.735 -171.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.8 m -136.24 142.07 43.99 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 123.827 0.851 . . . . 72.15 109.481 176.637 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.33 150.52 34.75 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-N 114.602 -1.181 . . . . 70.2 111.982 176.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 77.51 -42.61 1.99 Allowed Glycine 0 CA--C 1.524 0.608 0 C-N-CA 125.015 1.293 . . . . 61.32 110.594 -171.43 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 12.9 ttpt -79.43 -80.49 0.12 Allowed 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 125.202 1.401 . . . . 71.03 110.76 -168.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 8.1 mp0 -70.97 -21.45 62.32 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 124.707 1.203 . . . . 74.2 110.865 -175.482 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 31.5 p90 -164.94 172.75 12.41 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 125.302 1.441 . . . . 74.22 108.817 -173.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 57.4 t -130.99 108.54 15.29 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 C-N-CA 125.002 1.321 . . . . 74.5 108.591 -178.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.6 164.13 22.12 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 124.387 1.075 . . . . 71.22 108.422 165.757 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -135.53 114.39 12.02 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 106.858 -1.534 . . . . 74.43 106.858 -168.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.5 m -56.69 -8.45 0.58 Allowed 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.433 1.493 . . . . 74.54 114.208 -177.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 50.6 m -135.3 83.3 38.61 Favored Pre-proline 0 CA--C 1.543 0.684 0 C-N-CA 125.016 1.327 . . . . 71.12 109.504 -179.112 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -74.66 177.82 7.95 Favored 'Trans proline' 0 CA--C 1.539 0.761 1 C-N-CA 125.583 4.189 . . . . 65.04 114.006 -178.725 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 81.3 t -142.0 147.84 46.24 Favored Pre-proline 0 N--CA 1.475 0.797 0 C-N-CA 127.111 2.164 . . . . 70.43 108.932 -168.271 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo -90.47 174.95 2.84 Favored 'Trans proline' 0 CA--C 1.536 0.59 0 C-N-CA 123.863 3.042 . . . . 72.32 113.455 178.096 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 15.5 m -105.85 176.28 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 C-N-CA 125.464 1.506 . . . . 73.31 109.266 166.343 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 67.1 m -52.5 -51.17 60.78 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 126.686 1.994 . . . . 71.3 112.351 177.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 16.7 mt-30 -149.72 164.17 21.91 Favored Pre-proline 0 CA--C 1.537 0.478 0 C-N-CA 125.1 1.36 . . . . 64.32 109.516 176.119 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -68.58 135.44 33.42 Favored 'Trans proline' 0 N--CA 1.452 -0.952 0 C-N-CA 122.416 2.077 . . . . 63.35 108.717 167.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 175.19 -125.51 1.09 Allowed Glycine 0 N--CA 1.445 -0.754 0 N-CA-C 106.614 -2.594 . . . . 75.53 106.614 -171.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.03 152.82 43.16 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 117.938 0.869 . . . . 75.4 109.786 176.823 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 39.2 mm -59.09 157.93 1.86 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 N-CA-C 106.811 -1.551 . . . . 73.04 106.811 163.3 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -115.84 122.09 44.35 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 107.093 -1.447 . . . . 75.13 107.093 174.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 36.7 t -114.85 113.14 42.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 N-CA-C 105.949 -1.871 . . . . 74.24 105.949 171.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 16.2 t -101.19 139.38 22.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 107.09 -1.448 . . . . 65.54 107.09 179.24 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -105.75 138.44 41.94 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 107.872 -1.158 . . . . 75.14 107.872 154.474 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.0 mp -111.46 148.43 33.15 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 124.549 1.14 . . . . 74.12 108.8 174.367 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 48.7 p90 -138.35 171.72 13.96 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 123.631 0.772 . . . . 74.45 112.044 -179.601 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 27.2 t90 -145.48 177.15 9.07 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 127.701 2.401 . . . . 74.32 107.886 172.393 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.439 ' HH ' ' CE1' ' A' ' 102' ' ' HIS . 56.1 t80 -72.16 -31.61 66.11 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.524 1.53 . . . . 61.5 114.758 178.434 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -116.69 20.99 11.69 Favored Glycine 0 CA--C 1.526 0.721 0 CA-C-O 118.573 -1.126 . . . . 42.54 114.228 -161.086 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 21.2 p -106.85 86.77 2.49 Favored Pre-proline 0 CA--C 1.538 0.49 0 C-N-CA 125.81 1.644 . . . . 65.53 110.309 -169.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -52.63 -36.45 71.83 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 122.7 2.267 . . . . 72.4 113.061 -175.219 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 17.0 m170 -55.27 -29.33 57.92 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 118.214 -0.898 . . . . 70.44 112.774 176.131 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 80.3 m -63.88 -66.45 0.54 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.555 1.542 . . . . 74.01 109.772 179.313 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.401 ' HB2' ' CD2' ' A' ' 99' ' ' HIS . 19.2 t80 -59.2 -34.85 72.64 Favored 'General case' 0 N--CA 1.469 0.485 0 O-C-N 121.489 -0.757 . . . . 74.54 111.907 -178.645 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.58 -28.7 69.53 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 118.633 -0.698 . . . . 71.12 112.327 179.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -93.86 -20.45 20.04 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.985 1.314 . . . . 72.22 112.126 -174.669 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -42.89 -65.45 0.55 Allowed Pre-proline 0 CA--C 1.542 0.654 0 N-CA-C 114.393 1.257 . . . . 74.52 114.393 -174.335 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -74.73 -6.65 18.47 Favored 'Trans proline' 0 CA--C 1.534 0.522 0 CA-C-N 122.327 1.867 . . . . 51.24 114.525 -176.315 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 67.0 m -75.44 -39.81 58.37 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 120.411 1.459 . . . . 71.3 108.905 163.209 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 14.2 tt -87.19 -34.51 7.57 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 N-CA-C 112.846 0.684 . . . . 75.32 112.846 -171.215 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 31.4 t -49.72 -57.34 12.52 Favored Pre-proline 0 CA--C 1.537 0.451 0 CA-C-N 119.837 1.199 . . . . 73.54 111.138 175.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -67.02 -7.41 18.62 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 CA-C-N 121.302 1.501 . . . . 72.33 114.11 -177.09 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 70.9 t90 -80.27 -62.21 1.75 Allowed 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 119.326 0.966 . . . . 75.13 108.837 164.183 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 5.2 p -68.57 -19.08 64.45 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 113.35 0.87 . . . . 73.42 113.35 -172.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . 0.322 4.9 pt-20 -69.66 -20.78 63.57 Favored 'General case' 0 CA--C 1.556 1.179 0 C-N-CA 124.273 1.029 . . . . 74.43 110.912 170.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 67.2 mmtt -115.89 6.52 14.26 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.633 1.573 . . . . 74.03 113.256 -170.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 51.7 mt -63.43 150.41 89.81 Favored Pre-proline 0 C--O 1.236 0.391 0 CA-C-N 118.702 0.683 . . . . 74.03 110.021 176.723 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -73.11 177.26 8.02 Favored 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 124.555 3.503 . . . . 75.11 111.701 -176.02 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -74.6 -0.72 18.73 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.175 0.99 . . . . 64.52 113.475 179.104 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -104.07 -1.38 27.47 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 126.589 1.956 . . . . 73.21 111.339 -177.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 48.2 t -131.3 154.53 40.74 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 126.303 1.841 . . . . 73.33 106.708 -179.505 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 48.7 t60 -137.69 157.45 46.44 Favored 'General case' 0 N--CA 1.45 -0.468 0 O-C-N 121.674 -0.641 . . . . 72.1 109.41 169.344 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 46.3 t80 -124.6 135.16 52.88 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.644 1.178 . . . . 74.3 110.674 -171.561 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 67.1 t -132.85 137.86 53.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 C-N-CA 124.299 1.04 . . . . 73.23 108.54 -169.115 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -114.16 121.64 44.37 Favored 'General case' 0 CA--C 1.514 -0.414 0 N-CA-C 106.628 -1.619 . . . . 74.4 106.628 170.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 13.1 mt -136.57 144.79 48.7 Favored Pre-proline 0 CA--C 1.537 0.454 0 CA-C-N 118.607 0.639 . . . . 75.41 112.304 -177.453 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -77.56 125.61 7.7 Favored 'Trans proline' 0 CA--C 1.534 0.482 0 C-N-CA 122.166 1.911 . . . . 74.44 112.307 -175.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -68.29 112.28 5.08 Favored 'General case' 0 CA--C 1.54 0.567 0 O-C-N 120.741 -1.225 . . . . 64.34 109.286 167.76 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 8.1 mt -110.41 95.57 5.65 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 106.274 -1.751 . . . . 72.0 106.274 177.215 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -115.5 16.68 16.58 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 114.861 1.43 . . . . 72.52 114.861 -172.623 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 93.22 170.99 39.75 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 125.258 1.409 . . . . 53.35 110.058 -178.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 58.41 -153.48 27.76 Favored Glycine 0 CA--C 1.532 1.101 0 N-CA-C 110.246 -1.142 . . . . 74.51 110.246 -172.533 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 8.8 tp -60.19 -17.27 13.8 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 C-N-CA 123.866 0.866 . . . . 73.11 112.751 -177.208 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 19.1 m95 -58.52 -35.41 72.22 Favored 'General case' 0 C--N 1.34 0.193 0 O-C-N 121.009 -1.057 . . . . 72.3 110.847 176.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 33.4 m-20 -76.66 -33.33 58.3 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 109.283 -0.636 . . . . 72.31 109.283 -174.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 29.8 t -63.17 -65.64 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 C-N-CA 124.797 1.239 . . . . 72.5 108.992 172.639 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 46.4 m170 -67.66 -2.4 6.81 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 114.138 1.162 . . . . 74.4 114.138 -171.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -102.04 -27.39 7.0 Favored Glycine 0 C--N 1.336 0.563 0 CA-C-N 120.221 1.373 . . . . 64.34 110.171 -176.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 31.7 mt-30 -56.09 -26.86 51.34 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 118.226 -0.893 . . . . 75.52 112.527 176.362 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 3.7 ttt -46.78 -62.96 1.15 Allowed 'General case' 0 C--N 1.342 0.246 0 N-CA-C 114.796 1.406 . . . . 71.53 114.796 -170.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -53.06 -45.69 68.21 Favored 'General case' 0 C--N 1.331 -0.211 0 O-C-N 123.779 0.674 . . . . 63.22 110.045 -176.331 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 28.7 mt -61.87 -39.08 90.64 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-O 116.682 -1.628 . . . . 75.22 109.67 178.079 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -60.62 -49.45 77.49 Favored 'General case' 0 C--N 1.349 0.567 0 CA-C-N 121.625 2.011 . . . . 75.53 109.538 175.596 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -54.57 -54.02 46.87 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 124.452 1.101 . . . . 72.15 108.425 -175.002 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -75.1 -14.04 60.54 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 112.885 0.698 . . . . 75.42 112.885 -178.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.9 t -61.37 -33.97 74.53 Favored 'General case' 0 C--O 1.236 0.379 0 O-C-N 121.431 -0.793 . . . . 74.4 110.809 173.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 47.5 mtp . . . . . 0 N--CA 1.447 -0.591 0 C-N-CA 123.602 0.761 . . . . 70.34 111.914 -171.164 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.135 0 CA-C-O 119.229 -0.415 . . . . 74.42 111.112 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 21.7 t -53.64 -68.15 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 C-N-CA 125.691 1.596 . . . . 65.14 109.658 169.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -70.65 -32.5 69.81 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 119.961 1.255 . . . . 72.24 112.978 -174.273 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -60.44 -33.27 72.3 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.119 0.968 . . . . 73.3 109.266 173.238 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -72.88 -52.75 13.49 Favored 'General case' 0 N--CA 1.446 -0.656 0 O-C-N 120.413 -1.429 . . . . 75.03 109.312 174.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 40.8 mt -61.9 -44.56 99.05 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-O 118.244 -0.884 . . . . 75.4 109.72 -171.414 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . 0.401 ' CD2' ' HB2' ' A' ' 41' ' ' TYR . 48.6 m-70 -81.54 -72.68 0.42 Allowed 'General case' 0 CA--C 1.52 -0.189 0 C-N-CA 124.694 1.198 . . . . 70.51 111.065 -179.414 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 8.9 mtmt -65.8 -28.2 68.83 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-N 118.319 0.509 . . . . 74.51 111.307 -168.223 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.79 -31.13 9.97 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 122.792 0.437 . . . . 74.04 111.028 -170.526 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . 0.439 ' CE1' ' HH ' ' A' ' 35' ' ' TYR . 4.0 t60 43.83 70.06 0.35 Allowed 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 127.509 2.323 . . . . 75.21 112.126 172.671 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 21.0 mtpt -96.44 19.09 12.66 Favored 'General case' 0 N--CA 1.467 0.38 0 O-C-N 121.716 -0.615 . . . . 71.12 111.805 -172.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 12.9 ttpt 46.5 57.77 5.16 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 127.75 2.42 . . . . 74.43 111.971 176.563 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 52.6 mt -73.98 43.28 0.16 Allowed 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 130.428 3.491 . . . . 74.13 112.193 -176.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -82.94 1.43 39.69 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 127.582 2.353 . . . . 73.25 113.464 -177.211 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 32.9 p -144.11 161.7 43.95 Favored Pre-proline 0 C--O 1.239 0.523 0 C-N-CA 123.726 0.81 . . . . 74.53 109.916 -172.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.43 -13.99 20.37 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 122.471 2.114 . . . . 73.05 113.445 -179.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -63.96 -60.98 2.58 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 107.888 -1.152 . . . . 74.35 107.888 163.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -61.59 -46.23 90.72 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-O 119.066 -0.492 . . . . 64.33 111.492 -166.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 14.3 mtt -59.89 -42.45 93.81 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 118.427 0.558 . . . . 73.04 110.998 179.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -72.26 -47.49 49.85 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 109.455 -0.572 . . . . 73.33 109.455 -171.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -66.02 -24.11 66.69 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 118.888 0.767 . . . . 75.51 112.183 178.104 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . 0.484 ' CZ ' ' HE3' ' A' ' 118' ' ' LYS . 9.3 t80 -68.19 -60.4 2.5 Favored 'General case' 0 C--O 1.234 0.257 0 O-C-N 121.488 -0.758 . . . . 73.13 109.682 173.17 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 82.0 mt -65.56 -26.21 67.77 Favored 'General case' 0 N--CA 1.456 -0.127 0 C-N-CA 123.648 0.779 . . . . 75.43 110.424 -177.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -57.44 -39.47 76.34 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 119.189 0.904 . . . . 71.32 109.332 177.39 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -60.56 -8.52 9.82 Favored Glycine 0 CA--C 1.531 1.036 0 CA-C-O 116.981 -2.011 . . . . 65.42 114.176 172.291 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.484 ' HE3' ' CZ ' ' A' ' 114' ' ' PHE . 0.5 OUTLIER -131.85 21.65 4.58 Favored 'General case' 0 C--N 1.347 0.491 0 CA-C-N 121.324 2.562 . . . . 72.23 111.671 -175.469 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 82.22 60.3 2.16 Favored Glycine 0 C--N 1.333 0.396 0 N-CA-C 109.713 -1.355 . . . . 70.2 109.713 171.04 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 28.3 t -135.97 121.12 27.9 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 C-N-CA 125.361 1.464 . . . . 74.41 107.114 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 52.9 t0 -66.18 116.34 7.15 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 124.149 0.979 . . . . 63.11 110.364 -179.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 7.2 ttmt -61.57 -41.31 97.22 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 124.502 1.121 . . . . 74.23 109.442 177.578 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -63.39 -36.75 84.75 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 119.118 -0.468 . . . . 63.41 111.603 -175.078 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 15.7 mmtp -80.97 -37.58 29.07 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-O 118.493 -0.765 . . . . 73.32 109.181 176.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 82.7 t80 -54.3 -60.33 3.49 Favored 'General case' 0 N--CA 1.445 -0.68 0 O-C-N 123.805 0.691 . . . . 75.15 110.389 -177.459 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 20.1 mt -66.46 -40.78 89.6 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 123.271 0.629 . . . . 75.33 110.569 -175.462 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 34.2 t -56.18 -48.47 76.28 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 123.802 0.841 . . . . 74.33 109.629 -178.304 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 1.3 t -80.42 -30.98 37.7 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-O 119.196 -0.431 . . . . 72.42 110.192 -175.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 58.5 t80 -55.53 -50.75 69.19 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 119.161 0.891 . . . . 65.31 110.362 174.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -95.78 47.84 1.12 Allowed 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 124.065 0.946 . . . . 72.11 109.23 177.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 37.5 t -128.42 165.44 20.63 Favored 'General case' 0 C--O 1.238 0.474 0 O-C-N 120.998 -1.064 . . . . 65.14 109.642 173.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -58.99 -25.76 63.92 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 115.426 -0.806 . . . . 71.25 110.82 163.692 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -48.46 -54.66 13.37 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 124.45 1.1 . . . . 75.11 111.32 178.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 11.8 mm -65.37 -42.95 94.81 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.392 0 N-CA-C 113.339 0.866 . . . . 75.13 113.339 170.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 14.2 tttt -54.02 -36.95 63.57 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 118.866 -0.588 . . . . 74.41 109.746 -175.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -82.89 -8.55 85.68 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 126.443 1.973 . . . . 41.04 113.273 -174.303 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -100.91 -52.99 3.16 Favored 'General case' 0 C--O 1.227 -0.102 0 N-CA-C 107.397 -1.335 . . . . 71.2 107.397 171.611 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 2.6 ptm -53.85 -37.6 63.8 Favored 'General case' 0 C--O 1.223 -0.313 0 C-N-CA 123.989 0.915 . . . . 73.31 111.682 -175.184 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -49.72 -44.98 48.64 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.124 0.97 . . . . 73.32 113.13 178.488 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -68.76 -61.65 1.72 Allowed 'General case' 0 CA--C 1.519 -0.228 0 C-N-CA 125.922 1.689 . . . . 73.34 107.188 -176.537 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -44.23 -42.97 6.92 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.713 1.605 . . . . 65.31 111.777 177.331 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -64.97 -58.64 5.59 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 124.925 1.29 . . . . 75.15 111.428 -177.138 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.49 -37.46 86.88 Favored 'General case' 0 C--N 1.342 0.272 0 CA-C-N 119.733 1.152 . . . . 75.44 110.626 -179.211 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 51.0 mt -56.83 -43.16 80.8 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 123.859 0.863 . . . . 75.42 110.236 178.477 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -58.35 -46.26 86.6 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 119.153 0.888 . . . . 72.44 110.611 -177.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -67.96 -34.87 77.38 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 123.527 0.731 . . . . 74.14 110.721 -178.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -59.22 -52.59 65.01 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 107.76 -1.2 . . . . 72.13 107.76 175.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 -69.87 16.56 0.06 Allowed 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 126.208 1.803 . . . . 74.34 115.698 -174.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 57.93 17.51 4.37 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 126.572 1.949 . . . . 73.53 114.162 175.031 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 30.1 t -69.64 132.99 32.61 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 N-CA-C 108.4 -0.963 . . . . 74.1 108.4 -176.553 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -130.13 -4.0 4.46 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 124.58 1.152 . . . . 71.31 113.07 -177.452 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -169.1 -174.82 37.95 Favored Glycine 0 CA--C 1.526 0.75 0 C-N-CA 126.283 1.896 . . . . 54.23 110.064 174.291 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.42 ' HA ' ' C ' ' A' ' 154' ' ' PRO . 4.8 m -143.21 159.47 55.51 Favored Pre-proline 0 CA--C 1.537 0.474 0 C-N-CA 125.99 1.716 . . . . 75.33 109.871 -172.04 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . 0.42 ' C ' ' HA ' ' A' ' 153' ' ' VAL . 27.8 Cg_endo -61.45 162.57 42.49 Favored 'Cis proline' 0 N--CA 1.455 -0.792 0 C-N-CA 124.647 -0.98 . . . . 74.12 111.206 -11.319 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 6.5 m -156.97 138.64 14.13 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 107.026 -1.472 . . . . 71.21 107.026 176.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 98.8 mtp -114.11 158.11 21.7 Favored 'General case' 0 N--CA 1.438 -1.064 0 N-CA-C 108.067 -1.086 . . . . 71.02 108.067 171.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 37.6 t -140.77 134.04 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 N-CA-C 106.148 -1.797 . . . . 70.02 106.148 177.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 13.1 t -102.24 119.44 50.55 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.9 0 N-CA-C 105.92 -1.881 . . . . 72.42 105.92 171.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . 0.443 HD21 ' HG2' ' A' ' 186' ' ' GLU . 15.4 t30 56.01 24.28 7.59 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 128.512 2.725 . . . . 72.42 114.285 158.807 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 61.64 30.84 75.87 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 127.287 2.375 . . . . 54.25 113.823 -172.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 42.6 mttt -131.81 -34.79 1.29 Allowed 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 119.427 1.614 . . . . 75.34 113.344 -175.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -124.33 128.24 48.8 Favored 'General case' 0 CA--C 1.512 -0.512 0 N-CA-C 108.941 -0.763 . . . . 75.31 108.941 -179.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 26.5 ttp85 -107.72 136.62 47.16 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 105.141 -2.17 . . . . 74.53 105.141 174.123 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 9.8 p90 -150.51 170.1 19.91 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 107.705 -1.22 . . . . 75.22 107.705 178.102 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 9.7 p30 -167.65 177.47 5.84 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 108.81 -0.811 . . . . 74.45 108.81 -178.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 16.5 mt -58.94 -40.85 81.41 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 C-N-CA 124.942 1.297 . . . . 65.24 108.615 -174.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -74.62 -39.29 41.38 Favored Glycine 0 N--CA 1.447 -0.602 0 CA-C-O 118.851 -0.972 . . . . 75.22 111.626 -178.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 2.6 m -57.97 -59.45 5.25 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 124.462 1.105 . . . . 72.23 109.695 174.607 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -61.82 -51.11 69.6 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 109.718 -0.475 . . . . 72.3 109.718 -176.366 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 132.63 4.14 3.55 Favored Glycine 0 CA--C 1.528 0.896 0 CA-C-O 119.137 -0.813 . . . . 53.44 113.855 177.024 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 164.36 163.65 17.87 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 108.445 -1.862 . . . . 71.54 108.445 -174.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -66.06 -43.86 8.33 Favored 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 122.474 2.116 . . . . 71.33 110.079 -173.495 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -54.1 -38.61 65.55 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 125.199 1.399 . . . . 72.34 111.766 173.038 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -76.1 -26.25 56.25 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.432 1.093 . . . . 74.13 109.511 -173.142 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -56.64 -48.3 77.85 Favored 'General case' 0 CA--C 1.528 0.106 0 C-N-CA 123.997 0.919 . . . . 73.1 109.696 177.196 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 61.8 mt -62.05 -34.23 75.87 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 118.127 0.421 . . . . 70.44 110.777 179.052 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -54.6 -42.33 71.0 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 123.496 0.718 . . . . 73.32 110.289 175.877 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -73.25 -46.11 51.97 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-O 118.008 -0.996 . . . . 74.44 110.237 173.357 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -55.18 -34.94 64.28 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 118.843 0.747 . . . . 72.43 112.11 -174.047 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -94.24 -32.11 13.81 Favored 'General case' 0 C--N 1.333 -0.147 0 C-N-CA 124.859 1.264 . . . . 75.33 110.059 -167.401 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 35.5 t80 -64.69 -58.28 6.72 Favored 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 123.991 0.916 . . . . 73.32 110.497 167.521 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 56.1 mt -58.01 -35.77 71.71 Favored 'General case' 0 C--O 1.224 -0.268 0 C-N-CA 124.825 1.25 . . . . 73.14 112.294 -164.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 38.1 mt -45.09 -52.8 1.79 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 C-N-CA 124.279 1.031 . . . . 73.1 109.974 173.223 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -58.16 -34.53 70.4 Favored 'General case' 0 N--CA 1.447 -0.596 0 O-C-N 121.213 -0.929 . . . . 75.21 111.534 -177.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.3 -32.77 68.77 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 123.71 0.804 . . . . 71.05 110.934 -178.34 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . 0.443 ' HG2' HD21 ' A' ' 159' ' ' ASN . 2.5 mp0 -93.1 -43.87 8.66 Favored 'General case' 0 C--O 1.224 -0.256 0 CA-C-N 119.954 1.252 . . . . 75.42 112.298 168.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.54 -34.24 68.94 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 125.5 1.52 . . . . 62.15 110.308 -172.335 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.339 0.147 0 C-N-CA 124.776 1.23 . . . . 75.13 111.933 178.931 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 . . . . . 0 N--CA 1.466 0.368 0 CA-C-O 123.603 1.668 . . . . 74.23 110.313 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -81.69 11.14 5.05 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 113.735 -1.575 . . . . 71.42 114.565 -159.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 36.1 m-85 -134.65 175.56 9.44 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 126.696 1.998 . . . . 72.44 108.89 -172.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 31.9 m -137.13 136.95 38.72 Favored 'General case' 0 CA--C 1.535 0.387 0 O-C-N 119.972 -1.705 . . . . 74.3 110.679 172.251 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -68.6 153.13 44.36 Favored 'General case' 0 C--N 1.342 0.271 0 CA-C-O 121.709 0.766 . . . . 75.53 109.043 178.162 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 75.58 -31.7 1.21 Allowed Glycine 0 CA--C 1.53 0.988 0 C-N-CA 124.134 0.873 . . . . 55.52 111.309 -165.113 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 38.5 tttt -95.43 -84.26 0.34 Allowed 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 118.946 1.373 . . . . 74.42 110.264 -170.027 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -68.6 -25.17 64.73 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.794 1.637 . . . . 71.42 110.655 -178.523 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 31.9 p90 -162.09 170.27 19.48 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 107.35 -1.352 . . . . 74.44 107.35 -173.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 13.7 t -134.63 108.24 10.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 107.958 -1.127 . . . . 74.22 107.958 -178.426 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -63.56 152.57 38.32 Favored 'General case' 0 N--CA 1.44 -0.928 0 O-C-N 121.178 -0.951 . . . . 74.22 108.968 164.102 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -120.13 107.08 12.6 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 125.565 1.546 . . . . 75.31 109.535 179.734 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 70.3 m -67.02 21.06 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.864 1.666 . . . . 64.43 114.193 173.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 4.4 t -132.3 81.92 59.45 Favored Pre-proline 0 CA--C 1.53 0.195 0 N-CA-C 106.674 -1.602 . . . . 71.25 106.674 153.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -72.25 178.58 5.89 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 123.031 2.487 . . . . 72.23 111.139 -175.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 39.4 t -137.48 142.06 35.89 Favored Pre-proline 0 CA--C 1.539 0.538 0 N-CA-C 109.15 -0.685 . . . . 73.12 109.15 -170.468 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -79.36 178.55 7.29 Favored 'Trans proline' 0 CA--C 1.536 0.599 0 C-N-CA 123.739 2.959 . . . . 72.5 111.733 172.684 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 16.2 m -131.91 172.43 16.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 126.079 1.752 . . . . 75.44 109.735 179.084 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 13.1 t -53.86 -58.74 6.15 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.831 1.253 . . . . 74.24 110.625 173.584 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -144.78 164.97 24.67 Favored Pre-proline 0 CA--C 1.531 0.234 0 O-C-N 121.301 -0.874 . . . . 74.5 111.342 173.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -80.52 -172.88 1.64 Allowed 'Trans proline' 0 N--CA 1.452 -0.966 0 C-N-CA 123.219 2.613 . . . . 63.5 110.995 170.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 104.68 -86.67 0.52 Allowed Glycine 0 N--CA 1.451 -0.321 0 N-CA-C 106.832 -2.507 . . . . 71.14 106.832 179.168 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 67.0 mttt -68.06 149.16 50.01 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-O 121.511 0.672 . . . . 74.53 109.281 170.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 29.8 mm -80.01 141.56 15.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 107.663 -1.236 . . . . 75.25 107.663 168.51 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -87.96 132.43 34.24 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 106.493 -1.669 . . . . 64.02 106.493 173.147 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 46.4 t -131.2 136.22 58.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 N-CA-C 106.181 -1.785 . . . . 72.4 106.181 169.605 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 23.5 t -135.34 123.29 38.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 N-CA-C 108.005 -1.109 . . . . 61.51 108.005 -171.006 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -91.09 145.2 24.88 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 124.948 1.299 . . . . 74.22 108.847 166.101 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 5.5 mp -125.31 137.63 54.07 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.572 1.549 . . . . 73.13 107.744 168.002 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 30.9 p90 -141.78 172.67 12.37 Favored 'General case' 0 CA--C 1.549 0.918 0 N-CA-C 113.616 0.969 . . . . 72.33 113.616 -173.277 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 27.8 t90 -156.44 150.23 24.9 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.489 1.115 . . . . 72.41 111.806 -178.218 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -60.47 -9.17 3.32 Favored 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 114.843 1.423 . . . . 73.31 114.843 -179.842 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -123.84 19.0 7.48 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 125.447 1.499 . . . . 54.24 114.25 -169.337 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 22.4 p -104.26 86.7 1.4 Allowed Pre-proline 0 CA--C 1.536 0.431 0 CA-C-N 119.782 1.791 . . . . 52.13 110.744 -175.248 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -52.47 -35.83 67.57 Favored 'Trans proline' 0 CA--C 1.534 0.476 0 C-N-CA 122.769 2.313 . . . . 74.23 113.334 -177.242 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 11.5 m170 -64.74 -24.55 67.6 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 118.341 -0.838 . . . . 74.4 112.063 -178.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 83.6 m -59.39 -53.94 52.45 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.33 1.052 . . . . 71.45 109.144 175.198 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 59.9 t80 -56.78 -40.44 75.88 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 119.253 0.933 . . . . 72.24 111.041 -176.163 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -70.16 2.37 3.74 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 113.303 0.853 . . . . 75.43 113.303 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -125.71 -29.9 3.1 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 127.602 2.361 . . . . 75.23 111.261 179.163 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -37.5 -62.13 0.65 Allowed Pre-proline 0 CA--C 1.544 0.735 0 C-N-CA 126.401 1.88 . . . . 64.22 113.708 -174.667 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -79.52 -10.68 14.53 Favored 'Trans proline' 0 N--CA 1.454 -0.818 0 CA-C-N 121.191 1.461 . . . . 75.14 114.937 -175.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 51.1 m -70.87 -41.27 71.59 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 119.605 1.093 . . . . 74.32 109.335 164.715 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 17.3 tt -81.84 -42.64 19.32 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 CA-C-O 118.136 -0.935 . . . . 64.04 111.926 -169.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 79.5 t -44.84 -60.22 3.3 Favored Pre-proline 0 CA--C 1.544 0.716 0 CA-C-N 120.012 1.278 . . . . 74.25 112.803 177.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -73.79 -15.0 24.16 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 122.284 1.989 . . . . 73.22 112.112 -174.377 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 76.0 t90 -64.53 -61.59 2.12 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 119.73 1.15 . . . . 74.22 108.498 163.147 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -63.96 -34.53 78.2 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 113.008 0.744 . . . . 72.23 113.008 -171.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -59.13 -36.5 75.32 Favored 'General case' 0 C--O 1.237 0.441 0 O-C-N 121.389 -0.819 . . . . 74.34 110.908 175.16 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 29.9 mmmt -93.98 10.01 35.23 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.879 1.271 . . . . 75.02 111.863 -170.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 23.1 mt -61.6 157.54 46.72 Favored Pre-proline 0 CA--C 1.54 0.564 0 CA-C-N 119.5 1.045 . . . . 72.52 112.811 -178.082 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -77.98 178.05 8.06 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 124.991 3.794 . . . . 71.14 111.695 178.246 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -74.45 -0.2 16.69 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.032 1.333 . . . . 75.04 114.437 -174.302 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -126.22 18.75 7.65 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.782 1.233 . . . . 51.41 110.726 -172.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 42.5 t -124.82 139.18 51.76 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 N-CA-C 108.063 -1.088 . . . . 74.0 108.063 170.161 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 82.7 t60 -113.59 153.25 29.14 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 125.6 1.56 . . . . 74.03 106.908 166.33 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.463 ' CE2' ' HD2' ' A' ' 62' ' ' ARG . 24.2 t80 -136.57 141.5 43.33 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 108.63 -0.878 . . . . 74.35 108.63 -178.833 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 60.2 t -134.38 147.19 30.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 C-N-CA 126.622 1.969 . . . . 75.54 107.253 -170.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.463 ' HD2' ' CE2' ' A' ' 60' ' ' PHE . 0.0 OUTLIER -126.79 121.73 32.78 Favored 'General case' 0 CA--C 1.516 -0.358 0 N-CA-C 104.35 -2.463 . . . . 74.42 104.35 176.298 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 32.7 mt -127.09 151.97 75.08 Favored Pre-proline 0 N--CA 1.467 0.386 0 CA-C-N 118.961 0.8 . . . . 73.32 111.112 177.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -72.57 130.56 16.15 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 122.194 1.929 . . . . 64.54 109.828 178.003 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -75.48 100.8 4.62 Favored 'General case' 0 CA--C 1.536 0.409 0 O-C-N 121.42 -0.8 . . . . 62.13 109.006 176.389 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 42.8 mt -95.43 78.43 3.41 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.657 1.583 . . . . 74.22 111.548 -174.442 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -110.38 12.97 22.96 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 114.275 1.213 . . . . 73.14 114.275 -169.535 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 108.95 152.06 14.91 Favored Glycine 0 CA--C 1.518 0.275 0 C-N-CA 125.259 1.409 . . . . 63.2 110.626 173.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 52.82 -139.57 32.12 Favored Glycine 0 CA--C 1.521 0.439 0 C-N-CA 123.641 0.639 . . . . 42.12 111.952 -173.552 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 5.5 tp -58.62 -20.87 17.31 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 C-N-CA 124.963 1.305 . . . . 74.4 112.507 -168.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 23.6 m95 -57.3 -38.26 73.72 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.898 0.879 . . . . 73.41 110.92 173.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 14.0 m-80 -74.8 -43.46 54.63 Favored 'General case' 0 C--N 1.339 0.147 0 O-C-N 121.804 -0.56 . . . . 73.55 111.794 175.356 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 61.3 t -57.67 -54.57 29.71 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 C-N-CA 124.31 1.044 . . . . 73.11 108.588 -177.176 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 57.5 m170 -79.4 24.67 0.34 Allowed 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.662 1.585 . . . . 75.45 111.546 175.605 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -114.85 -33.53 1.68 Allowed Glycine 0 CA--C 1.524 0.637 0 C-N-CA 125.573 1.559 . . . . 64.23 111.69 170.722 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 31.6 mt-30 -63.29 -31.62 72.82 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 118.402 -0.808 . . . . 72.33 112.771 -179.111 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 16.7 ttp -60.42 -50.71 72.51 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-N 119.754 1.161 . . . . 73.24 111.535 -174.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 17.5 t80 -53.78 -50.9 65.07 Favored 'General case' 0 CA--C 1.53 0.178 0 O-C-N 123.72 0.638 . . . . 75.42 109.933 -179.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 76.0 mt -61.11 -36.73 80.49 Favored 'General case' 0 C--O 1.222 -0.378 0 CA-C-O 117.774 -1.108 . . . . 75.34 111.155 177.401 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.5 m -66.89 -35.26 79.61 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 120.622 1.556 . . . . 74.15 111.09 178.23 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.19 -56.83 16.74 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 107.544 -1.28 . . . . 73.42 107.544 178.085 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -66.29 -25.29 66.79 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.2 1.4 . . . . 71.04 112.744 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 16.1 t -73.07 -6.8 47.99 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.37 1.468 . . . . 71.12 113.442 -175.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 9.8 mtm . . . . . 0 N--CA 1.467 0.42 0 CA-C-N 119.998 1.272 . . . . 54.35 112.893 162.329 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 0.305 0 N-CA-C 113.011 0.745 . . . . 74.14 113.011 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 3.8 t -62.76 -67.06 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-N 119.275 0.943 . . . . 75.44 108.51 161.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -60.78 -48.68 80.69 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 107.744 -1.206 . . . . 73.43 107.744 -167.163 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.407 ' CD ' ' HE2' ' A' ' 100' ' ' LYS . 4.1 mm-40 -51.89 -33.66 37.72 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 128.006 2.522 . . . . 75.33 110.368 -176.024 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -79.56 -13.81 59.28 Favored 'General case' 0 N--CA 1.444 -0.746 0 O-C-N 120.621 -1.3 . . . . 73.34 113.215 -172.177 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 14.3 mt -114.01 -49.33 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 N-CA-C 106.008 -1.849 . . . . 73.41 106.008 -175.561 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 61.5 m-70 -76.08 -40.27 53.48 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 124.22 1.008 . . . . 74.25 112.564 -176.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.407 ' HE2' ' CD ' ' A' ' 96' ' ' GLU . 25.5 mtmt -93.59 -37.8 11.69 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 120.431 1.469 . . . . 75.01 111.69 172.179 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -122.55 32.47 5.75 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 113.214 0.82 . . . . 73.45 113.214 -160.264 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 41.2 t-80 -41.88 97.67 0.01 OUTLIER 'General case' 0 C--O 1.241 0.639 0 C-N-CA 129.472 3.109 . . . . 65.03 112.432 -172.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.09 27.61 1.58 Allowed 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 126.133 1.773 . . . . 73.14 112.036 175.841 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 2.7 tttp 65.4 -61.53 0.24 Allowed 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 128.72 2.808 . . . . 72.41 112.004 -175.184 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 87.7 mt 74.96 17.03 2.81 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 127.532 2.333 . . . . 75.1 113.696 174.475 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -85.14 33.71 0.55 Allowed 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.018 1.327 . . . . 74.11 112.703 -174.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -152.29 158.21 33.63 Favored Pre-proline 0 C--O 1.237 0.412 0 C-N-CA 124.425 1.09 . . . . 74.13 108.974 167.256 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -64.99 -41.47 17.1 Favored 'Trans proline' 0 N--CA 1.451 -0.975 0 C-N-CA 122.147 1.898 . . . . 65.21 111.331 177.463 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -58.76 -47.21 85.48 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 118.746 0.703 . . . . 73.03 110.03 176.175 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -62.7 -31.67 72.62 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 123.362 0.665 . . . . 72.34 111.473 -176.076 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 74.1 mtm -81.06 -35.76 31.36 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 118.475 -0.774 . . . . 75.21 112.5 173.22 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -77.66 -47.95 17.99 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 119.29 0.95 . . . . 75.43 111.449 -172.486 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -58.05 -31.83 67.42 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 125.477 1.511 . . . . 55.14 111.866 -172.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 38.4 t80 -75.08 -48.2 25.04 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 123.851 0.86 . . . . 72.25 112.22 174.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 88.4 mt -65.63 -25.07 67.21 Favored 'General case' 0 N--CA 1.455 -0.186 0 O-C-N 121.333 -0.854 . . . . 62.01 110.489 -176.018 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -53.4 -23.88 10.94 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.975 0.91 . . . . 72.54 112.579 171.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -84.09 -15.5 69.5 Favored Glycine 0 CA--C 1.53 0.971 0 C-N-CA 124.258 0.932 . . . . 72.21 114.272 174.483 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 45.5 mmtt -129.03 39.79 3.73 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 120.294 2.047 . . . . 74.44 110.691 -162.072 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 74.34 39.75 42.44 Favored Glycine 0 N--CA 1.448 -0.529 0 N-CA-C 110.989 -0.845 . . . . 75.23 110.989 170.076 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 89.2 t -128.56 143.88 39.7 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 N-CA-C 106.068 -1.827 . . . . 74.41 106.068 172.138 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 16.0 t0 -95.64 129.15 42.93 Favored 'General case' 0 C--N 1.331 -0.212 0 O-C-N 121.909 -0.495 . . . . 61.32 109.67 177.484 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -67.57 -46.96 71.18 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 123.268 0.627 . . . . 74.41 110.405 -177.265 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -57.31 -37.67 72.85 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 117.731 0.241 . . . . 75.11 110.993 -174.4 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 16.3 mmtp -97.17 -29.21 13.72 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-O 117.227 -1.368 . . . . 72.21 108.756 -169.097 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 89.6 t80 -51.71 -60.42 3.18 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 119.164 0.893 . . . . 72.4 109.391 165.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 7.1 mt -65.49 -42.81 91.76 Favored 'General case' 0 C--O 1.234 0.253 0 O-C-N 121.875 -0.516 . . . . 74.2 110.693 -170.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 2.5 m -58.04 -56.02 27.39 Favored 'General case' 0 C--O 1.223 -0.321 0 CA-C-O 118.321 -0.847 . . . . 74.35 109.007 176.052 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 28.8 m -59.68 -39.68 85.31 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.749 0.82 . . . . 62.12 111.215 -175.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -57.2 -46.81 82.54 Favored 'General case' 0 C--O 1.236 0.357 0 O-C-N 121.353 -0.842 . . . . 72.51 109.576 175.55 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -89.26 30.48 0.97 Allowed 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.309 1.044 . . . . 75.13 111.983 175.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 72.7 m -110.89 150.62 28.92 Favored 'General case' 0 C--O 1.236 0.363 0 O-C-N 120.699 -1.251 . . . . 73.01 109.926 171.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -59.91 -22.9 63.01 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.407 1.083 . . . . 73.33 111.616 175.098 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -44.87 -55.76 5.14 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 125.345 1.458 . . . . 71.52 111.955 172.59 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 45.4 mm -66.73 -34.87 72.88 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.253 0 C-N-CA 123.104 0.562 . . . . 74.53 109.806 -178.551 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 25.8 tttm -57.35 -39.46 75.97 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 118.717 -0.658 . . . . 73.22 110.501 179.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -69.79 -27.67 72.94 Favored Glycine 0 CA--C 1.523 0.572 0 C-N-CA 124.075 0.845 . . . . 63.23 111.98 -176.379 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -80.31 -48.56 12.81 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 108.502 -0.925 . . . . 73.2 108.502 175.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 91.6 mmm -54.16 -45.84 72.16 Favored 'General case' 0 C--N 1.339 0.119 0 C-N-CA 125.305 1.442 . . . . 70.31 111.118 -178.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -63.86 -44.77 92.11 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 119.087 0.858 . . . . 65.44 111.687 -176.03 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 33.4 mttt -60.77 -61.47 2.56 Favored 'General case' 0 C--N 1.341 0.219 0 N-CA-C 108.922 -0.77 . . . . 73.42 108.922 171.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -47.41 -40.98 19.13 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.283 1.033 . . . . 73.12 111.564 -175.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -59.21 -64.92 0.77 Allowed 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 124.171 0.989 . . . . 72.25 108.823 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.85 -23.03 65.97 Favored 'General case' 0 N--CA 1.461 0.097 0 CA-C-O 118.278 -0.868 . . . . 75.25 112.723 -175.401 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 55.9 mt -59.73 -50.28 74.44 Favored 'General case' 0 C--O 1.227 -0.122 0 CA-C-N 118.972 0.805 . . . . 70.14 109.662 173.618 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -63.88 -32.86 74.52 Favored 'General case' 0 CA--C 1.537 0.476 0 O-C-N 121.908 -0.495 . . . . 65.42 111.307 -172.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 11.3 mmt -62.36 -45.44 93.17 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 125.502 1.521 . . . . 74.4 110.381 174.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -58.24 -47.2 84.27 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 109.017 -0.734 . . . . 75.23 109.017 -177.438 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 31.8 m-85 -68.85 5.31 1.15 Allowed 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 126.417 1.887 . . . . 72.54 114.674 -176.297 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 62.6 mt-30 54.04 28.88 9.34 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 126.234 1.814 . . . . 70.43 112.363 -179.272 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 44.3 t -78.53 135.95 24.93 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 N-CA-C 107.424 -1.325 . . . . 74.11 107.424 176.142 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -142.66 14.96 1.96 Allowed 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 121.501 0.667 . . . . 75.45 111.397 -176.873 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -173.76 177.27 46.14 Favored Glycine 0 CA--C 1.52 0.398 0 C-N-CA 125.939 1.733 . . . . 63.43 110.144 174.503 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.413 ' HA ' ' C ' ' A' ' 154' ' ' PRO . 12.4 m -141.14 150.89 60.31 Favored Pre-proline 0 CA--C 1.539 0.523 0 C-N-CA 124.337 1.055 . . . . 73.2 109.793 179.365 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . 0.413 ' C ' ' HA ' ' A' ' 153' ' ' VAL . 38.8 Cg_endo -68.91 150.18 87.56 Favored 'Cis proline' 0 N--CA 1.459 -0.526 0 C-N-CA 125.067 -0.805 . . . . 73.04 112.072 -1.005 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 51.6 m -148.33 117.32 6.77 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.738 1.615 . . . . 72.12 107.197 175.461 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 96.4 mtp -94.69 158.84 15.34 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 108.38 -0.97 . . . . 74.34 108.38 167.188 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 38.2 t -140.42 138.27 36.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 106.459 -1.682 . . . . 74.13 106.459 171.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 95.3 t -103.53 132.32 50.13 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 N-CA-C 107.606 -1.257 . . . . 71.54 107.606 168.132 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 4.9 t30 48.79 23.63 0.7 Allowed 'General case' 0 C--N 1.331 -0.231 1 C-N-CA 132.159 4.184 . . . . 64.11 115.963 167.041 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 70.12 24.4 76.58 Favored Glycine 0 CA--C 1.527 0.792 0 C-N-CA 126.209 1.862 . . . . 63.13 114.498 -175.182 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 48.7 mttp -137.02 -28.54 0.94 Allowed 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 120.202 2.001 . . . . 74.23 113.996 -171.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -125.04 105.83 9.48 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 108.466 -0.939 . . . . 75.34 108.466 -175.001 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 32.5 ttp85 -83.03 136.73 34.39 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 105.166 -2.161 . . . . 73.01 105.166 171.331 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 15.3 p90 -152.32 170.03 21.05 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 107.845 -1.169 . . . . 64.3 107.845 174.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -179.52 178.98 0.63 Allowed 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 123.877 0.871 . . . . 75.43 109.177 179.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 29.5 mt -45.37 -52.78 2.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 C-N-CA 129.217 3.007 . . . . 74.41 109.71 174.429 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -75.41 -21.22 77.9 Favored Glycine 0 C--N 1.338 0.639 0 CA-C-O 119.435 -0.647 . . . . 61.13 113.443 -176.737 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 14.4 m -75.19 -68.23 0.58 Allowed 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 118.492 1.146 . . . . 73.4 108.084 169.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -75.0 -31.33 61.39 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-O 117.415 -1.279 . . . . 72.3 113.443 -162.223 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 134.78 5.39 2.5 Favored Glycine 0 CA--C 1.533 1.201 0 N-CA-C 117.171 1.628 . . . . 74.01 117.171 174.265 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 126.42 167.95 12.51 Favored Glycine 0 CA--C 1.529 0.953 0 CA-C-N 119.446 1.623 . . . . 73.31 110.378 -173.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -61.44 -40.47 47.93 Favored 'Trans proline' 0 CA--C 1.534 0.502 0 C-N-CA 123.059 2.506 . . . . 72.41 113.736 -156.294 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -65.93 -33.2 75.29 Favored 'General case' 0 CA--C 1.532 0.283 0 O-C-N 121.206 -0.934 . . . . 74.11 111.379 177.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -72.44 -25.99 61.66 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 123.274 0.63 . . . . 73.03 110.515 176.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 6.6 m -63.84 -47.44 80.76 Favored 'General case' 0 C--O 1.233 0.195 0 O-C-N 120.867 -1.146 . . . . 75.05 108.443 -178.152 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 59.9 mt -62.79 -33.26 74.83 Favored 'General case' 0 C--O 1.224 -0.258 0 CA-C-O 119.484 -0.293 . . . . 74.3 110.788 175.633 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 14.0 tptt -54.23 -36.75 63.87 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-O 118.939 -0.553 . . . . 74.12 111.089 176.132 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -80.09 -44.85 19.28 Favored 'General case' 0 CA--C 1.509 -0.63 0 CA-C-O 117.665 -1.16 . . . . 75.41 110.077 175.262 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -50.43 -42.41 53.89 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 119.251 0.932 . . . . 73.44 111.169 -179.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -82.19 -33.3 29.49 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 124.693 1.197 . . . . 74.12 109.827 -165.415 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 19.2 t80 -69.79 -51.06 37.08 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.892 1.277 . . . . 73.23 110.496 170.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 62.5 mt -61.32 -27.96 68.87 Favored 'General case' 0 N--CA 1.462 0.133 0 C-N-CA 125.274 1.429 . . . . 74.45 112.871 -174.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 24.4 mt -56.61 -63.11 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 N-CA-C 108.178 -1.045 . . . . 74.45 108.178 171.539 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 7.8 tm-20 -60.36 -33.38 72.36 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.646 1.179 . . . . 72.24 111.324 -173.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 43.6 tptt -48.72 -57.99 5.46 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 124.344 1.058 . . . . 74.53 109.971 173.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 25.0 mm-40 -77.07 -34.55 57.01 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 123.504 0.721 . . . . 74.12 111.715 -178.419 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.75 -36.87 83.46 Favored 'General case' 0 N--CA 1.462 0.155 0 O-C-N 120.959 -1.088 . . . . 70.43 109.99 -174.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.369 0 C-N-CA 124.103 0.961 . . . . 71.0 112.065 177.883 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.235 0.302 0 CA-C-O 120.951 0.405 . . . . 75.51 110.723 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -142.85 8.02 1.67 Allowed 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 124.527 1.131 . . . . 72.32 111.752 -173.413 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 -145.97 157.77 43.88 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 125.016 1.327 . . . . 75.13 109.383 -170.451 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 51.1 m -134.06 141.26 47.12 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-O 121.692 0.758 . . . . 74.43 109.698 -179.115 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.43 144.28 57.29 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 124.12 0.968 . . . . 73.55 110.021 -178.779 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 79.1 -46.07 2.9 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 126.059 1.79 . . . . 71.34 111.099 -170.196 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 9.2 tptp -67.14 -70.42 0.25 Allowed 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 125.467 1.507 . . . . 72.53 109.748 -172.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 11.2 mp0 -88.24 -27.49 21.73 Favored 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 123.46 0.704 . . . . 73.14 110.735 -176.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 39.7 p90 -156.12 177.11 11.8 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 121.087 -1.008 . . . . 75.12 110.267 -171.462 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 17.7 t -134.1 112.73 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 N-CA-C 108.577 -0.897 . . . . 73.32 108.577 -175.266 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.32 163.66 26.09 Favored 'General case' 0 C--N 1.329 -0.314 0 O-C-N 120.652 -1.28 . . . . 75.11 109.01 164.459 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -132.01 113.52 13.49 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 123.959 0.904 . . . . 70.33 109.107 -176.241 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.9 m -61.16 -10.49 6.55 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 114.657 1.355 . . . . 63.33 114.657 -179.095 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 15.7 m -117.86 79.88 13.86 Favored Pre-proline 0 N--CA 1.448 -0.57 0 CA-C-N 119.834 1.197 . . . . 71.2 108.312 171.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_endo -69.06 174.79 8.4 Favored 'Trans proline' 0 N--CA 1.451 -1.012 0 C-N-CA 122.566 2.178 . . . . 74.44 111.336 175.175 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 50.5 t -143.22 134.76 12.84 Favored Pre-proline 0 C--N 1.33 -0.271 0 N-CA-C 106.203 -1.777 . . . . 72.44 106.203 -176.437 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -75.37 173.86 13.79 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 121.067 1.178 . . . . 71.14 110.56 176.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 16.3 m -116.2 165.19 11.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 C-N-CA 124.864 1.266 . . . . 75.44 108.87 175.006 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 3.4 m -48.75 -53.77 17.69 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 124.823 1.249 . . . . 71.43 112.418 174.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 2.2 pm0 -147.45 159.56 41.37 Favored Pre-proline 0 N--CA 1.449 -0.496 0 CA-C-N 120.413 1.46 . . . . 72.03 111.045 177.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -65.09 -177.07 0.54 Allowed 'Trans proline' 0 CA--C 1.544 1.021 0 C-N-CA 123.902 3.068 . . . . 74.33 111.135 166.218 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 119.97 -80.3 0.32 Allowed Glycine 0 CA--C 1.525 0.692 0 C-N-CA 125.211 1.386 . . . . 62.21 111.34 174.358 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -109.04 144.72 36.69 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 124.192 0.997 . . . . 71.32 109.232 179.122 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 47.2 mm -59.26 146.74 8.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 C-N-CA 124.481 1.112 . . . . 73.34 108.484 175.397 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -107.71 90.16 3.22 Favored 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 105.872 -1.899 . . . . 75.31 105.872 175.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 47.8 t -84.22 125.36 40.23 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.174 0 N-CA-C 105.505 -2.035 . . . . 73.33 105.505 170.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 41.9 t -119.35 113.39 41.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 N-CA-C 107.291 -1.374 . . . . 72.21 107.291 -175.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -72.01 131.6 43.13 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 107.83 -1.174 . . . . 62.33 107.83 156.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.1 mp -119.68 130.59 55.12 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 106.826 -1.546 . . . . 70.5 106.826 165.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 6.1 p90 -142.75 170.35 15.87 Favored 'General case' 0 C--O 1.237 0.416 0 O-C-N 123.9 0.75 . . . . 74.53 112.639 -170.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 27.4 t90 -142.44 149.02 38.73 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 127.224 2.21 . . . . 62.31 108.344 -178.291 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 9.3 p90 -60.67 -20.11 60.1 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 115.905 1.817 . . . . 72.21 115.905 -172.178 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -100.69 -89.13 2.04 Favored Glycine 0 N--CA 1.449 -0.498 0 N-CA-C 106.931 -2.468 . . . . 54.45 106.931 -176.418 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 30.8 t 44.8 80.64 0.28 Allowed Pre-proline 0 CA--C 1.538 0.483 0 C-N-CA 126.172 1.789 . . . . 71.54 112.491 175.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -59.76 -21.36 63.12 Favored 'Trans proline' 0 CA--C 1.536 0.595 0 C-N-CA 121.993 1.795 . . . . 63.34 113.493 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 18.6 m170 -82.39 -39.37 22.79 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.757 1.223 . . . . 73.11 111.047 179.638 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 74.5 m -58.21 -43.25 87.58 Favored 'General case' 0 N--CA 1.462 0.143 0 C-N-CA 124.949 1.3 . . . . 63.12 111.271 -175.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 68.5 t80 -61.39 -27.84 68.82 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.819 0.848 . . . . 73.41 111.207 178.153 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -77.89 10.76 2.58 Favored 'General case' 0 CA--C 1.544 0.719 0 O-C-N 120.598 -1.314 . . . . 75.42 112.88 174.606 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 10.9 t80 -138.43 -23.63 0.98 Allowed 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 125.796 1.639 . . . . 74.54 111.994 174.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -35.12 -66.14 0.25 Allowed Pre-proline 0 CA--C 1.541 0.622 0 C-N-CA 127.074 2.15 . . . . 71.4 112.594 176.592 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -72.07 -11.36 27.13 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 CA-C-N 120.907 1.36 . . . . 72.54 114.476 -173.297 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 82.0 m -82.15 -35.65 28.22 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 119.469 1.031 . . . . 71.4 110.072 172.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 18.7 tt -90.46 -26.03 5.33 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 O-C-N 121.989 -0.445 . . . . 73.53 111.994 -173.274 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 14.5 t -52.15 -65.1 1.12 Allowed Pre-proline 0 CA--C 1.543 0.685 0 C-N-CA 124.668 1.187 . . . . 73.33 111.214 172.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -71.98 -13.71 29.04 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 CA-C-N 121.522 1.579 . . . . 74.14 112.613 -174.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 70.8 t90 -68.03 -58.46 4.46 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 119.115 0.871 . . . . 75.14 109.331 168.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 7.2 p -62.22 -34.64 76.87 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.306 0.643 . . . . 73.33 112.476 -169.671 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -59.5 -49.49 77.58 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 118.749 0.704 . . . . 73.45 110.655 177.349 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.14 18.4 1.39 Allowed 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 124.643 1.177 . . . . 74.52 113.17 -174.162 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 26.3 mt -63.39 153.34 82.71 Favored Pre-proline 0 N--CA 1.449 -0.506 0 CA-C-N 118.476 0.58 . . . . 73.34 110.803 175.011 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -80.11 166.2 20.95 Favored 'Trans proline' 0 N--CA 1.446 -1.283 0 C-N-CA 124.679 3.586 . . . . 72.42 111.025 -179.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -65.46 -7.9 16.46 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 114.793 1.405 . . . . 71.53 114.793 -175.2 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -104.65 8.18 35.14 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 125.454 1.502 . . . . 74.23 111.62 -177.572 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 67.1 t -120.67 152.24 23.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 106.418 -1.697 . . . . 75.0 106.418 177.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 16.9 t60 -134.25 124.88 26.64 Favored 'General case' 0 N--CA 1.439 -1.014 0 N-CA-C 108.036 -1.098 . . . . 74.21 108.036 166.408 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 29.4 t80 -84.68 140.15 31.52 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 107.004 -1.48 . . . . 72.45 107.004 173.233 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 88.7 t -133.34 150.36 32.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 C-N-CA 126.693 1.997 . . . . 73.41 106.128 178.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 18.3 mtt180 -131.23 120.81 23.77 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 106.127 -1.805 . . . . 75.24 106.127 179.166 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 40.3 mt -127.56 151.01 74.47 Favored Pre-proline 0 N--CA 1.473 0.691 0 CA-C-N 120.369 1.441 . . . . 71.42 110.618 173.225 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -71.89 131.24 17.97 Favored 'Trans proline' 0 N--CA 1.453 -0.901 0 C-N-CA 122.357 2.038 . . . . 74.23 110.064 176.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -77.38 81.75 3.85 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 123.758 0.823 . . . . 70.42 110.717 177.208 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 33.6 mt -77.25 95.36 4.31 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.002 0.921 . . . . 75.11 109.313 -177.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 37.4 m-85 -123.49 20.05 9.59 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.158 0.983 . . . . 71.42 112.343 -177.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 85.79 -174.55 48.15 Favored Glycine 0 C--N 1.336 0.553 0 N-CA-C 110.702 -0.959 . . . . 70.01 110.702 -178.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 44.88 71.37 0.48 Allowed Glycine 0 CA--C 1.526 0.731 0 C-N-CA 125.308 1.432 . . . . 73.34 113.914 166.297 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . 0.256 5.5 tp 58.23 -19.85 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.739 0 C-N-CA 130.288 3.435 . . . . 75.31 115.671 -176.58 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 10.6 m95 -56.85 -39.77 74.89 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 121.277 1.853 . . . . 74.54 110.302 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 25.1 p30 -73.88 -43.67 57.8 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 125.357 1.463 . . . . 72.15 113.395 -177.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 78.9 t -56.5 -49.26 78.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 N-CA-C 108.906 -0.776 . . . . 73.43 108.906 177.345 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 43.8 m170 -72.19 -2.6 19.37 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 114.473 1.286 . . . . 74.4 114.473 179.125 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -107.02 -21.6 8.02 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 124.921 1.248 . . . . 74.02 112.475 177.517 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 54.4 tt0 -64.26 -30.93 71.96 Favored 'General case' 0 CA--C 1.539 0.527 0 O-C-N 121.716 -0.873 . . . . 75.12 111.682 -175.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -67.52 -37.52 82.89 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 126.004 1.721 . . . . 73.34 112.613 -174.495 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 26.6 t80 -64.11 -48.47 76.0 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-N 119.647 1.112 . . . . 72.43 109.018 -171.688 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 54.8 mt -56.87 -36.41 70.05 Favored 'General case' 0 C--O 1.223 -0.341 0 C-N-CA 124.228 1.011 . . . . 71.35 110.101 173.483 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.15 -44.25 76.46 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 119.764 1.165 . . . . 74.1 111.382 178.103 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -53.22 -58.62 6.42 Favored 'General case' 0 CA--C 1.529 0.14 0 N-CA-C 107.561 -1.274 . . . . 72.01 107.561 -178.749 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -67.62 -23.15 65.33 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 111.968 0.358 . . . . 72.4 111.968 -176.544 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 17.4 t -62.16 -25.53 67.82 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-O 118.485 -0.769 . . . . 74.12 112.783 178.033 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 3.2 ptp . . . . . 0 N--CA 1.467 0.415 0 CA-C-N 119.762 1.165 . . . . 74.32 113.372 172.666 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 0.261 0 N-CA-C 113.202 0.816 . . . . 74.43 113.202 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 82.4 t -59.11 -61.37 1.46 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 N-CA-C 107.627 -1.249 . . . . 74.03 107.627 169.369 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -61.22 -47.56 85.55 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.106 0.962 . . . . 73.3 111.05 -176.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -72.13 2.41 5.89 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.659 1.984 . . . . 73.45 112.124 -173.331 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -117.23 3.32 12.63 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 124.96 1.304 . . . . 73.53 112.282 171.08 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 83.8 mt -124.15 -60.94 1.81 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.373 0 N-CA-C 106.096 -1.816 . . . . 71.32 106.096 -175.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 83.3 m-70 -59.79 -64.87 0.79 Allowed 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 125.0 1.32 . . . . 74.23 111.237 -179.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 4.6 ptmt -82.41 -7.03 59.64 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 114.693 1.368 . . . . 75.34 114.693 -175.167 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -114.91 -37.5 4.16 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 113.665 0.987 . . . . 74.31 113.665 -173.085 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 12.1 t-160 45.63 53.06 8.92 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 127.695 2.398 . . . . 74.43 113.162 -178.355 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . 0.289 0.0 OUTLIER -70.71 12.97 0.21 Allowed 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 115.308 1.595 . . . . 74.13 115.308 172.966 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 26.2 ttmt 45.43 61.48 2.57 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 128.676 2.79 . . . . 63.05 110.863 171.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 63.1 mt -76.44 60.75 1.63 Allowed 'General case' 0 C--N 1.315 -0.93 0 C-N-CA 128.895 2.878 . . . . 74.25 107.181 177.643 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -103.03 -12.16 17.63 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 127.928 2.491 . . . . 75.14 111.11 -176.028 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -114.27 154.09 46.36 Favored Pre-proline 0 C--O 1.236 0.393 0 C-N-CA 124.967 1.307 . . . . 63.34 108.163 177.091 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -67.72 -36.35 19.18 Favored 'Trans proline' 0 N--CA 1.45 -1.067 0 C-N-CA 121.226 1.284 . . . . 75.0 110.73 -177.159 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -55.63 -55.18 35.09 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 123.559 0.743 . . . . 75.43 110.161 174.077 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -57.54 -50.86 71.71 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 125.053 1.341 . . . . 75.11 109.801 -175.597 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 51.2 mtt -55.82 -53.71 53.39 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 123.958 0.903 . . . . 72.44 111.355 178.51 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -71.75 -36.95 70.57 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 124.288 1.035 . . . . 71.23 110.597 -168.573 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -62.4 -42.59 99.55 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 118.699 0.682 . . . . 74.13 111.723 174.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 8.9 t80 -61.28 -51.48 68.75 Favored 'General case' 0 N--CA 1.455 -0.192 0 O-C-N 121.4 -0.813 . . . . 75.13 110.534 177.577 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 58.3 mt -70.55 -22.88 62.55 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 110.075 -0.342 . . . . 75.4 110.075 -175.647 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -58.21 -36.02 72.51 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 118.85 0.75 . . . . 64.21 109.431 171.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -71.81 -4.74 59.29 Favored Glycine 0 N--CA 1.442 -0.918 0 CA-C-O 116.459 -2.3 . . . . 65.22 115.034 170.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.483 ' HA ' ' HE2' ' A' ' 118' ' ' LYS . 5.7 mmpt? -116.74 -9.13 11.32 Favored 'General case' 0 C--N 1.348 0.537 0 CA-C-N 122.553 3.176 . . . . 74.41 114.245 -171.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 97.0 59.02 1.01 Allowed Glycine 0 N--CA 1.452 -0.234 0 N-CA-C 108.486 -1.845 . . . . 75.14 108.486 -168.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 53.7 t -142.31 153.05 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 C-N-CA 129.372 3.069 . . . . 72.42 104.089 167.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 41.6 t0 -111.67 128.91 56.21 Favored 'General case' 0 C--N 1.331 -0.221 0 O-C-N 121.116 -0.99 . . . . 72.15 108.746 -177.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 14.2 mtpt -60.75 -31.35 70.69 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 119.277 0.944 . . . . 74.23 110.374 172.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -59.81 -20.93 59.86 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 119.844 1.202 . . . . 71.23 112.214 173.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 65.0 mmtt -113.3 -33.11 6.06 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-N 119.8 1.182 . . . . 72.32 112.057 -175.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -62.64 -56.41 18.01 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 118.814 0.734 . . . . 74.03 109.926 -178.268 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 9.9 mt -72.76 -46.5 53.05 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.861 0.839 . . . . 74.05 111.173 -163.182 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 21.0 p -53.61 -41.79 67.03 Favored 'General case' 0 N--CA 1.444 -0.736 0 C-N-CA 125.511 1.525 . . . . 73.45 108.822 177.412 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 40.9 m -76.48 -41.39 47.36 Favored 'General case' 0 C--O 1.222 -0.356 0 N-CA-C 108.322 -0.992 . . . . 61.41 108.322 -176.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 61.6 t80 -56.57 -32.27 65.02 Favored 'General case' 0 C--O 1.235 0.337 0 O-C-N 120.709 -1.245 . . . . 75.21 110.878 178.153 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -105.17 26.4 9.38 Favored 'General case' 0 C--O 1.243 0.714 0 N-CA-C 113.432 0.901 . . . . 75.11 113.432 175.485 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 11.1 p -99.68 157.02 16.77 Favored 'General case' 0 C--O 1.234 0.275 0 O-C-N 120.919 -1.113 . . . . 74.05 111.317 175.726 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -67.19 -27.59 67.39 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 115.538 -0.755 . . . . 74.44 111.921 -175.637 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -55.09 -47.0 75.52 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 121.524 0.678 . . . . 72.24 110.324 175.734 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 32.8 mm -64.08 -37.72 80.57 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 C-N-CA 123.787 0.835 . . . . 73.25 109.149 179.4 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 10.5 mttt -58.31 -35.23 71.54 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 119.64 1.109 . . . . 75.31 110.591 172.393 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -73.51 -40.21 47.98 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 109.816 -1.314 . . . . 64.45 109.816 -173.769 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 2.3 mm100 -68.98 -43.1 75.61 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 123.391 0.676 . . . . 72.13 109.824 178.361 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 45.4 mtp -60.54 -42.76 97.19 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-O 117.495 -1.241 . . . . 74.12 111.478 177.15 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -62.8 -39.99 95.98 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 120.638 1.563 . . . . 74.45 110.839 -178.432 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 9.3 mmtt -59.62 -65.48 0.67 Allowed 'General case' 0 N--CA 1.463 0.176 0 C-N-CA 123.803 0.841 . . . . 73.23 110.316 170.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -57.92 -34.84 70.28 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 119.472 1.033 . . . . 73.2 111.257 -171.195 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 14.2 tmtt? -61.62 -61.55 2.44 Favored 'General case' 0 CA--C 1.518 -0.25 0 C-N-CA 124.895 1.278 . . . . 65.14 110.172 176.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.08 -25.98 68.35 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 119.74 1.154 . . . . 72.53 110.903 -178.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 25.4 mt -69.62 -54.24 14.92 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 118.429 -0.796 . . . . 75.21 111.712 -176.378 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -58.75 -49.32 78.08 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 118.873 0.76 . . . . 75.23 111.196 -169.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -61.03 -40.39 93.4 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 123.527 0.731 . . . . 73.52 112.515 175.742 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . 0.442 ' C ' ' H ' ' A' ' 149' ' ' GLN . . . -67.3 -36.42 81.46 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 118.278 -0.868 . . . . 42.33 110.019 -179.526 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -67.78 14.14 0.06 Allowed 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.824 1.65 . . . . 74.34 113.359 175.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' GLN . . . . . 0.442 ' H ' ' C ' ' A' ' 147' ' ' ALA . 23.5 mt-30 54.29 21.52 3.19 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 127.12 2.168 . . . . 73.13 113.839 -179.023 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 44.4 t -71.47 142.04 15.97 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 N-CA-C 108.576 -0.898 . . . . 74.22 108.576 179.4 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -112.64 -14.09 13.2 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 124.662 1.185 . . . . 65.13 112.717 -176.112 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 167.49 -160.16 33.71 Favored Glycine 0 N--CA 1.446 -0.699 0 N-CA-C 108.119 -1.992 . . . . 43.13 108.119 -165.398 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 31.0 m -138.69 157.31 72.18 Favored Pre-proline 0 CA--C 1.536 0.425 0 C-N-CA 124.345 1.058 . . . . 65.21 109.741 -178.185 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_endo -66.59 156.9 81.91 Favored 'Cis proline' 0 N--CA 1.459 -0.552 0 C-N-CA 124.738 -0.943 . . . . 74.51 111.621 -7.063 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 5.6 m -156.86 138.37 13.99 Favored 'General case' 0 N--CA 1.466 0.339 0 O-C-N 121.102 -0.999 . . . . 74.01 109.239 171.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 92.1 mtp -112.32 148.64 33.79 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 125.148 1.379 . . . . 64.34 109.164 171.605 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 26.7 t -137.09 151.8 27.48 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 C-N-CA 124.623 1.169 . . . . 73.1 108.027 176.667 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 39.9 t -130.2 123.5 56.04 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 C-N-CA 126.053 1.741 . . . . 74.45 106.819 -178.351 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 16.6 m-20 50.01 21.15 0.68 Allowed 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 127.805 2.442 . . . . 65.25 114.973 173.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 51.74 45.17 55.17 Favored Glycine 0 CA--C 1.531 1.07 0 CA-C-O 117.697 -1.613 . . . . 73.04 112.924 -165.419 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 12.1 mtpp -139.44 -33.98 0.59 Allowed 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 119.595 1.697 . . . . 74.3 113.056 178.348 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -121.81 148.25 44.92 Favored 'General case' 0 CA--C 1.506 -0.729 0 N-CA-C 108.154 -1.054 . . . . 74.1 108.154 176.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 48.8 ttp85 -136.4 139.39 42.42 Favored 'General case' 0 N--CA 1.442 -0.857 0 N-CA-C 106.268 -1.753 . . . . 73.23 106.268 179.426 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 22.9 p90 -154.94 174.59 14.92 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 108.255 -1.017 . . . . 74.03 108.255 -179.364 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -177.41 173.73 1.67 Allowed 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 107.736 -1.209 . . . . 74.42 107.736 -176.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 17.8 mt -45.4 -50.13 3.25 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 C-N-CA 127.964 2.506 . . . . 73.34 108.408 162.462 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -73.86 9.5 8.72 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 126.433 1.968 . . . . 45.34 114.699 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 22.6 m -120.51 -54.15 2.08 Favored 'General case' 0 N--CA 1.458 -0.047 0 CA-C-N 119.198 1.499 . . . . 75.2 109.764 163.387 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -61.25 -53.1 61.14 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.511 1.125 . . . . 62.41 110.78 -172.571 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 146.02 -17.42 1.75 Allowed Glycine 0 CA--C 1.523 0.553 0 CA-C-O 119.614 -0.548 . . . . 73.34 113.764 178.417 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 169.47 176.37 39.3 Favored Glycine 0 CA--C 1.528 0.872 0 N-CA-C 108.885 -1.686 . . . . 71.13 108.885 -169.332 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -63.9 -52.48 1.71 Allowed 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 123.072 2.515 . . . . 73.23 111.611 -175.177 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -59.8 -39.74 86.0 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 119.295 0.952 . . . . 75.31 109.732 178.053 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -60.77 -32.65 71.96 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.523 0.729 . . . . 74.42 110.494 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 26.6 m -65.63 -43.68 88.77 Favored 'General case' 0 N--CA 1.453 -0.282 0 O-C-N 120.716 -1.24 . . . . 63.12 109.617 179.083 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 48.0 mt -66.46 -28.24 68.44 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 118.891 0.768 . . . . 72.33 111.354 176.139 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 10.1 tptt -51.29 -49.23 61.67 Favored 'General case' 0 C--O 1.232 0.182 0 N-CA-C 109.005 -0.739 . . . . 74.34 109.005 169.48 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -74.46 -38.79 62.85 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-O 119.012 -0.518 . . . . 72.25 111.54 -178.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.08 -43.94 87.29 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 118.005 0.366 . . . . 72.13 111.099 -176.625 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -74.04 -28.52 61.46 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 123.244 0.618 . . . . 74.54 110.58 -174.471 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 9.9 t80 -74.08 -57.0 4.26 Favored 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 125.053 1.341 . . . . 74.44 110.425 178.454 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 77.8 mt -61.95 -24.7 67.16 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 124.997 1.319 . . . . 74.32 112.955 -171.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 35.6 mt -53.3 -54.94 15.06 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 C-N-CA 123.348 0.659 . . . . 72.21 109.36 170.014 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -66.07 -38.23 87.8 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 118.342 0.519 . . . . 65.21 111.229 -177.073 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.4 -46.44 66.29 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 124.325 1.05 . . . . 75.01 110.182 -176.723 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -74.64 -51.83 13.37 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 123.087 0.555 . . . . 71.21 112.082 173.237 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 3.2 tpm_? -48.07 -45.31 32.36 Favored 'General case' 0 CA--C 1.516 -0.357 0 C-N-CA 124.82 1.248 . . . . 74.22 112.086 -175.422 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.353 0 C-N-CA 125.696 1.598 . . . . 72.55 111.746 -174.566 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 . . . . . 0 CA--C 1.502 -0.888 0 CA-C-O 120.931 0.396 . . . . 65.31 111.011 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 76.38 10.46 2.95 Favored 'General case' 0 N--CA 1.442 -0.852 0 C-N-CA 130.078 3.351 . . . . 64.22 115.556 -172.133 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 29.7 m-85 -139.83 178.1 7.48 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 126.648 1.979 . . . . 73.23 108.305 179.383 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 95.0 m -144.3 143.88 31.2 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 108.287 -1.005 . . . . 75.23 108.287 166.238 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.64 152.27 45.69 Favored 'General case' 0 C--O 1.227 -0.123 0 O-C-N 121.393 -0.817 . . . . 74.02 108.838 172.386 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 70.33 -44.37 0.58 Allowed Glycine 0 CA--C 1.534 1.224 0 C-N-CA 125.504 1.525 . . . . 52.32 112.287 -162.36 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.5 tptm -70.21 -58.57 3.63 Favored 'General case' 0 CA--C 1.519 -0.222 0 C-N-CA 126.295 1.838 . . . . 72.41 111.165 -169.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -113.78 -23.42 9.68 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 126.04 1.736 . . . . 73.53 109.965 -172.056 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 42.4 p90 -157.22 173.38 17.05 Favored 'General case' 0 N--CA 1.47 0.525 0 O-C-N 120.96 -1.088 . . . . 74.13 109.586 -176.147 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 24.9 t -135.52 117.89 21.77 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 C-N-CA 123.437 0.695 . . . . 74.53 109.193 -174.576 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.9 162.54 28.04 Favored 'General case' 0 CA--C 1.537 0.446 0 O-C-N 121.189 -0.945 . . . . 70.15 109.055 167.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -136.18 108.28 7.21 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 126.679 1.992 . . . . 73.51 108.294 -167.52 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.8 p -63.27 -0.46 0.82 Allowed 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 115.493 1.664 . . . . 74.44 115.493 -176.229 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 49.0 m -131.0 76.41 76.98 Favored Pre-proline 0 N--CA 1.451 -0.389 0 CA-C-N 119.841 1.201 . . . . 72.11 109.428 174.036 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -65.97 176.64 3.58 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 123.894 3.063 . . . . 73.13 112.688 -176.487 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 40.2 t -133.81 136.03 25.81 Favored Pre-proline 0 CA--C 1.537 0.443 0 C-N-CA 125.539 1.536 . . . . 73.53 108.336 -169.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -76.24 178.45 7.48 Favored 'Trans proline' 0 CA--C 1.534 0.509 0 C-N-CA 123.491 2.794 . . . . 60.04 111.443 176.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 27.9 m -132.85 174.1 13.81 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 C-N-CA 125.336 1.454 . . . . 73.53 109.674 170.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 73.9 m -58.45 -51.36 70.15 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 126.33 1.852 . . . . 64.22 112.335 175.002 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 41.7 tt0 -143.16 145.29 32.06 Favored Pre-proline 0 CA--C 1.534 0.361 0 C-N-CA 124.278 1.031 . . . . 73.55 108.733 -177.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -74.54 90.91 1.0 Allowed 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 123.158 2.572 . . . . 72.54 109.202 165.2 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -137.12 -94.9 0.38 Allowed Glycine 0 C--N 1.336 0.542 0 O-C-N 121.497 -0.752 . . . . 73.12 111.304 -172.387 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 12.7 mptt -80.02 159.95 26.03 Favored 'General case' 0 C--O 1.227 -0.13 0 N-CA-C 107.693 -1.225 . . . . 73.01 107.693 170.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 49.2 mm -70.46 130.46 34.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 106.135 -1.802 . . . . 72.23 106.135 167.227 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -83.8 130.48 34.94 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 106.203 -1.777 . . . . 71.44 106.203 173.422 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 13.9 t -119.42 144.17 28.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 105.813 -1.921 . . . . 75.32 105.813 166.049 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 37.8 t -133.98 101.65 3.94 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.137 0 N-CA-C 106.512 -1.662 . . . . 73.34 106.512 -174.225 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -76.17 137.33 39.99 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 106.143 -1.799 . . . . 73.34 106.143 161.115 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.4 mp -120.93 134.19 55.29 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 105.494 -2.039 . . . . 73.51 105.494 163.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 42.6 p90 -134.76 172.77 12.5 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 123.552 0.741 . . . . 73.32 110.962 -177.379 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 22.9 t90 -148.55 167.68 24.77 Favored 'General case' 0 N--CA 1.463 0.209 0 C-N-CA 125.225 1.41 . . . . 72.04 108.644 178.405 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 17.6 t80 -67.34 -43.98 80.19 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.865 0.866 . . . . 65.3 112.026 172.253 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -95.71 22.79 37.26 Favored Glycine 0 CA--C 1.527 0.79 0 CA-C-O 119.026 -0.875 . . . . 64.35 113.954 -163.479 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 22.0 p -105.08 86.11 1.46 Allowed Pre-proline 0 CA--C 1.532 0.274 0 CA-C-N 118.843 1.321 . . . . 71.21 109.372 -177.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_endo -56.96 -24.97 60.07 Favored 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 122.325 2.016 . . . . 73.41 113.133 -177.093 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 15.6 m170 -68.11 -26.03 65.6 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 119.028 0.831 . . . . 73.31 111.037 178.243 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 84.6 m -65.29 -32.81 74.66 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.814 0.846 . . . . 61.23 109.48 -174.168 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -63.78 -46.35 85.6 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 125.657 1.583 . . . . 75.52 110.687 -178.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -53.58 -33.82 56.18 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 122.6 0.36 . . . . 75.11 110.467 178.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -87.78 -37.45 16.59 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-O 116.171 -1.871 . . . . 73.13 113.002 -175.233 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -39.23 -63.78 0.59 Allowed Pre-proline 0 N--CA 1.477 0.885 0 CA-C-N 120.724 1.602 . . . . 75.33 113.712 -168.378 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -71.95 -8.97 23.95 Favored 'Trans proline' 0 CA--C 1.535 0.525 0 CA-C-N 121.885 1.709 . . . . 72.32 114.726 -177.338 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.9 m -76.01 -44.11 41.01 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 108.311 -0.996 . . . . 75.42 108.311 167.128 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 14.5 tt -85.89 -35.93 9.99 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 CA-C-O 118.541 -0.742 . . . . 75.54 112.01 -169.402 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 68.9 t -49.79 -59.97 5.89 Favored Pre-proline 0 CA--C 1.541 0.621 0 CA-C-N 120.358 1.435 . . . . 75.43 111.479 176.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -70.12 -20.6 32.91 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 121.332 1.355 . . . . 73.54 112.16 -174.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 81.9 t90 -61.01 -54.28 46.83 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 117.559 -1.21 . . . . 73.13 111.204 175.392 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.2 t -57.99 -40.7 81.37 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 120.646 1.566 . . . . 71.51 111.132 -179.118 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -62.8 -31.56 72.58 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 121.36 0.6 . . . . 74.33 110.5 -178.75 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -104.96 39.68 1.66 Allowed 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 126.175 1.79 . . . . 65.22 112.653 178.135 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 19.2 mt -89.51 160.26 42.34 Favored Pre-proline 0 C--O 1.238 0.454 0 C-N-CA 126.855 2.062 . . . . 72.41 109.995 165.389 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -78.99 175.85 10.49 Favored 'Trans proline' 0 N--CA 1.451 -0.989 0 C-N-CA 124.772 3.648 . . . . 74.35 112.015 175.312 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -72.35 -4.82 32.16 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 114.537 1.31 . . . . 73.41 114.537 -173.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -111.32 5.49 19.83 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 126.681 1.992 . . . . 75.33 111.907 -173.423 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 34.8 t -119.98 156.56 22.69 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 C-N-CA 124.658 1.183 . . . . 74.12 108.377 177.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 83.0 t60 -147.79 116.48 6.7 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.251 1.82 . . . . 74.22 108.694 -178.081 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -93.54 131.4 38.81 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 124.908 1.283 . . . . 73.43 109.801 -177.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 43.8 t -119.98 146.61 24.52 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 C-N-CA 124.703 1.201 . . . . 72.33 108.049 178.627 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 17.4 mtm180 -123.75 132.47 53.81 Favored 'General case' 0 CA--C 1.504 -0.794 0 N-CA-C 107.565 -1.272 . . . . 73.24 107.565 168.658 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 26.7 mt -141.76 153.64 64.9 Favored Pre-proline 0 C--N 1.321 -0.649 0 C-N-CA 124.388 1.075 . . . . 64.33 108.61 -179.513 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -73.39 154.64 50.91 Favored 'Trans proline' 0 N--CA 1.446 -1.278 0 C-N-CA 121.328 1.352 . . . . 71.43 111.772 178.365 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -97.96 72.89 2.23 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 125.521 1.528 . . . . 71.25 107.847 179.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 84.3 mt -74.31 78.73 1.84 Allowed 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.374 1.069 . . . . 75.25 111.238 -170.497 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -112.95 54.33 0.73 Allowed 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 125.242 1.417 . . . . 74.42 110.886 -176.409 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 60.17 173.5 0.83 Allowed Glycine 0 CA--C 1.529 0.928 0 C-N-CA 126.914 2.197 . . . . 61.23 114.615 178.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 53.0 -147.8 14.88 Favored Glycine 0 CA--C 1.53 1.015 0 O-C-N 121.282 -1.128 . . . . 75.22 111.193 -179.444 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -64.53 -10.95 9.71 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 O-C-N 122.01 -0.7 . . . . 74.22 112.886 179.518 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 34.6 m95 -70.55 -28.53 64.99 Favored 'General case' 0 C--N 1.341 0.201 0 CA-C-N 119.9 1.227 . . . . 74.51 110.775 171.524 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -72.02 -45.46 60.8 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 119.103 -1.039 . . . . 72.45 109.449 166.373 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 75.6 t -64.17 -55.65 20.77 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 N-CA-C 111.917 0.339 . . . . 64.24 111.917 -167.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 28.3 m170 -70.72 6.98 1.24 Allowed 'General case' 0 CA--C 1.535 0.386 0 O-C-N 121.529 -0.732 . . . . 74.22 112.468 179.573 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -102.69 -33.71 4.33 Favored Glycine 0 N--CA 1.439 -1.128 0 CA-C-O 118.63 -1.094 . . . . 55.13 111.36 173.36 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . 0.417 0.0 OUTLIER -71.25 -36.56 71.83 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 118.951 1.376 . . . . 73.45 112.146 -166.029 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -53.82 -45.32 70.81 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-O 116.192 -1.861 . . . . 73.14 113.253 175.819 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 50.1 t80 -45.96 -52.2 12.06 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 125.736 1.614 . . . . 75.41 109.668 -177.126 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 18.1 mt -60.34 -44.06 95.88 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 126.605 1.962 . . . . 73.13 110.555 -177.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -64.51 -40.38 95.53 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 119.283 0.947 . . . . 73.43 110.872 -178.648 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.38 -51.22 70.84 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 107.903 -1.147 . . . . 73.12 107.903 -176.011 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -69.34 -27.24 65.18 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.067 0.947 . . . . 73.4 111.495 178.221 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 4.0 t -63.07 -16.68 60.71 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.368 1.067 . . . . 65.21 113.181 176.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 13.6 mtp . . . . . 0 C--O 1.233 0.225 0 C-N-CA 124.013 0.925 . . . . 74.12 112.531 173.906 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.227 -0.129 0 CA-C-O 119.209 -0.424 . . . . 64.02 110.974 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 37.3 t -54.17 -63.18 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-O 117.767 -1.111 . . . . 74.22 109.296 167.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -60.16 -41.44 92.81 Favored 'General case' 0 CA--C 1.548 0.875 0 CA-C-N 121.349 1.886 . . . . 71.23 109.273 -174.279 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -74.97 4.54 6.41 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 129.291 3.036 . . . . 71.11 111.568 -176.11 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -111.27 -3.16 15.44 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 125.184 1.393 . . . . 72.32 113.251 169.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 8.1 mt -126.28 -44.62 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 107.873 -1.158 . . . . 74.43 107.873 -172.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 85.2 m-70 -70.53 -65.13 0.77 Allowed 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 123.316 0.646 . . . . 73.22 111.38 177.42 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.84 -20.51 38.84 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 115.044 1.498 . . . . 72.23 115.044 -176.316 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -81.68 -39.89 23.64 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.294 -1.002 . . . . 74.14 108.294 173.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 4.0 t60 52.06 64.55 1.8 Allowed 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.168 1.387 . . . . 74.03 108.783 -174.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 3.7 mmpt? -92.32 147.34 22.99 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 124.352 1.061 . . . . 75.42 108.578 171.717 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 27.9 tttp -84.35 55.41 3.35 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 127.181 2.192 . . . . 70.43 110.14 -178.144 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 95.7 mt -75.89 34.16 0.12 Allowed 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 127.758 2.423 . . . . 74.43 111.599 -176.387 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -70.8 11.73 0.35 Allowed 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 127.001 2.12 . . . . 65.41 114.373 -165.486 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -147.98 161.39 34.91 Favored Pre-proline 0 N--CA 1.47 0.57 0 C-N-CA 126.551 1.94 . . . . 64.15 111.091 179.344 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -56.76 -48.34 19.11 Favored 'Trans proline' 0 CA--C 1.51 -0.681 0 C-N-CA 123.738 2.958 . . . . 75.31 111.981 177.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -60.04 -34.3 73.2 Favored 'General case' 0 N--CA 1.44 -0.97 0 C-N-CA 125.484 1.513 . . . . 71.41 111.336 -175.303 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -71.4 -48.23 51.13 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 126.059 1.744 . . . . 74.1 109.592 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 71.1 mtm -59.82 -49.77 76.42 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 123.814 0.846 . . . . 71.41 109.558 175.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -62.4 -43.88 97.76 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 125.409 1.484 . . . . 71.23 111.135 -177.012 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -53.01 -41.97 65.16 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 123.792 0.837 . . . . 72.31 111.303 177.295 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 93.6 t80 -76.43 -46.82 25.4 Favored 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 124.26 1.024 . . . . 72.01 109.551 -174.486 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 25.9 mt -65.38 -29.97 70.74 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.514 1.126 . . . . 74.44 110.252 -178.354 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -53.98 -31.58 51.28 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.806 0.842 . . . . 63.15 111.361 178.584 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -94.77 12.42 68.65 Favored Glycine 0 CA--C 1.527 0.785 0 CA-C-O 117.406 -1.774 . . . . 62.2 113.907 176.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 7.8 mmtm -132.46 11.33 4.48 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 120.097 1.949 . . . . 75.42 111.835 -173.229 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 97.77 42.09 3.19 Favored Glycine 0 N--CA 1.463 0.475 0 CA-C-N 119.769 1.168 . . . . 61.23 111.863 177.578 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 46.8 t -136.85 158.82 37.11 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 C-N-CA 127.101 2.16 . . . . 73.14 105.474 172.641 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -116.27 126.94 54.26 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 108.856 -0.794 . . . . 65.32 108.856 174.006 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 1.7 mtpm? -56.13 -37.0 68.87 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 123.169 0.588 . . . . 73.33 110.393 171.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -64.11 -14.92 58.16 Favored 'General case' 0 C--O 1.226 -0.165 0 C-N-CA 124.931 1.292 . . . . 63.21 111.992 -178.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 14.6 mmtp -114.66 -33.46 5.51 Favored 'General case' 0 C--O 1.225 -0.196 0 C-N-CA 124.367 1.067 . . . . 75.54 111.837 178.438 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 12.8 t80 -54.82 -61.39 2.34 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 123.632 0.773 . . . . 74.31 109.353 175.306 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 32.3 mt -73.88 -37.12 64.81 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 121.663 0.744 . . . . 74.01 110.798 -161.522 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 18.8 p -66.92 -21.35 65.99 Favored 'General case' 0 N--CA 1.442 -0.856 0 C-N-CA 125.204 1.401 . . . . 75.42 111.757 179.57 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 34.0 m -97.98 -31.74 12.01 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.181 0.992 . . . . 73.43 109.867 174.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 45.4 t80 -57.83 -56.33 23.33 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 124.624 1.17 . . . . 75.12 110.219 177.008 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 -89.47 56.89 3.75 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 108.002 -1.11 . . . . 71.0 108.002 173.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -134.96 160.24 38.94 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 124.061 0.944 . . . . 74.05 110.424 172.336 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -55.28 -28.09 51.04 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.68 1.592 . . . . 75.33 112.654 -179.114 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -45.32 -67.13 0.31 Allowed 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 125.691 1.597 . . . . 73.41 108.728 171.535 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 24.7 mm -61.28 -40.24 85.36 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 CA-C-O 117.524 -1.227 . . . . 74.2 111.295 -178.288 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 18.4 mtpp -54.74 -38.34 67.02 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 120.537 1.517 . . . . 75.23 110.137 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -78.22 -43.57 13.04 Favored Glycine 0 N--CA 1.442 -0.94 0 N-CA-C 110.589 -1.005 . . . . 74.51 110.589 -177.137 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 9.2 mt-30 -62.12 -39.57 92.98 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 123.15 0.58 . . . . 74.33 109.688 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 1.7 mtp -56.42 -57.59 11.63 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 124.673 1.189 . . . . 64.35 109.28 173.594 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -70.82 -31.2 67.85 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 118.898 -1.121 . . . . 73.22 112.227 -168.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 4.5 mttt -63.2 -59.18 5.09 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 123.88 0.872 . . . . 74.52 110.814 170.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -58.13 -35.58 71.7 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 119.459 1.027 . . . . 75.35 110.807 179.683 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 10.0 tmtt? -61.11 -53.2 60.08 Favored 'General case' 0 N--CA 1.456 -0.139 0 O-C-N 120.437 -1.415 . . . . 73.42 110.557 177.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.02 -25.11 64.33 Favored 'General case' 0 C--O 1.221 -0.396 0 CA-C-N 120.096 1.316 . . . . 74.45 111.874 176.756 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 30.0 mt -70.68 -59.27 2.92 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 119.57 1.077 . . . . 75.5 110.991 -178.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -55.42 -44.68 76.49 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 118.412 0.551 . . . . 74.03 111.176 -170.642 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 4.1 ppp? -64.49 -41.75 96.27 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 113.574 0.953 . . . . 74.24 113.574 176.394 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -64.62 -29.81 70.82 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 116.374 -1.774 . . . . 64.13 110.869 -178.375 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -80.0 11.77 3.17 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 127.787 2.435 . . . . 73.41 113.369 176.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 21.4 mt-30 59.67 18.63 7.34 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 127.51 2.324 . . . . 75.22 115.039 -177.332 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 40.2 t -73.43 141.45 16.27 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 O-C-N 121.12 -0.988 . . . . 75.21 108.919 -179.461 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -135.91 3.26 2.93 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.032 0.933 . . . . 64.11 113.078 -177.557 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -174.33 -173.93 40.72 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 108.711 -1.756 . . . . 75.23 108.711 -179.164 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.441 ' HA ' ' C ' ' A' ' 154' ' ' PRO . 6.4 m -139.41 154.16 71.45 Favored Pre-proline 0 CA--C 1.535 0.398 0 C-N-CA 125.794 1.638 . . . . 74.54 109.349 176.597 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . 0.441 ' C ' ' HA ' ' A' ' 153' ' ' VAL . 35.7 Cg_endo -65.03 160.04 72.13 Favored 'Cis proline' 0 CA--C 1.533 0.431 0 C-N-CA 125.317 -0.701 . . . . 74.01 113.793 -2.269 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 17.7 m -157.81 141.66 15.75 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 124.816 1.246 . . . . 71.32 108.367 173.594 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 19.2 mmm -123.5 155.88 36.69 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 125.968 1.707 . . . . 75.44 108.512 167.341 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 6.1 t -135.26 153.77 34.5 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 N-CA-C 106.946 -1.502 . . . . 75.1 106.946 174.43 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 58.5 t -126.45 123.86 64.21 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 C-N-CA 126.439 1.896 . . . . 72.32 106.995 173.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 1.2 t30 54.56 16.7 1.41 Allowed 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 129.472 3.109 . . . . 72.21 115.898 166.697 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 74.37 28.43 63.83 Favored Glycine 0 CA--C 1.523 0.572 0 C-N-CA 128.866 3.127 . . . . 74.43 113.205 -176.131 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 33.5 mttt -139.33 -31.26 0.7 Allowed 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 114.848 1.425 . . . . 75.01 114.848 -166.268 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -125.13 138.51 54.16 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 107.91 -1.144 . . . . 72.0 107.91 177.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 71.0 ttt-85 -122.6 141.57 51.57 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 105.381 -2.081 . . . . 72.33 105.381 178.126 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 11.4 p90 -153.9 170.66 20.49 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 107.097 -1.446 . . . . 75.43 107.097 -179.243 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -173.97 -178.99 1.62 Allowed 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 123.822 0.849 . . . . 73.23 109.103 178.643 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 15.6 mt -52.0 -48.36 40.93 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 C-N-CA 126.245 1.818 . . . . 64.42 109.324 176.085 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -71.65 -34.36 63.02 Favored Glycine 0 CA--C 1.525 0.676 0 CA-C-O 118.744 -1.031 . . . . 74.31 113.009 179.302 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 3.5 m -65.21 -55.79 16.51 Favored 'General case' 0 C--O 1.227 -0.09 0 CA-C-N 119.649 1.724 . . . . 54.32 109.523 174.021 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -67.29 -49.53 63.86 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 124.507 1.123 . . . . 72.31 111.111 -171.03 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 124.43 5.13 7.32 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 125.069 1.319 . . . . 74.34 113.921 -176.633 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 162.04 173.63 30.94 Favored Glycine 0 CA--C 1.528 0.874 0 CA-C-N 118.839 1.319 . . . . 70.25 111.014 175.726 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -66.62 -47.66 2.73 Favored 'Trans proline' 0 CA--C 1.532 0.416 0 C-N-CA 122.785 2.323 . . . . 74.44 111.157 -175.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -54.01 -46.6 71.85 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.143 0.977 . . . . 74.23 110.16 172.528 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -65.33 -26.48 68.06 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.684 0.794 . . . . 72.24 110.403 -176.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 25.0 m -65.83 -40.82 92.16 Favored 'General case' 0 CA--C 1.533 0.3 0 O-C-N 120.663 -1.273 . . . . 71.24 109.524 178.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 37.7 mt -66.62 -29.72 69.82 Favored 'General case' 0 C--N 1.342 0.249 0 CA-C-N 119.507 1.049 . . . . 75.3 111.132 175.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.65 -47.78 66.86 Favored 'General case' 0 C--N 1.339 0.145 0 C-N-CA 124.093 0.957 . . . . 74.13 109.208 171.241 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -72.75 -42.1 64.41 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-O 118.33 -0.843 . . . . 74.04 110.845 178.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -53.18 -48.01 68.37 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 118.699 0.681 . . . . 74.43 111.788 -173.385 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -75.8 -34.53 60.18 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 123.01 0.524 . . . . 73.3 110.752 -172.13 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -66.2 -48.36 70.87 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 124.83 1.252 . . . . 63.01 111.087 174.206 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 68.7 mt -65.52 -32.69 74.42 Favored 'General case' 0 N--CA 1.457 -0.077 0 C-N-CA 124.312 1.045 . . . . 65.35 111.155 -177.248 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 29.0 mt -50.39 -57.85 2.15 Favored 'Isoleucine or valine' 0 C--N 1.34 0.179 0 CA-C-O 117.976 -1.011 . . . . 75.13 108.781 168.177 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -57.74 -37.04 72.89 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 119.813 1.188 . . . . 75.3 111.552 -176.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 22.6 tptt -56.54 -38.97 72.61 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.466 0.706 . . . . 75.11 111.469 -175.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 51.3 mm-40 -90.98 -42.88 10.3 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 123.741 0.816 . . . . 73.32 111.665 176.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.95 -37.65 77.25 Favored 'General case' 0 C--N 1.333 -0.128 0 O-C-N 120.76 -1.212 . . . . 74.53 110.175 -177.033 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.432 0 C-N-CA 124.834 1.253 . . . . 72.32 111.584 178.82 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.927 0 N-CA-C 109.08 -1.608 . . . . 54.31 109.08 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 70.77 120.7 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 128.065 2.546 . . . . 75.04 110.504 170.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -128.33 4.91 5.73 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 113.883 1.068 . . . . 74.15 113.883 -161.647 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 16.1 m-85 -140.95 161.86 36.83 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 125.332 1.453 . . . . 71.33 108.234 -170.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 24.6 m -133.73 141.94 47.74 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.123 0.569 . . . . 74.01 109.564 -177.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -70.37 152.96 43.53 Favored 'General case' 0 C--O 1.235 0.316 0 O-C-N 121.477 -0.764 . . . . 75.21 109.423 173.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 73.28 -41.35 0.92 Allowed Glycine 0 CA--C 1.531 1.049 0 C-N-CA 125.877 1.703 . . . . 51.23 111.626 -164.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 17.6 tptt -74.89 -85.16 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 126.631 1.972 . . . . 74.2 110.612 -174.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.7 mp0 -77.82 -25.03 48.58 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 125.343 1.457 . . . . 73.5 110.075 -174.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 41.2 p90 -161.17 178.01 9.69 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 123.885 0.874 . . . . 73.03 109.719 -173.121 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 79.2 t -132.47 109.28 14.58 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 C-N-CA 125.074 1.35 . . . . 74.11 108.179 -179.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.22 162.63 24.56 Favored 'General case' 0 C--O 1.235 0.317 0 O-C-N 120.815 -1.178 . . . . 73.34 108.24 158.327 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -140.88 118.34 11.49 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 124.049 0.94 . . . . 74.22 109.584 -172.069 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.2 m -71.11 7.9 1.11 Allowed 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.99 1.316 . . . . 64.54 113.025 -174.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 33.0 m -134.47 82.13 46.85 Favored Pre-proline 0 N--CA 1.449 -0.505 0 C-N-CA 125.592 1.557 . . . . 74.23 109.224 173.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -75.16 -174.85 2.11 Favored 'Trans proline' 0 CA--C 1.544 1.005 0 C-N-CA 124.966 3.778 . . . . 62.22 114.011 -174.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 10.8 t -141.92 143.27 27.82 Favored Pre-proline 0 CA--C 1.545 0.788 0 C-N-CA 125.872 1.669 . . . . 74.54 109.339 168.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -90.05 178.87 2.14 Favored 'Trans proline' 0 CA--C 1.543 0.956 1 C-N-CA 125.777 4.318 . . . . 74.21 113.068 170.025 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 4.6 m -112.85 -177.7 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 C-N-CA 126.085 1.754 . . . . 74.35 110.327 171.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 12.6 t -63.12 -38.29 90.57 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 125.941 1.696 . . . . 72.21 112.05 172.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -153.53 143.49 15.34 Favored Pre-proline 0 N--CA 1.45 -0.457 0 CA-C-O 117.532 -1.223 . . . . 72.03 107.72 -179.424 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -72.62 178.0 6.82 Favored 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 122.437 2.091 . . . . 71.21 111.118 173.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 133.46 -95.85 0.29 Allowed Glycine 0 C--N 1.332 0.318 0 N-CA-C 108.456 -1.858 . . . . 73.43 108.456 174.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.28 137.73 50.97 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 107.461 -1.311 . . . . 75.11 107.461 176.592 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 33.6 mm -67.69 133.32 31.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 106.79 -1.559 . . . . 75.42 106.79 175.021 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -83.95 143.65 29.69 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.283 -0.636 . . . . 73.05 109.283 176.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 25.7 t -133.68 109.53 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.225 0 N-CA-C 106.381 -1.711 . . . . 74.13 106.381 171.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 58.6 t -96.56 115.06 34.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 N-CA-C 106.104 -1.813 . . . . 71.02 106.104 179.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -76.45 134.99 39.4 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 107.937 -1.134 . . . . 75.24 107.937 157.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.3 mp -125.95 123.23 38.09 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 125.661 1.584 . . . . 73.31 108.011 170.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 15.9 p90 -138.94 176.71 8.46 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.376 1.071 . . . . 64.34 110.816 -170.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 25.0 t90 -147.1 172.12 14.25 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.997 1.319 . . . . 75.51 107.857 177.054 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 19.7 t80 -56.01 -41.0 74.22 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 126.374 1.869 . . . . 55.5 113.129 173.115 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -92.99 -106.87 1.76 Allowed Glycine 0 N--CA 1.449 -0.483 0 N-CA-C 107.965 -2.054 . . . . 74.01 107.965 -168.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 21.1 p 44.22 72.34 1.23 Allowed Pre-proline 0 C--O 1.221 -0.419 0 C-N-CA 125.373 1.469 . . . . 74.21 112.03 175.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -58.93 -24.9 75.02 Favored 'Trans proline' 0 CA--C 1.539 0.739 0 CA-C-N 121.596 1.606 . . . . 71.53 113.419 -171.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 19.7 m170 -71.98 -33.03 67.82 Favored 'General case' 0 CA--C 1.549 0.926 0 CA-C-O 118.059 -0.972 . . . . 73.45 112.512 172.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 15.9 p -65.85 -38.33 88.57 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 120.746 1.612 . . . . 75.13 110.793 -179.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 34.8 t80 -64.56 -31.32 72.49 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 123.199 0.6 . . . . 72.25 111.657 176.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.9 -3.99 25.64 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 112.597 0.591 . . . . 71.42 112.597 174.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 26.1 t80 -117.45 -21.33 8.69 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 125.358 1.463 . . . . 74.22 111.982 -176.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -46.33 -63.52 1.29 Allowed Pre-proline 0 N--CA 1.474 0.762 0 CA-C-N 120.446 1.475 . . . . 73.43 112.432 178.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -71.93 -6.77 19.78 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 CA-C-N 121.856 1.698 . . . . 72.35 114.084 -175.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.0 m -78.95 -42.83 25.92 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.172 1.389 . . . . 73.31 108.535 169.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 20.2 tt -89.84 -36.48 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 O-C-N 121.5 -0.75 . . . . 73.21 112.035 -171.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 54.2 t -50.69 -54.24 38.12 Favored Pre-proline 0 CA--C 1.54 0.565 0 C-N-CA 124.787 1.235 . . . . 73.1 111.591 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -68.73 -36.34 14.3 Favored 'Trans proline' 0 N--CA 1.454 -0.852 0 CA-C-N 121.098 1.428 . . . . 74.34 111.416 178.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 79.2 t90 -54.75 -51.05 66.9 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 118.801 0.728 . . . . 73.31 109.486 177.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -63.16 -37.39 87.04 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 117.857 0.299 . . . . 61.45 111.292 -175.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -62.59 -48.69 78.31 Favored 'General case' 0 N--CA 1.453 -0.299 0 O-C-N 121.58 -0.7 . . . . 75.14 109.255 179.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.54 18.24 2.37 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.84 0.856 . . . . 71.41 113.087 -173.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 19.7 mt -65.02 156.34 80.88 Favored Pre-proline 0 N--CA 1.451 -0.381 0 C-N-CA 123.483 0.713 . . . . 74.42 110.355 174.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -76.06 177.13 9.14 Favored 'Trans proline' 0 N--CA 1.452 -0.917 0 C-N-CA 124.648 3.566 . . . . 71.14 111.164 177.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -67.32 -7.99 28.87 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.535 1.134 . . . . 54.3 113.371 -178.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -107.29 1.77 24.09 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 119.804 1.184 . . . . 74.5 112.369 -168.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 40.7 t -125.66 137.52 57.41 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 N-CA-C 107.835 -1.172 . . . . 74.4 107.835 -172.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 67.2 t60 -127.5 99.94 5.81 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 124.687 1.195 . . . . 72.13 109.227 -177.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 35.0 t80 -80.51 142.15 34.47 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 114.389 -1.278 . . . . 71.42 110.863 176.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 32.6 t -135.08 154.57 36.41 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 C-N-CA 126.573 1.949 . . . . 73.24 106.85 178.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 9.6 mtm180 -132.11 120.18 21.98 Favored 'General case' 0 CA--C 1.516 -0.341 0 C-N-CA 124.364 1.066 . . . . 65.25 108.479 175.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 28.9 mt -132.33 153.28 81.18 Favored Pre-proline 0 C--N 1.33 -0.279 0 O-C-N 121.903 -0.498 . . . . 75.51 110.614 -177.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -81.71 144.97 14.22 Favored 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 123.455 2.77 . . . . 73.32 112.149 -178.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -90.91 74.42 6.47 Favored 'General case' 0 CA--C 1.528 0.122 0 C-N-CA 124.221 1.008 . . . . 73.01 109.338 -171.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 15.7 mt -74.32 86.84 1.99 Allowed 'General case' 0 CA--C 1.543 0.683 0 O-C-N 121.226 -0.921 . . . . 64.14 110.96 -170.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -105.87 24.76 11.82 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.495 1.118 . . . . 70.43 112.414 -178.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 89.14 171.28 45.53 Favored Glycine 0 CA--C 1.528 0.854 0 N-CA-C 110.215 -1.154 . . . . 64.22 110.215 -175.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 46.5 -146.49 3.27 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 124.117 0.865 . . . . 73.24 113.249 177.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 6.7 tp -63.92 -18.57 22.77 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 C-N-CA 123.288 0.635 . . . . 72.54 112.544 -172.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 9.4 m95 -62.16 -44.36 96.79 Favored 'General case' 0 C--N 1.344 0.362 0 CA-C-N 119.537 1.062 . . . . 72.41 109.537 176.316 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 4.3 p30 -77.08 -39.44 49.74 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 117.858 -1.067 . . . . 72.15 111.884 178.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 56.1 t -55.83 -52.03 53.47 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-N 119.153 0.888 . . . . 72.53 109.811 -178.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 34.0 m170 -63.64 -31.94 73.26 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 118.691 -0.671 . . . . 65.23 112.808 -176.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -87.98 -12.08 66.59 Favored Glycine 0 C--N 1.335 0.515 0 CA-C-N 119.701 1.137 . . . . 64.42 111.706 -175.143 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -60.97 -43.77 98.31 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 123.662 0.785 . . . . 75.04 110.667 -173.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 3.7 ppp? -50.22 -32.96 17.9 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 125.318 1.447 . . . . 71.14 114.155 177.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -59.92 -49.52 77.37 Favored 'General case' 0 N--CA 1.458 -0.072 0 C-N-CA 125.181 1.392 . . . . 74.43 108.421 -175.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 29.2 mt -66.26 -36.54 83.27 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 124.486 1.114 . . . . 74.31 109.732 179.244 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.02 -46.86 82.6 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 120.006 1.275 . . . . 74.03 110.801 176.71 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.31 -50.79 64.22 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 125.878 1.671 . . . . 71.41 107.961 -175.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -62.12 -46.31 89.61 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.516 1.126 . . . . 73.22 111.52 174.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 7.1 t -53.3 -32.89 50.98 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 126.102 1.761 . . . . 65.41 113.941 -172.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' MET . . . . . 0.433 ' HE3' ' H ' ' A' ' 121' ' ' ASP . 8.1 ptp -81.39 -10.84 59.44 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 114.16 1.17 . . . . 72.35 114.16 179.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 93.92 50.72 2.23 Favored Glycine 0 CA--C 1.524 0.607 0 C-N-CA 126.137 1.827 . . . . 71.41 111.862 170.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 18.1 m -66.17 129.96 31.04 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 CA-C-N 118.683 1.241 . . . . 72.43 109.309 176.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -80.55 50.34 1.29 Allowed 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.014 1.326 . . . . 73.4 111.328 -179.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 37.1 m-70 57.81 36.04 26.04 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 127.034 2.134 . . . . 72.44 111.813 -176.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -60.18 103.65 0.25 Allowed 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.418 1.487 . . . . 72.41 108.567 174.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.3 t 44.02 71.91 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.809 0 C-N-CA 128.37 2.668 . . . . 74.42 113.848 166.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 12.5 t-80 -61.15 -34.98 75.87 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.594 1.158 . . . . 74.12 113.971 -177.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -61.61 -46.12 91.19 Favored 'General case' 0 CA--C 1.51 -0.582 0 C-N-CA 123.628 0.771 . . . . 71.34 111.636 177.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -66.92 -19.12 65.67 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 113.059 0.763 . . . . 60.44 113.059 -162.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 66.9 t -51.61 -70.6 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 C-N-CA 128.369 2.668 . . . . 64.02 111.063 160.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -54.27 -43.07 70.7 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 125.948 1.699 . . . . 72.43 110.977 176.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -83.63 14.86 3.5 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 126.018 1.727 . . . . 73.15 110.846 -174.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -114.76 -19.85 10.87 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 126.081 1.752 . . . . 72.5 114.604 157.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 36.9 mt -80.5 -66.71 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 N-CA-C 108.373 -0.973 . . . . 73.32 108.373 175.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -78.45 -66.96 0.79 Allowed 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 114.038 1.125 . . . . 71.13 114.038 -163.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 29.8 mtpt -50.3 -53.19 30.47 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 125.36 1.464 . . . . 73.45 109.996 177.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 22.4 mm-40 -75.68 -28.11 58.54 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 125.609 1.563 . . . . 64.34 109.426 -168.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 22.3 t-160 64.86 26.57 12.89 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 126.217 1.807 . . . . 63.31 111.358 174.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 28.2 mmtp -70.61 140.23 51.59 Favored 'General case' 0 C--N 1.342 0.251 0 O-C-N 121.1 -1.0 . . . . 75.01 109.665 177.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 19.8 tttt -56.97 -51.03 70.84 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 125.277 1.431 . . . . 73.32 111.313 -171.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 50.2 mt 47.86 35.14 4.5 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.363 1.465 . . . . 74.33 112.496 173.082 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -94.11 -7.16 43.25 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 113.941 1.089 . . . . 64.45 113.941 -169.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 17.3 p -135.98 155.23 77.86 Favored Pre-proline 0 C--O 1.235 0.308 0 CA-C-N 119.242 0.928 . . . . 71.11 109.639 -177.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -63.14 -33.61 72.03 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 122.088 1.858 . . . . 72.3 111.843 -178.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -66.32 -23.88 66.44 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 118.467 0.576 . . . . 74.5 111.974 176.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -81.77 -44.79 16.53 Favored 'General case' 0 CA--C 1.528 0.111 0 C-N-CA 123.57 0.748 . . . . 73.33 109.851 175.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 44.4 mtt -66.11 -54.55 24.24 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 123.628 0.771 . . . . 72.03 109.162 -175.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.403 ' HB3' ' HE2' ' A' ' 122' ' ' LYS . . . -68.18 -29.91 68.89 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 119.073 -0.489 . . . . 64.42 111.518 -173.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -62.21 -48.61 79.25 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 123.524 0.73 . . . . 72.24 110.464 169.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 86.8 t80 -62.4 -42.52 99.49 Favored 'General case' 0 N--CA 1.447 -0.592 0 O-C-N 122.21 -0.306 . . . . 75.41 111.725 -179.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 35.3 mt -80.89 -11.59 59.56 Favored 'General case' 0 N--CA 1.451 -0.408 0 O-C-N 121.339 -0.851 . . . . 73.02 111.071 -172.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -54.51 -37.65 65.59 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 118.082 0.401 . . . . 61.35 110.506 178.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -84.53 8.97 66.25 Favored Glycine 0 CA--C 1.528 0.857 0 C-N-CA 124.928 1.251 . . . . 63.15 114.818 175.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 52.4 mmtt -133.74 45.01 2.7 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-N 119.485 1.643 . . . . 65.13 110.256 -169.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 63.25 22.84 65.72 Favored Glycine 0 CA--C 1.53 1.022 0 CA-C-O 118.6 -1.111 . . . . 62.24 113.503 170.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 41.9 t -114.17 151.89 15.91 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 C-N-CA 127.528 2.331 . . . . 75.41 106.335 173.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . 0.433 ' H ' ' HE3' ' A' ' 84' ' ' MET . 8.0 t70 -115.67 140.56 49.08 Favored 'General case' 0 C--O 1.235 0.33 0 O-C-N 121.963 -0.461 . . . . 74.43 110.322 172.566 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.403 ' HE2' ' HB3' ' A' ' 112' ' ' ALA . 10.8 mttt -62.69 -39.97 95.67 Favored 'General case' 0 CA--C 1.527 0.061 0 CA-C-O 118.42 -0.8 . . . . 75.54 110.519 178.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 59.2 mt-10 -50.99 -52.39 43.25 Favored 'General case' 0 N--CA 1.457 -0.124 0 CA-C-N 118.888 0.767 . . . . 74.34 109.954 176.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 88.1 mttt -79.53 -42.14 25.8 Favored 'General case' 0 CA--C 1.515 -0.399 0 N-CA-C 107.075 -1.454 . . . . 74.23 107.075 -166.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 62.4 t80 -55.78 -60.32 3.62 Favored 'General case' 0 N--CA 1.443 -0.821 0 C-N-CA 123.798 0.839 . . . . 73.2 109.357 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 47.8 mt -67.2 -37.81 84.28 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-O 118.953 -0.546 . . . . 73.03 110.799 -172.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 2.9 t -64.73 -41.77 95.7 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 119.42 1.009 . . . . 72.53 110.127 -176.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 3.4 t -80.23 -31.77 38.53 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 118.839 0.745 . . . . 71.01 111.069 -179.011 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 91.0 t80 -53.45 -52.93 57.87 Favored 'General case' 0 C--O 1.234 0.268 0 O-C-N 121.294 -0.879 . . . . 73.13 109.369 170.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -86.58 56.5 4.03 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 125.205 1.402 . . . . 74.44 109.033 176.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 14.9 t -136.26 168.5 19.29 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 124.037 0.935 . . . . 74.25 110.549 176.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -69.34 -27.16 65.11 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.249 0.62 . . . . 65.11 110.053 167.288 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -51.73 -53.73 36.14 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 124.209 1.003 . . . . 71.21 111.005 -178.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 14.3 mm -65.17 -36.56 78.05 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 CA-C-O 118.763 -0.637 . . . . 74.44 110.853 177.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 22.4 mttt -57.88 -38.3 75.52 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 119.511 1.05 . . . . 75.42 110.369 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -72.2 -17.73 77.57 Favored Glycine 0 CA--C 1.528 0.86 0 N-CA-C 111.842 -0.503 . . . . 73.4 111.842 -177.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 6.9 mt-30 -88.98 -42.77 11.58 Favored 'General case' 0 N--CA 1.453 -0.276 0 O-C-N 121.542 -0.975 . . . . 71.3 110.514 174.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 91.7 mmm -58.37 -52.58 65.01 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 108.636 -0.876 . . . . 74.2 108.636 -178.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -65.85 -30.46 71.08 Favored 'General case' 0 CA--C 1.535 0.365 0 CA-C-N 119.112 0.869 . . . . 71.13 112.509 -172.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 13.5 mmtt -63.3 -68.54 0.33 Allowed 'General case' 0 C--O 1.227 -0.083 0 C-N-CA 126.081 1.752 . . . . 73.32 109.606 171.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -54.73 -36.27 64.59 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 119.218 0.917 . . . . 62.23 111.208 -174.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -54.57 -66.14 0.45 Allowed 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 126.374 1.87 . . . . 70.21 110.949 172.176 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.69 -31.51 72.23 Favored 'General case' 0 N--CA 1.466 0.33 0 O-C-N 121.433 -0.792 . . . . 74.33 111.142 -174.233 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 49.2 mt -60.11 -54.29 47.67 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 123.968 0.907 . . . . 65.21 109.778 178.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -54.13 -42.14 69.17 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 118.842 0.746 . . . . 74.22 111.341 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -64.25 -43.51 94.68 Favored 'General case' 0 C--O 1.235 0.336 0 O-C-N 121.499 -0.751 . . . . 73.33 111.229 178.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -63.35 -40.17 96.55 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 123.72 0.808 . . . . 73.43 110.383 -179.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 52.8 m-85 -72.78 11.92 0.59 Allowed 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 114.181 1.178 . . . . 74.53 114.181 -178.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 55.59 27.81 11.0 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.295 1.438 . . . . 75.15 113.347 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 40.8 t -64.02 -47.78 88.89 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 C-N-CA 124.995 1.318 . . . . 74.51 112.791 -168.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 82.0 p 55.0 -54.51 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 128.713 2.805 . . . . 74.43 114.82 -166.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -146.94 -166.76 12.55 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 127.161 2.315 . . . . 53.44 110.506 -173.28 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 29.1 m -143.83 155.12 59.54 Favored Pre-proline 0 C--O 1.239 0.551 0 C-N-CA 125.47 1.508 . . . . 73.31 108.779 -172.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -68.81 145.38 77.12 Favored 'Cis proline' 0 C--N 1.345 0.359 0 C-N-CA 125.055 -0.81 . . . . 74.02 113.918 0.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 37.8 m -149.43 127.94 12.31 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 125.431 1.493 . . . . 74.45 107.533 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 20.2 mmm -115.26 148.46 39.13 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 125.561 1.544 . . . . 74.23 107.916 172.126 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 49.9 t -138.96 115.38 10.09 Favored 'Isoleucine or valine' 0 C--O 1.238 0.482 0 N-CA-C 109.571 -0.529 . . . . 75.04 109.571 -177.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 95.2 t -84.48 127.23 40.03 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 N-CA-C 107.764 -1.198 . . . . 73.41 107.764 170.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 6.1 t30 49.34 26.15 1.5 Allowed 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 130.128 3.371 . . . . 74.1 115.243 165.306 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 56.8 28.77 57.71 Favored Glycine 0 CA--C 1.527 0.825 0 C-N-CA 126.311 1.91 . . . . 52.1 114.172 -172.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 6.1 mtpt -131.72 -22.33 2.4 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 120.08 1.94 . . . . 73.11 112.916 -179.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -128.08 126.75 41.81 Favored 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 107.954 -1.128 . . . . 75.44 107.954 179.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 9.2 ttp85 -109.27 134.29 51.96 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 127.187 2.195 . . . . 71.15 105.643 176.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 11.8 p90 -152.26 167.55 28.25 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.675 -0.861 . . . . 74.33 108.675 -178.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -175.9 177.8 1.59 Allowed 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.655 1.182 . . . . 73.23 109.903 -179.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 10.8 mt -47.1 -47.7 8.72 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.131 0 C-N-CA 127.145 2.178 . . . . 64.15 109.394 176.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -80.86 -8.89 86.97 Favored Glycine 0 N--CA 1.448 -0.556 0 CA-C-O 118.092 -1.393 . . . . 52.45 113.715 -177.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 1.2 m -82.94 -65.79 0.97 Allowed 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 119.743 1.771 . . . . 73.21 107.504 164.032 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -59.51 -54.85 41.8 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 124.388 1.075 . . . . 71.3 109.774 -168.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 140.58 -8.45 2.84 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 124.764 1.173 . . . . 72.01 114.106 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 171.38 167.08 31.13 Favored Glycine 0 CA--C 1.526 0.73 0 CA-C-N 119.598 1.699 . . . . 72.11 109.401 -174.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_endo -64.5 -45.36 9.28 Favored 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 122.902 2.401 . . . . 72.12 111.518 -173.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -65.12 -25.55 67.81 Favored 'General case' 0 CA--C 1.537 0.445 0 O-C-N 121.32 -0.862 . . . . 74.3 111.536 174.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -77.07 -28.28 54.6 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.745 0.818 . . . . 72.01 111.021 177.147 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 93.4 m -60.12 -45.51 92.75 Favored 'General case' 0 N--CA 1.464 0.235 0 O-C-N 120.581 -1.324 . . . . 63.22 109.854 178.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 52.5 mt -62.09 -31.83 72.31 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 118.028 0.376 . . . . 75.12 110.622 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 14.2 ttpt -55.8 -40.16 72.31 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 124.131 0.973 . . . . 75.42 110.07 174.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -75.05 -44.82 45.47 Favored 'General case' 0 CA--C 1.509 -0.614 0 CA-C-O 117.876 -1.059 . . . . 73.3 111.196 173.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -51.66 -47.45 63.8 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 119.048 0.84 . . . . 72.31 111.75 -172.019 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -68.91 -47.48 65.71 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.209 1.004 . . . . 73.53 110.524 -175.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -55.17 -49.35 72.08 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 125.301 1.441 . . . . 73.41 111.164 175.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 77.5 mt -66.11 -34.78 78.83 Favored 'General case' 0 C--O 1.232 0.14 0 C-N-CA 124.617 1.167 . . . . 74.45 111.583 -178.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 28.8 mt -60.5 -54.52 33.95 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.143 0 N-CA-C 107.845 -1.169 . . . . 64.44 107.845 173.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -53.36 -42.33 66.72 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 119.271 0.941 . . . . 73.33 111.042 -179.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 42.9 tptt -59.96 -37.0 78.32 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 126.296 1.838 . . . . 75.33 111.881 -177.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 34.7 mm-40 -90.44 -31.34 16.85 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.562 1.145 . . . . 75.21 111.784 177.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . 0.505 ' HA ' ' HE ' ' A' ' 187' ' ' ARG . 1.4 tpm_? -61.18 -37.96 84.81 Favored 'General case' 0 CA--C 1.514 -0.419 0 O-C-N 120.439 -1.413 . . . . 74.42 110.071 178.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -49.31 -36.29 20.55 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 127.856 2.462 . . . . 65.43 110.975 173.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -56.86 -34.67 68.06 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-O 118.896 -0.574 . . . . 72.34 110.777 -175.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -134.32 57.49 1.8 Allowed 'General case' 0 C--O 1.235 0.291 0 CA-C-N 118.213 0.46 . . . . 74.3 110.914 -178.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 59.3 tttt -115.13 38.29 3.24 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 127.05 2.14 . . . . 74.42 111.638 -170.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 5.6 tttp . . . . . 0 C--O 1.246 0.884 0 CA-C-O 116.641 -1.647 . . . . 74.13 112.357 -168.775 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.658 0 N-CA-C 107.852 -2.099 . . . . 75.24 107.852 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 75.74 135.48 0.06 Allowed 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 127.898 2.479 . . . . 75.31 111.234 165.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -131.66 6.86 4.41 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.455 1.102 . . . . 73.21 111.866 -177.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 34.0 m-85 -130.35 160.62 33.42 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 124.104 0.962 . . . . 71.21 110.006 -169.104 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 59.7 m -137.07 133.27 35.22 Favored 'General case' 0 C--O 1.239 0.541 0 N-CA-C 107.04 -1.467 . . . . 75.24 107.04 179.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.26 146.62 54.71 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 109.101 -0.703 . . . . 74.32 109.101 174.003 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 79.92 -35.13 2.11 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 126.332 1.92 . . . . 75.11 112.081 -170.023 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 21.4 tptt -77.54 -63.92 1.27 Allowed 'General case' 0 CA--C 1.518 -0.279 0 C-N-CA 124.687 1.195 . . . . 74.24 110.456 -176.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -98.16 -26.15 14.66 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 125.002 1.321 . . . . 61.33 109.362 -171.171 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 45.0 p90 -157.96 174.96 14.46 Favored 'General case' 0 N--CA 1.468 0.429 0 O-C-N 121.55 -0.719 . . . . 72.53 110.625 -172.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 48.7 t -132.72 106.9 11.25 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 N-CA-C 107.548 -1.279 . . . . 71.14 107.548 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 13.4 tt0 -64.81 147.94 52.24 Favored 'General case' 0 N--CA 1.445 -0.693 0 O-C-N 120.111 -1.618 . . . . 72.42 109.209 165.419 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -110.55 103.96 12.62 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.252 -1.34 . . . . 75.13 110.005 -178.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 79.6 p -65.0 5.85 0.3 Allowed 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 114.521 1.304 . . . . 64.23 114.521 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 8.8 t -128.37 85.28 60.85 Favored Pre-proline 0 N--CA 1.449 -0.479 0 N-CA-C 105.975 -1.861 . . . . 71.45 105.975 159.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -72.34 178.91 5.55 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 123.608 2.872 . . . . 73.51 111.097 -176.157 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 10.9 t -142.99 137.47 14.95 Favored Pre-proline 0 CA--C 1.539 0.521 0 C-N-CA 124.029 0.932 . . . . 64.35 109.186 -176.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -79.37 -178.52 4.66 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 C-N-CA 124.53 3.487 . . . . 75.22 111.703 175.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 29.6 m -132.29 166.23 29.77 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 125.798 1.639 . . . . 74.15 109.009 168.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 5.2 m -44.92 -49.66 10.91 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 127.138 2.175 . . . . 62.33 113.304 178.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 36.4 tt0 -145.62 144.38 22.45 Favored Pre-proline 0 CA--C 1.539 0.521 0 C-N-CA 124.588 1.155 . . . . 72.44 108.766 176.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -70.55 -167.49 0.26 Allowed 'Trans proline' 0 CA--C 1.544 0.976 0 C-N-CA 123.452 2.768 . . . . 74.24 110.455 164.142 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 120.26 -65.35 0.44 Allowed Glycine 0 C--N 1.333 0.395 0 N-CA-C 109.007 -1.637 . . . . 64.12 109.007 177.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -103.55 146.7 28.16 Favored 'General case' 0 C--O 1.232 0.132 0 C-N-CA 125.352 1.461 . . . . 74.22 108.899 170.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 49.5 mm -68.69 139.68 20.18 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 N-CA-C 106.247 -1.76 . . . . 74.43 106.247 173.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -94.81 104.14 16.04 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 106.913 -1.514 . . . . 54.13 106.913 175.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 55.2 t -102.99 128.53 55.82 Favored 'Isoleucine or valine' 0 C--O 1.231 0.089 0 N-CA-C 106.482 -1.673 . . . . 73.14 106.482 173.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 17.6 t -133.73 118.99 31.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 N-CA-C 107.717 -1.216 . . . . 73.14 107.717 -173.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -87.86 144.77 26.41 Favored 'General case' 0 C--O 1.238 0.478 0 N-CA-C 107.737 -1.208 . . . . 74.32 107.737 160.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.9 mp -124.34 125.06 43.71 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 125.042 1.337 . . . . 73.54 108.235 174.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -115.11 175.95 5.28 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.564 0.746 . . . . 72.42 112.717 -169.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 25.3 t90 -148.29 -178.54 6.36 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 126.526 1.93 . . . . 73.22 108.235 168.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 4.0 m-30 -104.86 4.3 31.92 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 126.912 2.085 . . . . 72.11 112.377 179.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -129.6 18.74 5.39 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 124.689 1.137 . . . . 63.22 111.242 -178.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 21.9 p -105.03 85.59 1.3 Allowed Pre-proline 0 N--CA 1.449 -0.511 0 C-N-CA 125.11 1.364 . . . . 72.54 108.587 -177.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -59.82 -24.93 77.76 Favored 'Trans proline' 0 CA--C 1.535 0.558 0 CA-C-N 120.833 1.333 . . . . 64.24 112.291 -175.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 14.1 m170 -74.57 -15.31 60.85 Favored 'General case' 0 CA--C 1.538 0.489 0 O-C-N 121.233 -0.917 . . . . 75.52 112.403 178.039 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 71.5 m -62.25 -43.61 98.43 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 119.356 0.98 . . . . 72.21 108.815 167.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -57.28 -44.84 84.38 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 125.125 1.37 . . . . 74.25 111.013 175.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.37 -10.49 11.46 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 114.005 1.113 . . . . 62.32 114.005 -179.269 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 6.2 t80 -119.51 -25.54 5.99 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-O 117.221 -1.371 . . . . 74.22 112.537 -169.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -37.86 -67.5 0.25 Allowed Pre-proline 0 N--CA 1.472 0.659 0 C-N-CA 125.902 1.681 . . . . 74.11 113.378 179.078 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -70.84 -5.48 16.99 Favored 'Trans proline' 0 CA--C 1.537 0.639 0 CA-C-N 121.249 1.482 . . . . 74.13 114.067 -173.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.9 m -103.75 4.47 35.27 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 128.501 2.72 . . . . 74.43 110.647 177.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 16.8 tt -131.32 -30.52 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-N 120.406 1.457 . . . . 75.12 111.74 171.271 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 18.3 t -45.69 -64.87 0.77 Allowed Pre-proline 0 CA--C 1.537 0.464 0 C-N-CA 125.096 1.358 . . . . 74.52 110.168 173.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -69.33 -28.86 26.82 Favored 'Trans proline' 0 N--CA 1.451 -0.972 0 CA-C-N 120.791 1.318 . . . . 73.13 111.029 -172.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 70.7 t90 -59.2 -53.29 60.0 Favored 'General case' 0 C--N 1.341 0.198 0 CA-C-N 119.093 0.861 . . . . 74.11 109.581 174.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 90.6 p -58.77 -39.75 81.95 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 122.244 0.218 . . . . 61.12 111.07 -176.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -70.93 -12.94 61.83 Favored 'General case' 0 CA--C 1.54 0.587 0 O-C-N 121.154 -0.966 . . . . 73.25 112.874 178.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 68.4 mmtt -103.76 -2.03 27.05 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 125.771 1.628 . . . . 64.34 114.154 175.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 18.4 mt -54.93 147.68 31.74 Favored Pre-proline 0 N--CA 1.452 -0.327 0 CA-C-N 119.714 1.143 . . . . 63.12 110.997 -178.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -74.46 164.89 32.95 Favored 'Trans proline' 0 N--CA 1.439 -1.696 0 C-N-CA 123.346 2.698 . . . . 54.03 109.82 -176.161 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -65.43 1.02 1.26 Allowed 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.03 1.332 . . . . 64.33 114.009 178.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -98.73 0.09 43.83 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 127.965 2.506 . . . . 61.45 112.107 -179.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 57.5 t -131.81 157.09 43.08 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 C-N-CA 124.518 1.127 . . . . 75.52 108.569 -169.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 78.9 t60 -132.64 138.89 47.51 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 107.499 -1.297 . . . . 75.11 107.499 162.061 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 73.4 t80 -106.0 144.13 33.15 Favored 'General case' 0 CA--C 1.519 -0.224 0 N-CA-C 107.915 -1.143 . . . . 75.14 107.915 179.095 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 48.6 t -136.86 148.83 26.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 N-CA-C 108.239 -1.022 . . . . 73.12 108.239 178.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 23.1 mtt180 -115.47 128.08 55.77 Favored 'General case' 0 CA--C 1.513 -0.467 0 N-CA-C 105.867 -1.901 . . . . 73.25 105.867 165.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 23.5 mt -128.41 149.95 73.0 Favored Pre-proline 0 N--CA 1.467 0.391 0 CA-C-N 118.616 0.644 . . . . 73.43 111.173 170.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -78.29 129.62 9.62 Favored 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 122.482 2.122 . . . . 72.15 111.363 178.058 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -76.74 120.33 21.76 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.971 1.308 . . . . 72.13 110.179 174.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 47.7 mt -107.62 56.93 0.63 Allowed 'General case' 0 C--O 1.232 0.146 0 O-C-N 121.026 -1.046 . . . . 72.32 113.456 -167.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -77.33 53.26 1.01 Allowed 'General case' 0 CA--C 1.548 0.869 0 N-CA-C 113.456 0.91 . . . . 72.11 113.456 -176.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 80.29 -54.28 4.52 Favored Glycine 0 CA--C 1.53 1.02 0 C-N-CA 126.693 2.092 . . . . 63.41 114.486 155.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -82.52 -150.98 9.27 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 125.639 1.59 . . . . 62.21 110.377 172.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 9.7 tp -50.29 -19.88 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 C-N-CA 126.648 1.979 . . . . 72.22 113.604 -172.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 28.1 m95 -49.42 -52.93 25.53 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 125.484 1.513 . . . . 75.14 112.16 173.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 20.0 p30 -75.22 -29.58 60.31 Favored 'General case' 0 CA--C 1.522 -0.118 0 N-CA-C 112.288 0.477 . . . . 62.11 112.288 -178.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 81.5 t -61.32 -50.48 80.26 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.33 0 N-CA-C 107.809 -1.182 . . . . 73.55 107.809 174.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 60.8 m170 -70.44 14.63 0.12 Allowed 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 125.714 1.605 . . . . 72.22 113.004 173.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -129.58 -33.37 0.53 Allowed Glycine 0 CA--C 1.528 0.845 0 O-C-N 119.914 -1.741 . . . . 65.22 113.352 -173.086 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -64.71 -36.42 84.23 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 117.961 0.88 . . . . 72.53 111.073 -176.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -60.1 -45.04 94.28 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-O 116.37 -1.776 . . . . 71.22 112.126 179.644 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 25.9 t80 -52.22 -48.99 64.81 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 120.33 1.423 . . . . 71.42 109.935 -176.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 13.3 mt -67.04 -37.49 84.2 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 118.234 -0.889 . . . . 71.13 109.486 -178.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.3 m -63.74 -39.57 94.62 Favored 'General case' 0 C--N 1.342 0.253 0 CA-C-N 119.756 1.162 . . . . 72.22 111.407 174.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -60.4 -54.02 50.59 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 125.44 1.496 . . . . 74.13 107.035 -179.447 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.406 ' HA ' ' CG1' ' A' ' 86' ' ' VAL . 3.2 mt-10 -63.69 -31.41 72.57 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 112.592 0.59 . . . . 74.34 112.592 178.316 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.9 t -54.5 -19.15 5.25 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 118.003 -0.998 . . . . 71.33 112.288 171.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 9.1 mtp -107.25 -9.69 16.02 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 115.33 1.604 . . . . 75.34 115.33 -174.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 105.7 -11.5 46.07 Favored Glycine 0 CA--C 1.525 0.717 0 CA-C-O 118.116 -1.38 . . . . 43.23 113.025 175.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.406 ' CG1' ' HA ' ' A' ' 82' ' ' GLU . 6.2 p 44.13 82.37 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 C-N-CA 125.904 1.682 . . . . 71.11 115.02 151.134 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -46.83 117.59 1.73 Allowed 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 126.166 1.786 . . . . 73.33 110.225 177.436 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 20.2 m-70 -59.41 -24.72 63.7 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 116.079 -0.509 . . . . 72.52 110.979 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -60.56 -10.49 5.17 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.603 1.161 . . . . 51.34 113.271 176.341 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 33.2 m -121.69 2.67 6.38 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 CA-C-N 120.773 1.624 . . . . 55.51 113.438 178.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -57.65 -20.8 35.95 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 115.52 1.674 . . . . 73.35 115.52 -172.203 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -86.61 -56.04 3.6 Favored 'General case' 0 CA--C 1.513 -0.472 0 C-N-CA 124.37 1.068 . . . . 75.41 109.432 172.092 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -49.69 -30.96 10.08 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.433 1.093 . . . . 54.41 112.971 -171.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 70.2 t -54.58 -61.58 0.96 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.841 0 C-N-CA 123.925 0.89 . . . . 60.23 111.157 171.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -71.99 -35.23 69.41 Favored 'General case' 0 N--CA 1.473 0.693 0 O-C-N 119.966 -1.709 . . . . 75.53 111.785 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -67.73 -12.31 60.25 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.003 0.921 . . . . 72.41 111.46 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -84.46 -16.57 42.07 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.259 1.024 . . . . 73.11 111.547 173.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 10.0 mm -96.16 -37.14 7.04 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 C-N-CA 124.546 1.138 . . . . 72.32 110.243 -176.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 88.1 m-70 -103.74 -64.78 1.06 Allowed 'General case' 0 C--O 1.233 0.21 0 C-N-CA 122.838 0.455 . . . . 73.44 110.667 -169.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 21.3 mtpt -63.26 -15.94 58.72 Favored 'General case' 0 N--CA 1.464 0.27 0 O-C-N 121.876 -0.515 . . . . 75.42 111.309 177.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -123.83 -58.41 1.58 Allowed 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.565 1.146 . . . . 73.41 112.4 -173.015 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 2.4 t60 63.94 62.53 0.88 Allowed 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.749 1.62 . . . . 71.32 112.448 -176.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 7.8 mmmt -77.91 22.51 0.28 Allowed 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 127.628 2.371 . . . . 72.43 113.916 -178.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 18.0 ttpp 46.53 40.29 8.02 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 126.309 1.844 . . . . 62.11 111.669 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 40.3 mt -72.67 59.51 0.46 Allowed 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 129.61 3.164 . . . . 63.14 109.313 178.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -106.42 10.98 31.32 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 128.386 2.674 . . . . 75.43 111.429 -172.252 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -150.75 157.4 35.97 Favored Pre-proline 0 C--N 1.328 -0.335 0 C-N-CA 124.645 1.178 . . . . 74.41 109.497 -175.786 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -66.14 -42.43 10.8 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 121.905 1.737 . . . . 72.21 109.973 -175.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -55.98 -53.56 55.38 Favored 'General case' 0 N--CA 1.437 -1.098 0 C-N-CA 124.011 0.924 . . . . 74.52 111.86 173.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 24.0 tp10 -62.35 -41.19 98.39 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 118.206 0.457 . . . . 73.51 109.988 -175.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 38.5 mtt -60.65 -51.05 71.05 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 123.056 0.542 . . . . 64.15 110.335 175.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -61.71 -44.0 97.76 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 124.678 1.191 . . . . 74.43 110.329 -177.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -66.57 -4.93 9.66 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.624 1.57 . . . . 75.53 112.414 177.769 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -95.54 -54.76 3.26 Favored 'General case' 0 C--O 1.234 0.266 0 O-C-N 120.061 -1.649 . . . . 65.42 109.669 163.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 33.7 mt -65.37 -15.4 62.53 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 124.123 0.969 . . . . 74.21 112.066 -172.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -57.92 -16.81 13.35 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.078 0.951 . . . . 73.41 111.805 172.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -105.84 8.07 42.43 Favored Glycine 0 CA--C 1.531 1.043 0 C-N-CA 125.304 1.431 . . . . 71.12 114.43 171.013 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 30.1 mmtm -134.88 42.05 2.82 Favored 'General case' 0 C--O 1.225 -0.221 0 CA-C-N 119.751 1.776 . . . . 74.34 109.046 -172.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 70.49 42.09 64.85 Favored Glycine 0 C--N 1.336 0.541 0 N-CA-C 111.901 -0.48 . . . . 74.11 111.901 169.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 65.9 t -134.0 115.18 20.73 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 CA-C-O 122.601 1.191 . . . . 71.14 108.869 178.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 49.9 t0 -67.99 123.69 21.33 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 115.164 -0.926 . . . . 75.33 109.926 166.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 5.2 ttmt -62.51 -35.35 79.11 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 122.895 0.478 . . . . 75.15 110.233 175.088 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 61.7 mm-40 -64.76 -22.03 66.89 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 123.548 0.739 . . . . 75.32 111.69 179.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 67.9 mmtt -91.25 -53.28 4.42 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 107.937 -1.134 . . . . 75.41 107.937 176.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -47.39 -69.45 0.13 Allowed 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 126.348 1.859 . . . . 75.12 111.399 -175.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 15.5 mt -63.51 -41.45 98.51 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 118.655 0.661 . . . . 71.12 110.409 -167.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 35.3 t -59.87 -54.2 49.0 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 125.368 1.467 . . . . 74.14 109.549 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 30.2 m -64.57 -40.02 94.8 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.426 1.09 . . . . 62.24 109.72 -175.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -57.03 -47.48 80.81 Favored 'General case' 0 C--O 1.231 0.108 0 C-N-CA 124.293 1.037 . . . . 71.14 108.952 176.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -84.7 29.43 0.61 Allowed 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 126.685 1.994 . . . . 62.41 111.771 -177.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 3.2 t -115.14 165.92 12.39 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 124.573 1.149 . . . . 75.41 111.072 -171.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -59.77 -33.38 71.62 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.509 1.124 . . . . 65.41 110.769 170.294 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -52.84 -54.56 32.58 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 124.562 1.145 . . . . 75.45 111.258 -176.13 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 48.3 mm -74.92 -25.82 18.87 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 CA-C-O 119.226 -0.416 . . . . 73.21 110.393 -175.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 12.8 tttt -53.78 -41.42 67.2 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 124.386 1.074 . . . . 72.22 109.813 170.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -67.99 -22.33 74.0 Favored Glycine 0 CA--C 1.528 0.854 0 C-N-CA 124.205 0.907 . . . . 64.41 113.549 -178.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -88.85 -43.22 11.37 Favored 'General case' 0 N--CA 1.455 -0.182 0 O-C-N 121.421 -1.046 . . . . 72.34 109.357 174.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 4.2 mtp -57.38 -41.53 80.39 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 112.836 0.68 . . . . 72.42 112.836 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 22.9 pt-20 -60.28 -49.28 78.23 Favored 'General case' 0 C--O 1.233 0.205 0 O-C-N 121.95 -0.469 . . . . 73.35 111.171 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 76.1 mttt -60.64 -59.11 5.92 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 124.12 0.968 . . . . 61.24 108.603 178.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -53.13 -41.41 65.05 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 118.87 -0.586 . . . . 64.13 111.522 -174.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 26.8 ttmt -64.83 -59.9 3.68 Favored 'General case' 0 C--N 1.344 0.334 0 CA-C-N 119.015 0.825 . . . . 73.52 109.932 -179.365 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.39 -28.91 70.11 Favored 'General case' 0 C--N 1.343 0.308 0 CA-C-N 118.612 0.642 . . . . 71.23 110.746 -174.056 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 52.1 mt -68.52 -52.16 35.11 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-O 118.675 -0.679 . . . . 73.12 110.606 177.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -55.78 -50.42 70.51 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 118.97 0.804 . . . . 73.43 111.437 -175.093 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -59.13 -47.59 84.73 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 118.938 -0.554 . . . . 61.14 111.776 176.814 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -71.42 -21.25 62.01 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 119.303 0.956 . . . . 65.12 111.589 -174.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 21.5 m-85 -77.93 10.84 2.54 Favored 'General case' 0 CA--C 1.541 0.609 0 O-C-N 121.002 -1.061 . . . . 75.24 112.564 170.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 53.62 34.05 17.85 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 126.778 2.031 . . . . 72.42 112.534 -177.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 34.8 t -75.72 141.85 15.26 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 N-CA-C 107.415 -1.328 . . . . 74.31 107.415 174.184 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -135.69 -4.02 2.29 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 124.452 1.101 . . . . 65.43 112.621 170.619 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -160.48 177.54 36.86 Favored Glycine 0 N--CA 1.448 -0.501 0 N-CA-C 109.843 -1.303 . . . . 74.34 109.843 -176.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.425 ' HA ' ' C ' ' A' ' 154' ' ' PRO . 23.7 m -145.26 149.22 40.69 Favored Pre-proline 0 C--O 1.238 0.487 0 C-N-CA 124.336 1.054 . . . . 73.24 108.974 -179.439 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . 0.425 ' C ' ' HA ' ' A' ' 153' ' ' VAL . 41.0 Cg_endo -67.64 153.87 86.52 Favored 'Cis proline' 0 C--O 1.237 0.447 0 C-N-CA 125.195 -0.752 . . . . 73.22 112.728 0.325 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 55.0 m -150.7 127.54 11.0 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 125.305 1.442 . . . . 71.32 107.367 177.357 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 91.1 mtp -105.42 157.85 17.06 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-O 122.171 0.986 . . . . 73.53 109.161 168.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 21.4 t -141.01 149.64 20.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 106.858 -1.534 . . . . 73.24 106.858 177.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 41.4 t -122.62 123.56 68.69 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 C-N-CA 125.958 1.703 . . . . 65.22 106.648 172.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 56.48 16.51 2.52 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 127.37 2.268 . . . . 75.33 114.782 167.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 60.81 33.89 84.86 Favored Glycine 0 CA--C 1.528 0.889 0 CA-C-O 118.205 -1.331 . . . . 74.53 113.867 -169.117 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 61.9 mttt -132.04 -33.31 1.35 Allowed 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 119.457 1.629 . . . . 73.11 113.262 -177.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -122.63 122.61 39.23 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 107.444 -1.317 . . . . 73.41 107.444 -178.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 35.9 ttp180 -103.33 137.73 41.06 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 104.805 -2.295 . . . . 73.14 104.805 170.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 21.1 p90 -152.65 162.24 41.51 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 107.075 -1.454 . . . . 73.25 107.075 176.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -171.08 176.55 3.96 Favored 'General case' 0 CA--C 1.514 -0.426 0 N-CA-C 109.235 -0.654 . . . . 61.43 109.235 -178.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 40.5 mt -47.78 -49.45 10.55 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 C-N-CA 126.881 2.072 . . . . 75.23 110.34 -177.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -84.51 0.14 89.28 Favored Glycine 0 CA--C 1.522 0.525 0 CA-C-O 118.788 -1.007 . . . . 52.22 113.767 -177.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 10.5 m -90.85 -66.27 0.94 Allowed 'General case' 0 N--CA 1.456 -0.157 0 CA-C-N 119.872 1.836 . . . . 73.15 107.179 161.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -70.13 -30.5 67.7 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-O 117.446 -1.264 . . . . 72.42 113.154 -161.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 129.86 22.09 1.18 Allowed Glycine 0 CA--C 1.538 1.51 0 N-CA-C 116.247 1.259 . . . . 62.41 116.247 171.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 113.12 164.28 15.89 Favored Glycine 0 CA--C 1.532 1.113 0 CA-C-N 120.028 1.914 . . . . 72.32 110.249 -176.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -63.23 -32.06 73.89 Favored 'Trans proline' 0 CA--C 1.536 0.622 0 CA-C-N 120.53 2.165 . . . . 75.32 113.816 -156.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 80.9 mt-10 -71.64 -29.94 65.2 Favored 'General case' 0 C--O 1.232 0.184 0 O-C-N 121.004 -1.06 . . . . 61.31 111.559 176.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -72.99 -24.79 60.81 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 122.773 0.429 . . . . 64.33 110.613 173.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 3.1 m -65.24 -45.57 84.08 Favored 'General case' 0 C--O 1.233 0.217 0 O-C-N 121.014 -1.054 . . . . 72.15 109.296 -175.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 39.8 mt -60.56 -33.42 72.67 Favored 'General case' 0 C--O 1.225 -0.213 0 CA-C-N 118.235 0.47 . . . . 65.22 111.206 175.214 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 10.3 tttt -58.05 -35.14 70.9 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-O 118.091 -0.956 . . . . 73.53 110.207 179.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -78.94 -44.89 21.6 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-N 119.359 0.982 . . . . 75.32 110.299 171.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -55.38 -31.49 61.85 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 118.604 0.638 . . . . 65.41 112.649 -175.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -90.61 -44.41 9.55 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 124.699 1.199 . . . . 54.21 109.41 -171.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 25.5 t80 -61.18 -49.21 78.12 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 121.382 0.611 . . . . 73.11 110.604 175.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 89.7 mt -63.07 -21.29 66.07 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 123.879 0.871 . . . . 74.31 112.491 -174.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 28.4 mt -57.36 -59.32 3.37 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.306 0 N-CA-C 107.395 -1.335 . . . . 72.14 107.395 168.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -56.52 -38.55 71.98 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 120.083 1.311 . . . . 73.42 111.618 -177.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 2.7 tmtt? -59.39 -39.82 84.6 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.249 0.619 . . . . 73.34 110.457 -178.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -89.05 -31.14 18.2 Favored 'General case' 0 CA--C 1.517 -0.301 0 O-C-N 121.424 -0.798 . . . . 73.22 112.75 177.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -60.55 -35.89 77.14 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.741 0.781 . . . . 74.25 111.039 -177.537 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -69.42 -10.09 56.44 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 123.719 0.808 . . . . 52.41 112.636 176.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -64.65 -47.26 79.14 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 119.921 1.237 . . . . 54.01 109.765 169.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -75.75 -39.29 57.42 Favored 'General case' 0 CA--C 1.528 0.101 0 O-C-N 123.684 0.615 . . . . 61.24 110.233 176.065 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 53.74 78.06 0.16 Allowed 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 126.391 1.877 . . . . 74.53 111.114 -177.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.245 0.834 0 C-N-CA 125.526 1.53 . . . . 73.11 110.696 -173.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.508 -0.356 0 N-CA-C 109.129 -1.588 . . . . 63.34 109.129 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -138.04 152.23 48.63 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 107.3 -1.37 . . . . 61.45 107.3 151.16 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 27.3 t0 -141.9 15.41 2.11 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 125.991 1.716 . . . . 71.32 110.023 -178.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 -155.34 153.22 30.17 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 126.581 1.953 . . . . 74.41 108.086 -173.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 74.7 m -128.25 144.59 51.14 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 121.337 0.589 . . . . 74.2 110.02 -172.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -70.1 144.42 52.1 Favored 'General case' 0 N--CA 1.456 -0.127 0 O-C-N 121.375 -0.828 . . . . 61.42 109.196 -179.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 67.44 -15.17 0.44 Allowed Glycine 0 CA--C 1.532 1.14 0 C-N-CA 126.05 1.786 . . . . 63.14 113.45 -167.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -94.54 -60.25 1.75 Allowed 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 125.218 1.407 . . . . 74.52 107.594 -171.104 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -106.57 -25.59 11.75 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 126.423 1.889 . . . . 75.01 110.18 -177.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 41.1 p90 -153.48 170.15 21.45 Favored 'General case' 0 C--N 1.332 -0.164 0 O-C-N 120.895 -1.128 . . . . 75.12 110.266 -171.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 26.8 t -128.93 103.42 9.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 107.158 -1.423 . . . . 73.44 107.158 -176.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -80.78 169.85 17.06 Favored 'General case' 0 C--O 1.237 0.446 0 O-C-N 119.243 -2.161 . . . . 75.43 109.672 174.705 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -127.59 110.88 13.14 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 107.543 -1.28 . . . . 75.45 107.543 -177.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -60.33 -14.27 17.51 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.824 1.649 . . . . 72.41 112.814 175.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 4.0 p -109.52 85.06 3.44 Favored Pre-proline 0 N--CA 1.451 -0.39 0 N-CA-C 107.618 -1.253 . . . . 74.35 107.618 166.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -67.52 179.35 2.6 Favored 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 122.479 2.119 . . . . 74.23 111.038 178.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 31.0 t -134.47 139.57 33.1 Favored Pre-proline 0 CA--C 1.536 0.425 0 N-CA-C 107.55 -1.278 . . . . 73.33 107.55 -178.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -75.58 177.25 8.92 Favored 'Trans proline' 0 CA--C 1.536 0.588 0 C-N-CA 122.937 2.425 . . . . 73.41 110.577 173.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 35.4 m -139.86 166.85 20.01 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 C-N-CA 123.426 0.69 . . . . 61.11 110.859 179.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 3.4 t -54.43 -60.1 3.8 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 126.26 1.824 . . . . 71.43 110.027 172.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 4.1 tp-100 -120.71 84.97 38.23 Favored Pre-proline 0 N--CA 1.454 -0.243 0 C-N-CA 125.335 1.454 . . . . 74.25 108.316 -163.155 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -67.75 -8.71 23.22 Favored 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 122.18 1.92 . . . . 75.3 112.183 177.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -61.21 -25.59 64.83 Favored Glycine 0 CA--C 1.53 1.022 0 O-C-N 120.848 -1.157 . . . . 65.23 112.118 168.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 56.2 mttm -125.66 150.87 47.24 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-N 119.391 1.595 . . . . 73.03 109.39 -179.157 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 51.2 mm -78.09 127.62 38.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 106.28 -1.748 . . . . 75.15 106.28 177.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -91.24 118.71 30.71 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 107.716 -1.216 . . . . 64.03 107.716 -174.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 42.1 t -120.42 115.94 48.67 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 N-CA-C 106.985 -1.487 . . . . 65.43 106.985 -178.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 16.8 t -124.48 103.59 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 N-CA-C 107.642 -1.244 . . . . 71.14 107.642 -163.299 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -67.67 135.83 53.4 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 125.48 1.512 . . . . 74.31 108.594 164.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.0 mp -119.85 125.61 48.94 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 124.741 1.216 . . . . 75.25 107.72 160.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -130.77 164.27 25.49 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.086 0.954 . . . . 65.23 111.222 -174.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 25.9 t90 -143.27 142.58 31.41 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.163 0.985 . . . . 74.42 109.975 177.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 5.7 m-30 -61.57 -25.5 67.36 Favored 'General case' 0 CA--C 1.533 0.309 0 O-C-N 121.757 -0.59 . . . . 74.41 111.505 175.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -91.57 19.9 44.87 Favored Glycine 0 CA--C 1.53 1.026 0 CA-C-O 118.53 -1.15 . . . . 73.44 113.255 -179.349 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 46.1 t -104.46 85.66 1.18 Allowed Pre-proline 0 CA--C 1.541 0.606 0 C-N-CA 125.281 1.432 . . . . 64.14 110.719 -173.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_endo -67.17 5.28 0.89 Allowed 'Trans proline' 0 CA--C 1.536 0.619 0 C-N-CA 124.672 3.581 . . . . 73.25 114.606 179.164 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 22.9 m170 -107.11 -20.02 13.43 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 126.27 1.828 . . . . 64.51 111.546 175.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 94.4 m -78.82 -34.55 45.15 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.602 0.761 . . . . 74.54 110.901 -175.238 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 14.1 t80 -55.91 -41.4 74.49 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 124.917 1.287 . . . . 74.22 110.575 178.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -45.39 -51.7 10.94 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 125.766 1.626 . . . . 72.52 110.859 179.302 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -84.39 -21.23 30.89 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 125.791 1.636 . . . . 75.23 112.695 -167.075 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 59.0 mm-40 -45.15 -62.59 1.58 Allowed Pre-proline 0 N--CA 1.469 0.505 0 CA-C-N 120.001 1.273 . . . . 74.25 112.562 -176.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -71.11 -5.13 16.3 Favored 'Trans proline' 0 CA--C 1.538 0.724 0 C-N-CA 121.839 1.693 . . . . 60.34 114.455 -178.032 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 74.7 m -87.74 -34.69 18.26 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 119.643 1.11 . . . . 75.3 109.561 168.22 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 19.2 tt -92.78 -29.05 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 CA-C-N 119.708 1.14 . . . . 75.11 112.189 -174.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 38.6 t -49.19 -62.92 1.94 Allowed Pre-proline 0 CA--C 1.536 0.437 0 CA-C-O 117.797 -1.097 . . . . 75.51 109.943 170.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -66.3 -25.38 49.6 Favored 'Trans proline' 0 N--CA 1.451 -0.973 0 CA-C-N 120.737 1.299 . . . . 75.14 112.591 -173.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 58.4 t90 -65.88 -54.92 20.34 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 123.564 0.746 . . . . 74.13 110.406 173.345 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 88.8 p -57.61 -38.66 75.3 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.187 0.595 . . . . 71.0 112.24 -170.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 72.2 mt-10 -59.13 -36.84 75.9 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.796 1.238 . . . . 75.14 111.291 177.208 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 4.7 mmmm -92.51 2.82 56.46 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 125.35 1.46 . . . . 74.53 112.019 -167.094 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 33.7 mt -62.06 155.98 61.01 Favored Pre-proline 0 C--O 1.239 0.502 0 C-N-CA 125.558 1.543 . . . . 71.34 112.122 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -81.4 171.57 13.5 Favored 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 125.143 3.895 . . . . 72.44 112.452 -177.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -69.12 -2.34 9.99 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 126.513 1.925 . . . . 73.51 115.28 -177.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -115.79 0.24 13.11 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.756 1.222 . . . . 74.22 111.939 -178.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 86.1 t -96.71 150.6 4.36 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 N-CA-C 107.751 -1.203 . . . . 73.44 107.751 168.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 33.8 t60 -129.94 99.6 5.16 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 124.983 1.313 . . . . 71.45 107.829 165.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 51.4 t80 -77.21 145.23 37.73 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 114.9 -1.046 . . . . 75.25 109.606 178.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 21.6 t -142.09 157.04 19.93 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 C-N-CA 125.998 1.719 . . . . 74.22 107.695 -177.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 57.7 mtt180 -130.56 131.74 45.19 Favored 'General case' 0 N--CA 1.462 0.144 0 N-CA-C 107.793 -1.188 . . . . 74.03 107.793 163.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 37.3 mt -133.63 157.35 78.17 Favored Pre-proline 0 N--CA 1.468 0.438 0 C-N-CA 124.532 1.133 . . . . 73.25 108.935 176.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -74.85 164.72 32.94 Favored 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 121.381 1.388 . . . . 74.2 111.289 177.608 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -111.45 112.6 24.46 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 125.777 1.631 . . . . 75.11 107.53 -177.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 26.8 mt -115.68 60.29 0.71 Allowed 'General case' 0 C--O 1.234 0.274 0 O-C-N 121.489 -0.757 . . . . 73.14 112.602 -161.093 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -65.53 -14.83 61.89 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 114.613 1.338 . . . . 72.31 114.613 -171.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 122.65 -37.78 2.73 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 125.329 1.442 . . . . 64.25 111.763 175.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -77.96 -157.77 10.03 Favored Glycine 0 CA--C 1.527 0.787 0 C-N-CA 124.383 0.992 . . . . 75.53 110.844 172.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 6.3 tp -45.11 -24.28 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 127.996 2.519 . . . . 74.11 113.396 179.288 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 37.6 m95 -44.19 -50.72 8.62 Favored 'General case' 0 N--CA 1.441 -0.899 0 C-N-CA 126.657 1.983 . . . . 73.12 111.277 172.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 26.4 p30 -77.71 -29.27 51.21 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 113.852 1.056 . . . . 73.03 113.852 -179.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 73.8 t -60.89 -50.0 82.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 108.757 -0.831 . . . . 72.31 108.757 174.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 55.9 m170 -72.29 -0.65 12.78 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.034 1.734 . . . . 73.24 112.538 171.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -100.51 -14.56 32.14 Favored Glycine 0 CA--C 1.525 0.661 0 CA-C-N 120.205 1.366 . . . . 72.14 112.309 -175.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -96.63 -27.13 14.94 Favored 'General case' 0 N--CA 1.45 -0.473 0 O-C-N 121.792 -0.828 . . . . 72.3 112.102 -159.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -65.11 -42.37 94.02 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-O 116.833 -1.556 . . . . 73.03 111.244 -177.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 7.7 t80 -52.21 -56.13 16.66 Favored 'General case' 0 C--N 1.34 0.194 0 CA-C-N 119.466 1.03 . . . . 74.24 109.01 -176.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 44.5 mt -64.89 -32.07 73.61 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 116.497 -1.716 . . . . 74.44 111.247 -177.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.3 m -70.3 -38.18 74.93 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 120.77 1.623 . . . . 75.32 111.356 177.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.7 -54.25 47.56 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 124.395 1.078 . . . . 73.13 109.211 175.338 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -56.21 -37.69 70.0 Favored 'General case' 0 C--O 1.226 -0.154 0 C-N-CA 125.139 1.375 . . . . 73.33 110.485 177.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -50.95 -20.31 1.3 Allowed 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.538 1.535 . . . . 73.12 113.769 176.443 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 53.6 mtm -99.78 -7.92 24.86 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 120.422 1.465 . . . . 73.32 113.992 176.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 68.6 46.4 62.17 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 109.804 -1.318 . . . . 75.14 109.804 -178.469 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 10.8 m -58.6 93.8 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 C-N-CA 125.102 1.361 . . . . 72.21 111.904 178.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -84.82 14.0 5.26 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.065 1.346 . . . . 74.24 111.997 -176.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 14.8 m-70 -79.07 52.89 1.34 Allowed 'General case' 0 C--O 1.238 0.495 0 C-N-CA 127.271 2.229 . . . . 73.13 111.916 -172.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 66.78 179.29 0.22 Allowed 'General case' 0 C--O 1.239 0.548 0 C-N-CA 128.743 2.817 . . . . 74.44 111.521 -171.021 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.2 p -61.27 155.94 3.89 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 C-N-CA 123.524 0.73 . . . . 74.42 109.255 -176.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 1.5 p80 -75.51 35.79 0.12 Allowed 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 114.191 1.182 . . . . 73.12 114.191 -175.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -56.41 -66.97 0.35 Allowed 'General case' 0 CA--C 1.515 -0.391 0 C-N-CA 125.044 1.338 . . . . 74.24 109.373 178.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -52.92 -36.74 59.97 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 118.761 -0.638 . . . . 74.21 111.152 -178.345 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 4.1 t -57.43 -51.27 71.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 CA-C-N 119.551 1.068 . . . . 70.1 110.83 -179.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -65.18 -52.84 52.48 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 123.686 0.794 . . . . 75.21 109.256 175.71 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -58.02 -26.89 62.99 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.605 1.562 . . . . 73.21 110.978 -172.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -72.91 -16.03 61.57 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 125.822 1.649 . . . . 75.32 113.572 -179.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 19.4 mt -92.61 -43.1 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 N-CA-C 107.353 -1.351 . . . . 64.43 107.353 174.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 30.5 p80 -102.86 -64.11 1.1 Allowed 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 113.54 0.941 . . . . 71.33 113.54 -166.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 29.6 mtpt -68.14 -16.06 63.84 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 119.916 1.235 . . . . 65.43 111.783 176.13 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -99.48 -23.32 15.14 Favored 'General case' 0 C--N 1.331 -0.212 0 O-C-N 120.834 -1.166 . . . . 70.51 111.92 171.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 7.2 t60 57.4 84.6 0.09 Allowed 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.629 1.572 . . . . 72.2 112.497 172.202 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 8.3 mmtp -136.71 152.23 50.13 Favored 'General case' 0 CA--C 1.52 -0.193 0 C-N-CA 124.187 0.995 . . . . 65.02 111.193 -169.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 9.3 ttmm -71.18 -51.19 26.23 Favored 'General case' 0 C--O 1.224 -0.253 0 N-CA-C 109.261 -0.644 . . . . 73.54 109.261 -177.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 77.9 mt 50.54 32.17 6.39 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.893 1.277 . . . . 63.13 113.514 179.053 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -86.81 8.67 21.82 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 114.768 1.395 . . . . 73.22 114.768 -167.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -143.34 157.84 58.97 Favored Pre-proline 0 N--CA 1.471 0.605 0 O-C-N 120.846 -1.159 . . . . 73.24 109.392 -172.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -58.77 -42.68 50.79 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 121.905 1.736 . . . . 74.14 111.738 -177.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -63.05 -53.45 53.62 Favored 'General case' 0 N--CA 1.442 -0.86 0 O-C-N 124.342 1.026 . . . . 74.21 110.486 -178.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 44.3 tp10 -58.11 -33.61 69.31 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.362 0.665 . . . . 70.24 111.04 -172.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 69.1 mtm -72.68 -56.86 4.66 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 118.149 -0.929 . . . . 72.41 111.595 169.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -59.63 -49.87 76.06 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 124.764 1.226 . . . . 74.45 112.529 -171.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -68.08 -36.7 80.25 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 124.62 1.168 . . . . 75.51 111.591 -170.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . 0.424 ' CZ ' ' HE3' ' A' ' 118' ' ' LYS . 84.8 t80 -58.06 -38.93 77.27 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.229 0.612 . . . . 70.22 110.878 171.416 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 14.0 mt -77.66 -19.18 55.84 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 123.924 0.89 . . . . 73.13 110.278 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.4 -20.06 58.26 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 121.149 -0.969 . . . . 71.44 111.249 173.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -97.06 -6.5 57.86 Favored Glycine 0 CA--C 1.528 0.888 0 CA-C-O 118.877 -0.957 . . . . 64.42 114.112 169.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.424 ' HE3' ' CZ ' ' A' ' 114' ' ' PHE . 48.2 mttm -125.27 61.91 1.19 Allowed 'General case' 0 N--CA 1.456 -0.134 0 CA-C-N 119.938 1.869 . . . . 74.2 108.406 -175.083 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 71.69 18.48 77.34 Favored Glycine 0 CA--C 1.525 0.661 0 CA-C-O 119.021 -0.877 . . . . 65.44 114.646 161.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 28.3 t -125.89 139.88 50.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 C-N-CA 125.707 1.603 . . . . 73.45 108.04 -176.608 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 65.5 t0 -85.68 121.2 28.01 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 107.712 -1.218 . . . . 54.31 107.712 167.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 15.3 ttpt -57.32 -35.62 70.09 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 124.053 0.941 . . . . 75.33 110.394 176.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -65.68 -39.6 91.47 Favored 'General case' 0 N--CA 1.454 -0.26 0 O-C-N 121.491 -0.756 . . . . 64.32 111.566 178.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 46.0 mttm -75.68 -44.25 43.2 Favored 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 106.819 -1.548 . . . . 75.04 106.819 -173.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -49.02 -68.06 0.21 Allowed 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 125.605 1.562 . . . . 72.45 110.579 174.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 18.3 mt -65.33 -32.59 74.32 Favored 'General case' 0 C--O 1.234 0.253 0 O-C-N 121.379 -0.825 . . . . 72.2 111.155 -170.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 35.7 t -56.98 -58.26 8.92 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 107.637 -1.245 . . . . 75.1 107.637 177.017 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . 0.341 10.1 t -71.79 -30.13 65.2 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 119.919 -0.712 . . . . 74.12 110.864 -175.32 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 31.1 t80 -54.65 -35.36 63.4 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 120.646 -1.283 . . . . 74.45 111.085 174.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -102.72 18.14 22.12 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.618 1.167 . . . . 65.02 112.744 179.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 28.8 m -104.53 160.99 14.49 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 125.652 1.581 . . . . 73.3 111.926 176.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -59.9 -25.97 65.54 Favored 'General case' 0 CA--C 1.532 0.288 0 O-C-N 122.143 -0.348 . . . . 72.33 111.058 171.051 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -50.01 -28.75 7.42 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 125.386 1.474 . . . . 64.1 113.304 173.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 5.5 mm -101.64 -36.06 4.49 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 C-N-CA 125.159 1.384 . . . . 74.42 110.671 176.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 35.3 tttm -53.91 -39.06 65.47 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 124.073 0.949 . . . . 75.43 110.463 174.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -72.55 -16.05 77.57 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 125.152 1.358 . . . . 51.14 111.916 -170.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -99.1 -39.22 8.6 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 123.393 0.677 . . . . 73.03 109.494 176.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 75.6 mmm -58.47 -37.83 76.32 Favored 'General case' 0 C--N 1.342 0.257 0 N-CA-C 109.77 -0.456 . . . . 74.03 109.77 177.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -59.66 -51.53 69.41 Favored 'General case' 0 CA--C 1.535 0.374 0 O-C-N 121.303 -0.873 . . . . 71.4 110.737 173.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 4.3 mmtp -61.98 -58.14 9.01 Favored 'General case' 0 C--N 1.344 0.327 0 CA-C-O 117.987 -1.006 . . . . 73.21 111.47 -175.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -59.5 -30.75 68.79 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 119.474 1.034 . . . . 62.12 110.671 -176.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 2.2 tmpt? -66.16 -58.87 4.48 Favored 'General case' 0 C--N 1.344 0.357 0 O-C-N 121.035 -1.04 . . . . 73.21 109.99 176.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 15.2 ptpt -62.61 -37.82 87.78 Favored 'General case' 0 C--N 1.341 0.22 0 CA-C-O 118.611 -0.709 . . . . 73.44 109.499 -173.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 35.7 mt -57.89 -59.77 4.73 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.467 1.107 . . . . 71.34 110.984 175.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -56.01 -40.61 73.63 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 119.03 0.832 . . . . 75.23 111.765 -175.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -63.25 -50.52 69.84 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 109.918 -0.401 . . . . 74.33 109.918 175.503 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -69.67 -22.44 63.44 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-O 118.572 -0.727 . . . . 72.13 112.4 -172.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -73.98 -8.27 55.49 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 125.37 1.468 . . . . 74.14 113.864 171.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 52.61 72.66 0.39 Allowed 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 124.793 1.237 . . . . 75.31 110.919 -167.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 47.4 t -101.63 145.83 10.93 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 N-CA-C 107.457 -1.312 . . . . 75.41 107.457 166.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -123.27 -13.89 7.58 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 123.629 0.772 . . . . 70.5 112.787 172.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -159.35 -163.7 13.59 Favored Glycine 0 C--N 1.334 0.431 0 O-C-N 121.047 -1.033 . . . . 75.32 113.213 179.051 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.467 ' HA ' ' C ' ' A' ' 154' ' ' PRO . 15.4 m -144.11 146.78 35.1 Favored Pre-proline 0 C--N 1.328 -0.335 0 C-N-CA 126.102 1.761 . . . . 65.44 107.086 173.055 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . 0.467 ' C ' ' HA ' ' A' ' 153' ' ' VAL . 60.8 Cg_endo -67.31 150.95 83.68 Favored 'Cis proline' 0 N--CA 1.46 -0.479 0 C-N-CA 125.2 -0.75 . . . . 64.42 112.149 1.524 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 85.8 m -151.15 127.75 10.81 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 105.769 -1.937 . . . . 73.31 105.769 174.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 14.6 mmm -110.81 150.81 28.6 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 106.569 -1.641 . . . . 75.24 106.569 165.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 46.6 t -129.11 128.91 67.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 107.114 -1.439 . . . . 73.21 107.114 171.301 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 77.4 t -93.1 123.04 45.06 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 N-CA-C 107.48 -1.304 . . . . 74.44 107.48 164.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 2.7 t30 64.58 11.74 6.92 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 129.114 2.966 . . . . 63.54 115.52 159.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 71.19 23.33 78.19 Favored Glycine 0 CA--C 1.526 0.742 0 CA-C-O 117.711 -1.605 . . . . 74.42 112.973 -170.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 35.9 mttt -133.58 -30.18 1.3 Allowed 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 120.043 1.921 . . . . 71.22 112.402 -175.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 80.3 m-85 -124.34 115.01 20.31 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 118.943 -0.551 . . . . 74.5 110.864 -179.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 6.3 ptt180 -96.01 141.41 29.45 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 106.685 -1.598 . . . . 64.51 106.685 171.171 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 15.1 p90 -151.71 164.84 36.08 Favored 'General case' 0 C--N 1.309 -1.154 0 O-C-N 120.721 -1.237 . . . . 73.13 108.376 176.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -168.19 169.12 11.19 Favored 'General case' 0 CA--C 1.513 -0.445 0 CA-C-N 116.001 -0.545 . . . . 73.21 109.611 -174.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 42.0 mt -51.73 -47.79 38.57 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 C-N-CA 125.41 1.484 . . . . 73.2 109.702 -175.115 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -84.13 -4.65 88.16 Favored Glycine 0 CA--C 1.527 0.791 0 CA-C-O 117.701 -1.611 . . . . 64.44 113.38 -176.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 52.1 m -87.24 -56.31 3.42 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 121.224 2.512 . . . . 72.32 108.249 163.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -79.0 -28.02 43.36 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-O 116.9 -1.524 . . . . 71.34 113.969 -165.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 154.12 -46.7 0.54 Allowed Glycine 0 CA--C 1.527 0.793 0 CA-C-N 121.343 1.883 . . . . 65.3 115.457 176.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 154.26 167.13 15.83 Favored Glycine 0 CA--C 1.534 1.224 0 N-CA-C 108.159 -1.977 . . . . 74.01 108.159 -153.145 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -67.69 -23.48 42.35 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 CA-C-N 120.525 2.163 . . . . 63.41 113.294 -164.182 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -70.0 -46.4 65.22 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 123.013 1.387 . . . . 75.25 109.557 174.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -66.97 -21.51 65.96 Favored 'General case' 0 N--CA 1.445 -0.675 0 C-N-CA 126.622 1.969 . . . . 74.44 111.344 -175.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 3.2 m -70.6 -43.76 68.68 Favored 'General case' 0 CA--C 1.529 0.16 0 O-C-N 121.126 -0.984 . . . . 72.15 109.162 -177.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 53.4 mt -62.84 -33.27 74.9 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 118.288 0.495 . . . . 73.35 110.799 177.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 7.5 tttt -52.58 -51.42 59.88 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 125.099 1.36 . . . . 75.43 109.33 173.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -68.78 -39.89 79.96 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-O 118.287 -0.864 . . . . 73.11 110.846 175.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -55.8 -49.04 74.28 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 119.215 0.916 . . . . 75.44 111.201 -174.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -72.88 -43.13 62.9 Favored 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 122.76 0.424 . . . . 72.41 110.333 -172.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 15.9 t80 -60.45 -52.33 65.67 Favored 'General case' 0 N--CA 1.44 -0.946 0 C-N-CA 124.736 1.214 . . . . 74.33 110.048 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 95.9 mt -62.63 -34.8 77.78 Favored 'General case' 0 C--O 1.233 0.213 0 C-N-CA 123.206 0.602 . . . . 71.05 110.768 -178.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 38.1 mt -60.8 -61.96 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 N-CA-C 108.419 -0.956 . . . . 73.41 108.419 173.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -56.98 -32.79 66.44 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 124.491 1.117 . . . . 74.25 111.509 -173.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 79.3 tttt -58.51 -66.93 0.41 Allowed 'General case' 0 C--O 1.232 0.156 0 C-N-CA 125.425 1.49 . . . . 74.25 110.571 171.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 43.0 mm-40 -65.38 -19.34 65.9 Favored 'General case' 0 N--CA 1.446 -0.625 0 O-C-N 121.03 -1.044 . . . . 73.01 113.258 -177.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.94 -44.79 63.04 Favored 'General case' 0 CA--C 1.533 0.319 0 O-C-N 120.974 -1.079 . . . . 74.03 109.327 169.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -56.2 -32.57 64.51 Favored 'General case' 0 C--O 1.232 0.133 0 C-N-CA 124.214 1.005 . . . . 74.54 110.73 -177.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -51.91 -28.02 14.93 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.336 1.054 . . . . 63.44 113.483 178.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -133.44 40.36 3.16 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 118.978 0.808 . . . . 74.11 111.5 174.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 25.4 tttp -130.45 33.68 4.26 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.559 1.543 . . . . 74.13 109.937 176.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 6.2 mtpm? . . . . . 0 C--O 1.25 1.102 0 C-N-CA 127.016 2.126 . . . . 75.42 108.616 -162.364 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.984 0 N-CA-C 108.441 -1.864 . . . . 73.41 108.441 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -108.53 69.17 0.71 Allowed 'General case' 0 CA--C 1.512 -0.483 0 N-CA-C 106.969 -1.493 . . . . 74.53 106.969 -146.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -81.55 8.92 8.43 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-N 112.757 -2.02 . . . . 71.25 114.835 -161.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 42.7 m-85 -134.18 167.03 21.41 Favored 'General case' 0 N--CA 1.442 -0.854 0 C-N-CA 124.803 1.241 . . . . 75.35 108.641 -164.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 94.2 m -134.2 141.24 46.97 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 108.451 -0.944 . . . . 74.15 108.451 173.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -70.28 143.58 52.03 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-O 122.069 0.938 . . . . 73.22 110.055 175.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 61.46 16.0 48.28 Favored Glycine 0 CA--C 1.529 0.917 0 C-N-CA 124.898 1.237 . . . . 51.44 112.762 -166.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 8.1 ttmt -118.4 -85.23 0.65 Allowed 'General case' 0 CA--C 1.517 -0.31 0 N-CA-C 105.879 -1.897 . . . . 72.44 105.879 172.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 38.4 mp0 -75.6 -21.97 57.32 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 118.675 0.67 . . . . 75.2 112.462 -179.505 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 47.9 p90 -159.78 176.0 12.47 Favored 'General case' 0 CA--C 1.52 -0.179 0 O-C-N 121.477 -0.765 . . . . 73.43 110.726 -170.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 44.3 t -140.68 96.05 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 N-CA-C 108.534 -0.913 . . . . 70.01 108.534 -170.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.39 146.18 27.81 Favored 'General case' 0 C--O 1.237 0.402 0 O-C-N 121.089 -1.007 . . . . 61.21 110.677 177.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -100.68 146.46 27.17 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 114.467 -1.242 . . . . 75.12 108.192 -170.675 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.8 p -81.85 -23.77 36.2 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 125.569 1.547 . . . . 73.31 111.12 179.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 69.3 m -115.27 84.32 11.35 Favored Pre-proline 0 N--CA 1.455 -0.18 0 C-N-CA 124.783 1.233 . . . . 75.0 109.587 -178.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -75.01 174.75 12.25 Favored 'Trans proline' 0 N--CA 1.451 -0.995 0 C-N-CA 122.113 1.875 . . . . 75.4 112.288 -178.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 20.7 t -130.2 130.46 23.06 Favored Pre-proline 0 CA--C 1.534 0.342 0 CA-C-N 114.937 -1.029 . . . . 63.21 108.714 -173.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -76.73 175.91 10.78 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 124.277 3.318 . . . . 74.12 112.865 178.04 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 19.4 m -120.25 168.56 12.48 Favored 'Isoleucine or valine' 0 C--O 1.24 0.567 0 C-N-CA 126.366 1.866 . . . . 75.22 110.264 173.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 38.9 m -54.91 -53.01 61.02 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 126.664 1.986 . . . . 74.21 110.777 174.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 3.5 mm-40 -141.58 144.27 32.74 Favored Pre-proline 0 N--CA 1.451 -0.392 0 N-CA-C 106.564 -1.643 . . . . 74.23 106.564 178.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -71.51 165.01 33.81 Favored 'Trans proline' 0 N--CA 1.447 -1.224 0 C-N-CA 121.269 1.313 . . . . 71.22 109.156 162.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 159.57 -35.04 0.47 Allowed Glycine 0 CA--C 1.519 0.329 0 CA-C-O 119.547 -0.585 . . . . 64.04 112.784 167.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -129.71 163.58 25.85 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.581 1.553 . . . . 75.33 109.707 162.463 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 28.2 mm -66.31 126.34 25.46 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 N-CA-C 106.467 -1.679 . . . . 65.35 106.467 168.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -89.3 123.45 33.5 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 125.992 1.717 . . . . 72.53 106.762 -176.66 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 28.3 t -123.73 135.29 63.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 108.002 -1.11 . . . . 73.45 108.002 -179.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 40.3 t -126.76 125.9 67.72 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.177 0 N-CA-C 108.262 -1.014 . . . . 75.52 108.262 -175.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -87.46 134.91 33.53 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 125.164 1.386 . . . . 72.31 107.769 162.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.2 mp -122.23 123.5 41.61 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 124.715 1.206 . . . . 73.53 108.354 165.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -131.8 171.59 13.33 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.754 1.622 . . . . 72.01 110.979 -169.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 27.3 t90 -147.22 168.92 20.49 Favored 'General case' 0 CA--C 1.537 0.452 0 O-C-N 120.86 -1.15 . . . . 74.03 109.46 168.038 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 14.6 t80 -60.77 -53.51 56.5 Favored 'General case' 0 N--CA 1.461 0.076 0 C-N-CA 126.062 1.745 . . . . 74.12 111.425 174.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -68.66 -84.41 0.13 Allowed Glycine 0 C--N 1.336 0.575 0 N-CA-C 110.697 -0.961 . . . . 55.44 110.697 -159.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 14.5 t 42.54 71.93 1.27 Allowed Pre-proline 0 CA--C 1.533 0.289 0 C-N-CA 125.961 1.704 . . . . 54.55 113.415 149.163 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -67.3 3.42 1.7 Allowed 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 122.264 1.976 . . . . 73.34 113.71 -176.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 18.7 m170 -108.66 -28.98 8.96 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 119.857 1.208 . . . . 71.33 111.978 173.062 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 85.7 m -60.27 -46.32 90.24 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 119.545 1.066 . . . . 63.14 109.754 -175.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 32.7 t80 -66.62 -22.13 66.12 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 121.085 -1.009 . . . . 73.24 112.187 -178.329 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -74.64 -3.54 31.85 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 120.931 -1.106 . . . . 52.34 112.782 175.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 15.6 t80 -121.82 -25.14 5.08 Favored 'General case' 0 C--O 1.226 -0.171 0 C-N-CA 125.372 1.469 . . . . 65.0 112.511 -168.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 56.9 mm-40 -42.39 -63.23 0.96 Allowed Pre-proline 0 CA--C 1.539 0.553 0 C-N-CA 124.253 1.021 . . . . 73.04 112.403 -177.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -73.3 -8.73 22.34 Favored 'Trans proline' 0 N--CA 1.46 -0.445 0 CA-C-N 122.535 1.941 . . . . 74.1 114.966 -177.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.4 m -70.8 -44.91 65.63 Favored 'General case' 0 CA--C 1.543 0.708 0 O-C-N 121.034 -1.042 . . . . 74.33 108.525 166.293 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 12.9 tt -94.78 -36.02 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 C-N-CA 123.86 0.864 . . . . 74.42 112.418 -165.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 41.9 t -46.8 -58.85 6.09 Favored Pre-proline 0 CA--C 1.538 0.493 0 C-N-CA 125.691 1.596 . . . . 74.53 110.443 176.001 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -72.53 -25.51 17.72 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 121.646 1.564 . . . . 74.33 112.929 -178.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 79.6 t90 -60.24 -52.01 67.11 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 119.757 1.162 . . . . 74.4 109.014 173.315 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.2 t -55.88 -42.8 76.46 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.321 0.648 . . . . 71.3 110.522 177.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 90.0 mt-10 -64.05 -10.34 21.52 Favored 'General case' 0 N--CA 1.468 0.474 0 O-C-N 121.207 -0.933 . . . . 71.1 113.352 -179.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 19.3 mmmt -122.49 8.48 9.58 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 126.116 1.767 . . . . 74.13 112.277 -171.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 25.2 mt -64.73 153.59 87.39 Favored Pre-proline 0 C--O 1.24 0.566 0 C-N-CA 125.029 1.331 . . . . 74.41 111.177 177.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -74.54 167.25 27.56 Favored 'Trans proline' 0 N--CA 1.448 -1.154 0 C-N-CA 124.658 3.572 . . . . 73.05 110.494 179.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -73.12 -2.19 20.45 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.385 1.474 . . . . 74.31 113.349 -175.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -101.75 8.29 41.55 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.01 1.324 . . . . 75.04 111.15 177.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 60.8 t -124.58 155.13 32.47 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 C-N-CA 124.521 1.128 . . . . 74.04 108.766 -177.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 63.9 t60 -139.27 123.72 18.26 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 126.903 2.081 . . . . 73.43 106.333 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 47.4 t80 -107.97 139.4 42.65 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 108.079 -1.082 . . . . 64.44 108.079 -176.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 25.9 t -135.2 153.75 34.61 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 N-CA-C 105.511 -2.033 . . . . 75.23 105.511 -177.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -127.86 140.16 52.19 Favored 'General case' 0 CA--C 1.512 -0.512 0 N-CA-C 105.341 -2.096 . . . . 75.32 105.341 167.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 97.5 mt -138.54 144.46 42.45 Favored Pre-proline 0 C--N 1.326 -0.416 0 N-CA-C 108.829 -0.804 . . . . 71.42 108.829 174.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -71.6 148.25 53.05 Favored 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 121.526 1.484 . . . . 72.45 110.913 178.098 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -93.28 86.53 5.34 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 124.962 1.305 . . . . 75.14 108.362 -178.019 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 46.8 mt -80.86 65.45 6.01 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 121.006 -1.059 . . . . 65.13 112.601 -169.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 13.0 m-85 -80.02 27.2 0.32 Allowed 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 115.111 1.523 . . . . 64.12 115.111 -168.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 66.54 -168.32 35.48 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 109.217 -1.553 . . . . 63.2 109.217 -166.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 56.15 -151.03 23.03 Favored Glycine 0 CA--C 1.526 0.747 0 CA-C-N 117.848 0.824 . . . . 73.33 111.34 178.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 9.6 tp -70.45 -12.04 15.65 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 N-CA-C 112.471 0.545 . . . . 74.2 112.471 173.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 9.4 m95 -64.42 -36.16 83.24 Favored 'General case' 0 C--O 1.224 -0.266 0 O-C-N 120.004 -1.685 . . . . 72.23 112.178 -171.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 11.5 p30 -76.54 -28.34 56.27 Favored 'General case' 0 CA--C 1.518 -0.254 0 N-CA-C 113.051 0.76 . . . . 74.41 113.051 177.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 94.2 t -65.61 -51.69 59.79 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 N-CA-C 107.21 -1.404 . . . . 71.1 107.21 172.281 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 59.0 m170 -79.1 54.18 1.58 Allowed 'General case' 0 C--O 1.239 0.505 0 C-N-CA 125.493 1.517 . . . . 72.23 111.446 172.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -164.82 -29.28 0.02 OUTLIER Glycine 0 N--CA 1.445 -0.752 0 CA-C-N 115.485 -0.78 . . . . 74.52 112.717 156.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -62.32 -25.78 68.07 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 119.314 1.557 . . . . 75.22 114.045 -173.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 40.3 ttp -53.3 -40.12 64.53 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 124.358 1.063 . . . . 71.32 112.546 -177.404 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -58.47 -47.1 85.15 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 125.074 1.349 . . . . 74.12 108.523 178.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 15.5 mt -68.81 -34.69 75.93 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-O 116.487 -1.721 . . . . 72.23 111.095 -178.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -63.73 -45.12 91.33 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 121.761 2.073 . . . . 75.13 111.335 174.509 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -52.53 -60.6 3.04 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.454 1.102 . . . . 75.4 108.723 -176.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -67.19 -27.56 67.37 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.26 1.024 . . . . 74.21 110.043 -174.696 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.0 t -51.68 -39.86 59.04 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 124.52 1.128 . . . . 53.05 111.621 176.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 44.7 mtm -71.53 -11.6 60.95 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 118.761 0.71 . . . . 64.31 112.439 -176.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 81.8 25.4 53.19 Favored Glycine 0 CA--C 1.527 0.831 0 CA-C-N 118.862 0.756 . . . . 71.1 112.402 -178.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 17.4 m -49.79 153.31 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 C-N-CA 125.632 1.573 . . . . 74.45 112.111 173.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -132.05 23.15 4.53 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 126.513 1.925 . . . . 62.14 111.458 -176.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 3.2 t-160 -55.09 121.1 8.02 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 125.592 1.557 . . . . 72.11 107.554 170.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.74 121.26 15.57 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 108.728 -0.841 . . . . 75.25 108.728 -179.121 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 70.8 t 62.13 167.44 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.081 0 C-N-CA 125.218 1.407 . . . . 74.45 112.057 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 53.1 p-80 -132.07 9.45 4.48 Favored 'General case' 0 N--CA 1.465 0.289 0 O-C-N 120.131 -1.606 . . . . 64.52 114.911 -167.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -50.73 -60.89 2.58 Favored 'General case' 0 C--O 1.217 -0.645 0 C-N-CA 124.938 1.295 . . . . 73.24 109.016 177.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -56.52 -17.56 8.79 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 120.874 1.67 . . . . 71.25 114.986 -174.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 25.6 t -73.36 -66.43 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 CA-C-N 119.895 1.225 . . . . 70.34 108.805 167.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -60.0 -36.98 78.35 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.261 1.025 . . . . 75.41 110.776 -175.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -60.15 -35.55 75.57 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 125.382 1.473 . . . . 72.34 110.745 176.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -65.22 -22.18 66.85 Favored 'General case' 0 CA--C 1.534 0.338 0 O-C-N 121.163 -0.961 . . . . 63.13 112.053 176.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 55.5 mt -87.34 -60.01 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.884 0 N-CA-C 105.883 -1.895 . . . . 73.3 105.883 178.106 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 31.6 p80 -92.55 -53.64 4.11 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 115.379 1.622 . . . . 72.15 115.379 -168.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 34.2 mmtt -62.64 -20.4 64.75 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.238 1.015 . . . . 75.51 111.742 175.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -117.19 -26.2 6.86 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 118.053 -0.975 . . . . 70.42 113.148 -171.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 1.9 t-160 53.46 42.97 31.91 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.275 1.43 . . . . 72.1 111.994 178.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 25.4 mmtp -74.79 157.52 35.03 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 120.941 -1.099 . . . . 75.33 110.218 175.353 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 11.0 tttt -80.17 36.47 0.35 Allowed 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 127.872 2.469 . . . . 74.23 111.748 -173.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 24.7 mt -64.54 32.82 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 130.452 3.501 . . . . 74.43 115.182 -174.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -79.8 13.09 2.29 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 129.636 3.174 . . . . 61.3 113.14 178.562 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -148.04 158.53 41.74 Favored Pre-proline 0 N--CA 1.463 0.221 0 CA-C-N 119.21 0.914 . . . . 75.4 111.852 -179.628 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -67.93 -19.55 46.09 Favored 'Trans proline' 0 N--CA 1.455 -0.773 0 C-N-CA 123.225 2.617 . . . . 62.31 112.106 174.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -60.39 -71.19 0.14 Allowed 'General case' 0 C--O 1.22 -0.497 0 N-CA-C 107.398 -1.334 . . . . 73.03 107.398 167.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -51.51 -42.61 61.83 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 124.289 1.036 . . . . 73.51 112.395 -176.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 48.0 mtt -58.72 -57.15 14.28 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 109.67 -0.493 . . . . 74.24 109.67 179.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -65.73 -37.33 86.1 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 119.536 -0.269 . . . . 65.15 111.111 -177.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -60.63 -48.77 80.31 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 127.533 2.333 . . . . 74.45 110.341 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -65.72 -47.81 74.06 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 123.666 0.787 . . . . 75.12 110.698 177.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 66.9 mt -75.15 -13.06 60.43 Favored 'General case' 0 N--CA 1.457 -0.101 0 CA-C-O 119.051 -0.5 . . . . 74.54 111.76 -173.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -49.11 -53.58 20.05 Favored 'General case' 0 CA--C 1.52 -0.178 0 C-N-CA 125.099 1.36 . . . . 70.25 109.882 -174.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -72.21 7.2 8.41 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 125.453 1.501 . . . . 74.43 115.571 178.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 20.3 mttm -125.43 25.94 6.94 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 120.788 2.294 . . . . 75.24 111.57 -170.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 74.46 40.82 38.53 Favored Glycine 0 C--N 1.334 0.448 0 N-CA-C 111.142 -0.783 . . . . 74.4 111.142 -179.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 58.4 t -131.0 111.61 20.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 N-CA-C 107.147 -1.427 . . . . 64.11 107.147 173.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -70.57 136.54 49.34 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 123.993 0.917 . . . . 71.52 111.47 173.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 26.9 tttt -64.74 -48.25 75.27 Favored 'General case' 0 CA--C 1.516 -0.362 0 N-CA-C 109.762 -0.458 . . . . 74.33 109.762 -176.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 60.1 mm-40 -63.85 -39.19 93.63 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 122.775 0.43 . . . . 71.24 110.237 -174.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 3.9 mtpm? -75.62 -38.77 58.71 Favored 'General case' 0 CA--C 1.515 -0.376 0 N-CA-C 108.282 -1.007 . . . . 73.31 108.282 -177.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 87.4 t80 -57.76 -60.5 3.6 Favored 'General case' 0 N--CA 1.44 -0.925 0 O-C-N 123.794 0.684 . . . . 72.52 110.294 178.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 15.7 mt -65.61 -37.27 86.13 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-O 118.937 -0.554 . . . . 74.41 109.754 -175.108 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 45.6 t -60.14 -51.85 67.86 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 108.582 -0.896 . . . . 72.52 108.582 177.094 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . 0.278 1.3 t -69.12 -33.12 72.97 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 119.454 1.025 . . . . 73.21 109.873 -173.792 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 53.2 t80 -51.1 -48.56 61.65 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.361 1.465 . . . . 73.51 110.664 170.14 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -95.14 17.63 13.77 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 113.213 0.82 . . . . 72.43 113.213 -179.074 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 58.0 m -107.67 172.47 6.81 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 119.772 1.169 . . . . 74.44 111.694 179.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -63.84 -23.84 67.51 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 115.92 -0.582 . . . . 75.5 112.338 -174.724 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -53.58 -59.87 4.04 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.671 1.189 . . . . 75.44 110.032 176.006 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 14.2 mm -67.1 -26.21 35.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 C-N-CA 123.032 0.533 . . . . 73.54 111.605 -179.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 6.8 tttp -55.48 -45.45 76.99 Favored 'General case' 0 N--CA 1.464 0.225 0 O-C-N 120.938 -1.101 . . . . 72.23 109.639 171.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -72.76 -10.91 77.45 Favored Glycine 0 CA--C 1.524 0.63 0 C-N-CA 123.475 0.559 . . . . 72.22 112.009 -172.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 7.5 mm100 -108.66 -38.52 5.63 Favored 'General case' 0 N--CA 1.44 -0.938 0 C-N-CA 126.332 1.853 . . . . 75.11 109.357 -171.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -62.98 -41.91 99.69 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 118.368 -0.825 . . . . 75.12 110.332 174.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -67.71 -44.66 77.17 Favored 'General case' 0 CA--C 1.535 0.365 0 CA-C-N 119.137 0.881 . . . . 73.35 110.266 178.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 3.1 ttmt -63.23 -56.13 19.15 Favored 'General case' 0 N--CA 1.449 -0.475 0 O-C-N 121.034 -1.041 . . . . 75.35 111.164 -174.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -59.64 -33.27 71.31 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 118.029 0.377 . . . . 65.31 110.661 -176.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 2.0 tmtm? -60.1 -60.54 3.66 Favored 'General case' 0 CA--C 1.531 0.245 0 O-C-N 121.269 -0.894 . . . . 75.03 110.925 172.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.44 -18.79 63.0 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 119.265 0.939 . . . . 73.45 112.039 -173.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 45.4 mt -69.5 -54.55 13.64 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 123.96 0.904 . . . . 73.45 110.338 172.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -53.58 -47.37 70.2 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 119.558 1.072 . . . . 73.41 112.588 -174.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -62.33 -45.13 94.6 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 112.704 0.631 . . . . 71.1 112.704 175.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -63.21 -35.65 81.01 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 118.496 0.589 . . . . 74.34 109.88 -179.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 -74.19 9.2 1.72 Allowed 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 114.014 1.116 . . . . 74.53 114.014 173.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 60.86 19.5 9.76 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 126.294 1.838 . . . . 74.34 112.649 176.063 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 25.8 t -75.16 141.14 16.31 Favored 'Isoleucine or valine' 0 C--O 1.24 0.58 0 N-CA-C 107.996 -1.113 . . . . 74.44 107.996 -177.042 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -141.49 0.5 1.48 Allowed 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 118.846 -0.597 . . . . 75.33 112.408 173.409 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -160.12 167.96 35.63 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 108.6 -1.8 . . . . 72.33 108.6 170.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.413 ' HA ' ' C ' ' A' ' 154' ' ' PRO . 30.0 m -123.88 156.03 66.08 Favored Pre-proline 0 C--O 1.238 0.473 0 C-N-CA 125.697 1.599 . . . . 71.35 107.614 176.515 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . 0.413 ' C ' ' HA ' ' A' ' 153' ' ' VAL . 94.8 Cg_endo -67.33 157.92 83.53 Favored 'Cis proline' 0 N--CA 1.46 -0.447 0 O-C-N 122.607 0.793 . . . . 73.41 113.323 -2.083 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 5.1 m -154.86 136.93 14.69 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 107.989 -1.115 . . . . 74.32 107.989 171.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 91.8 mtp -111.13 152.92 26.44 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 107.135 -1.432 . . . . 70.32 107.135 169.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 41.0 t -138.98 128.66 31.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 N-CA-C 107.92 -1.141 . . . . 73.43 107.92 178.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 42.7 t -104.03 130.71 54.23 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 C-N-CA 124.371 1.069 . . . . 71.41 108.634 173.013 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 45.29 23.53 0.12 Allowed 'General case' 0 N--CA 1.464 0.264 1 C-N-CA 131.728 4.011 . . . . 71.41 114.374 177.278 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 59.41 31.33 69.91 Favored Glycine 0 CA--C 1.531 1.091 0 CA-C-O 117.69 -1.616 . . . . 52.43 113.882 -170.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 10.5 mtpt -131.27 -30.56 1.72 Allowed 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 119.622 1.711 . . . . 72.32 113.386 -177.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -122.16 118.59 29.0 Favored 'General case' 0 CA--C 1.519 -0.235 0 N-CA-C 107.907 -1.146 . . . . 74.24 107.907 -174.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 36.2 ttp85 -100.49 135.8 41.36 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 105.04 -2.207 . . . . 72.03 105.04 175.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 18.1 p90 -154.07 166.5 32.84 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 108.346 -0.983 . . . . 73.13 108.346 172.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -170.94 178.56 3.39 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.998 0.428 . . . . 75.15 110.77 -175.346 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 43.3 mt -55.89 -45.06 79.74 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 C-N-CA 124.904 1.282 . . . . 75.51 108.799 -179.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -88.32 29.4 5.68 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 126.481 1.991 . . . . 75.13 113.155 174.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 19.0 p -119.99 -51.16 2.24 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 107.482 -1.303 . . . . 74.14 107.482 156.315 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -66.52 -39.55 88.7 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 125.097 1.359 . . . . 64.21 112.319 -175.042 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 110.61 11.56 19.05 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 124.103 0.859 . . . . 73.32 113.48 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 159.99 170.4 24.53 Favored Glycine 0 CA--C 1.524 0.598 0 CA-C-N 119.469 1.634 . . . . 62.04 110.525 175.02 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -66.44 -42.36 10.05 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 122.019 1.813 . . . . 74.14 110.762 -175.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -70.1 -34.33 73.0 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 109.166 -0.679 . . . . 63.32 109.166 -177.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 41.7 mm-40 -67.37 -28.9 68.33 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.544 1.538 . . . . 74.3 110.472 174.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 23.6 m -66.0 -40.72 91.39 Favored 'General case' 0 CA--C 1.531 0.212 0 O-C-N 120.467 -1.396 . . . . 73.13 108.844 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 61.1 mt -66.36 -24.48 66.51 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 119.343 0.974 . . . . 71.24 112.423 177.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 9.4 mttt -56.58 -54.25 48.09 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 108.564 -0.902 . . . . 74.14 108.564 168.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -68.14 -43.62 77.92 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 120.326 -0.549 . . . . 74.43 109.931 -178.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.42 -26.98 63.89 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 124.247 1.019 . . . . 70.24 112.864 -174.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -100.69 -32.57 10.66 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 123.769 0.827 . . . . 45.31 111.474 -173.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 33.7 t80 -62.45 -52.01 65.24 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 124.178 0.991 . . . . 73.42 109.906 170.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 48.9 mt -55.39 -32.54 62.72 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 124.304 1.042 . . . . 73.22 112.164 -176.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 81.3 mt -54.19 -62.73 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.309 0 N-CA-C 107.857 -1.164 . . . . 73.41 107.857 174.401 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 -61.53 -37.43 83.75 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 121.193 0.52 . . . . 73.12 111.56 -171.188 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -58.14 -52.21 66.5 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.106 0.963 . . . . 71.41 109.875 179.695 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -68.06 -42.53 80.34 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-O 121.603 0.716 . . . . 74.3 112.586 174.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 5.5 tpm_? -53.61 -46.72 70.53 Favored 'General case' 0 CA--C 1.516 -0.334 0 C-N-CA 125.188 1.395 . . . . 75.45 110.326 -175.09 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -61.35 -15.8 39.73 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 125.201 1.401 . . . . 63.01 112.159 -177.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -62.89 -26.02 68.59 Favored 'General case' 0 CA--C 1.535 0.384 0 O-C-N 121.394 -0.816 . . . . 72.4 112.247 171.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . 55.24 69.12 0.77 Allowed 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 127.351 2.26 . . . . 63.44 109.606 176.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 48.2 tttm -83.5 31.27 0.46 Allowed 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 123.82 0.848 . . . . 73.12 110.866 -168.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 17.2 pttp . . . . . 0 C--O 1.247 0.958 0 C-N-CA 126.171 1.789 . . . . 72.42 110.179 178.113 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.526 0 N-CA-C 107.974 -2.05 . . . . 73.01 107.974 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.414 ' C ' ' H ' ' A' ' 6' ' ' TYR . 1.6 m-20 49.39 79.4 0.08 Allowed 'General case' 0 N--CA 1.458 -0.055 0 C-N-CA 125.607 1.563 . . . . 74.31 110.049 -164.402 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -69.33 8.33 0.62 Allowed 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 125.262 1.425 . . . . 72.14 113.524 177.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.414 ' H ' ' C ' ' A' ' 4' ' ' ASP . 36.8 m-85 -138.6 167.53 21.74 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 126.603 1.961 . . . . 71.54 108.944 -171.649 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 59.3 m -133.99 133.32 41.17 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 107.213 -1.402 . . . . 74.43 107.213 176.034 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -69.37 137.78 53.13 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 108.166 -1.05 . . . . 52.53 108.166 168.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 72.47 24.78 75.68 Favored Glycine 0 CA--C 1.528 0.867 0 N-CA-C 111.251 -0.74 . . . . 61.43 111.251 -167.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 18.4 tttm -140.4 -85.02 0.21 Allowed 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 106.81 -1.552 . . . . 74.45 106.81 171.044 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -72.92 -23.93 60.76 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 124.588 1.155 . . . . 73.42 111.044 -177.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 44.8 p90 -157.74 167.51 29.84 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 123.508 0.723 . . . . 71.42 109.468 -171.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 93.5 t -133.99 119.71 32.99 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 C-N-CA 124.321 1.048 . . . . 75.42 109.089 -179.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.91 161.42 30.15 Favored 'General case' 0 C--N 1.328 -0.351 0 O-C-N 120.19 -1.568 . . . . 63.2 109.633 172.307 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -119.53 108.12 14.13 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 124.022 0.929 . . . . 72.02 108.988 177.704 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.8 m -61.9 -5.64 2.23 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 124.864 1.266 . . . . 74.51 113.946 -178.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -121.02 84.6 39.54 Favored Pre-proline 0 N--CA 1.449 -0.483 0 N-CA-C 106.334 -1.728 . . . . 73.44 106.334 167.298 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -67.19 177.62 3.62 Favored 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 123.084 2.523 . . . . 74.33 111.129 179.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 36.4 t -136.8 139.67 29.61 Favored Pre-proline 0 C--N 1.327 -0.371 0 C-N-CA 124.552 1.141 . . . . 72.32 108.085 -166.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -76.14 177.78 8.32 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 123.0 2.466 . . . . 62.41 112.356 175.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 4.0 m -126.83 -174.61 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 C-N-CA 126.952 2.101 . . . . 73.12 108.301 177.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -66.18 -41.59 90.04 Favored 'General case' 0 CA--C 1.538 0.517 0 O-C-N 121.51 -0.744 . . . . 71.34 109.752 176.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 -168.12 166.04 7.52 Favored Pre-proline 0 CA--C 1.539 0.535 0 C-N-CA 127.63 2.372 . . . . 74.52 108.325 -179.127 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -61.25 167.25 9.64 Favored 'Trans proline' 0 CA--C 1.543 0.952 0 C-N-CA 122.051 1.834 . . . . 71.43 110.681 162.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 137.05 -64.08 0.57 Allowed Glycine 0 C--N 1.338 0.64 0 O-C-N 121.296 -0.877 . . . . 70.15 112.509 170.146 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.416 ' HE2' ' N ' ' A' ' 26' ' ' LYS . 0.2 OUTLIER -113.43 144.16 43.27 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 118.966 1.383 . . . . 74.25 107.756 176.389 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 45.4 mm -67.54 129.66 32.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 104.991 -2.226 . . . . 74.35 104.991 170.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -90.47 138.57 31.44 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 107.322 -1.362 . . . . 72.42 107.322 177.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 58.5 t -129.43 116.47 39.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 106.414 -1.699 . . . . 74.51 106.414 175.114 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 23.4 t -106.58 112.35 39.27 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 N-CA-C 107.891 -1.151 . . . . 73.53 107.891 -175.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -77.53 130.3 36.78 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 107.843 -1.169 . . . . 73.41 107.843 159.076 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 5.3 mp -114.68 130.75 56.86 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 124.236 1.014 . . . . 71.25 108.587 164.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 33.4 p90 -134.17 168.58 18.59 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.608 0.763 . . . . 75.1 111.255 -172.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 25.2 t90 -147.96 168.45 22.26 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 126.597 1.959 . . . . 75.05 107.691 173.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 2.1 m-30 -81.41 -41.13 22.36 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 109.181 -0.674 . . . . 74.25 109.181 179.301 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -76.5 21.64 2.35 Favored Glycine 0 CA--C 1.532 1.105 0 C-N-CA 124.81 1.195 . . . . 60.23 114.089 -175.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 51.8 t -105.0 87.23 1.79 Allowed Pre-proline 0 CA--C 1.537 0.475 0 C-N-CA 126.752 2.021 . . . . 73.03 110.391 -170.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -54.11 -42.61 65.59 Favored 'Trans proline' 0 CA--C 1.534 0.514 0 C-N-CA 122.387 2.058 . . . . 74.22 113.284 177.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 26.7 m170 -72.87 -24.16 60.82 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 119.227 0.922 . . . . 74.12 111.734 -172.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 99.6 m -62.57 -39.25 93.09 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.846 0.858 . . . . 61.33 110.56 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 21.8 t80 -62.67 -45.94 90.5 Favored 'General case' 0 C--N 1.341 0.229 0 C-N-CA 123.616 0.766 . . . . 74.45 111.061 -176.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.61 -9.97 31.61 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 112.695 0.628 . . . . 74.2 112.695 -176.056 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -97.97 -22.61 16.2 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 124.97 1.308 . . . . 72.52 111.267 178.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -44.81 -64.83 0.74 Allowed Pre-proline 0 CA--C 1.54 0.57 0 C-N-CA 125.007 1.323 . . . . 71.2 112.47 -172.069 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -69.96 -4.91 15.11 Favored 'Trans proline' 0 N--CA 1.459 -0.509 0 C-N-CA 122.1 1.867 . . . . 72.35 115.547 -176.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.8 m -87.12 -41.11 14.04 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 108.529 -0.915 . . . . 72.53 108.529 171.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 19.0 tt -84.62 -29.35 6.87 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 O-C-N 121.586 -0.696 . . . . 72.01 111.422 -174.011 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 34.8 t -48.88 -66.32 0.61 Allowed Pre-proline 0 CA--C 1.534 0.339 0 CA-C-O 117.428 -1.272 . . . . 71.43 110.84 172.126 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -58.86 -41.45 62.42 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 121.67 1.58 . . . . 75.05 110.125 -175.206 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 61.6 t90 -52.71 -57.33 10.45 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 118.519 0.599 . . . . 74.14 110.473 177.095 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 78.1 p -59.96 -34.61 73.49 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.272 0.629 . . . . 74.22 112.483 -177.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -78.67 -16.77 56.9 Favored 'General case' 0 CA--C 1.533 0.317 0 O-C-N 121.303 -0.873 . . . . 75.44 112.835 178.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 42.2 mmtm -106.04 2.16 27.04 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 126.089 1.756 . . . . 74.44 112.662 -178.078 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 37.2 mt -57.7 148.73 55.88 Favored Pre-proline 0 C--O 1.236 0.37 0 C-N-CA 124.397 1.079 . . . . 74.41 110.741 177.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -77.55 170.93 18.41 Favored 'Trans proline' 0 N--CA 1.443 -1.451 0 C-N-CA 124.015 3.143 . . . . 64.43 111.014 178.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -67.84 3.4 1.51 Allowed 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 115.075 1.509 . . . . 74.12 115.075 -170.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -118.56 1.42 11.7 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 126.94 2.096 . . . . 64.51 112.568 -177.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 23.1 t -120.19 123.29 70.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 CA-C-N 119.369 0.986 . . . . 54.31 109.569 -179.014 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 80.1 t60 -115.05 107.63 15.6 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 126.155 1.782 . . . . 75.43 109.663 -174.317 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 26.5 t80 -78.34 139.63 38.81 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.688 1.195 . . . . 74.22 110.762 179.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 88.8 t -131.51 146.61 33.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 C-N-CA 127.698 2.399 . . . . 75.55 106.681 -178.132 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 29.7 mtt-85 -131.63 120.03 22.25 Favored 'General case' 0 CA--C 1.508 -0.669 0 N-CA-C 106.929 -1.508 . . . . 71.41 106.929 -177.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 75.2 mt -129.93 148.68 70.57 Favored Pre-proline 0 C--N 1.325 -0.464 0 O-C-N 123.419 0.45 . . . . 75.24 112.187 179.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -75.87 134.77 16.77 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 122.8 2.333 . . . . 74.55 110.457 177.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -75.97 108.7 9.03 Favored 'General case' 0 CA--C 1.535 0.395 0 O-C-N 121.477 -0.764 . . . . 71.02 109.059 170.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 49.5 mt -103.03 94.19 5.42 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 127.165 2.186 . . . . 72.14 108.548 -179.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -130.8 43.53 3.09 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 119.221 0.918 . . . . 65.14 112.21 -175.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 74.63 164.23 11.35 Favored Glycine 0 CA--C 1.522 0.525 0 C-N-CA 124.767 1.175 . . . . 74.51 112.358 175.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 52.33 -144.11 20.45 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.416 -1.073 . . . . 73.32 110.416 -175.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 4.8 tp -64.4 -15.12 16.9 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 CA-C-O 118.093 -0.955 . . . . 73.52 111.431 -172.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 19.7 m95 -59.81 -33.59 71.93 Favored 'General case' 0 C--N 1.342 0.275 0 CA-C-N 120.732 1.605 . . . . 73.25 111.139 173.126 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 7.3 m-80 -80.52 -32.32 36.9 Favored 'General case' 0 C--N 1.339 0.147 0 CA-C-N 118.766 0.712 . . . . 73.32 111.708 177.137 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.404 ' C ' ' H ' ' A' ' 75' ' ' GLY . 70.5 t -68.44 -58.83 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 N-CA-C 108.512 -0.922 . . . . 72.35 108.512 178.159 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 52.1 m170 -72.14 47.21 0.15 Allowed 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 126.625 1.97 . . . . 74.24 109.578 167.113 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.404 ' H ' ' C ' ' A' ' 73' ' ' VAL . . . -164.49 1.24 0.05 OUTLIER Glycine 0 CA--C 1.527 0.818 0 C-N-CA 127.055 2.264 . . . . 55.53 113.28 -176.795 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -108.2 -24.13 11.65 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 120.78 2.29 . . . . 75.21 113.23 -174.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 3.0 ptt? -85.14 -23.45 28.41 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 114.361 1.245 . . . . 74.22 114.361 -170.194 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 29.5 t80 -56.58 -48.68 76.87 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 119.861 1.21 . . . . 74.4 107.94 176.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 35.1 mt -60.84 -46.85 88.95 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 114.846 -1.07 . . . . 72.35 109.672 178.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.72 -41.94 98.29 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 119.503 1.047 . . . . 72.33 111.525 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -54.53 -53.24 57.04 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 123.99 0.916 . . . . 74.42 108.993 -177.31 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -76.54 -24.85 53.64 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 124.645 1.178 . . . . 72.04 112.212 -176.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 7.7 t -55.11 -11.71 0.76 Allowed 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.629 1.572 . . . . 72.13 113.46 172.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 9.1 mtp -110.25 -10.53 14.62 Favored 'General case' 0 C--O 1.225 -0.213 0 C-N-CA 124.165 0.986 . . . . 75.52 112.799 177.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 64.73 37.42 94.33 Favored Glycine 0 CA--C 1.527 0.821 0 CA-C-N 119.926 1.239 . . . . 63.34 111.234 -176.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 27.1 m -57.33 -41.36 78.19 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 C-N-CA 123.496 0.718 . . . . 73.41 111.11 175.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 51.48 75.25 0.21 Allowed 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 126.449 1.9 . . . . 72.45 110.293 173.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 54.7 m170 -71.02 -72.11 0.23 Allowed 'General case' 0 N--CA 1.465 0.285 0 O-C-N 121.574 -0.704 . . . . 72.3 109.581 -174.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 14.5 t0 -174.74 -67.1 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 128.059 2.543 . . . . 64.21 105.041 167.004 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 15.0 m -140.42 157.98 24.77 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 C-N-CA 124.126 0.971 . . . . 74.43 112.127 -173.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 32.5 m80 -73.94 100.66 3.59 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 125.907 1.683 . . . . 74.23 108.423 171.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -139.78 -69.14 0.41 Allowed 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 125.884 1.674 . . . . 75.41 107.55 176.222 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -66.08 -36.83 84.26 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 123.335 0.654 . . . . 72.0 111.53 -166.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 82.7 t -62.0 -35.19 67.03 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.379 0 N-CA-C 109.468 -0.567 . . . . 75.42 109.468 175.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -80.44 -46.97 15.07 Favored 'General case' 0 CA--C 1.527 0.062 0 CA-C-N 119.738 1.154 . . . . 75.44 109.908 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.405 ' OE1' ' HE3' ' A' ' 100' ' ' LYS . 13.4 mm-40 -50.99 -38.13 49.15 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.715 1.606 . . . . 73.31 110.251 178.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -75.56 -14.71 60.41 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.75 1.22 . . . . 64.33 113.826 -174.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 51.9 mt -121.01 -24.45 2.79 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 C-N-CA 125.123 1.369 . . . . 75.22 109.307 -169.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -100.16 -68.3 0.82 Allowed 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 124.977 1.311 . . . . 75.42 108.419 176.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.405 ' HE3' ' OE1' ' A' ' 96' ' ' GLU . 0.1 OUTLIER -65.96 -32.9 74.66 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 119.601 1.091 . . . . 74.41 110.985 -177.456 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -112.98 -21.11 11.28 Favored 'General case' 0 CA--C 1.528 0.101 0 N-CA-C 113.53 0.937 . . . . 75.41 113.53 -170.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 3.2 t60 45.08 62.98 1.9 Allowed 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 125.726 1.611 . . . . 63.53 114.644 175.06 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 19.3 mmtp -77.78 158.95 29.33 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.634 1.174 . . . . 72.52 111.794 174.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 28.7 tttt -93.27 45.87 1.19 Allowed 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 125.089 1.356 . . . . 75.52 112.381 -172.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 53.6 mt -69.0 51.76 0.08 Allowed 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 131.387 3.875 . . . . 73.21 111.475 -179.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -98.37 1.5 47.0 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 126.232 1.813 . . . . 71.4 111.924 -177.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -131.52 150.62 76.87 Favored Pre-proline 0 N--CA 1.467 0.388 0 C-N-CA 124.128 0.971 . . . . 65.41 109.936 -178.483 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_exo -59.62 -42.59 45.77 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 121.675 1.583 . . . . 74.25 110.782 -176.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 10.5 mp0 -61.35 -38.08 85.65 Favored 'General case' 0 N--CA 1.438 -1.065 0 C-N-CA 124.447 1.099 . . . . 74.14 110.623 -179.078 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -71.42 -47.05 58.37 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 125.591 1.557 . . . . 72.03 110.369 -176.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 58.2 mtt -58.56 -55.63 32.61 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 124.609 1.164 . . . . 72.44 109.154 174.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -64.28 -31.12 72.2 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.825 1.25 . . . . 74.42 111.559 -175.18 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -63.6 -46.68 84.7 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 119.478 1.036 . . . . 74.33 110.955 173.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 72.0 t80 -65.71 -44.32 86.45 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 121.866 0.841 . . . . 75.14 109.972 177.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 53.0 mt -69.27 -23.94 63.9 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 124.459 1.104 . . . . 75.45 111.481 -176.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.81 -13.92 18.4 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 122.902 0.481 . . . . 74.43 112.2 176.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -110.93 3.2 28.72 Favored Glycine 0 CA--C 1.526 0.755 0 C-N-CA 124.705 1.145 . . . . 63.23 114.046 170.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -135.42 51.31 2.08 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 119.383 1.592 . . . . 74.4 108.847 -171.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 92.56 13.85 56.35 Favored Glycine 0 CA--C 1.526 0.756 0 O-C-N 124.149 0.905 . . . . 63.41 114.395 162.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 99.1 t -129.99 165.06 31.07 Favored 'Isoleucine or valine' 0 C--O 1.231 0.116 0 CA-C-N 118.317 1.058 . . . . 74.12 109.35 -167.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 45.2 t0 -129.27 130.86 46.74 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 107.36 -1.348 . . . . 74.34 107.36 174.202 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 3.3 mttp -57.23 -36.98 71.59 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 119.075 0.852 . . . . 71.03 110.571 174.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -61.05 -24.16 65.99 Favored 'General case' 0 C--O 1.231 0.098 0 C-N-CA 124.173 0.989 . . . . 74.11 112.209 176.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 88.2 mttt -102.31 -49.37 3.91 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 119.97 1.259 . . . . 71.32 108.465 -177.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 68.4 t80 -48.92 -61.96 1.78 Allowed 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 126.331 1.852 . . . . 72.12 111.953 -178.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 15.9 mt -66.66 -31.63 72.42 Favored 'General case' 0 CA--C 1.534 0.352 0 O-C-N 121.486 -0.759 . . . . 75.2 110.475 -172.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 34.3 t -61.57 -50.4 72.79 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 124.299 1.04 . . . . 54.23 109.128 179.017 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . 0.272 0.0 OUTLIER -70.15 -34.76 73.43 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 119.164 0.893 . . . . 74.02 110.332 178.264 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 49.2 t80 -54.96 -55.29 32.36 Favored 'General case' 0 CA--C 1.529 0.17 0 O-C-N 121.592 -0.693 . . . . 74.42 110.422 179.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 -94.16 49.66 1.33 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.4 0.68 . . . . 75.24 109.294 176.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -123.2 164.15 19.26 Favored 'General case' 0 C--O 1.241 0.626 0 C-N-CA 125.626 1.57 . . . . 61.44 109.322 170.678 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.17 -30.96 70.72 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-O 119.293 -0.384 . . . . 74.05 110.464 178.446 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -45.3 -66.92 0.33 Allowed 'General case' 0 C--O 1.234 0.264 0 C-N-CA 124.97 1.308 . . . . 71.35 110.959 176.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 8.0 mm -64.54 -32.82 59.39 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 CA-C-O 118.56 -0.733 . . . . 75.03 111.21 -178.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 10.5 mttp -57.87 -35.35 70.84 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 119.1 0.863 . . . . 72.43 110.617 174.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -82.65 -31.78 29.09 Favored Glycine 0 C--N 1.339 0.695 0 CA-C-O 122.583 1.101 . . . . 72.44 110.696 -175.112 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 2.8 mm100 -74.51 -39.86 62.14 Favored 'General case' 0 N--CA 1.45 -0.46 0 O-C-N 121.539 -0.977 . . . . 75.54 109.835 -176.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 9.3 mtp -60.63 -51.26 70.15 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 119.069 -0.491 . . . . 75.21 110.379 174.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -63.64 -29.16 70.44 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 118.86 0.754 . . . . 73.41 112.435 -174.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 14.7 mtmt -61.47 -75.15 0.07 Allowed 'General case' 0 CA--C 1.522 -0.102 0 N-CA-C 107.86 -1.163 . . . . 74.11 107.86 165.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -49.12 -35.07 15.44 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.228 1.011 . . . . 74.43 112.619 -169.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 9.9 tmtt? -58.02 -46.94 84.48 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 126.301 1.84 . . . . 74.33 112.366 177.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 9.5 ptpp? -77.79 -33.44 52.59 Favored 'General case' 0 C--N 1.34 0.176 0 CA-C-N 120.824 1.647 . . . . 64.02 111.199 173.573 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 41.5 mt -59.35 -46.21 89.27 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 119.032 0.833 . . . . 71.24 109.973 -174.151 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -58.67 -37.03 75.12 Favored 'General case' 0 CA--C 1.534 0.349 0 O-C-N 121.814 -0.554 . . . . 60.53 111.592 -178.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 1.1 mtm -76.8 -31.85 57.25 Favored 'General case' 0 C--O 1.23 0.044 0 O-C-N 122.138 -0.352 . . . . 75.22 110.857 179.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -56.46 -46.24 80.47 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 108.82 -0.808 . . . . 75.45 108.82 172.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 35.8 m-85 -76.74 10.16 2.38 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 114.175 1.176 . . . . 75.24 114.175 177.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 59.1 23.47 11.69 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 127.562 2.345 . . . . 74.0 113.98 176.004 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 66.4 t -67.05 133.97 30.76 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 C-N-CA 124.031 0.932 . . . . 74.42 108.653 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -130.49 -5.65 4.21 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 125.244 1.418 . . . . 75.32 113.132 -177.641 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 170.98 139.51 2.78 Favored Glycine 0 N--CA 1.448 -0.541 0 N-CA-C 107.666 -2.173 . . . . 64.24 107.666 174.174 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.422 ' HA ' ' C ' ' A' ' 154' ' ' PRO . 17.2 m -83.37 152.72 64.84 Favored Pre-proline 0 CA--C 1.534 0.364 0 C-N-CA 124.559 1.144 . . . . 73.45 109.647 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . 0.422 ' C ' ' HA ' ' A' ' 153' ' ' VAL . 53.7 Cg_endo -70.74 157.71 94.59 Favored 'Cis proline' 0 CA--C 1.531 0.359 0 C-N-CA 125.15 -0.771 . . . . 75.35 113.623 3.405 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 36.5 m -157.13 115.17 3.19 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 107.461 -1.311 . . . . 72.3 107.461 175.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 93.7 mtp -96.3 158.24 15.53 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 108.705 -0.85 . . . . 75.53 108.705 164.01 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 5.2 t -136.48 138.47 46.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 106.586 -1.635 . . . . 75.24 106.586 174.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 51.2 t -103.18 125.22 57.66 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 N-CA-C 106.734 -1.58 . . . . 74.41 106.734 164.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 9.4 t30 52.98 21.54 2.08 Favored 'General case' 0 N--CA 1.462 0.153 0 C-N-CA 130.89 3.676 . . . . 72.15 115.521 162.112 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 73.34 22.62 78.57 Favored Glycine 0 CA--C 1.526 0.72 0 CA-C-O 117.69 -1.617 . . . . 64.42 114.068 -176.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 10.4 mtpt -134.18 -24.4 1.64 Allowed 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 120.248 2.024 . . . . 73.24 113.122 -174.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -128.2 120.2 26.78 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 124.179 0.991 . . . . 74.22 109.033 -173.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 41.5 ttp85 -102.56 126.83 49.76 Favored 'General case' 0 CA--C 1.52 -0.178 0 C-N-CA 126.117 1.767 . . . . 75.31 107.886 174.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 13.4 p90 -145.28 174.0 11.48 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 107.277 -1.379 . . . . 75.32 107.277 177.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 174.89 -175.25 0.08 Allowed 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 125.437 1.495 . . . . 64.41 108.595 176.423 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 6.5 mt -45.58 -52.27 2.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 C-N-CA 129.901 3.281 . . . . 75.43 108.574 172.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -75.61 19.28 2.6 Favored Glycine 0 CA--C 1.524 0.641 0 C-N-CA 128.062 2.744 . . . . 74.12 114.911 176.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 19.2 m -129.27 -50.1 1.19 Allowed 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 119.315 1.557 . . . . 62.1 110.847 157.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -71.16 -19.56 62.4 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.691 0.797 . . . . 74.43 111.944 -174.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 103.44 4.14 46.83 Favored Glycine 0 CA--C 1.525 0.66 0 O-C-N 120.624 -1.298 . . . . 62.35 113.296 175.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 154.03 177.06 27.07 Favored Glycine 0 CA--C 1.53 0.981 0 CA-C-N 119.239 1.52 . . . . 72.23 111.268 172.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -65.07 -37.51 32.55 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 122.851 2.367 . . . . 73.53 113.38 -169.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -69.37 -42.32 75.37 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 119.454 1.025 . . . . 74.51 108.413 -178.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 51.2 mm-40 -66.03 -26.89 67.73 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.685 1.194 . . . . 64.43 110.235 179.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 46.0 m -64.36 -41.34 96.77 Favored 'General case' 0 CA--C 1.534 0.354 0 O-C-N 120.075 -1.641 . . . . 65.34 110.638 -178.276 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 36.9 mt -65.88 -32.04 73.32 Favored 'General case' 0 C--N 1.341 0.203 0 CA-C-N 119.061 0.846 . . . . 75.43 110.532 175.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.03 -39.8 69.53 Favored 'General case' 0 CA--C 1.522 -0.127 0 C-N-CA 124.903 1.281 . . . . 73.4 109.535 174.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -78.21 -41.48 34.33 Favored 'General case' 0 CA--C 1.505 -0.763 0 CA-C-O 117.638 -1.172 . . . . 74.01 111.076 173.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -55.63 -45.97 77.49 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 119.52 1.055 . . . . 72.53 109.889 -172.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.93 -37.6 55.01 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 125.204 1.401 . . . . 55.53 109.519 -167.643 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 12.9 t80 -67.78 -47.8 68.13 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.512 1.125 . . . . 65.33 111.253 173.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 78.8 mt -63.33 -35.88 81.85 Favored 'General case' 0 C--O 1.232 0.169 0 C-N-CA 123.889 0.876 . . . . 73.52 110.83 -176.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 34.7 mt -53.31 -54.61 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 CA-C-O 118.338 -0.839 . . . . 73.32 109.181 170.275 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -55.92 -41.78 75.08 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 119.554 1.07 . . . . 73.15 111.553 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.86 -55.72 27.34 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 125.157 1.383 . . . . 74.45 108.267 -179.363 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 26.4 mm-40 -71.38 -32.74 68.82 Favored 'General case' 0 C--O 1.225 -0.186 0 C-N-CA 124.514 1.125 . . . . 73.34 113.094 -178.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.91 -24.52 62.46 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 120.762 -1.211 . . . . 71.54 111.719 -178.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -59.11 -23.75 62.38 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.302 0.641 . . . . 73.11 111.928 171.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -54.68 -22.06 12.6 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.327 1.051 . . . . 74.31 112.463 169.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -119.04 -7.96 10.28 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 113.721 1.008 . . . . 61.44 113.721 168.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 23.3 ttmt -101.03 51.1 0.86 Allowed 'General case' 0 CA--C 1.536 0.419 0 O-C-N 120.513 -1.367 . . . . 75.43 110.698 -172.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.159 0 C-N-CA 127.694 2.398 . . . . 75.34 111.981 177.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.929 0 N-CA-C 108.668 -1.773 . . . . 73.24 108.668 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 178.19 142.18 0.1 Allowed 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 129.118 2.967 . . . . 65.51 103.341 -159.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -143.03 6.87 1.58 Allowed 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.527 0.679 . . . . 61.43 111.723 -166.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 -132.87 178.96 6.47 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.561 1.144 . . . . 71.34 109.619 -168.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.0 m -148.05 141.93 25.78 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.588 1.555 . . . . 72.13 109.467 175.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.98 137.28 56.4 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 124.338 1.055 . . . . 72.43 110.043 178.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.7 -17.4 15.54 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 125.959 1.742 . . . . 74.53 112.76 -171.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 4.4 ttmt -92.86 -86.47 0.25 Allowed 'General case' 0 CA--C 1.519 -0.218 0 CA-C-N 119.028 1.414 . . . . 72.13 107.783 -176.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -77.53 -21.34 52.77 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.627 0.771 . . . . 63.21 110.364 -175.354 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 14.0 p90 -161.51 175.95 11.59 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.784 1.234 . . . . 71.13 109.296 -175.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 41.3 t -135.05 154.41 36.21 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.811 0 C-N-CA 126.377 1.871 . . . . 74.12 108.321 -175.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -103.88 170.59 7.84 Favored 'General case' 0 CA--C 1.521 -0.164 0 O-C-N 119.649 -1.907 . . . . 61.22 109.63 166.209 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -128.56 113.22 15.18 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 106.956 -1.498 . . . . 73.33 106.956 169.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.4 m -58.43 -15.06 9.27 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 117.129 -1.415 . . . . 74.22 113.744 176.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.6 m -107.96 75.91 0.56 Allowed Pre-proline 0 C--N 1.343 0.307 0 CA-C-N 120.526 1.512 . . . . 74.54 110.179 169.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -71.54 174.46 10.92 Favored 'Trans proline' 0 N--CA 1.444 -1.386 0 C-N-CA 123.19 2.594 . . . . 71.32 110.241 178.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 64.7 t -139.26 125.76 12.51 Favored Pre-proline 0 C--N 1.323 -0.583 0 N-CA-C 107.042 -1.466 . . . . 70.12 107.042 -165.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -73.78 174.84 11.62 Favored 'Trans proline' 0 N--CA 1.453 -0.892 0 C-N-CA 122.646 2.231 . . . . 75.54 110.897 178.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 34.0 m -139.39 -174.03 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 C-N-CA 124.645 1.178 . . . . 74.44 109.404 178.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 15.2 t -48.19 -68.89 0.14 Allowed 'General case' 0 N--CA 1.442 -0.852 0 C-N-CA 128.17 2.588 . . . . 73.35 110.458 172.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -152.94 163.47 23.4 Favored Pre-proline 0 CA--C 1.534 0.354 0 C-N-CA 124.399 1.08 . . . . 52.44 110.297 174.36 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -78.79 -7.1 15.51 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 124.058 3.172 . . . . 74.41 113.095 177.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -58.15 -37.29 85.85 Favored Glycine 0 C--N 1.338 0.667 0 C-N-CA 125.537 1.541 . . . . 71.11 113.605 -170.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 28.2 mttp -119.32 124.58 46.99 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 126.388 1.875 . . . . 74.01 106.087 165.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 44.7 mm -54.98 136.26 17.23 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 N-CA-C 106.931 -1.507 . . . . 70.13 106.931 168.2 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -104.4 93.12 4.63 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 106.425 -1.695 . . . . 75.24 106.425 -176.112 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 26.6 t -88.31 135.86 24.62 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 N-CA-C 106.624 -1.621 . . . . 74.51 106.624 174.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 33.6 t -129.31 135.84 60.83 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 N-CA-C 107.243 -1.392 . . . . 63.24 107.243 -176.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 15.9 tm-20 -114.0 140.57 48.32 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 125.133 1.373 . . . . 74.45 107.699 167.063 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.4 mp -130.76 114.72 15.7 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 124.615 1.166 . . . . 75.33 108.466 -179.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 18.9 p90 -107.36 174.85 5.7 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 124.603 1.161 . . . . 74.3 111.931 -176.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 22.6 t90 -145.34 162.01 38.27 Favored 'General case' 0 C--O 1.225 -0.219 0 C-N-CA 125.068 1.347 . . . . 74.54 107.999 162.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 59.8 t80 -56.7 -42.43 79.1 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 126.062 1.745 . . . . 75.52 112.121 172.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -95.39 29.73 9.2 Favored Glycine 0 CA--C 1.531 1.089 0 O-C-N 120.938 -1.101 . . . . 61.34 113.665 -168.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 23.3 t -106.03 81.87 0.82 Allowed Pre-proline 0 CA--C 1.537 0.472 0 C-N-CA 130.474 3.51 . . . . 75.13 111.528 -173.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -79.14 62.02 8.35 Favored 'Trans proline' 0 CA--C 1.544 1.023 0 C-N-CA 121.694 1.596 . . . . 74.24 111.482 -177.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 -160.35 -49.99 0.05 OUTLIER 'General case' 0 C--O 1.226 -0.182 0 C-N-CA 126.123 1.769 . . . . 74.42 109.095 -178.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 1.1 p -61.52 -37.36 83.45 Favored 'General case' 0 CA--C 1.548 0.872 0 CA-C-O 121.769 0.795 . . . . 74.13 110.339 -173.036 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -61.76 -29.15 69.94 Favored 'General case' 0 N--CA 1.468 0.465 0 O-C-N 120.084 -1.635 . . . . 73.22 112.87 176.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -78.01 3.61 14.34 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.903 1.281 . . . . 74.5 111.107 177.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 24.4 t80 -125.49 -27.78 3.39 Favored 'General case' 0 C--O 1.223 -0.308 0 C-N-CA 126.781 2.033 . . . . 74.2 111.0 178.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -39.51 -65.76 0.39 Allowed Pre-proline 0 CA--C 1.544 0.712 0 CA-C-N 120.286 1.403 . . . . 74.44 114.638 -177.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -75.89 -9.05 19.43 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 CA-C-N 122.17 1.811 . . . . 73.24 114.185 -178.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 4.2 m -68.44 -42.68 78.51 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 108.45 -0.944 . . . . 73.13 108.45 164.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 19.9 tt -88.21 -34.55 7.23 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 N-CA-C 112.762 0.652 . . . . 73.03 112.762 -172.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 16.2 t -44.73 -54.72 12.14 Favored Pre-proline 0 CA--C 1.549 0.936 0 C-N-CA 124.409 1.084 . . . . 73.55 113.464 176.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -74.07 -21.35 18.23 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 121.905 1.737 . . . . 72.43 112.356 -178.136 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 86.3 t90 -66.15 -51.61 56.21 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 118.679 0.672 . . . . 72.12 109.75 170.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 5.1 p -67.05 -24.14 65.96 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 119.075 0.852 . . . . 74.35 112.277 -175.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 73.6 mt-10 -59.9 -54.7 43.08 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 120.793 -1.192 . . . . 74.11 110.302 168.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 54.5 mmtt -76.68 6.73 5.49 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 125.316 1.446 . . . . 75.2 113.555 -168.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 36.6 mt -62.28 157.15 56.29 Favored Pre-proline 0 N--CA 1.448 -0.574 0 C-N-CA 122.986 0.514 . . . . 73.31 111.268 178.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -77.72 174.88 11.93 Favored 'Trans proline' 0 N--CA 1.449 -1.117 0 C-N-CA 124.809 3.673 . . . . 73.53 110.296 173.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -71.26 -5.74 34.47 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.636 0.774 . . . . 73.12 112.888 177.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -95.66 7.88 45.03 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 123.856 0.862 . . . . 74.45 109.847 -176.205 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 22.6 t -138.76 152.75 24.8 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 N-CA-C 107.628 -1.249 . . . . 73.51 107.628 -176.046 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 41.3 t60 -137.47 162.1 34.59 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 107.332 -1.359 . . . . 61.11 107.332 165.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 35.1 t80 -125.99 137.74 53.69 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 124.237 1.015 . . . . 74.45 108.493 -173.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 52.8 t -132.44 147.84 31.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 107.421 -1.325 . . . . 63.13 107.421 -175.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 44.0 mtm180 -124.21 136.0 53.85 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 107.236 -1.394 . . . . 71.52 107.236 163.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 92.8 mt -129.7 144.91 54.84 Favored Pre-proline 0 C--N 1.328 -0.361 0 O-C-N 123.654 0.596 . . . . 62.33 109.96 172.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -73.9 143.83 33.65 Favored 'Trans proline' 0 N--CA 1.451 -0.984 0 C-N-CA 120.756 0.971 . . . . 75.13 109.835 175.269 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -89.28 106.31 18.36 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 126.297 1.839 . . . . 72.14 107.841 174.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 57.8 mt -102.83 60.09 0.79 Allowed 'General case' 0 C--O 1.237 0.417 0 C-N-CA 125.343 1.457 . . . . 73.34 111.491 -168.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 -88.15 -6.54 57.82 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 114.569 1.322 . . . . 71.11 114.569 -164.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 106.58 -173.22 19.26 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 108.548 -1.821 . . . . 43.32 108.548 -175.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 44.39 64.79 1.91 Allowed Glycine 0 CA--C 1.528 0.904 0 CA-C-O 117.929 -1.484 . . . . 64.33 112.444 173.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . 0.276 2.8 tt 64.96 -15.97 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 131.153 3.781 . . . . 74.53 116.192 -176.486 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 10.4 m95 -57.01 -36.83 70.86 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 121.185 1.811 . . . . 73.15 112.311 -174.256 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -73.02 -40.25 65.31 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-O 118.693 -0.67 . . . . 63.2 112.4 -178.078 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 92.3 t -57.92 -51.67 67.71 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 C-N-CA 123.605 0.762 . . . . 74.53 109.474 -175.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 65.4 m170 -69.23 -0.69 6.45 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.541 1.136 . . . . 73.53 113.259 178.049 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -101.19 -47.85 1.52 Allowed Glycine 0 CA--C 1.526 0.761 0 N-CA-C 109.852 -1.299 . . . . 73.32 109.852 174.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -53.28 -34.02 55.56 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 127.383 2.273 . . . . 75.24 114.684 -164.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -57.98 -42.91 86.08 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-O 117.742 -1.123 . . . . 74.14 112.443 178.469 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -55.4 -54.1 47.9 Favored 'General case' 0 CA--C 1.526 0.042 0 N-CA-C 108.639 -0.875 . . . . 75.24 108.639 -175.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 15.7 mt -55.74 -37.56 68.64 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.664 1.186 . . . . 74.53 110.982 177.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.3 m -73.39 -39.76 64.86 Favored 'General case' 0 C--N 1.343 0.324 0 CA-C-N 119.498 1.044 . . . . 72.23 110.588 -177.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 1.2 tt -56.3 -51.1 69.46 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 125.219 1.407 . . . . 64.52 108.054 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -62.19 -29.66 70.53 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.694 1.198 . . . . 73.02 110.757 177.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 10.4 t -65.17 -30.66 71.59 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.873 0.869 . . . . 75.12 111.351 -171.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 16.6 mtm -69.23 -13.91 62.67 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 119.682 1.128 . . . . 70.31 112.861 173.344 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 67.47 44.8 82.55 Favored Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 110.127 -1.189 . . . . 71.21 110.127 -170.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 27.7 m -57.22 -35.28 48.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 CA-C-O 118.839 -0.6 . . . . 72.22 111.264 171.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 44.73 67.38 0.71 Allowed 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 126.421 1.888 . . . . 71.42 110.807 -179.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 9.6 t-80 -87.08 152.08 22.67 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 114.45 -1.25 . . . . 75.34 109.926 -168.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -47.2 -52.93 14.43 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 125.998 1.719 . . . . 73.22 113.365 -170.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 21.2 m -142.0 160.49 20.55 Favored 'Isoleucine or valine' 0 C--O 1.243 0.711 0 C-N-CA 125.993 1.717 . . . . 64.32 107.504 167.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 25.0 m170 -97.26 5.79 49.43 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.114 0.966 . . . . 74.23 112.93 -176.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -54.06 -59.23 4.92 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 125.629 1.572 . . . . 74.22 110.166 179.162 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -61.78 -22.74 65.68 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 113.722 1.008 . . . . 74.23 113.722 -166.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 74.9 t -60.81 -69.37 0.18 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.322 0 C-N-CA 124.897 1.279 . . . . 74.01 108.587 170.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -60.4 -47.7 84.94 Favored 'General case' 0 CA--C 1.521 -0.165 0 C-N-CA 123.666 0.786 . . . . 74.45 109.814 -175.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -59.61 -26.93 65.86 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 124.198 0.999 . . . . 71.43 111.038 -176.287 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -88.56 -8.96 53.87 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 112.928 0.714 . . . . 55.44 112.928 -179.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 14.7 mm -73.27 -60.65 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 N-CA-C 106.053 -1.832 . . . . 74.41 106.053 154.256 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 35.0 p80 -88.27 -70.41 0.64 Allowed 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 114.325 1.231 . . . . 74.12 114.325 -152.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 25.5 mttp -58.76 -31.3 68.23 Favored 'General case' 0 N--CA 1.463 0.19 0 C-N-CA 123.954 0.901 . . . . 73.21 110.74 177.008 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -69.58 -38.47 77.39 Favored 'General case' 0 N--CA 1.452 -0.34 0 O-C-N 121.814 -0.554 . . . . 64.31 110.602 176.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 3.4 t-160 48.77 92.45 0.02 OUTLIER 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 129.578 3.151 . . . . 74.21 110.891 -164.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.526 ' HE3' ' CE1' ' A' ' 114' ' ' PHE . 0.2 OUTLIER -132.85 147.28 52.3 Favored 'General case' 0 CA--C 1.515 -0.392 0 C-N-CA 123.374 0.67 . . . . 73.33 110.667 170.722 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 3.9 ttmt -79.48 95.47 5.82 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 106.249 -1.76 . . . . 75.53 106.249 -175.189 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 90.0 mt -121.07 46.18 2.1 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 126.379 1.872 . . . . 73.53 110.645 -177.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -80.05 8.08 7.83 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 115.025 1.491 . . . . 72.32 115.025 -174.617 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -153.13 153.86 30.13 Favored Pre-proline 0 C--N 1.326 -0.421 0 C-N-CA 124.737 1.215 . . . . 74.2 109.056 -163.201 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_endo -65.29 -42.84 12.27 Favored 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 122.421 2.081 . . . . 75.54 110.759 -170.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.424 ' HG2' ' H ' ' A' ' 109' ' ' GLU . 9.4 pt-20 -64.61 -36.79 85.4 Favored 'General case' 0 N--CA 1.444 -0.738 0 C-N-CA 124.209 1.004 . . . . 72.32 111.449 -177.674 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -65.74 -52.9 47.45 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 125.8 1.64 . . . . 74.44 110.192 175.065 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 49.6 mtm -59.3 -43.51 92.6 Favored 'General case' 0 CA--C 1.529 0.164 0 O-C-N 121.804 -0.56 . . . . 74.45 110.616 178.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -61.46 -52.24 65.36 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 124.195 0.998 . . . . 64.32 109.676 177.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -50.81 -46.48 59.86 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 125.371 1.469 . . . . 73.1 110.696 -179.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . 0.526 ' CE1' ' HE3' ' A' ' 103' ' ' LYS . 57.5 t80 -61.15 -41.75 97.32 Favored 'General case' 0 N--CA 1.449 -0.497 0 O-C-N 121.768 -0.582 . . . . 74.44 112.217 -178.001 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 36.7 mt -83.28 -16.53 45.94 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 123.782 0.833 . . . . 75.43 111.144 -174.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -72.53 66.61 0.71 Allowed 'General case' 0 C--O 1.234 0.267 0 C-N-CA 127.539 2.336 . . . . 64.23 110.891 -171.049 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -178.4 -37.81 0.06 OUTLIER Glycine 0 N--CA 1.442 -0.95 0 C-N-CA 127.557 2.503 . . . . 61.33 109.941 -177.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 1.7 ptpt -86.32 3.12 44.76 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 119.428 1.614 . . . . 74.0 114.111 -163.186 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 118.36 -2.77 16.1 Favored Glycine 0 N--CA 1.449 -0.499 0 CA-C-O 118.694 -1.059 . . . . 61.25 111.135 -167.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 42.5 t -96.7 149.48 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.948 0 N-CA-C 103.642 -2.725 . . . . 74.24 103.642 169.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -124.34 143.35 50.63 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 106.942 -1.503 . . . . 64.33 106.942 169.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 24.4 mtpt -55.8 -48.86 74.64 Favored 'General case' 0 CA--C 1.516 -0.327 0 CA-C-O 118.56 -0.733 . . . . 74.15 109.285 178.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -55.01 -35.91 64.9 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 118.71 0.687 . . . . 70.33 111.779 -177.108 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 27.8 mmmt -94.99 -29.54 14.58 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 123.537 0.735 . . . . 74.1 109.392 -165.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 82.1 t80 -66.55 -64.57 0.83 Allowed 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 127.2 2.2 . . . . 73.32 109.413 169.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 12.8 mt -58.27 -43.75 88.08 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.236 1.014 . . . . 73.55 109.939 -170.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 22.7 t -52.68 -26.49 14.03 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 126.294 1.838 . . . . 73.44 113.176 -179.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . 0.278 1.4 t -116.73 -23.55 8.09 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 119.363 0.983 . . . . 70.33 110.712 -176.262 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 27.9 t80 -53.59 -52.57 59.35 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.721 1.208 . . . . 73.11 108.84 166.2 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 18.0 m-80 -91.98 38.85 1.0 Allowed 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 124.551 1.141 . . . . 74.51 110.574 -177.016 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 3.2 t -140.06 169.95 16.75 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 114.627 1.343 . . . . 73.12 114.627 178.187 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -52.98 -30.6 35.93 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 126.802 2.041 . . . . 74.3 111.133 -179.458 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -52.33 -63.73 1.05 Allowed 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 125.351 1.461 . . . . 74.33 110.824 173.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 11.5 mm -63.55 -27.37 42.83 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.141 0 O-C-N 121.452 -0.78 . . . . 75.41 112.298 176.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.09 -40.44 73.64 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 119.604 1.093 . . . . 74.13 109.708 173.275 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -64.84 -26.63 71.31 Favored Glycine 0 CA--C 1.532 1.114 0 C-N-CA 124.569 1.08 . . . . 70.03 112.744 177.295 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 6.9 mt-30 -85.42 -45.31 11.98 Favored 'General case' 0 C--O 1.235 0.291 0 O-C-N 120.943 -1.328 . . . . 64.43 110.287 179.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 82.4 mmm -61.84 -31.45 71.7 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 123.645 0.778 . . . . 74.21 110.764 179.275 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -64.73 -51.84 60.25 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 119.502 1.046 . . . . 71.51 111.321 175.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 5.8 mttm -62.82 -57.57 10.42 Favored 'General case' 0 CA--C 1.512 -0.497 0 C-N-CA 123.761 0.824 . . . . 74.43 109.29 -175.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -52.95 -40.52 63.73 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 119.494 -0.289 . . . . 72.45 110.883 -176.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.68 -62.14 2.02 Favored 'General case' 0 C--N 1.343 0.292 0 CA-C-N 118.7 0.682 . . . . 74.35 110.007 174.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 8.0 ptmt -68.52 -16.55 63.92 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 113.019 0.748 . . . . 75.32 113.019 -169.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 65.9 mt -69.47 -59.65 2.84 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 123.687 0.795 . . . . 74.15 110.104 168.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -54.51 -43.72 72.1 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 118.736 0.698 . . . . 73.04 112.531 -173.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 2.1 ptm -63.21 -44.4 95.43 Favored 'General case' 0 N--CA 1.468 0.458 0 O-C-N 121.677 -0.639 . . . . 75.4 112.377 175.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -64.11 -40.82 97.03 Favored 'General case' 0 CA--C 1.536 0.433 0 O-C-N 121.893 -0.505 . . . . 75.43 109.739 -178.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 21.5 m-85 -70.42 9.0 0.68 Allowed 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 126.944 2.098 . . . . 74.35 113.426 173.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 58.3 mt-30 53.76 35.54 21.65 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 126.612 1.965 . . . . 75.12 114.046 178.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 43.4 t -77.68 89.21 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 O-C-N 120.698 -1.251 . . . . 72.2 108.602 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -82.34 -12.13 58.16 Favored 'General case' 0 N--CA 1.469 0.496 0 O-C-N 120.586 -1.321 . . . . 64.1 113.458 177.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -171.18 -171.64 36.59 Favored Glycine 0 CA--C 1.524 0.639 0 C-N-CA 125.216 1.389 . . . . 73.53 109.65 -173.066 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.429 ' HA ' ' C ' ' A' ' 154' ' ' PRO . 29.0 m -137.92 158.38 71.48 Favored Pre-proline 0 CA--C 1.544 0.72 0 C-N-CA 124.756 1.222 . . . . 64.04 109.155 178.667 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . 0.429 ' C ' ' HA ' ' A' ' 153' ' ' VAL . 31.4 Cg_endo -62.49 152.17 65.46 Favored 'Cis proline' 0 N--CA 1.452 -0.969 0 C-N-CA 123.569 -1.429 . . . . 74.0 112.788 -10.221 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 77.6 m -141.07 127.08 19.39 Favored 'General case' 0 N--CA 1.443 -0.805 0 C-N-CA 126.457 1.903 . . . . 74.44 107.013 170.041 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 33.1 mmm -107.08 160.27 15.68 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 124.908 1.283 . . . . 71.43 107.57 159.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 6.3 t -142.02 148.29 20.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 106.955 -1.498 . . . . 74.41 106.955 177.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 58.8 t -121.36 126.0 74.39 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 N-CA-C 106.314 -1.735 . . . . 73.34 106.314 168.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 55.25 17.82 2.21 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 127.339 2.256 . . . . 65.12 115.006 171.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 58.41 31.37 66.32 Favored Glycine 0 CA--C 1.53 0.969 0 CA-C-O 117.926 -1.485 . . . . 72.35 112.791 -168.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 1.2 mtpm? -126.38 -42.88 1.8 Allowed 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 119.656 1.728 . . . . 73.34 111.779 -177.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -111.65 147.34 35.73 Favored 'General case' 0 CA--C 1.511 -0.551 0 N-CA-C 106.941 -1.503 . . . . 74.2 106.941 179.11 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 41.4 ttp85 -125.01 135.87 53.18 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 105.601 -2.0 . . . . 73.1 105.601 175.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 7.4 p90 -153.54 171.41 18.78 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 107.295 -1.372 . . . . 72.22 107.295 -178.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 174.97 176.33 0.17 Allowed 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 123.726 0.81 . . . . 73.41 108.915 -178.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 38.7 mt -57.14 -35.2 47.41 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 C-N-CA 128.266 2.626 . . . . 72.41 110.268 -173.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -86.62 -3.55 83.73 Favored Glycine 0 CA--C 1.525 0.687 0 CA-C-O 117.617 -1.657 . . . . 64.31 113.278 -177.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 19.4 m -105.72 -54.59 2.46 Favored 'General case' 0 C--N 1.342 0.248 0 CA-C-N 119.04 1.42 . . . . 75.11 108.86 168.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -60.74 -29.14 69.2 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 125.234 1.414 . . . . 65.34 112.4 -179.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 98.43 8.59 54.65 Favored Glycine 0 CA--C 1.527 0.841 0 CA-C-O 119.115 -0.825 . . . . 73.05 113.712 175.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 163.68 171.42 29.9 Favored Glycine 0 CA--C 1.527 0.827 0 CA-C-N 119.543 1.671 . . . . 72.52 111.781 177.299 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -69.37 -44.34 2.41 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 122.097 1.864 . . . . 64.53 111.129 -175.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -68.6 -34.45 75.8 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 118.913 0.779 . . . . 73.53 109.473 179.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -62.8 -33.27 74.86 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 123.226 0.611 . . . . 75.02 109.828 176.181 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 37.1 m -65.41 -40.55 93.52 Favored 'General case' 0 CA--C 1.534 0.358 0 O-C-N 120.924 -1.11 . . . . 65.42 109.332 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 58.7 mt -64.55 -36.46 84.28 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 119.644 1.111 . . . . 75.23 110.647 175.009 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 27.0 tttt -50.93 -51.76 49.0 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.176 0.991 . . . . 63.41 108.904 172.344 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -67.67 -40.85 84.45 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-O 118.415 -0.803 . . . . 65.11 111.143 177.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -56.59 -41.59 77.24 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 119.05 0.841 . . . . 72.24 111.347 -174.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -85.93 -36.75 19.68 Favored 'General case' 0 CA--C 1.511 -0.532 0 N-CA-C 109.171 -0.677 . . . . 74.2 109.171 -168.271 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -59.3 -54.17 49.85 Favored 'General case' 0 N--CA 1.438 -1.059 0 N-CA-C 109.064 -0.717 . . . . 74.32 109.064 170.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 90.9 mt -61.93 -32.04 72.41 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-O 118.271 -0.871 . . . . 73.34 112.47 -175.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 26.6 mt -51.16 -65.97 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.212 0 CA-C-N 119.211 0.914 . . . . 75.12 109.352 166.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 9.8 tm-20 -69.76 -20.09 63.5 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.984 0.913 . . . . 75.11 112.101 -171.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.24 -52.95 60.09 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 124.962 1.305 . . . . 64.34 109.05 168.551 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 42.2 mm-40 -74.99 -39.7 61.1 Favored 'General case' 0 C--N 1.334 -0.104 0 C-N-CA 123.578 0.751 . . . . 72.44 111.891 -176.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.14 -36.03 74.53 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 124.023 0.929 . . . . 75.41 109.767 -177.69 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -61.7 -16.18 46.86 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.273 1.029 . . . . 61.34 112.417 177.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -65.52 -35.48 80.98 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 119.168 0.894 . . . . 63.0 111.533 173.065 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -118.04 -18.09 9.5 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 113.922 1.082 . . . . 71.44 113.922 -173.01 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 36.6 tttt 44.83 80.16 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 126.804 2.042 . . . . 73.52 113.213 168.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 8.6 mmtt . . . . . 0 C--O 1.25 1.081 0 C-N-CA 125.694 1.598 . . . . 74.15 111.525 166.39 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.812 0 N-CA-C 108.608 -1.797 . . . . 60.11 108.608 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -86.25 131.99 34.1 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 124.538 1.135 . . . . 65.12 108.155 -174.404 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -117.83 10.99 13.4 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 113.172 0.805 . . . . 71.31 113.172 -171.214 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -141.55 164.15 30.99 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 125.558 1.543 . . . . 75.52 107.705 -173.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 29.4 m -133.04 130.98 40.11 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.14 -0.689 . . . . 74.32 109.14 -176.046 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.36 124.18 21.57 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 108.061 -1.089 . . . . 63.13 108.061 176.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 101.1 -38.49 3.12 Favored Glycine 0 CA--C 1.527 0.832 0 C-N-CA 128.556 2.979 . . . . 71.12 111.393 -173.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 8.4 tptp -75.21 -67.3 0.67 Allowed 'General case' 0 C--O 1.226 -0.163 0 C-N-CA 126.364 1.866 . . . . 74.03 109.442 -175.15 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 5.3 mp0 -93.28 -28.65 16.09 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 126.229 1.812 . . . . 74.34 109.691 -173.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 55.2 p90 -152.54 167.26 29.41 Favored 'General case' 0 N--CA 1.469 0.523 0 O-C-N 121.012 -1.055 . . . . 74.41 110.73 -171.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 93.4 t -133.51 117.01 26.09 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-N 119.661 1.119 . . . . 74.33 109.716 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -71.71 166.75 21.3 Favored 'General case' 0 N--CA 1.447 -0.614 0 O-C-N 121.085 -1.009 . . . . 73.11 110.727 174.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -126.68 104.48 8.11 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 124.803 1.241 . . . . 73.42 108.207 173.055 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 44.2 p -67.52 -6.39 19.55 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 124.068 0.947 . . . . 70.01 112.425 176.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 70.0 m -104.86 80.51 0.49 Allowed Pre-proline 0 N--CA 1.451 -0.396 0 N-CA-C 107.006 -1.479 . . . . 74.01 107.006 160.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -70.95 -179.48 3.48 Favored 'Trans proline' 0 N--CA 1.452 -0.969 0 C-N-CA 123.224 2.616 . . . . 72.01 110.519 -177.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 11.8 t -140.21 136.18 16.76 Favored Pre-proline 0 CA--C 1.534 0.361 0 N-CA-C 108.365 -0.976 . . . . 72.42 108.365 178.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -76.53 174.68 12.43 Favored 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 122.603 2.202 . . . . 63.35 111.413 172.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.4 m -112.18 -174.91 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 125.906 1.682 . . . . 72.24 109.539 179.184 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 21.4 m -67.01 -51.84 49.99 Favored 'General case' 0 N--CA 1.45 -0.465 0 O-C-N 121.318 -0.864 . . . . 75.2 109.484 170.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -146.41 161.03 40.26 Favored Pre-proline 0 N--CA 1.446 -0.63 0 C-N-CA 124.176 0.99 . . . . 73.4 109.636 177.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -69.28 -164.58 0.12 Allowed 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 124.358 3.372 . . . . 74.12 111.726 170.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.74 -110.11 3.96 Favored Glycine 0 N--CA 1.448 -0.531 0 N-CA-C 107.457 -2.257 . . . . 64.41 107.457 179.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 8.3 mttp -63.53 135.33 56.78 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 109.639 -0.504 . . . . 73.14 109.639 -178.258 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 38.6 mm -62.3 144.08 14.63 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 N-CA-C 107.423 -1.325 . . . . 73.14 107.423 170.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -101.75 118.62 37.31 Favored 'General case' 0 N--CA 1.458 -0.038 0 N-CA-C 107.564 -1.272 . . . . 74.1 107.564 -177.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 48.8 t -108.77 134.82 49.51 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 N-CA-C 107.716 -1.216 . . . . 75.01 107.716 171.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 6.8 t -132.83 111.05 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 C-N-CA 123.842 0.857 . . . . 72.44 109.814 -174.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 -65.82 127.98 34.16 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 125.255 1.422 . . . . 72.02 108.916 162.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.6 mp -102.45 148.68 25.21 Favored 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 107.596 -1.261 . . . . 73.11 107.596 155.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 37.7 p90 -141.94 170.76 15.12 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 118.848 0.749 . . . . 71.0 111.554 173.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 28.1 t90 -156.41 158.43 37.31 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.889 1.276 . . . . 72.3 110.041 172.323 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 7.4 t80 -70.68 -15.52 62.72 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 113.444 0.905 . . . . 74.41 113.444 -177.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -104.84 12.58 49.83 Favored Glycine 0 CA--C 1.522 0.47 0 CA-C-O 117.554 -1.692 . . . . 74.15 113.067 -175.002 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 24.8 p -112.95 85.3 7.7 Favored Pre-proline 0 CA--C 1.538 0.486 0 CA-C-N 119.938 1.869 . . . . 72.1 108.53 -178.122 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_endo -59.38 -26.31 81.48 Favored 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 121.735 1.623 . . . . 72.15 113.187 -177.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 29.1 m170 -68.27 -23.16 64.74 Favored 'General case' 0 CA--C 1.535 0.379 0 O-C-N 121.346 -0.846 . . . . 71.04 110.89 178.063 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 73.4 m -60.04 -48.06 83.26 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.022 0.929 . . . . 74.53 108.499 171.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 27.1 t80 -63.38 -46.05 88.29 Favored 'General case' 0 N--CA 1.467 0.419 0 O-C-N 120.892 -1.13 . . . . 74.24 111.46 175.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -55.99 -34.9 66.19 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 118.416 0.553 . . . . 74.32 111.737 -176.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -71.23 -23.04 61.93 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 127.174 2.19 . . . . 74.23 113.697 178.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -48.75 -67.05 0.46 Allowed Pre-proline 0 CA--C 1.541 0.614 0 C-N-CA 124.222 1.009 . . . . 64.34 113.21 -165.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -70.93 -6.82 20.03 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 CA-C-N 122.081 1.779 . . . . 75.34 114.636 -177.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.4 m -69.38 -47.4 64.35 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 119.432 1.014 . . . . 74.53 108.318 164.316 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 16.7 tt -94.5 -32.64 4.69 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 C-N-CA 123.814 0.846 . . . . 73.14 112.733 -165.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 22.8 t -49.54 -61.85 3.09 Favored Pre-proline 0 CA--C 1.542 0.646 0 C-N-CA 124.849 1.26 . . . . 75.44 110.551 178.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -64.08 -34.37 58.41 Favored 'Trans proline' 0 N--CA 1.454 -0.795 0 CA-C-N 120.454 1.198 . . . . 75.42 112.329 179.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 72.7 t90 -59.73 -50.57 73.33 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 119.768 1.167 . . . . 73.43 110.679 177.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 42.0 t -59.57 -44.9 93.16 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 123.947 0.899 . . . . 74.2 108.97 -176.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 57.5 mt-10 -61.99 -35.61 79.02 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 121.162 -0.961 . . . . 72.53 110.737 178.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 70.4 mmtt -77.19 -2.96 37.15 Favored 'General case' 0 C--O 1.237 0.432 0 O-C-N 120.42 -1.425 . . . . 74.2 114.482 177.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 26.8 mt -54.57 147.21 30.81 Favored Pre-proline 0 C--O 1.237 0.414 0 CA-C-N 120.405 1.457 . . . . 74.43 111.588 -177.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -74.28 164.95 33.0 Favored 'Trans proline' 0 N--CA 1.445 -1.34 0 C-N-CA 124.035 3.157 . . . . 70.31 110.602 -176.062 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -66.23 -4.65 8.13 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 125.753 1.621 . . . . 50.31 115.025 -171.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 -118.52 22.71 11.93 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.646 1.579 . . . . 72.44 110.744 179.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 57.8 t -121.61 160.18 23.34 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 N-CA-C 107.531 -1.285 . . . . 73.44 107.531 167.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 75.3 t60 -137.27 152.7 50.09 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 125.766 1.626 . . . . 74.22 107.3 167.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 57.5 t80 -130.79 137.37 49.41 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 123.787 0.835 . . . . 73.45 108.849 -171.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 47.4 t -134.07 155.35 39.42 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 C-N-CA 126.426 1.89 . . . . 75.22 106.906 -173.056 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 4.0 mpt_? -127.07 134.89 50.19 Favored 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 104.364 -2.458 . . . . 74.54 104.364 166.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 68.0 mt -131.85 148.79 71.33 Favored Pre-proline 0 N--CA 1.465 0.293 0 CA-C-N 119.51 1.05 . . . . 74.54 108.629 170.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -69.11 141.78 48.9 Favored 'Trans proline' 0 N--CA 1.451 -1.016 0 C-N-CA 121.421 1.414 . . . . 71.21 110.409 171.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -91.46 67.32 5.6 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 124.535 1.134 . . . . 72.11 108.44 -176.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 54.9 mt -64.8 65.94 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 127.538 2.335 . . . . 74.24 112.724 -171.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -98.2 48.66 1.0 Allowed 'General case' 0 C--O 1.237 0.416 0 C-N-CA 125.229 1.412 . . . . 73.35 111.437 -170.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 67.48 167.83 3.62 Favored Glycine 0 CA--C 1.531 1.034 0 C-N-CA 124.218 0.913 . . . . 74.14 112.11 -177.27 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 50.94 -143.22 14.85 Favored Glycine 0 CA--C 1.526 0.736 0 O-C-N 122.091 -0.653 . . . . 44.2 113.121 176.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 4.9 tp -63.63 -11.77 9.58 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 C-N-CA 123.955 0.902 . . . . 73.31 111.547 -173.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 18.4 m95 -73.81 -33.45 64.18 Favored 'General case' 0 CA--C 1.531 0.243 0 O-C-N 120.661 -1.274 . . . . 72.24 110.909 175.2 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -64.78 -44.06 91.22 Favored 'General case' 0 C--O 1.236 0.382 0 O-C-N 121.33 -0.856 . . . . 65.34 109.834 168.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 91.5 t -62.78 -53.99 39.66 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 N-CA-C 109.169 -0.678 . . . . 75.33 109.169 -173.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 19.3 m170 -88.96 51.15 2.09 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.864 1.266 . . . . 74.55 109.455 173.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -140.71 -55.53 0.04 OUTLIER Glycine 0 N--CA 1.443 -0.891 0 C-N-CA 124.75 1.167 . . . . 71.01 110.224 167.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.94 -28.75 58.36 Favored 'General case' 0 CA--C 1.554 1.109 0 N-CA-C 114.617 1.34 . . . . 70.54 114.617 -166.223 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 34.8 ttp -58.22 -38.14 76.23 Favored 'General case' 0 N--CA 1.469 0.489 0 O-C-N 119.299 -2.126 . . . . 74.3 112.119 -176.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 27.9 t80 -56.12 -50.28 71.55 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 123.774 0.83 . . . . 71.41 109.5 -179.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 42.3 mt -66.1 -42.43 89.28 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-O 117.495 -1.241 . . . . 74.53 109.825 179.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.39 -42.36 86.93 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 120.317 1.417 . . . . 73.42 110.623 -178.192 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -54.94 -52.13 63.95 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 125.131 1.372 . . . . 74.35 108.813 -174.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -78.79 -25.37 44.29 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.415 0.686 . . . . 74.32 111.505 -177.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 12.6 t -62.49 -33.42 74.84 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 125.124 1.37 . . . . 74.11 111.387 176.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' MET . . . . . 0.415 ' SD ' ' HA ' ' A' ' 125' ' ' PHE . 30.6 mtp -81.11 -7.87 59.65 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 125.718 1.607 . . . . 74.23 111.616 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 58.53 36.06 83.16 Favored Glycine 0 C--N 1.336 0.565 0 C-N-CA 125.284 1.421 . . . . 61.11 110.803 177.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.4 m -57.78 135.84 21.54 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 N-CA-C 108.691 -0.855 . . . . 72.54 108.691 177.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -72.53 175.61 6.15 Favored 'General case' 0 C--O 1.244 0.777 0 N-CA-C 109.133 -0.691 . . . . 74.41 109.133 176.105 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 75.57 163.1 0.25 Allowed 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 127.91 2.484 . . . . 75.45 110.067 -177.444 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -127.46 33.87 4.78 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 125.249 1.42 . . . . 71.43 109.156 -158.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.9 t -85.26 43.77 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.946 0 C-N-CA 125.208 1.403 . . . . 74.41 110.895 -167.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 11.0 p-80 -58.21 -12.25 3.42 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 128.787 2.835 . . . . 70.3 116.254 -174.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -91.46 -47.16 7.59 Favored 'General case' 0 CA--C 1.515 -0.391 0 O-C-N 121.25 -0.906 . . . . 75.11 109.64 173.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -53.6 -36.42 61.95 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-O 117.748 -1.12 . . . . 75.45 112.869 -176.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 57.9 t -45.06 -65.32 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 124.845 1.258 . . . . 74.41 110.987 166.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -57.87 -46.34 85.01 Favored 'General case' 0 C--O 1.226 -0.146 0 CA-C-N 118.583 0.629 . . . . 75.32 110.722 178.289 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -59.27 -37.54 77.89 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.499 0.72 . . . . 73.25 110.637 -174.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -68.51 -31.72 71.17 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 124.791 1.236 . . . . 60.52 113.016 178.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 55.9 mt -78.75 -57.25 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 N-CA-C 105.897 -1.89 . . . . 74.15 105.897 -179.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 85.2 m-70 -74.13 -72.26 0.29 Allowed 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 127.032 2.133 . . . . 73.44 112.031 -172.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 43.5 mttt -65.68 -30.68 71.4 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 119.396 0.998 . . . . 74.32 112.063 -173.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -93.58 -26.76 16.97 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 118.427 0.558 . . . . 72.24 110.788 -173.481 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 49.29 53.2 13.05 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 126.029 1.732 . . . . 74.44 113.766 175.671 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 2.5 mmpt? -85.23 22.33 1.5 Allowed 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.955 1.302 . . . . 73.53 114.401 -173.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 12.2 ttmt 70.29 -69.66 0.17 Allowed 'General case' 0 C--O 1.222 -0.342 0 C-N-CA 128.151 2.58 . . . . 74.25 109.873 -179.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 39.3 mt 63.08 28.93 16.25 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 127.176 2.19 . . . . 75.23 112.342 175.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -79.3 -10.08 59.73 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 115.142 1.534 . . . . 65.33 115.142 -175.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 24.8 p -137.13 159.43 69.86 Favored Pre-proline 0 C--O 1.236 0.39 0 O-C-N 120.932 -1.105 . . . . 74.53 109.08 -177.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -61.55 -34.84 84.34 Favored 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 122.04 1.827 . . . . 73.23 110.607 177.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -63.83 -40.28 96.23 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 123.404 0.681 . . . . 74.22 112.216 176.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -65.01 -48.37 74.19 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.696 0.798 . . . . 74.42 110.123 177.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 57.8 mtt -63.54 -50.46 69.47 Favored 'General case' 0 C--O 1.231 0.09 0 C-N-CA 123.893 0.877 . . . . 75.13 110.773 -179.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -71.46 -39.46 70.94 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-O 118.414 -0.803 . . . . 62.34 110.234 -170.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -61.62 -28.46 69.38 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 119.288 0.949 . . . . 64.43 112.293 176.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -75.25 -58.76 3.08 Favored 'General case' 0 N--CA 1.443 -0.806 0 O-C-N 121.827 -0.546 . . . . 73.12 110.176 175.047 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 53.8 mt -66.59 -22.48 66.13 Favored 'General case' 0 CA--C 1.532 0.261 0 O-C-N 121.748 -0.595 . . . . 72.11 110.756 -173.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -55.93 -17.53 6.78 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 125.215 1.406 . . . . 64.41 112.719 175.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -90.98 -5.83 67.65 Favored Glycine 0 CA--C 1.524 0.625 0 CA-C-O 118.079 -1.4 . . . . 71.44 114.51 174.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 17.2 mmtt -134.79 29.92 3.45 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 120.217 2.009 . . . . 72.45 111.749 -156.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 83.82 29.86 30.81 Favored Glycine 0 CA--C 1.52 0.405 0 N-CA-C 111.558 -0.617 . . . . 64.3 111.558 175.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 87.7 t -123.87 119.15 56.21 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 N-CA-C 107.126 -1.435 . . . . 74.14 107.126 175.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 66.3 t0 -70.25 124.37 23.96 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-O 121.185 0.517 . . . . 74.33 109.745 172.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 9.5 ttpt -60.15 -40.3 89.41 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 124.128 0.971 . . . . 73.05 110.206 176.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -68.07 -27.25 66.33 Favored 'General case' 0 C--O 1.236 0.347 0 O-C-N 121.489 -0.757 . . . . 71.35 111.325 -177.103 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 52.2 mttm -77.71 -48.13 17.44 Favored 'General case' 0 CA--C 1.509 -0.611 0 N-CA-C 107.217 -1.401 . . . . 72.11 107.217 177.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.415 ' HA ' ' SD ' ' A' ' 84' ' ' MET . 34.0 t80 -44.81 -64.87 0.61 Allowed 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 124.751 1.22 . . . . 74.33 110.592 177.26 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 22.3 mt -68.69 -40.57 79.98 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 119.22 -0.419 . . . . 71.23 110.552 -170.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 46.6 t -58.33 -56.73 18.28 Favored 'General case' 0 C--N 1.341 0.209 0 N-CA-C 108.059 -1.089 . . . . 75.25 108.059 -179.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 55.2 m -62.03 -43.3 99.13 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 123.808 0.843 . . . . 74.31 110.325 -176.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 45.5 t80 -51.46 -45.86 62.86 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 123.838 0.855 . . . . 74.35 110.591 177.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -98.05 35.06 1.8 Allowed 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.456 1.102 . . . . 70.31 111.155 178.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -120.03 155.84 32.1 Favored 'General case' 0 C--O 1.235 0.316 0 O-C-N 120.929 -1.107 . . . . 74.01 109.807 174.617 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -64.79 -22.3 66.96 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.654 0.782 . . . . 74.41 111.293 174.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -53.95 -29.11 41.27 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 125.173 1.389 . . . . 75.25 113.17 173.333 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 11.2 mm -77.23 -39.4 28.48 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.484 0 C-N-CA 123.829 0.852 . . . . 74.32 113.149 169.263 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 9.9 tttp -58.89 -34.61 71.86 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 118.309 -0.853 . . . . 74.44 110.002 -170.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -67.81 -23.4 74.12 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 123.915 0.769 . . . . 53.32 112.952 -178.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -91.28 -45.51 8.57 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 121.923 0.868 . . . . 72.02 108.974 178.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 5.2 ttm -62.17 -40.27 95.46 Favored 'General case' 0 N--CA 1.426 -1.647 0 C-N-CA 126.293 1.837 . . . . 75.52 110.142 -177.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 21.8 pt-20 -69.44 -37.51 77.42 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 120.042 1.292 . . . . 73.2 112.531 -177.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 10.2 mmtt -62.59 -59.4 4.98 Favored 'General case' 0 C--O 1.225 -0.23 0 N-CA-C 107.402 -1.333 . . . . 74.42 107.402 171.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -54.78 -43.3 72.68 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 119.56 1.073 . . . . 73.31 111.707 -175.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 11.6 tmtt? -49.77 -64.25 0.87 Allowed 'General case' 0 CA--C 1.518 -0.283 0 C-N-CA 125.167 1.387 . . . . 74.45 110.272 174.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.2 -29.82 64.34 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 120.031 -0.668 . . . . 72.22 110.972 -170.616 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 38.0 mt -61.5 -53.3 58.23 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 123.843 0.857 . . . . 74.44 110.383 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -57.67 -40.76 80.11 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 118.823 0.738 . . . . 64.11 110.814 -175.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -64.97 -48.11 75.18 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.769 0.828 . . . . 74.4 110.635 177.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -68.91 -28.97 67.15 Favored 'General case' 0 CA--C 1.533 0.297 0 O-C-N 121.791 -0.568 . . . . 54.02 111.27 -175.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -71.57 7.88 1.29 Allowed 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 125.057 1.343 . . . . 73.22 112.976 171.03 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 57.53 28.42 15.54 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 127.522 2.329 . . . . 74.15 113.335 177.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 15.5 t -77.31 141.55 15.43 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 O-C-N 120.865 -1.147 . . . . 75.33 108.057 -179.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -142.14 10.87 1.95 Allowed 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 121.618 0.723 . . . . 72.23 112.248 179.636 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -171.64 178.98 43.66 Favored Glycine 0 N--CA 1.442 -0.933 0 N-CA-C 108.301 -1.92 . . . . 62.22 108.301 172.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.463 ' HA ' ' C ' ' A' ' 154' ' ' PRO . 0.8 OUTLIER -145.51 147.2 32.51 Favored Pre-proline 0 C--N 1.32 -0.681 0 C-N-CA 126.66 1.984 . . . . 71.22 106.082 -175.155 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . 0.463 ' C ' ' HA ' ' A' ' 153' ' ' VAL . 37.6 Cg_endo -65.59 157.67 77.33 Favored 'Cis proline' 0 CA--C 1.531 0.351 0 N-CA-C 114.74 1.015 . . . . 74.33 114.74 3.217 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 18.1 m -158.92 141.05 13.82 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 124.758 1.223 . . . . 73.22 109.227 172.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 98.5 mtp -113.38 156.04 24.15 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 126.529 1.932 . . . . 73.43 107.947 165.192 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 40.6 t -135.42 144.19 34.72 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.36 0 N-CA-C 106.898 -1.519 . . . . 72.43 106.898 172.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 6.0 t -113.81 124.1 70.12 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 N-CA-C 105.828 -1.916 . . . . 74.31 105.828 172.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 48.9 22.58 0.58 Allowed 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 129.948 3.299 . . . . 71.24 115.927 165.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 59.67 36.21 88.84 Favored Glycine 0 CA--C 1.527 0.835 0 CA-C-O 118.335 -1.258 . . . . 64.11 114.223 -169.018 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 32.1 mttm -128.37 -44.39 1.4 Allowed 'General case' 0 C--O 1.233 0.222 0 CA-C-N 119.269 1.534 . . . . 64.23 111.887 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -116.84 120.29 38.05 Favored 'General case' 0 C--N 1.332 -0.174 0 O-C-N 122.194 -0.316 . . . . 60.05 110.767 -174.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 35.8 ttp85 -98.75 126.58 44.41 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 106.752 -1.573 . . . . 64.23 106.752 171.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 7.8 p90 -145.36 163.42 34.63 Favored 'General case' 0 C--N 1.316 -0.872 0 O-C-N 120.829 -1.169 . . . . 74.2 108.438 177.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -173.33 173.1 3.61 Favored 'General case' 0 CA--C 1.516 -0.357 0 N-CA-C 109.786 -0.45 . . . . 74.31 109.786 -172.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 9.1 mt -52.48 -47.99 46.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 C-N-CA 127.648 2.379 . . . . 74.44 109.959 -175.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -83.54 3.98 83.31 Favored Glycine 0 CA--C 1.526 0.752 0 CA-C-O 117.9 -1.5 . . . . 74.23 114.027 179.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -102.39 -53.73 2.83 Favored 'General case' 0 C--O 1.226 -0.174 0 CA-C-N 120.518 2.159 . . . . 72.03 107.771 166.634 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -60.0 -52.62 64.6 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 123.872 0.869 . . . . 73.21 110.75 -178.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 129.76 8.59 3.41 Favored Glycine 0 CA--C 1.526 0.724 0 CA-C-O 119.092 -0.838 . . . . 61.14 113.882 -176.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 154.96 174.38 24.82 Favored Glycine 0 CA--C 1.528 0.895 0 CA-C-N 119.192 1.496 . . . . 64.33 110.496 178.208 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -62.48 -49.39 5.89 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 122.67 2.247 . . . . 73.42 111.136 -175.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -67.96 -37.34 81.45 Favored 'General case' 0 CA--C 1.53 0.182 0 O-C-N 121.305 -0.872 . . . . 74.22 110.013 -177.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -59.35 -29.93 68.02 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.204 0.601 . . . . 71.41 110.862 175.491 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 30.5 m -66.74 -41.91 87.1 Favored 'General case' 0 CA--C 1.529 0.172 0 O-C-N 120.698 -1.251 . . . . 74.21 109.361 178.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 44.6 mt -63.87 -36.33 83.58 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 118.928 0.786 . . . . 65.53 110.458 174.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -54.39 -44.74 72.55 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 118.219 -0.896 . . . . 75.22 109.585 173.779 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -68.66 -43.39 76.29 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-O 117.711 -1.138 . . . . 73.51 111.867 173.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -52.46 -49.81 63.92 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 119.458 1.026 . . . . 75.23 111.367 -170.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -70.68 -36.95 73.58 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 124.103 0.961 . . . . 72.31 111.055 -171.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -68.07 -48.22 66.15 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 126.213 1.805 . . . . 75.34 111.412 177.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 85.1 mt -61.92 -44.03 97.62 Favored 'General case' 0 CA--C 1.527 0.076 0 C-N-CA 123.673 0.789 . . . . 74.01 110.225 -176.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 56.8 mt -51.78 -51.16 29.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 C-N-CA 124.479 1.112 . . . . 72.15 109.387 174.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 14.9 tm-20 -61.18 -27.23 68.27 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 124.512 1.125 . . . . 74.43 112.419 -178.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . 0.434 ' HA ' ' HE3' ' A' ' 185' ' ' LYS . 0.3 OUTLIER -61.7 -60.73 3.23 Favored 'General case' 0 C--O 1.232 0.162 0 N-CA-C 107.833 -1.173 . . . . 74.02 107.833 176.602 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 66.8 mt-10 -67.41 -34.82 78.04 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 125.781 1.632 . . . . 74.3 111.594 -173.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.93 -21.43 64.76 Favored 'General case' 0 N--CA 1.462 0.173 0 O-C-N 120.776 -1.202 . . . . 73.11 111.911 -177.59 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -60.66 -24.39 65.55 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 122.979 0.511 . . . . 74.03 111.955 173.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -65.43 -18.11 65.06 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 118.69 0.677 . . . . 74.12 112.197 174.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -129.61 15.65 5.95 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.631 1.573 . . . . 75.14 112.225 -176.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 14.3 tptt 46.9 83.52 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 127.053 2.141 . . . . 75.14 112.669 -172.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 8.0 mttp . . . . . 0 C--O 1.251 1.148 0 C-N-CA 128.899 2.88 . . . . 72.31 115.39 162.668 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.672 0 N-CA-C 108.69 -1.764 . . . . 71.43 108.69 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -62.87 138.24 58.48 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 123.531 0.732 . . . . 74.11 109.234 -175.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -142.28 9.37 1.86 Allowed 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.029 0.932 . . . . 75.52 112.593 -175.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.458 ' CD2' HD13 ' A' ' 178' ' ' LEU . 34.7 m-85 -142.02 167.16 22.79 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 124.755 1.222 . . . . 75.51 109.687 -170.754 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 18.9 m -130.87 133.63 46.07 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.697 1.199 . . . . 73.14 109.691 175.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.03 128.7 36.84 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 124.709 1.204 . . . . 70.13 109.98 173.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 71.52 24.33 76.96 Favored Glycine 0 CA--C 1.531 1.037 0 CA-C-O 118.721 -1.044 . . . . 75.44 111.946 -170.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 3.9 ttmt -127.39 -85.77 0.59 Allowed 'General case' 0 CA--C 1.518 -0.263 0 C-N-CA 125.119 1.368 . . . . 65.03 107.866 165.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 36.9 mp0 -64.31 -23.24 67.23 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 123.484 0.713 . . . . 74.11 110.824 -179.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 46.0 p90 -162.98 -178.53 6.14 Favored 'General case' 0 N--CA 1.462 0.174 0 O-C-N 121.731 -0.606 . . . . 75.14 111.88 -169.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 85.1 t -140.0 111.95 4.91 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 C-N-CA 125.428 1.491 . . . . 74.0 109.116 -178.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -75.7 163.42 27.31 Favored 'General case' 0 C--O 1.234 0.289 0 O-C-N 119.997 -1.689 . . . . 72.54 109.162 162.498 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -123.77 129.76 51.57 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 124.958 1.303 . . . . 74.53 108.657 -176.514 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 57.1 p -59.79 -27.54 66.65 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-O 118.228 -0.891 . . . . 74.0 112.363 -178.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 9.3 p -114.65 84.19 9.8 Favored Pre-proline 0 N--CA 1.452 -0.345 0 CA-C-N 119.068 0.849 . . . . 72.51 110.507 -175.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -70.75 175.19 9.27 Favored 'Trans proline' 0 N--CA 1.451 -1.01 0 C-N-CA 122.897 2.398 . . . . 64.15 110.915 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 24.6 t -139.18 136.46 18.12 Favored Pre-proline 0 CA--C 1.542 0.644 0 C-N-CA 123.674 0.79 . . . . 74.22 109.122 -167.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -73.05 176.93 8.42 Favored 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 123.917 3.078 . . . . 75.51 112.949 175.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 15.4 m -137.02 164.71 29.53 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 C-N-CA 124.601 1.16 . . . . 75.43 112.63 -167.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 13.4 t -58.49 -30.4 66.98 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 126.769 2.028 . . . . 73.11 112.965 175.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -155.58 86.06 3.29 Favored Pre-proline 0 N--CA 1.446 -0.657 0 CA-C-N 119.636 1.107 . . . . 74.32 109.425 -170.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -65.28 86.8 0.19 Allowed 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 122.224 1.949 . . . . 74.21 108.991 172.186 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -174.25 -41.8 0.05 OUTLIER Glycine 0 CA--C 1.525 0.714 0 CA-C-O 118.846 -0.975 . . . . 73.11 112.296 -165.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 9.5 mptt -108.06 152.19 24.84 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 106.759 -1.571 . . . . 74.15 106.759 160.011 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 32.6 mm -57.81 148.39 5.53 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 N-CA-C 105.868 -1.901 . . . . 64.23 105.868 162.121 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -117.55 117.47 29.51 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 106.958 -1.497 . . . . 72.21 106.958 -178.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 43.1 t -116.61 129.79 72.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 N-CA-C 107.327 -1.361 . . . . 74.12 107.327 179.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 4.8 t -118.9 134.37 62.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 106.143 -1.799 . . . . 74.53 106.143 179.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -107.89 101.8 11.04 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 104.631 -2.359 . . . . 60.51 104.631 162.031 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 5.4 mp -82.98 118.67 23.65 Favored 'General case' 0 CA--C 1.522 -0.114 0 N-CA-C 106.917 -1.512 . . . . 73.51 106.917 177.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 49.4 p90 -124.22 168.39 13.0 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.163 0.585 . . . . 71.22 112.045 -171.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 22.6 t90 -146.14 143.43 29.32 Favored 'General case' 0 C--N 1.343 0.312 0 C-N-CA 125.142 1.377 . . . . 75.2 109.238 174.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 5.4 t80 -49.15 -42.15 38.7 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 126.739 2.016 . . . . 75.21 112.571 171.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -83.57 15.61 34.9 Favored Glycine 0 CA--C 1.525 0.7 0 CA-C-O 119.163 -0.799 . . . . 64.12 113.017 -171.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 53.5 t -105.12 85.62 1.34 Allowed Pre-proline 0 N--CA 1.447 -0.613 0 C-N-CA 126.322 1.849 . . . . 71.53 108.148 178.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -61.44 -32.68 88.92 Favored 'Trans proline' 0 CA--C 1.534 0.5 0 C-N-CA 122.085 1.856 . . . . 70.12 110.279 177.198 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 5.4 m170 -53.44 -48.72 68.55 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 126.201 1.8 . . . . 75.13 110.134 175.258 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 84.1 m -59.57 -38.07 80.17 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.008 0.923 . . . . 73.42 109.555 -168.102 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 38.5 t80 -62.74 -23.45 67.19 Favored 'General case' 0 N--CA 1.47 0.55 0 O-C-N 120.892 -1.13 . . . . 75.02 112.559 179.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -55.96 -40.32 73.07 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 118.983 0.81 . . . . 74.41 110.043 172.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -85.44 -21.66 28.65 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 125.833 1.653 . . . . 73.11 112.681 -168.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -38.93 -67.08 0.28 Allowed Pre-proline 0 N--CA 1.478 0.937 0 C-N-CA 125.348 1.459 . . . . 73.02 112.662 -176.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -73.95 -10.29 22.88 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 CA-C-N 121.803 1.68 . . . . 71.15 114.406 -174.351 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.8 m -72.32 -45.21 60.92 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 107.975 -1.12 . . . . 75.11 107.975 166.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 20.2 tt -92.28 -36.54 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 N-CA-C 113.207 0.817 . . . . 74.5 113.207 -167.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 29.3 t -43.5 -60.48 2.51 Favored Pre-proline 0 CA--C 1.543 0.686 0 C-N-CA 125.31 1.444 . . . . 73.01 110.962 175.135 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -69.62 -29.93 23.73 Favored 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 121.725 1.617 . . . . 74.42 112.011 -177.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 72.5 t90 -57.44 -49.75 75.23 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 119.074 0.852 . . . . 75.22 109.209 175.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 44.2 t -61.73 -37.08 82.9 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 122.942 0.497 . . . . 71.04 110.636 178.099 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -59.6 -44.66 93.32 Favored 'General case' 0 CA--C 1.533 0.324 0 O-C-N 120.757 -1.214 . . . . 65.0 110.979 176.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -85.99 4.99 35.37 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 119.197 0.908 . . . . 74.04 113.179 -173.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 60.7 mt -58.6 148.72 65.34 Favored Pre-proline 0 N--CA 1.447 -0.612 0 N-CA-C 109.785 -0.45 . . . . 73.43 109.785 173.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -70.69 174.45 10.3 Favored 'Trans proline' 0 N--CA 1.447 -1.252 0 C-N-CA 123.982 3.121 . . . . 74.34 110.623 -178.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -67.68 0.95 2.76 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.986 1.314 . . . . 62.23 114.093 178.253 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -117.88 4.08 12.19 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 125.598 1.559 . . . . 73.33 111.916 -170.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 59.5 t -126.4 138.03 55.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 N-CA-C 105.721 -1.955 . . . . 74.22 105.721 179.243 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 3.2 p-80 -126.74 147.14 50.0 Favored 'General case' 0 N--CA 1.444 -0.768 0 C-N-CA 123.827 0.851 . . . . 74.03 109.13 179.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 28.1 t80 -110.96 140.5 45.41 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 124.199 1.0 . . . . 74.44 108.661 -173.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 82.4 t -133.71 113.54 18.66 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.441 0 N-CA-C 108.283 -1.006 . . . . 75.43 108.283 -170.011 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 29.1 mtm180 -101.07 114.96 29.39 Favored 'General case' 0 CA--C 1.506 -0.716 0 N-CA-C 105.84 -1.911 . . . . 72.55 105.84 -175.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 79.1 mt -130.36 145.58 58.02 Favored Pre-proline 0 C--N 1.328 -0.365 0 C-N-CA 123.177 0.591 . . . . 74.43 109.679 175.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -76.65 134.92 15.61 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 122.829 2.353 . . . . 74.2 110.474 172.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -77.11 95.03 4.14 Favored 'General case' 0 CA--C 1.539 0.533 0 O-C-N 121.55 -0.719 . . . . 64.31 110.035 178.058 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 29.6 mt -88.63 75.09 8.33 Favored 'General case' 0 CA--C 1.539 0.553 0 O-C-N 120.057 -1.652 . . . . 75.23 111.372 -172.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -87.0 30.28 0.77 Allowed 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 113.947 1.091 . . . . 75.12 113.947 -175.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 72.31 -165.01 54.42 Favored Glycine 0 CA--C 1.527 0.826 0 N-CA-C 108.341 -1.904 . . . . 55.11 108.341 -168.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 56.34 -156.47 11.64 Favored Glycine 0 CA--C 1.529 0.95 0 CA-C-N 117.891 0.846 . . . . 75.03 113.601 172.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 9.5 tp -61.67 -20.98 24.49 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 C-N-CA 123.481 0.712 . . . . 74.51 112.219 172.182 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 11.9 m95 -59.3 -42.07 90.49 Favored 'General case' 0 C--N 1.343 0.313 0 CA-C-N 120.097 1.317 . . . . 73.35 110.798 -171.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 12.1 p30 -79.93 -28.15 39.75 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 112.979 0.733 . . . . 72.34 112.979 178.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 92.4 t -63.12 -45.99 97.18 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 N-CA-C 108.089 -1.078 . . . . 75.12 108.089 175.055 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 64.2 m170 -76.61 15.13 0.67 Allowed 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 124.759 1.224 . . . . 71.44 112.644 169.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -123.73 -22.48 2.23 Favored Glycine 0 CA--C 1.532 1.141 0 CA-C-N 120.358 1.436 . . . . 55.42 114.182 178.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 33.7 tt0 -72.92 -28.98 62.78 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 118.286 1.043 . . . . 65.21 111.553 -172.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 6.5 ttp -61.52 -47.79 83.99 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-O 117.512 -1.232 . . . . 73.23 111.724 -177.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 13.7 t80 -52.62 -52.91 53.28 Favored 'General case' 0 N--CA 1.462 0.138 0 N-CA-C 108.813 -0.81 . . . . 74.25 108.813 -176.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 47.3 mt -56.61 -44.22 80.93 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 114.829 -1.078 . . . . 71.53 109.993 177.014 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 2.5 m -62.94 -40.92 99.1 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 120.353 1.433 . . . . 75.11 112.087 -174.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -55.88 -54.14 48.26 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.897 0.879 . . . . 61.53 108.76 176.584 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -74.36 -10.71 59.85 Favored 'General case' 0 CA--C 1.543 0.68 0 O-C-N 121.407 -0.808 . . . . 75.44 111.5 -176.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 9.3 t -88.29 -20.03 25.97 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 126.496 1.918 . . . . 71.41 113.578 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 8.5 ptp -81.66 -21.65 38.0 Favored 'General case' 0 N--CA 1.466 0.334 0 O-C-N 120.89 -1.132 . . . . 74.21 110.072 157.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 80.82 56.13 3.17 Favored Glycine 0 C--N 1.332 0.317 0 N-CA-C 109.373 -1.491 . . . . 63.31 109.373 179.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 5.5 m -53.5 125.71 8.32 Favored 'Isoleucine or valine' 0 C--O 1.239 0.511 0 CA-C-O 121.407 0.622 . . . . 72.54 109.837 178.015 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -131.2 29.54 4.63 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 124.909 1.284 . . . . 72.31 110.146 -175.102 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 18.6 t-160 -153.7 79.96 1.15 Allowed 'General case' 0 CA--C 1.536 0.416 0 O-C-N 121.439 -0.788 . . . . 72.42 109.088 168.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -162.85 179.57 7.52 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.078 0.551 . . . . 75.32 111.238 173.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 9.3 p -97.36 -10.16 8.88 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 C-N-CA 126.201 1.8 . . . . 73.53 111.251 173.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 13.8 m-70 49.1 52.39 14.46 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.301 1.44 . . . . 63.44 110.696 -174.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -143.99 -45.71 0.27 Allowed 'General case' 0 CA--C 1.515 -0.399 0 C-N-CA 123.558 0.743 . . . . 63.25 110.757 176.495 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -61.82 -29.57 70.25 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 118.028 0.376 . . . . 74.1 111.65 -176.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 48.5 t -53.42 -61.98 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 C-N-CA 124.159 0.983 . . . . 75.44 108.552 171.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.403 ' CD2' ' CD2' ' A' ' 99' ' ' HIS . 4.8 t80 -69.1 -41.95 76.76 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 119.174 -0.441 . . . . 55.13 110.716 -175.142 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -52.86 -39.66 62.75 Favored 'General case' 0 C--O 1.233 0.21 0 C-N-CA 124.671 1.188 . . . . 75.44 111.024 -178.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -63.76 -27.53 69.26 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 124.022 0.929 . . . . 72.42 111.055 -176.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 52.2 mt -85.45 -60.51 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.933 0 C-N-CA 125.97 1.708 . . . . 75.15 107.299 176.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . 0.403 ' CD2' ' CD2' ' A' ' 95' ' ' PHE . 20.7 p80 -76.18 -57.17 4.02 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 119.719 1.145 . . . . 72.43 113.256 -169.016 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -83.07 -33.15 26.48 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-N 118.404 0.547 . . . . 71.12 110.989 -171.187 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -97.51 -30.77 12.69 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 124.145 0.978 . . . . 75.31 111.091 -171.06 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 5.2 t-160 45.08 88.53 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 127.901 2.48 . . . . 74.1 112.885 176.056 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.463 ' HE2' ' CE1' ' A' ' 114' ' ' PHE . 0.0 OUTLIER -106.38 155.31 19.68 Favored 'General case' 0 CA--C 1.507 -0.7 0 CA-C-O 121.579 0.704 . . . . 73.52 111.128 164.429 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 5.2 ttmt -58.03 101.97 0.09 Allowed 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 106.698 -1.593 . . . . 74.44 106.698 165.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 93.0 mt -130.42 70.1 1.45 Allowed 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 126.934 2.094 . . . . 73.52 108.701 178.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -114.86 1.67 14.13 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.463 1.105 . . . . 74.45 112.619 -175.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -138.63 152.57 71.11 Favored Pre-proline 0 CA--C 1.531 0.249 0 C-N-CA 125.342 1.457 . . . . 75.24 109.209 -175.197 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -65.15 -34.02 47.56 Favored 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 121.395 1.396 . . . . 71.44 110.473 -179.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -64.37 -21.02 66.5 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 118.536 0.607 . . . . 73.54 112.343 174.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -84.06 -55.06 4.41 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 107.894 -1.15 . . . . 74.45 107.894 177.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 3.9 mpp? -58.21 -51.78 68.33 Favored 'General case' 0 C--N 1.34 0.187 0 C-N-CA 123.213 0.605 . . . . 75.23 111.135 179.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -67.28 -41.45 85.45 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 118.3 -0.857 . . . . 60.23 110.319 -173.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -57.8 -46.98 83.88 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 118.831 0.741 . . . . 74.34 110.006 174.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . 0.463 ' CE1' ' HE2' ' A' ' 103' ' ' LYS . 84.7 t80 -60.48 -46.9 88.39 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 118.015 0.37 . . . . 64.14 110.817 -176.561 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 46.0 mt -75.62 -17.98 59.84 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 119.356 -0.354 . . . . 74.1 111.007 -176.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.18 -9.85 2.41 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.481 1.512 . . . . 53.35 114.115 -179.096 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -121.34 15.37 9.29 Favored Glycine 0 CA--C 1.533 1.194 0 C-N-CA 126.666 2.079 . . . . 75.22 112.808 176.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 2.8 mmpt? -135.01 25.87 3.59 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.905 1.282 . . . . 75.21 110.891 -172.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 94.13 20.69 29.73 Favored Glycine 0 CA--C 1.524 0.617 0 C-N-CA 124.08 0.848 . . . . 70.51 113.529 172.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 94.0 t -132.98 130.01 58.13 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 C-N-CA 124.675 1.19 . . . . 74.22 107.817 -169.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -98.98 134.06 42.36 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 112.251 0.463 . . . . 74.03 112.251 -176.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 39.6 mtpt -60.74 -35.07 75.45 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 118.491 -0.766 . . . . 74.34 110.017 176.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -55.87 -46.51 78.24 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 119.086 0.857 . . . . 75.22 110.479 176.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 25.8 mmtt -78.27 -46.27 20.68 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 106.724 -1.584 . . . . 72.23 106.724 -174.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 47.6 t80 -54.06 -65.15 0.62 Allowed 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 125.455 1.502 . . . . 74.15 111.391 -176.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 9.3 mt -70.45 -33.76 71.68 Favored 'General case' 0 N--CA 1.467 0.418 0 O-C-N 121.146 -0.971 . . . . 72.11 111.06 -166.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 17.1 t -58.02 -57.8 11.21 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 107.198 -1.408 . . . . 63.25 107.198 172.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 38.4 m -62.85 -39.81 95.52 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-O 118.987 -0.53 . . . . 74.31 110.238 -175.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 54.7 t80 -56.42 -41.79 76.97 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 119.975 1.262 . . . . 73.54 110.064 -179.046 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 33.7 m-80 -84.43 -10.78 57.22 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 124.367 1.067 . . . . 74.21 113.745 -179.382 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 4.3 m -86.73 154.93 20.58 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 126.125 1.77 . . . . 71.43 112.645 -169.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -63.01 -29.83 71.13 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 114.171 1.174 . . . . 75.31 114.171 -171.541 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -57.21 -43.99 83.26 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 120.297 1.408 . . . . 75.24 111.231 -177.287 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 4.6 mm -58.48 -43.86 87.73 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.496 0 C-N-CA 126.394 1.878 . . . . 73.02 110.721 174.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 17.3 tttm -51.82 -37.49 51.99 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.941 0.896 . . . . 71.34 109.161 174.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -71.95 -40.13 57.78 Favored Glycine 0 CA--C 1.527 0.787 0 C-N-CA 124.634 1.111 . . . . 73.13 111.599 179.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -72.22 -34.37 68.29 Favored 'General case' 0 C--N 1.329 -0.311 0 O-C-N 120.906 -1.349 . . . . 73.23 110.551 -179.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 55.1 mtp -65.06 -51.29 62.33 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 124.599 1.16 . . . . 73.43 109.395 176.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -55.88 -38.78 70.62 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 119.298 0.953 . . . . 74.42 110.926 -172.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 21.6 mtmt -66.67 -61.6 1.88 Allowed 'General case' 0 C--N 1.342 0.255 0 CA-C-O 117.703 -1.141 . . . . 75.25 110.911 176.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -52.31 -39.13 60.16 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 120.834 1.652 . . . . 73.32 111.298 -177.226 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 11.0 tttt -62.49 -54.46 39.68 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 125.514 1.526 . . . . 73.3 112.454 178.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.01 -30.61 67.97 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 119.824 1.193 . . . . 74.21 110.623 179.166 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 40.3 mt -60.2 -47.25 86.76 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-O 118.932 -0.556 . . . . 72.1 110.558 -177.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -54.76 -45.93 74.28 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 118.016 0.371 . . . . 72.04 111.56 -177.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 13.2 ptp -70.57 -42.05 71.6 Favored 'General case' 0 CA--C 1.523 -0.079 0 N-CA-C 112.117 0.414 . . . . 72.22 112.117 -179.172 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -60.59 -38.53 84.96 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 123.747 0.819 . . . . 55.21 109.126 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 23.4 m-85 -76.47 6.16 6.17 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 114.12 1.155 . . . . 74.44 114.12 175.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 54.2 mt-30 57.63 36.19 26.46 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 127.073 2.149 . . . . 74.55 112.829 -179.22 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 36.1 t -82.94 145.87 7.85 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 N-CA-C 108.072 -1.084 . . . . 73.52 108.072 171.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -140.18 -7.79 1.18 Allowed 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 124.53 1.132 . . . . 64.23 112.642 173.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -154.43 -176.77 27.1 Favored Glycine 0 CA--C 1.52 0.396 0 N-CA-C 108.601 -1.8 . . . . 73.13 108.601 -178.209 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.41 ' HA ' ' C ' ' A' ' 154' ' ' PRO . 31.4 m -137.49 158.37 72.18 Favored Pre-proline 0 CA--C 1.54 0.563 0 N-CA-C 108.628 -0.879 . . . . 71.44 108.628 174.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . 0.41 ' C ' ' HA ' ' A' ' 153' ' ' VAL . 61.5 Cg_endo -63.05 160.56 59.06 Favored 'Cis proline' 0 N--CA 1.455 -0.771 0 C-N-CA 123.252 -1.562 . . . . 75.51 112.055 -12.026 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 9.4 m -159.04 111.05 2.16 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 105.537 -2.023 . . . . 74.12 105.537 174.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 92.7 mtp -84.39 155.61 22.21 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 108.579 -0.897 . . . . 74.42 108.579 165.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 10.0 t -138.48 150.71 24.16 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 N-CA-C 106.82 -1.548 . . . . 75.24 106.82 174.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 55.2 t -134.98 123.79 41.49 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 N-CA-C 105.908 -1.886 . . . . 74.43 105.908 -178.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 9.3 m-20 52.33 13.1 0.27 Allowed 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 129.814 3.246 . . . . 74.2 114.598 178.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 59.17 42.31 97.09 Favored Glycine 0 CA--C 1.527 0.785 0 CA-C-O 118.612 -1.105 . . . . 75.44 111.826 -166.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 13.5 mtpp -133.19 -38.85 0.94 Allowed 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 125.119 1.367 . . . . 72.54 111.219 -177.23 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -116.29 154.2 30.59 Favored 'General case' 0 CA--C 1.502 -0.901 0 N-CA-C 108.409 -0.96 . . . . 71.54 108.409 177.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 28.4 ttp85 -132.7 135.11 45.58 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 105.034 -2.21 . . . . 65.24 105.034 174.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 45.5 p90 -149.77 173.26 13.92 Favored 'General case' 0 C--N 1.324 -0.543 0 O-C-N 121.465 -0.772 . . . . 74.32 109.123 169.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -167.5 174.24 8.03 Favored 'General case' 0 CA--C 1.515 -0.367 0 N-CA-C 109.76 -0.459 . . . . 43.3 109.76 178.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 14.7 mt -51.77 -51.27 28.47 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 C-N-CA 125.917 1.687 . . . . 71.5 110.33 -179.183 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -76.09 -20.7 77.23 Favored Glycine 0 CA--C 1.527 0.8 0 CA-C-O 118.096 -1.391 . . . . 70.31 113.467 -178.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 66.6 m -70.18 -64.25 0.93 Allowed 'General case' 0 C--O 1.235 0.33 0 CA-C-N 120.011 1.906 . . . . 74.23 108.407 168.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -55.76 -48.74 74.76 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 127.354 2.261 . . . . 71.43 111.943 -174.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 130.89 -6.49 5.78 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 124.532 1.063 . . . . 74.3 114.303 178.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 165.59 169.67 29.51 Favored Glycine 0 CA--C 1.526 0.758 0 CA-C-N 119.218 1.509 . . . . 71.21 110.413 178.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -61.07 -43.43 29.89 Favored 'Trans proline' 0 N--CA 1.461 -0.439 0 C-N-CA 123.047 2.498 . . . . 74.21 111.351 -174.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 -60.32 -44.43 95.48 Favored 'General case' 0 CA--C 1.536 0.424 0 O-C-N 121.468 -0.77 . . . . 73.33 110.474 176.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -66.5 -23.94 66.33 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.511 1.125 . . . . 74.44 110.648 -177.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 28.3 m -66.58 -44.31 82.6 Favored 'General case' 0 N--CA 1.455 -0.19 0 O-C-N 121.056 -1.027 . . . . 74.52 109.668 179.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 54.9 mt -68.15 -23.51 64.88 Favored 'General case' 0 C--N 1.341 0.217 0 CA-C-N 118.702 0.683 . . . . 74.15 111.938 179.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.12 -54.9 37.36 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 108.245 -1.02 . . . . 75.52 108.245 168.577 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.458 HD13 ' CD2' ' A' ' 6' ' ' TYR . 3.0 mm? -64.74 -44.69 89.33 Favored 'General case' 0 CA--C 1.515 -0.383 0 N-CA-C 110.016 -0.365 . . . . 73.42 110.016 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -54.86 -34.38 62.86 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 112.538 0.57 . . . . 73.12 112.538 -175.018 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -94.61 -36.55 11.74 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 123.475 0.71 . . . . 70.23 110.929 -170.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 37.9 t80 -57.25 -53.45 57.99 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.757 0.823 . . . . 74.21 109.65 171.156 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 26.5 mt -55.75 -46.8 77.75 Favored 'General case' 0 CA--C 1.516 -0.329 0 C-N-CA 124.43 1.092 . . . . 72.43 111.403 -177.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 46.2 mt -48.46 -58.65 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.139 0 N-CA-C 109.025 -0.731 . . . . 74.33 109.025 176.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 6.9 tm-20 -65.1 -26.64 68.3 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 119.254 0.934 . . . . 73.31 111.882 -176.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 3.7 tmtm? -64.9 -58.28 6.59 Favored 'General case' 0 C--O 1.234 0.282 0 O-C-N 120.645 -1.284 . . . . 73.35 109.634 172.018 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -60.54 -40.8 92.85 Favored 'General case' 0 N--CA 1.438 -1.04 0 C-N-CA 125.525 1.53 . . . . 75.22 112.077 -177.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.68 -43.37 80.31 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 125.859 1.664 . . . . 72.13 110.299 179.428 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -57.49 -29.52 64.35 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 119.884 1.22 . . . . 72.43 111.202 -174.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -53.2 -29.45 32.16 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.06 0.944 . . . . 73.24 113.39 174.079 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -147.98 50.49 1.04 Allowed 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 125.797 1.639 . . . . 73.52 109.894 -174.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 49.9 tttt -84.26 44.4 1.02 Allowed 'General case' 0 N--CA 1.476 0.851 0 O-C-N 120.934 -1.104 . . . . 74.53 109.237 -178.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.097 0 C-N-CA 127.038 2.135 . . . . 70.42 112.292 -161.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.934 0 N-CA-C 108.599 -1.8 . . . . 72.3 108.599 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . 0.27 0.0 OUTLIER 59.4 164.03 0.05 OUTLIER 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.148 0.579 . . . . 63.34 110.598 -135.492 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -152.93 14.48 0.54 Allowed 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.123 0.969 . . . . 74.23 112.127 175.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 25.5 m-85 -146.6 160.72 41.81 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 123.932 0.893 . . . . 74.41 110.275 -167.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 31.5 m -128.78 136.59 50.74 Favored 'General case' 0 C--O 1.238 0.461 0 O-C-N 121.418 -0.801 . . . . 62.31 108.846 -177.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -70.99 149.99 46.1 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 122.119 0.961 . . . . 60.54 109.1 174.229 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 62.32 12.04 36.6 Favored Glycine 0 CA--C 1.533 1.208 0 CA-C-O 118.556 -1.136 . . . . 73.54 112.582 -167.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.8 tptt -126.97 -84.24 0.61 Allowed 'General case' 0 C--N 1.339 0.131 0 CA-C-N 119.885 1.842 . . . . 74.42 107.346 -178.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.6 mp0 -74.52 -26.82 60.23 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 125.477 1.511 . . . . 75.44 110.372 179.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 34.3 p90 -158.61 174.86 14.41 Favored 'General case' 0 N--CA 1.456 -0.131 0 O-C-N 121.18 -0.95 . . . . 75.41 109.451 -175.223 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 24.7 t -135.76 128.56 47.07 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.107 0 C-N-CA 124.418 1.087 . . . . 64.12 108.196 -179.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -87.74 169.28 12.23 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.211 1.404 . . . . 74.53 110.782 165.204 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -136.38 122.48 20.29 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 124.641 1.176 . . . . 74.11 111.054 177.037 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.6 p -63.13 -0.07 0.69 Allowed 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 128.657 2.783 . . . . 74.14 114.693 179.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 74.1 m -137.7 78.87 35.82 Favored Pre-proline 0 N--CA 1.447 -0.592 0 N-CA-C 107.546 -1.279 . . . . 73.25 107.546 173.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -68.97 179.6 3.17 Favored 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 123.339 2.692 . . . . 74.52 111.818 -176.39 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 40.4 t -126.84 136.97 29.57 Favored Pre-proline 0 CA--C 1.536 0.407 0 N-CA-C 108.503 -0.925 . . . . 75.43 108.503 -169.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -78.18 -179.09 5.13 Favored 'Trans proline' 0 CA--C 1.537 0.635 0 C-N-CA 122.882 2.388 . . . . 73.33 111.861 178.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 3.7 m -131.96 179.78 4.07 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 C-N-CA 127.294 2.237 . . . . 73.44 109.504 176.306 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 47.3 t -64.15 -70.58 0.21 Allowed 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 124.879 1.272 . . . . 53.25 108.324 168.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 57.2 tp60 -116.54 143.03 30.49 Favored Pre-proline 0 N--CA 1.45 -0.443 0 N-CA-C 105.543 -2.021 . . . . 73.33 105.543 -176.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -86.21 -164.13 0.21 Allowed 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 123.699 2.932 . . . . 73.42 110.306 176.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 94.3 -77.84 0.97 Allowed Glycine 0 N--CA 1.444 -0.771 0 N-CA-C 108.889 -1.684 . . . . 74.3 108.889 174.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 87.2 mttt -62.98 136.56 57.91 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 107.919 -1.141 . . . . 65.41 107.919 178.271 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 25.8 mm -73.78 124.66 31.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 106.134 -1.802 . . . . 74.45 106.134 176.117 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -73.76 146.93 43.94 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.104 -1.073 . . . . 75.31 108.104 175.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 60.1 t -133.35 135.6 55.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 106.382 -1.71 . . . . 72.23 106.382 164.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 60.9 t -130.38 101.28 5.65 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 N-CA-C 106.4 -1.704 . . . . 62.12 106.4 -169.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -72.04 133.64 45.39 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 107.679 -1.23 . . . . 71.53 107.679 164.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.1 mp -119.71 126.87 52.13 Favored 'General case' 0 C--O 1.231 0.109 0 N-CA-C 108.536 -0.912 . . . . 74.43 108.536 167.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 21.6 p90 -135.3 163.59 29.66 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 124.649 1.18 . . . . 70.04 111.131 -171.007 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 34.2 t90 -143.44 157.75 44.2 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 124.647 1.179 . . . . 73.24 107.948 173.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 31.3 t80 -46.23 -57.88 4.16 Favored 'General case' 0 N--CA 1.444 -0.745 0 C-N-CA 128.063 2.545 . . . . 75.34 113.707 -177.11 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -75.46 -83.68 0.41 Allowed Glycine 0 N--CA 1.444 -0.767 0 N-CA-C 108.548 -1.821 . . . . 72.1 108.548 -170.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 9.1 t 42.63 65.53 5.1 Favored Pre-proline 0 CA--C 1.541 0.62 0 C-N-CA 126.032 1.733 . . . . 63.41 112.752 164.128 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -62.57 -20.12 69.81 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 122.413 2.076 . . . . 74.35 112.471 -175.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 15.1 m-70 -83.95 -21.4 31.8 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 117.732 -1.128 . . . . 74.41 113.938 172.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 99.0 m -68.16 -41.87 80.9 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 119.931 1.241 . . . . 74.52 109.56 175.141 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 19.1 t80 -54.06 -42.81 69.68 Favored 'General case' 0 C--N 1.341 0.202 0 C-N-CA 124.155 0.982 . . . . 75.14 110.804 -174.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -51.68 -43.87 62.88 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.815 0.846 . . . . 71.51 111.909 -179.094 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -76.84 -24.59 52.7 Favored 'General case' 0 C--O 1.225 -0.231 0 CA-C-O 117.061 -1.447 . . . . 71.35 112.725 -171.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -44.45 -67.79 0.33 Allowed Pre-proline 0 CA--C 1.543 0.68 0 CA-C-N 120.421 1.464 . . . . 75.13 113.677 -170.037 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -70.92 -4.62 15.17 Favored 'Trans proline' 0 CA--C 1.536 0.611 0 C-N-CA 121.801 1.667 . . . . 74.11 112.815 -175.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -96.52 -0.8 48.38 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 127.181 2.192 . . . . 61.04 111.151 173.461 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 20.6 tt -126.93 -28.38 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 CA-C-N 120.885 1.675 . . . . 74.15 112.978 171.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 54.6 t -50.92 -60.14 6.14 Favored Pre-proline 0 CA--C 1.538 0.493 0 CA-C-N 119.612 1.096 . . . . 73.51 110.974 178.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -69.16 -32.51 20.93 Favored 'Trans proline' 0 N--CA 1.451 -0.998 0 CA-C-N 121.07 1.418 . . . . 70.24 111.067 -175.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 83.4 t90 -53.38 -53.41 51.51 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 119.842 1.201 . . . . 73.34 110.242 173.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 21.5 t -60.48 -37.42 81.0 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.676 0.79 . . . . 73.55 111.288 -177.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -61.66 -45.82 92.41 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 119.32 0.963 . . . . 73.02 110.88 173.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 2.6 mptp? -83.49 7.93 15.51 Favored 'General case' 0 C--O 1.234 0.261 0 O-C-N 120.625 -1.297 . . . . 74.44 113.544 -169.081 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 35.2 mt -61.59 157.49 47.01 Favored Pre-proline 0 CA--C 1.537 0.471 0 C-N-CA 125.198 1.399 . . . . 72.35 111.784 179.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -74.85 167.98 25.87 Favored 'Trans proline' 0 N--CA 1.451 -0.993 0 C-N-CA 124.752 3.635 . . . . 73.13 110.548 172.123 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -77.69 -4.95 48.75 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.755 0.822 . . . . 55.33 113.133 178.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -94.43 7.04 46.91 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 119.272 0.942 . . . . 72.42 110.647 177.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 96.8 t -126.55 138.0 56.06 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 N-CA-C 106.715 -1.587 . . . . 75.12 106.715 -177.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 68.5 t60 -123.48 108.84 13.11 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 124.9 1.28 . . . . 74.13 108.747 -178.004 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 51.8 t80 -87.81 137.55 32.24 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 123.788 0.835 . . . . 74.21 109.528 -178.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 47.7 t -136.28 150.18 27.66 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 C-N-CA 126.215 1.806 . . . . 74.02 107.409 -174.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 30.4 mtp180 -132.72 126.08 31.69 Favored 'General case' 0 C--O 1.232 0.166 0 N-CA-C 106.885 -1.524 . . . . 72.22 106.885 -176.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 86.8 mt -138.47 144.82 44.11 Favored Pre-proline 0 N--CA 1.467 0.402 0 C-N-CA 124.141 0.976 . . . . 63.34 109.587 -178.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -74.79 152.82 42.37 Favored 'Trans proline' 0 N--CA 1.456 -0.735 0 C-N-CA 122.14 1.893 . . . . 73.44 111.672 177.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -89.48 107.21 18.94 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 125.237 1.415 . . . . 61.04 109.09 177.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 39.8 mt -105.71 78.59 1.36 Allowed 'General case' 0 C--O 1.236 0.356 0 C-N-CA 125.151 1.381 . . . . 72.24 108.103 -173.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -121.96 59.95 0.99 Allowed 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 124.706 1.202 . . . . 72.43 110.197 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 68.85 164.74 3.58 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 125.983 1.754 . . . . 71.32 114.174 167.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 48.72 -142.7 8.6 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 124.252 0.929 . . . . 74.11 111.276 -175.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -56.7 -17.29 4.83 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 C-N-CA 124.71 1.204 . . . . 73.21 113.524 -175.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 13.3 m95 -60.97 -42.85 99.1 Favored 'General case' 0 C--N 1.341 0.211 0 O-C-N 120.442 -1.411 . . . . 75.24 109.959 178.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 7.5 m-80 -72.21 -17.97 61.88 Favored 'General case' 0 CA--C 1.527 0.095 0 O-C-N 121.566 -0.709 . . . . 74.31 112.512 176.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 64.8 t -92.53 -13.25 8.76 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 C-N-CA 123.786 0.834 . . . . 74.4 111.605 -173.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 52.0 m170 -115.45 4.49 14.3 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.342 1.057 . . . . 74.14 111.924 172.141 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -102.93 -41.73 2.22 Favored Glycine 0 N--CA 1.448 -0.526 0 N-CA-C 109.518 -1.433 . . . . 53.23 109.518 -176.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . 0.268 1.3 pm0 -49.12 -43.86 41.85 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 125.16 1.384 . . . . 75.13 113.027 -179.689 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 5.1 ppp? -54.35 -37.16 64.61 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 114.154 1.168 . . . . 75.55 114.154 -172.276 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 39.4 t80 -56.49 -43.07 79.34 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 122.835 1.302 . . . . 74.14 109.049 -172.2 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 12.9 mt -68.87 -34.8 76.05 Favored 'General case' 0 N--CA 1.442 -0.867 0 C-N-CA 125.991 1.716 . . . . 75.41 110.729 -177.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -68.53 -50.99 47.8 Favored 'General case' 0 C--N 1.344 0.356 0 CA-C-N 121.125 1.784 . . . . 71.5 110.182 176.026 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -51.09 -52.96 38.42 Favored 'General case' 0 CA--C 1.535 0.376 0 O-C-N 123.968 0.793 . . . . 75.13 109.459 -177.543 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -65.12 -28.14 69.22 Favored 'General case' 0 N--CA 1.465 0.289 0 O-C-N 121.517 -0.739 . . . . 73.55 112.866 -179.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 8.5 t -69.63 -19.76 63.62 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 118.09 -0.957 . . . . 64.51 111.682 -175.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 4.9 ptp -93.6 -16.97 23.82 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 121.116 1.78 . . . . 74.22 112.364 170.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 79.7 63.46 2.0 Favored Glycine 0 CA--C 1.522 0.47 0 N-CA-C 109.153 -1.579 . . . . 44.44 109.153 -179.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 4.4 m -58.27 107.72 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 C-N-CA 124.336 1.054 . . . . 72.52 109.761 178.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -92.13 172.06 8.68 Favored 'General case' 0 C--O 1.237 0.446 0 O-C-N 121.363 -0.835 . . . . 75.1 109.143 170.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 6.8 t-160 76.15 19.98 1.71 Allowed 'General case' 0 C--O 1.242 0.692 0 C-N-CA 127.485 2.314 . . . . 75.42 113.545 176.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -153.9 154.83 34.58 Favored 'General case' 0 CA--C 1.546 0.815 0 O-C-N 120.968 -1.083 . . . . 73.42 108.988 154.181 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.0 t -77.18 29.07 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 127.761 2.424 . . . . 73.24 112.481 -174.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 71.9 m80 50.0 48.55 21.76 Favored 'General case' 0 CA--C 1.544 0.749 0 O-C-N 120.401 -1.437 . . . . 73.14 109.832 -168.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -130.23 -48.78 1.1 Allowed 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 128.092 2.557 . . . . 61.13 109.055 -178.005 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -68.34 -22.35 64.69 Favored 'General case' 0 N--CA 1.449 -0.478 0 O-C-N 121.471 -0.768 . . . . 62.4 111.663 -174.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 57.3 t -60.05 -65.08 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 CA-C-N 119.997 1.271 . . . . 65.34 108.258 164.182 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -51.4 -49.36 61.72 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 125.114 1.366 . . . . 75.13 112.086 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.409 ' OE1' ' HE3' ' A' ' 100' ' ' LYS . 3.5 mm-40 -62.04 -13.8 29.64 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 126.825 2.05 . . . . 71.55 112.442 -178.272 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -108.0 1.51 22.55 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 125.638 1.575 . . . . 74.33 111.024 178.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 28.3 mt -110.74 -58.1 3.78 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.286 0 N-CA-C 107.741 -1.207 . . . . 74.0 107.741 172.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 80.3 m-70 -66.37 -60.7 2.51 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 119.051 0.841 . . . . 73.24 111.09 -177.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.409 ' HE3' ' OE1' ' A' ' 96' ' ' GLU . 0.6 OUTLIER -68.17 -30.0 69.01 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 118.999 0.818 . . . . 75.54 110.646 -174.06 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -98.38 -36.89 9.83 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 123.84 0.856 . . . . 74.32 111.715 -168.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 5.0 t-160 44.26 57.31 4.37 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 128.713 2.805 . . . . 72.22 112.778 178.004 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -64.88 -173.37 0.11 Allowed 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.897 1.679 . . . . 73.54 111.756 170.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 18.8 ttmm -109.49 54.3 0.66 Allowed 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 126.447 1.899 . . . . 74.43 110.415 175.09 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 24.8 mt -75.39 58.32 0.98 Allowed 'General case' 0 C--N 1.322 -0.587 0 C-N-CA 127.479 2.311 . . . . 75.22 108.452 179.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -114.6 -2.36 13.12 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 127.832 2.453 . . . . 74.15 111.346 -171.307 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 45.1 p -135.4 151.28 74.5 Favored Pre-proline 0 C--O 1.232 0.14 0 C-N-CA 124.729 1.212 . . . . 72.33 108.715 179.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -66.59 -23.83 49.17 Favored 'Trans proline' 0 N--CA 1.459 -0.5 0 C-N-CA 121.888 1.725 . . . . 73.44 111.955 179.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -58.27 -60.32 3.94 Favored 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 124.71 1.204 . . . . 75.11 110.479 167.034 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 19.5 tp10 -66.49 -40.07 89.09 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 120.978 -0.289 . . . . 74.24 110.842 -174.06 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 3.6 mtt -67.01 -47.06 72.62 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 120.722 -0.391 . . . . 74.45 111.447 -175.007 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -63.28 -48.35 78.49 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 118.94 -0.552 . . . . 72.22 110.59 -177.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -70.96 -5.42 30.83 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 118.847 0.748 . . . . 64.11 112.928 -178.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 87.0 t80 -100.18 -35.22 9.73 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 124.626 1.17 . . . . 73.44 112.38 176.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 76.9 mt -83.22 -17.75 41.66 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 123.134 0.574 . . . . 72.33 111.166 175.502 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -52.17 -30.31 26.33 Favored 'General case' 0 CA--C 1.528 0.115 0 C-N-CA 125.765 1.626 . . . . 74.22 112.657 -175.375 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -93.28 -2.0 66.3 Favored Glycine 0 N--CA 1.441 -1.01 0 CA-C-O 118.473 -1.182 . . . . 73.05 112.312 -175.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.12 39.46 3.11 Favored 'General case' 0 C--N 1.342 0.242 0 CA-C-N 119.134 1.467 . . . . 73.54 111.273 -163.569 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 90.45 11.57 62.32 Favored Glycine 0 CA--C 1.527 0.785 0 CA-C-O 118.541 -1.144 . . . . 55.22 113.849 169.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 30.7 t -113.36 128.92 69.94 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 C-N-CA 125.643 1.577 . . . . 73.03 107.237 175.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -99.16 141.13 32.32 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 122.884 0.474 . . . . 64.31 111.811 173.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 5.1 mtmt -66.15 -33.82 76.64 Favored 'General case' 0 CA--C 1.537 0.449 0 O-C-N 121.501 -0.749 . . . . 74.24 111.423 178.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -64.9 -33.61 76.43 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 125.116 1.367 . . . . 75.05 111.323 178.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 7.2 mmtp -79.55 -50.77 10.22 Favored 'General case' 0 C--O 1.23 0.066 0 N-CA-C 107.888 -1.153 . . . . 72.43 107.888 172.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 52.0 t80 -53.39 -67.47 0.25 Allowed 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.831 1.252 . . . . 74.24 113.332 -165.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 25.4 mt -62.79 -38.84 92.25 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 122.738 0.415 . . . . 75.21 111.228 -165.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 22.5 t -57.43 -46.5 83.48 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 124.16 0.984 . . . . 73.31 111.295 -176.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 9.9 t -80.73 -33.66 35.02 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 110.355 -0.239 . . . . 73.24 110.355 178.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 76.8 t80 -55.62 -38.28 69.29 Favored 'General case' 0 C--O 1.237 0.396 0 O-C-N 121.266 -0.896 . . . . 70.21 111.138 176.091 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -91.99 16.83 10.31 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.428 1.491 . . . . 75.04 112.082 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 2.2 p -106.48 171.89 7.11 Favored 'General case' 0 C--O 1.24 0.589 0 CA-C-N 119.804 1.183 . . . . 74.01 111.895 -175.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -67.2 -17.78 64.97 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 123.883 0.873 . . . . 74.0 112.081 172.34 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -57.9 -56.31 23.62 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 119.106 0.866 . . . . 74.21 109.29 178.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 13.7 mm -59.39 -41.33 84.07 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.134 0 CA-C-O 119.169 -0.443 . . . . 74.3 110.583 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 13.0 mttt -57.31 -35.14 69.46 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 119.31 0.959 . . . . 71.4 111.637 175.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -81.61 -22.38 60.21 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 125.071 1.32 . . . . 64.35 113.009 -178.183 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -82.39 -39.6 22.46 Favored 'General case' 0 CA--C 1.535 0.399 0 O-C-N 121.382 -1.069 . . . . 74.12 110.097 173.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 92.8 mmm -61.26 -41.19 96.5 Favored 'General case' 0 C--O 1.231 0.099 0 C-N-CA 124.105 0.962 . . . . 62.3 111.169 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -57.13 -43.13 82.12 Favored 'General case' 0 CA--C 1.535 0.4 0 O-C-N 121.032 -1.043 . . . . 74.35 111.375 178.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 13.3 mtmt -60.29 -66.06 0.58 Allowed 'General case' 0 C--N 1.342 0.272 0 CA-C-N 118.549 0.613 . . . . 75.04 110.518 176.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -59.94 -26.97 66.39 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 119.027 0.83 . . . . 75.3 111.64 -170.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.55 -56.11 8.26 Favored 'General case' 0 C--N 1.34 0.158 0 O-C-N 121.368 -0.832 . . . . 74.3 110.509 176.411 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.55 -32.7 73.66 Favored 'General case' 0 C--N 1.342 0.26 0 CA-C-N 119.172 0.896 . . . . 75.3 110.365 -177.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 42.1 mt -59.67 -54.97 40.17 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 118.007 -0.997 . . . . 73.42 110.288 179.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -54.66 -37.44 65.72 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 119.616 1.098 . . . . 74.21 112.166 -178.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -73.25 -42.7 62.23 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 122.903 0.481 . . . . 74.44 110.777 -179.808 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -59.83 -44.95 93.8 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 123.605 0.762 . . . . 64.54 109.099 175.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 15.9 m-85 -63.0 -7.35 5.12 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.242 1.417 . . . . 73.41 113.337 177.151 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 61.7 mt-30 56.21 47.56 19.13 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 127.208 2.203 . . . . 75.23 111.01 -174.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 95.3 t -82.72 141.54 14.82 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 O-C-N 120.665 -1.272 . . . . 73.54 108.196 178.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 11.7 p -104.93 -19.75 13.76 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 124.178 0.991 . . . . 73.42 113.092 -174.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 179.12 -148.08 8.04 Favored Glycine 0 N--CA 1.452 -0.275 0 N-CA-C 108.81 -1.716 . . . . 73.31 108.81 -170.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.426 ' HA ' ' C ' ' A' ' 154' ' ' PRO . 22.3 m -147.09 153.93 45.81 Favored Pre-proline 0 C--O 1.243 0.738 0 C-N-CA 127.115 2.166 . . . . 74.23 106.717 167.46 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . 0.426 ' C ' ' HA ' ' A' ' 153' ' ' VAL . 98.2 Cg_endo -66.9 158.24 81.64 Favored 'Cis proline' 0 N--CA 1.458 -0.587 0 C-N-CA 124.132 -1.195 . . . . 71.21 112.154 -3.633 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 97.8 m -156.82 146.46 20.69 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 106.391 -1.707 . . . . 70.01 106.391 172.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 28.7 mmm -114.78 165.48 12.78 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 106.689 -1.596 . . . . 60.33 106.689 161.096 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 78.0 t -137.41 143.9 33.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 106.383 -1.71 . . . . 75.41 106.383 160.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 20.0 t -105.21 134.48 46.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 N-CA-C 105.915 -1.883 . . . . 70.4 105.915 162.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 4.0 t30 50.77 17.02 0.36 Allowed 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 130.197 3.399 . . . . 72.11 116.359 166.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 70.23 25.23 75.92 Favored Glycine 0 CA--C 1.527 0.836 0 CA-C-O 117.231 -1.872 . . . . 73.5 113.659 -171.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 21.6 mtpt -128.72 -37.05 1.79 Allowed 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 119.878 1.839 . . . . 75.14 114.032 179.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 -121.4 108.79 14.1 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 119.708 1.14 . . . . 72.42 111.557 -168.126 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 18.9 ptt180 -90.56 32.79 0.94 Allowed 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 126.96 2.104 . . . . 74.24 115.532 -171.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 4.0 p90 -52.06 155.51 1.86 Allowed 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 122.154 0.978 . . . . 63.23 110.085 -177.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -160.96 174.66 13.47 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 107.811 -1.181 . . . . 73.01 107.811 -175.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 3.5 mt -46.3 -52.67 3.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 C-N-CA 126.108 1.763 . . . . 74.44 108.163 161.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -78.28 19.72 4.46 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 126.828 2.156 . . . . 65.2 114.621 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 18.8 m -125.27 -48.89 1.7 Allowed 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 119.37 1.585 . . . . 74.51 109.12 154.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -63.2 -34.84 78.52 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-O 118.166 -0.921 . . . . 53.44 112.909 -170.276 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 117.75 5.5 13.87 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 123.586 0.612 . . . . 72.42 113.547 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 153.35 174.39 23.6 Favored Glycine 0 CA--C 1.527 0.805 0 CA-C-N 119.22 1.51 . . . . 45.21 110.543 177.03 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -64.05 -45.18 10.72 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 122.308 2.005 . . . . 75.3 110.826 -173.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -66.41 -39.46 89.02 Favored 'General case' 0 N--CA 1.453 -0.304 0 O-C-N 121.269 -0.895 . . . . 75.32 110.173 177.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -62.58 -27.45 69.2 Favored 'General case' 0 CA--C 1.537 0.466 0 O-C-N 122.306 -0.246 . . . . 74.11 110.932 175.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 24.9 m -61.84 -45.9 91.79 Favored 'General case' 0 CA--C 1.534 0.354 0 O-C-N 120.469 -1.394 . . . . 74.52 109.537 179.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 33.2 mt -65.51 -24.38 67.12 Favored 'General case' 0 N--CA 1.466 0.366 0 O-C-N 121.365 -0.834 . . . . 72.52 112.043 177.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.74 -46.18 74.24 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-O 118.796 -0.621 . . . . 74.14 109.427 169.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -76.51 -39.35 53.29 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-O 117.27 -1.348 . . . . 75.53 110.565 -178.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -52.65 -49.88 64.32 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 120.015 1.28 . . . . 75.52 111.754 -172.088 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -66.1 -45.33 81.57 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 125.235 1.414 . . . . 74.03 110.786 -173.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -62.45 -46.88 86.51 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 126.003 1.721 . . . . 74.32 111.448 176.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 83.0 mt -64.32 -38.83 92.44 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 118.487 -0.768 . . . . 75.42 110.118 -176.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 39.5 mt -55.6 -51.5 57.66 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 CA-C-N 119.369 0.986 . . . . 74.3 108.655 172.333 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -67.97 7.4 0.54 Allowed 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 127.378 2.271 . . . . 75.43 114.414 174.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -110.73 -45.29 3.51 Favored 'General case' 0 N--CA 1.454 -0.252 0 O-C-N 120.841 -1.162 . . . . 73.24 108.823 165.74 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 26.9 mm-40 -54.66 -38.49 67.0 Favored 'General case' 0 CA--C 1.512 -0.495 0 C-N-CA 126.326 1.85 . . . . 75.23 115.403 -173.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.73 -23.41 29.01 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 118.624 -1.23 . . . . 72.11 114.14 -176.586 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -103.05 -20.29 14.24 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 126.484 1.914 . . . . 74.51 113.084 175.126 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -83.99 -20.73 32.33 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.785 1.634 . . . . 73.25 112.67 -174.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -151.66 72.66 1.04 Allowed 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.029 1.332 . . . . 75.01 110.435 173.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 4.5 pttt -88.61 53.47 2.72 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 124.51 1.124 . . . . 70.42 111.983 -175.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 24.1 mttt . . . . . 0 C--O 1.248 0.976 0 N-CA-C 106.29 -1.744 . . . . 75.54 106.29 142.934 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.506 -0.505 0 N-CA-C 108.946 -1.662 . . . . 72.05 108.946 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.466 ' C ' ' H ' ' A' ' 6' ' ' TYR . 1.3 m-20 43.46 66.8 0.74 Allowed 'General case' 0 C--N 1.341 0.203 0 C-N-CA 125.87 1.668 . . . . 70.41 110.159 155.152 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -75.04 25.18 0.09 Allowed 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.517 1.127 . . . . 74.01 113.161 -172.386 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.466 ' H ' ' C ' ' A' ' 4' ' ' ASP . 33.1 m-85 -140.53 170.3 16.05 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 128.19 2.596 . . . . 75.34 108.838 -176.418 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 95.0 m -141.69 137.48 31.76 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 124.932 1.293 . . . . 75.24 108.269 176.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.66 130.62 43.93 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 108.729 -0.841 . . . . 73.33 108.729 172.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 80.07 15.92 77.83 Favored Glycine 0 CA--C 1.525 0.681 0 CA-C-O 119.33 -0.705 . . . . 63.1 112.966 -174.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.1 tpmt? -133.25 -55.99 0.91 Allowed 'General case' 0 CA--C 1.519 -0.242 0 CA-C-N 118.384 1.092 . . . . 73.13 109.345 -177.146 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 8.1 mp0 -105.42 -21.2 13.27 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 124.388 1.075 . . . . 74.52 110.642 179.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 42.6 p90 -159.44 168.16 26.95 Favored 'General case' 0 C--O 1.234 0.253 0 O-C-N 121.119 -0.988 . . . . 74.24 110.641 -171.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 84.0 t -126.13 111.47 26.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 C-N-CA 124.894 1.277 . . . . 72.42 108.504 178.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -78.08 165.61 23.79 Favored 'General case' 0 C--O 1.239 0.5 0 O-C-N 120.871 -1.143 . . . . 64.55 109.246 169.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -133.87 111.41 10.46 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 126.011 1.725 . . . . 73.31 107.333 -175.728 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 76.3 p -65.24 0.24 1.48 Allowed 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 125.985 1.714 . . . . 63.04 113.26 179.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 38.6 m -128.92 73.74 81.4 Favored Pre-proline 0 N--CA 1.439 -1.001 0 N-CA-C 105.397 -2.075 . . . . 55.35 105.397 -176.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -72.93 177.86 7.18 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 124.211 3.274 . . . . 74.32 110.922 -170.209 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 6.1 t -140.61 116.67 7.67 Favored Pre-proline 0 CA--C 1.537 0.46 0 C-N-CA 123.321 0.648 . . . . 75.41 109.442 176.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -72.79 -176.36 2.3 Favored 'Trans proline' 0 CA--C 1.537 0.672 0 C-N-CA 123.858 3.038 . . . . 70.22 110.854 171.011 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 3.5 m -133.85 160.61 41.89 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 N-CA-C 106.016 -1.846 . . . . 74.41 106.016 176.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 3.4 m -47.75 -66.88 0.33 Allowed 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 125.392 1.477 . . . . 72.44 113.766 166.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 11.8 tp60 -128.71 81.25 71.12 Favored Pre-proline 0 N--CA 1.469 0.48 0 C-N-CA 123.9 0.88 . . . . 73.33 108.718 -169.003 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.565 ' C ' ' H ' ' A' ' 26' ' ' LYS . 36.2 Cg_endo -73.05 -57.51 0.07 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.095 0 CA-C-N 119.122 0.722 . . . . 71.35 110.314 179.236 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 51.35 -23.34 0.01 OUTLIER Glycine 0 CA--C 1.53 1.019 0 C-N-CA 127.831 2.634 . . . . 31.43 115.243 -159.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.565 ' H ' ' C ' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -140.05 -167.06 2.22 Favored 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 129.548 3.139 . . . . 74.45 105.483 -161.931 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 30.4 mm -87.75 130.65 37.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 N-CA-C 106.207 -1.775 . . . . 74.34 106.207 168.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -69.71 140.04 53.48 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 105.608 -1.997 . . . . 74.41 105.608 173.131 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 54.8 t -128.2 134.32 65.21 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 N-CA-C 105.769 -1.937 . . . . 71.5 105.769 160.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 30.1 t -123.14 112.71 34.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 105.95 -1.87 . . . . 74.21 105.95 172.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 62.6 tt0 -72.26 122.01 20.36 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 106.347 -1.723 . . . . 74.54 106.347 156.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.5 mp -109.65 137.91 46.78 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-N 119.212 0.914 . . . . 75.12 108.919 166.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 9.5 p90 -145.66 171.26 14.98 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 122.986 0.514 . . . . 75.24 110.487 -168.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 42.2 t90 -156.7 151.57 25.97 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.38 1.472 . . . . 75.33 109.9 171.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 19.4 t80 -45.58 -48.49 14.5 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 127.789 2.436 . . . . 71.21 114.408 -174.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -75.14 -88.59 0.23 Allowed Glycine 0 C--N 1.341 0.806 0 N-CA-C 109.75 -1.34 . . . . 73.24 109.75 -169.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 12.7 t 42.76 72.49 1.13 Allowed Pre-proline 0 CA--C 1.538 0.483 0 C-N-CA 126.44 1.896 . . . . 74.34 112.955 160.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -59.16 -38.83 84.13 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 121.191 1.261 . . . . 72.3 112.199 -178.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 17.8 m170 -65.79 -30.38 71.02 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 119.142 0.883 . . . . 73.33 111.031 -179.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 82.1 m -62.67 -38.11 89.06 Favored 'General case' 0 C--N 1.343 0.32 0 CA-C-N 118.407 0.549 . . . . 64.13 110.158 177.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 38.6 t80 -62.0 -44.28 97.06 Favored 'General case' 0 C--N 1.339 0.139 0 O-C-N 121.614 -0.679 . . . . 72.55 110.828 -175.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -56.52 -34.45 67.02 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 118.285 0.493 . . . . 73.52 111.333 178.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -82.52 -16.0 50.28 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.837 1.655 . . . . 75.32 113.445 -178.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -43.26 -63.48 0.99 Allowed Pre-proline 0 CA--C 1.539 0.554 0 CA-C-N 120.042 1.292 . . . . 75.33 112.422 -173.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -85.79 -7.36 8.46 Favored 'Trans proline' 0 N--CA 1.452 -0.921 0 C-N-CA 121.645 1.563 . . . . 73.14 114.687 -174.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 26.0 m -66.01 -46.84 76.49 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 107.355 -1.35 . . . . 75.04 107.355 166.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 20.5 tt -84.2 -35.31 10.72 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 N-CA-C 113.528 0.936 . . . . 74.3 113.528 -166.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 42.9 t -48.16 -61.18 3.34 Favored Pre-proline 0 CA--C 1.545 0.779 0 O-C-N 121.237 -0.914 . . . . 73.43 111.803 178.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -72.5 -6.59 19.33 Favored 'Trans proline' 0 N--CA 1.454 -0.794 0 C-N-CA 122.007 1.805 . . . . 75.34 113.708 -177.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 79.8 t90 -72.25 -62.48 1.42 Allowed 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 120.085 1.312 . . . . 74.32 107.691 161.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 22.4 p -53.79 -33.3 55.55 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 115.035 1.494 . . . . 64.22 115.035 -169.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 58.4 mt-10 -80.45 -24.84 39.29 Favored 'General case' 0 CA--C 1.54 0.572 0 O-C-N 120.663 -1.273 . . . . 70.03 112.007 -179.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 11.1 mptt -96.2 9.26 41.57 Favored 'General case' 0 C--O 1.225 -0.196 0 C-N-CA 124.97 1.308 . . . . 74.54 112.009 -168.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 35.2 mt -62.15 160.14 33.26 Favored Pre-proline 0 C--O 1.242 0.661 0 C-N-CA 129.327 3.051 . . . . 74.43 113.41 -177.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -80.09 170.18 16.75 Favored 'Trans proline' 0 N--CA 1.448 -1.164 0 C-N-CA 124.752 3.634 . . . . 73.52 110.273 176.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -70.1 -5.06 24.24 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 124.112 0.965 . . . . 72.21 112.919 -179.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -104.38 9.61 35.69 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.428 1.091 . . . . 72.34 111.988 -171.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 93.1 t -120.46 149.52 23.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 N-CA-C 108.166 -1.05 . . . . 73.15 108.166 -177.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 21.9 t-160 -124.88 84.75 2.32 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 128.092 2.557 . . . . 72.42 105.931 -179.127 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 45.5 t80 -68.26 129.43 39.9 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 108.794 -0.817 . . . . 75.42 108.794 174.045 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 40.7 t -136.21 155.13 34.41 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.651 0 C-N-CA 126.461 1.904 . . . . 72.33 106.351 175.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 34.6 mtp180 -133.28 123.35 25.34 Favored 'General case' 0 CA--C 1.515 -0.375 0 N-CA-C 105.371 -2.085 . . . . 75.22 105.371 -176.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 78.0 mt -134.62 144.58 51.4 Favored Pre-proline 0 CA--C 1.533 0.307 0 CA-C-N 119.461 1.028 . . . . 75.32 110.716 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -77.1 129.32 10.42 Favored 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 122.589 2.192 . . . . 65.14 111.36 177.178 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -69.69 114.53 7.98 Favored 'General case' 0 CA--C 1.537 0.465 0 O-C-N 121.519 -0.738 . . . . 73.0 110.245 174.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 14.6 mt -106.62 103.15 12.52 Favored 'General case' 0 N--CA 1.466 0.351 0 O-C-N 121.059 -1.026 . . . . 75.22 110.247 -178.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -133.03 13.35 4.29 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 114.901 1.445 . . . . 73.52 114.901 -174.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -169.47 -116.9 0.39 Allowed Glycine 0 C--N 1.333 0.385 0 CA-C-N 119.603 1.092 . . . . 74.15 112.382 176.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -114.52 -73.6 0.58 Allowed Glycine 0 C--N 1.334 0.438 0 C-N-CA 126.225 1.869 . . . . 71.44 108.448 171.048 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 6.4 tp -58.84 -24.77 27.22 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-N 118.248 1.024 . . . . 72.11 112.164 -174.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 10.5 m95 -59.47 -48.8 80.26 Favored 'General case' 0 N--CA 1.455 -0.201 0 O-C-N 121.444 -0.785 . . . . 71.42 111.547 172.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 11.7 p30 -77.94 -30.64 50.57 Favored 'General case' 0 CA--C 1.509 -0.601 0 CA-C-O 117.663 -1.161 . . . . 75.15 113.599 177.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 74.5 t -57.15 -58.22 6.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 108.824 -0.806 . . . . 73.51 108.824 172.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 37.4 m170 -65.58 -24.18 67.02 Favored 'General case' 0 CA--C 1.528 0.109 0 N-CA-C 112.416 0.525 . . . . 75.22 112.416 178.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -78.96 -18.99 73.77 Favored Glycine 0 N--CA 1.444 -0.804 0 CA-C-O 118.966 -0.908 . . . . 73.3 111.302 178.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.71 -55.77 13.6 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 118.275 1.037 . . . . 73.4 109.606 -160.427 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 3.7 ptm -55.21 -28.78 55.54 Favored 'General case' 0 N--CA 1.454 -0.273 0 O-C-N 124.129 0.893 . . . . 75.44 113.294 -166.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 29.7 t80 -55.22 -52.06 64.59 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 124.007 0.923 . . . . 74.22 109.981 176.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 37.9 mt -66.54 -43.1 86.03 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 117.979 -1.01 . . . . 75.05 109.821 179.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.6 -41.67 90.86 Favored 'General case' 0 C--N 1.344 0.354 0 CA-C-N 120.3 1.409 . . . . 65.03 110.906 -179.31 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.4 -55.45 33.38 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 123.882 0.873 . . . . 71.31 109.077 -178.484 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -74.74 -14.53 60.73 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 112.505 0.558 . . . . 75.34 112.505 -177.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 3.2 t -70.44 -10.22 58.53 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.821 1.249 . . . . 72.32 112.222 171.384 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 43.4 mtm -100.44 6.9 44.47 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.423 1.089 . . . . 75.33 112.887 168.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 74.15 6.47 74.5 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 125.912 1.72 . . . . 62.21 113.611 171.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 29.2 m -55.34 123.35 6.08 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 C-N-CA 125.3 1.44 . . . . 75.54 111.401 -167.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -123.28 117.46 25.34 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 106.901 -1.518 . . . . 72.15 106.901 -165.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 52.4 -175.48 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.398 1.479 . . . . 74.23 113.368 -167.667 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 29.1 t70 62.88 -12.85 0.07 Allowed 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 127.693 2.397 . . . . 74.14 113.814 -164.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.4 p -135.65 133.53 51.66 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 C-N-CA 125.584 1.553 . . . . 74.45 110.117 178.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -178.51 -67.59 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 128.211 2.604 . . . . 71.23 109.408 166.308 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -63.43 -55.25 25.8 Favored 'General case' 0 CA--C 1.509 -0.615 0 C-N-CA 123.972 0.909 . . . . 75.2 109.793 -172.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -65.45 -14.87 61.89 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-O 118.872 -0.585 . . . . 74.0 112.003 -168.234 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.9 t -62.26 -76.8 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 N-CA-C 108.515 -0.92 . . . . 72.22 108.515 164.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -51.26 -46.92 62.54 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 126.018 1.727 . . . . 73.04 112.103 -176.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 22.2 mm-40 -60.9 -44.17 97.52 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.514 1.526 . . . . 71.2 109.242 -175.38 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -74.91 -3.49 32.39 Favored 'General case' 0 CA--C 1.531 0.245 0 O-C-N 120.62 -1.3 . . . . 73.22 113.158 -179.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 72.8 mt -104.18 -54.78 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 N-CA-C 106.554 -1.647 . . . . 74.04 106.554 177.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 90.7 m-70 -80.54 -56.13 4.38 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 123.495 0.718 . . . . 73.22 112.014 -173.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 2.2 mmtp -71.87 -12.95 61.52 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 123.753 0.821 . . . . 74.21 112.05 -178.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -117.07 -31.32 5.4 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.963 0.905 . . . . 74.31 112.494 -174.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 5.2 t60 45.15 61.04 2.7 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 125.903 1.681 . . . . 73.3 111.209 -176.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 7.8 mtpp -76.94 159.45 29.97 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.727 -1.124 . . . . 74.31 108.454 170.082 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 46.5 tttt -85.82 38.35 0.75 Allowed 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 125.726 1.61 . . . . 64.14 111.735 -173.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 43.3 mt -72.61 51.07 0.26 Allowed 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 128.815 2.846 . . . . 73.42 112.053 -167.146 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -103.12 3.66 36.14 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 129.463 3.105 . . . . 74.11 112.21 -177.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -134.39 156.03 79.26 Favored Pre-proline 0 N--CA 1.467 0.413 0 CA-C-N 118.556 0.616 . . . . 73.14 110.66 171.073 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -70.89 -19.84 30.25 Favored 'Trans proline' 0 N--CA 1.449 -1.108 0 C-N-CA 121.658 1.572 . . . . 72.31 111.889 -177.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.7 -62.95 1.48 Allowed 'General case' 0 C--O 1.224 -0.255 0 CA-C-N 119.859 1.209 . . . . 74.14 108.961 168.11 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -45.79 -56.55 5.2 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 127.229 2.211 . . . . 72.45 110.413 178.358 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 57.4 mtt -54.91 -50.45 68.77 Favored 'General case' 0 N--CA 1.458 -0.065 0 C-N-CA 123.7 0.8 . . . . 71.13 111.354 -178.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -77.1 -40.63 45.21 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-O 119.043 -0.504 . . . . 75.33 111.013 -170.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -56.43 -35.61 68.04 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 125.12 1.368 . . . . 73.1 110.525 174.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 82.8 t80 -71.81 -54.08 11.28 Favored 'General case' 0 N--CA 1.44 -0.952 0 C-N-CA 122.969 0.508 . . . . 73.53 110.2 176.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 73.5 mt -69.64 -18.31 63.58 Favored 'General case' 0 CA--C 1.52 -0.178 0 C-N-CA 123.454 0.702 . . . . 73.11 112.428 -173.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -57.17 -16.71 8.54 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.226 1.41 . . . . 64.34 112.32 -176.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -110.38 8.12 30.58 Favored Glycine 0 CA--C 1.526 0.74 0 C-N-CA 124.94 1.257 . . . . 53.25 113.588 177.073 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 30.9 mmtt -129.09 27.6 5.37 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 119.608 1.704 . . . . 73.25 111.398 -169.096 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 85.56 41.54 7.27 Favored Glycine 0 N--CA 1.447 -0.579 0 CA-C-O 119.199 -0.778 . . . . 75.12 111.245 178.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 95.0 t -135.83 141.91 40.59 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 106.968 -1.493 . . . . 70.43 106.968 173.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 66.2 t0 -97.12 123.62 40.92 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 108.231 -1.025 . . . . 54.33 108.231 167.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -57.88 -38.97 76.73 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.789 0.835 . . . . 73.33 109.245 177.071 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -61.87 -41.46 97.88 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 123.638 0.775 . . . . 74.42 111.225 -177.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 21.1 mmtt -79.59 -47.28 15.75 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 108.074 -1.084 . . . . 71.32 108.074 -176.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 80.2 t80 -44.98 -59.3 2.64 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 126.322 1.849 . . . . 73.02 110.126 -177.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 32.4 mt -69.38 -36.32 76.69 Favored 'General case' 0 C--O 1.234 0.245 0 O-C-N 122.107 -0.371 . . . . 73.21 111.217 -176.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 23.2 t -56.05 -47.8 77.22 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 109.442 -0.577 . . . . 72.0 109.442 178.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . 0.259 15.0 t -77.28 -31.62 54.94 Favored 'General case' 0 CA--C 1.543 0.712 0 C-N-CA 123.116 0.567 . . . . 75.44 111.543 -179.089 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 76.4 t80 -56.19 -36.49 68.45 Favored 'General case' 0 N--CA 1.471 0.621 0 O-C-N 120.357 -1.465 . . . . 75.3 111.893 172.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 48.0 m-20 -102.97 13.39 34.43 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.085 0.954 . . . . 73.12 111.216 176.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 40.0 t -88.81 163.65 15.58 Favored 'General case' 0 C--O 1.235 0.298 0 O-C-N 120.469 -1.395 . . . . 75.55 109.263 174.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -59.11 -24.96 63.41 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 114.92 -1.036 . . . . 64.41 110.85 170.328 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -48.91 -63.48 1.08 Allowed 'General case' 0 C--O 1.236 0.387 0 C-N-CA 124.568 1.147 . . . . 72.33 110.955 176.089 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 7.1 mm -58.36 -32.58 45.49 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 N-CA-C 113.532 0.938 . . . . 74.23 113.532 176.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 2.7 tttp -57.7 -35.05 70.1 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 118.844 0.747 . . . . 71.11 110.151 -178.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -80.13 -37.24 22.3 Favored Glycine 0 C--N 1.34 0.798 0 C-N-CA 124.864 1.221 . . . . 64.22 111.969 -178.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 2.4 mm100 -70.74 -39.8 73.1 Favored 'General case' 0 C--N 1.331 -0.238 0 O-C-N 121.582 -0.952 . . . . 72.03 109.312 -178.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -62.23 -50.09 73.15 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 123.668 0.787 . . . . 75.12 110.191 176.475 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -63.42 -43.23 98.08 Favored 'General case' 0 CA--C 1.521 -0.151 0 CA-C-O 117.744 -1.122 . . . . 73.51 111.095 -177.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 44.7 mtmt -59.29 -59.67 5.09 Favored 'General case' 0 C--N 1.343 0.31 0 CA-C-O 117.991 -1.004 . . . . 73.33 108.748 177.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -54.35 -35.73 63.07 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 119.852 1.206 . . . . 71.13 112.012 -179.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 35.8 tttt -65.97 -66.44 0.55 Allowed 'General case' 0 C--N 1.342 0.278 0 N-CA-C 108.467 -0.938 . . . . 71.25 108.467 177.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 17.7 ptmt -60.02 -28.14 67.48 Favored 'General case' 0 C--O 1.227 -0.106 0 C-N-CA 123.476 0.71 . . . . 73.25 111.187 -171.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 36.2 mt -68.75 -58.58 4.01 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 124.816 1.246 . . . . 65.04 111.976 173.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -55.6 -50.6 69.69 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 118.957 0.799 . . . . 72.31 110.244 -169.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -58.87 -42.74 90.18 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 113.007 0.743 . . . . 73.22 113.007 174.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -65.84 -26.37 67.63 Favored 'General case' 0 N--CA 1.462 0.155 0 C-N-CA 123.33 0.652 . . . . 75.45 111.622 -178.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 36.2 m-85 -84.17 20.13 1.67 Allowed 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.3 1.44 . . . . 71.32 112.125 172.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 11.5 mm100 64.35 6.44 3.05 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 127.399 2.279 . . . . 74.54 115.536 173.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 42.9 t -51.7 -57.27 3.63 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.985 0 C-N-CA 127.639 2.376 . . . . 72.23 113.858 -164.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . 0.281 73.5 p 54.97 -40.05 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 128.912 2.885 . . . . 75.35 117.365 -165.341 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -150.45 -177.87 24.79 Favored Glycine 0 CA--C 1.521 0.422 0 C-N-CA 125.951 1.739 . . . . 64.14 110.285 -171.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.437 ' HA ' ' C ' ' A' ' 154' ' ' PRO . 17.3 m -133.26 157.33 78.47 Favored Pre-proline 0 C--O 1.239 0.545 0 N-CA-C 108.801 -0.815 . . . . 74.53 108.801 -178.186 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . 0.437 ' C ' ' HA ' ' A' ' 153' ' ' VAL . 37.4 Cg_endo -66.74 154.07 83.43 Favored 'Cis proline' 0 N--CA 1.46 -0.489 0 C-N-CA 124.478 -1.051 . . . . 71.42 112.494 -4.265 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 35.3 m -155.06 110.61 3.1 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 105.194 -2.15 . . . . 73.44 105.194 172.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 95.9 mtp -89.5 152.12 21.61 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 107.5 -1.296 . . . . 71.42 107.5 164.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 15.0 t -138.97 139.41 40.48 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.288 0 N-CA-C 108.113 -1.069 . . . . 71.31 108.113 175.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 11.4 t -112.34 124.09 68.7 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 C-N-CA 126.395 1.878 . . . . 75.21 106.516 176.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 1.4 t30 51.0 17.13 0.4 Allowed 'General case' 0 C--O 1.223 -0.308 0 C-N-CA 128.836 2.854 . . . . 72.21 114.813 170.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 58.71 38.99 92.97 Favored Glycine 0 CA--C 1.525 0.66 0 C-N-CA 125.69 1.614 . . . . 71.52 112.829 -168.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 37.6 mttt -132.95 -38.27 0.98 Allowed 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 124.51 1.124 . . . . 74.22 112.29 178.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -116.6 118.24 32.07 Favored 'General case' 0 CA--C 1.517 -0.311 0 N-CA-C 108.284 -1.006 . . . . 71.34 108.284 -178.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 37.3 ttp85 -105.43 123.33 47.7 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 126.536 1.934 . . . . 75.42 106.972 174.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 13.5 p90 -150.23 170.97 17.72 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 107.529 -1.286 . . . . 75.15 107.529 -176.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -178.84 178.77 0.75 Allowed 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.166 -0.679 . . . . 75.3 109.166 -173.197 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 23.7 mt -47.96 -55.95 2.28 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 C-N-CA 127.733 2.413 . . . . 73.24 109.044 174.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -75.67 8.01 23.15 Favored Glycine 0 CA--C 1.526 0.727 0 C-N-CA 127.028 2.251 . . . . 74.1 114.794 178.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 4.7 m -110.72 -52.25 2.8 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-N 119.507 1.653 . . . . 74.41 109.886 168.038 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -65.39 -53.11 47.97 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 125.652 1.581 . . . . 62.43 111.598 -178.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 142.59 -7.16 2.21 Favored Glycine 0 CA--C 1.528 0.846 0 CA-C-O 119.056 -0.858 . . . . 70.33 114.41 -174.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 155.7 175.72 27.04 Favored Glycine 0 CA--C 1.53 0.983 0 CA-C-N 119.514 1.657 . . . . 50.11 110.149 -175.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -61.21 -53.67 2.31 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 122.918 2.412 . . . . 65.22 111.247 -175.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 8.2 mp0 -62.85 -32.89 74.2 Favored 'General case' 0 CA--C 1.536 0.411 0 O-C-N 121.434 -0.791 . . . . 71.43 110.924 179.134 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -66.17 -30.76 71.3 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.218 0.607 . . . . 74.5 110.131 178.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 37.7 m -65.59 -46.21 80.24 Favored 'General case' 0 N--CA 1.455 -0.221 0 O-C-N 121.364 -0.835 . . . . 72.21 110.453 -173.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 64.0 mt -62.89 -28.08 69.8 Favored 'General case' 0 C--O 1.223 -0.306 0 CA-C-N 118.559 0.618 . . . . 75.31 111.447 -177.027 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 2.6 tttt -53.58 -49.41 67.8 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 124.819 1.248 . . . . 74.21 109.338 172.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -67.12 -44.51 79.72 Favored 'General case' 0 CA--C 1.515 -0.392 0 N-CA-C 109.329 -0.619 . . . . 73.4 109.329 175.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -56.78 -31.73 64.94 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 118.34 -0.838 . . . . 71.33 112.71 -174.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -84.16 -52.0 6.61 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 126.357 1.863 . . . . 73.34 108.666 -176.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 16.6 t80 -60.84 -45.61 93.8 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 123.896 0.878 . . . . 72.12 110.998 -175.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 93.1 mt -61.22 -28.66 69.32 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.06 0.944 . . . . 73.14 112.527 -178.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 44.0 mt -60.3 -52.78 57.36 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 CA-C-N 119.931 1.241 . . . . 75.14 108.357 173.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -66.71 -5.72 12.98 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 126.802 2.041 . . . . 74.04 112.901 177.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -98.12 -23.74 15.6 Favored 'General case' 0 N--CA 1.463 0.21 0 O-C-N 120.868 -1.145 . . . . 74.44 111.525 173.187 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 30.5 mm-40 -96.54 -33.57 11.78 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 123.785 0.834 . . . . 70.33 112.734 -176.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.12 -32.55 23.07 Favored 'General case' 0 N--CA 1.476 0.841 0 O-C-N 120.847 -1.158 . . . . 74.43 110.522 168.748 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -64.56 -23.22 67.2 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 126.713 2.005 . . . . 73.41 111.883 179.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -58.05 -45.83 86.39 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 109.125 -0.695 . . . . 55.13 109.125 174.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -86.42 -39.12 16.67 Favored 'General case' 0 N--CA 1.456 -0.152 0 O-C-N 121.875 -0.516 . . . . 63.32 110.098 178.254 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 28.2 mttp -138.7 73.12 1.42 Allowed 'General case' 0 N--CA 1.442 -0.837 0 C-N-CA 125.577 1.551 . . . . 74.04 109.245 -164.028 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 32.3 mtmt . . . . . 0 C--O 1.243 0.752 0 N-CA-C 105.37 -2.085 . . . . 74.41 105.37 147.142 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.624 0 N-CA-C 108.69 -1.764 . . . . 72.52 108.69 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 63.99 159.69 0.09 Allowed 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 128.037 2.535 . . . . 75.53 110.857 -171.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -153.23 15.88 0.54 Allowed 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 114.058 1.133 . . . . 72.22 114.058 -175.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 38.5 m-85 -135.49 160.2 39.2 Favored 'General case' 0 C--O 1.24 0.589 0 C-N-CA 125.1 1.36 . . . . 73.31 108.884 -173.299 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 88.6 m -125.89 134.78 51.49 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 109.217 -0.66 . . . . 72.54 109.217 178.062 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.03 144.36 57.33 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 121.837 0.827 . . . . 74.24 111.077 176.003 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 76.85 -19.61 3.28 Favored Glycine 0 CA--C 1.527 0.807 0 CA-C-O 118.674 -1.07 . . . . 61.42 112.366 -172.324 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 20.3 ttmt -97.43 -84.3 0.38 Allowed 'General case' 0 CA--C 1.511 -0.55 0 CA-C-N 119.116 1.458 . . . . 75.45 108.007 -177.101 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -64.61 -26.31 68.34 Favored 'General case' 0 N--CA 1.442 -0.854 0 C-N-CA 124.748 1.219 . . . . 64.43 110.145 -175.19 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 12.7 p90 -163.91 171.8 14.85 Favored 'General case' 0 C--O 1.233 0.206 0 O-C-N 121.091 -1.006 . . . . 71.43 108.58 -172.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 24.4 t -132.34 110.83 16.8 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 C-N-CA 123.614 0.765 . . . . 74.34 110.035 -177.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -68.75 159.77 31.65 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 124.793 1.237 . . . . 70.42 109.112 166.514 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -134.08 116.36 15.37 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 124.214 1.005 . . . . 64.11 108.425 -174.454 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -61.6 -1.1 0.51 Allowed 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 125.805 1.642 . . . . 75.25 113.908 -177.539 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 48.9 m -133.82 85.57 40.94 Favored Pre-proline 0 CA--C 1.541 0.598 0 C-N-CA 127.583 2.353 . . . . 71.12 108.284 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -77.54 -178.73 4.81 Favored 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 124.647 3.564 . . . . 75.14 113.388 -178.372 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 25.9 t -136.55 148.21 62.88 Favored Pre-proline 0 CA--C 1.548 0.875 0 C-N-CA 126.525 1.93 . . . . 73.22 109.005 -178.115 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -82.19 -178.68 4.2 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 124.567 3.511 . . . . 73.53 112.572 173.493 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.9 m -131.36 172.18 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 124.975 1.31 . . . . 75.13 109.513 172.003 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 66.4 m -48.89 -56.15 9.62 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 125.614 1.565 . . . . 73.22 112.142 176.273 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -144.35 152.08 52.85 Favored Pre-proline 0 C--O 1.239 0.529 0 C-N-CA 125.363 1.465 . . . . 72.31 108.072 -172.604 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -69.45 178.33 4.49 Favored 'Trans proline' 0 N--CA 1.451 -0.982 0 C-N-CA 122.492 2.128 . . . . 74.54 109.251 165.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.26 -118.87 6.2 Favored Glycine 0 N--CA 1.45 -0.402 0 N-CA-C 106.951 -2.46 . . . . 72.05 106.951 -166.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -61.01 137.55 58.23 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 119.519 1.66 . . . . 74.34 110.916 -163.225 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 42.1 mm -62.72 138.88 22.02 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 N-CA-C 107.12 -1.437 . . . . 71.2 107.12 168.113 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.7 124.41 36.69 Favored 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 127.138 2.175 . . . . 73.12 106.851 -178.668 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.7 t -128.82 102.29 7.8 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.174 0 N-CA-C 106.438 -1.69 . . . . 72.23 106.438 176.173 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 52.3 t -97.33 114.25 33.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 107.278 -1.378 . . . . 74.15 107.278 -177.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 67.7 tt0 -72.28 134.27 45.47 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 107.6 -1.259 . . . . 54.14 107.6 152.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 5.0 mp -111.36 136.02 51.08 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 107.061 -1.459 . . . . 75.41 107.061 160.035 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 28.9 p90 -134.28 166.71 22.18 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.229 1.011 . . . . 75.03 110.642 -177.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 26.6 t90 -150.36 158.95 44.72 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.724 1.21 . . . . 74.24 108.888 176.101 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 5.3 m-30 -83.59 51.29 1.97 Allowed 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.427 0.691 . . . . 75.23 111.302 178.171 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -174.91 18.84 0.05 OUTLIER Glycine 0 N--CA 1.463 0.446 0 O-C-N 120.287 -1.508 . . . . 74.51 114.273 -174.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 20.6 p -118.41 86.28 27.76 Favored Pre-proline 0 N--CA 1.449 -0.513 0 C-N-CA 124.907 1.283 . . . . 74.12 108.252 -172.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -63.15 -11.79 26.86 Favored 'Trans proline' 0 CA--C 1.541 0.874 0 C-N-CA 122.279 1.986 . . . . 74.22 114.03 -170.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 35.3 m170 -73.74 -22.73 59.78 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 119.209 0.913 . . . . 72.42 112.625 168.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 79.1 m -67.53 -65.85 0.64 Allowed 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.564 1.545 . . . . 74.43 110.67 -173.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 14.2 t80 -59.32 -29.23 67.47 Favored 'General case' 0 N--CA 1.467 0.419 0 O-C-N 121.415 -0.803 . . . . 74.11 112.036 -179.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.47 -26.22 68.62 Favored 'General case' 0 CA--C 1.542 0.652 0 O-C-N 121.452 -0.78 . . . . 75.53 112.615 176.04 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 20.8 t80 -93.97 -18.03 22.32 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 124.999 1.319 . . . . 75.44 112.426 -173.066 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -38.22 -63.04 0.59 Allowed Pre-proline 0 N--CA 1.472 0.631 0 C-N-CA 125.451 1.5 . . . . 74.55 112.767 175.079 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -77.23 -11.44 17.6 Favored 'Trans proline' 0 CA--C 1.534 0.524 0 CA-C-N 121.775 1.67 . . . . 72.15 114.533 -171.103 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.8 m -72.15 -44.97 62.27 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 107.786 -1.19 . . . . 73.4 107.786 166.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 14.3 tt -94.15 -28.65 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 N-CA-C 113.47 0.915 . . . . 75.04 113.47 -165.339 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 14.1 t -47.88 -60.94 3.5 Favored Pre-proline 0 CA--C 1.544 0.724 0 C-N-CA 124.87 1.268 . . . . 73.43 110.027 171.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_endo -72.28 -7.77 21.54 Favored 'Trans proline' 0 C--N 1.348 0.538 0 CA-C-N 121.555 1.591 . . . . 63.35 113.34 -175.247 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 82.6 t90 -77.57 -61.11 2.1 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 119.591 1.087 . . . . 73.12 108.297 165.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 47.9 t -60.23 -36.55 77.98 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.156 1.382 . . . . 72.31 112.593 -169.483 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -75.04 -10.76 59.77 Favored 'General case' 0 CA--C 1.54 0.566 0 O-C-N 120.78 -1.2 . . . . 65.52 111.922 -177.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -111.86 18.82 18.52 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 127.736 2.414 . . . . 74.5 113.228 -176.212 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 39.1 mt -75.22 156.18 85.8 Favored Pre-proline 0 N--CA 1.448 -0.565 0 C-N-CA 125.044 1.338 . . . . 64.42 111.424 -177.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -77.78 172.35 15.83 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 124.964 3.776 . . . . 75.42 111.096 179.045 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -66.12 -2.83 4.57 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 114.501 1.297 . . . . 71.02 114.501 -178.577 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -102.74 1.69 34.69 Favored 'General case' 0 C--O 1.223 -0.335 0 C-N-CA 125.05 1.34 . . . . 74.35 112.453 -177.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 39.1 t -125.99 131.52 71.67 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 CA-C-N 120.161 1.346 . . . . 70.32 108.381 -170.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 86.5 t60 -131.67 101.69 5.59 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 125.096 1.358 . . . . 74.31 109.214 -176.169 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 10.4 t80 -82.66 138.55 34.1 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 126.579 1.951 . . . . 73.55 109.476 -176.111 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 23.6 t -130.08 154.32 40.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 106.974 -1.491 . . . . 73.51 106.974 178.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 66.5 mtt85 -123.86 129.7 51.42 Favored 'General case' 0 CA--C 1.513 -0.448 0 N-CA-C 105.279 -2.119 . . . . 75.31 105.279 168.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 47.5 mt -134.24 148.92 69.8 Favored Pre-proline 0 C--N 1.33 -0.256 0 N-CA-C 108.921 -0.77 . . . . 75.31 108.921 175.354 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -73.8 140.24 28.78 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 122.347 2.031 . . . . 74.4 110.287 178.024 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -79.1 88.42 4.83 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.883 0.873 . . . . 73.24 110.549 178.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 10.1 mt -87.68 96.73 10.54 Favored 'General case' 0 C--N 1.331 -0.214 0 O-C-N 120.188 -1.57 . . . . 73.42 109.858 -177.336 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 48.0 m-85 -115.84 36.36 4.05 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 123.929 0.892 . . . . 74.41 110.958 179.34 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 78.66 -161.47 48.12 Favored Glycine 0 C--N 1.336 0.555 0 N-CA-C 110.004 -1.239 . . . . 73.52 110.004 -179.307 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 44.82 -131.79 7.78 Favored Glycine 0 CA--C 1.532 1.106 0 C-N-CA 125.355 1.455 . . . . 45.43 113.106 172.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 7.7 tp -80.76 -18.47 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 123.73 0.812 . . . . 74.04 110.962 174.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 8.6 m95 -58.52 -38.4 77.64 Favored 'General case' 0 C--N 1.338 0.097 0 O-C-N 121.226 -0.921 . . . . 72.44 111.664 -171.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -83.04 -28.24 29.74 Favored 'General case' 0 C--O 1.232 0.134 0 N-CA-C 113.647 0.98 . . . . 71.25 113.647 177.044 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 33.3 t -59.66 -52.4 61.49 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 N-CA-C 107.336 -1.357 . . . . 75.12 107.336 174.613 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 65.6 m170 -75.01 47.82 0.36 Allowed 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 126.968 2.107 . . . . 75.42 111.261 170.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -153.46 -42.17 0.02 OUTLIER Glycine 0 CA--C 1.526 0.734 0 C-N-CA 124.93 1.252 . . . . 75.44 111.775 177.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 37.9 tt0 -61.95 -26.31 68.12 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.421 1.088 . . . . 75.33 113.783 -168.003 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 1.7 ptt? -71.6 -34.05 69.55 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 120.121 1.328 . . . . 64.31 112.718 -177.395 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 45.1 t80 -54.81 -51.9 64.36 Favored 'General case' 0 N--CA 1.463 0.209 0 C-N-CA 124.067 0.947 . . . . 74.11 109.459 -176.034 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 36.7 mt -57.62 -40.47 79.23 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 124.66 1.184 . . . . 55.23 110.338 178.091 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.8 m -70.36 -35.02 73.28 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 118.717 0.689 . . . . 72.25 111.247 -178.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -57.52 -56.22 24.66 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 125.073 1.349 . . . . 74.2 108.452 178.694 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -73.33 -21.16 60.62 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.907 0.883 . . . . 63.5 112.098 -178.308 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 27.8 t -66.1 -3.51 5.64 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 117.621 -1.181 . . . . 73.35 113.102 175.242 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 44.2 mtm -100.33 -1.95 34.82 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 120.933 1.697 . . . . 73.14 113.599 169.517 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 74.04 26.64 68.24 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 111.204 -0.758 . . . . 70.41 111.204 177.195 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.9 m -60.48 153.11 4.96 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 N-CA-C 108.147 -1.057 . . . . 74.2 108.147 161.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -149.95 158.6 44.33 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 107.928 -1.138 . . . . 62.31 107.928 166.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 43.9 m80 45.86 47.08 12.26 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.483 1.513 . . . . 72.53 111.108 -177.035 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -97.52 5.9 48.9 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 127.654 2.382 . . . . 70.52 112.491 -170.078 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.5 t 66.65 92.14 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.24 0.577 0 C-N-CA 127.528 2.331 . . . . 72.44 111.463 -176.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 12.4 m-70 -66.58 -32.08 73.19 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 124.3 1.04 . . . . 61.35 112.856 171.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -62.14 -46.27 89.77 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-O 117.821 -1.085 . . . . 75.1 112.176 -176.319 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -54.56 -36.4 64.31 Favored 'General case' 0 N--CA 1.457 -0.109 0 CA-C-N 119.159 0.89 . . . . 73.23 112.382 -175.336 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 58.4 t -58.32 -57.94 8.69 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 C-N-CA 124.091 0.957 . . . . 74.33 108.921 177.051 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -69.39 -37.98 77.77 Favored 'General case' 0 C--N 1.335 -0.058 0 C-N-CA 123.132 0.573 . . . . 74.53 112.36 -176.823 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -58.75 -32.61 69.4 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.608 1.563 . . . . 71.23 110.042 176.367 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -79.61 -20.83 45.91 Favored 'General case' 0 N--CA 1.448 -0.565 0 O-C-N 120.848 -1.157 . . . . 74.03 111.318 178.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 31.8 mt -94.45 -35.72 6.45 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 O-C-N 120.555 -1.341 . . . . 74.11 109.241 -179.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 57.8 m-70 -90.42 -63.64 1.25 Allowed 'General case' 0 C--O 1.233 0.232 0 C-N-CA 124.489 1.116 . . . . 64.32 110.954 -174.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 7.5 mtmt -68.07 -35.61 78.48 Favored 'General case' 0 N--CA 1.463 0.223 0 O-C-N 121.929 -0.482 . . . . 74.24 110.583 -176.163 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -99.87 -70.29 0.74 Allowed 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 108.51 -0.922 . . . . 74.23 108.51 -172.467 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 7.5 t-80 74.6 64.01 0.07 Allowed 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 128.618 2.767 . . . . 73.11 113.301 -177.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 65.2 mttt -76.53 28.97 0.12 Allowed 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 114.755 1.391 . . . . 73.43 114.755 179.515 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 10.0 tmtt? 46.52 57.91 5.05 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 125.958 1.703 . . . . 72.52 112.509 176.189 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 44.7 mt -67.46 42.4 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 130.16 3.384 . . . . 72.03 112.197 179.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -88.36 6.44 37.26 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 128.679 2.792 . . . . 71.2 113.14 -178.563 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -139.7 156.49 71.03 Favored Pre-proline 0 CA--C 1.537 0.479 0 C-N-CA 123.809 0.844 . . . . 74.43 111.335 178.614 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -64.69 -39.4 26.96 Favored 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 122.579 2.186 . . . . 72.23 112.386 -179.243 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -59.2 -42.89 92.0 Favored 'General case' 0 C--O 1.225 -0.187 0 CA-C-N 118.09 0.404 . . . . 71.22 110.177 176.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -60.52 -38.31 83.99 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 123.109 0.564 . . . . 64.45 110.615 -177.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 54.2 mtt -68.45 -49.91 56.44 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 123.908 0.883 . . . . 73.12 110.467 175.173 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -64.75 -47.14 79.29 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 124.811 1.244 . . . . 74.02 110.783 -171.188 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -62.2 -29.13 70.16 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 126.061 1.744 . . . . 73.34 112.836 176.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 73.0 t80 -76.85 -54.86 6.04 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 109.933 -0.395 . . . . 74.21 109.933 174.177 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 56.4 mt -68.07 -21.19 65.0 Favored 'General case' 0 CA--C 1.516 -0.345 0 O-C-N 121.809 -0.557 . . . . 75.4 110.584 -168.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -55.03 -13.65 1.23 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.402 0.681 . . . . 72.15 112.236 169.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -88.06 -9.69 70.23 Favored Glycine 0 N--CA 1.433 -1.51 0 CA-C-O 116.97 -2.017 . . . . 53.4 110.235 179.216 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -130.35 10.94 5.34 Favored 'General case' 0 C--N 1.347 0.466 0 CA-C-N 120.985 2.393 . . . . 72.45 112.947 -170.137 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 86.83 70.68 1.3 Allowed Glycine 0 N--CA 1.445 -0.731 0 N-CA-C 109.454 -1.458 . . . . 73.24 109.454 -179.198 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 25.7 t -141.4 129.71 22.83 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.816 0 C-N-CA 127.168 2.187 . . . . 74.12 107.271 172.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 41.2 t0 -89.45 123.16 33.33 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 124.185 0.994 . . . . 73.21 110.639 178.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 11.2 mtmt -59.07 -38.7 80.06 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 124.194 0.998 . . . . 61.13 111.02 171.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 75.7 mm-40 -65.17 -15.22 62.19 Favored 'General case' 0 C--N 1.329 -0.318 0 O-C-N 120.983 -1.073 . . . . 74.31 112.889 -177.403 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 9.7 mmtm -117.95 -42.33 2.83 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-O 117.585 -1.198 . . . . 74.12 110.777 -178.189 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 81.3 t80 -46.65 -65.71 0.52 Allowed 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 125.238 1.415 . . . . 74.43 111.12 171.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 18.0 mt -62.3 -38.38 89.15 Favored 'General case' 0 N--CA 1.465 0.279 0 O-C-N 122.055 -0.403 . . . . 72.34 110.827 -173.459 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 31.8 t -54.17 -61.76 2.09 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 107.883 -1.154 . . . . 73.13 107.883 177.178 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . 0.281 4.8 t -69.41 -30.2 68.1 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 118.268 -0.873 . . . . 73.43 110.699 -173.541 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 60.8 t80 -56.49 -42.1 77.73 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 119.87 1.214 . . . . 74.2 111.212 176.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -94.7 13.72 23.5 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.906 1.282 . . . . 73.34 111.854 179.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 50.5 m -103.56 161.98 13.43 Favored 'General case' 0 N--CA 1.469 0.504 0 O-C-N 120.618 -1.302 . . . . 54.24 111.167 176.406 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -63.52 -33.88 76.57 Favored 'General case' 0 C--O 1.225 -0.215 0 C-N-CA 122.628 0.371 . . . . 72.41 111.944 -171.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -50.99 -46.95 61.55 Favored 'General case' 0 CA--C 1.534 0.339 0 O-C-N 121.705 -0.622 . . . . 74.23 111.98 -175.636 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 48.2 mm -68.53 -33.6 60.89 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-O 118.912 -0.566 . . . . 74.53 110.01 179.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 12.3 tttt -55.05 -38.47 68.04 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 119.453 1.024 . . . . 71.11 110.45 171.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -70.96 -42.44 59.76 Favored Glycine 0 C--N 1.335 0.503 0 N-CA-C 110.603 -0.999 . . . . 64.22 110.603 -175.117 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -67.11 -43.82 81.48 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 123.946 0.898 . . . . 75.31 109.833 -179.51 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 86.7 mmm -58.54 -52.59 65.0 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 125.397 1.479 . . . . 64.43 109.665 175.272 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -63.26 -39.16 93.82 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 120.001 1.273 . . . . 72.53 112.004 -173.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 7.2 mmtt -56.29 -59.77 4.47 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 119.057 0.844 . . . . 75.12 109.227 170.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -53.62 -42.58 67.9 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 118.308 0.504 . . . . 71.32 110.948 -175.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 7.7 tttt -57.99 -60.8 3.16 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 125.532 1.533 . . . . 75.45 109.872 177.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 2.2 pttt -71.03 -17.62 62.61 Favored 'General case' 0 CA--C 1.529 0.169 0 N-CA-C 112.313 0.486 . . . . 74.15 112.313 -174.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 32.6 mt -73.81 -56.12 5.36 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 124.021 0.928 . . . . 74.54 111.01 170.305 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -57.16 -43.19 82.29 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 119.049 0.84 . . . . 73.24 111.577 -171.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 3.8 ppp? -60.62 -44.29 96.49 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 113.146 0.795 . . . . 74.24 113.146 174.289 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -62.92 -35.75 81.12 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 124.247 1.019 . . . . 75.13 111.096 179.263 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 31.0 m-85 -74.54 14.37 0.48 Allowed 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.11 1.364 . . . . 74.1 113.317 177.458 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 57.32 18.65 4.47 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 126.023 1.729 . . . . 71.25 114.112 178.212 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 20.6 t -75.0 137.05 23.8 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 CA-C-N 119.177 0.898 . . . . 74.03 109.309 -174.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -132.42 2.97 3.88 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.524 0.73 . . . . 54.31 112.191 -172.345 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -173.54 -168.91 35.27 Favored Glycine 0 CA--C 1.527 0.83 0 C-N-CA 127.278 2.371 . . . . 73.34 110.054 178.228 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.415 ' HA ' ' C ' ' A' ' 154' ' ' PRO . 3.5 m -149.04 157.37 40.05 Favored Pre-proline 0 CA--C 1.537 0.476 0 C-N-CA 125.943 1.697 . . . . 61.5 109.092 -175.798 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . 0.415 ' C ' ' HA ' ' A' ' 153' ' ' VAL . 18.7 Cg_endo -62.31 159.79 56.17 Favored 'Cis proline' 0 N--CA 1.454 -0.848 0 C-N-CA 124.527 -1.031 . . . . 75.32 111.571 -9.837 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 7.7 m -155.56 139.71 16.52 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 107.695 -1.224 . . . . 74.11 107.695 176.174 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 98.8 mtp -119.11 160.26 22.41 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-N 114.666 -1.152 . . . . 75.13 108.17 170.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 39.6 t -139.89 156.01 25.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 106.188 -1.782 . . . . 74.44 106.188 178.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 48.2 t -126.18 120.39 56.67 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 N-CA-C 107.242 -1.392 . . . . 72.21 107.242 171.033 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 23.2 m-20 51.64 21.87 1.45 Allowed 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 127.794 2.437 . . . . 72.14 114.405 175.199 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 57.02 32.89 63.15 Favored Glycine 0 CA--C 1.528 0.854 0 CA-C-O 118.239 -1.312 . . . . 62.33 113.996 -168.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 8.0 mtpt -126.79 -29.94 2.81 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 119.491 1.646 . . . . 73.43 111.467 -178.437 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -126.07 128.91 48.12 Favored 'General case' 0 CA--C 1.519 -0.225 0 N-CA-C 108.553 -0.906 . . . . 75.34 108.553 179.221 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 3.7 ttp85 -101.04 132.45 46.46 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 105.673 -1.973 . . . . 74.42 105.673 171.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 13.9 p90 -147.9 161.93 40.32 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.65 -0.871 . . . . 73.11 108.65 173.276 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -170.47 -171.87 1.15 Allowed 'General case' 0 N--CA 1.474 0.762 0 O-C-N 121.741 -0.6 . . . . 75.24 111.162 -174.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 12.2 mt -71.72 -26.02 25.29 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 C-N-CA 126.137 1.775 . . . . 73.34 110.263 -179.168 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -66.16 -54.78 22.16 Favored Glycine 0 N--CA 1.444 -0.811 0 N-CA-C 110.196 -1.161 . . . . 60.42 110.196 168.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 11.4 m -69.06 -59.17 3.22 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 117.398 0.599 . . . . 64.12 111.036 -163.219 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -67.35 -35.79 80.09 Favored 'General case' 0 CA--C 1.537 0.462 0 O-C-N 122.034 -0.416 . . . . 73.03 111.862 -167.482 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 140.64 4.09 1.25 Allowed Glycine 0 CA--C 1.531 1.049 0 C-N-CA 125.59 1.567 . . . . 74.23 115.744 175.362 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 137.36 178.18 15.71 Favored Glycine 0 CA--C 1.531 1.078 0 CA-C-N 119.797 1.798 . . . . 74.42 109.59 -168.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -64.68 -44.48 10.66 Favored 'Trans proline' 0 N--CA 1.459 -0.553 0 C-N-CA 123.243 2.629 . . . . 75.51 112.006 -166.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -56.13 -44.75 79.49 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.363 0.665 . . . . 73.04 109.968 178.377 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -71.68 -27.53 63.11 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 116.012 -0.54 . . . . 74.43 110.36 -173.554 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 90.0 m -59.13 -43.56 92.0 Favored 'General case' 0 CA--C 1.533 0.319 0 O-C-N 120.612 -1.305 . . . . 74.13 110.636 177.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 52.0 mt -64.46 -35.46 81.0 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 119.228 0.922 . . . . 75.53 110.852 177.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 21.2 tttt -55.3 -36.02 65.73 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 124.423 1.089 . . . . 73.43 110.121 176.196 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -79.57 -43.9 22.1 Favored 'General case' 0 CA--C 1.513 -0.47 0 CA-C-O 117.67 -1.157 . . . . 73.12 110.294 173.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -51.33 -43.2 61.68 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 119.459 1.027 . . . . 71.34 111.979 -177.017 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -82.39 -38.5 24.02 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 123.954 0.902 . . . . 72.23 109.274 -167.268 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 30.8 t80 -61.07 -55.96 26.52 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 124.442 1.097 . . . . 72.42 110.535 171.27 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 91.2 mt -61.72 -29.83 70.36 Favored 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 124.09 0.956 . . . . 74.13 111.83 -173.274 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 30.2 mt -56.47 -60.97 1.37 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.151 0 N-CA-C 108.151 -1.055 . . . . 72.53 108.151 168.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 10.9 tm-20 -52.31 -40.74 62.26 Favored 'General case' 0 N--CA 1.457 -0.113 0 C-N-CA 124.28 1.032 . . . . 74.22 111.554 -177.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 12.7 tptp -58.09 -47.92 81.75 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 123.047 0.539 . . . . 74.4 111.254 -179.434 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 41.5 mm-40 -74.53 -39.47 62.35 Favored 'General case' 0 C--O 1.223 -0.312 0 C-N-CA 123.082 0.553 . . . . 74.4 110.865 178.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.65 -37.89 89.14 Favored 'General case' 0 C--N 1.331 -0.216 0 O-C-N 120.269 -1.519 . . . . 72.31 109.253 -175.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -60.75 -19.4 58.98 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 125.267 1.427 . . . . 73.35 111.808 177.288 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -58.48 -29.83 66.52 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 118.667 0.667 . . . . 73.23 111.564 173.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -137.85 35.24 2.39 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 111.923 0.342 . . . . 72.14 111.923 -175.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 15.2 tptm -84.74 52.03 2.29 Favored 'General case' 0 CA--C 1.534 0.337 0 O-C-N 121.329 -0.857 . . . . 75.22 110.462 179.252 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 19.7 pttt . . . . . 0 C--O 1.244 0.809 0 C-N-CA 128.863 2.865 . . . . 74.31 112.293 175.51 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.527 0 N-CA-C 110.462 -1.055 . . . . 63.44 110.462 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 74.93 86.03 0.1 Allowed 'General case' 0 C--O 1.232 0.148 0 C-N-CA 126.007 1.723 . . . . 74.42 109.45 173.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -82.69 16.29 2.26 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 126.366 1.866 . . . . 74.23 114.187 -177.355 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 42.1 m-85 -143.63 164.32 30.75 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 124.431 1.093 . . . . 74.12 110.5 -165.176 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 57.3 m -133.67 130.53 38.34 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.754 1.221 . . . . 75.0 108.609 -176.024 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.91 140.89 58.91 Favored 'General case' 0 C--O 1.232 0.162 0 O-C-N 121.636 -0.665 . . . . 72.23 109.732 175.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 82.52 -23.19 5.74 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 125.877 1.703 . . . . 44.53 112.297 -170.461 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 75.1 tttt -96.64 -72.77 0.62 Allowed 'General case' 0 CA--C 1.508 -0.642 0 CA-C-N 118.405 1.103 . . . . 73.0 110.517 -169.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 16.5 mp0 -76.3 -23.89 54.36 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 124.639 1.175 . . . . 75.44 109.702 178.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 41.3 p90 -162.19 174.46 12.87 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.699 0.8 . . . . 74.4 110.717 -171.265 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 59.8 t -131.95 113.74 22.89 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 N-CA-C 108.123 -1.066 . . . . 74.12 108.123 178.28 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.68 160.51 32.11 Favored 'General case' 0 C--O 1.234 0.283 0 O-C-N 120.602 -1.311 . . . . 73.12 108.736 163.418 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -134.75 116.75 15.23 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 124.43 1.092 . . . . 73.24 110.133 -178.312 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 4.3 p -67.39 6.3 0.62 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 127.274 2.23 . . . . 73.35 113.918 176.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 18.6 m -127.12 71.43 75.96 Favored Pre-proline 0 N--CA 1.45 -0.447 0 C-N-CA 126.023 1.729 . . . . 73.2 108.205 174.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -76.69 179.81 6.09 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 124.125 3.216 . . . . 73.33 112.533 -170.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 88.3 t -140.8 128.2 12.15 Favored Pre-proline 0 CA--C 1.544 0.73 0 C-N-CA 124.284 1.034 . . . . 72.31 110.448 -167.393 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -82.65 178.73 5.87 Favored 'Trans proline' 0 CA--C 1.542 0.897 0 C-N-CA 124.794 3.663 . . . . 71.5 112.326 176.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 28.2 m -134.07 167.29 26.55 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 C-N-CA 124.202 1.001 . . . . 73.42 112.077 -179.268 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 11.2 t -64.42 -49.29 72.11 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 127.427 2.291 . . . . 62.13 109.568 170.163 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 30.9 tt0 -113.74 80.99 5.39 Favored Pre-proline 0 CA--C 1.541 0.601 0 C-N-CA 124.264 1.026 . . . . 75.51 110.451 -173.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -68.97 97.18 0.56 Allowed 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 123.928 3.086 . . . . 74.15 108.216 174.434 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -175.5 -58.97 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.378 0 N-CA-C 110.715 -0.954 . . . . 54.14 110.715 -175.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.46 145.04 28.36 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 107.172 -1.418 . . . . 75.42 107.172 166.634 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 36.9 mm -66.11 131.74 31.79 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 N-CA-C 105.721 -1.955 . . . . 64.24 105.721 167.298 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -80.65 142.58 33.84 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 108.699 -0.852 . . . . 74.51 108.699 171.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 47.1 t -131.57 114.38 25.29 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 N-CA-C 106.391 -1.707 . . . . 71.13 106.391 161.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 4.7 t -92.89 141.85 14.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 106.81 -1.552 . . . . 74.32 106.81 171.256 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 79.4 tt0 -107.64 106.25 16.51 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 105.217 -2.142 . . . . 74.34 105.217 156.286 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.0 mp -74.93 155.43 37.45 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 108.624 -0.88 . . . . 74.31 108.624 165.087 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -140.71 164.02 31.32 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 115.777 -0.647 . . . . 75.41 112.207 -163.849 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 23.6 t90 -159.63 129.76 5.58 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 121.559 0.695 . . . . 75.24 110.642 158.403 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 11.2 m-30 -45.24 -27.3 0.62 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 126.392 1.877 . . . . 75.11 114.611 165.045 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -80.77 2.42 79.6 Favored Glycine 0 CA--C 1.531 1.067 0 CA-C-N 119.63 1.105 . . . . 73.04 114.161 -178.151 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 54.1 t -105.44 86.89 1.86 Allowed Pre-proline 0 CA--C 1.539 0.543 0 C-N-CA 125.71 1.604 . . . . 71.02 112.72 -165.304 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -63.81 -25.13 68.05 Favored 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 121.862 1.708 . . . . 72.12 112.95 177.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 13.7 m-70 -61.76 -46.39 89.78 Favored 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 108.365 -0.976 . . . . 75.1 108.365 173.337 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 87.7 m -60.09 -39.03 84.7 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.83 0.852 . . . . 52.1 109.037 -170.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 45.7 t80 -51.96 -40.46 60.88 Favored 'General case' 0 C--N 1.344 0.344 0 C-N-CA 125.3 1.44 . . . . 72.12 110.763 178.316 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.74 -26.25 68.28 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 118.817 -0.611 . . . . 75.14 112.546 -178.337 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -79.3 -25.73 42.37 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-O 117.558 -1.21 . . . . 75.04 111.741 -176.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 28.8 mm-40 -37.64 -69.39 0.19 Allowed Pre-proline 0 N--CA 1.471 0.606 0 C-N-CA 125.379 1.472 . . . . 74.45 112.829 -171.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -68.68 -6.67 18.45 Favored 'Trans proline' 0 CA--C 1.536 0.62 0 CA-C-N 121.98 1.743 . . . . 72.2 115.696 -172.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 60.1 m -85.26 -40.25 16.82 Favored 'General case' 0 CA--C 1.537 0.464 0 O-C-N 121.019 -1.051 . . . . 64.44 109.293 168.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 21.0 tt -93.51 -26.16 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 CA-C-N 118.575 0.625 . . . . 74.55 112.467 -171.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 19.3 t -53.18 -64.73 1.46 Allowed Pre-proline 0 C--O 1.236 0.385 0 C-N-CA 125.728 1.611 . . . . 74.43 110.059 172.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -63.11 -34.6 68.83 Favored 'Trans proline' 0 N--CA 1.451 -0.971 0 CA-C-N 120.898 1.356 . . . . 75.1 111.396 -174.142 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 86.7 t90 -54.54 -51.92 63.69 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 124.195 0.998 . . . . 73.33 110.521 174.242 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 98.7 p -59.25 -38.07 79.15 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 118.428 0.558 . . . . 74.44 111.84 -176.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -71.49 -18.71 62.27 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.691 0.796 . . . . 64.22 112.116 179.281 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 67.7 mmtt -94.72 -1.89 52.15 Favored 'General case' 0 C--O 1.232 0.164 0 C-N-CA 124.98 1.312 . . . . 74.14 112.983 179.101 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 36.9 mt -61.16 149.73 81.4 Favored Pre-proline 0 N--CA 1.45 -0.438 0 CA-C-N 119.846 1.203 . . . . 72.14 111.927 -175.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -77.48 165.06 27.87 Favored 'Trans proline' 0 N--CA 1.447 -1.221 0 C-N-CA 123.82 3.013 . . . . 73.41 111.547 -175.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -66.77 12.46 0.07 Allowed 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 127.421 2.288 . . . . 62.1 115.072 -176.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -128.36 14.76 6.65 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.449 1.499 . . . . 74.0 111.211 175.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 90.2 t -116.28 155.98 17.56 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 O-C-N 120.64 -1.288 . . . . 71.13 109.445 177.347 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 16.9 t-160 -132.43 102.84 5.89 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 125.955 1.702 . . . . 72.12 106.905 168.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -89.21 139.04 30.89 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 109.228 -0.656 . . . . 75.22 109.228 172.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 78.2 t -143.8 145.74 21.74 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.102 0 C-N-CA 124.675 1.19 . . . . 72.32 108.616 -176.317 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 22.2 mtp180 -111.21 119.28 38.39 Favored 'General case' 0 N--CA 1.463 0.193 0 N-CA-C 105.838 -1.912 . . . . 74.43 105.838 174.156 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 21.0 mt -128.18 147.02 61.74 Favored Pre-proline 0 N--CA 1.473 0.721 0 C-N-CA 123.543 0.737 . . . . 71.03 111.406 176.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -77.38 149.04 27.25 Favored 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 122.639 2.226 . . . . 73.01 112.206 -178.216 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -95.21 126.03 40.25 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 122.232 1.015 . . . . 73.03 108.671 174.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 60.9 mt -113.03 52.26 0.8 Allowed 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 125.927 1.691 . . . . 74.02 111.583 -165.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 50.4 m-85 -83.42 63.89 7.55 Favored 'General case' 0 CA--C 1.54 0.57 0 O-C-N 121.332 -0.855 . . . . 71.23 111.784 -177.015 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 61.77 6.77 9.73 Favored Glycine 0 N--CA 1.476 1.366 0 N-CA-C 117.428 1.731 . . . . 63.42 117.428 142.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -170.47 103.85 0.2 Allowed Glycine 0 C--O 1.226 -0.406 0 N-CA-C 106.851 -2.5 . . . . 73.22 106.851 -176.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . 0.308 3.6 tp 58.34 -40.38 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 C-N-CA 130.501 3.52 . . . . 70.12 115.637 -171.063 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 12.5 m95 -49.26 -42.33 40.54 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 126.282 1.833 . . . . 75.24 111.606 -176.049 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 12.6 p30 -76.74 -28.69 55.87 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 114.284 1.216 . . . . 73.34 114.284 -178.323 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 86.0 t -70.28 -53.42 23.17 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 N-CA-C 106.347 -1.723 . . . . 74.33 106.347 174.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 40.5 m170 -68.03 39.42 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 128.905 2.882 . . . . 73.33 113.263 169.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -156.47 -46.66 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.424 0 O-C-N 121.204 -0.935 . . . . 72.21 111.378 177.397 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -50.66 -41.57 55.66 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.136 0.975 . . . . 75.52 112.144 -176.049 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 4.1 ttt -54.1 -35.39 62.07 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.387 1.075 . . . . 75.25 113.462 -175.547 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 39.3 t80 -59.94 -42.38 93.87 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 118.918 0.781 . . . . 74.43 109.844 -179.102 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 16.3 mt -66.0 -40.51 91.22 Favored 'General case' 0 C--O 1.227 -0.102 0 C-N-CA 125.094 1.358 . . . . 74.33 109.427 179.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.78 -37.02 85.81 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.666 0.786 . . . . 74.55 110.833 175.673 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.35 -56.33 15.13 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 124.092 0.957 . . . . 73.32 109.266 -178.422 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -72.06 -15.51 62.02 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 112.534 0.568 . . . . 61.21 112.534 -178.36 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 38.5 t -60.39 -18.99 54.22 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.521 1.129 . . . . 74.44 111.409 170.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 45.9 mtm -98.81 -13.68 20.01 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 120.282 1.401 . . . . 72.25 114.421 173.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 69.87 31.97 70.04 Favored Glycine 0 CA--C 1.529 0.922 0 CA-C-N 119.105 0.866 . . . . 74.43 112.655 -179.001 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 20.5 m -52.44 157.07 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 C-N-CA 126.112 1.765 . . . . 72.14 111.895 175.396 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -147.73 3.6 0.74 Allowed 'General case' 0 CA--C 1.543 0.704 0 O-C-N 121.308 -0.87 . . . . 73.24 112.672 173.335 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 8.0 m80 -131.54 131.26 43.23 Favored 'General case' 0 CA--C 1.529 0.166 0 O-C-N 120.045 -1.659 . . . . 72.55 109.782 -170.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 11.6 t0 54.05 27.95 8.17 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 128.367 2.667 . . . . 63.52 114.67 177.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 15.5 m -117.38 -164.36 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 C-N-CA 127.969 2.507 . . . . 74.05 109.543 -179.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . 0.257 0.3 OUTLIER 51.98 -85.48 0.01 OUTLIER 'General case' 0 C--O 1.233 0.213 0 C-N-CA 128.73 2.812 . . . . 65.42 113.052 -173.885 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -58.27 -58.94 6.25 Favored 'General case' 0 CA--C 1.51 -0.577 0 CA-C-N 119.507 1.049 . . . . 75.14 110.344 -178.549 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -60.36 -19.84 57.19 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 113.189 0.811 . . . . 71.45 113.189 -175.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 17.6 t -71.57 -62.18 1.4 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 N-CA-C 108.375 -0.972 . . . . 75.42 108.375 172.383 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 41.3 m-85 -64.42 -35.88 82.35 Favored 'General case' 0 C--N 1.338 0.082 0 C-N-CA 124.267 1.027 . . . . 75.31 111.89 -174.561 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 34.8 mm-40 -57.93 -45.19 86.97 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 125.553 1.541 . . . . 65.53 109.435 175.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -64.28 -19.67 65.56 Favored 'General case' 0 CA--C 1.542 0.645 0 O-C-N 121.574 -0.704 . . . . 74.11 112.195 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 64.4 mt -101.74 -25.93 3.66 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 C-N-CA 125.679 1.592 . . . . 71.03 110.298 -173.239 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 83.8 m-70 -117.58 -53.71 2.4 Favored 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 124.323 1.049 . . . . 73.24 111.835 -174.391 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -72.1 -32.66 67.2 Favored 'General case' 0 N--CA 1.468 0.45 0 O-C-N 121.309 -0.869 . . . . 71.34 110.949 176.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -101.71 -36.32 8.76 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 119.425 1.011 . . . . 75.41 112.597 177.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 22.7 t-160 44.5 63.62 1.61 Allowed 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.901 1.68 . . . . 74.2 112.07 -171.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 37.7 mmtt -64.19 170.71 3.49 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.208 1.403 . . . . 74.22 110.96 171.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 63.3 tttt -81.38 30.02 0.35 Allowed 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 125.985 1.714 . . . . 71.05 112.622 -173.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 31.0 mt -71.89 32.08 0.05 Allowed 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 128.8 2.84 . . . . 73.31 114.452 -165.112 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -78.85 8.37 5.61 Favored 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 126.864 2.066 . . . . 74.11 114.303 -178.333 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -150.75 156.77 36.15 Favored Pre-proline 0 CA--C 1.534 0.332 0 C-N-CA 124.25 1.02 . . . . 75.21 109.566 -174.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -65.42 -30.23 53.21 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 121.818 1.678 . . . . 61.32 114.0 -170.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -66.26 -53.69 33.86 Favored 'General case' 0 C--O 1.223 -0.31 0 CA-C-O 118.13 -0.938 . . . . 75.44 109.563 178.004 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -50.89 -48.19 60.5 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 119.353 0.979 . . . . 75.02 111.286 178.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 59.7 mtt -54.96 -55.19 33.48 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 123.937 0.895 . . . . 70.42 110.173 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -66.73 -42.61 86.0 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.565 1.146 . . . . 75.45 110.989 -172.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -61.0 -40.06 92.08 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 126.192 1.797 . . . . 74.43 109.853 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 38.7 t80 -68.81 -50.86 46.65 Favored 'General case' 0 N--CA 1.454 -0.243 0 O-C-N 121.807 -0.558 . . . . 75.42 109.644 178.193 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 50.7 mt -68.45 -15.94 63.73 Favored 'General case' 0 N--CA 1.452 -0.341 0 O-C-N 121.988 -0.445 . . . . 71.22 110.323 -172.561 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -54.19 -31.41 52.87 Favored 'General case' 0 CA--C 1.534 0.329 0 O-C-N 121.88 -0.513 . . . . 72.35 111.987 169.4 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -83.65 1.92 88.07 Favored Glycine 0 CA--C 1.534 1.22 0 CA-C-O 119.113 -0.826 . . . . 74.33 113.988 173.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 13.5 mmtp -131.62 27.31 4.68 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 120.036 1.918 . . . . 73.24 111.292 -166.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 73.33 36.1 55.77 Favored Glycine 0 CA--C 1.521 0.453 0 CA-C-O 119.825 -0.431 . . . . 71.13 112.295 173.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 31.8 t -126.51 123.11 62.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 N-CA-C 106.704 -1.591 . . . . 71.54 106.704 178.389 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -69.75 153.56 43.19 Favored 'General case' 0 CA--C 1.537 0.454 0 O-C-N 122.021 -0.424 . . . . 63.13 111.533 173.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 6.1 ttpt -83.48 -36.84 23.82 Favored 'General case' 0 N--CA 1.465 0.299 0 O-C-N 120.419 -1.426 . . . . 72.25 110.46 175.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 58.0 mt-10 -57.83 -52.86 63.72 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 118.859 0.754 . . . . 74.23 109.693 -176.504 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 7.6 mmmt -73.32 -38.52 65.78 Favored 'General case' 0 CA--C 1.508 -0.639 0 N-CA-C 108.353 -0.98 . . . . 75.44 108.353 -167.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 61.4 t80 -57.88 -62.49 1.77 Allowed 'General case' 0 N--CA 1.436 -1.174 0 O-C-N 124.732 1.27 . . . . 74.3 109.13 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 16.0 mt -68.05 -31.15 70.6 Favored 'General case' 0 C--O 1.238 0.485 0 O-C-N 121.985 -0.447 . . . . 75.11 111.305 -176.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 33.2 t -56.15 -59.8 4.41 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 107.4 -1.333 . . . . 63.13 107.4 175.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 4.5 t -71.86 -36.18 70.04 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 118.963 -0.541 . . . . 73.24 109.934 -171.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 61.6 t80 -51.62 -43.98 62.74 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.93 1.292 . . . . 73.41 111.733 176.394 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 54.4 m-20 -104.39 33.61 3.45 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 121.779 -0.576 . . . . 73.4 110.667 -179.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 22.6 t -122.95 165.76 16.18 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.178 1.391 . . . . 62.22 110.926 177.182 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -57.19 -29.42 63.67 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.168 1.387 . . . . 64.03 111.517 177.746 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -53.57 -58.89 5.57 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 123.918 0.887 . . . . 65.3 110.849 177.586 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 38.6 mm -74.17 -28.28 23.07 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-O 118.421 -0.8 . . . . 74.41 109.89 -176.099 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 7.4 mmtt -53.97 -43.12 69.65 Favored 'General case' 0 C--N 1.34 0.169 0 CA-C-N 119.639 1.108 . . . . 64.31 110.002 170.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -66.76 -20.47 70.35 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 124.389 0.995 . . . . 63.21 112.944 -177.516 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -90.13 -41.31 11.71 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 117.954 0.877 . . . . 71.14 110.1 174.342 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 87.8 mmm -64.39 -35.93 82.48 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 124.825 1.25 . . . . 73.45 112.3 -179.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -61.31 -51.29 69.48 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 119.039 0.836 . . . . 74.41 109.804 177.248 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 2.7 mmtt -65.04 -55.45 18.82 Favored 'General case' 0 CA--C 1.514 -0.419 0 C-N-CA 123.932 0.893 . . . . 74.52 109.275 -176.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -55.02 -34.5 63.54 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 119.681 1.128 . . . . 54.22 111.688 -178.086 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 5.7 tmtt? -77.87 -51.31 10.65 Favored 'General case' 0 C--N 1.346 0.437 0 CA-C-N 119.884 1.22 . . . . 75.5 111.344 -179.244 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 18.3 ptmt -60.54 -30.63 69.89 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 119.558 1.072 . . . . 74.34 110.527 178.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 48.4 mt -68.86 -56.91 6.46 Favored 'General case' 0 N--CA 1.443 -0.802 0 C-N-CA 123.442 0.697 . . . . 74.11 110.232 177.384 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -53.93 -41.5 67.77 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 119.887 1.221 . . . . 54.21 113.32 -173.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -65.22 -46.74 79.43 Favored 'General case' 0 N--CA 1.464 0.25 0 O-C-N 122.049 -0.407 . . . . 71.22 111.932 175.149 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -69.73 -35.04 74.66 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 118.733 0.697 . . . . 73.13 111.557 -176.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -69.48 9.29 0.49 Allowed 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 125.536 1.534 . . . . 71.34 113.763 171.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 10.9 mm100 59.04 24.72 13.02 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 126.005 1.722 . . . . 73.43 113.16 177.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 39.3 t -69.18 150.57 10.51 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 O-C-N 120.643 -1.286 . . . . 62.04 108.475 -178.197 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -145.98 6.27 1.02 Allowed 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.311 0.644 . . . . 52.22 111.947 -166.02 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 159.52 -171.99 36.05 Favored Glycine 0 N--CA 1.446 -0.688 0 N-CA-C 109.127 -1.589 . . . . 64.53 109.127 -166.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.461 ' HA ' ' C ' ' A' ' 154' ' ' PRO . 15.3 m -139.72 161.93 53.77 Favored Pre-proline 0 CA--C 1.539 0.531 0 C-N-CA 124.064 0.945 . . . . 74.42 110.261 176.615 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . 0.461 ' C ' ' HA ' ' A' ' 153' ' ' VAL . 20.6 Cg_endo -58.37 156.63 36.13 Favored 'Cis proline' 0 CA--C 1.532 0.384 0 C-N-CA 123.928 -1.28 . . . . 73.3 111.065 -14.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' THR . . . . . 0.42 ' HA ' ' HB3' ' A' ' 165' ' ' ASP . 11.0 m -147.95 109.96 4.53 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.066 -1.087 . . . . 74.42 108.066 171.255 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 36.2 mmm -89.27 158.73 17.73 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 108.337 -0.986 . . . . 71.35 108.337 170.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 11.5 t -145.19 121.56 3.97 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 N-CA-C 108.575 -0.898 . . . . 75.25 108.575 174.128 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 77.2 t -91.83 131.51 38.73 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 N-CA-C 108.524 -0.917 . . . . 70.45 108.524 169.367 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 44.1 t30 48.88 19.45 0.27 Allowed 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 130.082 3.353 . . . . 73.11 115.323 168.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 69.62 23.75 76.54 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 125.357 1.456 . . . . 71.35 112.852 -175.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 55.9 mttt -131.55 -31.45 1.59 Allowed 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 118.596 1.198 . . . . 74.23 113.111 -171.285 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -125.68 108.08 11.19 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 123.529 0.732 . . . . 73.2 109.12 -175.532 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 41.7 ttt-85 -90.36 124.12 34.67 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 126.985 2.114 . . . . 72.51 106.039 174.475 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 18.1 p90 -149.42 166.95 27.54 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 107.67 -1.233 . . . . 73.52 107.67 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . 0.42 ' HB3' ' HA ' ' A' ' 155' ' ' THR . 10.4 p-10 178.24 178.07 0.4 Allowed 'General case' 0 CA--C 1.51 -0.562 0 C-N-CA 124.86 1.264 . . . . 75.53 109.205 -178.666 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 18.2 mt -54.35 -38.49 40.54 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.673 0 C-N-CA 126.405 1.882 . . . . 72.42 109.834 178.204 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -65.27 -30.96 79.03 Favored Glycine 0 CA--C 1.526 0.764 0 C-N-CA 124.321 0.963 . . . . 61.14 113.266 175.499 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 51.0 m -84.61 -62.19 1.61 Allowed 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.898 0.879 . . . . 65.52 110.064 178.148 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -59.0 -32.87 70.08 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 126.583 1.953 . . . . 73.25 112.071 -173.274 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 102.07 2.58 51.7 Favored Glycine 0 CA--C 1.526 0.727 0 CA-C-O 118.656 -1.08 . . . . 63.11 112.453 178.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 169.24 172.66 36.17 Favored Glycine 0 CA--C 1.531 1.041 0 CA-C-N 119.256 1.528 . . . . 63.41 111.556 175.579 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -66.44 -49.37 1.82 Allowed 'Trans proline' 0 CA--C 1.534 0.502 0 C-N-CA 123.046 2.497 . . . . 74.3 112.459 -175.357 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -57.09 -43.67 82.43 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 119.406 1.003 . . . . 74.1 109.865 175.429 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -57.79 -34.88 70.08 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.21 -0.905 . . . . 71.4 109.958 -178.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 48.8 m -67.4 -41.51 84.81 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-O 118.179 -0.915 . . . . 74.25 110.689 -178.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 49.7 mt -66.45 -35.64 80.81 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 119.836 1.198 . . . . 64.14 111.039 176.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 10.3 mttt -51.39 -48.56 62.54 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.244 1.418 . . . . 64.21 110.09 170.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -67.58 -48.85 65.68 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-O 118.346 -0.835 . . . . 75.44 110.478 173.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -52.91 -37.55 60.86 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 123.375 0.67 . . . . 73.03 111.977 -172.576 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -81.36 -47.55 13.12 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.659 1.184 . . . . 74.3 110.657 -173.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -56.56 -47.79 78.72 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 108.82 -0.807 . . . . 74.02 108.82 176.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 29.4 mt -63.57 -32.44 73.9 Favored 'General case' 0 CA--C 1.514 -0.438 0 C-N-CA 125.3 1.44 . . . . 64.12 112.205 -170.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 30.0 mt -58.38 -61.49 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 N-CA-C 107.046 -1.465 . . . . 73.33 107.046 174.058 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -53.05 -37.19 61.38 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 123.869 0.867 . . . . 64.12 111.691 -179.339 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.72 -39.09 67.88 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.547 0.739 . . . . 75.12 111.046 -176.063 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 63.8 mm-40 -95.14 -33.85 12.49 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 124.133 0.973 . . . . 71.53 112.135 175.126 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.05 -34.45 74.89 Favored 'General case' 0 CA--C 1.529 0.17 0 O-C-N 120.598 -1.314 . . . . 74.52 109.908 -179.022 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -67.89 -12.02 59.83 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 124.914 1.286 . . . . 70.34 112.174 179.385 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -69.84 -14.83 62.94 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 118.758 0.708 . . . . 73.33 111.825 169.247 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . 54.02 26.85 6.8 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 128.234 2.614 . . . . 73.52 113.074 175.016 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 3.1 ttpm? 50.61 37.74 17.08 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.254 1.422 . . . . 73.21 111.818 -173.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 20.1 pttm . . . . . 0 C--O 1.243 0.756 0 CA-C-O 117.06 -1.448 . . . . 75.32 110.694 179.912 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.631 0 N-CA-C 107.91 -2.076 . . . . 73.5 107.91 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -136.02 134.67 38.75 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-N 118.615 1.207 . . . . 70.22 110.977 -154.428 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -134.21 11.37 3.86 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 126.278 1.831 . . . . 72.51 111.546 -170.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 -140.02 158.18 44.47 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 124.697 1.199 . . . . 71.44 108.485 -169.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 24.4 m -134.76 138.94 44.77 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 108.777 -0.823 . . . . 75.32 108.777 -178.577 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -71.14 143.74 50.47 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 109.146 -0.687 . . . . 75.42 109.146 174.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 68.1 14.28 65.78 Favored Glycine 0 CA--C 1.523 0.577 0 CA-C-O 119.315 -0.714 . . . . 72.42 112.515 -168.054 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 6.7 tttm -130.92 -82.56 0.53 Allowed 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 107.532 -1.285 . . . . 72.41 107.532 179.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 7.5 mp0 -79.44 -24.59 42.35 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 124.587 1.155 . . . . 70.4 111.361 -178.392 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 41.3 p90 -155.89 174.57 15.13 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 107.329 -1.36 . . . . 71.42 107.329 -177.075 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 23.0 t -132.29 146.82 32.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 108.474 -0.935 . . . . 74.23 108.474 -175.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -109.22 156.52 19.8 Favored 'General case' 0 N--CA 1.451 -0.409 0 O-C-N 120.894 -1.129 . . . . 75.43 109.161 166.398 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -126.02 120.22 29.72 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 125.747 1.619 . . . . 72.33 108.695 -169.338 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.8 m -55.13 -15.53 2.31 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.616 1.567 . . . . 72.02 114.223 -177.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 10.4 p -128.59 84.99 61.51 Favored Pre-proline 0 N--CA 1.445 -0.688 0 CA-C-N 119.164 0.893 . . . . 54.2 111.55 -179.552 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -73.08 179.79 5.07 Favored 'Trans proline' 0 CA--C 1.542 0.923 0 C-N-CA 124.449 3.432 . . . . 74.52 113.822 178.19 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 6.7 t -128.94 142.3 44.66 Favored Pre-proline 0 N--CA 1.47 0.564 0 C-N-CA 125.347 1.459 . . . . 70.24 108.102 173.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -76.73 176.52 10.01 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 123.608 2.872 . . . . 73.42 111.216 172.042 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.7 m -115.99 179.4 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 C-N-CA 124.017 0.927 . . . . 74.33 109.418 170.095 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 34.7 t -56.15 -64.03 0.99 Allowed 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 123.82 0.848 . . . . 75.21 108.906 169.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 19.1 mt-30 -150.38 161.23 31.27 Favored Pre-proline 0 C--O 1.237 0.442 0 O-C-N 121.68 -0.638 . . . . 74.51 110.761 -174.172 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -70.82 166.38 29.11 Favored 'Trans proline' 0 N--CA 1.45 -1.049 0 C-N-CA 122.747 2.298 . . . . 74.04 109.333 171.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 143.04 -86.57 0.18 Allowed Glycine 0 N--CA 1.449 -0.495 0 N-CA-C 108.894 -1.683 . . . . 65.43 108.894 -175.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.29 158.0 15.64 Favored 'General case' 0 N--CA 1.462 0.161 0 N-CA-C 108.616 -0.883 . . . . 74.42 108.616 -176.616 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 48.0 mm -66.63 154.91 7.61 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 N-CA-C 106.585 -1.635 . . . . 75.35 106.585 166.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -108.59 90.32 3.26 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 107.449 -1.315 . . . . 75.4 107.449 172.466 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 41.4 t -94.61 119.8 43.11 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.175 0 N-CA-C 106.654 -1.61 . . . . 74.11 106.654 176.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 25.4 t -119.45 110.99 31.2 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 N-CA-C 108.507 -0.923 . . . . 70.54 108.507 -174.291 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -72.61 126.94 31.1 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 108.046 -1.094 . . . . 73.53 108.046 154.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.5 mp -109.7 139.9 44.2 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 106.634 -1.617 . . . . 75.35 106.634 151.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 9.3 p90 -146.07 168.06 21.85 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 125.323 1.449 . . . . 74.12 107.974 -173.116 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 24.1 t90 -142.18 151.75 42.49 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 107.664 -1.236 . . . . 75.34 107.664 -177.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -47.15 -31.28 3.42 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.882 1.273 . . . . 74.42 112.085 166.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -109.5 17.9 30.52 Favored Glycine 0 CA--C 1.527 0.809 0 CA-C-O 117.577 -1.68 . . . . 74.42 115.138 -159.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 23.0 p -104.83 86.33 1.45 Allowed Pre-proline 0 CA--C 1.538 0.516 0 CA-C-N 119.644 1.722 . . . . 71.1 110.723 -170.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -58.51 -27.24 81.58 Favored 'Trans proline' 0 CA--C 1.54 0.776 0 CA-C-N 121.778 1.671 . . . . 54.11 114.232 -174.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 10.9 m170 -59.84 -19.63 52.14 Favored 'General case' 0 CA--C 1.537 0.449 0 O-C-N 121.365 -0.835 . . . . 72.44 112.592 174.067 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 98.8 m -71.01 -36.07 72.28 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.922 1.289 . . . . 65.13 110.632 -176.156 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 38.4 m-85 -61.68 -36.48 80.97 Favored 'General case' 0 N--CA 1.471 0.595 0 O-C-N 120.794 -1.191 . . . . 74.12 111.711 -177.462 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.74 -12.09 43.41 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 124.505 1.122 . . . . 71.33 112.209 179.299 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 27.1 t80 -126.41 -25.28 3.49 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-O 116.353 -1.784 . . . . 74.21 112.701 -172.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -45.37 -62.77 1.51 Allowed Pre-proline 0 N--CA 1.473 0.722 0 CA-C-N 121.619 2.009 . . . . 65.3 113.107 -177.517 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -70.38 -7.81 22.12 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 CA-C-N 121.179 1.457 . . . . 74.23 114.932 -178.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 25.4 m -80.84 -37.53 29.83 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.093 0.957 . . . . 64.11 110.061 170.295 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 20.6 tt -91.65 -31.62 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 C-N-CA 123.147 0.579 . . . . 75.12 111.617 -174.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 12.5 t -46.93 -62.8 1.71 Allowed Pre-proline 0 CA--C 1.539 0.533 0 CA-C-O 117.975 -1.012 . . . . 61.41 111.027 174.256 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -66.83 -34.91 29.13 Favored 'Trans proline' 0 N--CA 1.452 -0.939 0 CA-C-N 121.222 1.472 . . . . 75.4 111.027 -176.194 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 91.2 t90 -55.09 -47.32 75.08 Favored 'General case' 0 C--N 1.341 0.217 0 CA-C-N 119.778 1.172 . . . . 74.2 109.929 174.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 49.7 p -59.51 -38.1 80.06 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 122.783 0.433 . . . . 71.15 111.604 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.4 mt-10 -75.32 -10.55 59.55 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.34 1.456 . . . . 74.15 112.483 177.506 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 9.7 mmmm -119.44 9.8 11.69 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 126.447 1.899 . . . . 72.35 112.772 -174.571 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 27.5 mt -65.02 160.6 55.05 Favored Pre-proline 0 CA--C 1.538 0.506 0 C-N-CA 124.402 1.081 . . . . 75.34 111.661 172.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -82.66 169.7 13.39 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 124.913 3.742 . . . . 73.22 111.409 175.088 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -71.83 16.64 0.11 Allowed 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 126.755 2.022 . . . . 74.45 114.062 -175.304 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -127.09 -4.96 6.19 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 126.601 1.961 . . . . 73.4 113.074 -179.09 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 48.5 t -113.68 113.98 45.49 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.307 0 N-CA-C 106.689 -1.597 . . . . 74.3 106.689 -178.011 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 79.5 t60 -101.3 112.71 25.3 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 107.045 -1.465 . . . . 73.23 107.045 174.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 27.6 t80 -84.6 143.99 28.91 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 114.855 -1.066 . . . . 74.2 109.16 176.153 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 48.8 t -136.24 141.09 42.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 N-CA-C 106.387 -1.708 . . . . 73.4 106.387 -177.316 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 60.1 mtm-85 -123.43 113.33 18.65 Favored 'General case' 0 CA--C 1.508 -0.635 0 N-CA-C 104.613 -2.366 . . . . 74.34 104.613 176.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 5.8 mt -124.67 149.23 61.61 Favored Pre-proline 0 N--CA 1.466 0.326 0 CA-C-N 120.443 1.474 . . . . 73.11 110.043 174.294 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -67.53 143.43 62.85 Favored 'Trans proline' 0 N--CA 1.45 -1.051 0 C-N-CA 121.123 1.215 . . . . 63.14 110.743 -177.305 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -79.17 59.19 2.69 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.684 1.594 . . . . 70.25 111.49 -179.665 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 10.6 mt -74.1 88.13 1.91 Allowed 'General case' 0 C--N 1.328 -0.356 0 O-C-N 120.382 -1.449 . . . . 62.32 108.502 -176.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -141.61 1.98 1.57 Allowed 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 114.352 1.241 . . . . 75.55 114.352 175.649 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -153.04 179.0 29.82 Favored Glycine 0 C--N 1.333 0.401 0 O-C-N 121.078 -1.014 . . . . 72.31 113.814 -163.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -51.81 -53.56 29.18 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 128.589 2.995 . . . . 65.4 113.117 -164.289 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 9.8 tp -106.39 -6.85 10.24 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 C-N-CA 124.886 1.274 . . . . 73.1 110.884 173.39 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 8.9 m95 -73.76 -24.7 59.9 Favored 'General case' 0 N--CA 1.448 -0.568 0 O-C-N 120.876 -1.14 . . . . 74.31 111.495 -171.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -70.38 -46.94 63.04 Favored 'General case' 0 C--O 1.234 0.244 0 O-C-N 121.321 -0.862 . . . . 75.51 109.299 169.457 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 25.7 t -63.31 -53.13 49.65 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 C-N-CA 122.774 0.43 . . . . 72.04 110.189 -173.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 38.6 m170 -67.31 1.88 1.95 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.225 1.01 . . . . 70.02 113.185 178.457 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -109.19 -43.5 1.17 Allowed Glycine 0 C--N 1.338 0.669 0 CA-C-N 120.702 1.592 . . . . 63.21 110.697 -176.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -54.37 -36.62 64.07 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 113.391 0.886 . . . . 74.43 113.391 -170.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 5.9 ttt -45.21 -45.79 11.94 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 125.849 1.659 . . . . 64.25 114.434 -179.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 34.8 t80 -56.85 -42.34 79.53 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 121.52 0.676 . . . . 71.44 109.775 -173.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 18.2 mt -68.75 -42.11 77.97 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 117.082 -1.437 . . . . 73.21 109.291 178.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -56.51 -40.61 75.31 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 121.046 1.748 . . . . 74.53 110.944 178.255 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.07 -59.79 4.32 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 123.686 0.794 . . . . 71.11 110.219 179.243 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -65.24 -16.37 63.47 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 118.806 0.73 . . . . 73.32 112.208 -178.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -53.25 -25.74 15.52 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.208 1.003 . . . . 74.41 111.724 174.355 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 11.6 mtp -107.1 -11.42 15.64 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.429 1.492 . . . . 64.42 112.05 -172.464 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 63.23 39.32 97.75 Favored Glycine 0 CA--C 1.53 0.973 0 N-CA-C 110.743 -0.943 . . . . 73.23 110.743 -173.7 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 20.5 m -66.2 161.79 3.18 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 C-N-CA 125.005 1.322 . . . . 64.11 110.76 167.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 51.24 -162.16 0.07 Allowed 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 106.589 -1.634 . . . . 75.34 106.589 -163.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 42.9 m170 -91.18 -85.23 0.24 Allowed 'General case' 0 N--CA 1.465 0.293 0 O-C-N 119.353 -2.092 . . . . 73.15 108.832 164.246 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 41.6 t0 -139.5 43.08 2.01 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-O 122.333 1.064 . . . . 71.43 109.536 -178.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 21.6 m -147.07 161.74 8.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 C-N-CA 128.443 2.697 . . . . 73.14 107.941 -176.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 21.2 p80 -156.04 35.59 0.34 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 122.011 0.91 . . . . 72.22 113.013 -168.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -49.95 -64.45 0.8 Allowed 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 126.286 1.834 . . . . 75.32 110.768 -173.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -60.82 -26.21 67.15 Favored 'General case' 0 N--CA 1.457 -0.119 0 CA-C-O 117.96 -1.019 . . . . 74.52 113.029 -178.216 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 39.0 t -59.19 -62.67 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.339 0.14 0 N-CA-C 107.683 -1.229 . . . . 72.03 107.683 178.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -61.95 -49.57 75.59 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 123.874 0.87 . . . . 74.1 110.343 -179.387 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -57.29 -38.36 73.86 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.922 0.889 . . . . 72.1 110.488 -173.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -67.88 -43.79 78.55 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-O 122.46 1.124 . . . . 71.51 111.12 -178.452 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 45.2 mt -71.57 -36.29 59.48 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 N-CA-C 108.207 -1.034 . . . . 75.45 108.207 -175.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 81.1 m-70 -95.68 -74.03 0.57 Allowed 'General case' 0 N--CA 1.446 -0.66 0 O-C-N 121.46 -0.775 . . . . 75.32 109.936 -171.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 22.5 mmtt -64.12 -18.53 64.51 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 125.099 1.36 . . . . 75.21 112.097 -176.359 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -108.82 -19.83 13.27 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 113.516 0.932 . . . . 74.2 113.516 179.243 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 3.9 t60 44.02 57.64 4.08 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 126.389 1.876 . . . . 75.22 112.059 173.325 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 12.6 mmtm -75.51 160.65 29.95 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.668 1.187 . . . . 70.01 109.992 178.308 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 32.7 tttt -77.61 29.83 0.16 Allowed 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 127.466 2.307 . . . . 74.24 113.892 -178.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 27.6 mt -74.62 49.88 0.41 Allowed 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 127.489 2.316 . . . . 74.15 111.734 -169.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -90.37 -0.26 57.56 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 128.093 2.557 . . . . 72.3 112.333 -178.535 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 23.8 p -141.01 153.41 67.18 Favored Pre-proline 0 C--O 1.233 0.23 0 C-N-CA 123.424 0.69 . . . . 73.54 110.135 173.439 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -63.89 -28.4 67.21 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 122.528 2.152 . . . . 63.51 112.642 -176.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 27.8 mp0 -70.35 -36.71 74.36 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 119.594 1.088 . . . . 72.13 110.31 177.286 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -73.37 -40.36 64.44 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.847 0.859 . . . . 74.14 109.544 178.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 45.1 mtt -58.47 -61.29 2.7 Favored 'General case' 0 C--N 1.343 0.286 0 C-N-CA 126.044 1.738 . . . . 65.2 109.935 174.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -62.91 -41.26 99.38 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 123.888 0.875 . . . . 71.35 111.476 -170.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -56.65 -41.91 78.04 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.049 0.452 . . . . 72.05 111.212 176.199 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 80.8 t80 -70.57 -40.69 73.17 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 123.614 0.766 . . . . 71.44 112.061 -179.173 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 56.1 mt -75.97 -17.02 59.88 Favored 'General case' 0 C--N 1.332 -0.181 0 O-C-N 121.378 -0.826 . . . . 75.12 111.445 -177.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -54.06 -28.33 38.18 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.981 0.912 . . . . 64.24 111.832 -178.075 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -89.54 -1.68 77.45 Favored Glycine 0 CA--C 1.529 0.94 0 CA-C-O 117.741 -1.589 . . . . 72.24 115.151 177.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 39.5 mttt -129.33 26.42 5.41 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 120.791 2.295 . . . . 74.15 112.647 -166.313 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 104.7 3.93 42.91 Favored Glycine 0 CA--C 1.527 0.812 0 C-N-CA 123.542 0.591 . . . . 71.13 113.463 173.101 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 77.0 t -106.3 165.09 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 C-N-CA 125.277 1.431 . . . . 75.2 107.899 179.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 60.8 t0 -132.87 132.24 41.87 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 105.711 -1.959 . . . . 61.02 105.711 176.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 21.3 mtpt -55.72 -36.03 66.77 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 123.523 0.729 . . . . 73.0 110.885 176.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -60.2 -50.87 71.96 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 118.875 0.761 . . . . 74.43 109.874 174.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -78.04 -28.03 48.91 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 108.979 -0.749 . . . . 75.44 108.979 -167.452 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 32.8 t80 -68.66 -69.73 0.31 Allowed 'General case' 0 N--CA 1.437 -1.09 0 C-N-CA 125.434 1.493 . . . . 74.35 108.845 173.627 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 8.1 mt -68.04 -37.99 81.99 Favored 'General case' 0 CA--C 1.531 0.24 0 O-C-N 121.244 -0.91 . . . . 73.31 110.348 -163.164 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 3.9 t -66.61 -21.13 66.13 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 118.781 -0.628 . . . . 73.05 112.232 -175.167 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 3.1 t -98.42 -35.11 10.39 Favored 'General case' 0 C--N 1.342 0.27 0 CA-C-N 119.196 0.907 . . . . 73.02 110.448 171.113 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 80.2 t80 -49.31 -55.69 11.95 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 119.184 0.902 . . . . 61.41 110.533 177.344 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 -86.08 55.61 3.61 Favored 'General case' 0 C--O 1.231 0.105 0 N-CA-C 108.714 -0.847 . . . . 71.04 108.714 174.356 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -157.91 166.53 32.4 Favored 'General case' 0 C--O 1.237 0.396 0 O-C-N 120.93 -1.106 . . . . 75.33 111.33 -177.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -74.6 -29.61 61.37 Favored 'General case' 0 N--CA 1.456 -0.14 0 CA-C-N 115.613 -0.721 . . . . 73.02 112.836 -162.551 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -56.73 -49.48 75.05 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 119.658 1.117 . . . . 73.34 110.258 -177.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 35.5 mm -63.02 -39.44 85.23 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.345 0 C-N-CA 125.161 1.384 . . . . 75.23 109.493 177.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 28.0 tttm -55.83 -42.67 76.08 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 118.585 -0.721 . . . . 75.21 109.562 175.305 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -71.18 -24.95 76.48 Favored Glycine 0 CA--C 1.523 0.559 0 C-N-CA 124.796 1.189 . . . . 74.15 111.958 -171.525 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -87.61 -50.4 6.53 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 124.347 1.059 . . . . 73.4 108.39 179.114 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 1.2 ppp? -58.49 -43.11 88.87 Favored 'General case' 0 C--N 1.34 0.161 0 C-N-CA 123.627 0.771 . . . . 74.25 109.737 -176.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -60.13 -40.01 88.27 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-O 118.464 -0.779 . . . . 64.23 112.133 -176.024 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -59.85 -59.38 5.52 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 123.906 0.883 . . . . 70.41 109.855 173.813 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -54.01 -34.0 58.7 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 118.038 0.381 . . . . 72.21 111.175 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 49.6 tttt -67.55 -59.67 3.17 Favored 'General case' 0 C--O 1.232 0.149 0 O-C-N 121.322 -0.861 . . . . 75.43 110.852 177.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.45 -24.28 64.7 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 118.452 0.569 . . . . 74.43 111.566 -174.686 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 32.6 mt -67.33 -53.16 32.05 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 118.52 -0.752 . . . . 75.34 110.203 170.543 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -53.92 -44.86 70.94 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 118.957 0.799 . . . . 71.42 112.291 -174.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 13.5 ptp -63.48 -46.9 84.03 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 119.423 -0.323 . . . . 63.12 111.551 176.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -58.87 -43.31 90.86 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 118.354 -0.831 . . . . 63.23 109.481 -179.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 18.1 m-85 -66.28 5.4 0.55 Allowed 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 115.078 1.511 . . . . 73.24 115.078 -175.096 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 59.2 mm-40 62.46 34.31 15.5 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 121.143 1.792 . . . . 71.54 113.198 176.39 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 57.5 t -80.5 -76.97 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 CA-C-O 118.415 -0.803 . . . . 73.35 111.18 -165.072 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . 0.26 1.6 p 54.59 -22.45 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 129.293 3.037 . . . . 72.44 118.18 -179.731 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -99.45 -179.84 30.89 Favored Glycine 0 CA--C 1.532 1.102 0 CA-C-N 121.6 2.0 . . . . 72.45 111.807 168.467 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 3.1 m -165.2 148.06 6.94 Favored Pre-proline 0 CA--C 1.547 0.865 0 C-N-CA 129.351 3.06 . . . . 75.33 108.033 167.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -67.34 142.35 62.2 Favored 'Cis proline' 0 N--CA 1.452 -0.923 0 CA-C-N 120.006 1.038 . . . . 71.32 110.543 -5.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' THR . . . . . 0.529 ' CG2' ' HE ' ' A' ' 163' ' ' ARG . 25.3 m -147.07 133.4 19.56 Favored 'General case' 0 N--CA 1.447 -0.575 0 N-CA-C 107.979 -1.119 . . . . 75.34 107.979 -174.253 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 42.6 mmm -111.81 163.69 13.89 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.324 1.45 . . . . 64.44 109.434 176.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 38.7 t -142.32 151.67 18.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 C-N-CA 125.154 1.382 . . . . 71.15 107.528 168.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 60.5 t -118.61 125.46 74.41 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 C-N-CA 125.802 1.641 . . . . 74.15 106.966 166.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 14.9 m-20 55.15 10.99 0.47 Allowed 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 128.016 2.526 . . . . 71.42 115.926 172.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 82.59 12.57 79.99 Favored Glycine 0 CA--C 1.522 0.524 0 CA-C-O 117.921 -1.488 . . . . 73.02 113.45 -174.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 45.1 mttt -121.67 -52.34 2.02 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-N 119.083 1.441 . . . . 70.2 111.227 -166.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 74.6 m-85 -99.68 122.65 43.0 Favored 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 108.086 -1.079 . . . . 75.34 108.086 -179.52 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . 0.529 ' HE ' ' CG2' ' A' ' 155' ' ' THR . 0.1 OUTLIER -92.46 133.42 35.93 Favored 'General case' 0 N--CA 1.446 -0.675 0 C-N-CA 126.888 2.075 . . . . 72.45 105.496 169.256 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 20.6 p90 -147.93 167.96 23.49 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.062 -1.088 . . . . 63.23 108.062 168.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -174.65 -179.41 1.49 Allowed 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 123.957 0.903 . . . . 74.42 108.921 178.191 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 13.5 mt -55.61 -45.07 78.75 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 C-N-CA 126.99 2.116 . . . . 75.22 108.408 176.022 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -61.69 -39.54 97.56 Favored Glycine 0 C--N 1.338 0.667 0 C-N-CA 124.154 0.883 . . . . 73.5 112.415 178.323 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 16.2 m -74.36 -56.79 4.47 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 118.678 1.239 . . . . 71.05 110.273 178.565 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -74.15 -33.19 63.43 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 125.201 1.401 . . . . 72.31 113.626 -163.127 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 147.4 -46.77 0.7 Allowed Glycine 0 CA--C 1.521 0.424 0 O-C-N 123.648 0.593 . . . . 62.3 112.259 -178.047 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 168.16 -174.19 43.0 Favored Glycine 0 CA--C 1.53 0.972 0 N-CA-C 109.209 -1.557 . . . . 75.22 109.209 -156.31 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -66.76 -55.59 0.32 Allowed 'Trans proline' 0 N--CA 1.452 -0.958 0 C-N-CA 122.618 2.212 . . . . 73.14 111.003 -170.319 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -60.46 -41.85 95.0 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 121.838 0.827 . . . . 75.23 109.58 179.35 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -56.48 -29.87 62.27 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 124.971 1.308 . . . . 71.32 111.864 179.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 89.5 m -67.04 -44.49 80.06 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-O 118.358 -0.829 . . . . 65.33 109.817 179.411 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 55.9 mt -60.52 -37.82 82.4 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 118.945 0.793 . . . . 74.23 109.682 175.264 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 8.7 ttpp -52.25 -39.89 60.95 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 117.626 -1.178 . . . . 74.42 110.326 175.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -79.16 -43.38 24.08 Favored 'General case' 0 C--N 1.346 0.454 0 CA-C-N 120.601 1.546 . . . . 75.41 111.869 172.071 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -51.54 -41.86 61.38 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 119.287 0.949 . . . . 72.32 111.818 -175.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -78.37 -38.91 40.74 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 124.801 1.24 . . . . 60.54 110.613 -172.286 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 24.1 t80 -64.46 -54.6 29.94 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 125.091 1.356 . . . . 73.45 110.444 174.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 87.6 mt -60.98 -23.24 65.2 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.251 1.02 . . . . 72.5 113.294 -174.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 23.7 mt -57.02 -59.89 2.63 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 CA-C-N 119.275 0.943 . . . . 73.52 108.816 170.339 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 10.6 tm-20 -56.87 -37.58 71.54 Favored 'General case' 0 C--O 1.227 -0.108 0 C-N-CA 124.581 1.152 . . . . 71.53 110.356 -177.519 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 12.8 tptt -53.14 -41.06 64.73 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 124.292 1.037 . . . . 72.42 111.863 -179.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 32.5 mm-40 -91.67 -41.76 10.55 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.036 0.934 . . . . 74.34 111.242 178.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.38 -35.68 78.16 Favored 'General case' 0 C--O 1.234 0.268 0 O-C-N 120.645 -1.284 . . . . 73.42 109.952 -175.852 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -58.24 -25.03 61.22 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 125.275 1.43 . . . . 74.43 112.045 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -59.0 -39.38 81.68 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 124.138 0.975 . . . . 75.35 110.653 177.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -138.91 52.08 1.79 Allowed 'General case' 0 C--O 1.233 0.209 0 C-N-CA 122.84 0.456 . . . . 74.33 109.915 -172.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 15.9 pttm -84.53 31.4 0.52 Allowed 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 125.193 1.397 . . . . 74.34 113.706 -165.4 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.252 1.204 0 C-N-CA 127.487 2.315 . . . . 74.14 110.819 -167.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.67 0 N-CA-C 109.816 -1.314 . . . . 35.52 109.816 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 66.08 -68.36 0.13 Allowed 'General case' 0 CA--C 1.503 -0.829 0 C-N-CA 128.641 2.777 . . . . 53.41 110.909 -173.352 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . 0.336 13.8 m-20 75.99 11.31 3.04 Favored 'General case' 0 N--CA 1.435 -1.21 0 C-N-CA 128.43 2.692 . . . . 73.13 116.222 168.378 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -142.82 172.2 13.02 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 126.758 2.023 . . . . 74.14 107.73 173.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 61.5 m -140.78 138.0 33.77 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.887 0.875 . . . . 64.42 109.462 178.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.04 144.75 57.07 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 122.132 0.968 . . . . 72.34 110.272 175.425 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 80.5 -36.75 2.24 Favored Glycine 0 CA--C 1.526 0.776 0 C-N-CA 126.64 2.067 . . . . 63.42 111.787 -167.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -84.0 -76.5 0.29 Allowed 'General case' 0 CA--C 1.515 -0.372 0 C-N-CA 124.774 1.23 . . . . 73.4 110.134 -165.452 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 15.8 mp0 -78.87 -24.87 44.02 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 124.929 1.292 . . . . 74.0 110.452 178.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 37.9 p90 -160.32 174.41 14.22 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 123.806 0.842 . . . . 74.42 109.726 -172.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 32.8 t -132.48 112.49 19.27 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 C-N-CA 123.797 0.839 . . . . 74.22 109.13 178.418 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -71.0 154.44 41.81 Favored 'General case' 0 C--O 1.235 0.33 0 O-C-N 120.89 -1.131 . . . . 73.24 109.155 162.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -124.31 113.85 18.78 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 124.476 1.11 . . . . 74.34 110.292 -173.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 59.3 p -69.66 13.34 0.14 Allowed 'General case' 0 C--O 1.236 0.379 0 C-N-CA 127.177 2.191 . . . . 71.4 114.278 -175.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 32.1 t -143.28 78.77 14.67 Favored Pre-proline 0 N--CA 1.454 -0.239 0 N-CA-C 108.085 -1.08 . . . . 74.41 108.085 165.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -67.22 -179.92 2.07 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 122.867 2.378 . . . . 74.21 111.922 -173.239 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 40.6 t -130.71 136.66 29.28 Favored Pre-proline 0 C--O 1.233 0.212 0 N-CA-C 107.073 -1.454 . . . . 72.12 107.073 179.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -79.27 173.71 12.93 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 121.836 1.69 . . . . 72.14 110.939 176.204 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 20.7 m -122.4 169.49 13.69 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 C-N-CA 125.09 1.356 . . . . 73.33 109.622 -178.183 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.1 t -47.74 -64.25 0.84 Allowed 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 126.406 1.882 . . . . 63.01 109.808 176.314 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -147.07 164.58 22.59 Favored Pre-proline 0 C--O 1.237 0.401 0 C-N-CA 123.931 0.893 . . . . 74.31 109.86 178.168 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_endo -66.3 176.07 4.35 Favored 'Trans proline' 0 N--CA 1.45 -1.04 0 C-N-CA 122.081 1.854 . . . . 72.22 111.066 163.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 129.39 -89.42 0.31 Allowed Glycine 0 N--CA 1.448 -0.559 0 N-CA-C 108.059 -2.016 . . . . 74.25 108.059 -178.029 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -85.21 163.53 18.64 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 117.919 0.86 . . . . 74.14 109.322 -179.085 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 46.9 mm -77.13 137.51 22.3 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 N-CA-C 105.204 -2.147 . . . . 74.43 105.204 158.125 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -99.3 118.0 35.0 Favored 'General case' 0 N--CA 1.445 -0.725 0 N-CA-C 105.859 -1.904 . . . . 73.54 105.859 -179.442 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 60.2 t -121.64 131.81 72.22 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 N-CA-C 106.723 -1.584 . . . . 74.22 106.723 -179.091 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 43.2 t -127.09 138.72 54.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 106.241 -1.763 . . . . 73.02 106.241 -175.22 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -106.32 137.74 43.74 Favored 'General case' 0 C--O 1.239 0.525 0 N-CA-C 106.655 -1.609 . . . . 74.52 106.655 158.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 5.3 mp -115.69 137.21 52.31 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 107.455 -1.313 . . . . 75.1 107.455 163.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 31.3 p90 -141.44 169.01 18.41 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 124.122 0.969 . . . . 74.04 110.034 -172.101 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 29.7 t90 -155.11 153.21 30.49 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 123.663 0.785 . . . . 72.54 109.464 179.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 56.2 t80 -44.08 -51.26 8.08 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 129.366 3.067 . . . . 75.44 113.84 -172.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -72.05 -90.49 0.11 Allowed Glycine 0 C--N 1.339 0.705 0 N-CA-C 110.944 -0.862 . . . . 71.24 110.944 -171.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 34.4 t 43.51 68.92 2.63 Favored Pre-proline 0 CA--C 1.546 0.797 0 C-N-CA 125.283 1.433 . . . . 74.54 113.824 163.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -63.53 -14.87 45.1 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 122.743 2.295 . . . . 74.41 114.126 -176.415 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 20.3 m170 -84.24 -22.85 30.68 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 119.856 1.207 . . . . 75.24 112.537 172.07 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 60.4 m -62.65 -48.73 78.06 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 120.284 1.402 . . . . 72.13 110.619 -174.105 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 45.4 t80 -61.75 -27.55 68.81 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 120.554 -1.341 . . . . 73.4 112.23 -175.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.26 -6.58 40.81 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.558 0.743 . . . . 73.15 112.73 177.285 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 26.8 t80 -123.64 -13.93 7.39 Favored 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 126.387 1.875 . . . . 73.13 111.594 -175.52 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 67.0 tt0 -50.73 -64.64 1.22 Allowed Pre-proline 0 CA--C 1.536 0.433 0 CA-C-N 119.813 1.188 . . . . 74.13 111.512 -178.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -74.96 -4.77 15.91 Favored 'Trans proline' 0 N--CA 1.453 -0.881 0 CA-C-N 120.831 1.333 . . . . 72.34 114.294 -175.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.5 m -70.15 -47.25 62.49 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 107.892 -1.151 . . . . 73.53 107.892 163.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 19.3 tt -96.8 -28.5 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 N-CA-C 113.704 1.001 . . . . 74.33 113.704 -165.627 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 74.0 t -54.19 -55.97 31.08 Favored Pre-proline 0 CA--C 1.545 0.772 0 CA-C-N 119.64 1.109 . . . . 75.3 111.314 173.457 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -68.14 -24.93 37.88 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 CA-C-N 120.85 1.339 . . . . 71.23 111.794 -179.006 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 77.8 t90 -62.38 -55.18 30.39 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 119.274 0.943 . . . . 75.04 109.008 170.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.5 p -61.01 -41.95 97.52 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 123.704 0.802 . . . . 64.2 112.555 -173.248 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -62.63 -39.86 95.14 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 119.282 0.946 . . . . 75.03 110.886 175.619 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 8.0 mptt -90.88 20.06 5.1 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 113.543 0.942 . . . . 75.24 113.543 -170.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 32.1 mt -65.71 164.85 23.23 Favored Pre-proline 0 CA--C 1.543 0.674 0 C-N-CA 126.421 1.888 . . . . 70.31 111.75 175.081 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -83.7 174.45 8.65 Favored 'Trans proline' 0 N--CA 1.454 -0.838 1 C-N-CA 125.64 4.226 . . . . 74.51 110.933 174.203 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -71.24 -10.26 59.47 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 113.829 1.048 . . . . 72.41 113.829 -176.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -103.61 5.79 36.76 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 119.364 0.984 . . . . 72.11 112.074 -170.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 87.6 t -117.42 152.61 19.29 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 C-N-CA 124.9 1.28 . . . . 74.32 107.793 -178.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 22.6 t-160 -136.78 92.91 2.79 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 126.486 1.914 . . . . 71.23 106.651 178.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -79.78 132.67 36.21 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 124.488 1.115 . . . . 74.34 109.692 173.466 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 23.4 t -136.51 158.62 37.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 C-N-CA 125.453 1.501 . . . . 74.34 107.76 -179.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 55.7 mtp180 -131.41 128.42 39.51 Favored 'General case' 0 CA--C 1.506 -0.718 0 N-CA-C 106.897 -1.52 . . . . 73.41 106.897 179.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 70.1 mt -127.44 153.2 77.29 Favored Pre-proline 0 N--CA 1.464 0.267 0 O-C-N 123.379 0.425 . . . . 73.51 111.082 173.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -75.42 134.14 16.79 Favored 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 122.371 2.047 . . . . 71.32 111.209 179.019 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -75.0 95.78 3.07 Favored 'General case' 0 CA--C 1.54 0.562 0 O-C-N 121.038 -1.039 . . . . 73.21 111.598 176.241 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 20.0 mt -88.6 95.38 10.22 Favored 'General case' 0 CA--C 1.541 0.62 0 O-C-N 120.42 -1.425 . . . . 73.53 111.188 -177.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -133.83 5.33 3.63 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 116.027 1.862 . . . . 74.02 116.027 -173.342 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -154.33 -143.62 3.72 Favored Glycine 0 C--N 1.336 0.573 0 CA-C-N 119.039 0.836 . . . . 65.43 114.269 -166.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -89.96 -85.58 1.34 Allowed Glycine 0 CA--C 1.524 0.607 0 N-CA-C 106.887 -2.485 . . . . 73.04 106.887 155.242 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.2 tt -58.61 -25.23 27.73 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 N-CA-C 113.133 0.79 . . . . 73.13 113.133 -168.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 10.8 m95 -54.55 -40.7 68.96 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 123.891 0.876 . . . . 74.23 112.214 175.137 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 17.2 p30 -91.73 -27.32 18.12 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 112.892 0.701 . . . . 75.41 112.892 179.034 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 39.4 t -64.71 -41.59 92.64 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-N 118.536 0.607 . . . . 73.15 109.578 174.095 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 66.6 m170 -79.14 7.08 8.12 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.821 1.248 . . . . 73.2 112.327 170.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -103.08 -37.55 3.1 Favored Glycine 0 CA--C 1.525 0.69 0 O-C-N 120.989 -1.069 . . . . 75.14 111.594 -179.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -65.12 -25.6 67.83 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 114.456 1.28 . . . . 74.5 114.456 -165.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 6.6 ttt -62.95 -43.02 99.94 Favored 'General case' 0 N--CA 1.463 0.191 0 O-C-N 120.926 -1.109 . . . . 74.04 112.055 -175.262 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -51.29 -52.85 41.38 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 125.011 1.324 . . . . 75.3 108.367 -176.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 13.7 mt -63.37 -39.56 94.87 Favored 'General case' 0 C--O 1.226 -0.182 0 C-N-CA 124.451 1.1 . . . . 71.44 110.122 -178.296 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.4 m -66.71 -38.38 86.6 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 118.873 0.761 . . . . 73.2 109.775 -178.048 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.48 -60.13 4.11 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 124.063 0.945 . . . . 75.05 108.535 177.478 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -60.84 -25.03 66.34 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 124.166 0.986 . . . . 75.11 112.686 -177.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -62.98 -5.62 3.11 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.885 1.674 . . . . 75.52 114.566 176.406 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 29.5 mtm -100.2 -1.47 36.43 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 115.047 1.499 . . . . 63.51 115.047 165.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 80.41 17.76 72.91 Favored Glycine 0 CA--C 1.529 0.968 0 O-C-N 121.606 -0.684 . . . . 72.3 112.386 175.474 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 27.5 m -70.92 60.32 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.95 0 C-N-CA 126.907 2.083 . . . . 73.35 113.008 -178.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 57.9 -173.41 0.09 Allowed 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 124.947 1.299 . . . . 62.12 109.772 -156.003 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 31.7 m80 -142.62 30.44 1.51 Allowed 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 125.365 1.466 . . . . 73.41 108.81 165.49 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -126.24 -56.82 1.42 Allowed 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.699 1.2 . . . . 74.34 111.8 -167.188 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.1 p -58.62 126.96 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 C-N-CA 127.029 2.131 . . . . 74.51 112.054 -175.105 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 4.4 p80 -146.22 65.55 1.2 Allowed 'General case' 0 C--O 1.233 0.229 0 CA-C-O 121.943 0.877 . . . . 74.33 112.643 173.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -91.92 -73.54 0.54 Allowed 'General case' 0 C--O 1.224 -0.271 0 N-CA-C 108.639 -0.875 . . . . 72.24 108.639 161.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -65.62 -22.06 66.63 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 114.384 1.253 . . . . 72.03 114.384 -159.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 56.2 t -62.93 -61.45 1.65 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.189 0 N-CA-C 108.079 -1.082 . . . . 74.34 108.079 172.02 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -62.84 -42.2 99.64 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 125.29 1.436 . . . . 74.12 110.636 -178.361 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -71.66 3.66 3.85 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 124.828 1.251 . . . . 65.54 112.351 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -115.52 5.08 14.35 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 115.658 1.725 . . . . 52.3 115.658 164.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 13.6 mt -117.21 -51.13 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 CA-C-N 120.476 1.489 . . . . 73.32 108.732 177.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 88.2 m-70 -63.97 -83.04 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 126.025 1.73 . . . . 72.22 113.231 -179.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.64 -16.71 64.3 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 126.711 2.004 . . . . 75.22 114.606 -177.452 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -97.17 -32.91 11.7 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 124.572 1.149 . . . . 74.43 111.64 178.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 1.8 t-160 50.38 36.37 12.97 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 125.572 1.549 . . . . 75.51 112.924 173.424 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.35 164.76 25.12 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 124.039 0.936 . . . . 73.41 108.784 168.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 10.2 mtpt -61.82 -72.11 0.13 Allowed 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 124.94 1.296 . . . . 73.12 109.433 172.602 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 77.2 mt 50.91 54.52 11.09 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 124.707 1.203 . . . . 73.22 111.455 -172.316 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -109.81 1.36 19.27 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.666 1.586 . . . . 74.34 113.326 -170.231 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -147.22 156.49 46.49 Favored Pre-proline 0 C--O 1.234 0.287 0 C-N-CA 126.948 2.099 . . . . 73.32 109.63 -167.448 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -70.99 -38.19 5.4 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 122.759 2.306 . . . . 75.24 110.927 -170.119 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -62.2 -48.93 77.81 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 109.022 -0.732 . . . . 75.01 109.022 172.037 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -58.45 -39.74 80.7 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 124.853 1.261 . . . . 74.24 111.737 -171.227 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 59.3 mtm -78.0 -50.23 12.53 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 124.523 1.129 . . . . 72.12 111.336 174.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -64.42 -39.53 94.02 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 119.05 0.841 . . . . 74.33 110.93 -173.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -71.03 -22.5 62.14 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 123.764 0.826 . . . . 73.33 111.509 -179.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 91.4 t80 -73.29 -51.46 17.51 Favored 'General case' 0 N--CA 1.45 -0.473 0 O-C-N 121.495 -0.753 . . . . 64.13 109.631 170.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 68.2 mt -69.83 -17.7 63.4 Favored 'General case' 0 N--CA 1.452 -0.351 0 O-C-N 121.728 -0.608 . . . . 72.43 111.337 -175.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -55.9 -18.09 8.1 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.91 0.884 . . . . 72.13 111.563 167.468 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -98.51 3.75 59.59 Favored Glycine 0 CA--C 1.527 0.803 0 CA-C-O 117.416 -1.769 . . . . 54.31 114.835 171.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.498 ' HA ' ' HE2' ' A' ' 118' ' ' LYS . 7.7 mmpt? -125.85 13.66 7.96 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 120.654 2.227 . . . . 72.32 113.123 -169.375 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 87.23 26.62 30.34 Favored Glycine 0 CA--C 1.522 0.517 0 CA-C-N 118.836 0.744 . . . . 61.52 112.526 -179.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 76.2 t -112.07 136.76 47.25 Favored 'Isoleucine or valine' 0 C--O 1.24 0.605 0 C-N-CA 125.648 1.579 . . . . 75.02 107.186 175.276 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 32.0 t0 -85.53 116.28 23.74 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 108.551 -0.907 . . . . 61.22 108.551 171.422 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 3.1 tttm -52.77 -48.08 67.06 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 125.638 1.575 . . . . 71.51 109.437 177.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -65.6 -22.72 66.7 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 113.078 0.77 . . . . 73.31 113.078 -175.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 49.4 mmtt -82.9 -50.74 8.29 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 107.673 -1.232 . . . . 74.01 107.673 175.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -49.08 -62.0 1.77 Allowed 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 125.648 1.579 . . . . 74.51 109.729 -179.14 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 20.5 mt -62.93 -39.27 94.09 Favored 'General case' 0 C--O 1.233 0.213 0 C-N-CA 122.744 0.417 . . . . 73.23 110.889 -174.419 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 39.5 t -57.17 -50.95 71.23 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 123.145 0.578 . . . . 73.12 109.919 -177.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 2.6 t -81.35 -33.14 32.61 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 119.184 -0.436 . . . . 73.43 110.761 -175.453 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 82.3 t80 -50.35 -52.39 37.51 Favored 'General case' 0 C--N 1.344 0.34 0 C-N-CA 124.719 1.207 . . . . 72.22 109.467 172.199 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -90.39 55.56 3.08 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 124.265 1.026 . . . . 75.4 109.495 174.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 22.7 t -140.64 162.2 35.94 Favored 'General case' 0 C--O 1.234 0.258 0 O-C-N 121.083 -1.011 . . . . 71.13 110.795 172.613 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -58.08 -26.97 63.22 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.733 1.213 . . . . 71.44 110.673 168.506 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -53.31 -59.27 4.79 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 124.492 1.117 . . . . 74.42 111.218 179.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 41.7 mm -69.06 -26.3 31.89 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 C-N-CA 123.266 0.626 . . . . 74.44 110.355 178.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 17.7 tttt -58.37 -36.32 73.31 Favored 'General case' 0 CA--C 1.522 -0.1 0 O-C-N 121.35 -0.844 . . . . 73.1 111.008 175.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -63.3 -46.1 93.64 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 110.665 -0.974 . . . . 72.34 110.665 178.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -66.04 -44.84 83.47 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 123.196 0.599 . . . . 72.41 110.008 -179.16 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 94.9 mmm -57.32 -47.84 80.5 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 118.595 -0.717 . . . . 75.33 109.948 176.231 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -65.87 -40.92 92.07 Favored 'General case' 0 N--CA 1.457 -0.098 0 CA-C-N 119.573 1.079 . . . . 74.03 112.126 -175.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 11.2 mtpt -60.13 -58.13 9.87 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-O 118.242 -0.885 . . . . 75.43 109.579 176.27 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -53.64 -39.8 65.29 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 119.137 0.88 . . . . 75.43 110.762 178.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 25.7 ttmt -60.97 -63.07 1.42 Allowed 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.128 0.971 . . . . 71.35 110.481 178.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 16.6 ptmt -64.89 -24.01 67.4 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 123.463 0.705 . . . . 70.32 111.0 -176.041 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 41.7 mt -75.77 -53.76 8.0 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 118.637 -0.697 . . . . 74.04 111.055 175.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -52.57 -54.28 35.02 Favored 'General case' 0 C--O 1.228 -0.04 0 C-N-CA 123.865 0.866 . . . . 65.34 110.52 -173.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 3.9 ppp? -55.37 -47.06 76.38 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 113.23 0.826 . . . . 72.33 113.23 177.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -69.11 -29.85 68.01 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-O 118.093 -0.956 . . . . 64.51 110.291 -176.157 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 23.5 m-85 -71.81 16.29 0.12 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.241 1.416 . . . . 75.42 113.431 173.355 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 16.8 mm-40 63.31 17.54 10.33 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.062 1.345 . . . . 74.11 112.724 174.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 59.1 t -65.84 90.88 0.11 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.376 0 C-N-CA 125.712 1.605 . . . . 73.1 109.379 -174.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -95.97 88.59 4.94 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-O 123.137 1.446 . . . . 75.21 108.237 161.843 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 104.65 -162.5 14.85 Favored Glycine 0 N--CA 1.445 -0.712 0 CA-C-N 112.645 -2.07 . . . . 73.3 111.818 164.404 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 16.6 m -144.38 155.48 57.5 Favored Pre-proline 0 CA--C 1.539 0.524 0 C-N-CA 126.314 1.846 . . . . 75.32 107.37 178.092 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_endo -64.76 160.15 70.4 Favored 'Cis proline' 0 CA--C 1.54 0.823 0 C-N-CA 124.195 -1.169 . . . . 75.44 110.465 -12.093 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 5.4 m -153.42 108.12 3.14 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 123.686 0.795 . . . . 73.21 109.575 -179.616 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 50.7 mmm -93.87 153.44 18.25 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 124.288 1.035 . . . . 74.23 109.946 169.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 94.2 t -145.21 155.04 13.73 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 C-N-CA 125.102 1.361 . . . . 74.5 107.393 175.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 50.6 t -126.25 123.95 64.7 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 C-N-CA 127.783 2.433 . . . . 73.44 107.164 177.288 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 15.9 m-20 52.23 18.44 0.88 Allowed 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 129.294 3.038 . . . . 70.51 114.685 174.286 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 62.89 31.34 80.16 Favored Glycine 0 CA--C 1.532 1.152 0 CA-C-O 118.025 -1.431 . . . . 73.24 113.92 -169.288 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 9.2 mtpt -133.87 -28.15 1.41 Allowed 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 119.863 1.831 . . . . 75.15 113.334 -175.506 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -125.83 129.05 48.63 Favored 'General case' 0 CA--C 1.512 -0.5 0 N-CA-C 107.7 -1.222 . . . . 73.44 107.7 177.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 2.4 ttp85 -114.73 134.96 54.68 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 127.124 2.169 . . . . 75.21 105.787 179.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 28.2 p90 -151.22 167.26 28.34 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.988 -0.745 . . . . 72.01 108.988 -179.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -176.03 178.25 1.48 Allowed 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.269 1.028 . . . . 74.11 109.896 -178.175 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 38.1 mt -52.18 -42.23 35.51 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 C-N-CA 126.482 1.913 . . . . 73.23 110.459 178.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -80.25 -21.58 64.68 Favored Glycine 0 CA--C 1.526 0.722 0 CA-C-O 118.646 -1.086 . . . . 73.41 112.56 -179.407 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 1.1 m -72.83 -63.91 1.07 Allowed 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 119.716 1.758 . . . . 70.43 107.484 170.359 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -64.33 -38.59 91.56 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 123.907 0.883 . . . . 74.5 111.065 -168.568 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 121.06 -3.87 11.46 Favored Glycine 0 CA--C 1.525 0.674 0 CA-C-O 118.268 -1.295 . . . . 61.23 112.872 175.061 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 175.74 172.65 40.75 Favored Glycine 0 CA--C 1.528 0.852 0 CA-C-N 119.364 1.582 . . . . 71.03 110.231 -175.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -65.74 -44.68 7.69 Favored 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 122.524 2.149 . . . . 72.42 109.82 -177.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -63.64 -38.28 90.52 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-O 122.228 1.013 . . . . 74.41 110.467 -176.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -68.0 -29.18 68.13 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 126.291 1.836 . . . . 75.44 109.433 -176.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 35.9 m -64.85 -45.09 87.57 Favored 'General case' 0 CA--C 1.533 0.325 0 O-C-N 121.082 -1.011 . . . . 75.31 110.069 -176.229 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 46.0 mt -63.97 -32.05 73.45 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 118.799 0.727 . . . . 73.54 110.784 177.542 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 1.9 ttmt -55.41 -38.89 69.53 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 124.31 1.044 . . . . 64.33 110.148 175.258 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -76.47 -41.58 46.71 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-O 118.136 -0.935 . . . . 74.32 110.552 174.174 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -52.67 -50.36 63.4 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 119.325 0.966 . . . . 70.31 112.025 -175.442 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -72.12 -42.19 66.33 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 123.323 0.649 . . . . 55.34 109.347 -173.144 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 10.9 t80 -63.0 -46.38 87.94 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 124.468 1.107 . . . . 74.42 111.158 178.255 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 81.3 mt -67.69 -34.17 76.38 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 123.649 0.78 . . . . 73.22 111.024 -178.381 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 29.5 mt -53.75 -55.82 11.86 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 N-CA-C 107.995 -1.113 . . . . 71.53 107.995 166.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -56.63 -31.91 64.8 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.979 0.912 . . . . 74.14 112.863 -177.689 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 9.3 tptm -68.83 -48.21 64.1 Favored 'General case' 0 N--CA 1.463 0.209 0 O-C-N 121.401 -0.812 . . . . 63.41 110.535 -179.305 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 35.6 mm-40 -74.75 -42.47 58.18 Favored 'General case' 0 C--O 1.222 -0.367 0 O-C-N 121.955 -0.466 . . . . 63.21 111.228 178.508 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.05 -34.28 74.64 Favored 'General case' 0 N--CA 1.465 0.288 0 O-C-N 121.073 -1.017 . . . . 74.43 110.739 -176.874 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -64.65 -11.83 39.53 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.56 0.744 . . . . 65.05 112.378 175.355 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -64.09 -25.78 68.25 Favored 'General case' 0 C--O 1.223 -0.316 0 CA-C-N 119.446 1.021 . . . . 43.03 111.65 168.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . 58.55 6.58 0.6 Allowed 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 127.107 2.163 . . . . 62.33 113.877 -177.414 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 50.79 53.89 12.19 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.733 1.613 . . . . 74.44 111.461 -158.586 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 11.9 pttp . . . . . 0 C--O 1.247 0.966 0 CA-C-O 117.328 -1.32 . . . . 73.44 109.282 173.554 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.459 0.23 0 N-CA-C 109.235 -1.546 . . . . 72.35 109.235 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 45.21 73.67 0.15 Allowed 'General case' 0 CA--C 1.515 -0.391 0 C-N-CA 127.148 2.179 . . . . 65.31 110.316 -175.442 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -73.26 11.95 0.66 Allowed 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 127.096 2.158 . . . . 72.12 113.025 -179.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 14.4 m-85 -146.43 157.74 43.8 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 126.01 1.724 . . . . 75.02 108.056 -175.19 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.9 m -131.23 132.8 44.89 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 107.671 -1.233 . . . . 73.51 107.671 -174.328 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -69.61 148.45 49.34 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 108.158 -1.052 . . . . 73.44 108.158 175.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 63.69 13.61 52.04 Favored Glycine 0 CA--C 1.535 1.308 0 C-N-CA 124.68 1.134 . . . . 65.34 113.445 -167.02 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.94 -63.06 0.98 Allowed 'General case' 0 CA--C 1.52 -0.208 0 CA-C-N 119.775 1.788 . . . . 74.44 107.804 -177.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.4 mp0 -98.44 -25.91 14.63 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.342 1.457 . . . . 73.53 110.505 178.109 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 50.6 p90 -154.56 167.12 31.16 Favored 'General case' 0 N--CA 1.467 0.41 0 O-C-N 121.238 -0.914 . . . . 74.42 111.697 -171.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 59.2 t -132.9 115.91 25.37 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 C-N-CA 124.859 1.263 . . . . 74.14 109.058 -171.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -80.43 167.3 20.35 Favored 'General case' 0 C--O 1.236 0.392 0 O-C-N 119.972 -1.705 . . . . 72.32 110.478 174.301 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -126.16 124.64 40.96 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 124.237 1.015 . . . . 72.2 108.88 172.694 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 8.2 m -67.34 -9.45 41.32 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.838 0.855 . . . . 74.4 113.163 179.296 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 30.2 m -129.32 74.47 80.96 Favored Pre-proline 0 CA--C 1.537 0.454 0 C-N-CA 124.224 1.01 . . . . 63.54 108.625 -177.009 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -69.56 -179.01 2.53 Favored 'Trans proline' 0 N--CA 1.46 -0.459 0 C-N-CA 125.056 3.837 . . . . 73.3 112.281 -172.12 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.2 t -128.68 138.93 34.18 Favored Pre-proline 0 CA--C 1.532 0.27 0 C-N-CA 124.672 1.189 . . . . 75.24 107.93 -174.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_endo -73.13 179.1 5.74 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 122.42 2.08 . . . . 74.03 112.613 176.286 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.4 m -127.46 168.25 20.9 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 C-N-CA 126.826 2.051 . . . . 75.23 108.945 174.028 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 70.9 m -47.01 -61.84 1.69 Allowed 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 126.795 2.038 . . . . 62.4 110.508 176.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -145.82 165.38 21.17 Favored Pre-proline 0 C--O 1.238 0.492 0 C-N-CA 127.347 2.259 . . . . 73.03 105.375 163.079 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -70.88 -164.66 0.15 Allowed 'Trans proline' 0 CA--C 1.541 0.862 0 C-N-CA 122.62 2.213 . . . . 73.22 110.222 173.325 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 118.1 -112.68 2.45 Favored Glycine 0 N--CA 1.447 -0.627 0 N-CA-C 106.301 -2.72 . . . . 72.45 106.301 -179.388 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 33.4 mttm -54.46 133.69 45.81 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 124.136 0.974 . . . . 65.45 108.721 172.177 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 31.8 mm -64.59 140.72 19.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 106.377 -1.712 . . . . 75.05 106.377 169.541 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -99.21 139.17 35.26 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 107.559 -1.274 . . . . 74.32 107.559 -177.65 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 56.1 t -128.54 130.43 69.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 105.895 -1.891 . . . . 75.15 105.895 176.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 11.3 t -131.2 108.05 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 N-CA-C 107.417 -1.327 . . . . 63.32 107.417 -172.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -69.0 143.34 54.38 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 124.27 1.028 . . . . 64.31 108.556 162.26 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 5.0 mp -121.75 131.08 53.88 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 108.881 -0.785 . . . . 73.2 108.881 158.416 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 23.9 p90 -127.33 176.77 7.18 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.477 1.111 . . . . 71.12 110.469 179.249 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . 0.435 ' HE1' ' HA ' ' A' ' 71' ' ' TRP . 27.1 t90 -151.0 175.8 11.73 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.082 1.353 . . . . 75.02 109.559 174.551 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.465 ' HH ' ' CE1' ' A' ' 102' ' ' HIS . 40.2 t80 -61.5 -73.18 0.1 Allowed 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.616 1.166 . . . . 74.24 112.876 172.741 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -81.86 52.03 4.53 Favored Glycine 0 C--N 1.339 0.705 0 C-N-CA 124.823 1.201 . . . . 44.4 110.358 -171.123 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 35.8 t -113.5 84.81 8.25 Favored Pre-proline 0 CA--C 1.538 0.487 0 C-N-CA 127.462 2.305 . . . . 72.44 106.051 -163.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -72.57 168.56 24.08 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 123.314 2.676 . . . . 74.12 109.217 171.228 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 5.2 m170 63.98 -45.7 0.27 Allowed 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 126.476 1.91 . . . . 73.42 112.116 -165.007 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 3.8 m -46.74 -53.14 12.43 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 126.745 2.018 . . . . 75.15 110.604 176.425 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 11.7 t80 -58.92 -49.92 75.99 Favored 'General case' 0 C--N 1.341 0.229 0 C-N-CA 125.361 1.464 . . . . 73.03 110.894 176.51 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.76 -13.52 61.51 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 112.742 0.645 . . . . 60.14 112.742 -171.356 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 7.0 t80 -90.71 -16.85 27.76 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 125.714 1.605 . . . . 71.51 112.073 179.262 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -46.68 -67.27 0.4 Allowed Pre-proline 0 N--CA 1.469 0.485 0 CA-C-N 120.059 1.299 . . . . 73.24 112.566 -172.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -69.02 -9.13 25.52 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 CA-C-N 122.033 1.762 . . . . 75.33 114.496 -177.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.9 m -70.91 -43.18 68.83 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 119.758 1.163 . . . . 74.42 108.798 167.167 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 21.1 tt -105.2 -28.51 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 N-CA-C 113.825 1.046 . . . . 72.44 113.825 -164.504 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 27.5 t -46.37 -60.4 3.72 Favored Pre-proline 0 CA--C 1.54 0.559 0 C-N-CA 124.794 1.238 . . . . 73.2 109.434 173.438 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -61.85 -35.31 79.16 Favored 'Trans proline' 0 N--CA 1.453 -0.883 0 CA-C-N 120.31 1.146 . . . . 75.35 112.974 -177.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 72.8 t90 -57.24 -51.62 68.61 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.367 0.667 . . . . 74.3 110.402 179.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 29.5 t -58.89 -39.18 80.69 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 121.132 0.491 . . . . 72.02 110.269 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -68.92 -25.55 64.64 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 121.173 -0.954 . . . . 72.51 111.407 -177.429 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 14.3 mmtp -96.72 10.08 39.79 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.576 1.15 . . . . 75.43 112.879 177.477 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 34.9 mt -60.88 151.23 74.44 Favored Pre-proline 0 C--O 1.237 0.395 0 CA-C-N 119.532 1.06 . . . . 75.23 110.964 174.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -76.07 169.69 21.58 Favored 'Trans proline' 0 N--CA 1.445 -1.378 0 C-N-CA 124.065 3.177 . . . . 71.55 110.485 177.533 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -65.13 -4.19 4.64 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 125.044 1.338 . . . . 74.52 113.391 173.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -100.68 8.4 43.36 Favored 'General case' 0 N--CA 1.463 0.182 0 C-N-CA 125.709 1.603 . . . . 75.21 110.597 -177.056 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 61.0 t -129.53 160.03 40.93 Favored 'Isoleucine or valine' 0 C--O 1.239 0.542 0 O-C-N 121.214 -0.929 . . . . 51.45 108.798 -179.651 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 29.2 t60 -132.93 155.39 49.17 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 126.268 1.827 . . . . 61.41 107.249 165.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 55.7 t80 -132.5 134.01 44.49 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 108.102 -1.073 . . . . 71.22 108.102 -175.104 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 47.6 t -135.31 155.38 37.2 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 C-N-CA 126.551 1.941 . . . . 71.13 107.264 -172.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 16.4 mtt85 -133.2 130.32 38.94 Favored 'General case' 0 CA--C 1.513 -0.46 0 N-CA-C 105.197 -2.149 . . . . 74.04 105.197 176.284 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 37.6 mt -135.58 144.74 50.45 Favored Pre-proline 0 N--CA 1.469 0.514 0 CA-C-N 120.113 1.324 . . . . 74.34 110.082 175.502 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -74.89 157.45 43.21 Favored 'Trans proline' 0 N--CA 1.462 -0.353 0 C-N-CA 122.379 2.053 . . . . 74.11 110.728 -179.414 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -101.04 94.55 6.05 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 123.984 0.914 . . . . 64.24 110.12 -175.463 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 22.5 mt -86.43 76.75 9.58 Favored 'General case' 0 CA--C 1.539 0.54 0 O-C-N 120.612 -1.305 . . . . 73.1 111.869 -172.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -82.49 20.2 1.14 Allowed 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 115.129 1.529 . . . . 75.44 115.129 -176.156 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 89.01 -48.09 3.43 Favored Glycine 0 CA--C 1.525 0.704 0 O-C-N 119.924 -1.735 . . . . 62.43 112.834 168.214 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -72.55 -152.11 1.58 Allowed Glycine 0 CA--C 1.529 0.958 0 C-N-CA 124.337 0.97 . . . . 71.31 110.737 174.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 7.1 tp -46.75 -30.88 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 C-N-CA 124.1 0.96 . . . . 75.33 112.055 177.371 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . 0.435 ' HA ' ' HE1' ' A' ' 34' ' ' TRP . 19.4 m95 -50.31 -27.47 6.23 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 126.069 1.748 . . . . 73.03 113.391 177.757 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 20.2 m-20 -73.91 -36.42 64.72 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-N 119.576 1.08 . . . . 75.04 110.496 177.153 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.417 ' C ' ' H ' ' A' ' 75' ' ' GLY . 40.7 t -73.82 -55.19 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 N-CA-C 107.966 -1.124 . . . . 75.2 107.966 174.839 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 34.9 m170 -65.95 31.92 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 129.534 3.134 . . . . 74.34 112.175 170.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.417 ' H ' ' C ' ' A' ' 73' ' ' VAL . . . -149.21 -42.55 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 125.353 1.454 . . . . 61.13 111.191 173.122 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -54.6 -41.84 70.42 Favored 'General case' 0 C--O 1.223 -0.328 0 CA-C-O 117.753 -1.118 . . . . 74.11 112.439 -175.06 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -44.47 -44.34 8.47 Favored 'General case' 0 CA--C 1.514 -0.407 0 N-CA-C 114.123 1.157 . . . . 71.22 114.123 -173.303 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 28.8 t80 -61.88 -45.76 92.34 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 118.525 0.602 . . . . 73.5 110.236 -176.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 50.0 mt -61.35 -45.24 95.22 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-O 116.726 -1.606 . . . . 64.33 109.251 175.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -62.41 -45.68 92.03 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 120.652 1.569 . . . . 72.21 110.776 -176.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.82 -60.6 2.99 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 125.998 1.719 . . . . 72.1 109.469 178.495 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -69.75 -28.92 66.18 Favored 'General case' 0 C--O 1.231 0.095 0 CA-C-O 118.927 -0.558 . . . . 64.23 111.76 -175.21 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 6.2 t -51.67 -37.16 49.33 Favored 'General case' 0 CA--C 1.52 -0.184 0 C-N-CA 124.343 1.057 . . . . 71.52 110.712 178.091 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 30.8 mtp -75.84 -22.47 56.23 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-O 118.762 -0.637 . . . . 75.13 111.696 -170.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 88.39 14.46 61.86 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 123.9 0.762 . . . . 54.4 112.982 -179.092 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 28.4 m -62.29 130.2 26.41 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 C-N-CA 125.046 1.339 . . . . 75.23 109.312 179.158 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -123.47 75.88 1.36 Allowed 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 123.577 0.751 . . . . 63.21 109.021 -165.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -79.16 -5.46 54.25 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 117.099 2.259 . . . . 75.23 117.099 -170.437 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 44.38 51.96 7.51 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 126.331 1.852 . . . . 73.24 112.109 -176.207 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.5 p -144.95 -47.25 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 CA-C-O 117.474 -1.251 . . . . 64.54 113.381 176.297 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 44.92 34.78 1.31 Allowed 'General case' 0 N--CA 1.478 0.945 0 CA-C-N 120.607 1.548 . . . . 72.14 113.138 -176.738 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -136.37 -44.54 0.62 Allowed 'General case' 0 C--O 1.221 -0.421 0 O-C-N 120.815 -1.178 . . . . 73.4 108.887 172.557 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -61.11 -16.51 44.97 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 114.533 1.308 . . . . 75.34 114.533 -176.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 55.8 t -71.49 -65.63 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 CA-C-O 117.575 -1.203 . . . . 73.4 108.614 166.241 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -54.61 -46.78 73.89 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 120.387 1.449 . . . . 73.23 111.98 -179.58 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -58.45 -40.49 82.77 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.427 1.491 . . . . 75.43 110.196 -178.705 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.411 ' HB1' ' CE1' ' A' ' 114' ' ' PHE . . . -74.2 4.53 5.53 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 125.798 1.639 . . . . 64.11 112.84 -178.641 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 61.7 mt -115.25 -57.12 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.891 0 N-CA-C 104.975 -2.232 . . . . 74.13 104.975 177.129 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 88.0 m-70 -80.67 -61.24 2.03 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 123.664 0.786 . . . . 75.41 112.616 -173.178 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -68.34 -21.16 64.75 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 119.063 0.847 . . . . 73.24 112.209 -177.756 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -94.45 -53.56 3.86 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 124.548 1.139 . . . . 73.44 108.771 -175.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . 0.465 ' CE1' ' HH ' ' A' ' 35' ' ' TYR . 6.9 t60 58.49 88.0 0.07 Allowed 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.513 1.525 . . . . 70.34 110.65 -169.792 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 3.3 mmpt? -116.33 13.79 15.62 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.389 1.076 . . . . 72.11 113.302 -176.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 30.4 tttm 69.87 -64.23 0.36 Allowed 'General case' 0 C--O 1.221 -0.418 0 C-N-CA 128.2 2.6 . . . . 73.32 109.558 -174.333 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 40.6 mt 54.47 44.66 28.48 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.813 1.645 . . . . 73.43 112.508 177.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -94.63 14.54 20.72 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.283 1.433 . . . . 72.33 114.189 -173.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -156.13 155.35 29.01 Favored Pre-proline 0 CA--C 1.535 0.395 0 C-N-CA 127.97 2.508 . . . . 75.22 107.662 -178.078 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -64.21 -44.99 10.71 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.546 2.164 . . . . 71.41 109.959 -173.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -69.01 -29.38 67.55 Favored 'General case' 0 N--CA 1.438 -1.039 0 C-N-CA 124.189 0.995 . . . . 72.43 111.15 -174.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -54.47 -42.15 70.34 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.95 1.3 . . . . 72.4 110.356 173.039 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 2.5 mtt -76.85 -48.53 18.14 Favored 'General case' 0 CA--C 1.512 -0.514 0 C-N-CA 124.193 0.997 . . . . 75.45 108.92 -178.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -62.29 -37.16 84.46 Favored 'General case' 0 N--CA 1.447 -0.619 0 O-C-N 123.408 0.443 . . . . 73.44 111.337 -172.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -56.07 -46.85 78.83 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 125.287 1.435 . . . . 53.44 112.61 172.075 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . 0.411 ' CE1' ' HB1' ' A' ' 97' ' ' ALA . 19.0 t80 -74.27 -41.68 60.85 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 123.548 0.739 . . . . 74.32 111.45 -177.401 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 18.2 mt -76.94 -14.71 59.83 Favored 'General case' 0 C--N 1.332 -0.172 0 O-C-N 121.33 -0.856 . . . . 73.24 110.4 -176.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -48.48 -41.71 30.58 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.805 0.842 . . . . 74.51 110.127 172.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -82.09 10.09 54.67 Favored Glycine 0 CA--C 1.529 0.965 0 CA-C-O 117.975 -1.458 . . . . 75.43 114.805 177.265 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 23.8 mmtt -127.34 8.77 6.58 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 121.338 2.569 . . . . 72.43 112.615 -174.412 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 86.87 49.31 4.11 Favored Glycine 0 C--N 1.333 0.392 0 N-CA-C 109.669 -1.372 . . . . 65.22 109.669 -177.416 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 39.0 t -134.58 132.89 54.72 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 N-CA-C 105.18 -2.156 . . . . 73.14 105.18 169.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -92.27 133.65 35.63 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 123.68 0.792 . . . . 75.24 110.002 173.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 17.6 mtpt -64.58 -37.0 86.05 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 118.747 -0.644 . . . . 75.11 110.386 174.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -67.02 -26.82 66.97 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 118.707 0.685 . . . . 71.24 111.72 178.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 13.0 mttm -77.61 -57.06 4.02 Favored 'General case' 0 CA--C 1.518 -0.27 0 N-CA-C 106.402 -1.703 . . . . 75.42 106.402 171.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 41.3 t80 -51.86 -59.49 4.26 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 124.808 1.243 . . . . 73.03 112.174 -166.46 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 19.7 mt -73.54 -33.74 64.86 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 110.275 -0.268 . . . . 52.35 110.275 -170.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 29.7 m -62.26 -49.44 75.7 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 109.315 -0.624 . . . . 74.33 109.315 179.122 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 23.9 m -65.71 -41.33 92.44 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 124.553 1.141 . . . . 75.01 110.22 178.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 42.2 t80 -49.19 -48.69 45.05 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 119.691 1.132 . . . . 73.31 110.82 173.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 14.5 m-20 -92.64 38.89 1.02 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.647 0.779 . . . . 72.23 111.16 -178.121 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 7.7 t -122.86 172.26 8.6 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.403 1.481 . . . . 73.24 111.653 -177.334 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -67.09 -40.39 86.92 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.824 1.25 . . . . 75.44 110.52 178.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -50.58 -49.85 55.25 Favored 'General case' 0 C--N 1.34 0.166 0 C-N-CA 123.725 0.81 . . . . 63.13 110.463 -177.503 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 21.5 mm -69.51 -38.85 77.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 C-N-CA 124.218 1.007 . . . . 64.15 111.269 -178.305 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 1.7 mtmt -55.53 -33.26 63.65 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 124.066 0.947 . . . . 73.54 110.964 177.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -73.23 -48.42 19.44 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 110.831 -0.907 . . . . 65.25 110.831 178.357 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -63.34 -36.2 82.92 Favored 'General case' 0 CA--C 1.532 0.255 0 O-C-N 121.715 -0.874 . . . . 74.54 109.587 -177.502 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.32 -34.9 78.71 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-O 117.755 -1.116 . . . . 73.52 111.483 178.605 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -80.48 -39.84 27.3 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 120.588 1.54 . . . . 74.1 111.634 175.021 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.92 -59.02 5.67 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 118.864 -0.589 . . . . 74.32 110.763 179.116 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -58.85 -44.45 91.01 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 118.882 0.765 . . . . 75.41 109.056 -176.315 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 1.9 tmtt? -50.38 -57.73 7.3 Favored 'General case' 0 CA--C 1.528 0.11 0 C-N-CA 123.996 0.918 . . . . 73.12 111.139 -179.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.94 -35.06 69.51 Favored 'General case' 0 C--O 1.231 0.099 0 CA-C-N 118.834 0.743 . . . . 74.23 111.384 -175.28 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 37.8 mt -59.0 -49.56 77.44 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 123.577 0.751 . . . . 74.12 110.646 -177.477 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -54.47 -48.0 72.32 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 119.154 0.888 . . . . 73.12 111.722 -179.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 1.5 mtm -66.63 -34.8 78.68 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 120.332 -0.547 . . . . 72.22 109.774 -177.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -59.91 -43.86 94.62 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 118.426 0.557 . . . . 70.44 109.66 176.348 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -70.01 4.98 1.77 Allowed 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 126.183 1.793 . . . . 74.51 113.492 177.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 54.37 36.78 26.2 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 126.936 2.094 . . . . 75.43 112.124 -175.1 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 89.8 t -69.36 135.05 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 107.674 -1.232 . . . . 71.32 107.674 172.161 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 5.7 p -129.23 -16.12 4.04 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 126.787 2.035 . . . . 74.34 110.343 -176.132 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -168.36 -170.88 33.62 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 125.944 1.735 . . . . 65.12 112.825 -175.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.412 ' HA ' ' C ' ' A' ' 154' ' ' PRO . 14.8 m -142.46 153.04 61.82 Favored Pre-proline 0 CA--C 1.546 0.819 0 C-N-CA 127.323 2.249 . . . . 75.32 108.316 175.613 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . 0.412 ' C ' ' HA ' ' A' ' 153' ' ' VAL . 56.2 Cg_endo -63.52 152.71 71.36 Favored 'Cis proline' 0 CA--C 1.537 0.673 0 C-N-CA 124.578 -1.009 . . . . 64.44 113.145 -6.884 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 59.2 m -145.91 144.26 30.07 Favored 'General case' 0 C--O 1.239 0.547 0 C-N-CA 125.31 1.444 . . . . 73.44 108.529 175.251 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 19.8 mmm -123.97 158.41 32.12 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 125.774 1.63 . . . . 75.41 108.209 163.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 21.5 t -142.1 136.47 29.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 106.939 -1.504 . . . . 73.24 106.939 174.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 28.9 t -104.01 135.2 42.8 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 N-CA-C 107.098 -1.445 . . . . 72.12 107.098 168.726 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 1.4 t30 47.12 10.8 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.688 1 C-N-CA 133.111 4.565 . . . . 73.43 117.541 171.153 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 83.69 20.11 60.48 Favored Glycine 0 CA--C 1.526 0.777 0 CA-C-O 117.806 -1.552 . . . . 52.04 115.559 -169.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 48.0 mttt -131.81 -41.39 1.04 Allowed 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 119.971 1.885 . . . . 74.51 114.358 -170.302 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 -112.74 107.51 16.19 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 108.293 -1.003 . . . . 75.33 108.293 -171.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 63.2 ttp85 -88.92 113.41 24.43 Favored 'General case' 0 C--O 1.231 0.109 0 C-N-CA 126.5 1.92 . . . . 73.13 106.797 175.023 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 5.3 p90 -136.51 169.59 17.45 Favored 'General case' 0 C--N 1.319 -0.75 0 O-C-N 120.343 -1.473 . . . . 63.13 107.186 177.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . 0.41 ' CG ' ' H ' ' A' ' 166' ' ' ILE . 3.9 t70 -174.97 -178.78 1.28 Allowed 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 122.548 0.339 . . . . 74.12 110.129 177.333 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . 0.41 ' H ' ' CG ' ' A' ' 165' ' ' ASP . 21.5 mt -46.33 -50.05 5.23 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 C-N-CA 128.555 2.742 . . . . 75.03 107.728 160.378 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -76.16 16.57 4.51 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 125.847 1.689 . . . . 70.41 114.392 178.012 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 17.8 m -128.3 -51.13 1.29 Allowed 'General case' 0 C--O 1.224 -0.239 0 CA-C-N 118.795 1.298 . . . . 75.33 109.705 168.565 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -70.32 -34.65 72.94 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 125.12 1.368 . . . . 73.54 112.266 -175.253 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 122.58 -5.96 9.87 Favored Glycine 0 C--N 1.341 0.83 0 CA-C-O 118.512 -1.16 . . . . 64.45 114.793 175.089 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 165.84 174.31 35.21 Favored Glycine 0 CA--C 1.532 1.097 0 CA-C-N 119.745 1.772 . . . . 74.51 110.003 -175.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -64.9 -52.61 1.18 Allowed 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 122.408 2.072 . . . . 71.31 111.772 -169.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -62.29 -28.68 69.9 Favored 'General case' 0 N--CA 1.463 0.223 0 O-C-N 120.965 -1.084 . . . . 73.42 111.547 178.491 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -67.4 -27.21 66.89 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.141 0.576 . . . . 74.32 110.366 177.527 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 19.7 m -77.66 -42.9 33.07 Favored 'General case' 0 CA--C 1.53 0.177 0 O-C-N 121.052 -1.03 . . . . 73.43 110.915 -169.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 35.8 mt -63.88 -31.77 73.07 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 118.918 0.781 . . . . 74.22 111.013 178.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 4.8 tttt -48.48 -56.48 8.17 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 126.602 1.961 . . . . 71.53 108.041 168.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -65.48 -41.37 93.38 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-O 116.941 -1.504 . . . . 74.53 111.554 176.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -53.82 -48.68 69.67 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 120.917 1.689 . . . . 70.41 111.699 -175.395 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -69.52 -47.09 64.92 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 122.943 0.497 . . . . 63.54 110.577 -176.072 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -60.47 -42.61 96.59 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 123.565 0.746 . . . . 73.41 111.285 178.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 90.6 mt -67.09 -37.4 83.9 Favored 'General case' 0 C--N 1.332 -0.171 0 O-C-N 120.949 -1.094 . . . . 74.21 111.221 178.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 31.6 mt -58.25 -51.94 65.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 CA-C-N 119.259 0.936 . . . . 70.11 108.582 172.059 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -52.06 -43.07 63.62 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 124.59 1.156 . . . . 73.23 109.976 175.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 71.3 tttt -79.66 -0.32 33.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 117.124 -1.417 . . . . 74.14 113.161 -175.486 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -103.11 -33.33 9.27 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 125.662 1.585 . . . . 73.12 114.43 178.435 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.39 -55.76 4.98 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 107.372 -1.344 . . . . 73.04 107.372 -179.222 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -65.27 -20.36 66.38 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.172 -0.922 . . . . 75.43 111.795 -176.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -46.69 -35.49 6.11 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 130.127 3.371 . . . . 73.0 113.706 175.459 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -101.07 13.3 35.63 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.721 1.208 . . . . 63.2 113.148 -178.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 49.3 tttm 56.41 76.93 0.27 Allowed 'General case' 0 C--N 1.343 0.294 0 C-N-CA 126.946 2.098 . . . . 74.3 109.805 -163.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 36.1 mtpt . . . . . 0 C--O 1.254 1.29 0 C-N-CA 126.069 1.748 . . . . 65.0 108.735 -179.24 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.947 0 N-CA-C 111.39 -0.684 . . . . 72.12 111.39 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 43.83 68.64 0.5 Allowed 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 127.445 2.298 . . . . 71.2 111.895 168.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -75.55 5.6 5.77 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 112.954 -1.93 . . . . 74.32 114.234 -171.48 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 30.1 m-85 -135.0 165.02 26.31 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 126.066 1.746 . . . . 73.2 108.04 -171.472 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 13.6 m -130.05 131.66 45.89 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 108.001 -1.111 . . . . 74.44 108.001 -178.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.89 154.02 42.03 Favored 'General case' 0 C--O 1.232 0.158 0 O-C-N 121.093 -1.005 . . . . 73.22 109.265 173.597 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 71.02 -36.17 0.51 Allowed Glycine 0 CA--C 1.53 1.001 0 C-N-CA 125.723 1.63 . . . . 64.01 112.859 -163.398 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 4.7 tptt -83.38 -83.37 0.14 Allowed 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 124.783 1.233 . . . . 72.14 108.993 -173.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 23.6 mp0 -73.41 -24.61 60.3 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 125.596 1.558 . . . . 73.23 110.47 -177.294 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 43.6 p90 -158.7 176.03 12.89 Favored 'General case' 0 N--CA 1.468 0.466 0 O-C-N 121.165 -0.959 . . . . 62.03 110.728 -173.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 62.0 t -134.55 107.63 9.33 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 124.921 1.288 . . . . 75.31 109.344 -177.283 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -73.23 147.14 44.94 Favored 'General case' 0 N--CA 1.444 -0.744 0 O-C-N 120.942 -1.099 . . . . 72.11 109.963 166.123 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -111.68 134.67 53.09 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 125.29 1.436 . . . . 74.31 109.92 -178.579 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 5.4 p -80.69 4.11 19.88 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 125.33 1.452 . . . . 53.13 114.137 -176.356 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -141.7 83.91 12.62 Favored Pre-proline 0 N--CA 1.45 -0.471 0 N-CA-C 106.781 -1.562 . . . . 71.54 106.781 173.342 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -70.92 -176.25 1.74 Allowed 'Trans proline' 0 CA--C 1.536 0.598 0 C-N-CA 124.086 3.191 . . . . 73.11 111.799 -175.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 22.1 t -131.65 137.5 30.52 Favored Pre-proline 0 CA--C 1.536 0.431 0 C-N-CA 123.942 0.897 . . . . 75.22 108.788 -174.186 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -78.95 176.39 9.89 Favored 'Trans proline' 0 CA--C 1.536 0.584 0 C-N-CA 123.67 2.914 . . . . 71.42 111.607 176.07 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.6 m -125.29 178.91 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 C-N-CA 125.307 1.443 . . . . 72.43 109.529 171.575 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 51.3 m -59.11 -58.18 9.79 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 124.537 1.135 . . . . 71.31 111.276 174.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -143.89 154.15 58.28 Favored Pre-proline 0 CA--C 1.536 0.428 0 C-N-CA 123.954 0.902 . . . . 73.12 109.509 173.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -70.29 167.04 26.29 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 123.37 2.713 . . . . 72.41 111.009 177.136 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 131.72 -96.39 0.33 Allowed Glycine 0 N--CA 1.449 -0.471 0 N-CA-C 109.412 -1.475 . . . . 63.04 109.412 178.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.39 126.11 29.03 Favored 'General case' 0 CA--C 1.518 -0.268 0 N-CA-C 108.53 -0.915 . . . . 75.43 108.53 -175.364 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 34.2 mm -61.68 140.17 19.51 Favored 'Isoleucine or valine' 0 C--O 1.24 0.581 0 N-CA-C 107.111 -1.44 . . . . 75.24 107.111 176.459 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -93.87 153.39 18.28 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 118.296 -1.361 . . . . 73.41 108.558 -177.135 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 16.1 t -146.31 121.81 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 N-CA-C 105.106 -2.183 . . . . 75.43 105.106 -177.567 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 57.3 t -123.07 119.47 57.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 106.898 -1.519 . . . . 73.33 106.898 -175.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -80.24 124.01 28.45 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 106.489 -1.671 . . . . 74.42 106.489 157.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.7 mp -110.47 145.24 38.02 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 107.031 -1.47 . . . . 74.32 107.031 160.022 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 18.5 p90 -154.23 176.93 11.68 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 124.138 0.975 . . . . 71.22 110.07 -172.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 30.4 t90 -146.9 176.61 9.77 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 126.445 1.898 . . . . 72.44 108.268 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 23.7 t80 -56.22 -57.9 10.24 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 125.818 1.647 . . . . 73.22 111.467 178.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -93.4 -76.68 1.34 Allowed Glycine 0 C--N 1.338 0.677 0 N-CA-C 111.125 -0.79 . . . . 71.23 111.125 -155.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . 0.289 10.7 p 42.68 74.97 0.68 Allowed Pre-proline 0 CA--C 1.534 0.352 0 C-N-CA 126.409 1.884 . . . . 64.42 112.45 165.828 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -54.95 -27.43 54.08 Favored 'Trans proline' 0 CA--C 1.537 0.668 0 CA-C-N 121.078 1.421 . . . . 64.51 113.023 -175.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 10.6 m170 -70.34 -37.45 74.67 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.598 1.159 . . . . 73.15 111.861 175.001 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 18.7 p -67.37 -31.58 71.92 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 119.833 1.197 . . . . 74.54 111.087 -178.451 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 89.9 t80 -65.97 -26.02 67.37 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.314 1.046 . . . . 74.31 111.733 176.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -74.35 -7.76 53.94 Favored 'General case' 0 CA--C 1.536 0.424 0 O-C-N 120.879 -1.138 . . . . 42.15 112.15 172.196 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -126.76 -20.34 4.3 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-O 118.023 -0.989 . . . . 63.14 113.125 -163.511 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . 0.253 0.0 OUTLIER -50.44 -64.28 1.38 Allowed Pre-proline 0 N--CA 1.475 0.794 0 CA-C-N 120.689 1.586 . . . . 72.34 113.893 -175.551 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -70.52 -9.29 25.52 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 CA-C-N 122.099 1.785 . . . . 72.35 114.015 -176.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 85.4 m -79.87 -36.44 36.61 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 119.564 1.074 . . . . 74.44 109.671 169.398 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 15.8 tt -85.14 -35.49 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 CA-C-N 119.367 0.985 . . . . 72.13 111.617 -177.125 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 55.8 t -48.29 -62.65 2.05 Favored Pre-proline 0 CA--C 1.538 0.504 0 CA-C-O 117.413 -1.28 . . . . 73.3 112.088 -177.094 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -68.11 -29.53 33.15 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 121.428 1.418 . . . . 64.21 111.32 -176.041 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 77.2 t90 -54.23 -57.79 9.83 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 119.322 0.965 . . . . 75.51 109.973 177.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.2 -23.39 62.94 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 112.587 0.588 . . . . 73.24 112.587 -172.572 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 78.0 mt-10 -66.42 -48.19 70.8 Favored 'General case' 0 C--O 1.235 0.301 0 O-C-N 120.926 -1.109 . . . . 71.12 109.716 169.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 30.0 mmmt -74.57 3.6 7.46 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.524 1.53 . . . . 73.35 112.817 -169.678 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 37.7 mt -59.09 159.45 14.31 Favored Pre-proline 0 CA--C 1.543 0.674 0 C-N-CA 125.363 1.465 . . . . 74.11 112.129 177.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -87.27 174.0 5.39 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 125.204 3.936 . . . . 74.21 112.265 178.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -66.83 -21.26 66.03 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 114.307 1.225 . . . . 61.02 114.307 -175.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 40.9 m-20 -86.81 6.89 29.4 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.722 1.209 . . . . 71.5 111.146 -175.292 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 46.8 t -129.0 151.76 36.22 Favored 'Isoleucine or valine' 0 C--O 1.24 0.589 0 C-N-CA 125.194 1.398 . . . . 73.23 108.412 -173.245 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 79.6 t60 -133.96 144.5 48.81 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 125.498 1.519 . . . . 73.3 107.852 173.574 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 24.7 t80 -128.42 136.82 51.4 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 123.763 0.825 . . . . 74.4 110.535 -172.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 70.9 t -133.64 148.96 30.52 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 C-N-CA 126.253 1.821 . . . . 71.23 107.935 -174.532 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -123.79 125.31 44.47 Favored 'General case' 0 CA--C 1.512 -0.515 0 N-CA-C 105.615 -1.995 . . . . 74.14 105.615 172.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 20.7 mt -133.43 150.93 76.44 Favored Pre-proline 0 N--CA 1.47 0.539 0 CA-C-N 119.474 1.033 . . . . 70.22 111.092 176.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -73.63 139.29 27.96 Favored 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 121.64 1.56 . . . . 75.34 110.578 179.13 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -79.93 79.06 6.51 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.225 1.01 . . . . 53.42 109.382 173.216 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 48.8 mt -72.76 106.02 4.57 Favored 'General case' 0 C--N 1.329 -0.304 0 O-C-N 120.99 -1.069 . . . . 72.13 109.363 175.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -128.8 28.06 5.4 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.424 1.489 . . . . 74.43 112.376 178.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 76.9 169.78 31.54 Favored Glycine 0 CA--C 1.523 0.589 0 C-N-CA 125.454 1.502 . . . . 72.44 111.166 -178.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 56.77 -151.04 26.15 Favored Glycine 0 CA--C 1.529 0.937 0 N-CA-C 111.083 -0.807 . . . . 72.04 111.083 -175.129 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.2 tt -60.47 -21.33 22.84 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 C-N-CA 124.183 0.993 . . . . 72.35 112.658 -174.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 23.9 m95 -63.31 -32.1 73.43 Favored 'General case' 0 CA--C 1.53 0.178 0 O-C-N 121.725 -0.609 . . . . 75.51 110.715 173.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -77.49 -43.57 31.74 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-N 118.676 0.671 . . . . 75.51 110.46 173.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 58.7 t -55.29 -58.21 5.12 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 C-N-CA 124.077 0.951 . . . . 74.51 109.916 -175.258 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 61.5 m170 -69.89 -7.61 41.73 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 118.568 -0.729 . . . . 74.11 112.042 -178.425 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -93.45 -18.55 38.27 Favored Glycine 0 C--N 1.338 0.652 0 CA-C-N 120.288 1.404 . . . . 73.21 110.242 -177.449 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -74.76 -36.6 62.57 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 118.58 1.19 . . . . 75.31 110.97 -173.452 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 34.2 ttp -53.82 -45.28 70.78 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.659 1.583 . . . . 74.42 113.436 179.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 10.7 t80 -57.5 -44.21 84.82 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 109.172 -0.677 . . . . 75.24 109.172 -177.115 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 24.4 mt -65.94 -44.9 83.71 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-O 117.092 -1.432 . . . . 75.12 109.53 178.331 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -56.42 -41.71 76.83 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 121.165 1.802 . . . . 65.25 112.318 178.501 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.0 -59.43 4.92 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 124.853 1.261 . . . . 75.12 109.154 -174.675 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -72.46 -24.37 61.19 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 111.442 0.164 . . . . 73.22 111.442 -174.382 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.4 t -58.92 -8.5 1.41 Allowed 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.597 1.559 . . . . 73.2 113.516 176.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 6.8 mtp -111.21 -4.3 15.05 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 125.453 1.501 . . . . 72.11 113.963 -179.415 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 68.38 26.45 74.26 Favored Glycine 0 CA--C 1.528 0.861 0 CA-C-N 118.513 0.597 . . . . 70.44 112.2 176.16 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 12.9 m -68.45 169.85 1.16 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 C-N-CA 124.155 0.982 . . . . 72.21 110.816 172.066 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 55.82 -163.76 0.14 Allowed 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.421 1.488 . . . . 72.54 110.223 -171.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 33.8 m170 -107.96 -73.61 0.68 Allowed 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 105.894 -1.891 . . . . 74.13 105.894 153.579 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -139.66 0.71 1.85 Allowed 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 112.898 0.703 . . . . 75.31 112.898 -168.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.4 p -90.22 159.88 2.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 C-N-CA 125.046 1.338 . . . . 74.42 110.868 174.67 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 26.5 p80 -147.37 15.51 1.14 Allowed 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 114.865 1.432 . . . . 70.21 114.865 179.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -49.14 -55.88 10.93 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 125.772 1.629 . . . . 72.04 111.448 -175.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -64.89 -27.68 69.03 Favored 'General case' 0 CA--C 1.528 0.102 0 N-CA-C 113.421 0.897 . . . . 74.13 113.421 -174.043 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 60.0 t -58.45 -58.69 5.51 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 N-CA-C 108.393 -0.965 . . . . 75.51 108.393 172.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 -58.84 -49.9 76.0 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 124.296 1.038 . . . . 74.04 110.873 179.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -71.27 -2.97 17.94 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 126.184 1.793 . . . . 73.44 112.64 -173.529 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -96.37 -28.33 14.52 Favored 'General case' 0 N--CA 1.453 -0.28 0 O-C-N 120.84 -1.162 . . . . 73.35 112.405 169.646 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 12.1 mt -84.65 -58.49 3.46 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.513 0 N-CA-C 106.799 -1.556 . . . . 74.33 106.799 178.027 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 58.0 m-70 -73.61 -61.43 1.84 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 118.8 0.727 . . . . 73.04 112.734 -163.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.6 -12.1 60.0 Favored 'General case' 0 N--CA 1.473 0.7 0 O-C-N 120.614 -1.304 . . . . 75.41 114.18 179.42 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -114.46 -27.82 7.41 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 113.888 1.07 . . . . 75.15 113.888 -171.045 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . 0.41 ' C ' ' H ' ' A' ' 104' ' ' LYS 0.272 5.1 m170 43.72 46.63 6.41 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 127.632 2.373 . . . . 73.33 112.868 169.387 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.457 ' HE2' ' HA ' ' A' ' 103' ' ' LYS . 7.9 mmpt? -68.37 12.12 0.14 Allowed 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 125.109 1.364 . . . . 72.03 114.614 178.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.41 ' H ' ' C ' ' A' ' 102' ' ' HIS . 4.2 ttpm? 68.14 -52.27 0.53 Allowed 'General case' 0 C--O 1.223 -0.293 0 C-N-CA 129.384 3.074 . . . . 75.23 111.057 -177.771 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 64.8 mt 51.84 43.96 29.72 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 125.957 1.703 . . . . 75.21 110.295 171.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -84.76 -24.97 28.56 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 124.369 1.067 . . . . 54.11 112.536 -175.371 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 44.4 p -124.06 160.08 53.71 Favored Pre-proline 0 N--CA 1.463 0.193 0 CA-C-N 119.767 1.167 . . . . 75.53 111.474 -169.423 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -71.15 -15.91 31.92 Favored 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 121.344 1.363 . . . . 73.12 112.809 178.273 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.43 -59.91 2.58 Favored 'General case' 0 N--CA 1.462 0.153 0 N-CA-C 107.064 -1.458 . . . . 63.0 107.064 166.458 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -58.52 -42.03 86.79 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 123.928 0.891 . . . . 71.33 112.09 -170.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 41.1 mtt -65.57 -55.75 16.01 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 122.963 0.505 . . . . 73.41 111.099 175.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -70.86 -40.08 72.54 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 119.45 -0.31 . . . . 75.32 110.721 -166.121 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -60.79 -38.35 85.03 Favored 'General case' 0 C--N 1.338 0.103 0 C-N-CA 122.84 0.456 . . . . 73.3 110.638 175.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 82.9 t80 -72.0 -48.19 46.53 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 122.848 0.459 . . . . 72.12 111.206 -177.359 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 55.7 mt -68.29 -16.79 64.09 Favored 'General case' 0 C--O 1.23 0.049 0 O-C-N 121.49 -0.756 . . . . 65.14 111.219 -174.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -52.09 -18.03 1.29 Allowed 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.762 1.225 . . . . 63.44 112.867 172.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -86.37 -12.4 70.16 Favored Glycine 0 CA--C 1.529 0.938 0 O-C-N 120.927 -1.108 . . . . 72.13 113.148 177.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -116.84 6.04 13.09 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 119.485 1.643 . . . . 73.42 113.544 -161.587 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 87.65 48.92 4.04 Favored Glycine 0 C--N 1.334 0.439 0 N-CA-C 109.754 -1.338 . . . . 72.43 109.754 -169.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 55.9 t -129.81 155.08 41.19 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 N-CA-C 104.794 -2.299 . . . . 65.43 104.794 165.7 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -127.31 135.3 50.36 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 106.538 -1.653 . . . . 65.44 106.538 -176.27 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 2.5 mtmt -67.39 -42.43 83.35 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 118.817 0.735 . . . . 72.25 111.431 -175.238 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -62.48 -36.22 81.81 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 123.859 0.864 . . . . 74.51 110.1 -178.563 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 40.8 mttm -73.08 -53.48 10.97 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 106.042 -1.836 . . . . 75.1 106.042 176.264 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 33.1 t80 -51.98 -60.67 2.92 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 125.246 1.418 . . . . 73.22 110.874 -172.21 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 11.8 mt -68.67 -37.29 79.51 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 123.063 0.545 . . . . 74.04 110.191 -170.21 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 11.2 t -65.1 -37.07 86.29 Favored 'General case' 0 CA--C 1.534 0.335 0 O-C-N 122.05 -0.406 . . . . 71.54 109.999 179.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 51.6 m -70.02 -40.87 74.97 Favored 'General case' 0 N--CA 1.455 -0.209 0 O-C-N 121.87 -0.519 . . . . 63.11 111.003 171.664 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 77.5 t80 -54.23 -48.93 70.55 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 119.3 0.954 . . . . 74.44 109.269 179.454 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 55.3 m-20 -91.46 59.09 3.75 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.905 1.282 . . . . 74.31 109.74 171.657 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 68.3 p -123.64 163.33 21.26 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-O 121.951 0.881 . . . . 63.33 111.702 168.197 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -68.44 -32.13 71.94 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.675 0.79 . . . . 60.33 110.21 172.303 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -56.54 -50.46 71.79 Favored 'General case' 0 C--O 1.234 0.26 0 O-C-N 121.796 -0.565 . . . . 64.52 110.045 -179.187 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 26.5 mm -63.94 -34.18 66.77 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-O 118.407 -0.806 . . . . 74.04 110.983 177.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 54.2 tttt -53.53 -41.76 66.72 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 118.898 0.772 . . . . 65.53 109.394 174.507 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -71.91 -33.81 62.56 Favored Glycine 0 C--N 1.337 0.61 0 C-N-CA 125.015 1.293 . . . . 73.25 111.75 -178.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 -73.3 -36.58 66.3 Favored 'General case' 0 N--CA 1.452 -0.36 0 O-C-N 121.824 -0.809 . . . . 71.21 110.503 -178.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 14.7 mtp -62.17 -52.01 65.51 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 118.119 0.418 . . . . 74.14 110.458 173.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -65.84 -37.01 85.06 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-O 118.696 -0.669 . . . . 74.4 111.913 -168.529 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 3.0 mtmt -56.52 -64.09 0.98 Allowed 'General case' 0 C--N 1.341 0.222 0 CA-C-O 118.357 -0.83 . . . . 75.01 109.041 172.448 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -55.99 -37.91 69.74 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 118.567 0.621 . . . . 73.13 111.437 -173.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 9.5 tmtt? -55.41 -59.82 4.28 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 124.228 1.011 . . . . 75.14 110.3 178.092 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 8.6 ptmt -69.67 -31.2 69.13 Favored 'General case' 0 C--N 1.343 0.307 0 CA-C-N 120.158 1.345 . . . . 75.54 111.974 179.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 21.9 mt -60.63 -54.41 45.68 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 118.624 0.647 . . . . 75.5 109.376 -174.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -54.4 -41.07 68.85 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 122.503 0.321 . . . . 74.24 111.237 -178.244 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -63.65 -45.71 88.94 Favored 'General case' 0 N--CA 1.461 0.11 0 C-N-CA 123.08 0.552 . . . . 70.23 111.3 178.239 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -62.33 -39.45 93.11 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 123.442 0.697 . . . . 71.42 110.11 -178.508 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 34.9 m-85 -75.67 8.0 3.32 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.662 1.185 . . . . 72.21 113.441 177.405 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 13.3 mt-30 49.93 39.06 17.73 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 126.998 2.119 . . . . 74.22 112.729 -175.678 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 46.6 t -74.2 138.27 21.49 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 N-CA-C 106.276 -1.75 . . . . 74.31 106.276 168.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -141.68 4.48 1.73 Allowed 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.873 0.869 . . . . 73.1 111.607 -178.449 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 177.28 -177.22 48.29 Favored Glycine 0 CA--C 1.524 0.631 0 C-N-CA 126.243 1.877 . . . . 74.13 108.709 -174.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 12.9 m -149.15 149.99 30.89 Favored Pre-proline 0 C--O 1.24 0.586 0 C-N-CA 125.378 1.471 . . . . 75.53 108.91 -175.471 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -68.98 147.89 83.87 Favored 'Cis proline' 0 CA--C 1.537 0.648 0 O-C-N 122.532 0.754 . . . . 73.4 112.148 -1.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 62.9 m -150.53 131.57 14.34 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 126.559 1.944 . . . . 73.42 107.442 179.27 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 93.3 mtp -116.36 163.12 16.49 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 124.153 0.981 . . . . 73.03 109.615 172.022 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 6.3 t -139.75 143.71 29.89 Favored 'Isoleucine or valine' 0 C--O 1.24 0.595 0 N-CA-C 106.522 -1.659 . . . . 71.31 106.522 179.041 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 96.8 t -113.29 134.7 55.16 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 C-N-CA 124.929 1.291 . . . . 74.21 107.545 167.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 7.8 t30 49.24 9.34 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 131.63 3.972 . . . . 74.34 116.344 172.361 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 81.48 19.81 65.53 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 126.124 1.821 . . . . 64.2 114.306 -171.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 24.1 mtpt -137.78 -30.19 0.83 Allowed 'General case' 0 N--CA 1.479 1.002 0 CA-C-N 120.292 2.046 . . . . 71.22 113.498 -167.541 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -118.7 142.41 47.69 Favored 'General case' 0 CA--C 1.508 -0.662 0 N-CA-C 107.318 -1.364 . . . . 75.4 107.318 174.524 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 21.7 ttp180 -123.48 144.34 49.59 Favored 'General case' 0 N--CA 1.44 -0.955 0 N-CA-C 104.877 -2.268 . . . . 72.44 104.877 178.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 14.1 p90 -154.22 173.32 16.27 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 107.596 -1.261 . . . . 75.4 107.596 178.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -173.42 175.65 3.01 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 107.681 -1.229 . . . . 75.42 107.681 -177.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 23.6 mt -56.23 -44.93 80.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 C-N-CA 126.493 1.917 . . . . 75.43 108.746 -177.498 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -72.46 -34.92 60.02 Favored Glycine 0 N--CA 1.442 -0.927 0 CA-C-O 117.996 -1.446 . . . . 62.34 112.093 -175.252 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 72.9 m -69.03 -57.3 5.63 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 118.924 1.362 . . . . 73.14 109.36 172.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -63.21 -44.84 94.19 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 123.1 0.56 . . . . 72.41 111.322 -169.187 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 141.28 -18.32 2.68 Favored Glycine 0 CA--C 1.523 0.573 0 C-N-CA 123.768 0.699 . . . . 74.0 114.197 173.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 169.82 169.23 32.8 Favored Glycine 0 CA--C 1.527 0.814 0 N-CA-C 107.19 -2.364 . . . . 41.33 107.19 -172.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -64.34 -36.11 46.99 Favored 'Trans proline' 0 N--CA 1.459 -0.543 0 C-N-CA 122.643 2.229 . . . . 75.0 111.984 -168.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -56.62 -48.96 76.34 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 123.453 0.701 . . . . 75.1 110.331 171.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -67.15 -27.6 67.43 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 123.797 0.839 . . . . 75.23 109.909 -169.078 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -51.29 -48.36 62.29 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 124.143 0.977 . . . . 70.12 110.197 173.75 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 55.9 mt -65.91 -34.02 77.16 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 117.851 0.296 . . . . 71.3 111.261 -179.318 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.78 -48.4 75.4 Favored 'General case' 0 N--CA 1.456 -0.165 0 N-CA-C 108.652 -0.87 . . . . 75.35 108.652 174.662 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -66.88 -44.7 80.23 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-O 117.848 -1.072 . . . . 73.53 110.843 175.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -50.38 -50.3 51.91 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 118.967 0.803 . . . . 74.24 110.329 -178.078 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -72.92 -44.37 61.31 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 123.625 0.77 . . . . 72.21 109.663 -170.133 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 5.5 t80 -59.76 -47.95 83.63 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 124.312 1.045 . . . . 75.54 111.894 176.063 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 82.7 mt -63.28 -44.63 94.52 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 108.967 -0.753 . . . . 74.14 108.967 -174.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 65.2 mt -58.14 -45.68 88.53 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 123.236 0.614 . . . . 73.22 109.43 174.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -65.84 -17.57 64.73 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 123.694 0.798 . . . . 75.31 112.571 179.492 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 13.5 tptp -84.23 -57.29 3.23 Favored 'General case' 0 N--CA 1.441 -0.917 0 N-CA-C 106.911 -1.514 . . . . 75.2 106.911 173.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -55.88 -20.19 14.77 Favored 'General case' 0 CA--C 1.513 -0.465 0 C-N-CA 129.856 3.262 . . . . 74.0 116.245 -167.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 2.6 mtm180 -71.88 -68.85 0.43 Allowed 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 117.784 -1.566 . . . . 74.4 110.629 168.336 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -53.41 -37.05 62.14 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-O 124.02 1.866 . . . . 72.03 111.076 -173.061 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . 0.282 . . -43.35 -35.34 1.49 Allowed 'General case' 0 N--CA 1.433 -1.314 1 C-N-CA 133.054 4.542 . . . . 71.14 113.156 176.145 . . . . . . . . 3 2 . 1 . 016 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -126.94 -17.01 4.99 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 119.459 1.027 . . . . 74.41 112.609 166.43 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -146.38 83.14 1.61 Allowed 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 128.218 2.607 . . . . 73.34 107.876 -164.37 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 2.0 ttmt . . . . . 0 C--O 1.252 1.21 0 CA-C-N 114.925 -1.034 . . . . 65.24 113.316 142.874 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.626 0 N-CA-C 109.832 -1.307 . . . . 73.43 109.832 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -76.95 139.87 40.29 Favored 'General case' 0 CA--C 1.519 -0.217 0 N-CA-C 109.205 -0.665 . . . . 74.14 109.205 -176.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -117.1 11.49 14.21 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 123.968 0.907 . . . . 72.41 112.631 178.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 -135.89 159.87 40.35 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 125.381 1.472 . . . . 73.2 109.735 -171.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.8 m -136.24 142.07 43.99 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 123.827 0.851 . . . . 72.15 109.481 176.637 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.33 150.52 34.75 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-N 114.602 -1.181 . . . . 70.2 111.982 176.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 77.51 -42.61 1.99 Allowed Glycine 0 CA--C 1.524 0.608 0 C-N-CA 125.015 1.293 . . . . 61.32 110.594 -171.43 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 12.9 ttpt -79.43 -80.49 0.12 Allowed 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 125.202 1.401 . . . . 71.03 110.76 -168.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 8.1 mp0 -70.97 -21.45 62.32 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 124.707 1.203 . . . . 74.2 110.865 -175.482 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 31.5 p90 -164.94 172.75 12.41 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 125.302 1.441 . . . . 74.22 108.817 -173.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 57.4 t -130.99 108.54 15.29 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 C-N-CA 125.002 1.321 . . . . 74.5 108.591 -178.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.6 164.13 22.12 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 124.387 1.075 . . . . 71.22 108.422 165.757 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -135.53 114.39 12.02 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 106.858 -1.534 . . . . 74.43 106.858 -168.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.5 m -56.69 -8.45 0.58 Allowed 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.433 1.493 . . . . 74.54 114.208 -177.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 50.6 m -135.3 83.3 38.61 Favored Pre-proline 0 CA--C 1.543 0.684 0 C-N-CA 125.016 1.327 . . . . 71.12 109.504 -179.112 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -74.66 177.82 7.95 Favored 'Trans proline' 0 CA--C 1.539 0.761 1 C-N-CA 125.583 4.189 . . . . 65.04 114.006 -178.725 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 81.3 t -142.0 147.84 46.24 Favored Pre-proline 0 N--CA 1.475 0.797 0 C-N-CA 127.111 2.164 . . . . 70.43 108.932 -168.271 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo -90.47 174.95 2.84 Favored 'Trans proline' 0 CA--C 1.536 0.59 0 C-N-CA 123.863 3.042 . . . . 72.32 113.455 178.096 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 15.5 m -105.85 176.28 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 C-N-CA 125.464 1.506 . . . . 73.31 109.266 166.343 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 67.1 m -52.5 -51.17 60.78 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 126.686 1.994 . . . . 71.3 112.351 177.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 16.7 mt-30 -149.72 164.17 21.91 Favored Pre-proline 0 CA--C 1.537 0.478 0 C-N-CA 125.1 1.36 . . . . 64.32 109.516 176.119 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -68.58 135.44 33.42 Favored 'Trans proline' 0 N--CA 1.452 -0.952 0 C-N-CA 122.416 2.077 . . . . 63.35 108.717 167.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 175.19 -125.51 1.09 Allowed Glycine 0 N--CA 1.445 -0.754 0 N-CA-C 106.614 -2.594 . . . . 75.53 106.614 -171.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.03 152.82 43.16 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 117.938 0.869 . . . . 75.4 109.786 176.823 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 39.2 mm -59.09 157.93 1.86 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 N-CA-C 106.811 -1.551 . . . . 73.04 106.811 163.3 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -115.84 122.09 44.35 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 107.093 -1.447 . . . . 75.13 107.093 174.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 36.7 t -114.85 113.14 42.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 N-CA-C 105.949 -1.871 . . . . 74.24 105.949 171.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 16.2 t -101.19 139.38 22.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 107.09 -1.448 . . . . 65.54 107.09 179.24 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -105.75 138.44 41.94 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 107.872 -1.158 . . . . 75.14 107.872 154.474 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.0 mp -111.46 148.43 33.15 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 124.549 1.14 . . . . 74.12 108.8 174.367 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 48.7 p90 -138.35 171.72 13.96 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 123.631 0.772 . . . . 74.45 112.044 -179.601 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 27.2 t90 -145.48 177.15 9.07 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 127.701 2.401 . . . . 74.32 107.886 172.393 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.439 ' HH ' ' CE1' ' A' ' 102' ' ' HIS . 56.1 t80 -72.16 -31.61 66.11 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.524 1.53 . . . . 61.5 114.758 178.434 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -116.69 20.99 11.69 Favored Glycine 0 CA--C 1.526 0.721 0 CA-C-O 118.573 -1.126 . . . . 42.54 114.228 -161.086 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 21.2 p -106.85 86.77 2.49 Favored Pre-proline 0 CA--C 1.538 0.49 0 C-N-CA 125.81 1.644 . . . . 65.53 110.309 -169.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -52.63 -36.45 71.83 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 122.7 2.267 . . . . 72.4 113.061 -175.219 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 17.0 m170 -55.27 -29.33 57.92 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 118.214 -0.898 . . . . 70.44 112.774 176.131 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 80.3 m -63.88 -66.45 0.54 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.555 1.542 . . . . 74.01 109.772 179.313 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.401 ' HB2' ' CD2' ' A' ' 99' ' ' HIS . 19.2 t80 -59.2 -34.85 72.64 Favored 'General case' 0 N--CA 1.469 0.485 0 O-C-N 121.489 -0.757 . . . . 74.54 111.907 -178.645 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.58 -28.7 69.53 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 118.633 -0.698 . . . . 71.12 112.327 179.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -93.86 -20.45 20.04 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.985 1.314 . . . . 72.22 112.126 -174.669 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -42.89 -65.45 0.55 Allowed Pre-proline 0 CA--C 1.542 0.654 0 N-CA-C 114.393 1.257 . . . . 74.52 114.393 -174.335 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -74.73 -6.65 18.47 Favored 'Trans proline' 0 CA--C 1.534 0.522 0 CA-C-N 122.327 1.867 . . . . 51.24 114.525 -176.315 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 67.0 m -75.44 -39.81 58.37 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 120.411 1.459 . . . . 71.3 108.905 163.209 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 14.2 tt -87.19 -34.51 7.57 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 N-CA-C 112.846 0.684 . . . . 75.32 112.846 -171.215 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 31.4 t -49.72 -57.34 12.52 Favored Pre-proline 0 CA--C 1.537 0.451 0 CA-C-N 119.837 1.199 . . . . 73.54 111.138 175.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -67.02 -7.41 18.62 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 CA-C-N 121.302 1.501 . . . . 72.33 114.11 -177.09 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 70.9 t90 -80.27 -62.21 1.75 Allowed 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 119.326 0.966 . . . . 75.13 108.837 164.183 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 5.2 p -68.57 -19.08 64.45 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 113.35 0.87 . . . . 73.42 113.35 -172.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . 0.322 4.9 pt-20 -69.66 -20.78 63.57 Favored 'General case' 0 CA--C 1.556 1.179 0 C-N-CA 124.273 1.029 . . . . 74.43 110.912 170.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 67.2 mmtt -115.89 6.52 14.26 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.633 1.573 . . . . 74.03 113.256 -170.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 51.7 mt -63.43 150.41 89.81 Favored Pre-proline 0 C--O 1.236 0.391 0 CA-C-N 118.702 0.683 . . . . 74.03 110.021 176.723 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -73.11 177.26 8.02 Favored 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 124.555 3.503 . . . . 75.11 111.701 -176.02 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -74.6 -0.72 18.73 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.175 0.99 . . . . 64.52 113.475 179.104 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -104.07 -1.38 27.47 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 126.589 1.956 . . . . 73.21 111.339 -177.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 48.2 t -131.3 154.53 40.74 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 126.303 1.841 . . . . 73.33 106.708 -179.505 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 48.7 t60 -137.69 157.45 46.44 Favored 'General case' 0 N--CA 1.45 -0.468 0 O-C-N 121.674 -0.641 . . . . 72.1 109.41 169.344 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 46.3 t80 -124.6 135.16 52.88 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.644 1.178 . . . . 74.3 110.674 -171.561 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 67.1 t -132.85 137.86 53.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 C-N-CA 124.299 1.04 . . . . 73.23 108.54 -169.115 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -114.16 121.64 44.37 Favored 'General case' 0 CA--C 1.514 -0.414 0 N-CA-C 106.628 -1.619 . . . . 74.4 106.628 170.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 13.1 mt -136.57 144.79 48.7 Favored Pre-proline 0 CA--C 1.537 0.454 0 CA-C-N 118.607 0.639 . . . . 75.41 112.304 -177.453 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -77.56 125.61 7.7 Favored 'Trans proline' 0 CA--C 1.534 0.482 0 C-N-CA 122.166 1.911 . . . . 74.44 112.307 -175.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -68.29 112.28 5.08 Favored 'General case' 0 CA--C 1.54 0.567 0 O-C-N 120.741 -1.225 . . . . 64.34 109.286 167.76 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 8.1 mt -110.41 95.57 5.65 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 106.274 -1.751 . . . . 72.0 106.274 177.215 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -115.5 16.68 16.58 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 114.861 1.43 . . . . 72.52 114.861 -172.623 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 93.22 170.99 39.75 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 125.258 1.409 . . . . 53.35 110.058 -178.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 58.41 -153.48 27.76 Favored Glycine 0 CA--C 1.532 1.101 0 N-CA-C 110.246 -1.142 . . . . 74.51 110.246 -172.533 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 8.8 tp -60.19 -17.27 13.8 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 C-N-CA 123.866 0.866 . . . . 73.11 112.751 -177.208 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 19.1 m95 -58.52 -35.41 72.22 Favored 'General case' 0 C--N 1.34 0.193 0 O-C-N 121.009 -1.057 . . . . 72.3 110.847 176.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 33.4 m-20 -76.66 -33.33 58.3 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 109.283 -0.636 . . . . 72.31 109.283 -174.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 29.8 t -63.17 -65.64 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 C-N-CA 124.797 1.239 . . . . 72.5 108.992 172.639 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 46.4 m170 -67.66 -2.4 6.81 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 114.138 1.162 . . . . 74.4 114.138 -171.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -102.04 -27.39 7.0 Favored Glycine 0 C--N 1.336 0.563 0 CA-C-N 120.221 1.373 . . . . 64.34 110.171 -176.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 31.7 mt-30 -56.09 -26.86 51.34 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 118.226 -0.893 . . . . 75.52 112.527 176.362 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 3.7 ttt -46.78 -62.96 1.15 Allowed 'General case' 0 C--N 1.342 0.246 0 N-CA-C 114.796 1.406 . . . . 71.53 114.796 -170.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -53.06 -45.69 68.21 Favored 'General case' 0 C--N 1.331 -0.211 0 O-C-N 123.779 0.674 . . . . 63.22 110.045 -176.331 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 28.7 mt -61.87 -39.08 90.64 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-O 116.682 -1.628 . . . . 75.22 109.67 178.079 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -60.62 -49.45 77.49 Favored 'General case' 0 C--N 1.349 0.567 0 CA-C-N 121.625 2.011 . . . . 75.53 109.538 175.596 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -54.57 -54.02 46.87 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 124.452 1.101 . . . . 72.15 108.425 -175.002 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -75.1 -14.04 60.54 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 112.885 0.698 . . . . 75.42 112.885 -178.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.9 t -61.37 -33.97 74.53 Favored 'General case' 0 C--O 1.236 0.379 0 O-C-N 121.431 -0.793 . . . . 74.4 110.809 173.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 47.5 mtp -77.66 -21.11 52.66 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 123.602 0.761 . . . . 70.34 111.914 -171.164 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 68.76 63.77 3.35 Favored Glycine 0 C--N 1.335 0.511 0 N-CA-C 107.296 -2.322 . . . . 72.21 107.296 -164.326 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 17.3 m -74.83 154.4 6.48 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 N-CA-C 109.467 -0.568 . . . . 74.05 109.467 167.158 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 59.7 mt-10 -58.56 -64.91 0.76 Allowed 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.001 0.52 . . . . 74.22 109.948 -175.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -171.31 -178.69 2.44 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.696 1.598 . . . . 72.42 109.714 155.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -150.95 154.14 36.56 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 127.21 2.204 . . . . 75.43 107.573 179.41 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 38.5 t -78.15 -4.31 6.56 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.824 0 O-C-N 120.706 -1.246 . . . . 73.44 112.298 -173.213 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 11.3 m170 54.76 56.41 6.74 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.995 1.718 . . . . 74.3 111.024 -174.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -152.04 -48.92 0.11 Allowed 'General case' 0 CA--C 1.513 -0.477 0 C-N-CA 124.257 1.023 . . . . 75.33 110.745 -178.077 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -57.59 -32.27 67.0 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 124.041 0.936 . . . . 74.42 111.112 179.222 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 21.7 t -53.64 -68.15 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 C-N-CA 125.691 1.596 . . . . 65.14 109.658 169.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -70.65 -32.5 69.81 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 119.961 1.255 . . . . 72.24 112.978 -174.273 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -60.44 -33.27 72.3 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.119 0.968 . . . . 73.3 109.266 173.238 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -72.88 -52.75 13.49 Favored 'General case' 0 N--CA 1.446 -0.656 0 O-C-N 120.413 -1.429 . . . . 75.03 109.312 174.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 40.8 mt -61.9 -44.56 99.05 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-O 118.244 -0.884 . . . . 75.4 109.72 -171.414 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . 0.401 ' CD2' ' HB2' ' A' ' 41' ' ' TYR . 48.6 m-70 -81.54 -72.68 0.42 Allowed 'General case' 0 CA--C 1.52 -0.189 0 C-N-CA 124.694 1.198 . . . . 70.51 111.065 -179.414 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 8.9 mtmt -65.8 -28.2 68.83 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-N 118.319 0.509 . . . . 74.51 111.307 -168.223 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.79 -31.13 9.97 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 122.792 0.437 . . . . 74.04 111.028 -170.526 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . 0.439 ' CE1' ' HH ' ' A' ' 35' ' ' TYR . 4.0 t60 43.83 70.06 0.35 Allowed 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 127.509 2.323 . . . . 75.21 112.126 172.671 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 21.0 mtpt -96.44 19.09 12.66 Favored 'General case' 0 N--CA 1.467 0.38 0 O-C-N 121.716 -0.615 . . . . 71.12 111.805 -172.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 12.9 ttpt 46.5 57.77 5.16 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 127.75 2.42 . . . . 74.43 111.971 176.563 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 52.6 mt -73.98 43.28 0.16 Allowed 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 130.428 3.491 . . . . 74.13 112.193 -176.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -82.94 1.43 39.69 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 127.582 2.353 . . . . 73.25 113.464 -177.211 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 32.9 p -144.11 161.7 43.95 Favored Pre-proline 0 C--O 1.239 0.523 0 C-N-CA 123.726 0.81 . . . . 74.53 109.916 -172.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.43 -13.99 20.37 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 122.471 2.114 . . . . 73.05 113.445 -179.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -63.96 -60.98 2.58 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 107.888 -1.152 . . . . 74.35 107.888 163.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -61.59 -46.23 90.72 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-O 119.066 -0.492 . . . . 64.33 111.492 -166.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 14.3 mtt -59.89 -42.45 93.81 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 118.427 0.558 . . . . 73.04 110.998 179.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -72.26 -47.49 49.85 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 109.455 -0.572 . . . . 73.33 109.455 -171.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -66.02 -24.11 66.69 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 118.888 0.767 . . . . 75.51 112.183 178.104 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . 0.484 ' CZ ' ' HE3' ' A' ' 118' ' ' LYS . 9.3 t80 -68.19 -60.4 2.5 Favored 'General case' 0 C--O 1.234 0.257 0 O-C-N 121.488 -0.758 . . . . 73.13 109.682 173.17 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 82.0 mt -65.56 -26.21 67.77 Favored 'General case' 0 N--CA 1.456 -0.127 0 C-N-CA 123.648 0.779 . . . . 75.43 110.424 -177.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -57.44 -39.47 76.34 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 119.189 0.904 . . . . 71.32 109.332 177.39 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -60.56 -8.52 9.82 Favored Glycine 0 CA--C 1.531 1.036 0 CA-C-O 116.981 -2.011 . . . . 65.42 114.176 172.291 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.484 ' HE3' ' CZ ' ' A' ' 114' ' ' PHE . 0.5 OUTLIER -131.85 21.65 4.58 Favored 'General case' 0 C--N 1.347 0.491 0 CA-C-N 121.324 2.562 . . . . 72.23 111.671 -175.469 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 82.22 60.3 2.16 Favored Glycine 0 C--N 1.333 0.396 0 N-CA-C 109.713 -1.355 . . . . 70.2 109.713 171.04 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 28.3 t -135.97 121.12 27.9 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 C-N-CA 125.361 1.464 . . . . 74.41 107.114 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 52.9 t0 -66.18 116.34 7.15 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 124.149 0.979 . . . . 63.11 110.364 -179.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 7.2 ttmt -61.57 -41.31 97.22 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 124.502 1.121 . . . . 74.23 109.442 177.578 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -63.39 -36.75 84.75 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 119.118 -0.468 . . . . 63.41 111.603 -175.078 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 15.7 mmtp -80.97 -37.58 29.07 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-O 118.493 -0.765 . . . . 73.32 109.181 176.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 82.7 t80 -54.3 -60.33 3.49 Favored 'General case' 0 N--CA 1.445 -0.68 0 O-C-N 123.805 0.691 . . . . 75.15 110.389 -177.459 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 20.1 mt -66.46 -40.78 89.6 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 123.271 0.629 . . . . 75.33 110.569 -175.462 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 34.2 t -56.18 -48.47 76.28 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 123.802 0.841 . . . . 74.33 109.629 -178.304 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 1.3 t -80.42 -30.98 37.7 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-O 119.196 -0.431 . . . . 72.42 110.192 -175.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 58.5 t80 -55.53 -50.75 69.19 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 119.161 0.891 . . . . 65.31 110.362 174.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -95.78 47.84 1.12 Allowed 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 124.065 0.946 . . . . 72.11 109.23 177.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 37.5 t -128.42 165.44 20.63 Favored 'General case' 0 C--O 1.238 0.474 0 O-C-N 120.998 -1.064 . . . . 65.14 109.642 173.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -58.99 -25.76 63.92 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 115.426 -0.806 . . . . 71.25 110.82 163.692 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -48.46 -54.66 13.37 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 124.45 1.1 . . . . 75.11 111.32 178.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 11.8 mm -65.37 -42.95 94.81 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.392 0 N-CA-C 113.339 0.866 . . . . 75.13 113.339 170.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 14.2 tttt -54.02 -36.95 63.57 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 118.866 -0.588 . . . . 74.41 109.746 -175.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -82.89 -8.55 85.68 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 126.443 1.973 . . . . 41.04 113.273 -174.303 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -100.91 -52.99 3.16 Favored 'General case' 0 C--O 1.227 -0.102 0 N-CA-C 107.397 -1.335 . . . . 71.2 107.397 171.611 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 2.6 ptm -53.85 -37.6 63.8 Favored 'General case' 0 C--O 1.223 -0.313 0 C-N-CA 123.989 0.915 . . . . 73.31 111.682 -175.184 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -49.72 -44.98 48.64 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.124 0.97 . . . . 73.32 113.13 178.488 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -68.76 -61.65 1.72 Allowed 'General case' 0 CA--C 1.519 -0.228 0 C-N-CA 125.922 1.689 . . . . 73.34 107.188 -176.537 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -44.23 -42.97 6.92 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.713 1.605 . . . . 65.31 111.777 177.331 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -64.97 -58.64 5.59 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 124.925 1.29 . . . . 75.15 111.428 -177.138 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.49 -37.46 86.88 Favored 'General case' 0 C--N 1.342 0.272 0 CA-C-N 119.733 1.152 . . . . 75.44 110.626 -179.211 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 51.0 mt -56.83 -43.16 80.8 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 123.859 0.863 . . . . 75.42 110.236 178.477 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -58.35 -46.26 86.6 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 119.153 0.888 . . . . 72.44 110.611 -177.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -67.96 -34.87 77.38 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 123.527 0.731 . . . . 74.14 110.721 -178.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -59.22 -52.59 65.01 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 107.76 -1.2 . . . . 72.13 107.76 175.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 -69.87 16.56 0.06 Allowed 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 126.208 1.803 . . . . 74.34 115.698 -174.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 57.93 17.51 4.37 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 126.572 1.949 . . . . 73.53 114.162 175.031 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 30.1 t -69.64 132.99 32.61 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 N-CA-C 108.4 -0.963 . . . . 74.1 108.4 -176.553 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -130.13 -4.0 4.46 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 124.58 1.152 . . . . 71.31 113.07 -177.452 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -169.1 -174.82 37.95 Favored Glycine 0 CA--C 1.526 0.75 0 C-N-CA 126.283 1.896 . . . . 54.23 110.064 174.291 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.42 ' HA ' ' C ' ' A' ' 154' ' ' PRO . 4.8 m -143.21 159.47 55.51 Favored Pre-proline 0 CA--C 1.537 0.474 0 C-N-CA 125.99 1.716 . . . . 75.33 109.871 -172.04 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . 0.42 ' C ' ' HA ' ' A' ' 153' ' ' VAL . 27.8 Cg_endo -61.45 162.57 42.49 Favored 'Cis proline' 0 N--CA 1.455 -0.792 0 C-N-CA 124.647 -0.98 . . . . 74.12 111.206 -11.319 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 6.5 m -156.97 138.64 14.13 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 107.026 -1.472 . . . . 71.21 107.026 176.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 98.8 mtp -114.11 158.11 21.7 Favored 'General case' 0 N--CA 1.438 -1.064 0 N-CA-C 108.067 -1.086 . . . . 71.02 108.067 171.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 37.6 t -140.77 134.04 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 N-CA-C 106.148 -1.797 . . . . 70.02 106.148 177.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 13.1 t -102.24 119.44 50.55 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.9 0 N-CA-C 105.92 -1.881 . . . . 72.42 105.92 171.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.443 HD21 ' HG2' ' A' ' 186' ' ' GLU . 15.4 t30 56.01 24.28 7.59 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 128.512 2.725 . . . . 72.42 114.285 158.807 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 61.64 30.84 75.87 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 127.287 2.375 . . . . 54.25 113.823 -172.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 42.6 mttt -131.81 -34.79 1.29 Allowed 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 119.427 1.614 . . . . 75.34 113.344 -175.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -124.33 128.24 48.8 Favored 'General case' 0 CA--C 1.512 -0.512 0 N-CA-C 108.941 -0.763 . . . . 75.31 108.941 -179.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 26.5 ttp85 -107.72 136.62 47.16 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 105.141 -2.17 . . . . 74.53 105.141 174.123 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 9.8 p90 -150.51 170.1 19.91 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 107.705 -1.22 . . . . 75.22 107.705 178.102 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 9.7 p30 -167.65 177.47 5.84 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 108.81 -0.811 . . . . 74.45 108.81 -178.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 16.5 mt -58.94 -40.85 81.41 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 C-N-CA 124.942 1.297 . . . . 65.24 108.615 -174.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -74.62 -39.29 41.38 Favored Glycine 0 N--CA 1.447 -0.602 0 CA-C-O 118.851 -0.972 . . . . 75.22 111.626 -178.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 2.6 m -57.97 -59.45 5.25 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 124.462 1.105 . . . . 72.23 109.695 174.607 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -61.82 -51.11 69.6 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 109.718 -0.475 . . . . 72.3 109.718 -176.366 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 132.63 4.14 3.55 Favored Glycine 0 CA--C 1.528 0.896 0 CA-C-O 119.137 -0.813 . . . . 53.44 113.855 177.024 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 164.36 163.65 17.87 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 108.445 -1.862 . . . . 71.54 108.445 -174.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -66.06 -43.86 8.33 Favored 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 122.474 2.116 . . . . 71.33 110.079 -173.495 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -54.1 -38.61 65.55 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 125.199 1.399 . . . . 72.34 111.766 173.038 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -76.1 -26.25 56.25 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.432 1.093 . . . . 74.13 109.511 -173.142 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -56.64 -48.3 77.85 Favored 'General case' 0 CA--C 1.528 0.106 0 C-N-CA 123.997 0.919 . . . . 73.1 109.696 177.196 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 61.8 mt -62.05 -34.23 75.87 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 118.127 0.421 . . . . 70.44 110.777 179.052 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -54.6 -42.33 71.0 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 123.496 0.718 . . . . 73.32 110.289 175.877 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -73.25 -46.11 51.97 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-O 118.008 -0.996 . . . . 74.44 110.237 173.357 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -55.18 -34.94 64.28 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 118.843 0.747 . . . . 72.43 112.11 -174.047 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -94.24 -32.11 13.81 Favored 'General case' 0 C--N 1.333 -0.147 0 C-N-CA 124.859 1.264 . . . . 75.33 110.059 -167.401 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 35.5 t80 -64.69 -58.28 6.72 Favored 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 123.991 0.916 . . . . 73.32 110.497 167.521 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 56.1 mt -58.01 -35.77 71.71 Favored 'General case' 0 C--O 1.224 -0.268 0 C-N-CA 124.825 1.25 . . . . 73.14 112.294 -164.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 38.1 mt -45.09 -52.8 1.79 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 C-N-CA 124.279 1.031 . . . . 73.1 109.974 173.223 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -58.16 -34.53 70.4 Favored 'General case' 0 N--CA 1.447 -0.596 0 O-C-N 121.213 -0.929 . . . . 75.21 111.534 -177.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.3 -32.77 68.77 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 123.71 0.804 . . . . 71.05 110.934 -178.34 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . 0.443 ' HG2' HD21 ' A' ' 159' ' ' ASN . 2.5 mp0 -93.1 -43.87 8.66 Favored 'General case' 0 C--O 1.224 -0.256 0 CA-C-N 119.954 1.252 . . . . 75.42 112.298 168.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.54 -34.24 68.94 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 125.5 1.52 . . . . 62.15 110.308 -172.335 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -60.35 -22.08 62.85 Favored 'General case' 0 C--N 1.339 0.147 0 C-N-CA 124.776 1.23 . . . . 75.13 111.933 178.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -55.67 -38.26 69.37 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 123.609 0.764 . . . . 74.13 110.535 173.314 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -80.84 -21.34 40.86 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 113.557 0.947 . . . . 62.52 113.557 178.166 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 62.1 tttt 44.62 58.41 3.9 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.232 1.813 . . . . 72.14 112.55 -177.434 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.02 0 C-N-CA 123.957 0.903 . . . . 75.32 109.976 176.045 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.476 0 N-CA-C 110.241 -1.144 . . . . 72.21 110.241 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 49.2 68.56 0.7 Allowed 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 127.108 2.163 . . . . 74.23 110.313 175.507 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -81.69 11.14 5.05 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 113.735 -1.575 . . . . 71.42 114.565 -159.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 36.1 m-85 -134.65 175.56 9.44 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 126.696 1.998 . . . . 72.44 108.89 -172.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 31.9 m -137.13 136.95 38.72 Favored 'General case' 0 CA--C 1.535 0.387 0 O-C-N 119.972 -1.705 . . . . 74.3 110.679 172.251 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -68.6 153.13 44.36 Favored 'General case' 0 C--N 1.342 0.271 0 CA-C-O 121.709 0.766 . . . . 75.53 109.043 178.162 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 75.58 -31.7 1.21 Allowed Glycine 0 CA--C 1.53 0.988 0 C-N-CA 124.134 0.873 . . . . 55.52 111.309 -165.113 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 38.5 tttt -95.43 -84.26 0.34 Allowed 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 118.946 1.373 . . . . 74.42 110.264 -170.027 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -68.6 -25.17 64.73 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.794 1.637 . . . . 71.42 110.655 -178.523 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 31.9 p90 -162.09 170.27 19.48 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 107.35 -1.352 . . . . 74.44 107.35 -173.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 13.7 t -134.63 108.24 10.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 107.958 -1.127 . . . . 74.22 107.958 -178.426 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -63.56 152.57 38.32 Favored 'General case' 0 N--CA 1.44 -0.928 0 O-C-N 121.178 -0.951 . . . . 74.22 108.968 164.102 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -120.13 107.08 12.6 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 125.565 1.546 . . . . 75.31 109.535 179.734 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 70.3 m -67.02 21.06 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.864 1.666 . . . . 64.43 114.193 173.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 4.4 t -132.3 81.92 59.45 Favored Pre-proline 0 CA--C 1.53 0.195 0 N-CA-C 106.674 -1.602 . . . . 71.25 106.674 153.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -72.25 178.58 5.89 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 123.031 2.487 . . . . 72.23 111.139 -175.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 39.4 t -137.48 142.06 35.89 Favored Pre-proline 0 CA--C 1.539 0.538 0 N-CA-C 109.15 -0.685 . . . . 73.12 109.15 -170.468 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -79.36 178.55 7.29 Favored 'Trans proline' 0 CA--C 1.536 0.599 0 C-N-CA 123.739 2.959 . . . . 72.5 111.733 172.684 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 16.2 m -131.91 172.43 16.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 126.079 1.752 . . . . 75.44 109.735 179.084 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 13.1 t -53.86 -58.74 6.15 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.831 1.253 . . . . 74.24 110.625 173.584 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -144.78 164.97 24.67 Favored Pre-proline 0 CA--C 1.531 0.234 0 O-C-N 121.301 -0.874 . . . . 74.5 111.342 173.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -80.52 -172.88 1.64 Allowed 'Trans proline' 0 N--CA 1.452 -0.966 0 C-N-CA 123.219 2.613 . . . . 63.5 110.995 170.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 104.68 -86.67 0.52 Allowed Glycine 0 N--CA 1.451 -0.321 0 N-CA-C 106.832 -2.507 . . . . 71.14 106.832 179.168 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 67.0 mttt -68.06 149.16 50.01 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-O 121.511 0.672 . . . . 74.53 109.281 170.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 29.8 mm -80.01 141.56 15.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 107.663 -1.236 . . . . 75.25 107.663 168.51 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -87.96 132.43 34.24 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 106.493 -1.669 . . . . 64.02 106.493 173.147 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 46.4 t -131.2 136.22 58.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 N-CA-C 106.181 -1.785 . . . . 72.4 106.181 169.605 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 23.5 t -135.34 123.29 38.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 N-CA-C 108.005 -1.109 . . . . 61.51 108.005 -171.006 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -91.09 145.2 24.88 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 124.948 1.299 . . . . 74.22 108.847 166.101 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 5.5 mp -125.31 137.63 54.07 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.572 1.549 . . . . 73.13 107.744 168.002 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 30.9 p90 -141.78 172.67 12.37 Favored 'General case' 0 CA--C 1.549 0.918 0 N-CA-C 113.616 0.969 . . . . 72.33 113.616 -173.277 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 27.8 t90 -156.44 150.23 24.9 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.489 1.115 . . . . 72.41 111.806 -178.218 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -60.47 -9.17 3.32 Favored 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 114.843 1.423 . . . . 73.31 114.843 -179.842 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -123.84 19.0 7.48 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 125.447 1.499 . . . . 54.24 114.25 -169.337 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 22.4 p -104.26 86.7 1.4 Allowed Pre-proline 0 CA--C 1.536 0.431 0 CA-C-N 119.782 1.791 . . . . 52.13 110.744 -175.248 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -52.47 -35.83 67.57 Favored 'Trans proline' 0 CA--C 1.534 0.476 0 C-N-CA 122.769 2.313 . . . . 74.23 113.334 -177.242 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 11.5 m170 -64.74 -24.55 67.6 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 118.341 -0.838 . . . . 74.4 112.063 -178.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 83.6 m -59.39 -53.94 52.45 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.33 1.052 . . . . 71.45 109.144 175.198 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 59.9 t80 -56.78 -40.44 75.88 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 119.253 0.933 . . . . 72.24 111.041 -176.163 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -70.16 2.37 3.74 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 113.303 0.853 . . . . 75.43 113.303 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -125.71 -29.9 3.1 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 127.602 2.361 . . . . 75.23 111.261 179.163 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -37.5 -62.13 0.65 Allowed Pre-proline 0 CA--C 1.544 0.735 0 C-N-CA 126.401 1.88 . . . . 64.22 113.708 -174.667 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -79.52 -10.68 14.53 Favored 'Trans proline' 0 N--CA 1.454 -0.818 0 CA-C-N 121.191 1.461 . . . . 75.14 114.937 -175.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 51.1 m -70.87 -41.27 71.59 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 119.605 1.093 . . . . 74.32 109.335 164.715 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 17.3 tt -81.84 -42.64 19.32 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 CA-C-O 118.136 -0.935 . . . . 64.04 111.926 -169.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 79.5 t -44.84 -60.22 3.3 Favored Pre-proline 0 CA--C 1.544 0.716 0 CA-C-N 120.012 1.278 . . . . 74.25 112.803 177.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -73.79 -15.0 24.16 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 122.284 1.989 . . . . 73.22 112.112 -174.377 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 76.0 t90 -64.53 -61.59 2.12 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 119.73 1.15 . . . . 74.22 108.498 163.147 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -63.96 -34.53 78.2 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 113.008 0.744 . . . . 72.23 113.008 -171.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -59.13 -36.5 75.32 Favored 'General case' 0 C--O 1.237 0.441 0 O-C-N 121.389 -0.819 . . . . 74.34 110.908 175.16 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 29.9 mmmt -93.98 10.01 35.23 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.879 1.271 . . . . 75.02 111.863 -170.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 23.1 mt -61.6 157.54 46.72 Favored Pre-proline 0 CA--C 1.54 0.564 0 CA-C-N 119.5 1.045 . . . . 72.52 112.811 -178.082 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -77.98 178.05 8.06 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 124.991 3.794 . . . . 71.14 111.695 178.246 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -74.45 -0.2 16.69 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.032 1.333 . . . . 75.04 114.437 -174.302 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -126.22 18.75 7.65 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.782 1.233 . . . . 51.41 110.726 -172.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 42.5 t -124.82 139.18 51.76 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 N-CA-C 108.063 -1.088 . . . . 74.0 108.063 170.161 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 82.7 t60 -113.59 153.25 29.14 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 125.6 1.56 . . . . 74.03 106.908 166.33 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.463 ' CE2' ' HD2' ' A' ' 62' ' ' ARG . 24.2 t80 -136.57 141.5 43.33 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 108.63 -0.878 . . . . 74.35 108.63 -178.833 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 60.2 t -134.38 147.19 30.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 C-N-CA 126.622 1.969 . . . . 75.54 107.253 -170.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.463 ' HD2' ' CE2' ' A' ' 60' ' ' PHE . 0.0 OUTLIER -126.79 121.73 32.78 Favored 'General case' 0 CA--C 1.516 -0.358 0 N-CA-C 104.35 -2.463 . . . . 74.42 104.35 176.298 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 32.7 mt -127.09 151.97 75.08 Favored Pre-proline 0 N--CA 1.467 0.386 0 CA-C-N 118.961 0.8 . . . . 73.32 111.112 177.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -72.57 130.56 16.15 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 122.194 1.929 . . . . 64.54 109.828 178.003 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -75.48 100.8 4.62 Favored 'General case' 0 CA--C 1.536 0.409 0 O-C-N 121.42 -0.8 . . . . 62.13 109.006 176.389 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 42.8 mt -95.43 78.43 3.41 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.657 1.583 . . . . 74.22 111.548 -174.442 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -110.38 12.97 22.96 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 114.275 1.213 . . . . 73.14 114.275 -169.535 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 108.95 152.06 14.91 Favored Glycine 0 CA--C 1.518 0.275 0 C-N-CA 125.259 1.409 . . . . 63.2 110.626 173.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 52.82 -139.57 32.12 Favored Glycine 0 CA--C 1.521 0.439 0 C-N-CA 123.641 0.639 . . . . 42.12 111.952 -173.552 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 5.5 tp -58.62 -20.87 17.31 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 C-N-CA 124.963 1.305 . . . . 74.4 112.507 -168.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 23.6 m95 -57.3 -38.26 73.72 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.898 0.879 . . . . 73.41 110.92 173.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 14.0 m-80 -74.8 -43.46 54.63 Favored 'General case' 0 C--N 1.339 0.147 0 O-C-N 121.804 -0.56 . . . . 73.55 111.794 175.356 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 61.3 t -57.67 -54.57 29.71 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 C-N-CA 124.31 1.044 . . . . 73.11 108.588 -177.176 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 57.5 m170 -79.4 24.67 0.34 Allowed 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.662 1.585 . . . . 75.45 111.546 175.605 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -114.85 -33.53 1.68 Allowed Glycine 0 CA--C 1.524 0.637 0 C-N-CA 125.573 1.559 . . . . 64.23 111.69 170.722 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 31.6 mt-30 -63.29 -31.62 72.82 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 118.402 -0.808 . . . . 72.33 112.771 -179.111 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 16.7 ttp -60.42 -50.71 72.51 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-N 119.754 1.161 . . . . 73.24 111.535 -174.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 17.5 t80 -53.78 -50.9 65.07 Favored 'General case' 0 CA--C 1.53 0.178 0 O-C-N 123.72 0.638 . . . . 75.42 109.933 -179.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 76.0 mt -61.11 -36.73 80.49 Favored 'General case' 0 C--O 1.222 -0.378 0 CA-C-O 117.774 -1.108 . . . . 75.34 111.155 177.401 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.5 m -66.89 -35.26 79.61 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 120.622 1.556 . . . . 74.15 111.09 178.23 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.19 -56.83 16.74 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 107.544 -1.28 . . . . 73.42 107.544 178.085 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -66.29 -25.29 66.79 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.2 1.4 . . . . 71.04 112.744 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 16.1 t -73.07 -6.8 47.99 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.37 1.468 . . . . 71.12 113.442 -175.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 9.8 mtm -84.23 -6.8 59.45 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 119.998 1.272 . . . . 54.35 112.893 162.329 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 81.6 28.54 42.82 Favored Glycine 0 CA--C 1.519 0.33 0 C-N-CA 124.81 1.195 . . . . 53.45 110.601 177.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 26.2 m -86.04 123.18 39.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 107.012 -1.477 . . . . 74.44 107.012 171.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 47.8 tt0 -75.7 -59.31 2.81 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 107.251 -1.389 . . . . 73.03 107.251 171.419 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER 51.39 -172.01 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 126.993 2.117 . . . . 74.24 113.433 -173.511 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -154.69 -176.04 5.72 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 126.198 1.799 . . . . 75.32 107.686 -177.71 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 15.6 m 45.31 54.47 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 C-N-CA 126.881 2.073 . . . . 75.13 113.103 168.621 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 24.1 p-80 -72.42 31.62 0.06 Allowed 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 126.919 2.088 . . . . 74.13 114.54 -176.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.412 ' HA ' ' CD2' ' A' ' 95' ' ' PHE . 1.0 OUTLIER -63.72 -56.93 11.87 Favored 'General case' 0 C--O 1.217 -0.609 0 C-N-CA 125.584 1.554 . . . . 75.33 112.214 176.664 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -61.45 -20.03 62.66 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 120.602 1.546 . . . . 74.14 113.011 -177.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 3.8 t -62.76 -67.06 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-N 119.275 0.943 . . . . 75.44 108.51 161.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.412 ' CD2' ' HA ' ' A' ' 92' ' ' ASN . 0.1 OUTLIER -60.78 -48.68 80.69 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 107.744 -1.206 . . . . 73.43 107.744 -167.163 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.407 ' CD ' ' HE2' ' A' ' 100' ' ' LYS . 4.1 mm-40 -51.89 -33.66 37.72 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 128.006 2.522 . . . . 75.33 110.368 -176.024 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -79.56 -13.81 59.28 Favored 'General case' 0 N--CA 1.444 -0.746 0 O-C-N 120.621 -1.3 . . . . 73.34 113.215 -172.177 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 14.3 mt -114.01 -49.33 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 N-CA-C 106.008 -1.849 . . . . 73.41 106.008 -175.561 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 61.5 m-70 -76.08 -40.27 53.48 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 124.22 1.008 . . . . 74.25 112.564 -176.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.407 ' HE2' ' CD ' ' A' ' 96' ' ' GLU . 25.5 mtmt -93.59 -37.8 11.69 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 120.431 1.469 . . . . 75.01 111.69 172.179 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -122.55 32.47 5.75 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 113.214 0.82 . . . . 73.45 113.214 -160.264 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 41.2 t-80 -41.88 97.67 0.01 OUTLIER 'General case' 0 C--O 1.241 0.639 0 C-N-CA 129.472 3.109 . . . . 65.03 112.432 -172.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.09 27.61 1.58 Allowed 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 126.133 1.773 . . . . 73.14 112.036 175.841 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 2.7 tttp 65.4 -61.53 0.24 Allowed 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 128.72 2.808 . . . . 72.41 112.004 -175.184 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 87.7 mt 74.96 17.03 2.81 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 127.532 2.333 . . . . 75.1 113.696 174.475 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -85.14 33.71 0.55 Allowed 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.018 1.327 . . . . 74.11 112.703 -174.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -152.29 158.21 33.63 Favored Pre-proline 0 C--O 1.237 0.412 0 C-N-CA 124.425 1.09 . . . . 74.13 108.974 167.256 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -64.99 -41.47 17.1 Favored 'Trans proline' 0 N--CA 1.451 -0.975 0 C-N-CA 122.147 1.898 . . . . 65.21 111.331 177.463 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -58.76 -47.21 85.48 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 118.746 0.703 . . . . 73.03 110.03 176.175 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -62.7 -31.67 72.62 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 123.362 0.665 . . . . 72.34 111.473 -176.076 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 74.1 mtm -81.06 -35.76 31.36 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 118.475 -0.774 . . . . 75.21 112.5 173.22 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -77.66 -47.95 17.99 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 119.29 0.95 . . . . 75.43 111.449 -172.486 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -58.05 -31.83 67.42 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 125.477 1.511 . . . . 55.14 111.866 -172.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 38.4 t80 -75.08 -48.2 25.04 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 123.851 0.86 . . . . 72.25 112.22 174.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 88.4 mt -65.63 -25.07 67.21 Favored 'General case' 0 N--CA 1.455 -0.186 0 O-C-N 121.333 -0.854 . . . . 62.01 110.489 -176.018 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -53.4 -23.88 10.94 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.975 0.91 . . . . 72.54 112.579 171.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -84.09 -15.5 69.5 Favored Glycine 0 CA--C 1.53 0.971 0 C-N-CA 124.258 0.932 . . . . 72.21 114.272 174.483 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 45.5 mmtt -129.03 39.79 3.73 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 120.294 2.047 . . . . 74.44 110.691 -162.072 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 74.34 39.75 42.44 Favored Glycine 0 N--CA 1.448 -0.529 0 N-CA-C 110.989 -0.845 . . . . 75.23 110.989 170.076 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 89.2 t -128.56 143.88 39.7 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 N-CA-C 106.068 -1.827 . . . . 74.41 106.068 172.138 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 16.0 t0 -95.64 129.15 42.93 Favored 'General case' 0 C--N 1.331 -0.212 0 O-C-N 121.909 -0.495 . . . . 61.32 109.67 177.484 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -67.57 -46.96 71.18 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 123.268 0.627 . . . . 74.41 110.405 -177.265 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -57.31 -37.67 72.85 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 117.731 0.241 . . . . 75.11 110.993 -174.4 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 16.3 mmtp -97.17 -29.21 13.72 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-O 117.227 -1.368 . . . . 72.21 108.756 -169.097 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 89.6 t80 -51.71 -60.42 3.18 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 119.164 0.893 . . . . 72.4 109.391 165.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 7.1 mt -65.49 -42.81 91.76 Favored 'General case' 0 C--O 1.234 0.253 0 O-C-N 121.875 -0.516 . . . . 74.2 110.693 -170.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 2.5 m -58.04 -56.02 27.39 Favored 'General case' 0 C--O 1.223 -0.321 0 CA-C-O 118.321 -0.847 . . . . 74.35 109.007 176.052 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 28.8 m -59.68 -39.68 85.31 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.749 0.82 . . . . 62.12 111.215 -175.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -57.2 -46.81 82.54 Favored 'General case' 0 C--O 1.236 0.357 0 O-C-N 121.353 -0.842 . . . . 72.51 109.576 175.55 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -89.26 30.48 0.97 Allowed 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.309 1.044 . . . . 75.13 111.983 175.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 72.7 m -110.89 150.62 28.92 Favored 'General case' 0 C--O 1.236 0.363 0 O-C-N 120.699 -1.251 . . . . 73.01 109.926 171.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -59.91 -22.9 63.01 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.407 1.083 . . . . 73.33 111.616 175.098 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -44.87 -55.76 5.14 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 125.345 1.458 . . . . 71.52 111.955 172.59 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 45.4 mm -66.73 -34.87 72.88 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.253 0 C-N-CA 123.104 0.562 . . . . 74.53 109.806 -178.551 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 25.8 tttm -57.35 -39.46 75.97 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 118.717 -0.658 . . . . 73.22 110.501 179.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -69.79 -27.67 72.94 Favored Glycine 0 CA--C 1.523 0.572 0 C-N-CA 124.075 0.845 . . . . 63.23 111.98 -176.379 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -80.31 -48.56 12.81 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 108.502 -0.925 . . . . 73.2 108.502 175.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 91.6 mmm -54.16 -45.84 72.16 Favored 'General case' 0 C--N 1.339 0.119 0 C-N-CA 125.305 1.442 . . . . 70.31 111.118 -178.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -63.86 -44.77 92.11 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 119.087 0.858 . . . . 65.44 111.687 -176.03 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 33.4 mttt -60.77 -61.47 2.56 Favored 'General case' 0 C--N 1.341 0.219 0 N-CA-C 108.922 -0.77 . . . . 73.42 108.922 171.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -47.41 -40.98 19.13 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.283 1.033 . . . . 73.12 111.564 -175.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -59.21 -64.92 0.77 Allowed 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 124.171 0.989 . . . . 72.25 108.823 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.85 -23.03 65.97 Favored 'General case' 0 N--CA 1.461 0.097 0 CA-C-O 118.278 -0.868 . . . . 75.25 112.723 -175.401 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 55.9 mt -59.73 -50.28 74.44 Favored 'General case' 0 C--O 1.227 -0.122 0 CA-C-N 118.972 0.805 . . . . 70.14 109.662 173.618 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -63.88 -32.86 74.52 Favored 'General case' 0 CA--C 1.537 0.476 0 O-C-N 121.908 -0.495 . . . . 65.42 111.307 -172.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 11.3 mmt -62.36 -45.44 93.17 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 125.502 1.521 . . . . 74.4 110.381 174.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -58.24 -47.2 84.27 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 109.017 -0.734 . . . . 75.23 109.017 -177.438 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 31.8 m-85 -68.85 5.31 1.15 Allowed 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 126.417 1.887 . . . . 72.54 114.674 -176.297 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 62.6 mt-30 54.04 28.88 9.34 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 126.234 1.814 . . . . 70.43 112.363 -179.272 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 44.3 t -78.53 135.95 24.93 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 N-CA-C 107.424 -1.325 . . . . 74.11 107.424 176.142 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -142.66 14.96 1.96 Allowed 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 121.501 0.667 . . . . 75.45 111.397 -176.873 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -173.76 177.27 46.14 Favored Glycine 0 CA--C 1.52 0.398 0 C-N-CA 125.939 1.733 . . . . 63.43 110.144 174.503 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.413 ' HA ' ' C ' ' A' ' 154' ' ' PRO . 12.4 m -141.14 150.89 60.31 Favored Pre-proline 0 CA--C 1.539 0.523 0 C-N-CA 124.337 1.055 . . . . 73.2 109.793 179.365 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . 0.413 ' C ' ' HA ' ' A' ' 153' ' ' VAL . 38.8 Cg_endo -68.91 150.18 87.56 Favored 'Cis proline' 0 N--CA 1.459 -0.526 0 C-N-CA 125.067 -0.805 . . . . 73.04 112.072 -1.005 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 51.6 m -148.33 117.32 6.77 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.738 1.615 . . . . 72.12 107.197 175.461 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 96.4 mtp -94.69 158.84 15.34 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 108.38 -0.97 . . . . 74.34 108.38 167.188 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 38.2 t -140.42 138.27 36.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 106.459 -1.682 . . . . 74.13 106.459 171.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 95.3 t -103.53 132.32 50.13 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 N-CA-C 107.606 -1.257 . . . . 71.54 107.606 168.132 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 4.9 t30 48.79 23.63 0.7 Allowed 'General case' 0 C--N 1.331 -0.231 1 C-N-CA 132.159 4.184 . . . . 64.11 115.963 167.041 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 70.12 24.4 76.58 Favored Glycine 0 CA--C 1.527 0.792 0 C-N-CA 126.209 1.862 . . . . 63.13 114.498 -175.182 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 48.7 mttp -137.02 -28.54 0.94 Allowed 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 120.202 2.001 . . . . 74.23 113.996 -171.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -125.04 105.83 9.48 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 108.466 -0.939 . . . . 75.34 108.466 -175.001 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 32.5 ttp85 -83.03 136.73 34.39 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 105.166 -2.161 . . . . 73.01 105.166 171.331 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 15.3 p90 -152.32 170.03 21.05 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 107.845 -1.169 . . . . 64.3 107.845 174.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -179.52 178.98 0.63 Allowed 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 123.877 0.871 . . . . 75.43 109.177 179.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 29.5 mt -45.37 -52.78 2.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 C-N-CA 129.217 3.007 . . . . 74.41 109.71 174.429 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -75.41 -21.22 77.9 Favored Glycine 0 C--N 1.338 0.639 0 CA-C-O 119.435 -0.647 . . . . 61.13 113.443 -176.737 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 14.4 m -75.19 -68.23 0.58 Allowed 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 118.492 1.146 . . . . 73.4 108.084 169.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -75.0 -31.33 61.39 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-O 117.415 -1.279 . . . . 72.3 113.443 -162.223 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 134.78 5.39 2.5 Favored Glycine 0 CA--C 1.533 1.201 0 N-CA-C 117.171 1.628 . . . . 74.01 117.171 174.265 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 126.42 167.95 12.51 Favored Glycine 0 CA--C 1.529 0.953 0 CA-C-N 119.446 1.623 . . . . 73.31 110.378 -173.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -61.44 -40.47 47.93 Favored 'Trans proline' 0 CA--C 1.534 0.502 0 C-N-CA 123.059 2.506 . . . . 72.41 113.736 -156.294 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -65.93 -33.2 75.29 Favored 'General case' 0 CA--C 1.532 0.283 0 O-C-N 121.206 -0.934 . . . . 74.11 111.379 177.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -72.44 -25.99 61.66 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 123.274 0.63 . . . . 73.03 110.515 176.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 6.6 m -63.84 -47.44 80.76 Favored 'General case' 0 C--O 1.233 0.195 0 O-C-N 120.867 -1.146 . . . . 75.05 108.443 -178.152 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 59.9 mt -62.79 -33.26 74.83 Favored 'General case' 0 C--O 1.224 -0.258 0 CA-C-O 119.484 -0.293 . . . . 74.3 110.788 175.633 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 14.0 tptt -54.23 -36.75 63.87 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-O 118.939 -0.553 . . . . 74.12 111.089 176.132 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -80.09 -44.85 19.28 Favored 'General case' 0 CA--C 1.509 -0.63 0 CA-C-O 117.665 -1.16 . . . . 75.41 110.077 175.262 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -50.43 -42.41 53.89 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 119.251 0.932 . . . . 73.44 111.169 -179.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -82.19 -33.3 29.49 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 124.693 1.197 . . . . 74.12 109.827 -165.415 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 19.2 t80 -69.79 -51.06 37.08 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.892 1.277 . . . . 73.23 110.496 170.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 62.5 mt -61.32 -27.96 68.87 Favored 'General case' 0 N--CA 1.462 0.133 0 C-N-CA 125.274 1.429 . . . . 74.45 112.871 -174.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 24.4 mt -56.61 -63.11 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 N-CA-C 108.178 -1.045 . . . . 74.45 108.178 171.539 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 7.8 tm-20 -60.36 -33.38 72.36 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.646 1.179 . . . . 72.24 111.324 -173.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 43.6 tptt -48.72 -57.99 5.46 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 124.344 1.058 . . . . 74.53 109.971 173.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 25.0 mm-40 -77.07 -34.55 57.01 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 123.504 0.721 . . . . 74.12 111.715 -178.419 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.75 -36.87 83.46 Favored 'General case' 0 N--CA 1.462 0.155 0 O-C-N 120.959 -1.088 . . . . 70.43 109.99 -174.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -62.81 -14.07 41.01 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.103 0.961 . . . . 71.0 112.065 177.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -61.13 -28.14 68.89 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 118.886 0.766 . . . . 73.25 111.575 169.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . 59.41 14.68 3.92 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 127.251 2.22 . . . . 74.41 113.527 169.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . 0.264 0.0 OUTLIER 57.24 24.98 10.52 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 126.266 1.826 . . . . 73.14 114.381 -169.284 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.172 0 C-N-CA 124.588 1.155 . . . . 75.53 110.327 177.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.176 0 N-CA-C 109.412 -1.475 . . . . 63.21 109.412 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.86 147.34 51.85 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 119.387 1.593 . . . . 75.51 110.723 176.879 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -142.85 8.02 1.67 Allowed 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 124.527 1.131 . . . . 72.32 111.752 -173.413 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 -145.97 157.77 43.88 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 125.016 1.327 . . . . 75.13 109.383 -170.451 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 51.1 m -134.06 141.26 47.12 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-O 121.692 0.758 . . . . 74.43 109.698 -179.115 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.43 144.28 57.29 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 124.12 0.968 . . . . 73.55 110.021 -178.779 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 79.1 -46.07 2.9 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 126.059 1.79 . . . . 71.34 111.099 -170.196 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 9.2 tptp -67.14 -70.42 0.25 Allowed 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 125.467 1.507 . . . . 72.53 109.748 -172.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 11.2 mp0 -88.24 -27.49 21.73 Favored 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 123.46 0.704 . . . . 73.14 110.735 -176.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 39.7 p90 -156.12 177.11 11.8 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 121.087 -1.008 . . . . 75.12 110.267 -171.462 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 17.7 t -134.1 112.73 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 N-CA-C 108.577 -0.897 . . . . 73.32 108.577 -175.266 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.32 163.66 26.09 Favored 'General case' 0 C--N 1.329 -0.314 0 O-C-N 120.652 -1.28 . . . . 75.11 109.01 164.459 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -132.01 113.52 13.49 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 123.959 0.904 . . . . 70.33 109.107 -176.241 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.9 m -61.16 -10.49 6.55 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 114.657 1.355 . . . . 63.33 114.657 -179.095 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 15.7 m -117.86 79.88 13.86 Favored Pre-proline 0 N--CA 1.448 -0.57 0 CA-C-N 119.834 1.197 . . . . 71.2 108.312 171.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_endo -69.06 174.79 8.4 Favored 'Trans proline' 0 N--CA 1.451 -1.012 0 C-N-CA 122.566 2.178 . . . . 74.44 111.336 175.175 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 50.5 t -143.22 134.76 12.84 Favored Pre-proline 0 C--N 1.33 -0.271 0 N-CA-C 106.203 -1.777 . . . . 72.44 106.203 -176.437 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -75.37 173.86 13.79 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 121.067 1.178 . . . . 71.14 110.56 176.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 16.3 m -116.2 165.19 11.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 C-N-CA 124.864 1.266 . . . . 75.44 108.87 175.006 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 3.4 m -48.75 -53.77 17.69 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 124.823 1.249 . . . . 71.43 112.418 174.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 2.2 pm0 -147.45 159.56 41.37 Favored Pre-proline 0 N--CA 1.449 -0.496 0 CA-C-N 120.413 1.46 . . . . 72.03 111.045 177.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -65.09 -177.07 0.54 Allowed 'Trans proline' 0 CA--C 1.544 1.021 0 C-N-CA 123.902 3.068 . . . . 74.33 111.135 166.218 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 119.97 -80.3 0.32 Allowed Glycine 0 CA--C 1.525 0.692 0 C-N-CA 125.211 1.386 . . . . 62.21 111.34 174.358 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -109.04 144.72 36.69 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 124.192 0.997 . . . . 71.32 109.232 179.122 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 47.2 mm -59.26 146.74 8.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 C-N-CA 124.481 1.112 . . . . 73.34 108.484 175.397 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -107.71 90.16 3.22 Favored 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 105.872 -1.899 . . . . 75.31 105.872 175.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 47.8 t -84.22 125.36 40.23 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.174 0 N-CA-C 105.505 -2.035 . . . . 73.33 105.505 170.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 41.9 t -119.35 113.39 41.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 N-CA-C 107.291 -1.374 . . . . 72.21 107.291 -175.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -72.01 131.6 43.13 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 107.83 -1.174 . . . . 62.33 107.83 156.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.1 mp -119.68 130.59 55.12 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 106.826 -1.546 . . . . 70.5 106.826 165.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 6.1 p90 -142.75 170.35 15.87 Favored 'General case' 0 C--O 1.237 0.416 0 O-C-N 123.9 0.75 . . . . 74.53 112.639 -170.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 27.4 t90 -142.44 149.02 38.73 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 127.224 2.21 . . . . 62.31 108.344 -178.291 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 9.3 p90 -60.67 -20.11 60.1 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 115.905 1.817 . . . . 72.21 115.905 -172.178 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -100.69 -89.13 2.04 Favored Glycine 0 N--CA 1.449 -0.498 0 N-CA-C 106.931 -2.468 . . . . 54.45 106.931 -176.418 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 30.8 t 44.8 80.64 0.28 Allowed Pre-proline 0 CA--C 1.538 0.483 0 C-N-CA 126.172 1.789 . . . . 71.54 112.491 175.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -59.76 -21.36 63.12 Favored 'Trans proline' 0 CA--C 1.536 0.595 0 C-N-CA 121.993 1.795 . . . . 63.34 113.493 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 18.6 m170 -82.39 -39.37 22.79 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.757 1.223 . . . . 73.11 111.047 179.638 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 74.5 m -58.21 -43.25 87.58 Favored 'General case' 0 N--CA 1.462 0.143 0 C-N-CA 124.949 1.3 . . . . 63.12 111.271 -175.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 68.5 t80 -61.39 -27.84 68.82 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.819 0.848 . . . . 73.41 111.207 178.153 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -77.89 10.76 2.58 Favored 'General case' 0 CA--C 1.544 0.719 0 O-C-N 120.598 -1.314 . . . . 75.42 112.88 174.606 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 10.9 t80 -138.43 -23.63 0.98 Allowed 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 125.796 1.639 . . . . 74.54 111.994 174.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -35.12 -66.14 0.25 Allowed Pre-proline 0 CA--C 1.541 0.622 0 C-N-CA 127.074 2.15 . . . . 71.4 112.594 176.592 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -72.07 -11.36 27.13 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 CA-C-N 120.907 1.36 . . . . 72.54 114.476 -173.297 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 82.0 m -82.15 -35.65 28.22 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 119.469 1.031 . . . . 71.4 110.072 172.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 18.7 tt -90.46 -26.03 5.33 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 O-C-N 121.989 -0.445 . . . . 73.53 111.994 -173.274 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 14.5 t -52.15 -65.1 1.12 Allowed Pre-proline 0 CA--C 1.543 0.685 0 C-N-CA 124.668 1.187 . . . . 73.33 111.214 172.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -71.98 -13.71 29.04 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 CA-C-N 121.522 1.579 . . . . 74.14 112.613 -174.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 70.8 t90 -68.03 -58.46 4.46 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 119.115 0.871 . . . . 75.14 109.331 168.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 7.2 p -62.22 -34.64 76.87 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.306 0.643 . . . . 73.33 112.476 -169.671 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -59.5 -49.49 77.58 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 118.749 0.704 . . . . 73.45 110.655 177.349 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.14 18.4 1.39 Allowed 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 124.643 1.177 . . . . 74.52 113.17 -174.162 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 26.3 mt -63.39 153.34 82.71 Favored Pre-proline 0 N--CA 1.449 -0.506 0 CA-C-N 118.476 0.58 . . . . 73.34 110.803 175.011 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -80.11 166.2 20.95 Favored 'Trans proline' 0 N--CA 1.446 -1.283 0 C-N-CA 124.679 3.586 . . . . 72.42 111.025 -179.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -65.46 -7.9 16.46 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 114.793 1.405 . . . . 71.53 114.793 -175.2 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -104.65 8.18 35.14 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 125.454 1.502 . . . . 74.23 111.62 -177.572 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 67.1 t -120.67 152.24 23.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 106.418 -1.697 . . . . 75.0 106.418 177.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 16.9 t60 -134.25 124.88 26.64 Favored 'General case' 0 N--CA 1.439 -1.014 0 N-CA-C 108.036 -1.098 . . . . 74.21 108.036 166.408 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 29.4 t80 -84.68 140.15 31.52 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 107.004 -1.48 . . . . 72.45 107.004 173.233 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 88.7 t -133.34 150.36 32.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 C-N-CA 126.693 1.997 . . . . 73.41 106.128 178.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 18.3 mtt180 -131.23 120.81 23.77 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 106.127 -1.805 . . . . 75.24 106.127 179.166 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 40.3 mt -127.56 151.01 74.47 Favored Pre-proline 0 N--CA 1.473 0.691 0 CA-C-N 120.369 1.441 . . . . 71.42 110.618 173.225 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -71.89 131.24 17.97 Favored 'Trans proline' 0 N--CA 1.453 -0.901 0 C-N-CA 122.357 2.038 . . . . 74.23 110.064 176.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -77.38 81.75 3.85 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 123.758 0.823 . . . . 70.42 110.717 177.208 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 33.6 mt -77.25 95.36 4.31 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.002 0.921 . . . . 75.11 109.313 -177.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 37.4 m-85 -123.49 20.05 9.59 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.158 0.983 . . . . 71.42 112.343 -177.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 85.79 -174.55 48.15 Favored Glycine 0 C--N 1.336 0.553 0 N-CA-C 110.702 -0.959 . . . . 70.01 110.702 -178.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 44.88 71.37 0.48 Allowed Glycine 0 CA--C 1.526 0.731 0 C-N-CA 125.308 1.432 . . . . 73.34 113.914 166.297 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . 0.256 5.5 tp 58.23 -19.85 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.739 0 C-N-CA 130.288 3.435 . . . . 75.31 115.671 -176.58 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 10.6 m95 -56.85 -39.77 74.89 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 121.277 1.853 . . . . 74.54 110.302 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 25.1 p30 -73.88 -43.67 57.8 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 125.357 1.463 . . . . 72.15 113.395 -177.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 78.9 t -56.5 -49.26 78.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 N-CA-C 108.906 -0.776 . . . . 73.43 108.906 177.345 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 43.8 m170 -72.19 -2.6 19.37 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 114.473 1.286 . . . . 74.4 114.473 179.125 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -107.02 -21.6 8.02 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 124.921 1.248 . . . . 74.02 112.475 177.517 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 54.4 tt0 -64.26 -30.93 71.96 Favored 'General case' 0 CA--C 1.539 0.527 0 O-C-N 121.716 -0.873 . . . . 75.12 111.682 -175.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -67.52 -37.52 82.89 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 126.004 1.721 . . . . 73.34 112.613 -174.495 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 26.6 t80 -64.11 -48.47 76.0 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-N 119.647 1.112 . . . . 72.43 109.018 -171.688 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 54.8 mt -56.87 -36.41 70.05 Favored 'General case' 0 C--O 1.223 -0.341 0 C-N-CA 124.228 1.011 . . . . 71.35 110.101 173.483 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.15 -44.25 76.46 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 119.764 1.165 . . . . 74.1 111.382 178.103 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -53.22 -58.62 6.42 Favored 'General case' 0 CA--C 1.529 0.14 0 N-CA-C 107.561 -1.274 . . . . 72.01 107.561 -178.749 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -67.62 -23.15 65.33 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 111.968 0.358 . . . . 72.4 111.968 -176.544 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 17.4 t -62.16 -25.53 67.82 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-O 118.485 -0.769 . . . . 74.12 112.783 178.033 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 3.2 ptp -103.1 -11.09 18.34 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 119.762 1.165 . . . . 74.32 113.372 172.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 120.58 -52.05 0.75 Allowed Glycine 0 CA--C 1.523 0.574 0 C-N-CA 125.557 1.551 . . . . 65.24 112.748 163.314 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 35.9 m 45.58 18.58 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 C-N-CA 129.227 3.011 . . . . 74.22 116.974 173.156 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 3.1 pm0 -43.39 102.95 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 126.615 1.966 . . . . 73.5 112.18 -163.421 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 32.3 t-80 -108.65 -16.45 14.19 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.031 1.332 . . . . 73.54 111.129 -173.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 64.72 10.83 6.32 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 126.423 1.889 . . . . 71.51 114.525 176.855 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 10.7 p -157.79 -25.56 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.852 0 N-CA-C 115.046 1.498 . . . . 70.12 115.046 178.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 73.7 m-70 60.4 -5.07 0.1 Allowed 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 117.308 2.336 . . . . 71.42 117.308 177.647 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -57.68 -46.25 84.56 Favored 'General case' 0 C--O 1.221 -0.428 0 CA-C-N 120.137 1.335 . . . . 65.11 113.085 -173.114 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -61.55 -25.84 67.57 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 119.768 1.167 . . . . 74.43 113.202 -173.354 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 82.4 t -59.11 -61.37 1.46 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 N-CA-C 107.627 -1.249 . . . . 74.03 107.627 169.369 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -61.22 -47.56 85.55 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.106 0.962 . . . . 73.3 111.05 -176.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -72.13 2.41 5.89 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.659 1.984 . . . . 73.45 112.124 -173.331 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -117.23 3.32 12.63 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 124.96 1.304 . . . . 73.53 112.282 171.08 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 83.8 mt -124.15 -60.94 1.81 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.373 0 N-CA-C 106.096 -1.816 . . . . 71.32 106.096 -175.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 83.3 m-70 -59.79 -64.87 0.79 Allowed 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 125.0 1.32 . . . . 74.23 111.237 -179.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 4.6 ptmt -82.41 -7.03 59.64 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 114.693 1.368 . . . . 75.34 114.693 -175.167 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -114.91 -37.5 4.16 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 113.665 0.987 . . . . 74.31 113.665 -173.085 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 12.1 t-160 45.63 53.06 8.92 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 127.695 2.398 . . . . 74.43 113.162 -178.355 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . 0.289 0.0 OUTLIER -70.71 12.97 0.21 Allowed 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 115.308 1.595 . . . . 74.13 115.308 172.966 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 26.2 ttmt 45.43 61.48 2.57 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 128.676 2.79 . . . . 63.05 110.863 171.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 63.1 mt -76.44 60.75 1.63 Allowed 'General case' 0 C--N 1.315 -0.93 0 C-N-CA 128.895 2.878 . . . . 74.25 107.181 177.643 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -103.03 -12.16 17.63 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 127.928 2.491 . . . . 75.14 111.11 -176.028 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -114.27 154.09 46.36 Favored Pre-proline 0 C--O 1.236 0.393 0 C-N-CA 124.967 1.307 . . . . 63.34 108.163 177.091 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -67.72 -36.35 19.18 Favored 'Trans proline' 0 N--CA 1.45 -1.067 0 C-N-CA 121.226 1.284 . . . . 75.0 110.73 -177.159 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -55.63 -55.18 35.09 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 123.559 0.743 . . . . 75.43 110.161 174.077 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -57.54 -50.86 71.71 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 125.053 1.341 . . . . 75.11 109.801 -175.597 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 51.2 mtt -55.82 -53.71 53.39 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 123.958 0.903 . . . . 72.44 111.355 178.51 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -71.75 -36.95 70.57 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 124.288 1.035 . . . . 71.23 110.597 -168.573 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -62.4 -42.59 99.55 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 118.699 0.682 . . . . 74.13 111.723 174.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 8.9 t80 -61.28 -51.48 68.75 Favored 'General case' 0 N--CA 1.455 -0.192 0 O-C-N 121.4 -0.813 . . . . 75.13 110.534 177.577 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 58.3 mt -70.55 -22.88 62.55 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 110.075 -0.342 . . . . 75.4 110.075 -175.647 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -58.21 -36.02 72.51 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 118.85 0.75 . . . . 64.21 109.431 171.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -71.81 -4.74 59.29 Favored Glycine 0 N--CA 1.442 -0.918 0 CA-C-O 116.459 -2.3 . . . . 65.22 115.034 170.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.483 ' HA ' ' HE2' ' A' ' 118' ' ' LYS . 5.7 mmpt? -116.74 -9.13 11.32 Favored 'General case' 0 C--N 1.348 0.537 0 CA-C-N 122.553 3.176 . . . . 74.41 114.245 -171.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 97.0 59.02 1.01 Allowed Glycine 0 N--CA 1.452 -0.234 0 N-CA-C 108.486 -1.845 . . . . 75.14 108.486 -168.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 53.7 t -142.31 153.05 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 C-N-CA 129.372 3.069 . . . . 72.42 104.089 167.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 41.6 t0 -111.67 128.91 56.21 Favored 'General case' 0 C--N 1.331 -0.221 0 O-C-N 121.116 -0.99 . . . . 72.15 108.746 -177.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 14.2 mtpt -60.75 -31.35 70.69 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 119.277 0.944 . . . . 74.23 110.374 172.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -59.81 -20.93 59.86 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 119.844 1.202 . . . . 71.23 112.214 173.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 65.0 mmtt -113.3 -33.11 6.06 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-N 119.8 1.182 . . . . 72.32 112.057 -175.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -62.64 -56.41 18.01 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 118.814 0.734 . . . . 74.03 109.926 -178.268 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 9.9 mt -72.76 -46.5 53.05 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.861 0.839 . . . . 74.05 111.173 -163.182 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 21.0 p -53.61 -41.79 67.03 Favored 'General case' 0 N--CA 1.444 -0.736 0 C-N-CA 125.511 1.525 . . . . 73.45 108.822 177.412 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 40.9 m -76.48 -41.39 47.36 Favored 'General case' 0 C--O 1.222 -0.356 0 N-CA-C 108.322 -0.992 . . . . 61.41 108.322 -176.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 61.6 t80 -56.57 -32.27 65.02 Favored 'General case' 0 C--O 1.235 0.337 0 O-C-N 120.709 -1.245 . . . . 75.21 110.878 178.153 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -105.17 26.4 9.38 Favored 'General case' 0 C--O 1.243 0.714 0 N-CA-C 113.432 0.901 . . . . 75.11 113.432 175.485 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 11.1 p -99.68 157.02 16.77 Favored 'General case' 0 C--O 1.234 0.275 0 O-C-N 120.919 -1.113 . . . . 74.05 111.317 175.726 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -67.19 -27.59 67.39 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 115.538 -0.755 . . . . 74.44 111.921 -175.637 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -55.09 -47.0 75.52 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 121.524 0.678 . . . . 72.24 110.324 175.734 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 32.8 mm -64.08 -37.72 80.57 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 C-N-CA 123.787 0.835 . . . . 73.25 109.149 179.4 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 10.5 mttt -58.31 -35.23 71.54 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 119.64 1.109 . . . . 75.31 110.591 172.393 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -73.51 -40.21 47.98 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 109.816 -1.314 . . . . 64.45 109.816 -173.769 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 2.3 mm100 -68.98 -43.1 75.61 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 123.391 0.676 . . . . 72.13 109.824 178.361 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 45.4 mtp -60.54 -42.76 97.19 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-O 117.495 -1.241 . . . . 74.12 111.478 177.15 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -62.8 -39.99 95.98 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 120.638 1.563 . . . . 74.45 110.839 -178.432 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 9.3 mmtt -59.62 -65.48 0.67 Allowed 'General case' 0 N--CA 1.463 0.176 0 C-N-CA 123.803 0.841 . . . . 73.23 110.316 170.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -57.92 -34.84 70.28 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 119.472 1.033 . . . . 73.2 111.257 -171.195 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 14.2 tmtt? -61.62 -61.55 2.44 Favored 'General case' 0 CA--C 1.518 -0.25 0 C-N-CA 124.895 1.278 . . . . 65.14 110.172 176.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.08 -25.98 68.35 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 119.74 1.154 . . . . 72.53 110.903 -178.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 25.4 mt -69.62 -54.24 14.92 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 118.429 -0.796 . . . . 75.21 111.712 -176.378 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -58.75 -49.32 78.08 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 118.873 0.76 . . . . 75.23 111.196 -169.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -61.03 -40.39 93.4 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 123.527 0.731 . . . . 73.52 112.515 175.742 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.442 ' C ' ' H ' ' A' ' 149' ' ' GLN . . . -67.3 -36.42 81.46 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 118.278 -0.868 . . . . 42.33 110.019 -179.526 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -67.78 14.14 0.06 Allowed 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.824 1.65 . . . . 74.34 113.359 175.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . 0.442 ' H ' ' C ' ' A' ' 147' ' ' ALA . 23.5 mt-30 54.29 21.52 3.19 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 127.12 2.168 . . . . 73.13 113.839 -179.023 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 44.4 t -71.47 142.04 15.97 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 N-CA-C 108.576 -0.898 . . . . 74.22 108.576 179.4 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -112.64 -14.09 13.2 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 124.662 1.185 . . . . 65.13 112.717 -176.112 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 167.49 -160.16 33.71 Favored Glycine 0 N--CA 1.446 -0.699 0 N-CA-C 108.119 -1.992 . . . . 43.13 108.119 -165.398 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 31.0 m -138.69 157.31 72.18 Favored Pre-proline 0 CA--C 1.536 0.425 0 C-N-CA 124.345 1.058 . . . . 65.21 109.741 -178.185 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_endo -66.59 156.9 81.91 Favored 'Cis proline' 0 N--CA 1.459 -0.552 0 C-N-CA 124.738 -0.943 . . . . 74.51 111.621 -7.063 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 5.6 m -156.86 138.37 13.99 Favored 'General case' 0 N--CA 1.466 0.339 0 O-C-N 121.102 -0.999 . . . . 74.01 109.239 171.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 92.1 mtp -112.32 148.64 33.79 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 125.148 1.379 . . . . 64.34 109.164 171.605 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 26.7 t -137.09 151.8 27.48 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 C-N-CA 124.623 1.169 . . . . 73.1 108.027 176.667 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 39.9 t -130.2 123.5 56.04 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 C-N-CA 126.053 1.741 . . . . 74.45 106.819 -178.351 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 16.6 m-20 50.01 21.15 0.68 Allowed 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 127.805 2.442 . . . . 65.25 114.973 173.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 51.74 45.17 55.17 Favored Glycine 0 CA--C 1.531 1.07 0 CA-C-O 117.697 -1.613 . . . . 73.04 112.924 -165.419 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 12.1 mtpp -139.44 -33.98 0.59 Allowed 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 119.595 1.697 . . . . 74.3 113.056 178.348 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -121.81 148.25 44.92 Favored 'General case' 0 CA--C 1.506 -0.729 0 N-CA-C 108.154 -1.054 . . . . 74.1 108.154 176.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 48.8 ttp85 -136.4 139.39 42.42 Favored 'General case' 0 N--CA 1.442 -0.857 0 N-CA-C 106.268 -1.753 . . . . 73.23 106.268 179.426 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 22.9 p90 -154.94 174.59 14.92 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 108.255 -1.017 . . . . 74.03 108.255 -179.364 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -177.41 173.73 1.67 Allowed 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 107.736 -1.209 . . . . 74.42 107.736 -176.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 17.8 mt -45.4 -50.13 3.25 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 C-N-CA 127.964 2.506 . . . . 73.34 108.408 162.462 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -73.86 9.5 8.72 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 126.433 1.968 . . . . 45.34 114.699 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 22.6 m -120.51 -54.15 2.08 Favored 'General case' 0 N--CA 1.458 -0.047 0 CA-C-N 119.198 1.499 . . . . 75.2 109.764 163.387 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -61.25 -53.1 61.14 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.511 1.125 . . . . 62.41 110.78 -172.571 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 146.02 -17.42 1.75 Allowed Glycine 0 CA--C 1.523 0.553 0 CA-C-O 119.614 -0.548 . . . . 73.34 113.764 178.417 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 169.47 176.37 39.3 Favored Glycine 0 CA--C 1.528 0.872 0 N-CA-C 108.885 -1.686 . . . . 71.13 108.885 -169.332 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -63.9 -52.48 1.71 Allowed 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 123.072 2.515 . . . . 73.23 111.611 -175.177 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -59.8 -39.74 86.0 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 119.295 0.952 . . . . 75.31 109.732 178.053 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -60.77 -32.65 71.96 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.523 0.729 . . . . 74.42 110.494 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 26.6 m -65.63 -43.68 88.77 Favored 'General case' 0 N--CA 1.453 -0.282 0 O-C-N 120.716 -1.24 . . . . 63.12 109.617 179.083 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 48.0 mt -66.46 -28.24 68.44 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 118.891 0.768 . . . . 72.33 111.354 176.139 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 10.1 tptt -51.29 -49.23 61.67 Favored 'General case' 0 C--O 1.232 0.182 0 N-CA-C 109.005 -0.739 . . . . 74.34 109.005 169.48 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -74.46 -38.79 62.85 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-O 119.012 -0.518 . . . . 72.25 111.54 -178.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.08 -43.94 87.29 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 118.005 0.366 . . . . 72.13 111.099 -176.625 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -74.04 -28.52 61.46 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 123.244 0.618 . . . . 74.54 110.58 -174.471 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 9.9 t80 -74.08 -57.0 4.26 Favored 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 125.053 1.341 . . . . 74.44 110.425 178.454 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 77.8 mt -61.95 -24.7 67.16 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 124.997 1.319 . . . . 74.32 112.955 -171.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 35.6 mt -53.3 -54.94 15.06 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 C-N-CA 123.348 0.659 . . . . 72.21 109.36 170.014 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -66.07 -38.23 87.8 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 118.342 0.519 . . . . 65.21 111.229 -177.073 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.4 -46.44 66.29 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 124.325 1.05 . . . . 75.01 110.182 -176.723 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -74.64 -51.83 13.37 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 123.087 0.555 . . . . 71.21 112.082 173.237 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 3.2 tpm_? -48.07 -45.31 32.36 Favored 'General case' 0 CA--C 1.516 -0.357 0 C-N-CA 124.82 1.248 . . . . 74.22 112.086 -175.422 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -58.79 -20.27 48.47 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 125.696 1.598 . . . . 72.55 111.746 -174.566 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -59.47 -39.41 83.6 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 124.031 0.932 . . . . 74.54 111.254 172.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -132.98 42.74 3.03 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 126.318 1.847 . . . . 72.31 109.588 -168.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 40.2 tttm -134.51 85.82 2.22 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 102.583 -3.117 . . . . 74.12 102.583 174.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 55.0 mttt . . . . . 0 C--O 1.257 1.497 0 N-CA-C 107.557 -1.275 . . . . 75.52 107.557 -171.625 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.665 0 N-CA-C 108.852 -1.699 . . . . 75.44 108.852 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -76.27 -53.54 8.08 Favored 'General case' 0 CA--C 1.502 -0.888 0 C-N-CA 122.907 0.483 . . . . 65.31 111.011 -170.178 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 76.38 10.46 2.95 Favored 'General case' 0 N--CA 1.442 -0.852 0 C-N-CA 130.078 3.351 . . . . 64.22 115.556 -172.133 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 29.7 m-85 -139.83 178.1 7.48 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 126.648 1.979 . . . . 73.23 108.305 179.383 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 95.0 m -144.3 143.88 31.2 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 108.287 -1.005 . . . . 75.23 108.287 166.238 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.64 152.27 45.69 Favored 'General case' 0 C--O 1.227 -0.123 0 O-C-N 121.393 -0.817 . . . . 74.02 108.838 172.386 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 70.33 -44.37 0.58 Allowed Glycine 0 CA--C 1.534 1.224 0 C-N-CA 125.504 1.525 . . . . 52.32 112.287 -162.36 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.5 tptm -70.21 -58.57 3.63 Favored 'General case' 0 CA--C 1.519 -0.222 0 C-N-CA 126.295 1.838 . . . . 72.41 111.165 -169.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -113.78 -23.42 9.68 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 126.04 1.736 . . . . 73.53 109.965 -172.056 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 42.4 p90 -157.22 173.38 17.05 Favored 'General case' 0 N--CA 1.47 0.525 0 O-C-N 120.96 -1.088 . . . . 74.13 109.586 -176.147 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 24.9 t -135.52 117.89 21.77 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 C-N-CA 123.437 0.695 . . . . 74.53 109.193 -174.576 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.9 162.54 28.04 Favored 'General case' 0 CA--C 1.537 0.446 0 O-C-N 121.189 -0.945 . . . . 70.15 109.055 167.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -136.18 108.28 7.21 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 126.679 1.992 . . . . 73.51 108.294 -167.52 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.8 p -63.27 -0.46 0.82 Allowed 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 115.493 1.664 . . . . 74.44 115.493 -176.229 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 49.0 m -131.0 76.41 76.98 Favored Pre-proline 0 N--CA 1.451 -0.389 0 CA-C-N 119.841 1.201 . . . . 72.11 109.428 174.036 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -65.97 176.64 3.58 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 123.894 3.063 . . . . 73.13 112.688 -176.487 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 40.2 t -133.81 136.03 25.81 Favored Pre-proline 0 CA--C 1.537 0.443 0 C-N-CA 125.539 1.536 . . . . 73.53 108.336 -169.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -76.24 178.45 7.48 Favored 'Trans proline' 0 CA--C 1.534 0.509 0 C-N-CA 123.491 2.794 . . . . 60.04 111.443 176.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 27.9 m -132.85 174.1 13.81 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 C-N-CA 125.336 1.454 . . . . 73.53 109.674 170.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 73.9 m -58.45 -51.36 70.15 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 126.33 1.852 . . . . 64.22 112.335 175.002 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 41.7 tt0 -143.16 145.29 32.06 Favored Pre-proline 0 CA--C 1.534 0.361 0 C-N-CA 124.278 1.031 . . . . 73.55 108.733 -177.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -74.54 90.91 1.0 Allowed 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 123.158 2.572 . . . . 72.54 109.202 165.2 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -137.12 -94.9 0.38 Allowed Glycine 0 C--N 1.336 0.542 0 O-C-N 121.497 -0.752 . . . . 73.12 111.304 -172.387 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 12.7 mptt -80.02 159.95 26.03 Favored 'General case' 0 C--O 1.227 -0.13 0 N-CA-C 107.693 -1.225 . . . . 73.01 107.693 170.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 49.2 mm -70.46 130.46 34.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 106.135 -1.802 . . . . 72.23 106.135 167.227 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -83.8 130.48 34.94 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 106.203 -1.777 . . . . 71.44 106.203 173.422 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 13.9 t -119.42 144.17 28.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 105.813 -1.921 . . . . 75.32 105.813 166.049 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 37.8 t -133.98 101.65 3.94 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.137 0 N-CA-C 106.512 -1.662 . . . . 73.34 106.512 -174.225 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -76.17 137.33 39.99 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 106.143 -1.799 . . . . 73.34 106.143 161.115 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.4 mp -120.93 134.19 55.29 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 105.494 -2.039 . . . . 73.51 105.494 163.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 42.6 p90 -134.76 172.77 12.5 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 123.552 0.741 . . . . 73.32 110.962 -177.379 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 22.9 t90 -148.55 167.68 24.77 Favored 'General case' 0 N--CA 1.463 0.209 0 C-N-CA 125.225 1.41 . . . . 72.04 108.644 178.405 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 17.6 t80 -67.34 -43.98 80.19 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.865 0.866 . . . . 65.3 112.026 172.253 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -95.71 22.79 37.26 Favored Glycine 0 CA--C 1.527 0.79 0 CA-C-O 119.026 -0.875 . . . . 64.35 113.954 -163.479 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 22.0 p -105.08 86.11 1.46 Allowed Pre-proline 0 CA--C 1.532 0.274 0 CA-C-N 118.843 1.321 . . . . 71.21 109.372 -177.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_endo -56.96 -24.97 60.07 Favored 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 122.325 2.016 . . . . 73.41 113.133 -177.093 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 15.6 m170 -68.11 -26.03 65.6 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 119.028 0.831 . . . . 73.31 111.037 178.243 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 84.6 m -65.29 -32.81 74.66 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.814 0.846 . . . . 61.23 109.48 -174.168 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -63.78 -46.35 85.6 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 125.657 1.583 . . . . 75.52 110.687 -178.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -53.58 -33.82 56.18 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 122.6 0.36 . . . . 75.11 110.467 178.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -87.78 -37.45 16.59 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-O 116.171 -1.871 . . . . 73.13 113.002 -175.233 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -39.23 -63.78 0.59 Allowed Pre-proline 0 N--CA 1.477 0.885 0 CA-C-N 120.724 1.602 . . . . 75.33 113.712 -168.378 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -71.95 -8.97 23.95 Favored 'Trans proline' 0 CA--C 1.535 0.525 0 CA-C-N 121.885 1.709 . . . . 72.32 114.726 -177.338 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.9 m -76.01 -44.11 41.01 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 108.311 -0.996 . . . . 75.42 108.311 167.128 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 14.5 tt -85.89 -35.93 9.99 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 CA-C-O 118.541 -0.742 . . . . 75.54 112.01 -169.402 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 68.9 t -49.79 -59.97 5.89 Favored Pre-proline 0 CA--C 1.541 0.621 0 CA-C-N 120.358 1.435 . . . . 75.43 111.479 176.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -70.12 -20.6 32.91 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 121.332 1.355 . . . . 73.54 112.16 -174.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 81.9 t90 -61.01 -54.28 46.83 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 117.559 -1.21 . . . . 73.13 111.204 175.392 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.2 t -57.99 -40.7 81.37 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 120.646 1.566 . . . . 71.51 111.132 -179.118 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -62.8 -31.56 72.58 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 121.36 0.6 . . . . 74.33 110.5 -178.75 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -104.96 39.68 1.66 Allowed 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 126.175 1.79 . . . . 65.22 112.653 178.135 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 19.2 mt -89.51 160.26 42.34 Favored Pre-proline 0 C--O 1.238 0.454 0 C-N-CA 126.855 2.062 . . . . 72.41 109.995 165.389 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -78.99 175.85 10.49 Favored 'Trans proline' 0 N--CA 1.451 -0.989 0 C-N-CA 124.772 3.648 . . . . 74.35 112.015 175.312 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -72.35 -4.82 32.16 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 114.537 1.31 . . . . 73.41 114.537 -173.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -111.32 5.49 19.83 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 126.681 1.992 . . . . 75.33 111.907 -173.423 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 34.8 t -119.98 156.56 22.69 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 C-N-CA 124.658 1.183 . . . . 74.12 108.377 177.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 83.0 t60 -147.79 116.48 6.7 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.251 1.82 . . . . 74.22 108.694 -178.081 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -93.54 131.4 38.81 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 124.908 1.283 . . . . 73.43 109.801 -177.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 43.8 t -119.98 146.61 24.52 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 C-N-CA 124.703 1.201 . . . . 72.33 108.049 178.627 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 17.4 mtm180 -123.75 132.47 53.81 Favored 'General case' 0 CA--C 1.504 -0.794 0 N-CA-C 107.565 -1.272 . . . . 73.24 107.565 168.658 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 26.7 mt -141.76 153.64 64.9 Favored Pre-proline 0 C--N 1.321 -0.649 0 C-N-CA 124.388 1.075 . . . . 64.33 108.61 -179.513 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -73.39 154.64 50.91 Favored 'Trans proline' 0 N--CA 1.446 -1.278 0 C-N-CA 121.328 1.352 . . . . 71.43 111.772 178.365 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -97.96 72.89 2.23 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 125.521 1.528 . . . . 71.25 107.847 179.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 84.3 mt -74.31 78.73 1.84 Allowed 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.374 1.069 . . . . 75.25 111.238 -170.497 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -112.95 54.33 0.73 Allowed 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 125.242 1.417 . . . . 74.42 110.886 -176.409 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 60.17 173.5 0.83 Allowed Glycine 0 CA--C 1.529 0.928 0 C-N-CA 126.914 2.197 . . . . 61.23 114.615 178.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 53.0 -147.8 14.88 Favored Glycine 0 CA--C 1.53 1.015 0 O-C-N 121.282 -1.128 . . . . 75.22 111.193 -179.444 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -64.53 -10.95 9.71 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 O-C-N 122.01 -0.7 . . . . 74.22 112.886 179.518 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 34.6 m95 -70.55 -28.53 64.99 Favored 'General case' 0 C--N 1.341 0.201 0 CA-C-N 119.9 1.227 . . . . 74.51 110.775 171.524 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -72.02 -45.46 60.8 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 119.103 -1.039 . . . . 72.45 109.449 166.373 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 75.6 t -64.17 -55.65 20.77 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 N-CA-C 111.917 0.339 . . . . 64.24 111.917 -167.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 28.3 m170 -70.72 6.98 1.24 Allowed 'General case' 0 CA--C 1.535 0.386 0 O-C-N 121.529 -0.732 . . . . 74.22 112.468 179.573 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -102.69 -33.71 4.33 Favored Glycine 0 N--CA 1.439 -1.128 0 CA-C-O 118.63 -1.094 . . . . 55.13 111.36 173.36 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . 0.417 0.0 OUTLIER -71.25 -36.56 71.83 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 118.951 1.376 . . . . 73.45 112.146 -166.029 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -53.82 -45.32 70.81 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-O 116.192 -1.861 . . . . 73.14 113.253 175.819 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 50.1 t80 -45.96 -52.2 12.06 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 125.736 1.614 . . . . 75.41 109.668 -177.126 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 18.1 mt -60.34 -44.06 95.88 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 126.605 1.962 . . . . 73.13 110.555 -177.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -64.51 -40.38 95.53 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 119.283 0.947 . . . . 73.43 110.872 -178.648 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.38 -51.22 70.84 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 107.903 -1.147 . . . . 73.12 107.903 -176.011 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -69.34 -27.24 65.18 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.067 0.947 . . . . 73.4 111.495 178.221 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 4.0 t -63.07 -16.68 60.71 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.368 1.067 . . . . 65.21 113.181 176.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 13.6 mtp -92.64 -4.18 53.74 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 124.013 0.925 . . . . 74.12 112.531 173.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 74.91 9.73 83.57 Favored Glycine 0 CA--C 1.524 0.615 0 C-N-CA 125.454 1.502 . . . . 74.11 112.341 173.403 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 30.8 m -53.71 117.18 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 C-N-CA 124.245 1.018 . . . . 75.54 110.648 -173.712 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -53.27 -63.6 1.1 Allowed 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.913 1.285 . . . . 75.11 110.301 -169.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . 0.275 2.1 m170 43.58 54.09 5.56 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 127.323 2.249 . . . . 62.12 113.504 167.045 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -65.03 67.04 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 127.868 2.467 . . . . 65.13 110.11 169.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 69.1 t -153.49 -56.75 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 C-N-CA 130.221 3.409 . . . . 72.23 106.501 -175.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . 0.258 0.2 OUTLIER 44.25 29.85 0.4 Allowed 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 127.659 2.384 . . . . 73.31 115.477 171.652 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -137.42 -33.79 0.72 Allowed 'General case' 0 C--O 1.22 -0.46 0 C-N-CA 125.417 1.487 . . . . 71.41 109.642 -178.208 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -56.5 -35.51 68.11 Favored 'General case' 0 C--O 1.227 -0.129 0 CA-C-N 119.412 1.006 . . . . 64.02 110.974 177.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 37.3 t -54.17 -63.18 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-O 117.767 -1.111 . . . . 74.22 109.296 167.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -60.16 -41.44 92.81 Favored 'General case' 0 CA--C 1.548 0.875 0 CA-C-N 121.349 1.886 . . . . 71.23 109.273 -174.279 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -74.97 4.54 6.41 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 129.291 3.036 . . . . 71.11 111.568 -176.11 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -111.27 -3.16 15.44 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 125.184 1.393 . . . . 72.32 113.251 169.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 8.1 mt -126.28 -44.62 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 107.873 -1.158 . . . . 74.43 107.873 -172.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 85.2 m-70 -70.53 -65.13 0.77 Allowed 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 123.316 0.646 . . . . 73.22 111.38 177.42 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.84 -20.51 38.84 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 115.044 1.498 . . . . 72.23 115.044 -176.316 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -81.68 -39.89 23.64 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.294 -1.002 . . . . 74.14 108.294 173.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 4.0 t60 52.06 64.55 1.8 Allowed 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.168 1.387 . . . . 74.03 108.783 -174.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 3.7 mmpt? -92.32 147.34 22.99 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 124.352 1.061 . . . . 75.42 108.578 171.717 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 27.9 tttp -84.35 55.41 3.35 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 127.181 2.192 . . . . 70.43 110.14 -178.144 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 95.7 mt -75.89 34.16 0.12 Allowed 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 127.758 2.423 . . . . 74.43 111.599 -176.387 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -70.8 11.73 0.35 Allowed 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 127.001 2.12 . . . . 65.41 114.373 -165.486 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -147.98 161.39 34.91 Favored Pre-proline 0 N--CA 1.47 0.57 0 C-N-CA 126.551 1.94 . . . . 64.15 111.091 179.344 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -56.76 -48.34 19.11 Favored 'Trans proline' 0 CA--C 1.51 -0.681 0 C-N-CA 123.738 2.958 . . . . 75.31 111.981 177.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -60.04 -34.3 73.2 Favored 'General case' 0 N--CA 1.44 -0.97 0 C-N-CA 125.484 1.513 . . . . 71.41 111.336 -175.303 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -71.4 -48.23 51.13 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 126.059 1.744 . . . . 74.1 109.592 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 71.1 mtm -59.82 -49.77 76.42 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 123.814 0.846 . . . . 71.41 109.558 175.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -62.4 -43.88 97.76 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 125.409 1.484 . . . . 71.23 111.135 -177.012 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -53.01 -41.97 65.16 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 123.792 0.837 . . . . 72.31 111.303 177.295 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 93.6 t80 -76.43 -46.82 25.4 Favored 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 124.26 1.024 . . . . 72.01 109.551 -174.486 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 25.9 mt -65.38 -29.97 70.74 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.514 1.126 . . . . 74.44 110.252 -178.354 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -53.98 -31.58 51.28 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.806 0.842 . . . . 63.15 111.361 178.584 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -94.77 12.42 68.65 Favored Glycine 0 CA--C 1.527 0.785 0 CA-C-O 117.406 -1.774 . . . . 62.2 113.907 176.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 7.8 mmtm -132.46 11.33 4.48 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 120.097 1.949 . . . . 75.42 111.835 -173.229 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 97.77 42.09 3.19 Favored Glycine 0 N--CA 1.463 0.475 0 CA-C-N 119.769 1.168 . . . . 61.23 111.863 177.578 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 46.8 t -136.85 158.82 37.11 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 C-N-CA 127.101 2.16 . . . . 73.14 105.474 172.641 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -116.27 126.94 54.26 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 108.856 -0.794 . . . . 65.32 108.856 174.006 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 1.7 mtpm? -56.13 -37.0 68.87 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 123.169 0.588 . . . . 73.33 110.393 171.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -64.11 -14.92 58.16 Favored 'General case' 0 C--O 1.226 -0.165 0 C-N-CA 124.931 1.292 . . . . 63.21 111.992 -178.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 14.6 mmtp -114.66 -33.46 5.51 Favored 'General case' 0 C--O 1.225 -0.196 0 C-N-CA 124.367 1.067 . . . . 75.54 111.837 178.438 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 12.8 t80 -54.82 -61.39 2.34 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 123.632 0.773 . . . . 74.31 109.353 175.306 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 32.3 mt -73.88 -37.12 64.81 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 121.663 0.744 . . . . 74.01 110.798 -161.522 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 18.8 p -66.92 -21.35 65.99 Favored 'General case' 0 N--CA 1.442 -0.856 0 C-N-CA 125.204 1.401 . . . . 75.42 111.757 179.57 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 34.0 m -97.98 -31.74 12.01 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.181 0.992 . . . . 73.43 109.867 174.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 45.4 t80 -57.83 -56.33 23.33 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 124.624 1.17 . . . . 75.12 110.219 177.008 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 -89.47 56.89 3.75 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 108.002 -1.11 . . . . 71.0 108.002 173.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -134.96 160.24 38.94 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 124.061 0.944 . . . . 74.05 110.424 172.336 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -55.28 -28.09 51.04 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.68 1.592 . . . . 75.33 112.654 -179.114 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -45.32 -67.13 0.31 Allowed 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 125.691 1.597 . . . . 73.41 108.728 171.535 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 24.7 mm -61.28 -40.24 85.36 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 CA-C-O 117.524 -1.227 . . . . 74.2 111.295 -178.288 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 18.4 mtpp -54.74 -38.34 67.02 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 120.537 1.517 . . . . 75.23 110.137 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -78.22 -43.57 13.04 Favored Glycine 0 N--CA 1.442 -0.94 0 N-CA-C 110.589 -1.005 . . . . 74.51 110.589 -177.137 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 9.2 mt-30 -62.12 -39.57 92.98 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 123.15 0.58 . . . . 74.33 109.688 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 1.7 mtp -56.42 -57.59 11.63 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 124.673 1.189 . . . . 64.35 109.28 173.594 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -70.82 -31.2 67.85 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 118.898 -1.121 . . . . 73.22 112.227 -168.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 4.5 mttt -63.2 -59.18 5.09 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 123.88 0.872 . . . . 74.52 110.814 170.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -58.13 -35.58 71.7 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 119.459 1.027 . . . . 75.35 110.807 179.683 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 10.0 tmtt? -61.11 -53.2 60.08 Favored 'General case' 0 N--CA 1.456 -0.139 0 O-C-N 120.437 -1.415 . . . . 73.42 110.557 177.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.02 -25.11 64.33 Favored 'General case' 0 C--O 1.221 -0.396 0 CA-C-N 120.096 1.316 . . . . 74.45 111.874 176.756 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 30.0 mt -70.68 -59.27 2.92 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 119.57 1.077 . . . . 75.5 110.991 -178.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -55.42 -44.68 76.49 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 118.412 0.551 . . . . 74.03 111.176 -170.642 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 4.1 ppp? -64.49 -41.75 96.27 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 113.574 0.953 . . . . 74.24 113.574 176.394 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -64.62 -29.81 70.82 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 116.374 -1.774 . . . . 64.13 110.869 -178.375 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -80.0 11.77 3.17 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 127.787 2.435 . . . . 73.41 113.369 176.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 21.4 mt-30 59.67 18.63 7.34 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 127.51 2.324 . . . . 75.22 115.039 -177.332 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 40.2 t -73.43 141.45 16.27 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 O-C-N 121.12 -0.988 . . . . 75.21 108.919 -179.461 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -135.91 3.26 2.93 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.032 0.933 . . . . 64.11 113.078 -177.557 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -174.33 -173.93 40.72 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 108.711 -1.756 . . . . 75.23 108.711 -179.164 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.441 ' HA ' ' C ' ' A' ' 154' ' ' PRO . 6.4 m -139.41 154.16 71.45 Favored Pre-proline 0 CA--C 1.535 0.398 0 C-N-CA 125.794 1.638 . . . . 74.54 109.349 176.597 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . 0.441 ' C ' ' HA ' ' A' ' 153' ' ' VAL . 35.7 Cg_endo -65.03 160.04 72.13 Favored 'Cis proline' 0 CA--C 1.533 0.431 0 C-N-CA 125.317 -0.701 . . . . 74.01 113.793 -2.269 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 17.7 m -157.81 141.66 15.75 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 124.816 1.246 . . . . 71.32 108.367 173.594 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 19.2 mmm -123.5 155.88 36.69 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 125.968 1.707 . . . . 75.44 108.512 167.341 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 6.1 t -135.26 153.77 34.5 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 N-CA-C 106.946 -1.502 . . . . 75.1 106.946 174.43 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 58.5 t -126.45 123.86 64.21 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 C-N-CA 126.439 1.896 . . . . 72.32 106.995 173.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 1.2 t30 54.56 16.7 1.41 Allowed 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 129.472 3.109 . . . . 72.21 115.898 166.697 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 74.37 28.43 63.83 Favored Glycine 0 CA--C 1.523 0.572 0 C-N-CA 128.866 3.127 . . . . 74.43 113.205 -176.131 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 33.5 mttt -139.33 -31.26 0.7 Allowed 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 114.848 1.425 . . . . 75.01 114.848 -166.268 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -125.13 138.51 54.16 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 107.91 -1.144 . . . . 72.0 107.91 177.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 71.0 ttt-85 -122.6 141.57 51.57 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 105.381 -2.081 . . . . 72.33 105.381 178.126 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 11.4 p90 -153.9 170.66 20.49 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 107.097 -1.446 . . . . 75.43 107.097 -179.243 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -173.97 -178.99 1.62 Allowed 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 123.822 0.849 . . . . 73.23 109.103 178.643 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 15.6 mt -52.0 -48.36 40.93 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 C-N-CA 126.245 1.818 . . . . 64.42 109.324 176.085 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -71.65 -34.36 63.02 Favored Glycine 0 CA--C 1.525 0.676 0 CA-C-O 118.744 -1.031 . . . . 74.31 113.009 179.302 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 3.5 m -65.21 -55.79 16.51 Favored 'General case' 0 C--O 1.227 -0.09 0 CA-C-N 119.649 1.724 . . . . 54.32 109.523 174.021 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -67.29 -49.53 63.86 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 124.507 1.123 . . . . 72.31 111.111 -171.03 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 124.43 5.13 7.32 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 125.069 1.319 . . . . 74.34 113.921 -176.633 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 162.04 173.63 30.94 Favored Glycine 0 CA--C 1.528 0.874 0 CA-C-N 118.839 1.319 . . . . 70.25 111.014 175.726 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -66.62 -47.66 2.73 Favored 'Trans proline' 0 CA--C 1.532 0.416 0 C-N-CA 122.785 2.323 . . . . 74.44 111.157 -175.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -54.01 -46.6 71.85 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.143 0.977 . . . . 74.23 110.16 172.528 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -65.33 -26.48 68.06 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.684 0.794 . . . . 72.24 110.403 -176.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 25.0 m -65.83 -40.82 92.16 Favored 'General case' 0 CA--C 1.533 0.3 0 O-C-N 120.663 -1.273 . . . . 71.24 109.524 178.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 37.7 mt -66.62 -29.72 69.82 Favored 'General case' 0 C--N 1.342 0.249 0 CA-C-N 119.507 1.049 . . . . 75.3 111.132 175.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.65 -47.78 66.86 Favored 'General case' 0 C--N 1.339 0.145 0 C-N-CA 124.093 0.957 . . . . 74.13 109.208 171.241 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -72.75 -42.1 64.41 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-O 118.33 -0.843 . . . . 74.04 110.845 178.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -53.18 -48.01 68.37 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 118.699 0.681 . . . . 74.43 111.788 -173.385 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -75.8 -34.53 60.18 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 123.01 0.524 . . . . 73.3 110.752 -172.13 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -66.2 -48.36 70.87 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 124.83 1.252 . . . . 63.01 111.087 174.206 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 68.7 mt -65.52 -32.69 74.42 Favored 'General case' 0 N--CA 1.457 -0.077 0 C-N-CA 124.312 1.045 . . . . 65.35 111.155 -177.248 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 29.0 mt -50.39 -57.85 2.15 Favored 'Isoleucine or valine' 0 C--N 1.34 0.179 0 CA-C-O 117.976 -1.011 . . . . 75.13 108.781 168.177 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -57.74 -37.04 72.89 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 119.813 1.188 . . . . 75.3 111.552 -176.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 22.6 tptt -56.54 -38.97 72.61 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.466 0.706 . . . . 75.11 111.469 -175.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 51.3 mm-40 -90.98 -42.88 10.3 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 123.741 0.816 . . . . 73.32 111.665 176.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.95 -37.65 77.25 Favored 'General case' 0 C--N 1.333 -0.128 0 O-C-N 120.76 -1.212 . . . . 74.53 110.175 -177.033 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -57.09 -27.34 61.67 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 124.834 1.253 . . . . 72.32 111.584 178.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -57.01 -24.52 54.26 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 123.261 0.624 . . . . 73.32 112.043 175.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -124.86 21.38 8.28 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 128.508 2.723 . . . . 63.22 111.886 -174.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 5.7 tttt -123.12 34.86 5.01 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 119.333 0.97 . . . . 65.35 112.44 -170.429 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . 0.264 7.3 pttm . . . . . 0 C--O 1.248 0.995 0 N-CA-C 105.877 -1.898 . . . . 75.12 105.877 168.266 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 . . . . . 0 N--CA 1.464 0.245 0 CA-C-O 121.732 0.777 . . . . 75.040000000000006 110.504 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -128.33 4.91 5.73 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 113.883 1.068 . . . . 74.150000000000006 113.883 -161.647 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 16.1 m-85 -140.95 161.86 36.83 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 125.332 1.453 . . . . 71.329999999999998 108.234 -170.165 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 24.6 m -133.73 141.94 47.74 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.123 0.569 . . . . 73.329999999999998 109.564 -177.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -70.37 152.96 43.53 Favored 'General case' 0 C--O 1.235 0.316 0 O-C-N 121.477 -0.764 . . . . 75.209999999999994 109.423 173.68 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 73.28 -41.35 0.92 Allowed Glycine 0 CA--C 1.531 1.049 0 C-N-CA 125.877 1.703 . . . . 45.030000000000001 111.626 -164.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 17.6 tptt -74.89 -85.16 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 126.631 1.972 . . . . 54.140000000000001 110.612 -174.551 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.7 mp0 -77.82 -25.03 48.58 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 125.343 1.457 . . . . 73.040000000000006 110.075 -174.692 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 41.2 p90 -161.17 178.01 9.69 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 123.885 0.874 . . . . 70.349999999999994 109.719 -173.121 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 79.2 t -132.47 109.28 14.58 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 C-N-CA 125.074 1.35 . . . . 74.109999999999999 108.179 -179.154 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.22 162.63 24.56 Favored 'General case' 0 C--O 1.235 0.317 0 O-C-N 120.815 -1.178 . . . . 70.209999999999994 108.24 158.327 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -140.88 118.34 11.49 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 124.049 0.94 . . . . 72.129999999999995 109.584 -172.069 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.2 m -71.11 7.9 1.11 Allowed 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.99 1.316 . . . . 64.540000000000006 113.025 -174.647 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 33.0 m -134.47 82.13 46.85 Favored Pre-proline 0 N--CA 1.449 -0.505 0 C-N-CA 125.592 1.557 . . . . 74.230000000000004 109.224 173.887 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -75.16 -174.85 2.11 Favored 'Trans proline' 0 CA--C 1.544 1.005 0 C-N-CA 124.966 3.778 . . . . 41.329999999999998 114.011 -174.005 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 10.8 t -141.92 143.27 27.82 Favored Pre-proline 0 CA--C 1.545 0.788 0 C-N-CA 125.872 1.669 . . . . 71.219999999999999 109.339 168.015 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -90.05 178.87 2.14 Favored 'Trans proline' 0 CA--C 1.543 0.956 1 C-N-CA 125.777 4.318 . . . . 71.209999999999994 113.068 170.025 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 4.6 m -112.85 -177.7 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 C-N-CA 126.085 1.754 . . . . 72.239999999999995 110.327 171.86 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 12.6 t -63.12 -38.29 90.57 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 125.941 1.696 . . . . 72.209999999999994 112.05 172.511 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -153.53 143.49 15.34 Favored Pre-proline 0 N--CA 1.45 -0.457 0 CA-C-O 117.532 -1.223 . . . . 72.030000000000001 107.72 -179.424 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -72.62 178.0 6.82 Favored 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 122.437 2.091 . . . . 71.209999999999994 111.118 173.268 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 133.46 -95.85 0.29 Allowed Glycine 0 C--N 1.332 0.318 0 N-CA-C 108.456 -1.858 . . . . 73.430000000000007 108.456 174.071 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.642 ' H ' ' HE3' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -70.28 137.73 50.97 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 107.461 -1.311 . . . . 73.340000000000003 107.461 176.592 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 33.6 mm -67.69 133.32 31.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 106.79 -1.559 . . . . 60.200000000000003 106.79 175.021 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -83.95 143.65 29.69 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.283 -0.636 . . . . 62.399999999999999 109.283 176.913 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 25.7 t -133.68 109.53 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.225 0 N-CA-C 106.381 -1.711 . . . . 63.439999999999998 106.381 171.634 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 58.6 t -96.56 115.06 34.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 N-CA-C 106.104 -1.813 . . . . 71.019999999999996 106.104 179.098 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -76.45 134.99 39.4 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 107.937 -1.134 . . . . 71.430000000000007 107.937 157.266 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.744 HD22 HG21 ' A' ' 150' ' ' VAL . 3.3 mp -125.95 123.23 38.09 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 125.661 1.584 . . . . 73.310000000000002 108.011 170.83 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 15.9 p90 -138.94 176.71 8.46 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.376 1.071 . . . . 64.340000000000003 110.816 -170.776 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 25.0 t90 -147.1 172.12 14.25 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.997 1.319 . . . . 75.510000000000005 107.857 177.054 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 19.7 t80 -56.01 -41.0 74.22 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 126.374 1.869 . . . . 45.119999999999997 113.129 173.115 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -92.99 -106.87 1.76 Allowed Glycine 0 N--CA 1.449 -0.483 0 N-CA-C 107.965 -2.054 . . . . 74.010000000000005 107.965 -168.091 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 21.1 p 44.22 72.34 1.23 Allowed Pre-proline 0 C--O 1.221 -0.419 0 C-N-CA 125.373 1.469 . . . . 65.120000000000005 112.03 175.63 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -58.93 -24.9 75.02 Favored 'Trans proline' 0 CA--C 1.539 0.739 0 CA-C-N 121.596 1.606 . . . . 71.530000000000001 113.419 -171.079 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 19.7 m170 -71.98 -33.03 67.82 Favored 'General case' 0 CA--C 1.549 0.926 0 CA-C-O 118.059 -0.972 . . . . 73.450000000000003 112.512 172.125 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 15.9 p -65.85 -38.33 88.57 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 120.746 1.612 . . . . 73.140000000000001 110.793 -179.166 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 34.8 t80 -64.56 -31.32 72.49 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 123.199 0.6 . . . . 72.25 111.657 176.503 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.9 -3.99 25.64 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 112.597 0.591 . . . . 71.420000000000002 112.597 174.434 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 26.1 t80 -117.45 -21.33 8.69 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 125.358 1.463 . . . . 74.219999999999999 111.982 -176.887 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -46.33 -63.52 1.29 Allowed Pre-proline 0 N--CA 1.474 0.762 0 CA-C-N 120.446 1.475 . . . . 73.430000000000007 112.432 178.434 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -71.93 -6.77 19.78 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 CA-C-N 121.856 1.698 . . . . 72.349999999999994 114.084 -175.406 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.0 m -78.95 -42.83 25.92 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.172 1.389 . . . . 71.230000000000004 108.535 169.379 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 20.2 tt -89.84 -36.48 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 O-C-N 121.5 -0.75 . . . . 73.209999999999994 112.035 -171.304 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 54.2 t -50.69 -54.24 38.12 Favored Pre-proline 0 CA--C 1.54 0.565 0 C-N-CA 124.787 1.235 . . . . 62.409999999999997 111.591 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -68.73 -36.34 14.3 Favored 'Trans proline' 0 N--CA 1.454 -0.852 0 CA-C-N 121.098 1.428 . . . . 55.450000000000003 111.416 178.629 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.505 ' CH2' ' HB1' ' A' ' 179' ' ' ALA . 79.2 t90 -54.75 -51.05 66.9 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 118.801 0.728 . . . . 72.310000000000002 109.486 177.326 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -63.16 -37.39 87.04 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 117.857 0.299 . . . . 61.450000000000003 111.292 -175.844 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -62.59 -48.69 78.31 Favored 'General case' 0 N--CA 1.453 -0.299 0 O-C-N 121.58 -0.7 . . . . 75.140000000000001 109.255 179.241 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.54 18.24 2.37 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.84 0.856 . . . . 64.010000000000005 113.087 -173.91 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 19.7 mt -65.02 156.34 80.88 Favored Pre-proline 0 N--CA 1.451 -0.381 0 C-N-CA 123.483 0.713 . . . . 62.310000000000002 110.355 174.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -76.06 177.13 9.14 Favored 'Trans proline' 0 N--CA 1.452 -0.917 0 C-N-CA 124.648 3.566 . . . . 71.140000000000001 111.164 177.882 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -67.32 -7.99 28.87 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.535 1.134 . . . . 54.299999999999997 113.371 -178.51 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -107.29 1.77 24.09 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 119.804 1.184 . . . . 71.420000000000002 112.369 -168.592 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 40.7 t -125.66 137.52 57.41 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 N-CA-C 107.835 -1.172 . . . . 74.400000000000006 107.835 -172.512 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 67.2 t60 -127.5 99.94 5.81 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 124.687 1.195 . . . . 72.129999999999995 109.227 -177.064 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 35.0 t80 -80.51 142.15 34.47 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 114.389 -1.278 . . . . 61.329999999999998 110.863 176.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 32.6 t -135.08 154.57 36.41 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 C-N-CA 126.573 1.949 . . . . 73.239999999999995 106.85 178.585 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 9.6 mtm180 -132.11 120.18 21.98 Favored 'General case' 0 CA--C 1.516 -0.341 0 C-N-CA 124.364 1.066 . . . . 62.299999999999997 108.479 175.377 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 28.9 mt -132.33 153.28 81.18 Favored Pre-proline 0 C--N 1.33 -0.279 0 O-C-N 121.903 -0.498 . . . . 75.510000000000005 110.614 -177.885 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -81.71 144.97 14.22 Favored 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 123.455 2.77 . . . . 73.319999999999993 112.149 -178.846 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -90.91 74.42 6.47 Favored 'General case' 0 CA--C 1.528 0.122 0 C-N-CA 124.221 1.008 . . . . 62.530000000000001 109.338 -171.104 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 15.7 mt -74.32 86.84 1.99 Allowed 'General case' 0 CA--C 1.543 0.683 0 O-C-N 121.226 -0.921 . . . . 64.140000000000001 110.96 -170.605 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -105.87 24.76 11.82 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.495 1.118 . . . . 70.430000000000007 112.414 -178.735 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 89.14 171.28 45.53 Favored Glycine 0 CA--C 1.528 0.854 0 N-CA-C 110.215 -1.154 . . . . 64.219999999999999 110.215 -175.724 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 46.5 -146.49 3.27 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 124.117 0.865 . . . . 73.239999999999995 113.249 177.653 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 6.7 tp -63.92 -18.57 22.77 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 C-N-CA 123.288 0.635 . . . . 72.540000000000006 112.544 -172.617 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 9.4 m95 -62.16 -44.36 96.79 Favored 'General case' 0 C--N 1.344 0.362 0 CA-C-N 119.537 1.062 . . . . 71.019999999999996 109.537 176.316 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 4.3 p30 -77.08 -39.44 49.74 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 117.858 -1.067 . . . . 71.230000000000004 111.884 178.903 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 56.1 t -55.83 -52.03 53.47 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-N 119.153 0.888 . . . . 72.219999999999999 109.811 -178.906 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 34.0 m170 -63.64 -31.94 73.26 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 118.691 -0.671 . . . . 65.230000000000004 112.808 -176.547 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -87.98 -12.08 66.59 Favored Glycine 0 C--N 1.335 0.515 0 CA-C-N 119.701 1.137 . . . . 33.039999999999999 111.706 -175.143 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -60.97 -43.77 98.31 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 123.662 0.785 . . . . 75.040000000000006 110.667 -173.311 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 3.7 ppp? -50.22 -32.96 17.9 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 125.318 1.447 . . . . 64.510000000000005 114.155 177.685 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -59.92 -49.52 77.37 Favored 'General case' 0 N--CA 1.458 -0.072 0 C-N-CA 125.181 1.392 . . . . 74.430000000000007 108.421 -175.221 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 29.2 mt -66.26 -36.54 83.27 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 124.486 1.114 . . . . 74.310000000000002 109.732 179.244 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.02 -46.86 82.6 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 120.006 1.275 . . . . 74.030000000000001 110.801 176.71 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.31 -50.79 64.22 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 125.878 1.671 . . . . 71.409999999999997 107.961 -175.79 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -62.12 -46.31 89.61 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.516 1.126 . . . . 73.219999999999999 111.52 174.806 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 7.1 t -53.3 -32.89 50.98 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 126.102 1.761 . . . . 65.409999999999997 113.941 -172.385 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' MET . . . . . 0.456 ' HE3' HG13 ' A' ' 120' ' ' VAL . 8.1 ptp . . . . . 0 N--CA 1.467 0.416 0 N-CA-C 114.16 1.17 . . . . 70.420000000000002 114.16 179.659 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.342 0 N-CA-C 113.059 0.763 . . . . 60.439999999999998 113.059 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 66.9 t -51.61 -70.6 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 C-N-CA 128.369 2.668 . . . . 61.229999999999997 111.063 160.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -54.27 -43.07 70.7 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 125.948 1.699 . . . . 72.430000000000007 110.977 176.058 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -83.63 14.86 3.5 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 126.018 1.727 . . . . 73.150000000000006 110.846 -174.32 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -114.76 -19.85 10.87 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 126.081 1.752 . . . . 71.099999999999994 114.604 157.439 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 36.9 mt -80.5 -66.71 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 N-CA-C 108.373 -0.973 . . . . 73.319999999999993 108.373 175.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -78.45 -66.96 0.79 Allowed 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 114.038 1.125 . . . . 71.129999999999995 114.038 -163.14 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 29.8 mtpt -50.3 -53.19 30.47 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 125.36 1.464 . . . . 63.109999999999999 109.996 177.758 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 22.4 mm-40 -75.68 -28.11 58.54 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 125.609 1.563 . . . . 64.340000000000003 109.426 -168.067 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 22.3 t-160 64.86 26.57 12.89 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 126.217 1.807 . . . . 61.049999999999997 111.358 174.389 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 28.2 mmtp -70.61 140.23 51.59 Favored 'General case' 0 C--N 1.342 0.251 0 O-C-N 121.1 -1.0 . . . . 75.010000000000005 109.665 177.361 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 19.8 tttt -56.97 -51.03 70.84 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 125.277 1.431 . . . . 73.319999999999993 111.313 -171.688 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 50.2 mt 47.86 35.14 4.5 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.363 1.465 . . . . 74.329999999999998 112.496 173.082 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -94.11 -7.16 43.25 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 113.941 1.089 . . . . 55.240000000000002 113.941 -169.78 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 17.3 p -135.98 155.23 77.86 Favored Pre-proline 0 C--O 1.235 0.308 0 CA-C-N 119.242 0.928 . . . . 71.109999999999999 109.639 -177.15 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -63.14 -33.61 72.03 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 122.088 1.858 . . . . 72.010000000000005 111.843 -178.616 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -66.32 -23.88 66.44 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 118.467 0.576 . . . . 74.5 111.974 176.299 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -81.77 -44.79 16.53 Favored 'General case' 0 CA--C 1.528 0.111 0 C-N-CA 123.57 0.748 . . . . 73.329999999999998 109.851 175.492 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 44.4 mtt -66.11 -54.55 24.24 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 123.628 0.771 . . . . 61.530000000000001 109.162 -175.11 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.489 ' HB2' ' CD1' ' A' ' 125' ' ' PHE . . . -68.18 -29.91 68.89 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 119.073 -0.489 . . . . 55.149999999999999 111.518 -173.905 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -62.21 -48.61 79.25 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 123.524 0.73 . . . . 71.329999999999998 110.464 169.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 86.8 t80 -62.4 -42.52 99.49 Favored 'General case' 0 N--CA 1.447 -0.592 0 O-C-N 122.21 -0.306 . . . . 75.409999999999997 111.725 -179.698 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 35.3 mt -80.89 -11.59 59.56 Favored 'General case' 0 N--CA 1.451 -0.408 0 O-C-N 121.339 -0.851 . . . . 51.210000000000001 111.071 -172.875 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -54.51 -37.65 65.59 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 118.082 0.401 . . . . 61.350000000000001 110.506 178.058 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -84.53 8.97 66.25 Favored Glycine 0 CA--C 1.528 0.857 0 C-N-CA 124.928 1.251 . . . . 53.25 114.818 175.616 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 52.4 mmtt -133.74 45.01 2.7 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-N 119.485 1.643 . . . . 65.129999999999995 110.256 -169.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 63.25 22.84 65.72 Favored Glycine 0 CA--C 1.53 1.022 0 CA-C-O 118.6 -1.111 . . . . 62.240000000000002 113.503 170.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.456 HG13 ' HE3' ' A' ' 84' ' ' MET . 41.9 t -114.17 151.89 15.91 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 C-N-CA 127.528 2.331 . . . . 75.409999999999997 106.335 173.368 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -115.67 140.56 49.08 Favored 'General case' 0 C--O 1.235 0.33 0 O-C-N 121.963 -0.461 . . . . 74.430000000000007 110.322 172.566 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 10.8 mttt -62.69 -39.97 95.67 Favored 'General case' 0 CA--C 1.527 0.061 0 CA-C-O 118.42 -0.8 . . . . 63.109999999999999 110.519 178.88 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 59.2 mt-10 -50.99 -52.39 43.25 Favored 'General case' 0 N--CA 1.457 -0.124 0 CA-C-N 118.888 0.767 . . . . 64.120000000000005 109.954 176.663 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 88.1 mttt -79.53 -42.14 25.8 Favored 'General case' 0 CA--C 1.515 -0.399 0 N-CA-C 107.075 -1.454 . . . . 61.539999999999999 107.075 -166.27 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.489 ' CD1' ' HB2' ' A' ' 112' ' ' ALA . 62.4 t80 -55.78 -60.32 3.62 Favored 'General case' 0 N--CA 1.443 -0.821 0 C-N-CA 123.798 0.839 . . . . 72.010000000000005 109.357 179.716 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 47.8 mt -67.2 -37.81 84.28 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-O 118.953 -0.546 . . . . 73.030000000000001 110.799 -172.802 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 2.9 t -64.73 -41.77 95.7 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 119.42 1.009 . . . . 72.530000000000001 110.127 -176.691 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 3.4 t -80.23 -31.77 38.53 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 118.839 0.745 . . . . 71.010000000000005 111.069 -179.011 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 91.0 t80 -53.45 -52.93 57.87 Favored 'General case' 0 C--O 1.234 0.268 0 O-C-N 121.294 -0.879 . . . . 63.5 109.369 170.882 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -86.58 56.5 4.03 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 125.205 1.402 . . . . 74.439999999999998 109.033 176.708 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 14.9 t -136.26 168.5 19.29 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 124.037 0.935 . . . . 74.25 110.549 176.182 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -69.34 -27.16 65.11 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.249 0.62 . . . . 65.109999999999999 110.053 167.288 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -51.73 -53.73 36.14 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 124.209 1.003 . . . . 71.209999999999994 111.005 -178.558 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.4 HD13 ' HA ' ' A' ' 134' ' ' ILE . 14.3 mm -65.17 -36.56 78.05 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 CA-C-O 118.763 -0.637 . . . . 74.349999999999994 110.853 177.862 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 22.4 mttt -57.88 -38.3 75.52 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 119.511 1.05 . . . . 75.420000000000002 110.369 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -72.2 -17.73 77.57 Favored Glycine 0 CA--C 1.528 0.86 0 N-CA-C 111.842 -0.503 . . . . 72.400000000000006 111.842 -177.897 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 6.9 mt-30 -88.98 -42.77 11.58 Favored 'General case' 0 N--CA 1.453 -0.276 0 O-C-N 121.542 -0.975 . . . . 61.409999999999997 110.514 174.535 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 91.7 mmm -58.37 -52.58 65.01 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 108.636 -0.876 . . . . 74.200000000000003 108.636 -178.884 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -65.85 -30.46 71.08 Favored 'General case' 0 CA--C 1.535 0.365 0 CA-C-N 119.112 0.869 . . . . 71.129999999999995 112.509 -172.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 13.5 mmtt -63.3 -68.54 0.33 Allowed 'General case' 0 C--O 1.227 -0.083 0 C-N-CA 126.081 1.752 . . . . 73.319999999999993 109.606 171.074 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -54.73 -36.27 64.59 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 119.218 0.917 . . . . 62.229999999999997 111.208 -174.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -54.57 -66.14 0.45 Allowed 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 126.374 1.87 . . . . 70.209999999999994 110.949 172.176 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.69 -31.51 72.23 Favored 'General case' 0 N--CA 1.466 0.33 0 O-C-N 121.433 -0.792 . . . . 64.219999999999999 111.142 -174.233 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 49.2 mt -60.11 -54.29 47.67 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 123.968 0.907 . . . . 65.209999999999994 109.778 178.745 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -54.13 -42.14 69.17 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 118.842 0.746 . . . . 74.219999999999999 111.341 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -64.25 -43.51 94.68 Favored 'General case' 0 C--O 1.235 0.336 0 O-C-N 121.499 -0.751 . . . . 73.239999999999995 111.229 178.807 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -63.35 -40.17 96.55 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 123.72 0.808 . . . . 73.430000000000007 110.383 -179.466 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 52.8 m-85 -72.78 11.92 0.59 Allowed 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 114.181 1.178 . . . . 74.230000000000004 114.181 -178.658 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 55.59 27.81 11.0 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.295 1.438 . . . . 75.150000000000006 113.347 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.744 HG21 HD22 ' A' ' 32' ' ' LEU . 40.8 t -64.02 -47.78 88.89 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 C-N-CA 124.995 1.318 . . . . 74.510000000000005 112.791 -168.317 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 82.0 p 55.0 -54.51 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 128.713 2.805 . . . . 74.430000000000007 114.82 -166.029 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -146.94 -166.76 12.55 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 127.161 2.315 . . . . 45.439999999999998 110.506 -173.28 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 29.1 m -143.83 155.12 59.54 Favored Pre-proline 0 C--O 1.239 0.551 0 C-N-CA 125.47 1.508 . . . . 73.310000000000002 108.779 -172.65 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -68.81 145.38 77.12 Favored 'Cis proline' 0 C--N 1.345 0.359 0 C-N-CA 125.055 -0.81 . . . . 74.019999999999996 113.918 0.705 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 37.8 m -149.43 127.94 12.31 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 125.431 1.493 . . . . 51.329999999999998 107.533 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 20.2 mmm -115.26 148.46 39.13 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 125.561 1.544 . . . . 74.230000000000004 107.916 172.126 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 49.9 t -138.96 115.38 10.09 Favored 'Isoleucine or valine' 0 C--O 1.238 0.482 0 N-CA-C 109.571 -0.529 . . . . 75.040000000000006 109.571 -177.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.569 HG23 ' CE1' ' A' ' 164' ' ' PHE . 95.2 t -84.48 127.23 40.03 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 N-CA-C 107.764 -1.198 . . . . 72.219999999999999 107.764 170.477 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 6.1 t30 49.34 26.15 1.5 Allowed 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 130.128 3.371 . . . . 65.519999999999996 115.243 165.306 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 56.8 28.77 57.71 Favored Glycine 0 CA--C 1.527 0.825 0 C-N-CA 126.311 1.91 . . . . 34.439999999999998 114.172 -172.694 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 6.1 mtpt -131.72 -22.33 2.4 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 120.08 1.94 . . . . 73.109999999999999 112.916 -179.488 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -128.08 126.75 41.81 Favored 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 107.954 -1.128 . . . . 75.439999999999998 107.954 179.125 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 9.2 ttp85 -109.27 134.29 51.96 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 127.187 2.195 . . . . 70.099999999999994 105.643 176.531 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 164' ' ' PHE . . . . . 0.569 ' CE1' HG23 ' A' ' 158' ' ' VAL . 11.8 p90 -152.26 167.55 28.25 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.675 -0.861 . . . . 74.329999999999998 108.675 -178.897 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -175.9 177.8 1.59 Allowed 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.655 1.182 . . . . 72.340000000000003 109.903 -179.594 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 10.8 mt -47.1 -47.7 8.72 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.131 0 C-N-CA 127.145 2.178 . . . . 55.310000000000002 109.394 176.44 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -80.86 -8.89 86.97 Favored Glycine 0 N--CA 1.448 -0.556 0 CA-C-O 118.092 -1.393 . . . . 52.450000000000003 113.715 -177.678 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 1.2 m -82.94 -65.79 0.97 Allowed 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 119.743 1.771 . . . . 63.43 107.504 164.032 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -59.51 -54.85 41.8 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 124.388 1.075 . . . . 65.25 109.774 -168.844 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 140.58 -8.45 2.84 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 124.764 1.173 . . . . 72.010000000000005 114.106 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 171.38 167.08 31.13 Favored Glycine 0 CA--C 1.526 0.73 0 CA-C-N 119.598 1.699 . . . . 63.409999999999997 109.401 -174.533 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_endo -64.5 -45.36 9.28 Favored 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 122.902 2.401 . . . . 72.120000000000005 111.518 -173.659 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -65.12 -25.55 67.81 Favored 'General case' 0 CA--C 1.537 0.445 0 O-C-N 121.32 -0.862 . . . . 63.409999999999997 111.536 174.578 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -77.07 -28.28 54.6 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.745 0.818 . . . . 72.010000000000005 111.021 177.147 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 93.4 m -60.12 -45.51 92.75 Favored 'General case' 0 N--CA 1.464 0.235 0 O-C-N 120.581 -1.324 . . . . 51.100000000000001 109.854 178.332 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 52.5 mt -62.09 -31.83 72.31 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 118.028 0.376 . . . . 73.230000000000004 110.622 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 14.2 ttpt -55.8 -40.16 72.31 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 124.131 0.973 . . . . 71.510000000000005 110.07 174.035 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -75.05 -44.82 45.47 Favored 'General case' 0 CA--C 1.509 -0.614 0 CA-C-O 117.876 -1.059 . . . . 73.299999999999997 111.196 173.726 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.505 ' HB1' ' CH2' ' A' ' 50' ' ' TRP . . . -51.66 -47.45 63.8 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 119.048 0.84 . . . . 62.420000000000002 111.75 -172.019 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -68.91 -47.48 65.71 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.209 1.004 . . . . 72.019999999999996 110.524 -175.299 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -55.17 -49.35 72.08 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 125.301 1.441 . . . . 73.409999999999997 111.164 175.273 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 77.5 mt -66.11 -34.78 78.83 Favored 'General case' 0 C--O 1.232 0.14 0 C-N-CA 124.617 1.167 . . . . 71.400000000000006 111.583 -178.674 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 28.8 mt -60.5 -54.52 33.95 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.143 0 N-CA-C 107.845 -1.169 . . . . 64.439999999999998 107.845 173.581 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -53.36 -42.33 66.72 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 119.271 0.941 . . . . 73.329999999999998 111.042 -179.311 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 42.9 tptt -59.96 -37.0 78.32 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 126.296 1.838 . . . . 53.310000000000002 111.881 -177.59 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 34.7 mm-40 -90.44 -31.34 16.85 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.562 1.145 . . . . 75.209999999999994 111.784 177.607 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 187' ' ' ARG . . . . . 0.567 ' HA ' ' HE ' ' A' ' 187' ' ' ARG . 1.4 tpm_? -61.18 -37.96 84.81 Favored 'General case' 0 CA--C 1.514 -0.419 0 O-C-N 120.439 -1.413 . . . . 74.420000000000002 110.071 178.787 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.273 0 C-N-CA 127.856 2.462 . . . . 61.399999999999999 110.975 173.477 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 . . . . . 0 N--CA 1.456 -0.153 0 CA-C-O 122.606 1.193 . . . . 75.310000000000002 111.234 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -131.66 6.86 4.41 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.455 1.102 . . . . 73.209999999999994 111.866 -177.952 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 34.0 m-85 -130.35 160.62 33.42 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 124.104 0.962 . . . . 44.539999999999999 110.006 -169.104 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 59.7 m -137.07 133.27 35.22 Favored 'General case' 0 C--O 1.239 0.541 0 N-CA-C 107.04 -1.467 . . . . 75.239999999999995 107.04 179.0 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.26 146.62 54.71 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 109.101 -0.703 . . . . 74.319999999999993 109.101 174.003 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 79.92 -35.13 2.11 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 126.332 1.92 . . . . 51.329999999999998 112.081 -170.023 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 21.4 tptt -77.54 -63.92 1.27 Allowed 'General case' 0 CA--C 1.518 -0.279 0 C-N-CA 124.687 1.195 . . . . 74.239999999999995 110.456 -176.895 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -98.16 -26.15 14.66 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 125.002 1.321 . . . . 41.119999999999997 109.362 -171.171 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 45.0 p90 -157.96 174.96 14.46 Favored 'General case' 0 N--CA 1.468 0.429 0 O-C-N 121.55 -0.719 . . . . 72.530000000000001 110.625 -172.522 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 48.7 t -132.72 106.9 11.25 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 N-CA-C 107.548 -1.279 . . . . 65.319999999999993 107.548 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 13.4 tt0 -64.81 147.94 52.24 Favored 'General case' 0 N--CA 1.445 -0.693 0 O-C-N 120.111 -1.618 . . . . 71.340000000000003 109.209 165.419 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -110.55 103.96 12.62 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.252 -1.34 . . . . 75.129999999999995 110.005 -178.76 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 79.6 p -65.0 5.85 0.3 Allowed 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 114.521 1.304 . . . . 41.509999999999998 114.521 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 8.8 t -128.37 85.28 60.85 Favored Pre-proline 0 N--CA 1.449 -0.479 0 N-CA-C 105.975 -1.861 . . . . 61.219999999999999 105.975 159.806 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -72.34 178.91 5.55 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 123.608 2.872 . . . . 62.420000000000002 111.097 -176.157 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 10.9 t -142.99 137.47 14.95 Favored Pre-proline 0 CA--C 1.539 0.521 0 C-N-CA 124.029 0.932 . . . . 64.209999999999994 109.186 -176.884 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -79.37 -178.52 4.66 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 C-N-CA 124.53 3.487 . . . . 75.219999999999999 111.703 175.666 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 29.6 m -132.29 166.23 29.77 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 125.798 1.639 . . . . 74.150000000000006 109.009 168.0 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 5.2 m -44.92 -49.66 10.91 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 127.138 2.175 . . . . 62.329999999999998 113.304 178.77 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 36.4 tt0 -145.62 144.38 22.45 Favored Pre-proline 0 CA--C 1.539 0.521 0 C-N-CA 124.588 1.155 . . . . 72.439999999999998 108.766 176.552 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -70.55 -167.49 0.26 Allowed 'Trans proline' 0 CA--C 1.544 0.976 0 C-N-CA 123.452 2.768 . . . . 65.530000000000001 110.455 164.142 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 120.26 -65.35 0.44 Allowed Glycine 0 C--N 1.333 0.395 0 N-CA-C 109.007 -1.637 . . . . 64.120000000000005 109.007 177.347 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -103.55 146.7 28.16 Favored 'General case' 0 C--O 1.232 0.132 0 C-N-CA 125.352 1.461 . . . . 53.43 108.899 170.91 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 49.5 mm -68.69 139.68 20.18 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 N-CA-C 106.247 -1.76 . . . . 64.430000000000007 106.247 173.266 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -94.81 104.14 16.04 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 106.913 -1.514 . . . . 51.009999999999998 106.913 175.678 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 55.2 t -102.99 128.53 55.82 Favored 'Isoleucine or valine' 0 C--O 1.231 0.089 0 N-CA-C 106.482 -1.673 . . . . 60.530000000000001 106.482 173.118 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 17.6 t -133.73 118.99 31.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 N-CA-C 107.717 -1.216 . . . . 61.219999999999999 107.717 -173.434 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -87.86 144.77 26.41 Favored 'General case' 0 C--O 1.238 0.478 0 N-CA-C 107.737 -1.208 . . . . 74.319999999999993 107.737 160.754 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.9 mp -124.34 125.06 43.71 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 125.042 1.337 . . . . 73.540000000000006 108.235 174.386 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -115.11 175.95 5.28 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.564 0.746 . . . . 72.340000000000003 112.717 -169.883 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' TRP . . . . . 0.501 ' CB ' HG21 ' A' ' 153' ' ' VAL . 25.3 t90 -148.29 -178.54 6.36 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 126.526 1.93 . . . . 73.219999999999999 108.235 168.279 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.419 ' CG ' HG21 ' A' ' 98' ' ' ILE . 4.0 m-30 -104.86 4.3 31.92 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 126.912 2.085 . . . . 64.530000000000001 112.377 179.403 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -129.6 18.74 5.39 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 124.689 1.137 . . . . 63.219999999999999 111.242 -178.265 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.553 ' HB3' HG23 ' A' ' 153' ' ' VAL . 21.9 p -105.03 85.59 1.3 Allowed Pre-proline 0 N--CA 1.449 -0.511 0 C-N-CA 125.11 1.364 . . . . 72.540000000000006 108.587 -177.146 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -59.82 -24.93 77.76 Favored 'Trans proline' 0 CA--C 1.535 0.558 0 CA-C-N 120.833 1.333 . . . . 60.25 112.291 -175.236 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 14.1 m170 -74.57 -15.31 60.85 Favored 'General case' 0 CA--C 1.538 0.489 0 O-C-N 121.233 -0.917 . . . . 74.140000000000001 112.403 178.039 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 71.5 m -62.25 -43.61 98.43 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 119.356 0.98 . . . . 33.109999999999999 108.815 167.855 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -57.28 -44.84 84.38 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 125.125 1.37 . . . . 74.129999999999995 111.013 175.292 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.37 -10.49 11.46 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 114.005 1.113 . . . . 62.32 114.005 -179.269 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.437 ' HB2' HD11 ' A' ' 166' ' ' ILE . 6.2 t80 -119.51 -25.54 5.99 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-O 117.221 -1.371 . . . . 73.329999999999998 112.537 -169.096 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -37.86 -67.5 0.25 Allowed Pre-proline 0 N--CA 1.472 0.659 0 C-N-CA 125.902 1.681 . . . . 74.109999999999999 113.378 179.078 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -70.84 -5.48 16.99 Favored 'Trans proline' 0 CA--C 1.537 0.639 0 CA-C-N 121.249 1.482 . . . . 74.129999999999995 114.067 -173.017 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.9 m -103.75 4.47 35.27 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 128.501 2.72 . . . . 72.310000000000002 110.647 177.511 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 16.8 tt -131.32 -30.52 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-N 120.406 1.457 . . . . 71.530000000000001 111.74 171.271 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 18.3 t -45.69 -64.87 0.77 Allowed Pre-proline 0 CA--C 1.537 0.464 0 C-N-CA 125.096 1.358 . . . . 74.329999999999998 110.168 173.441 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -69.33 -28.86 26.82 Favored 'Trans proline' 0 N--CA 1.451 -0.972 0 CA-C-N 120.791 1.318 . . . . 73.129999999999995 111.029 -172.363 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.489 ' CH2' ' HB1' ' A' ' 179' ' ' ALA . 70.7 t90 -59.2 -53.29 60.0 Favored 'General case' 0 C--N 1.341 0.198 0 CA-C-N 119.093 0.861 . . . . 74.109999999999999 109.581 174.862 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 90.6 p -58.77 -39.75 81.95 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 122.244 0.218 . . . . 61.119999999999997 111.07 -176.654 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -70.93 -12.94 61.83 Favored 'General case' 0 CA--C 1.54 0.587 0 O-C-N 121.154 -0.966 . . . . 73.25 112.874 178.153 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 68.4 mmtt -103.76 -2.03 27.05 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 125.771 1.628 . . . . 60.32 114.154 175.489 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 18.4 mt -54.93 147.68 31.74 Favored Pre-proline 0 N--CA 1.452 -0.327 0 CA-C-N 119.714 1.143 . . . . 42.350000000000001 110.997 -178.394 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -74.46 164.89 32.95 Favored 'Trans proline' 0 N--CA 1.439 -1.696 0 C-N-CA 123.346 2.698 . . . . 54.030000000000001 109.82 -176.161 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -65.43 1.02 1.26 Allowed 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.03 1.332 . . . . 64.329999999999998 114.009 178.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -98.73 0.09 43.83 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 127.965 2.506 . . . . 54.539999999999999 112.107 -179.389 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 57.5 t -131.81 157.09 43.08 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 C-N-CA 124.518 1.127 . . . . 75.519999999999996 108.569 -169.788 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 78.9 t60 -132.64 138.89 47.51 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 107.499 -1.297 . . . . 72.209999999999994 107.499 162.061 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 73.4 t80 -106.0 144.13 33.15 Favored 'General case' 0 CA--C 1.519 -0.224 0 N-CA-C 107.915 -1.143 . . . . 65.340000000000003 107.915 179.095 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 48.6 t -136.86 148.83 26.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 N-CA-C 108.239 -1.022 . . . . 73.120000000000005 108.239 178.531 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 23.1 mtt180 -115.47 128.08 55.77 Favored 'General case' 0 CA--C 1.513 -0.467 0 N-CA-C 105.867 -1.901 . . . . 73.25 105.867 165.409 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 23.5 mt -128.41 149.95 73.0 Favored Pre-proline 0 N--CA 1.467 0.391 0 CA-C-N 118.616 0.644 . . . . 73.25 111.173 170.494 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -78.29 129.62 9.62 Favored 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 122.482 2.122 . . . . 60.420000000000002 111.363 178.058 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -76.74 120.33 21.76 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.971 1.308 . . . . 62.32 110.179 174.918 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 47.7 mt -107.62 56.93 0.63 Allowed 'General case' 0 C--O 1.232 0.146 0 O-C-N 121.026 -1.046 . . . . 72.319999999999993 113.456 -167.382 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -77.33 53.26 1.01 Allowed 'General case' 0 CA--C 1.548 0.869 0 N-CA-C 113.456 0.91 . . . . 72.109999999999999 113.456 -176.826 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 80.29 -54.28 4.52 Favored Glycine 0 CA--C 1.53 1.02 0 C-N-CA 126.693 2.092 . . . . 61.43 114.486 155.866 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -82.52 -150.98 9.27 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 125.639 1.59 . . . . 62.210000000000001 110.377 172.855 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 9.7 tp -50.29 -19.88 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 C-N-CA 126.648 1.979 . . . . 72.219999999999999 113.604 -172.546 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 28.1 m95 -49.42 -52.93 25.53 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 125.484 1.513 . . . . 75.140000000000001 112.16 173.276 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 20.0 p30 -75.22 -29.58 60.31 Favored 'General case' 0 CA--C 1.522 -0.118 0 N-CA-C 112.288 0.477 . . . . 62.109999999999999 112.288 -178.655 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 81.5 t -61.32 -50.48 80.26 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.33 0 N-CA-C 107.809 -1.182 . . . . 73.549999999999997 107.809 174.707 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 60.8 m170 -70.44 14.63 0.12 Allowed 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 125.714 1.605 . . . . 72.219999999999999 113.004 173.122 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -129.58 -33.37 0.53 Allowed Glycine 0 CA--C 1.528 0.845 0 O-C-N 119.914 -1.741 . . . . 53.450000000000003 113.352 -173.086 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -64.71 -36.42 84.23 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 117.961 0.88 . . . . 63.130000000000003 111.073 -176.285 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -60.1 -45.04 94.28 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-O 116.37 -1.776 . . . . 71.219999999999999 112.126 179.644 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 25.9 t80 -52.22 -48.99 64.81 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 120.33 1.423 . . . . 54.509999999999998 109.935 -176.898 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 13.3 mt -67.04 -37.49 84.2 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 118.234 -0.889 . . . . 64.209999999999994 109.486 -178.03 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.3 m -63.74 -39.57 94.62 Favored 'General case' 0 C--N 1.342 0.253 0 CA-C-N 119.756 1.162 . . . . 72.219999999999999 111.407 174.169 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -60.4 -54.02 50.59 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 125.44 1.496 . . . . 65.530000000000001 107.035 -179.447 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -63.69 -31.41 72.57 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 112.592 0.59 . . . . 71.109999999999999 112.592 178.316 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.9 t -54.5 -19.15 5.25 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 118.003 -0.998 . . . . 71.329999999999998 112.288 171.821 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 9.1 mtp . . . . . 0 N--CA 1.453 -0.312 0 N-CA-C 115.33 1.604 . . . . 75.340000000000003 115.33 -174.818 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 0.351 0 N-CA-C 112.971 0.73 . . . . 54.409999999999997 112.971 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 70.2 t -54.58 -61.58 0.96 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.841 0 C-N-CA 123.925 0.89 . . . . 60.229999999999997 111.157 171.79 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -71.99 -35.23 69.41 Favored 'General case' 0 N--CA 1.473 0.693 0 O-C-N 119.966 -1.709 . . . . 75.530000000000001 111.785 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -67.73 -12.31 60.25 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.003 0.921 . . . . 72.409999999999997 111.46 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -84.46 -16.57 42.07 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.259 1.024 . . . . 73.109999999999999 111.547 173.092 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.616 HD13 HD12 ' A' ' 105' ' ' LEU . 10.0 mm -96.16 -37.14 7.04 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 C-N-CA 124.546 1.138 . . . . 72.319999999999993 110.243 -176.438 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 88.1 m-70 -103.74 -64.78 1.06 Allowed 'General case' 0 C--O 1.233 0.21 0 C-N-CA 122.838 0.455 . . . . 73.439999999999998 110.667 -169.612 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 21.3 mtpt -63.26 -15.94 58.72 Favored 'General case' 0 N--CA 1.464 0.27 0 O-C-N 121.876 -0.515 . . . . 64.420000000000002 111.309 177.247 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -123.83 -58.41 1.58 Allowed 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.565 1.146 . . . . 73.409999999999997 112.4 -173.015 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 2.4 t60 63.94 62.53 0.88 Allowed 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.749 1.62 . . . . 71.319999999999993 112.448 -176.518 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 7.8 mmmt -77.91 22.51 0.28 Allowed 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 127.628 2.371 . . . . 72.430000000000007 113.916 -178.64 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 18.0 ttpp 46.53 40.29 8.02 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 126.309 1.844 . . . . 62.109999999999999 111.669 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.616 HD12 HD13 ' A' ' 98' ' ' ILE . 40.3 mt -72.67 59.51 0.46 Allowed 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 129.61 3.164 . . . . 63.119999999999997 109.313 178.482 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -106.42 10.98 31.32 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 128.386 2.674 . . . . 42.25 111.429 -172.252 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -150.75 157.4 35.97 Favored Pre-proline 0 C--N 1.328 -0.335 0 C-N-CA 124.645 1.178 . . . . 74.409999999999997 109.497 -175.786 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -66.14 -42.43 10.8 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 121.905 1.737 . . . . 71.420000000000002 109.973 -175.611 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -55.98 -53.56 55.38 Favored 'General case' 0 N--CA 1.437 -1.098 0 C-N-CA 124.011 0.924 . . . . 71.340000000000003 111.86 173.684 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 24.0 tp10 -62.35 -41.19 98.39 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 118.206 0.457 . . . . 71.329999999999998 109.988 -175.422 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 38.5 mtt -60.65 -51.05 71.05 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 123.056 0.542 . . . . 63.520000000000003 110.335 175.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.432 ' HB1' ' HG3' ' A' ' 122' ' ' LYS . . . -61.71 -44.0 97.76 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 124.678 1.191 . . . . 62.340000000000003 110.329 -177.28 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -66.57 -4.93 9.66 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.624 1.57 . . . . 75.530000000000001 112.414 177.769 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -95.54 -54.76 3.26 Favored 'General case' 0 C--O 1.234 0.266 0 O-C-N 120.061 -1.649 . . . . 55.039999999999999 109.669 163.755 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 33.7 mt -65.37 -15.4 62.53 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 124.123 0.969 . . . . 62.219999999999999 112.066 -172.281 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -57.92 -16.81 13.35 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.078 0.951 . . . . 60.130000000000003 111.805 172.394 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -105.84 8.07 42.43 Favored Glycine 0 CA--C 1.531 1.043 0 C-N-CA 125.304 1.431 . . . . 60.530000000000001 114.43 171.013 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 30.1 mmtm -134.88 42.05 2.82 Favored 'General case' 0 C--O 1.225 -0.221 0 CA-C-N 119.751 1.776 . . . . 51.25 109.046 -172.62 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 70.49 42.09 64.85 Favored Glycine 0 C--N 1.336 0.541 0 N-CA-C 111.901 -0.48 . . . . 74.109999999999999 111.901 169.744 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 65.9 t -134.0 115.18 20.73 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 CA-C-O 122.601 1.191 . . . . 51.329999999999998 108.869 178.529 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 49.9 t0 -67.99 123.69 21.33 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 115.164 -0.926 . . . . 75.329999999999998 109.926 166.494 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.432 ' HG3' ' HB1' ' A' ' 112' ' ' ALA . 5.2 ttmt -62.51 -35.35 79.11 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 122.895 0.478 . . . . 75.150000000000006 110.233 175.088 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 61.7 mm-40 -64.76 -22.03 66.89 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 123.548 0.739 . . . . 71.430000000000007 111.69 179.135 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 67.9 mmtt -91.25 -53.28 4.42 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 107.937 -1.134 . . . . 75.409999999999997 107.937 176.393 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -47.39 -69.45 0.13 Allowed 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 126.348 1.859 . . . . 75.120000000000005 111.399 -175.381 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 15.5 mt -63.51 -41.45 98.51 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 118.655 0.661 . . . . 62.32 110.409 -167.298 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 35.3 t -59.87 -54.2 49.0 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 125.368 1.467 . . . . 74.140000000000001 109.549 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 30.2 m -64.57 -40.02 94.8 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.426 1.09 . . . . 62.240000000000002 109.72 -175.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -57.03 -47.48 80.81 Favored 'General case' 0 C--O 1.231 0.108 0 C-N-CA 124.293 1.037 . . . . 71.140000000000001 108.952 176.619 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -84.7 29.43 0.61 Allowed 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 126.685 1.994 . . . . 62.409999999999997 111.771 -177.374 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 3.2 t -115.14 165.92 12.39 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 124.573 1.149 . . . . 64.140000000000001 111.072 -171.24 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -59.77 -33.38 71.62 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.509 1.124 . . . . 65.409999999999997 110.769 170.294 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -52.84 -54.56 32.58 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 124.562 1.145 . . . . 71.109999999999999 111.258 -176.13 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 48.3 mm -74.92 -25.82 18.87 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 CA-C-O 119.226 -0.416 . . . . 73.209999999999994 110.393 -175.443 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 12.8 tttt -53.78 -41.42 67.2 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 124.386 1.074 . . . . 63.409999999999997 109.813 170.308 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -67.99 -22.33 74.0 Favored Glycine 0 CA--C 1.528 0.854 0 C-N-CA 124.205 0.907 . . . . 64.409999999999997 113.549 -178.922 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -88.85 -43.22 11.37 Favored 'General case' 0 N--CA 1.455 -0.182 0 O-C-N 121.421 -1.046 . . . . 72.340000000000003 109.357 174.595 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 4.2 mtp -57.38 -41.53 80.39 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 112.836 0.68 . . . . 72.420000000000002 112.836 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 22.9 pt-20 -60.28 -49.28 78.23 Favored 'General case' 0 C--O 1.233 0.205 0 O-C-N 121.95 -0.469 . . . . 73.349999999999994 111.171 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 76.1 mttt -60.64 -59.11 5.92 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 124.12 0.968 . . . . 61.240000000000002 108.603 178.285 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -53.13 -41.41 65.05 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 118.87 -0.586 . . . . 64.129999999999995 111.522 -174.121 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 26.8 ttmt -64.83 -59.9 3.68 Favored 'General case' 0 C--N 1.344 0.334 0 CA-C-N 119.015 0.825 . . . . 73.519999999999996 109.932 -179.365 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.39 -28.91 70.11 Favored 'General case' 0 C--N 1.343 0.308 0 CA-C-N 118.612 0.642 . . . . 61.520000000000003 110.746 -174.056 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 52.1 mt -68.52 -52.16 35.11 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-O 118.675 -0.679 . . . . 71.319999999999993 110.606 177.429 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -55.78 -50.42 70.51 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 118.97 0.804 . . . . 73.430000000000007 111.437 -175.093 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -59.13 -47.59 84.73 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 118.938 -0.554 . . . . 61.140000000000001 111.776 176.814 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -71.42 -21.25 62.01 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 119.303 0.956 . . . . 65.120000000000005 111.589 -174.292 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 21.5 m-85 -77.93 10.84 2.54 Favored 'General case' 0 CA--C 1.541 0.609 0 O-C-N 121.002 -1.061 . . . . 75.239999999999995 112.564 170.26 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 53.62 34.05 17.85 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 126.778 2.031 . . . . 72.420000000000002 112.534 -177.145 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 34.8 t -75.72 141.85 15.26 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 N-CA-C 107.415 -1.328 . . . . 42.039999999999999 107.415 174.184 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -135.69 -4.02 2.29 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 124.452 1.101 . . . . 61.520000000000003 112.621 170.619 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -160.48 177.54 36.86 Favored Glycine 0 N--CA 1.448 -0.501 0 N-CA-C 109.843 -1.303 . . . . 60.539999999999999 109.843 -176.634 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.553 HG23 ' HB3' ' A' ' 37' ' ' CYS . 23.7 m -145.26 149.22 40.69 Favored Pre-proline 0 C--O 1.238 0.487 0 C-N-CA 124.336 1.054 . . . . 65.439999999999998 108.974 -179.439 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 154' ' ' PRO . . . . . 0.425 ' C ' ' HA ' ' A' ' 153' ' ' VAL . 41.0 Cg_endo -67.64 153.87 86.52 Favored 'Cis proline' 0 C--O 1.237 0.447 0 C-N-CA 125.195 -0.752 . . . . 64.310000000000002 112.728 0.325 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 55.0 m -150.7 127.54 11.0 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 125.305 1.442 . . . . 71.319999999999993 107.367 177.357 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 91.1 mtp -105.42 157.85 17.06 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-O 122.171 0.986 . . . . 73.530000000000001 109.161 168.503 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 21.4 t -141.01 149.64 20.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 106.858 -1.534 . . . . 63.229999999999997 106.858 177.085 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 41.4 t -122.62 123.56 68.69 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 C-N-CA 125.958 1.703 . . . . 65.219999999999999 106.648 172.524 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 56.48 16.51 2.52 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 127.37 2.268 . . . . 63.32 114.782 167.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 60.81 33.89 84.86 Favored Glycine 0 CA--C 1.528 0.889 0 CA-C-O 118.205 -1.331 . . . . 52.049999999999997 113.867 -169.117 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 61.9 mttt -132.04 -33.31 1.35 Allowed 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 119.457 1.629 . . . . 72.540000000000006 113.262 -177.876 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -122.63 122.61 39.23 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 107.444 -1.317 . . . . 73.409999999999997 107.444 -178.834 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 35.9 ttp180 -103.33 137.73 41.06 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 104.805 -2.295 . . . . 71.430000000000007 104.805 170.756 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 21.1 p90 -152.65 162.24 41.51 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 107.075 -1.454 . . . . 73.25 107.075 176.595 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -171.08 176.55 3.96 Favored 'General case' 0 CA--C 1.514 -0.426 0 N-CA-C 109.235 -0.654 . . . . 60.520000000000003 109.235 -178.898 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.437 HD11 ' HB2' ' A' ' 43' ' ' PHE . 40.5 mt -47.78 -49.45 10.55 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 C-N-CA 126.881 2.072 . . . . 73.510000000000005 110.34 -177.932 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -84.51 0.14 89.28 Favored Glycine 0 CA--C 1.522 0.525 0 CA-C-O 118.788 -1.007 . . . . 41.219999999999999 113.767 -177.343 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 10.5 m -90.85 -66.27 0.94 Allowed 'General case' 0 N--CA 1.456 -0.157 0 CA-C-N 119.872 1.836 . . . . 73.150000000000006 107.179 161.402 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.6 ' HB1' HD23 ' A' ' 178' ' ' LEU . . . -70.13 -30.5 67.7 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-O 117.446 -1.264 . . . . 72.420000000000002 113.154 -161.276 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 129.86 22.09 1.18 Allowed Glycine 0 CA--C 1.538 1.51 0 N-CA-C 116.247 1.259 . . . . 62.409999999999997 116.247 171.664 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 113.12 164.28 15.89 Favored Glycine 0 CA--C 1.532 1.113 0 CA-C-N 120.028 1.914 . . . . 33.100000000000001 110.249 -176.36 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -63.23 -32.06 73.89 Favored 'Trans proline' 0 CA--C 1.536 0.622 0 CA-C-N 120.53 2.165 . . . . 43.329999999999998 113.816 -156.887 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 80.9 mt-10 -71.64 -29.94 65.2 Favored 'General case' 0 C--O 1.232 0.184 0 O-C-N 121.004 -1.06 . . . . 52.420000000000002 111.559 176.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -72.99 -24.79 60.81 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 122.773 0.429 . . . . 64.329999999999998 110.613 173.801 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 3.1 m -65.24 -45.57 84.08 Favored 'General case' 0 C--O 1.233 0.217 0 O-C-N 121.014 -1.054 . . . . 62.539999999999999 109.296 -175.515 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 39.8 mt -60.56 -33.42 72.67 Favored 'General case' 0 C--O 1.225 -0.213 0 CA-C-N 118.235 0.47 . . . . 54.210000000000001 111.206 175.214 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 10.3 tttt -58.05 -35.14 70.9 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-O 118.091 -0.956 . . . . 73.530000000000001 110.207 179.075 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.6 HD23 ' HB1' ' A' ' 169' ' ' ALA . 4.5 mm? -78.94 -44.89 21.6 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-N 119.359 0.982 . . . . 75.319999999999993 110.299 171.371 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.489 ' HB1' ' CH2' ' A' ' 50' ' ' TRP . . . -55.38 -31.49 61.85 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 118.604 0.638 . . . . 65.409999999999997 112.649 -175.652 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -90.61 -44.41 9.55 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 124.699 1.199 . . . . 42.43 109.41 -171.808 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 25.5 t80 -61.18 -49.21 78.12 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 121.382 0.611 . . . . 72.219999999999999 110.604 175.91 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 89.7 mt -63.07 -21.29 66.07 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 123.879 0.871 . . . . 71.239999999999995 112.491 -174.35 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 28.4 mt -57.36 -59.32 3.37 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.306 0 N-CA-C 107.395 -1.335 . . . . 72.140000000000001 107.395 168.644 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -56.52 -38.55 71.98 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 120.083 1.311 . . . . 73.420000000000002 111.618 -177.273 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 2.7 tmtt? -59.39 -39.82 84.6 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.249 0.619 . . . . 73.340000000000003 110.457 -178.343 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -89.05 -31.14 18.2 Favored 'General case' 0 CA--C 1.517 -0.301 0 O-C-N 121.424 -0.798 . . . . 71.349999999999994 112.75 177.392 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -60.55 -35.89 77.14 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.741 0.781 . . . . 74.25 111.039 -177.537 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.491 0 C-N-CA 123.719 0.808 . . . . 52.409999999999997 112.636 176.761 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.449 -0.478 0 N-CA-C 107.3 -1.37 . . . . 61.450000000000003 107.3 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 27.3 t0 -141.9 15.41 2.11 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 125.991 1.716 . . . . 71.319999999999993 110.023 -178.494 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 -155.34 153.22 30.17 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 126.581 1.953 . . . . 74.409999999999997 108.086 -173.916 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 74.7 m -128.25 144.59 51.14 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 121.337 0.589 . . . . 74.200000000000003 110.02 -172.708 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -70.1 144.42 52.1 Favored 'General case' 0 N--CA 1.456 -0.127 0 O-C-N 121.375 -0.828 . . . . 52.240000000000002 109.196 -179.056 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 67.44 -15.17 0.44 Allowed Glycine 0 CA--C 1.532 1.14 0 C-N-CA 126.05 1.786 . . . . 63.140000000000001 113.45 -167.633 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -94.54 -60.25 1.75 Allowed 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 125.218 1.407 . . . . 64.230000000000004 107.594 -171.104 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -106.57 -25.59 11.75 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 126.423 1.889 . . . . 75.010000000000005 110.18 -177.167 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 41.1 p90 -153.48 170.15 21.45 Favored 'General case' 0 C--N 1.332 -0.164 0 O-C-N 120.895 -1.128 . . . . 75.019999999999996 110.266 -171.506 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 26.8 t -128.93 103.42 9.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 107.158 -1.423 . . . . 54.240000000000002 107.158 -176.862 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -80.78 169.85 17.06 Favored 'General case' 0 C--O 1.237 0.446 0 O-C-N 119.243 -2.161 . . . . 54.43 109.672 174.705 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -127.59 110.88 13.14 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 107.543 -1.28 . . . . 75.219999999999999 107.543 -177.952 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -60.33 -14.27 17.51 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.824 1.649 . . . . 72.409999999999997 112.814 175.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 4.0 p -109.52 85.06 3.44 Favored Pre-proline 0 N--CA 1.451 -0.39 0 N-CA-C 107.618 -1.253 . . . . 74.349999999999994 107.618 166.009 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -67.52 179.35 2.6 Favored 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 122.479 2.119 . . . . 74.230000000000004 111.038 178.788 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 31.0 t -134.47 139.57 33.1 Favored Pre-proline 0 CA--C 1.536 0.425 0 N-CA-C 107.55 -1.278 . . . . 62.520000000000003 107.55 -178.901 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -75.58 177.25 8.92 Favored 'Trans proline' 0 CA--C 1.536 0.588 0 C-N-CA 122.937 2.425 . . . . 73.409999999999997 110.577 173.581 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 35.4 m -139.86 166.85 20.01 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 C-N-CA 123.426 0.69 . . . . 60.299999999999997 110.859 179.376 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 3.4 t -54.43 -60.1 3.8 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 126.26 1.824 . . . . 71.430000000000007 110.027 172.62 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 4.1 tp-100 -120.71 84.97 38.23 Favored Pre-proline 0 N--CA 1.454 -0.243 0 C-N-CA 125.335 1.454 . . . . 73.209999999999994 108.316 -163.155 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -67.75 -8.71 23.22 Favored 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 122.18 1.92 . . . . 75.299999999999997 112.183 177.248 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -61.21 -25.59 64.83 Favored Glycine 0 CA--C 1.53 1.022 0 O-C-N 120.848 -1.157 . . . . 65.230000000000004 112.118 168.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 56.2 mttm -125.66 150.87 47.24 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-N 119.391 1.595 . . . . 73.030000000000001 109.39 -179.157 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 51.2 mm -78.09 127.62 38.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 106.28 -1.748 . . . . 55.32 106.28 177.225 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -91.24 118.71 30.71 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 107.716 -1.216 . . . . 64.030000000000001 107.716 -174.827 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 42.1 t -120.42 115.94 48.67 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 N-CA-C 106.985 -1.487 . . . . 64.319999999999993 106.985 -178.429 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 16.8 t -124.48 103.59 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 N-CA-C 107.642 -1.244 . . . . 71.140000000000001 107.642 -163.299 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -67.67 135.83 53.4 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 125.48 1.512 . . . . 74.310000000000002 108.594 164.568 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.0 mp -119.85 125.61 48.94 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 124.741 1.216 . . . . 75.25 107.72 160.692 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -130.77 164.27 25.49 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.086 0.954 . . . . 65.230000000000004 111.222 -174.83 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 25.9 t90 -143.27 142.58 31.41 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.163 0.985 . . . . 74.420000000000002 109.975 177.257 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 5.7 m-30 -61.57 -25.5 67.36 Favored 'General case' 0 CA--C 1.533 0.309 0 O-C-N 121.757 -0.59 . . . . 74.409999999999997 111.505 175.651 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -91.57 19.9 44.87 Favored Glycine 0 CA--C 1.53 1.026 0 CA-C-O 118.53 -1.15 . . . . 73.439999999999998 113.255 -179.349 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 46.1 t -104.46 85.66 1.18 Allowed Pre-proline 0 CA--C 1.541 0.606 0 C-N-CA 125.281 1.432 . . . . 60.509999999999998 110.719 -173.114 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_endo -67.17 5.28 0.89 Allowed 'Trans proline' 0 CA--C 1.536 0.619 0 C-N-CA 124.672 3.581 . . . . 72.219999999999999 114.606 179.164 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 22.9 m170 -107.11 -20.02 13.43 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 126.27 1.828 . . . . 64.109999999999999 111.546 175.193 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 94.4 m -78.82 -34.55 45.15 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.602 0.761 . . . . 74.540000000000006 110.901 -175.238 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 14.1 t80 -55.91 -41.4 74.49 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 124.917 1.287 . . . . 72.099999999999994 110.575 178.163 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -45.39 -51.7 10.94 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 125.766 1.626 . . . . 64.420000000000002 110.859 179.302 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -84.39 -21.23 30.89 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 125.791 1.636 . . . . 75.230000000000004 112.695 -167.075 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 59.0 mm-40 -45.15 -62.59 1.58 Allowed Pre-proline 0 N--CA 1.469 0.505 0 CA-C-N 120.001 1.273 . . . . 61.539999999999999 112.562 -176.86 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -71.11 -5.13 16.3 Favored 'Trans proline' 0 CA--C 1.538 0.724 0 C-N-CA 121.839 1.693 . . . . 60.340000000000003 114.455 -178.032 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 74.7 m -87.74 -34.69 18.26 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 119.643 1.11 . . . . 75.299999999999997 109.561 168.22 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 19.2 tt -92.78 -29.05 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 CA-C-N 119.708 1.14 . . . . 63.119999999999997 112.189 -174.628 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 38.6 t -49.19 -62.92 1.94 Allowed Pre-proline 0 CA--C 1.536 0.437 0 CA-C-O 117.797 -1.097 . . . . 75.510000000000005 109.943 170.033 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -66.3 -25.38 49.6 Favored 'Trans proline' 0 N--CA 1.451 -0.973 0 CA-C-N 120.737 1.299 . . . . 75.140000000000001 112.591 -173.298 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.407 ' CZ2' HD21 ' A' ' 54' ' ' LEU . 58.4 t90 -65.88 -54.92 20.34 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 123.564 0.746 . . . . 61.530000000000001 110.406 173.345 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 88.8 p -57.61 -38.66 75.3 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.187 0.595 . . . . 63.310000000000002 112.24 -170.363 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 72.2 mt-10 -59.13 -36.84 75.9 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.796 1.238 . . . . 75.140000000000001 111.291 177.208 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 4.7 mmmm -92.51 2.82 56.46 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 125.35 1.46 . . . . 74.530000000000001 112.019 -167.094 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.407 HD21 ' CZ2' ' A' ' 50' ' ' TRP . 33.7 mt -62.06 155.98 61.01 Favored Pre-proline 0 C--O 1.239 0.502 0 C-N-CA 125.558 1.543 . . . . 71.230000000000004 112.122 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -81.4 171.57 13.5 Favored 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 125.143 3.895 . . . . 72.439999999999998 112.452 -177.815 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -69.12 -2.34 9.99 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 126.513 1.925 . . . . 73.510000000000005 115.28 -177.253 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -115.79 0.24 13.11 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.756 1.222 . . . . 74.219999999999999 111.939 -178.712 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 86.1 t -96.71 150.6 4.36 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 N-CA-C 107.751 -1.203 . . . . 73.010000000000005 107.751 168.709 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 33.8 t60 -129.94 99.6 5.16 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 124.983 1.313 . . . . 71.450000000000003 107.829 165.195 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 51.4 t80 -77.21 145.23 37.73 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 114.9 -1.046 . . . . 75.25 109.606 178.9 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 21.6 t -142.09 157.04 19.93 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 C-N-CA 125.998 1.719 . . . . 74.030000000000001 107.695 -177.823 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 57.7 mtt180 -130.56 131.74 45.19 Favored 'General case' 0 N--CA 1.462 0.144 0 N-CA-C 107.793 -1.188 . . . . 74.030000000000001 107.793 163.543 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 37.3 mt -133.63 157.35 78.17 Favored Pre-proline 0 N--CA 1.468 0.438 0 C-N-CA 124.532 1.133 . . . . 71.0 108.935 176.585 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -74.85 164.72 32.94 Favored 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 121.381 1.388 . . . . 74.200000000000003 111.289 177.608 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -111.45 112.6 24.46 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 125.777 1.631 . . . . 75.109999999999999 107.53 -177.03 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 26.8 mt -115.68 60.29 0.71 Allowed 'General case' 0 C--O 1.234 0.274 0 O-C-N 121.489 -0.757 . . . . 73.140000000000001 112.602 -161.093 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -65.53 -14.83 61.89 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 114.613 1.338 . . . . 72.019999999999996 114.613 -171.292 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 122.65 -37.78 2.73 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 125.329 1.442 . . . . 64.25 111.763 175.291 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -77.96 -157.77 10.03 Favored Glycine 0 CA--C 1.527 0.787 0 C-N-CA 124.383 0.992 . . . . 75.530000000000001 110.844 172.789 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 6.3 tp -45.11 -24.28 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 127.996 2.519 . . . . 74.109999999999999 113.396 179.288 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 37.6 m95 -44.19 -50.72 8.62 Favored 'General case' 0 N--CA 1.441 -0.899 0 C-N-CA 126.657 1.983 . . . . 73.120000000000005 111.277 172.475 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 26.4 p30 -77.71 -29.27 51.21 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 113.852 1.056 . . . . 73.030000000000001 113.852 -179.721 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 73.8 t -60.89 -50.0 82.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 108.757 -0.831 . . . . 72.310000000000002 108.757 174.439 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 55.9 m170 -72.29 -0.65 12.78 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.034 1.734 . . . . 73.239999999999995 112.538 171.641 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -100.51 -14.56 32.14 Favored Glycine 0 CA--C 1.525 0.661 0 CA-C-N 120.205 1.366 . . . . 72.140000000000001 112.309 -175.61 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -96.63 -27.13 14.94 Favored 'General case' 0 N--CA 1.45 -0.473 0 O-C-N 121.792 -0.828 . . . . 60.43 112.102 -159.311 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -65.11 -42.37 94.02 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-O 116.833 -1.556 . . . . 73.030000000000001 111.244 -177.865 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 7.7 t80 -52.21 -56.13 16.66 Favored 'General case' 0 C--N 1.34 0.194 0 CA-C-N 119.466 1.03 . . . . 74.239999999999995 109.01 -176.837 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 44.5 mt -64.89 -32.07 73.61 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 116.497 -1.716 . . . . 71.519999999999996 111.247 -177.893 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.688 ' CG2' HG23 ' A' ' 128' ' ' THR . 1.3 m -70.3 -38.18 74.93 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 120.77 1.623 . . . . 75.319999999999993 111.356 177.957 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.7 -54.25 47.56 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 124.395 1.078 . . . . 71.219999999999999 109.211 175.338 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -56.21 -37.69 70.0 Favored 'General case' 0 C--O 1.226 -0.154 0 C-N-CA 125.139 1.375 . . . . 73.329999999999998 110.485 177.488 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -50.95 -20.31 1.3 Allowed 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.538 1.535 . . . . 54.520000000000003 113.769 176.443 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 53.6 mtm . . . . . 0 N--CA 1.466 0.368 0 CA-C-N 120.422 1.465 . . . . 72.200000000000003 113.992 176.593 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.187 0 CA-C-O 118.761 -0.638 . . . . 74.209999999999994 111.152 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 4.1 t -57.43 -51.27 71.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 CA-C-N 119.551 1.068 . . . . 53.210000000000001 110.83 -179.421 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -65.18 -52.84 52.48 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 123.686 0.794 . . . . 75.209999999999994 109.256 175.71 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -58.02 -26.89 62.99 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.605 1.562 . . . . 73.209999999999994 110.978 -172.644 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.44 ' HA ' ' HB2' ' A' ' 101' ' ' GLU . . . -72.91 -16.03 61.57 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 125.822 1.649 . . . . 54.399999999999999 113.572 -179.383 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 19.4 mt -92.61 -43.1 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 N-CA-C 107.353 -1.351 . . . . 64.430000000000007 107.353 174.773 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 30.5 p80 -102.86 -64.11 1.1 Allowed 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 113.54 0.941 . . . . 71.329999999999998 113.54 -166.533 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 29.6 mtpt -68.14 -16.06 63.84 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 119.916 1.235 . . . . 65.430000000000007 111.783 176.13 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.44 ' HB2' ' HA ' ' A' ' 97' ' ' ALA . 20.9 mt-10 -99.48 -23.32 15.14 Favored 'General case' 0 C--N 1.331 -0.212 0 O-C-N 120.834 -1.166 . . . . 70.510000000000005 111.92 171.498 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 7.2 t60 57.4 84.6 0.09 Allowed 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.629 1.572 . . . . 72.200000000000003 112.497 172.202 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 8.3 mmtp -136.71 152.23 50.13 Favored 'General case' 0 CA--C 1.52 -0.193 0 C-N-CA 124.187 0.995 . . . . 65.019999999999996 111.193 -169.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 9.3 ttmm -71.18 -51.19 26.23 Favored 'General case' 0 C--O 1.224 -0.253 0 N-CA-C 109.261 -0.644 . . . . 73.540000000000006 109.261 -177.54 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 77.9 mt 50.54 32.17 6.39 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.893 1.277 . . . . 62.100000000000001 113.514 179.053 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -86.81 8.67 21.82 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 114.768 1.395 . . . . 73.219999999999999 114.768 -167.404 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -143.34 157.84 58.97 Favored Pre-proline 0 N--CA 1.471 0.605 0 O-C-N 120.846 -1.159 . . . . 53.409999999999997 109.392 -172.946 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -58.77 -42.68 50.79 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 121.905 1.736 . . . . 70.349999999999994 111.738 -177.151 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -63.05 -53.45 53.62 Favored 'General case' 0 N--CA 1.442 -0.86 0 O-C-N 124.342 1.026 . . . . 73.319999999999993 110.486 -178.25 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 44.3 tp10 -58.11 -33.61 69.31 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.362 0.665 . . . . 70.239999999999995 111.04 -172.42 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 69.1 mtm -72.68 -56.86 4.66 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 118.149 -0.929 . . . . 72.319999999999993 111.595 169.817 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -59.63 -49.87 76.06 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 124.764 1.226 . . . . 72.310000000000002 112.529 -171.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -68.08 -36.7 80.25 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 124.62 1.168 . . . . 73.299999999999997 111.591 -170.861 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' PHE . . . . . 0.465 ' CZ ' ' HE3' ' A' ' 118' ' ' LYS . 84.8 t80 -58.06 -38.93 77.27 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.229 0.612 . . . . 70.219999999999999 110.878 171.416 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 14.0 mt -77.66 -19.18 55.84 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 123.924 0.89 . . . . 72.120000000000005 110.278 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.4 -20.06 58.26 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 121.149 -0.969 . . . . 71.439999999999998 111.249 173.239 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -97.06 -6.5 57.86 Favored Glycine 0 CA--C 1.528 0.888 0 CA-C-O 118.877 -0.957 . . . . 64.019999999999996 114.112 169.557 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.465 ' HE3' ' CZ ' ' A' ' 114' ' ' PHE . 48.2 mttm -125.27 61.91 1.19 Allowed 'General case' 0 N--CA 1.456 -0.134 0 CA-C-N 119.938 1.869 . . . . 74.200000000000003 108.406 -175.083 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 71.69 18.48 77.34 Favored Glycine 0 CA--C 1.525 0.661 0 CA-C-O 119.021 -0.877 . . . . 65.439999999999998 114.646 161.596 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 28.3 t -125.89 139.88 50.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 C-N-CA 125.707 1.603 . . . . 62.530000000000001 108.04 -176.608 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 65.5 t0 -85.68 121.2 28.01 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 107.712 -1.218 . . . . 54.310000000000002 107.712 167.409 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 15.3 ttpt -57.32 -35.62 70.09 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 124.053 0.941 . . . . 75.329999999999998 110.394 176.127 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -65.68 -39.6 91.47 Favored 'General case' 0 N--CA 1.454 -0.26 0 O-C-N 121.491 -0.756 . . . . 64.319999999999993 111.566 178.823 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.457 ' O ' HG22 ' A' ' 128' ' ' THR . 46.0 mttm -75.68 -44.25 43.2 Favored 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 106.819 -1.548 . . . . 74.219999999999999 106.819 -173.815 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -49.02 -68.06 0.21 Allowed 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 125.605 1.562 . . . . 72.450000000000003 110.579 174.259 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 18.3 mt -65.33 -32.59 74.32 Favored 'General case' 0 C--O 1.234 0.253 0 O-C-N 121.379 -0.825 . . . . 72.200000000000003 111.155 -170.433 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 35.7 t -56.98 -58.26 8.92 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 107.637 -1.245 . . . . 75.099999999999994 107.637 177.017 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' THR . . . . . 0.688 HG23 ' CG2' ' A' ' 80' ' ' THR 0.341 10.1 t -71.79 -30.13 65.2 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 119.919 -0.712 . . . . 74.120000000000005 110.864 -175.32 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 31.1 t80 -54.65 -35.36 63.4 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 120.646 -1.283 . . . . 74.450000000000003 111.085 174.228 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -102.72 18.14 22.12 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.618 1.167 . . . . 34.100000000000001 112.744 179.241 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 28.8 m -104.53 160.99 14.49 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 125.652 1.581 . . . . 73.299999999999997 111.926 176.811 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -59.9 -25.97 65.54 Favored 'General case' 0 CA--C 1.532 0.288 0 O-C-N 122.143 -0.348 . . . . 51.020000000000003 111.058 171.051 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -50.01 -28.75 7.42 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 125.386 1.474 . . . . 52.299999999999997 113.304 173.637 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.501 HD11 ' HA ' ' A' ' 80' ' ' THR . 5.5 mm -101.64 -36.06 4.49 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 C-N-CA 125.159 1.384 . . . . 74.420000000000002 110.671 176.366 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 35.3 tttm -53.91 -39.06 65.47 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 124.073 0.949 . . . . 75.430000000000007 110.463 174.68 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -72.55 -16.05 77.57 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 125.152 1.358 . . . . 51.140000000000001 111.916 -170.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -99.1 -39.22 8.6 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 123.393 0.677 . . . . 73.030000000000001 109.494 176.594 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 75.6 mmm -58.47 -37.83 76.32 Favored 'General case' 0 C--N 1.342 0.257 0 N-CA-C 109.77 -0.456 . . . . 64.140000000000001 109.77 177.789 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -59.66 -51.53 69.41 Favored 'General case' 0 CA--C 1.535 0.374 0 O-C-N 121.303 -0.873 . . . . 71.400000000000006 110.737 173.865 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 4.3 mmtp -61.98 -58.14 9.01 Favored 'General case' 0 C--N 1.344 0.327 0 CA-C-O 117.987 -1.006 . . . . 73.209999999999994 111.47 -175.294 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -59.5 -30.75 68.79 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 119.474 1.034 . . . . 51.200000000000003 110.671 -176.715 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 2.2 tmpt? -66.16 -58.87 4.48 Favored 'General case' 0 C--N 1.344 0.357 0 O-C-N 121.035 -1.04 . . . . 73.209999999999994 109.99 176.796 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 15.2 ptpt -62.61 -37.82 87.78 Favored 'General case' 0 C--N 1.341 0.22 0 CA-C-O 118.611 -0.709 . . . . 73.439999999999998 109.499 -173.863 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 35.7 mt -57.89 -59.77 4.73 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.467 1.107 . . . . 64.439999999999998 110.984 175.363 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -56.01 -40.61 73.63 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 119.03 0.832 . . . . 75.230000000000004 111.765 -175.854 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -63.25 -50.52 69.84 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 109.918 -0.401 . . . . 74.329999999999998 109.918 175.503 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -69.67 -22.44 63.44 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-O 118.572 -0.727 . . . . 72.129999999999995 112.4 -172.927 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -73.98 -8.27 55.49 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 125.37 1.468 . . . . 72.519999999999996 113.864 171.926 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 52.61 72.66 0.39 Allowed 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 124.793 1.237 . . . . 75.310000000000002 110.919 -167.588 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 47.4 t -101.63 145.83 10.93 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 N-CA-C 107.457 -1.312 . . . . 71.219999999999999 107.457 166.463 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -123.27 -13.89 7.58 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 123.629 0.772 . . . . 70.5 112.787 172.836 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -159.35 -163.7 13.59 Favored Glycine 0 C--N 1.334 0.431 0 O-C-N 121.047 -1.033 . . . . 75.319999999999993 113.213 179.051 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.451 ' HA ' ' C ' ' A' ' 154' ' ' PRO . 15.4 m -144.11 146.78 35.1 Favored Pre-proline 0 C--N 1.328 -0.335 0 C-N-CA 126.102 1.761 . . . . 65.439999999999998 107.086 173.055 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 154' ' ' PRO . . . . . 0.451 ' C ' ' HA ' ' A' ' 153' ' ' VAL . 60.8 Cg_endo -67.31 150.95 83.68 Favored 'Cis proline' 0 N--CA 1.46 -0.479 0 C-N-CA 125.2 -0.75 . . . . 64.420000000000002 112.149 1.524 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 85.8 m -151.15 127.75 10.81 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 105.769 -1.937 . . . . 42.509999999999998 105.769 174.564 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 14.6 mmm -110.81 150.81 28.6 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 106.569 -1.641 . . . . 72.140000000000001 106.569 165.857 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 46.6 t -129.11 128.91 67.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 107.114 -1.439 . . . . 73.209999999999994 107.114 171.301 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.503 HG23 ' CE1' ' A' ' 164' ' ' PHE . 77.4 t -93.1 123.04 45.06 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 N-CA-C 107.48 -1.304 . . . . 62.229999999999997 107.48 164.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 2.7 t30 64.58 11.74 6.92 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 129.114 2.966 . . . . 60.539999999999999 115.52 159.242 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 71.19 23.33 78.19 Favored Glycine 0 CA--C 1.526 0.742 0 CA-C-O 117.711 -1.605 . . . . 74.420000000000002 112.973 -170.914 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 35.9 mttt -133.58 -30.18 1.3 Allowed 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 120.043 1.921 . . . . 65.420000000000002 112.402 -175.473 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 80.3 m-85 -124.34 115.01 20.31 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 118.943 -0.551 . . . . 74.5 110.864 -179.599 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 6.3 ptt180 -96.01 141.41 29.45 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 106.685 -1.598 . . . . 61.25 106.685 171.171 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 164' ' ' PHE . . . . . 0.503 ' CE1' HG23 ' A' ' 158' ' ' VAL . 15.1 p90 -151.71 164.84 36.08 Favored 'General case' 0 C--N 1.309 -1.154 0 O-C-N 120.721 -1.237 . . . . 73.040000000000006 108.376 176.635 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -168.19 169.12 11.19 Favored 'General case' 0 CA--C 1.513 -0.445 0 CA-C-N 116.001 -0.545 . . . . 73.209999999999994 109.611 -174.564 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.442 HD12 ' HG3' ' A' ' 154' ' ' PRO . 42.0 mt -51.73 -47.79 38.57 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 C-N-CA 125.41 1.484 . . . . 62.32 109.702 -175.115 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -84.13 -4.65 88.16 Favored Glycine 0 CA--C 1.527 0.791 0 CA-C-O 117.701 -1.611 . . . . 64.439999999999998 113.38 -176.784 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 52.1 m -87.24 -56.31 3.42 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 121.224 2.512 . . . . 71.439999999999998 108.249 163.471 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.75 ' HB1' HD23 ' A' ' 178' ' ' LEU . . . -79.0 -28.02 43.36 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-O 116.9 -1.524 . . . . 71.340000000000003 113.969 -165.856 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 154.12 -46.7 0.54 Allowed Glycine 0 CA--C 1.527 0.793 0 CA-C-N 121.343 1.883 . . . . 42.109999999999999 115.457 176.799 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 154.26 167.13 15.83 Favored Glycine 0 CA--C 1.534 1.224 0 N-CA-C 108.159 -1.977 . . . . 64.140000000000001 108.159 -153.145 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -67.69 -23.48 42.35 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 CA-C-N 120.525 2.163 . . . . 31.23 113.294 -164.182 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -70.0 -46.4 65.22 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 123.013 1.387 . . . . 65.430000000000007 109.557 174.072 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -66.97 -21.51 65.96 Favored 'General case' 0 N--CA 1.445 -0.675 0 C-N-CA 126.622 1.969 . . . . 74.439999999999998 111.344 -175.896 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 3.2 m -70.6 -43.76 68.68 Favored 'General case' 0 CA--C 1.529 0.16 0 O-C-N 121.126 -0.984 . . . . 72.150000000000006 109.162 -177.831 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 53.4 mt -62.84 -33.27 74.9 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 118.288 0.495 . . . . 73.349999999999994 110.799 177.702 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 7.5 tttt -52.58 -51.42 59.88 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 125.099 1.36 . . . . 74.340000000000003 109.33 173.695 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.75 HD23 ' HB1' ' A' ' 169' ' ' ALA . 4.3 mm? -68.78 -39.89 79.96 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-O 118.287 -0.864 . . . . 54.399999999999999 110.846 175.265 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -55.8 -49.04 74.28 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 119.215 0.916 . . . . 75.120000000000005 111.201 -174.824 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -72.88 -43.13 62.9 Favored 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 122.76 0.424 . . . . 71.049999999999997 110.333 -172.246 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 15.9 t80 -60.45 -52.33 65.67 Favored 'General case' 0 N--CA 1.44 -0.946 0 C-N-CA 124.736 1.214 . . . . 74.329999999999998 110.048 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 182' ' ' LEU . . . . . 0.501 ' HB2' HG21 ' A' ' 158' ' ' VAL . 95.9 mt -62.63 -34.8 77.78 Favored 'General case' 0 C--O 1.233 0.213 0 C-N-CA 123.206 0.602 . . . . 71.049999999999997 110.768 -178.41 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 38.1 mt -60.8 -61.96 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 N-CA-C 108.419 -0.956 . . . . 73.409999999999997 108.419 173.526 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -56.98 -32.79 66.44 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 124.491 1.117 . . . . 65.25 111.509 -173.384 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 79.3 tttt -58.51 -66.93 0.41 Allowed 'General case' 0 C--O 1.232 0.156 0 C-N-CA 125.425 1.49 . . . . 74.25 110.571 171.798 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 43.0 mm-40 -65.38 -19.34 65.9 Favored 'General case' 0 N--CA 1.446 -0.625 0 O-C-N 121.03 -1.044 . . . . 73.010000000000005 113.258 -177.441 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.94 -44.79 63.04 Favored 'General case' 0 CA--C 1.533 0.319 0 O-C-N 120.974 -1.079 . . . . 74.030000000000001 109.327 169.713 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.133 0 C-N-CA 124.214 1.005 . . . . 73.299999999999997 110.73 -177.648 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 . . . . . 0 CA--C 1.512 -0.483 0 N-CA-C 106.969 -1.493 . . . . 74.530000000000001 106.969 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -81.55 8.92 8.43 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-N 112.757 -2.02 . . . . 50.409999999999997 114.835 -161.512 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 42.7 m-85 -134.18 167.03 21.41 Favored 'General case' 0 N--CA 1.442 -0.854 0 C-N-CA 124.803 1.241 . . . . 75.349999999999994 108.641 -164.015 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 94.2 m -134.2 141.24 46.97 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 108.451 -0.944 . . . . 63.549999999999997 108.451 173.698 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -70.28 143.58 52.03 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-O 122.069 0.938 . . . . 63.530000000000001 110.055 175.071 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 61.46 16.0 48.28 Favored Glycine 0 CA--C 1.529 0.917 0 C-N-CA 124.898 1.237 . . . . 51.439999999999998 112.762 -166.27 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 8.1 ttmt -118.4 -85.23 0.65 Allowed 'General case' 0 CA--C 1.517 -0.31 0 N-CA-C 105.879 -1.897 . . . . 61.43 105.879 172.047 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.434 ' HB3' HD11 ' A' ' 178' ' ' LEU . 38.4 mp0 -75.6 -21.97 57.32 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 118.675 0.67 . . . . 73.450000000000003 112.462 -179.505 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 47.9 p90 -159.78 176.0 12.47 Favored 'General case' 0 CA--C 1.52 -0.179 0 O-C-N 121.477 -0.765 . . . . 64.099999999999994 110.726 -170.654 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 44.3 t -140.68 96.05 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 N-CA-C 108.534 -0.913 . . . . 70.010000000000005 108.534 -170.795 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.39 146.18 27.81 Favored 'General case' 0 C--O 1.237 0.402 0 O-C-N 121.089 -1.007 . . . . 60.310000000000002 110.677 177.863 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -100.68 146.46 27.17 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 114.467 -1.242 . . . . 74.319999999999993 108.192 -170.675 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.8 p -81.85 -23.77 36.2 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 125.569 1.547 . . . . 54.109999999999999 111.12 179.674 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 69.3 m -115.27 84.32 11.35 Favored Pre-proline 0 N--CA 1.455 -0.18 0 C-N-CA 124.783 1.233 . . . . 75.0 109.587 -178.711 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -75.01 174.75 12.25 Favored 'Trans proline' 0 N--CA 1.451 -0.995 0 C-N-CA 122.113 1.875 . . . . 75.400000000000006 112.288 -178.866 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 20.7 t -130.2 130.46 23.06 Favored Pre-proline 0 CA--C 1.534 0.342 0 CA-C-N 114.937 -1.029 . . . . 44.409999999999997 108.714 -173.265 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -76.73 175.91 10.78 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 124.277 3.318 . . . . 72.099999999999994 112.865 178.04 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 19.4 m -120.25 168.56 12.48 Favored 'Isoleucine or valine' 0 C--O 1.24 0.567 0 C-N-CA 126.366 1.866 . . . . 75.219999999999999 110.264 173.661 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 38.9 m -54.91 -53.01 61.02 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 126.664 1.986 . . . . 74.129999999999995 110.777 174.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 3.5 mm-40 -141.58 144.27 32.74 Favored Pre-proline 0 N--CA 1.451 -0.392 0 N-CA-C 106.564 -1.643 . . . . 74.230000000000004 106.564 178.838 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -71.51 165.01 33.81 Favored 'Trans proline' 0 N--CA 1.447 -1.224 0 C-N-CA 121.269 1.313 . . . . 64.150000000000006 109.156 162.557 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 159.57 -35.04 0.47 Allowed Glycine 0 CA--C 1.519 0.329 0 CA-C-O 119.547 -0.585 . . . . 63.340000000000003 112.784 167.393 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -129.71 163.58 25.85 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.581 1.553 . . . . 75.329999999999998 109.707 162.463 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.435 HD12 ' HB3' ' A' ' 186' ' ' GLU . 28.2 mm -66.31 126.34 25.46 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 N-CA-C 106.467 -1.679 . . . . 50.409999999999997 106.467 168.43 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -89.3 123.45 33.5 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 125.992 1.717 . . . . 72.530000000000001 106.762 -176.66 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 28.3 t -123.73 135.29 63.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 108.002 -1.11 . . . . 73.450000000000003 108.002 -179.117 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 40.3 t -126.76 125.9 67.72 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.177 0 N-CA-C 108.262 -1.014 . . . . 53.149999999999999 108.262 -175.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -87.46 134.91 33.53 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 125.164 1.386 . . . . 72.310000000000002 107.769 162.676 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.2 mp -122.23 123.5 41.61 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 124.715 1.206 . . . . 73.530000000000001 108.354 165.823 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -131.8 171.59 13.33 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.754 1.622 . . . . 72.010000000000005 110.979 -169.452 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 27.3 t90 -147.22 168.92 20.49 Favored 'General case' 0 CA--C 1.537 0.452 0 O-C-N 120.86 -1.15 . . . . 74.030000000000001 109.46 168.038 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 14.6 t80 -60.77 -53.51 56.5 Favored 'General case' 0 N--CA 1.461 0.076 0 C-N-CA 126.062 1.745 . . . . 74.120000000000005 111.425 174.292 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -68.66 -84.41 0.13 Allowed Glycine 0 C--N 1.336 0.575 0 N-CA-C 110.697 -0.961 . . . . 55.439999999999998 110.697 -159.759 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 14.5 t 42.54 71.93 1.27 Allowed Pre-proline 0 CA--C 1.533 0.289 0 C-N-CA 125.961 1.704 . . . . 53.240000000000002 113.415 149.163 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -67.3 3.42 1.7 Allowed 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 122.264 1.976 . . . . 72.420000000000002 113.71 -176.096 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 18.7 m170 -108.66 -28.98 8.96 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 119.857 1.208 . . . . 71.329999999999998 111.978 173.062 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 85.7 m -60.27 -46.32 90.24 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 119.545 1.066 . . . . 33.240000000000002 109.754 -175.118 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 32.7 t80 -66.62 -22.13 66.12 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 121.085 -1.009 . . . . 73.239999999999995 112.187 -178.329 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -74.64 -3.54 31.85 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 120.931 -1.106 . . . . 34.340000000000003 112.782 175.023 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.425 ' CG ' HD11 ' A' ' 166' ' ' ILE . 15.6 t80 -121.82 -25.14 5.08 Favored 'General case' 0 C--O 1.226 -0.171 0 C-N-CA 125.372 1.469 . . . . 65.0 112.511 -168.913 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 56.9 mm-40 -42.39 -63.23 0.96 Allowed Pre-proline 0 CA--C 1.539 0.553 0 C-N-CA 124.253 1.021 . . . . 73.040000000000006 112.403 -177.719 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -73.3 -8.73 22.34 Favored 'Trans proline' 0 N--CA 1.46 -0.445 0 CA-C-N 122.535 1.941 . . . . 74.099999999999994 114.966 -177.651 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.4 m -70.8 -44.91 65.63 Favored 'General case' 0 CA--C 1.543 0.708 0 O-C-N 121.034 -1.042 . . . . 74.329999999999998 108.525 166.293 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 12.9 tt -94.78 -36.02 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 C-N-CA 123.86 0.864 . . . . 73.409999999999997 112.418 -165.86 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 41.9 t -46.8 -58.85 6.09 Favored Pre-proline 0 CA--C 1.538 0.493 0 C-N-CA 125.691 1.596 . . . . 74.530000000000001 110.443 176.001 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -72.53 -25.51 17.72 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 121.646 1.564 . . . . 71.540000000000006 112.929 -178.523 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.457 ' CG ' HD22 ' A' ' 176' ' ' LEU . 79.6 t90 -60.24 -52.01 67.11 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 119.757 1.162 . . . . 74.400000000000006 109.014 173.315 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.2 t -55.88 -42.8 76.46 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.321 0.648 . . . . 64.200000000000003 110.522 177.209 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 90.0 mt-10 -64.05 -10.34 21.52 Favored 'General case' 0 N--CA 1.468 0.474 0 O-C-N 121.207 -0.933 . . . . 62.030000000000001 113.352 -179.714 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 19.3 mmmt -122.49 8.48 9.58 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 126.116 1.767 . . . . 74.129999999999995 112.277 -171.712 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 25.2 mt -64.73 153.59 87.39 Favored Pre-proline 0 C--O 1.24 0.566 0 C-N-CA 125.029 1.331 . . . . 74.409999999999997 111.177 177.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -74.54 167.25 27.56 Favored 'Trans proline' 0 N--CA 1.448 -1.154 0 C-N-CA 124.658 3.572 . . . . 73.049999999999997 110.494 179.662 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -73.12 -2.19 20.45 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.385 1.474 . . . . 73.430000000000007 113.349 -175.419 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -101.75 8.29 41.55 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.01 1.324 . . . . 64.040000000000006 111.15 177.874 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 60.8 t -124.58 155.13 32.47 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 C-N-CA 124.521 1.128 . . . . 64.319999999999993 108.766 -177.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 63.9 t60 -139.27 123.72 18.26 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 126.903 2.081 . . . . 72.019999999999996 106.333 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 47.4 t80 -107.97 139.4 42.65 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 108.079 -1.082 . . . . 60.030000000000001 108.079 -176.82 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 25.9 t -135.2 153.75 34.61 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 N-CA-C 105.511 -2.033 . . . . 75.230000000000004 105.511 -177.48 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -127.86 140.16 52.19 Favored 'General case' 0 CA--C 1.512 -0.512 0 N-CA-C 105.341 -2.096 . . . . 75.299999999999997 105.341 167.44 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 97.5 mt -138.54 144.46 42.45 Favored Pre-proline 0 C--N 1.326 -0.416 0 N-CA-C 108.829 -0.804 . . . . 71.420000000000002 108.829 174.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -71.6 148.25 53.05 Favored 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 121.526 1.484 . . . . 72.450000000000003 110.913 178.098 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -93.28 86.53 5.34 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 124.962 1.305 . . . . 74.530000000000001 108.362 -178.019 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 46.8 mt -80.86 65.45 6.01 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 121.006 -1.059 . . . . 65.129999999999995 112.601 -169.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 13.0 m-85 -80.02 27.2 0.32 Allowed 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 115.111 1.523 . . . . 64.120000000000005 115.111 -168.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 66.54 -168.32 35.48 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 109.217 -1.553 . . . . 63.200000000000003 109.217 -166.572 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 56.15 -151.03 23.03 Favored Glycine 0 CA--C 1.526 0.747 0 CA-C-N 117.848 0.824 . . . . 64.25 111.34 178.866 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 9.6 tp -70.45 -12.04 15.65 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 N-CA-C 112.471 0.545 . . . . 74.200000000000003 112.471 173.162 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 9.4 m95 -64.42 -36.16 83.24 Favored 'General case' 0 C--O 1.224 -0.266 0 O-C-N 120.004 -1.685 . . . . 62.509999999999998 112.178 -171.338 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 11.5 p30 -76.54 -28.34 56.27 Favored 'General case' 0 CA--C 1.518 -0.254 0 N-CA-C 113.051 0.76 . . . . 73.430000000000007 113.051 177.754 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 94.2 t -65.61 -51.69 59.79 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 N-CA-C 107.21 -1.404 . . . . 63.229999999999997 107.21 172.281 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 59.0 m170 -79.1 54.18 1.58 Allowed 'General case' 0 C--O 1.239 0.505 0 C-N-CA 125.493 1.517 . . . . 72.230000000000004 111.446 172.497 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -164.82 -29.28 0.02 OUTLIER Glycine 0 N--CA 1.445 -0.752 0 CA-C-N 115.485 -0.78 . . . . 62.32 112.717 156.046 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -62.32 -25.78 68.07 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 119.314 1.557 . . . . 64.329999999999998 114.045 -173.701 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 40.3 ttp -53.3 -40.12 64.53 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 124.358 1.063 . . . . 52.020000000000003 112.546 -177.404 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -58.47 -47.1 85.15 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 125.074 1.349 . . . . 72.120000000000005 108.523 178.466 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 15.5 mt -68.81 -34.69 75.93 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-O 116.487 -1.721 . . . . 72.109999999999999 111.095 -178.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.642 HG22 HG23 ' A' ' 128' ' ' THR . 0.0 OUTLIER -63.73 -45.12 91.33 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 121.761 2.073 . . . . 75.129999999999995 111.335 174.509 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -52.53 -60.6 3.04 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.454 1.102 . . . . 62.399999999999999 108.723 -176.892 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -67.19 -27.56 67.37 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.26 1.024 . . . . 71.439999999999998 110.043 -174.696 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.0 t -51.68 -39.86 59.04 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 124.52 1.128 . . . . 45.310000000000002 111.621 176.553 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 44.7 mtm . . . . . 0 CA--C 1.534 0.327 0 CA-C-N 118.761 0.71 . . . . 64.310000000000002 112.439 -176.979 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.545 0.752 0 N-CA-C 114.986 1.476 . . . . 71.25 114.986 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 25.6 t -73.36 -66.43 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 CA-C-N 119.895 1.225 . . . . 63.130000000000003 108.805 167.738 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -60.0 -36.98 78.35 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.261 1.025 . . . . 71.040000000000006 110.776 -175.748 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -60.15 -35.55 75.57 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 125.382 1.473 . . . . 62.520000000000003 110.745 176.738 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.428 ' HB2' ' CZ ' ' A' ' 114' ' ' PHE . . . -65.22 -22.18 66.85 Favored 'General case' 0 CA--C 1.534 0.338 0 O-C-N 121.163 -0.961 . . . . 63.130000000000003 112.053 176.979 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 55.5 mt -87.34 -60.01 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.884 0 N-CA-C 105.883 -1.895 . . . . 51.229999999999997 105.883 178.106 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 31.6 p80 -92.55 -53.64 4.11 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 115.379 1.622 . . . . 72.150000000000006 115.379 -168.228 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 34.2 mmtt -62.64 -20.4 64.75 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.238 1.015 . . . . 70.099999999999994 111.742 175.6 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -117.19 -26.2 6.86 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 118.053 -0.975 . . . . 70.420000000000002 113.148 -171.424 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 1.9 t-160 53.46 42.97 31.91 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.275 1.43 . . . . 72.099999999999994 111.994 178.631 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 25.4 mmtp -74.79 157.52 35.03 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 120.941 -1.099 . . . . 75.329999999999998 110.218 175.353 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 11.0 tttt -80.17 36.47 0.35 Allowed 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 127.872 2.469 . . . . 62.130000000000003 111.748 -173.9 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.403 ' HA ' ' HB3' ' A' ' 110' ' ' GLU . 24.7 mt -64.54 32.82 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 130.452 3.501 . . . . 71.540000000000006 115.182 -174.72 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -79.8 13.09 2.29 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 129.636 3.174 . . . . 60.039999999999999 113.14 178.562 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -148.04 158.53 41.74 Favored Pre-proline 0 N--CA 1.463 0.221 0 CA-C-N 119.21 0.914 . . . . 75.400000000000006 111.852 -179.628 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -67.93 -19.55 46.09 Favored 'Trans proline' 0 N--CA 1.455 -0.773 0 C-N-CA 123.225 2.617 . . . . 62.310000000000002 112.106 174.594 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -60.39 -71.19 0.14 Allowed 'General case' 0 C--O 1.22 -0.497 0 N-CA-C 107.398 -1.334 . . . . 73.030000000000001 107.398 167.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.403 ' HB3' ' HA ' ' A' ' 105' ' ' LEU . 3.7 mm-40 -51.51 -42.61 61.83 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 124.289 1.036 . . . . 73.510000000000005 112.395 -176.599 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 48.0 mtt -58.72 -57.15 14.28 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 109.67 -0.493 . . . . 74.239999999999995 109.67 179.503 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.508 ' HB1' ' HG3' ' A' ' 122' ' ' LYS . . . -65.73 -37.33 86.1 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 119.536 -0.269 . . . . 65.150000000000006 111.111 -177.627 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -60.63 -48.77 80.31 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 127.533 2.333 . . . . 72.129999999999995 110.341 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' PHE . . . . . 0.428 ' CZ ' ' HB2' ' A' ' 97' ' ' ALA . 81.4 t80 -65.72 -47.81 74.06 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 123.666 0.787 . . . . 75.120000000000005 110.698 177.109 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 66.9 mt -75.15 -13.06 60.43 Favored 'General case' 0 N--CA 1.457 -0.101 0 CA-C-O 119.051 -0.5 . . . . 74.540000000000006 111.76 -173.686 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -49.11 -53.58 20.05 Favored 'General case' 0 CA--C 1.52 -0.178 0 C-N-CA 125.099 1.36 . . . . 70.25 109.882 -174.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -72.21 7.2 8.41 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 125.453 1.501 . . . . 65.540000000000006 115.571 178.115 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 20.3 mttm -125.43 25.94 6.94 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 120.788 2.294 . . . . 63.25 111.57 -170.751 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 74.46 40.82 38.53 Favored Glycine 0 C--N 1.334 0.448 0 N-CA-C 111.142 -0.783 . . . . 74.400000000000006 111.142 -179.418 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 58.4 t -131.0 111.61 20.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 N-CA-C 107.147 -1.427 . . . . 64.109999999999999 107.147 173.363 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -70.57 136.54 49.34 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 123.993 0.917 . . . . 50.210000000000001 111.47 173.191 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.508 ' HG3' ' HB1' ' A' ' 112' ' ' ALA . 26.9 tttt -64.74 -48.25 75.27 Favored 'General case' 0 CA--C 1.516 -0.362 0 N-CA-C 109.762 -0.458 . . . . 74.329999999999998 109.762 -176.618 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 60.1 mm-40 -63.85 -39.19 93.63 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 122.775 0.43 . . . . 71.239999999999995 110.237 -174.417 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 3.9 mtpm? -75.62 -38.77 58.71 Favored 'General case' 0 CA--C 1.515 -0.376 0 N-CA-C 108.282 -1.007 . . . . 62.310000000000002 108.282 -177.373 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 87.4 t80 -57.76 -60.5 3.6 Favored 'General case' 0 N--CA 1.44 -0.925 0 O-C-N 123.794 0.684 . . . . 72.519999999999996 110.294 178.234 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 15.7 mt -65.61 -37.27 86.13 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-O 118.937 -0.554 . . . . 74.409999999999997 109.754 -175.108 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 45.6 t -60.14 -51.85 67.86 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 108.582 -0.896 . . . . 72.519999999999996 108.582 177.094 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' THR . . . . . 0.642 HG23 HG22 ' A' ' 80' ' ' THR 0.278 1.3 t -69.12 -33.12 72.97 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 119.454 1.025 . . . . 72.140000000000001 109.873 -173.792 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 53.2 t80 -51.1 -48.56 61.65 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.361 1.465 . . . . 73.510000000000005 110.664 170.14 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -95.14 17.63 13.77 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 113.213 0.82 . . . . 72.430000000000007 113.213 -179.074 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 58.0 m -107.67 172.47 6.81 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 119.772 1.169 . . . . 74.439999999999998 111.694 179.487 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -63.84 -23.84 67.51 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 115.92 -0.582 . . . . 75.5 112.338 -174.724 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -53.58 -59.87 4.04 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.671 1.189 . . . . 65.140000000000001 110.032 176.006 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.49 HD11 ' HA ' ' A' ' 80' ' ' THR . 14.2 mm -67.1 -26.21 35.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 C-N-CA 123.032 0.533 . . . . 73.040000000000006 111.605 -179.239 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 6.8 tttp -55.48 -45.45 76.99 Favored 'General case' 0 N--CA 1.464 0.225 0 O-C-N 120.938 -1.101 . . . . 72.230000000000004 109.639 171.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -72.76 -10.91 77.45 Favored Glycine 0 CA--C 1.524 0.63 0 C-N-CA 123.475 0.559 . . . . 72.219999999999999 112.009 -172.53 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 7.5 mm100 -108.66 -38.52 5.63 Favored 'General case' 0 N--CA 1.44 -0.938 0 C-N-CA 126.332 1.853 . . . . 65.040000000000006 109.357 -171.494 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -62.98 -41.91 99.69 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 118.368 -0.825 . . . . 71.109999999999999 110.332 174.0 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -67.71 -44.66 77.17 Favored 'General case' 0 CA--C 1.535 0.365 0 CA-C-N 119.137 0.881 . . . . 73.349999999999994 110.266 178.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 3.1 ttmt -63.23 -56.13 19.15 Favored 'General case' 0 N--CA 1.449 -0.475 0 O-C-N 121.034 -1.041 . . . . 74.230000000000004 111.164 -174.503 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -59.64 -33.27 71.31 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 118.029 0.377 . . . . 65.310000000000002 110.661 -176.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 2.0 tmtm? -60.1 -60.54 3.66 Favored 'General case' 0 CA--C 1.531 0.245 0 O-C-N 121.269 -0.894 . . . . 71.439999999999998 110.925 172.526 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.44 -18.79 63.0 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 119.265 0.939 . . . . 54.140000000000001 112.039 -173.727 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 45.4 mt -69.5 -54.55 13.64 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 123.96 0.904 . . . . 73.450000000000003 110.338 172.359 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -53.58 -47.37 70.2 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 119.558 1.072 . . . . 71.310000000000002 112.588 -174.337 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -62.33 -45.13 94.6 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 112.704 0.631 . . . . 65.439999999999998 112.704 175.922 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -63.21 -35.65 81.01 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 118.496 0.589 . . . . 74.340000000000003 109.88 -179.718 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 -74.19 9.2 1.72 Allowed 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 114.014 1.116 . . . . 71.140000000000001 114.014 173.029 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 60.86 19.5 9.76 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 126.294 1.838 . . . . 73.439999999999998 112.649 176.063 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 25.8 t -75.16 141.14 16.31 Favored 'Isoleucine or valine' 0 C--O 1.24 0.58 0 N-CA-C 107.996 -1.113 . . . . 52.299999999999997 107.996 -177.042 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -141.49 0.5 1.48 Allowed 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 118.846 -0.597 . . . . 75.329999999999998 112.408 173.409 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -160.12 167.96 35.63 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 108.6 -1.8 . . . . 72.329999999999998 108.6 170.532 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 30.0 m -123.88 156.03 66.08 Favored Pre-proline 0 C--O 1.238 0.473 0 C-N-CA 125.697 1.599 . . . . 71.230000000000004 107.614 176.515 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' PRO . . . . . 0.417 ' HG3' HD12 ' A' ' 166' ' ' ILE . 94.8 Cg_endo -67.33 157.92 83.53 Favored 'Cis proline' 0 N--CA 1.46 -0.447 0 O-C-N 122.607 0.793 . . . . 73.409999999999997 113.323 -2.083 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 5.1 m -154.86 136.93 14.69 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 107.989 -1.115 . . . . 74.319999999999993 107.989 171.014 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 91.8 mtp -111.13 152.92 26.44 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 107.135 -1.432 . . . . 61.240000000000002 107.135 169.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 41.0 t -138.98 128.66 31.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 N-CA-C 107.92 -1.141 . . . . 73.430000000000007 107.92 178.467 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 42.7 t -104.03 130.71 54.23 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 C-N-CA 124.371 1.069 . . . . 61.229999999999997 108.634 173.013 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 45.29 23.53 0.12 Allowed 'General case' 0 N--CA 1.464 0.264 1 C-N-CA 131.728 4.011 . . . . 61.329999999999998 114.374 177.278 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 59.41 31.33 69.91 Favored Glycine 0 CA--C 1.531 1.091 0 CA-C-O 117.69 -1.616 . . . . 52.43 113.882 -170.764 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 10.5 mtpt -131.27 -30.56 1.72 Allowed 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 119.622 1.711 . . . . 72.319999999999993 113.386 -177.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -122.16 118.59 29.0 Favored 'General case' 0 CA--C 1.519 -0.235 0 N-CA-C 107.907 -1.146 . . . . 74.239999999999995 107.907 -174.864 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 36.2 ttp85 -100.49 135.8 41.36 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 105.04 -2.207 . . . . 72.019999999999996 105.04 175.475 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 18.1 p90 -154.07 166.5 32.84 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 108.346 -0.983 . . . . 73.129999999999995 108.346 172.915 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -170.94 178.56 3.39 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.998 0.428 . . . . 75.150000000000006 110.77 -175.346 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.425 HD11 ' CG ' ' A' ' 43' ' ' PHE . 43.3 mt -55.89 -45.06 79.74 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 C-N-CA 124.904 1.282 . . . . 64.120000000000005 108.799 -179.406 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -88.32 29.4 5.68 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 126.481 1.991 . . . . 75.129999999999995 113.155 174.637 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 19.0 p -119.99 -51.16 2.24 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 107.482 -1.303 . . . . 74.140000000000001 107.482 156.315 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.414 ' HB2' HD23 ' A' ' 178' ' ' LEU . . . -66.52 -39.55 88.7 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 125.097 1.359 . . . . 64.209999999999994 112.319 -175.042 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 110.61 11.56 19.05 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 124.103 0.859 . . . . 64.340000000000003 113.48 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 159.99 170.4 24.53 Favored Glycine 0 CA--C 1.524 0.598 0 CA-C-N 119.469 1.634 . . . . 62.039999999999999 110.525 175.02 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -66.44 -42.36 10.05 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 122.019 1.813 . . . . 74.140000000000001 110.762 -175.816 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -70.1 -34.33 73.0 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 109.166 -0.679 . . . . 62.229999999999997 109.166 -177.488 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 41.7 mm-40 -67.37 -28.9 68.33 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.544 1.538 . . . . 73.109999999999999 110.472 174.056 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 23.6 m -66.0 -40.72 91.39 Favored 'General case' 0 CA--C 1.531 0.212 0 O-C-N 120.467 -1.396 . . . . 73.030000000000001 108.844 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 176' ' ' LEU . . . . . 0.457 HD22 ' CG ' ' A' ' 50' ' ' TRP . 61.1 mt -66.36 -24.48 66.51 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 119.343 0.974 . . . . 71.239999999999995 112.423 177.65 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 9.4 mttt -56.58 -54.25 48.09 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 108.564 -0.902 . . . . 74.019999999999996 108.564 168.683 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.434 HD11 ' HB3' ' A' ' 11' ' ' GLU . 2.9 mm? -68.14 -43.62 77.92 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 120.326 -0.549 . . . . 55.530000000000001 109.931 -178.952 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.42 -26.98 63.89 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 124.247 1.019 . . . . 70.239999999999995 112.864 -174.688 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 180' ' ' ASP . . . . . 0.406 ' HA ' HD12 ' A' ' 183' ' ' ILE . 15.8 t70 -100.69 -32.57 10.66 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 123.769 0.827 . . . . 44.509999999999998 111.474 -173.587 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 33.7 t80 -62.45 -52.01 65.24 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 124.178 0.991 . . . . 71.409999999999997 109.906 170.939 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 48.9 mt -55.39 -32.54 62.72 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 124.304 1.042 . . . . 73.219999999999999 112.164 -176.085 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.406 HD12 ' HA ' ' A' ' 180' ' ' ASP . 81.3 mt -54.19 -62.73 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.309 0 N-CA-C 107.857 -1.164 . . . . 44.149999999999999 107.857 174.401 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 -61.53 -37.43 83.75 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 121.193 0.52 . . . . 73.120000000000005 111.56 -171.188 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -58.14 -52.21 66.5 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.106 0.963 . . . . 43.409999999999997 109.875 179.695 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 186' ' ' GLU . . . . . 0.435 ' HB3' HD12 ' A' ' 27' ' ' ILE . 3.2 mm-40 -68.06 -42.53 80.34 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-O 121.603 0.716 . . . . 74.299999999999997 112.586 174.581 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 5.5 tpm_? -53.61 -46.72 70.53 Favored 'General case' 0 CA--C 1.516 -0.334 0 C-N-CA 125.188 1.395 . . . . 75.450000000000003 110.326 -175.09 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.286 0 C-N-CA 125.201 1.401 . . . . 63.009999999999998 112.159 -177.733 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 . . . . . 0 N--CA 1.458 -0.055 0 CA-C-O 123.108 1.433 . . . . 74.310000000000002 110.049 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -69.33 8.33 0.62 Allowed 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 125.262 1.425 . . . . 72.140000000000001 113.524 177.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -138.6 167.53 21.74 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 126.603 1.961 . . . . 64.319999999999993 108.944 -171.649 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 59.3 m -133.99 133.32 41.17 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 107.213 -1.402 . . . . 74.430000000000007 107.213 176.034 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -69.37 137.78 53.13 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 108.166 -1.05 . . . . 52.530000000000001 108.166 168.681 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 72.47 24.78 75.68 Favored Glycine 0 CA--C 1.528 0.867 0 N-CA-C 111.251 -0.74 . . . . 61.43 111.251 -167.797 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 18.4 tttm -140.4 -85.02 0.21 Allowed 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 106.81 -1.552 . . . . 74.450000000000003 106.81 171.044 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.494 ' HB3' HD21 ' A' ' 178' ' ' LEU . 13.3 mm-40 -72.92 -23.93 60.76 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 124.588 1.155 . . . . 72.409999999999997 111.044 -177.262 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 44.8 p90 -157.74 167.51 29.84 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 123.508 0.723 . . . . 62.109999999999999 109.468 -171.45 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 93.5 t -133.99 119.71 32.99 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 C-N-CA 124.321 1.048 . . . . 75.420000000000002 109.089 -179.695 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.91 161.42 30.15 Favored 'General case' 0 C--N 1.328 -0.351 0 O-C-N 120.19 -1.568 . . . . 63.200000000000003 109.633 172.307 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -119.53 108.12 14.13 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 124.022 0.929 . . . . 72.019999999999996 108.988 177.704 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.8 m -61.9 -5.64 2.23 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 124.864 1.266 . . . . 74.510000000000005 113.946 -178.81 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -121.02 84.6 39.54 Favored Pre-proline 0 N--CA 1.449 -0.483 0 N-CA-C 106.334 -1.728 . . . . 73.439999999999998 106.334 167.298 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -67.19 177.62 3.62 Favored 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 123.084 2.523 . . . . 74.329999999999998 111.129 179.625 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 36.4 t -136.8 139.67 29.61 Favored Pre-proline 0 C--N 1.327 -0.371 0 C-N-CA 124.552 1.141 . . . . 72.319999999999993 108.085 -166.546 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -76.14 177.78 8.32 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 123.0 2.466 . . . . 62.409999999999997 112.356 175.571 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 4.0 m -126.83 -174.61 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 C-N-CA 126.952 2.101 . . . . 73.120000000000005 108.301 177.164 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -66.18 -41.59 90.04 Favored 'General case' 0 CA--C 1.538 0.517 0 O-C-N 121.51 -0.744 . . . . 44.109999999999999 109.752 176.849 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 -168.12 166.04 7.52 Favored Pre-proline 0 CA--C 1.539 0.535 0 C-N-CA 127.63 2.372 . . . . 60.210000000000001 108.325 -179.127 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -61.25 167.25 9.64 Favored 'Trans proline' 0 CA--C 1.543 0.952 0 C-N-CA 122.051 1.834 . . . . 71.430000000000007 110.681 162.628 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 137.05 -64.08 0.57 Allowed Glycine 0 C--N 1.338 0.64 0 O-C-N 121.296 -0.877 . . . . 53.119999999999997 112.509 170.146 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.447 ' N ' ' HE2' ' A' ' 26' ' ' LYS . 0.2 OUTLIER -113.43 144.16 43.27 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 118.966 1.383 . . . . 74.25 107.756 176.389 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 45.4 mm -67.54 129.66 32.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 104.991 -2.226 . . . . 72.540000000000006 104.991 170.842 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -90.47 138.57 31.44 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 107.322 -1.362 . . . . 72.420000000000002 107.322 177.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 58.5 t -129.43 116.47 39.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 106.414 -1.699 . . . . 71.140000000000001 106.414 175.114 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 23.4 t -106.58 112.35 39.27 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 N-CA-C 107.891 -1.151 . . . . 72.209999999999994 107.891 -175.586 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -77.53 130.3 36.78 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 107.843 -1.169 . . . . 61.240000000000002 107.843 159.076 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.743 HD22 HG21 ' A' ' 150' ' ' VAL . 5.3 mp -114.68 130.75 56.86 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 124.236 1.014 . . . . 71.0 108.587 164.406 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 33.4 p90 -134.17 168.58 18.59 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.608 0.763 . . . . 75.099999999999994 111.255 -172.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 25.2 t90 -147.96 168.45 22.26 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 126.597 1.959 . . . . 75.049999999999997 107.691 173.414 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 2.1 m-30 -81.41 -41.13 22.36 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 109.181 -0.674 . . . . 74.230000000000004 109.181 179.301 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -76.5 21.64 2.35 Favored Glycine 0 CA--C 1.532 1.105 0 C-N-CA 124.81 1.195 . . . . 60.229999999999997 114.089 -175.547 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 51.8 t -105.0 87.23 1.79 Allowed Pre-proline 0 CA--C 1.537 0.475 0 C-N-CA 126.752 2.021 . . . . 71.5 110.391 -170.632 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -54.11 -42.61 65.59 Favored 'Trans proline' 0 CA--C 1.534 0.514 0 C-N-CA 122.387 2.058 . . . . 54.439999999999998 113.284 177.863 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 26.7 m170 -72.87 -24.16 60.82 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 119.227 0.922 . . . . 70.200000000000003 111.734 -172.737 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 99.6 m -62.57 -39.25 93.09 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.846 0.858 . . . . 60.25 110.56 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 21.8 t80 -62.67 -45.94 90.5 Favored 'General case' 0 C--N 1.341 0.229 0 C-N-CA 123.616 0.766 . . . . 72.209999999999994 111.061 -176.245 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.61 -9.97 31.61 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 112.695 0.628 . . . . 74.200000000000003 112.695 -176.056 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.437 ' HB2' HD11 ' A' ' 166' ' ' ILE . 2.6 t80 -97.97 -22.61 16.2 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 124.97 1.308 . . . . 71.430000000000007 111.267 178.013 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -44.81 -64.83 0.74 Allowed Pre-proline 0 CA--C 1.54 0.57 0 C-N-CA 125.007 1.323 . . . . 71.200000000000003 112.47 -172.069 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -69.96 -4.91 15.11 Favored 'Trans proline' 0 N--CA 1.459 -0.509 0 C-N-CA 122.1 1.867 . . . . 64.239999999999995 115.547 -176.425 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.8 m -87.12 -41.11 14.04 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 108.529 -0.915 . . . . 72.530000000000001 108.529 171.372 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 19.0 tt -84.62 -29.35 6.87 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 O-C-N 121.586 -0.696 . . . . 72.010000000000005 111.422 -174.011 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 34.8 t -48.88 -66.32 0.61 Allowed Pre-proline 0 CA--C 1.534 0.339 0 CA-C-O 117.428 -1.272 . . . . 71.430000000000007 110.84 172.126 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -58.86 -41.45 62.42 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 121.67 1.58 . . . . 75.049999999999997 110.125 -175.206 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 61.6 t90 -52.71 -57.33 10.45 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 118.519 0.599 . . . . 74.140000000000001 110.473 177.095 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 78.1 p -59.96 -34.61 73.49 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.272 0.629 . . . . 73.049999999999997 112.483 -177.467 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -78.67 -16.77 56.9 Favored 'General case' 0 CA--C 1.533 0.317 0 O-C-N 121.303 -0.873 . . . . 62.109999999999999 112.835 178.343 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 42.2 mmtm -106.04 2.16 27.04 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 126.089 1.756 . . . . 74.439999999999998 112.662 -178.078 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 37.2 mt -57.7 148.73 55.88 Favored Pre-proline 0 C--O 1.236 0.37 0 C-N-CA 124.397 1.079 . . . . 74.409999999999997 110.741 177.873 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -77.55 170.93 18.41 Favored 'Trans proline' 0 N--CA 1.443 -1.451 0 C-N-CA 124.015 3.143 . . . . 54.450000000000003 111.014 178.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -67.84 3.4 1.51 Allowed 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 115.075 1.509 . . . . 74.120000000000005 115.075 -170.812 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -118.56 1.42 11.7 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 126.94 2.096 . . . . 43.240000000000002 112.568 -177.775 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 23.1 t -120.19 123.29 70.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 CA-C-N 119.369 0.986 . . . . 51.0 109.569 -179.014 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 80.1 t60 -115.05 107.63 15.6 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 126.155 1.782 . . . . 75.430000000000007 109.663 -174.317 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 26.5 t80 -78.34 139.63 38.81 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.688 1.195 . . . . 64.140000000000001 110.762 179.744 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 88.8 t -131.51 146.61 33.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 C-N-CA 127.698 2.399 . . . . 75.549999999999997 106.681 -178.132 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 29.7 mtt-85 -131.63 120.03 22.25 Favored 'General case' 0 CA--C 1.508 -0.669 0 N-CA-C 106.929 -1.508 . . . . 65.030000000000001 106.929 -177.58 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 75.2 mt -129.93 148.68 70.57 Favored Pre-proline 0 C--N 1.325 -0.464 0 O-C-N 123.419 0.45 . . . . 74.140000000000001 112.187 179.677 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -75.87 134.77 16.77 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 122.8 2.333 . . . . 71.219999999999999 110.457 177.55 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -75.97 108.7 9.03 Favored 'General case' 0 CA--C 1.535 0.395 0 O-C-N 121.477 -0.764 . . . . 71.019999999999996 109.059 170.155 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 49.5 mt -103.03 94.19 5.42 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 127.165 2.186 . . . . 72.140000000000001 108.548 -179.533 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -130.8 43.53 3.09 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 119.221 0.918 . . . . 64.450000000000003 112.21 -175.826 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.452 ' H ' ' ND2' ' A' ' 72' ' ' ASN . . . 74.63 164.23 11.35 Favored Glycine 0 CA--C 1.522 0.525 0 C-N-CA 124.767 1.175 . . . . 74.510000000000005 112.358 175.41 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 52.33 -144.11 20.45 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.416 -1.073 . . . . 73.319999999999993 110.416 -175.708 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 4.8 tp -64.4 -15.12 16.9 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 CA-C-O 118.093 -0.955 . . . . 73.239999999999995 111.431 -172.279 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 19.7 m95 -59.81 -33.59 71.93 Favored 'General case' 0 C--N 1.342 0.275 0 CA-C-N 120.732 1.605 . . . . 73.25 111.139 173.126 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.452 ' ND2' ' H ' ' A' ' 68' ' ' GLY . 7.3 m-80 -80.52 -32.32 36.9 Favored 'General case' 0 C--N 1.339 0.147 0 CA-C-N 118.766 0.712 . . . . 73.319999999999993 111.708 177.137 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 70.5 t -68.44 -58.83 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 N-CA-C 108.512 -0.922 . . . . 72.349999999999994 108.512 178.159 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 52.1 m170 -72.14 47.21 0.15 Allowed 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 126.625 1.97 . . . . 74.239999999999995 109.578 167.113 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -164.49 1.24 0.05 OUTLIER Glycine 0 CA--C 1.527 0.818 0 C-N-CA 127.055 2.264 . . . . 55.530000000000001 113.28 -176.795 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -108.2 -24.13 11.65 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 120.78 2.29 . . . . 63.109999999999999 113.23 -174.79 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 3.0 ptt? -85.14 -23.45 28.41 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 114.361 1.245 . . . . 74.219999999999999 114.361 -170.194 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 29.5 t80 -56.58 -48.68 76.87 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 119.861 1.21 . . . . 74.400000000000006 107.94 176.866 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 35.1 mt -60.84 -46.85 88.95 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 114.846 -1.07 . . . . 72.349999999999994 109.672 178.833 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.586 HG22 HG23 ' A' ' 128' ' ' THR . 0.2 OUTLIER -61.72 -41.94 98.29 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 119.503 1.047 . . . . 51.420000000000002 111.525 -179.837 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -54.53 -53.24 57.04 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 123.99 0.916 . . . . 74.420000000000002 108.993 -177.31 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -76.54 -24.85 53.64 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 124.645 1.178 . . . . 71.019999999999996 112.212 -176.635 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 7.7 t -55.11 -11.71 0.76 Allowed 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.629 1.572 . . . . 72.129999999999995 113.46 172.928 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 9.1 mtp . . . . . 0 C--O 1.225 -0.213 0 C-N-CA 124.165 0.986 . . . . 75.519999999999996 112.799 177.745 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.135 0 N-CA-C 111.53 0.196 . . . . 61.450000000000003 111.53 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 82.7 t -62.0 -35.19 67.03 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.379 0 N-CA-C 109.468 -0.567 . . . . 75.420000000000002 109.468 175.676 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -80.44 -46.97 15.07 Favored 'General case' 0 CA--C 1.527 0.062 0 CA-C-N 119.738 1.154 . . . . 73.510000000000005 109.908 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.413 ' OE1' ' HE3' ' A' ' 100' ' ' LYS . 13.4 mm-40 -50.99 -38.13 49.15 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.715 1.606 . . . . 73.310000000000002 110.251 178.855 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.4 ' HA ' ' HB2' ' A' ' 101' ' ' GLU . . . -75.56 -14.71 60.41 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.75 1.22 . . . . 64.329999999999998 113.826 -174.659 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.424 HD13 HG21 ' A' ' 98' ' ' ILE . 51.9 mt -121.01 -24.45 2.79 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 C-N-CA 125.123 1.369 . . . . 45.450000000000003 109.307 -169.721 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -100.16 -68.3 0.82 Allowed 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 124.977 1.311 . . . . 73.120000000000005 108.419 176.87 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.413 ' HE3' ' OE1' ' A' ' 96' ' ' GLU . 0.1 OUTLIER -65.96 -32.9 74.66 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 119.601 1.091 . . . . 71.319999999999993 110.985 -177.456 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.4 ' HB2' ' HA ' ' A' ' 97' ' ' ALA . 20.3 mt-10 -112.98 -21.11 11.28 Favored 'General case' 0 CA--C 1.528 0.101 0 N-CA-C 113.53 0.937 . . . . 72.099999999999994 113.53 -170.508 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 3.2 t60 45.08 62.98 1.9 Allowed 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 125.726 1.611 . . . . 63.530000000000001 114.644 175.06 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 19.3 mmtp -77.78 158.95 29.33 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.634 1.174 . . . . 63.310000000000002 111.794 174.726 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 28.7 tttt -93.27 45.87 1.19 Allowed 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 125.089 1.356 . . . . 75.519999999999996 112.381 -172.422 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 53.6 mt -69.0 51.76 0.08 Allowed 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 131.387 3.875 . . . . 72.120000000000005 111.475 -179.545 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -98.37 1.5 47.0 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 126.232 1.813 . . . . 71.400000000000006 111.924 -177.452 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -131.52 150.62 76.87 Favored Pre-proline 0 N--CA 1.467 0.388 0 C-N-CA 124.128 0.971 . . . . 65.239999999999995 109.936 -178.483 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_exo -59.62 -42.59 45.77 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 121.675 1.583 . . . . 64.209999999999994 110.782 -176.818 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 10.5 mp0 -61.35 -38.08 85.65 Favored 'General case' 0 N--CA 1.438 -1.065 0 C-N-CA 124.447 1.099 . . . . 74.140000000000001 110.623 -179.078 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -71.42 -47.05 58.37 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 125.591 1.557 . . . . 71.0 110.369 -176.904 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 58.2 mtt -58.56 -55.63 32.61 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 124.609 1.164 . . . . 71.540000000000006 109.154 174.108 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -64.28 -31.12 72.2 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.825 1.25 . . . . 74.420000000000002 111.559 -175.18 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -63.6 -46.68 84.7 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 119.478 1.036 . . . . 74.329999999999998 110.955 173.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 72.0 t80 -65.71 -44.32 86.45 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 121.866 0.841 . . . . 75.140000000000001 109.972 177.403 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.447 HD23 ' HA ' ' A' ' 115' ' ' LEU . 53.0 mt -69.27 -23.94 63.9 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 124.459 1.104 . . . . 75.450000000000003 111.481 -176.904 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.81 -13.92 18.4 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 122.902 0.481 . . . . 74.140000000000001 112.2 176.401 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -110.93 3.2 28.72 Favored Glycine 0 CA--C 1.526 0.755 0 C-N-CA 124.705 1.145 . . . . 63.229999999999997 114.046 170.292 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -135.42 51.31 2.08 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 119.383 1.592 . . . . 73.200000000000003 108.847 -171.52 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 92.56 13.85 56.35 Favored Glycine 0 CA--C 1.526 0.756 0 O-C-N 124.149 0.905 . . . . 43.130000000000003 114.395 162.733 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 99.1 t -129.99 165.06 31.07 Favored 'Isoleucine or valine' 0 C--O 1.231 0.116 0 CA-C-N 118.317 1.058 . . . . 64.310000000000002 109.35 -167.876 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 45.2 t0 -129.27 130.86 46.74 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 107.36 -1.348 . . . . 74.340000000000003 107.36 174.202 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 3.3 mttp -57.23 -36.98 71.59 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 119.075 0.852 . . . . 71.030000000000001 110.571 174.103 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -61.05 -24.16 65.99 Favored 'General case' 0 C--O 1.231 0.098 0 C-N-CA 124.173 0.989 . . . . 74.109999999999999 112.209 176.747 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 88.2 mttt -102.31 -49.37 3.91 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 119.97 1.259 . . . . 63.130000000000003 108.465 -177.598 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 68.4 t80 -48.92 -61.96 1.78 Allowed 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 126.331 1.852 . . . . 72.120000000000005 111.953 -178.716 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 15.9 mt -66.66 -31.63 72.42 Favored 'General case' 0 CA--C 1.534 0.352 0 O-C-N 121.486 -0.759 . . . . 75.200000000000003 110.475 -172.651 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 34.3 t -61.57 -50.4 72.79 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 124.299 1.04 . . . . 54.229999999999997 109.128 179.017 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' THR . . . . . 0.586 HG23 HG22 ' A' ' 80' ' ' THR 0.272 0.0 OUTLIER -70.15 -34.76 73.43 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 119.164 0.893 . . . . 71.209999999999994 110.332 178.264 . . . . . . . . 4 4 . 1 . 005 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 49.2 t80 -54.96 -55.29 32.36 Favored 'General case' 0 CA--C 1.529 0.17 0 O-C-N 121.592 -0.693 . . . . 74.420000000000002 110.422 179.648 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 -94.16 49.66 1.33 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.4 0.68 . . . . 74.219999999999999 109.294 176.661 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -123.2 164.15 19.26 Favored 'General case' 0 C--O 1.241 0.626 0 C-N-CA 125.626 1.57 . . . . 51.140000000000001 109.322 170.678 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.17 -30.96 70.72 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-O 119.293 -0.384 . . . . 74.049999999999997 110.464 178.446 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -45.3 -66.92 0.33 Allowed 'General case' 0 C--O 1.234 0.264 0 C-N-CA 124.97 1.308 . . . . 70.349999999999994 110.959 176.928 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 8.0 mm -64.54 -32.82 59.39 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 CA-C-O 118.56 -0.733 . . . . 75.030000000000001 111.21 -178.134 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 10.5 mttp -57.87 -35.35 70.84 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 119.1 0.863 . . . . 72.400000000000006 110.617 174.627 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -82.65 -31.78 29.09 Favored Glycine 0 C--N 1.339 0.695 0 CA-C-O 122.583 1.101 . . . . 72.439999999999998 110.696 -175.112 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 2.8 mm100 -74.51 -39.86 62.14 Favored 'General case' 0 N--CA 1.45 -0.46 0 O-C-N 121.539 -0.977 . . . . 75.540000000000006 109.835 -176.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 9.3 mtp -60.63 -51.26 70.15 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 119.069 -0.491 . . . . 65.209999999999994 110.379 174.102 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -63.64 -29.16 70.44 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 118.86 0.754 . . . . 73.409999999999997 112.435 -174.939 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 14.7 mtmt -61.47 -75.15 0.07 Allowed 'General case' 0 CA--C 1.522 -0.102 0 N-CA-C 107.86 -1.163 . . . . 74.109999999999999 107.86 165.681 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -49.12 -35.07 15.44 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.228 1.011 . . . . 74.430000000000007 112.619 -169.326 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 9.9 tmtt? -58.02 -46.94 84.48 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 126.301 1.84 . . . . 72.209999999999994 112.366 177.357 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 9.5 ptpp? -77.79 -33.44 52.59 Favored 'General case' 0 C--N 1.34 0.176 0 CA-C-N 120.824 1.647 . . . . 62.340000000000003 111.199 173.573 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 41.5 mt -59.35 -46.21 89.27 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 119.032 0.833 . . . . 71.239999999999995 109.973 -174.151 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -58.67 -37.03 75.12 Favored 'General case' 0 CA--C 1.534 0.349 0 O-C-N 121.814 -0.554 . . . . 60.530000000000001 111.592 -178.357 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 1.1 mtm -76.8 -31.85 57.25 Favored 'General case' 0 C--O 1.23 0.044 0 O-C-N 122.138 -0.352 . . . . 64.319999999999993 110.857 179.407 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -56.46 -46.24 80.47 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 108.82 -0.808 . . . . 75.450000000000003 108.82 172.622 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 35.8 m-85 -76.74 10.16 2.38 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 114.175 1.176 . . . . 75.239999999999995 114.175 177.877 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 59.1 23.47 11.69 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 127.562 2.345 . . . . 54.119999999999997 113.98 176.004 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.814 HG22 HG21 ' A' ' 155' ' ' THR . 66.4 t -67.05 133.97 30.76 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 C-N-CA 124.031 0.932 . . . . 71.200000000000003 108.653 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -130.49 -5.65 4.21 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 125.244 1.418 . . . . 75.319999999999993 113.132 -177.641 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 170.98 139.51 2.78 Favored Glycine 0 N--CA 1.448 -0.541 0 N-CA-C 107.666 -2.173 . . . . 64.239999999999995 107.666 174.174 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.429 ' HA ' ' C ' ' A' ' 154' ' ' PRO . 17.2 m -83.37 152.72 64.84 Favored Pre-proline 0 CA--C 1.534 0.364 0 C-N-CA 124.559 1.144 . . . . 70.439999999999998 109.647 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 154' ' ' PRO . . . . . 0.486 ' HG3' HD12 ' A' ' 166' ' ' ILE . 53.7 Cg_endo -70.74 157.71 94.59 Favored 'Cis proline' 0 CA--C 1.531 0.359 0 C-N-CA 125.15 -0.771 . . . . 75.349999999999994 113.623 3.405 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 155' ' ' THR . . . . . 0.814 HG21 HG22 ' A' ' 150' ' ' VAL . 36.5 m -157.13 115.17 3.19 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 107.461 -1.311 . . . . 71.010000000000005 107.461 175.338 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 93.7 mtp -96.3 158.24 15.53 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 108.705 -0.85 . . . . 75.530000000000001 108.705 164.01 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 5.2 t -136.48 138.47 46.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 106.586 -1.635 . . . . 74.129999999999995 106.586 174.365 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.54 HG23 ' CE1' ' A' ' 164' ' ' PHE . 51.2 t -103.18 125.22 57.66 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 N-CA-C 106.734 -1.58 . . . . 74.209999999999994 106.734 164.184 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 9.4 t30 52.98 21.54 2.08 Favored 'General case' 0 N--CA 1.462 0.153 0 C-N-CA 130.89 3.676 . . . . 72.150000000000006 115.521 162.112 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 73.34 22.62 78.57 Favored Glycine 0 CA--C 1.526 0.72 0 CA-C-O 117.69 -1.617 . . . . 51.210000000000001 114.068 -176.415 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 10.4 mtpt -134.18 -24.4 1.64 Allowed 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 120.248 2.024 . . . . 72.409999999999997 113.122 -174.828 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -128.2 120.2 26.78 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 124.179 0.991 . . . . 74.120000000000005 109.033 -173.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 41.5 ttp85 -102.56 126.83 49.76 Favored 'General case' 0 CA--C 1.52 -0.178 0 C-N-CA 126.117 1.767 . . . . 71.230000000000004 107.886 174.63 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 164' ' ' PHE . . . . . 0.54 ' CE1' HG23 ' A' ' 158' ' ' VAL . 13.4 p90 -145.28 174.0 11.48 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 107.277 -1.379 . . . . 73.530000000000001 107.277 177.375 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 174.89 -175.25 0.08 Allowed 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 125.437 1.495 . . . . 63.409999999999997 108.595 176.423 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.486 HD12 ' HG3' ' A' ' 154' ' ' PRO . 6.5 mt -45.58 -52.27 2.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 C-N-CA 129.901 3.281 . . . . 63.200000000000003 108.574 172.624 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -75.61 19.28 2.6 Favored Glycine 0 CA--C 1.524 0.641 0 C-N-CA 128.062 2.744 . . . . 74.120000000000005 114.911 176.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 19.2 m -129.27 -50.1 1.19 Allowed 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 119.315 1.557 . . . . 62.100000000000001 110.847 157.594 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -71.16 -19.56 62.4 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.691 0.797 . . . . 72.439999999999998 111.944 -174.68 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 103.44 4.14 46.83 Favored Glycine 0 CA--C 1.525 0.66 0 O-C-N 120.624 -1.298 . . . . 62.350000000000001 113.296 175.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 171' ' ' GLY . . . . . 0.438 ' HA2' HG23 ' A' ' 166' ' ' ILE . . . 154.03 177.06 27.07 Favored Glycine 0 CA--C 1.53 0.981 0 CA-C-N 119.239 1.52 . . . . 63.530000000000001 111.268 172.339 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -65.07 -37.51 32.55 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 122.851 2.367 . . . . 65.230000000000004 113.38 -169.318 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -69.37 -42.32 75.37 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 119.454 1.025 . . . . 74.510000000000005 108.413 -178.297 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 51.2 mm-40 -66.03 -26.89 67.73 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.685 1.194 . . . . 64.430000000000007 110.235 179.308 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 46.0 m -64.36 -41.34 96.77 Favored 'General case' 0 CA--C 1.534 0.354 0 O-C-N 120.075 -1.641 . . . . 64.540000000000006 110.638 -178.276 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 36.9 mt -65.88 -32.04 73.32 Favored 'General case' 0 C--N 1.341 0.203 0 CA-C-N 119.061 0.846 . . . . 72.120000000000005 110.532 175.708 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.03 -39.8 69.53 Favored 'General case' 0 CA--C 1.522 -0.127 0 C-N-CA 124.903 1.281 . . . . 70.230000000000004 109.535 174.833 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.494 HD21 ' HB3' ' A' ' 11' ' ' GLU . 4.5 mm? -78.21 -41.48 34.33 Favored 'General case' 0 CA--C 1.505 -0.763 0 CA-C-O 117.638 -1.172 . . . . 70.099999999999994 111.076 173.916 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -55.63 -45.97 77.49 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 119.52 1.055 . . . . 55.350000000000001 109.889 -172.828 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.93 -37.6 55.01 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 125.204 1.401 . . . . 55.530000000000001 109.519 -167.643 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 12.9 t80 -67.78 -47.8 68.13 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.512 1.125 . . . . 65.329999999999998 111.253 173.181 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 78.8 mt -63.33 -35.88 81.85 Favored 'General case' 0 C--O 1.232 0.169 0 C-N-CA 123.889 0.876 . . . . 64.439999999999998 110.83 -176.563 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 34.7 mt -53.31 -54.61 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 CA-C-O 118.338 -0.839 . . . . 73.319999999999993 109.181 170.275 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -55.92 -41.78 75.08 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 119.554 1.07 . . . . 73.129999999999995 111.553 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.86 -55.72 27.34 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 125.157 1.383 . . . . 74.450000000000003 108.267 -179.363 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 26.4 mm-40 -71.38 -32.74 68.82 Favored 'General case' 0 C--O 1.225 -0.186 0 C-N-CA 124.514 1.125 . . . . 73.340000000000003 113.094 -178.882 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.91 -24.52 62.46 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 120.762 -1.211 . . . . 44.409999999999997 111.719 -178.905 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 0.259 0 C-N-CA 123.302 0.641 . . . . 71.120000000000005 111.928 171.725 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 . . . . . 0 N--CA 1.445 -0.691 0 N-CA-C 103.341 -2.837 . . . . 65.510000000000005 103.341 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -143.03 6.87 1.58 Allowed 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.527 0.679 . . . . 61.43 111.723 -166.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 -132.87 178.96 6.47 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.561 1.144 . . . . 71.340000000000003 109.619 -168.422 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.0 m -148.05 141.93 25.78 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.588 1.555 . . . . 71.030000000000001 109.467 175.313 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.98 137.28 56.4 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 124.338 1.055 . . . . 72.329999999999998 110.043 178.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.7 -17.4 15.54 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 125.959 1.742 . . . . 21.530000000000001 112.76 -171.625 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 4.4 ttmt -92.86 -86.47 0.25 Allowed 'General case' 0 CA--C 1.519 -0.218 0 CA-C-N 119.028 1.414 . . . . 63.109999999999999 107.783 -176.226 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.422 ' HB3' HD21 ' A' ' 178' ' ' LEU . 0.4 OUTLIER -77.53 -21.34 52.77 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.627 0.771 . . . . 63.210000000000001 110.364 -175.354 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 14.0 p90 -161.51 175.95 11.59 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.784 1.234 . . . . 64.109999999999999 109.296 -175.196 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 41.3 t -135.05 154.41 36.21 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.811 0 C-N-CA 126.377 1.871 . . . . 63.5 108.321 -175.744 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -103.88 170.59 7.84 Favored 'General case' 0 CA--C 1.521 -0.164 0 O-C-N 119.649 -1.907 . . . . 51.350000000000001 109.63 166.209 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -128.56 113.22 15.18 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 106.956 -1.498 . . . . 73.329999999999998 106.956 169.848 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.4 m -58.43 -15.06 9.27 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 117.129 -1.415 . . . . 73.209999999999994 113.744 176.834 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.6 m -107.96 75.91 0.56 Allowed Pre-proline 0 C--N 1.343 0.307 0 CA-C-N 120.526 1.512 . . . . 41.539999999999999 110.179 169.65 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -71.54 174.46 10.92 Favored 'Trans proline' 0 N--CA 1.444 -1.386 0 C-N-CA 123.19 2.594 . . . . 70.120000000000005 110.241 178.644 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 64.7 t -139.26 125.76 12.51 Favored Pre-proline 0 C--N 1.323 -0.583 0 N-CA-C 107.042 -1.466 . . . . 53.219999999999999 107.042 -165.433 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -73.78 174.84 11.62 Favored 'Trans proline' 0 N--CA 1.453 -0.892 0 C-N-CA 122.646 2.231 . . . . 75.540000000000006 110.897 178.831 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 34.0 m -139.39 -174.03 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 C-N-CA 124.645 1.178 . . . . 64.329999999999998 109.404 178.858 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 15.2 t -48.19 -68.89 0.14 Allowed 'General case' 0 N--CA 1.442 -0.852 0 C-N-CA 128.17 2.588 . . . . 73.349999999999994 110.458 172.88 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -152.94 163.47 23.4 Favored Pre-proline 0 CA--C 1.534 0.354 0 C-N-CA 124.399 1.08 . . . . 52.32 110.297 174.36 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -78.79 -7.1 15.51 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 124.058 3.172 . . . . 64.319999999999993 113.095 177.682 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -58.15 -37.29 85.85 Favored Glycine 0 C--N 1.338 0.667 0 C-N-CA 125.537 1.541 . . . . 71.109999999999999 113.605 -170.362 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 28.2 mttp -119.32 124.58 46.99 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 126.388 1.875 . . . . 73.230000000000004 106.087 165.389 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 44.7 mm -54.98 136.26 17.23 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 N-CA-C 106.931 -1.507 . . . . 51.119999999999997 106.931 168.2 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -104.4 93.12 4.63 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 106.425 -1.695 . . . . 71.450000000000003 106.425 -176.112 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 26.6 t -88.31 135.86 24.62 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 N-CA-C 106.624 -1.621 . . . . 74.510000000000005 106.624 174.479 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 33.6 t -129.31 135.84 60.83 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 N-CA-C 107.243 -1.392 . . . . 61.210000000000001 107.243 -176.813 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 15.9 tm-20 -114.0 140.57 48.32 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 125.133 1.373 . . . . 72.010000000000005 107.699 167.063 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.4 mp -130.76 114.72 15.7 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 124.615 1.166 . . . . 70.540000000000006 108.466 -179.54 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 18.9 p90 -107.36 174.85 5.7 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 124.603 1.161 . . . . 74.299999999999997 111.931 -176.542 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 22.6 t90 -145.34 162.01 38.27 Favored 'General case' 0 C--O 1.225 -0.219 0 C-N-CA 125.068 1.347 . . . . 72.5 107.999 162.837 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 59.8 t80 -56.7 -42.43 79.1 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 126.062 1.745 . . . . 75.519999999999996 112.121 172.756 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -95.39 29.73 9.2 Favored Glycine 0 CA--C 1.531 1.089 0 O-C-N 120.938 -1.101 . . . . 61.340000000000003 113.665 -168.455 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 23.3 t -106.03 81.87 0.82 Allowed Pre-proline 0 CA--C 1.537 0.472 0 C-N-CA 130.474 3.51 . . . . 74.239999999999995 111.528 -173.191 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -79.14 62.02 8.35 Favored 'Trans proline' 0 CA--C 1.544 1.023 0 C-N-CA 121.694 1.596 . . . . 74.239999999999995 111.482 -177.457 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 2.4 m80 -160.35 -49.99 0.05 OUTLIER 'General case' 0 C--O 1.226 -0.182 0 C-N-CA 126.123 1.769 . . . . 74.420000000000002 109.095 -178.678 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 1.1 p -61.52 -37.36 83.45 Favored 'General case' 0 CA--C 1.548 0.872 0 CA-C-O 121.769 0.795 . . . . 74.129999999999995 110.339 -173.036 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -61.76 -29.15 69.94 Favored 'General case' 0 N--CA 1.468 0.465 0 O-C-N 120.084 -1.635 . . . . 73.219999999999999 112.87 176.213 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -78.01 3.61 14.34 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.903 1.281 . . . . 51.350000000000001 111.107 177.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 24.4 t80 -125.49 -27.78 3.39 Favored 'General case' 0 C--O 1.223 -0.308 0 C-N-CA 126.781 2.033 . . . . 72.200000000000003 111.0 178.161 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -39.51 -65.76 0.39 Allowed Pre-proline 0 CA--C 1.544 0.712 0 CA-C-N 120.286 1.403 . . . . 74.439999999999998 114.638 -177.128 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -75.89 -9.05 19.43 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 CA-C-N 122.17 1.811 . . . . 73.239999999999995 114.185 -178.116 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 4.2 m -68.44 -42.68 78.51 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 108.45 -0.944 . . . . 73.129999999999995 108.45 164.517 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 19.9 tt -88.21 -34.55 7.23 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 N-CA-C 112.762 0.652 . . . . 73.030000000000001 112.762 -172.466 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 16.2 t -44.73 -54.72 12.14 Favored Pre-proline 0 CA--C 1.549 0.936 0 C-N-CA 124.409 1.084 . . . . 44.130000000000003 113.464 176.317 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -74.07 -21.35 18.23 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 121.905 1.737 . . . . 70.430000000000007 112.356 -178.136 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 86.3 t90 -66.15 -51.61 56.21 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 118.679 0.672 . . . . 72.120000000000005 109.75 170.587 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 5.1 p -67.05 -24.14 65.96 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 119.075 0.852 . . . . 73.420000000000002 112.277 -175.142 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 73.6 mt-10 -59.9 -54.7 43.08 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 120.793 -1.192 . . . . 74.109999999999999 110.302 168.451 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 54.5 mmtt -76.68 6.73 5.49 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 125.316 1.446 . . . . 50.149999999999999 113.555 -168.278 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 36.6 mt -62.28 157.15 56.29 Favored Pre-proline 0 N--CA 1.448 -0.574 0 C-N-CA 122.986 0.514 . . . . 54.030000000000001 111.268 178.908 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -77.72 174.88 11.93 Favored 'Trans proline' 0 N--CA 1.449 -1.117 0 C-N-CA 124.809 3.673 . . . . 63.409999999999997 110.296 173.51 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -71.26 -5.74 34.47 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.636 0.774 . . . . 73.120000000000005 112.888 177.725 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -95.66 7.88 45.03 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 123.856 0.862 . . . . 60.149999999999999 109.847 -176.205 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 22.6 t -138.76 152.75 24.8 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 N-CA-C 107.628 -1.249 . . . . 70.329999999999998 107.628 -176.046 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 41.3 t60 -137.47 162.1 34.59 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 107.332 -1.359 . . . . 54.350000000000001 107.332 165.663 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 35.1 t80 -125.99 137.74 53.69 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 124.237 1.015 . . . . 73.519999999999996 108.493 -173.59 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 52.8 t -132.44 147.84 31.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 107.421 -1.325 . . . . 63.130000000000003 107.421 -175.547 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 44.0 mtm180 -124.21 136.0 53.85 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 107.236 -1.394 . . . . 71.329999999999998 107.236 163.365 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 92.8 mt -129.7 144.91 54.84 Favored Pre-proline 0 C--N 1.328 -0.361 0 O-C-N 123.654 0.596 . . . . 53.009999999999998 109.96 172.791 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -73.9 143.83 33.65 Favored 'Trans proline' 0 N--CA 1.451 -0.984 0 C-N-CA 120.756 0.971 . . . . 75.129999999999995 109.835 175.269 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -89.28 106.31 18.36 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 126.297 1.839 . . . . 55.420000000000002 107.841 174.584 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 57.8 mt -102.83 60.09 0.79 Allowed 'General case' 0 C--O 1.237 0.417 0 C-N-CA 125.343 1.457 . . . . 73.340000000000003 111.491 -168.49 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 -88.15 -6.54 57.82 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 114.569 1.322 . . . . 71.109999999999999 114.569 -164.85 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 106.58 -173.22 19.26 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 108.548 -1.821 . . . . 34.210000000000001 108.548 -175.152 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.489 ' O ' HG22 ' A' ' 70' ' ' ILE . . . 44.39 64.79 1.91 Allowed Glycine 0 CA--C 1.528 0.904 0 CA-C-O 117.929 -1.484 . . . . 64.329999999999998 112.444 173.768 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.489 HG22 ' O ' ' A' ' 69' ' ' GLY 0.276 2.8 tt 64.96 -15.97 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 131.153 3.781 . . . . 74.530000000000001 116.192 -176.486 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 10.4 m95 -57.01 -36.83 70.86 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 121.185 1.811 . . . . 65.200000000000003 112.311 -174.256 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -73.02 -40.25 65.31 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-O 118.693 -0.67 . . . . 63.200000000000003 112.4 -178.078 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 92.3 t -57.92 -51.67 67.71 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 C-N-CA 123.605 0.762 . . . . 70.420000000000002 109.474 -175.835 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 65.4 m170 -69.23 -0.69 6.45 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.541 1.136 . . . . 65.109999999999999 113.259 178.049 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -101.19 -47.85 1.52 Allowed Glycine 0 CA--C 1.526 0.761 0 N-CA-C 109.852 -1.299 . . . . 50.130000000000003 109.852 174.616 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -53.28 -34.02 55.56 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 127.383 2.273 . . . . 75.239999999999995 114.684 -164.371 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -57.98 -42.91 86.08 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-O 117.742 -1.123 . . . . 63.119999999999997 112.443 178.469 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -55.4 -54.1 47.9 Favored 'General case' 0 CA--C 1.526 0.042 0 N-CA-C 108.639 -0.875 . . . . 74.310000000000002 108.639 -175.398 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 15.7 mt -55.74 -37.56 68.64 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.664 1.186 . . . . 64.209999999999994 110.982 177.907 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.456 ' HA ' HD11 ' A' ' 134' ' ' ILE . 1.3 m -73.39 -39.76 64.86 Favored 'General case' 0 C--N 1.343 0.324 0 CA-C-N 119.498 1.044 . . . . 72.230000000000004 110.588 -177.691 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 1.2 tt -56.3 -51.1 69.46 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 125.219 1.407 . . . . 64.519999999999996 108.054 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -62.19 -29.66 70.53 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.694 1.198 . . . . 73.019999999999996 110.757 177.837 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 10.4 t -65.17 -30.66 71.59 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.873 0.869 . . . . 75.120000000000005 111.351 -171.367 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 16.6 mtm . . . . . 0 N--CA 1.468 0.443 0 CA-C-N 119.682 1.128 . . . . 63.109999999999999 112.861 173.344 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.321 0 N-CA-C 113.722 1.008 . . . . 44.530000000000001 113.722 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 74.9 t -60.81 -69.37 0.18 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.322 0 C-N-CA 124.897 1.279 . . . . 72.430000000000007 108.587 170.039 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -60.4 -47.7 84.94 Favored 'General case' 0 CA--C 1.521 -0.165 0 C-N-CA 123.666 0.786 . . . . 74.450000000000003 109.814 -175.146 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -59.61 -26.93 65.86 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 124.198 0.999 . . . . 61.310000000000002 111.038 -176.287 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -88.56 -8.96 53.87 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 112.928 0.714 . . . . 43.340000000000003 112.928 -179.342 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 14.7 mm -73.27 -60.65 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 N-CA-C 106.053 -1.832 . . . . 74.409999999999997 106.053 154.256 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 35.0 p80 -88.27 -70.41 0.64 Allowed 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 114.325 1.231 . . . . 74.120000000000005 114.325 -152.768 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 25.5 mttp -58.76 -31.3 68.23 Favored 'General case' 0 N--CA 1.463 0.19 0 C-N-CA 123.954 0.901 . . . . 53.100000000000001 110.74 177.008 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -69.58 -38.47 77.39 Favored 'General case' 0 N--CA 1.452 -0.34 0 O-C-N 121.814 -0.554 . . . . 64.310000000000002 110.602 176.467 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 4.8 t-80 48.77 92.45 0.02 OUTLIER 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 129.578 3.151 . . . . 63.119999999999997 110.891 -164.829 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.529 ' HE3' ' CE1' ' A' ' 114' ' ' PHE . 0.2 OUTLIER -132.85 147.28 52.3 Favored 'General case' 0 CA--C 1.515 -0.392 0 C-N-CA 123.374 0.67 . . . . 72.25 110.667 170.722 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 3.9 ttmt -79.48 95.47 5.82 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 106.249 -1.76 . . . . 73.010000000000005 106.249 -175.189 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 90.0 mt -121.07 46.18 2.1 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 126.379 1.872 . . . . 73.530000000000001 110.645 -177.74 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -80.05 8.08 7.83 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 115.025 1.491 . . . . 72.319999999999993 115.025 -174.617 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -153.13 153.86 30.13 Favored Pre-proline 0 C--N 1.326 -0.421 0 C-N-CA 124.737 1.215 . . . . 72.030000000000001 109.056 -163.201 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_endo -65.29 -42.84 12.27 Favored 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 122.421 2.081 . . . . 75.540000000000006 110.759 -170.861 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -64.61 -36.79 85.4 Favored 'General case' 0 N--CA 1.444 -0.738 0 C-N-CA 124.209 1.004 . . . . 72.319999999999993 111.449 -177.674 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -65.74 -52.9 47.45 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 125.8 1.64 . . . . 71.340000000000003 110.192 175.065 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 49.6 mtm -59.3 -43.51 92.6 Favored 'General case' 0 CA--C 1.529 0.164 0 O-C-N 121.804 -0.56 . . . . 74.450000000000003 110.616 178.812 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.406 ' HB1' ' CG ' ' A' ' 122' ' ' LYS . . . -61.46 -52.24 65.36 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 124.195 0.998 . . . . 64.319999999999993 109.676 177.575 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -50.81 -46.48 59.86 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 125.371 1.469 . . . . 73.099999999999994 110.696 -179.134 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' PHE . . . . . 0.529 ' CE1' ' HE3' ' A' ' 103' ' ' LYS . 57.5 t80 -61.15 -41.75 97.32 Favored 'General case' 0 N--CA 1.449 -0.497 0 O-C-N 121.768 -0.582 . . . . 74.439999999999998 112.217 -178.001 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 36.7 mt -83.28 -16.53 45.94 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 123.782 0.833 . . . . 75.430000000000007 111.144 -174.264 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -72.53 66.61 0.71 Allowed 'General case' 0 C--O 1.234 0.267 0 C-N-CA 127.539 2.336 . . . . 64.230000000000004 110.891 -171.049 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -178.4 -37.81 0.06 OUTLIER Glycine 0 N--CA 1.442 -0.95 0 C-N-CA 127.557 2.503 . . . . 35.409999999999997 109.941 -177.861 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 1.7 ptpt -86.32 3.12 44.76 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 119.428 1.614 . . . . 74.0 114.111 -163.186 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 118.36 -2.77 16.1 Favored Glycine 0 N--CA 1.449 -0.499 0 CA-C-O 118.694 -1.059 . . . . 61.25 111.135 -167.411 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 42.5 t -96.7 149.48 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.948 0 N-CA-C 103.642 -2.725 . . . . 74.239999999999995 103.642 169.628 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -124.34 143.35 50.63 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 106.942 -1.503 . . . . 62.100000000000001 106.942 169.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.406 ' CG ' ' HB1' ' A' ' 112' ' ' ALA . 24.4 mtpt -55.8 -48.86 74.64 Favored 'General case' 0 CA--C 1.516 -0.327 0 CA-C-O 118.56 -0.733 . . . . 65.409999999999997 109.285 178.494 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -55.01 -35.91 64.9 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 118.71 0.687 . . . . 70.329999999999998 111.779 -177.108 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 27.8 mmmt -94.99 -29.54 14.58 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 123.537 0.735 . . . . 74.099999999999994 109.392 -165.379 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 82.1 t80 -66.55 -64.57 0.83 Allowed 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 127.2 2.2 . . . . 73.319999999999993 109.413 169.612 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 12.8 mt -58.27 -43.75 88.08 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.236 1.014 . . . . 71.099999999999994 109.939 -170.526 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 22.7 t -52.68 -26.49 14.03 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 126.294 1.838 . . . . 54.340000000000003 113.176 -179.438 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' THR . . . . . 0.416 HG23 HG23 ' A' ' 80' ' ' THR 0.278 1.4 t -116.73 -23.55 8.09 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 119.363 0.983 . . . . 70.329999999999998 110.712 -176.262 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 129' ' ' TYR . . . . . 0.429 ' HA ' HG13 ' A' ' 134' ' ' ILE . 27.9 t80 -53.59 -52.57 59.35 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.721 1.208 . . . . 73.109999999999999 108.84 166.2 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 18.0 m-80 -91.98 38.85 1.0 Allowed 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 124.551 1.141 . . . . 74.510000000000005 110.574 -177.016 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 3.2 t -140.06 169.95 16.75 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 114.627 1.343 . . . . 53.520000000000003 114.627 178.187 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -52.98 -30.6 35.93 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 126.802 2.041 . . . . 73.519999999999996 111.133 -179.458 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -52.33 -63.73 1.05 Allowed 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 125.351 1.461 . . . . 74.329999999999998 110.824 173.789 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.456 HD11 ' HA ' ' A' ' 80' ' ' THR . 11.5 mm -63.55 -27.37 42.83 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.141 0 O-C-N 121.452 -0.78 . . . . 75.409999999999997 112.298 176.959 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.09 -40.44 73.64 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 119.604 1.093 . . . . 70.120000000000005 109.708 173.275 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -64.84 -26.63 71.31 Favored Glycine 0 CA--C 1.532 1.114 0 C-N-CA 124.569 1.08 . . . . 61.520000000000003 112.744 177.295 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 6.9 mt-30 -85.42 -45.31 11.98 Favored 'General case' 0 C--O 1.235 0.291 0 O-C-N 120.943 -1.328 . . . . 60.409999999999997 110.287 179.239 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 82.4 mmm -61.84 -31.45 71.7 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 123.645 0.778 . . . . 71.019999999999996 110.764 179.275 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -64.73 -51.84 60.25 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 119.502 1.046 . . . . 71.510000000000005 111.321 175.588 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 5.8 mttm -62.82 -57.57 10.42 Favored 'General case' 0 CA--C 1.512 -0.497 0 C-N-CA 123.761 0.824 . . . . 64.340000000000003 109.29 -175.497 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -52.95 -40.52 63.73 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 119.494 -0.289 . . . . 72.450000000000003 110.883 -176.4 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.68 -62.14 2.02 Favored 'General case' 0 C--N 1.343 0.292 0 CA-C-N 118.7 0.682 . . . . 73.530000000000001 110.007 174.831 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 8.0 ptmt -68.52 -16.55 63.92 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 113.019 0.748 . . . . 72.230000000000004 113.019 -169.543 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 65.9 mt -69.47 -59.65 2.84 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 123.687 0.795 . . . . 74.150000000000006 110.104 168.46 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -54.51 -43.72 72.1 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 118.736 0.698 . . . . 73.040000000000006 112.531 -173.409 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 2.1 ptm -63.21 -44.4 95.43 Favored 'General case' 0 N--CA 1.468 0.458 0 O-C-N 121.677 -0.639 . . . . 75.400000000000006 112.377 175.797 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -64.11 -40.82 97.03 Favored 'General case' 0 CA--C 1.536 0.433 0 O-C-N 121.893 -0.505 . . . . 75.430000000000007 109.739 -178.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 21.5 m-85 -70.42 9.0 0.68 Allowed 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 126.944 2.098 . . . . 65.230000000000004 113.426 173.892 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 58.3 mt-30 53.76 35.54 21.65 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 126.612 1.965 . . . . 75.120000000000005 114.046 178.415 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.437 HG22 HG21 ' A' ' 155' ' ' THR . 43.4 t -77.68 89.21 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 O-C-N 120.698 -1.251 . . . . 72.200000000000003 108.602 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -82.34 -12.13 58.16 Favored 'General case' 0 N--CA 1.469 0.496 0 O-C-N 120.586 -1.321 . . . . 60.119999999999997 113.458 177.923 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -171.18 -171.64 36.59 Favored Glycine 0 CA--C 1.524 0.639 0 C-N-CA 125.216 1.389 . . . . 73.530000000000001 109.65 -173.066 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.438 ' HA ' ' C ' ' A' ' 154' ' ' PRO . 29.0 m -137.92 158.38 71.48 Favored Pre-proline 0 CA--C 1.544 0.72 0 C-N-CA 124.756 1.222 . . . . 45.539999999999999 109.155 178.667 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 154' ' ' PRO . . . . . 0.438 ' C ' ' HA ' ' A' ' 153' ' ' VAL . 31.4 Cg_endo -62.49 152.17 65.46 Favored 'Cis proline' 0 N--CA 1.452 -0.969 0 C-N-CA 123.569 -1.429 . . . . 74.0 112.788 -10.221 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 155' ' ' THR . . . . . 0.437 HG21 HG22 ' A' ' 150' ' ' VAL . 77.6 m -141.07 127.08 19.39 Favored 'General case' 0 N--CA 1.443 -0.805 0 C-N-CA 126.457 1.903 . . . . 74.439999999999998 107.013 170.041 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 33.1 mmm -107.08 160.27 15.68 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 124.908 1.283 . . . . 65.010000000000005 107.57 159.68 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 6.3 t -142.02 148.29 20.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 106.955 -1.498 . . . . 74.409999999999997 106.955 177.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.504 HG23 ' CE1' ' A' ' 164' ' ' PHE . 58.8 t -121.36 126.0 74.39 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 N-CA-C 106.314 -1.735 . . . . 63.240000000000002 106.314 168.838 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 55.25 17.82 2.21 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 127.339 2.256 . . . . 65.120000000000005 115.006 171.443 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 58.41 31.37 66.32 Favored Glycine 0 CA--C 1.53 0.969 0 CA-C-O 117.926 -1.485 . . . . 72.349999999999994 112.791 -168.78 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 1.2 mtpm? -126.38 -42.88 1.8 Allowed 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 119.656 1.728 . . . . 73.340000000000003 111.779 -177.351 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -111.65 147.34 35.73 Favored 'General case' 0 CA--C 1.511 -0.551 0 N-CA-C 106.941 -1.503 . . . . 74.200000000000003 106.941 179.11 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 41.4 ttp85 -125.01 135.87 53.18 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 105.601 -2.0 . . . . 72.310000000000002 105.601 175.338 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 164' ' ' PHE . . . . . 0.504 ' CE1' HG23 ' A' ' 158' ' ' VAL . 7.4 p90 -153.54 171.41 18.78 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 107.295 -1.372 . . . . 72.219999999999999 107.295 -178.578 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 174.97 176.33 0.17 Allowed 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 123.726 0.81 . . . . 64.219999999999999 108.915 -178.78 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 38.7 mt -57.14 -35.2 47.41 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 C-N-CA 128.266 2.626 . . . . 72.409999999999997 110.268 -173.271 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -86.62 -3.55 83.73 Favored Glycine 0 CA--C 1.525 0.687 0 CA-C-O 117.617 -1.657 . . . . 41.420000000000002 113.278 -177.379 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 19.4 m -105.72 -54.59 2.46 Favored 'General case' 0 C--N 1.342 0.248 0 CA-C-N 119.04 1.42 . . . . 75.109999999999999 108.86 168.786 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -60.74 -29.14 69.2 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 125.234 1.414 . . . . 44.210000000000001 112.4 -179.264 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 98.43 8.59 54.65 Favored Glycine 0 CA--C 1.527 0.841 0 CA-C-O 119.115 -0.825 . . . . 73.049999999999997 113.712 175.396 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 163.68 171.42 29.9 Favored Glycine 0 CA--C 1.527 0.827 0 CA-C-N 119.543 1.671 . . . . 72.519999999999996 111.781 177.299 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -69.37 -44.34 2.41 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 122.097 1.864 . . . . 60.240000000000002 111.129 -175.197 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -68.6 -34.45 75.8 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 118.913 0.779 . . . . 71.209999999999994 109.473 179.782 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -62.8 -33.27 74.86 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 123.226 0.611 . . . . 75.019999999999996 109.828 176.181 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 37.1 m -65.41 -40.55 93.52 Favored 'General case' 0 CA--C 1.534 0.358 0 O-C-N 120.924 -1.11 . . . . 65.420000000000002 109.332 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 58.7 mt -64.55 -36.46 84.28 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 119.644 1.111 . . . . 70.129999999999995 110.647 175.009 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 27.0 tttt -50.93 -51.76 49.0 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.176 0.991 . . . . 55.43 108.904 172.344 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.428 HD13 ' HA ' ' A' ' 178' ' ' LEU . 4.2 mm? -67.67 -40.85 84.45 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-O 118.415 -0.803 . . . . 52.530000000000001 111.143 177.56 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -56.59 -41.59 77.24 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 119.05 0.841 . . . . 52.210000000000001 111.347 -174.812 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -85.93 -36.75 19.68 Favored 'General case' 0 CA--C 1.511 -0.532 0 N-CA-C 109.171 -0.677 . . . . 74.200000000000003 109.171 -168.271 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -59.3 -54.17 49.85 Favored 'General case' 0 N--CA 1.438 -1.059 0 N-CA-C 109.064 -0.717 . . . . 74.319999999999993 109.064 170.798 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 90.9 mt -61.93 -32.04 72.41 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-O 118.271 -0.871 . . . . 73.340000000000003 112.47 -175.135 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 26.6 mt -51.16 -65.97 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.212 0 CA-C-N 119.211 0.914 . . . . 72.109999999999999 109.352 166.51 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 9.8 tm-20 -69.76 -20.09 63.5 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.984 0.913 . . . . 64.420000000000002 112.101 -171.392 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.24 -52.95 60.09 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 124.962 1.305 . . . . 64.340000000000003 109.05 168.551 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 42.2 mm-40 -74.99 -39.7 61.1 Favored 'General case' 0 C--N 1.334 -0.104 0 C-N-CA 123.578 0.751 . . . . 72.439999999999998 111.891 -176.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.14 -36.03 74.53 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 124.023 0.929 . . . . 75.409999999999997 109.767 -177.69 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.381 0 C-N-CA 124.273 1.029 . . . . 55.310000000000002 112.417 177.981 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.234 0.288 0 N-CA-C 108.155 -1.054 . . . . 53.109999999999999 108.155 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -117.83 10.99 13.4 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 113.172 0.805 . . . . 71.310000000000002 113.172 -171.214 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -141.55 164.15 30.99 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 125.558 1.543 . . . . 75.409999999999997 107.705 -173.356 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 29.4 m -133.04 130.98 40.11 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.14 -0.689 . . . . 72.030000000000001 109.14 -176.046 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.36 124.18 21.57 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 108.061 -1.089 . . . . 61.109999999999999 108.061 176.562 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 101.1 -38.49 3.12 Favored Glycine 0 CA--C 1.527 0.832 0 C-N-CA 128.556 2.979 . . . . 71.120000000000005 111.393 -173.303 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 8.4 tptp -75.21 -67.3 0.67 Allowed 'General case' 0 C--O 1.226 -0.163 0 C-N-CA 126.364 1.866 . . . . 73.150000000000006 109.442 -175.15 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 5.3 mp0 -93.28 -28.65 16.09 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 126.229 1.812 . . . . 71.230000000000004 109.691 -173.237 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 55.2 p90 -152.54 167.26 29.41 Favored 'General case' 0 N--CA 1.469 0.523 0 O-C-N 121.012 -1.055 . . . . 73.519999999999996 110.73 -171.256 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 93.4 t -133.51 117.01 26.09 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-N 119.661 1.119 . . . . 74.329999999999998 109.716 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -71.71 166.75 21.3 Favored 'General case' 0 N--CA 1.447 -0.614 0 O-C-N 121.085 -1.009 . . . . 73.109999999999999 110.727 174.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -126.68 104.48 8.11 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 124.803 1.241 . . . . 63.420000000000002 108.207 173.055 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 44.2 p -67.52 -6.39 19.55 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 124.068 0.947 . . . . 70.010000000000005 112.425 176.216 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 70.0 m -104.86 80.51 0.49 Allowed Pre-proline 0 N--CA 1.451 -0.396 0 N-CA-C 107.006 -1.479 . . . . 64.329999999999998 107.006 160.51 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -70.95 -179.48 3.48 Favored 'Trans proline' 0 N--CA 1.452 -0.969 0 C-N-CA 123.224 2.616 . . . . 60.229999999999997 110.519 -177.62 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 11.8 t -140.21 136.18 16.76 Favored Pre-proline 0 CA--C 1.534 0.361 0 N-CA-C 108.365 -0.976 . . . . 72.420000000000002 108.365 178.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -76.53 174.68 12.43 Favored 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 122.603 2.202 . . . . 53.32 111.413 172.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.4 m -112.18 -174.91 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 125.906 1.682 . . . . 63.039999999999999 109.539 179.184 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 21.4 m -67.01 -51.84 49.99 Favored 'General case' 0 N--CA 1.45 -0.465 0 O-C-N 121.318 -0.864 . . . . 75.200000000000003 109.484 170.649 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -146.41 161.03 40.26 Favored Pre-proline 0 N--CA 1.446 -0.63 0 C-N-CA 124.176 0.99 . . . . 73.329999999999998 109.636 177.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -69.28 -164.58 0.12 Allowed 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 124.358 3.372 . . . . 74.120000000000005 111.726 170.433 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.74 -110.11 3.96 Favored Glycine 0 N--CA 1.448 -0.531 0 N-CA-C 107.457 -2.257 . . . . 64.409999999999997 107.457 179.464 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 8.3 mttp -63.53 135.33 56.78 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 109.639 -0.504 . . . . 42.25 109.639 -178.258 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 38.6 mm -62.3 144.08 14.63 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 N-CA-C 107.423 -1.325 . . . . 73.140000000000001 107.423 170.331 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -101.75 118.62 37.31 Favored 'General case' 0 N--CA 1.458 -0.038 0 N-CA-C 107.564 -1.272 . . . . 74.099999999999994 107.564 -177.841 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 48.8 t -108.77 134.82 49.51 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 N-CA-C 107.716 -1.216 . . . . 43.439999999999998 107.716 171.876 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 6.8 t -132.83 111.05 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 C-N-CA 123.842 0.857 . . . . 72.439999999999998 109.814 -174.915 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 -65.82 127.98 34.16 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 125.255 1.422 . . . . 72.019999999999996 108.916 162.144 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.6 mp -102.45 148.68 25.21 Favored 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 107.596 -1.261 . . . . 53.350000000000001 107.596 155.56 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 37.7 p90 -141.94 170.76 15.12 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 118.848 0.749 . . . . 71.0 111.554 173.406 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 28.1 t90 -156.41 158.43 37.31 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.889 1.276 . . . . 72.299999999999997 110.041 172.323 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 7.4 t80 -70.68 -15.52 62.72 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 113.444 0.905 . . . . 74.409999999999997 113.444 -177.616 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -104.84 12.58 49.83 Favored Glycine 0 CA--C 1.522 0.47 0 CA-C-O 117.554 -1.692 . . . . 74.150000000000006 113.067 -175.002 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 24.8 p -112.95 85.3 7.7 Favored Pre-proline 0 CA--C 1.538 0.486 0 CA-C-N 119.938 1.869 . . . . 72.099999999999994 108.53 -178.122 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_endo -59.38 -26.31 81.48 Favored 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 121.735 1.623 . . . . 72.150000000000006 113.187 -177.498 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 29.1 m170 -68.27 -23.16 64.74 Favored 'General case' 0 CA--C 1.535 0.379 0 O-C-N 121.346 -0.846 . . . . 71.040000000000006 110.89 178.063 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 73.4 m -60.04 -48.06 83.26 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.022 0.929 . . . . 73.030000000000001 108.499 171.615 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 27.1 t80 -63.38 -46.05 88.29 Favored 'General case' 0 N--CA 1.467 0.419 0 O-C-N 120.892 -1.13 . . . . 73.510000000000005 111.46 175.852 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -55.99 -34.9 66.19 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 118.416 0.553 . . . . 52.329999999999998 111.737 -176.09 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -71.23 -23.04 61.93 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 127.174 2.19 . . . . 71.420000000000002 113.697 178.342 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -48.75 -67.05 0.46 Allowed Pre-proline 0 CA--C 1.541 0.614 0 C-N-CA 124.222 1.009 . . . . 61.109999999999999 113.21 -165.588 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -70.93 -6.82 20.03 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 CA-C-N 122.081 1.779 . . . . 72.519999999999996 114.636 -177.714 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.4 m -69.38 -47.4 64.35 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 119.432 1.014 . . . . 72.439999999999998 108.318 164.316 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 16.7 tt -94.5 -32.64 4.69 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 C-N-CA 123.814 0.846 . . . . 73.140000000000001 112.733 -165.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 22.8 t -49.54 -61.85 3.09 Favored Pre-proline 0 CA--C 1.542 0.646 0 C-N-CA 124.849 1.26 . . . . 75.129999999999995 110.551 178.294 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -64.08 -34.37 58.41 Favored 'Trans proline' 0 N--CA 1.454 -0.795 0 CA-C-N 120.454 1.198 . . . . 75.420000000000002 112.329 179.137 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.457 ' CZ2' HD21 ' A' ' 54' ' ' LEU . 72.7 t90 -59.73 -50.57 73.33 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 119.768 1.167 . . . . 73.430000000000007 110.679 177.594 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 42.0 t -59.57 -44.9 93.16 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 123.947 0.899 . . . . 25.23 108.97 -176.775 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 57.5 mt-10 -61.99 -35.61 79.02 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 121.162 -0.961 . . . . 71.099999999999994 110.737 178.168 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 70.4 mmtt -77.19 -2.96 37.15 Favored 'General case' 0 C--O 1.237 0.432 0 O-C-N 120.42 -1.425 . . . . 74.099999999999994 114.482 177.822 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.457 HD21 ' CZ2' ' A' ' 50' ' ' TRP . 26.8 mt -54.57 147.21 30.81 Favored Pre-proline 0 C--O 1.237 0.414 0 CA-C-N 120.405 1.457 . . . . 73.040000000000006 111.588 -177.686 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -74.28 164.95 33.0 Favored 'Trans proline' 0 N--CA 1.445 -1.34 0 C-N-CA 124.035 3.157 . . . . 52.439999999999998 110.602 -176.062 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -66.23 -4.65 8.13 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 125.753 1.621 . . . . 34.149999999999999 115.025 -171.509 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 -118.52 22.71 11.93 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.646 1.579 . . . . 62.5 110.744 179.704 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 57.8 t -121.61 160.18 23.34 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 N-CA-C 107.531 -1.285 . . . . 73.439999999999998 107.531 167.794 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 75.3 t60 -137.27 152.7 50.09 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 125.766 1.626 . . . . 73.140000000000001 107.3 167.552 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 57.5 t80 -130.79 137.37 49.41 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 123.787 0.835 . . . . 73.450000000000003 108.849 -171.86 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 47.4 t -134.07 155.35 39.42 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 C-N-CA 126.426 1.89 . . . . 73.010000000000005 106.906 -173.056 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 4.0 mpt_? -127.07 134.89 50.19 Favored 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 104.364 -2.458 . . . . 74.540000000000006 104.364 166.633 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 68.0 mt -131.85 148.79 71.33 Favored Pre-proline 0 N--CA 1.465 0.293 0 CA-C-N 119.51 1.05 . . . . 74.540000000000006 108.629 170.784 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -69.11 141.78 48.9 Favored 'Trans proline' 0 N--CA 1.451 -1.016 0 C-N-CA 121.421 1.414 . . . . 71.209999999999994 110.409 171.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -91.46 67.32 5.6 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 124.535 1.134 . . . . 72.109999999999999 108.44 -176.84 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 54.9 mt -64.8 65.94 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 127.538 2.335 . . . . 74.239999999999995 112.724 -171.658 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -98.2 48.66 1.0 Allowed 'General case' 0 C--O 1.237 0.416 0 C-N-CA 125.229 1.412 . . . . 73.349999999999994 111.437 -170.8 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 67.48 167.83 3.62 Favored Glycine 0 CA--C 1.531 1.034 0 C-N-CA 124.218 0.913 . . . . 74.140000000000001 112.11 -177.27 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 50.94 -143.22 14.85 Favored Glycine 0 CA--C 1.526 0.736 0 O-C-N 122.091 -0.653 . . . . 41.520000000000003 113.121 176.34 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 4.9 tp -63.63 -11.77 9.58 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 C-N-CA 123.955 0.902 . . . . 73.310000000000002 111.547 -173.112 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 18.4 m95 -73.81 -33.45 64.18 Favored 'General case' 0 CA--C 1.531 0.243 0 O-C-N 120.661 -1.274 . . . . 72.239999999999995 110.909 175.2 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -64.78 -44.06 91.22 Favored 'General case' 0 C--O 1.236 0.382 0 O-C-N 121.33 -0.856 . . . . 65.340000000000003 109.834 168.072 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 91.5 t -62.78 -53.99 39.66 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 N-CA-C 109.169 -0.678 . . . . 60.200000000000003 109.169 -173.885 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 19.3 m170 -88.96 51.15 2.09 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.864 1.266 . . . . 72.409999999999997 109.455 173.478 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -140.71 -55.53 0.04 OUTLIER Glycine 0 N--CA 1.443 -0.891 0 C-N-CA 124.75 1.167 . . . . 34.539999999999999 110.224 167.7 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.519 ' OE1' HD12 ' A' ' 134' ' ' ILE . 0.0 OUTLIER -55.94 -28.75 58.36 Favored 'General case' 0 CA--C 1.554 1.109 0 N-CA-C 114.617 1.34 . . . . 62.539999999999999 114.617 -166.223 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 34.8 ttp -58.22 -38.14 76.23 Favored 'General case' 0 N--CA 1.469 0.489 0 O-C-N 119.299 -2.126 . . . . 74.299999999999997 112.119 -176.833 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 27.9 t80 -56.12 -50.28 71.55 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 123.774 0.83 . . . . 63.409999999999997 109.5 -179.555 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 42.3 mt -66.1 -42.43 89.28 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-O 117.495 -1.241 . . . . 74.530000000000001 109.825 179.725 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.669 ' HA ' HD11 ' A' ' 134' ' ' ILE . 0.2 OUTLIER -58.39 -42.36 86.93 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 120.317 1.417 . . . . 71.219999999999999 110.623 -178.192 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -54.94 -52.13 63.95 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 125.131 1.372 . . . . 65.239999999999995 108.813 -174.881 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -78.79 -25.37 44.29 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.415 0.686 . . . . 74.319999999999993 111.505 -177.261 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 12.6 t -62.49 -33.42 74.84 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 125.124 1.37 . . . . 74.109999999999999 111.387 176.441 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' MET . . . . . 0.41 ' SD ' ' HA ' ' A' ' 125' ' ' PHE . 30.6 mtp . . . . . 0 C--O 1.236 0.382 0 C-N-CA 125.718 1.607 . . . . 71.540000000000006 111.616 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 0.262 0 CA-C-O 117.748 -1.12 . . . . 64.140000000000001 112.869 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 57.9 t -45.06 -65.32 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 124.845 1.258 . . . . 63.450000000000003 110.987 166.838 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -57.87 -46.34 85.01 Favored 'General case' 0 C--O 1.226 -0.146 0 CA-C-N 118.583 0.629 . . . . 75.319999999999993 110.722 178.289 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -59.27 -37.54 77.89 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.499 0.72 . . . . 73.25 110.637 -174.905 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.473 ' HB1' ' CE2' ' A' ' 114' ' ' PHE . . . -68.51 -31.72 71.17 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 124.791 1.236 . . . . 44.109999999999999 113.016 178.248 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 55.9 mt -78.75 -57.25 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 N-CA-C 105.897 -1.89 . . . . 60.450000000000003 105.897 -179.533 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 85.2 m-70 -74.13 -72.26 0.29 Allowed 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 127.032 2.133 . . . . 73.439999999999998 112.031 -172.791 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 43.5 mttt -65.68 -30.68 71.4 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 119.396 0.998 . . . . 74.319999999999993 112.063 -173.68 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -93.58 -26.76 16.97 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 118.427 0.558 . . . . 72.239999999999995 110.788 -173.481 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 49.29 53.2 13.05 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 126.029 1.732 . . . . 74.230000000000004 113.766 175.671 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 2.5 mmpt? -85.23 22.33 1.5 Allowed 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.955 1.302 . . . . 60.329999999999998 114.401 -173.598 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 12.2 ttmt 70.29 -69.66 0.17 Allowed 'General case' 0 C--O 1.222 -0.342 0 C-N-CA 128.151 2.58 . . . . 72.439999999999998 109.873 -179.33 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.431 ' H ' ' HG2' ' A' ' 110' ' ' GLU . 39.3 mt 63.08 28.93 16.25 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 127.176 2.19 . . . . 75.230000000000004 112.342 175.838 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -79.3 -10.08 59.73 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 115.142 1.534 . . . . 65.329999999999998 115.142 -175.601 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 24.8 p -137.13 159.43 69.86 Favored Pre-proline 0 C--O 1.236 0.39 0 O-C-N 120.932 -1.105 . . . . 40.32 109.08 -177.507 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -61.55 -34.84 84.34 Favored 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 122.04 1.827 . . . . 73.230000000000004 110.607 177.008 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -63.83 -40.28 96.23 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 123.404 0.681 . . . . 74.219999999999999 112.216 176.921 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.431 ' HG2' ' H ' ' A' ' 105' ' ' LEU . 6.9 tp10 -65.01 -48.37 74.19 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.696 0.798 . . . . 72.409999999999997 110.123 177.731 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 57.8 mtt -63.54 -50.46 69.47 Favored 'General case' 0 C--O 1.231 0.09 0 C-N-CA 123.893 0.877 . . . . 75.129999999999995 110.773 -179.523 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.434 ' HB1' ' CG ' ' A' ' 122' ' ' LYS . . . -71.46 -39.46 70.94 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-O 118.414 -0.803 . . . . 62.340000000000003 110.234 -170.438 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -61.62 -28.46 69.38 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 119.288 0.949 . . . . 64.430000000000007 112.293 176.839 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' PHE . . . . . 0.473 ' CE2' ' HB1' ' A' ' 97' ' ' ALA . 86.1 t80 -75.25 -58.76 3.08 Favored 'General case' 0 N--CA 1.443 -0.806 0 O-C-N 121.827 -0.546 . . . . 73.120000000000005 110.176 175.047 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 53.8 mt -66.59 -22.48 66.13 Favored 'General case' 0 CA--C 1.532 0.261 0 O-C-N 121.748 -0.595 . . . . 72.109999999999999 110.756 -173.37 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -55.93 -17.53 6.78 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 125.215 1.406 . . . . 63.140000000000001 112.719 175.9 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -90.98 -5.83 67.65 Favored Glycine 0 CA--C 1.524 0.625 0 CA-C-O 118.079 -1.4 . . . . 71.439999999999998 114.51 174.342 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 17.2 mmtt -134.79 29.92 3.45 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 120.217 2.009 . . . . 72.450000000000003 111.749 -156.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 83.82 29.86 30.81 Favored Glycine 0 CA--C 1.52 0.405 0 N-CA-C 111.558 -0.617 . . . . 64.299999999999997 111.558 175.534 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 87.7 t -123.87 119.15 56.21 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 N-CA-C 107.126 -1.435 . . . . 74.140000000000001 107.126 175.404 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 66.3 t0 -70.25 124.37 23.96 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-O 121.185 0.517 . . . . 64.430000000000007 109.745 172.447 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.434 ' CG ' ' HB1' ' A' ' 112' ' ' ALA . 9.5 ttpt -60.15 -40.3 89.41 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 124.128 0.971 . . . . 73.049999999999997 110.206 176.995 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -68.07 -27.25 66.33 Favored 'General case' 0 C--O 1.236 0.347 0 O-C-N 121.489 -0.757 . . . . 71.349999999999994 111.325 -177.103 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 52.2 mttm -77.71 -48.13 17.44 Favored 'General case' 0 CA--C 1.509 -0.611 0 N-CA-C 107.217 -1.401 . . . . 71.120000000000005 107.217 177.036 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.421 ' CD1' ' HB2' ' A' ' 112' ' ' ALA . 34.0 t80 -44.81 -64.87 0.61 Allowed 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 124.751 1.22 . . . . 71.140000000000001 110.592 177.26 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 22.3 mt -68.69 -40.57 79.98 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 119.22 -0.419 . . . . 64.049999999999997 110.552 -170.05 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 46.6 t -58.33 -56.73 18.28 Favored 'General case' 0 C--N 1.341 0.209 0 N-CA-C 108.059 -1.089 . . . . 75.25 108.059 -179.539 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 55.2 m -62.03 -43.3 99.13 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 123.808 0.843 . . . . 33.399999999999999 110.325 -176.077 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 45.5 t80 -51.46 -45.86 62.86 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 123.838 0.855 . . . . 72.430000000000007 110.591 177.327 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -98.05 35.06 1.8 Allowed 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.456 1.102 . . . . 60.409999999999997 111.155 178.592 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -120.03 155.84 32.1 Favored 'General case' 0 C--O 1.235 0.316 0 O-C-N 120.929 -1.107 . . . . 74.010000000000005 109.807 174.617 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -64.79 -22.3 66.96 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.654 0.782 . . . . 74.409999999999997 111.293 174.658 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -53.95 -29.11 41.27 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 125.173 1.389 . . . . 73.319999999999993 113.17 173.333 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.669 HD11 ' HA ' ' A' ' 80' ' ' THR . 11.2 mm -77.23 -39.4 28.48 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.484 0 C-N-CA 123.829 0.852 . . . . 74.200000000000003 113.149 169.263 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 9.9 tttp -58.89 -34.61 71.86 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 118.309 -0.853 . . . . 65.239999999999995 110.002 -170.32 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -67.81 -23.4 74.12 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 123.915 0.769 . . . . 53.32 112.952 -178.845 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -91.28 -45.51 8.57 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 121.923 0.868 . . . . 72.019999999999996 108.974 178.4 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 5.2 ttm -62.17 -40.27 95.46 Favored 'General case' 0 N--CA 1.426 -1.647 0 C-N-CA 126.293 1.837 . . . . 74.0 110.142 -177.596 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 21.8 pt-20 -69.44 -37.51 77.42 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 120.042 1.292 . . . . 73.200000000000003 112.531 -177.04 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 10.2 mmtt -62.59 -59.4 4.98 Favored 'General case' 0 C--O 1.225 -0.23 0 N-CA-C 107.402 -1.333 . . . . 74.420000000000002 107.402 171.866 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -54.78 -43.3 72.68 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 119.56 1.073 . . . . 55.450000000000003 111.707 -175.481 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 11.6 tmtt? -49.77 -64.25 0.87 Allowed 'General case' 0 CA--C 1.518 -0.283 0 C-N-CA 125.167 1.387 . . . . 74.450000000000003 110.272 174.198 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.2 -29.82 64.34 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 120.031 -0.668 . . . . 65.340000000000003 110.972 -170.616 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 38.0 mt -61.5 -53.3 58.23 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 123.843 0.857 . . . . 74.439999999999998 110.383 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -57.67 -40.76 80.11 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 118.823 0.738 . . . . 53.420000000000002 110.814 -175.01 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -64.97 -48.11 75.18 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.769 0.828 . . . . 73.219999999999999 110.635 177.852 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -68.91 -28.97 67.15 Favored 'General case' 0 CA--C 1.533 0.297 0 O-C-N 121.791 -0.568 . . . . 53.140000000000001 111.27 -175.261 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -71.57 7.88 1.29 Allowed 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 125.057 1.343 . . . . 73.219999999999999 112.976 171.03 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 57.53 28.42 15.54 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 127.522 2.329 . . . . 74.150000000000006 113.335 177.77 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 15.5 t -77.31 141.55 15.43 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 O-C-N 120.865 -1.147 . . . . 75.329999999999998 108.057 -179.167 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -142.14 10.87 1.95 Allowed 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 121.618 0.723 . . . . 72.230000000000004 112.248 179.636 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -171.64 178.98 43.66 Favored Glycine 0 N--CA 1.442 -0.933 0 N-CA-C 108.301 -1.92 . . . . 62.219999999999999 108.301 172.32 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.457 ' HA ' ' C ' ' A' ' 154' ' ' PRO . 0.8 OUTLIER -145.51 147.2 32.51 Favored Pre-proline 0 C--N 1.32 -0.681 0 C-N-CA 126.66 1.984 . . . . 62.119999999999997 106.082 -175.155 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 154' ' ' PRO . . . . . 0.544 ' HG3' HD12 ' A' ' 166' ' ' ILE . 37.6 Cg_endo -65.59 157.67 77.33 Favored 'Cis proline' 0 CA--C 1.531 0.351 0 N-CA-C 114.74 1.015 . . . . 74.329999999999998 114.74 3.217 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 18.1 m -158.92 141.05 13.82 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 124.758 1.223 . . . . 73.219999999999999 109.227 172.867 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 98.5 mtp -113.38 156.04 24.15 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 126.529 1.932 . . . . 61.450000000000003 107.947 165.192 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 40.6 t -135.42 144.19 34.72 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.36 0 N-CA-C 106.898 -1.519 . . . . 72.430000000000007 106.898 172.569 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 6.0 t -113.81 124.1 70.12 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 N-CA-C 105.828 -1.916 . . . . 74.310000000000002 105.828 172.218 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 48.9 22.58 0.58 Allowed 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 129.948 3.299 . . . . 62.020000000000003 115.927 165.305 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 59.67 36.21 88.84 Favored Glycine 0 CA--C 1.527 0.835 0 CA-C-O 118.335 -1.258 . . . . 64.109999999999999 114.223 -169.018 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 32.1 mttm -128.37 -44.39 1.4 Allowed 'General case' 0 C--O 1.233 0.222 0 CA-C-N 119.269 1.534 . . . . 63.43 111.887 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -116.84 120.29 38.05 Favored 'General case' 0 C--N 1.332 -0.174 0 O-C-N 122.194 -0.316 . . . . 60.049999999999997 110.767 -174.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 35.8 ttp85 -98.75 126.58 44.41 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 106.752 -1.573 . . . . 64.230000000000004 106.752 171.591 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 7.8 p90 -145.36 163.42 34.63 Favored 'General case' 0 C--N 1.316 -0.872 0 O-C-N 120.829 -1.169 . . . . 74.200000000000003 108.438 177.478 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -173.33 173.1 3.61 Favored 'General case' 0 CA--C 1.516 -0.357 0 N-CA-C 109.786 -0.45 . . . . 63.32 109.786 -172.828 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.544 HD12 ' HG3' ' A' ' 154' ' ' PRO . 9.1 mt -52.48 -47.99 46.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 C-N-CA 127.648 2.379 . . . . 70.530000000000001 109.959 -175.644 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -83.54 3.98 83.31 Favored Glycine 0 CA--C 1.526 0.752 0 CA-C-O 117.9 -1.5 . . . . 71.230000000000004 114.027 179.468 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -102.39 -53.73 2.83 Favored 'General case' 0 C--O 1.226 -0.174 0 CA-C-N 120.518 2.159 . . . . 54.439999999999998 107.771 166.634 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -60.0 -52.62 64.6 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 123.872 0.869 . . . . 73.209999999999994 110.75 -178.746 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 129.76 8.59 3.41 Favored Glycine 0 CA--C 1.526 0.724 0 CA-C-O 119.092 -0.838 . . . . 61.140000000000001 113.882 -176.546 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 154.96 174.38 24.82 Favored Glycine 0 CA--C 1.528 0.895 0 CA-C-N 119.192 1.496 . . . . 41.210000000000001 110.496 178.208 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -62.48 -49.39 5.89 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 122.67 2.247 . . . . 65.230000000000004 111.136 -175.765 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -67.96 -37.34 81.45 Favored 'General case' 0 CA--C 1.53 0.182 0 O-C-N 121.305 -0.872 . . . . 74.219999999999999 110.013 -177.656 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -59.35 -29.93 68.02 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.204 0.601 . . . . 71.409999999999997 110.862 175.491 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 30.5 m -66.74 -41.91 87.1 Favored 'General case' 0 CA--C 1.529 0.172 0 O-C-N 120.698 -1.251 . . . . 74.209999999999994 109.361 178.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 44.6 mt -63.87 -36.33 83.58 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 118.928 0.786 . . . . 65.530000000000001 110.458 174.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -54.39 -44.74 72.55 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 118.219 -0.896 . . . . 73.5 109.585 173.779 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.448 HD13 ' HA ' ' A' ' 178' ' ' LEU . 4.2 mm? -68.66 -43.39 76.29 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-O 117.711 -1.138 . . . . 73.510000000000005 111.867 173.061 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -52.46 -49.81 63.92 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 119.458 1.026 . . . . 70.150000000000006 111.367 -170.914 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -70.68 -36.95 73.58 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 124.103 0.961 . . . . 72.310000000000002 111.055 -171.477 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -68.07 -48.22 66.15 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 126.213 1.805 . . . . 72.430000000000007 111.412 177.533 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 85.1 mt -61.92 -44.03 97.62 Favored 'General case' 0 CA--C 1.527 0.076 0 C-N-CA 123.673 0.789 . . . . 52.310000000000002 110.225 -176.729 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 56.8 mt -51.78 -51.16 29.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 C-N-CA 124.479 1.112 . . . . 72.150000000000006 109.387 174.521 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 14.9 tm-20 -61.18 -27.23 68.27 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 124.512 1.125 . . . . 74.430000000000007 112.419 -178.441 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 185' ' ' LYS . . . . . 0.472 ' HE3' ' HA ' ' A' ' 185' ' ' LYS . 0.3 OUTLIER -61.7 -60.73 3.23 Favored 'General case' 0 C--O 1.232 0.162 0 N-CA-C 107.833 -1.173 . . . . 51.340000000000003 107.833 176.602 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 66.8 mt-10 -67.41 -34.82 78.04 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 125.781 1.632 . . . . 72.150000000000006 111.594 -173.845 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.93 -21.43 64.76 Favored 'General case' 0 N--CA 1.462 0.173 0 O-C-N 120.776 -1.202 . . . . 73.109999999999999 111.911 -177.59 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.357 0 C-N-CA 122.979 0.511 . . . . 52.43 111.955 173.535 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 . . . . . 0 CA--C 1.524 -0.035 0 N-CA-C 109.234 -0.654 . . . . 74.109999999999999 109.234 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -142.28 9.37 1.86 Allowed 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.029 0.932 . . . . 73.310000000000002 112.593 -175.784 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 34.7 m-85 -142.02 167.16 22.79 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 124.755 1.222 . . . . 75.510000000000005 109.687 -170.754 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 18.9 m -130.87 133.63 46.07 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.697 1.199 . . . . 73.140000000000001 109.691 175.164 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.03 128.7 36.84 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 124.709 1.204 . . . . 70.129999999999995 109.98 173.141 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 71.52 24.33 76.96 Favored Glycine 0 CA--C 1.531 1.037 0 CA-C-O 118.721 -1.044 . . . . 63.240000000000002 111.946 -170.611 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 3.9 ttmt -127.39 -85.77 0.59 Allowed 'General case' 0 CA--C 1.518 -0.263 0 C-N-CA 125.119 1.368 . . . . 51.539999999999999 107.866 165.619 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.491 ' HB3' HD11 ' A' ' 178' ' ' LEU . 36.9 mp0 -64.31 -23.24 67.23 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 123.484 0.713 . . . . 74.109999999999999 110.824 -179.758 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 46.0 p90 -162.98 -178.53 6.14 Favored 'General case' 0 N--CA 1.462 0.174 0 O-C-N 121.731 -0.606 . . . . 54.450000000000003 111.88 -169.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 85.1 t -140.0 111.95 4.91 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 C-N-CA 125.428 1.491 . . . . 70.450000000000003 109.116 -178.751 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -75.7 163.42 27.31 Favored 'General case' 0 C--O 1.234 0.289 0 O-C-N 119.997 -1.689 . . . . 64.239999999999995 109.162 162.498 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -123.77 129.76 51.57 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 124.958 1.303 . . . . 72.120000000000005 108.657 -176.514 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 57.1 p -59.79 -27.54 66.65 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-O 118.228 -0.891 . . . . 74.0 112.363 -178.601 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 9.3 p -114.65 84.19 9.8 Favored Pre-proline 0 N--CA 1.452 -0.345 0 CA-C-N 119.068 0.849 . . . . 72.510000000000005 110.507 -175.834 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -70.75 175.19 9.27 Favored 'Trans proline' 0 N--CA 1.451 -1.01 0 C-N-CA 122.897 2.398 . . . . 64.150000000000006 110.915 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 24.6 t -139.18 136.46 18.12 Favored Pre-proline 0 CA--C 1.542 0.644 0 C-N-CA 123.674 0.79 . . . . 74.219999999999999 109.122 -167.337 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -73.05 176.93 8.42 Favored 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 123.917 3.078 . . . . 74.310000000000002 112.949 175.706 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 15.4 m -137.02 164.71 29.53 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 C-N-CA 124.601 1.16 . . . . 75.430000000000007 112.63 -167.696 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 13.4 t -58.49 -30.4 66.98 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 126.769 2.028 . . . . 72.540000000000006 112.965 175.47 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -155.58 86.06 3.29 Favored Pre-proline 0 N--CA 1.446 -0.657 0 CA-C-N 119.636 1.107 . . . . 73.140000000000001 109.425 -170.915 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -65.28 86.8 0.19 Allowed 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 122.224 1.949 . . . . 74.209999999999994 108.991 172.186 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -174.25 -41.8 0.05 OUTLIER Glycine 0 CA--C 1.525 0.714 0 CA-C-O 118.846 -0.975 . . . . 73.109999999999999 112.296 -165.612 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 9.5 mptt -108.06 152.19 24.84 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 106.759 -1.571 . . . . 73.109999999999999 106.759 160.011 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 32.6 mm -57.81 148.39 5.53 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 N-CA-C 105.868 -1.901 . . . . 63.340000000000003 105.868 162.121 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -117.55 117.47 29.51 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 106.958 -1.497 . . . . 72.209999999999994 106.958 -178.229 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 43.1 t -116.61 129.79 72.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 N-CA-C 107.327 -1.361 . . . . 74.120000000000005 107.327 179.409 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 4.8 t -118.9 134.37 62.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 106.143 -1.799 . . . . 74.530000000000001 106.143 179.427 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -107.89 101.8 11.04 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 104.631 -2.359 . . . . 60.509999999999998 104.631 162.031 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.441 HD22 HG21 ' A' ' 150' ' ' VAL . 5.4 mp -82.98 118.67 23.65 Favored 'General case' 0 CA--C 1.522 -0.114 0 N-CA-C 106.917 -1.512 . . . . 72.450000000000003 106.917 177.178 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 49.4 p90 -124.22 168.39 13.0 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.163 0.585 . . . . 71.219999999999999 112.045 -171.74 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' TRP . . . . . 0.493 ' HB3' HG21 ' A' ' 153' ' ' VAL . 22.6 t90 -146.14 143.43 29.32 Favored 'General case' 0 C--N 1.343 0.312 0 C-N-CA 125.142 1.377 . . . . 75.200000000000003 109.238 174.614 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 5.4 t80 -49.15 -42.15 38.7 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 126.739 2.016 . . . . 75.209999999999994 112.571 171.743 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -83.57 15.61 34.9 Favored Glycine 0 CA--C 1.525 0.7 0 CA-C-O 119.163 -0.799 . . . . 64.120000000000005 113.017 -171.839 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 53.5 t -105.12 85.62 1.34 Allowed Pre-proline 0 N--CA 1.447 -0.613 0 C-N-CA 126.322 1.849 . . . . 51.020000000000003 108.148 178.933 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -61.44 -32.68 88.92 Favored 'Trans proline' 0 CA--C 1.534 0.5 0 C-N-CA 122.085 1.856 . . . . 70.120000000000005 110.279 177.198 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 5.4 m170 -53.44 -48.72 68.55 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 126.201 1.8 . . . . 64.230000000000004 110.134 175.258 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 84.1 m -59.57 -38.07 80.17 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.008 0.923 . . . . 73.420000000000002 109.555 -168.102 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 38.5 t80 -62.74 -23.45 67.19 Favored 'General case' 0 N--CA 1.47 0.55 0 O-C-N 120.892 -1.13 . . . . 73.340000000000003 112.559 179.64 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -55.96 -40.32 73.07 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 118.983 0.81 . . . . 74.409999999999997 110.043 172.631 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -85.44 -21.66 28.65 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 125.833 1.653 . . . . 62.229999999999997 112.681 -168.518 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -38.93 -67.08 0.28 Allowed Pre-proline 0 N--CA 1.478 0.937 0 C-N-CA 125.348 1.459 . . . . 73.019999999999996 112.662 -176.284 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -73.95 -10.29 22.88 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 CA-C-N 121.803 1.68 . . . . 71.099999999999994 114.406 -174.351 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.8 m -72.32 -45.21 60.92 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 107.975 -1.12 . . . . 75.109999999999999 107.975 166.863 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 20.2 tt -92.28 -36.54 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 N-CA-C 113.207 0.817 . . . . 73.420000000000002 113.207 -167.376 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 29.3 t -43.5 -60.48 2.51 Favored Pre-proline 0 CA--C 1.543 0.686 0 C-N-CA 125.31 1.444 . . . . 64.150000000000006 110.962 175.135 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -69.62 -29.93 23.73 Favored 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 121.725 1.617 . . . . 74.420000000000002 112.011 -177.432 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.49 ' CZ2' ' HB1' ' A' ' 179' ' ' ALA . 72.5 t90 -57.44 -49.75 75.23 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 119.074 0.852 . . . . 75.219999999999999 109.209 175.764 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 44.2 t -61.73 -37.08 82.9 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 122.942 0.497 . . . . 61.119999999999997 110.636 178.099 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -59.6 -44.66 93.32 Favored 'General case' 0 CA--C 1.533 0.324 0 O-C-N 120.757 -1.214 . . . . 64.150000000000006 110.979 176.738 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -85.99 4.99 35.37 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 119.197 0.908 . . . . 74.040000000000006 113.179 -173.486 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 60.7 mt -58.6 148.72 65.34 Favored Pre-proline 0 N--CA 1.447 -0.612 0 N-CA-C 109.785 -0.45 . . . . 73.430000000000007 109.785 173.485 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -70.69 174.45 10.3 Favored 'Trans proline' 0 N--CA 1.447 -1.252 0 C-N-CA 123.982 3.121 . . . . 64.200000000000003 110.623 -178.752 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -67.68 0.95 2.76 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.986 1.314 . . . . 62.229999999999997 114.093 178.253 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -117.88 4.08 12.19 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 125.598 1.559 . . . . 65.329999999999998 111.916 -170.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 59.5 t -126.4 138.03 55.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 N-CA-C 105.721 -1.955 . . . . 62.25 105.721 179.243 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 3.2 p-80 -126.74 147.14 50.0 Favored 'General case' 0 N--CA 1.444 -0.768 0 C-N-CA 123.827 0.851 . . . . 41.140000000000001 109.13 179.126 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 28.1 t80 -110.96 140.5 45.41 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 124.199 1.0 . . . . 71.109999999999999 108.661 -173.266 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 82.4 t -133.71 113.54 18.66 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.441 0 N-CA-C 108.283 -1.006 . . . . 73.400000000000006 108.283 -170.011 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 29.1 mtm180 -101.07 114.96 29.39 Favored 'General case' 0 CA--C 1.506 -0.716 0 N-CA-C 105.84 -1.911 . . . . 64.519999999999996 105.84 -175.309 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 79.1 mt -130.36 145.58 58.02 Favored Pre-proline 0 C--N 1.328 -0.365 0 C-N-CA 123.177 0.591 . . . . 72.310000000000002 109.679 175.606 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -76.65 134.92 15.61 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 122.829 2.353 . . . . 74.030000000000001 110.474 172.804 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -77.11 95.03 4.14 Favored 'General case' 0 CA--C 1.539 0.533 0 O-C-N 121.55 -0.719 . . . . 53.009999999999998 110.035 178.058 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 29.6 mt -88.63 75.09 8.33 Favored 'General case' 0 CA--C 1.539 0.553 0 O-C-N 120.057 -1.652 . . . . 75.230000000000004 111.372 -172.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -87.0 30.28 0.77 Allowed 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 113.947 1.091 . . . . 75.120000000000005 113.947 -175.281 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 72.31 -165.01 54.42 Favored Glycine 0 CA--C 1.527 0.826 0 N-CA-C 108.341 -1.904 . . . . 51.32 108.341 -168.805 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 56.34 -156.47 11.64 Favored Glycine 0 CA--C 1.529 0.95 0 CA-C-N 117.891 0.846 . . . . 75.030000000000001 113.601 172.028 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 9.5 tp -61.67 -20.98 24.49 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 C-N-CA 123.481 0.712 . . . . 74.510000000000005 112.219 172.182 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 11.9 m95 -59.3 -42.07 90.49 Favored 'General case' 0 C--N 1.343 0.313 0 CA-C-N 120.097 1.317 . . . . 73.349999999999994 110.798 -171.266 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -79.93 -28.15 39.75 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 112.979 0.733 . . . . 62.210000000000001 112.979 178.579 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 92.4 t -63.12 -45.99 97.18 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 N-CA-C 108.089 -1.078 . . . . 54.310000000000002 108.089 175.055 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 64.2 m170 -76.61 15.13 0.67 Allowed 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 124.759 1.224 . . . . 71.439999999999998 112.644 169.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -123.73 -22.48 2.23 Favored Glycine 0 CA--C 1.532 1.141 0 CA-C-N 120.358 1.436 . . . . 53.140000000000001 114.182 178.144 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 33.7 tt0 -72.92 -28.98 62.78 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 118.286 1.043 . . . . 65.209999999999994 111.553 -172.146 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 6.5 ttp -61.52 -47.79 83.99 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-O 117.512 -1.232 . . . . 73.230000000000004 111.724 -177.624 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 13.7 t80 -52.62 -52.91 53.28 Favored 'General case' 0 N--CA 1.462 0.138 0 N-CA-C 108.813 -0.81 . . . . 74.25 108.813 -176.315 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 47.3 mt -56.61 -44.22 80.93 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 114.829 -1.078 . . . . 71.019999999999996 109.993 177.014 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.685 ' HA ' HD11 ' A' ' 134' ' ' ILE . 2.5 m -62.94 -40.92 99.1 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 120.353 1.433 . . . . 73.049999999999997 112.087 -174.969 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -55.88 -54.14 48.26 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.897 0.879 . . . . 61.530000000000001 108.76 176.584 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -74.36 -10.71 59.85 Favored 'General case' 0 CA--C 1.543 0.68 0 O-C-N 121.407 -0.808 . . . . 75.439999999999998 111.5 -176.269 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 9.3 t -88.29 -20.03 25.97 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 126.496 1.918 . . . . 71.409999999999997 113.578 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 8.5 ptp . . . . . 0 N--CA 1.466 0.334 0 O-C-N 120.89 -1.132 . . . . 74.209999999999994 110.072 157.904 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.297 0 N-CA-C 111.65 0.241 . . . . 73.230000000000004 111.65 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 48.5 t -53.42 -61.98 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 C-N-CA 124.159 0.983 . . . . 73.299999999999997 108.552 171.879 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -69.1 -41.95 76.76 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 119.174 -0.441 . . . . 55.130000000000003 110.716 -175.142 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -52.86 -39.66 62.75 Favored 'General case' 0 C--O 1.233 0.21 0 C-N-CA 124.671 1.188 . . . . 75.310000000000002 111.024 -178.334 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -63.76 -27.53 69.26 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 124.022 0.929 . . . . 72.230000000000004 111.055 -176.773 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 52.2 mt -85.45 -60.51 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.933 0 C-N-CA 125.97 1.708 . . . . 75.150000000000006 107.299 176.12 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 24.9 p-80 -76.18 -57.17 4.02 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 119.719 1.145 . . . . 51.109999999999999 113.256 -169.016 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -83.07 -33.15 26.48 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-N 118.404 0.547 . . . . 71.120000000000005 110.989 -171.187 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -97.51 -30.77 12.69 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 124.145 0.978 . . . . 75.310000000000002 111.091 -171.06 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 5.2 t-160 45.08 88.53 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 127.901 2.48 . . . . 74.099999999999994 112.885 176.056 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.488 ' HE2' ' CE1' ' A' ' 114' ' ' PHE . 0.0 OUTLIER -106.38 155.31 19.68 Favored 'General case' 0 CA--C 1.507 -0.7 0 CA-C-O 121.579 0.704 . . . . 73.519999999999996 111.128 164.429 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 5.2 ttmt -58.03 101.97 0.09 Allowed 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 106.698 -1.593 . . . . 65.400000000000006 106.698 165.782 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 93.0 mt -130.42 70.1 1.45 Allowed 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 126.934 2.094 . . . . 72.319999999999993 108.701 178.453 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -114.86 1.67 14.13 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.463 1.105 . . . . 62.43 112.619 -175.523 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -138.63 152.57 71.11 Favored Pre-proline 0 CA--C 1.531 0.249 0 C-N-CA 125.342 1.457 . . . . 75.239999999999995 109.209 -175.197 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -65.15 -34.02 47.56 Favored 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 121.395 1.396 . . . . 71.329999999999998 110.473 -179.424 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -64.37 -21.02 66.5 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 118.536 0.607 . . . . 73.310000000000002 112.343 174.497 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -84.06 -55.06 4.41 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 107.894 -1.15 . . . . 74.450000000000003 107.894 177.808 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 3.9 mpp? -58.21 -51.78 68.33 Favored 'General case' 0 C--N 1.34 0.187 0 C-N-CA 123.213 0.605 . . . . 73.099999999999994 111.135 179.374 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.612 ' HB1' ' HG2' ' A' ' 122' ' ' LYS . . . -67.28 -41.45 85.45 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 118.3 -0.857 . . . . 53.43 110.319 -173.864 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -57.8 -46.98 83.88 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 118.831 0.741 . . . . 74.340000000000003 110.006 174.752 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' PHE . . . . . 0.488 ' CE1' ' HE2' ' A' ' 103' ' ' LYS . 84.7 t80 -60.48 -46.9 88.39 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 118.015 0.37 . . . . 43.299999999999997 110.817 -176.561 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 46.0 mt -75.62 -17.98 59.84 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 119.356 -0.354 . . . . 52.039999999999999 111.007 -176.478 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.18 -9.85 2.41 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.481 1.512 . . . . 41.240000000000002 114.115 -179.096 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -121.34 15.37 9.29 Favored Glycine 0 CA--C 1.533 1.194 0 C-N-CA 126.666 2.079 . . . . 75.219999999999999 112.808 176.741 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 2.8 mmpt? -135.01 25.87 3.59 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.905 1.282 . . . . 75.209999999999994 110.891 -172.779 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 94.13 20.69 29.73 Favored Glycine 0 CA--C 1.524 0.617 0 C-N-CA 124.08 0.848 . . . . 64.219999999999999 113.529 172.813 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 94.0 t -132.98 130.01 58.13 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 C-N-CA 124.675 1.19 . . . . 74.129999999999995 107.817 -169.704 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -98.98 134.06 42.36 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 112.251 0.463 . . . . 73.120000000000005 112.251 -176.601 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.612 ' HG2' ' HB1' ' A' ' 112' ' ' ALA . 39.6 mtpt -60.74 -35.07 75.45 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 118.491 -0.766 . . . . 74.340000000000003 110.017 176.878 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -55.87 -46.51 78.24 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 119.086 0.857 . . . . 53.109999999999999 110.479 176.937 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 25.8 mmtt -78.27 -46.27 20.68 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 106.724 -1.584 . . . . 72.230000000000004 106.724 -174.802 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.51 ' CD2' ' HB2' ' A' ' 112' ' ' ALA . 47.6 t80 -54.06 -65.15 0.62 Allowed 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 125.455 1.502 . . . . 72.400000000000006 111.391 -176.504 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 9.3 mt -70.45 -33.76 71.68 Favored 'General case' 0 N--CA 1.467 0.418 0 O-C-N 121.146 -0.971 . . . . 55.399999999999999 111.06 -166.832 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 17.1 t -58.02 -57.8 11.21 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 107.198 -1.408 . . . . 62.130000000000003 107.198 172.447 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 38.4 m -62.85 -39.81 95.52 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-O 118.987 -0.53 . . . . 74.310000000000002 110.238 -175.18 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 54.7 t80 -56.42 -41.79 76.97 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 119.975 1.262 . . . . 73.540000000000006 110.064 -179.046 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 33.7 m-80 -84.43 -10.78 57.22 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 124.367 1.067 . . . . 74.209999999999994 113.745 -179.382 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 4.3 m -86.73 154.93 20.58 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 126.125 1.77 . . . . 71.430000000000007 112.645 -169.52 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -63.01 -29.83 71.13 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 114.171 1.174 . . . . 75.310000000000002 114.171 -171.541 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -57.21 -43.99 83.26 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 120.297 1.408 . . . . 54.329999999999998 111.231 -177.287 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.685 HD11 ' HA ' ' A' ' 80' ' ' THR . 4.6 mm -58.48 -43.86 87.73 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.496 0 C-N-CA 126.394 1.878 . . . . 72.120000000000005 110.721 174.098 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 17.3 tttm -51.82 -37.49 51.99 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.941 0.896 . . . . 61.229999999999997 109.161 174.433 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -71.95 -40.13 57.78 Favored Glycine 0 CA--C 1.527 0.787 0 C-N-CA 124.634 1.111 . . . . 72.329999999999998 111.599 179.587 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -72.22 -34.37 68.29 Favored 'General case' 0 C--N 1.329 -0.311 0 O-C-N 120.906 -1.349 . . . . 72.099999999999994 110.551 -179.415 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 55.1 mtp -65.06 -51.29 62.33 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 124.599 1.16 . . . . 71.209999999999994 109.395 176.453 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -55.88 -38.78 70.62 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 119.298 0.953 . . . . 74.420000000000002 110.926 -172.519 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 21.6 mtmt -66.67 -61.6 1.88 Allowed 'General case' 0 C--N 1.342 0.255 0 CA-C-O 117.703 -1.141 . . . . 61.32 110.911 176.53 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -52.31 -39.13 60.16 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 120.834 1.652 . . . . 54.520000000000003 111.298 -177.226 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 11.0 tttt -62.49 -54.46 39.68 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 125.514 1.526 . . . . 54.509999999999998 112.454 178.704 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.01 -30.61 67.97 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 119.824 1.193 . . . . 72.099999999999994 110.623 179.166 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 40.3 mt -60.2 -47.25 86.76 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-O 118.932 -0.556 . . . . 72.099999999999994 110.558 -177.856 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -54.76 -45.93 74.28 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 118.016 0.371 . . . . 72.040000000000006 111.56 -177.467 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 13.2 ptp -70.57 -42.05 71.6 Favored 'General case' 0 CA--C 1.523 -0.079 0 N-CA-C 112.117 0.414 . . . . 55.210000000000001 112.117 -179.172 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -60.59 -38.53 84.96 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 123.747 0.819 . . . . 52.100000000000001 109.126 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 23.4 m-85 -76.47 6.16 6.17 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 114.12 1.155 . . . . 72.120000000000005 114.12 175.527 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 54.2 mt-30 57.63 36.19 26.46 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 127.073 2.149 . . . . 71.340000000000003 112.829 -179.22 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.441 HG21 HD22 ' A' ' 32' ' ' LEU . 36.1 t -82.94 145.87 7.85 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 N-CA-C 108.072 -1.084 . . . . 71.140000000000001 108.072 171.762 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -140.18 -7.79 1.18 Allowed 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 124.53 1.132 . . . . 64.230000000000004 112.642 173.902 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -154.43 -176.77 27.1 Favored Glycine 0 CA--C 1.52 0.396 0 N-CA-C 108.601 -1.8 . . . . 73.129999999999995 108.601 -178.209 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.493 HG21 ' HB3' ' A' ' 34' ' ' TRP . 31.4 m -137.49 158.37 72.18 Favored Pre-proline 0 CA--C 1.54 0.563 0 N-CA-C 108.628 -0.879 . . . . 71.439999999999998 108.628 174.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 154' ' ' PRO . . . . . 0.413 ' C ' ' HA ' ' A' ' 153' ' ' VAL . 61.5 Cg_endo -63.05 160.56 59.06 Favored 'Cis proline' 0 N--CA 1.455 -0.771 0 C-N-CA 123.252 -1.562 . . . . 75.510000000000005 112.055 -12.026 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 155' ' ' THR . . . . . 0.424 HG21 HG22 ' A' ' 150' ' ' VAL . 9.4 m -159.04 111.05 2.16 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 105.537 -2.023 . . . . 71.549999999999997 105.537 174.332 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 92.7 mtp -84.39 155.61 22.21 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 108.579 -0.897 . . . . 71.049999999999997 108.579 165.143 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 10.0 t -138.48 150.71 24.16 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 N-CA-C 106.82 -1.548 . . . . 75.239999999999995 106.82 174.329 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 55.2 t -134.98 123.79 41.49 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 N-CA-C 105.908 -1.886 . . . . 73.040000000000006 105.908 -178.133 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 9.3 m-20 52.33 13.1 0.27 Allowed 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 129.814 3.246 . . . . 74.200000000000003 114.598 178.028 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 59.17 42.31 97.09 Favored Glycine 0 CA--C 1.527 0.785 0 CA-C-O 118.612 -1.105 . . . . 75.439999999999998 111.826 -166.753 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 13.5 mtpp -133.19 -38.85 0.94 Allowed 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 125.119 1.367 . . . . 63.229999999999997 111.219 -177.23 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -116.29 154.2 30.59 Favored 'General case' 0 CA--C 1.502 -0.901 0 N-CA-C 108.409 -0.96 . . . . 70.319999999999993 108.409 177.848 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 28.4 ttp85 -132.7 135.11 45.58 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 105.034 -2.21 . . . . 65.239999999999995 105.034 174.873 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 45.5 p90 -149.77 173.26 13.92 Favored 'General case' 0 C--N 1.324 -0.543 0 O-C-N 121.465 -0.772 . . . . 74.319999999999993 109.123 169.8 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -167.5 174.24 8.03 Favored 'General case' 0 CA--C 1.515 -0.367 0 N-CA-C 109.76 -0.459 . . . . 43.299999999999997 109.76 178.663 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 14.7 mt -51.77 -51.27 28.47 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 C-N-CA 125.917 1.687 . . . . 71.5 110.33 -179.183 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -76.09 -20.7 77.23 Favored Glycine 0 CA--C 1.527 0.8 0 CA-C-O 118.096 -1.391 . . . . 70.310000000000002 113.467 -178.072 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 66.6 m -70.18 -64.25 0.93 Allowed 'General case' 0 C--O 1.235 0.33 0 CA-C-N 120.011 1.906 . . . . 71.049999999999997 108.407 168.828 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -55.76 -48.74 74.76 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 127.354 2.261 . . . . 71.430000000000007 111.943 -174.04 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 130.89 -6.49 5.78 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 124.532 1.063 . . . . 74.299999999999997 114.303 178.197 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 165.59 169.67 29.51 Favored Glycine 0 CA--C 1.526 0.758 0 CA-C-N 119.218 1.509 . . . . 52.439999999999998 110.413 178.713 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -61.07 -43.43 29.89 Favored 'Trans proline' 0 N--CA 1.461 -0.439 0 C-N-CA 123.047 2.498 . . . . 74.209999999999994 111.351 -174.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 -60.32 -44.43 95.48 Favored 'General case' 0 CA--C 1.536 0.424 0 O-C-N 121.468 -0.77 . . . . 71.310000000000002 110.474 176.332 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -66.5 -23.94 66.33 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.511 1.125 . . . . 74.439999999999998 110.648 -177.527 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 28.3 m -66.58 -44.31 82.6 Favored 'General case' 0 N--CA 1.455 -0.19 0 O-C-N 121.056 -1.027 . . . . 74.519999999999996 109.668 179.457 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 54.9 mt -68.15 -23.51 64.88 Favored 'General case' 0 C--N 1.341 0.217 0 CA-C-N 118.702 0.683 . . . . 74.150000000000006 111.938 179.141 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.12 -54.9 37.36 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 108.245 -1.02 . . . . 50.439999999999998 108.245 168.577 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.491 HD11 ' HB3' ' A' ' 11' ' ' GLU . 3.0 mm? -64.74 -44.69 89.33 Favored 'General case' 0 CA--C 1.515 -0.383 0 N-CA-C 110.016 -0.365 . . . . 70.310000000000002 110.016 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.49 ' HB1' ' CZ2' ' A' ' 50' ' ' TRP . . . -54.86 -34.38 62.86 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 112.538 0.57 . . . . 73.120000000000005 112.538 -175.018 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -94.61 -36.55 11.74 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 123.475 0.71 . . . . 54.32 110.929 -170.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 37.9 t80 -57.25 -53.45 57.99 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.757 0.823 . . . . 74.209999999999994 109.65 171.156 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 26.5 mt -55.75 -46.8 77.75 Favored 'General case' 0 CA--C 1.516 -0.329 0 C-N-CA 124.43 1.092 . . . . 72.430000000000007 111.403 -177.154 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 46.2 mt -48.46 -58.65 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.139 0 N-CA-C 109.025 -0.731 . . . . 71.109999999999999 109.025 176.378 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 6.9 tm-20 -65.1 -26.64 68.3 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 119.254 0.934 . . . . 73.310000000000002 111.882 -176.195 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 3.7 tmtm? -64.9 -58.28 6.59 Favored 'General case' 0 C--O 1.234 0.282 0 O-C-N 120.645 -1.284 . . . . 62.420000000000002 109.634 172.018 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -60.54 -40.8 92.85 Favored 'General case' 0 N--CA 1.438 -1.04 0 C-N-CA 125.525 1.53 . . . . 75.219999999999999 112.077 -177.763 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.68 -43.37 80.31 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 125.859 1.664 . . . . 44.210000000000001 110.299 179.428 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.451 0 CA-C-N 119.884 1.22 . . . . 72.430000000000007 111.202 -174.708 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . 0.27 0.0 OUTLIER . . . . . 0 N--CA 1.471 0.59 0 CA-C-O 120.561 0.22 . . . . 63.340000000000003 110.598 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -152.93 14.48 0.54 Allowed 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.123 0.969 . . . . 74.230000000000004 112.127 175.281 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 25.5 m-85 -146.6 160.72 41.81 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 123.932 0.893 . . . . 74.409999999999997 110.275 -167.71 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 31.5 m -128.78 136.59 50.74 Favored 'General case' 0 C--O 1.238 0.461 0 O-C-N 121.418 -0.801 . . . . 62.310000000000002 108.846 -177.623 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -70.99 149.99 46.1 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 122.119 0.961 . . . . 43.340000000000003 109.1 174.229 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 62.32 12.04 36.6 Favored Glycine 0 CA--C 1.533 1.208 0 CA-C-O 118.556 -1.136 . . . . 73.540000000000006 112.582 -167.659 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.8 tptt -126.97 -84.24 0.61 Allowed 'General case' 0 C--N 1.339 0.131 0 CA-C-N 119.885 1.842 . . . . 74.420000000000002 107.346 -178.853 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.6 mp0 -74.52 -26.82 60.23 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 125.477 1.511 . . . . 74.430000000000007 110.372 179.441 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 34.3 p90 -158.61 174.86 14.41 Favored 'General case' 0 N--CA 1.456 -0.131 0 O-C-N 121.18 -0.95 . . . . 74.109999999999999 109.451 -175.223 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 24.7 t -135.76 128.56 47.07 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.107 0 C-N-CA 124.418 1.087 . . . . 52.229999999999997 108.196 -179.708 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.424 ' HG3' ' CE1' ' A' ' 162' ' ' TYR . 0.7 OUTLIER -87.74 169.28 12.23 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.211 1.404 . . . . 74.530000000000001 110.782 165.204 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -136.38 122.48 20.29 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 124.641 1.176 . . . . 74.109999999999999 111.054 177.037 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.6 p -63.13 -0.07 0.69 Allowed 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 128.657 2.783 . . . . 74.140000000000001 114.693 179.515 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 74.1 m -137.7 78.87 35.82 Favored Pre-proline 0 N--CA 1.447 -0.592 0 N-CA-C 107.546 -1.279 . . . . 73.25 107.546 173.611 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -68.97 179.6 3.17 Favored 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 123.339 2.692 . . . . 74.519999999999996 111.818 -176.39 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 40.4 t -126.84 136.97 29.57 Favored Pre-proline 0 CA--C 1.536 0.407 0 N-CA-C 108.503 -0.925 . . . . 70.349999999999994 108.503 -169.895 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -78.18 -179.09 5.13 Favored 'Trans proline' 0 CA--C 1.537 0.635 0 C-N-CA 122.882 2.388 . . . . 72.25 111.861 178.225 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 3.7 m -131.96 179.78 4.07 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 C-N-CA 127.294 2.237 . . . . 53.020000000000003 109.504 176.306 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 47.3 t -64.15 -70.58 0.21 Allowed 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 124.879 1.272 . . . . 53.25 108.324 168.543 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 57.2 tp60 -116.54 143.03 30.49 Favored Pre-proline 0 N--CA 1.45 -0.443 0 N-CA-C 105.543 -2.021 . . . . 62.109999999999999 105.543 -176.503 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -86.21 -164.13 0.21 Allowed 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 123.699 2.932 . . . . 73.420000000000002 110.306 176.834 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 94.3 -77.84 0.97 Allowed Glycine 0 N--CA 1.444 -0.771 0 N-CA-C 108.889 -1.684 . . . . 74.299999999999997 108.889 174.606 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 87.2 mttt -62.98 136.56 57.91 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 107.919 -1.141 . . . . 55.310000000000002 107.919 178.271 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.446 HD12 ' HB3' ' A' ' 186' ' ' GLU . 25.8 mm -73.78 124.66 31.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 106.134 -1.802 . . . . 74.450000000000003 106.134 176.117 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -73.76 146.93 43.94 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.104 -1.073 . . . . 75.310000000000002 108.104 175.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 60.1 t -133.35 135.6 55.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 106.382 -1.71 . . . . 72.230000000000004 106.382 164.762 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 60.9 t -130.38 101.28 5.65 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 N-CA-C 106.4 -1.704 . . . . 62.030000000000001 106.4 -169.826 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -72.04 133.64 45.39 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 107.679 -1.23 . . . . 71.530000000000001 107.679 164.294 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.1 mp -119.71 126.87 52.13 Favored 'General case' 0 C--O 1.231 0.109 0 N-CA-C 108.536 -0.912 . . . . 74.319999999999993 108.536 167.835 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 21.6 p90 -135.3 163.59 29.66 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 124.649 1.18 . . . . 70.040000000000006 111.131 -171.007 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' TRP . . . . . 0.449 ' HB3' HG21 ' A' ' 153' ' ' VAL . 34.2 t90 -143.44 157.75 44.2 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 124.647 1.179 . . . . 73.239999999999995 107.948 173.672 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 31.3 t80 -46.23 -57.88 4.16 Favored 'General case' 0 N--CA 1.444 -0.745 0 C-N-CA 128.063 2.545 . . . . 75.340000000000003 113.707 -177.11 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -75.46 -83.68 0.41 Allowed Glycine 0 N--CA 1.444 -0.767 0 N-CA-C 108.548 -1.821 . . . . 72.099999999999994 108.548 -170.842 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 9.1 t 42.63 65.53 5.1 Favored Pre-proline 0 CA--C 1.541 0.62 0 C-N-CA 126.032 1.733 . . . . 63.409999999999997 112.752 164.128 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -62.57 -20.12 69.81 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 122.413 2.076 . . . . 74.239999999999995 112.471 -175.624 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 15.1 m-70 -83.95 -21.4 31.8 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 117.732 -1.128 . . . . 74.409999999999997 113.938 172.852 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 99.0 m -68.16 -41.87 80.9 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 119.931 1.241 . . . . 74.519999999999996 109.56 175.141 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 19.1 t80 -54.06 -42.81 69.68 Favored 'General case' 0 C--N 1.341 0.202 0 C-N-CA 124.155 0.982 . . . . 75.140000000000001 110.804 -174.726 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -51.68 -43.87 62.88 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.815 0.846 . . . . 71.129999999999995 111.909 -179.094 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -76.84 -24.59 52.7 Favored 'General case' 0 C--O 1.225 -0.231 0 CA-C-O 117.061 -1.447 . . . . 71.349999999999994 112.725 -171.613 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -44.45 -67.79 0.33 Allowed Pre-proline 0 CA--C 1.543 0.68 0 CA-C-N 120.421 1.464 . . . . 75.129999999999995 113.677 -170.037 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -70.92 -4.62 15.17 Favored 'Trans proline' 0 CA--C 1.536 0.611 0 C-N-CA 121.801 1.667 . . . . 54.049999999999997 112.815 -175.413 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -96.52 -0.8 48.38 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 127.181 2.192 . . . . 55.100000000000001 111.151 173.461 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 20.6 tt -126.93 -28.38 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 CA-C-N 120.885 1.675 . . . . 74.010000000000005 112.978 171.769 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 54.6 t -50.92 -60.14 6.14 Favored Pre-proline 0 CA--C 1.538 0.493 0 CA-C-N 119.612 1.096 . . . . 73.510000000000005 110.974 178.14 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -69.16 -32.51 20.93 Favored 'Trans proline' 0 N--CA 1.451 -0.998 0 CA-C-N 121.07 1.418 . . . . 43.340000000000003 111.067 -175.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.451 ' CZ2' ' HB1' ' A' ' 179' ' ' ALA . 83.4 t90 -53.38 -53.41 51.51 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 119.842 1.201 . . . . 73.299999999999997 110.242 173.928 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 21.5 t -60.48 -37.42 81.0 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.676 0.79 . . . . 73.549999999999997 111.288 -177.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -61.66 -45.82 92.41 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 119.32 0.963 . . . . 63.43 110.88 173.083 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 2.6 mptp? -83.49 7.93 15.51 Favored 'General case' 0 C--O 1.234 0.261 0 O-C-N 120.625 -1.297 . . . . 73.420000000000002 113.544 -169.081 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 35.2 mt -61.59 157.49 47.01 Favored Pre-proline 0 CA--C 1.537 0.471 0 C-N-CA 125.198 1.399 . . . . 70.319999999999993 111.784 179.558 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -74.85 167.98 25.87 Favored 'Trans proline' 0 N--CA 1.451 -0.993 0 C-N-CA 124.752 3.635 . . . . 73.129999999999995 110.548 172.123 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -77.69 -4.95 48.75 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.755 0.822 . . . . 55.329999999999998 113.133 178.568 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -94.43 7.04 46.91 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 119.272 0.942 . . . . 72.420000000000002 110.647 177.408 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 96.8 t -126.55 138.0 56.06 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 N-CA-C 106.715 -1.587 . . . . 64.519999999999996 106.715 -177.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 68.5 t60 -123.48 108.84 13.11 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 124.9 1.28 . . . . 72.340000000000003 108.747 -178.004 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 51.8 t80 -87.81 137.55 32.24 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 123.788 0.835 . . . . 72.340000000000003 109.528 -178.275 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 47.7 t -136.28 150.18 27.66 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 C-N-CA 126.215 1.806 . . . . 74.019999999999996 107.409 -174.444 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 30.4 mtp180 -132.72 126.08 31.69 Favored 'General case' 0 C--O 1.232 0.166 0 N-CA-C 106.885 -1.524 . . . . 72.219999999999999 106.885 -176.627 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 86.8 mt -138.47 144.82 44.11 Favored Pre-proline 0 N--CA 1.467 0.402 0 C-N-CA 124.141 0.976 . . . . 62.329999999999998 109.587 -178.181 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -74.79 152.82 42.37 Favored 'Trans proline' 0 N--CA 1.456 -0.735 0 C-N-CA 122.14 1.893 . . . . 73.439999999999998 111.672 177.865 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -89.48 107.21 18.94 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 125.237 1.415 . . . . 61.039999999999999 109.09 177.483 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.442 HD13 ' HE3' ' A' ' 138' ' ' MET . 39.8 mt -105.71 78.59 1.36 Allowed 'General case' 0 C--O 1.236 0.356 0 C-N-CA 125.151 1.381 . . . . 61.109999999999999 108.103 -173.611 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -121.96 59.95 0.99 Allowed 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 124.706 1.202 . . . . 62.340000000000003 110.197 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 68.85 164.74 3.58 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 125.983 1.754 . . . . 71.319999999999993 114.174 167.919 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 48.72 -142.7 8.6 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 124.252 0.929 . . . . 74.109999999999999 111.276 -175.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -56.7 -17.29 4.83 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 C-N-CA 124.71 1.204 . . . . 63.100000000000001 113.524 -175.914 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 13.3 m95 -60.97 -42.85 99.1 Favored 'General case' 0 C--N 1.341 0.211 0 O-C-N 120.442 -1.411 . . . . 75.239999999999995 109.959 178.435 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 7.5 m-80 -72.21 -17.97 61.88 Favored 'General case' 0 CA--C 1.527 0.095 0 O-C-N 121.566 -0.709 . . . . 74.310000000000002 112.512 176.528 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 64.8 t -92.53 -13.25 8.76 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 C-N-CA 123.786 0.834 . . . . 74.400000000000006 111.605 -173.658 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 52.0 m170 -115.45 4.49 14.3 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.342 1.057 . . . . 74.140000000000001 111.924 172.141 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -102.93 -41.73 2.22 Favored Glycine 0 N--CA 1.448 -0.526 0 N-CA-C 109.518 -1.433 . . . . 43.409999999999997 109.518 -176.804 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . 0.268 1.3 pm0 -49.12 -43.86 41.85 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 125.16 1.384 . . . . 75.129999999999995 113.027 -179.689 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 5.1 ppp? -54.35 -37.16 64.61 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 114.154 1.168 . . . . 64.129999999999995 114.154 -172.276 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 39.4 t80 -56.49 -43.07 79.34 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 122.835 1.302 . . . . 74.140000000000001 109.049 -172.2 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 12.9 mt -68.87 -34.8 76.05 Favored 'General case' 0 N--CA 1.442 -0.867 0 C-N-CA 125.991 1.716 . . . . 75.150000000000006 110.729 -177.87 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.75 HG22 HG23 ' A' ' 128' ' ' THR . 0.0 OUTLIER -68.53 -50.99 47.8 Favored 'General case' 0 C--N 1.344 0.356 0 CA-C-N 121.125 1.784 . . . . 71.5 110.182 176.026 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.464 HD21 HD22 ' A' ' 115' ' ' LEU . 0.7 OUTLIER -51.09 -52.96 38.42 Favored 'General case' 0 CA--C 1.535 0.376 0 O-C-N 123.968 0.793 . . . . 75.129999999999995 109.459 -177.543 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -65.12 -28.14 69.22 Favored 'General case' 0 N--CA 1.465 0.289 0 O-C-N 121.517 -0.739 . . . . 35.130000000000003 112.866 -179.408 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 8.5 t -69.63 -19.76 63.62 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 118.09 -0.957 . . . . 64.510000000000005 111.682 -175.678 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 4.9 ptp . . . . . 0 N--CA 1.471 0.617 0 CA-C-N 121.116 1.78 . . . . 74.219999999999999 112.364 170.794 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.478 0 CA-C-O 118.65 -0.691 . . . . 60.130000000000003 111.663 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 57.3 t -60.05 -65.08 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 CA-C-N 119.997 1.271 . . . . 65.340000000000003 108.258 164.182 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -51.4 -49.36 61.72 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 125.114 1.366 . . . . 74.099999999999994 112.086 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.418 ' OE1' ' HE3' ' A' ' 100' ' ' LYS . 3.5 mm-40 -62.04 -13.8 29.64 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 126.825 2.05 . . . . 71.549999999999997 112.442 -178.272 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.451 ' HB1' ' CZ ' ' A' ' 114' ' ' PHE . . . -108.0 1.51 22.55 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 125.638 1.575 . . . . 74.329999999999998 111.024 178.871 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 28.3 mt -110.74 -58.1 3.78 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.286 0 N-CA-C 107.741 -1.207 . . . . 72.109999999999999 107.741 172.173 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 80.3 m-70 -66.37 -60.7 2.51 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 119.051 0.841 . . . . 73.239999999999995 111.09 -177.641 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.418 ' HE3' ' OE1' ' A' ' 96' ' ' GLU . 0.6 OUTLIER -68.17 -30.0 69.01 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 118.999 0.818 . . . . 75.540000000000006 110.646 -174.06 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -98.38 -36.89 9.83 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 123.84 0.856 . . . . 70.239999999999995 111.715 -168.548 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 5.0 t-160 44.26 57.31 4.37 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 128.713 2.805 . . . . 72.219999999999999 112.778 178.004 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -64.88 -173.37 0.11 Allowed 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.897 1.679 . . . . 71.140000000000001 111.756 170.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 18.8 ttmm -109.49 54.3 0.66 Allowed 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 126.447 1.899 . . . . 72.319999999999993 110.415 175.09 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 24.8 mt -75.39 58.32 0.98 Allowed 'General case' 0 C--N 1.322 -0.587 0 C-N-CA 127.479 2.311 . . . . 72.230000000000004 108.452 179.323 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -114.6 -2.36 13.12 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 127.832 2.453 . . . . 74.150000000000006 111.346 -171.307 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 45.1 p -135.4 151.28 74.5 Favored Pre-proline 0 C--O 1.232 0.14 0 C-N-CA 124.729 1.212 . . . . 51.229999999999997 108.715 179.629 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -66.59 -23.83 49.17 Favored 'Trans proline' 0 N--CA 1.459 -0.5 0 C-N-CA 121.888 1.725 . . . . 71.409999999999997 111.955 179.01 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -58.27 -60.32 3.94 Favored 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 124.71 1.204 . . . . 75.109999999999999 110.479 167.034 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 19.5 tp10 -66.49 -40.07 89.09 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 120.978 -0.289 . . . . 53.450000000000003 110.842 -174.06 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 3.6 mtt -67.01 -47.06 72.62 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 120.722 -0.391 . . . . 74.450000000000003 111.447 -175.007 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -63.28 -48.35 78.49 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 118.94 -0.552 . . . . 54.219999999999999 110.59 -177.558 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -70.96 -5.42 30.83 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 118.847 0.748 . . . . 53.119999999999997 112.928 -178.919 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' PHE . . . . . 0.451 ' CZ ' ' HB1' ' A' ' 97' ' ' ALA . 87.0 t80 -100.18 -35.22 9.73 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 124.626 1.17 . . . . 63.049999999999997 112.38 176.528 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.464 HD22 HD21 ' A' ' 81' ' ' LEU . 76.9 mt -83.22 -17.75 41.66 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 123.134 0.574 . . . . 72.329999999999998 111.166 175.502 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -52.17 -30.31 26.33 Favored 'General case' 0 CA--C 1.528 0.115 0 C-N-CA 125.765 1.626 . . . . 73.299999999999997 112.657 -175.375 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -93.28 -2.0 66.3 Favored Glycine 0 N--CA 1.441 -1.01 0 CA-C-O 118.473 -1.182 . . . . 73.049999999999997 112.312 -175.915 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.12 39.46 3.11 Favored 'General case' 0 C--N 1.342 0.242 0 CA-C-N 119.134 1.467 . . . . 72.209999999999994 111.273 -163.569 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 90.45 11.57 62.32 Favored Glycine 0 CA--C 1.527 0.785 0 CA-C-O 118.541 -1.144 . . . . 51.420000000000002 113.849 169.319 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 30.7 t -113.36 128.92 69.94 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 C-N-CA 125.643 1.577 . . . . 73.030000000000001 107.237 175.645 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -99.16 141.13 32.32 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 122.884 0.474 . . . . 54.240000000000002 111.811 173.57 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 5.1 mtmt -66.15 -33.82 76.64 Favored 'General case' 0 CA--C 1.537 0.449 0 O-C-N 121.501 -0.749 . . . . 74.239999999999995 111.423 178.843 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -64.9 -33.61 76.43 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 125.116 1.367 . . . . 75.049999999999997 111.323 178.698 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 7.2 mmtp -79.55 -50.77 10.22 Favored 'General case' 0 C--O 1.23 0.066 0 N-CA-C 107.888 -1.153 . . . . 61.030000000000001 107.888 172.929 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 52.0 t80 -53.39 -67.47 0.25 Allowed 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.831 1.252 . . . . 72.519999999999996 113.332 -165.607 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 25.4 mt -62.79 -38.84 92.25 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 122.738 0.415 . . . . 65.109999999999999 111.228 -165.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 22.5 t -57.43 -46.5 83.48 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 124.16 0.984 . . . . 72.349999999999994 111.295 -176.31 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' THR . . . . . 0.75 HG23 HG22 ' A' ' 80' ' ' THR . 9.9 t -80.73 -33.66 35.02 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 110.355 -0.239 . . . . 73.239999999999995 110.355 178.732 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 76.8 t80 -55.62 -38.28 69.29 Favored 'General case' 0 C--O 1.237 0.396 0 O-C-N 121.266 -0.896 . . . . 70.209999999999994 111.138 176.091 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -91.99 16.83 10.31 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.428 1.491 . . . . 75.040000000000006 112.082 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 2.2 p -106.48 171.89 7.11 Favored 'General case' 0 C--O 1.24 0.589 0 CA-C-N 119.804 1.183 . . . . 71.239999999999995 111.895 -175.092 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -67.2 -17.78 64.97 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 123.883 0.873 . . . . 74.0 112.081 172.34 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -57.9 -56.31 23.62 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 119.106 0.866 . . . . 74.209999999999994 109.29 178.349 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 13.7 mm -59.39 -41.33 84.07 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.134 0 CA-C-O 119.169 -0.443 . . . . 63.25 110.583 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 13.0 mttt -57.31 -35.14 69.46 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 119.31 0.959 . . . . 71.219999999999999 111.637 175.308 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -81.61 -22.38 60.21 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 125.071 1.32 . . . . 64.349999999999994 113.009 -178.183 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -82.39 -39.6 22.46 Favored 'General case' 0 CA--C 1.535 0.399 0 O-C-N 121.382 -1.069 . . . . 74.120000000000005 110.097 173.348 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' MET . . . . . 0.442 ' HE3' HD13 ' A' ' 66' ' ' LEU . 92.8 mmm -61.26 -41.19 96.5 Favored 'General case' 0 C--O 1.231 0.099 0 C-N-CA 124.105 0.962 . . . . 62.299999999999997 111.169 -179.767 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -57.13 -43.13 82.12 Favored 'General case' 0 CA--C 1.535 0.4 0 O-C-N 121.032 -1.043 . . . . 52.130000000000003 111.375 178.199 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 13.3 mtmt -60.29 -66.06 0.58 Allowed 'General case' 0 C--N 1.342 0.272 0 CA-C-N 118.549 0.613 . . . . 75.040000000000006 110.518 176.216 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -59.94 -26.97 66.39 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 119.027 0.83 . . . . 75.299999999999997 111.64 -170.421 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.55 -56.11 8.26 Favored 'General case' 0 C--N 1.34 0.158 0 O-C-N 121.368 -0.832 . . . . 74.299999999999997 110.509 176.411 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.55 -32.7 73.66 Favored 'General case' 0 C--N 1.342 0.26 0 CA-C-N 119.172 0.896 . . . . 64.099999999999994 110.365 -177.839 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 42.1 mt -59.67 -54.97 40.17 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 118.007 -0.997 . . . . 73.420000000000002 110.288 179.263 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -54.66 -37.44 65.72 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 119.616 1.098 . . . . 74.209999999999994 112.166 -178.636 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -73.25 -42.7 62.23 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 122.903 0.481 . . . . 53.140000000000001 110.777 -179.808 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -59.83 -44.95 93.8 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 123.605 0.762 . . . . 31.140000000000001 109.099 175.624 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 15.9 m-85 -63.0 -7.35 5.12 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.242 1.417 . . . . 73.409999999999997 113.337 177.151 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 61.7 mt-30 56.21 47.56 19.13 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 127.208 2.203 . . . . 75.230000000000004 111.01 -174.07 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 95.3 t -82.72 141.54 14.82 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 O-C-N 120.665 -1.272 . . . . 34.25 108.196 178.216 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 11.7 p -104.93 -19.75 13.76 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 124.178 0.991 . . . . 73.420000000000002 113.092 -174.529 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 179.12 -148.08 8.04 Favored Glycine 0 N--CA 1.452 -0.275 0 N-CA-C 108.81 -1.716 . . . . 61.329999999999998 108.81 -170.537 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.449 HG21 ' HB3' ' A' ' 34' ' ' TRP . 22.3 m -147.09 153.93 45.81 Favored Pre-proline 0 C--O 1.243 0.738 0 C-N-CA 127.115 2.166 . . . . 74.230000000000004 106.717 167.46 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 154' ' ' PRO . . . . . 0.483 ' HG3' HD12 ' A' ' 166' ' ' ILE . 98.2 Cg_endo -66.9 158.24 81.64 Favored 'Cis proline' 0 N--CA 1.458 -0.587 0 C-N-CA 124.132 -1.195 . . . . 64.329999999999998 112.154 -3.633 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 97.8 m -156.82 146.46 20.69 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 106.391 -1.707 . . . . 55.109999999999999 106.391 172.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 28.7 mmm -114.78 165.48 12.78 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 106.689 -1.596 . . . . 60.329999999999998 106.689 161.096 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 78.0 t -137.41 143.9 33.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 106.383 -1.71 . . . . 75.409999999999997 106.383 160.852 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.5 HG23 ' CE1' ' A' ' 164' ' ' PHE . 20.0 t -105.21 134.48 46.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 N-CA-C 105.915 -1.883 . . . . 64.540000000000006 105.915 162.936 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 4.0 t30 50.77 17.02 0.36 Allowed 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 130.197 3.399 . . . . 72.109999999999999 116.359 166.024 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 70.23 25.23 75.92 Favored Glycine 0 CA--C 1.527 0.836 0 CA-C-O 117.231 -1.872 . . . . 73.5 113.659 -171.875 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 21.6 mtpt -128.72 -37.05 1.79 Allowed 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 119.878 1.839 . . . . 73.510000000000005 114.032 179.202 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 162' ' ' TYR . . . . . 0.424 ' CE1' ' HG3' ' A' ' 14' ' ' GLU . 76.6 m-85 -121.4 108.79 14.1 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 119.708 1.14 . . . . 72.420000000000002 111.557 -168.126 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 18.9 ptt180 -90.56 32.79 0.94 Allowed 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 126.96 2.104 . . . . 74.239999999999995 115.532 -171.318 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 164' ' ' PHE . . . . . 0.5 ' CE1' HG23 ' A' ' 158' ' ' VAL . 4.0 p90 -52.06 155.51 1.86 Allowed 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 122.154 0.978 . . . . 63.229999999999997 110.085 -177.933 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -160.96 174.66 13.47 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 107.811 -1.181 . . . . 65.400000000000006 107.811 -175.35 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.483 HD12 ' HG3' ' A' ' 154' ' ' PRO . 3.5 mt -46.3 -52.67 3.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 C-N-CA 126.108 1.763 . . . . 71.129999999999995 108.163 161.354 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -78.28 19.72 4.46 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 126.828 2.156 . . . . 33.32 114.621 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 18.8 m -125.27 -48.89 1.7 Allowed 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 119.37 1.585 . . . . 74.510000000000005 109.12 154.393 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -63.2 -34.84 78.52 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-O 118.166 -0.921 . . . . 53.439999999999998 112.909 -170.276 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 117.75 5.5 13.87 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 123.586 0.612 . . . . 72.420000000000002 113.547 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 153.35 174.39 23.6 Favored Glycine 0 CA--C 1.527 0.805 0 CA-C-N 119.22 1.51 . . . . 45.210000000000001 110.543 177.03 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -64.05 -45.18 10.72 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 122.308 2.005 . . . . 63.25 110.826 -173.532 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -66.41 -39.46 89.02 Favored 'General case' 0 N--CA 1.453 -0.304 0 O-C-N 121.269 -0.895 . . . . 75.120000000000005 110.173 177.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -62.58 -27.45 69.2 Favored 'General case' 0 CA--C 1.537 0.466 0 O-C-N 122.306 -0.246 . . . . 71.209999999999994 110.932 175.775 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 24.9 m -61.84 -45.9 91.79 Favored 'General case' 0 CA--C 1.534 0.354 0 O-C-N 120.469 -1.394 . . . . 63.5 109.537 179.646 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 33.2 mt -65.51 -24.38 67.12 Favored 'General case' 0 N--CA 1.466 0.366 0 O-C-N 121.365 -0.834 . . . . 72.329999999999998 112.043 177.699 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.74 -46.18 74.24 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-O 118.796 -0.621 . . . . 71.420000000000002 109.427 169.89 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -76.51 -39.35 53.29 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-O 117.27 -1.348 . . . . 74.209999999999994 110.565 -178.662 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.451 ' HB1' ' CZ2' ' A' ' 50' ' ' TRP . . . -52.65 -49.88 64.32 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 120.015 1.28 . . . . 71.310000000000002 111.754 -172.088 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -66.1 -45.33 81.57 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 125.235 1.414 . . . . 44.240000000000002 110.786 -173.503 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -62.45 -46.88 86.51 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 126.003 1.721 . . . . 74.319999999999993 111.448 176.264 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 83.0 mt -64.32 -38.83 92.44 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 118.487 -0.768 . . . . 74.129999999999995 110.118 -176.298 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 39.5 mt -55.6 -51.5 57.66 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 CA-C-N 119.369 0.986 . . . . 74.299999999999997 108.655 172.333 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 184' ' ' GLU . . . . . 0.406 ' HA ' ' HD3' ' A' ' 187' ' ' ARG . 6.2 tm-20 -67.97 7.4 0.54 Allowed 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 127.378 2.271 . . . . 75.430000000000007 114.414 174.613 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 185' ' ' LYS . . . . . 0.444 ' HE3' ' HA ' ' A' ' 185' ' ' LYS . 0.5 OUTLIER -110.73 -45.29 3.51 Favored 'General case' 0 N--CA 1.454 -0.252 0 O-C-N 120.841 -1.162 . . . . 71.450000000000003 108.823 165.74 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 186' ' ' GLU . . . . . 0.446 ' HB3' HD12 ' A' ' 27' ' ' ILE . 26.9 mm-40 -54.66 -38.49 67.0 Favored 'General case' 0 CA--C 1.512 -0.495 0 C-N-CA 126.326 1.85 . . . . 61.240000000000002 115.403 -173.835 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 187' ' ' ARG . . . . . 0.406 ' HD3' ' HA ' ' A' ' 184' ' ' GLU . 0.0 OUTLIER -55.73 -23.41 29.01 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 118.624 -1.23 . . . . 72.109999999999999 114.14 -176.586 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.238 0.463 0 C-N-CA 126.484 1.914 . . . . 74.510000000000005 113.084 175.126 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ASP . . . . . 0.412 ' C ' ' H ' ' A' ' 6' ' ' TYR . 1.3 m-20 . . . . . 0 CA--C 1.53 0.189 0 N-CA-C 110.159 -0.312 . . . . 70.409999999999997 110.159 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -75.04 25.18 0.09 Allowed 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.517 1.127 . . . . 74.010000000000005 113.161 -172.386 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.412 ' H ' ' C ' ' A' ' 4' ' ' ASP . 33.1 m-85 -140.53 170.3 16.05 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 128.19 2.596 . . . . 75.340000000000003 108.838 -176.418 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 95.0 m -141.69 137.48 31.76 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 124.932 1.293 . . . . 61.340000000000003 108.269 176.541 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.66 130.62 43.93 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 108.729 -0.841 . . . . 73.329999999999998 108.729 172.69 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 80.07 15.92 77.83 Favored Glycine 0 CA--C 1.525 0.681 0 CA-C-O 119.33 -0.705 . . . . 63.100000000000001 112.966 -174.3 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.1 tpmt? -133.25 -55.99 0.91 Allowed 'General case' 0 CA--C 1.519 -0.242 0 CA-C-N 118.384 1.092 . . . . 65.340000000000003 109.345 -177.146 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.436 ' HB3' HD21 ' A' ' 178' ' ' LEU . 8.1 mp0 -105.42 -21.2 13.27 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 124.388 1.075 . . . . 74.519999999999996 110.642 179.362 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 42.6 p90 -159.44 168.16 26.95 Favored 'General case' 0 C--O 1.234 0.253 0 O-C-N 121.119 -0.988 . . . . 64.120000000000005 110.641 -171.781 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 84.0 t -126.13 111.47 26.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 C-N-CA 124.894 1.277 . . . . 63.0 108.504 178.054 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -78.08 165.61 23.79 Favored 'General case' 0 C--O 1.239 0.5 0 O-C-N 120.871 -1.143 . . . . 64.549999999999997 109.246 169.812 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -133.87 111.41 10.46 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 126.011 1.725 . . . . 73.310000000000002 107.333 -175.728 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 76.3 p -65.24 0.24 1.48 Allowed 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 125.985 1.714 . . . . 45.43 113.26 179.08 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 38.6 m -128.92 73.74 81.4 Favored Pre-proline 0 N--CA 1.439 -1.001 0 N-CA-C 105.397 -2.075 . . . . 55.350000000000001 105.397 -176.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -72.93 177.86 7.18 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 124.211 3.274 . . . . 52.049999999999997 110.922 -170.209 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 6.1 t -140.61 116.67 7.67 Favored Pre-proline 0 CA--C 1.537 0.46 0 C-N-CA 123.321 0.648 . . . . 74.200000000000003 109.442 176.633 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -72.79 -176.36 2.3 Favored 'Trans proline' 0 CA--C 1.537 0.672 0 C-N-CA 123.858 3.038 . . . . 70.219999999999999 110.854 171.011 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.407 HG11 ' CD ' ' A' ' 28' ' ' GLU . 3.5 m -133.85 160.61 41.89 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 N-CA-C 106.016 -1.846 . . . . 44.420000000000002 106.016 176.723 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 3.4 m -47.75 -66.88 0.33 Allowed 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 125.392 1.477 . . . . 63.119999999999997 113.766 166.62 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 11.8 tp60 -128.71 81.25 71.12 Favored Pre-proline 0 N--CA 1.469 0.48 0 C-N-CA 123.9 0.88 . . . . 61.299999999999997 108.718 -169.003 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.507 ' C ' ' H ' ' A' ' 26' ' ' LYS . 36.2 Cg_endo -73.05 -57.51 0.07 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.095 0 CA-C-N 119.122 0.722 . . . . 71.349999999999994 110.314 179.236 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 51.35 -23.34 0.01 OUTLIER Glycine 0 CA--C 1.53 1.019 0 C-N-CA 127.831 2.634 . . . . 31.239999999999998 115.243 -159.566 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.507 ' H ' ' C ' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -140.05 -167.06 2.22 Favored 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 129.548 3.139 . . . . 74.450000000000003 105.483 -161.931 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.53 HD12 ' HB3' ' A' ' 186' ' ' GLU . 30.4 mm -87.75 130.65 37.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 N-CA-C 106.207 -1.775 . . . . 74.209999999999994 106.207 168.515 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.407 ' CD ' HG11 ' A' ' 21' ' ' VAL . 5.0 tp10 -69.71 140.04 53.48 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 105.608 -1.997 . . . . 65.329999999999998 105.608 173.131 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 54.8 t -128.2 134.32 65.21 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 N-CA-C 105.769 -1.937 . . . . 55.420000000000002 105.769 160.463 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 30.1 t -123.14 112.71 34.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 105.95 -1.87 . . . . 74.209999999999994 105.95 172.608 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 62.6 tt0 -72.26 122.01 20.36 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 106.347 -1.723 . . . . 74.540000000000006 106.347 156.716 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.489 HD22 HG21 ' A' ' 150' ' ' VAL . 4.5 mp -109.65 137.91 46.78 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-N 119.212 0.914 . . . . 55.219999999999999 108.919 166.119 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 9.5 p90 -145.66 171.26 14.98 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 122.986 0.514 . . . . 75.239999999999995 110.487 -168.533 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' TRP . . . . . 0.421 ' HB3' HG21 ' A' ' 153' ' ' VAL . 42.2 t90 -156.7 151.57 25.97 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.38 1.472 . . . . 75.329999999999998 109.9 171.942 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 19.4 t80 -45.58 -48.49 14.5 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 127.789 2.436 . . . . 71.209999999999994 114.408 -174.78 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -75.14 -88.59 0.23 Allowed Glycine 0 C--N 1.341 0.806 0 N-CA-C 109.75 -1.34 . . . . 72.400000000000006 109.75 -169.382 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 12.7 t 42.76 72.49 1.13 Allowed Pre-proline 0 CA--C 1.538 0.483 0 C-N-CA 126.44 1.896 . . . . 74.340000000000003 112.955 160.237 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -59.16 -38.83 84.13 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 121.191 1.261 . . . . 52.210000000000001 112.199 -178.948 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 17.8 m170 -65.79 -30.38 71.02 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 119.142 0.883 . . . . 73.329999999999998 111.031 -179.125 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 82.1 m -62.67 -38.11 89.06 Favored 'General case' 0 C--N 1.343 0.32 0 CA-C-N 118.407 0.549 . . . . 64.129999999999995 110.158 177.853 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 38.6 t80 -62.0 -44.28 97.06 Favored 'General case' 0 C--N 1.339 0.139 0 O-C-N 121.614 -0.679 . . . . 62.409999999999997 110.828 -175.904 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -56.52 -34.45 67.02 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 118.285 0.493 . . . . 53.32 111.333 178.619 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.46 ' HB2' HD11 ' A' ' 166' ' ' ILE . 6.0 t80 -82.52 -16.0 50.28 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.837 1.655 . . . . 75.319999999999993 113.445 -178.462 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -43.26 -63.48 0.99 Allowed Pre-proline 0 CA--C 1.539 0.554 0 CA-C-N 120.042 1.292 . . . . 75.329999999999998 112.422 -173.218 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -85.79 -7.36 8.46 Favored 'Trans proline' 0 N--CA 1.452 -0.921 0 C-N-CA 121.645 1.563 . . . . 64.530000000000001 114.687 -174.828 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 26.0 m -66.01 -46.84 76.49 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 107.355 -1.35 . . . . 75.040000000000006 107.355 166.204 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 20.5 tt -84.2 -35.31 10.72 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 N-CA-C 113.528 0.936 . . . . 64.299999999999997 113.528 -166.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 42.9 t -48.16 -61.18 3.34 Favored Pre-proline 0 CA--C 1.545 0.779 0 O-C-N 121.237 -0.914 . . . . 73.430000000000007 111.803 178.938 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -72.5 -6.59 19.33 Favored 'Trans proline' 0 N--CA 1.454 -0.794 0 C-N-CA 122.007 1.805 . . . . 64.420000000000002 113.708 -177.421 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.43 ' CZ2' ' HB1' ' A' ' 179' ' ' ALA . 79.8 t90 -72.25 -62.48 1.42 Allowed 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 120.085 1.312 . . . . 73.329999999999998 107.691 161.185 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 22.4 p -53.79 -33.3 55.55 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 115.035 1.494 . . . . 64.219999999999999 115.035 -169.509 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 58.4 mt-10 -80.45 -24.84 39.29 Favored 'General case' 0 CA--C 1.54 0.572 0 O-C-N 120.663 -1.273 . . . . 70.030000000000001 112.007 -179.678 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 11.1 mptt -96.2 9.26 41.57 Favored 'General case' 0 C--O 1.225 -0.196 0 C-N-CA 124.97 1.308 . . . . 62.350000000000001 112.009 -168.555 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 35.2 mt -62.15 160.14 33.26 Favored Pre-proline 0 C--O 1.242 0.661 0 C-N-CA 129.327 3.051 . . . . 73.109999999999999 113.41 -177.672 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -80.09 170.18 16.75 Favored 'Trans proline' 0 N--CA 1.448 -1.164 0 C-N-CA 124.752 3.634 . . . . 72.129999999999995 110.273 176.759 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -70.1 -5.06 24.24 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 124.112 0.965 . . . . 72.209999999999994 112.919 -179.453 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -104.38 9.61 35.69 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.428 1.091 . . . . 72.340000000000003 111.988 -171.684 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.448 HG21 HD13 ' A' ' 183' ' ' ILE . 93.1 t -120.46 149.52 23.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 N-CA-C 108.166 -1.05 . . . . 73.150000000000006 108.166 -177.772 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 21.9 t-160 -124.88 84.75 2.32 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 128.092 2.557 . . . . 72.420000000000002 105.931 -179.127 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 45.5 t80 -68.26 129.43 39.9 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 108.794 -0.817 . . . . 75.420000000000002 108.794 174.045 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 40.7 t -136.21 155.13 34.41 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.651 0 C-N-CA 126.461 1.904 . . . . 42.119999999999997 106.351 175.634 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 34.6 mtp180 -133.28 123.35 25.34 Favored 'General case' 0 CA--C 1.515 -0.375 0 N-CA-C 105.371 -2.085 . . . . 74.299999999999997 105.371 -176.445 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 78.0 mt -134.62 144.58 51.4 Favored Pre-proline 0 CA--C 1.533 0.307 0 CA-C-N 119.461 1.028 . . . . 71.400000000000006 110.716 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -77.1 129.32 10.42 Favored 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 122.589 2.192 . . . . 53.299999999999997 111.36 177.178 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -69.69 114.53 7.98 Favored 'General case' 0 CA--C 1.537 0.465 0 O-C-N 121.519 -0.738 . . . . 73.0 110.245 174.654 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.49 HD22 ' HA ' ' A' ' 72' ' ' ASN . 14.6 mt -106.62 103.15 12.52 Favored 'General case' 0 N--CA 1.466 0.351 0 O-C-N 121.059 -1.026 . . . . 62.210000000000001 110.247 -178.903 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -133.03 13.35 4.29 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 114.901 1.445 . . . . 73.519999999999996 114.901 -174.375 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -169.47 -116.9 0.39 Allowed Glycine 0 C--N 1.333 0.385 0 CA-C-N 119.603 1.092 . . . . 74.150000000000006 112.382 176.908 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -114.52 -73.6 0.58 Allowed Glycine 0 C--N 1.334 0.438 0 C-N-CA 126.225 1.869 . . . . 42.210000000000001 108.448 171.048 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 6.4 tp -58.84 -24.77 27.22 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-N 118.248 1.024 . . . . 64.040000000000006 112.164 -174.765 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 10.5 m95 -59.47 -48.8 80.26 Favored 'General case' 0 N--CA 1.455 -0.201 0 O-C-N 121.444 -0.785 . . . . 71.420000000000002 111.547 172.869 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.49 ' HA ' HD22 ' A' ' 66' ' ' LEU . 1.7 p-10 -77.94 -30.64 50.57 Favored 'General case' 0 CA--C 1.509 -0.601 0 CA-C-O 117.663 -1.161 . . . . 74.049999999999997 113.599 177.413 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 74.5 t -57.15 -58.22 6.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 108.824 -0.806 . . . . 73.510000000000005 108.824 172.652 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 37.4 m170 -65.58 -24.18 67.02 Favored 'General case' 0 CA--C 1.528 0.109 0 N-CA-C 112.416 0.525 . . . . 75.219999999999999 112.416 178.782 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -78.96 -18.99 73.77 Favored Glycine 0 N--CA 1.444 -0.804 0 CA-C-O 118.966 -0.908 . . . . 42.409999999999997 111.302 178.473 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.491 HE22 HD12 ' A' ' 134' ' ' ILE . 0.0 OUTLIER -66.71 -55.77 13.6 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 118.275 1.037 . . . . 73.400000000000006 109.606 -160.427 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 3.7 ptm -55.21 -28.78 55.54 Favored 'General case' 0 N--CA 1.454 -0.273 0 O-C-N 124.129 0.893 . . . . 75.430000000000007 113.294 -166.91 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 29.7 t80 -55.22 -52.06 64.59 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 124.007 0.923 . . . . 74.219999999999999 109.981 176.354 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 37.9 mt -66.54 -43.1 86.03 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 117.979 -1.01 . . . . 75.049999999999997 109.821 179.429 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.74 HG22 HG23 ' A' ' 128' ' ' THR . 0.2 OUTLIER -59.6 -41.67 90.86 Favored 'General case' 0 C--N 1.344 0.354 0 CA-C-N 120.3 1.409 . . . . 55.240000000000002 110.906 -179.31 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.4 -55.45 33.38 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 123.882 0.873 . . . . 62.399999999999999 109.077 -178.484 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -74.74 -14.53 60.73 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 112.505 0.558 . . . . 73.25 112.505 -177.589 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 3.2 t -70.44 -10.22 58.53 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.821 1.249 . . . . 72.319999999999993 112.222 171.384 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 43.4 mtm . . . . . 0 CA--C 1.535 0.386 0 C-N-CA 124.423 1.089 . . . . 75.329999999999998 112.887 168.165 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.445 0 CA-C-O 118.872 -0.585 . . . . 60.119999999999997 112.003 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.9 t -62.26 -76.8 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 N-CA-C 108.515 -0.92 . . . . 71.420000000000002 108.515 164.76 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -51.26 -46.92 62.54 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 126.018 1.727 . . . . 70.340000000000003 112.103 -176.785 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 22.2 mm-40 -60.9 -44.17 97.52 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.514 1.526 . . . . 71.200000000000003 109.242 -175.38 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -74.91 -3.49 32.39 Favored 'General case' 0 CA--C 1.531 0.245 0 O-C-N 120.62 -1.3 . . . . 73.219999999999999 113.158 -179.28 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 72.8 mt -104.18 -54.78 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 N-CA-C 106.554 -1.647 . . . . 74.019999999999996 106.554 177.204 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 90.7 m-70 -80.54 -56.13 4.38 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 123.495 0.718 . . . . 73.219999999999999 112.014 -173.629 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 2.2 mmtp -71.87 -12.95 61.52 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 123.753 0.821 . . . . 74.209999999999994 112.05 -178.355 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -117.07 -31.32 5.4 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.963 0.905 . . . . 74.310000000000002 112.494 -174.621 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 5.2 t60 45.15 61.04 2.7 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 125.903 1.681 . . . . 64.120000000000005 111.209 -176.515 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 7.8 mtpp -76.94 159.45 29.97 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.727 -1.124 . . . . 73.510000000000005 108.454 170.082 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 46.5 tttt -85.82 38.35 0.75 Allowed 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 125.726 1.61 . . . . 61.109999999999999 111.735 -173.736 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 43.3 mt -72.61 51.07 0.26 Allowed 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 128.815 2.846 . . . . 73.420000000000002 112.053 -167.146 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -103.12 3.66 36.14 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 129.463 3.105 . . . . 72.239999999999995 112.21 -177.553 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -134.39 156.03 79.26 Favored Pre-proline 0 N--CA 1.467 0.413 0 CA-C-N 118.556 0.616 . . . . 71.010000000000005 110.66 171.073 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -70.89 -19.84 30.25 Favored 'Trans proline' 0 N--CA 1.449 -1.108 0 C-N-CA 121.658 1.572 . . . . 62.549999999999997 111.889 -177.343 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.7 -62.95 1.48 Allowed 'General case' 0 C--O 1.224 -0.255 0 CA-C-N 119.859 1.209 . . . . 64.310000000000002 108.961 168.11 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -45.79 -56.55 5.2 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 127.229 2.211 . . . . 72.450000000000003 110.413 178.358 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 57.4 mtt -54.91 -50.45 68.77 Favored 'General case' 0 N--CA 1.458 -0.065 0 C-N-CA 123.7 0.8 . . . . 61.130000000000003 111.354 -178.719 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.632 ' HB1' ' HG3' ' A' ' 122' ' ' LYS . . . -77.1 -40.63 45.21 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-O 119.043 -0.504 . . . . 71.439999999999998 111.013 -170.124 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -56.43 -35.61 68.04 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 125.12 1.368 . . . . 73.099999999999994 110.525 174.714 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 82.8 t80 -71.81 -54.08 11.28 Favored 'General case' 0 N--CA 1.44 -0.952 0 C-N-CA 122.969 0.508 . . . . 73.530000000000001 110.2 176.839 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 73.5 mt -69.64 -18.31 63.58 Favored 'General case' 0 CA--C 1.52 -0.178 0 C-N-CA 123.454 0.702 . . . . 61.219999999999999 112.428 -173.136 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -57.17 -16.71 8.54 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.226 1.41 . . . . 41.210000000000001 112.32 -176.847 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -110.38 8.12 30.58 Favored Glycine 0 CA--C 1.526 0.74 0 C-N-CA 124.94 1.257 . . . . 53.25 113.588 177.073 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 30.9 mmtt -129.09 27.6 5.37 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 119.608 1.704 . . . . 73.25 111.398 -169.096 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 85.56 41.54 7.27 Favored Glycine 0 N--CA 1.447 -0.579 0 CA-C-O 119.199 -0.778 . . . . 75.120000000000005 111.245 178.582 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 95.0 t -135.83 141.91 40.59 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 106.968 -1.493 . . . . 42.009999999999998 106.968 173.345 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 66.2 t0 -97.12 123.62 40.92 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 108.231 -1.025 . . . . 54.329999999999998 108.231 167.618 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.632 ' HG3' ' HB1' ' A' ' 112' ' ' ALA . 0.2 OUTLIER -57.88 -38.97 76.73 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.789 0.835 . . . . 73.329999999999998 109.245 177.071 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -61.87 -41.46 97.88 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 123.638 0.775 . . . . 74.420000000000002 111.225 -177.671 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 21.1 mmtt -79.59 -47.28 15.75 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 108.074 -1.084 . . . . 71.319999999999993 108.074 -176.622 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 80.2 t80 -44.98 -59.3 2.64 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 126.322 1.849 . . . . 73.019999999999996 110.126 -177.301 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 32.4 mt -69.38 -36.32 76.69 Favored 'General case' 0 C--O 1.234 0.245 0 O-C-N 122.107 -0.371 . . . . 73.209999999999994 111.217 -176.399 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 23.2 t -56.05 -47.8 77.22 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 109.442 -0.577 . . . . 72.0 109.442 178.579 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' THR . . . . . 0.74 HG23 HG22 ' A' ' 80' ' ' THR 0.259 15.0 t -77.28 -31.62 54.94 Favored 'General case' 0 CA--C 1.543 0.712 0 C-N-CA 123.116 0.567 . . . . 75.439999999999998 111.543 -179.089 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 76.4 t80 -56.19 -36.49 68.45 Favored 'General case' 0 N--CA 1.471 0.621 0 O-C-N 120.357 -1.465 . . . . 74.400000000000006 111.893 172.561 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 48.0 m-20 -102.97 13.39 34.43 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.085 0.954 . . . . 73.120000000000005 111.216 176.742 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 40.0 t -88.81 163.65 15.58 Favored 'General case' 0 C--O 1.235 0.298 0 O-C-N 120.469 -1.395 . . . . 75.409999999999997 109.263 174.739 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -59.11 -24.96 63.41 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 114.92 -1.036 . . . . 64.409999999999997 110.85 170.328 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -48.91 -63.48 1.08 Allowed 'General case' 0 C--O 1.236 0.387 0 C-N-CA 124.568 1.147 . . . . 72.329999999999998 110.955 176.089 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.51 HD11 ' HA ' ' A' ' 80' ' ' THR . 7.1 mm -58.36 -32.58 45.49 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 N-CA-C 113.532 0.938 . . . . 72.530000000000001 113.532 176.189 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 2.7 tttp -57.7 -35.05 70.1 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 118.844 0.747 . . . . 65.329999999999998 110.151 -178.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -80.13 -37.24 22.3 Favored Glycine 0 C--N 1.34 0.798 0 C-N-CA 124.864 1.221 . . . . 63.520000000000003 111.969 -178.488 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 2.4 mm100 -70.74 -39.8 73.1 Favored 'General case' 0 C--N 1.331 -0.238 0 O-C-N 121.582 -0.952 . . . . 72.030000000000001 109.312 -178.718 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -62.23 -50.09 73.15 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 123.668 0.787 . . . . 75.120000000000005 110.191 176.475 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -63.42 -43.23 98.08 Favored 'General case' 0 CA--C 1.521 -0.151 0 CA-C-O 117.744 -1.122 . . . . 73.510000000000005 111.095 -177.497 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 44.7 mtmt -59.29 -59.67 5.09 Favored 'General case' 0 C--N 1.343 0.31 0 CA-C-O 117.991 -1.004 . . . . 54.420000000000002 108.748 177.548 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -54.35 -35.73 63.07 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 119.852 1.206 . . . . 60.119999999999997 112.012 -179.361 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 35.8 tttt -65.97 -66.44 0.55 Allowed 'General case' 0 C--N 1.342 0.278 0 N-CA-C 108.467 -0.938 . . . . 65.319999999999993 108.467 177.445 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 17.7 ptmt -60.02 -28.14 67.48 Favored 'General case' 0 C--O 1.227 -0.106 0 C-N-CA 123.476 0.71 . . . . 73.25 111.187 -171.749 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 36.2 mt -68.75 -58.58 4.01 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 124.816 1.246 . . . . 65.040000000000006 111.976 173.201 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -55.6 -50.6 69.69 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 118.957 0.799 . . . . 72.310000000000002 110.244 -169.874 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -58.87 -42.74 90.18 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 113.007 0.743 . . . . 62.340000000000003 113.007 174.882 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -65.84 -26.37 67.63 Favored 'General case' 0 N--CA 1.462 0.155 0 C-N-CA 123.33 0.652 . . . . 75.450000000000003 111.622 -178.955 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 36.2 m-85 -84.17 20.13 1.67 Allowed 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.3 1.44 . . . . 70.109999999999999 112.125 172.628 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 11.5 mm100 64.35 6.44 3.05 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 127.399 2.279 . . . . 74.140000000000001 115.536 173.706 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.489 HG21 HD22 ' A' ' 32' ' ' LEU . 42.9 t -51.7 -57.27 3.63 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.985 0 C-N-CA 127.639 2.376 . . . . 62.210000000000001 113.858 -164.756 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . 0.281 73.5 p 54.97 -40.05 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 128.912 2.885 . . . . 63.119999999999997 117.365 -165.341 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -150.45 -177.87 24.79 Favored Glycine 0 CA--C 1.521 0.422 0 C-N-CA 125.951 1.739 . . . . 64.140000000000001 110.285 -171.848 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.442 ' HA ' ' C ' ' A' ' 154' ' ' PRO . 17.3 m -133.26 157.33 78.47 Favored Pre-proline 0 C--O 1.239 0.545 0 N-CA-C 108.801 -0.815 . . . . 74.530000000000001 108.801 -178.186 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 154' ' ' PRO . . . . . 0.524 ' HG3' HD12 ' A' ' 166' ' ' ILE . 37.4 Cg_endo -66.74 154.07 83.43 Favored 'Cis proline' 0 N--CA 1.46 -0.489 0 C-N-CA 124.478 -1.051 . . . . 71.420000000000002 112.494 -4.265 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 155' ' ' THR . . . . . 0.444 HG21 HG22 ' A' ' 150' ' ' VAL . 35.3 m -155.06 110.61 3.1 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 105.194 -2.15 . . . . 73.439999999999998 105.194 172.874 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 95.9 mtp -89.5 152.12 21.61 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 107.5 -1.296 . . . . 62.210000000000001 107.5 164.247 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 15.0 t -138.97 139.41 40.48 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.288 0 N-CA-C 108.113 -1.069 . . . . 71.310000000000002 108.113 175.248 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 11.4 t -112.34 124.09 68.7 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 C-N-CA 126.395 1.878 . . . . 75.209999999999994 106.516 176.664 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 1.4 t30 51.0 17.13 0.4 Allowed 'General case' 0 C--O 1.223 -0.308 0 C-N-CA 128.836 2.854 . . . . 72.209999999999994 114.813 170.406 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 58.71 38.99 92.97 Favored Glycine 0 CA--C 1.525 0.66 0 C-N-CA 125.69 1.614 . . . . 35.210000000000001 112.829 -168.539 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 37.6 mttt -132.95 -38.27 0.98 Allowed 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 124.51 1.124 . . . . 74.219999999999999 112.29 178.818 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -116.6 118.24 32.07 Favored 'General case' 0 CA--C 1.517 -0.311 0 N-CA-C 108.284 -1.006 . . . . 71.340000000000003 108.284 -178.597 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 37.3 ttp85 -105.43 123.33 47.7 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 126.536 1.934 . . . . 75.420000000000002 106.972 174.259 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 13.5 p90 -150.23 170.97 17.72 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 107.529 -1.286 . . . . 65.439999999999998 107.529 -176.782 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -178.84 178.77 0.75 Allowed 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.166 -0.679 . . . . 75.299999999999997 109.166 -173.197 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.524 HD12 ' HG3' ' A' ' 154' ' ' PRO . 23.7 mt -47.96 -55.95 2.28 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 C-N-CA 127.733 2.413 . . . . 72.019999999999996 109.044 174.01 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -75.67 8.01 23.15 Favored Glycine 0 CA--C 1.526 0.727 0 C-N-CA 127.028 2.251 . . . . 51.340000000000003 114.794 178.688 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 4.7 m -110.72 -52.25 2.8 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-N 119.507 1.653 . . . . 72.219999999999999 109.886 168.038 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -65.39 -53.11 47.97 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 125.652 1.581 . . . . 62.43 111.598 -178.371 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 142.59 -7.16 2.21 Favored Glycine 0 CA--C 1.528 0.846 0 CA-C-O 119.056 -0.858 . . . . 64.049999999999997 114.41 -174.298 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 155.7 175.72 27.04 Favored Glycine 0 CA--C 1.53 0.983 0 CA-C-N 119.514 1.657 . . . . 44.43 110.149 -175.705 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -61.21 -53.67 2.31 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 122.918 2.412 . . . . 65.219999999999999 111.247 -175.617 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 8.2 mp0 -62.85 -32.89 74.2 Favored 'General case' 0 CA--C 1.536 0.411 0 O-C-N 121.434 -0.791 . . . . 44.32 110.924 179.134 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -66.17 -30.76 71.3 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.218 0.607 . . . . 70.219999999999999 110.131 178.107 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 37.7 m -65.59 -46.21 80.24 Favored 'General case' 0 N--CA 1.455 -0.221 0 O-C-N 121.364 -0.835 . . . . 72.209999999999994 110.453 -173.832 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 64.0 mt -62.89 -28.08 69.8 Favored 'General case' 0 C--O 1.223 -0.306 0 CA-C-N 118.559 0.618 . . . . 73.120000000000005 111.447 -177.027 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 2.6 tttt -53.58 -49.41 67.8 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 124.819 1.248 . . . . 72.010000000000005 109.338 172.45 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.436 HD21 ' HB3' ' A' ' 11' ' ' GLU . 4.1 mm? -67.12 -44.51 79.72 Favored 'General case' 0 CA--C 1.515 -0.392 0 N-CA-C 109.329 -0.619 . . . . 55.399999999999999 109.329 175.655 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.43 ' HB1' ' CZ2' ' A' ' 50' ' ' TRP . . . -56.78 -31.73 64.94 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 118.34 -0.838 . . . . 34.119999999999997 112.71 -174.247 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -84.16 -52.0 6.61 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 126.357 1.863 . . . . 73.340000000000003 108.666 -176.808 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 16.6 t80 -60.84 -45.61 93.8 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 123.896 0.878 . . . . 72.120000000000005 110.998 -175.938 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 93.1 mt -61.22 -28.66 69.32 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.06 0.944 . . . . 73.140000000000001 112.527 -178.59 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.448 HD13 HG21 ' A' ' 58' ' ' VAL . 44.0 mt -60.3 -52.78 57.36 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 CA-C-N 119.931 1.241 . . . . 61.200000000000003 108.357 173.743 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -66.71 -5.72 12.98 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 126.802 2.041 . . . . 74.040000000000006 112.901 177.514 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -98.12 -23.74 15.6 Favored 'General case' 0 N--CA 1.463 0.21 0 O-C-N 120.868 -1.145 . . . . 74.439999999999998 111.525 173.187 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 186' ' ' GLU . . . . . 0.53 ' HB3' HD12 ' A' ' 27' ' ' ILE . 30.5 mm-40 -96.54 -33.57 11.78 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 123.785 0.834 . . . . 64.340000000000003 112.734 -176.868 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 187' ' ' ARG . . . . . 0.411 ' HE ' HD11 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -51.12 -32.55 23.07 Favored 'General case' 0 N--CA 1.476 0.841 0 O-C-N 120.847 -1.158 . . . . 72.319999999999993 110.522 168.748 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.478 0 C-N-CA 126.713 2.005 . . . . 33.240000000000002 111.883 179.773 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 . . . . . 0 CA--C 1.532 0.28 0 CA-C-O 121.083 0.468 . . . . 75.530000000000001 110.857 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -153.23 15.88 0.54 Allowed 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 114.058 1.133 . . . . 71.549999999999997 114.058 -175.687 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 38.5 m-85 -135.49 160.2 39.2 Favored 'General case' 0 C--O 1.24 0.589 0 C-N-CA 125.1 1.36 . . . . 73.310000000000002 108.884 -173.299 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 88.6 m -125.89 134.78 51.49 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 109.217 -0.66 . . . . 72.540000000000006 109.217 178.062 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.03 144.36 57.33 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 121.837 0.827 . . . . 74.239999999999995 111.077 176.003 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 76.85 -19.61 3.28 Favored Glycine 0 CA--C 1.527 0.807 0 CA-C-O 118.674 -1.07 . . . . 60.32 112.366 -172.324 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 20.3 ttmt -97.43 -84.3 0.38 Allowed 'General case' 0 CA--C 1.511 -0.55 0 CA-C-N 119.116 1.458 . . . . 71.430000000000007 108.007 -177.101 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.443 ' HB3' HD21 ' A' ' 178' ' ' LEU . 5.0 mp0 -64.61 -26.31 68.34 Favored 'General case' 0 N--CA 1.442 -0.854 0 C-N-CA 124.748 1.219 . . . . 53.119999999999997 110.145 -175.19 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 12.7 p90 -163.91 171.8 14.85 Favored 'General case' 0 C--O 1.233 0.206 0 O-C-N 121.091 -1.006 . . . . 71.430000000000007 108.58 -172.809 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 24.4 t -132.34 110.83 16.8 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 C-N-CA 123.614 0.765 . . . . 54.240000000000002 110.035 -177.932 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -68.75 159.77 31.65 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 124.793 1.237 . . . . 70.420000000000002 109.112 166.514 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -134.08 116.36 15.37 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 124.214 1.005 . . . . 64.109999999999999 108.425 -174.454 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -61.6 -1.1 0.51 Allowed 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 125.805 1.642 . . . . 62.229999999999997 113.908 -177.539 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 48.9 m -133.82 85.57 40.94 Favored Pre-proline 0 CA--C 1.541 0.598 0 C-N-CA 127.583 2.353 . . . . 70.540000000000006 108.284 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -77.54 -178.73 4.81 Favored 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 124.647 3.564 . . . . 71.209999999999994 113.388 -178.372 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 25.9 t -136.55 148.21 62.88 Favored Pre-proline 0 CA--C 1.548 0.875 0 C-N-CA 126.525 1.93 . . . . 65.430000000000007 109.005 -178.115 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -82.19 -178.68 4.2 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 124.567 3.511 . . . . 72.439999999999998 112.572 173.493 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.9 m -131.36 172.18 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 124.975 1.31 . . . . 75.129999999999995 109.513 172.003 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 66.4 m -48.89 -56.15 9.62 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 125.614 1.565 . . . . 73.219999999999999 112.142 176.273 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -144.35 152.08 52.85 Favored Pre-proline 0 C--O 1.239 0.529 0 C-N-CA 125.363 1.465 . . . . 72.310000000000002 108.072 -172.604 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -69.45 178.33 4.49 Favored 'Trans proline' 0 N--CA 1.451 -0.982 0 C-N-CA 122.492 2.128 . . . . 74.540000000000006 109.251 165.63 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.26 -118.87 6.2 Favored Glycine 0 N--CA 1.45 -0.402 0 N-CA-C 106.951 -2.46 . . . . 72.049999999999997 106.951 -166.611 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -61.01 137.55 58.23 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 119.519 1.66 . . . . 71.109999999999999 110.916 -163.225 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 42.1 mm -62.72 138.88 22.02 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 N-CA-C 107.12 -1.437 . . . . 50.049999999999997 107.12 168.113 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.7 124.41 36.69 Favored 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 127.138 2.175 . . . . 73.120000000000005 106.851 -178.668 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.7 t -128.82 102.29 7.8 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.174 0 N-CA-C 106.438 -1.69 . . . . 72.230000000000004 106.438 176.173 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 52.3 t -97.33 114.25 33.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 107.278 -1.378 . . . . 60.119999999999997 107.278 -177.891 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 67.7 tt0 -72.28 134.27 45.47 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 107.6 -1.259 . . . . 51.539999999999999 107.6 152.49 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 5.0 mp -111.36 136.02 51.08 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 107.061 -1.459 . . . . 75.409999999999997 107.061 160.035 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 28.9 p90 -134.28 166.71 22.18 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.229 1.011 . . . . 73.120000000000005 110.642 -177.815 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' TRP . . . . . 0.438 ' HB3' HG21 ' A' ' 153' ' ' VAL . 26.6 t90 -150.36 158.95 44.72 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.724 1.21 . . . . 74.239999999999995 108.888 176.101 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 5.3 m-30 -83.59 51.29 1.97 Allowed 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.427 0.691 . . . . 75.230000000000004 111.302 178.171 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -174.91 18.84 0.05 OUTLIER Glycine 0 N--CA 1.463 0.446 0 O-C-N 120.287 -1.508 . . . . 72.040000000000006 114.273 -174.424 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.532 ' HB3' HG23 ' A' ' 153' ' ' VAL . 20.6 p -118.41 86.28 27.76 Favored Pre-proline 0 N--CA 1.449 -0.513 0 C-N-CA 124.907 1.283 . . . . 73.209999999999994 108.252 -172.756 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -63.15 -11.79 26.86 Favored 'Trans proline' 0 CA--C 1.541 0.874 0 C-N-CA 122.279 1.986 . . . . 74.120000000000005 114.03 -170.63 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 35.3 m170 -73.74 -22.73 59.78 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 119.209 0.913 . . . . 62.409999999999997 112.625 168.908 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 79.1 m -67.53 -65.85 0.64 Allowed 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.564 1.545 . . . . 74.430000000000007 110.67 -173.781 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 14.2 t80 -59.32 -29.23 67.47 Favored 'General case' 0 N--CA 1.467 0.419 0 O-C-N 121.415 -0.803 . . . . 73.209999999999994 112.036 -179.575 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.47 -26.22 68.62 Favored 'General case' 0 CA--C 1.542 0.652 0 O-C-N 121.452 -0.78 . . . . 75.530000000000001 112.615 176.04 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 20.8 t80 -93.97 -18.03 22.32 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 124.999 1.319 . . . . 65.420000000000002 112.426 -173.066 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -38.22 -63.04 0.59 Allowed Pre-proline 0 N--CA 1.472 0.631 0 C-N-CA 125.451 1.5 . . . . 74.549999999999997 112.767 175.079 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -77.23 -11.44 17.6 Favored 'Trans proline' 0 CA--C 1.534 0.524 0 CA-C-N 121.775 1.67 . . . . 72.150000000000006 114.533 -171.103 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.8 m -72.15 -44.97 62.27 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 107.786 -1.19 . . . . 73.219999999999999 107.786 166.727 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 14.3 tt -94.15 -28.65 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 N-CA-C 113.47 0.915 . . . . 74.430000000000007 113.47 -165.339 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 14.1 t -47.88 -60.94 3.5 Favored Pre-proline 0 CA--C 1.544 0.724 0 C-N-CA 124.87 1.268 . . . . 61.399999999999999 110.027 171.822 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_endo -72.28 -7.77 21.54 Favored 'Trans proline' 0 C--N 1.348 0.538 0 CA-C-N 121.555 1.591 . . . . 63.350000000000001 113.34 -175.247 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 82.6 t90 -77.57 -61.11 2.1 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 119.591 1.087 . . . . 73.120000000000005 108.297 165.84 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 47.9 t -60.23 -36.55 77.98 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.156 1.382 . . . . 72.310000000000002 112.593 -169.483 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -75.04 -10.76 59.77 Favored 'General case' 0 CA--C 1.54 0.566 0 O-C-N 120.78 -1.2 . . . . 65.519999999999996 111.922 -177.424 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -111.86 18.82 18.52 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 127.736 2.414 . . . . 73.019999999999996 113.228 -176.212 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 39.1 mt -75.22 156.18 85.8 Favored Pre-proline 0 N--CA 1.448 -0.565 0 C-N-CA 125.044 1.338 . . . . 62.240000000000002 111.424 -177.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -77.78 172.35 15.83 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 124.964 3.776 . . . . 73.150000000000006 111.096 179.045 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -66.12 -2.83 4.57 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 114.501 1.297 . . . . 63.210000000000001 114.501 -178.577 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -102.74 1.69 34.69 Favored 'General case' 0 C--O 1.223 -0.335 0 C-N-CA 125.05 1.34 . . . . 74.349999999999994 112.453 -177.945 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 39.1 t -125.99 131.52 71.67 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 CA-C-N 120.161 1.346 . . . . 70.319999999999993 108.381 -170.932 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 86.5 t60 -131.67 101.69 5.59 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 125.096 1.358 . . . . 74.310000000000002 109.214 -176.169 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 10.4 t80 -82.66 138.55 34.1 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 126.579 1.951 . . . . 73.549999999999997 109.476 -176.111 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 23.6 t -130.08 154.32 40.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 106.974 -1.491 . . . . 54.119999999999997 106.974 178.514 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 66.5 mtt85 -123.86 129.7 51.42 Favored 'General case' 0 CA--C 1.513 -0.448 0 N-CA-C 105.279 -2.119 . . . . 75.310000000000002 105.279 168.99 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 47.5 mt -134.24 148.92 69.8 Favored Pre-proline 0 C--N 1.33 -0.256 0 N-CA-C 108.921 -0.77 . . . . 53.100000000000001 108.921 175.354 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -73.8 140.24 28.78 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 122.347 2.031 . . . . 74.400000000000006 110.287 178.024 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -79.1 88.42 4.83 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.883 0.873 . . . . 73.239999999999995 110.549 178.756 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 10.1 mt -87.68 96.73 10.54 Favored 'General case' 0 C--N 1.331 -0.214 0 O-C-N 120.188 -1.57 . . . . 73.420000000000002 109.858 -177.336 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 48.0 m-85 -115.84 36.36 4.05 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 123.929 0.892 . . . . 74.409999999999997 110.958 179.34 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 78.66 -161.47 48.12 Favored Glycine 0 C--N 1.336 0.555 0 N-CA-C 110.004 -1.239 . . . . 63.340000000000003 110.004 -179.307 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 44.82 -131.79 7.78 Favored Glycine 0 CA--C 1.532 1.106 0 C-N-CA 125.355 1.455 . . . . 22.129999999999999 113.106 172.811 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 7.7 tp -80.76 -18.47 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 123.73 0.812 . . . . 73.319999999999993 110.962 174.693 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 8.6 m95 -58.52 -38.4 77.64 Favored 'General case' 0 C--N 1.338 0.097 0 O-C-N 121.226 -0.921 . . . . 72.439999999999998 111.664 -171.528 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -83.04 -28.24 29.74 Favored 'General case' 0 C--O 1.232 0.134 0 N-CA-C 113.647 0.98 . . . . 71.25 113.647 177.044 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 33.3 t -59.66 -52.4 61.49 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 N-CA-C 107.336 -1.357 . . . . 75.120000000000005 107.336 174.613 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 65.6 m170 -75.01 47.82 0.36 Allowed 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 126.968 2.107 . . . . 75.420000000000002 111.261 170.803 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -153.46 -42.17 0.02 OUTLIER Glycine 0 CA--C 1.526 0.734 0 C-N-CA 124.93 1.252 . . . . 75.439999999999998 111.775 177.708 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 37.9 tt0 -61.95 -26.31 68.12 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.421 1.088 . . . . 75.329999999999998 113.783 -168.003 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 1.7 ptt? -71.6 -34.05 69.55 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 120.121 1.328 . . . . 64.310000000000002 112.718 -177.395 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 45.1 t80 -54.81 -51.9 64.36 Favored 'General case' 0 N--CA 1.463 0.209 0 C-N-CA 124.067 0.947 . . . . 74.109999999999999 109.459 -176.034 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 36.7 mt -57.62 -40.47 79.23 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 124.66 1.184 . . . . 55.229999999999997 110.338 178.091 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.679 ' CG2' HG23 ' A' ' 128' ' ' THR . 1.8 m -70.36 -35.02 73.28 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 118.717 0.689 . . . . 65.109999999999999 111.247 -178.833 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -57.52 -56.22 24.66 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 125.073 1.349 . . . . 74.200000000000003 108.452 178.694 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -73.33 -21.16 60.62 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.907 0.883 . . . . 63.5 112.098 -178.308 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 27.8 t -66.1 -3.51 5.64 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 117.621 -1.181 . . . . 60.219999999999999 113.102 175.242 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 44.2 mtm . . . . . 0 N--CA 1.464 0.235 0 CA-C-N 120.933 1.697 . . . . 62.509999999999998 113.599 169.517 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.109 0 CA-C-O 118.946 -0.549 . . . . 72.310000000000002 112.382 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 58.4 t -58.32 -57.94 8.69 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 C-N-CA 124.091 0.957 . . . . 74.329999999999998 108.921 177.051 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -69.39 -37.98 77.77 Favored 'General case' 0 C--N 1.335 -0.058 0 C-N-CA 123.132 0.573 . . . . 74.530000000000001 112.36 -176.823 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -58.75 -32.61 69.4 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.608 1.563 . . . . 71.230000000000004 110.042 176.367 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -79.61 -20.83 45.91 Favored 'General case' 0 N--CA 1.448 -0.565 0 O-C-N 120.848 -1.157 . . . . 61.210000000000001 111.318 178.788 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 31.8 mt -94.45 -35.72 6.45 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 O-C-N 120.555 -1.341 . . . . 72.120000000000005 109.241 -179.682 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 57.8 m-70 -90.42 -63.64 1.25 Allowed 'General case' 0 C--O 1.233 0.232 0 C-N-CA 124.489 1.116 . . . . 53.539999999999999 110.954 -174.952 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 7.5 mtmt -68.07 -35.61 78.48 Favored 'General case' 0 N--CA 1.463 0.223 0 O-C-N 121.929 -0.482 . . . . 74.239999999999995 110.583 -176.163 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -99.87 -70.29 0.74 Allowed 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 108.51 -0.922 . . . . 74.230000000000004 108.51 -172.467 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 7.5 t-80 74.6 64.01 0.07 Allowed 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 128.618 2.767 . . . . 73.109999999999999 113.301 -177.743 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 65.2 mttt -76.53 28.97 0.12 Allowed 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 114.755 1.391 . . . . 73.430000000000007 114.755 179.515 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 10.0 tmtt? 46.52 57.91 5.05 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 125.958 1.703 . . . . 72.340000000000003 112.509 176.189 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 44.7 mt -67.46 42.4 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 130.16 3.384 . . . . 72.030000000000001 112.197 179.413 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -88.36 6.44 37.26 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 128.679 2.792 . . . . 53.350000000000001 113.14 -178.563 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -139.7 156.49 71.03 Favored Pre-proline 0 CA--C 1.537 0.479 0 C-N-CA 123.809 0.844 . . . . 73.049999999999997 111.335 178.614 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -64.69 -39.4 26.96 Favored 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 122.579 2.186 . . . . 72.230000000000004 112.386 -179.243 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -59.2 -42.89 92.0 Favored 'General case' 0 C--O 1.225 -0.187 0 CA-C-N 118.09 0.404 . . . . 63.009999999999998 110.177 176.359 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -60.52 -38.31 83.99 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 123.109 0.564 . . . . 64.450000000000003 110.615 -177.0 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 54.2 mtt -68.45 -49.91 56.44 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 123.908 0.883 . . . . 63.299999999999997 110.467 175.173 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -64.75 -47.14 79.29 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 124.811 1.244 . . . . 72.010000000000005 110.783 -171.188 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -62.2 -29.13 70.16 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 126.061 1.744 . . . . 63.229999999999997 112.836 176.602 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 73.0 t80 -76.85 -54.86 6.04 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 109.933 -0.395 . . . . 73.319999999999993 109.933 174.177 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 56.4 mt -68.07 -21.19 65.0 Favored 'General case' 0 CA--C 1.516 -0.345 0 O-C-N 121.809 -0.557 . . . . 70.019999999999996 110.584 -168.698 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -55.03 -13.65 1.23 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.402 0.681 . . . . 72.150000000000006 112.236 169.711 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -88.06 -9.69 70.23 Favored Glycine 0 N--CA 1.433 -1.51 0 CA-C-O 116.97 -2.017 . . . . 53.399999999999999 110.235 179.216 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -130.35 10.94 5.34 Favored 'General case' 0 C--N 1.347 0.466 0 CA-C-N 120.985 2.393 . . . . 72.450000000000003 112.947 -170.137 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 86.83 70.68 1.3 Allowed Glycine 0 N--CA 1.445 -0.731 0 N-CA-C 109.454 -1.458 . . . . 52.420000000000002 109.454 -179.198 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 25.7 t -141.4 129.71 22.83 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.816 0 C-N-CA 127.168 2.187 . . . . 74.120000000000005 107.271 172.788 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 41.2 t0 -89.45 123.16 33.33 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 124.185 0.994 . . . . 73.209999999999994 110.639 178.793 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 11.2 mtmt -59.07 -38.7 80.06 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 124.194 0.998 . . . . 51.049999999999997 111.02 171.192 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 75.7 mm-40 -65.17 -15.22 62.19 Favored 'General case' 0 C--N 1.329 -0.318 0 O-C-N 120.983 -1.073 . . . . 74.310000000000002 112.889 -177.403 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.541 ' O ' HG22 ' A' ' 128' ' ' THR . 9.7 mmtm -117.95 -42.33 2.83 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-O 117.585 -1.198 . . . . 74.120000000000005 110.777 -178.189 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 81.3 t80 -46.65 -65.71 0.52 Allowed 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 125.238 1.415 . . . . 71.099999999999994 111.12 171.89 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 18.0 mt -62.3 -38.38 89.15 Favored 'General case' 0 N--CA 1.465 0.279 0 O-C-N 122.055 -0.403 . . . . 72.340000000000003 110.827 -173.459 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 31.8 t -54.17 -61.76 2.09 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 107.883 -1.154 . . . . 62.329999999999998 107.883 177.178 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' THR . . . . . 0.679 HG23 ' CG2' ' A' ' 80' ' ' THR 0.281 4.8 t -69.41 -30.2 68.1 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 118.268 -0.873 . . . . 62.100000000000001 110.699 -173.541 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 60.8 t80 -56.49 -42.1 77.73 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 119.87 1.214 . . . . 74.200000000000003 111.212 176.209 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -94.7 13.72 23.5 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.906 1.282 . . . . 73.340000000000003 111.854 179.699 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 50.5 m -103.56 161.98 13.43 Favored 'General case' 0 N--CA 1.469 0.504 0 O-C-N 120.618 -1.302 . . . . 51.420000000000002 111.167 176.406 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -63.52 -33.88 76.57 Favored 'General case' 0 C--O 1.225 -0.215 0 C-N-CA 122.628 0.371 . . . . 72.409999999999997 111.944 -171.537 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -50.99 -46.95 61.55 Favored 'General case' 0 CA--C 1.534 0.339 0 O-C-N 121.705 -0.622 . . . . 50.219999999999999 111.98 -175.636 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 48.2 mm -68.53 -33.6 60.89 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-O 118.912 -0.566 . . . . 74.510000000000005 110.01 179.764 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 12.3 tttt -55.05 -38.47 68.04 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 119.453 1.024 . . . . 71.109999999999999 110.45 171.588 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -70.96 -42.44 59.76 Favored Glycine 0 C--N 1.335 0.503 0 N-CA-C 110.603 -0.999 . . . . 64.219999999999999 110.603 -175.117 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -67.11 -43.82 81.48 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 123.946 0.898 . . . . 74.030000000000001 109.833 -179.51 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 86.7 mmm -58.54 -52.59 65.0 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 125.397 1.479 . . . . 64.430000000000007 109.665 175.272 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -63.26 -39.16 93.82 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 120.001 1.273 . . . . 33.439999999999998 112.004 -173.87 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 7.2 mmtt -56.29 -59.77 4.47 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 119.057 0.844 . . . . 54.539999999999999 109.227 170.921 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -53.62 -42.58 67.9 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 118.308 0.504 . . . . 70.409999999999997 110.948 -175.413 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 7.7 tttt -57.99 -60.8 3.16 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 125.532 1.533 . . . . 63.420000000000002 109.872 177.98 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 2.2 pttt -71.03 -17.62 62.61 Favored 'General case' 0 CA--C 1.529 0.169 0 N-CA-C 112.313 0.486 . . . . 74.150000000000006 112.313 -174.494 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 32.6 mt -73.81 -56.12 5.36 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 124.021 0.928 . . . . 74.540000000000006 111.01 170.305 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -57.16 -43.19 82.29 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 119.049 0.84 . . . . 72.200000000000003 111.577 -171.951 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 3.8 ppp? -60.62 -44.29 96.49 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 113.146 0.795 . . . . 72.510000000000005 113.146 174.289 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -62.92 -35.75 81.12 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 124.247 1.019 . . . . 75.129999999999995 111.096 179.263 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 31.0 m-85 -74.54 14.37 0.48 Allowed 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.11 1.364 . . . . 73.219999999999999 113.317 177.458 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 57.32 18.65 4.47 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 126.023 1.729 . . . . 54.43 114.112 178.212 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.458 HG13 HG21 ' A' ' 155' ' ' THR . 20.6 t -75.0 137.05 23.8 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 CA-C-N 119.177 0.898 . . . . 72.040000000000006 109.309 -174.815 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -132.42 2.97 3.88 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.524 0.73 . . . . 54.310000000000002 112.191 -172.345 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -173.54 -168.91 35.27 Favored Glycine 0 CA--C 1.527 0.83 0 C-N-CA 127.278 2.371 . . . . 51.219999999999999 110.054 178.228 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.532 HG23 ' HB3' ' A' ' 37' ' ' CYS . 3.5 m -149.04 157.37 40.05 Favored Pre-proline 0 CA--C 1.537 0.476 0 C-N-CA 125.943 1.697 . . . . 61.5 109.092 -175.798 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -62.31 159.79 56.17 Favored 'Cis proline' 0 N--CA 1.454 -0.848 0 C-N-CA 124.527 -1.031 . . . . 73.430000000000007 111.571 -9.837 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 155' ' ' THR . . . . . 0.458 HG21 HG13 ' A' ' 150' ' ' VAL . 7.7 m -155.56 139.71 16.52 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 107.695 -1.224 . . . . 44.350000000000001 107.695 176.174 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 98.8 mtp -119.11 160.26 22.41 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-N 114.666 -1.152 . . . . 74.230000000000004 108.17 170.799 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 39.6 t -139.89 156.01 25.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 106.188 -1.782 . . . . 74.230000000000004 106.188 178.685 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 48.2 t -126.18 120.39 56.67 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 N-CA-C 107.242 -1.392 . . . . 72.209999999999994 107.242 171.033 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 23.2 m-20 51.64 21.87 1.45 Allowed 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 127.794 2.437 . . . . 72.140000000000001 114.405 175.199 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 57.02 32.89 63.15 Favored Glycine 0 CA--C 1.528 0.854 0 CA-C-O 118.239 -1.312 . . . . 62.329999999999998 113.996 -168.946 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 8.0 mtpt -126.79 -29.94 2.81 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 119.491 1.646 . . . . 73.430000000000007 111.467 -178.437 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -126.07 128.91 48.12 Favored 'General case' 0 CA--C 1.519 -0.225 0 N-CA-C 108.553 -0.906 . . . . 75.340000000000003 108.553 179.221 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 3.7 ttp85 -101.04 132.45 46.46 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 105.673 -1.973 . . . . 74.420000000000002 105.673 171.601 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 13.9 p90 -147.9 161.93 40.32 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.65 -0.871 . . . . 73.109999999999999 108.65 173.276 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -170.47 -171.87 1.15 Allowed 'General case' 0 N--CA 1.474 0.762 0 O-C-N 121.741 -0.6 . . . . 75.239999999999995 111.162 -174.977 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 12.2 mt -71.72 -26.02 25.29 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 C-N-CA 126.137 1.775 . . . . 72.439999999999998 110.263 -179.168 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -66.16 -54.78 22.16 Favored Glycine 0 N--CA 1.444 -0.811 0 N-CA-C 110.196 -1.161 . . . . 24.030000000000001 110.196 168.947 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 11.4 m -69.06 -59.17 3.22 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 117.398 0.599 . . . . 63.340000000000003 111.036 -163.219 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.468 ' CB ' HD23 ' A' ' 178' ' ' LEU . . . -67.35 -35.79 80.09 Favored 'General case' 0 CA--C 1.537 0.462 0 O-C-N 122.034 -0.416 . . . . 50.329999999999998 111.862 -167.482 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 140.64 4.09 1.25 Allowed Glycine 0 CA--C 1.531 1.049 0 C-N-CA 125.59 1.567 . . . . 74.230000000000004 115.744 175.362 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 137.36 178.18 15.71 Favored Glycine 0 CA--C 1.531 1.078 0 CA-C-N 119.797 1.798 . . . . 74.420000000000002 109.59 -168.812 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -64.68 -44.48 10.66 Favored 'Trans proline' 0 N--CA 1.459 -0.553 0 C-N-CA 123.243 2.629 . . . . 52.420000000000002 112.006 -166.779 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -56.13 -44.75 79.49 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.363 0.665 . . . . 73.040000000000006 109.968 178.377 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -71.68 -27.53 63.11 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 116.012 -0.54 . . . . 74.430000000000007 110.36 -173.554 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 90.0 m -59.13 -43.56 92.0 Favored 'General case' 0 CA--C 1.533 0.319 0 O-C-N 120.612 -1.305 . . . . 74.129999999999995 110.636 177.929 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 52.0 mt -64.46 -35.46 81.0 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 119.228 0.922 . . . . 74.420000000000002 110.852 177.85 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 21.2 tttt -55.3 -36.02 65.73 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 124.423 1.089 . . . . 61.399999999999999 110.121 176.196 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.468 HD23 ' CB ' ' A' ' 169' ' ' ALA . 4.6 mm? -79.57 -43.9 22.1 Favored 'General case' 0 CA--C 1.513 -0.47 0 CA-C-O 117.67 -1.157 . . . . 73.120000000000005 110.294 173.432 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -51.33 -43.2 61.68 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 119.459 1.027 . . . . 62.509999999999998 111.979 -177.017 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -82.39 -38.5 24.02 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 123.954 0.902 . . . . 64.450000000000003 109.274 -167.268 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 30.8 t80 -61.07 -55.96 26.52 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 124.442 1.097 . . . . 53.130000000000003 110.535 171.27 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 91.2 mt -61.72 -29.83 70.36 Favored 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 124.09 0.956 . . . . 72.420000000000002 111.83 -173.274 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 30.2 mt -56.47 -60.97 1.37 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.151 0 N-CA-C 108.151 -1.055 . . . . 72.420000000000002 108.151 168.801 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 10.9 tm-20 -52.31 -40.74 62.26 Favored 'General case' 0 N--CA 1.457 -0.113 0 C-N-CA 124.28 1.032 . . . . 74.219999999999999 111.554 -177.551 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 12.7 tptp -58.09 -47.92 81.75 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 123.047 0.539 . . . . 72.430000000000007 111.254 -179.434 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 41.5 mm-40 -74.53 -39.47 62.35 Favored 'General case' 0 C--O 1.223 -0.312 0 C-N-CA 123.082 0.553 . . . . 71.409999999999997 110.865 178.449 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.65 -37.89 89.14 Favored 'General case' 0 C--N 1.331 -0.216 0 O-C-N 120.269 -1.519 . . . . 72.310000000000002 109.253 -175.965 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.255 0 C-N-CA 125.267 1.427 . . . . 45.009999999999998 111.808 177.288 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 . . . . . 0 C--O 1.232 0.148 0 CA-C-O 122.509 1.147 . . . . 74.420000000000002 109.45 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -82.69 16.29 2.26 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 126.366 1.866 . . . . 74.230000000000004 114.187 -177.355 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 42.1 m-85 -143.63 164.32 30.75 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 124.431 1.093 . . . . 74.120000000000005 110.5 -165.176 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 57.3 m -133.67 130.53 38.34 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.754 1.221 . . . . 64.109999999999999 108.609 -176.024 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.91 140.89 58.91 Favored 'General case' 0 C--O 1.232 0.162 0 O-C-N 121.636 -0.665 . . . . 63.0 109.732 175.464 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 82.52 -23.19 5.74 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 125.877 1.703 . . . . 44.530000000000001 112.297 -170.461 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 75.1 tttt -96.64 -72.77 0.62 Allowed 'General case' 0 CA--C 1.508 -0.642 0 CA-C-N 118.405 1.103 . . . . 73.0 110.517 -169.761 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.501 ' HB3' HD11 ' A' ' 178' ' ' LEU . 16.5 mp0 -76.3 -23.89 54.36 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 124.639 1.175 . . . . 73.340000000000003 109.702 178.816 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 41.3 p90 -162.19 174.46 12.87 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.699 0.8 . . . . 63.049999999999997 110.717 -171.265 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 59.8 t -131.95 113.74 22.89 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 N-CA-C 108.123 -1.066 . . . . 74.120000000000005 108.123 178.28 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.68 160.51 32.11 Favored 'General case' 0 C--O 1.234 0.283 0 O-C-N 120.602 -1.311 . . . . 72.109999999999999 108.736 163.418 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -134.75 116.75 15.23 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 124.43 1.092 . . . . 73.239999999999995 110.133 -178.312 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 4.3 p -67.39 6.3 0.62 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 127.274 2.23 . . . . 54.350000000000001 113.918 176.664 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 18.6 m -127.12 71.43 75.96 Favored Pre-proline 0 N--CA 1.45 -0.447 0 C-N-CA 126.023 1.729 . . . . 73.200000000000003 108.205 174.796 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -76.69 179.81 6.09 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 124.125 3.216 . . . . 73.329999999999998 112.533 -170.948 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 88.3 t -140.8 128.2 12.15 Favored Pre-proline 0 CA--C 1.544 0.73 0 C-N-CA 124.284 1.034 . . . . 61.5 110.448 -167.393 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -82.65 178.73 5.87 Favored 'Trans proline' 0 CA--C 1.542 0.897 0 C-N-CA 124.794 3.663 . . . . 62.539999999999999 112.326 176.615 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 28.2 m -134.07 167.29 26.55 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 C-N-CA 124.202 1.001 . . . . 73.310000000000002 112.077 -179.268 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 11.2 t -64.42 -49.29 72.11 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 127.427 2.291 . . . . 60.43 109.568 170.163 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 30.9 tt0 -113.74 80.99 5.39 Favored Pre-proline 0 CA--C 1.541 0.601 0 C-N-CA 124.264 1.026 . . . . 75.510000000000005 110.451 -173.74 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -68.97 97.18 0.56 Allowed 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 123.928 3.086 . . . . 71.25 108.216 174.434 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -175.5 -58.97 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.378 0 N-CA-C 110.715 -0.954 . . . . 42.32 110.715 -175.553 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.46 145.04 28.36 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 107.172 -1.418 . . . . 74.439999999999998 107.172 166.634 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 36.9 mm -66.11 131.74 31.79 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 N-CA-C 105.721 -1.955 . . . . 64.239999999999995 105.721 167.298 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -80.65 142.58 33.84 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 108.699 -0.852 . . . . 72.209999999999994 108.699 171.916 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.442 HG22 HG22 ' A' ' 158' ' ' VAL . 47.1 t -131.57 114.38 25.29 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 N-CA-C 106.391 -1.707 . . . . 71.129999999999995 106.391 161.815 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 4.7 t -92.89 141.85 14.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 106.81 -1.552 . . . . 74.319999999999993 106.81 171.256 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 79.4 tt0 -107.64 106.25 16.51 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 105.217 -2.142 . . . . 70.310000000000002 105.217 156.286 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.0 mp -74.93 155.43 37.45 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 108.624 -0.88 . . . . 71.420000000000002 108.624 165.087 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -140.71 164.02 31.32 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 115.777 -0.647 . . . . 75.409999999999997 112.207 -163.849 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' TRP . . . . . 0.55 ' HB3' HG21 ' A' ' 153' ' ' VAL . 23.6 t90 -159.63 129.76 5.58 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 121.559 0.695 . . . . 71.439999999999998 110.642 158.403 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 11.2 m-30 -45.24 -27.3 0.62 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 126.392 1.877 . . . . 71.530000000000001 114.611 165.045 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -80.77 2.42 79.6 Favored Glycine 0 CA--C 1.531 1.067 0 CA-C-N 119.63 1.105 . . . . 72.140000000000001 114.161 -178.151 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 54.1 t -105.44 86.89 1.86 Allowed Pre-proline 0 CA--C 1.539 0.543 0 C-N-CA 125.71 1.604 . . . . 71.019999999999996 112.72 -165.304 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -63.81 -25.13 68.05 Favored 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 121.862 1.708 . . . . 72.120000000000005 112.95 177.954 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 13.7 m-70 -61.76 -46.39 89.78 Favored 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 108.365 -0.976 . . . . 75.099999999999994 108.365 173.337 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 87.7 m -60.09 -39.03 84.7 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.83 0.852 . . . . 52.100000000000001 109.037 -170.911 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 45.7 t80 -51.96 -40.46 60.88 Favored 'General case' 0 C--N 1.344 0.344 0 C-N-CA 125.3 1.44 . . . . 72.120000000000005 110.763 178.316 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.74 -26.25 68.28 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 118.817 -0.611 . . . . 52.149999999999999 112.546 -178.337 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.465 ' CD2' HD11 ' A' ' 166' ' ' ILE . 1.5 t80 -79.3 -25.73 42.37 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-O 117.558 -1.21 . . . . 64.019999999999996 111.741 -176.483 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 28.8 mm-40 -37.64 -69.39 0.19 Allowed Pre-proline 0 N--CA 1.471 0.606 0 C-N-CA 125.379 1.472 . . . . 74.450000000000003 112.829 -171.629 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -68.68 -6.67 18.45 Favored 'Trans proline' 0 CA--C 1.536 0.62 0 CA-C-N 121.98 1.743 . . . . 72.200000000000003 115.696 -172.778 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 60.1 m -85.26 -40.25 16.82 Favored 'General case' 0 CA--C 1.537 0.464 0 O-C-N 121.019 -1.051 . . . . 64.439999999999998 109.293 168.984 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 21.0 tt -93.51 -26.16 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 CA-C-N 118.575 0.625 . . . . 72.329999999999998 112.467 -171.571 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 19.3 t -53.18 -64.73 1.46 Allowed Pre-proline 0 C--O 1.236 0.385 0 C-N-CA 125.728 1.611 . . . . 70.439999999999998 110.059 172.522 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -63.11 -34.6 68.83 Favored 'Trans proline' 0 N--CA 1.451 -0.971 0 CA-C-N 120.898 1.356 . . . . 75.099999999999994 111.396 -174.142 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 86.7 t90 -54.54 -51.92 63.69 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 124.195 0.998 . . . . 72.239999999999995 110.521 174.242 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 98.7 p -59.25 -38.07 79.15 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 118.428 0.558 . . . . 74.310000000000002 111.84 -176.592 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -71.49 -18.71 62.27 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.691 0.796 . . . . 64.219999999999999 112.116 179.281 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 67.7 mmtt -94.72 -1.89 52.15 Favored 'General case' 0 C--O 1.232 0.164 0 C-N-CA 124.98 1.312 . . . . 62.439999999999998 112.983 179.101 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 36.9 mt -61.16 149.73 81.4 Favored Pre-proline 0 N--CA 1.45 -0.438 0 CA-C-N 119.846 1.203 . . . . 72.140000000000001 111.927 -175.733 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -77.48 165.06 27.87 Favored 'Trans proline' 0 N--CA 1.447 -1.221 0 C-N-CA 123.82 3.013 . . . . 71.219999999999999 111.547 -175.11 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -66.77 12.46 0.07 Allowed 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 127.421 2.288 . . . . 35.340000000000003 115.072 -176.703 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -128.36 14.76 6.65 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.449 1.499 . . . . 74.0 111.211 175.591 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 90.2 t -116.28 155.98 17.56 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 O-C-N 120.64 -1.288 . . . . 71.129999999999995 109.445 177.347 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 16.9 t-160 -132.43 102.84 5.89 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 125.955 1.702 . . . . 72.120000000000005 106.905 168.764 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -89.21 139.04 30.89 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 109.228 -0.656 . . . . 73.530000000000001 109.228 172.861 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 78.2 t -143.8 145.74 21.74 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.102 0 C-N-CA 124.675 1.19 . . . . 72.319999999999993 108.616 -176.317 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 22.2 mtp180 -111.21 119.28 38.39 Favored 'General case' 0 N--CA 1.463 0.193 0 N-CA-C 105.838 -1.912 . . . . 74.430000000000007 105.838 174.156 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 21.0 mt -128.18 147.02 61.74 Favored Pre-proline 0 N--CA 1.473 0.721 0 C-N-CA 123.543 0.737 . . . . 71.030000000000001 111.406 176.788 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -77.38 149.04 27.25 Favored 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 122.639 2.226 . . . . 70.019999999999996 112.206 -178.216 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -95.21 126.03 40.25 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 122.232 1.015 . . . . 73.030000000000001 108.671 174.668 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.461 HD22 ' HE1' ' A' ' 138' ' ' MET . 60.9 mt -113.03 52.26 0.8 Allowed 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 125.927 1.691 . . . . 74.019999999999996 111.583 -165.934 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 50.4 m-85 -83.42 63.89 7.55 Favored 'General case' 0 CA--C 1.54 0.57 0 O-C-N 121.332 -0.855 . . . . 71.230000000000004 111.784 -177.015 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 61.77 6.77 9.73 Favored Glycine 0 N--CA 1.476 1.366 0 N-CA-C 117.428 1.731 . . . . 61.020000000000003 117.428 142.673 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -170.47 103.85 0.2 Allowed Glycine 0 C--O 1.226 -0.406 0 N-CA-C 106.851 -2.5 . . . . 64.519999999999996 106.851 -176.705 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . 0.308 3.6 tp 58.34 -40.38 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 C-N-CA 130.501 3.52 . . . . 70.120000000000005 115.637 -171.063 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 12.5 m95 -49.26 -42.33 40.54 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 126.282 1.833 . . . . 74.450000000000003 111.606 -176.049 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 12.6 p30 -76.74 -28.69 55.87 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 114.284 1.216 . . . . 73.019999999999996 114.284 -178.323 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 86.0 t -70.28 -53.42 23.17 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 N-CA-C 106.347 -1.723 . . . . 74.200000000000003 106.347 174.797 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 40.5 m170 -68.03 39.42 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 128.905 2.882 . . . . 72.219999999999999 113.263 169.509 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -156.47 -46.66 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.424 0 O-C-N 121.204 -0.935 . . . . 72.209999999999994 111.378 177.397 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -50.66 -41.57 55.66 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.136 0.975 . . . . 33.25 112.144 -176.049 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 4.1 ttt -54.1 -35.39 62.07 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.387 1.075 . . . . 75.25 113.462 -175.547 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 39.3 t80 -59.94 -42.38 93.87 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 118.918 0.781 . . . . 74.430000000000007 109.844 -179.102 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 16.3 mt -66.0 -40.51 91.22 Favored 'General case' 0 C--O 1.227 -0.102 0 C-N-CA 125.094 1.358 . . . . 74.329999999999998 109.427 179.59 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.444 HG23 HG23 ' A' ' 128' ' ' THR . 0.2 OUTLIER -63.78 -37.02 85.81 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.666 0.786 . . . . 74.549999999999997 110.833 175.673 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.35 -56.33 15.13 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 124.092 0.957 . . . . 42.130000000000003 109.266 -178.422 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -72.06 -15.51 62.02 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 112.534 0.568 . . . . 42.25 112.534 -178.36 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 38.5 t -60.39 -18.99 54.22 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.521 1.129 . . . . 74.439999999999998 111.409 170.867 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 45.9 mtm . . . . . 0 N--CA 1.47 0.537 0 CA-C-N 120.282 1.401 . . . . 70.230000000000004 114.421 173.565 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 0.532 0 N-CA-C 113.189 0.811 . . . . 71.450000000000003 113.189 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 17.6 t -71.57 -62.18 1.4 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 N-CA-C 108.375 -0.972 . . . . 75.420000000000002 108.375 172.383 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 41.3 m-85 -64.42 -35.88 82.35 Favored 'General case' 0 C--N 1.338 0.082 0 C-N-CA 124.267 1.027 . . . . 72.400000000000006 111.89 -174.561 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 34.8 mm-40 -57.93 -45.19 86.97 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 125.553 1.541 . . . . 65.530000000000001 109.435 175.725 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -64.28 -19.67 65.56 Favored 'General case' 0 CA--C 1.542 0.645 0 O-C-N 121.574 -0.704 . . . . 64.329999999999998 112.195 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 64.4 mt -101.74 -25.93 3.66 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 C-N-CA 125.679 1.592 . . . . 63.539999999999999 110.298 -173.239 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 83.8 m-70 -117.58 -53.71 2.4 Favored 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 124.323 1.049 . . . . 73.239999999999995 111.835 -174.391 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -72.1 -32.66 67.2 Favored 'General case' 0 N--CA 1.468 0.45 0 O-C-N 121.309 -0.869 . . . . 64.310000000000002 110.949 176.956 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -101.71 -36.32 8.76 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 119.425 1.011 . . . . 54.420000000000002 112.597 177.953 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 22.7 t-160 44.5 63.62 1.61 Allowed 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.901 1.68 . . . . 74.140000000000001 112.07 -171.97 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 37.7 mmtt -64.19 170.71 3.49 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.208 1.403 . . . . 65.120000000000005 110.96 171.639 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 63.3 tttt -81.38 30.02 0.35 Allowed 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 125.985 1.714 . . . . 70.239999999999995 112.622 -173.477 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.477 HD23 ' HB3' ' A' ' 110' ' ' GLU . 31.0 mt -71.89 32.08 0.05 Allowed 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 128.8 2.84 . . . . 41.149999999999999 114.452 -165.112 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -78.85 8.37 5.61 Favored 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 126.864 2.066 . . . . 71.409999999999997 114.303 -178.333 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -150.75 156.77 36.15 Favored Pre-proline 0 CA--C 1.534 0.332 0 C-N-CA 124.25 1.02 . . . . 75.209999999999994 109.566 -174.983 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -65.42 -30.23 53.21 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 121.818 1.678 . . . . 61.219999999999999 114.0 -170.823 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -66.26 -53.69 33.86 Favored 'General case' 0 C--O 1.223 -0.31 0 CA-C-O 118.13 -0.938 . . . . 75.439999999999998 109.563 178.004 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.477 ' HB3' HD23 ' A' ' 105' ' ' LEU . 13.5 mm-40 -50.89 -48.19 60.5 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 119.353 0.979 . . . . 73.230000000000004 111.286 178.459 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 59.7 mtt -54.96 -55.19 33.48 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 123.937 0.895 . . . . 44.43 110.173 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.44 ' HB1' ' CG ' ' A' ' 122' ' ' LYS . . . -66.73 -42.61 86.0 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.565 1.146 . . . . 75.450000000000003 110.989 -172.665 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -61.0 -40.06 92.08 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 126.192 1.797 . . . . 74.430000000000007 109.853 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 38.7 t80 -68.81 -50.86 46.65 Favored 'General case' 0 N--CA 1.454 -0.243 0 O-C-N 121.807 -0.558 . . . . 75.420000000000002 109.644 178.193 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 50.7 mt -68.45 -15.94 63.73 Favored 'General case' 0 N--CA 1.452 -0.341 0 O-C-N 121.988 -0.445 . . . . 35.219999999999999 110.323 -172.561 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -54.19 -31.41 52.87 Favored 'General case' 0 CA--C 1.534 0.329 0 O-C-N 121.88 -0.513 . . . . 65.439999999999998 111.987 169.4 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -83.65 1.92 88.07 Favored Glycine 0 CA--C 1.534 1.22 0 CA-C-O 119.113 -0.826 . . . . 74.329999999999998 113.988 173.652 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 13.5 mmtp -131.62 27.31 4.68 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 120.036 1.918 . . . . 44.219999999999999 111.292 -166.941 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 73.33 36.1 55.77 Favored Glycine 0 CA--C 1.521 0.453 0 CA-C-O 119.825 -0.431 . . . . 71.129999999999995 112.295 173.87 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 31.8 t -126.51 123.11 62.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 N-CA-C 106.704 -1.591 . . . . 65.209999999999994 106.704 178.389 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -69.75 153.56 43.19 Favored 'General case' 0 CA--C 1.537 0.454 0 O-C-N 122.021 -0.424 . . . . 63.130000000000003 111.533 173.78 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.44 ' CG ' ' HB1' ' A' ' 112' ' ' ALA . 6.1 ttpt -83.48 -36.84 23.82 Favored 'General case' 0 N--CA 1.465 0.299 0 O-C-N 120.419 -1.426 . . . . 72.25 110.46 175.492 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 58.0 mt-10 -57.83 -52.86 63.72 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 118.859 0.754 . . . . 74.230000000000004 109.693 -176.504 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 7.6 mmmt -73.32 -38.52 65.78 Favored 'General case' 0 CA--C 1.508 -0.639 0 N-CA-C 108.353 -0.98 . . . . 72.109999999999999 108.353 -167.79 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 61.4 t80 -57.88 -62.49 1.77 Allowed 'General case' 0 N--CA 1.436 -1.174 0 O-C-N 124.732 1.27 . . . . 73.439999999999998 109.13 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 16.0 mt -68.05 -31.15 70.6 Favored 'General case' 0 C--O 1.238 0.485 0 O-C-N 121.985 -0.447 . . . . 75.109999999999999 111.305 -176.77 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 33.2 t -56.15 -59.8 4.41 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 107.4 -1.333 . . . . 41.409999999999997 107.4 175.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' THR . . . . . 0.444 HG23 HG23 ' A' ' 80' ' ' THR . 4.5 t -71.86 -36.18 70.04 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 118.963 -0.541 . . . . 73.239999999999995 109.934 -171.73 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 61.6 t80 -51.62 -43.98 62.74 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.93 1.292 . . . . 73.409999999999997 111.733 176.394 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 54.4 m-20 -104.39 33.61 3.45 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 121.779 -0.576 . . . . 73.400000000000006 110.667 -179.768 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 22.6 t -122.95 165.76 16.18 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.178 1.391 . . . . 62.219999999999999 110.926 177.182 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -57.19 -29.42 63.67 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.168 1.387 . . . . 61.240000000000002 111.517 177.746 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -53.57 -58.89 5.57 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 123.918 0.887 . . . . 61.310000000000002 110.849 177.586 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 38.6 mm -74.17 -28.28 23.07 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-O 118.421 -0.8 . . . . 73.230000000000004 109.89 -176.099 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 7.4 mmtt -53.97 -43.12 69.65 Favored 'General case' 0 C--N 1.34 0.169 0 CA-C-N 119.639 1.108 . . . . 63.509999999999998 110.002 170.815 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -66.76 -20.47 70.35 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 124.389 0.995 . . . . 53.439999999999998 112.944 -177.516 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -90.13 -41.31 11.71 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 117.954 0.877 . . . . 71.140000000000001 110.1 174.342 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' MET . . . . . 0.461 ' HE1' HD22 ' A' ' 66' ' ' LEU . 87.8 mmm -64.39 -35.93 82.48 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 124.825 1.25 . . . . 65.439999999999998 112.3 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -61.31 -51.29 69.48 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 119.039 0.836 . . . . 54.229999999999997 109.804 177.248 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 2.7 mmtt -65.04 -55.45 18.82 Favored 'General case' 0 CA--C 1.514 -0.419 0 C-N-CA 123.932 0.893 . . . . 74.519999999999996 109.275 -176.614 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -55.02 -34.5 63.54 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 119.681 1.128 . . . . 22.239999999999998 111.688 -178.086 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 5.7 tmtt? -77.87 -51.31 10.65 Favored 'General case' 0 C--N 1.346 0.437 0 CA-C-N 119.884 1.22 . . . . 72.430000000000007 111.344 -179.244 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 18.3 ptmt -60.54 -30.63 69.89 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 119.558 1.072 . . . . 65.329999999999998 110.527 178.802 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 48.4 mt -68.86 -56.91 6.46 Favored 'General case' 0 N--CA 1.443 -0.802 0 C-N-CA 123.442 0.697 . . . . 74.109999999999999 110.232 177.384 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -53.93 -41.5 67.77 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 119.887 1.221 . . . . 54.210000000000001 113.32 -173.737 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -65.22 -46.74 79.43 Favored 'General case' 0 N--CA 1.464 0.25 0 O-C-N 122.049 -0.407 . . . . 65.140000000000001 111.932 175.149 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -69.73 -35.04 74.66 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 118.733 0.697 . . . . 72.420000000000002 111.557 -176.409 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -69.48 9.29 0.49 Allowed 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 125.536 1.534 . . . . 71.340000000000003 113.763 171.618 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 10.9 mm100 59.04 24.72 13.02 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 126.005 1.722 . . . . 70.310000000000002 113.16 177.727 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 39.3 t -69.18 150.57 10.51 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 O-C-N 120.643 -1.286 . . . . 62.039999999999999 108.475 -178.197 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -145.98 6.27 1.02 Allowed 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.311 0.644 . . . . 52.219999999999999 111.947 -166.02 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 159.52 -171.99 36.05 Favored Glycine 0 N--CA 1.446 -0.688 0 N-CA-C 109.127 -1.589 . . . . 64.530000000000001 109.127 -166.918 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.55 HG21 ' HB3' ' A' ' 34' ' ' TRP . 15.3 m -139.72 161.93 53.77 Favored Pre-proline 0 CA--C 1.539 0.531 0 C-N-CA 124.064 0.945 . . . . 74.420000000000002 110.261 176.615 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 154' ' ' PRO . . . . . 0.46 ' C ' ' HA ' ' A' ' 153' ' ' VAL . 20.6 Cg_endo -58.37 156.63 36.13 Favored 'Cis proline' 0 CA--C 1.532 0.384 0 C-N-CA 123.928 -1.28 . . . . 73.299999999999997 111.065 -14.916 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 155' ' ' THR . . . . . 0.444 ' HA ' ' HB3' ' A' ' 165' ' ' ASP . 11.0 m -147.95 109.96 4.53 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.066 -1.087 . . . . 64.310000000000002 108.066 171.255 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 36.2 mmm -89.27 158.73 17.73 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 108.337 -0.986 . . . . 71.349999999999994 108.337 170.833 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 11.5 t -145.19 121.56 3.97 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 N-CA-C 108.575 -0.898 . . . . 73.109999999999999 108.575 174.128 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.566 HG23 ' CE1' ' A' ' 164' ' ' PHE . 77.2 t -91.83 131.51 38.73 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 N-CA-C 108.524 -0.917 . . . . 70.450000000000003 108.524 169.367 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 44.1 t30 48.88 19.45 0.27 Allowed 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 130.082 3.353 . . . . 73.109999999999999 115.323 168.996 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 69.62 23.75 76.54 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 125.357 1.456 . . . . 35.530000000000001 112.852 -175.858 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 55.9 mttt -131.55 -31.45 1.59 Allowed 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 118.596 1.198 . . . . 52.409999999999997 113.111 -171.285 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 162' ' ' TYR . . . . . 0.521 ' CG ' HD22 ' A' ' 182' ' ' LEU . 96.5 m-85 -125.68 108.08 11.19 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 123.529 0.732 . . . . 62.329999999999998 109.12 -175.532 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 41.7 ttt-85 -90.36 124.12 34.67 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 126.985 2.114 . . . . 72.510000000000005 106.039 174.475 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 164' ' ' PHE . . . . . 0.566 ' CE1' HG23 ' A' ' 158' ' ' VAL . 18.1 p90 -149.42 166.95 27.54 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 107.67 -1.233 . . . . 73.519999999999996 107.67 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 165' ' ' ASP . . . . . 0.444 ' HB3' ' HA ' ' A' ' 155' ' ' THR . 10.4 p-10 178.24 178.07 0.4 Allowed 'General case' 0 CA--C 1.51 -0.562 0 C-N-CA 124.86 1.264 . . . . 75.530000000000001 109.205 -178.666 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.465 HD11 ' CD2' ' A' ' 43' ' ' PHE . 18.2 mt -54.35 -38.49 40.54 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.673 0 C-N-CA 126.405 1.882 . . . . 72.420000000000002 109.834 178.204 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -65.27 -30.96 79.03 Favored Glycine 0 CA--C 1.526 0.764 0 C-N-CA 124.321 0.963 . . . . 42.140000000000001 113.266 175.499 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 51.0 m -84.61 -62.19 1.61 Allowed 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.898 0.879 . . . . 65.519999999999996 110.064 178.148 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -59.0 -32.87 70.08 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 126.583 1.953 . . . . 73.25 112.071 -173.274 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 102.07 2.58 51.7 Favored Glycine 0 CA--C 1.526 0.727 0 CA-C-O 118.656 -1.08 . . . . 34.030000000000001 112.453 178.714 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 169.24 172.66 36.17 Favored Glycine 0 CA--C 1.531 1.041 0 CA-C-N 119.256 1.528 . . . . 53.210000000000001 111.556 175.579 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -66.44 -49.37 1.82 Allowed 'Trans proline' 0 CA--C 1.534 0.502 0 C-N-CA 123.046 2.497 . . . . 74.299999999999997 112.459 -175.357 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -57.09 -43.67 82.43 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 119.406 1.003 . . . . 74.099999999999994 109.865 175.429 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -57.79 -34.88 70.08 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.21 -0.905 . . . . 71.400000000000006 109.958 -178.631 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 48.8 m -67.4 -41.51 84.81 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-O 118.179 -0.915 . . . . 74.25 110.689 -178.377 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 49.7 mt -66.45 -35.64 80.81 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 119.836 1.198 . . . . 54.329999999999998 111.039 176.864 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 10.3 mttt -51.39 -48.56 62.54 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.244 1.418 . . . . 63.240000000000002 110.09 170.881 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.501 HD11 ' HB3' ' A' ' 11' ' ' GLU . 3.2 mm? -67.58 -48.85 65.68 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-O 118.346 -0.835 . . . . 72.109999999999999 110.478 173.833 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -52.91 -37.55 60.86 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 123.375 0.67 . . . . 73.030000000000001 111.977 -172.576 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -81.36 -47.55 13.12 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.659 1.184 . . . . 74.299999999999997 110.657 -173.886 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -56.56 -47.79 78.72 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 108.82 -0.807 . . . . 65.439999999999998 108.82 176.876 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 182' ' ' LEU . . . . . 0.521 HD22 ' CG ' ' A' ' 162' ' ' TYR . 29.4 mt -63.57 -32.44 73.9 Favored 'General case' 0 CA--C 1.514 -0.438 0 C-N-CA 125.3 1.44 . . . . 61.030000000000001 112.205 -170.672 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 30.0 mt -58.38 -61.49 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 N-CA-C 107.046 -1.465 . . . . 71.019999999999996 107.046 174.058 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -53.05 -37.19 61.38 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 123.869 0.867 . . . . 64.120000000000005 111.691 -179.339 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 185' ' ' LYS . . . . . 0.457 ' HA ' ' HE2' ' A' ' 185' ' ' LYS . 0.0 OUTLIER -54.72 -39.09 67.88 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.547 0.739 . . . . 62.340000000000003 111.046 -176.063 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 63.8 mm-40 -95.14 -33.85 12.49 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 124.133 0.973 . . . . 65.549999999999997 112.135 175.126 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.05 -34.45 74.89 Favored 'General case' 0 CA--C 1.529 0.17 0 O-C-N 120.598 -1.314 . . . . 74.519999999999996 109.908 -179.022 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.237 0.427 0 C-N-CA 124.914 1.286 . . . . 54.210000000000001 112.174 179.385 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 . . . . . 0 CA--C 1.514 -0.43 0 CA-C-O 120.788 0.327 . . . . 62.200000000000003 110.977 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -134.21 11.37 3.86 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 126.278 1.831 . . . . 65.349999999999994 111.546 -170.698 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 -140.02 158.18 44.47 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 124.697 1.199 . . . . 71.439999999999998 108.485 -169.775 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 24.4 m -134.76 138.94 44.77 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 108.777 -0.823 . . . . 71.400000000000006 108.777 -178.577 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -71.14 143.74 50.47 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 109.146 -0.687 . . . . 75.420000000000002 109.146 174.192 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 68.1 14.28 65.78 Favored Glycine 0 CA--C 1.523 0.577 0 CA-C-O 119.315 -0.714 . . . . 32.439999999999998 112.515 -168.054 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 6.7 tttm -130.92 -82.56 0.53 Allowed 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 107.532 -1.285 . . . . 72.409999999999997 107.532 179.69 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.441 ' HB3' HD21 ' A' ' 178' ' ' LEU . 7.5 mp0 -79.44 -24.59 42.35 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 124.587 1.155 . . . . 70.400000000000006 111.361 -178.392 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 41.3 p90 -155.89 174.57 15.13 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 107.329 -1.36 . . . . 64.310000000000002 107.329 -177.075 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 23.0 t -132.29 146.82 32.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 108.474 -0.935 . . . . 74.230000000000004 108.474 -175.446 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -109.22 156.52 19.8 Favored 'General case' 0 N--CA 1.451 -0.409 0 O-C-N 120.894 -1.129 . . . . 75.430000000000007 109.161 166.398 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -126.02 120.22 29.72 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 125.747 1.619 . . . . 72.329999999999998 108.695 -169.338 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.8 m -55.13 -15.53 2.31 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.616 1.567 . . . . 61.350000000000001 114.223 -177.666 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 10.4 p -128.59 84.99 61.51 Favored Pre-proline 0 N--CA 1.445 -0.688 0 CA-C-N 119.164 0.893 . . . . 52.240000000000002 111.55 -179.552 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -73.08 179.79 5.07 Favored 'Trans proline' 0 CA--C 1.542 0.923 0 C-N-CA 124.449 3.432 . . . . 61.439999999999998 113.822 178.19 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 6.7 t -128.94 142.3 44.66 Favored Pre-proline 0 N--CA 1.47 0.564 0 C-N-CA 125.347 1.459 . . . . 70.239999999999995 108.102 173.989 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -76.73 176.52 10.01 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 123.608 2.872 . . . . 64.519999999999996 111.216 172.042 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.7 m -115.99 179.4 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 C-N-CA 124.017 0.927 . . . . 73.299999999999997 109.418 170.095 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 34.7 t -56.15 -64.03 0.99 Allowed 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 123.82 0.848 . . . . 73.150000000000006 108.906 169.448 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 19.1 mt-30 -150.38 161.23 31.27 Favored Pre-proline 0 C--O 1.237 0.442 0 O-C-N 121.68 -0.638 . . . . 73.329999999999998 110.761 -174.172 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -70.82 166.38 29.11 Favored 'Trans proline' 0 N--CA 1.45 -1.049 0 C-N-CA 122.747 2.298 . . . . 74.040000000000006 109.333 171.531 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 143.04 -86.57 0.18 Allowed Glycine 0 N--CA 1.449 -0.495 0 N-CA-C 108.894 -1.683 . . . . 65.430000000000007 108.894 -175.872 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.29 158.0 15.64 Favored 'General case' 0 N--CA 1.462 0.161 0 N-CA-C 108.616 -0.883 . . . . 74.109999999999999 108.616 -176.616 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 48.0 mm -66.63 154.91 7.61 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 N-CA-C 106.585 -1.635 . . . . 75.349999999999994 106.585 166.801 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -108.59 90.32 3.26 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 107.449 -1.315 . . . . 75.400000000000006 107.449 172.466 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 41.4 t -94.61 119.8 43.11 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.175 0 N-CA-C 106.654 -1.61 . . . . 70.430000000000007 106.654 176.889 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 25.4 t -119.45 110.99 31.2 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 N-CA-C 108.507 -0.923 . . . . 70.540000000000006 108.507 -174.291 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -72.61 126.94 31.1 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 108.046 -1.094 . . . . 71.129999999999995 108.046 154.488 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.5 mp -109.7 139.9 44.2 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 106.634 -1.617 . . . . 75.349999999999994 106.634 151.729 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 9.3 p90 -146.07 168.06 21.85 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 125.323 1.449 . . . . 74.120000000000005 107.974 -173.116 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 24.1 t90 -142.18 151.75 42.49 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 107.664 -1.236 . . . . 64.510000000000005 107.664 -177.146 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -47.15 -31.28 3.42 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.882 1.273 . . . . 74.420000000000002 112.085 166.982 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -109.5 17.9 30.52 Favored Glycine 0 CA--C 1.527 0.809 0 CA-C-O 117.577 -1.68 . . . . 74.420000000000002 115.138 -159.846 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 23.0 p -104.83 86.33 1.45 Allowed Pre-proline 0 CA--C 1.538 0.516 0 CA-C-N 119.644 1.722 . . . . 71.099999999999994 110.723 -170.434 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -58.51 -27.24 81.58 Favored 'Trans proline' 0 CA--C 1.54 0.776 0 CA-C-N 121.778 1.671 . . . . 52.020000000000003 114.232 -174.833 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 10.9 m170 -59.84 -19.63 52.14 Favored 'General case' 0 CA--C 1.537 0.449 0 O-C-N 121.365 -0.835 . . . . 72.439999999999998 112.592 174.067 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 98.8 m -71.01 -36.07 72.28 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.922 1.289 . . . . 65.129999999999995 110.632 -176.156 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 38.4 m-85 -61.68 -36.48 80.97 Favored 'General case' 0 N--CA 1.471 0.595 0 O-C-N 120.794 -1.191 . . . . 74.120000000000005 111.711 -177.462 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.74 -12.09 43.41 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 124.505 1.122 . . . . 71.329999999999998 112.209 179.299 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 27.1 t80 -126.41 -25.28 3.49 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-O 116.353 -1.784 . . . . 73.109999999999999 112.701 -172.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -45.37 -62.77 1.51 Allowed Pre-proline 0 N--CA 1.473 0.722 0 CA-C-N 121.619 2.009 . . . . 65.299999999999997 113.107 -177.517 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -70.38 -7.81 22.12 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 CA-C-N 121.179 1.457 . . . . 74.230000000000004 114.932 -178.872 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 25.4 m -80.84 -37.53 29.83 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.093 0.957 . . . . 64.109999999999999 110.061 170.295 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 20.6 tt -91.65 -31.62 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 C-N-CA 123.147 0.579 . . . . 74.420000000000002 111.617 -174.394 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 12.5 t -46.93 -62.8 1.71 Allowed Pre-proline 0 CA--C 1.539 0.533 0 CA-C-O 117.975 -1.012 . . . . 54.409999999999997 111.027 174.256 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -66.83 -34.91 29.13 Favored 'Trans proline' 0 N--CA 1.452 -0.939 0 CA-C-N 121.222 1.472 . . . . 54.32 111.027 -176.194 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 91.2 t90 -55.09 -47.32 75.08 Favored 'General case' 0 C--N 1.341 0.217 0 CA-C-N 119.778 1.172 . . . . 74.200000000000003 109.929 174.537 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 49.7 p -59.51 -38.1 80.06 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 122.783 0.433 . . . . 71.150000000000006 111.604 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.4 mt-10 -75.32 -10.55 59.55 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.34 1.456 . . . . 74.150000000000006 112.483 177.506 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 9.7 mmmm -119.44 9.8 11.69 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 126.447 1.899 . . . . 72.349999999999994 112.772 -174.571 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 27.5 mt -65.02 160.6 55.05 Favored Pre-proline 0 CA--C 1.538 0.506 0 C-N-CA 124.402 1.081 . . . . 55.25 111.661 172.501 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -82.66 169.7 13.39 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 124.913 3.742 . . . . 73.219999999999999 111.409 175.088 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -71.83 16.64 0.11 Allowed 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 126.755 2.022 . . . . 74.450000000000003 114.062 -175.304 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -127.09 -4.96 6.19 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 126.601 1.961 . . . . 73.400000000000006 113.074 -179.09 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.466 HG21 HD13 ' A' ' 183' ' ' ILE . 48.5 t -113.68 113.98 45.49 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.307 0 N-CA-C 106.689 -1.597 . . . . 54.439999999999998 106.689 -178.011 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 79.5 t60 -101.3 112.71 25.3 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 107.045 -1.465 . . . . 63.350000000000001 107.045 174.663 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 27.6 t80 -84.6 143.99 28.91 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 114.855 -1.066 . . . . 74.140000000000001 109.16 176.153 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 48.8 t -136.24 141.09 42.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 N-CA-C 106.387 -1.708 . . . . 71.239999999999995 106.387 -177.316 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 60.1 mtm-85 -123.43 113.33 18.65 Favored 'General case' 0 CA--C 1.508 -0.635 0 N-CA-C 104.613 -2.366 . . . . 74.340000000000003 104.613 176.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 5.8 mt -124.67 149.23 61.61 Favored Pre-proline 0 N--CA 1.466 0.326 0 CA-C-N 120.443 1.474 . . . . 54.109999999999999 110.043 174.294 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -67.53 143.43 62.85 Favored 'Trans proline' 0 N--CA 1.45 -1.051 0 C-N-CA 121.123 1.215 . . . . 54.420000000000002 110.743 -177.305 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -79.17 59.19 2.69 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.684 1.594 . . . . 50.310000000000002 111.49 -179.665 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 10.6 mt -74.1 88.13 1.91 Allowed 'General case' 0 C--N 1.328 -0.356 0 O-C-N 120.382 -1.449 . . . . 62.240000000000002 108.502 -176.673 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -141.61 1.98 1.57 Allowed 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 114.352 1.241 . . . . 75.549999999999997 114.352 175.649 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -153.04 179.0 29.82 Favored Glycine 0 C--N 1.333 0.401 0 O-C-N 121.078 -1.014 . . . . 72.049999999999997 113.814 -163.873 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -51.81 -53.56 29.18 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 128.589 2.995 . . . . 65.400000000000006 113.117 -164.289 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 9.8 tp -106.39 -6.85 10.24 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 C-N-CA 124.886 1.274 . . . . 51.32 110.884 173.39 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 8.9 m95 -73.76 -24.7 59.9 Favored 'General case' 0 N--CA 1.448 -0.568 0 O-C-N 120.876 -1.14 . . . . 73.549999999999997 111.495 -171.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -70.38 -46.94 63.04 Favored 'General case' 0 C--O 1.234 0.244 0 O-C-N 121.321 -0.862 . . . . 74.120000000000005 109.299 169.457 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 25.7 t -63.31 -53.13 49.65 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 C-N-CA 122.774 0.43 . . . . 70.299999999999997 110.189 -173.917 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 38.6 m170 -67.31 1.88 1.95 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.225 1.01 . . . . 54.43 113.185 178.457 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -109.19 -43.5 1.17 Allowed Glycine 0 C--N 1.338 0.669 0 CA-C-N 120.702 1.592 . . . . 63.210000000000001 110.697 -176.596 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -54.37 -36.62 64.07 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 113.391 0.886 . . . . 74.430000000000007 113.391 -170.832 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 5.9 ttt -45.21 -45.79 11.94 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 125.849 1.659 . . . . 64.25 114.434 -179.812 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 34.8 t80 -56.85 -42.34 79.53 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 121.52 0.676 . . . . 62.240000000000002 109.775 -173.904 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 18.2 mt -68.75 -42.11 77.97 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 117.082 -1.437 . . . . 60.43 109.291 178.909 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -56.51 -40.61 75.31 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 121.046 1.748 . . . . 74.530000000000001 110.944 178.255 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.07 -59.79 4.32 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 123.686 0.794 . . . . 71.109999999999999 110.219 179.243 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -65.24 -16.37 63.47 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 118.806 0.73 . . . . 73.319999999999993 112.208 -178.951 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -53.25 -25.74 15.52 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.208 1.003 . . . . 61.109999999999999 111.724 174.355 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 11.6 mtp . . . . . 0 CA--C 1.531 0.243 0 C-N-CA 125.429 1.492 . . . . 64.420000000000002 112.05 -172.464 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.119 0 CA-C-O 117.96 -1.019 . . . . 35.329999999999998 113.029 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 39.0 t -59.19 -62.67 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.339 0.14 0 N-CA-C 107.683 -1.229 . . . . 61.240000000000002 107.683 178.669 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -61.95 -49.57 75.59 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 123.874 0.87 . . . . 74.099999999999994 110.343 -179.387 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -57.29 -38.36 73.86 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.922 0.889 . . . . 72.099999999999994 110.488 -173.957 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.427 ' HA ' ' HB2' ' A' ' 101' ' ' GLU . . . -67.88 -43.79 78.55 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-O 122.46 1.124 . . . . 71.510000000000005 111.12 -178.452 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 45.2 mt -71.57 -36.29 59.48 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 N-CA-C 108.207 -1.034 . . . . 75.450000000000003 108.207 -175.371 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 81.1 m-70 -95.68 -74.03 0.57 Allowed 'General case' 0 N--CA 1.446 -0.66 0 O-C-N 121.46 -0.775 . . . . 75.319999999999993 109.936 -171.528 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 22.5 mmtt -64.12 -18.53 64.51 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 125.099 1.36 . . . . 75.209999999999994 112.097 -176.359 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.427 ' HB2' ' HA ' ' A' ' 97' ' ' ALA . 0.4 OUTLIER -108.82 -19.83 13.27 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 113.516 0.932 . . . . 74.200000000000003 113.516 179.243 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 3.9 t60 44.02 57.64 4.08 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 126.389 1.876 . . . . 75.219999999999999 112.059 173.325 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 12.6 mmtm -75.51 160.65 29.95 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.668 1.187 . . . . 65.319999999999993 109.992 178.308 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 32.7 tttt -77.61 29.83 0.16 Allowed 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 127.466 2.307 . . . . 74.239999999999995 113.892 -178.716 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 27.6 mt -74.62 49.88 0.41 Allowed 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 127.489 2.316 . . . . 74.150000000000006 111.734 -169.816 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -90.37 -0.26 57.56 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 128.093 2.557 . . . . 72.299999999999997 112.333 -178.535 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 23.8 p -141.01 153.41 67.18 Favored Pre-proline 0 C--O 1.233 0.23 0 C-N-CA 123.424 0.69 . . . . 63.439999999999998 110.135 173.439 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -63.89 -28.4 67.21 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 122.528 2.152 . . . . 63.509999999999998 112.642 -176.649 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 27.8 mp0 -70.35 -36.71 74.36 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 119.594 1.088 . . . . 70.239999999999995 110.31 177.286 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -73.37 -40.36 64.44 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.847 0.859 . . . . 74.140000000000001 109.544 178.612 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 45.1 mtt -58.47 -61.29 2.7 Favored 'General case' 0 C--N 1.343 0.286 0 C-N-CA 126.044 1.738 . . . . 65.200000000000003 109.935 174.671 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -62.91 -41.26 99.38 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 123.888 0.875 . . . . 71.349999999999994 111.476 -170.952 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -56.65 -41.91 78.04 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.049 0.452 . . . . 72.049999999999997 111.212 176.199 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' PHE . . . . . 0.407 ' CZ ' ' HB1' ' A' ' 97' ' ' ALA . 80.8 t80 -70.57 -40.69 73.17 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 123.614 0.766 . . . . 71.299999999999997 112.061 -179.173 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 56.1 mt -75.97 -17.02 59.88 Favored 'General case' 0 C--N 1.332 -0.181 0 O-C-N 121.378 -0.826 . . . . 55.229999999999997 111.445 -177.796 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -54.06 -28.33 38.18 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.981 0.912 . . . . 64.239999999999995 111.832 -178.075 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -89.54 -1.68 77.45 Favored Glycine 0 CA--C 1.529 0.94 0 CA-C-O 117.741 -1.589 . . . . 61.210000000000001 115.151 177.937 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 39.5 mttt -129.33 26.42 5.41 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 120.791 2.295 . . . . 74.150000000000006 112.647 -166.313 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 104.7 3.93 42.91 Favored Glycine 0 CA--C 1.527 0.812 0 C-N-CA 123.542 0.591 . . . . 71.129999999999995 113.463 173.101 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 77.0 t -106.3 165.09 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 C-N-CA 125.277 1.431 . . . . 75.200000000000003 107.899 179.733 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 60.8 t0 -132.87 132.24 41.87 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 105.711 -1.959 . . . . 61.020000000000003 105.711 176.849 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 21.3 mtpt -55.72 -36.03 66.77 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 123.523 0.729 . . . . 71.140000000000001 110.885 176.935 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -60.2 -50.87 71.96 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 118.875 0.761 . . . . 74.430000000000007 109.874 174.609 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -78.04 -28.03 48.91 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 108.979 -0.749 . . . . 60.299999999999997 108.979 -167.452 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 32.8 t80 -68.66 -69.73 0.31 Allowed 'General case' 0 N--CA 1.437 -1.09 0 C-N-CA 125.434 1.493 . . . . 72.329999999999998 108.845 173.627 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 8.1 mt -68.04 -37.99 81.99 Favored 'General case' 0 CA--C 1.531 0.24 0 O-C-N 121.244 -0.91 . . . . 73.310000000000002 110.348 -163.164 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 3.9 t -66.61 -21.13 66.13 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 118.781 -0.628 . . . . 73.049999999999997 112.232 -175.167 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 3.1 t -98.42 -35.11 10.39 Favored 'General case' 0 C--N 1.342 0.27 0 CA-C-N 119.196 0.907 . . . . 72.140000000000001 110.448 171.113 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 80.2 t80 -49.31 -55.69 11.95 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 119.184 0.902 . . . . 61.409999999999997 110.533 177.344 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 -86.08 55.61 3.61 Favored 'General case' 0 C--O 1.231 0.105 0 N-CA-C 108.714 -0.847 . . . . 53.340000000000003 108.714 174.356 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -157.91 166.53 32.4 Favored 'General case' 0 C--O 1.237 0.396 0 O-C-N 120.93 -1.106 . . . . 60.549999999999997 111.33 -177.973 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -74.6 -29.61 61.37 Favored 'General case' 0 N--CA 1.456 -0.14 0 CA-C-N 115.613 -0.721 . . . . 73.019999999999996 112.836 -162.551 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -56.73 -49.48 75.05 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 119.658 1.117 . . . . 73.340000000000003 110.258 -177.941 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 35.5 mm -63.02 -39.44 85.23 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.345 0 C-N-CA 125.161 1.384 . . . . 64.340000000000003 109.493 177.857 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 28.0 tttm -55.83 -42.67 76.08 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 118.585 -0.721 . . . . 72.329999999999998 109.562 175.305 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -71.18 -24.95 76.48 Favored Glycine 0 CA--C 1.523 0.559 0 C-N-CA 124.796 1.189 . . . . 70.450000000000003 111.958 -171.525 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -87.61 -50.4 6.53 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 124.347 1.059 . . . . 73.400000000000006 108.39 179.114 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 1.2 ppp? -58.49 -43.11 88.87 Favored 'General case' 0 C--N 1.34 0.161 0 C-N-CA 123.627 0.771 . . . . 74.25 109.737 -176.903 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -60.13 -40.01 88.27 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-O 118.464 -0.779 . . . . 64.230000000000004 112.133 -176.024 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -59.85 -59.38 5.52 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 123.906 0.883 . . . . 62.009999999999998 109.855 173.813 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -54.01 -34.0 58.7 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 118.038 0.381 . . . . 45.100000000000001 111.175 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 49.6 tttt -67.55 -59.67 3.17 Favored 'General case' 0 C--O 1.232 0.149 0 O-C-N 121.322 -0.861 . . . . 75.430000000000007 110.852 177.83 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.45 -24.28 64.7 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 118.452 0.569 . . . . 65.230000000000004 111.566 -174.686 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 32.6 mt -67.33 -53.16 32.05 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 118.52 -0.752 . . . . 75.340000000000003 110.203 170.543 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -53.92 -44.86 70.94 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 118.957 0.799 . . . . 71.420000000000002 112.291 -174.733 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 13.5 ptp -63.48 -46.9 84.03 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 119.423 -0.323 . . . . 53.119999999999997 111.551 176.692 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -58.87 -43.31 90.86 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 118.354 -0.831 . . . . 53.350000000000001 109.481 -179.762 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 18.1 m-85 -66.28 5.4 0.55 Allowed 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 115.078 1.511 . . . . 73.239999999999995 115.078 -175.096 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 59.2 mm-40 62.46 34.31 15.5 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 121.143 1.792 . . . . 71.409999999999997 113.198 176.39 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.818 HG22 ' NH2' ' A' ' 163' ' ' ARG . 57.5 t -80.5 -76.97 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 CA-C-O 118.415 -0.803 . . . . 73.349999999999994 111.18 -165.072 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . 0.26 1.6 p 54.59 -22.45 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 129.293 3.037 . . . . 62.310000000000002 118.18 -179.731 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.45 ' O ' HG13 ' A' ' 153' ' ' VAL . . . -99.45 -179.84 30.89 Favored Glycine 0 CA--C 1.532 1.102 0 CA-C-N 121.6 2.0 . . . . 43.549999999999997 111.807 168.467 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.45 HG13 ' O ' ' A' ' 152' ' ' GLY . 3.1 m -165.2 148.06 6.94 Favored Pre-proline 0 CA--C 1.547 0.865 0 C-N-CA 129.351 3.06 . . . . 75.329999999999998 108.033 167.808 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -67.34 142.35 62.2 Favored 'Cis proline' 0 N--CA 1.452 -0.923 0 CA-C-N 120.006 1.038 . . . . 71.319999999999993 110.543 -5.821 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 155' ' ' THR . . . . . 0.5 ' CG2' ' HE ' ' A' ' 163' ' ' ARG . 25.3 m -147.07 133.4 19.56 Favored 'General case' 0 N--CA 1.447 -0.575 0 N-CA-C 107.979 -1.119 . . . . 65.340000000000003 107.979 -174.253 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 42.6 mmm -111.81 163.69 13.89 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.324 1.45 . . . . 53.009999999999998 109.434 176.957 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 38.7 t -142.32 151.67 18.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 C-N-CA 125.154 1.382 . . . . 61.210000000000001 107.528 168.744 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 60.5 t -118.61 125.46 74.41 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 C-N-CA 125.802 1.641 . . . . 74.150000000000006 106.966 166.614 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 14.9 m-20 55.15 10.99 0.47 Allowed 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 128.016 2.526 . . . . 65.209999999999994 115.926 172.751 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 82.59 12.57 79.99 Favored Glycine 0 CA--C 1.522 0.524 0 CA-C-O 117.921 -1.488 . . . . 22.199999999999999 113.45 -174.537 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 45.1 mttt -121.67 -52.34 2.02 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-N 119.083 1.441 . . . . 61.340000000000003 111.227 -166.645 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 74.6 m-85 -99.68 122.65 43.0 Favored 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 108.086 -1.079 . . . . 75.340000000000003 108.086 -179.52 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 163' ' ' ARG . . . . . 0.818 ' NH2' HG22 ' A' ' 150' ' ' VAL . 0.1 OUTLIER -92.46 133.42 35.93 Favored 'General case' 0 N--CA 1.446 -0.675 0 C-N-CA 126.888 2.075 . . . . 72.450000000000003 105.496 169.256 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 20.6 p90 -147.93 167.96 23.49 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.062 -1.088 . . . . 62.030000000000001 108.062 168.975 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -174.65 -179.41 1.49 Allowed 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 123.957 0.903 . . . . 63.539999999999999 108.921 178.191 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 13.5 mt -55.61 -45.07 78.75 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 C-N-CA 126.99 2.116 . . . . 71.140000000000001 108.408 176.022 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -61.69 -39.54 97.56 Favored Glycine 0 C--N 1.338 0.667 0 C-N-CA 124.154 0.883 . . . . 73.5 112.415 178.323 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 16.2 m -74.36 -56.79 4.47 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 118.678 1.239 . . . . 71.049999999999997 110.273 178.565 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -74.15 -33.19 63.43 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 125.201 1.401 . . . . 72.310000000000002 113.626 -163.127 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 147.4 -46.77 0.7 Allowed Glycine 0 CA--C 1.521 0.424 0 O-C-N 123.648 0.593 . . . . 62.299999999999997 112.259 -178.047 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 168.16 -174.19 43.0 Favored Glycine 0 CA--C 1.53 0.972 0 N-CA-C 109.209 -1.557 . . . . 75.219999999999999 109.209 -156.31 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -66.76 -55.59 0.32 Allowed 'Trans proline' 0 N--CA 1.452 -0.958 0 C-N-CA 122.618 2.212 . . . . 73.140000000000001 111.003 -170.319 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -60.46 -41.85 95.0 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 121.838 0.827 . . . . 75.230000000000004 109.58 179.35 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -56.48 -29.87 62.27 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 124.971 1.308 . . . . 71.319999999999993 111.864 179.498 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 89.5 m -67.04 -44.49 80.06 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-O 118.358 -0.829 . . . . 65.329999999999998 109.817 179.411 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 55.9 mt -60.52 -37.82 82.4 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 118.945 0.793 . . . . 74.230000000000004 109.682 175.264 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 8.7 ttpp -52.25 -39.89 60.95 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 117.626 -1.178 . . . . 74.239999999999995 110.326 175.876 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.441 HD21 ' HB3' ' A' ' 11' ' ' GLU . 4.5 mm? -79.16 -43.38 24.08 Favored 'General case' 0 C--N 1.346 0.454 0 CA-C-N 120.601 1.546 . . . . 75.409999999999997 111.869 172.071 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -51.54 -41.86 61.38 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 119.287 0.949 . . . . 45.439999999999998 111.818 -175.906 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -78.37 -38.91 40.74 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 124.801 1.24 . . . . 51.439999999999998 110.613 -172.286 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 24.1 t80 -64.46 -54.6 29.94 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 125.091 1.356 . . . . 62.119999999999997 110.444 174.89 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 87.6 mt -60.98 -23.24 65.2 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.251 1.02 . . . . 72.5 113.294 -174.697 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.466 HD13 HG21 ' A' ' 58' ' ' VAL . 23.7 mt -57.02 -59.89 2.63 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 CA-C-N 119.275 0.943 . . . . 55.530000000000001 108.816 170.339 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 10.6 tm-20 -56.87 -37.58 71.54 Favored 'General case' 0 C--O 1.227 -0.108 0 C-N-CA 124.581 1.152 . . . . 71.530000000000001 110.356 -177.519 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 12.8 tptt -53.14 -41.06 64.73 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 124.292 1.037 . . . . 72.420000000000002 111.863 -179.771 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 32.5 mm-40 -91.67 -41.76 10.55 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.036 0.934 . . . . 71.219999999999999 111.242 178.507 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.38 -35.68 78.16 Favored 'General case' 0 C--O 1.234 0.268 0 O-C-N 120.645 -1.284 . . . . 73.420000000000002 109.952 -175.852 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.237 0.423 0 C-N-CA 125.275 1.43 . . . . 71.109999999999999 112.045 -179.927 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 . . . . . 0 CA--C 1.503 -0.829 0 CA-C-O 119.552 -0.261 . . . . 53.409999999999997 110.909 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . 0.336 13.8 m-20 75.99 11.31 3.04 Favored 'General case' 0 N--CA 1.435 -1.21 0 C-N-CA 128.43 2.692 . . . . 73.129999999999995 116.222 168.378 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -142.82 172.2 13.02 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 126.758 2.023 . . . . 74.140000000000001 107.73 173.806 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 61.5 m -140.78 138.0 33.77 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.887 0.875 . . . . 64.420000000000002 109.462 178.8 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.04 144.75 57.07 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 122.132 0.968 . . . . 72.340000000000003 110.272 175.425 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 80.5 -36.75 2.24 Favored Glycine 0 CA--C 1.526 0.776 0 C-N-CA 126.64 2.067 . . . . 63.420000000000002 111.787 -167.762 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -84.0 -76.5 0.29 Allowed 'General case' 0 CA--C 1.515 -0.372 0 C-N-CA 124.774 1.23 . . . . 54.329999999999998 110.134 -165.452 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 15.8 mp0 -78.87 -24.87 44.02 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 124.929 1.292 . . . . 74.0 110.452 178.949 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 37.9 p90 -160.32 174.41 14.22 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 123.806 0.842 . . . . 74.310000000000002 109.726 -172.89 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 32.8 t -132.48 112.49 19.27 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 C-N-CA 123.797 0.839 . . . . 74.219999999999999 109.13 178.418 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -71.0 154.44 41.81 Favored 'General case' 0 C--O 1.235 0.33 0 O-C-N 120.89 -1.131 . . . . 72.310000000000002 109.155 162.992 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -124.31 113.85 18.78 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 124.476 1.11 . . . . 54.329999999999998 110.292 -173.907 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 59.3 p -69.66 13.34 0.14 Allowed 'General case' 0 C--O 1.236 0.379 0 C-N-CA 127.177 2.191 . . . . 70.120000000000005 114.278 -175.92 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 32.1 t -143.28 78.77 14.67 Favored Pre-proline 0 N--CA 1.454 -0.239 0 N-CA-C 108.085 -1.08 . . . . 74.409999999999997 108.085 165.852 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -67.22 -179.92 2.07 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 122.867 2.378 . . . . 64.209999999999994 111.922 -173.239 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 40.6 t -130.71 136.66 29.28 Favored Pre-proline 0 C--O 1.233 0.212 0 N-CA-C 107.073 -1.454 . . . . 72.120000000000005 107.073 179.682 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -79.27 173.71 12.93 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 121.836 1.69 . . . . 72.140000000000001 110.939 176.204 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 20.7 m -122.4 169.49 13.69 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 C-N-CA 125.09 1.356 . . . . 72.430000000000007 109.622 -178.183 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.1 t -47.74 -64.25 0.84 Allowed 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 126.406 1.882 . . . . 63.009999999999998 109.808 176.314 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -147.07 164.58 22.59 Favored Pre-proline 0 C--O 1.237 0.401 0 C-N-CA 123.931 0.893 . . . . 74.310000000000002 109.86 178.168 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_endo -66.3 176.07 4.35 Favored 'Trans proline' 0 N--CA 1.45 -1.04 0 C-N-CA 122.081 1.854 . . . . 64.150000000000006 111.066 163.767 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 129.39 -89.42 0.31 Allowed Glycine 0 N--CA 1.448 -0.559 0 N-CA-C 108.059 -2.016 . . . . 51.329999999999998 108.059 -178.029 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -85.21 163.53 18.64 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 117.919 0.86 . . . . 60.109999999999999 109.322 -179.085 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 46.9 mm -77.13 137.51 22.3 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 N-CA-C 105.204 -2.147 . . . . 73.439999999999998 105.204 158.125 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -99.3 118.0 35.0 Favored 'General case' 0 N--CA 1.445 -0.725 0 N-CA-C 105.859 -1.904 . . . . 72.409999999999997 105.859 -179.442 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 60.2 t -121.64 131.81 72.22 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 N-CA-C 106.723 -1.584 . . . . 74.219999999999999 106.723 -179.091 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 43.2 t -127.09 138.72 54.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 106.241 -1.763 . . . . 72.019999999999996 106.241 -175.22 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -106.32 137.74 43.74 Favored 'General case' 0 C--O 1.239 0.525 0 N-CA-C 106.655 -1.609 . . . . 65.25 106.655 158.828 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 5.3 mp -115.69 137.21 52.31 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 107.455 -1.313 . . . . 74.120000000000005 107.455 163.714 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 31.3 p90 -141.44 169.01 18.41 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 124.122 0.969 . . . . 71.109999999999999 110.034 -172.101 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' TRP . . . . . 0.5 ' HB3' HG21 ' A' ' 153' ' ' VAL . 29.7 t90 -155.11 153.21 30.49 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 123.663 0.785 . . . . 63.109999999999999 109.464 179.313 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 56.2 t80 -44.08 -51.26 8.08 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 129.366 3.067 . . . . 75.430000000000007 113.84 -172.999 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -72.05 -90.49 0.11 Allowed Glycine 0 C--N 1.339 0.705 0 N-CA-C 110.944 -0.862 . . . . 71.239999999999995 110.944 -171.986 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 34.4 t 43.51 68.92 2.63 Favored Pre-proline 0 CA--C 1.546 0.797 0 C-N-CA 125.283 1.433 . . . . 74.540000000000006 113.824 163.842 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -63.53 -14.87 45.1 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 122.743 2.295 . . . . 73.310000000000002 114.126 -176.415 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 20.3 m170 -84.24 -22.85 30.68 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 119.856 1.207 . . . . 75.239999999999995 112.537 172.07 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 60.4 m -62.65 -48.73 78.06 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 120.284 1.402 . . . . 72.129999999999995 110.619 -174.105 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 45.4 t80 -61.75 -27.55 68.81 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 120.554 -1.341 . . . . 71.549999999999997 112.23 -175.595 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.26 -6.58 40.81 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.558 0.743 . . . . 73.150000000000006 112.73 177.285 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.403 ' CB ' HD11 ' A' ' 166' ' ' ILE . 26.8 t80 -123.64 -13.93 7.39 Favored 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 126.387 1.875 . . . . 73.129999999999995 111.594 -175.52 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 67.0 tt0 -50.73 -64.64 1.22 Allowed Pre-proline 0 CA--C 1.536 0.433 0 CA-C-N 119.813 1.188 . . . . 72.140000000000001 111.512 -178.725 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -74.96 -4.77 15.91 Favored 'Trans proline' 0 N--CA 1.453 -0.881 0 CA-C-N 120.831 1.333 . . . . 62.039999999999999 114.294 -175.659 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.5 m -70.15 -47.25 62.49 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 107.892 -1.151 . . . . 54.310000000000002 107.892 163.952 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 19.3 tt -96.8 -28.5 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 N-CA-C 113.704 1.001 . . . . 65.140000000000001 113.704 -165.627 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 74.0 t -54.19 -55.97 31.08 Favored Pre-proline 0 CA--C 1.545 0.772 0 CA-C-N 119.64 1.109 . . . . 75.299999999999997 111.314 173.457 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -68.14 -24.93 37.88 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 CA-C-N 120.85 1.339 . . . . 61.049999999999997 111.794 -179.006 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 77.8 t90 -62.38 -55.18 30.39 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 119.274 0.943 . . . . 75.040000000000006 109.008 170.848 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.5 p -61.01 -41.95 97.52 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 123.704 0.802 . . . . 55.119999999999997 112.555 -173.248 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -62.63 -39.86 95.14 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 119.282 0.946 . . . . 73.109999999999999 110.886 175.619 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 8.0 mptt -90.88 20.06 5.1 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 113.543 0.942 . . . . 74.409999999999997 113.543 -170.618 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 32.1 mt -65.71 164.85 23.23 Favored Pre-proline 0 CA--C 1.543 0.674 0 C-N-CA 126.421 1.888 . . . . 70.310000000000002 111.75 175.081 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -83.7 174.45 8.65 Favored 'Trans proline' 0 N--CA 1.454 -0.838 1 C-N-CA 125.64 4.226 . . . . 61.219999999999999 110.933 174.203 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -71.24 -10.26 59.47 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 113.829 1.048 . . . . 72.409999999999997 113.829 -176.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -103.61 5.79 36.76 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 119.364 0.984 . . . . 72.109999999999999 112.074 -170.794 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 87.6 t -117.42 152.61 19.29 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 C-N-CA 124.9 1.28 . . . . 73.200000000000003 107.793 -178.764 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 22.6 t-160 -136.78 92.91 2.79 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 126.486 1.914 . . . . 64.310000000000002 106.651 178.765 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -79.78 132.67 36.21 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 124.488 1.115 . . . . 74.340000000000003 109.692 173.466 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 23.4 t -136.51 158.62 37.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 C-N-CA 125.453 1.501 . . . . 74.340000000000003 107.76 -179.582 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 55.7 mtp180 -131.41 128.42 39.51 Favored 'General case' 0 CA--C 1.506 -0.718 0 N-CA-C 106.897 -1.52 . . . . 73.409999999999997 106.897 179.487 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 70.1 mt -127.44 153.2 77.29 Favored Pre-proline 0 N--CA 1.464 0.267 0 O-C-N 123.379 0.425 . . . . 73.510000000000005 111.082 173.885 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -75.42 134.14 16.79 Favored 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 122.371 2.047 . . . . 65.219999999999999 111.209 179.019 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -75.0 95.78 3.07 Favored 'General case' 0 CA--C 1.54 0.562 0 O-C-N 121.038 -1.039 . . . . 73.209999999999994 111.598 176.241 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 20.0 mt -88.6 95.38 10.22 Favored 'General case' 0 CA--C 1.541 0.62 0 O-C-N 120.42 -1.425 . . . . 73.530000000000001 111.188 -177.728 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -133.83 5.33 3.63 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 116.027 1.862 . . . . 64.319999999999993 116.027 -173.342 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -154.33 -143.62 3.72 Favored Glycine 0 C--N 1.336 0.573 0 CA-C-N 119.039 0.836 . . . . 50.039999999999999 114.269 -166.975 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -89.96 -85.58 1.34 Allowed Glycine 0 CA--C 1.524 0.607 0 N-CA-C 106.887 -2.485 . . . . 73.040000000000006 106.887 155.242 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.2 tt -58.61 -25.23 27.73 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 N-CA-C 113.133 0.79 . . . . 70.040000000000006 113.133 -168.861 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' TRP . . . . . 0.401 ' HA ' ' CD1' ' A' ' 34' ' ' TRP . 10.8 m95 -54.55 -40.7 68.96 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 123.891 0.876 . . . . 74.219999999999999 112.214 175.137 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 17.2 p30 -91.73 -27.32 18.12 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 112.892 0.701 . . . . 53.43 112.892 179.034 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 39.4 t -64.71 -41.59 92.64 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-N 118.536 0.607 . . . . 65.230000000000004 109.578 174.095 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 66.6 m170 -79.14 7.08 8.12 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.821 1.248 . . . . 73.200000000000003 112.327 170.966 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -103.08 -37.55 3.1 Favored Glycine 0 CA--C 1.525 0.69 0 O-C-N 120.989 -1.069 . . . . 75.140000000000001 111.594 -179.548 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -65.12 -25.6 67.83 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 114.456 1.28 . . . . 74.5 114.456 -165.908 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 6.6 ttt -62.95 -43.02 99.94 Favored 'General case' 0 N--CA 1.463 0.191 0 O-C-N 120.926 -1.109 . . . . 62.350000000000001 112.055 -175.262 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -51.29 -52.85 41.38 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 125.011 1.324 . . . . 75.299999999999997 108.367 -176.857 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 13.7 mt -63.37 -39.56 94.87 Favored 'General case' 0 C--O 1.226 -0.182 0 C-N-CA 124.451 1.1 . . . . 70.430000000000007 110.122 -178.296 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.467 HG23 HG23 ' A' ' 128' ' ' THR . 1.4 m -66.71 -38.38 86.6 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 118.873 0.761 . . . . 70.5 109.775 -178.048 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.48 -60.13 4.11 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 124.063 0.945 . . . . 72.099999999999994 108.535 177.478 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -60.84 -25.03 66.34 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 124.166 0.986 . . . . 75.109999999999999 112.686 -177.742 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -62.98 -5.62 3.11 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.885 1.674 . . . . 71.040000000000006 114.566 176.406 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 29.5 mtm . . . . . 0 N--CA 1.473 0.685 0 N-CA-C 115.047 1.499 . . . . 33.43 115.047 165.843 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.294 0 N-CA-C 114.384 1.253 . . . . 64.120000000000005 114.384 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 56.2 t -62.93 -61.45 1.65 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.189 0 N-CA-C 108.079 -1.082 . . . . 55.420000000000002 108.079 172.02 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -62.84 -42.2 99.64 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 125.29 1.436 . . . . 74.120000000000005 110.636 -178.361 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -71.66 3.66 3.85 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 124.828 1.251 . . . . 65.540000000000006 112.351 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -115.52 5.08 14.35 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 115.658 1.725 . . . . 52.299999999999997 115.658 164.934 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 13.6 mt -117.21 -51.13 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 CA-C-N 120.476 1.489 . . . . 61.109999999999999 108.732 177.681 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 88.2 m-70 -63.97 -83.04 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 126.025 1.73 . . . . 72.219999999999999 113.231 -179.606 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.64 -16.71 64.3 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 126.711 2.004 . . . . 65.409999999999997 114.606 -177.452 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -97.17 -32.91 11.7 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 124.572 1.149 . . . . 74.430000000000007 111.64 178.875 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 1.8 t-160 50.38 36.37 12.97 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 125.572 1.549 . . . . 75.319999999999993 112.924 173.424 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.453 ' HG2' ' H ' ' A' ' 103' ' ' LYS . 0.1 OUTLIER -71.35 164.76 25.12 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 124.039 0.936 . . . . 73.409999999999997 108.784 168.959 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 10.2 mtpt -61.82 -72.11 0.13 Allowed 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 124.94 1.296 . . . . 73.120000000000005 109.433 172.602 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.418 HD21 ' HE3' ' A' ' 103' ' ' LYS . 77.2 mt 50.91 54.52 11.09 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 124.707 1.203 . . . . 72.040000000000006 111.455 -172.316 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -109.81 1.36 19.27 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.666 1.586 . . . . 65.310000000000002 113.326 -170.231 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -147.22 156.49 46.49 Favored Pre-proline 0 C--O 1.234 0.287 0 C-N-CA 126.948 2.099 . . . . 32.350000000000001 109.63 -167.448 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -70.99 -38.19 5.4 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 122.759 2.306 . . . . 62.119999999999997 110.927 -170.119 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -62.2 -48.93 77.81 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 109.022 -0.732 . . . . 61.039999999999999 109.022 172.037 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -58.45 -39.74 80.7 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 124.853 1.261 . . . . 62.130000000000003 111.737 -171.227 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 59.3 mtm -78.0 -50.23 12.53 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 124.523 1.129 . . . . 54.310000000000002 111.336 174.679 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.403 ' HB1' ' HG3' ' A' ' 122' ' ' LYS . . . -64.42 -39.53 94.02 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 119.05 0.841 . . . . 43.32 110.93 -173.63 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -71.03 -22.5 62.14 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 123.764 0.826 . . . . 73.329999999999998 111.509 -179.516 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 91.4 t80 -73.29 -51.46 17.51 Favored 'General case' 0 N--CA 1.45 -0.473 0 O-C-N 121.495 -0.753 . . . . 64.129999999999995 109.631 170.691 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 68.2 mt -69.83 -17.7 63.4 Favored 'General case' 0 N--CA 1.452 -0.351 0 O-C-N 121.728 -0.608 . . . . 72.129999999999995 111.337 -175.8 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -55.9 -18.09 8.1 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.91 0.884 . . . . 71.510000000000005 111.563 167.468 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -98.51 3.75 59.59 Favored Glycine 0 CA--C 1.527 0.803 0 CA-C-O 117.416 -1.769 . . . . 54.310000000000002 114.835 171.76 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.547 ' HA ' ' HE2' ' A' ' 118' ' ' LYS . 7.7 mmpt? -125.85 13.66 7.96 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 120.654 2.227 . . . . 70.420000000000002 113.123 -169.375 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 87.23 26.62 30.34 Favored Glycine 0 CA--C 1.522 0.517 0 CA-C-N 118.836 0.744 . . . . 61.520000000000003 112.526 -179.818 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 76.2 t -112.07 136.76 47.25 Favored 'Isoleucine or valine' 0 C--O 1.24 0.605 0 C-N-CA 125.648 1.579 . . . . 75.019999999999996 107.186 175.276 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 32.0 t0 -85.53 116.28 23.74 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 108.551 -0.907 . . . . 61.219999999999999 108.551 171.422 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.403 ' HG3' ' HB1' ' A' ' 112' ' ' ALA . 3.1 tttm -52.77 -48.08 67.06 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 125.638 1.575 . . . . 53.329999999999998 109.437 177.746 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -65.6 -22.72 66.7 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 113.078 0.77 . . . . 73.200000000000003 113.078 -175.98 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 49.4 mmtt -82.9 -50.74 8.29 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 107.673 -1.232 . . . . 64.299999999999997 107.673 175.815 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -49.08 -62.0 1.77 Allowed 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 125.648 1.579 . . . . 74.129999999999995 109.729 -179.14 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 20.5 mt -62.93 -39.27 94.09 Favored 'General case' 0 C--O 1.233 0.213 0 C-N-CA 122.744 0.417 . . . . 52.210000000000001 110.889 -174.419 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 39.5 t -57.17 -50.95 71.23 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 123.145 0.578 . . . . 73.120000000000005 109.919 -177.65 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' THR . . . . . 0.467 HG23 HG23 ' A' ' 80' ' ' THR . 2.6 t -81.35 -33.14 32.61 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 119.184 -0.436 . . . . 72.219999999999999 110.761 -175.453 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 82.3 t80 -50.35 -52.39 37.51 Favored 'General case' 0 C--N 1.344 0.34 0 C-N-CA 124.719 1.207 . . . . 72.219999999999999 109.467 172.199 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -90.39 55.56 3.08 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 124.265 1.026 . . . . 75.400000000000006 109.495 174.703 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 22.7 t -140.64 162.2 35.94 Favored 'General case' 0 C--O 1.234 0.258 0 O-C-N 121.083 -1.011 . . . . 62.25 110.795 172.613 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -58.08 -26.97 63.22 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.733 1.213 . . . . 71.439999999999998 110.673 168.506 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -53.31 -59.27 4.79 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 124.492 1.117 . . . . 63.229999999999997 111.218 179.749 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 41.7 mm -69.06 -26.3 31.89 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 C-N-CA 123.266 0.626 . . . . 63.340000000000003 110.355 178.706 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 17.7 tttt -58.37 -36.32 73.31 Favored 'General case' 0 CA--C 1.522 -0.1 0 O-C-N 121.35 -0.844 . . . . 73.099999999999994 111.008 175.768 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -63.3 -46.1 93.64 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 110.665 -0.974 . . . . 72.340000000000003 110.665 178.822 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -66.04 -44.84 83.47 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 123.196 0.599 . . . . 53.119999999999997 110.008 -179.16 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 94.9 mmm -57.32 -47.84 80.5 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 118.595 -0.717 . . . . 63.020000000000003 109.948 176.231 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -65.87 -40.92 92.07 Favored 'General case' 0 N--CA 1.457 -0.098 0 CA-C-N 119.573 1.079 . . . . 71.109999999999999 112.126 -175.812 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 11.2 mtpt -60.13 -58.13 9.87 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-O 118.242 -0.885 . . . . 74.230000000000004 109.579 176.27 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -53.64 -39.8 65.29 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 119.137 0.88 . . . . 75.430000000000007 110.762 178.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 25.7 ttmt -60.97 -63.07 1.42 Allowed 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.128 0.971 . . . . 64.439999999999998 110.481 178.837 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 16.6 ptmt -64.89 -24.01 67.4 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 123.463 0.705 . . . . 62.219999999999999 111.0 -176.041 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.427 HD23 ' HA ' ' A' ' 144' ' ' LEU . 41.7 mt -75.77 -53.76 8.0 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 118.637 -0.697 . . . . 54.32 111.055 175.554 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -52.57 -54.28 35.02 Favored 'General case' 0 C--O 1.228 -0.04 0 C-N-CA 123.865 0.866 . . . . 53.119999999999997 110.52 -173.626 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 3.9 ppp? -55.37 -47.06 76.38 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 113.23 0.826 . . . . 60.310000000000002 113.23 177.803 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -69.11 -29.85 68.01 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-O 118.093 -0.956 . . . . 64.510000000000005 110.291 -176.157 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 23.5 m-85 -71.81 16.29 0.12 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.241 1.416 . . . . 75.420000000000002 113.431 173.355 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 16.8 mm-40 63.31 17.54 10.33 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.062 1.345 . . . . 74.109999999999999 112.724 174.282 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 59.1 t -65.84 90.88 0.11 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.376 0 C-N-CA 125.712 1.605 . . . . 72.530000000000001 109.379 -174.652 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -95.97 88.59 4.94 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-O 123.137 1.446 . . . . 71.340000000000003 108.237 161.843 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 104.65 -162.5 14.85 Favored Glycine 0 N--CA 1.445 -0.712 0 CA-C-N 112.645 -2.07 . . . . 73.299999999999997 111.818 164.404 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.5 HG21 ' HB3' ' A' ' 34' ' ' TRP . 16.6 m -144.38 155.48 57.5 Favored Pre-proline 0 CA--C 1.539 0.524 0 C-N-CA 126.314 1.846 . . . . 74.150000000000006 107.37 178.092 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_endo -64.76 160.15 70.4 Favored 'Cis proline' 0 CA--C 1.54 0.823 0 C-N-CA 124.195 -1.169 . . . . 75.439999999999998 110.465 -12.093 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 5.4 m -153.42 108.12 3.14 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 123.686 0.795 . . . . 65.209999999999994 109.575 -179.616 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 50.7 mmm -93.87 153.44 18.25 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 124.288 1.035 . . . . 74.230000000000004 109.946 169.665 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 94.2 t -145.21 155.04 13.73 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 C-N-CA 125.102 1.361 . . . . 74.5 107.393 175.785 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 50.6 t -126.25 123.95 64.7 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 C-N-CA 127.783 2.433 . . . . 73.439999999999998 107.164 177.288 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 15.9 m-20 52.23 18.44 0.88 Allowed 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 129.294 3.038 . . . . 70.510000000000005 114.685 174.286 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 62.89 31.34 80.16 Favored Glycine 0 CA--C 1.532 1.152 0 CA-C-O 118.025 -1.431 . . . . 73.239999999999995 113.92 -169.288 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 9.2 mtpt -133.87 -28.15 1.41 Allowed 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 119.863 1.831 . . . . 72.209999999999994 113.334 -175.506 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -125.83 129.05 48.63 Favored 'General case' 0 CA--C 1.512 -0.5 0 N-CA-C 107.7 -1.222 . . . . 72.430000000000007 107.7 177.817 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 2.4 ttp85 -114.73 134.96 54.68 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 127.124 2.169 . . . . 74.409999999999997 105.787 179.781 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 28.2 p90 -151.22 167.26 28.34 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.988 -0.745 . . . . 70.400000000000006 108.988 -179.462 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -176.03 178.25 1.48 Allowed 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.269 1.028 . . . . 74.109999999999999 109.896 -178.175 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.403 HD11 ' CB ' ' A' ' 43' ' ' PHE . 38.1 mt -52.18 -42.23 35.51 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 C-N-CA 126.482 1.913 . . . . 53.130000000000003 110.459 178.914 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -80.25 -21.58 64.68 Favored Glycine 0 CA--C 1.526 0.722 0 CA-C-O 118.646 -1.086 . . . . 72.109999999999999 112.56 -179.407 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 1.1 m -72.83 -63.91 1.07 Allowed 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 119.716 1.758 . . . . 65.129999999999995 107.484 170.359 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -64.33 -38.59 91.56 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 123.907 0.883 . . . . 64.150000000000006 111.065 -168.568 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 121.06 -3.87 11.46 Favored Glycine 0 CA--C 1.525 0.674 0 CA-C-O 118.268 -1.295 . . . . 60.329999999999998 112.872 175.061 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 175.74 172.65 40.75 Favored Glycine 0 CA--C 1.528 0.852 0 CA-C-N 119.364 1.582 . . . . 71.030000000000001 110.231 -175.815 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -65.74 -44.68 7.69 Favored 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 122.524 2.149 . . . . 60.219999999999999 109.82 -177.727 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -63.64 -38.28 90.52 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-O 122.228 1.013 . . . . 74.409999999999997 110.467 -176.927 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -68.0 -29.18 68.13 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 126.291 1.836 . . . . 63.240000000000002 109.433 -176.588 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 35.9 m -64.85 -45.09 87.57 Favored 'General case' 0 CA--C 1.533 0.325 0 O-C-N 121.082 -1.011 . . . . 75.310000000000002 110.069 -176.229 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 46.0 mt -63.97 -32.05 73.45 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 118.799 0.727 . . . . 73.540000000000006 110.784 177.542 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 1.9 ttmt -55.41 -38.89 69.53 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 124.31 1.044 . . . . 64.109999999999999 110.148 175.258 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.433 HD13 ' HA ' ' A' ' 178' ' ' LEU . 4.5 mm? -76.47 -41.58 46.71 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-O 118.136 -0.935 . . . . 74.129999999999995 110.552 174.174 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -52.67 -50.36 63.4 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 119.325 0.966 . . . . 70.310000000000002 112.025 -175.442 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -72.12 -42.19 66.33 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 123.323 0.649 . . . . 53.140000000000001 109.347 -173.144 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 10.9 t80 -63.0 -46.38 87.94 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 124.468 1.107 . . . . 74.019999999999996 111.158 178.255 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 81.3 mt -67.69 -34.17 76.38 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 123.649 0.78 . . . . 73.219999999999999 111.024 -178.381 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 29.5 mt -53.75 -55.82 11.86 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 N-CA-C 107.995 -1.113 . . . . 71.530000000000001 107.995 166.828 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -56.63 -31.91 64.8 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.979 0.912 . . . . 72.349999999999994 112.863 -177.689 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 9.3 tptm -68.83 -48.21 64.1 Favored 'General case' 0 N--CA 1.463 0.209 0 O-C-N 121.401 -0.812 . . . . 63.409999999999997 110.535 -179.305 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 35.6 mm-40 -74.75 -42.47 58.18 Favored 'General case' 0 C--O 1.222 -0.367 0 O-C-N 121.955 -0.466 . . . . 63.200000000000003 111.228 178.508 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.05 -34.28 74.64 Favored 'General case' 0 N--CA 1.465 0.288 0 O-C-N 121.073 -1.017 . . . . 74.430000000000007 110.739 -176.874 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.368 0 C-N-CA 123.56 0.744 . . . . 65.049999999999997 112.378 175.355 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.515 -0.391 0 CA-C-O 123.479 1.609 . . . . 64.510000000000005 110.316 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -73.26 11.95 0.66 Allowed 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 127.096 2.158 . . . . 72.120000000000005 113.025 -179.754 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 14.4 m-85 -146.43 157.74 43.8 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 126.01 1.724 . . . . 75.019999999999996 108.056 -175.19 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.9 m -131.23 132.8 44.89 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 107.671 -1.233 . . . . 73.510000000000005 107.671 -174.328 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -69.61 148.45 49.34 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 108.158 -1.052 . . . . 60.0 108.158 175.869 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 63.69 13.61 52.04 Favored Glycine 0 CA--C 1.535 1.308 0 C-N-CA 124.68 1.134 . . . . 65.340000000000003 113.445 -167.02 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.94 -63.06 0.98 Allowed 'General case' 0 CA--C 1.52 -0.208 0 CA-C-N 119.775 1.788 . . . . 73.540000000000006 107.804 -177.962 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.432 ' HB3' HD21 ' A' ' 178' ' ' LEU . 12.4 mp0 -98.44 -25.91 14.63 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.342 1.457 . . . . 71.109999999999999 110.505 178.109 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 50.6 p90 -154.56 167.12 31.16 Favored 'General case' 0 N--CA 1.467 0.41 0 O-C-N 121.238 -0.914 . . . . 73.319999999999993 111.697 -171.85 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 59.2 t -132.9 115.91 25.37 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 C-N-CA 124.859 1.263 . . . . 74.140000000000001 109.058 -171.931 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -80.43 167.3 20.35 Favored 'General case' 0 C--O 1.236 0.392 0 O-C-N 119.972 -1.705 . . . . 72.319999999999993 110.478 174.301 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -126.16 124.64 40.96 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 124.237 1.015 . . . . 72.200000000000003 108.88 172.694 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 8.2 m -67.34 -9.45 41.32 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.838 0.855 . . . . 34.109999999999999 113.163 179.296 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 30.2 m -129.32 74.47 80.96 Favored Pre-proline 0 CA--C 1.537 0.454 0 C-N-CA 124.224 1.01 . . . . 52.340000000000003 108.625 -177.009 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -69.56 -179.01 2.53 Favored 'Trans proline' 0 N--CA 1.46 -0.459 0 C-N-CA 125.056 3.837 . . . . 73.299999999999997 112.281 -172.12 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.2 t -128.68 138.93 34.18 Favored Pre-proline 0 CA--C 1.532 0.27 0 C-N-CA 124.672 1.189 . . . . 72.109999999999999 107.93 -174.909 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_endo -73.13 179.1 5.74 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 122.42 2.08 . . . . 72.319999999999993 112.613 176.286 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.4 m -127.46 168.25 20.9 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 C-N-CA 126.826 2.051 . . . . 71.510000000000005 108.945 174.028 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 70.9 m -47.01 -61.84 1.69 Allowed 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 126.795 2.038 . . . . 62.399999999999999 110.508 176.98 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -145.82 165.38 21.17 Favored Pre-proline 0 C--O 1.238 0.492 0 C-N-CA 127.347 2.259 . . . . 73.030000000000001 105.375 163.079 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -70.88 -164.66 0.15 Allowed 'Trans proline' 0 CA--C 1.541 0.862 0 C-N-CA 122.62 2.213 . . . . 73.219999999999999 110.222 173.325 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 118.1 -112.68 2.45 Favored Glycine 0 N--CA 1.447 -0.627 0 N-CA-C 106.301 -2.72 . . . . 72.450000000000003 106.301 -179.388 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 33.4 mttm -54.46 133.69 45.81 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 124.136 0.974 . . . . 65.450000000000003 108.721 172.177 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.424 HD12 ' HB3' ' A' ' 186' ' ' GLU . 31.8 mm -64.59 140.72 19.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 106.377 -1.712 . . . . 72.409999999999997 106.377 169.541 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -99.21 139.17 35.26 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 107.559 -1.274 . . . . 74.319999999999993 107.559 -177.65 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 56.1 t -128.54 130.43 69.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 105.895 -1.891 . . . . 53.329999999999998 105.895 176.684 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 11.3 t -131.2 108.05 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 N-CA-C 107.417 -1.327 . . . . 63.32 107.417 -172.591 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -69.0 143.34 54.38 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 124.27 1.028 . . . . 64.310000000000002 108.556 162.26 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.521 ' CD2' HG21 ' A' ' 150' ' ' VAL . 5.0 mp -121.75 131.08 53.88 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 108.881 -0.785 . . . . 73.200000000000003 108.881 158.416 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 23.9 p90 -127.33 176.77 7.18 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.477 1.111 . . . . 64.420000000000002 110.469 179.249 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 27.1 t90 -151.0 175.8 11.73 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.082 1.353 . . . . 75.019999999999996 109.559 174.551 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 40.2 t80 -61.5 -73.18 0.1 Allowed 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.616 1.166 . . . . 74.239999999999995 112.876 172.741 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -81.86 52.03 4.53 Favored Glycine 0 C--N 1.339 0.705 0 C-N-CA 124.823 1.201 . . . . 44.399999999999999 110.358 -171.123 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 35.8 t -113.5 84.81 8.25 Favored Pre-proline 0 CA--C 1.538 0.487 0 C-N-CA 127.462 2.305 . . . . 72.439999999999998 106.051 -163.848 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -72.57 168.56 24.08 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 123.314 2.676 . . . . 61.329999999999998 109.217 171.228 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 5.2 m170 63.98 -45.7 0.27 Allowed 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 126.476 1.91 . . . . 73.420000000000002 112.116 -165.007 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 3.8 m -46.74 -53.14 12.43 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 126.745 2.018 . . . . 75.150000000000006 110.604 176.425 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 11.7 t80 -58.92 -49.92 75.99 Favored 'General case' 0 C--N 1.341 0.229 0 C-N-CA 125.361 1.464 . . . . 72.120000000000005 110.894 176.51 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.76 -13.52 61.51 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 112.742 0.645 . . . . 55.020000000000003 112.742 -171.356 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 7.0 t80 -90.71 -16.85 27.76 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 125.714 1.605 . . . . 71.510000000000005 112.073 179.262 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -46.68 -67.27 0.4 Allowed Pre-proline 0 N--CA 1.469 0.485 0 CA-C-N 120.059 1.299 . . . . 73.239999999999995 112.566 -172.81 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -69.02 -9.13 25.52 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 CA-C-N 122.033 1.762 . . . . 75.239999999999995 114.496 -177.759 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.9 m -70.91 -43.18 68.83 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 119.758 1.163 . . . . 65.519999999999996 108.798 167.167 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 21.1 tt -105.2 -28.51 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 N-CA-C 113.825 1.046 . . . . 64.340000000000003 113.825 -164.504 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 27.5 t -46.37 -60.4 3.72 Favored Pre-proline 0 CA--C 1.54 0.559 0 C-N-CA 124.794 1.238 . . . . 61.329999999999998 109.434 173.438 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -61.85 -35.31 79.16 Favored 'Trans proline' 0 N--CA 1.453 -0.883 0 CA-C-N 120.31 1.146 . . . . 64.129999999999995 112.974 -177.95 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.403 ' CZ2' ' HB1' ' A' ' 179' ' ' ALA . 72.8 t90 -57.24 -51.62 68.61 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.367 0.667 . . . . 74.299999999999997 110.402 179.557 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 29.5 t -58.89 -39.18 80.69 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 121.132 0.491 . . . . 72.019999999999996 110.269 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -68.92 -25.55 64.64 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 121.173 -0.954 . . . . 72.510000000000005 111.407 -177.429 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 14.3 mmtp -96.72 10.08 39.79 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.576 1.15 . . . . 75.430000000000007 112.879 177.477 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 34.9 mt -60.88 151.23 74.44 Favored Pre-proline 0 C--O 1.237 0.395 0 CA-C-N 119.532 1.06 . . . . 75.230000000000004 110.964 174.613 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -76.07 169.69 21.58 Favored 'Trans proline' 0 N--CA 1.445 -1.378 0 C-N-CA 124.065 3.177 . . . . 64.209999999999994 110.485 177.533 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -65.13 -4.19 4.64 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 125.044 1.338 . . . . 74.519999999999996 113.391 173.784 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -100.68 8.4 43.36 Favored 'General case' 0 N--CA 1.463 0.182 0 C-N-CA 125.709 1.603 . . . . 75.209999999999994 110.597 -177.056 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 61.0 t -129.53 160.03 40.93 Favored 'Isoleucine or valine' 0 C--O 1.239 0.542 0 O-C-N 121.214 -0.929 . . . . 51.450000000000003 108.798 -179.651 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 29.2 t60 -132.93 155.39 49.17 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 126.268 1.827 . . . . 52.32 107.249 165.53 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 55.7 t80 -132.5 134.01 44.49 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 108.102 -1.073 . . . . 71.219999999999999 108.102 -175.104 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 47.6 t -135.31 155.38 37.2 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 C-N-CA 126.551 1.941 . . . . 71.129999999999995 107.264 -172.906 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 16.4 mtt85 -133.2 130.32 38.94 Favored 'General case' 0 CA--C 1.513 -0.46 0 N-CA-C 105.197 -2.149 . . . . 72.25 105.197 176.284 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 37.6 mt -135.58 144.74 50.45 Favored Pre-proline 0 N--CA 1.469 0.514 0 CA-C-N 120.113 1.324 . . . . 71.450000000000003 110.082 175.502 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -74.89 157.45 43.21 Favored 'Trans proline' 0 N--CA 1.462 -0.353 0 C-N-CA 122.379 2.053 . . . . 73.209999999999994 110.728 -179.414 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -101.04 94.55 6.05 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 123.984 0.914 . . . . 55.009999999999998 110.12 -175.463 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 22.5 mt -86.43 76.75 9.58 Favored 'General case' 0 CA--C 1.539 0.54 0 O-C-N 120.612 -1.305 . . . . 73.099999999999994 111.869 -172.793 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -82.49 20.2 1.14 Allowed 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 115.129 1.529 . . . . 75.439999999999998 115.129 -176.156 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 89.01 -48.09 3.43 Favored Glycine 0 CA--C 1.525 0.704 0 O-C-N 119.924 -1.735 . . . . 34.530000000000001 112.834 168.214 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -72.55 -152.11 1.58 Allowed Glycine 0 CA--C 1.529 0.958 0 C-N-CA 124.337 0.97 . . . . 71.310000000000002 110.737 174.699 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 7.1 tp -46.75 -30.88 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 C-N-CA 124.1 0.96 . . . . 75.329999999999998 112.055 177.371 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 19.4 m95 -50.31 -27.47 6.23 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 126.069 1.748 . . . . 73.030000000000001 113.391 177.757 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 20.2 m-20 -73.91 -36.42 64.72 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-N 119.576 1.08 . . . . 75.040000000000006 110.496 177.153 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.401 ' C ' ' H ' ' A' ' 75' ' ' GLY . 40.7 t -73.82 -55.19 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 N-CA-C 107.966 -1.124 . . . . 73.310000000000002 107.966 174.839 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 34.9 m170 -65.95 31.92 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 129.534 3.134 . . . . 72.239999999999995 112.175 170.936 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.401 ' H ' ' C ' ' A' ' 73' ' ' VAL . . . -149.21 -42.55 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 125.353 1.454 . . . . 35.100000000000001 111.191 173.122 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -54.6 -41.84 70.42 Favored 'General case' 0 C--O 1.223 -0.328 0 CA-C-O 117.753 -1.118 . . . . 74.109999999999999 112.439 -175.06 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -44.47 -44.34 8.47 Favored 'General case' 0 CA--C 1.514 -0.407 0 N-CA-C 114.123 1.157 . . . . 71.219999999999999 114.123 -173.303 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 28.8 t80 -61.88 -45.76 92.34 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 118.525 0.602 . . . . 72.540000000000006 110.236 -176.898 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 50.0 mt -61.35 -45.24 95.22 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-O 116.726 -1.606 . . . . 61.329999999999998 109.251 175.415 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -62.41 -45.68 92.03 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 120.652 1.569 . . . . 61.5 110.776 -176.966 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.82 -60.6 2.99 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 125.998 1.719 . . . . 65.349999999999994 109.469 178.495 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -69.75 -28.92 66.18 Favored 'General case' 0 C--O 1.231 0.095 0 CA-C-O 118.927 -0.558 . . . . 64.230000000000004 111.76 -175.21 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 6.2 t -51.67 -37.16 49.33 Favored 'General case' 0 CA--C 1.52 -0.184 0 C-N-CA 124.343 1.057 . . . . 71.519999999999996 110.712 178.091 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 30.8 mtp . . . . . 0 N--CA 1.448 -0.562 0 CA-C-O 118.762 -0.637 . . . . 62.009999999999998 111.696 -170.913 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.387 0 N-CA-C 114.533 1.308 . . . . 62.140000000000001 114.533 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 55.8 t -71.49 -65.63 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 CA-C-O 117.575 -1.203 . . . . 54.43 108.614 166.241 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -54.61 -46.78 73.89 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 120.387 1.449 . . . . 72.120000000000005 111.98 -179.58 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -58.45 -40.49 82.77 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.427 1.491 . . . . 75.430000000000007 110.196 -178.705 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.51 ' HB1' ' CE1' ' A' ' 114' ' ' PHE . . . -74.2 4.53 5.53 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 125.798 1.639 . . . . 64.109999999999999 112.84 -178.641 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 61.7 mt -115.25 -57.12 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.891 0 N-CA-C 104.975 -2.232 . . . . 73.049999999999997 104.975 177.129 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 88.0 m-70 -80.67 -61.24 2.03 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 123.664 0.786 . . . . 75.409999999999997 112.616 -173.178 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -68.34 -21.16 64.75 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 119.063 0.847 . . . . 72.150000000000006 112.209 -177.756 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -94.45 -53.56 3.86 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 124.548 1.139 . . . . 73.439999999999998 108.771 -175.86 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 6.9 t60 58.49 88.0 0.07 Allowed 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.513 1.525 . . . . 64.329999999999998 110.65 -169.792 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 3.3 mmpt? -116.33 13.79 15.62 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.389 1.076 . . . . 72.109999999999999 113.302 -176.896 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 30.4 tttm 69.87 -64.23 0.36 Allowed 'General case' 0 C--O 1.221 -0.418 0 C-N-CA 128.2 2.6 . . . . 52.439999999999998 109.558 -174.333 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.413 HD22 ' HA ' ' A' ' 111' ' ' MET . 40.6 mt 54.47 44.66 28.48 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.813 1.645 . . . . 72.120000000000005 112.508 177.867 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -94.63 14.54 20.72 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.283 1.433 . . . . 72.329999999999998 114.189 -173.871 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -156.13 155.35 29.01 Favored Pre-proline 0 CA--C 1.535 0.395 0 C-N-CA 127.97 2.508 . . . . 75.219999999999999 107.662 -178.078 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -64.21 -44.99 10.71 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.546 2.164 . . . . 64.140000000000001 109.959 -173.733 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -69.01 -29.38 67.55 Favored 'General case' 0 N--CA 1.438 -1.039 0 C-N-CA 124.189 0.995 . . . . 72.430000000000007 111.15 -174.82 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -54.47 -42.15 70.34 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.95 1.3 . . . . 71.329999999999998 110.356 173.039 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' MET . . . . . 0.413 ' HA ' HD22 ' A' ' 105' ' ' LEU . 2.5 mtt -76.85 -48.53 18.14 Favored 'General case' 0 CA--C 1.512 -0.514 0 C-N-CA 124.193 0.997 . . . . 75.450000000000003 108.92 -178.986 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.498 ' HB1' ' CG ' ' A' ' 122' ' ' LYS . . . -62.29 -37.16 84.46 Favored 'General case' 0 N--CA 1.447 -0.619 0 O-C-N 123.408 0.443 . . . . 73.439999999999998 111.337 -172.549 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -56.07 -46.85 78.83 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 125.287 1.435 . . . . 53.439999999999998 112.61 172.075 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' PHE . . . . . 0.51 ' CE1' ' HB1' ' A' ' 97' ' ' ALA . 19.0 t80 -74.27 -41.68 60.85 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 123.548 0.739 . . . . 71.299999999999997 111.45 -177.401 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 18.2 mt -76.94 -14.71 59.83 Favored 'General case' 0 C--N 1.332 -0.172 0 O-C-N 121.33 -0.856 . . . . 63.200000000000003 110.4 -176.511 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -48.48 -41.71 30.58 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.805 0.842 . . . . 70.129999999999995 110.127 172.786 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -82.09 10.09 54.67 Favored Glycine 0 CA--C 1.529 0.965 0 CA-C-O 117.975 -1.458 . . . . 75.430000000000007 114.805 177.265 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 23.8 mmtt -127.34 8.77 6.58 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 121.338 2.569 . . . . 72.430000000000007 112.615 -174.412 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 86.87 49.31 4.11 Favored Glycine 0 C--N 1.333 0.392 0 N-CA-C 109.669 -1.372 . . . . 65.219999999999999 109.669 -177.416 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 39.0 t -134.58 132.89 54.72 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 N-CA-C 105.18 -2.156 . . . . 73.140000000000001 105.18 169.845 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -92.27 133.65 35.63 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 123.68 0.792 . . . . 75.239999999999995 110.002 173.855 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.498 ' CG ' ' HB1' ' A' ' 112' ' ' ALA . 17.6 mtpt -64.58 -37.0 86.05 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 118.747 -0.644 . . . . 75.109999999999999 110.386 174.947 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -67.02 -26.82 66.97 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 118.707 0.685 . . . . 65.030000000000001 111.72 178.943 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 13.0 mttm -77.61 -57.06 4.02 Favored 'General case' 0 CA--C 1.518 -0.27 0 N-CA-C 106.402 -1.703 . . . . 71.530000000000001 106.402 171.994 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 41.3 t80 -51.86 -59.49 4.26 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 124.808 1.243 . . . . 65.510000000000005 112.174 -166.46 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 19.7 mt -73.54 -33.74 64.86 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 110.275 -0.268 . . . . 52.039999999999999 110.275 -170.933 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 29.7 m -62.26 -49.44 75.7 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 109.315 -0.624 . . . . 74.329999999999998 109.315 179.122 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 23.9 m -65.71 -41.33 92.44 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 124.553 1.141 . . . . 75.010000000000005 110.22 178.704 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 42.2 t80 -49.19 -48.69 45.05 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 119.691 1.132 . . . . 73.310000000000002 110.82 173.826 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 14.5 m-20 -92.64 38.89 1.02 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.647 0.779 . . . . 72.230000000000004 111.16 -178.121 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 7.7 t -122.86 172.26 8.6 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.403 1.481 . . . . 73.030000000000001 111.653 -177.334 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -67.09 -40.39 86.92 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.824 1.25 . . . . 75.200000000000003 110.52 178.603 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -50.58 -49.85 55.25 Favored 'General case' 0 C--N 1.34 0.166 0 C-N-CA 123.725 0.81 . . . . 63.130000000000003 110.463 -177.503 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 21.5 mm -69.51 -38.85 77.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 C-N-CA 124.218 1.007 . . . . 64.150000000000006 111.269 -178.305 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 1.7 mtmt -55.53 -33.26 63.65 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 124.066 0.947 . . . . 73.540000000000006 110.964 177.841 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -73.23 -48.42 19.44 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 110.831 -0.907 . . . . 43.119999999999997 110.831 178.357 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -63.34 -36.2 82.92 Favored 'General case' 0 CA--C 1.532 0.255 0 O-C-N 121.715 -0.874 . . . . 73.150000000000006 109.587 -177.502 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.32 -34.9 78.71 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-O 117.755 -1.116 . . . . 64.150000000000006 111.483 178.605 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -80.48 -39.84 27.3 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 120.588 1.54 . . . . 73.049999999999997 111.634 175.021 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.92 -59.02 5.67 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 118.864 -0.589 . . . . 74.099999999999994 110.763 179.116 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -58.85 -44.45 91.01 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 118.882 0.765 . . . . 75.409999999999997 109.056 -176.315 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 1.9 tmtt? -50.38 -57.73 7.3 Favored 'General case' 0 CA--C 1.528 0.11 0 C-N-CA 123.996 0.918 . . . . 73.120000000000005 111.139 -179.634 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.94 -35.06 69.51 Favored 'General case' 0 C--O 1.231 0.099 0 CA-C-N 118.834 0.743 . . . . 74.230000000000004 111.384 -175.28 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 37.8 mt -59.0 -49.56 77.44 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 123.577 0.751 . . . . 72.340000000000003 110.646 -177.477 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -54.47 -48.0 72.32 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 119.154 0.888 . . . . 73.120000000000005 111.722 -179.646 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 1.5 mtm -66.63 -34.8 78.68 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 120.332 -0.547 . . . . 64.349999999999994 109.774 -177.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -59.91 -43.86 94.62 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 118.426 0.557 . . . . 63.329999999999998 109.66 176.348 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -70.01 4.98 1.77 Allowed 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 126.183 1.793 . . . . 74.510000000000005 113.492 177.581 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 54.37 36.78 26.2 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 126.936 2.094 . . . . 75.430000000000007 112.124 -175.1 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.521 HG21 ' CD2' ' A' ' 32' ' ' LEU . 89.8 t -69.36 135.05 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 107.674 -1.232 . . . . 71.319999999999993 107.674 172.161 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 5.7 p -129.23 -16.12 4.04 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 126.787 2.035 . . . . 74.340000000000003 110.343 -176.132 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -168.36 -170.88 33.62 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 125.944 1.735 . . . . 61.409999999999997 112.825 -175.5 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 14.8 m -142.46 153.04 61.82 Favored Pre-proline 0 CA--C 1.546 0.819 0 C-N-CA 127.323 2.249 . . . . 75.319999999999993 108.316 175.613 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -63.52 152.71 71.36 Favored 'Cis proline' 0 CA--C 1.537 0.673 0 C-N-CA 124.578 -1.009 . . . . 64.439999999999998 113.145 -6.884 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 59.2 m -145.91 144.26 30.07 Favored 'General case' 0 C--O 1.239 0.547 0 C-N-CA 125.31 1.444 . . . . 73.439999999999998 108.529 175.251 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 19.8 mmm -123.97 158.41 32.12 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 125.774 1.63 . . . . 75.409999999999997 108.209 163.711 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 21.5 t -142.1 136.47 29.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 106.939 -1.504 . . . . 72.519999999999996 106.939 174.536 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.425 HG23 ' CE1' ' A' ' 164' ' ' PHE . 28.9 t -104.01 135.2 42.8 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 N-CA-C 107.098 -1.445 . . . . 72.120000000000005 107.098 168.726 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 1.4 t30 47.12 10.8 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.688 1 C-N-CA 133.111 4.565 . . . . 73.430000000000007 117.541 171.153 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 83.69 20.11 60.48 Favored Glycine 0 CA--C 1.526 0.777 0 CA-C-O 117.806 -1.552 . . . . 33.409999999999997 115.559 -169.965 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 48.0 mttt -131.81 -41.39 1.04 Allowed 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 119.971 1.885 . . . . 70.409999999999997 114.358 -170.302 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 -112.74 107.51 16.19 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 108.293 -1.003 . . . . 72.099999999999994 108.293 -171.772 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 63.2 ttp85 -88.92 113.41 24.43 Favored 'General case' 0 C--O 1.231 0.109 0 C-N-CA 126.5 1.92 . . . . 73.129999999999995 106.797 175.023 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 164' ' ' PHE . . . . . 0.425 ' CE1' HG23 ' A' ' 158' ' ' VAL . 5.3 p90 -136.51 169.59 17.45 Favored 'General case' 0 C--N 1.319 -0.75 0 O-C-N 120.343 -1.473 . . . . 54.210000000000001 107.186 177.8 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -174.97 -178.78 1.28 Allowed 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 122.548 0.339 . . . . 55.539999999999999 110.129 177.333 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 21.5 mt -46.33 -50.05 5.23 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 C-N-CA 128.555 2.742 . . . . 75.030000000000001 107.728 160.378 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -76.16 16.57 4.51 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 125.847 1.689 . . . . 70.409999999999997 114.392 178.012 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 17.8 m -128.3 -51.13 1.29 Allowed 'General case' 0 C--O 1.224 -0.239 0 CA-C-N 118.795 1.298 . . . . 71.409999999999997 109.705 168.565 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -70.32 -34.65 72.94 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 125.12 1.368 . . . . 64.109999999999999 112.266 -175.253 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 122.58 -5.96 9.87 Favored Glycine 0 C--N 1.341 0.83 0 CA-C-O 118.512 -1.16 . . . . 64.450000000000003 114.793 175.089 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 165.84 174.31 35.21 Favored Glycine 0 CA--C 1.532 1.097 0 CA-C-N 119.745 1.772 . . . . 50.229999999999997 110.003 -175.829 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -64.9 -52.61 1.18 Allowed 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 122.408 2.072 . . . . 71.310000000000002 111.772 -169.889 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -62.29 -28.68 69.9 Favored 'General case' 0 N--CA 1.463 0.223 0 O-C-N 120.965 -1.084 . . . . 73.420000000000002 111.547 178.491 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -67.4 -27.21 66.89 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.141 0.576 . . . . 74.319999999999993 110.366 177.527 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 19.7 m -77.66 -42.9 33.07 Favored 'General case' 0 CA--C 1.53 0.177 0 O-C-N 121.052 -1.03 . . . . 73.430000000000007 110.915 -169.713 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 35.8 mt -63.88 -31.77 73.07 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 118.918 0.781 . . . . 74.219999999999999 111.013 178.683 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 4.8 tttt -48.48 -56.48 8.17 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 126.602 1.961 . . . . 70.420000000000002 108.041 168.847 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.463 HD13 ' HA ' ' A' ' 178' ' ' LEU . 4.1 mm? -65.48 -41.37 93.38 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-O 116.941 -1.504 . . . . 65.340000000000003 111.554 176.534 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.403 ' HB1' ' CZ2' ' A' ' 50' ' ' TRP . . . -53.82 -48.68 69.67 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 120.917 1.689 . . . . 50.039999999999999 111.699 -175.395 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -69.52 -47.09 64.92 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 122.943 0.497 . . . . 63.539999999999999 110.577 -176.072 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -60.47 -42.61 96.59 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 123.565 0.746 . . . . 73.409999999999997 111.285 178.799 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 90.6 mt -67.09 -37.4 83.9 Favored 'General case' 0 C--N 1.332 -0.171 0 O-C-N 120.949 -1.094 . . . . 72.420000000000002 111.221 178.635 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 31.6 mt -58.25 -51.94 65.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 CA-C-N 119.259 0.936 . . . . 70.109999999999999 108.582 172.059 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -52.06 -43.07 63.62 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 124.59 1.156 . . . . 73.230000000000004 109.976 175.95 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 71.3 tttt -79.66 -0.32 33.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 117.124 -1.417 . . . . 72.140000000000001 113.161 -175.486 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 186' ' ' GLU . . . . . 0.424 ' HB3' HD12 ' A' ' 27' ' ' ILE . 16.0 mm-40 -103.11 -33.33 9.27 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 125.662 1.585 . . . . 70.420000000000002 114.43 178.435 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.39 -55.76 4.98 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 107.372 -1.344 . . . . 73.040000000000006 107.372 -179.222 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.403 0 CA-C-N 115.172 -0.922 . . . . 75.430000000000007 111.795 -176.444 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 . . . . . 0 N--CA 1.471 0.576 0 CA-C-O 123.399 1.571 . . . . 71.200000000000003 111.895 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -75.55 5.6 5.77 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 112.954 -1.93 . . . . 73.099999999999994 114.234 -171.48 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 30.1 m-85 -135.0 165.02 26.31 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 126.066 1.746 . . . . 71.140000000000001 108.04 -171.472 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 13.6 m -130.05 131.66 45.89 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 108.001 -1.111 . . . . 74.439999999999998 108.001 -178.741 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.89 154.02 42.03 Favored 'General case' 0 C--O 1.232 0.158 0 O-C-N 121.093 -1.005 . . . . 73.219999999999999 109.265 173.597 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 71.02 -36.17 0.51 Allowed Glycine 0 CA--C 1.53 1.001 0 C-N-CA 125.723 1.63 . . . . 53.200000000000003 112.859 -163.398 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 4.7 tptt -83.38 -83.37 0.14 Allowed 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 124.783 1.233 . . . . 70.549999999999997 108.993 -173.745 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 23.6 mp0 -73.41 -24.61 60.3 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 125.596 1.558 . . . . 73.230000000000004 110.47 -177.294 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 43.6 p90 -158.7 176.03 12.89 Favored 'General case' 0 N--CA 1.468 0.466 0 O-C-N 121.165 -0.959 . . . . 61.310000000000002 110.728 -173.568 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 62.0 t -134.55 107.63 9.33 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 124.921 1.288 . . . . 74.420000000000002 109.344 -177.283 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -73.23 147.14 44.94 Favored 'General case' 0 N--CA 1.444 -0.744 0 O-C-N 120.942 -1.099 . . . . 72.109999999999999 109.963 166.123 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -111.68 134.67 53.09 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 125.29 1.436 . . . . 73.409999999999997 109.92 -178.579 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 5.4 p -80.69 4.11 19.88 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 125.33 1.452 . . . . 53.130000000000003 114.137 -176.356 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -141.7 83.91 12.62 Favored Pre-proline 0 N--CA 1.45 -0.471 0 N-CA-C 106.781 -1.562 . . . . 70.019999999999996 106.781 173.342 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -70.92 -176.25 1.74 Allowed 'Trans proline' 0 CA--C 1.536 0.598 0 C-N-CA 124.086 3.191 . . . . 73.109999999999999 111.799 -175.959 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 22.1 t -131.65 137.5 30.52 Favored Pre-proline 0 CA--C 1.536 0.431 0 C-N-CA 123.942 0.897 . . . . 73.010000000000005 108.788 -174.186 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -78.95 176.39 9.89 Favored 'Trans proline' 0 CA--C 1.536 0.584 0 C-N-CA 123.67 2.914 . . . . 71.420000000000002 111.607 176.07 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.6 m -125.29 178.91 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 C-N-CA 125.307 1.443 . . . . 72.129999999999995 109.529 171.575 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 51.3 m -59.11 -58.18 9.79 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 124.537 1.135 . . . . 53.130000000000003 111.276 174.854 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -143.89 154.15 58.28 Favored Pre-proline 0 CA--C 1.536 0.428 0 C-N-CA 123.954 0.902 . . . . 73.120000000000005 109.509 173.751 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -70.29 167.04 26.29 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 123.37 2.713 . . . . 72.409999999999997 111.009 177.136 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 131.72 -96.39 0.33 Allowed Glycine 0 N--CA 1.449 -0.471 0 N-CA-C 109.412 -1.475 . . . . 63.039999999999999 109.412 178.965 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.39 126.11 29.03 Favored 'General case' 0 CA--C 1.518 -0.268 0 N-CA-C 108.53 -0.915 . . . . 75.409999999999997 108.53 -175.364 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 34.2 mm -61.68 140.17 19.51 Favored 'Isoleucine or valine' 0 C--O 1.24 0.581 0 N-CA-C 107.111 -1.44 . . . . 72.409999999999997 107.111 176.459 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -93.87 153.39 18.28 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 118.296 -1.361 . . . . 73.409999999999997 108.558 -177.135 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 16.1 t -146.31 121.81 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 N-CA-C 105.106 -2.183 . . . . 51.539999999999999 105.106 -177.567 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 57.3 t -123.07 119.47 57.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 106.898 -1.519 . . . . 63.539999999999999 106.898 -175.906 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -80.24 124.01 28.45 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 106.489 -1.671 . . . . 74.150000000000006 106.489 157.6 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.7 mp -110.47 145.24 38.02 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 107.031 -1.47 . . . . 74.319999999999993 107.031 160.022 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 18.5 p90 -154.23 176.93 11.68 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 124.138 0.975 . . . . 70.510000000000005 110.07 -172.833 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' TRP . . . . . 0.51 ' CB ' HG21 ' A' ' 153' ' ' VAL . 30.4 t90 -146.9 176.61 9.77 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 126.445 1.898 . . . . 72.439999999999998 108.268 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 23.7 t80 -56.22 -57.9 10.24 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 125.818 1.647 . . . . 73.219999999999999 111.467 178.778 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -93.4 -76.68 1.34 Allowed Glycine 0 C--N 1.338 0.677 0 N-CA-C 111.125 -0.79 . . . . 54.100000000000001 111.125 -155.763 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . 0.289 10.7 p 42.68 74.97 0.68 Allowed Pre-proline 0 CA--C 1.534 0.352 0 C-N-CA 126.409 1.884 . . . . 61.32 112.45 165.828 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -54.95 -27.43 54.08 Favored 'Trans proline' 0 CA--C 1.537 0.668 0 CA-C-N 121.078 1.421 . . . . 55.520000000000003 113.023 -175.801 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 10.6 m170 -70.34 -37.45 74.67 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.598 1.159 . . . . 73.150000000000006 111.861 175.001 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 18.7 p -67.37 -31.58 71.92 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 119.833 1.197 . . . . 74.540000000000006 111.087 -178.451 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 89.9 t80 -65.97 -26.02 67.37 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.314 1.046 . . . . 73.140000000000001 111.733 176.0 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -74.35 -7.76 53.94 Favored 'General case' 0 CA--C 1.536 0.424 0 O-C-N 120.879 -1.138 . . . . 42.149999999999999 112.15 172.196 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -126.76 -20.34 4.3 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-O 118.023 -0.989 . . . . 63.140000000000001 113.125 -163.511 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . 0.253 0.0 OUTLIER -50.44 -64.28 1.38 Allowed Pre-proline 0 N--CA 1.475 0.794 0 CA-C-N 120.689 1.586 . . . . 72.340000000000003 113.893 -175.551 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -70.52 -9.29 25.52 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 CA-C-N 122.099 1.785 . . . . 72.349999999999994 114.015 -176.732 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 85.4 m -79.87 -36.44 36.61 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 119.564 1.074 . . . . 74.430000000000007 109.671 169.398 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 15.8 tt -85.14 -35.49 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 CA-C-N 119.367 0.985 . . . . 72.129999999999995 111.617 -177.125 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 55.8 t -48.29 -62.65 2.05 Favored Pre-proline 0 CA--C 1.538 0.504 0 CA-C-O 117.413 -1.28 . . . . 73.299999999999997 112.088 -177.094 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -68.11 -29.53 33.15 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 121.428 1.418 . . . . 64.209999999999994 111.32 -176.041 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 77.2 t90 -54.23 -57.79 9.83 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 119.322 0.965 . . . . 72.519999999999996 109.973 177.985 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.2 -23.39 62.94 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 112.587 0.588 . . . . 72.109999999999999 112.587 -172.572 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 78.0 mt-10 -66.42 -48.19 70.8 Favored 'General case' 0 C--O 1.235 0.301 0 O-C-N 120.926 -1.109 . . . . 71.120000000000005 109.716 169.619 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 30.0 mmmt -74.57 3.6 7.46 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.524 1.53 . . . . 64.439999999999998 112.817 -169.678 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 37.7 mt -59.09 159.45 14.31 Favored Pre-proline 0 CA--C 1.543 0.674 0 C-N-CA 125.363 1.465 . . . . 72.209999999999994 112.129 177.99 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -87.27 174.0 5.39 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 125.204 3.936 . . . . 70.340000000000003 112.265 178.619 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -66.83 -21.26 66.03 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 114.307 1.225 . . . . 61.020000000000003 114.307 -175.681 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 40.9 m-20 -86.81 6.89 29.4 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.722 1.209 . . . . 71.5 111.146 -175.292 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 46.8 t -129.0 151.76 36.22 Favored 'Isoleucine or valine' 0 C--O 1.24 0.589 0 C-N-CA 125.194 1.398 . . . . 62.009999999999998 108.412 -173.245 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 79.6 t60 -133.96 144.5 48.81 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 125.498 1.519 . . . . 73.299999999999997 107.852 173.574 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 24.7 t80 -128.42 136.82 51.4 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 123.763 0.825 . . . . 74.400000000000006 110.535 -172.774 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 70.9 t -133.64 148.96 30.52 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 C-N-CA 126.253 1.821 . . . . 71.230000000000004 107.935 -174.532 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -123.79 125.31 44.47 Favored 'General case' 0 CA--C 1.512 -0.515 0 N-CA-C 105.615 -1.995 . . . . 71.030000000000001 105.615 172.906 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 20.7 mt -133.43 150.93 76.44 Favored Pre-proline 0 N--CA 1.47 0.539 0 CA-C-N 119.474 1.033 . . . . 60.030000000000001 111.092 176.944 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -73.63 139.29 27.96 Favored 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 121.64 1.56 . . . . 75.340000000000003 110.578 179.13 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -79.93 79.06 6.51 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.225 1.01 . . . . 53.420000000000002 109.382 173.216 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 48.8 mt -72.76 106.02 4.57 Favored 'General case' 0 C--N 1.329 -0.304 0 O-C-N 120.99 -1.069 . . . . 72.109999999999999 109.363 175.656 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -128.8 28.06 5.4 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.424 1.489 . . . . 71.030000000000001 112.376 178.709 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 76.9 169.78 31.54 Favored Glycine 0 CA--C 1.523 0.589 0 C-N-CA 125.454 1.502 . . . . 72.439999999999998 111.166 -178.959 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 56.77 -151.04 26.15 Favored Glycine 0 CA--C 1.529 0.937 0 N-CA-C 111.083 -0.807 . . . . 72.040000000000006 111.083 -175.129 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.2 tt -60.47 -21.33 22.84 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 C-N-CA 124.183 0.993 . . . . 72.349999999999994 112.658 -174.879 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' TRP . . . . . 0.435 ' CH2' HG22 ' A' ' 153' ' ' VAL . 23.9 m95 -63.31 -32.1 73.43 Favored 'General case' 0 CA--C 1.53 0.178 0 O-C-N 121.725 -0.609 . . . . 73.129999999999995 110.715 173.998 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -77.49 -43.57 31.74 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-N 118.676 0.671 . . . . 75.510000000000005 110.46 173.683 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 58.7 t -55.29 -58.21 5.12 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 C-N-CA 124.077 0.951 . . . . 74.510000000000005 109.916 -175.258 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 61.5 m170 -69.89 -7.61 41.73 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 118.568 -0.729 . . . . 74.109999999999999 112.042 -178.425 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -93.45 -18.55 38.27 Favored Glycine 0 C--N 1.338 0.652 0 CA-C-N 120.288 1.404 . . . . 73.209999999999994 110.242 -177.449 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -74.76 -36.6 62.57 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 118.58 1.19 . . . . 63.310000000000002 110.97 -173.452 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 34.2 ttp -53.82 -45.28 70.78 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.659 1.583 . . . . 73.129999999999995 113.436 179.839 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 10.7 t80 -57.5 -44.21 84.82 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 109.172 -0.677 . . . . 75.239999999999995 109.172 -177.115 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 24.4 mt -65.94 -44.9 83.71 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-O 117.092 -1.432 . . . . 73.230000000000004 109.53 178.331 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.416 ' HA ' HD11 ' A' ' 134' ' ' ILE . 0.2 OUTLIER -56.42 -41.71 76.83 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 121.165 1.802 . . . . 65.040000000000006 112.318 178.501 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.0 -59.43 4.92 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 124.853 1.261 . . . . 24.219999999999999 109.154 -174.675 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -72.46 -24.37 61.19 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 111.442 0.164 . . . . 73.219999999999999 111.442 -174.382 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.4 t -58.92 -8.5 1.41 Allowed 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.597 1.559 . . . . 73.200000000000003 113.516 176.832 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 6.8 mtp . . . . . 0 C--O 1.233 0.22 0 C-N-CA 125.453 1.501 . . . . 72.109999999999999 113.963 -179.415 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.102 0 N-CA-C 113.421 0.897 . . . . 71.120000000000005 113.421 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 60.0 t -58.45 -58.69 5.51 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 N-CA-C 108.393 -0.965 . . . . 75.510000000000005 108.393 172.914 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 -58.84 -49.9 76.0 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 124.296 1.038 . . . . 74.040000000000006 110.873 179.648 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -71.27 -2.97 17.94 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 126.184 1.793 . . . . 73.439999999999998 112.64 -173.529 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.451 ' HB1' ' CE2' ' A' ' 114' ' ' PHE . . . -96.37 -28.33 14.52 Favored 'General case' 0 N--CA 1.453 -0.28 0 O-C-N 120.84 -1.162 . . . . 73.299999999999997 112.405 169.646 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 12.1 mt -84.65 -58.49 3.46 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.513 0 N-CA-C 106.799 -1.556 . . . . 43.240000000000002 106.799 178.027 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 58.0 m-70 -73.61 -61.43 1.84 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 118.8 0.727 . . . . 63.119999999999997 112.734 -163.739 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.6 -12.1 60.0 Favored 'General case' 0 N--CA 1.473 0.7 0 O-C-N 120.614 -1.304 . . . . 75.329999999999998 114.18 179.42 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -114.46 -27.82 7.41 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 113.888 1.07 . . . . 73.420000000000002 113.888 -171.045 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . 0.272 2.7 m-70 43.72 46.63 6.41 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 127.632 2.373 . . . . 55.229999999999997 112.868 169.387 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.468 ' HA ' ' HE2' ' A' ' 103' ' ' LYS . 7.9 mmpt? -68.37 12.12 0.14 Allowed 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 125.109 1.364 . . . . 64.109999999999999 114.614 178.978 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 4.2 ttpm? 68.14 -52.27 0.53 Allowed 'General case' 0 C--O 1.223 -0.293 0 C-N-CA 129.384 3.074 . . . . 75.230000000000004 111.057 -177.771 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 64.8 mt 51.84 43.96 29.72 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 125.957 1.703 . . . . 75.209999999999994 110.295 171.649 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -84.76 -24.97 28.56 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 124.369 1.067 . . . . 54.109999999999999 112.536 -175.371 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 44.4 p -124.06 160.08 53.71 Favored Pre-proline 0 N--CA 1.463 0.193 0 CA-C-N 119.767 1.167 . . . . 71.120000000000005 111.474 -169.423 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -71.15 -15.91 31.92 Favored 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 121.344 1.363 . . . . 61.310000000000002 112.809 178.273 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.43 -59.91 2.58 Favored 'General case' 0 N--CA 1.462 0.153 0 N-CA-C 107.064 -1.458 . . . . 63.0 107.064 166.458 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -58.52 -42.03 86.79 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 123.928 0.891 . . . . 53.240000000000002 112.09 -170.902 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 41.1 mtt -65.57 -55.75 16.01 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 122.963 0.505 . . . . 73.409999999999997 111.099 175.87 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.401 ' HB1' ' CG ' ' A' ' 122' ' ' LYS . . . -70.86 -40.08 72.54 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 119.45 -0.31 . . . . 75.319999999999993 110.721 -166.121 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -60.79 -38.35 85.03 Favored 'General case' 0 C--N 1.338 0.103 0 C-N-CA 122.84 0.456 . . . . 65.219999999999999 110.638 175.915 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' PHE . . . . . 0.451 ' CE2' ' HB1' ' A' ' 97' ' ' ALA . 82.9 t80 -72.0 -48.19 46.53 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 122.848 0.459 . . . . 72.120000000000005 111.206 -177.359 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 55.7 mt -68.29 -16.79 64.09 Favored 'General case' 0 C--O 1.23 0.049 0 O-C-N 121.49 -0.756 . . . . 54.32 111.219 -174.535 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -52.09 -18.03 1.29 Allowed 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.762 1.225 . . . . 63.439999999999998 112.867 172.856 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -86.37 -12.4 70.16 Favored Glycine 0 CA--C 1.529 0.938 0 O-C-N 120.927 -1.108 . . . . 72.129999999999995 113.148 177.812 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -116.84 6.04 13.09 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 119.485 1.643 . . . . 72.230000000000004 113.544 -161.587 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 87.65 48.92 4.04 Favored Glycine 0 C--N 1.334 0.439 0 N-CA-C 109.754 -1.338 . . . . 71.140000000000001 109.754 -169.681 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 55.9 t -129.81 155.08 41.19 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 N-CA-C 104.794 -2.299 . . . . 65.430000000000007 104.794 165.7 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -127.31 135.3 50.36 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 106.538 -1.653 . . . . 65.439999999999998 106.538 -176.27 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.401 ' CG ' ' HB1' ' A' ' 112' ' ' ALA . 2.5 mtmt -67.39 -42.43 83.35 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 118.817 0.735 . . . . 72.25 111.431 -175.238 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -62.48 -36.22 81.81 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 123.859 0.864 . . . . 74.510000000000005 110.1 -178.563 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 40.8 mttm -73.08 -53.48 10.97 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 106.042 -1.836 . . . . 73.319999999999993 106.042 176.264 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 33.1 t80 -51.98 -60.67 2.92 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 125.246 1.418 . . . . 73.219999999999999 110.874 -172.21 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 11.8 mt -68.67 -37.29 79.51 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 123.063 0.545 . . . . 53.130000000000003 110.191 -170.21 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 11.2 t -65.1 -37.07 86.29 Favored 'General case' 0 CA--C 1.534 0.335 0 O-C-N 122.05 -0.406 . . . . 50.5 109.999 179.685 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 51.6 m -70.02 -40.87 74.97 Favored 'General case' 0 N--CA 1.455 -0.209 0 O-C-N 121.87 -0.519 . . . . 61.310000000000002 111.003 171.664 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 77.5 t80 -54.23 -48.93 70.55 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 119.3 0.954 . . . . 74.439999999999998 109.269 179.454 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 55.3 m-20 -91.46 59.09 3.75 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.905 1.282 . . . . 73.329999999999998 109.74 171.657 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 68.3 p -123.64 163.33 21.26 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-O 121.951 0.881 . . . . 51.030000000000001 111.702 168.197 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -68.44 -32.13 71.94 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.675 0.79 . . . . 60.329999999999998 110.21 172.303 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -56.54 -50.46 71.79 Favored 'General case' 0 C--O 1.234 0.26 0 O-C-N 121.796 -0.565 . . . . 50.119999999999997 110.045 -179.187 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.416 HD11 ' HA ' ' A' ' 80' ' ' THR . 26.5 mm -63.94 -34.18 66.77 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-O 118.407 -0.806 . . . . 72.140000000000001 110.983 177.897 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 54.2 tttt -53.53 -41.76 66.72 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 118.898 0.772 . . . . 65.530000000000001 109.394 174.507 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -71.91 -33.81 62.56 Favored Glycine 0 C--N 1.337 0.61 0 C-N-CA 125.015 1.293 . . . . 33.210000000000001 111.75 -178.806 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 -73.3 -36.58 66.3 Favored 'General case' 0 N--CA 1.452 -0.36 0 O-C-N 121.824 -0.809 . . . . 64.230000000000004 110.503 -178.892 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 14.7 mtp -62.17 -52.01 65.51 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 118.119 0.418 . . . . 74.140000000000001 110.458 173.827 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -65.84 -37.01 85.06 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-O 118.696 -0.669 . . . . 52.240000000000002 111.913 -168.529 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 3.0 mtmt -56.52 -64.09 0.98 Allowed 'General case' 0 C--N 1.341 0.222 0 CA-C-O 118.357 -0.83 . . . . 63.140000000000001 109.041 172.448 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -55.99 -37.91 69.74 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 118.567 0.621 . . . . 73.129999999999995 111.437 -173.983 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 9.5 tmtt? -55.41 -59.82 4.28 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 124.228 1.011 . . . . 72.239999999999995 110.3 178.092 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 8.6 ptmt -69.67 -31.2 69.13 Favored 'General case' 0 C--N 1.343 0.307 0 CA-C-N 120.158 1.345 . . . . 62.140000000000001 111.974 179.828 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 21.9 mt -60.63 -54.41 45.68 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 118.624 0.647 . . . . 74.409999999999997 109.376 -174.974 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -54.4 -41.07 68.85 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 122.503 0.321 . . . . 60.420000000000002 111.237 -178.244 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -63.65 -45.71 88.94 Favored 'General case' 0 N--CA 1.461 0.11 0 C-N-CA 123.08 0.552 . . . . 70.230000000000004 111.3 178.239 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -62.33 -39.45 93.11 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 123.442 0.697 . . . . 71.420000000000002 110.11 -178.508 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 34.9 m-85 -75.67 8.0 3.32 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.662 1.185 . . . . 72.209999999999994 113.441 177.405 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 13.3 mt-30 49.93 39.06 17.73 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 126.998 2.119 . . . . 74.219999999999999 112.729 -175.678 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 46.6 t -74.2 138.27 21.49 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 N-CA-C 106.276 -1.75 . . . . 74.310000000000002 106.276 168.963 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -141.68 4.48 1.73 Allowed 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.873 0.869 . . . . 44.149999999999999 111.607 -178.449 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 177.28 -177.22 48.29 Favored Glycine 0 CA--C 1.524 0.631 0 C-N-CA 126.243 1.877 . . . . 74.129999999999995 108.709 -174.861 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.51 HG21 ' CB ' ' A' ' 34' ' ' TRP . 12.9 m -149.15 149.99 30.89 Favored Pre-proline 0 C--O 1.24 0.586 0 C-N-CA 125.378 1.471 . . . . 75.530000000000001 108.91 -175.471 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -68.98 147.89 83.87 Favored 'Cis proline' 0 CA--C 1.537 0.648 0 O-C-N 122.532 0.754 . . . . 64.219999999999999 112.148 -1.995 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 62.9 m -150.53 131.57 14.34 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 126.559 1.944 . . . . 64.230000000000004 107.442 179.27 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 93.3 mtp -116.36 163.12 16.49 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 124.153 0.981 . . . . 71.409999999999997 109.615 172.022 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 6.3 t -139.75 143.71 29.89 Favored 'Isoleucine or valine' 0 C--O 1.24 0.595 0 N-CA-C 106.522 -1.659 . . . . 71.140000000000001 106.522 179.041 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.522 HG23 ' CE1' ' A' ' 164' ' ' PHE . 96.8 t -113.29 134.7 55.16 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 C-N-CA 124.929 1.291 . . . . 72.400000000000006 107.545 167.802 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 7.8 t30 49.24 9.34 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 131.63 3.972 . . . . 62.020000000000003 116.344 172.361 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 81.48 19.81 65.53 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 126.124 1.821 . . . . 64.200000000000003 114.306 -171.751 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 24.1 mtpt -137.78 -30.19 0.83 Allowed 'General case' 0 N--CA 1.479 1.002 0 CA-C-N 120.292 2.046 . . . . 63.219999999999999 113.498 -167.541 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -118.7 142.41 47.69 Favored 'General case' 0 CA--C 1.508 -0.662 0 N-CA-C 107.318 -1.364 . . . . 72.109999999999999 107.318 174.524 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 21.7 ttp180 -123.48 144.34 49.59 Favored 'General case' 0 N--CA 1.44 -0.955 0 N-CA-C 104.877 -2.268 . . . . 72.439999999999998 104.877 178.795 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 164' ' ' PHE . . . . . 0.522 ' CE1' HG23 ' A' ' 158' ' ' VAL . 14.1 p90 -154.22 173.32 16.27 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 107.596 -1.261 . . . . 75.400000000000006 107.596 178.749 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -173.42 175.65 3.01 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 107.681 -1.229 . . . . 62.299999999999997 107.681 -177.577 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 23.6 mt -56.23 -44.93 80.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 C-N-CA 126.493 1.917 . . . . 62.549999999999997 108.746 -177.498 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -72.46 -34.92 60.02 Favored Glycine 0 N--CA 1.442 -0.927 0 CA-C-O 117.996 -1.446 . . . . 62.340000000000003 112.093 -175.252 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 72.9 m -69.03 -57.3 5.63 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 118.924 1.362 . . . . 70.109999999999999 109.36 172.442 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -63.21 -44.84 94.19 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 123.1 0.56 . . . . 72.409999999999997 111.322 -169.187 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 141.28 -18.32 2.68 Favored Glycine 0 CA--C 1.523 0.573 0 C-N-CA 123.768 0.699 . . . . 71.420000000000002 114.197 173.984 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 169.82 169.23 32.8 Favored Glycine 0 CA--C 1.527 0.814 0 N-CA-C 107.19 -2.364 . . . . 41.329999999999998 107.19 -172.964 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -64.34 -36.11 46.99 Favored 'Trans proline' 0 N--CA 1.459 -0.543 0 C-N-CA 122.643 2.229 . . . . 75.0 111.984 -168.948 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -56.62 -48.96 76.34 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 123.453 0.701 . . . . 60.310000000000002 110.331 171.954 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -67.15 -27.6 67.43 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 123.797 0.839 . . . . 75.230000000000004 109.909 -169.078 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -51.29 -48.36 62.29 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 124.143 0.977 . . . . 55.509999999999998 110.197 173.75 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 55.9 mt -65.91 -34.02 77.16 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 117.851 0.296 . . . . 64.129999999999995 111.261 -179.318 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.78 -48.4 75.4 Favored 'General case' 0 N--CA 1.456 -0.165 0 N-CA-C 108.652 -0.87 . . . . 74.219999999999999 108.652 174.662 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.478 HD13 ' HA ' ' A' ' 178' ' ' LEU . 4.3 mm? -66.88 -44.7 80.23 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-O 117.848 -1.072 . . . . 65.519999999999996 110.843 175.954 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -50.38 -50.3 51.91 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 118.967 0.803 . . . . 61.219999999999999 110.329 -178.078 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -72.92 -44.37 61.31 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 123.625 0.77 . . . . 42.450000000000003 109.663 -170.133 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 5.5 t80 -59.76 -47.95 83.63 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 124.312 1.045 . . . . 75.540000000000006 111.894 176.063 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 182' ' ' LEU . . . . . 0.463 ' HB2' HG21 ' A' ' 158' ' ' VAL . 82.7 mt -63.28 -44.63 94.52 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 108.967 -0.753 . . . . 64.019999999999996 108.967 -174.966 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 65.2 mt -58.14 -45.68 88.53 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 123.236 0.614 . . . . 73.200000000000003 109.43 174.891 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -65.84 -17.57 64.73 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 123.694 0.798 . . . . 63.43 112.571 179.492 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 13.5 tptp -84.23 -57.29 3.23 Favored 'General case' 0 N--CA 1.441 -0.917 0 N-CA-C 106.911 -1.514 . . . . 75.200000000000003 106.911 173.923 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -55.88 -20.19 14.77 Favored 'General case' 0 CA--C 1.513 -0.465 0 C-N-CA 129.856 3.262 . . . . 71.120000000000005 116.245 -167.797 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 2.6 mtm180 -71.88 -68.85 0.43 Allowed 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 117.784 -1.566 . . . . 74.030000000000001 110.629 168.336 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.471 0 CA-C-O 124.02 1.866 . . . . 64.230000000000004 111.076 -173.061 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 . . . . . 0 CA--C 1.519 -0.217 0 N-CA-C 109.205 -0.665 . . . . 74.140000000000001 109.205 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -117.1 11.49 14.21 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 123.968 0.907 . . . . 72.409999999999997 112.631 178.675 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 -135.89 159.87 40.35 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 125.381 1.472 . . . . 73.200000000000003 109.735 -171.895 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.8 m -136.24 142.07 43.99 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 123.827 0.851 . . . . 72.150000000000006 109.481 176.637 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.33 150.52 34.75 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-N 114.602 -1.181 . . . . 70.200000000000003 111.982 176.691 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 77.51 -42.61 1.99 Allowed Glycine 0 CA--C 1.524 0.608 0 C-N-CA 125.015 1.293 . . . . 61.32 110.594 -171.43 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 12.9 ttpt -79.43 -80.49 0.12 Allowed 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 125.202 1.401 . . . . 65.129999999999995 110.76 -168.702 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 8.1 mp0 -70.97 -21.45 62.32 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 124.707 1.203 . . . . 64.409999999999997 110.865 -175.482 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 31.5 p90 -164.94 172.75 12.41 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 125.302 1.441 . . . . 74.219999999999999 108.817 -173.667 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 57.4 t -130.99 108.54 15.29 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 C-N-CA 125.002 1.321 . . . . 71.150000000000006 108.591 -178.678 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.6 164.13 22.12 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 124.387 1.075 . . . . 42.299999999999997 108.422 165.757 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -135.53 114.39 12.02 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 106.858 -1.534 . . . . 54.409999999999997 106.858 -168.942 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.5 m -56.69 -8.45 0.58 Allowed 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.433 1.493 . . . . 74.540000000000006 114.208 -177.926 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 50.6 m -135.3 83.3 38.61 Favored Pre-proline 0 CA--C 1.543 0.684 0 C-N-CA 125.016 1.327 . . . . 70.519999999999996 109.504 -179.112 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -74.66 177.82 7.95 Favored 'Trans proline' 0 CA--C 1.539 0.761 1 C-N-CA 125.583 4.189 . . . . 64.010000000000005 114.006 -178.725 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 81.3 t -142.0 147.84 46.24 Favored Pre-proline 0 N--CA 1.475 0.797 0 C-N-CA 127.111 2.164 . . . . 64.239999999999995 108.932 -168.271 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo -90.47 174.95 2.84 Favored 'Trans proline' 0 CA--C 1.536 0.59 0 C-N-CA 123.863 3.042 . . . . 70.319999999999993 113.455 178.096 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 15.5 m -105.85 176.28 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 C-N-CA 125.464 1.506 . . . . 35.210000000000001 109.266 166.343 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 67.1 m -52.5 -51.17 60.78 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 126.686 1.994 . . . . 53.329999999999998 112.351 177.728 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 16.7 mt-30 -149.72 164.17 21.91 Favored Pre-proline 0 CA--C 1.537 0.478 0 C-N-CA 125.1 1.36 . . . . 64.319999999999993 109.516 176.119 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -68.58 135.44 33.42 Favored 'Trans proline' 0 N--CA 1.452 -0.952 0 C-N-CA 122.416 2.077 . . . . 63.350000000000001 108.717 167.449 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 175.19 -125.51 1.09 Allowed Glycine 0 N--CA 1.445 -0.754 0 N-CA-C 106.614 -2.594 . . . . 63.409999999999997 106.614 -171.971 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.03 152.82 43.16 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 117.938 0.869 . . . . 75.400000000000006 109.786 176.823 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 39.2 mm -59.09 157.93 1.86 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 N-CA-C 106.811 -1.551 . . . . 73.040000000000006 106.811 163.3 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -115.84 122.09 44.35 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 107.093 -1.447 . . . . 70.129999999999995 107.093 174.694 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 36.7 t -114.85 113.14 42.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 N-CA-C 105.949 -1.871 . . . . 71.450000000000003 105.949 171.802 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 16.2 t -101.19 139.38 22.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 107.09 -1.448 . . . . 63.530000000000001 107.09 179.24 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -105.75 138.44 41.94 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 107.872 -1.158 . . . . 71.010000000000005 107.872 154.474 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.0 mp -111.46 148.43 33.15 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 124.549 1.14 . . . . 74.120000000000005 108.8 174.367 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 48.7 p90 -138.35 171.72 13.96 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 123.631 0.772 . . . . 74.450000000000003 112.044 -179.601 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 27.2 t90 -145.48 177.15 9.07 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 127.701 2.401 . . . . 63.530000000000001 107.886 172.393 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 56.1 t80 -72.16 -31.61 66.11 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.524 1.53 . . . . 61.32 114.758 178.434 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -116.69 20.99 11.69 Favored Glycine 0 CA--C 1.526 0.721 0 CA-C-O 118.573 -1.126 . . . . 42.539999999999999 114.228 -161.086 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 21.2 p -106.85 86.77 2.49 Favored Pre-proline 0 CA--C 1.538 0.49 0 C-N-CA 125.81 1.644 . . . . 65.530000000000001 110.309 -169.738 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -52.63 -36.45 71.83 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 122.7 2.267 . . . . 64.230000000000004 113.061 -175.219 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 17.0 m170 -55.27 -29.33 57.92 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 118.214 -0.898 . . . . 70.439999999999998 112.774 176.131 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 80.3 m -63.88 -66.45 0.54 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.555 1.542 . . . . 72.420000000000002 109.772 179.313 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.434 ' HB2' ' CD2' ' A' ' 99' ' ' HIS . 19.2 t80 -59.2 -34.85 72.64 Favored 'General case' 0 N--CA 1.469 0.485 0 O-C-N 121.489 -0.757 . . . . 73.040000000000006 111.907 -178.645 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.58 -28.7 69.53 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 118.633 -0.698 . . . . 71.120000000000005 112.327 179.676 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -93.86 -20.45 20.04 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.985 1.314 . . . . 72.219999999999999 112.126 -174.669 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -42.89 -65.45 0.55 Allowed Pre-proline 0 CA--C 1.542 0.654 0 N-CA-C 114.393 1.257 . . . . 71.430000000000007 114.393 -174.335 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -74.73 -6.65 18.47 Favored 'Trans proline' 0 CA--C 1.534 0.522 0 CA-C-N 122.327 1.867 . . . . 41.039999999999999 114.525 -176.315 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 67.0 m -75.44 -39.81 58.37 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 120.411 1.459 . . . . 42.240000000000002 108.905 163.209 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 14.2 tt -87.19 -34.51 7.57 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 N-CA-C 112.846 0.684 . . . . 71.329999999999998 112.846 -171.215 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 31.4 t -49.72 -57.34 12.52 Favored Pre-proline 0 CA--C 1.537 0.451 0 CA-C-N 119.837 1.199 . . . . 73.209999999999994 111.138 175.951 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -67.02 -7.41 18.62 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 CA-C-N 121.302 1.501 . . . . 63.409999999999997 114.11 -177.09 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.464 ' CH2' ' HB1' ' A' ' 179' ' ' ALA . 70.9 t90 -80.27 -62.21 1.75 Allowed 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 119.326 0.966 . . . . 72.019999999999996 108.837 164.183 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 5.2 p -68.57 -19.08 64.45 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 113.35 0.87 . . . . 73.420000000000002 113.35 -172.0 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . 0.322 4.9 pt-20 -69.66 -20.78 63.57 Favored 'General case' 0 CA--C 1.556 1.179 0 C-N-CA 124.273 1.029 . . . . 54.240000000000002 110.912 170.976 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 67.2 mmtt -115.89 6.52 14.26 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.633 1.573 . . . . 72.420000000000002 113.256 -170.695 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 51.7 mt -63.43 150.41 89.81 Favored Pre-proline 0 C--O 1.236 0.391 0 CA-C-N 118.702 0.683 . . . . 70.409999999999997 110.021 176.723 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -73.11 177.26 8.02 Favored 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 124.555 3.503 . . . . 72.5 111.701 -176.02 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -74.6 -0.72 18.73 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.175 0.99 . . . . 64.519999999999996 113.475 179.104 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -104.07 -1.38 27.47 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 126.589 1.956 . . . . 73.209999999999994 111.339 -177.98 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 48.2 t -131.3 154.53 40.74 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 126.303 1.841 . . . . 73.329999999999998 106.708 -179.505 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 48.7 t60 -137.69 157.45 46.44 Favored 'General case' 0 N--CA 1.45 -0.468 0 O-C-N 121.674 -0.641 . . . . 72.099999999999994 109.41 169.344 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 46.3 t80 -124.6 135.16 52.88 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.644 1.178 . . . . 74.299999999999997 110.674 -171.561 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 67.1 t -132.85 137.86 53.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 C-N-CA 124.299 1.04 . . . . 73.230000000000004 108.54 -169.115 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -114.16 121.64 44.37 Favored 'General case' 0 CA--C 1.514 -0.414 0 N-CA-C 106.628 -1.619 . . . . 62.399999999999999 106.628 170.952 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 13.1 mt -136.57 144.79 48.7 Favored Pre-proline 0 CA--C 1.537 0.454 0 CA-C-N 118.607 0.639 . . . . 75.409999999999997 112.304 -177.453 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -77.56 125.61 7.7 Favored 'Trans proline' 0 CA--C 1.534 0.482 0 C-N-CA 122.166 1.911 . . . . 74.439999999999998 112.307 -175.691 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -68.29 112.28 5.08 Favored 'General case' 0 CA--C 1.54 0.567 0 O-C-N 120.741 -1.225 . . . . 64.340000000000003 109.286 167.76 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 8.1 mt -110.41 95.57 5.65 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 106.274 -1.751 . . . . 62.140000000000001 106.274 177.215 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -115.5 16.68 16.58 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 114.861 1.43 . . . . 72.519999999999996 114.861 -172.623 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 93.22 170.99 39.75 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 125.258 1.409 . . . . 35.210000000000001 110.058 -178.566 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 58.41 -153.48 27.76 Favored Glycine 0 CA--C 1.532 1.101 0 N-CA-C 110.246 -1.142 . . . . 64.400000000000006 110.246 -172.533 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 8.8 tp -60.19 -17.27 13.8 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 C-N-CA 123.866 0.866 . . . . 72.409999999999997 112.751 -177.208 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 19.1 m95 -58.52 -35.41 72.22 Favored 'General case' 0 C--N 1.34 0.193 0 O-C-N 121.009 -1.057 . . . . 72.299999999999997 110.847 176.82 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 33.4 m-20 -76.66 -33.33 58.3 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 109.283 -0.636 . . . . 72.310000000000002 109.283 -174.863 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 29.8 t -63.17 -65.64 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 C-N-CA 124.797 1.239 . . . . 61.509999999999998 108.992 172.639 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 46.4 m170 -67.66 -2.4 6.81 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 114.138 1.162 . . . . 74.400000000000006 114.138 -171.543 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -102.04 -27.39 7.0 Favored Glycine 0 C--N 1.336 0.563 0 CA-C-N 120.221 1.373 . . . . 52.109999999999999 110.171 -176.783 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 31.7 mt-30 -56.09 -26.86 51.34 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 118.226 -0.893 . . . . 75.519999999999996 112.527 176.362 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 3.7 ttt -46.78 -62.96 1.15 Allowed 'General case' 0 C--N 1.342 0.246 0 N-CA-C 114.796 1.406 . . . . 43.229999999999997 114.796 -170.81 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -53.06 -45.69 68.21 Favored 'General case' 0 C--N 1.331 -0.211 0 O-C-N 123.779 0.674 . . . . 63.219999999999999 110.045 -176.331 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 28.7 mt -61.87 -39.08 90.64 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-O 116.682 -1.628 . . . . 75.219999999999999 109.67 178.079 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.549 ' HA ' HD11 ' A' ' 134' ' ' ILE . 0.0 OUTLIER -60.62 -49.45 77.49 Favored 'General case' 0 C--N 1.349 0.567 0 CA-C-N 121.625 2.011 . . . . 75.530000000000001 109.538 175.596 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -54.57 -54.02 46.87 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 124.452 1.101 . . . . 72.150000000000006 108.425 -175.002 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -75.1 -14.04 60.54 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 112.885 0.698 . . . . 75.420000000000002 112.885 -178.872 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.402 ' HB3' HG21 ' A' ' 128' ' ' THR . 2.9 t -61.37 -33.97 74.53 Favored 'General case' 0 C--O 1.236 0.379 0 O-C-N 121.431 -0.793 . . . . 74.400000000000006 110.809 173.969 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 47.5 mtp . . . . . 0 N--CA 1.447 -0.591 0 C-N-CA 123.602 0.761 . . . . 53.240000000000002 111.914 -171.164 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.135 0 CA-C-O 119.229 -0.415 . . . . 42.420000000000002 111.112 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 21.7 t -53.64 -68.15 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 C-N-CA 125.691 1.596 . . . . 65.140000000000001 109.658 169.969 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -70.65 -32.5 69.81 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 119.961 1.255 . . . . 71.239999999999995 112.978 -174.273 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -60.44 -33.27 72.3 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.119 0.968 . . . . 73.299999999999997 109.266 173.238 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.451 ' HA ' ' HB2' ' A' ' 101' ' ' GLU . . . -72.88 -52.75 13.49 Favored 'General case' 0 N--CA 1.446 -0.656 0 O-C-N 120.413 -1.429 . . . . 75.030000000000001 109.312 174.909 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 40.8 mt -61.9 -44.56 99.05 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-O 118.244 -0.884 . . . . 72.299999999999997 109.72 -171.414 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' HIS . . . . . 0.434 ' CD2' ' HB2' ' A' ' 41' ' ' TYR . 48.6 m-70 -81.54 -72.68 0.42 Allowed 'General case' 0 CA--C 1.52 -0.189 0 C-N-CA 124.694 1.198 . . . . 70.510000000000005 111.065 -179.414 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 8.9 mtmt -65.8 -28.2 68.83 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-N 118.319 0.509 . . . . 74.510000000000005 111.307 -168.223 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.451 ' HB2' ' HA ' ' A' ' 97' ' ' ALA . 0.0 OUTLIER -103.79 -31.13 9.97 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 122.792 0.437 . . . . 74.040000000000006 111.028 -170.526 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 4.0 t60 43.83 70.06 0.35 Allowed 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 127.509 2.323 . . . . 75.209999999999994 112.126 172.671 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 21.0 mtpt -96.44 19.09 12.66 Favored 'General case' 0 N--CA 1.467 0.38 0 O-C-N 121.716 -0.615 . . . . 71.120000000000005 111.805 -172.961 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 12.9 ttpt 46.5 57.77 5.16 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 127.75 2.42 . . . . 74.430000000000007 111.971 176.563 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.496 ' HA ' ' HB3' ' A' ' 110' ' ' GLU . 52.6 mt -73.98 43.28 0.16 Allowed 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 130.428 3.491 . . . . 74.129999999999995 112.193 -176.74 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -82.94 1.43 39.69 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 127.582 2.353 . . . . 55.119999999999997 113.464 -177.211 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 32.9 p -144.11 161.7 43.95 Favored Pre-proline 0 C--O 1.239 0.523 0 C-N-CA 123.726 0.81 . . . . 74.530000000000001 109.916 -172.743 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.43 -13.99 20.37 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 122.471 2.114 . . . . 65.209999999999994 113.445 -179.765 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -63.96 -60.98 2.58 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 107.888 -1.152 . . . . 74.349999999999994 107.888 163.596 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.496 ' HB3' ' HA ' ' A' ' 105' ' ' LEU . 0.1 OUTLIER -61.59 -46.23 90.72 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-O 119.066 -0.492 . . . . 53.229999999999997 111.492 -166.974 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 14.3 mtt -59.89 -42.45 93.81 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 118.427 0.558 . . . . 72.530000000000001 110.998 179.749 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -72.26 -47.49 49.85 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 109.455 -0.572 . . . . 73.329999999999998 109.455 -171.926 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -66.02 -24.11 66.69 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 118.888 0.767 . . . . 75.219999999999999 112.183 178.104 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' PHE . . . . . 0.525 ' CZ ' ' HE3' ' A' ' 118' ' ' LYS . 9.3 t80 -68.19 -60.4 2.5 Favored 'General case' 0 C--O 1.234 0.257 0 O-C-N 121.488 -0.758 . . . . 73.129999999999995 109.682 173.17 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 82.0 mt -65.56 -26.21 67.77 Favored 'General case' 0 N--CA 1.456 -0.127 0 C-N-CA 123.648 0.779 . . . . 45.43 110.424 -177.917 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -57.44 -39.47 76.34 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 119.189 0.904 . . . . 33.520000000000003 109.332 177.39 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -60.56 -8.52 9.82 Favored Glycine 0 CA--C 1.531 1.036 0 CA-C-O 116.981 -2.011 . . . . 22.510000000000002 114.176 172.291 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.525 ' HE3' ' CZ ' ' A' ' 114' ' ' PHE . 0.5 OUTLIER -131.85 21.65 4.58 Favored 'General case' 0 C--N 1.347 0.491 0 CA-C-N 121.324 2.562 . . . . 65.439999999999998 111.671 -175.469 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 82.22 60.3 2.16 Favored Glycine 0 C--N 1.333 0.396 0 N-CA-C 109.713 -1.355 . . . . 70.200000000000003 109.713 171.04 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 28.3 t -135.97 121.12 27.9 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 C-N-CA 125.361 1.464 . . . . 70.409999999999997 107.114 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 52.9 t0 -66.18 116.34 7.15 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 124.149 0.979 . . . . 63.109999999999999 110.364 -179.854 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 7.2 ttmt -61.57 -41.31 97.22 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 124.502 1.121 . . . . 54.439999999999998 109.442 177.578 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -63.39 -36.75 84.75 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 119.118 -0.468 . . . . 63.119999999999997 111.603 -175.078 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 15.7 mmtp -80.97 -37.58 29.07 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-O 118.493 -0.765 . . . . 63.229999999999997 109.181 176.925 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 82.7 t80 -54.3 -60.33 3.49 Favored 'General case' 0 N--CA 1.445 -0.68 0 O-C-N 123.805 0.691 . . . . 73.129999999999995 110.389 -177.459 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 20.1 mt -66.46 -40.78 89.6 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 123.271 0.629 . . . . 55.329999999999998 110.569 -175.462 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 34.2 t -56.18 -48.47 76.28 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 123.802 0.841 . . . . 70.450000000000003 109.629 -178.304 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' THR . . . . . 0.44 HG23 HG22 ' A' ' 80' ' ' THR . 1.3 t -80.42 -30.98 37.7 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-O 119.196 -0.431 . . . . 64.329999999999998 110.192 -175.647 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 58.5 t80 -55.53 -50.75 69.19 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 119.161 0.891 . . . . 52.299999999999997 110.362 174.665 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -95.78 47.84 1.12 Allowed 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 124.065 0.946 . . . . 72.109999999999999 109.23 177.867 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 37.5 t -128.42 165.44 20.63 Favored 'General case' 0 C--O 1.238 0.474 0 O-C-N 120.998 -1.064 . . . . 65.140000000000001 109.642 173.903 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -58.99 -25.76 63.92 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 115.426 -0.806 . . . . 71.25 110.82 163.692 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -48.46 -54.66 13.37 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 124.45 1.1 . . . . 62.219999999999999 111.32 178.85 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.549 HD11 ' HA ' ' A' ' 80' ' ' THR . 11.8 mm -65.37 -42.95 94.81 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.392 0 N-CA-C 113.339 0.866 . . . . 74.310000000000002 113.339 170.751 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 14.2 tttt -54.02 -36.95 63.57 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 118.866 -0.588 . . . . 71.409999999999997 109.746 -175.667 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -82.89 -8.55 85.68 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 126.443 1.973 . . . . 41.039999999999999 113.273 -174.303 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -100.91 -52.99 3.16 Favored 'General case' 0 C--O 1.227 -0.102 0 N-CA-C 107.397 -1.335 . . . . 62.119999999999997 107.397 171.611 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' MET . . . . . 0.438 ' HE3' ' HB2' ' A' ' 138' ' ' MET . 2.6 ptm -53.85 -37.6 63.8 Favored 'General case' 0 C--O 1.223 -0.313 0 C-N-CA 123.989 0.915 . . . . 65.030000000000001 111.682 -175.184 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -49.72 -44.98 48.64 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.124 0.97 . . . . 73.319999999999993 113.13 178.488 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -68.76 -61.65 1.72 Allowed 'General case' 0 CA--C 1.519 -0.228 0 C-N-CA 125.922 1.689 . . . . 61.130000000000003 107.188 -176.537 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -44.23 -42.97 6.92 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.713 1.605 . . . . 62.0 111.777 177.331 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -64.97 -58.64 5.59 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 124.925 1.29 . . . . 72.409999999999997 111.428 -177.138 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.49 -37.46 86.88 Favored 'General case' 0 C--N 1.342 0.272 0 CA-C-N 119.733 1.152 . . . . 70.310000000000002 110.626 -179.211 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 51.0 mt -56.83 -43.16 80.8 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 123.859 0.863 . . . . 75.019999999999996 110.236 178.477 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -58.35 -46.26 86.6 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 119.153 0.888 . . . . 72.439999999999998 110.611 -177.951 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -67.96 -34.87 77.38 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 123.527 0.731 . . . . 74.140000000000001 110.721 -178.949 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -59.22 -52.59 65.01 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 107.76 -1.2 . . . . 72.129999999999995 107.76 175.914 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 -69.87 16.56 0.06 Allowed 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 126.208 1.803 . . . . 74.340000000000003 115.698 -174.838 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 57.93 17.51 4.37 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 126.572 1.949 . . . . 73.530000000000001 114.162 175.031 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 30.1 t -69.64 132.99 32.61 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 N-CA-C 108.4 -0.963 . . . . 74.099999999999994 108.4 -176.553 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -130.13 -4.0 4.46 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 124.58 1.152 . . . . 71.310000000000002 113.07 -177.452 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -169.1 -174.82 37.95 Favored Glycine 0 CA--C 1.526 0.75 0 C-N-CA 126.283 1.896 . . . . 54.229999999999997 110.064 174.291 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.416 ' HA ' ' C ' ' A' ' 154' ' ' PRO . 4.8 m -143.21 159.47 55.51 Favored Pre-proline 0 CA--C 1.537 0.474 0 C-N-CA 125.99 1.716 . . . . 74.230000000000004 109.871 -172.04 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 154' ' ' PRO . . . . . 0.416 ' C ' ' HA ' ' A' ' 153' ' ' VAL . 27.8 Cg_endo -61.45 162.57 42.49 Favored 'Cis proline' 0 N--CA 1.455 -0.792 0 C-N-CA 124.647 -0.98 . . . . 64.400000000000006 111.206 -11.319 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 6.5 m -156.97 138.64 14.13 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 107.026 -1.472 . . . . 40.530000000000001 107.026 176.82 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 98.8 mtp -114.11 158.11 21.7 Favored 'General case' 0 N--CA 1.438 -1.064 0 N-CA-C 108.067 -1.086 . . . . 71.019999999999996 108.067 171.689 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 37.6 t -140.77 134.04 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 N-CA-C 106.148 -1.797 . . . . 63.200000000000003 106.148 177.59 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.405 HG23 ' CE1' ' A' ' 164' ' ' PHE . 13.1 t -102.24 119.44 50.55 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.9 0 N-CA-C 105.92 -1.881 . . . . 72.420000000000002 105.92 171.951 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 15.4 t30 56.01 24.28 7.59 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 128.512 2.725 . . . . 62.229999999999997 114.285 158.807 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 61.64 30.84 75.87 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 127.287 2.375 . . . . 54.25 113.823 -172.86 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 42.6 mttt -131.81 -34.79 1.29 Allowed 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 119.427 1.614 . . . . 74.230000000000004 113.344 -175.686 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -124.33 128.24 48.8 Favored 'General case' 0 CA--C 1.512 -0.512 0 N-CA-C 108.941 -0.763 . . . . 75.310000000000002 108.941 -179.797 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 26.5 ttp85 -107.72 136.62 47.16 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 105.141 -2.17 . . . . 64.340000000000003 105.141 174.123 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 164' ' ' PHE . . . . . 0.405 ' CE1' HG23 ' A' ' 158' ' ' VAL . 9.8 p90 -150.51 170.1 19.91 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 107.705 -1.22 . . . . 73.409999999999997 107.705 178.102 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 165' ' ' ASP . . . . . 0.422 ' H ' ' HB2' ' A' ' 168' ' ' SER . 9.7 p30 -167.65 177.47 5.84 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 108.81 -0.811 . . . . 74.450000000000003 108.81 -178.923 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 16.5 mt -58.94 -40.85 81.41 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 C-N-CA 124.942 1.297 . . . . 65.239999999999995 108.615 -174.913 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -74.62 -39.29 41.38 Favored Glycine 0 N--CA 1.447 -0.602 0 CA-C-O 118.851 -0.972 . . . . 64.219999999999999 111.626 -178.898 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 168' ' ' SER . . . . . 0.422 ' HB2' ' H ' ' A' ' 165' ' ' ASP . 2.6 m -57.97 -59.45 5.25 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 124.462 1.105 . . . . 72.230000000000004 109.695 174.607 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -61.82 -51.11 69.6 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 109.718 -0.475 . . . . 72.299999999999997 109.718 -176.366 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 132.63 4.14 3.55 Favored Glycine 0 CA--C 1.528 0.896 0 CA-C-O 119.137 -0.813 . . . . 53.439999999999998 113.855 177.024 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 164.36 163.65 17.87 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 108.445 -1.862 . . . . 71.540000000000006 108.445 -174.768 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -66.06 -43.86 8.33 Favored 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 122.474 2.116 . . . . 71.329999999999998 110.079 -173.495 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -54.1 -38.61 65.55 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 125.199 1.399 . . . . 72.340000000000003 111.766 173.038 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -76.1 -26.25 56.25 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.432 1.093 . . . . 74.129999999999995 109.511 -173.142 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -56.64 -48.3 77.85 Favored 'General case' 0 CA--C 1.528 0.106 0 C-N-CA 123.997 0.919 . . . . 73.099999999999994 109.696 177.196 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 61.8 mt -62.05 -34.23 75.87 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 118.127 0.421 . . . . 62.030000000000001 110.777 179.052 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -54.6 -42.33 71.0 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 123.496 0.718 . . . . 72.540000000000006 110.289 175.877 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.414 ' HA ' HD13 ' A' ' 178' ' ' LEU . 4.4 mm? -73.25 -46.11 51.97 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-O 118.008 -0.996 . . . . 74.439999999999998 110.237 173.357 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.464 ' HB1' ' CH2' ' A' ' 50' ' ' TRP . . . -55.18 -34.94 64.28 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 118.843 0.747 . . . . 72.430000000000007 112.11 -174.047 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -94.24 -32.11 13.81 Favored 'General case' 0 C--N 1.333 -0.147 0 C-N-CA 124.859 1.264 . . . . 75.329999999999998 110.059 -167.401 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 35.5 t80 -64.69 -58.28 6.72 Favored 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 123.991 0.916 . . . . 73.319999999999993 110.497 167.521 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 56.1 mt -58.01 -35.77 71.71 Favored 'General case' 0 C--O 1.224 -0.268 0 C-N-CA 124.825 1.25 . . . . 73.140000000000001 112.294 -164.641 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 38.1 mt -45.09 -52.8 1.79 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 C-N-CA 124.279 1.031 . . . . 72.209999999999994 109.974 173.223 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -58.16 -34.53 70.4 Favored 'General case' 0 N--CA 1.447 -0.596 0 O-C-N 121.213 -0.929 . . . . 75.209999999999994 111.534 -177.751 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.3 -32.77 68.77 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 123.71 0.804 . . . . 54.450000000000003 110.934 -178.34 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -93.1 -43.87 8.66 Favored 'General case' 0 C--O 1.224 -0.256 0 CA-C-N 119.954 1.252 . . . . 64.439999999999998 112.298 168.957 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.54 -34.24 68.94 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 125.5 1.52 . . . . 61.530000000000001 110.308 -172.335 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.339 0.147 0 C-N-CA 124.776 1.23 . . . . 75.129999999999995 111.933 178.931 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 . . . . . 0 N--CA 1.466 0.368 0 CA-C-O 123.603 1.668 . . . . 74.230000000000004 110.313 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -81.69 11.14 5.05 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 113.735 -1.575 . . . . 71.420000000000002 114.565 -159.884 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 36.1 m-85 -134.65 175.56 9.44 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 126.696 1.998 . . . . 72.439999999999998 108.89 -172.757 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 31.9 m -137.13 136.95 38.72 Favored 'General case' 0 CA--C 1.535 0.387 0 O-C-N 119.972 -1.705 . . . . 65.230000000000004 110.679 172.251 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -68.6 153.13 44.36 Favored 'General case' 0 C--N 1.342 0.271 0 CA-C-O 121.709 0.766 . . . . 61.130000000000003 109.043 178.162 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 75.58 -31.7 1.21 Allowed Glycine 0 CA--C 1.53 0.988 0 C-N-CA 124.134 0.873 . . . . 50.310000000000002 111.309 -165.113 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 38.5 tttt -95.43 -84.26 0.34 Allowed 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 118.946 1.373 . . . . 74.420000000000002 110.264 -170.027 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -68.6 -25.17 64.73 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.794 1.637 . . . . 65.5 110.655 -178.523 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 31.9 p90 -162.09 170.27 19.48 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 107.35 -1.352 . . . . 74.439999999999998 107.35 -173.822 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 13.7 t -134.63 108.24 10.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 107.958 -1.127 . . . . 62.229999999999997 107.958 -178.426 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -63.56 152.57 38.32 Favored 'General case' 0 N--CA 1.44 -0.928 0 O-C-N 121.178 -0.951 . . . . 74.219999999999999 108.968 164.102 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -120.13 107.08 12.6 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 125.565 1.546 . . . . 75.310000000000002 109.535 179.734 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 70.3 m -67.02 21.06 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.864 1.666 . . . . 43.329999999999998 114.193 173.889 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 4.4 t -132.3 81.92 59.45 Favored Pre-proline 0 CA--C 1.53 0.195 0 N-CA-C 106.674 -1.602 . . . . 62.240000000000002 106.674 153.616 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -72.25 178.58 5.89 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 123.031 2.487 . . . . 72.230000000000004 111.139 -175.64 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 39.4 t -137.48 142.06 35.89 Favored Pre-proline 0 CA--C 1.539 0.538 0 N-CA-C 109.15 -0.685 . . . . 73.120000000000005 109.15 -170.468 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -79.36 178.55 7.29 Favored 'Trans proline' 0 CA--C 1.536 0.599 0 C-N-CA 123.739 2.959 . . . . 53.43 111.733 172.684 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 16.2 m -131.91 172.43 16.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 126.079 1.752 . . . . 74.530000000000001 109.735 179.084 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 13.1 t -53.86 -58.74 6.15 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.831 1.253 . . . . 74.239999999999995 110.625 173.584 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -144.78 164.97 24.67 Favored Pre-proline 0 CA--C 1.531 0.234 0 O-C-N 121.301 -0.874 . . . . 74.5 111.342 173.788 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -80.52 -172.88 1.64 Allowed 'Trans proline' 0 N--CA 1.452 -0.966 0 C-N-CA 123.219 2.613 . . . . 63.299999999999997 110.995 170.948 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 104.68 -86.67 0.52 Allowed Glycine 0 N--CA 1.451 -0.321 0 N-CA-C 106.832 -2.507 . . . . 71.140000000000001 106.832 179.168 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 67.0 mttt -68.06 149.16 50.01 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-O 121.511 0.672 . . . . 71.109999999999999 109.281 170.87 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 29.8 mm -80.01 141.56 15.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 107.663 -1.236 . . . . 54.32 107.663 168.51 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -87.96 132.43 34.24 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 106.493 -1.669 . . . . 64.019999999999996 106.493 173.147 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 46.4 t -131.2 136.22 58.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 N-CA-C 106.181 -1.785 . . . . 55.420000000000002 106.181 169.605 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 23.5 t -135.34 123.29 38.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 N-CA-C 108.005 -1.109 . . . . 61.509999999999998 108.005 -171.006 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -91.09 145.2 24.88 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 124.948 1.299 . . . . 73.540000000000006 108.847 166.101 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.41 HD22 HG11 ' A' ' 150' ' ' VAL . 5.5 mp -125.31 137.63 54.07 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.572 1.549 . . . . 64.200000000000003 107.744 168.002 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 30.9 p90 -141.78 172.67 12.37 Favored 'General case' 0 CA--C 1.549 0.918 0 N-CA-C 113.616 0.969 . . . . 71.129999999999995 113.616 -173.277 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 27.8 t90 -156.44 150.23 24.9 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.489 1.115 . . . . 65.439999999999998 111.806 -178.218 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -60.47 -9.17 3.32 Favored 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 114.843 1.423 . . . . 72.129999999999995 114.843 -179.842 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -123.84 19.0 7.48 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 125.447 1.499 . . . . 54.240000000000002 114.25 -169.337 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.413 ' HB3' HG23 ' A' ' 153' ' ' VAL . 22.4 p -104.26 86.7 1.4 Allowed Pre-proline 0 CA--C 1.536 0.431 0 CA-C-N 119.782 1.791 . . . . 44.009999999999998 110.744 -175.248 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -52.47 -35.83 67.57 Favored 'Trans proline' 0 CA--C 1.534 0.476 0 C-N-CA 122.769 2.313 . . . . 74.230000000000004 113.334 -177.242 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 11.5 m170 -64.74 -24.55 67.6 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 118.341 -0.838 . . . . 74.400000000000006 112.063 -178.882 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 83.6 m -59.39 -53.94 52.45 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.33 1.052 . . . . 62.100000000000001 109.144 175.198 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 59.9 t80 -56.78 -40.44 75.88 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 119.253 0.933 . . . . 72.239999999999995 111.041 -176.163 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -70.16 2.37 3.74 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 113.303 0.853 . . . . 75.430000000000007 113.303 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -125.71 -29.9 3.1 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 127.602 2.361 . . . . 72.209999999999994 111.261 179.163 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -37.5 -62.13 0.65 Allowed Pre-proline 0 CA--C 1.544 0.735 0 C-N-CA 126.401 1.88 . . . . 62.200000000000003 113.708 -174.667 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -79.52 -10.68 14.53 Favored 'Trans proline' 0 N--CA 1.454 -0.818 0 CA-C-N 121.191 1.461 . . . . 72.129999999999995 114.937 -175.746 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 51.1 m -70.87 -41.27 71.59 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 119.605 1.093 . . . . 74.319999999999993 109.335 164.715 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 17.3 tt -81.84 -42.64 19.32 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 CA-C-O 118.136 -0.935 . . . . 62.409999999999997 111.926 -169.705 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 79.5 t -44.84 -60.22 3.3 Favored Pre-proline 0 CA--C 1.544 0.716 0 CA-C-N 120.012 1.278 . . . . 74.25 112.803 177.975 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -73.79 -15.0 24.16 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 122.284 1.989 . . . . 72.409999999999997 112.112 -174.377 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 76.0 t90 -64.53 -61.59 2.12 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 119.73 1.15 . . . . 71.329999999999998 108.498 163.147 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -63.96 -34.53 78.2 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 113.008 0.744 . . . . 54.350000000000001 113.008 -171.97 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -59.13 -36.5 75.32 Favored 'General case' 0 C--O 1.237 0.441 0 O-C-N 121.389 -0.819 . . . . 51.299999999999997 110.908 175.16 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 29.9 mmmt -93.98 10.01 35.23 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.879 1.271 . . . . 61.039999999999999 111.863 -170.992 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 23.1 mt -61.6 157.54 46.72 Favored Pre-proline 0 CA--C 1.54 0.564 0 CA-C-N 119.5 1.045 . . . . 72.439999999999998 112.811 -178.082 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -77.98 178.05 8.06 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 124.991 3.794 . . . . 65.5 111.695 178.246 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -74.45 -0.2 16.69 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.032 1.333 . . . . 75.040000000000006 114.437 -174.302 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -126.22 18.75 7.65 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.782 1.233 . . . . 32.219999999999999 110.726 -172.853 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 42.5 t -124.82 139.18 51.76 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 N-CA-C 108.063 -1.088 . . . . 53.530000000000001 108.063 170.161 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 82.7 t60 -113.59 153.25 29.14 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 125.6 1.56 . . . . 70.329999999999998 106.908 166.33 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.472 ' CE2' ' HD2' ' A' ' 62' ' ' ARG . 24.2 t80 -136.57 141.5 43.33 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 108.63 -0.878 . . . . 70.140000000000001 108.63 -178.833 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 60.2 t -134.38 147.19 30.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 C-N-CA 126.622 1.969 . . . . 61.299999999999997 107.253 -170.796 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.472 ' HD2' ' CE2' ' A' ' 60' ' ' PHE . 0.0 OUTLIER -126.79 121.73 32.78 Favored 'General case' 0 CA--C 1.516 -0.358 0 N-CA-C 104.35 -2.463 . . . . 73.030000000000001 104.35 176.298 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 32.7 mt -127.09 151.97 75.08 Favored Pre-proline 0 N--CA 1.467 0.386 0 CA-C-N 118.961 0.8 . . . . 50.030000000000001 111.112 177.905 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -72.57 130.56 16.15 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 122.194 1.929 . . . . 62.520000000000003 109.828 178.003 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -75.48 100.8 4.62 Favored 'General case' 0 CA--C 1.536 0.409 0 O-C-N 121.42 -0.8 . . . . 45.420000000000002 109.006 176.389 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 42.8 mt -95.43 78.43 3.41 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.657 1.583 . . . . 52.32 111.548 -174.442 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -110.38 12.97 22.96 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 114.275 1.213 . . . . 73.140000000000001 114.275 -169.535 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 108.95 152.06 14.91 Favored Glycine 0 CA--C 1.518 0.275 0 C-N-CA 125.259 1.409 . . . . 52.109999999999999 110.626 173.721 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 52.82 -139.57 32.12 Favored Glycine 0 CA--C 1.521 0.439 0 C-N-CA 123.641 0.639 . . . . 13.24 111.952 -173.552 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 5.5 tp -58.62 -20.87 17.31 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 C-N-CA 124.963 1.305 . . . . 71.140000000000001 112.507 -168.874 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 23.6 m95 -57.3 -38.26 73.72 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.898 0.879 . . . . 73.209999999999994 110.92 173.449 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 14.0 m-80 -74.8 -43.46 54.63 Favored 'General case' 0 C--N 1.339 0.147 0 O-C-N 121.804 -0.56 . . . . 61.210000000000001 111.794 175.356 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 61.3 t -57.67 -54.57 29.71 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 C-N-CA 124.31 1.044 . . . . 73.109999999999999 108.588 -177.176 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 57.5 m170 -79.4 24.67 0.34 Allowed 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.662 1.585 . . . . 72.120000000000005 111.546 175.605 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -114.85 -33.53 1.68 Allowed Glycine 0 CA--C 1.524 0.637 0 C-N-CA 125.573 1.559 . . . . 64.230000000000004 111.69 170.722 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 31.6 mt-30 -63.29 -31.62 72.82 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 118.402 -0.808 . . . . 72.329999999999998 112.771 -179.111 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 16.7 ttp -60.42 -50.71 72.51 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-N 119.754 1.161 . . . . 73.239999999999995 111.535 -174.842 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 17.5 t80 -53.78 -50.9 65.07 Favored 'General case' 0 CA--C 1.53 0.178 0 O-C-N 123.72 0.638 . . . . 75.420000000000002 109.933 -179.63 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 76.0 mt -61.11 -36.73 80.49 Favored 'General case' 0 C--O 1.222 -0.378 0 CA-C-O 117.774 -1.108 . . . . 72.510000000000005 111.155 177.401 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.422 ' HA ' HD11 ' A' ' 134' ' ' ILE . 1.5 m -66.89 -35.26 79.61 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 120.622 1.556 . . . . 74.150000000000006 111.09 178.23 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.19 -56.83 16.74 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 107.544 -1.28 . . . . 73.420000000000002 107.544 178.085 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -66.29 -25.29 66.79 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.2 1.4 . . . . 60.399999999999999 112.744 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 16.1 t -73.07 -6.8 47.99 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.37 1.468 . . . . 71.120000000000005 113.442 -175.738 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 9.8 mtm . . . . . 0 N--CA 1.467 0.42 0 CA-C-N 119.998 1.272 . . . . 53.520000000000003 112.893 162.329 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 0.305 0 N-CA-C 113.011 0.745 . . . . 53.240000000000002 113.011 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 3.8 t -62.76 -67.06 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-N 119.275 0.943 . . . . 73.140000000000001 108.51 161.581 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -60.78 -48.68 80.69 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 107.744 -1.206 . . . . 73.430000000000007 107.744 -167.163 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.414 ' CD ' ' HE2' ' A' ' 100' ' ' LYS . 4.1 mm-40 -51.89 -33.66 37.72 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 128.006 2.522 . . . . 75.329999999999998 110.368 -176.024 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.447 ' HA ' ' HB2' ' A' ' 101' ' ' GLU . . . -79.56 -13.81 59.28 Favored 'General case' 0 N--CA 1.444 -0.746 0 O-C-N 120.621 -1.3 . . . . 73.340000000000003 113.215 -172.177 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 14.3 mt -114.01 -49.33 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 N-CA-C 106.008 -1.849 . . . . 60.420000000000002 106.008 -175.561 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 76.8 m80 -76.08 -40.27 53.48 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 124.22 1.008 . . . . 74.25 112.564 -176.864 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.414 ' HE2' ' CD ' ' A' ' 96' ' ' GLU . 25.5 mtmt -93.59 -37.8 11.69 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 120.431 1.469 . . . . 75.010000000000005 111.69 172.179 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.447 ' HB2' ' HA ' ' A' ' 97' ' ' ALA . 27.5 mt-10 -122.55 32.47 5.75 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 113.214 0.82 . . . . 70.219999999999999 113.214 -160.264 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 41.2 t-80 -41.88 97.67 0.01 OUTLIER 'General case' 0 C--O 1.241 0.639 0 C-N-CA 129.472 3.109 . . . . 65.030000000000001 112.432 -172.67 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.09 27.61 1.58 Allowed 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 126.133 1.773 . . . . 71.049999999999997 112.036 175.841 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 2.7 tttp 65.4 -61.53 0.24 Allowed 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 128.72 2.808 . . . . 72.409999999999997 112.004 -175.184 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 87.7 mt 74.96 17.03 2.81 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 127.532 2.333 . . . . 75.099999999999994 113.696 174.475 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -85.14 33.71 0.55 Allowed 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.018 1.327 . . . . 74.109999999999999 112.703 -174.76 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -152.29 158.21 33.63 Favored Pre-proline 0 C--O 1.237 0.412 0 C-N-CA 124.425 1.09 . . . . 73.439999999999998 108.974 167.256 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -64.99 -41.47 17.1 Favored 'Trans proline' 0 N--CA 1.451 -0.975 0 C-N-CA 122.147 1.898 . . . . 63.520000000000003 111.331 177.463 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -58.76 -47.21 85.48 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 118.746 0.703 . . . . 64.25 110.03 176.175 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -62.7 -31.67 72.62 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 123.362 0.665 . . . . 72.340000000000003 111.473 -176.076 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 74.1 mtm -81.06 -35.76 31.36 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 118.475 -0.774 . . . . 75.209999999999994 112.5 173.22 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -77.66 -47.95 17.99 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 119.29 0.95 . . . . 55.439999999999998 111.449 -172.486 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -58.05 -31.83 67.42 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 125.477 1.511 . . . . 52.43 111.866 -172.86 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 38.4 t80 -75.08 -48.2 25.04 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 123.851 0.86 . . . . 72.25 112.22 174.653 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 88.4 mt -65.63 -25.07 67.21 Favored 'General case' 0 N--CA 1.455 -0.186 0 O-C-N 121.333 -0.854 . . . . 62.0 110.489 -176.018 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -53.4 -23.88 10.94 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.975 0.91 . . . . 72.540000000000006 112.579 171.446 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -84.09 -15.5 69.5 Favored Glycine 0 CA--C 1.53 0.971 0 C-N-CA 124.258 0.932 . . . . 72.209999999999994 114.272 174.483 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 45.5 mmtt -129.03 39.79 3.73 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 120.294 2.047 . . . . 74.439999999999998 110.691 -162.072 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 74.34 39.75 42.44 Favored Glycine 0 N--CA 1.448 -0.529 0 N-CA-C 110.989 -0.845 . . . . 75.230000000000004 110.989 170.076 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 89.2 t -128.56 143.88 39.7 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 N-CA-C 106.068 -1.827 . . . . 74.409999999999997 106.068 172.138 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 16.0 t0 -95.64 129.15 42.93 Favored 'General case' 0 C--N 1.331 -0.212 0 O-C-N 121.909 -0.495 . . . . 61.32 109.67 177.484 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -67.57 -46.96 71.18 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 123.268 0.627 . . . . 73.510000000000005 110.405 -177.265 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -57.31 -37.67 72.85 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 117.731 0.241 . . . . 72.319999999999993 110.993 -174.4 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 16.3 mmtp -97.17 -29.21 13.72 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-O 117.227 -1.368 . . . . 70.0 108.756 -169.097 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 89.6 t80 -51.71 -60.42 3.18 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 119.164 0.893 . . . . 72.099999999999994 109.391 165.966 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 7.1 mt -65.49 -42.81 91.76 Favored 'General case' 0 C--O 1.234 0.253 0 O-C-N 121.875 -0.516 . . . . 71.420000000000002 110.693 -170.718 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 2.5 m -58.04 -56.02 27.39 Favored 'General case' 0 C--O 1.223 -0.321 0 CA-C-O 118.321 -0.847 . . . . 74.349999999999994 109.007 176.052 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 28.8 m -59.68 -39.68 85.31 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.749 0.82 . . . . 62.119999999999997 111.215 -175.617 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -57.2 -46.81 82.54 Favored 'General case' 0 C--O 1.236 0.357 0 O-C-N 121.353 -0.842 . . . . 72.510000000000005 109.576 175.55 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -89.26 30.48 0.97 Allowed 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.309 1.044 . . . . 75.129999999999995 111.983 175.963 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 72.7 m -110.89 150.62 28.92 Favored 'General case' 0 C--O 1.236 0.363 0 O-C-N 120.699 -1.251 . . . . 73.010000000000005 109.926 171.814 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -59.91 -22.9 63.01 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.407 1.083 . . . . 73.329999999999998 111.616 175.098 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -44.87 -55.76 5.14 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 125.345 1.458 . . . . 71.519999999999996 111.955 172.59 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.422 HD11 ' HA ' ' A' ' 80' ' ' THR . 45.4 mm -66.73 -34.87 72.88 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.253 0 C-N-CA 123.104 0.562 . . . . 71.25 109.806 -178.551 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 25.8 tttm -57.35 -39.46 75.97 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 118.717 -0.658 . . . . 72.010000000000005 110.501 179.681 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -69.79 -27.67 72.94 Favored Glycine 0 CA--C 1.523 0.572 0 C-N-CA 124.075 0.845 . . . . 53.530000000000001 111.98 -176.379 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -80.31 -48.56 12.81 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 108.502 -0.925 . . . . 70.209999999999994 108.502 175.998 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 91.6 mmm -54.16 -45.84 72.16 Favored 'General case' 0 C--N 1.339 0.119 0 C-N-CA 125.305 1.442 . . . . 70.310000000000002 111.118 -178.697 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -63.86 -44.77 92.11 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 119.087 0.858 . . . . 65.439999999999998 111.687 -176.03 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 33.4 mttt -60.77 -61.47 2.56 Favored 'General case' 0 C--N 1.341 0.219 0 N-CA-C 108.922 -0.77 . . . . 71.150000000000006 108.922 171.641 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -47.41 -40.98 19.13 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.283 1.033 . . . . 45.229999999999997 111.564 -175.998 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -59.21 -64.92 0.77 Allowed 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 124.171 0.989 . . . . 63.509999999999998 108.823 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.85 -23.03 65.97 Favored 'General case' 0 N--CA 1.461 0.097 0 CA-C-O 118.278 -0.868 . . . . 74.120000000000005 112.723 -175.401 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 55.9 mt -59.73 -50.28 74.44 Favored 'General case' 0 C--O 1.227 -0.122 0 CA-C-N 118.972 0.805 . . . . 65.420000000000002 109.662 173.618 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -63.88 -32.86 74.52 Favored 'General case' 0 CA--C 1.537 0.476 0 O-C-N 121.908 -0.495 . . . . 62.229999999999997 111.307 -172.66 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 146' ' ' MET . . . . . 0.406 ' H ' ' HG2' ' A' ' 146' ' ' MET . 11.3 mmt -62.36 -45.44 93.17 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 125.502 1.521 . . . . 63.299999999999997 110.381 174.811 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -58.24 -47.2 84.27 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 109.017 -0.734 . . . . 75.230000000000004 109.017 -177.438 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 31.8 m-85 -68.85 5.31 1.15 Allowed 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 126.417 1.887 . . . . 72.540000000000006 114.674 -176.297 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 62.6 mt-30 54.04 28.88 9.34 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 126.234 1.814 . . . . 64.209999999999994 112.363 -179.272 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.412 HG13 HG21 ' A' ' 155' ' ' THR . 44.3 t -78.53 135.95 24.93 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 N-CA-C 107.424 -1.325 . . . . 74.109999999999999 107.424 176.142 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -142.66 14.96 1.96 Allowed 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 121.501 0.667 . . . . 72.230000000000004 111.397 -176.873 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -173.76 177.27 46.14 Favored Glycine 0 CA--C 1.52 0.398 0 C-N-CA 125.939 1.733 . . . . 63.43 110.144 174.503 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.416 ' HA ' ' C ' ' A' ' 154' ' ' PRO . 12.4 m -141.14 150.89 60.31 Favored Pre-proline 0 CA--C 1.539 0.523 0 C-N-CA 124.337 1.055 . . . . 73.200000000000003 109.793 179.365 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 154' ' ' PRO . . . . . 0.416 ' C ' ' HA ' ' A' ' 153' ' ' VAL . 38.8 Cg_endo -68.91 150.18 87.56 Favored 'Cis proline' 0 N--CA 1.459 -0.526 0 C-N-CA 125.067 -0.805 . . . . 61.109999999999999 112.072 -1.005 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 155' ' ' THR . . . . . 0.412 HG21 HG13 ' A' ' 150' ' ' VAL . 51.6 m -148.33 117.32 6.77 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.738 1.615 . . . . 71.409999999999997 107.197 175.461 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 96.4 mtp -94.69 158.84 15.34 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 108.38 -0.97 . . . . 64.109999999999999 108.38 167.188 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 38.2 t -140.42 138.27 36.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 106.459 -1.682 . . . . 70.340000000000003 106.459 171.963 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.597 HG23 ' CE1' ' A' ' 164' ' ' PHE . 95.3 t -103.53 132.32 50.13 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 N-CA-C 107.606 -1.257 . . . . 63.219999999999999 107.606 168.132 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 4.9 t30 48.79 23.63 0.7 Allowed 'General case' 0 C--N 1.331 -0.231 1 C-N-CA 132.159 4.184 . . . . 64.109999999999999 115.963 167.041 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 70.12 24.4 76.58 Favored Glycine 0 CA--C 1.527 0.792 0 C-N-CA 126.209 1.862 . . . . 63.130000000000003 114.498 -175.182 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 48.7 mttp -137.02 -28.54 0.94 Allowed 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 120.202 2.001 . . . . 74.230000000000004 113.996 -171.669 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -125.04 105.83 9.48 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 108.466 -0.939 . . . . 54.439999999999998 108.466 -175.001 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 32.5 ttp85 -83.03 136.73 34.39 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 105.166 -2.161 . . . . 71.209999999999994 105.166 171.331 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 164' ' ' PHE . . . . . 0.597 ' CE1' HG23 ' A' ' 158' ' ' VAL . 15.3 p90 -152.32 170.03 21.05 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 107.845 -1.169 . . . . 62.399999999999999 107.845 174.93 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -179.52 178.98 0.63 Allowed 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 123.877 0.871 . . . . 73.140000000000001 109.177 179.764 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.416 HG23 ' HA2' ' A' ' 171' ' ' GLY . 29.5 mt -45.37 -52.78 2.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 C-N-CA 129.217 3.007 . . . . 72.319999999999993 109.71 174.429 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -75.41 -21.22 77.9 Favored Glycine 0 C--N 1.338 0.639 0 CA-C-O 119.435 -0.647 . . . . 54.409999999999997 113.443 -176.737 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 14.4 m -75.19 -68.23 0.58 Allowed 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 118.492 1.146 . . . . 63.200000000000003 108.084 169.986 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.514 ' HB1' HD23 ' A' ' 178' ' ' LEU . . . -75.0 -31.33 61.39 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-O 117.415 -1.279 . . . . 45.140000000000001 113.443 -162.223 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 134.78 5.39 2.5 Favored Glycine 0 CA--C 1.533 1.201 0 N-CA-C 117.171 1.628 . . . . 62.030000000000001 117.171 174.265 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 171' ' ' GLY . . . . . 0.416 ' HA2' HG23 ' A' ' 166' ' ' ILE . . . 126.42 167.95 12.51 Favored Glycine 0 CA--C 1.529 0.953 0 CA-C-N 119.446 1.623 . . . . 73.310000000000002 110.378 -173.914 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -61.44 -40.47 47.93 Favored 'Trans proline' 0 CA--C 1.534 0.502 0 C-N-CA 123.059 2.506 . . . . 51.310000000000002 113.736 -156.294 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -65.93 -33.2 75.29 Favored 'General case' 0 CA--C 1.532 0.283 0 O-C-N 121.206 -0.934 . . . . 70.430000000000007 111.379 177.816 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -72.44 -25.99 61.66 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 123.274 0.63 . . . . 73.030000000000001 110.515 176.61 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 6.6 m -63.84 -47.44 80.76 Favored 'General case' 0 C--O 1.233 0.195 0 O-C-N 120.867 -1.146 . . . . 75.049999999999997 108.443 -178.152 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 59.9 mt -62.79 -33.26 74.83 Favored 'General case' 0 C--O 1.224 -0.258 0 CA-C-O 119.484 -0.293 . . . . 74.299999999999997 110.788 175.633 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 14.0 tptt -54.23 -36.75 63.87 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-O 118.939 -0.553 . . . . 65.200000000000003 111.089 176.132 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.514 HD23 ' HB1' ' A' ' 169' ' ' ALA . 4.6 mm? -80.09 -44.85 19.28 Favored 'General case' 0 CA--C 1.509 -0.63 0 CA-C-O 117.665 -1.16 . . . . 75.409999999999997 110.077 175.262 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -50.43 -42.41 53.89 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 119.251 0.932 . . . . 73.439999999999998 111.169 -179.327 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -82.19 -33.3 29.49 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 124.693 1.197 . . . . 74.120000000000005 109.827 -165.415 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 19.2 t80 -69.79 -51.06 37.08 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.892 1.277 . . . . 73.230000000000004 110.496 170.8 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 62.5 mt -61.32 -27.96 68.87 Favored 'General case' 0 N--CA 1.462 0.133 0 C-N-CA 125.274 1.429 . . . . 74.450000000000003 112.871 -174.924 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 24.4 mt -56.61 -63.11 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 N-CA-C 108.178 -1.045 . . . . 65.319999999999993 108.178 171.539 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 7.8 tm-20 -60.36 -33.38 72.36 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.646 1.179 . . . . 72.239999999999995 111.324 -173.81 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 43.6 tptt -48.72 -57.99 5.46 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 124.344 1.058 . . . . 65.340000000000003 109.971 173.765 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 25.0 mm-40 -77.07 -34.55 57.01 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 123.504 0.721 . . . . 74.120000000000005 111.715 -178.419 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.75 -36.87 83.46 Favored 'General case' 0 N--CA 1.462 0.155 0 O-C-N 120.959 -1.088 . . . . 60.130000000000003 109.99 -174.92 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.369 0 C-N-CA 124.103 0.961 . . . . 71.0 112.065 177.883 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.235 0.302 0 CA-C-O 120.951 0.405 . . . . 75.510000000000005 110.723 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -142.85 8.02 1.67 Allowed 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 124.527 1.131 . . . . 72.319999999999993 111.752 -173.413 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 -145.97 157.77 43.88 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 125.016 1.327 . . . . 75.129999999999995 109.383 -170.451 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 51.1 m -134.06 141.26 47.12 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-O 121.692 0.758 . . . . 74.430000000000007 109.698 -179.115 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.43 144.28 57.29 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 124.12 0.968 . . . . 50.229999999999997 110.021 -178.779 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 79.1 -46.07 2.9 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 126.059 1.79 . . . . 71.129999999999995 111.099 -170.196 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 9.2 tptp -67.14 -70.42 0.25 Allowed 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 125.467 1.507 . . . . 72.530000000000001 109.748 -172.842 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.432 ' HB3' HD21 ' A' ' 178' ' ' LEU . 11.2 mp0 -88.24 -27.49 21.73 Favored 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 123.46 0.704 . . . . 71.430000000000007 110.735 -176.829 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 39.7 p90 -156.12 177.11 11.8 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 121.087 -1.008 . . . . 74.310000000000002 110.267 -171.462 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 17.7 t -134.1 112.73 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 N-CA-C 108.577 -0.897 . . . . 73.319999999999993 108.577 -175.266 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.32 163.66 26.09 Favored 'General case' 0 C--N 1.329 -0.314 0 O-C-N 120.652 -1.28 . . . . 75.109999999999999 109.01 164.459 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -132.01 113.52 13.49 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 123.959 0.904 . . . . 53.219999999999999 109.107 -176.241 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.9 m -61.16 -10.49 6.55 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 114.657 1.355 . . . . 45.530000000000001 114.657 -179.095 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 15.7 m -117.86 79.88 13.86 Favored Pre-proline 0 N--CA 1.448 -0.57 0 CA-C-N 119.834 1.197 . . . . 71.200000000000003 108.312 171.581 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_endo -69.06 174.79 8.4 Favored 'Trans proline' 0 N--CA 1.451 -1.012 0 C-N-CA 122.566 2.178 . . . . 72.530000000000001 111.336 175.175 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 50.5 t -143.22 134.76 12.84 Favored Pre-proline 0 C--N 1.33 -0.271 0 N-CA-C 106.203 -1.777 . . . . 51.030000000000001 106.203 -176.437 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -75.37 173.86 13.79 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 121.067 1.178 . . . . 63.299999999999997 110.56 176.934 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 16.3 m -116.2 165.19 11.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 C-N-CA 124.864 1.266 . . . . 63.509999999999998 108.87 175.006 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 3.4 m -48.75 -53.77 17.69 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 124.823 1.249 . . . . 71.430000000000007 112.418 174.742 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 2.2 pm0 -147.45 159.56 41.37 Favored Pre-proline 0 N--CA 1.449 -0.496 0 CA-C-N 120.413 1.46 . . . . 72.030000000000001 111.045 177.84 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -65.09 -177.07 0.54 Allowed 'Trans proline' 0 CA--C 1.544 1.021 0 C-N-CA 123.902 3.068 . . . . 74.329999999999998 111.135 166.218 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 119.97 -80.3 0.32 Allowed Glycine 0 CA--C 1.525 0.692 0 C-N-CA 125.211 1.386 . . . . 52.210000000000001 111.34 174.358 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -109.04 144.72 36.69 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 124.192 0.997 . . . . 71.319999999999993 109.232 179.122 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 47.2 mm -59.26 146.74 8.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 C-N-CA 124.481 1.112 . . . . 73.340000000000003 108.484 175.397 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -107.71 90.16 3.22 Favored 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 105.872 -1.899 . . . . 75.310000000000002 105.872 175.907 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 47.8 t -84.22 125.36 40.23 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.174 0 N-CA-C 105.505 -2.035 . . . . 72.530000000000001 105.505 170.946 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 41.9 t -119.35 113.39 41.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 N-CA-C 107.291 -1.374 . . . . 72.209999999999994 107.291 -175.989 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -72.01 131.6 43.13 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 107.83 -1.174 . . . . 54.439999999999998 107.83 156.98 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.1 mp -119.68 130.59 55.12 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 106.826 -1.546 . . . . 70.340000000000003 106.826 165.96 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 6.1 p90 -142.75 170.35 15.87 Favored 'General case' 0 C--O 1.237 0.416 0 O-C-N 123.9 0.75 . . . . 74.530000000000001 112.639 -170.996 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' TRP . . . . . 0.458 ' HB3' HG21 ' A' ' 153' ' ' VAL . 27.4 t90 -142.44 149.02 38.73 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 127.224 2.21 . . . . 62.310000000000002 108.344 -178.291 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 9.3 p90 -60.67 -20.11 60.1 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 115.905 1.817 . . . . 71.129999999999995 115.905 -172.178 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -100.69 -89.13 2.04 Favored Glycine 0 N--CA 1.449 -0.498 0 N-CA-C 106.931 -2.468 . . . . 54.450000000000003 106.931 -176.418 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 30.8 t 44.8 80.64 0.28 Allowed Pre-proline 0 CA--C 1.538 0.483 0 C-N-CA 126.172 1.789 . . . . 71.230000000000004 112.491 175.748 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -59.76 -21.36 63.12 Favored 'Trans proline' 0 CA--C 1.536 0.595 0 C-N-CA 121.993 1.795 . . . . 63.340000000000003 113.493 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 18.6 m170 -82.39 -39.37 22.79 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.757 1.223 . . . . 73.109999999999999 111.047 179.638 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 74.5 m -58.21 -43.25 87.58 Favored 'General case' 0 N--CA 1.462 0.143 0 C-N-CA 124.949 1.3 . . . . 63.119999999999997 111.271 -175.998 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 68.5 t80 -61.39 -27.84 68.82 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.819 0.848 . . . . 73.329999999999998 111.207 178.153 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -77.89 10.76 2.58 Favored 'General case' 0 CA--C 1.544 0.719 0 O-C-N 120.598 -1.314 . . . . 65.310000000000002 112.88 174.606 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 10.9 t80 -138.43 -23.63 0.98 Allowed 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 125.796 1.639 . . . . 74.540000000000006 111.994 174.731 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -35.12 -66.14 0.25 Allowed Pre-proline 0 CA--C 1.541 0.622 0 C-N-CA 127.074 2.15 . . . . 71.400000000000006 112.594 176.592 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -72.07 -11.36 27.13 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 CA-C-N 120.907 1.36 . . . . 72.540000000000006 114.476 -173.297 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 82.0 m -82.15 -35.65 28.22 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 119.469 1.031 . . . . 71.400000000000006 110.072 172.947 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 18.7 tt -90.46 -26.03 5.33 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 O-C-N 121.989 -0.445 . . . . 73.530000000000001 111.994 -173.274 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 14.5 t -52.15 -65.1 1.12 Allowed Pre-proline 0 CA--C 1.543 0.685 0 C-N-CA 124.668 1.187 . . . . 72.25 111.214 172.773 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -71.98 -13.71 29.04 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 CA-C-N 121.522 1.579 . . . . 62.210000000000001 112.613 -174.983 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 70.8 t90 -68.03 -58.46 4.46 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 119.115 0.871 . . . . 71.230000000000004 109.331 168.738 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 7.2 p -62.22 -34.64 76.87 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.306 0.643 . . . . 73.329999999999998 112.476 -169.671 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -59.5 -49.49 77.58 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 118.749 0.704 . . . . 73.450000000000003 110.655 177.349 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.14 18.4 1.39 Allowed 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 124.643 1.177 . . . . 74.519999999999996 113.17 -174.162 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 26.3 mt -63.39 153.34 82.71 Favored Pre-proline 0 N--CA 1.449 -0.506 0 CA-C-N 118.476 0.58 . . . . 73.340000000000003 110.803 175.011 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -80.11 166.2 20.95 Favored 'Trans proline' 0 N--CA 1.446 -1.283 0 C-N-CA 124.679 3.586 . . . . 71.310000000000002 111.025 -179.747 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -65.46 -7.9 16.46 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 114.793 1.405 . . . . 71.530000000000001 114.793 -175.2 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -104.65 8.18 35.14 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 125.454 1.502 . . . . 74.230000000000004 111.62 -177.572 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 67.1 t -120.67 152.24 23.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 106.418 -1.697 . . . . 61.420000000000002 106.418 177.674 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 16.9 t60 -134.25 124.88 26.64 Favored 'General case' 0 N--CA 1.439 -1.014 0 N-CA-C 108.036 -1.098 . . . . 74.209999999999994 108.036 166.408 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 29.4 t80 -84.68 140.15 31.52 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 107.004 -1.48 . . . . 60.149999999999999 107.004 173.233 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 88.7 t -133.34 150.36 32.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 C-N-CA 126.693 1.997 . . . . 64.230000000000004 106.128 178.949 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 18.3 mtt180 -131.23 120.81 23.77 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 106.127 -1.805 . . . . 74.230000000000004 106.127 179.166 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 40.3 mt -127.56 151.01 74.47 Favored Pre-proline 0 N--CA 1.473 0.691 0 CA-C-N 120.369 1.441 . . . . 71.209999999999994 110.618 173.225 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -71.89 131.24 17.97 Favored 'Trans proline' 0 N--CA 1.453 -0.901 0 C-N-CA 122.357 2.038 . . . . 72.140000000000001 110.064 176.993 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -77.38 81.75 3.85 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 123.758 0.823 . . . . 70.420000000000002 110.717 177.208 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 33.6 mt -77.25 95.36 4.31 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.002 0.921 . . . . 73.319999999999993 109.313 -177.997 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 37.4 m-85 -123.49 20.05 9.59 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.158 0.983 . . . . 71.420000000000002 112.343 -177.596 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 85.79 -174.55 48.15 Favored Glycine 0 C--N 1.336 0.553 0 N-CA-C 110.702 -0.959 . . . . 70.010000000000005 110.702 -178.84 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 44.88 71.37 0.48 Allowed Glycine 0 CA--C 1.526 0.731 0 C-N-CA 125.308 1.432 . . . . 55.140000000000001 113.914 166.297 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . 0.256 5.5 tp 58.23 -19.85 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.739 0 C-N-CA 130.288 3.435 . . . . 73.109999999999999 115.671 -176.58 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 10.6 m95 -56.85 -39.77 74.89 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 121.277 1.853 . . . . 62.43 110.302 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 25.1 p30 -73.88 -43.67 57.8 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 125.357 1.463 . . . . 54.130000000000003 113.395 -177.77 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 78.9 t -56.5 -49.26 78.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 N-CA-C 108.906 -0.776 . . . . 62.200000000000003 108.906 177.345 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 43.8 m170 -72.19 -2.6 19.37 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 114.473 1.286 . . . . 73.329999999999998 114.473 179.125 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -107.02 -21.6 8.02 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 124.921 1.248 . . . . 74.019999999999996 112.475 177.517 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 54.4 tt0 -64.26 -30.93 71.96 Favored 'General case' 0 CA--C 1.539 0.527 0 O-C-N 121.716 -0.873 . . . . 75.120000000000005 111.682 -175.699 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -67.52 -37.52 82.89 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 126.004 1.721 . . . . 72.239999999999995 112.613 -174.495 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 26.6 t80 -64.11 -48.47 76.0 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-N 119.647 1.112 . . . . 72.430000000000007 109.018 -171.688 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 54.8 mt -56.87 -36.41 70.05 Favored 'General case' 0 C--O 1.223 -0.341 0 C-N-CA 124.228 1.011 . . . . 71.349999999999994 110.101 173.483 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.15 -44.25 76.46 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 119.764 1.165 . . . . 64.120000000000005 111.382 178.103 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -53.22 -58.62 6.42 Favored 'General case' 0 CA--C 1.529 0.14 0 N-CA-C 107.561 -1.274 . . . . 62.530000000000001 107.561 -178.749 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -67.62 -23.15 65.33 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 111.968 0.358 . . . . 72.400000000000006 111.968 -176.544 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 17.4 t -62.16 -25.53 67.82 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-O 118.485 -0.769 . . . . 54.109999999999999 112.783 178.033 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 3.2 ptp . . . . . 0 N--CA 1.467 0.415 0 CA-C-N 119.762 1.165 . . . . 61.229999999999997 113.372 172.666 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 0.261 0 N-CA-C 113.202 0.816 . . . . 74.430000000000007 113.202 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 82.4 t -59.11 -61.37 1.46 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 N-CA-C 107.627 -1.249 . . . . 65.329999999999998 107.627 169.369 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -61.22 -47.56 85.55 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.106 0.962 . . . . 61.030000000000001 111.05 -176.586 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -72.13 2.41 5.89 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.659 1.984 . . . . 72.409999999999997 112.124 -173.331 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -117.23 3.32 12.63 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 124.96 1.304 . . . . 63.32 112.282 171.08 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.475 HG12 HD12 ' A' ' 105' ' ' LEU . 83.8 mt -124.15 -60.94 1.81 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.373 0 N-CA-C 106.096 -1.816 . . . . 63.140000000000001 106.096 -175.595 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 83.3 m-70 -59.79 -64.87 0.79 Allowed 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 125.0 1.32 . . . . 74.230000000000004 111.237 -179.662 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 4.6 ptmt -82.41 -7.03 59.64 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 114.693 1.368 . . . . 75.340000000000003 114.693 -175.167 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -114.91 -37.5 4.16 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 113.665 0.987 . . . . 74.129999999999995 113.665 -173.085 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 12.1 t-160 45.63 53.06 8.92 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 127.695 2.398 . . . . 74.430000000000007 113.162 -178.355 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . 0.289 0.0 OUTLIER -70.71 12.97 0.21 Allowed 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 115.308 1.595 . . . . 71.319999999999993 115.308 172.966 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 26.2 ttmt 45.43 61.48 2.57 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 128.676 2.79 . . . . 61.210000000000001 110.863 171.806 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.475 HD12 HG12 ' A' ' 98' ' ' ILE . 63.1 mt -76.44 60.75 1.63 Allowed 'General case' 0 C--N 1.315 -0.93 0 C-N-CA 128.895 2.878 . . . . 54.350000000000001 107.181 177.643 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -103.03 -12.16 17.63 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 127.928 2.491 . . . . 75.140000000000001 111.11 -176.028 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -114.27 154.09 46.36 Favored Pre-proline 0 C--O 1.236 0.393 0 C-N-CA 124.967 1.307 . . . . 60.530000000000001 108.163 177.091 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -67.72 -36.35 19.18 Favored 'Trans proline' 0 N--CA 1.45 -1.067 0 C-N-CA 121.226 1.284 . . . . 73.510000000000005 110.73 -177.159 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -55.63 -55.18 35.09 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 123.559 0.743 . . . . 75.430000000000007 110.161 174.077 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -57.54 -50.86 71.71 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 125.053 1.341 . . . . 73.239999999999995 109.801 -175.597 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 51.2 mtt -55.82 -53.71 53.39 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 123.958 0.903 . . . . 72.439999999999998 111.355 178.51 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.609 ' HB1' ' HG2' ' A' ' 122' ' ' LYS . . . -71.75 -36.95 70.57 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 124.288 1.035 . . . . 71.230000000000004 110.597 -168.573 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -62.4 -42.59 99.55 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 118.699 0.682 . . . . 74.129999999999995 111.723 174.882 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 8.9 t80 -61.28 -51.48 68.75 Favored 'General case' 0 N--CA 1.455 -0.192 0 O-C-N 121.4 -0.813 . . . . 75.129999999999995 110.534 177.577 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 58.3 mt -70.55 -22.88 62.55 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 110.075 -0.342 . . . . 75.400000000000006 110.075 -175.647 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -58.21 -36.02 72.51 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 118.85 0.75 . . . . 63.530000000000001 109.431 171.893 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -71.81 -4.74 59.29 Favored Glycine 0 N--CA 1.442 -0.918 0 CA-C-O 116.459 -2.3 . . . . 34.340000000000003 115.034 170.975 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.505 ' HA ' ' HE2' ' A' ' 118' ' ' LYS . 5.7 mmpt? -116.74 -9.13 11.32 Favored 'General case' 0 C--N 1.348 0.537 0 CA-C-N 122.553 3.176 . . . . 71.239999999999995 114.245 -171.996 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 97.0 59.02 1.01 Allowed Glycine 0 N--CA 1.452 -0.234 0 N-CA-C 108.486 -1.845 . . . . 53.439999999999998 108.486 -168.942 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 53.7 t -142.31 153.05 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 C-N-CA 129.372 3.069 . . . . 63.509999999999998 104.089 167.986 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 41.6 t0 -111.67 128.91 56.21 Favored 'General case' 0 C--N 1.331 -0.221 0 O-C-N 121.116 -0.99 . . . . 64.140000000000001 108.746 -177.903 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.609 ' HG2' ' HB1' ' A' ' 112' ' ' ALA . 14.2 mtpt -60.75 -31.35 70.69 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 119.277 0.944 . . . . 74.230000000000004 110.374 172.991 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -59.81 -20.93 59.86 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 119.844 1.202 . . . . 65.25 112.214 173.66 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 65.0 mmtt -113.3 -33.11 6.06 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-N 119.8 1.182 . . . . 72.319999999999993 112.057 -175.76 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -62.64 -56.41 18.01 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 118.814 0.734 . . . . 72.329999999999998 109.926 -178.268 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 9.9 mt -72.76 -46.5 53.05 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.861 0.839 . . . . 74.049999999999997 111.173 -163.182 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 21.0 p -53.61 -41.79 67.03 Favored 'General case' 0 N--CA 1.444 -0.736 0 C-N-CA 125.511 1.525 . . . . 73.450000000000003 108.822 177.412 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 40.9 m -76.48 -41.39 47.36 Favored 'General case' 0 C--O 1.222 -0.356 0 N-CA-C 108.322 -0.992 . . . . 61.409999999999997 108.322 -176.938 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 61.6 t80 -56.57 -32.27 65.02 Favored 'General case' 0 C--O 1.235 0.337 0 O-C-N 120.709 -1.245 . . . . 72.519999999999996 110.878 178.153 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -105.17 26.4 9.38 Favored 'General case' 0 C--O 1.243 0.714 0 N-CA-C 113.432 0.901 . . . . 73.129999999999995 113.432 175.485 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 11.1 p -99.68 157.02 16.77 Favored 'General case' 0 C--O 1.234 0.275 0 O-C-N 120.919 -1.113 . . . . 74.049999999999997 111.317 175.726 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -67.19 -27.59 67.39 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 115.538 -0.755 . . . . 74.439999999999998 111.921 -175.637 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -55.09 -47.0 75.52 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 121.524 0.678 . . . . 72.239999999999995 110.324 175.734 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 32.8 mm -64.08 -37.72 80.57 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 C-N-CA 123.787 0.835 . . . . 72.5 109.149 179.4 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 10.5 mttt -58.31 -35.23 71.54 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 119.64 1.109 . . . . 75.310000000000002 110.591 172.393 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -73.51 -40.21 47.98 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 109.816 -1.314 . . . . 50.350000000000001 109.816 -173.769 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 2.3 mm100 -68.98 -43.1 75.61 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 123.391 0.676 . . . . 72.129999999999995 109.824 178.361 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 45.4 mtp -60.54 -42.76 97.19 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-O 117.495 -1.241 . . . . 64.25 111.478 177.15 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -62.8 -39.99 95.98 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 120.638 1.563 . . . . 74.450000000000003 110.839 -178.432 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 9.3 mmtt -59.62 -65.48 0.67 Allowed 'General case' 0 N--CA 1.463 0.176 0 C-N-CA 123.803 0.841 . . . . 73.230000000000004 110.316 170.976 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -57.92 -34.84 70.28 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 119.472 1.033 . . . . 73.200000000000003 111.257 -171.195 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 14.2 tmtt? -61.62 -61.55 2.44 Favored 'General case' 0 CA--C 1.518 -0.25 0 C-N-CA 124.895 1.278 . . . . 65.140000000000001 110.172 176.744 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.08 -25.98 68.35 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 119.74 1.154 . . . . 71.209999999999994 110.903 -178.992 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 25.4 mt -69.62 -54.24 14.92 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 118.429 -0.796 . . . . 75.209999999999994 111.712 -176.378 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -58.75 -49.32 78.08 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 118.873 0.76 . . . . 75.230000000000004 111.196 -169.445 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -61.03 -40.39 93.4 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 123.527 0.731 . . . . 73.120000000000005 112.515 175.742 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -67.3 -36.42 81.46 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 118.278 -0.868 . . . . 42.329999999999998 110.019 -179.526 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -67.78 14.14 0.06 Allowed 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.824 1.65 . . . . 64.209999999999994 113.359 175.891 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 54.29 21.52 3.19 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 127.12 2.168 . . . . 73.129999999999995 113.839 -179.023 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.449 HG13 HG21 ' A' ' 155' ' ' THR . 44.4 t -71.47 142.04 15.97 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 N-CA-C 108.576 -0.898 . . . . 62.030000000000001 108.576 179.4 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -112.64 -14.09 13.2 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 124.662 1.185 . . . . 60.140000000000001 112.717 -176.112 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 167.49 -160.16 33.71 Favored Glycine 0 N--CA 1.446 -0.699 0 N-CA-C 108.119 -1.992 . . . . 42.32 108.119 -165.398 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.458 HG21 ' HB3' ' A' ' 34' ' ' TRP . 31.0 m -138.69 157.31 72.18 Favored Pre-proline 0 CA--C 1.536 0.425 0 C-N-CA 124.345 1.058 . . . . 65.209999999999994 109.741 -178.185 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_endo -66.59 156.9 81.91 Favored 'Cis proline' 0 N--CA 1.459 -0.552 0 C-N-CA 124.738 -0.943 . . . . 74.430000000000007 111.621 -7.063 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 155' ' ' THR . . . . . 0.449 HG21 HG13 ' A' ' 150' ' ' VAL . 5.6 m -156.86 138.37 13.99 Favored 'General case' 0 N--CA 1.466 0.339 0 O-C-N 121.102 -0.999 . . . . 74.010000000000005 109.239 171.96 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 92.1 mtp -112.32 148.64 33.79 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 125.148 1.379 . . . . 54.409999999999997 109.164 171.605 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 26.7 t -137.09 151.8 27.48 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 C-N-CA 124.623 1.169 . . . . 63.119999999999997 108.027 176.667 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 39.9 t -130.2 123.5 56.04 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 C-N-CA 126.053 1.741 . . . . 73.310000000000002 106.819 -178.351 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 16.6 m-20 50.01 21.15 0.68 Allowed 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 127.805 2.442 . . . . 65.25 114.973 173.937 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 51.74 45.17 55.17 Favored Glycine 0 CA--C 1.531 1.07 0 CA-C-O 117.697 -1.613 . . . . 60.149999999999999 112.924 -165.419 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 12.1 mtpp -139.44 -33.98 0.59 Allowed 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 119.595 1.697 . . . . 63.119999999999997 113.056 178.348 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -121.81 148.25 44.92 Favored 'General case' 0 CA--C 1.506 -0.729 0 N-CA-C 108.154 -1.054 . . . . 74.099999999999994 108.154 176.809 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 48.8 ttp85 -136.4 139.39 42.42 Favored 'General case' 0 N--CA 1.442 -0.857 0 N-CA-C 106.268 -1.753 . . . . 73.230000000000004 106.268 179.426 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 22.9 p90 -154.94 174.59 14.92 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 108.255 -1.017 . . . . 74.030000000000001 108.255 -179.364 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -177.41 173.73 1.67 Allowed 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 107.736 -1.209 . . . . 64.329999999999998 107.736 -176.59 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.42 HG13 ' H ' ' A' ' 166' ' ' ILE . 17.8 mt -45.4 -50.13 3.25 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 C-N-CA 127.964 2.506 . . . . 55.32 108.408 162.462 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -73.86 9.5 8.72 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 126.433 1.968 . . . . 30.329999999999998 114.699 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 22.6 m -120.51 -54.15 2.08 Favored 'General case' 0 N--CA 1.458 -0.047 0 CA-C-N 119.198 1.499 . . . . 71.239999999999995 109.764 163.387 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -61.25 -53.1 61.14 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.511 1.125 . . . . 62.409999999999997 110.78 -172.571 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 146.02 -17.42 1.75 Allowed Glycine 0 CA--C 1.523 0.553 0 CA-C-O 119.614 -0.548 . . . . 73.340000000000003 113.764 178.417 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 169.47 176.37 39.3 Favored Glycine 0 CA--C 1.528 0.872 0 N-CA-C 108.885 -1.686 . . . . 42.140000000000001 108.885 -169.332 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -63.9 -52.48 1.71 Allowed 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 123.072 2.515 . . . . 73.230000000000004 111.611 -175.177 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -59.8 -39.74 86.0 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 119.295 0.952 . . . . 74.239999999999995 109.732 178.053 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -60.77 -32.65 71.96 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.523 0.729 . . . . 74.420000000000002 110.494 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 26.6 m -65.63 -43.68 88.77 Favored 'General case' 0 N--CA 1.453 -0.282 0 O-C-N 120.716 -1.24 . . . . 45.329999999999998 109.617 179.083 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 48.0 mt -66.46 -28.24 68.44 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 118.891 0.768 . . . . 72.329999999999998 111.354 176.139 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 10.1 tptt -51.29 -49.23 61.67 Favored 'General case' 0 C--O 1.232 0.182 0 N-CA-C 109.005 -0.739 . . . . 73.010000000000005 109.005 169.48 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.467 HD13 ' HA ' ' A' ' 178' ' ' LEU . 4.4 mm? -74.46 -38.79 62.85 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-O 119.012 -0.518 . . . . 61.229999999999997 111.54 -178.994 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.08 -43.94 87.29 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 118.005 0.366 . . . . 34.219999999999999 111.099 -176.625 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -74.04 -28.52 61.46 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 123.244 0.618 . . . . 64.019999999999996 110.58 -174.471 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 9.9 t80 -74.08 -57.0 4.26 Favored 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 125.053 1.341 . . . . 74.439999999999998 110.425 178.454 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 77.8 mt -61.95 -24.7 67.16 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 124.997 1.319 . . . . 74.319999999999993 112.955 -171.552 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 35.6 mt -53.3 -54.94 15.06 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 C-N-CA 123.348 0.659 . . . . 72.209999999999994 109.36 170.014 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -66.07 -38.23 87.8 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 118.342 0.519 . . . . 65.209999999999994 111.229 -177.073 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 185' ' ' LYS . . . . . 0.45 ' HE3' ' HA ' ' A' ' 185' ' ' LYS . 0.1 OUTLIER -52.4 -46.44 66.29 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 124.325 1.05 . . . . 75.010000000000005 110.182 -176.723 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -74.64 -51.83 13.37 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 123.087 0.555 . . . . 65.25 112.082 173.237 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 3.2 tpm_? -48.07 -45.31 32.36 Favored 'General case' 0 CA--C 1.516 -0.357 0 C-N-CA 124.82 1.248 . . . . 71.420000000000002 112.086 -175.422 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.353 0 C-N-CA 125.696 1.598 . . . . 72.549999999999997 111.746 -174.566 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 . . . . . 0 CA--C 1.502 -0.888 0 CA-C-O 120.931 0.396 . . . . 60.520000000000003 111.011 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 76.38 10.46 2.95 Favored 'General case' 0 N--CA 1.442 -0.852 0 C-N-CA 130.078 3.351 . . . . 64.219999999999999 115.556 -172.133 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 29.7 m-85 -139.83 178.1 7.48 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 126.648 1.979 . . . . 73.230000000000004 108.305 179.383 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 95.0 m -144.3 143.88 31.2 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 108.287 -1.005 . . . . 75.230000000000004 108.287 166.238 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.64 152.27 45.69 Favored 'General case' 0 C--O 1.227 -0.123 0 O-C-N 121.393 -0.817 . . . . 74.019999999999996 108.838 172.386 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 70.33 -44.37 0.58 Allowed Glycine 0 CA--C 1.534 1.224 0 C-N-CA 125.504 1.525 . . . . 30.199999999999999 112.287 -162.36 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.5 tptm -70.21 -58.57 3.63 Favored 'General case' 0 CA--C 1.519 -0.222 0 C-N-CA 126.295 1.838 . . . . 72.409999999999997 111.165 -169.966 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -113.78 -23.42 9.68 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 126.04 1.736 . . . . 73.530000000000001 109.965 -172.056 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 42.4 p90 -157.22 173.38 17.05 Favored 'General case' 0 N--CA 1.47 0.525 0 O-C-N 120.96 -1.088 . . . . 74.129999999999995 109.586 -176.147 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 24.9 t -135.52 117.89 21.77 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 C-N-CA 123.437 0.695 . . . . 74.530000000000001 109.193 -174.576 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.9 162.54 28.04 Favored 'General case' 0 CA--C 1.537 0.446 0 O-C-N 121.189 -0.945 . . . . 44.520000000000003 109.055 167.953 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -136.18 108.28 7.21 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 126.679 1.992 . . . . 71.409999999999997 108.294 -167.52 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.8 p -63.27 -0.46 0.82 Allowed 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 115.493 1.664 . . . . 74.439999999999998 115.493 -176.229 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 49.0 m -131.0 76.41 76.98 Favored Pre-proline 0 N--CA 1.451 -0.389 0 CA-C-N 119.841 1.201 . . . . 72.109999999999999 109.428 174.036 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -65.97 176.64 3.58 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 123.894 3.063 . . . . 63.130000000000003 112.688 -176.487 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 40.2 t -133.81 136.03 25.81 Favored Pre-proline 0 CA--C 1.537 0.443 0 C-N-CA 125.539 1.536 . . . . 73.530000000000001 108.336 -169.948 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -76.24 178.45 7.48 Favored 'Trans proline' 0 CA--C 1.534 0.509 0 C-N-CA 123.491 2.794 . . . . 60.039999999999999 111.443 176.894 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 27.9 m -132.85 174.1 13.81 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 C-N-CA 125.336 1.454 . . . . 54.049999999999997 109.674 170.991 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 73.9 m -58.45 -51.36 70.15 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 126.33 1.852 . . . . 64.219999999999999 112.335 175.002 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 41.7 tt0 -143.16 145.29 32.06 Favored Pre-proline 0 CA--C 1.534 0.361 0 C-N-CA 124.278 1.031 . . . . 73.549999999999997 108.733 -177.819 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -74.54 90.91 1.0 Allowed 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 123.158 2.572 . . . . 70.209999999999994 109.202 165.2 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -137.12 -94.9 0.38 Allowed Glycine 0 C--N 1.336 0.542 0 O-C-N 121.497 -0.752 . . . . 73.120000000000005 111.304 -172.387 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 12.7 mptt -80.02 159.95 26.03 Favored 'General case' 0 C--O 1.227 -0.13 0 N-CA-C 107.693 -1.225 . . . . 73.010000000000005 107.693 170.974 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 49.2 mm -70.46 130.46 34.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 106.135 -1.802 . . . . 65.140000000000001 106.135 167.227 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -83.8 130.48 34.94 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 106.203 -1.777 . . . . 64.299999999999997 106.203 173.422 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 13.9 t -119.42 144.17 28.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 105.813 -1.921 . . . . 63.109999999999999 105.813 166.049 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 37.8 t -133.98 101.65 3.94 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.137 0 N-CA-C 106.512 -1.662 . . . . 73.340000000000003 106.512 -174.225 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -76.17 137.33 39.99 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 106.143 -1.799 . . . . 73.340000000000003 106.143 161.115 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.4 mp -120.93 134.19 55.29 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 105.494 -2.039 . . . . 62.240000000000002 105.494 163.971 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 42.6 p90 -134.76 172.77 12.5 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 123.552 0.741 . . . . 73.319999999999993 110.962 -177.379 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' TRP . . . . . 0.611 ' CB ' HG21 ' A' ' 153' ' ' VAL . 22.9 t90 -148.55 167.68 24.77 Favored 'General case' 0 N--CA 1.463 0.209 0 C-N-CA 125.225 1.41 . . . . 72.040000000000006 108.644 178.405 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 17.6 t80 -67.34 -43.98 80.19 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.865 0.866 . . . . 65.299999999999997 112.026 172.253 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -95.71 22.79 37.26 Favored Glycine 0 CA--C 1.527 0.79 0 CA-C-O 119.026 -0.875 . . . . 44.130000000000003 113.954 -163.479 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.521 ' HB3' HG23 ' A' ' 153' ' ' VAL . 22.0 p -105.08 86.11 1.46 Allowed Pre-proline 0 CA--C 1.532 0.274 0 CA-C-N 118.843 1.321 . . . . 63.149999999999999 109.372 -177.906 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_endo -56.96 -24.97 60.07 Favored 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 122.325 2.016 . . . . 71.239999999999995 113.133 -177.093 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 15.6 m170 -68.11 -26.03 65.6 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 119.028 0.831 . . . . 73.310000000000002 111.037 178.243 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 84.6 m -65.29 -32.81 74.66 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.814 0.846 . . . . 61.229999999999997 109.48 -174.168 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -63.78 -46.35 85.6 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 125.657 1.583 . . . . 75.519999999999996 110.687 -178.793 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -53.58 -33.82 56.18 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 122.6 0.36 . . . . 71.109999999999999 110.467 178.972 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.452 ' HB2' HD11 ' A' ' 166' ' ' ILE . 2.4 t80 -87.78 -37.45 16.59 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-O 116.171 -1.871 . . . . 70.150000000000006 113.002 -175.233 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -39.23 -63.78 0.59 Allowed Pre-proline 0 N--CA 1.477 0.885 0 CA-C-N 120.724 1.602 . . . . 75.329999999999998 113.712 -168.378 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -71.95 -8.97 23.95 Favored 'Trans proline' 0 CA--C 1.535 0.525 0 CA-C-N 121.885 1.709 . . . . 70.340000000000003 114.726 -177.338 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.9 m -76.01 -44.11 41.01 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 108.311 -0.996 . . . . 75.420000000000002 108.311 167.128 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 14.5 tt -85.89 -35.93 9.99 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 CA-C-O 118.541 -0.742 . . . . 75.409999999999997 112.01 -169.402 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 68.9 t -49.79 -59.97 5.89 Favored Pre-proline 0 CA--C 1.541 0.621 0 CA-C-N 120.358 1.435 . . . . 63.340000000000003 111.479 176.847 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -70.12 -20.6 32.91 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 121.332 1.355 . . . . 65.400000000000006 112.16 -174.874 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 81.9 t90 -61.01 -54.28 46.83 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 117.559 -1.21 . . . . 73.129999999999995 111.204 175.392 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.2 t -57.99 -40.7 81.37 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 120.646 1.566 . . . . 62.149999999999999 111.132 -179.118 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -62.8 -31.56 72.58 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 121.36 0.6 . . . . 74.329999999999998 110.5 -178.75 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -104.96 39.68 1.66 Allowed 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 126.175 1.79 . . . . 65.219999999999999 112.653 178.135 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 19.2 mt -89.51 160.26 42.34 Favored Pre-proline 0 C--O 1.238 0.454 0 C-N-CA 126.855 2.062 . . . . 62.399999999999999 109.995 165.389 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -78.99 175.85 10.49 Favored 'Trans proline' 0 N--CA 1.451 -0.989 0 C-N-CA 124.772 3.648 . . . . 34.43 112.015 175.312 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -72.35 -4.82 32.16 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 114.537 1.31 . . . . 72.030000000000001 114.537 -173.646 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -111.32 5.49 19.83 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 126.681 1.992 . . . . 75.329999999999998 111.907 -173.423 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 34.8 t -119.98 156.56 22.69 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 C-N-CA 124.658 1.183 . . . . 71.340000000000003 108.377 177.972 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 83.0 t60 -147.79 116.48 6.7 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.251 1.82 . . . . 74.219999999999999 108.694 -178.081 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -93.54 131.4 38.81 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 124.908 1.283 . . . . 73.430000000000007 109.801 -177.914 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 43.8 t -119.98 146.61 24.52 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 C-N-CA 124.703 1.201 . . . . 71.319999999999993 108.049 178.627 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 17.4 mtm180 -123.75 132.47 53.81 Favored 'General case' 0 CA--C 1.504 -0.794 0 N-CA-C 107.565 -1.272 . . . . 71.109999999999999 107.565 168.658 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 26.7 mt -141.76 153.64 64.9 Favored Pre-proline 0 C--N 1.321 -0.649 0 C-N-CA 124.388 1.075 . . . . 60.210000000000001 108.61 -179.513 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -73.39 154.64 50.91 Favored 'Trans proline' 0 N--CA 1.446 -1.278 0 C-N-CA 121.328 1.352 . . . . 71.430000000000007 111.772 178.365 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -97.96 72.89 2.23 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 125.521 1.528 . . . . 61.520000000000003 107.847 179.736 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 84.3 mt -74.31 78.73 1.84 Allowed 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.374 1.069 . . . . 75.25 111.238 -170.497 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -112.95 54.33 0.73 Allowed 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 125.242 1.417 . . . . 74.420000000000002 110.886 -176.409 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 60.17 173.5 0.83 Allowed Glycine 0 CA--C 1.529 0.928 0 C-N-CA 126.914 2.197 . . . . 61.229999999999997 114.615 178.975 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 53.0 -147.8 14.88 Favored Glycine 0 CA--C 1.53 1.015 0 O-C-N 121.282 -1.128 . . . . 75.219999999999999 111.193 -179.444 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -64.53 -10.95 9.71 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 O-C-N 122.01 -0.7 . . . . 74.219999999999999 112.886 179.518 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' TRP . . . . . 0.455 ' CH2' HG22 ' A' ' 153' ' ' VAL . 34.6 m95 -70.55 -28.53 64.99 Favored 'General case' 0 C--N 1.341 0.201 0 CA-C-N 119.9 1.227 . . . . 74.510000000000005 110.775 171.524 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -72.02 -45.46 60.8 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 119.103 -1.039 . . . . 72.450000000000003 109.449 166.373 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 75.6 t -64.17 -55.65 20.77 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 N-CA-C 111.917 0.339 . . . . 64.239999999999995 111.917 -167.876 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 28.3 m170 -70.72 6.98 1.24 Allowed 'General case' 0 CA--C 1.535 0.386 0 O-C-N 121.529 -0.732 . . . . 74.219999999999999 112.468 179.573 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -102.69 -33.71 4.33 Favored Glycine 0 N--CA 1.439 -1.128 0 CA-C-O 118.63 -1.094 . . . . 55.0 111.36 173.36 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . 0.417 0.0 OUTLIER -71.25 -36.56 71.83 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 118.951 1.376 . . . . 73.450000000000003 112.146 -166.029 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -53.82 -45.32 70.81 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-O 116.192 -1.861 . . . . 73.140000000000001 113.253 175.819 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 50.1 t80 -45.96 -52.2 12.06 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 125.736 1.614 . . . . 74.049999999999997 109.668 -177.126 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 18.1 mt -60.34 -44.06 95.88 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 126.605 1.962 . . . . 70.439999999999998 110.555 -177.967 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -64.51 -40.38 95.53 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 119.283 0.947 . . . . 64.209999999999994 110.872 -178.648 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.38 -51.22 70.84 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 107.903 -1.147 . . . . 64.329999999999998 107.903 -176.011 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -69.34 -27.24 65.18 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.067 0.947 . . . . 73.400000000000006 111.495 178.221 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 4.0 t -63.07 -16.68 60.71 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.368 1.067 . . . . 61.219999999999999 113.181 176.972 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 13.6 mtp . . . . . 0 C--O 1.233 0.225 0 C-N-CA 124.013 0.925 . . . . 74.120000000000005 112.531 173.906 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.227 -0.129 0 CA-C-O 119.209 -0.424 . . . . 62.420000000000002 110.974 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 37.3 t -54.17 -63.18 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-O 117.767 -1.111 . . . . 74.219999999999999 109.296 167.899 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -60.16 -41.44 92.81 Favored 'General case' 0 CA--C 1.548 0.875 0 CA-C-N 121.349 1.886 . . . . 62.340000000000003 109.273 -174.279 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -74.97 4.54 6.41 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 129.291 3.036 . . . . 71.109999999999999 111.568 -176.11 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.401 ' HB1' ' CZ ' ' A' ' 114' ' ' PHE . . . -111.27 -3.16 15.44 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 125.184 1.393 . . . . 33.420000000000002 113.251 169.614 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 8.1 mt -126.28 -44.62 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 107.873 -1.158 . . . . 70.109999999999999 107.873 -172.916 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 85.2 m-70 -70.53 -65.13 0.77 Allowed 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 123.316 0.646 . . . . 73.219999999999999 111.38 177.42 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.84 -20.51 38.84 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 115.044 1.498 . . . . 64.230000000000004 115.044 -176.316 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -81.68 -39.89 23.64 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.294 -1.002 . . . . 74.140000000000001 108.294 173.817 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 4.0 t60 52.06 64.55 1.8 Allowed 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.168 1.387 . . . . 74.030000000000001 108.783 -174.952 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 3.7 mmpt? -92.32 147.34 22.99 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 124.352 1.061 . . . . 74.510000000000005 108.578 171.717 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 27.9 tttp -84.35 55.41 3.35 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 127.181 2.192 . . . . 54.439999999999998 110.14 -178.144 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 95.7 mt -75.89 34.16 0.12 Allowed 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 127.758 2.423 . . . . 74.430000000000007 111.599 -176.387 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -70.8 11.73 0.35 Allowed 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 127.001 2.12 . . . . 65.409999999999997 114.373 -165.486 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -147.98 161.39 34.91 Favored Pre-proline 0 N--CA 1.47 0.57 0 C-N-CA 126.551 1.94 . . . . 63.420000000000002 111.091 179.344 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -56.76 -48.34 19.11 Favored 'Trans proline' 0 CA--C 1.51 -0.681 0 C-N-CA 123.738 2.958 . . . . 75.310000000000002 111.981 177.995 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -60.04 -34.3 73.2 Favored 'General case' 0 N--CA 1.44 -0.97 0 C-N-CA 125.484 1.513 . . . . 70.450000000000003 111.336 -175.303 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -71.4 -48.23 51.13 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 126.059 1.744 . . . . 74.099999999999994 109.592 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 71.1 mtm -59.82 -49.77 76.42 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 123.814 0.846 . . . . 64.239999999999995 109.558 175.891 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -62.4 -43.88 97.76 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 125.409 1.484 . . . . 64.140000000000001 111.135 -177.012 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -53.01 -41.97 65.16 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 123.792 0.837 . . . . 71.319999999999993 111.303 177.295 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' PHE . . . . . 0.401 ' CZ ' ' HB1' ' A' ' 97' ' ' ALA . 93.6 t80 -76.43 -46.82 25.4 Favored 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 124.26 1.024 . . . . 63.310000000000002 109.551 -174.486 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 25.9 mt -65.38 -29.97 70.74 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.514 1.126 . . . . 74.299999999999997 110.252 -178.354 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -53.98 -31.58 51.28 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.806 0.842 . . . . 53.219999999999999 111.361 178.584 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -94.77 12.42 68.65 Favored Glycine 0 CA--C 1.527 0.785 0 CA-C-O 117.406 -1.774 . . . . 62.200000000000003 113.907 176.744 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 7.8 mmtm -132.46 11.33 4.48 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 120.097 1.949 . . . . 72.319999999999993 111.835 -173.229 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 97.77 42.09 3.19 Favored Glycine 0 N--CA 1.463 0.475 0 CA-C-N 119.769 1.168 . . . . 43.310000000000002 111.863 177.578 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 46.8 t -136.85 158.82 37.11 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 C-N-CA 127.101 2.16 . . . . 71.209999999999994 105.474 172.641 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -116.27 126.94 54.26 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 108.856 -0.794 . . . . 65.319999999999993 108.856 174.006 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 1.7 mtpm? -56.13 -37.0 68.87 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 123.169 0.588 . . . . 72.019999999999996 110.393 171.883 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -64.11 -14.92 58.16 Favored 'General case' 0 C--O 1.226 -0.165 0 C-N-CA 124.931 1.292 . . . . 62.100000000000001 111.992 -178.905 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 14.6 mmtp -114.66 -33.46 5.51 Favored 'General case' 0 C--O 1.225 -0.196 0 C-N-CA 124.367 1.067 . . . . 75.540000000000006 111.837 178.438 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 12.8 t80 -54.82 -61.39 2.34 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 123.632 0.773 . . . . 71.010000000000005 109.353 175.306 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 32.3 mt -73.88 -37.12 64.81 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 121.663 0.744 . . . . 72.239999999999995 110.798 -161.522 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 18.8 p -66.92 -21.35 65.99 Favored 'General case' 0 N--CA 1.442 -0.856 0 C-N-CA 125.204 1.401 . . . . 75.420000000000002 111.757 179.57 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 34.0 m -97.98 -31.74 12.01 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.181 0.992 . . . . 73.430000000000007 109.867 174.846 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 45.4 t80 -57.83 -56.33 23.33 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 124.624 1.17 . . . . 75.120000000000005 110.219 177.008 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 -89.47 56.89 3.75 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 108.002 -1.11 . . . . 71.0 108.002 173.871 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -134.96 160.24 38.94 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 124.061 0.944 . . . . 74.049999999999997 110.424 172.336 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -55.28 -28.09 51.04 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.68 1.592 . . . . 72.129999999999995 112.654 -179.114 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -45.32 -67.13 0.31 Allowed 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 125.691 1.597 . . . . 73.409999999999997 108.728 171.535 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 24.7 mm -61.28 -40.24 85.36 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 CA-C-O 117.524 -1.227 . . . . 73.019999999999996 111.295 -178.288 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 18.4 mtpp -54.74 -38.34 67.02 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 120.537 1.517 . . . . 75.230000000000004 110.137 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -78.22 -43.57 13.04 Favored Glycine 0 N--CA 1.442 -0.94 0 N-CA-C 110.589 -1.005 . . . . 63.32 110.589 -177.137 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 9.2 mt-30 -62.12 -39.57 92.98 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 123.15 0.58 . . . . 70.450000000000003 109.688 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 1.7 mtp -56.42 -57.59 11.63 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 124.673 1.189 . . . . 51.520000000000003 109.28 173.594 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -70.82 -31.2 67.85 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 118.898 -1.121 . . . . 73.219999999999999 112.227 -168.954 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 4.5 mttt -63.2 -59.18 5.09 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 123.88 0.872 . . . . 71.230000000000004 110.814 170.947 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -58.13 -35.58 71.7 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 119.459 1.027 . . . . 75.349999999999994 110.807 179.683 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 10.0 tmtt? -61.11 -53.2 60.08 Favored 'General case' 0 N--CA 1.456 -0.139 0 O-C-N 120.437 -1.415 . . . . 73.420000000000002 110.557 177.798 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.02 -25.11 64.33 Favored 'General case' 0 C--O 1.221 -0.396 0 CA-C-N 120.096 1.316 . . . . 74.209999999999994 111.874 176.756 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.427 HD23 ' HA ' ' A' ' 144' ' ' LEU . 30.0 mt -70.68 -59.27 2.92 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 119.57 1.077 . . . . 72.510000000000005 110.991 -178.759 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -55.42 -44.68 76.49 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 118.412 0.551 . . . . 74.030000000000001 111.176 -170.642 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 4.1 ppp? -64.49 -41.75 96.27 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 113.574 0.953 . . . . 74.239999999999995 113.574 176.394 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -64.62 -29.81 70.82 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 116.374 -1.774 . . . . 64.129999999999995 110.869 -178.375 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -80.0 11.77 3.17 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 127.787 2.435 . . . . 73.109999999999999 113.369 176.688 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 21.4 mt-30 59.67 18.63 7.34 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 127.51 2.324 . . . . 75.219999999999999 115.039 -177.332 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 40.2 t -73.43 141.45 16.27 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 O-C-N 121.12 -0.988 . . . . 60.5 108.919 -179.461 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -135.91 3.26 2.93 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.032 0.933 . . . . 64.109999999999999 113.078 -177.557 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -174.33 -173.93 40.72 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 108.711 -1.756 . . . . 52.310000000000002 108.711 -179.164 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.611 HG21 ' CB ' ' A' ' 34' ' ' TRP . 6.4 m -139.41 154.16 71.45 Favored Pre-proline 0 CA--C 1.535 0.398 0 C-N-CA 125.794 1.638 . . . . 74.540000000000006 109.349 176.597 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 154' ' ' PRO . . . . . 0.474 ' HG3' HD12 ' A' ' 166' ' ' ILE . 35.7 Cg_endo -65.03 160.04 72.13 Favored 'Cis proline' 0 CA--C 1.533 0.431 0 C-N-CA 125.317 -0.701 . . . . 71.319999999999993 113.793 -2.269 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 17.7 m -157.81 141.66 15.75 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 124.816 1.246 . . . . 61.200000000000003 108.367 173.594 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 19.2 mmm -123.5 155.88 36.69 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 125.968 1.707 . . . . 74.299999999999997 108.512 167.341 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 6.1 t -135.26 153.77 34.5 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 N-CA-C 106.946 -1.502 . . . . 33.43 106.946 174.43 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 58.5 t -126.45 123.86 64.21 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 C-N-CA 126.439 1.896 . . . . 61.43 106.995 173.931 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 1.2 t30 54.56 16.7 1.41 Allowed 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 129.472 3.109 . . . . 72.209999999999994 115.898 166.697 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 74.37 28.43 63.83 Favored Glycine 0 CA--C 1.523 0.572 0 C-N-CA 128.866 3.127 . . . . 74.430000000000007 113.205 -176.131 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 33.5 mttt -139.33 -31.26 0.7 Allowed 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 114.848 1.425 . . . . 45.409999999999997 114.848 -166.268 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -125.13 138.51 54.16 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 107.91 -1.144 . . . . 72.0 107.91 177.861 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 71.0 ttt-85 -122.6 141.57 51.57 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 105.381 -2.081 . . . . 72.329999999999998 105.381 178.126 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 11.4 p90 -153.9 170.66 20.49 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 107.097 -1.446 . . . . 74.010000000000005 107.097 -179.243 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -173.97 -178.99 1.62 Allowed 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 123.822 0.849 . . . . 61.549999999999997 109.103 178.643 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.474 HD12 ' HG3' ' A' ' 154' ' ' PRO . 15.6 mt -52.0 -48.36 40.93 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 C-N-CA 126.245 1.818 . . . . 60.240000000000002 109.324 176.085 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -71.65 -34.36 63.02 Favored Glycine 0 CA--C 1.525 0.676 0 CA-C-O 118.744 -1.031 . . . . 70.120000000000005 113.009 179.302 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 3.5 m -65.21 -55.79 16.51 Favored 'General case' 0 C--O 1.227 -0.09 0 CA-C-N 119.649 1.724 . . . . 45.009999999999998 109.523 174.021 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -67.29 -49.53 63.86 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 124.507 1.123 . . . . 72.310000000000002 111.111 -171.03 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 124.43 5.13 7.32 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 125.069 1.319 . . . . 65.109999999999999 113.921 -176.633 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 162.04 173.63 30.94 Favored Glycine 0 CA--C 1.528 0.874 0 CA-C-N 118.839 1.319 . . . . 70.25 111.014 175.726 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -66.62 -47.66 2.73 Favored 'Trans proline' 0 CA--C 1.532 0.416 0 C-N-CA 122.785 2.323 . . . . 74.439999999999998 111.157 -175.948 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -54.01 -46.6 71.85 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.143 0.977 . . . . 74.230000000000004 110.16 172.528 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -65.33 -26.48 68.06 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.684 0.794 . . . . 70.519999999999996 110.403 -176.808 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 25.0 m -65.83 -40.82 92.16 Favored 'General case' 0 CA--C 1.533 0.3 0 O-C-N 120.663 -1.273 . . . . 70.450000000000003 109.524 178.908 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 37.7 mt -66.62 -29.72 69.82 Favored 'General case' 0 C--N 1.342 0.249 0 CA-C-N 119.507 1.049 . . . . 51.109999999999999 111.132 175.919 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.65 -47.78 66.86 Favored 'General case' 0 C--N 1.339 0.145 0 C-N-CA 124.093 0.957 . . . . 74.129999999999995 109.208 171.241 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.423 HD13 ' HA ' ' A' ' 178' ' ' LEU . 4.4 mm? -72.75 -42.1 64.41 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-O 118.33 -0.843 . . . . 74.040000000000006 110.845 178.713 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -53.18 -48.01 68.37 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 118.699 0.681 . . . . 72.409999999999997 111.788 -173.385 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -75.8 -34.53 60.18 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 123.01 0.524 . . . . 73.299999999999997 110.752 -172.13 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -66.2 -48.36 70.87 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 124.83 1.252 . . . . 63.009999999999998 111.087 174.206 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 68.7 mt -65.52 -32.69 74.42 Favored 'General case' 0 N--CA 1.457 -0.077 0 C-N-CA 124.312 1.045 . . . . 62.340000000000003 111.155 -177.248 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 29.0 mt -50.39 -57.85 2.15 Favored 'Isoleucine or valine' 0 C--N 1.34 0.179 0 CA-C-O 117.976 -1.011 . . . . 74.409999999999997 108.781 168.177 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -57.74 -37.04 72.89 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 119.813 1.188 . . . . 62.149999999999999 111.552 -176.87 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 22.6 tptt -56.54 -38.97 72.61 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.466 0.706 . . . . 75.109999999999999 111.469 -175.72 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 51.3 mm-40 -90.98 -42.88 10.3 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 123.741 0.816 . . . . 44.340000000000003 111.665 176.561 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.95 -37.65 77.25 Favored 'General case' 0 C--N 1.333 -0.128 0 O-C-N 120.76 -1.212 . . . . 72.140000000000001 110.175 -177.033 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.432 0 C-N-CA 124.834 1.253 . . . . 71.430000000000007 111.584 178.82 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.927 0 N-CA-C 109.08 -1.608 . . . . 54.310000000000002 109.08 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 70.77 120.7 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 128.065 2.546 . . . . 75.040000000000006 110.504 170.523 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -128.33 4.91 5.73 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 113.883 1.068 . . . . 74.150000000000006 113.883 -161.647 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 16.1 m-85 -140.95 161.86 36.83 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 125.332 1.453 . . . . 71.329999999999998 108.234 -170.165 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 24.6 m -133.73 141.94 47.74 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.123 0.569 . . . . 73.329999999999998 109.564 -177.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -70.37 152.96 43.53 Favored 'General case' 0 C--O 1.235 0.316 0 O-C-N 121.477 -0.764 . . . . 75.209999999999994 109.423 173.68 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 73.28 -41.35 0.92 Allowed Glycine 0 CA--C 1.531 1.049 0 C-N-CA 125.877 1.703 . . . . 45.030000000000001 111.626 -164.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 17.6 tptt -74.89 -85.16 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 126.631 1.972 . . . . 54.140000000000001 110.612 -174.551 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.7 mp0 -77.82 -25.03 48.58 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 125.343 1.457 . . . . 73.040000000000006 110.075 -174.692 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 41.2 p90 -161.17 178.01 9.69 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 123.885 0.874 . . . . 70.349999999999994 109.719 -173.121 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 79.2 t -132.47 109.28 14.58 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 C-N-CA 125.074 1.35 . . . . 74.109999999999999 108.179 -179.154 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.22 162.63 24.56 Favored 'General case' 0 C--O 1.235 0.317 0 O-C-N 120.815 -1.178 . . . . 70.209999999999994 108.24 158.327 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -140.88 118.34 11.49 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 124.049 0.94 . . . . 72.129999999999995 109.584 -172.069 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.2 m -71.11 7.9 1.11 Allowed 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.99 1.316 . . . . 64.540000000000006 113.025 -174.647 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 33.0 m -134.47 82.13 46.85 Favored Pre-proline 0 N--CA 1.449 -0.505 0 C-N-CA 125.592 1.557 . . . . 74.230000000000004 109.224 173.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -75.16 -174.85 2.11 Favored 'Trans proline' 0 CA--C 1.544 1.005 0 C-N-CA 124.966 3.778 . . . . 41.329999999999998 114.011 -174.005 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 10.8 t -141.92 143.27 27.82 Favored Pre-proline 0 CA--C 1.545 0.788 0 C-N-CA 125.872 1.669 . . . . 71.219999999999999 109.339 168.015 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -90.05 178.87 2.14 Favored 'Trans proline' 0 CA--C 1.543 0.956 1 C-N-CA 125.777 4.318 . . . . 71.209999999999994 113.068 170.025 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 4.6 m -112.85 -177.7 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 C-N-CA 126.085 1.754 . . . . 72.239999999999995 110.327 171.86 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 12.6 t -63.12 -38.29 90.57 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 125.941 1.696 . . . . 72.209999999999994 112.05 172.511 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -153.53 143.49 15.34 Favored Pre-proline 0 N--CA 1.45 -0.457 0 CA-C-O 117.532 -1.223 . . . . 72.030000000000001 107.72 -179.424 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -72.62 178.0 6.82 Favored 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 122.437 2.091 . . . . 71.209999999999994 111.118 173.268 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 133.46 -95.85 0.29 Allowed Glycine 0 C--N 1.332 0.318 0 N-CA-C 108.456 -1.858 . . . . 73.430000000000007 108.456 174.071 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.642 ' H ' ' HE3' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -70.28 137.73 50.97 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 107.461 -1.311 . . . . 73.340000000000003 107.461 176.592 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 33.6 mm -67.69 133.32 31.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 106.79 -1.559 . . . . 60.200000000000003 106.79 175.021 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -83.95 143.65 29.69 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.283 -0.636 . . . . 62.399999999999999 109.283 176.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 25.7 t -133.68 109.53 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.225 0 N-CA-C 106.381 -1.711 . . . . 63.439999999999998 106.381 171.634 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 58.6 t -96.56 115.06 34.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 N-CA-C 106.104 -1.813 . . . . 71.019999999999996 106.104 179.098 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -76.45 134.99 39.4 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 107.937 -1.134 . . . . 71.430000000000007 107.937 157.266 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.744 HD22 HG21 ' A' ' 150' ' ' VAL . 3.3 mp -125.95 123.23 38.09 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 125.661 1.584 . . . . 73.310000000000002 108.011 170.83 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 15.9 p90 -138.94 176.71 8.46 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.376 1.071 . . . . 64.340000000000003 110.816 -170.776 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 25.0 t90 -147.1 172.12 14.25 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.997 1.319 . . . . 75.510000000000005 107.857 177.054 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 19.7 t80 -56.01 -41.0 74.22 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 126.374 1.869 . . . . 45.119999999999997 113.129 173.115 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -92.99 -106.87 1.76 Allowed Glycine 0 N--CA 1.449 -0.483 0 N-CA-C 107.965 -2.054 . . . . 74.010000000000005 107.965 -168.091 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 21.1 p 44.22 72.34 1.23 Allowed Pre-proline 0 C--O 1.221 -0.419 0 C-N-CA 125.373 1.469 . . . . 65.120000000000005 112.03 175.63 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -58.93 -24.9 75.02 Favored 'Trans proline' 0 CA--C 1.539 0.739 0 CA-C-N 121.596 1.606 . . . . 71.530000000000001 113.419 -171.079 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 19.7 m170 -71.98 -33.03 67.82 Favored 'General case' 0 CA--C 1.549 0.926 0 CA-C-O 118.059 -0.972 . . . . 73.450000000000003 112.512 172.125 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 15.9 p -65.85 -38.33 88.57 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 120.746 1.612 . . . . 73.140000000000001 110.793 -179.166 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 34.8 t80 -64.56 -31.32 72.49 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 123.199 0.6 . . . . 72.25 111.657 176.503 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.9 -3.99 25.64 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 112.597 0.591 . . . . 71.420000000000002 112.597 174.434 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 26.1 t80 -117.45 -21.33 8.69 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 125.358 1.463 . . . . 74.219999999999999 111.982 -176.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -46.33 -63.52 1.29 Allowed Pre-proline 0 N--CA 1.474 0.762 0 CA-C-N 120.446 1.475 . . . . 73.430000000000007 112.432 178.434 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -71.93 -6.77 19.78 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 CA-C-N 121.856 1.698 . . . . 72.349999999999994 114.084 -175.406 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.0 m -78.95 -42.83 25.92 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.172 1.389 . . . . 71.230000000000004 108.535 169.379 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 20.2 tt -89.84 -36.48 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 O-C-N 121.5 -0.75 . . . . 73.209999999999994 112.035 -171.304 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 54.2 t -50.69 -54.24 38.12 Favored Pre-proline 0 CA--C 1.54 0.565 0 C-N-CA 124.787 1.235 . . . . 62.409999999999997 111.591 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -68.73 -36.34 14.3 Favored 'Trans proline' 0 N--CA 1.454 -0.852 0 CA-C-N 121.098 1.428 . . . . 55.450000000000003 111.416 178.629 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.505 ' CH2' ' HB1' ' A' ' 179' ' ' ALA . 79.2 t90 -54.75 -51.05 66.9 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 118.801 0.728 . . . . 72.310000000000002 109.486 177.326 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -63.16 -37.39 87.04 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 117.857 0.299 . . . . 61.450000000000003 111.292 -175.844 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -62.59 -48.69 78.31 Favored 'General case' 0 N--CA 1.453 -0.299 0 O-C-N 121.58 -0.7 . . . . 75.140000000000001 109.255 179.241 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.54 18.24 2.37 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.84 0.856 . . . . 64.010000000000005 113.087 -173.91 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 19.7 mt -65.02 156.34 80.88 Favored Pre-proline 0 N--CA 1.451 -0.381 0 C-N-CA 123.483 0.713 . . . . 62.310000000000002 110.355 174.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -76.06 177.13 9.14 Favored 'Trans proline' 0 N--CA 1.452 -0.917 0 C-N-CA 124.648 3.566 . . . . 71.140000000000001 111.164 177.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -67.32 -7.99 28.87 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.535 1.134 . . . . 54.299999999999997 113.371 -178.51 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -107.29 1.77 24.09 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 119.804 1.184 . . . . 71.420000000000002 112.369 -168.592 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 40.7 t -125.66 137.52 57.41 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 N-CA-C 107.835 -1.172 . . . . 74.400000000000006 107.835 -172.512 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 67.2 t60 -127.5 99.94 5.81 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 124.687 1.195 . . . . 72.129999999999995 109.227 -177.064 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 35.0 t80 -80.51 142.15 34.47 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 114.389 -1.278 . . . . 61.329999999999998 110.863 176.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 32.6 t -135.08 154.57 36.41 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 C-N-CA 126.573 1.949 . . . . 73.239999999999995 106.85 178.585 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 9.6 mtm180 -132.11 120.18 21.98 Favored 'General case' 0 CA--C 1.516 -0.341 0 C-N-CA 124.364 1.066 . . . . 62.299999999999997 108.479 175.377 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 28.9 mt -132.33 153.28 81.18 Favored Pre-proline 0 C--N 1.33 -0.279 0 O-C-N 121.903 -0.498 . . . . 75.510000000000005 110.614 -177.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -81.71 144.97 14.22 Favored 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 123.455 2.77 . . . . 73.319999999999993 112.149 -178.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -90.91 74.42 6.47 Favored 'General case' 0 CA--C 1.528 0.122 0 C-N-CA 124.221 1.008 . . . . 62.530000000000001 109.338 -171.104 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 15.7 mt -74.32 86.84 1.99 Allowed 'General case' 0 CA--C 1.543 0.683 0 O-C-N 121.226 -0.921 . . . . 64.140000000000001 110.96 -170.605 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -105.87 24.76 11.82 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.495 1.118 . . . . 70.430000000000007 112.414 -178.735 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 89.14 171.28 45.53 Favored Glycine 0 CA--C 1.528 0.854 0 N-CA-C 110.215 -1.154 . . . . 64.219999999999999 110.215 -175.724 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 46.5 -146.49 3.27 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 124.117 0.865 . . . . 73.239999999999995 113.249 177.653 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 6.7 tp -63.92 -18.57 22.77 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 C-N-CA 123.288 0.635 . . . . 72.540000000000006 112.544 -172.617 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 9.4 m95 -62.16 -44.36 96.79 Favored 'General case' 0 C--N 1.344 0.362 0 CA-C-N 119.537 1.062 . . . . 71.019999999999996 109.537 176.316 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 4.3 p30 -77.08 -39.44 49.74 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 117.858 -1.067 . . . . 71.230000000000004 111.884 178.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 56.1 t -55.83 -52.03 53.47 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-N 119.153 0.888 . . . . 72.219999999999999 109.811 -178.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 34.0 m170 -63.64 -31.94 73.26 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 118.691 -0.671 . . . . 65.230000000000004 112.808 -176.547 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -87.98 -12.08 66.59 Favored Glycine 0 C--N 1.335 0.515 0 CA-C-N 119.701 1.137 . . . . 33.039999999999999 111.706 -175.143 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -60.97 -43.77 98.31 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 123.662 0.785 . . . . 75.040000000000006 110.667 -173.311 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 3.7 ppp? -50.22 -32.96 17.9 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 125.318 1.447 . . . . 64.510000000000005 114.155 177.685 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -59.92 -49.52 77.37 Favored 'General case' 0 N--CA 1.458 -0.072 0 C-N-CA 125.181 1.392 . . . . 74.430000000000007 108.421 -175.221 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 29.2 mt -66.26 -36.54 83.27 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 124.486 1.114 . . . . 74.310000000000002 109.732 179.244 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.02 -46.86 82.6 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 120.006 1.275 . . . . 74.030000000000001 110.801 176.71 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.31 -50.79 64.22 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 125.878 1.671 . . . . 71.409999999999997 107.961 -175.79 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -62.12 -46.31 89.61 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.516 1.126 . . . . 73.219999999999999 111.52 174.806 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 7.1 t -53.3 -32.89 50.98 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 126.102 1.761 . . . . 65.409999999999997 113.941 -172.385 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' MET . . . . . 0.456 ' HE3' HG13 ' A' ' 120' ' ' VAL . 8.1 ptp -81.39 -10.84 59.44 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 114.16 1.17 . . . . 70.420000000000002 114.16 179.659 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 93.92 50.72 2.23 Favored Glycine 0 CA--C 1.524 0.607 0 C-N-CA 126.137 1.827 . . . . 63.409999999999997 111.862 170.614 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 18.1 m -66.17 129.96 31.04 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 CA-C-N 118.683 1.241 . . . . 72.430000000000007 109.309 176.029 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -80.55 50.34 1.29 Allowed 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.014 1.326 . . . . 73.400000000000006 111.328 -179.553 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 37.1 m-70 57.81 36.04 26.04 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 127.034 2.134 . . . . 72.439999999999998 111.813 -176.354 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -60.18 103.65 0.25 Allowed 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.418 1.487 . . . . 72.409999999999997 108.567 174.486 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.3 t 44.02 71.91 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.809 0 C-N-CA 128.37 2.668 . . . . 70.519999999999996 113.848 166.156 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 12.5 t-80 -61.15 -34.98 75.87 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.594 1.158 . . . . 74.120000000000005 113.971 -177.484 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -61.61 -46.12 91.19 Favored 'General case' 0 CA--C 1.51 -0.582 0 C-N-CA 123.628 0.771 . . . . 71.340000000000003 111.636 177.574 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -66.92 -19.12 65.67 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 113.059 0.763 . . . . 60.439999999999998 113.059 -162.684 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 66.9 t -51.61 -70.6 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 C-N-CA 128.369 2.668 . . . . 61.229999999999997 111.063 160.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -54.27 -43.07 70.7 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 125.948 1.699 . . . . 72.430000000000007 110.977 176.058 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -83.63 14.86 3.5 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 126.018 1.727 . . . . 73.150000000000006 110.846 -174.32 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -114.76 -19.85 10.87 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 126.081 1.752 . . . . 71.099999999999994 114.604 157.439 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 36.9 mt -80.5 -66.71 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 N-CA-C 108.373 -0.973 . . . . 73.319999999999993 108.373 175.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -78.45 -66.96 0.79 Allowed 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 114.038 1.125 . . . . 71.129999999999995 114.038 -163.14 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 29.8 mtpt -50.3 -53.19 30.47 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 125.36 1.464 . . . . 63.109999999999999 109.996 177.758 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 22.4 mm-40 -75.68 -28.11 58.54 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 125.609 1.563 . . . . 64.340000000000003 109.426 -168.067 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 22.3 t-160 64.86 26.57 12.89 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 126.217 1.807 . . . . 61.049999999999997 111.358 174.389 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 28.2 mmtp -70.61 140.23 51.59 Favored 'General case' 0 C--N 1.342 0.251 0 O-C-N 121.1 -1.0 . . . . 75.010000000000005 109.665 177.361 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 19.8 tttt -56.97 -51.03 70.84 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 125.277 1.431 . . . . 73.319999999999993 111.313 -171.688 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 50.2 mt 47.86 35.14 4.5 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.363 1.465 . . . . 74.329999999999998 112.496 173.082 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -94.11 -7.16 43.25 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 113.941 1.089 . . . . 55.240000000000002 113.941 -169.78 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 17.3 p -135.98 155.23 77.86 Favored Pre-proline 0 C--O 1.235 0.308 0 CA-C-N 119.242 0.928 . . . . 71.109999999999999 109.639 -177.15 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -63.14 -33.61 72.03 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 122.088 1.858 . . . . 72.010000000000005 111.843 -178.616 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -66.32 -23.88 66.44 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 118.467 0.576 . . . . 74.5 111.974 176.299 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -81.77 -44.79 16.53 Favored 'General case' 0 CA--C 1.528 0.111 0 C-N-CA 123.57 0.748 . . . . 73.329999999999998 109.851 175.492 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 44.4 mtt -66.11 -54.55 24.24 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 123.628 0.771 . . . . 61.530000000000001 109.162 -175.11 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.489 ' HB2' ' CD1' ' A' ' 125' ' ' PHE . . . -68.18 -29.91 68.89 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 119.073 -0.489 . . . . 55.149999999999999 111.518 -173.905 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -62.21 -48.61 79.25 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 123.524 0.73 . . . . 71.329999999999998 110.464 169.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 86.8 t80 -62.4 -42.52 99.49 Favored 'General case' 0 N--CA 1.447 -0.592 0 O-C-N 122.21 -0.306 . . . . 75.409999999999997 111.725 -179.698 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 35.3 mt -80.89 -11.59 59.56 Favored 'General case' 0 N--CA 1.451 -0.408 0 O-C-N 121.339 -0.851 . . . . 51.210000000000001 111.071 -172.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -54.51 -37.65 65.59 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 118.082 0.401 . . . . 61.350000000000001 110.506 178.058 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -84.53 8.97 66.25 Favored Glycine 0 CA--C 1.528 0.857 0 C-N-CA 124.928 1.251 . . . . 53.25 114.818 175.616 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 52.4 mmtt -133.74 45.01 2.7 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-N 119.485 1.643 . . . . 65.129999999999995 110.256 -169.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 63.25 22.84 65.72 Favored Glycine 0 CA--C 1.53 1.022 0 CA-C-O 118.6 -1.111 . . . . 62.240000000000002 113.503 170.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.456 HG13 ' HE3' ' A' ' 84' ' ' MET . 41.9 t -114.17 151.89 15.91 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 C-N-CA 127.528 2.331 . . . . 75.409999999999997 106.335 173.368 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -115.67 140.56 49.08 Favored 'General case' 0 C--O 1.235 0.33 0 O-C-N 121.963 -0.461 . . . . 74.430000000000007 110.322 172.566 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 10.8 mttt -62.69 -39.97 95.67 Favored 'General case' 0 CA--C 1.527 0.061 0 CA-C-O 118.42 -0.8 . . . . 63.109999999999999 110.519 178.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 59.2 mt-10 -50.99 -52.39 43.25 Favored 'General case' 0 N--CA 1.457 -0.124 0 CA-C-N 118.888 0.767 . . . . 64.120000000000005 109.954 176.663 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 88.1 mttt -79.53 -42.14 25.8 Favored 'General case' 0 CA--C 1.515 -0.399 0 N-CA-C 107.075 -1.454 . . . . 61.539999999999999 107.075 -166.27 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.489 ' CD1' ' HB2' ' A' ' 112' ' ' ALA . 62.4 t80 -55.78 -60.32 3.62 Favored 'General case' 0 N--CA 1.443 -0.821 0 C-N-CA 123.798 0.839 . . . . 72.010000000000005 109.357 179.716 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 47.8 mt -67.2 -37.81 84.28 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-O 118.953 -0.546 . . . . 73.030000000000001 110.799 -172.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 2.9 t -64.73 -41.77 95.7 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 119.42 1.009 . . . . 72.530000000000001 110.127 -176.691 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 3.4 t -80.23 -31.77 38.53 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 118.839 0.745 . . . . 71.010000000000005 111.069 -179.011 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 91.0 t80 -53.45 -52.93 57.87 Favored 'General case' 0 C--O 1.234 0.268 0 O-C-N 121.294 -0.879 . . . . 63.5 109.369 170.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -86.58 56.5 4.03 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 125.205 1.402 . . . . 74.439999999999998 109.033 176.708 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 14.9 t -136.26 168.5 19.29 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 124.037 0.935 . . . . 74.25 110.549 176.182 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -69.34 -27.16 65.11 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.249 0.62 . . . . 65.109999999999999 110.053 167.288 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -51.73 -53.73 36.14 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 124.209 1.003 . . . . 71.209999999999994 111.005 -178.558 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.4 HD13 ' HA ' ' A' ' 134' ' ' ILE . 14.3 mm -65.17 -36.56 78.05 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 CA-C-O 118.763 -0.637 . . . . 74.349999999999994 110.853 177.862 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 22.4 mttt -57.88 -38.3 75.52 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 119.511 1.05 . . . . 75.420000000000002 110.369 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -72.2 -17.73 77.57 Favored Glycine 0 CA--C 1.528 0.86 0 N-CA-C 111.842 -0.503 . . . . 72.400000000000006 111.842 -177.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 6.9 mt-30 -88.98 -42.77 11.58 Favored 'General case' 0 N--CA 1.453 -0.276 0 O-C-N 121.542 -0.975 . . . . 61.409999999999997 110.514 174.535 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 91.7 mmm -58.37 -52.58 65.01 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 108.636 -0.876 . . . . 74.200000000000003 108.636 -178.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -65.85 -30.46 71.08 Favored 'General case' 0 CA--C 1.535 0.365 0 CA-C-N 119.112 0.869 . . . . 71.129999999999995 112.509 -172.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 13.5 mmtt -63.3 -68.54 0.33 Allowed 'General case' 0 C--O 1.227 -0.083 0 C-N-CA 126.081 1.752 . . . . 73.319999999999993 109.606 171.074 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -54.73 -36.27 64.59 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 119.218 0.917 . . . . 62.229999999999997 111.208 -174.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -54.57 -66.14 0.45 Allowed 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 126.374 1.87 . . . . 70.209999999999994 110.949 172.176 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.69 -31.51 72.23 Favored 'General case' 0 N--CA 1.466 0.33 0 O-C-N 121.433 -0.792 . . . . 64.219999999999999 111.142 -174.233 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 49.2 mt -60.11 -54.29 47.67 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 123.968 0.907 . . . . 65.209999999999994 109.778 178.745 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -54.13 -42.14 69.17 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 118.842 0.746 . . . . 74.219999999999999 111.341 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -64.25 -43.51 94.68 Favored 'General case' 0 C--O 1.235 0.336 0 O-C-N 121.499 -0.751 . . . . 73.239999999999995 111.229 178.807 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -63.35 -40.17 96.55 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 123.72 0.808 . . . . 73.430000000000007 110.383 -179.466 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 52.8 m-85 -72.78 11.92 0.59 Allowed 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 114.181 1.178 . . . . 74.230000000000004 114.181 -178.658 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 55.59 27.81 11.0 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.295 1.438 . . . . 75.150000000000006 113.347 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.744 HG21 HD22 ' A' ' 32' ' ' LEU . 40.8 t -64.02 -47.78 88.89 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 C-N-CA 124.995 1.318 . . . . 74.510000000000005 112.791 -168.317 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 82.0 p 55.0 -54.51 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 128.713 2.805 . . . . 74.430000000000007 114.82 -166.029 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -146.94 -166.76 12.55 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 127.161 2.315 . . . . 45.439999999999998 110.506 -173.28 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 29.1 m -143.83 155.12 59.54 Favored Pre-proline 0 C--O 1.239 0.551 0 C-N-CA 125.47 1.508 . . . . 73.310000000000002 108.779 -172.65 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -68.81 145.38 77.12 Favored 'Cis proline' 0 C--N 1.345 0.359 0 C-N-CA 125.055 -0.81 . . . . 74.019999999999996 113.918 0.705 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 37.8 m -149.43 127.94 12.31 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 125.431 1.493 . . . . 51.329999999999998 107.533 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 20.2 mmm -115.26 148.46 39.13 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 125.561 1.544 . . . . 74.230000000000004 107.916 172.126 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 49.9 t -138.96 115.38 10.09 Favored 'Isoleucine or valine' 0 C--O 1.238 0.482 0 N-CA-C 109.571 -0.529 . . . . 75.040000000000006 109.571 -177.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.569 HG23 ' CE1' ' A' ' 164' ' ' PHE . 95.2 t -84.48 127.23 40.03 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 N-CA-C 107.764 -1.198 . . . . 72.219999999999999 107.764 170.477 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 6.1 t30 49.34 26.15 1.5 Allowed 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 130.128 3.371 . . . . 65.519999999999996 115.243 165.306 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 56.8 28.77 57.71 Favored Glycine 0 CA--C 1.527 0.825 0 C-N-CA 126.311 1.91 . . . . 34.439999999999998 114.172 -172.694 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 6.1 mtpt -131.72 -22.33 2.4 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 120.08 1.94 . . . . 73.109999999999999 112.916 -179.488 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -128.08 126.75 41.81 Favored 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 107.954 -1.128 . . . . 75.439999999999998 107.954 179.125 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 9.2 ttp85 -109.27 134.29 51.96 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 127.187 2.195 . . . . 70.099999999999994 105.643 176.531 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' PHE . . . . . 0.569 ' CE1' HG23 ' A' ' 158' ' ' VAL . 11.8 p90 -152.26 167.55 28.25 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.675 -0.861 . . . . 74.329999999999998 108.675 -178.897 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -175.9 177.8 1.59 Allowed 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.655 1.182 . . . . 72.340000000000003 109.903 -179.594 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 10.8 mt -47.1 -47.7 8.72 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.131 0 C-N-CA 127.145 2.178 . . . . 55.310000000000002 109.394 176.44 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -80.86 -8.89 86.97 Favored Glycine 0 N--CA 1.448 -0.556 0 CA-C-O 118.092 -1.393 . . . . 52.450000000000003 113.715 -177.678 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 1.2 m -82.94 -65.79 0.97 Allowed 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 119.743 1.771 . . . . 63.43 107.504 164.032 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -59.51 -54.85 41.8 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 124.388 1.075 . . . . 65.25 109.774 -168.844 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 140.58 -8.45 2.84 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 124.764 1.173 . . . . 72.010000000000005 114.106 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 171.38 167.08 31.13 Favored Glycine 0 CA--C 1.526 0.73 0 CA-C-N 119.598 1.699 . . . . 63.409999999999997 109.401 -174.533 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_endo -64.5 -45.36 9.28 Favored 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 122.902 2.401 . . . . 72.120000000000005 111.518 -173.659 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -65.12 -25.55 67.81 Favored 'General case' 0 CA--C 1.537 0.445 0 O-C-N 121.32 -0.862 . . . . 63.409999999999997 111.536 174.578 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -77.07 -28.28 54.6 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.745 0.818 . . . . 72.010000000000005 111.021 177.147 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 93.4 m -60.12 -45.51 92.75 Favored 'General case' 0 N--CA 1.464 0.235 0 O-C-N 120.581 -1.324 . . . . 51.100000000000001 109.854 178.332 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 52.5 mt -62.09 -31.83 72.31 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 118.028 0.376 . . . . 73.230000000000004 110.622 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 14.2 ttpt -55.8 -40.16 72.31 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 124.131 0.973 . . . . 71.510000000000005 110.07 174.035 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -75.05 -44.82 45.47 Favored 'General case' 0 CA--C 1.509 -0.614 0 CA-C-O 117.876 -1.059 . . . . 73.299999999999997 111.196 173.726 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.505 ' HB1' ' CH2' ' A' ' 50' ' ' TRP . . . -51.66 -47.45 63.8 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 119.048 0.84 . . . . 62.420000000000002 111.75 -172.019 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -68.91 -47.48 65.71 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.209 1.004 . . . . 72.019999999999996 110.524 -175.299 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -55.17 -49.35 72.08 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 125.301 1.441 . . . . 73.409999999999997 111.164 175.273 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 77.5 mt -66.11 -34.78 78.83 Favored 'General case' 0 C--O 1.232 0.14 0 C-N-CA 124.617 1.167 . . . . 71.400000000000006 111.583 -178.674 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 28.8 mt -60.5 -54.52 33.95 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.143 0 N-CA-C 107.845 -1.169 . . . . 64.439999999999998 107.845 173.581 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -53.36 -42.33 66.72 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 119.271 0.941 . . . . 73.329999999999998 111.042 -179.311 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 42.9 tptt -59.96 -37.0 78.32 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 126.296 1.838 . . . . 53.310000000000002 111.881 -177.59 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 34.7 mm-40 -90.44 -31.34 16.85 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.562 1.145 . . . . 75.209999999999994 111.784 177.607 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 187' ' ' ARG . . . . . 0.567 ' HA ' ' HE ' ' A' ' 187' ' ' ARG . 1.4 tpm_? -61.18 -37.96 84.81 Favored 'General case' 0 CA--C 1.514 -0.419 0 O-C-N 120.439 -1.413 . . . . 74.420000000000002 110.071 178.787 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -49.31 -36.29 20.55 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 127.856 2.462 . . . . 61.399999999999999 110.975 173.477 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -56.86 -34.67 68.06 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-O 118.896 -0.574 . . . . 55.100000000000001 110.777 -175.152 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -134.32 57.49 1.8 Allowed 'General case' 0 C--O 1.235 0.291 0 CA-C-N 118.213 0.46 . . . . 23.120000000000001 110.914 -178.204 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 59.3 tttt -115.13 38.29 3.24 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 127.05 2.14 . . . . 73.230000000000004 111.638 -170.091 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 5.6 tttp . . . . . 0 C--O 1.246 0.884 0 CA-C-O 116.641 -1.647 . . . . 73.540000000000006 112.357 -168.775 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.658 0 N-CA-C 107.852 -2.099 . . . . 60.130000000000003 107.852 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 75.74 135.48 0.06 Allowed 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 127.898 2.479 . . . . 75.310000000000002 111.234 165.622 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -131.66 6.86 4.41 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.455 1.102 . . . . 73.209999999999994 111.866 -177.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 34.0 m-85 -130.35 160.62 33.42 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 124.104 0.962 . . . . 44.539999999999999 110.006 -169.104 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 59.7 m -137.07 133.27 35.22 Favored 'General case' 0 C--O 1.239 0.541 0 N-CA-C 107.04 -1.467 . . . . 75.239999999999995 107.04 179.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.26 146.62 54.71 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 109.101 -0.703 . . . . 74.319999999999993 109.101 174.003 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 79.92 -35.13 2.11 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 126.332 1.92 . . . . 51.329999999999998 112.081 -170.023 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 21.4 tptt -77.54 -63.92 1.27 Allowed 'General case' 0 CA--C 1.518 -0.279 0 C-N-CA 124.687 1.195 . . . . 74.239999999999995 110.456 -176.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -98.16 -26.15 14.66 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 125.002 1.321 . . . . 41.119999999999997 109.362 -171.171 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 45.0 p90 -157.96 174.96 14.46 Favored 'General case' 0 N--CA 1.468 0.429 0 O-C-N 121.55 -0.719 . . . . 72.530000000000001 110.625 -172.522 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 48.7 t -132.72 106.9 11.25 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 N-CA-C 107.548 -1.279 . . . . 65.319999999999993 107.548 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 13.4 tt0 -64.81 147.94 52.24 Favored 'General case' 0 N--CA 1.445 -0.693 0 O-C-N 120.111 -1.618 . . . . 71.340000000000003 109.209 165.419 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -110.55 103.96 12.62 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.252 -1.34 . . . . 75.129999999999995 110.005 -178.76 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 79.6 p -65.0 5.85 0.3 Allowed 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 114.521 1.304 . . . . 41.509999999999998 114.521 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 8.8 t -128.37 85.28 60.85 Favored Pre-proline 0 N--CA 1.449 -0.479 0 N-CA-C 105.975 -1.861 . . . . 61.219999999999999 105.975 159.806 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -72.34 178.91 5.55 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 123.608 2.872 . . . . 62.420000000000002 111.097 -176.157 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 10.9 t -142.99 137.47 14.95 Favored Pre-proline 0 CA--C 1.539 0.521 0 C-N-CA 124.029 0.932 . . . . 64.209999999999994 109.186 -176.884 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -79.37 -178.52 4.66 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 C-N-CA 124.53 3.487 . . . . 75.219999999999999 111.703 175.666 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 29.6 m -132.29 166.23 29.77 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 125.798 1.639 . . . . 74.150000000000006 109.009 168.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 5.2 m -44.92 -49.66 10.91 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 127.138 2.175 . . . . 62.329999999999998 113.304 178.77 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 36.4 tt0 -145.62 144.38 22.45 Favored Pre-proline 0 CA--C 1.539 0.521 0 C-N-CA 124.588 1.155 . . . . 72.439999999999998 108.766 176.552 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -70.55 -167.49 0.26 Allowed 'Trans proline' 0 CA--C 1.544 0.976 0 C-N-CA 123.452 2.768 . . . . 65.530000000000001 110.455 164.142 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 120.26 -65.35 0.44 Allowed Glycine 0 C--N 1.333 0.395 0 N-CA-C 109.007 -1.637 . . . . 64.120000000000005 109.007 177.347 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -103.55 146.7 28.16 Favored 'General case' 0 C--O 1.232 0.132 0 C-N-CA 125.352 1.461 . . . . 53.43 108.899 170.91 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 49.5 mm -68.69 139.68 20.18 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 N-CA-C 106.247 -1.76 . . . . 64.430000000000007 106.247 173.266 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -94.81 104.14 16.04 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 106.913 -1.514 . . . . 51.009999999999998 106.913 175.678 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 55.2 t -102.99 128.53 55.82 Favored 'Isoleucine or valine' 0 C--O 1.231 0.089 0 N-CA-C 106.482 -1.673 . . . . 60.530000000000001 106.482 173.118 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 17.6 t -133.73 118.99 31.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 N-CA-C 107.717 -1.216 . . . . 61.219999999999999 107.717 -173.434 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -87.86 144.77 26.41 Favored 'General case' 0 C--O 1.238 0.478 0 N-CA-C 107.737 -1.208 . . . . 74.319999999999993 107.737 160.754 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.9 mp -124.34 125.06 43.71 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 125.042 1.337 . . . . 73.540000000000006 108.235 174.386 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -115.11 175.95 5.28 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.564 0.746 . . . . 72.340000000000003 112.717 -169.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' TRP . . . . . 0.501 ' CB ' HG21 ' A' ' 153' ' ' VAL . 25.3 t90 -148.29 -178.54 6.36 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 126.526 1.93 . . . . 73.219999999999999 108.235 168.279 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.419 ' CG ' HG21 ' A' ' 98' ' ' ILE . 4.0 m-30 -104.86 4.3 31.92 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 126.912 2.085 . . . . 64.530000000000001 112.377 179.403 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -129.6 18.74 5.39 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 124.689 1.137 . . . . 63.219999999999999 111.242 -178.265 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.553 ' HB3' HG23 ' A' ' 153' ' ' VAL . 21.9 p -105.03 85.59 1.3 Allowed Pre-proline 0 N--CA 1.449 -0.511 0 C-N-CA 125.11 1.364 . . . . 72.540000000000006 108.587 -177.146 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -59.82 -24.93 77.76 Favored 'Trans proline' 0 CA--C 1.535 0.558 0 CA-C-N 120.833 1.333 . . . . 60.25 112.291 -175.236 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 14.1 m170 -74.57 -15.31 60.85 Favored 'General case' 0 CA--C 1.538 0.489 0 O-C-N 121.233 -0.917 . . . . 74.140000000000001 112.403 178.039 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 71.5 m -62.25 -43.61 98.43 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 119.356 0.98 . . . . 33.109999999999999 108.815 167.855 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -57.28 -44.84 84.38 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 125.125 1.37 . . . . 74.129999999999995 111.013 175.292 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.37 -10.49 11.46 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 114.005 1.113 . . . . 62.32 114.005 -179.269 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.437 ' HB2' HD11 ' A' ' 166' ' ' ILE . 6.2 t80 -119.51 -25.54 5.99 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-O 117.221 -1.371 . . . . 73.329999999999998 112.537 -169.096 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -37.86 -67.5 0.25 Allowed Pre-proline 0 N--CA 1.472 0.659 0 C-N-CA 125.902 1.681 . . . . 74.109999999999999 113.378 179.078 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -70.84 -5.48 16.99 Favored 'Trans proline' 0 CA--C 1.537 0.639 0 CA-C-N 121.249 1.482 . . . . 74.129999999999995 114.067 -173.017 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.9 m -103.75 4.47 35.27 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 128.501 2.72 . . . . 72.310000000000002 110.647 177.511 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 16.8 tt -131.32 -30.52 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-N 120.406 1.457 . . . . 71.530000000000001 111.74 171.271 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 18.3 t -45.69 -64.87 0.77 Allowed Pre-proline 0 CA--C 1.537 0.464 0 C-N-CA 125.096 1.358 . . . . 74.329999999999998 110.168 173.441 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -69.33 -28.86 26.82 Favored 'Trans proline' 0 N--CA 1.451 -0.972 0 CA-C-N 120.791 1.318 . . . . 73.129999999999995 111.029 -172.363 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.489 ' CH2' ' HB1' ' A' ' 179' ' ' ALA . 70.7 t90 -59.2 -53.29 60.0 Favored 'General case' 0 C--N 1.341 0.198 0 CA-C-N 119.093 0.861 . . . . 74.109999999999999 109.581 174.862 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 90.6 p -58.77 -39.75 81.95 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 122.244 0.218 . . . . 61.119999999999997 111.07 -176.654 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -70.93 -12.94 61.83 Favored 'General case' 0 CA--C 1.54 0.587 0 O-C-N 121.154 -0.966 . . . . 73.25 112.874 178.153 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 68.4 mmtt -103.76 -2.03 27.05 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 125.771 1.628 . . . . 60.32 114.154 175.489 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 18.4 mt -54.93 147.68 31.74 Favored Pre-proline 0 N--CA 1.452 -0.327 0 CA-C-N 119.714 1.143 . . . . 42.350000000000001 110.997 -178.394 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -74.46 164.89 32.95 Favored 'Trans proline' 0 N--CA 1.439 -1.696 0 C-N-CA 123.346 2.698 . . . . 54.030000000000001 109.82 -176.161 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -65.43 1.02 1.26 Allowed 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.03 1.332 . . . . 64.329999999999998 114.009 178.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -98.73 0.09 43.83 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 127.965 2.506 . . . . 54.539999999999999 112.107 -179.389 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 57.5 t -131.81 157.09 43.08 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 C-N-CA 124.518 1.127 . . . . 75.519999999999996 108.569 -169.788 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 78.9 t60 -132.64 138.89 47.51 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 107.499 -1.297 . . . . 72.209999999999994 107.499 162.061 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 73.4 t80 -106.0 144.13 33.15 Favored 'General case' 0 CA--C 1.519 -0.224 0 N-CA-C 107.915 -1.143 . . . . 65.340000000000003 107.915 179.095 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 48.6 t -136.86 148.83 26.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 N-CA-C 108.239 -1.022 . . . . 73.120000000000005 108.239 178.531 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 23.1 mtt180 -115.47 128.08 55.77 Favored 'General case' 0 CA--C 1.513 -0.467 0 N-CA-C 105.867 -1.901 . . . . 73.25 105.867 165.409 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 23.5 mt -128.41 149.95 73.0 Favored Pre-proline 0 N--CA 1.467 0.391 0 CA-C-N 118.616 0.644 . . . . 73.25 111.173 170.494 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -78.29 129.62 9.62 Favored 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 122.482 2.122 . . . . 60.420000000000002 111.363 178.058 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -76.74 120.33 21.76 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.971 1.308 . . . . 62.32 110.179 174.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 47.7 mt -107.62 56.93 0.63 Allowed 'General case' 0 C--O 1.232 0.146 0 O-C-N 121.026 -1.046 . . . . 72.319999999999993 113.456 -167.382 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -77.33 53.26 1.01 Allowed 'General case' 0 CA--C 1.548 0.869 0 N-CA-C 113.456 0.91 . . . . 72.109999999999999 113.456 -176.826 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 80.29 -54.28 4.52 Favored Glycine 0 CA--C 1.53 1.02 0 C-N-CA 126.693 2.092 . . . . 61.43 114.486 155.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -82.52 -150.98 9.27 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 125.639 1.59 . . . . 62.210000000000001 110.377 172.855 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 9.7 tp -50.29 -19.88 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 C-N-CA 126.648 1.979 . . . . 72.219999999999999 113.604 -172.546 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 28.1 m95 -49.42 -52.93 25.53 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 125.484 1.513 . . . . 75.140000000000001 112.16 173.276 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 20.0 p30 -75.22 -29.58 60.31 Favored 'General case' 0 CA--C 1.522 -0.118 0 N-CA-C 112.288 0.477 . . . . 62.109999999999999 112.288 -178.655 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 81.5 t -61.32 -50.48 80.26 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.33 0 N-CA-C 107.809 -1.182 . . . . 73.549999999999997 107.809 174.707 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 60.8 m170 -70.44 14.63 0.12 Allowed 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 125.714 1.605 . . . . 72.219999999999999 113.004 173.122 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -129.58 -33.37 0.53 Allowed Glycine 0 CA--C 1.528 0.845 0 O-C-N 119.914 -1.741 . . . . 53.450000000000003 113.352 -173.086 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -64.71 -36.42 84.23 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 117.961 0.88 . . . . 63.130000000000003 111.073 -176.285 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -60.1 -45.04 94.28 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-O 116.37 -1.776 . . . . 71.219999999999999 112.126 179.644 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 25.9 t80 -52.22 -48.99 64.81 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 120.33 1.423 . . . . 54.509999999999998 109.935 -176.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 13.3 mt -67.04 -37.49 84.2 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 118.234 -0.889 . . . . 64.209999999999994 109.486 -178.03 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.3 m -63.74 -39.57 94.62 Favored 'General case' 0 C--N 1.342 0.253 0 CA-C-N 119.756 1.162 . . . . 72.219999999999999 111.407 174.169 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.414 HD22 HG23 ' A' ' 86' ' ' VAL . 0.4 OUTLIER -60.4 -54.02 50.59 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 125.44 1.496 . . . . 65.530000000000001 107.035 -179.447 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.422 ' HA ' ' CG1' ' A' ' 86' ' ' VAL . 3.2 mt-10 -63.69 -31.41 72.57 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 112.592 0.59 . . . . 71.109999999999999 112.592 178.316 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.9 t -54.5 -19.15 5.25 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 118.003 -0.998 . . . . 71.329999999999998 112.288 171.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 9.1 mtp -107.25 -9.69 16.02 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 115.33 1.604 . . . . 75.340000000000003 115.33 -174.818 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 105.7 -11.5 46.07 Favored Glycine 0 CA--C 1.525 0.717 0 CA-C-O 118.116 -1.38 . . . . 43.229999999999997 113.025 175.483 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.422 ' CG1' ' HA ' ' A' ' 82' ' ' GLU . 6.2 p 44.13 82.37 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 C-N-CA 125.904 1.682 . . . . 40.340000000000003 115.02 151.134 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -46.83 117.59 1.73 Allowed 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 126.166 1.786 . . . . 73.329999999999998 110.225 177.436 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 20.2 m-70 -59.41 -24.72 63.7 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 116.079 -0.509 . . . . 63.539999999999999 110.979 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -60.56 -10.49 5.17 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.603 1.161 . . . . 51.340000000000003 113.271 176.341 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 33.2 m -121.69 2.67 6.38 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 CA-C-N 120.773 1.624 . . . . 41.439999999999998 113.438 178.661 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -57.65 -20.8 35.95 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 115.52 1.674 . . . . 71.540000000000006 115.52 -172.203 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -86.61 -56.04 3.6 Favored 'General case' 0 CA--C 1.513 -0.472 0 C-N-CA 124.37 1.068 . . . . 75.409999999999997 109.432 172.092 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -49.69 -30.96 10.08 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.433 1.093 . . . . 54.409999999999997 112.971 -171.616 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 70.2 t -54.58 -61.58 0.96 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.841 0 C-N-CA 123.925 0.89 . . . . 60.229999999999997 111.157 171.79 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -71.99 -35.23 69.41 Favored 'General case' 0 N--CA 1.473 0.693 0 O-C-N 119.966 -1.709 . . . . 75.530000000000001 111.785 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -67.73 -12.31 60.25 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.003 0.921 . . . . 72.409999999999997 111.46 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -84.46 -16.57 42.07 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.259 1.024 . . . . 73.109999999999999 111.547 173.092 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.616 HD13 HD12 ' A' ' 105' ' ' LEU . 10.0 mm -96.16 -37.14 7.04 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 C-N-CA 124.546 1.138 . . . . 72.319999999999993 110.243 -176.438 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 88.1 m-70 -103.74 -64.78 1.06 Allowed 'General case' 0 C--O 1.233 0.21 0 C-N-CA 122.838 0.455 . . . . 73.439999999999998 110.667 -169.612 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 21.3 mtpt -63.26 -15.94 58.72 Favored 'General case' 0 N--CA 1.464 0.27 0 O-C-N 121.876 -0.515 . . . . 64.420000000000002 111.309 177.247 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -123.83 -58.41 1.58 Allowed 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.565 1.146 . . . . 73.409999999999997 112.4 -173.015 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 2.4 t60 63.94 62.53 0.88 Allowed 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.749 1.62 . . . . 71.319999999999993 112.448 -176.518 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 7.8 mmmt -77.91 22.51 0.28 Allowed 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 127.628 2.371 . . . . 72.430000000000007 113.916 -178.64 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 18.0 ttpp 46.53 40.29 8.02 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 126.309 1.844 . . . . 62.109999999999999 111.669 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.616 HD12 HD13 ' A' ' 98' ' ' ILE . 40.3 mt -72.67 59.51 0.46 Allowed 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 129.61 3.164 . . . . 63.119999999999997 109.313 178.482 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -106.42 10.98 31.32 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 128.386 2.674 . . . . 42.25 111.429 -172.252 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -150.75 157.4 35.97 Favored Pre-proline 0 C--N 1.328 -0.335 0 C-N-CA 124.645 1.178 . . . . 74.409999999999997 109.497 -175.786 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -66.14 -42.43 10.8 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 121.905 1.737 . . . . 71.420000000000002 109.973 -175.611 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -55.98 -53.56 55.38 Favored 'General case' 0 N--CA 1.437 -1.098 0 C-N-CA 124.011 0.924 . . . . 71.340000000000003 111.86 173.684 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 24.0 tp10 -62.35 -41.19 98.39 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 118.206 0.457 . . . . 71.329999999999998 109.988 -175.422 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 38.5 mtt -60.65 -51.05 71.05 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 123.056 0.542 . . . . 63.520000000000003 110.335 175.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.432 ' HB1' ' HG3' ' A' ' 122' ' ' LYS . . . -61.71 -44.0 97.76 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 124.678 1.191 . . . . 62.340000000000003 110.329 -177.28 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -66.57 -4.93 9.66 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.624 1.57 . . . . 75.530000000000001 112.414 177.769 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -95.54 -54.76 3.26 Favored 'General case' 0 C--O 1.234 0.266 0 O-C-N 120.061 -1.649 . . . . 55.039999999999999 109.669 163.755 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 33.7 mt -65.37 -15.4 62.53 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 124.123 0.969 . . . . 62.219999999999999 112.066 -172.281 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -57.92 -16.81 13.35 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.078 0.951 . . . . 60.130000000000003 111.805 172.394 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -105.84 8.07 42.43 Favored Glycine 0 CA--C 1.531 1.043 0 C-N-CA 125.304 1.431 . . . . 60.530000000000001 114.43 171.013 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 30.1 mmtm -134.88 42.05 2.82 Favored 'General case' 0 C--O 1.225 -0.221 0 CA-C-N 119.751 1.776 . . . . 51.25 109.046 -172.62 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 70.49 42.09 64.85 Favored Glycine 0 C--N 1.336 0.541 0 N-CA-C 111.901 -0.48 . . . . 74.109999999999999 111.901 169.744 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 65.9 t -134.0 115.18 20.73 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 CA-C-O 122.601 1.191 . . . . 51.329999999999998 108.869 178.529 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 49.9 t0 -67.99 123.69 21.33 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 115.164 -0.926 . . . . 75.329999999999998 109.926 166.494 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.432 ' HG3' ' HB1' ' A' ' 112' ' ' ALA . 5.2 ttmt -62.51 -35.35 79.11 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 122.895 0.478 . . . . 75.150000000000006 110.233 175.088 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 61.7 mm-40 -64.76 -22.03 66.89 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 123.548 0.739 . . . . 71.430000000000007 111.69 179.135 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 67.9 mmtt -91.25 -53.28 4.42 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 107.937 -1.134 . . . . 75.409999999999997 107.937 176.393 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -47.39 -69.45 0.13 Allowed 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 126.348 1.859 . . . . 75.120000000000005 111.399 -175.381 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 15.5 mt -63.51 -41.45 98.51 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 118.655 0.661 . . . . 62.32 110.409 -167.298 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 35.3 t -59.87 -54.2 49.0 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 125.368 1.467 . . . . 74.140000000000001 109.549 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 30.2 m -64.57 -40.02 94.8 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.426 1.09 . . . . 62.240000000000002 109.72 -175.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -57.03 -47.48 80.81 Favored 'General case' 0 C--O 1.231 0.108 0 C-N-CA 124.293 1.037 . . . . 71.140000000000001 108.952 176.619 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -84.7 29.43 0.61 Allowed 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 126.685 1.994 . . . . 62.409999999999997 111.771 -177.374 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 3.2 t -115.14 165.92 12.39 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 124.573 1.149 . . . . 64.140000000000001 111.072 -171.24 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -59.77 -33.38 71.62 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.509 1.124 . . . . 65.409999999999997 110.769 170.294 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -52.84 -54.56 32.58 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 124.562 1.145 . . . . 71.109999999999999 111.258 -176.13 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 48.3 mm -74.92 -25.82 18.87 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 CA-C-O 119.226 -0.416 . . . . 73.209999999999994 110.393 -175.443 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 12.8 tttt -53.78 -41.42 67.2 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 124.386 1.074 . . . . 63.409999999999997 109.813 170.308 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -67.99 -22.33 74.0 Favored Glycine 0 CA--C 1.528 0.854 0 C-N-CA 124.205 0.907 . . . . 64.409999999999997 113.549 -178.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -88.85 -43.22 11.37 Favored 'General case' 0 N--CA 1.455 -0.182 0 O-C-N 121.421 -1.046 . . . . 72.340000000000003 109.357 174.595 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 4.2 mtp -57.38 -41.53 80.39 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 112.836 0.68 . . . . 72.420000000000002 112.836 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 22.9 pt-20 -60.28 -49.28 78.23 Favored 'General case' 0 C--O 1.233 0.205 0 O-C-N 121.95 -0.469 . . . . 73.349999999999994 111.171 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 76.1 mttt -60.64 -59.11 5.92 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 124.12 0.968 . . . . 61.240000000000002 108.603 178.285 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -53.13 -41.41 65.05 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 118.87 -0.586 . . . . 64.129999999999995 111.522 -174.121 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 26.8 ttmt -64.83 -59.9 3.68 Favored 'General case' 0 C--N 1.344 0.334 0 CA-C-N 119.015 0.825 . . . . 73.519999999999996 109.932 -179.365 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.39 -28.91 70.11 Favored 'General case' 0 C--N 1.343 0.308 0 CA-C-N 118.612 0.642 . . . . 61.520000000000003 110.746 -174.056 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 52.1 mt -68.52 -52.16 35.11 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-O 118.675 -0.679 . . . . 71.319999999999993 110.606 177.429 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -55.78 -50.42 70.51 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 118.97 0.804 . . . . 73.430000000000007 111.437 -175.093 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -59.13 -47.59 84.73 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 118.938 -0.554 . . . . 61.140000000000001 111.776 176.814 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -71.42 -21.25 62.01 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 119.303 0.956 . . . . 65.120000000000005 111.589 -174.292 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 21.5 m-85 -77.93 10.84 2.54 Favored 'General case' 0 CA--C 1.541 0.609 0 O-C-N 121.002 -1.061 . . . . 75.239999999999995 112.564 170.26 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 53.62 34.05 17.85 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 126.778 2.031 . . . . 72.420000000000002 112.534 -177.145 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 34.8 t -75.72 141.85 15.26 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 N-CA-C 107.415 -1.328 . . . . 42.039999999999999 107.415 174.184 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -135.69 -4.02 2.29 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 124.452 1.101 . . . . 61.520000000000003 112.621 170.619 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -160.48 177.54 36.86 Favored Glycine 0 N--CA 1.448 -0.501 0 N-CA-C 109.843 -1.303 . . . . 60.539999999999999 109.843 -176.634 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.553 HG23 ' HB3' ' A' ' 37' ' ' CYS . 23.7 m -145.26 149.22 40.69 Favored Pre-proline 0 C--O 1.238 0.487 0 C-N-CA 124.336 1.054 . . . . 65.439999999999998 108.974 -179.439 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' PRO . . . . . 0.425 ' C ' ' HA ' ' A' ' 153' ' ' VAL . 41.0 Cg_endo -67.64 153.87 86.52 Favored 'Cis proline' 0 C--O 1.237 0.447 0 C-N-CA 125.195 -0.752 . . . . 64.310000000000002 112.728 0.325 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 55.0 m -150.7 127.54 11.0 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 125.305 1.442 . . . . 71.319999999999993 107.367 177.357 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 91.1 mtp -105.42 157.85 17.06 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-O 122.171 0.986 . . . . 73.530000000000001 109.161 168.503 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 21.4 t -141.01 149.64 20.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 106.858 -1.534 . . . . 63.229999999999997 106.858 177.085 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 41.4 t -122.62 123.56 68.69 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 C-N-CA 125.958 1.703 . . . . 65.219999999999999 106.648 172.524 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 56.48 16.51 2.52 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 127.37 2.268 . . . . 63.32 114.782 167.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 60.81 33.89 84.86 Favored Glycine 0 CA--C 1.528 0.889 0 CA-C-O 118.205 -1.331 . . . . 52.049999999999997 113.867 -169.117 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 61.9 mttt -132.04 -33.31 1.35 Allowed 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 119.457 1.629 . . . . 72.540000000000006 113.262 -177.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -122.63 122.61 39.23 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 107.444 -1.317 . . . . 73.409999999999997 107.444 -178.834 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 35.9 ttp180 -103.33 137.73 41.06 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 104.805 -2.295 . . . . 71.430000000000007 104.805 170.756 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 21.1 p90 -152.65 162.24 41.51 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 107.075 -1.454 . . . . 73.25 107.075 176.595 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -171.08 176.55 3.96 Favored 'General case' 0 CA--C 1.514 -0.426 0 N-CA-C 109.235 -0.654 . . . . 60.520000000000003 109.235 -178.898 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.437 HD11 ' HB2' ' A' ' 43' ' ' PHE . 40.5 mt -47.78 -49.45 10.55 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 C-N-CA 126.881 2.072 . . . . 73.510000000000005 110.34 -177.932 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -84.51 0.14 89.28 Favored Glycine 0 CA--C 1.522 0.525 0 CA-C-O 118.788 -1.007 . . . . 41.219999999999999 113.767 -177.343 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 10.5 m -90.85 -66.27 0.94 Allowed 'General case' 0 N--CA 1.456 -0.157 0 CA-C-N 119.872 1.836 . . . . 73.150000000000006 107.179 161.402 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.6 ' HB1' HD23 ' A' ' 178' ' ' LEU . . . -70.13 -30.5 67.7 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-O 117.446 -1.264 . . . . 72.420000000000002 113.154 -161.276 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 129.86 22.09 1.18 Allowed Glycine 0 CA--C 1.538 1.51 0 N-CA-C 116.247 1.259 . . . . 62.409999999999997 116.247 171.664 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 113.12 164.28 15.89 Favored Glycine 0 CA--C 1.532 1.113 0 CA-C-N 120.028 1.914 . . . . 33.100000000000001 110.249 -176.36 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -63.23 -32.06 73.89 Favored 'Trans proline' 0 CA--C 1.536 0.622 0 CA-C-N 120.53 2.165 . . . . 43.329999999999998 113.816 -156.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 80.9 mt-10 -71.64 -29.94 65.2 Favored 'General case' 0 C--O 1.232 0.184 0 O-C-N 121.004 -1.06 . . . . 52.420000000000002 111.559 176.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -72.99 -24.79 60.81 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 122.773 0.429 . . . . 64.329999999999998 110.613 173.801 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 3.1 m -65.24 -45.57 84.08 Favored 'General case' 0 C--O 1.233 0.217 0 O-C-N 121.014 -1.054 . . . . 62.539999999999999 109.296 -175.515 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 39.8 mt -60.56 -33.42 72.67 Favored 'General case' 0 C--O 1.225 -0.213 0 CA-C-N 118.235 0.47 . . . . 54.210000000000001 111.206 175.214 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 10.3 tttt -58.05 -35.14 70.9 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-O 118.091 -0.956 . . . . 73.530000000000001 110.207 179.075 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.6 HD23 ' HB1' ' A' ' 169' ' ' ALA . 4.5 mm? -78.94 -44.89 21.6 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-N 119.359 0.982 . . . . 75.319999999999993 110.299 171.371 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.489 ' HB1' ' CH2' ' A' ' 50' ' ' TRP . . . -55.38 -31.49 61.85 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 118.604 0.638 . . . . 65.409999999999997 112.649 -175.652 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -90.61 -44.41 9.55 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 124.699 1.199 . . . . 42.43 109.41 -171.808 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 25.5 t80 -61.18 -49.21 78.12 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 121.382 0.611 . . . . 72.219999999999999 110.604 175.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 89.7 mt -63.07 -21.29 66.07 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 123.879 0.871 . . . . 71.239999999999995 112.491 -174.35 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 28.4 mt -57.36 -59.32 3.37 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.306 0 N-CA-C 107.395 -1.335 . . . . 72.140000000000001 107.395 168.644 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -56.52 -38.55 71.98 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 120.083 1.311 . . . . 73.420000000000002 111.618 -177.273 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 2.7 tmtt? -59.39 -39.82 84.6 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.249 0.619 . . . . 73.340000000000003 110.457 -178.343 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -89.05 -31.14 18.2 Favored 'General case' 0 CA--C 1.517 -0.301 0 O-C-N 121.424 -0.798 . . . . 71.349999999999994 112.75 177.392 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -60.55 -35.89 77.14 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.741 0.781 . . . . 74.25 111.039 -177.537 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -69.42 -10.09 56.44 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 123.719 0.808 . . . . 52.409999999999997 112.636 176.761 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -64.65 -47.26 79.14 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 119.921 1.237 . . . . 54.009999999999998 109.765 169.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -75.75 -39.29 57.42 Favored 'General case' 0 CA--C 1.528 0.101 0 O-C-N 123.684 0.615 . . . . 55.420000000000002 110.233 176.065 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 53.74 78.06 0.16 Allowed 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 126.391 1.877 . . . . 73.530000000000001 111.114 -177.86 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.245 0.834 0 C-N-CA 125.526 1.53 . . . . 64.129999999999995 110.696 -173.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.508 -0.356 0 N-CA-C 109.129 -1.588 . . . . 63.340000000000003 109.129 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -138.04 152.23 48.63 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 107.3 -1.37 . . . . 61.450000000000003 107.3 151.16 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 27.3 t0 -141.9 15.41 2.11 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 125.991 1.716 . . . . 71.319999999999993 110.023 -178.494 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 -155.34 153.22 30.17 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 126.581 1.953 . . . . 74.409999999999997 108.086 -173.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 74.7 m -128.25 144.59 51.14 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 121.337 0.589 . . . . 74.200000000000003 110.02 -172.708 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -70.1 144.42 52.1 Favored 'General case' 0 N--CA 1.456 -0.127 0 O-C-N 121.375 -0.828 . . . . 52.240000000000002 109.196 -179.056 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 67.44 -15.17 0.44 Allowed Glycine 0 CA--C 1.532 1.14 0 C-N-CA 126.05 1.786 . . . . 63.140000000000001 113.45 -167.633 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -94.54 -60.25 1.75 Allowed 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 125.218 1.407 . . . . 64.230000000000004 107.594 -171.104 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -106.57 -25.59 11.75 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 126.423 1.889 . . . . 75.010000000000005 110.18 -177.167 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 41.1 p90 -153.48 170.15 21.45 Favored 'General case' 0 C--N 1.332 -0.164 0 O-C-N 120.895 -1.128 . . . . 75.019999999999996 110.266 -171.506 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 26.8 t -128.93 103.42 9.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 107.158 -1.423 . . . . 54.240000000000002 107.158 -176.862 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -80.78 169.85 17.06 Favored 'General case' 0 C--O 1.237 0.446 0 O-C-N 119.243 -2.161 . . . . 54.43 109.672 174.705 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -127.59 110.88 13.14 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 107.543 -1.28 . . . . 75.219999999999999 107.543 -177.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -60.33 -14.27 17.51 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.824 1.649 . . . . 72.409999999999997 112.814 175.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 4.0 p -109.52 85.06 3.44 Favored Pre-proline 0 N--CA 1.451 -0.39 0 N-CA-C 107.618 -1.253 . . . . 74.349999999999994 107.618 166.009 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -67.52 179.35 2.6 Favored 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 122.479 2.119 . . . . 74.230000000000004 111.038 178.788 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 31.0 t -134.47 139.57 33.1 Favored Pre-proline 0 CA--C 1.536 0.425 0 N-CA-C 107.55 -1.278 . . . . 62.520000000000003 107.55 -178.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -75.58 177.25 8.92 Favored 'Trans proline' 0 CA--C 1.536 0.588 0 C-N-CA 122.937 2.425 . . . . 73.409999999999997 110.577 173.581 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 35.4 m -139.86 166.85 20.01 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 C-N-CA 123.426 0.69 . . . . 60.299999999999997 110.859 179.376 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 3.4 t -54.43 -60.1 3.8 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 126.26 1.824 . . . . 71.430000000000007 110.027 172.62 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 4.1 tp-100 -120.71 84.97 38.23 Favored Pre-proline 0 N--CA 1.454 -0.243 0 C-N-CA 125.335 1.454 . . . . 73.209999999999994 108.316 -163.155 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -67.75 -8.71 23.22 Favored 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 122.18 1.92 . . . . 75.299999999999997 112.183 177.248 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -61.21 -25.59 64.83 Favored Glycine 0 CA--C 1.53 1.022 0 O-C-N 120.848 -1.157 . . . . 65.230000000000004 112.118 168.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 56.2 mttm -125.66 150.87 47.24 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-N 119.391 1.595 . . . . 73.030000000000001 109.39 -179.157 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 51.2 mm -78.09 127.62 38.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 106.28 -1.748 . . . . 55.32 106.28 177.225 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -91.24 118.71 30.71 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 107.716 -1.216 . . . . 64.030000000000001 107.716 -174.827 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 42.1 t -120.42 115.94 48.67 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 N-CA-C 106.985 -1.487 . . . . 64.319999999999993 106.985 -178.429 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 16.8 t -124.48 103.59 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 N-CA-C 107.642 -1.244 . . . . 71.140000000000001 107.642 -163.299 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -67.67 135.83 53.4 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 125.48 1.512 . . . . 74.310000000000002 108.594 164.568 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.0 mp -119.85 125.61 48.94 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 124.741 1.216 . . . . 75.25 107.72 160.692 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -130.77 164.27 25.49 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.086 0.954 . . . . 65.230000000000004 111.222 -174.83 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 25.9 t90 -143.27 142.58 31.41 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.163 0.985 . . . . 74.420000000000002 109.975 177.257 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 5.7 m-30 -61.57 -25.5 67.36 Favored 'General case' 0 CA--C 1.533 0.309 0 O-C-N 121.757 -0.59 . . . . 74.409999999999997 111.505 175.651 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -91.57 19.9 44.87 Favored Glycine 0 CA--C 1.53 1.026 0 CA-C-O 118.53 -1.15 . . . . 73.439999999999998 113.255 -179.349 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 46.1 t -104.46 85.66 1.18 Allowed Pre-proline 0 CA--C 1.541 0.606 0 C-N-CA 125.281 1.432 . . . . 60.509999999999998 110.719 -173.114 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_endo -67.17 5.28 0.89 Allowed 'Trans proline' 0 CA--C 1.536 0.619 0 C-N-CA 124.672 3.581 . . . . 72.219999999999999 114.606 179.164 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 22.9 m170 -107.11 -20.02 13.43 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 126.27 1.828 . . . . 64.109999999999999 111.546 175.193 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 94.4 m -78.82 -34.55 45.15 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.602 0.761 . . . . 74.540000000000006 110.901 -175.238 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 14.1 t80 -55.91 -41.4 74.49 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 124.917 1.287 . . . . 72.099999999999994 110.575 178.163 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -45.39 -51.7 10.94 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 125.766 1.626 . . . . 64.420000000000002 110.859 179.302 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -84.39 -21.23 30.89 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 125.791 1.636 . . . . 75.230000000000004 112.695 -167.075 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 59.0 mm-40 -45.15 -62.59 1.58 Allowed Pre-proline 0 N--CA 1.469 0.505 0 CA-C-N 120.001 1.273 . . . . 61.539999999999999 112.562 -176.86 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -71.11 -5.13 16.3 Favored 'Trans proline' 0 CA--C 1.538 0.724 0 C-N-CA 121.839 1.693 . . . . 60.340000000000003 114.455 -178.032 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 74.7 m -87.74 -34.69 18.26 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 119.643 1.11 . . . . 75.299999999999997 109.561 168.22 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 19.2 tt -92.78 -29.05 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 CA-C-N 119.708 1.14 . . . . 63.119999999999997 112.189 -174.628 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 38.6 t -49.19 -62.92 1.94 Allowed Pre-proline 0 CA--C 1.536 0.437 0 CA-C-O 117.797 -1.097 . . . . 75.510000000000005 109.943 170.033 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -66.3 -25.38 49.6 Favored 'Trans proline' 0 N--CA 1.451 -0.973 0 CA-C-N 120.737 1.299 . . . . 75.140000000000001 112.591 -173.298 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.407 ' CZ2' HD21 ' A' ' 54' ' ' LEU . 58.4 t90 -65.88 -54.92 20.34 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 123.564 0.746 . . . . 61.530000000000001 110.406 173.345 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 88.8 p -57.61 -38.66 75.3 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.187 0.595 . . . . 63.310000000000002 112.24 -170.363 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 72.2 mt-10 -59.13 -36.84 75.9 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.796 1.238 . . . . 75.140000000000001 111.291 177.208 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 4.7 mmmm -92.51 2.82 56.46 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 125.35 1.46 . . . . 74.530000000000001 112.019 -167.094 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.407 HD21 ' CZ2' ' A' ' 50' ' ' TRP . 33.7 mt -62.06 155.98 61.01 Favored Pre-proline 0 C--O 1.239 0.502 0 C-N-CA 125.558 1.543 . . . . 71.230000000000004 112.122 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -81.4 171.57 13.5 Favored 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 125.143 3.895 . . . . 72.439999999999998 112.452 -177.815 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -69.12 -2.34 9.99 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 126.513 1.925 . . . . 73.510000000000005 115.28 -177.253 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -115.79 0.24 13.11 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.756 1.222 . . . . 74.219999999999999 111.939 -178.712 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 86.1 t -96.71 150.6 4.36 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 N-CA-C 107.751 -1.203 . . . . 73.010000000000005 107.751 168.709 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 33.8 t60 -129.94 99.6 5.16 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 124.983 1.313 . . . . 71.450000000000003 107.829 165.195 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 51.4 t80 -77.21 145.23 37.73 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 114.9 -1.046 . . . . 75.25 109.606 178.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 21.6 t -142.09 157.04 19.93 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 C-N-CA 125.998 1.719 . . . . 74.030000000000001 107.695 -177.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 57.7 mtt180 -130.56 131.74 45.19 Favored 'General case' 0 N--CA 1.462 0.144 0 N-CA-C 107.793 -1.188 . . . . 74.030000000000001 107.793 163.543 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 37.3 mt -133.63 157.35 78.17 Favored Pre-proline 0 N--CA 1.468 0.438 0 C-N-CA 124.532 1.133 . . . . 71.0 108.935 176.585 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -74.85 164.72 32.94 Favored 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 121.381 1.388 . . . . 74.200000000000003 111.289 177.608 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -111.45 112.6 24.46 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 125.777 1.631 . . . . 75.109999999999999 107.53 -177.03 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 26.8 mt -115.68 60.29 0.71 Allowed 'General case' 0 C--O 1.234 0.274 0 O-C-N 121.489 -0.757 . . . . 73.140000000000001 112.602 -161.093 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -65.53 -14.83 61.89 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 114.613 1.338 . . . . 72.019999999999996 114.613 -171.292 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 122.65 -37.78 2.73 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 125.329 1.442 . . . . 64.25 111.763 175.291 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -77.96 -157.77 10.03 Favored Glycine 0 CA--C 1.527 0.787 0 C-N-CA 124.383 0.992 . . . . 75.530000000000001 110.844 172.789 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 6.3 tp -45.11 -24.28 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 127.996 2.519 . . . . 74.109999999999999 113.396 179.288 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 37.6 m95 -44.19 -50.72 8.62 Favored 'General case' 0 N--CA 1.441 -0.899 0 C-N-CA 126.657 1.983 . . . . 73.120000000000005 111.277 172.475 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 26.4 p30 -77.71 -29.27 51.21 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 113.852 1.056 . . . . 73.030000000000001 113.852 -179.721 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 73.8 t -60.89 -50.0 82.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 108.757 -0.831 . . . . 72.310000000000002 108.757 174.439 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 55.9 m170 -72.29 -0.65 12.78 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.034 1.734 . . . . 73.239999999999995 112.538 171.641 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -100.51 -14.56 32.14 Favored Glycine 0 CA--C 1.525 0.661 0 CA-C-N 120.205 1.366 . . . . 72.140000000000001 112.309 -175.61 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -96.63 -27.13 14.94 Favored 'General case' 0 N--CA 1.45 -0.473 0 O-C-N 121.792 -0.828 . . . . 60.43 112.102 -159.311 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -65.11 -42.37 94.02 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-O 116.833 -1.556 . . . . 73.030000000000001 111.244 -177.865 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 7.7 t80 -52.21 -56.13 16.66 Favored 'General case' 0 C--N 1.34 0.194 0 CA-C-N 119.466 1.03 . . . . 74.239999999999995 109.01 -176.837 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 44.5 mt -64.89 -32.07 73.61 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 116.497 -1.716 . . . . 71.519999999999996 111.247 -177.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.688 ' CG2' HG23 ' A' ' 128' ' ' THR . 1.3 m -70.3 -38.18 74.93 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 120.77 1.623 . . . . 75.319999999999993 111.356 177.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.7 -54.25 47.56 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 124.395 1.078 . . . . 71.219999999999999 109.211 175.338 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -56.21 -37.69 70.0 Favored 'General case' 0 C--O 1.226 -0.154 0 C-N-CA 125.139 1.375 . . . . 73.329999999999998 110.485 177.488 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -50.95 -20.31 1.3 Allowed 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.538 1.535 . . . . 54.520000000000003 113.769 176.443 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 53.6 mtm -99.78 -7.92 24.86 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 120.422 1.465 . . . . 72.200000000000003 113.992 176.593 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 68.6 46.4 62.17 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 109.804 -1.318 . . . . 75.140000000000001 109.804 -178.469 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 10.8 m -58.6 93.8 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 C-N-CA 125.102 1.361 . . . . 70.239999999999995 111.904 178.506 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -84.82 14.0 5.26 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.065 1.346 . . . . 70.329999999999998 111.997 -176.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 14.8 m-70 -79.07 52.89 1.34 Allowed 'General case' 0 C--O 1.238 0.495 0 C-N-CA 127.271 2.229 . . . . 72.439999999999998 111.916 -172.276 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 66.78 179.29 0.22 Allowed 'General case' 0 C--O 1.239 0.548 0 C-N-CA 128.743 2.817 . . . . 64.049999999999997 111.521 -171.021 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.2 p -61.27 155.94 3.89 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 C-N-CA 123.524 0.73 . . . . 74.420000000000002 109.255 -176.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 1.5 p80 -75.51 35.79 0.12 Allowed 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 114.191 1.182 . . . . 73.120000000000005 114.191 -175.272 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -56.41 -66.97 0.35 Allowed 'General case' 0 CA--C 1.515 -0.391 0 C-N-CA 125.044 1.338 . . . . 74.239999999999995 109.373 178.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -52.92 -36.74 59.97 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 118.761 -0.638 . . . . 74.209999999999994 111.152 -178.345 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 4.1 t -57.43 -51.27 71.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 CA-C-N 119.551 1.068 . . . . 53.210000000000001 110.83 -179.421 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -65.18 -52.84 52.48 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 123.686 0.794 . . . . 75.209999999999994 109.256 175.71 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -58.02 -26.89 62.99 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.605 1.562 . . . . 73.209999999999994 110.978 -172.644 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.44 ' HA ' ' HB2' ' A' ' 101' ' ' GLU . . . -72.91 -16.03 61.57 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 125.822 1.649 . . . . 54.399999999999999 113.572 -179.383 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 19.4 mt -92.61 -43.1 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 N-CA-C 107.353 -1.351 . . . . 64.430000000000007 107.353 174.773 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 30.5 p80 -102.86 -64.11 1.1 Allowed 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 113.54 0.941 . . . . 71.329999999999998 113.54 -166.533 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 29.6 mtpt -68.14 -16.06 63.84 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 119.916 1.235 . . . . 65.430000000000007 111.783 176.13 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.44 ' HB2' ' HA ' ' A' ' 97' ' ' ALA . 20.9 mt-10 -99.48 -23.32 15.14 Favored 'General case' 0 C--N 1.331 -0.212 0 O-C-N 120.834 -1.166 . . . . 70.510000000000005 111.92 171.498 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 7.2 t60 57.4 84.6 0.09 Allowed 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.629 1.572 . . . . 72.200000000000003 112.497 172.202 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 8.3 mmtp -136.71 152.23 50.13 Favored 'General case' 0 CA--C 1.52 -0.193 0 C-N-CA 124.187 0.995 . . . . 65.019999999999996 111.193 -169.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 9.3 ttmm -71.18 -51.19 26.23 Favored 'General case' 0 C--O 1.224 -0.253 0 N-CA-C 109.261 -0.644 . . . . 73.540000000000006 109.261 -177.54 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 77.9 mt 50.54 32.17 6.39 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.893 1.277 . . . . 62.100000000000001 113.514 179.053 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -86.81 8.67 21.82 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 114.768 1.395 . . . . 73.219999999999999 114.768 -167.404 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -143.34 157.84 58.97 Favored Pre-proline 0 N--CA 1.471 0.605 0 O-C-N 120.846 -1.159 . . . . 53.409999999999997 109.392 -172.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -58.77 -42.68 50.79 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 121.905 1.736 . . . . 70.349999999999994 111.738 -177.151 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -63.05 -53.45 53.62 Favored 'General case' 0 N--CA 1.442 -0.86 0 O-C-N 124.342 1.026 . . . . 73.319999999999993 110.486 -178.25 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 44.3 tp10 -58.11 -33.61 69.31 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.362 0.665 . . . . 70.239999999999995 111.04 -172.42 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 69.1 mtm -72.68 -56.86 4.66 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 118.149 -0.929 . . . . 72.319999999999993 111.595 169.817 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -59.63 -49.87 76.06 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 124.764 1.226 . . . . 72.310000000000002 112.529 -171.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -68.08 -36.7 80.25 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 124.62 1.168 . . . . 73.299999999999997 111.591 -170.861 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' PHE . . . . . 0.465 ' CZ ' ' HE3' ' A' ' 118' ' ' LYS . 84.8 t80 -58.06 -38.93 77.27 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.229 0.612 . . . . 70.219999999999999 110.878 171.416 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 14.0 mt -77.66 -19.18 55.84 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 123.924 0.89 . . . . 72.120000000000005 110.278 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.4 -20.06 58.26 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 121.149 -0.969 . . . . 71.439999999999998 111.249 173.239 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -97.06 -6.5 57.86 Favored Glycine 0 CA--C 1.528 0.888 0 CA-C-O 118.877 -0.957 . . . . 64.019999999999996 114.112 169.557 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.465 ' HE3' ' CZ ' ' A' ' 114' ' ' PHE . 48.2 mttm -125.27 61.91 1.19 Allowed 'General case' 0 N--CA 1.456 -0.134 0 CA-C-N 119.938 1.869 . . . . 74.200000000000003 108.406 -175.083 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 71.69 18.48 77.34 Favored Glycine 0 CA--C 1.525 0.661 0 CA-C-O 119.021 -0.877 . . . . 65.439999999999998 114.646 161.596 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 28.3 t -125.89 139.88 50.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 C-N-CA 125.707 1.603 . . . . 62.530000000000001 108.04 -176.608 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 65.5 t0 -85.68 121.2 28.01 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 107.712 -1.218 . . . . 54.310000000000002 107.712 167.409 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 15.3 ttpt -57.32 -35.62 70.09 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 124.053 0.941 . . . . 75.329999999999998 110.394 176.127 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -65.68 -39.6 91.47 Favored 'General case' 0 N--CA 1.454 -0.26 0 O-C-N 121.491 -0.756 . . . . 64.319999999999993 111.566 178.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.457 ' O ' HG22 ' A' ' 128' ' ' THR . 46.0 mttm -75.68 -44.25 43.2 Favored 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 106.819 -1.548 . . . . 74.219999999999999 106.819 -173.815 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -49.02 -68.06 0.21 Allowed 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 125.605 1.562 . . . . 72.450000000000003 110.579 174.259 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 18.3 mt -65.33 -32.59 74.32 Favored 'General case' 0 C--O 1.234 0.253 0 O-C-N 121.379 -0.825 . . . . 72.200000000000003 111.155 -170.433 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 35.7 t -56.98 -58.26 8.92 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 107.637 -1.245 . . . . 75.099999999999994 107.637 177.017 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' THR . . . . . 0.688 HG23 ' CG2' ' A' ' 80' ' ' THR 0.341 10.1 t -71.79 -30.13 65.2 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 119.919 -0.712 . . . . 74.120000000000005 110.864 -175.32 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 31.1 t80 -54.65 -35.36 63.4 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 120.646 -1.283 . . . . 74.450000000000003 111.085 174.228 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -102.72 18.14 22.12 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.618 1.167 . . . . 34.100000000000001 112.744 179.241 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 28.8 m -104.53 160.99 14.49 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 125.652 1.581 . . . . 73.299999999999997 111.926 176.811 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -59.9 -25.97 65.54 Favored 'General case' 0 CA--C 1.532 0.288 0 O-C-N 122.143 -0.348 . . . . 51.020000000000003 111.058 171.051 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -50.01 -28.75 7.42 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 125.386 1.474 . . . . 52.299999999999997 113.304 173.637 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.501 HD11 ' HA ' ' A' ' 80' ' ' THR . 5.5 mm -101.64 -36.06 4.49 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 C-N-CA 125.159 1.384 . . . . 74.420000000000002 110.671 176.366 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 35.3 tttm -53.91 -39.06 65.47 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 124.073 0.949 . . . . 75.430000000000007 110.463 174.68 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -72.55 -16.05 77.57 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 125.152 1.358 . . . . 51.140000000000001 111.916 -170.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -99.1 -39.22 8.6 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 123.393 0.677 . . . . 73.030000000000001 109.494 176.594 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 75.6 mmm -58.47 -37.83 76.32 Favored 'General case' 0 C--N 1.342 0.257 0 N-CA-C 109.77 -0.456 . . . . 64.140000000000001 109.77 177.789 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -59.66 -51.53 69.41 Favored 'General case' 0 CA--C 1.535 0.374 0 O-C-N 121.303 -0.873 . . . . 71.400000000000006 110.737 173.865 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 4.3 mmtp -61.98 -58.14 9.01 Favored 'General case' 0 C--N 1.344 0.327 0 CA-C-O 117.987 -1.006 . . . . 73.209999999999994 111.47 -175.294 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -59.5 -30.75 68.79 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 119.474 1.034 . . . . 51.200000000000003 110.671 -176.715 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 2.2 tmpt? -66.16 -58.87 4.48 Favored 'General case' 0 C--N 1.344 0.357 0 O-C-N 121.035 -1.04 . . . . 73.209999999999994 109.99 176.796 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 15.2 ptpt -62.61 -37.82 87.78 Favored 'General case' 0 C--N 1.341 0.22 0 CA-C-O 118.611 -0.709 . . . . 73.439999999999998 109.499 -173.863 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 35.7 mt -57.89 -59.77 4.73 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.467 1.107 . . . . 64.439999999999998 110.984 175.363 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -56.01 -40.61 73.63 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 119.03 0.832 . . . . 75.230000000000004 111.765 -175.854 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -63.25 -50.52 69.84 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 109.918 -0.401 . . . . 74.329999999999998 109.918 175.503 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -69.67 -22.44 63.44 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-O 118.572 -0.727 . . . . 72.129999999999995 112.4 -172.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -73.98 -8.27 55.49 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 125.37 1.468 . . . . 72.519999999999996 113.864 171.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 52.61 72.66 0.39 Allowed 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 124.793 1.237 . . . . 75.310000000000002 110.919 -167.588 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 47.4 t -101.63 145.83 10.93 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 N-CA-C 107.457 -1.312 . . . . 71.219999999999999 107.457 166.463 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -123.27 -13.89 7.58 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 123.629 0.772 . . . . 70.5 112.787 172.836 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -159.35 -163.7 13.59 Favored Glycine 0 C--N 1.334 0.431 0 O-C-N 121.047 -1.033 . . . . 75.319999999999993 113.213 179.051 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.451 ' HA ' ' C ' ' A' ' 154' ' ' PRO . 15.4 m -144.11 146.78 35.1 Favored Pre-proline 0 C--N 1.328 -0.335 0 C-N-CA 126.102 1.761 . . . . 65.439999999999998 107.086 173.055 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 154' ' ' PRO . . . . . 0.451 ' C ' ' HA ' ' A' ' 153' ' ' VAL . 60.8 Cg_endo -67.31 150.95 83.68 Favored 'Cis proline' 0 N--CA 1.46 -0.479 0 C-N-CA 125.2 -0.75 . . . . 64.420000000000002 112.149 1.524 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 85.8 m -151.15 127.75 10.81 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 105.769 -1.937 . . . . 42.509999999999998 105.769 174.564 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 14.6 mmm -110.81 150.81 28.6 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 106.569 -1.641 . . . . 72.140000000000001 106.569 165.857 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 46.6 t -129.11 128.91 67.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 107.114 -1.439 . . . . 73.209999999999994 107.114 171.301 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.503 HG23 ' CE1' ' A' ' 164' ' ' PHE . 77.4 t -93.1 123.04 45.06 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 N-CA-C 107.48 -1.304 . . . . 62.229999999999997 107.48 164.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 2.7 t30 64.58 11.74 6.92 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 129.114 2.966 . . . . 60.539999999999999 115.52 159.242 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 71.19 23.33 78.19 Favored Glycine 0 CA--C 1.526 0.742 0 CA-C-O 117.711 -1.605 . . . . 74.420000000000002 112.973 -170.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 35.9 mttt -133.58 -30.18 1.3 Allowed 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 120.043 1.921 . . . . 65.420000000000002 112.402 -175.473 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 80.3 m-85 -124.34 115.01 20.31 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 118.943 -0.551 . . . . 74.5 110.864 -179.599 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 6.3 ptt180 -96.01 141.41 29.45 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 106.685 -1.598 . . . . 61.25 106.685 171.171 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' PHE . . . . . 0.503 ' CE1' HG23 ' A' ' 158' ' ' VAL . 15.1 p90 -151.71 164.84 36.08 Favored 'General case' 0 C--N 1.309 -1.154 0 O-C-N 120.721 -1.237 . . . . 73.040000000000006 108.376 176.635 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -168.19 169.12 11.19 Favored 'General case' 0 CA--C 1.513 -0.445 0 CA-C-N 116.001 -0.545 . . . . 73.209999999999994 109.611 -174.564 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.442 HD12 ' HG3' ' A' ' 154' ' ' PRO . 42.0 mt -51.73 -47.79 38.57 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 C-N-CA 125.41 1.484 . . . . 62.32 109.702 -175.115 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -84.13 -4.65 88.16 Favored Glycine 0 CA--C 1.527 0.791 0 CA-C-O 117.701 -1.611 . . . . 64.439999999999998 113.38 -176.784 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 52.1 m -87.24 -56.31 3.42 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 121.224 2.512 . . . . 71.439999999999998 108.249 163.471 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.75 ' HB1' HD23 ' A' ' 178' ' ' LEU . . . -79.0 -28.02 43.36 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-O 116.9 -1.524 . . . . 71.340000000000003 113.969 -165.856 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 154.12 -46.7 0.54 Allowed Glycine 0 CA--C 1.527 0.793 0 CA-C-N 121.343 1.883 . . . . 42.109999999999999 115.457 176.799 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 154.26 167.13 15.83 Favored Glycine 0 CA--C 1.534 1.224 0 N-CA-C 108.159 -1.977 . . . . 64.140000000000001 108.159 -153.145 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -67.69 -23.48 42.35 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 CA-C-N 120.525 2.163 . . . . 31.23 113.294 -164.182 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -70.0 -46.4 65.22 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 123.013 1.387 . . . . 65.430000000000007 109.557 174.072 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -66.97 -21.51 65.96 Favored 'General case' 0 N--CA 1.445 -0.675 0 C-N-CA 126.622 1.969 . . . . 74.439999999999998 111.344 -175.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 3.2 m -70.6 -43.76 68.68 Favored 'General case' 0 CA--C 1.529 0.16 0 O-C-N 121.126 -0.984 . . . . 72.150000000000006 109.162 -177.831 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 53.4 mt -62.84 -33.27 74.9 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 118.288 0.495 . . . . 73.349999999999994 110.799 177.702 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 7.5 tttt -52.58 -51.42 59.88 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 125.099 1.36 . . . . 74.340000000000003 109.33 173.695 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.75 HD23 ' HB1' ' A' ' 169' ' ' ALA . 4.3 mm? -68.78 -39.89 79.96 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-O 118.287 -0.864 . . . . 54.399999999999999 110.846 175.265 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -55.8 -49.04 74.28 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 119.215 0.916 . . . . 75.120000000000005 111.201 -174.824 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -72.88 -43.13 62.9 Favored 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 122.76 0.424 . . . . 71.049999999999997 110.333 -172.246 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 15.9 t80 -60.45 -52.33 65.67 Favored 'General case' 0 N--CA 1.44 -0.946 0 C-N-CA 124.736 1.214 . . . . 74.329999999999998 110.048 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.501 ' HB2' HG21 ' A' ' 158' ' ' VAL . 95.9 mt -62.63 -34.8 77.78 Favored 'General case' 0 C--O 1.233 0.213 0 C-N-CA 123.206 0.602 . . . . 71.049999999999997 110.768 -178.41 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 38.1 mt -60.8 -61.96 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 N-CA-C 108.419 -0.956 . . . . 73.409999999999997 108.419 173.526 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -56.98 -32.79 66.44 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 124.491 1.117 . . . . 65.25 111.509 -173.384 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 79.3 tttt -58.51 -66.93 0.41 Allowed 'General case' 0 C--O 1.232 0.156 0 C-N-CA 125.425 1.49 . . . . 74.25 110.571 171.798 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 43.0 mm-40 -65.38 -19.34 65.9 Favored 'General case' 0 N--CA 1.446 -0.625 0 O-C-N 121.03 -1.044 . . . . 73.010000000000005 113.258 -177.441 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.94 -44.79 63.04 Favored 'General case' 0 CA--C 1.533 0.319 0 O-C-N 120.974 -1.079 . . . . 74.030000000000001 109.327 169.713 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -56.2 -32.57 64.51 Favored 'General case' 0 C--O 1.232 0.133 0 C-N-CA 124.214 1.005 . . . . 73.299999999999997 110.73 -177.648 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -51.91 -28.02 14.93 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.336 1.054 . . . . 63.439999999999998 113.483 178.71 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -133.44 40.36 3.16 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 118.978 0.808 . . . . 74.109999999999999 111.5 174.713 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 25.4 tttp -130.45 33.68 4.26 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.559 1.543 . . . . 74.129999999999995 109.937 176.486 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 6.2 mtpm? . . . . . 0 C--O 1.25 1.102 0 C-N-CA 127.016 2.126 . . . . 64.120000000000005 108.616 -162.364 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.984 0 N-CA-C 108.441 -1.864 . . . . 73.409999999999997 108.441 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -108.53 69.17 0.71 Allowed 'General case' 0 CA--C 1.512 -0.483 0 N-CA-C 106.969 -1.493 . . . . 74.530000000000001 106.969 -146.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -81.55 8.92 8.43 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-N 112.757 -2.02 . . . . 50.409999999999997 114.835 -161.512 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 42.7 m-85 -134.18 167.03 21.41 Favored 'General case' 0 N--CA 1.442 -0.854 0 C-N-CA 124.803 1.241 . . . . 75.349999999999994 108.641 -164.015 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 94.2 m -134.2 141.24 46.97 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 108.451 -0.944 . . . . 63.549999999999997 108.451 173.698 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -70.28 143.58 52.03 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-O 122.069 0.938 . . . . 63.530000000000001 110.055 175.071 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 61.46 16.0 48.28 Favored Glycine 0 CA--C 1.529 0.917 0 C-N-CA 124.898 1.237 . . . . 51.439999999999998 112.762 -166.27 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 8.1 ttmt -118.4 -85.23 0.65 Allowed 'General case' 0 CA--C 1.517 -0.31 0 N-CA-C 105.879 -1.897 . . . . 61.43 105.879 172.047 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.434 ' HB3' HD11 ' A' ' 178' ' ' LEU . 38.4 mp0 -75.6 -21.97 57.32 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 118.675 0.67 . . . . 73.450000000000003 112.462 -179.505 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 47.9 p90 -159.78 176.0 12.47 Favored 'General case' 0 CA--C 1.52 -0.179 0 O-C-N 121.477 -0.765 . . . . 64.099999999999994 110.726 -170.654 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 44.3 t -140.68 96.05 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 N-CA-C 108.534 -0.913 . . . . 70.010000000000005 108.534 -170.795 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.39 146.18 27.81 Favored 'General case' 0 C--O 1.237 0.402 0 O-C-N 121.089 -1.007 . . . . 60.310000000000002 110.677 177.863 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -100.68 146.46 27.17 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 114.467 -1.242 . . . . 74.319999999999993 108.192 -170.675 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.8 p -81.85 -23.77 36.2 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 125.569 1.547 . . . . 54.109999999999999 111.12 179.674 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 69.3 m -115.27 84.32 11.35 Favored Pre-proline 0 N--CA 1.455 -0.18 0 C-N-CA 124.783 1.233 . . . . 75.0 109.587 -178.711 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -75.01 174.75 12.25 Favored 'Trans proline' 0 N--CA 1.451 -0.995 0 C-N-CA 122.113 1.875 . . . . 75.400000000000006 112.288 -178.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 20.7 t -130.2 130.46 23.06 Favored Pre-proline 0 CA--C 1.534 0.342 0 CA-C-N 114.937 -1.029 . . . . 44.409999999999997 108.714 -173.265 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -76.73 175.91 10.78 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 124.277 3.318 . . . . 72.099999999999994 112.865 178.04 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 19.4 m -120.25 168.56 12.48 Favored 'Isoleucine or valine' 0 C--O 1.24 0.567 0 C-N-CA 126.366 1.866 . . . . 75.219999999999999 110.264 173.661 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 38.9 m -54.91 -53.01 61.02 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 126.664 1.986 . . . . 74.129999999999995 110.777 174.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 3.5 mm-40 -141.58 144.27 32.74 Favored Pre-proline 0 N--CA 1.451 -0.392 0 N-CA-C 106.564 -1.643 . . . . 74.230000000000004 106.564 178.838 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -71.51 165.01 33.81 Favored 'Trans proline' 0 N--CA 1.447 -1.224 0 C-N-CA 121.269 1.313 . . . . 64.150000000000006 109.156 162.557 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 159.57 -35.04 0.47 Allowed Glycine 0 CA--C 1.519 0.329 0 CA-C-O 119.547 -0.585 . . . . 63.340000000000003 112.784 167.393 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -129.71 163.58 25.85 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.581 1.553 . . . . 75.329999999999998 109.707 162.463 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.435 HD12 ' HB3' ' A' ' 186' ' ' GLU . 28.2 mm -66.31 126.34 25.46 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 N-CA-C 106.467 -1.679 . . . . 50.409999999999997 106.467 168.43 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -89.3 123.45 33.5 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 125.992 1.717 . . . . 72.530000000000001 106.762 -176.66 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 28.3 t -123.73 135.29 63.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 108.002 -1.11 . . . . 73.450000000000003 108.002 -179.117 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 40.3 t -126.76 125.9 67.72 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.177 0 N-CA-C 108.262 -1.014 . . . . 53.149999999999999 108.262 -175.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -87.46 134.91 33.53 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 125.164 1.386 . . . . 72.310000000000002 107.769 162.676 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.2 mp -122.23 123.5 41.61 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 124.715 1.206 . . . . 73.530000000000001 108.354 165.823 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -131.8 171.59 13.33 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.754 1.622 . . . . 72.010000000000005 110.979 -169.452 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 27.3 t90 -147.22 168.92 20.49 Favored 'General case' 0 CA--C 1.537 0.452 0 O-C-N 120.86 -1.15 . . . . 74.030000000000001 109.46 168.038 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 14.6 t80 -60.77 -53.51 56.5 Favored 'General case' 0 N--CA 1.461 0.076 0 C-N-CA 126.062 1.745 . . . . 74.120000000000005 111.425 174.292 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -68.66 -84.41 0.13 Allowed Glycine 0 C--N 1.336 0.575 0 N-CA-C 110.697 -0.961 . . . . 55.439999999999998 110.697 -159.759 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 14.5 t 42.54 71.93 1.27 Allowed Pre-proline 0 CA--C 1.533 0.289 0 C-N-CA 125.961 1.704 . . . . 53.240000000000002 113.415 149.163 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -67.3 3.42 1.7 Allowed 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 122.264 1.976 . . . . 72.420000000000002 113.71 -176.096 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 18.7 m170 -108.66 -28.98 8.96 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 119.857 1.208 . . . . 71.329999999999998 111.978 173.062 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 85.7 m -60.27 -46.32 90.24 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 119.545 1.066 . . . . 33.240000000000002 109.754 -175.118 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 32.7 t80 -66.62 -22.13 66.12 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 121.085 -1.009 . . . . 73.239999999999995 112.187 -178.329 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -74.64 -3.54 31.85 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 120.931 -1.106 . . . . 34.340000000000003 112.782 175.023 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.425 ' CG ' HD11 ' A' ' 166' ' ' ILE . 15.6 t80 -121.82 -25.14 5.08 Favored 'General case' 0 C--O 1.226 -0.171 0 C-N-CA 125.372 1.469 . . . . 65.0 112.511 -168.913 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 56.9 mm-40 -42.39 -63.23 0.96 Allowed Pre-proline 0 CA--C 1.539 0.553 0 C-N-CA 124.253 1.021 . . . . 73.040000000000006 112.403 -177.719 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -73.3 -8.73 22.34 Favored 'Trans proline' 0 N--CA 1.46 -0.445 0 CA-C-N 122.535 1.941 . . . . 74.099999999999994 114.966 -177.651 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.4 m -70.8 -44.91 65.63 Favored 'General case' 0 CA--C 1.543 0.708 0 O-C-N 121.034 -1.042 . . . . 74.329999999999998 108.525 166.293 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 12.9 tt -94.78 -36.02 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 C-N-CA 123.86 0.864 . . . . 73.409999999999997 112.418 -165.86 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 41.9 t -46.8 -58.85 6.09 Favored Pre-proline 0 CA--C 1.538 0.493 0 C-N-CA 125.691 1.596 . . . . 74.530000000000001 110.443 176.001 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -72.53 -25.51 17.72 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 121.646 1.564 . . . . 71.540000000000006 112.929 -178.523 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.457 ' CG ' HD22 ' A' ' 176' ' ' LEU . 79.6 t90 -60.24 -52.01 67.11 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 119.757 1.162 . . . . 74.400000000000006 109.014 173.315 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.2 t -55.88 -42.8 76.46 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.321 0.648 . . . . 64.200000000000003 110.522 177.209 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 90.0 mt-10 -64.05 -10.34 21.52 Favored 'General case' 0 N--CA 1.468 0.474 0 O-C-N 121.207 -0.933 . . . . 62.030000000000001 113.352 -179.714 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 19.3 mmmt -122.49 8.48 9.58 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 126.116 1.767 . . . . 74.129999999999995 112.277 -171.712 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 25.2 mt -64.73 153.59 87.39 Favored Pre-proline 0 C--O 1.24 0.566 0 C-N-CA 125.029 1.331 . . . . 74.409999999999997 111.177 177.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -74.54 167.25 27.56 Favored 'Trans proline' 0 N--CA 1.448 -1.154 0 C-N-CA 124.658 3.572 . . . . 73.049999999999997 110.494 179.662 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -73.12 -2.19 20.45 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.385 1.474 . . . . 73.430000000000007 113.349 -175.419 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -101.75 8.29 41.55 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.01 1.324 . . . . 64.040000000000006 111.15 177.874 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 60.8 t -124.58 155.13 32.47 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 C-N-CA 124.521 1.128 . . . . 64.319999999999993 108.766 -177.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 63.9 t60 -139.27 123.72 18.26 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 126.903 2.081 . . . . 72.019999999999996 106.333 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 47.4 t80 -107.97 139.4 42.65 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 108.079 -1.082 . . . . 60.030000000000001 108.079 -176.82 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 25.9 t -135.2 153.75 34.61 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 N-CA-C 105.511 -2.033 . . . . 75.230000000000004 105.511 -177.48 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -127.86 140.16 52.19 Favored 'General case' 0 CA--C 1.512 -0.512 0 N-CA-C 105.341 -2.096 . . . . 75.299999999999997 105.341 167.44 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 97.5 mt -138.54 144.46 42.45 Favored Pre-proline 0 C--N 1.326 -0.416 0 N-CA-C 108.829 -0.804 . . . . 71.420000000000002 108.829 174.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -71.6 148.25 53.05 Favored 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 121.526 1.484 . . . . 72.450000000000003 110.913 178.098 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -93.28 86.53 5.34 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 124.962 1.305 . . . . 74.530000000000001 108.362 -178.019 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 46.8 mt -80.86 65.45 6.01 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 121.006 -1.059 . . . . 65.129999999999995 112.601 -169.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 13.0 m-85 -80.02 27.2 0.32 Allowed 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 115.111 1.523 . . . . 64.120000000000005 115.111 -168.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 66.54 -168.32 35.48 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 109.217 -1.553 . . . . 63.200000000000003 109.217 -166.572 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 56.15 -151.03 23.03 Favored Glycine 0 CA--C 1.526 0.747 0 CA-C-N 117.848 0.824 . . . . 64.25 111.34 178.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 9.6 tp -70.45 -12.04 15.65 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 N-CA-C 112.471 0.545 . . . . 74.200000000000003 112.471 173.162 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 9.4 m95 -64.42 -36.16 83.24 Favored 'General case' 0 C--O 1.224 -0.266 0 O-C-N 120.004 -1.685 . . . . 62.509999999999998 112.178 -171.338 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 11.5 p30 -76.54 -28.34 56.27 Favored 'General case' 0 CA--C 1.518 -0.254 0 N-CA-C 113.051 0.76 . . . . 73.430000000000007 113.051 177.754 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 94.2 t -65.61 -51.69 59.79 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 N-CA-C 107.21 -1.404 . . . . 63.229999999999997 107.21 172.281 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 59.0 m170 -79.1 54.18 1.58 Allowed 'General case' 0 C--O 1.239 0.505 0 C-N-CA 125.493 1.517 . . . . 72.230000000000004 111.446 172.497 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -164.82 -29.28 0.02 OUTLIER Glycine 0 N--CA 1.445 -0.752 0 CA-C-N 115.485 -0.78 . . . . 62.32 112.717 156.046 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -62.32 -25.78 68.07 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 119.314 1.557 . . . . 64.329999999999998 114.045 -173.701 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 40.3 ttp -53.3 -40.12 64.53 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 124.358 1.063 . . . . 52.020000000000003 112.546 -177.404 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -58.47 -47.1 85.15 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 125.074 1.349 . . . . 72.120000000000005 108.523 178.466 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 15.5 mt -68.81 -34.69 75.93 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-O 116.487 -1.721 . . . . 72.109999999999999 111.095 -178.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.642 HG22 HG23 ' A' ' 128' ' ' THR . 0.0 OUTLIER -63.73 -45.12 91.33 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 121.761 2.073 . . . . 75.129999999999995 111.335 174.509 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -52.53 -60.6 3.04 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.454 1.102 . . . . 62.399999999999999 108.723 -176.892 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -67.19 -27.56 67.37 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.26 1.024 . . . . 71.439999999999998 110.043 -174.696 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.0 t -51.68 -39.86 59.04 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 124.52 1.128 . . . . 45.310000000000002 111.621 176.553 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 44.7 mtm -71.53 -11.6 60.95 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 118.761 0.71 . . . . 64.310000000000002 112.439 -176.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 81.8 25.4 53.19 Favored Glycine 0 CA--C 1.527 0.831 0 CA-C-N 118.862 0.756 . . . . 71.099999999999994 112.402 -178.707 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 17.4 m -49.79 153.31 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 C-N-CA 125.632 1.573 . . . . 74.450000000000003 112.111 173.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -132.05 23.15 4.53 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 126.513 1.925 . . . . 62.140000000000001 111.458 -176.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 3.2 t-160 -55.09 121.1 8.02 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 125.592 1.557 . . . . 72.109999999999999 107.554 170.023 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.74 121.26 15.57 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 108.728 -0.841 . . . . 75.25 108.728 -179.121 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 70.8 t 62.13 167.44 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.081 0 C-N-CA 125.218 1.407 . . . . 60.020000000000003 112.057 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 53.1 p-80 -132.07 9.45 4.48 Favored 'General case' 0 N--CA 1.465 0.289 0 O-C-N 120.131 -1.606 . . . . 64.519999999999996 114.911 -167.578 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -50.73 -60.89 2.58 Favored 'General case' 0 C--O 1.217 -0.645 0 C-N-CA 124.938 1.295 . . . . 73.239999999999995 109.016 177.183 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -56.52 -17.56 8.79 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 120.874 1.67 . . . . 71.25 114.986 -174.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 25.6 t -73.36 -66.43 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 CA-C-N 119.895 1.225 . . . . 63.130000000000003 108.805 167.738 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -60.0 -36.98 78.35 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.261 1.025 . . . . 71.040000000000006 110.776 -175.748 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -60.15 -35.55 75.57 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 125.382 1.473 . . . . 62.520000000000003 110.745 176.738 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.428 ' HB2' ' CZ ' ' A' ' 114' ' ' PHE . . . -65.22 -22.18 66.85 Favored 'General case' 0 CA--C 1.534 0.338 0 O-C-N 121.163 -0.961 . . . . 63.130000000000003 112.053 176.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 55.5 mt -87.34 -60.01 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.884 0 N-CA-C 105.883 -1.895 . . . . 51.229999999999997 105.883 178.106 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 31.6 p80 -92.55 -53.64 4.11 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 115.379 1.622 . . . . 72.150000000000006 115.379 -168.228 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 34.2 mmtt -62.64 -20.4 64.75 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.238 1.015 . . . . 70.099999999999994 111.742 175.6 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -117.19 -26.2 6.86 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 118.053 -0.975 . . . . 70.420000000000002 113.148 -171.424 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 1.9 t-160 53.46 42.97 31.91 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.275 1.43 . . . . 72.099999999999994 111.994 178.631 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 25.4 mmtp -74.79 157.52 35.03 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 120.941 -1.099 . . . . 75.329999999999998 110.218 175.353 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 11.0 tttt -80.17 36.47 0.35 Allowed 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 127.872 2.469 . . . . 62.130000000000003 111.748 -173.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.403 ' HA ' ' HB3' ' A' ' 110' ' ' GLU . 24.7 mt -64.54 32.82 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 130.452 3.501 . . . . 71.540000000000006 115.182 -174.72 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -79.8 13.09 2.29 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 129.636 3.174 . . . . 60.039999999999999 113.14 178.562 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -148.04 158.53 41.74 Favored Pre-proline 0 N--CA 1.463 0.221 0 CA-C-N 119.21 0.914 . . . . 75.400000000000006 111.852 -179.628 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -67.93 -19.55 46.09 Favored 'Trans proline' 0 N--CA 1.455 -0.773 0 C-N-CA 123.225 2.617 . . . . 62.310000000000002 112.106 174.594 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -60.39 -71.19 0.14 Allowed 'General case' 0 C--O 1.22 -0.497 0 N-CA-C 107.398 -1.334 . . . . 73.030000000000001 107.398 167.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.403 ' HB3' ' HA ' ' A' ' 105' ' ' LEU . 3.7 mm-40 -51.51 -42.61 61.83 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 124.289 1.036 . . . . 73.510000000000005 112.395 -176.599 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 48.0 mtt -58.72 -57.15 14.28 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 109.67 -0.493 . . . . 74.239999999999995 109.67 179.503 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.508 ' HB1' ' HG3' ' A' ' 122' ' ' LYS . . . -65.73 -37.33 86.1 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 119.536 -0.269 . . . . 65.150000000000006 111.111 -177.627 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -60.63 -48.77 80.31 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 127.533 2.333 . . . . 72.129999999999995 110.341 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' PHE . . . . . 0.428 ' CZ ' ' HB2' ' A' ' 97' ' ' ALA . 81.4 t80 -65.72 -47.81 74.06 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 123.666 0.787 . . . . 75.120000000000005 110.698 177.109 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 66.9 mt -75.15 -13.06 60.43 Favored 'General case' 0 N--CA 1.457 -0.101 0 CA-C-O 119.051 -0.5 . . . . 74.540000000000006 111.76 -173.686 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -49.11 -53.58 20.05 Favored 'General case' 0 CA--C 1.52 -0.178 0 C-N-CA 125.099 1.36 . . . . 70.25 109.882 -174.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -72.21 7.2 8.41 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 125.453 1.501 . . . . 65.540000000000006 115.571 178.115 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 20.3 mttm -125.43 25.94 6.94 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 120.788 2.294 . . . . 63.25 111.57 -170.751 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 74.46 40.82 38.53 Favored Glycine 0 C--N 1.334 0.448 0 N-CA-C 111.142 -0.783 . . . . 74.400000000000006 111.142 -179.418 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 58.4 t -131.0 111.61 20.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 N-CA-C 107.147 -1.427 . . . . 64.109999999999999 107.147 173.363 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -70.57 136.54 49.34 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 123.993 0.917 . . . . 50.210000000000001 111.47 173.191 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.508 ' HG3' ' HB1' ' A' ' 112' ' ' ALA . 26.9 tttt -64.74 -48.25 75.27 Favored 'General case' 0 CA--C 1.516 -0.362 0 N-CA-C 109.762 -0.458 . . . . 74.329999999999998 109.762 -176.618 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 60.1 mm-40 -63.85 -39.19 93.63 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 122.775 0.43 . . . . 71.239999999999995 110.237 -174.417 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 3.9 mtpm? -75.62 -38.77 58.71 Favored 'General case' 0 CA--C 1.515 -0.376 0 N-CA-C 108.282 -1.007 . . . . 62.310000000000002 108.282 -177.373 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 87.4 t80 -57.76 -60.5 3.6 Favored 'General case' 0 N--CA 1.44 -0.925 0 O-C-N 123.794 0.684 . . . . 72.519999999999996 110.294 178.234 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 15.7 mt -65.61 -37.27 86.13 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-O 118.937 -0.554 . . . . 74.409999999999997 109.754 -175.108 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 45.6 t -60.14 -51.85 67.86 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 108.582 -0.896 . . . . 72.519999999999996 108.582 177.094 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' THR . . . . . 0.642 HG23 HG22 ' A' ' 80' ' ' THR 0.278 1.3 t -69.12 -33.12 72.97 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 119.454 1.025 . . . . 72.140000000000001 109.873 -173.792 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 53.2 t80 -51.1 -48.56 61.65 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.361 1.465 . . . . 73.510000000000005 110.664 170.14 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -95.14 17.63 13.77 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 113.213 0.82 . . . . 72.430000000000007 113.213 -179.074 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 58.0 m -107.67 172.47 6.81 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 119.772 1.169 . . . . 74.439999999999998 111.694 179.487 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -63.84 -23.84 67.51 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 115.92 -0.582 . . . . 75.5 112.338 -174.724 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -53.58 -59.87 4.04 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.671 1.189 . . . . 65.140000000000001 110.032 176.006 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.49 HD11 ' HA ' ' A' ' 80' ' ' THR . 14.2 mm -67.1 -26.21 35.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 C-N-CA 123.032 0.533 . . . . 73.040000000000006 111.605 -179.239 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 6.8 tttp -55.48 -45.45 76.99 Favored 'General case' 0 N--CA 1.464 0.225 0 O-C-N 120.938 -1.101 . . . . 72.230000000000004 109.639 171.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -72.76 -10.91 77.45 Favored Glycine 0 CA--C 1.524 0.63 0 C-N-CA 123.475 0.559 . . . . 72.219999999999999 112.009 -172.53 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 7.5 mm100 -108.66 -38.52 5.63 Favored 'General case' 0 N--CA 1.44 -0.938 0 C-N-CA 126.332 1.853 . . . . 65.040000000000006 109.357 -171.494 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -62.98 -41.91 99.69 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 118.368 -0.825 . . . . 71.109999999999999 110.332 174.0 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -67.71 -44.66 77.17 Favored 'General case' 0 CA--C 1.535 0.365 0 CA-C-N 119.137 0.881 . . . . 73.349999999999994 110.266 178.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 3.1 ttmt -63.23 -56.13 19.15 Favored 'General case' 0 N--CA 1.449 -0.475 0 O-C-N 121.034 -1.041 . . . . 74.230000000000004 111.164 -174.503 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -59.64 -33.27 71.31 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 118.029 0.377 . . . . 65.310000000000002 110.661 -176.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 2.0 tmtm? -60.1 -60.54 3.66 Favored 'General case' 0 CA--C 1.531 0.245 0 O-C-N 121.269 -0.894 . . . . 71.439999999999998 110.925 172.526 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.44 -18.79 63.0 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 119.265 0.939 . . . . 54.140000000000001 112.039 -173.727 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 45.4 mt -69.5 -54.55 13.64 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 123.96 0.904 . . . . 73.450000000000003 110.338 172.359 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -53.58 -47.37 70.2 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 119.558 1.072 . . . . 71.310000000000002 112.588 -174.337 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -62.33 -45.13 94.6 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 112.704 0.631 . . . . 65.439999999999998 112.704 175.922 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -63.21 -35.65 81.01 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 118.496 0.589 . . . . 74.340000000000003 109.88 -179.718 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 -74.19 9.2 1.72 Allowed 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 114.014 1.116 . . . . 71.140000000000001 114.014 173.029 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 60.86 19.5 9.76 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 126.294 1.838 . . . . 73.439999999999998 112.649 176.063 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 25.8 t -75.16 141.14 16.31 Favored 'Isoleucine or valine' 0 C--O 1.24 0.58 0 N-CA-C 107.996 -1.113 . . . . 52.299999999999997 107.996 -177.042 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -141.49 0.5 1.48 Allowed 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 118.846 -0.597 . . . . 75.329999999999998 112.408 173.409 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -160.12 167.96 35.63 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 108.6 -1.8 . . . . 72.329999999999998 108.6 170.532 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 30.0 m -123.88 156.03 66.08 Favored Pre-proline 0 C--O 1.238 0.473 0 C-N-CA 125.697 1.599 . . . . 71.230000000000004 107.614 176.515 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' PRO . . . . . 0.417 ' HG3' HD12 ' A' ' 166' ' ' ILE . 94.8 Cg_endo -67.33 157.92 83.53 Favored 'Cis proline' 0 N--CA 1.46 -0.447 0 O-C-N 122.607 0.793 . . . . 73.409999999999997 113.323 -2.083 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 5.1 m -154.86 136.93 14.69 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 107.989 -1.115 . . . . 74.319999999999993 107.989 171.014 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 91.8 mtp -111.13 152.92 26.44 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 107.135 -1.432 . . . . 61.240000000000002 107.135 169.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 41.0 t -138.98 128.66 31.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 N-CA-C 107.92 -1.141 . . . . 73.430000000000007 107.92 178.467 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 42.7 t -104.03 130.71 54.23 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 C-N-CA 124.371 1.069 . . . . 61.229999999999997 108.634 173.013 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 45.29 23.53 0.12 Allowed 'General case' 0 N--CA 1.464 0.264 1 C-N-CA 131.728 4.011 . . . . 61.329999999999998 114.374 177.278 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 59.41 31.33 69.91 Favored Glycine 0 CA--C 1.531 1.091 0 CA-C-O 117.69 -1.616 . . . . 52.43 113.882 -170.764 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 10.5 mtpt -131.27 -30.56 1.72 Allowed 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 119.622 1.711 . . . . 72.319999999999993 113.386 -177.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -122.16 118.59 29.0 Favored 'General case' 0 CA--C 1.519 -0.235 0 N-CA-C 107.907 -1.146 . . . . 74.239999999999995 107.907 -174.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 36.2 ttp85 -100.49 135.8 41.36 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 105.04 -2.207 . . . . 72.019999999999996 105.04 175.475 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 18.1 p90 -154.07 166.5 32.84 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 108.346 -0.983 . . . . 73.129999999999995 108.346 172.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -170.94 178.56 3.39 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.998 0.428 . . . . 75.150000000000006 110.77 -175.346 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.425 HD11 ' CG ' ' A' ' 43' ' ' PHE . 43.3 mt -55.89 -45.06 79.74 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 C-N-CA 124.904 1.282 . . . . 64.120000000000005 108.799 -179.406 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -88.32 29.4 5.68 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 126.481 1.991 . . . . 75.129999999999995 113.155 174.637 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 19.0 p -119.99 -51.16 2.24 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 107.482 -1.303 . . . . 74.140000000000001 107.482 156.315 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.414 ' HB2' HD23 ' A' ' 178' ' ' LEU . . . -66.52 -39.55 88.7 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 125.097 1.359 . . . . 64.209999999999994 112.319 -175.042 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 110.61 11.56 19.05 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 124.103 0.859 . . . . 64.340000000000003 113.48 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 159.99 170.4 24.53 Favored Glycine 0 CA--C 1.524 0.598 0 CA-C-N 119.469 1.634 . . . . 62.039999999999999 110.525 175.02 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -66.44 -42.36 10.05 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 122.019 1.813 . . . . 74.140000000000001 110.762 -175.816 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -70.1 -34.33 73.0 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 109.166 -0.679 . . . . 62.229999999999997 109.166 -177.488 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 41.7 mm-40 -67.37 -28.9 68.33 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.544 1.538 . . . . 73.109999999999999 110.472 174.056 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 23.6 m -66.0 -40.72 91.39 Favored 'General case' 0 CA--C 1.531 0.212 0 O-C-N 120.467 -1.396 . . . . 73.030000000000001 108.844 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 176' ' ' LEU . . . . . 0.457 HD22 ' CG ' ' A' ' 50' ' ' TRP . 61.1 mt -66.36 -24.48 66.51 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 119.343 0.974 . . . . 71.239999999999995 112.423 177.65 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 9.4 mttt -56.58 -54.25 48.09 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 108.564 -0.902 . . . . 74.019999999999996 108.564 168.683 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.434 HD11 ' HB3' ' A' ' 11' ' ' GLU . 2.9 mm? -68.14 -43.62 77.92 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 120.326 -0.549 . . . . 55.530000000000001 109.931 -178.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.42 -26.98 63.89 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 124.247 1.019 . . . . 70.239999999999995 112.864 -174.688 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 180' ' ' ASP . . . . . 0.406 ' HA ' HD12 ' A' ' 183' ' ' ILE . 15.8 t70 -100.69 -32.57 10.66 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 123.769 0.827 . . . . 44.509999999999998 111.474 -173.587 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 33.7 t80 -62.45 -52.01 65.24 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 124.178 0.991 . . . . 71.409999999999997 109.906 170.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 48.9 mt -55.39 -32.54 62.72 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 124.304 1.042 . . . . 73.219999999999999 112.164 -176.085 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.406 HD12 ' HA ' ' A' ' 180' ' ' ASP . 81.3 mt -54.19 -62.73 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.309 0 N-CA-C 107.857 -1.164 . . . . 44.149999999999999 107.857 174.401 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 -61.53 -37.43 83.75 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 121.193 0.52 . . . . 73.120000000000005 111.56 -171.188 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -58.14 -52.21 66.5 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.106 0.963 . . . . 43.409999999999997 109.875 179.695 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 186' ' ' GLU . . . . . 0.435 ' HB3' HD12 ' A' ' 27' ' ' ILE . 3.2 mm-40 -68.06 -42.53 80.34 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-O 121.603 0.716 . . . . 74.299999999999997 112.586 174.581 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 5.5 tpm_? -53.61 -46.72 70.53 Favored 'General case' 0 CA--C 1.516 -0.334 0 C-N-CA 125.188 1.395 . . . . 75.450000000000003 110.326 -175.09 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -61.35 -15.8 39.73 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 125.201 1.401 . . . . 63.009999999999998 112.159 -177.733 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -62.89 -26.02 68.59 Favored 'General case' 0 CA--C 1.535 0.384 0 O-C-N 121.394 -0.816 . . . . 42.210000000000001 112.247 171.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . 55.24 69.12 0.77 Allowed 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 127.351 2.26 . . . . 51.350000000000001 109.606 176.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 48.2 tttm -83.5 31.27 0.46 Allowed 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 123.82 0.848 . . . . 73.120000000000005 110.866 -168.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 17.2 pttp . . . . . 0 C--O 1.247 0.958 0 C-N-CA 126.171 1.789 . . . . 54.100000000000001 110.179 178.113 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.526 0 N-CA-C 107.974 -2.05 . . . . 73.010000000000005 107.974 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 49.39 79.4 0.08 Allowed 'General case' 0 N--CA 1.458 -0.055 0 C-N-CA 125.607 1.563 . . . . 74.310000000000002 110.049 -164.402 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -69.33 8.33 0.62 Allowed 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 125.262 1.425 . . . . 72.140000000000001 113.524 177.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -138.6 167.53 21.74 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 126.603 1.961 . . . . 64.319999999999993 108.944 -171.649 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 59.3 m -133.99 133.32 41.17 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 107.213 -1.402 . . . . 74.430000000000007 107.213 176.034 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -69.37 137.78 53.13 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 108.166 -1.05 . . . . 52.530000000000001 108.166 168.681 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 72.47 24.78 75.68 Favored Glycine 0 CA--C 1.528 0.867 0 N-CA-C 111.251 -0.74 . . . . 61.43 111.251 -167.797 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 18.4 tttm -140.4 -85.02 0.21 Allowed 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 106.81 -1.552 . . . . 74.450000000000003 106.81 171.044 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.494 ' HB3' HD21 ' A' ' 178' ' ' LEU . 13.3 mm-40 -72.92 -23.93 60.76 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 124.588 1.155 . . . . 72.409999999999997 111.044 -177.262 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 44.8 p90 -157.74 167.51 29.84 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 123.508 0.723 . . . . 62.109999999999999 109.468 -171.45 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 93.5 t -133.99 119.71 32.99 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 C-N-CA 124.321 1.048 . . . . 75.420000000000002 109.089 -179.695 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.91 161.42 30.15 Favored 'General case' 0 C--N 1.328 -0.351 0 O-C-N 120.19 -1.568 . . . . 63.200000000000003 109.633 172.307 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -119.53 108.12 14.13 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 124.022 0.929 . . . . 72.019999999999996 108.988 177.704 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.8 m -61.9 -5.64 2.23 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 124.864 1.266 . . . . 74.510000000000005 113.946 -178.81 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -121.02 84.6 39.54 Favored Pre-proline 0 N--CA 1.449 -0.483 0 N-CA-C 106.334 -1.728 . . . . 73.439999999999998 106.334 167.298 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -67.19 177.62 3.62 Favored 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 123.084 2.523 . . . . 74.329999999999998 111.129 179.625 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 36.4 t -136.8 139.67 29.61 Favored Pre-proline 0 C--N 1.327 -0.371 0 C-N-CA 124.552 1.141 . . . . 72.319999999999993 108.085 -166.546 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -76.14 177.78 8.32 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 123.0 2.466 . . . . 62.409999999999997 112.356 175.571 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 4.0 m -126.83 -174.61 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 C-N-CA 126.952 2.101 . . . . 73.120000000000005 108.301 177.164 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -66.18 -41.59 90.04 Favored 'General case' 0 CA--C 1.538 0.517 0 O-C-N 121.51 -0.744 . . . . 44.109999999999999 109.752 176.849 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 -168.12 166.04 7.52 Favored Pre-proline 0 CA--C 1.539 0.535 0 C-N-CA 127.63 2.372 . . . . 60.210000000000001 108.325 -179.127 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -61.25 167.25 9.64 Favored 'Trans proline' 0 CA--C 1.543 0.952 0 C-N-CA 122.051 1.834 . . . . 71.430000000000007 110.681 162.628 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 137.05 -64.08 0.57 Allowed Glycine 0 C--N 1.338 0.64 0 O-C-N 121.296 -0.877 . . . . 53.119999999999997 112.509 170.146 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.447 ' N ' ' HE2' ' A' ' 26' ' ' LYS . 0.2 OUTLIER -113.43 144.16 43.27 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 118.966 1.383 . . . . 74.25 107.756 176.389 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 45.4 mm -67.54 129.66 32.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 104.991 -2.226 . . . . 72.540000000000006 104.991 170.842 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -90.47 138.57 31.44 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 107.322 -1.362 . . . . 72.420000000000002 107.322 177.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 58.5 t -129.43 116.47 39.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 106.414 -1.699 . . . . 71.140000000000001 106.414 175.114 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 23.4 t -106.58 112.35 39.27 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 N-CA-C 107.891 -1.151 . . . . 72.209999999999994 107.891 -175.586 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -77.53 130.3 36.78 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 107.843 -1.169 . . . . 61.240000000000002 107.843 159.076 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.743 HD22 HG21 ' A' ' 150' ' ' VAL . 5.3 mp -114.68 130.75 56.86 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 124.236 1.014 . . . . 71.0 108.587 164.406 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 33.4 p90 -134.17 168.58 18.59 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.608 0.763 . . . . 75.099999999999994 111.255 -172.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 25.2 t90 -147.96 168.45 22.26 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 126.597 1.959 . . . . 75.049999999999997 107.691 173.414 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 2.1 m-30 -81.41 -41.13 22.36 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 109.181 -0.674 . . . . 74.230000000000004 109.181 179.301 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -76.5 21.64 2.35 Favored Glycine 0 CA--C 1.532 1.105 0 C-N-CA 124.81 1.195 . . . . 60.229999999999997 114.089 -175.547 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 51.8 t -105.0 87.23 1.79 Allowed Pre-proline 0 CA--C 1.537 0.475 0 C-N-CA 126.752 2.021 . . . . 71.5 110.391 -170.632 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -54.11 -42.61 65.59 Favored 'Trans proline' 0 CA--C 1.534 0.514 0 C-N-CA 122.387 2.058 . . . . 54.439999999999998 113.284 177.863 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 26.7 m170 -72.87 -24.16 60.82 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 119.227 0.922 . . . . 70.200000000000003 111.734 -172.737 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 99.6 m -62.57 -39.25 93.09 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.846 0.858 . . . . 60.25 110.56 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 21.8 t80 -62.67 -45.94 90.5 Favored 'General case' 0 C--N 1.341 0.229 0 C-N-CA 123.616 0.766 . . . . 72.209999999999994 111.061 -176.245 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.61 -9.97 31.61 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 112.695 0.628 . . . . 74.200000000000003 112.695 -176.056 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.437 ' HB2' HD11 ' A' ' 166' ' ' ILE . 2.6 t80 -97.97 -22.61 16.2 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 124.97 1.308 . . . . 71.430000000000007 111.267 178.013 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -44.81 -64.83 0.74 Allowed Pre-proline 0 CA--C 1.54 0.57 0 C-N-CA 125.007 1.323 . . . . 71.200000000000003 112.47 -172.069 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -69.96 -4.91 15.11 Favored 'Trans proline' 0 N--CA 1.459 -0.509 0 C-N-CA 122.1 1.867 . . . . 64.239999999999995 115.547 -176.425 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.8 m -87.12 -41.11 14.04 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 108.529 -0.915 . . . . 72.530000000000001 108.529 171.372 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 19.0 tt -84.62 -29.35 6.87 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 O-C-N 121.586 -0.696 . . . . 72.010000000000005 111.422 -174.011 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 34.8 t -48.88 -66.32 0.61 Allowed Pre-proline 0 CA--C 1.534 0.339 0 CA-C-O 117.428 -1.272 . . . . 71.430000000000007 110.84 172.126 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -58.86 -41.45 62.42 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 121.67 1.58 . . . . 75.049999999999997 110.125 -175.206 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 61.6 t90 -52.71 -57.33 10.45 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 118.519 0.599 . . . . 74.140000000000001 110.473 177.095 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 78.1 p -59.96 -34.61 73.49 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.272 0.629 . . . . 73.049999999999997 112.483 -177.467 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -78.67 -16.77 56.9 Favored 'General case' 0 CA--C 1.533 0.317 0 O-C-N 121.303 -0.873 . . . . 62.109999999999999 112.835 178.343 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 42.2 mmtm -106.04 2.16 27.04 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 126.089 1.756 . . . . 74.439999999999998 112.662 -178.078 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 37.2 mt -57.7 148.73 55.88 Favored Pre-proline 0 C--O 1.236 0.37 0 C-N-CA 124.397 1.079 . . . . 74.409999999999997 110.741 177.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -77.55 170.93 18.41 Favored 'Trans proline' 0 N--CA 1.443 -1.451 0 C-N-CA 124.015 3.143 . . . . 54.450000000000003 111.014 178.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -67.84 3.4 1.51 Allowed 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 115.075 1.509 . . . . 74.120000000000005 115.075 -170.812 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -118.56 1.42 11.7 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 126.94 2.096 . . . . 43.240000000000002 112.568 -177.775 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 23.1 t -120.19 123.29 70.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 CA-C-N 119.369 0.986 . . . . 51.0 109.569 -179.014 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 80.1 t60 -115.05 107.63 15.6 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 126.155 1.782 . . . . 75.430000000000007 109.663 -174.317 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 26.5 t80 -78.34 139.63 38.81 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.688 1.195 . . . . 64.140000000000001 110.762 179.744 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 88.8 t -131.51 146.61 33.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 C-N-CA 127.698 2.399 . . . . 75.549999999999997 106.681 -178.132 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 29.7 mtt-85 -131.63 120.03 22.25 Favored 'General case' 0 CA--C 1.508 -0.669 0 N-CA-C 106.929 -1.508 . . . . 65.030000000000001 106.929 -177.58 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 75.2 mt -129.93 148.68 70.57 Favored Pre-proline 0 C--N 1.325 -0.464 0 O-C-N 123.419 0.45 . . . . 74.140000000000001 112.187 179.677 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -75.87 134.77 16.77 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 122.8 2.333 . . . . 71.219999999999999 110.457 177.55 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -75.97 108.7 9.03 Favored 'General case' 0 CA--C 1.535 0.395 0 O-C-N 121.477 -0.764 . . . . 71.019999999999996 109.059 170.155 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 49.5 mt -103.03 94.19 5.42 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 127.165 2.186 . . . . 72.140000000000001 108.548 -179.533 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -130.8 43.53 3.09 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 119.221 0.918 . . . . 64.450000000000003 112.21 -175.826 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.452 ' H ' ' ND2' ' A' ' 72' ' ' ASN . . . 74.63 164.23 11.35 Favored Glycine 0 CA--C 1.522 0.525 0 C-N-CA 124.767 1.175 . . . . 74.510000000000005 112.358 175.41 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 52.33 -144.11 20.45 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.416 -1.073 . . . . 73.319999999999993 110.416 -175.708 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 4.8 tp -64.4 -15.12 16.9 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 CA-C-O 118.093 -0.955 . . . . 73.239999999999995 111.431 -172.279 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 19.7 m95 -59.81 -33.59 71.93 Favored 'General case' 0 C--N 1.342 0.275 0 CA-C-N 120.732 1.605 . . . . 73.25 111.139 173.126 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.452 ' ND2' ' H ' ' A' ' 68' ' ' GLY . 7.3 m-80 -80.52 -32.32 36.9 Favored 'General case' 0 C--N 1.339 0.147 0 CA-C-N 118.766 0.712 . . . . 73.319999999999993 111.708 177.137 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 70.5 t -68.44 -58.83 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 N-CA-C 108.512 -0.922 . . . . 72.349999999999994 108.512 178.159 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 52.1 m170 -72.14 47.21 0.15 Allowed 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 126.625 1.97 . . . . 74.239999999999995 109.578 167.113 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -164.49 1.24 0.05 OUTLIER Glycine 0 CA--C 1.527 0.818 0 C-N-CA 127.055 2.264 . . . . 55.530000000000001 113.28 -176.795 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -108.2 -24.13 11.65 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 120.78 2.29 . . . . 63.109999999999999 113.23 -174.79 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 3.0 ptt? -85.14 -23.45 28.41 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 114.361 1.245 . . . . 74.219999999999999 114.361 -170.194 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 29.5 t80 -56.58 -48.68 76.87 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 119.861 1.21 . . . . 74.400000000000006 107.94 176.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 35.1 mt -60.84 -46.85 88.95 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 114.846 -1.07 . . . . 72.349999999999994 109.672 178.833 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.586 HG22 HG23 ' A' ' 128' ' ' THR . 0.2 OUTLIER -61.72 -41.94 98.29 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 119.503 1.047 . . . . 51.420000000000002 111.525 -179.837 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -54.53 -53.24 57.04 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 123.99 0.916 . . . . 74.420000000000002 108.993 -177.31 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -76.54 -24.85 53.64 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 124.645 1.178 . . . . 71.019999999999996 112.212 -176.635 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 7.7 t -55.11 -11.71 0.76 Allowed 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.629 1.572 . . . . 72.129999999999995 113.46 172.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 9.1 mtp -110.25 -10.53 14.62 Favored 'General case' 0 C--O 1.225 -0.213 0 C-N-CA 124.165 0.986 . . . . 75.519999999999996 112.799 177.745 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 64.73 37.42 94.33 Favored Glycine 0 CA--C 1.527 0.821 0 CA-C-N 119.926 1.239 . . . . 61.219999999999999 111.234 -176.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 27.1 m -57.33 -41.36 78.19 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 C-N-CA 123.496 0.718 . . . . 62.520000000000003 111.11 175.469 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 51.48 75.25 0.21 Allowed 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 126.449 1.9 . . . . 72.450000000000003 110.293 173.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 54.7 m170 -71.02 -72.11 0.23 Allowed 'General case' 0 N--CA 1.465 0.285 0 O-C-N 121.574 -0.704 . . . . 72.299999999999997 109.581 -174.598 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 14.5 t0 -174.74 -67.1 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 128.059 2.543 . . . . 51.329999999999998 105.041 167.004 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 15.0 m -140.42 157.98 24.77 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 C-N-CA 124.126 0.971 . . . . 63.340000000000003 112.127 -173.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 32.5 m80 -73.94 100.66 3.59 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 125.907 1.683 . . . . 74.230000000000004 108.423 171.073 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -139.78 -69.14 0.41 Allowed 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 125.884 1.674 . . . . 75.409999999999997 107.55 176.222 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -66.08 -36.83 84.26 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 123.335 0.654 . . . . 61.450000000000003 111.53 -166.797 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 82.7 t -62.0 -35.19 67.03 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.379 0 N-CA-C 109.468 -0.567 . . . . 75.420000000000002 109.468 175.676 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -80.44 -46.97 15.07 Favored 'General case' 0 CA--C 1.527 0.062 0 CA-C-N 119.738 1.154 . . . . 73.510000000000005 109.908 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.413 ' OE1' ' HE3' ' A' ' 100' ' ' LYS . 13.4 mm-40 -50.99 -38.13 49.15 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.715 1.606 . . . . 73.310000000000002 110.251 178.855 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.4 ' HA ' ' HB2' ' A' ' 101' ' ' GLU . . . -75.56 -14.71 60.41 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.75 1.22 . . . . 64.329999999999998 113.826 -174.659 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.424 HD13 HG21 ' A' ' 98' ' ' ILE . 51.9 mt -121.01 -24.45 2.79 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 C-N-CA 125.123 1.369 . . . . 45.450000000000003 109.307 -169.721 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -100.16 -68.3 0.82 Allowed 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 124.977 1.311 . . . . 73.120000000000005 108.419 176.87 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.413 ' HE3' ' OE1' ' A' ' 96' ' ' GLU . 0.1 OUTLIER -65.96 -32.9 74.66 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 119.601 1.091 . . . . 71.319999999999993 110.985 -177.456 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.4 ' HB2' ' HA ' ' A' ' 97' ' ' ALA . 20.3 mt-10 -112.98 -21.11 11.28 Favored 'General case' 0 CA--C 1.528 0.101 0 N-CA-C 113.53 0.937 . . . . 72.099999999999994 113.53 -170.508 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 3.2 t60 45.08 62.98 1.9 Allowed 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 125.726 1.611 . . . . 63.530000000000001 114.644 175.06 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 19.3 mmtp -77.78 158.95 29.33 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.634 1.174 . . . . 63.310000000000002 111.794 174.726 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 28.7 tttt -93.27 45.87 1.19 Allowed 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 125.089 1.356 . . . . 75.519999999999996 112.381 -172.422 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 53.6 mt -69.0 51.76 0.08 Allowed 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 131.387 3.875 . . . . 72.120000000000005 111.475 -179.545 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -98.37 1.5 47.0 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 126.232 1.813 . . . . 71.400000000000006 111.924 -177.452 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -131.52 150.62 76.87 Favored Pre-proline 0 N--CA 1.467 0.388 0 C-N-CA 124.128 0.971 . . . . 65.239999999999995 109.936 -178.483 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_exo -59.62 -42.59 45.77 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 121.675 1.583 . . . . 64.209999999999994 110.782 -176.818 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 10.5 mp0 -61.35 -38.08 85.65 Favored 'General case' 0 N--CA 1.438 -1.065 0 C-N-CA 124.447 1.099 . . . . 74.140000000000001 110.623 -179.078 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -71.42 -47.05 58.37 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 125.591 1.557 . . . . 71.0 110.369 -176.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 58.2 mtt -58.56 -55.63 32.61 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 124.609 1.164 . . . . 71.540000000000006 109.154 174.108 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -64.28 -31.12 72.2 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.825 1.25 . . . . 74.420000000000002 111.559 -175.18 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -63.6 -46.68 84.7 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 119.478 1.036 . . . . 74.329999999999998 110.955 173.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 72.0 t80 -65.71 -44.32 86.45 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 121.866 0.841 . . . . 75.140000000000001 109.972 177.403 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.447 HD23 ' HA ' ' A' ' 115' ' ' LEU . 53.0 mt -69.27 -23.94 63.9 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 124.459 1.104 . . . . 75.450000000000003 111.481 -176.904 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.81 -13.92 18.4 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 122.902 0.481 . . . . 74.140000000000001 112.2 176.401 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -110.93 3.2 28.72 Favored Glycine 0 CA--C 1.526 0.755 0 C-N-CA 124.705 1.145 . . . . 63.229999999999997 114.046 170.292 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -135.42 51.31 2.08 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 119.383 1.592 . . . . 73.200000000000003 108.847 -171.52 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 92.56 13.85 56.35 Favored Glycine 0 CA--C 1.526 0.756 0 O-C-N 124.149 0.905 . . . . 43.130000000000003 114.395 162.733 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 99.1 t -129.99 165.06 31.07 Favored 'Isoleucine or valine' 0 C--O 1.231 0.116 0 CA-C-N 118.317 1.058 . . . . 64.310000000000002 109.35 -167.876 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 45.2 t0 -129.27 130.86 46.74 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 107.36 -1.348 . . . . 74.340000000000003 107.36 174.202 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 3.3 mttp -57.23 -36.98 71.59 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 119.075 0.852 . . . . 71.030000000000001 110.571 174.103 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -61.05 -24.16 65.99 Favored 'General case' 0 C--O 1.231 0.098 0 C-N-CA 124.173 0.989 . . . . 74.109999999999999 112.209 176.747 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 88.2 mttt -102.31 -49.37 3.91 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 119.97 1.259 . . . . 63.130000000000003 108.465 -177.598 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 68.4 t80 -48.92 -61.96 1.78 Allowed 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 126.331 1.852 . . . . 72.120000000000005 111.953 -178.716 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 15.9 mt -66.66 -31.63 72.42 Favored 'General case' 0 CA--C 1.534 0.352 0 O-C-N 121.486 -0.759 . . . . 75.200000000000003 110.475 -172.651 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 34.3 t -61.57 -50.4 72.79 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 124.299 1.04 . . . . 54.229999999999997 109.128 179.017 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' THR . . . . . 0.586 HG23 HG22 ' A' ' 80' ' ' THR 0.272 0.0 OUTLIER -70.15 -34.76 73.43 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 119.164 0.893 . . . . 71.209999999999994 110.332 178.264 . . . . . . . . 4 4 . 1 . 005 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 49.2 t80 -54.96 -55.29 32.36 Favored 'General case' 0 CA--C 1.529 0.17 0 O-C-N 121.592 -0.693 . . . . 74.420000000000002 110.422 179.648 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 -94.16 49.66 1.33 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.4 0.68 . . . . 74.219999999999999 109.294 176.661 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -123.2 164.15 19.26 Favored 'General case' 0 C--O 1.241 0.626 0 C-N-CA 125.626 1.57 . . . . 51.140000000000001 109.322 170.678 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.17 -30.96 70.72 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-O 119.293 -0.384 . . . . 74.049999999999997 110.464 178.446 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -45.3 -66.92 0.33 Allowed 'General case' 0 C--O 1.234 0.264 0 C-N-CA 124.97 1.308 . . . . 70.349999999999994 110.959 176.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 8.0 mm -64.54 -32.82 59.39 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 CA-C-O 118.56 -0.733 . . . . 75.030000000000001 111.21 -178.134 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 10.5 mttp -57.87 -35.35 70.84 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 119.1 0.863 . . . . 72.400000000000006 110.617 174.627 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -82.65 -31.78 29.09 Favored Glycine 0 C--N 1.339 0.695 0 CA-C-O 122.583 1.101 . . . . 72.439999999999998 110.696 -175.112 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 2.8 mm100 -74.51 -39.86 62.14 Favored 'General case' 0 N--CA 1.45 -0.46 0 O-C-N 121.539 -0.977 . . . . 75.540000000000006 109.835 -176.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 9.3 mtp -60.63 -51.26 70.15 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 119.069 -0.491 . . . . 65.209999999999994 110.379 174.102 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -63.64 -29.16 70.44 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 118.86 0.754 . . . . 73.409999999999997 112.435 -174.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 14.7 mtmt -61.47 -75.15 0.07 Allowed 'General case' 0 CA--C 1.522 -0.102 0 N-CA-C 107.86 -1.163 . . . . 74.109999999999999 107.86 165.681 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -49.12 -35.07 15.44 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.228 1.011 . . . . 74.430000000000007 112.619 -169.326 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 9.9 tmtt? -58.02 -46.94 84.48 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 126.301 1.84 . . . . 72.209999999999994 112.366 177.357 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 9.5 ptpp? -77.79 -33.44 52.59 Favored 'General case' 0 C--N 1.34 0.176 0 CA-C-N 120.824 1.647 . . . . 62.340000000000003 111.199 173.573 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 41.5 mt -59.35 -46.21 89.27 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 119.032 0.833 . . . . 71.239999999999995 109.973 -174.151 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -58.67 -37.03 75.12 Favored 'General case' 0 CA--C 1.534 0.349 0 O-C-N 121.814 -0.554 . . . . 60.530000000000001 111.592 -178.357 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 1.1 mtm -76.8 -31.85 57.25 Favored 'General case' 0 C--O 1.23 0.044 0 O-C-N 122.138 -0.352 . . . . 64.319999999999993 110.857 179.407 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -56.46 -46.24 80.47 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 108.82 -0.808 . . . . 75.450000000000003 108.82 172.622 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 35.8 m-85 -76.74 10.16 2.38 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 114.175 1.176 . . . . 75.239999999999995 114.175 177.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 59.1 23.47 11.69 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 127.562 2.345 . . . . 54.119999999999997 113.98 176.004 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.814 HG22 HG21 ' A' ' 155' ' ' THR . 66.4 t -67.05 133.97 30.76 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 C-N-CA 124.031 0.932 . . . . 71.200000000000003 108.653 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -130.49 -5.65 4.21 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 125.244 1.418 . . . . 75.319999999999993 113.132 -177.641 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 170.98 139.51 2.78 Favored Glycine 0 N--CA 1.448 -0.541 0 N-CA-C 107.666 -2.173 . . . . 64.239999999999995 107.666 174.174 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.429 ' HA ' ' C ' ' A' ' 154' ' ' PRO . 17.2 m -83.37 152.72 64.84 Favored Pre-proline 0 CA--C 1.534 0.364 0 C-N-CA 124.559 1.144 . . . . 70.439999999999998 109.647 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' PRO . . . . . 0.486 ' HG3' HD12 ' A' ' 166' ' ' ILE . 53.7 Cg_endo -70.74 157.71 94.59 Favored 'Cis proline' 0 CA--C 1.531 0.359 0 C-N-CA 125.15 -0.771 . . . . 75.349999999999994 113.623 3.405 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 155' ' ' THR . . . . . 0.814 HG21 HG22 ' A' ' 150' ' ' VAL . 36.5 m -157.13 115.17 3.19 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 107.461 -1.311 . . . . 71.010000000000005 107.461 175.338 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 93.7 mtp -96.3 158.24 15.53 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 108.705 -0.85 . . . . 75.530000000000001 108.705 164.01 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 5.2 t -136.48 138.47 46.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 106.586 -1.635 . . . . 74.129999999999995 106.586 174.365 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.54 HG23 ' CE1' ' A' ' 164' ' ' PHE . 51.2 t -103.18 125.22 57.66 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 N-CA-C 106.734 -1.58 . . . . 74.209999999999994 106.734 164.184 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 9.4 t30 52.98 21.54 2.08 Favored 'General case' 0 N--CA 1.462 0.153 0 C-N-CA 130.89 3.676 . . . . 72.150000000000006 115.521 162.112 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 73.34 22.62 78.57 Favored Glycine 0 CA--C 1.526 0.72 0 CA-C-O 117.69 -1.617 . . . . 51.210000000000001 114.068 -176.415 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 10.4 mtpt -134.18 -24.4 1.64 Allowed 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 120.248 2.024 . . . . 72.409999999999997 113.122 -174.828 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -128.2 120.2 26.78 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 124.179 0.991 . . . . 74.120000000000005 109.033 -173.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 41.5 ttp85 -102.56 126.83 49.76 Favored 'General case' 0 CA--C 1.52 -0.178 0 C-N-CA 126.117 1.767 . . . . 71.230000000000004 107.886 174.63 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' PHE . . . . . 0.54 ' CE1' HG23 ' A' ' 158' ' ' VAL . 13.4 p90 -145.28 174.0 11.48 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 107.277 -1.379 . . . . 73.530000000000001 107.277 177.375 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 174.89 -175.25 0.08 Allowed 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 125.437 1.495 . . . . 63.409999999999997 108.595 176.423 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.486 HD12 ' HG3' ' A' ' 154' ' ' PRO . 6.5 mt -45.58 -52.27 2.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 C-N-CA 129.901 3.281 . . . . 63.200000000000003 108.574 172.624 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -75.61 19.28 2.6 Favored Glycine 0 CA--C 1.524 0.641 0 C-N-CA 128.062 2.744 . . . . 74.120000000000005 114.911 176.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 19.2 m -129.27 -50.1 1.19 Allowed 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 119.315 1.557 . . . . 62.100000000000001 110.847 157.594 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -71.16 -19.56 62.4 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.691 0.797 . . . . 72.439999999999998 111.944 -174.68 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 103.44 4.14 46.83 Favored Glycine 0 CA--C 1.525 0.66 0 O-C-N 120.624 -1.298 . . . . 62.350000000000001 113.296 175.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 171' ' ' GLY . . . . . 0.438 ' HA2' HG23 ' A' ' 166' ' ' ILE . . . 154.03 177.06 27.07 Favored Glycine 0 CA--C 1.53 0.981 0 CA-C-N 119.239 1.52 . . . . 63.530000000000001 111.268 172.339 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -65.07 -37.51 32.55 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 122.851 2.367 . . . . 65.230000000000004 113.38 -169.318 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -69.37 -42.32 75.37 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 119.454 1.025 . . . . 74.510000000000005 108.413 -178.297 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 51.2 mm-40 -66.03 -26.89 67.73 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.685 1.194 . . . . 64.430000000000007 110.235 179.308 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 46.0 m -64.36 -41.34 96.77 Favored 'General case' 0 CA--C 1.534 0.354 0 O-C-N 120.075 -1.641 . . . . 64.540000000000006 110.638 -178.276 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 36.9 mt -65.88 -32.04 73.32 Favored 'General case' 0 C--N 1.341 0.203 0 CA-C-N 119.061 0.846 . . . . 72.120000000000005 110.532 175.708 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.03 -39.8 69.53 Favored 'General case' 0 CA--C 1.522 -0.127 0 C-N-CA 124.903 1.281 . . . . 70.230000000000004 109.535 174.833 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.494 HD21 ' HB3' ' A' ' 11' ' ' GLU . 4.5 mm? -78.21 -41.48 34.33 Favored 'General case' 0 CA--C 1.505 -0.763 0 CA-C-O 117.638 -1.172 . . . . 70.099999999999994 111.076 173.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -55.63 -45.97 77.49 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 119.52 1.055 . . . . 55.350000000000001 109.889 -172.828 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.93 -37.6 55.01 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 125.204 1.401 . . . . 55.530000000000001 109.519 -167.643 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 12.9 t80 -67.78 -47.8 68.13 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.512 1.125 . . . . 65.329999999999998 111.253 173.181 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 78.8 mt -63.33 -35.88 81.85 Favored 'General case' 0 C--O 1.232 0.169 0 C-N-CA 123.889 0.876 . . . . 64.439999999999998 110.83 -176.563 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 34.7 mt -53.31 -54.61 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 CA-C-O 118.338 -0.839 . . . . 73.319999999999993 109.181 170.275 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -55.92 -41.78 75.08 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 119.554 1.07 . . . . 73.129999999999995 111.553 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.86 -55.72 27.34 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 125.157 1.383 . . . . 74.450000000000003 108.267 -179.363 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 26.4 mm-40 -71.38 -32.74 68.82 Favored 'General case' 0 C--O 1.225 -0.186 0 C-N-CA 124.514 1.125 . . . . 73.340000000000003 113.094 -178.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.91 -24.52 62.46 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 120.762 -1.211 . . . . 44.409999999999997 111.719 -178.905 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -59.11 -23.75 62.38 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.302 0.641 . . . . 71.120000000000005 111.928 171.725 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -54.68 -22.06 12.6 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.327 1.051 . . . . 73.299999999999997 112.463 169.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -119.04 -7.96 10.28 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 113.721 1.008 . . . . 61.439999999999998 113.721 168.616 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 23.3 ttmt -101.03 51.1 0.86 Allowed 'General case' 0 CA--C 1.536 0.419 0 O-C-N 120.513 -1.367 . . . . 74.120000000000005 110.698 -172.782 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.159 0 C-N-CA 127.694 2.398 . . . . 73.420000000000002 111.981 177.199 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.929 0 N-CA-C 108.668 -1.773 . . . . 73.239999999999995 108.668 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 178.19 142.18 0.1 Allowed 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 129.118 2.967 . . . . 65.510000000000005 103.341 -159.533 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -143.03 6.87 1.58 Allowed 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.527 0.679 . . . . 61.43 111.723 -166.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 -132.87 178.96 6.47 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.561 1.144 . . . . 71.340000000000003 109.619 -168.422 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.0 m -148.05 141.93 25.78 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.588 1.555 . . . . 71.030000000000001 109.467 175.313 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.98 137.28 56.4 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 124.338 1.055 . . . . 72.329999999999998 110.043 178.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.7 -17.4 15.54 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 125.959 1.742 . . . . 21.530000000000001 112.76 -171.625 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 4.4 ttmt -92.86 -86.47 0.25 Allowed 'General case' 0 CA--C 1.519 -0.218 0 CA-C-N 119.028 1.414 . . . . 63.109999999999999 107.783 -176.226 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.422 ' HB3' HD21 ' A' ' 178' ' ' LEU . 0.4 OUTLIER -77.53 -21.34 52.77 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.627 0.771 . . . . 63.210000000000001 110.364 -175.354 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 14.0 p90 -161.51 175.95 11.59 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.784 1.234 . . . . 64.109999999999999 109.296 -175.196 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 41.3 t -135.05 154.41 36.21 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.811 0 C-N-CA 126.377 1.871 . . . . 63.5 108.321 -175.744 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -103.88 170.59 7.84 Favored 'General case' 0 CA--C 1.521 -0.164 0 O-C-N 119.649 -1.907 . . . . 51.350000000000001 109.63 166.209 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -128.56 113.22 15.18 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 106.956 -1.498 . . . . 73.329999999999998 106.956 169.848 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.4 m -58.43 -15.06 9.27 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 117.129 -1.415 . . . . 73.209999999999994 113.744 176.834 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.6 m -107.96 75.91 0.56 Allowed Pre-proline 0 C--N 1.343 0.307 0 CA-C-N 120.526 1.512 . . . . 41.539999999999999 110.179 169.65 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -71.54 174.46 10.92 Favored 'Trans proline' 0 N--CA 1.444 -1.386 0 C-N-CA 123.19 2.594 . . . . 70.120000000000005 110.241 178.644 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 64.7 t -139.26 125.76 12.51 Favored Pre-proline 0 C--N 1.323 -0.583 0 N-CA-C 107.042 -1.466 . . . . 53.219999999999999 107.042 -165.433 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -73.78 174.84 11.62 Favored 'Trans proline' 0 N--CA 1.453 -0.892 0 C-N-CA 122.646 2.231 . . . . 75.540000000000006 110.897 178.831 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 34.0 m -139.39 -174.03 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 C-N-CA 124.645 1.178 . . . . 64.329999999999998 109.404 178.858 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 15.2 t -48.19 -68.89 0.14 Allowed 'General case' 0 N--CA 1.442 -0.852 0 C-N-CA 128.17 2.588 . . . . 73.349999999999994 110.458 172.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -152.94 163.47 23.4 Favored Pre-proline 0 CA--C 1.534 0.354 0 C-N-CA 124.399 1.08 . . . . 52.32 110.297 174.36 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -78.79 -7.1 15.51 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 124.058 3.172 . . . . 64.319999999999993 113.095 177.682 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -58.15 -37.29 85.85 Favored Glycine 0 C--N 1.338 0.667 0 C-N-CA 125.537 1.541 . . . . 71.109999999999999 113.605 -170.362 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 28.2 mttp -119.32 124.58 46.99 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 126.388 1.875 . . . . 73.230000000000004 106.087 165.389 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 44.7 mm -54.98 136.26 17.23 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 N-CA-C 106.931 -1.507 . . . . 51.119999999999997 106.931 168.2 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -104.4 93.12 4.63 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 106.425 -1.695 . . . . 71.450000000000003 106.425 -176.112 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 26.6 t -88.31 135.86 24.62 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 N-CA-C 106.624 -1.621 . . . . 74.510000000000005 106.624 174.479 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 33.6 t -129.31 135.84 60.83 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 N-CA-C 107.243 -1.392 . . . . 61.210000000000001 107.243 -176.813 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 15.9 tm-20 -114.0 140.57 48.32 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 125.133 1.373 . . . . 72.010000000000005 107.699 167.063 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.4 mp -130.76 114.72 15.7 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 124.615 1.166 . . . . 70.540000000000006 108.466 -179.54 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 18.9 p90 -107.36 174.85 5.7 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 124.603 1.161 . . . . 74.299999999999997 111.931 -176.542 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 22.6 t90 -145.34 162.01 38.27 Favored 'General case' 0 C--O 1.225 -0.219 0 C-N-CA 125.068 1.347 . . . . 72.5 107.999 162.837 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 59.8 t80 -56.7 -42.43 79.1 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 126.062 1.745 . . . . 75.519999999999996 112.121 172.756 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -95.39 29.73 9.2 Favored Glycine 0 CA--C 1.531 1.089 0 O-C-N 120.938 -1.101 . . . . 61.340000000000003 113.665 -168.455 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 23.3 t -106.03 81.87 0.82 Allowed Pre-proline 0 CA--C 1.537 0.472 0 C-N-CA 130.474 3.51 . . . . 74.239999999999995 111.528 -173.191 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -79.14 62.02 8.35 Favored 'Trans proline' 0 CA--C 1.544 1.023 0 C-N-CA 121.694 1.596 . . . . 74.239999999999995 111.482 -177.457 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 2.4 m80 -160.35 -49.99 0.05 OUTLIER 'General case' 0 C--O 1.226 -0.182 0 C-N-CA 126.123 1.769 . . . . 74.420000000000002 109.095 -178.678 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 1.1 p -61.52 -37.36 83.45 Favored 'General case' 0 CA--C 1.548 0.872 0 CA-C-O 121.769 0.795 . . . . 74.129999999999995 110.339 -173.036 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -61.76 -29.15 69.94 Favored 'General case' 0 N--CA 1.468 0.465 0 O-C-N 120.084 -1.635 . . . . 73.219999999999999 112.87 176.213 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -78.01 3.61 14.34 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.903 1.281 . . . . 51.350000000000001 111.107 177.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 24.4 t80 -125.49 -27.78 3.39 Favored 'General case' 0 C--O 1.223 -0.308 0 C-N-CA 126.781 2.033 . . . . 72.200000000000003 111.0 178.161 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -39.51 -65.76 0.39 Allowed Pre-proline 0 CA--C 1.544 0.712 0 CA-C-N 120.286 1.403 . . . . 74.439999999999998 114.638 -177.128 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -75.89 -9.05 19.43 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 CA-C-N 122.17 1.811 . . . . 73.239999999999995 114.185 -178.116 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 4.2 m -68.44 -42.68 78.51 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 108.45 -0.944 . . . . 73.129999999999995 108.45 164.517 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 19.9 tt -88.21 -34.55 7.23 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 N-CA-C 112.762 0.652 . . . . 73.030000000000001 112.762 -172.466 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 16.2 t -44.73 -54.72 12.14 Favored Pre-proline 0 CA--C 1.549 0.936 0 C-N-CA 124.409 1.084 . . . . 44.130000000000003 113.464 176.317 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -74.07 -21.35 18.23 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 121.905 1.737 . . . . 70.430000000000007 112.356 -178.136 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 86.3 t90 -66.15 -51.61 56.21 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 118.679 0.672 . . . . 72.120000000000005 109.75 170.587 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 5.1 p -67.05 -24.14 65.96 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 119.075 0.852 . . . . 73.420000000000002 112.277 -175.142 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 73.6 mt-10 -59.9 -54.7 43.08 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 120.793 -1.192 . . . . 74.109999999999999 110.302 168.451 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 54.5 mmtt -76.68 6.73 5.49 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 125.316 1.446 . . . . 50.149999999999999 113.555 -168.278 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 36.6 mt -62.28 157.15 56.29 Favored Pre-proline 0 N--CA 1.448 -0.574 0 C-N-CA 122.986 0.514 . . . . 54.030000000000001 111.268 178.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -77.72 174.88 11.93 Favored 'Trans proline' 0 N--CA 1.449 -1.117 0 C-N-CA 124.809 3.673 . . . . 63.409999999999997 110.296 173.51 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -71.26 -5.74 34.47 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.636 0.774 . . . . 73.120000000000005 112.888 177.725 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -95.66 7.88 45.03 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 123.856 0.862 . . . . 60.149999999999999 109.847 -176.205 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 22.6 t -138.76 152.75 24.8 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 N-CA-C 107.628 -1.249 . . . . 70.329999999999998 107.628 -176.046 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 41.3 t60 -137.47 162.1 34.59 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 107.332 -1.359 . . . . 54.350000000000001 107.332 165.663 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 35.1 t80 -125.99 137.74 53.69 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 124.237 1.015 . . . . 73.519999999999996 108.493 -173.59 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 52.8 t -132.44 147.84 31.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 107.421 -1.325 . . . . 63.130000000000003 107.421 -175.547 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 44.0 mtm180 -124.21 136.0 53.85 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 107.236 -1.394 . . . . 71.329999999999998 107.236 163.365 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 92.8 mt -129.7 144.91 54.84 Favored Pre-proline 0 C--N 1.328 -0.361 0 O-C-N 123.654 0.596 . . . . 53.009999999999998 109.96 172.791 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -73.9 143.83 33.65 Favored 'Trans proline' 0 N--CA 1.451 -0.984 0 C-N-CA 120.756 0.971 . . . . 75.129999999999995 109.835 175.269 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -89.28 106.31 18.36 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 126.297 1.839 . . . . 55.420000000000002 107.841 174.584 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 57.8 mt -102.83 60.09 0.79 Allowed 'General case' 0 C--O 1.237 0.417 0 C-N-CA 125.343 1.457 . . . . 73.340000000000003 111.491 -168.49 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 -88.15 -6.54 57.82 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 114.569 1.322 . . . . 71.109999999999999 114.569 -164.85 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 106.58 -173.22 19.26 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 108.548 -1.821 . . . . 34.210000000000001 108.548 -175.152 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.489 ' O ' HG22 ' A' ' 70' ' ' ILE . . . 44.39 64.79 1.91 Allowed Glycine 0 CA--C 1.528 0.904 0 CA-C-O 117.929 -1.484 . . . . 64.329999999999998 112.444 173.768 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.489 HG22 ' O ' ' A' ' 69' ' ' GLY 0.276 2.8 tt 64.96 -15.97 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 131.153 3.781 . . . . 74.530000000000001 116.192 -176.486 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 10.4 m95 -57.01 -36.83 70.86 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 121.185 1.811 . . . . 65.200000000000003 112.311 -174.256 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -73.02 -40.25 65.31 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-O 118.693 -0.67 . . . . 63.200000000000003 112.4 -178.078 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 92.3 t -57.92 -51.67 67.71 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 C-N-CA 123.605 0.762 . . . . 70.420000000000002 109.474 -175.835 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 65.4 m170 -69.23 -0.69 6.45 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.541 1.136 . . . . 65.109999999999999 113.259 178.049 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -101.19 -47.85 1.52 Allowed Glycine 0 CA--C 1.526 0.761 0 N-CA-C 109.852 -1.299 . . . . 50.130000000000003 109.852 174.616 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -53.28 -34.02 55.56 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 127.383 2.273 . . . . 75.239999999999995 114.684 -164.371 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -57.98 -42.91 86.08 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-O 117.742 -1.123 . . . . 63.119999999999997 112.443 178.469 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -55.4 -54.1 47.9 Favored 'General case' 0 CA--C 1.526 0.042 0 N-CA-C 108.639 -0.875 . . . . 74.310000000000002 108.639 -175.398 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 15.7 mt -55.74 -37.56 68.64 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.664 1.186 . . . . 64.209999999999994 110.982 177.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.456 ' HA ' HD11 ' A' ' 134' ' ' ILE . 1.3 m -73.39 -39.76 64.86 Favored 'General case' 0 C--N 1.343 0.324 0 CA-C-N 119.498 1.044 . . . . 72.230000000000004 110.588 -177.691 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 1.2 tt -56.3 -51.1 69.46 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 125.219 1.407 . . . . 64.519999999999996 108.054 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -62.19 -29.66 70.53 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.694 1.198 . . . . 73.019999999999996 110.757 177.837 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 10.4 t -65.17 -30.66 71.59 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.873 0.869 . . . . 75.120000000000005 111.351 -171.367 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 16.6 mtm -69.23 -13.91 62.67 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 119.682 1.128 . . . . 63.109999999999999 112.861 173.344 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 67.47 44.8 82.55 Favored Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 110.127 -1.189 . . . . 71.209999999999994 110.127 -170.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 27.7 m -57.22 -35.28 48.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 CA-C-O 118.839 -0.6 . . . . 72.219999999999999 111.264 171.862 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 44.73 67.38 0.71 Allowed 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 126.421 1.888 . . . . 63.5 110.807 -179.175 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 9.6 t-80 -87.08 152.08 22.67 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 114.45 -1.25 . . . . 55.420000000000002 109.926 -168.857 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -47.2 -52.93 14.43 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 125.998 1.719 . . . . 70.540000000000006 113.365 -170.449 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 21.2 m -142.0 160.49 20.55 Favored 'Isoleucine or valine' 0 C--O 1.243 0.711 0 C-N-CA 125.993 1.717 . . . . 54.43 107.504 167.846 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 25.0 m170 -97.26 5.79 49.43 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.114 0.966 . . . . 71.319999999999993 112.93 -176.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -54.06 -59.23 4.92 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 125.629 1.572 . . . . 74.219999999999999 110.166 179.162 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -61.78 -22.74 65.68 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 113.722 1.008 . . . . 44.530000000000001 113.722 -166.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 74.9 t -60.81 -69.37 0.18 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.322 0 C-N-CA 124.897 1.279 . . . . 72.430000000000007 108.587 170.039 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -60.4 -47.7 84.94 Favored 'General case' 0 CA--C 1.521 -0.165 0 C-N-CA 123.666 0.786 . . . . 74.450000000000003 109.814 -175.146 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -59.61 -26.93 65.86 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 124.198 0.999 . . . . 61.310000000000002 111.038 -176.287 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -88.56 -8.96 53.87 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 112.928 0.714 . . . . 43.340000000000003 112.928 -179.342 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 14.7 mm -73.27 -60.65 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 N-CA-C 106.053 -1.832 . . . . 74.409999999999997 106.053 154.256 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 35.0 p80 -88.27 -70.41 0.64 Allowed 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 114.325 1.231 . . . . 74.120000000000005 114.325 -152.768 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 25.5 mttp -58.76 -31.3 68.23 Favored 'General case' 0 N--CA 1.463 0.19 0 C-N-CA 123.954 0.901 . . . . 53.100000000000001 110.74 177.008 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -69.58 -38.47 77.39 Favored 'General case' 0 N--CA 1.452 -0.34 0 O-C-N 121.814 -0.554 . . . . 64.310000000000002 110.602 176.467 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 4.8 t-80 48.77 92.45 0.02 OUTLIER 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 129.578 3.151 . . . . 63.119999999999997 110.891 -164.829 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.529 ' HE3' ' CE1' ' A' ' 114' ' ' PHE . 0.2 OUTLIER -132.85 147.28 52.3 Favored 'General case' 0 CA--C 1.515 -0.392 0 C-N-CA 123.374 0.67 . . . . 72.25 110.667 170.722 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 3.9 ttmt -79.48 95.47 5.82 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 106.249 -1.76 . . . . 73.010000000000005 106.249 -175.189 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 90.0 mt -121.07 46.18 2.1 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 126.379 1.872 . . . . 73.530000000000001 110.645 -177.74 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -80.05 8.08 7.83 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 115.025 1.491 . . . . 72.319999999999993 115.025 -174.617 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -153.13 153.86 30.13 Favored Pre-proline 0 C--N 1.326 -0.421 0 C-N-CA 124.737 1.215 . . . . 72.030000000000001 109.056 -163.201 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_endo -65.29 -42.84 12.27 Favored 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 122.421 2.081 . . . . 75.540000000000006 110.759 -170.861 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -64.61 -36.79 85.4 Favored 'General case' 0 N--CA 1.444 -0.738 0 C-N-CA 124.209 1.004 . . . . 72.319999999999993 111.449 -177.674 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -65.74 -52.9 47.45 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 125.8 1.64 . . . . 71.340000000000003 110.192 175.065 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 49.6 mtm -59.3 -43.51 92.6 Favored 'General case' 0 CA--C 1.529 0.164 0 O-C-N 121.804 -0.56 . . . . 74.450000000000003 110.616 178.812 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.406 ' HB1' ' CG ' ' A' ' 122' ' ' LYS . . . -61.46 -52.24 65.36 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 124.195 0.998 . . . . 64.319999999999993 109.676 177.575 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -50.81 -46.48 59.86 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 125.371 1.469 . . . . 73.099999999999994 110.696 -179.134 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' PHE . . . . . 0.529 ' CE1' ' HE3' ' A' ' 103' ' ' LYS . 57.5 t80 -61.15 -41.75 97.32 Favored 'General case' 0 N--CA 1.449 -0.497 0 O-C-N 121.768 -0.582 . . . . 74.439999999999998 112.217 -178.001 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 36.7 mt -83.28 -16.53 45.94 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 123.782 0.833 . . . . 75.430000000000007 111.144 -174.264 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -72.53 66.61 0.71 Allowed 'General case' 0 C--O 1.234 0.267 0 C-N-CA 127.539 2.336 . . . . 64.230000000000004 110.891 -171.049 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -178.4 -37.81 0.06 OUTLIER Glycine 0 N--CA 1.442 -0.95 0 C-N-CA 127.557 2.503 . . . . 35.409999999999997 109.941 -177.861 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 1.7 ptpt -86.32 3.12 44.76 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 119.428 1.614 . . . . 74.0 114.111 -163.186 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 118.36 -2.77 16.1 Favored Glycine 0 N--CA 1.449 -0.499 0 CA-C-O 118.694 -1.059 . . . . 61.25 111.135 -167.411 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 42.5 t -96.7 149.48 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.948 0 N-CA-C 103.642 -2.725 . . . . 74.239999999999995 103.642 169.628 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -124.34 143.35 50.63 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 106.942 -1.503 . . . . 62.100000000000001 106.942 169.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.406 ' CG ' ' HB1' ' A' ' 112' ' ' ALA . 24.4 mtpt -55.8 -48.86 74.64 Favored 'General case' 0 CA--C 1.516 -0.327 0 CA-C-O 118.56 -0.733 . . . . 65.409999999999997 109.285 178.494 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -55.01 -35.91 64.9 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 118.71 0.687 . . . . 70.329999999999998 111.779 -177.108 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 27.8 mmmt -94.99 -29.54 14.58 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 123.537 0.735 . . . . 74.099999999999994 109.392 -165.379 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 82.1 t80 -66.55 -64.57 0.83 Allowed 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 127.2 2.2 . . . . 73.319999999999993 109.413 169.612 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 12.8 mt -58.27 -43.75 88.08 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.236 1.014 . . . . 71.099999999999994 109.939 -170.526 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 22.7 t -52.68 -26.49 14.03 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 126.294 1.838 . . . . 54.340000000000003 113.176 -179.438 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' THR . . . . . 0.416 HG23 HG23 ' A' ' 80' ' ' THR 0.278 1.4 t -116.73 -23.55 8.09 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 119.363 0.983 . . . . 70.329999999999998 110.712 -176.262 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 129' ' ' TYR . . . . . 0.429 ' HA ' HG13 ' A' ' 134' ' ' ILE . 27.9 t80 -53.59 -52.57 59.35 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.721 1.208 . . . . 73.109999999999999 108.84 166.2 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 18.0 m-80 -91.98 38.85 1.0 Allowed 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 124.551 1.141 . . . . 74.510000000000005 110.574 -177.016 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 3.2 t -140.06 169.95 16.75 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 114.627 1.343 . . . . 53.520000000000003 114.627 178.187 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -52.98 -30.6 35.93 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 126.802 2.041 . . . . 73.519999999999996 111.133 -179.458 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -52.33 -63.73 1.05 Allowed 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 125.351 1.461 . . . . 74.329999999999998 110.824 173.789 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.456 HD11 ' HA ' ' A' ' 80' ' ' THR . 11.5 mm -63.55 -27.37 42.83 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.141 0 O-C-N 121.452 -0.78 . . . . 75.409999999999997 112.298 176.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.09 -40.44 73.64 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 119.604 1.093 . . . . 70.120000000000005 109.708 173.275 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -64.84 -26.63 71.31 Favored Glycine 0 CA--C 1.532 1.114 0 C-N-CA 124.569 1.08 . . . . 61.520000000000003 112.744 177.295 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 6.9 mt-30 -85.42 -45.31 11.98 Favored 'General case' 0 C--O 1.235 0.291 0 O-C-N 120.943 -1.328 . . . . 60.409999999999997 110.287 179.239 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 82.4 mmm -61.84 -31.45 71.7 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 123.645 0.778 . . . . 71.019999999999996 110.764 179.275 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -64.73 -51.84 60.25 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 119.502 1.046 . . . . 71.510000000000005 111.321 175.588 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 5.8 mttm -62.82 -57.57 10.42 Favored 'General case' 0 CA--C 1.512 -0.497 0 C-N-CA 123.761 0.824 . . . . 64.340000000000003 109.29 -175.497 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -52.95 -40.52 63.73 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 119.494 -0.289 . . . . 72.450000000000003 110.883 -176.4 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.68 -62.14 2.02 Favored 'General case' 0 C--N 1.343 0.292 0 CA-C-N 118.7 0.682 . . . . 73.530000000000001 110.007 174.831 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 8.0 ptmt -68.52 -16.55 63.92 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 113.019 0.748 . . . . 72.230000000000004 113.019 -169.543 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 65.9 mt -69.47 -59.65 2.84 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 123.687 0.795 . . . . 74.150000000000006 110.104 168.46 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -54.51 -43.72 72.1 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 118.736 0.698 . . . . 73.040000000000006 112.531 -173.409 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 2.1 ptm -63.21 -44.4 95.43 Favored 'General case' 0 N--CA 1.468 0.458 0 O-C-N 121.677 -0.639 . . . . 75.400000000000006 112.377 175.797 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -64.11 -40.82 97.03 Favored 'General case' 0 CA--C 1.536 0.433 0 O-C-N 121.893 -0.505 . . . . 75.430000000000007 109.739 -178.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 21.5 m-85 -70.42 9.0 0.68 Allowed 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 126.944 2.098 . . . . 65.230000000000004 113.426 173.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 58.3 mt-30 53.76 35.54 21.65 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 126.612 1.965 . . . . 75.120000000000005 114.046 178.415 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.437 HG22 HG21 ' A' ' 155' ' ' THR . 43.4 t -77.68 89.21 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 O-C-N 120.698 -1.251 . . . . 72.200000000000003 108.602 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -82.34 -12.13 58.16 Favored 'General case' 0 N--CA 1.469 0.496 0 O-C-N 120.586 -1.321 . . . . 60.119999999999997 113.458 177.923 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -171.18 -171.64 36.59 Favored Glycine 0 CA--C 1.524 0.639 0 C-N-CA 125.216 1.389 . . . . 73.530000000000001 109.65 -173.066 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.438 ' HA ' ' C ' ' A' ' 154' ' ' PRO . 29.0 m -137.92 158.38 71.48 Favored Pre-proline 0 CA--C 1.544 0.72 0 C-N-CA 124.756 1.222 . . . . 45.539999999999999 109.155 178.667 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' PRO . . . . . 0.438 ' C ' ' HA ' ' A' ' 153' ' ' VAL . 31.4 Cg_endo -62.49 152.17 65.46 Favored 'Cis proline' 0 N--CA 1.452 -0.969 0 C-N-CA 123.569 -1.429 . . . . 74.0 112.788 -10.221 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' THR . . . . . 0.437 HG21 HG22 ' A' ' 150' ' ' VAL . 77.6 m -141.07 127.08 19.39 Favored 'General case' 0 N--CA 1.443 -0.805 0 C-N-CA 126.457 1.903 . . . . 74.439999999999998 107.013 170.041 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 33.1 mmm -107.08 160.27 15.68 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 124.908 1.283 . . . . 65.010000000000005 107.57 159.68 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 6.3 t -142.02 148.29 20.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 106.955 -1.498 . . . . 74.409999999999997 106.955 177.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.504 HG23 ' CE1' ' A' ' 164' ' ' PHE . 58.8 t -121.36 126.0 74.39 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 N-CA-C 106.314 -1.735 . . . . 63.240000000000002 106.314 168.838 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 55.25 17.82 2.21 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 127.339 2.256 . . . . 65.120000000000005 115.006 171.443 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 58.41 31.37 66.32 Favored Glycine 0 CA--C 1.53 0.969 0 CA-C-O 117.926 -1.485 . . . . 72.349999999999994 112.791 -168.78 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 1.2 mtpm? -126.38 -42.88 1.8 Allowed 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 119.656 1.728 . . . . 73.340000000000003 111.779 -177.351 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -111.65 147.34 35.73 Favored 'General case' 0 CA--C 1.511 -0.551 0 N-CA-C 106.941 -1.503 . . . . 74.200000000000003 106.941 179.11 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 41.4 ttp85 -125.01 135.87 53.18 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 105.601 -2.0 . . . . 72.310000000000002 105.601 175.338 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' PHE . . . . . 0.504 ' CE1' HG23 ' A' ' 158' ' ' VAL . 7.4 p90 -153.54 171.41 18.78 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 107.295 -1.372 . . . . 72.219999999999999 107.295 -178.578 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 174.97 176.33 0.17 Allowed 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 123.726 0.81 . . . . 64.219999999999999 108.915 -178.78 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 38.7 mt -57.14 -35.2 47.41 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 C-N-CA 128.266 2.626 . . . . 72.409999999999997 110.268 -173.271 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -86.62 -3.55 83.73 Favored Glycine 0 CA--C 1.525 0.687 0 CA-C-O 117.617 -1.657 . . . . 41.420000000000002 113.278 -177.379 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 19.4 m -105.72 -54.59 2.46 Favored 'General case' 0 C--N 1.342 0.248 0 CA-C-N 119.04 1.42 . . . . 75.109999999999999 108.86 168.786 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -60.74 -29.14 69.2 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 125.234 1.414 . . . . 44.210000000000001 112.4 -179.264 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 98.43 8.59 54.65 Favored Glycine 0 CA--C 1.527 0.841 0 CA-C-O 119.115 -0.825 . . . . 73.049999999999997 113.712 175.396 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 163.68 171.42 29.9 Favored Glycine 0 CA--C 1.527 0.827 0 CA-C-N 119.543 1.671 . . . . 72.519999999999996 111.781 177.299 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -69.37 -44.34 2.41 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 122.097 1.864 . . . . 60.240000000000002 111.129 -175.197 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -68.6 -34.45 75.8 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 118.913 0.779 . . . . 71.209999999999994 109.473 179.782 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -62.8 -33.27 74.86 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 123.226 0.611 . . . . 75.019999999999996 109.828 176.181 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 37.1 m -65.41 -40.55 93.52 Favored 'General case' 0 CA--C 1.534 0.358 0 O-C-N 120.924 -1.11 . . . . 65.420000000000002 109.332 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 58.7 mt -64.55 -36.46 84.28 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 119.644 1.111 . . . . 70.129999999999995 110.647 175.009 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 27.0 tttt -50.93 -51.76 49.0 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.176 0.991 . . . . 55.43 108.904 172.344 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.428 HD13 ' HA ' ' A' ' 178' ' ' LEU . 4.2 mm? -67.67 -40.85 84.45 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-O 118.415 -0.803 . . . . 52.530000000000001 111.143 177.56 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -56.59 -41.59 77.24 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 119.05 0.841 . . . . 52.210000000000001 111.347 -174.812 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -85.93 -36.75 19.68 Favored 'General case' 0 CA--C 1.511 -0.532 0 N-CA-C 109.171 -0.677 . . . . 74.200000000000003 109.171 -168.271 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -59.3 -54.17 49.85 Favored 'General case' 0 N--CA 1.438 -1.059 0 N-CA-C 109.064 -0.717 . . . . 74.319999999999993 109.064 170.798 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 90.9 mt -61.93 -32.04 72.41 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-O 118.271 -0.871 . . . . 73.340000000000003 112.47 -175.135 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 26.6 mt -51.16 -65.97 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.212 0 CA-C-N 119.211 0.914 . . . . 72.109999999999999 109.352 166.51 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 9.8 tm-20 -69.76 -20.09 63.5 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.984 0.913 . . . . 64.420000000000002 112.101 -171.392 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.24 -52.95 60.09 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 124.962 1.305 . . . . 64.340000000000003 109.05 168.551 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 42.2 mm-40 -74.99 -39.7 61.1 Favored 'General case' 0 C--N 1.334 -0.104 0 C-N-CA 123.578 0.751 . . . . 72.439999999999998 111.891 -176.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.14 -36.03 74.53 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 124.023 0.929 . . . . 75.409999999999997 109.767 -177.69 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -61.7 -16.18 46.86 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.273 1.029 . . . . 55.310000000000002 112.417 177.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -65.52 -35.48 80.98 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 119.168 0.894 . . . . 63.0 111.533 173.065 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -118.04 -18.09 9.5 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 113.922 1.082 . . . . 65.120000000000005 113.922 -173.01 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 36.6 tttt 44.83 80.16 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 126.804 2.042 . . . . 61.5 113.213 168.697 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 8.6 mmtt . . . . . 0 C--O 1.25 1.081 0 C-N-CA 125.694 1.598 . . . . 73.340000000000003 111.525 166.39 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.812 0 N-CA-C 108.608 -1.797 . . . . 60.109999999999999 108.608 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -86.25 131.99 34.1 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 124.538 1.135 . . . . 53.109999999999999 108.155 -174.404 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -117.83 10.99 13.4 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 113.172 0.805 . . . . 71.310000000000002 113.172 -171.214 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -141.55 164.15 30.99 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 125.558 1.543 . . . . 75.409999999999997 107.705 -173.356 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 29.4 m -133.04 130.98 40.11 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.14 -0.689 . . . . 72.030000000000001 109.14 -176.046 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.36 124.18 21.57 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 108.061 -1.089 . . . . 61.109999999999999 108.061 176.562 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 101.1 -38.49 3.12 Favored Glycine 0 CA--C 1.527 0.832 0 C-N-CA 128.556 2.979 . . . . 71.120000000000005 111.393 -173.303 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 8.4 tptp -75.21 -67.3 0.67 Allowed 'General case' 0 C--O 1.226 -0.163 0 C-N-CA 126.364 1.866 . . . . 73.150000000000006 109.442 -175.15 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 5.3 mp0 -93.28 -28.65 16.09 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 126.229 1.812 . . . . 71.230000000000004 109.691 -173.237 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 55.2 p90 -152.54 167.26 29.41 Favored 'General case' 0 N--CA 1.469 0.523 0 O-C-N 121.012 -1.055 . . . . 73.519999999999996 110.73 -171.256 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 93.4 t -133.51 117.01 26.09 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-N 119.661 1.119 . . . . 74.329999999999998 109.716 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -71.71 166.75 21.3 Favored 'General case' 0 N--CA 1.447 -0.614 0 O-C-N 121.085 -1.009 . . . . 73.109999999999999 110.727 174.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -126.68 104.48 8.11 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 124.803 1.241 . . . . 63.420000000000002 108.207 173.055 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 44.2 p -67.52 -6.39 19.55 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 124.068 0.947 . . . . 70.010000000000005 112.425 176.216 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 70.0 m -104.86 80.51 0.49 Allowed Pre-proline 0 N--CA 1.451 -0.396 0 N-CA-C 107.006 -1.479 . . . . 64.329999999999998 107.006 160.51 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -70.95 -179.48 3.48 Favored 'Trans proline' 0 N--CA 1.452 -0.969 0 C-N-CA 123.224 2.616 . . . . 60.229999999999997 110.519 -177.62 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 11.8 t -140.21 136.18 16.76 Favored Pre-proline 0 CA--C 1.534 0.361 0 N-CA-C 108.365 -0.976 . . . . 72.420000000000002 108.365 178.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -76.53 174.68 12.43 Favored 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 122.603 2.202 . . . . 53.32 111.413 172.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.4 m -112.18 -174.91 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 125.906 1.682 . . . . 63.039999999999999 109.539 179.184 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 21.4 m -67.01 -51.84 49.99 Favored 'General case' 0 N--CA 1.45 -0.465 0 O-C-N 121.318 -0.864 . . . . 75.200000000000003 109.484 170.649 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -146.41 161.03 40.26 Favored Pre-proline 0 N--CA 1.446 -0.63 0 C-N-CA 124.176 0.99 . . . . 73.329999999999998 109.636 177.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -69.28 -164.58 0.12 Allowed 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 124.358 3.372 . . . . 74.120000000000005 111.726 170.433 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.74 -110.11 3.96 Favored Glycine 0 N--CA 1.448 -0.531 0 N-CA-C 107.457 -2.257 . . . . 64.409999999999997 107.457 179.464 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 8.3 mttp -63.53 135.33 56.78 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 109.639 -0.504 . . . . 42.25 109.639 -178.258 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 38.6 mm -62.3 144.08 14.63 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 N-CA-C 107.423 -1.325 . . . . 73.140000000000001 107.423 170.331 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -101.75 118.62 37.31 Favored 'General case' 0 N--CA 1.458 -0.038 0 N-CA-C 107.564 -1.272 . . . . 74.099999999999994 107.564 -177.841 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 48.8 t -108.77 134.82 49.51 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 N-CA-C 107.716 -1.216 . . . . 43.439999999999998 107.716 171.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 6.8 t -132.83 111.05 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 C-N-CA 123.842 0.857 . . . . 72.439999999999998 109.814 -174.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 -65.82 127.98 34.16 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 125.255 1.422 . . . . 72.019999999999996 108.916 162.144 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.6 mp -102.45 148.68 25.21 Favored 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 107.596 -1.261 . . . . 53.350000000000001 107.596 155.56 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 37.7 p90 -141.94 170.76 15.12 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 118.848 0.749 . . . . 71.0 111.554 173.406 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 28.1 t90 -156.41 158.43 37.31 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.889 1.276 . . . . 72.299999999999997 110.041 172.323 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 7.4 t80 -70.68 -15.52 62.72 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 113.444 0.905 . . . . 74.409999999999997 113.444 -177.616 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -104.84 12.58 49.83 Favored Glycine 0 CA--C 1.522 0.47 0 CA-C-O 117.554 -1.692 . . . . 74.150000000000006 113.067 -175.002 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 24.8 p -112.95 85.3 7.7 Favored Pre-proline 0 CA--C 1.538 0.486 0 CA-C-N 119.938 1.869 . . . . 72.099999999999994 108.53 -178.122 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_endo -59.38 -26.31 81.48 Favored 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 121.735 1.623 . . . . 72.150000000000006 113.187 -177.498 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 29.1 m170 -68.27 -23.16 64.74 Favored 'General case' 0 CA--C 1.535 0.379 0 O-C-N 121.346 -0.846 . . . . 71.040000000000006 110.89 178.063 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 73.4 m -60.04 -48.06 83.26 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.022 0.929 . . . . 73.030000000000001 108.499 171.615 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 27.1 t80 -63.38 -46.05 88.29 Favored 'General case' 0 N--CA 1.467 0.419 0 O-C-N 120.892 -1.13 . . . . 73.510000000000005 111.46 175.852 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -55.99 -34.9 66.19 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 118.416 0.553 . . . . 52.329999999999998 111.737 -176.09 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -71.23 -23.04 61.93 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 127.174 2.19 . . . . 71.420000000000002 113.697 178.342 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -48.75 -67.05 0.46 Allowed Pre-proline 0 CA--C 1.541 0.614 0 C-N-CA 124.222 1.009 . . . . 61.109999999999999 113.21 -165.588 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -70.93 -6.82 20.03 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 CA-C-N 122.081 1.779 . . . . 72.519999999999996 114.636 -177.714 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.4 m -69.38 -47.4 64.35 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 119.432 1.014 . . . . 72.439999999999998 108.318 164.316 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 16.7 tt -94.5 -32.64 4.69 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 C-N-CA 123.814 0.846 . . . . 73.140000000000001 112.733 -165.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 22.8 t -49.54 -61.85 3.09 Favored Pre-proline 0 CA--C 1.542 0.646 0 C-N-CA 124.849 1.26 . . . . 75.129999999999995 110.551 178.294 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -64.08 -34.37 58.41 Favored 'Trans proline' 0 N--CA 1.454 -0.795 0 CA-C-N 120.454 1.198 . . . . 75.420000000000002 112.329 179.137 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.457 ' CZ2' HD21 ' A' ' 54' ' ' LEU . 72.7 t90 -59.73 -50.57 73.33 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 119.768 1.167 . . . . 73.430000000000007 110.679 177.594 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 42.0 t -59.57 -44.9 93.16 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 123.947 0.899 . . . . 25.23 108.97 -176.775 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 57.5 mt-10 -61.99 -35.61 79.02 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 121.162 -0.961 . . . . 71.099999999999994 110.737 178.168 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 70.4 mmtt -77.19 -2.96 37.15 Favored 'General case' 0 C--O 1.237 0.432 0 O-C-N 120.42 -1.425 . . . . 74.099999999999994 114.482 177.822 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.457 HD21 ' CZ2' ' A' ' 50' ' ' TRP . 26.8 mt -54.57 147.21 30.81 Favored Pre-proline 0 C--O 1.237 0.414 0 CA-C-N 120.405 1.457 . . . . 73.040000000000006 111.588 -177.686 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -74.28 164.95 33.0 Favored 'Trans proline' 0 N--CA 1.445 -1.34 0 C-N-CA 124.035 3.157 . . . . 52.439999999999998 110.602 -176.062 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -66.23 -4.65 8.13 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 125.753 1.621 . . . . 34.149999999999999 115.025 -171.509 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 -118.52 22.71 11.93 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.646 1.579 . . . . 62.5 110.744 179.704 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 57.8 t -121.61 160.18 23.34 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 N-CA-C 107.531 -1.285 . . . . 73.439999999999998 107.531 167.794 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 75.3 t60 -137.27 152.7 50.09 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 125.766 1.626 . . . . 73.140000000000001 107.3 167.552 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 57.5 t80 -130.79 137.37 49.41 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 123.787 0.835 . . . . 73.450000000000003 108.849 -171.86 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 47.4 t -134.07 155.35 39.42 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 C-N-CA 126.426 1.89 . . . . 73.010000000000005 106.906 -173.056 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 4.0 mpt_? -127.07 134.89 50.19 Favored 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 104.364 -2.458 . . . . 74.540000000000006 104.364 166.633 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 68.0 mt -131.85 148.79 71.33 Favored Pre-proline 0 N--CA 1.465 0.293 0 CA-C-N 119.51 1.05 . . . . 74.540000000000006 108.629 170.784 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -69.11 141.78 48.9 Favored 'Trans proline' 0 N--CA 1.451 -1.016 0 C-N-CA 121.421 1.414 . . . . 71.209999999999994 110.409 171.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -91.46 67.32 5.6 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 124.535 1.134 . . . . 72.109999999999999 108.44 -176.84 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 54.9 mt -64.8 65.94 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 127.538 2.335 . . . . 74.239999999999995 112.724 -171.658 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -98.2 48.66 1.0 Allowed 'General case' 0 C--O 1.237 0.416 0 C-N-CA 125.229 1.412 . . . . 73.349999999999994 111.437 -170.8 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 67.48 167.83 3.62 Favored Glycine 0 CA--C 1.531 1.034 0 C-N-CA 124.218 0.913 . . . . 74.140000000000001 112.11 -177.27 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 50.94 -143.22 14.85 Favored Glycine 0 CA--C 1.526 0.736 0 O-C-N 122.091 -0.653 . . . . 41.520000000000003 113.121 176.34 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 4.9 tp -63.63 -11.77 9.58 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 C-N-CA 123.955 0.902 . . . . 73.310000000000002 111.547 -173.112 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 18.4 m95 -73.81 -33.45 64.18 Favored 'General case' 0 CA--C 1.531 0.243 0 O-C-N 120.661 -1.274 . . . . 72.239999999999995 110.909 175.2 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -64.78 -44.06 91.22 Favored 'General case' 0 C--O 1.236 0.382 0 O-C-N 121.33 -0.856 . . . . 65.340000000000003 109.834 168.072 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 91.5 t -62.78 -53.99 39.66 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 N-CA-C 109.169 -0.678 . . . . 60.200000000000003 109.169 -173.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 19.3 m170 -88.96 51.15 2.09 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.864 1.266 . . . . 72.409999999999997 109.455 173.478 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -140.71 -55.53 0.04 OUTLIER Glycine 0 N--CA 1.443 -0.891 0 C-N-CA 124.75 1.167 . . . . 34.539999999999999 110.224 167.7 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.519 ' OE1' HD12 ' A' ' 134' ' ' ILE . 0.0 OUTLIER -55.94 -28.75 58.36 Favored 'General case' 0 CA--C 1.554 1.109 0 N-CA-C 114.617 1.34 . . . . 62.539999999999999 114.617 -166.223 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 34.8 ttp -58.22 -38.14 76.23 Favored 'General case' 0 N--CA 1.469 0.489 0 O-C-N 119.299 -2.126 . . . . 74.299999999999997 112.119 -176.833 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 27.9 t80 -56.12 -50.28 71.55 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 123.774 0.83 . . . . 63.409999999999997 109.5 -179.555 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 42.3 mt -66.1 -42.43 89.28 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-O 117.495 -1.241 . . . . 74.530000000000001 109.825 179.725 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.669 ' HA ' HD11 ' A' ' 134' ' ' ILE . 0.2 OUTLIER -58.39 -42.36 86.93 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 120.317 1.417 . . . . 71.219999999999999 110.623 -178.192 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -54.94 -52.13 63.95 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 125.131 1.372 . . . . 65.239999999999995 108.813 -174.881 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -78.79 -25.37 44.29 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.415 0.686 . . . . 74.319999999999993 111.505 -177.261 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 12.6 t -62.49 -33.42 74.84 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 125.124 1.37 . . . . 74.109999999999999 111.387 176.441 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' MET . . . . . 0.41 ' SD ' ' HA ' ' A' ' 125' ' ' PHE . 30.6 mtp -81.11 -7.87 59.65 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 125.718 1.607 . . . . 71.540000000000006 111.616 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 58.53 36.06 83.16 Favored Glycine 0 C--N 1.336 0.565 0 C-N-CA 125.284 1.421 . . . . 61.109999999999999 110.803 177.875 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.4 m -57.78 135.84 21.54 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 N-CA-C 108.691 -0.855 . . . . 63.130000000000003 108.691 177.451 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -72.53 175.61 6.15 Favored 'General case' 0 C--O 1.244 0.777 0 N-CA-C 109.133 -0.691 . . . . 74.239999999999995 109.133 176.105 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 75.57 163.1 0.25 Allowed 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 127.91 2.484 . . . . 75.450000000000003 110.067 -177.444 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -127.46 33.87 4.78 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 125.249 1.42 . . . . 62.210000000000001 109.156 -158.758 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.9 t -85.26 43.77 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.946 0 C-N-CA 125.208 1.403 . . . . 70.120000000000005 110.895 -167.311 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 11.0 p-80 -58.21 -12.25 3.42 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 128.787 2.835 . . . . 54.539999999999999 116.254 -174.579 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 -91.46 -47.16 7.59 Favored 'General case' 0 CA--C 1.515 -0.391 0 O-C-N 121.25 -0.906 . . . . 75.109999999999999 109.64 173.81 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -53.6 -36.42 61.95 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-O 117.748 -1.12 . . . . 64.140000000000001 112.869 -176.409 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 57.9 t -45.06 -65.32 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 124.845 1.258 . . . . 63.450000000000003 110.987 166.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -57.87 -46.34 85.01 Favored 'General case' 0 C--O 1.226 -0.146 0 CA-C-N 118.583 0.629 . . . . 75.319999999999993 110.722 178.289 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -59.27 -37.54 77.89 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.499 0.72 . . . . 73.25 110.637 -174.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.473 ' HB1' ' CE2' ' A' ' 114' ' ' PHE . . . -68.51 -31.72 71.17 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 124.791 1.236 . . . . 44.109999999999999 113.016 178.248 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 55.9 mt -78.75 -57.25 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 N-CA-C 105.897 -1.89 . . . . 60.450000000000003 105.897 -179.533 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 85.2 m-70 -74.13 -72.26 0.29 Allowed 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 127.032 2.133 . . . . 73.439999999999998 112.031 -172.791 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 43.5 mttt -65.68 -30.68 71.4 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 119.396 0.998 . . . . 74.319999999999993 112.063 -173.68 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -93.58 -26.76 16.97 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 118.427 0.558 . . . . 72.239999999999995 110.788 -173.481 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 49.29 53.2 13.05 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 126.029 1.732 . . . . 74.230000000000004 113.766 175.671 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 2.5 mmpt? -85.23 22.33 1.5 Allowed 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.955 1.302 . . . . 60.329999999999998 114.401 -173.598 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 12.2 ttmt 70.29 -69.66 0.17 Allowed 'General case' 0 C--O 1.222 -0.342 0 C-N-CA 128.151 2.58 . . . . 72.439999999999998 109.873 -179.33 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.431 ' H ' ' HG2' ' A' ' 110' ' ' GLU . 39.3 mt 63.08 28.93 16.25 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 127.176 2.19 . . . . 75.230000000000004 112.342 175.838 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -79.3 -10.08 59.73 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 115.142 1.534 . . . . 65.329999999999998 115.142 -175.601 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 24.8 p -137.13 159.43 69.86 Favored Pre-proline 0 C--O 1.236 0.39 0 O-C-N 120.932 -1.105 . . . . 40.32 109.08 -177.507 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -61.55 -34.84 84.34 Favored 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 122.04 1.827 . . . . 73.230000000000004 110.607 177.008 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -63.83 -40.28 96.23 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 123.404 0.681 . . . . 74.219999999999999 112.216 176.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.431 ' HG2' ' H ' ' A' ' 105' ' ' LEU . 6.9 tp10 -65.01 -48.37 74.19 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.696 0.798 . . . . 72.409999999999997 110.123 177.731 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 57.8 mtt -63.54 -50.46 69.47 Favored 'General case' 0 C--O 1.231 0.09 0 C-N-CA 123.893 0.877 . . . . 75.129999999999995 110.773 -179.523 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.434 ' HB1' ' CG ' ' A' ' 122' ' ' LYS . . . -71.46 -39.46 70.94 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-O 118.414 -0.803 . . . . 62.340000000000003 110.234 -170.438 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -61.62 -28.46 69.38 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 119.288 0.949 . . . . 64.430000000000007 112.293 176.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' PHE . . . . . 0.473 ' CE2' ' HB1' ' A' ' 97' ' ' ALA . 86.1 t80 -75.25 -58.76 3.08 Favored 'General case' 0 N--CA 1.443 -0.806 0 O-C-N 121.827 -0.546 . . . . 73.120000000000005 110.176 175.047 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 53.8 mt -66.59 -22.48 66.13 Favored 'General case' 0 CA--C 1.532 0.261 0 O-C-N 121.748 -0.595 . . . . 72.109999999999999 110.756 -173.37 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -55.93 -17.53 6.78 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 125.215 1.406 . . . . 63.140000000000001 112.719 175.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -90.98 -5.83 67.65 Favored Glycine 0 CA--C 1.524 0.625 0 CA-C-O 118.079 -1.4 . . . . 71.439999999999998 114.51 174.342 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 17.2 mmtt -134.79 29.92 3.45 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 120.217 2.009 . . . . 72.450000000000003 111.749 -156.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 83.82 29.86 30.81 Favored Glycine 0 CA--C 1.52 0.405 0 N-CA-C 111.558 -0.617 . . . . 64.299999999999997 111.558 175.534 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 87.7 t -123.87 119.15 56.21 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 N-CA-C 107.126 -1.435 . . . . 74.140000000000001 107.126 175.404 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 66.3 t0 -70.25 124.37 23.96 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-O 121.185 0.517 . . . . 64.430000000000007 109.745 172.447 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.434 ' CG ' ' HB1' ' A' ' 112' ' ' ALA . 9.5 ttpt -60.15 -40.3 89.41 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 124.128 0.971 . . . . 73.049999999999997 110.206 176.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -68.07 -27.25 66.33 Favored 'General case' 0 C--O 1.236 0.347 0 O-C-N 121.489 -0.757 . . . . 71.349999999999994 111.325 -177.103 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 52.2 mttm -77.71 -48.13 17.44 Favored 'General case' 0 CA--C 1.509 -0.611 0 N-CA-C 107.217 -1.401 . . . . 71.120000000000005 107.217 177.036 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.421 ' CD1' ' HB2' ' A' ' 112' ' ' ALA . 34.0 t80 -44.81 -64.87 0.61 Allowed 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 124.751 1.22 . . . . 71.140000000000001 110.592 177.26 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 22.3 mt -68.69 -40.57 79.98 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 119.22 -0.419 . . . . 64.049999999999997 110.552 -170.05 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 46.6 t -58.33 -56.73 18.28 Favored 'General case' 0 C--N 1.341 0.209 0 N-CA-C 108.059 -1.089 . . . . 75.25 108.059 -179.539 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 55.2 m -62.03 -43.3 99.13 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 123.808 0.843 . . . . 33.399999999999999 110.325 -176.077 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 45.5 t80 -51.46 -45.86 62.86 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 123.838 0.855 . . . . 72.430000000000007 110.591 177.327 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -98.05 35.06 1.8 Allowed 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.456 1.102 . . . . 60.409999999999997 111.155 178.592 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -120.03 155.84 32.1 Favored 'General case' 0 C--O 1.235 0.316 0 O-C-N 120.929 -1.107 . . . . 74.010000000000005 109.807 174.617 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -64.79 -22.3 66.96 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.654 0.782 . . . . 74.409999999999997 111.293 174.658 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -53.95 -29.11 41.27 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 125.173 1.389 . . . . 73.319999999999993 113.17 173.333 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.669 HD11 ' HA ' ' A' ' 80' ' ' THR . 11.2 mm -77.23 -39.4 28.48 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.484 0 C-N-CA 123.829 0.852 . . . . 74.200000000000003 113.149 169.263 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 9.9 tttp -58.89 -34.61 71.86 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 118.309 -0.853 . . . . 65.239999999999995 110.002 -170.32 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -67.81 -23.4 74.12 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 123.915 0.769 . . . . 53.32 112.952 -178.845 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -91.28 -45.51 8.57 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 121.923 0.868 . . . . 72.019999999999996 108.974 178.4 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 5.2 ttm -62.17 -40.27 95.46 Favored 'General case' 0 N--CA 1.426 -1.647 0 C-N-CA 126.293 1.837 . . . . 74.0 110.142 -177.596 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 21.8 pt-20 -69.44 -37.51 77.42 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 120.042 1.292 . . . . 73.200000000000003 112.531 -177.04 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 10.2 mmtt -62.59 -59.4 4.98 Favored 'General case' 0 C--O 1.225 -0.23 0 N-CA-C 107.402 -1.333 . . . . 74.420000000000002 107.402 171.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -54.78 -43.3 72.68 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 119.56 1.073 . . . . 55.450000000000003 111.707 -175.481 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 11.6 tmtt? -49.77 -64.25 0.87 Allowed 'General case' 0 CA--C 1.518 -0.283 0 C-N-CA 125.167 1.387 . . . . 74.450000000000003 110.272 174.198 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.2 -29.82 64.34 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 120.031 -0.668 . . . . 65.340000000000003 110.972 -170.616 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 38.0 mt -61.5 -53.3 58.23 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 123.843 0.857 . . . . 74.439999999999998 110.383 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -57.67 -40.76 80.11 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 118.823 0.738 . . . . 53.420000000000002 110.814 -175.01 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -64.97 -48.11 75.18 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.769 0.828 . . . . 73.219999999999999 110.635 177.852 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -68.91 -28.97 67.15 Favored 'General case' 0 CA--C 1.533 0.297 0 O-C-N 121.791 -0.568 . . . . 53.140000000000001 111.27 -175.261 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -71.57 7.88 1.29 Allowed 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 125.057 1.343 . . . . 73.219999999999999 112.976 171.03 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 57.53 28.42 15.54 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 127.522 2.329 . . . . 74.150000000000006 113.335 177.77 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 15.5 t -77.31 141.55 15.43 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 O-C-N 120.865 -1.147 . . . . 75.329999999999998 108.057 -179.167 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -142.14 10.87 1.95 Allowed 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 121.618 0.723 . . . . 72.230000000000004 112.248 179.636 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -171.64 178.98 43.66 Favored Glycine 0 N--CA 1.442 -0.933 0 N-CA-C 108.301 -1.92 . . . . 62.219999999999999 108.301 172.32 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.457 ' HA ' ' C ' ' A' ' 154' ' ' PRO . 0.8 OUTLIER -145.51 147.2 32.51 Favored Pre-proline 0 C--N 1.32 -0.681 0 C-N-CA 126.66 1.984 . . . . 62.119999999999997 106.082 -175.155 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 154' ' ' PRO . . . . . 0.544 ' HG3' HD12 ' A' ' 166' ' ' ILE . 37.6 Cg_endo -65.59 157.67 77.33 Favored 'Cis proline' 0 CA--C 1.531 0.351 0 N-CA-C 114.74 1.015 . . . . 74.329999999999998 114.74 3.217 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 18.1 m -158.92 141.05 13.82 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 124.758 1.223 . . . . 73.219999999999999 109.227 172.867 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 98.5 mtp -113.38 156.04 24.15 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 126.529 1.932 . . . . 61.450000000000003 107.947 165.192 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 40.6 t -135.42 144.19 34.72 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.36 0 N-CA-C 106.898 -1.519 . . . . 72.430000000000007 106.898 172.569 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 6.0 t -113.81 124.1 70.12 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 N-CA-C 105.828 -1.916 . . . . 74.310000000000002 105.828 172.218 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 48.9 22.58 0.58 Allowed 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 129.948 3.299 . . . . 62.020000000000003 115.927 165.305 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 59.67 36.21 88.84 Favored Glycine 0 CA--C 1.527 0.835 0 CA-C-O 118.335 -1.258 . . . . 64.109999999999999 114.223 -169.018 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 32.1 mttm -128.37 -44.39 1.4 Allowed 'General case' 0 C--O 1.233 0.222 0 CA-C-N 119.269 1.534 . . . . 63.43 111.887 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -116.84 120.29 38.05 Favored 'General case' 0 C--N 1.332 -0.174 0 O-C-N 122.194 -0.316 . . . . 60.049999999999997 110.767 -174.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 35.8 ttp85 -98.75 126.58 44.41 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 106.752 -1.573 . . . . 64.230000000000004 106.752 171.591 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 7.8 p90 -145.36 163.42 34.63 Favored 'General case' 0 C--N 1.316 -0.872 0 O-C-N 120.829 -1.169 . . . . 74.200000000000003 108.438 177.478 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -173.33 173.1 3.61 Favored 'General case' 0 CA--C 1.516 -0.357 0 N-CA-C 109.786 -0.45 . . . . 63.32 109.786 -172.828 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.544 HD12 ' HG3' ' A' ' 154' ' ' PRO . 9.1 mt -52.48 -47.99 46.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 C-N-CA 127.648 2.379 . . . . 70.530000000000001 109.959 -175.644 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -83.54 3.98 83.31 Favored Glycine 0 CA--C 1.526 0.752 0 CA-C-O 117.9 -1.5 . . . . 71.230000000000004 114.027 179.468 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -102.39 -53.73 2.83 Favored 'General case' 0 C--O 1.226 -0.174 0 CA-C-N 120.518 2.159 . . . . 54.439999999999998 107.771 166.634 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -60.0 -52.62 64.6 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 123.872 0.869 . . . . 73.209999999999994 110.75 -178.746 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 129.76 8.59 3.41 Favored Glycine 0 CA--C 1.526 0.724 0 CA-C-O 119.092 -0.838 . . . . 61.140000000000001 113.882 -176.546 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 154.96 174.38 24.82 Favored Glycine 0 CA--C 1.528 0.895 0 CA-C-N 119.192 1.496 . . . . 41.210000000000001 110.496 178.208 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -62.48 -49.39 5.89 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 122.67 2.247 . . . . 65.230000000000004 111.136 -175.765 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -67.96 -37.34 81.45 Favored 'General case' 0 CA--C 1.53 0.182 0 O-C-N 121.305 -0.872 . . . . 74.219999999999999 110.013 -177.656 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -59.35 -29.93 68.02 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.204 0.601 . . . . 71.409999999999997 110.862 175.491 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 30.5 m -66.74 -41.91 87.1 Favored 'General case' 0 CA--C 1.529 0.172 0 O-C-N 120.698 -1.251 . . . . 74.209999999999994 109.361 178.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 44.6 mt -63.87 -36.33 83.58 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 118.928 0.786 . . . . 65.530000000000001 110.458 174.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -54.39 -44.74 72.55 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 118.219 -0.896 . . . . 73.5 109.585 173.779 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.448 HD13 ' HA ' ' A' ' 178' ' ' LEU . 4.2 mm? -68.66 -43.39 76.29 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-O 117.711 -1.138 . . . . 73.510000000000005 111.867 173.061 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -52.46 -49.81 63.92 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 119.458 1.026 . . . . 70.150000000000006 111.367 -170.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -70.68 -36.95 73.58 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 124.103 0.961 . . . . 72.310000000000002 111.055 -171.477 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -68.07 -48.22 66.15 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 126.213 1.805 . . . . 72.430000000000007 111.412 177.533 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 85.1 mt -61.92 -44.03 97.62 Favored 'General case' 0 CA--C 1.527 0.076 0 C-N-CA 123.673 0.789 . . . . 52.310000000000002 110.225 -176.729 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 56.8 mt -51.78 -51.16 29.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 C-N-CA 124.479 1.112 . . . . 72.150000000000006 109.387 174.521 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 14.9 tm-20 -61.18 -27.23 68.27 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 124.512 1.125 . . . . 74.430000000000007 112.419 -178.441 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 185' ' ' LYS . . . . . 0.472 ' HE3' ' HA ' ' A' ' 185' ' ' LYS . 0.3 OUTLIER -61.7 -60.73 3.23 Favored 'General case' 0 C--O 1.232 0.162 0 N-CA-C 107.833 -1.173 . . . . 51.340000000000003 107.833 176.602 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 66.8 mt-10 -67.41 -34.82 78.04 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 125.781 1.632 . . . . 72.150000000000006 111.594 -173.845 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.93 -21.43 64.76 Favored 'General case' 0 N--CA 1.462 0.173 0 O-C-N 120.776 -1.202 . . . . 73.109999999999999 111.911 -177.59 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -60.66 -24.39 65.55 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 122.979 0.511 . . . . 52.43 111.955 173.535 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -65.43 -18.11 65.06 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 118.69 0.677 . . . . 63.130000000000003 112.197 174.607 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -129.61 15.65 5.95 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.631 1.573 . . . . 75.140000000000001 112.225 -176.651 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 14.3 tptt 46.9 83.52 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 127.053 2.141 . . . . 72.230000000000004 112.669 -172.194 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 8.0 mttp . . . . . 0 C--O 1.251 1.148 0 C-N-CA 128.899 2.88 . . . . 72.200000000000003 115.39 162.668 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.672 0 N-CA-C 108.69 -1.764 . . . . 71.430000000000007 108.69 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -62.87 138.24 58.48 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 123.531 0.732 . . . . 74.109999999999999 109.234 -175.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -142.28 9.37 1.86 Allowed 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.029 0.932 . . . . 73.310000000000002 112.593 -175.784 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 34.7 m-85 -142.02 167.16 22.79 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 124.755 1.222 . . . . 75.510000000000005 109.687 -170.754 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 18.9 m -130.87 133.63 46.07 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.697 1.199 . . . . 73.140000000000001 109.691 175.164 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.03 128.7 36.84 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 124.709 1.204 . . . . 70.129999999999995 109.98 173.141 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 71.52 24.33 76.96 Favored Glycine 0 CA--C 1.531 1.037 0 CA-C-O 118.721 -1.044 . . . . 63.240000000000002 111.946 -170.611 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 3.9 ttmt -127.39 -85.77 0.59 Allowed 'General case' 0 CA--C 1.518 -0.263 0 C-N-CA 125.119 1.368 . . . . 51.539999999999999 107.866 165.619 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.491 ' HB3' HD11 ' A' ' 178' ' ' LEU . 36.9 mp0 -64.31 -23.24 67.23 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 123.484 0.713 . . . . 74.109999999999999 110.824 -179.758 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 46.0 p90 -162.98 -178.53 6.14 Favored 'General case' 0 N--CA 1.462 0.174 0 O-C-N 121.731 -0.606 . . . . 54.450000000000003 111.88 -169.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 85.1 t -140.0 111.95 4.91 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 C-N-CA 125.428 1.491 . . . . 70.450000000000003 109.116 -178.751 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -75.7 163.42 27.31 Favored 'General case' 0 C--O 1.234 0.289 0 O-C-N 119.997 -1.689 . . . . 64.239999999999995 109.162 162.498 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -123.77 129.76 51.57 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 124.958 1.303 . . . . 72.120000000000005 108.657 -176.514 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 57.1 p -59.79 -27.54 66.65 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-O 118.228 -0.891 . . . . 74.0 112.363 -178.601 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 9.3 p -114.65 84.19 9.8 Favored Pre-proline 0 N--CA 1.452 -0.345 0 CA-C-N 119.068 0.849 . . . . 72.510000000000005 110.507 -175.834 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -70.75 175.19 9.27 Favored 'Trans proline' 0 N--CA 1.451 -1.01 0 C-N-CA 122.897 2.398 . . . . 64.150000000000006 110.915 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 24.6 t -139.18 136.46 18.12 Favored Pre-proline 0 CA--C 1.542 0.644 0 C-N-CA 123.674 0.79 . . . . 74.219999999999999 109.122 -167.337 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -73.05 176.93 8.42 Favored 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 123.917 3.078 . . . . 74.310000000000002 112.949 175.706 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 15.4 m -137.02 164.71 29.53 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 C-N-CA 124.601 1.16 . . . . 75.430000000000007 112.63 -167.696 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 13.4 t -58.49 -30.4 66.98 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 126.769 2.028 . . . . 72.540000000000006 112.965 175.47 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -155.58 86.06 3.29 Favored Pre-proline 0 N--CA 1.446 -0.657 0 CA-C-N 119.636 1.107 . . . . 73.140000000000001 109.425 -170.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -65.28 86.8 0.19 Allowed 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 122.224 1.949 . . . . 74.209999999999994 108.991 172.186 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -174.25 -41.8 0.05 OUTLIER Glycine 0 CA--C 1.525 0.714 0 CA-C-O 118.846 -0.975 . . . . 73.109999999999999 112.296 -165.612 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 9.5 mptt -108.06 152.19 24.84 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 106.759 -1.571 . . . . 73.109999999999999 106.759 160.011 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 32.6 mm -57.81 148.39 5.53 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 N-CA-C 105.868 -1.901 . . . . 63.340000000000003 105.868 162.121 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -117.55 117.47 29.51 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 106.958 -1.497 . . . . 72.209999999999994 106.958 -178.229 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 43.1 t -116.61 129.79 72.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 N-CA-C 107.327 -1.361 . . . . 74.120000000000005 107.327 179.409 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 4.8 t -118.9 134.37 62.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 106.143 -1.799 . . . . 74.530000000000001 106.143 179.427 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -107.89 101.8 11.04 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 104.631 -2.359 . . . . 60.509999999999998 104.631 162.031 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.441 HD22 HG21 ' A' ' 150' ' ' VAL . 5.4 mp -82.98 118.67 23.65 Favored 'General case' 0 CA--C 1.522 -0.114 0 N-CA-C 106.917 -1.512 . . . . 72.450000000000003 106.917 177.178 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 49.4 p90 -124.22 168.39 13.0 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.163 0.585 . . . . 71.219999999999999 112.045 -171.74 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' TRP . . . . . 0.493 ' HB3' HG21 ' A' ' 153' ' ' VAL . 22.6 t90 -146.14 143.43 29.32 Favored 'General case' 0 C--N 1.343 0.312 0 C-N-CA 125.142 1.377 . . . . 75.200000000000003 109.238 174.614 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 5.4 t80 -49.15 -42.15 38.7 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 126.739 2.016 . . . . 75.209999999999994 112.571 171.743 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -83.57 15.61 34.9 Favored Glycine 0 CA--C 1.525 0.7 0 CA-C-O 119.163 -0.799 . . . . 64.120000000000005 113.017 -171.839 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 53.5 t -105.12 85.62 1.34 Allowed Pre-proline 0 N--CA 1.447 -0.613 0 C-N-CA 126.322 1.849 . . . . 51.020000000000003 108.148 178.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -61.44 -32.68 88.92 Favored 'Trans proline' 0 CA--C 1.534 0.5 0 C-N-CA 122.085 1.856 . . . . 70.120000000000005 110.279 177.198 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 5.4 m170 -53.44 -48.72 68.55 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 126.201 1.8 . . . . 64.230000000000004 110.134 175.258 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 84.1 m -59.57 -38.07 80.17 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.008 0.923 . . . . 73.420000000000002 109.555 -168.102 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 38.5 t80 -62.74 -23.45 67.19 Favored 'General case' 0 N--CA 1.47 0.55 0 O-C-N 120.892 -1.13 . . . . 73.340000000000003 112.559 179.64 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -55.96 -40.32 73.07 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 118.983 0.81 . . . . 74.409999999999997 110.043 172.631 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -85.44 -21.66 28.65 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 125.833 1.653 . . . . 62.229999999999997 112.681 -168.518 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -38.93 -67.08 0.28 Allowed Pre-proline 0 N--CA 1.478 0.937 0 C-N-CA 125.348 1.459 . . . . 73.019999999999996 112.662 -176.284 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -73.95 -10.29 22.88 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 CA-C-N 121.803 1.68 . . . . 71.099999999999994 114.406 -174.351 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.8 m -72.32 -45.21 60.92 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 107.975 -1.12 . . . . 75.109999999999999 107.975 166.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 20.2 tt -92.28 -36.54 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 N-CA-C 113.207 0.817 . . . . 73.420000000000002 113.207 -167.376 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 29.3 t -43.5 -60.48 2.51 Favored Pre-proline 0 CA--C 1.543 0.686 0 C-N-CA 125.31 1.444 . . . . 64.150000000000006 110.962 175.135 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -69.62 -29.93 23.73 Favored 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 121.725 1.617 . . . . 74.420000000000002 112.011 -177.432 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.49 ' CZ2' ' HB1' ' A' ' 179' ' ' ALA . 72.5 t90 -57.44 -49.75 75.23 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 119.074 0.852 . . . . 75.219999999999999 109.209 175.764 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 44.2 t -61.73 -37.08 82.9 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 122.942 0.497 . . . . 61.119999999999997 110.636 178.099 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -59.6 -44.66 93.32 Favored 'General case' 0 CA--C 1.533 0.324 0 O-C-N 120.757 -1.214 . . . . 64.150000000000006 110.979 176.738 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -85.99 4.99 35.37 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 119.197 0.908 . . . . 74.040000000000006 113.179 -173.486 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 60.7 mt -58.6 148.72 65.34 Favored Pre-proline 0 N--CA 1.447 -0.612 0 N-CA-C 109.785 -0.45 . . . . 73.430000000000007 109.785 173.485 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -70.69 174.45 10.3 Favored 'Trans proline' 0 N--CA 1.447 -1.252 0 C-N-CA 123.982 3.121 . . . . 64.200000000000003 110.623 -178.752 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -67.68 0.95 2.76 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.986 1.314 . . . . 62.229999999999997 114.093 178.253 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -117.88 4.08 12.19 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 125.598 1.559 . . . . 65.329999999999998 111.916 -170.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 59.5 t -126.4 138.03 55.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 N-CA-C 105.721 -1.955 . . . . 62.25 105.721 179.243 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 3.2 p-80 -126.74 147.14 50.0 Favored 'General case' 0 N--CA 1.444 -0.768 0 C-N-CA 123.827 0.851 . . . . 41.140000000000001 109.13 179.126 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 28.1 t80 -110.96 140.5 45.41 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 124.199 1.0 . . . . 71.109999999999999 108.661 -173.266 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 82.4 t -133.71 113.54 18.66 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.441 0 N-CA-C 108.283 -1.006 . . . . 73.400000000000006 108.283 -170.011 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 29.1 mtm180 -101.07 114.96 29.39 Favored 'General case' 0 CA--C 1.506 -0.716 0 N-CA-C 105.84 -1.911 . . . . 64.519999999999996 105.84 -175.309 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 79.1 mt -130.36 145.58 58.02 Favored Pre-proline 0 C--N 1.328 -0.365 0 C-N-CA 123.177 0.591 . . . . 72.310000000000002 109.679 175.606 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -76.65 134.92 15.61 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 122.829 2.353 . . . . 74.030000000000001 110.474 172.804 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -77.11 95.03 4.14 Favored 'General case' 0 CA--C 1.539 0.533 0 O-C-N 121.55 -0.719 . . . . 53.009999999999998 110.035 178.058 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 29.6 mt -88.63 75.09 8.33 Favored 'General case' 0 CA--C 1.539 0.553 0 O-C-N 120.057 -1.652 . . . . 75.230000000000004 111.372 -172.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -87.0 30.28 0.77 Allowed 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 113.947 1.091 . . . . 75.120000000000005 113.947 -175.281 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 72.31 -165.01 54.42 Favored Glycine 0 CA--C 1.527 0.826 0 N-CA-C 108.341 -1.904 . . . . 51.32 108.341 -168.805 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 56.34 -156.47 11.64 Favored Glycine 0 CA--C 1.529 0.95 0 CA-C-N 117.891 0.846 . . . . 75.030000000000001 113.601 172.028 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 9.5 tp -61.67 -20.98 24.49 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 C-N-CA 123.481 0.712 . . . . 74.510000000000005 112.219 172.182 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 11.9 m95 -59.3 -42.07 90.49 Favored 'General case' 0 C--N 1.343 0.313 0 CA-C-N 120.097 1.317 . . . . 73.349999999999994 110.798 -171.266 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -79.93 -28.15 39.75 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 112.979 0.733 . . . . 62.210000000000001 112.979 178.579 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 92.4 t -63.12 -45.99 97.18 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 N-CA-C 108.089 -1.078 . . . . 54.310000000000002 108.089 175.055 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 64.2 m170 -76.61 15.13 0.67 Allowed 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 124.759 1.224 . . . . 71.439999999999998 112.644 169.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -123.73 -22.48 2.23 Favored Glycine 0 CA--C 1.532 1.141 0 CA-C-N 120.358 1.436 . . . . 53.140000000000001 114.182 178.144 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 33.7 tt0 -72.92 -28.98 62.78 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 118.286 1.043 . . . . 65.209999999999994 111.553 -172.146 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 6.5 ttp -61.52 -47.79 83.99 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-O 117.512 -1.232 . . . . 73.230000000000004 111.724 -177.624 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 13.7 t80 -52.62 -52.91 53.28 Favored 'General case' 0 N--CA 1.462 0.138 0 N-CA-C 108.813 -0.81 . . . . 74.25 108.813 -176.315 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 47.3 mt -56.61 -44.22 80.93 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 114.829 -1.078 . . . . 71.019999999999996 109.993 177.014 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.685 ' HA ' HD11 ' A' ' 134' ' ' ILE . 2.5 m -62.94 -40.92 99.1 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 120.353 1.433 . . . . 73.049999999999997 112.087 -174.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -55.88 -54.14 48.26 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.897 0.879 . . . . 61.530000000000001 108.76 176.584 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -74.36 -10.71 59.85 Favored 'General case' 0 CA--C 1.543 0.68 0 O-C-N 121.407 -0.808 . . . . 75.439999999999998 111.5 -176.269 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 9.3 t -88.29 -20.03 25.97 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 126.496 1.918 . . . . 71.409999999999997 113.578 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 8.5 ptp -81.66 -21.65 38.0 Favored 'General case' 0 N--CA 1.466 0.334 0 O-C-N 120.89 -1.132 . . . . 74.209999999999994 110.072 157.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 80.82 56.13 3.17 Favored Glycine 0 C--N 1.332 0.317 0 N-CA-C 109.373 -1.491 . . . . 63.310000000000002 109.373 179.472 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 5.5 m -53.5 125.71 8.32 Favored 'Isoleucine or valine' 0 C--O 1.239 0.511 0 CA-C-O 121.407 0.622 . . . . 72.540000000000006 109.837 178.015 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -131.2 29.54 4.63 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 124.909 1.284 . . . . 72.310000000000002 110.146 -175.102 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 18.6 t-160 -153.7 79.96 1.15 Allowed 'General case' 0 CA--C 1.536 0.416 0 O-C-N 121.439 -0.788 . . . . 72.420000000000002 109.088 168.71 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -162.85 179.57 7.52 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.078 0.551 . . . . 60.229999999999997 111.238 173.773 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 9.3 p -97.36 -10.16 8.88 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 C-N-CA 126.201 1.8 . . . . 73.219999999999999 111.251 173.481 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 13.8 m-70 49.1 52.39 14.46 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.301 1.44 . . . . 60.299999999999997 110.696 -174.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -143.99 -45.71 0.27 Allowed 'General case' 0 CA--C 1.515 -0.399 0 C-N-CA 123.558 0.743 . . . . 61.119999999999997 110.757 176.495 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -61.82 -29.57 70.25 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 118.028 0.376 . . . . 73.230000000000004 111.65 -176.561 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 48.5 t -53.42 -61.98 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 C-N-CA 124.159 0.983 . . . . 73.299999999999997 108.552 171.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -69.1 -41.95 76.76 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 119.174 -0.441 . . . . 55.130000000000003 110.716 -175.142 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -52.86 -39.66 62.75 Favored 'General case' 0 C--O 1.233 0.21 0 C-N-CA 124.671 1.188 . . . . 75.310000000000002 111.024 -178.334 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -63.76 -27.53 69.26 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 124.022 0.929 . . . . 72.230000000000004 111.055 -176.773 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 52.2 mt -85.45 -60.51 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.933 0 C-N-CA 125.97 1.708 . . . . 75.150000000000006 107.299 176.12 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 24.9 p-80 -76.18 -57.17 4.02 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 119.719 1.145 . . . . 51.109999999999999 113.256 -169.016 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -83.07 -33.15 26.48 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-N 118.404 0.547 . . . . 71.120000000000005 110.989 -171.187 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -97.51 -30.77 12.69 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 124.145 0.978 . . . . 75.310000000000002 111.091 -171.06 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 5.2 t-160 45.08 88.53 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 127.901 2.48 . . . . 74.099999999999994 112.885 176.056 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.488 ' HE2' ' CE1' ' A' ' 114' ' ' PHE . 0.0 OUTLIER -106.38 155.31 19.68 Favored 'General case' 0 CA--C 1.507 -0.7 0 CA-C-O 121.579 0.704 . . . . 73.519999999999996 111.128 164.429 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 5.2 ttmt -58.03 101.97 0.09 Allowed 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 106.698 -1.593 . . . . 65.400000000000006 106.698 165.782 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 93.0 mt -130.42 70.1 1.45 Allowed 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 126.934 2.094 . . . . 72.319999999999993 108.701 178.453 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -114.86 1.67 14.13 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.463 1.105 . . . . 62.43 112.619 -175.523 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -138.63 152.57 71.11 Favored Pre-proline 0 CA--C 1.531 0.249 0 C-N-CA 125.342 1.457 . . . . 75.239999999999995 109.209 -175.197 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -65.15 -34.02 47.56 Favored 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 121.395 1.396 . . . . 71.329999999999998 110.473 -179.424 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -64.37 -21.02 66.5 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 118.536 0.607 . . . . 73.310000000000002 112.343 174.497 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -84.06 -55.06 4.41 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 107.894 -1.15 . . . . 74.450000000000003 107.894 177.808 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 3.9 mpp? -58.21 -51.78 68.33 Favored 'General case' 0 C--N 1.34 0.187 0 C-N-CA 123.213 0.605 . . . . 73.099999999999994 111.135 179.374 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.612 ' HB1' ' HG2' ' A' ' 122' ' ' LYS . . . -67.28 -41.45 85.45 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 118.3 -0.857 . . . . 53.43 110.319 -173.864 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -57.8 -46.98 83.88 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 118.831 0.741 . . . . 74.340000000000003 110.006 174.752 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' PHE . . . . . 0.488 ' CE1' ' HE2' ' A' ' 103' ' ' LYS . 84.7 t80 -60.48 -46.9 88.39 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 118.015 0.37 . . . . 43.299999999999997 110.817 -176.561 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 46.0 mt -75.62 -17.98 59.84 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 119.356 -0.354 . . . . 52.039999999999999 111.007 -176.478 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.18 -9.85 2.41 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.481 1.512 . . . . 41.240000000000002 114.115 -179.096 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -121.34 15.37 9.29 Favored Glycine 0 CA--C 1.533 1.194 0 C-N-CA 126.666 2.079 . . . . 75.219999999999999 112.808 176.741 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 2.8 mmpt? -135.01 25.87 3.59 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.905 1.282 . . . . 75.209999999999994 110.891 -172.779 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 94.13 20.69 29.73 Favored Glycine 0 CA--C 1.524 0.617 0 C-N-CA 124.08 0.848 . . . . 64.219999999999999 113.529 172.813 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 94.0 t -132.98 130.01 58.13 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 C-N-CA 124.675 1.19 . . . . 74.129999999999995 107.817 -169.704 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -98.98 134.06 42.36 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 112.251 0.463 . . . . 73.120000000000005 112.251 -176.601 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.612 ' HG2' ' HB1' ' A' ' 112' ' ' ALA . 39.6 mtpt -60.74 -35.07 75.45 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 118.491 -0.766 . . . . 74.340000000000003 110.017 176.878 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -55.87 -46.51 78.24 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 119.086 0.857 . . . . 53.109999999999999 110.479 176.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 25.8 mmtt -78.27 -46.27 20.68 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 106.724 -1.584 . . . . 72.230000000000004 106.724 -174.802 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.51 ' CD2' ' HB2' ' A' ' 112' ' ' ALA . 47.6 t80 -54.06 -65.15 0.62 Allowed 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 125.455 1.502 . . . . 72.400000000000006 111.391 -176.504 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 9.3 mt -70.45 -33.76 71.68 Favored 'General case' 0 N--CA 1.467 0.418 0 O-C-N 121.146 -0.971 . . . . 55.399999999999999 111.06 -166.832 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 17.1 t -58.02 -57.8 11.21 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 107.198 -1.408 . . . . 62.130000000000003 107.198 172.447 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 38.4 m -62.85 -39.81 95.52 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-O 118.987 -0.53 . . . . 74.310000000000002 110.238 -175.18 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 54.7 t80 -56.42 -41.79 76.97 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 119.975 1.262 . . . . 73.540000000000006 110.064 -179.046 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 33.7 m-80 -84.43 -10.78 57.22 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 124.367 1.067 . . . . 74.209999999999994 113.745 -179.382 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 4.3 m -86.73 154.93 20.58 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 126.125 1.77 . . . . 71.430000000000007 112.645 -169.52 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -63.01 -29.83 71.13 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 114.171 1.174 . . . . 75.310000000000002 114.171 -171.541 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -57.21 -43.99 83.26 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 120.297 1.408 . . . . 54.329999999999998 111.231 -177.287 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.685 HD11 ' HA ' ' A' ' 80' ' ' THR . 4.6 mm -58.48 -43.86 87.73 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.496 0 C-N-CA 126.394 1.878 . . . . 72.120000000000005 110.721 174.098 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 17.3 tttm -51.82 -37.49 51.99 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.941 0.896 . . . . 61.229999999999997 109.161 174.433 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -71.95 -40.13 57.78 Favored Glycine 0 CA--C 1.527 0.787 0 C-N-CA 124.634 1.111 . . . . 72.329999999999998 111.599 179.587 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -72.22 -34.37 68.29 Favored 'General case' 0 C--N 1.329 -0.311 0 O-C-N 120.906 -1.349 . . . . 72.099999999999994 110.551 -179.415 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 55.1 mtp -65.06 -51.29 62.33 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 124.599 1.16 . . . . 71.209999999999994 109.395 176.453 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -55.88 -38.78 70.62 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 119.298 0.953 . . . . 74.420000000000002 110.926 -172.519 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 21.6 mtmt -66.67 -61.6 1.88 Allowed 'General case' 0 C--N 1.342 0.255 0 CA-C-O 117.703 -1.141 . . . . 61.32 110.911 176.53 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -52.31 -39.13 60.16 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 120.834 1.652 . . . . 54.520000000000003 111.298 -177.226 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 11.0 tttt -62.49 -54.46 39.68 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 125.514 1.526 . . . . 54.509999999999998 112.454 178.704 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.01 -30.61 67.97 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 119.824 1.193 . . . . 72.099999999999994 110.623 179.166 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 40.3 mt -60.2 -47.25 86.76 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-O 118.932 -0.556 . . . . 72.099999999999994 110.558 -177.856 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -54.76 -45.93 74.28 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 118.016 0.371 . . . . 72.040000000000006 111.56 -177.467 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 13.2 ptp -70.57 -42.05 71.6 Favored 'General case' 0 CA--C 1.523 -0.079 0 N-CA-C 112.117 0.414 . . . . 55.210000000000001 112.117 -179.172 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -60.59 -38.53 84.96 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 123.747 0.819 . . . . 52.100000000000001 109.126 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 23.4 m-85 -76.47 6.16 6.17 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 114.12 1.155 . . . . 72.120000000000005 114.12 175.527 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 54.2 mt-30 57.63 36.19 26.46 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 127.073 2.149 . . . . 71.340000000000003 112.829 -179.22 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.441 HG21 HD22 ' A' ' 32' ' ' LEU . 36.1 t -82.94 145.87 7.85 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 N-CA-C 108.072 -1.084 . . . . 71.140000000000001 108.072 171.762 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -140.18 -7.79 1.18 Allowed 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 124.53 1.132 . . . . 64.230000000000004 112.642 173.902 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -154.43 -176.77 27.1 Favored Glycine 0 CA--C 1.52 0.396 0 N-CA-C 108.601 -1.8 . . . . 73.129999999999995 108.601 -178.209 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.493 HG21 ' HB3' ' A' ' 34' ' ' TRP . 31.4 m -137.49 158.37 72.18 Favored Pre-proline 0 CA--C 1.54 0.563 0 N-CA-C 108.628 -0.879 . . . . 71.439999999999998 108.628 174.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 154' ' ' PRO . . . . . 0.413 ' C ' ' HA ' ' A' ' 153' ' ' VAL . 61.5 Cg_endo -63.05 160.56 59.06 Favored 'Cis proline' 0 N--CA 1.455 -0.771 0 C-N-CA 123.252 -1.562 . . . . 75.510000000000005 112.055 -12.026 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 155' ' ' THR . . . . . 0.424 HG21 HG22 ' A' ' 150' ' ' VAL . 9.4 m -159.04 111.05 2.16 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 105.537 -2.023 . . . . 71.549999999999997 105.537 174.332 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 92.7 mtp -84.39 155.61 22.21 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 108.579 -0.897 . . . . 71.049999999999997 108.579 165.143 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 10.0 t -138.48 150.71 24.16 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 N-CA-C 106.82 -1.548 . . . . 75.239999999999995 106.82 174.329 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 55.2 t -134.98 123.79 41.49 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 N-CA-C 105.908 -1.886 . . . . 73.040000000000006 105.908 -178.133 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 9.3 m-20 52.33 13.1 0.27 Allowed 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 129.814 3.246 . . . . 74.200000000000003 114.598 178.028 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 59.17 42.31 97.09 Favored Glycine 0 CA--C 1.527 0.785 0 CA-C-O 118.612 -1.105 . . . . 75.439999999999998 111.826 -166.753 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 13.5 mtpp -133.19 -38.85 0.94 Allowed 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 125.119 1.367 . . . . 63.229999999999997 111.219 -177.23 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -116.29 154.2 30.59 Favored 'General case' 0 CA--C 1.502 -0.901 0 N-CA-C 108.409 -0.96 . . . . 70.319999999999993 108.409 177.848 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 28.4 ttp85 -132.7 135.11 45.58 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 105.034 -2.21 . . . . 65.239999999999995 105.034 174.873 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 45.5 p90 -149.77 173.26 13.92 Favored 'General case' 0 C--N 1.324 -0.543 0 O-C-N 121.465 -0.772 . . . . 74.319999999999993 109.123 169.8 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -167.5 174.24 8.03 Favored 'General case' 0 CA--C 1.515 -0.367 0 N-CA-C 109.76 -0.459 . . . . 43.299999999999997 109.76 178.663 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 14.7 mt -51.77 -51.27 28.47 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 C-N-CA 125.917 1.687 . . . . 71.5 110.33 -179.183 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -76.09 -20.7 77.23 Favored Glycine 0 CA--C 1.527 0.8 0 CA-C-O 118.096 -1.391 . . . . 70.310000000000002 113.467 -178.072 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 66.6 m -70.18 -64.25 0.93 Allowed 'General case' 0 C--O 1.235 0.33 0 CA-C-N 120.011 1.906 . . . . 71.049999999999997 108.407 168.828 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -55.76 -48.74 74.76 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 127.354 2.261 . . . . 71.430000000000007 111.943 -174.04 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 130.89 -6.49 5.78 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 124.532 1.063 . . . . 74.299999999999997 114.303 178.197 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 165.59 169.67 29.51 Favored Glycine 0 CA--C 1.526 0.758 0 CA-C-N 119.218 1.509 . . . . 52.439999999999998 110.413 178.713 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -61.07 -43.43 29.89 Favored 'Trans proline' 0 N--CA 1.461 -0.439 0 C-N-CA 123.047 2.498 . . . . 74.209999999999994 111.351 -174.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 -60.32 -44.43 95.48 Favored 'General case' 0 CA--C 1.536 0.424 0 O-C-N 121.468 -0.77 . . . . 71.310000000000002 110.474 176.332 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -66.5 -23.94 66.33 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.511 1.125 . . . . 74.439999999999998 110.648 -177.527 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 28.3 m -66.58 -44.31 82.6 Favored 'General case' 0 N--CA 1.455 -0.19 0 O-C-N 121.056 -1.027 . . . . 74.519999999999996 109.668 179.457 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 54.9 mt -68.15 -23.51 64.88 Favored 'General case' 0 C--N 1.341 0.217 0 CA-C-N 118.702 0.683 . . . . 74.150000000000006 111.938 179.141 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.12 -54.9 37.36 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 108.245 -1.02 . . . . 50.439999999999998 108.245 168.577 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.491 HD11 ' HB3' ' A' ' 11' ' ' GLU . 3.0 mm? -64.74 -44.69 89.33 Favored 'General case' 0 CA--C 1.515 -0.383 0 N-CA-C 110.016 -0.365 . . . . 70.310000000000002 110.016 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.49 ' HB1' ' CZ2' ' A' ' 50' ' ' TRP . . . -54.86 -34.38 62.86 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 112.538 0.57 . . . . 73.120000000000005 112.538 -175.018 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -94.61 -36.55 11.74 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 123.475 0.71 . . . . 54.32 110.929 -170.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 37.9 t80 -57.25 -53.45 57.99 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.757 0.823 . . . . 74.209999999999994 109.65 171.156 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 26.5 mt -55.75 -46.8 77.75 Favored 'General case' 0 CA--C 1.516 -0.329 0 C-N-CA 124.43 1.092 . . . . 72.430000000000007 111.403 -177.154 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 46.2 mt -48.46 -58.65 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.139 0 N-CA-C 109.025 -0.731 . . . . 71.109999999999999 109.025 176.378 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 6.9 tm-20 -65.1 -26.64 68.3 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 119.254 0.934 . . . . 73.310000000000002 111.882 -176.195 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 3.7 tmtm? -64.9 -58.28 6.59 Favored 'General case' 0 C--O 1.234 0.282 0 O-C-N 120.645 -1.284 . . . . 62.420000000000002 109.634 172.018 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -60.54 -40.8 92.85 Favored 'General case' 0 N--CA 1.438 -1.04 0 C-N-CA 125.525 1.53 . . . . 75.219999999999999 112.077 -177.763 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.68 -43.37 80.31 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 125.859 1.664 . . . . 44.210000000000001 110.299 179.428 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -57.49 -29.52 64.35 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 119.884 1.22 . . . . 72.430000000000007 111.202 -174.708 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -53.2 -29.45 32.16 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.06 0.944 . . . . 61.43 113.39 174.079 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -147.98 50.49 1.04 Allowed 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 125.797 1.639 . . . . 43.439999999999998 109.894 -174.592 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 49.9 tttt -84.26 44.4 1.02 Allowed 'General case' 0 N--CA 1.476 0.851 0 O-C-N 120.934 -1.104 . . . . 74.129999999999995 109.237 -178.25 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.097 0 C-N-CA 127.038 2.135 . . . . 63.420000000000002 112.292 -161.287 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.934 0 N-CA-C 108.599 -1.8 . . . . 45.100000000000001 108.599 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . 0.27 0.0 OUTLIER 59.4 164.03 0.05 OUTLIER 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.148 0.579 . . . . 63.340000000000003 110.598 -135.492 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -152.93 14.48 0.54 Allowed 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.123 0.969 . . . . 74.230000000000004 112.127 175.281 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 25.5 m-85 -146.6 160.72 41.81 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 123.932 0.893 . . . . 74.409999999999997 110.275 -167.71 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 31.5 m -128.78 136.59 50.74 Favored 'General case' 0 C--O 1.238 0.461 0 O-C-N 121.418 -0.801 . . . . 62.310000000000002 108.846 -177.623 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -70.99 149.99 46.1 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 122.119 0.961 . . . . 43.340000000000003 109.1 174.229 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 62.32 12.04 36.6 Favored Glycine 0 CA--C 1.533 1.208 0 CA-C-O 118.556 -1.136 . . . . 73.540000000000006 112.582 -167.659 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.8 tptt -126.97 -84.24 0.61 Allowed 'General case' 0 C--N 1.339 0.131 0 CA-C-N 119.885 1.842 . . . . 74.420000000000002 107.346 -178.853 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.6 mp0 -74.52 -26.82 60.23 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 125.477 1.511 . . . . 74.430000000000007 110.372 179.441 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 34.3 p90 -158.61 174.86 14.41 Favored 'General case' 0 N--CA 1.456 -0.131 0 O-C-N 121.18 -0.95 . . . . 74.109999999999999 109.451 -175.223 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 24.7 t -135.76 128.56 47.07 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.107 0 C-N-CA 124.418 1.087 . . . . 52.229999999999997 108.196 -179.708 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.424 ' HG3' ' CE1' ' A' ' 162' ' ' TYR . 0.7 OUTLIER -87.74 169.28 12.23 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.211 1.404 . . . . 74.530000000000001 110.782 165.204 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -136.38 122.48 20.29 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 124.641 1.176 . . . . 74.109999999999999 111.054 177.037 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.6 p -63.13 -0.07 0.69 Allowed 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 128.657 2.783 . . . . 74.140000000000001 114.693 179.515 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 74.1 m -137.7 78.87 35.82 Favored Pre-proline 0 N--CA 1.447 -0.592 0 N-CA-C 107.546 -1.279 . . . . 73.25 107.546 173.611 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -68.97 179.6 3.17 Favored 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 123.339 2.692 . . . . 74.519999999999996 111.818 -176.39 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 40.4 t -126.84 136.97 29.57 Favored Pre-proline 0 CA--C 1.536 0.407 0 N-CA-C 108.503 -0.925 . . . . 70.349999999999994 108.503 -169.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -78.18 -179.09 5.13 Favored 'Trans proline' 0 CA--C 1.537 0.635 0 C-N-CA 122.882 2.388 . . . . 72.25 111.861 178.225 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 3.7 m -131.96 179.78 4.07 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 C-N-CA 127.294 2.237 . . . . 53.020000000000003 109.504 176.306 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 47.3 t -64.15 -70.58 0.21 Allowed 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 124.879 1.272 . . . . 53.25 108.324 168.543 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 57.2 tp60 -116.54 143.03 30.49 Favored Pre-proline 0 N--CA 1.45 -0.443 0 N-CA-C 105.543 -2.021 . . . . 62.109999999999999 105.543 -176.503 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -86.21 -164.13 0.21 Allowed 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 123.699 2.932 . . . . 73.420000000000002 110.306 176.834 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 94.3 -77.84 0.97 Allowed Glycine 0 N--CA 1.444 -0.771 0 N-CA-C 108.889 -1.684 . . . . 74.299999999999997 108.889 174.606 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 87.2 mttt -62.98 136.56 57.91 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 107.919 -1.141 . . . . 55.310000000000002 107.919 178.271 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.446 HD12 ' HB3' ' A' ' 186' ' ' GLU . 25.8 mm -73.78 124.66 31.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 106.134 -1.802 . . . . 74.450000000000003 106.134 176.117 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -73.76 146.93 43.94 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.104 -1.073 . . . . 75.310000000000002 108.104 175.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 60.1 t -133.35 135.6 55.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 106.382 -1.71 . . . . 72.230000000000004 106.382 164.762 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 60.9 t -130.38 101.28 5.65 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 N-CA-C 106.4 -1.704 . . . . 62.030000000000001 106.4 -169.826 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -72.04 133.64 45.39 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 107.679 -1.23 . . . . 71.530000000000001 107.679 164.294 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.1 mp -119.71 126.87 52.13 Favored 'General case' 0 C--O 1.231 0.109 0 N-CA-C 108.536 -0.912 . . . . 74.319999999999993 108.536 167.835 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 21.6 p90 -135.3 163.59 29.66 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 124.649 1.18 . . . . 70.040000000000006 111.131 -171.007 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' TRP . . . . . 0.449 ' HB3' HG21 ' A' ' 153' ' ' VAL . 34.2 t90 -143.44 157.75 44.2 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 124.647 1.179 . . . . 73.239999999999995 107.948 173.672 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 31.3 t80 -46.23 -57.88 4.16 Favored 'General case' 0 N--CA 1.444 -0.745 0 C-N-CA 128.063 2.545 . . . . 75.340000000000003 113.707 -177.11 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -75.46 -83.68 0.41 Allowed Glycine 0 N--CA 1.444 -0.767 0 N-CA-C 108.548 -1.821 . . . . 72.099999999999994 108.548 -170.842 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 9.1 t 42.63 65.53 5.1 Favored Pre-proline 0 CA--C 1.541 0.62 0 C-N-CA 126.032 1.733 . . . . 63.409999999999997 112.752 164.128 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -62.57 -20.12 69.81 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 122.413 2.076 . . . . 74.239999999999995 112.471 -175.624 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 15.1 m-70 -83.95 -21.4 31.8 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 117.732 -1.128 . . . . 74.409999999999997 113.938 172.852 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 99.0 m -68.16 -41.87 80.9 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 119.931 1.241 . . . . 74.519999999999996 109.56 175.141 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 19.1 t80 -54.06 -42.81 69.68 Favored 'General case' 0 C--N 1.341 0.202 0 C-N-CA 124.155 0.982 . . . . 75.140000000000001 110.804 -174.726 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -51.68 -43.87 62.88 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.815 0.846 . . . . 71.129999999999995 111.909 -179.094 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -76.84 -24.59 52.7 Favored 'General case' 0 C--O 1.225 -0.231 0 CA-C-O 117.061 -1.447 . . . . 71.349999999999994 112.725 -171.613 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -44.45 -67.79 0.33 Allowed Pre-proline 0 CA--C 1.543 0.68 0 CA-C-N 120.421 1.464 . . . . 75.129999999999995 113.677 -170.037 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -70.92 -4.62 15.17 Favored 'Trans proline' 0 CA--C 1.536 0.611 0 C-N-CA 121.801 1.667 . . . . 54.049999999999997 112.815 -175.413 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -96.52 -0.8 48.38 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 127.181 2.192 . . . . 55.100000000000001 111.151 173.461 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 20.6 tt -126.93 -28.38 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 CA-C-N 120.885 1.675 . . . . 74.010000000000005 112.978 171.769 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 54.6 t -50.92 -60.14 6.14 Favored Pre-proline 0 CA--C 1.538 0.493 0 CA-C-N 119.612 1.096 . . . . 73.510000000000005 110.974 178.14 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -69.16 -32.51 20.93 Favored 'Trans proline' 0 N--CA 1.451 -0.998 0 CA-C-N 121.07 1.418 . . . . 43.340000000000003 111.067 -175.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.451 ' CZ2' ' HB1' ' A' ' 179' ' ' ALA . 83.4 t90 -53.38 -53.41 51.51 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 119.842 1.201 . . . . 73.299999999999997 110.242 173.928 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 21.5 t -60.48 -37.42 81.0 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.676 0.79 . . . . 73.549999999999997 111.288 -177.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -61.66 -45.82 92.41 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 119.32 0.963 . . . . 63.43 110.88 173.083 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 2.6 mptp? -83.49 7.93 15.51 Favored 'General case' 0 C--O 1.234 0.261 0 O-C-N 120.625 -1.297 . . . . 73.420000000000002 113.544 -169.081 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 35.2 mt -61.59 157.49 47.01 Favored Pre-proline 0 CA--C 1.537 0.471 0 C-N-CA 125.198 1.399 . . . . 70.319999999999993 111.784 179.558 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -74.85 167.98 25.87 Favored 'Trans proline' 0 N--CA 1.451 -0.993 0 C-N-CA 124.752 3.635 . . . . 73.129999999999995 110.548 172.123 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -77.69 -4.95 48.75 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.755 0.822 . . . . 55.329999999999998 113.133 178.568 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -94.43 7.04 46.91 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 119.272 0.942 . . . . 72.420000000000002 110.647 177.408 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 96.8 t -126.55 138.0 56.06 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 N-CA-C 106.715 -1.587 . . . . 64.519999999999996 106.715 -177.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 68.5 t60 -123.48 108.84 13.11 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 124.9 1.28 . . . . 72.340000000000003 108.747 -178.004 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 51.8 t80 -87.81 137.55 32.24 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 123.788 0.835 . . . . 72.340000000000003 109.528 -178.275 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 47.7 t -136.28 150.18 27.66 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 C-N-CA 126.215 1.806 . . . . 74.019999999999996 107.409 -174.444 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 30.4 mtp180 -132.72 126.08 31.69 Favored 'General case' 0 C--O 1.232 0.166 0 N-CA-C 106.885 -1.524 . . . . 72.219999999999999 106.885 -176.627 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 86.8 mt -138.47 144.82 44.11 Favored Pre-proline 0 N--CA 1.467 0.402 0 C-N-CA 124.141 0.976 . . . . 62.329999999999998 109.587 -178.181 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -74.79 152.82 42.37 Favored 'Trans proline' 0 N--CA 1.456 -0.735 0 C-N-CA 122.14 1.893 . . . . 73.439999999999998 111.672 177.865 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -89.48 107.21 18.94 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 125.237 1.415 . . . . 61.039999999999999 109.09 177.483 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.442 HD13 ' HE3' ' A' ' 138' ' ' MET . 39.8 mt -105.71 78.59 1.36 Allowed 'General case' 0 C--O 1.236 0.356 0 C-N-CA 125.151 1.381 . . . . 61.109999999999999 108.103 -173.611 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -121.96 59.95 0.99 Allowed 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 124.706 1.202 . . . . 62.340000000000003 110.197 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 68.85 164.74 3.58 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 125.983 1.754 . . . . 71.319999999999993 114.174 167.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 48.72 -142.7 8.6 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 124.252 0.929 . . . . 74.109999999999999 111.276 -175.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -56.7 -17.29 4.83 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 C-N-CA 124.71 1.204 . . . . 63.100000000000001 113.524 -175.914 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 13.3 m95 -60.97 -42.85 99.1 Favored 'General case' 0 C--N 1.341 0.211 0 O-C-N 120.442 -1.411 . . . . 75.239999999999995 109.959 178.435 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 7.5 m-80 -72.21 -17.97 61.88 Favored 'General case' 0 CA--C 1.527 0.095 0 O-C-N 121.566 -0.709 . . . . 74.310000000000002 112.512 176.528 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 64.8 t -92.53 -13.25 8.76 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 C-N-CA 123.786 0.834 . . . . 74.400000000000006 111.605 -173.658 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 52.0 m170 -115.45 4.49 14.3 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.342 1.057 . . . . 74.140000000000001 111.924 172.141 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -102.93 -41.73 2.22 Favored Glycine 0 N--CA 1.448 -0.526 0 N-CA-C 109.518 -1.433 . . . . 43.409999999999997 109.518 -176.804 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . 0.268 1.3 pm0 -49.12 -43.86 41.85 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 125.16 1.384 . . . . 75.129999999999995 113.027 -179.689 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 5.1 ppp? -54.35 -37.16 64.61 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 114.154 1.168 . . . . 64.129999999999995 114.154 -172.276 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 39.4 t80 -56.49 -43.07 79.34 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 122.835 1.302 . . . . 74.140000000000001 109.049 -172.2 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 12.9 mt -68.87 -34.8 76.05 Favored 'General case' 0 N--CA 1.442 -0.867 0 C-N-CA 125.991 1.716 . . . . 75.150000000000006 110.729 -177.87 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.75 HG22 HG23 ' A' ' 128' ' ' THR . 0.0 OUTLIER -68.53 -50.99 47.8 Favored 'General case' 0 C--N 1.344 0.356 0 CA-C-N 121.125 1.784 . . . . 71.5 110.182 176.026 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.464 HD21 HD22 ' A' ' 115' ' ' LEU . 0.7 OUTLIER -51.09 -52.96 38.42 Favored 'General case' 0 CA--C 1.535 0.376 0 O-C-N 123.968 0.793 . . . . 75.129999999999995 109.459 -177.543 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -65.12 -28.14 69.22 Favored 'General case' 0 N--CA 1.465 0.289 0 O-C-N 121.517 -0.739 . . . . 35.130000000000003 112.866 -179.408 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 8.5 t -69.63 -19.76 63.62 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 118.09 -0.957 . . . . 64.510000000000005 111.682 -175.678 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 4.9 ptp -93.6 -16.97 23.82 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 121.116 1.78 . . . . 74.219999999999999 112.364 170.794 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 79.7 63.46 2.0 Favored Glycine 0 CA--C 1.522 0.47 0 N-CA-C 109.153 -1.579 . . . . 22.440000000000001 109.153 -179.26 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 4.4 m -58.27 107.72 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 C-N-CA 124.336 1.054 . . . . 71.120000000000005 109.761 178.508 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -92.13 172.06 8.68 Favored 'General case' 0 C--O 1.237 0.446 0 O-C-N 121.363 -0.835 . . . . 75.099999999999994 109.143 170.625 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 6.8 t-160 76.15 19.98 1.71 Allowed 'General case' 0 C--O 1.242 0.692 0 C-N-CA 127.485 2.314 . . . . 74.049999999999997 113.545 176.562 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -153.9 154.83 34.58 Favored 'General case' 0 CA--C 1.546 0.815 0 O-C-N 120.968 -1.083 . . . . 73.420000000000002 108.988 154.181 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.0 t -77.18 29.07 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 127.761 2.424 . . . . 73.140000000000001 112.481 -174.415 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 71.9 m80 50.0 48.55 21.76 Favored 'General case' 0 CA--C 1.544 0.749 0 O-C-N 120.401 -1.437 . . . . 53.219999999999999 109.832 -168.48 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 40.7 m-20 -130.23 -48.78 1.1 Allowed 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 128.092 2.557 . . . . 61.100000000000001 109.055 -178.005 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -68.34 -22.35 64.69 Favored 'General case' 0 N--CA 1.449 -0.478 0 O-C-N 121.471 -0.768 . . . . 60.130000000000003 111.663 -174.623 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 57.3 t -60.05 -65.08 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 CA-C-N 119.997 1.271 . . . . 65.340000000000003 108.258 164.182 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -51.4 -49.36 61.72 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 125.114 1.366 . . . . 74.099999999999994 112.086 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.418 ' OE1' ' HE3' ' A' ' 100' ' ' LYS . 3.5 mm-40 -62.04 -13.8 29.64 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 126.825 2.05 . . . . 71.549999999999997 112.442 -178.272 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.451 ' HB1' ' CZ ' ' A' ' 114' ' ' PHE . . . -108.0 1.51 22.55 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 125.638 1.575 . . . . 74.329999999999998 111.024 178.871 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 28.3 mt -110.74 -58.1 3.78 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.286 0 N-CA-C 107.741 -1.207 . . . . 72.109999999999999 107.741 172.173 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 80.3 m-70 -66.37 -60.7 2.51 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 119.051 0.841 . . . . 73.239999999999995 111.09 -177.641 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.418 ' HE3' ' OE1' ' A' ' 96' ' ' GLU . 0.6 OUTLIER -68.17 -30.0 69.01 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 118.999 0.818 . . . . 75.540000000000006 110.646 -174.06 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -98.38 -36.89 9.83 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 123.84 0.856 . . . . 70.239999999999995 111.715 -168.548 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 5.0 t-160 44.26 57.31 4.37 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 128.713 2.805 . . . . 72.219999999999999 112.778 178.004 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -64.88 -173.37 0.11 Allowed 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.897 1.679 . . . . 71.140000000000001 111.756 170.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 18.8 ttmm -109.49 54.3 0.66 Allowed 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 126.447 1.899 . . . . 72.319999999999993 110.415 175.09 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 24.8 mt -75.39 58.32 0.98 Allowed 'General case' 0 C--N 1.322 -0.587 0 C-N-CA 127.479 2.311 . . . . 72.230000000000004 108.452 179.323 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -114.6 -2.36 13.12 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 127.832 2.453 . . . . 74.150000000000006 111.346 -171.307 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 45.1 p -135.4 151.28 74.5 Favored Pre-proline 0 C--O 1.232 0.14 0 C-N-CA 124.729 1.212 . . . . 51.229999999999997 108.715 179.629 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -66.59 -23.83 49.17 Favored 'Trans proline' 0 N--CA 1.459 -0.5 0 C-N-CA 121.888 1.725 . . . . 71.409999999999997 111.955 179.01 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -58.27 -60.32 3.94 Favored 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 124.71 1.204 . . . . 75.109999999999999 110.479 167.034 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 19.5 tp10 -66.49 -40.07 89.09 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 120.978 -0.289 . . . . 53.450000000000003 110.842 -174.06 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 3.6 mtt -67.01 -47.06 72.62 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 120.722 -0.391 . . . . 74.450000000000003 111.447 -175.007 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -63.28 -48.35 78.49 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 118.94 -0.552 . . . . 54.219999999999999 110.59 -177.558 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -70.96 -5.42 30.83 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 118.847 0.748 . . . . 53.119999999999997 112.928 -178.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' PHE . . . . . 0.451 ' CZ ' ' HB1' ' A' ' 97' ' ' ALA . 87.0 t80 -100.18 -35.22 9.73 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 124.626 1.17 . . . . 63.049999999999997 112.38 176.528 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.464 HD22 HD21 ' A' ' 81' ' ' LEU . 76.9 mt -83.22 -17.75 41.66 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 123.134 0.574 . . . . 72.329999999999998 111.166 175.502 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -52.17 -30.31 26.33 Favored 'General case' 0 CA--C 1.528 0.115 0 C-N-CA 125.765 1.626 . . . . 73.299999999999997 112.657 -175.375 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -93.28 -2.0 66.3 Favored Glycine 0 N--CA 1.441 -1.01 0 CA-C-O 118.473 -1.182 . . . . 73.049999999999997 112.312 -175.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.12 39.46 3.11 Favored 'General case' 0 C--N 1.342 0.242 0 CA-C-N 119.134 1.467 . . . . 72.209999999999994 111.273 -163.569 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 90.45 11.57 62.32 Favored Glycine 0 CA--C 1.527 0.785 0 CA-C-O 118.541 -1.144 . . . . 51.420000000000002 113.849 169.319 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 30.7 t -113.36 128.92 69.94 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 C-N-CA 125.643 1.577 . . . . 73.030000000000001 107.237 175.645 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -99.16 141.13 32.32 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 122.884 0.474 . . . . 54.240000000000002 111.811 173.57 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 5.1 mtmt -66.15 -33.82 76.64 Favored 'General case' 0 CA--C 1.537 0.449 0 O-C-N 121.501 -0.749 . . . . 74.239999999999995 111.423 178.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -64.9 -33.61 76.43 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 125.116 1.367 . . . . 75.049999999999997 111.323 178.698 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 7.2 mmtp -79.55 -50.77 10.22 Favored 'General case' 0 C--O 1.23 0.066 0 N-CA-C 107.888 -1.153 . . . . 61.030000000000001 107.888 172.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 52.0 t80 -53.39 -67.47 0.25 Allowed 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.831 1.252 . . . . 72.519999999999996 113.332 -165.607 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 25.4 mt -62.79 -38.84 92.25 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 122.738 0.415 . . . . 65.109999999999999 111.228 -165.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 22.5 t -57.43 -46.5 83.48 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 124.16 0.984 . . . . 72.349999999999994 111.295 -176.31 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' THR . . . . . 0.75 HG23 HG22 ' A' ' 80' ' ' THR . 9.9 t -80.73 -33.66 35.02 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 110.355 -0.239 . . . . 73.239999999999995 110.355 178.732 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 76.8 t80 -55.62 -38.28 69.29 Favored 'General case' 0 C--O 1.237 0.396 0 O-C-N 121.266 -0.896 . . . . 70.209999999999994 111.138 176.091 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -91.99 16.83 10.31 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.428 1.491 . . . . 75.040000000000006 112.082 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 2.2 p -106.48 171.89 7.11 Favored 'General case' 0 C--O 1.24 0.589 0 CA-C-N 119.804 1.183 . . . . 71.239999999999995 111.895 -175.092 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -67.2 -17.78 64.97 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 123.883 0.873 . . . . 74.0 112.081 172.34 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -57.9 -56.31 23.62 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 119.106 0.866 . . . . 74.209999999999994 109.29 178.349 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 13.7 mm -59.39 -41.33 84.07 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.134 0 CA-C-O 119.169 -0.443 . . . . 63.25 110.583 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 13.0 mttt -57.31 -35.14 69.46 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 119.31 0.959 . . . . 71.219999999999999 111.637 175.308 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -81.61 -22.38 60.21 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 125.071 1.32 . . . . 64.349999999999994 113.009 -178.183 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -82.39 -39.6 22.46 Favored 'General case' 0 CA--C 1.535 0.399 0 O-C-N 121.382 -1.069 . . . . 74.120000000000005 110.097 173.348 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' MET . . . . . 0.442 ' HE3' HD13 ' A' ' 66' ' ' LEU . 92.8 mmm -61.26 -41.19 96.5 Favored 'General case' 0 C--O 1.231 0.099 0 C-N-CA 124.105 0.962 . . . . 62.299999999999997 111.169 -179.767 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -57.13 -43.13 82.12 Favored 'General case' 0 CA--C 1.535 0.4 0 O-C-N 121.032 -1.043 . . . . 52.130000000000003 111.375 178.199 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 13.3 mtmt -60.29 -66.06 0.58 Allowed 'General case' 0 C--N 1.342 0.272 0 CA-C-N 118.549 0.613 . . . . 75.040000000000006 110.518 176.216 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -59.94 -26.97 66.39 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 119.027 0.83 . . . . 75.299999999999997 111.64 -170.421 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.55 -56.11 8.26 Favored 'General case' 0 C--N 1.34 0.158 0 O-C-N 121.368 -0.832 . . . . 74.299999999999997 110.509 176.411 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.55 -32.7 73.66 Favored 'General case' 0 C--N 1.342 0.26 0 CA-C-N 119.172 0.896 . . . . 64.099999999999994 110.365 -177.839 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 42.1 mt -59.67 -54.97 40.17 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 118.007 -0.997 . . . . 73.420000000000002 110.288 179.263 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -54.66 -37.44 65.72 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 119.616 1.098 . . . . 74.209999999999994 112.166 -178.636 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -73.25 -42.7 62.23 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 122.903 0.481 . . . . 53.140000000000001 110.777 -179.808 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -59.83 -44.95 93.8 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 123.605 0.762 . . . . 31.140000000000001 109.099 175.624 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 15.9 m-85 -63.0 -7.35 5.12 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.242 1.417 . . . . 73.409999999999997 113.337 177.151 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 61.7 mt-30 56.21 47.56 19.13 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 127.208 2.203 . . . . 75.230000000000004 111.01 -174.07 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 95.3 t -82.72 141.54 14.82 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 O-C-N 120.665 -1.272 . . . . 34.25 108.196 178.216 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 11.7 p -104.93 -19.75 13.76 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 124.178 0.991 . . . . 73.420000000000002 113.092 -174.529 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 179.12 -148.08 8.04 Favored Glycine 0 N--CA 1.452 -0.275 0 N-CA-C 108.81 -1.716 . . . . 61.329999999999998 108.81 -170.537 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.449 HG21 ' HB3' ' A' ' 34' ' ' TRP . 22.3 m -147.09 153.93 45.81 Favored Pre-proline 0 C--O 1.243 0.738 0 C-N-CA 127.115 2.166 . . . . 74.230000000000004 106.717 167.46 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' PRO . . . . . 0.483 ' HG3' HD12 ' A' ' 166' ' ' ILE . 98.2 Cg_endo -66.9 158.24 81.64 Favored 'Cis proline' 0 N--CA 1.458 -0.587 0 C-N-CA 124.132 -1.195 . . . . 64.329999999999998 112.154 -3.633 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 97.8 m -156.82 146.46 20.69 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 106.391 -1.707 . . . . 55.109999999999999 106.391 172.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 28.7 mmm -114.78 165.48 12.78 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 106.689 -1.596 . . . . 60.329999999999998 106.689 161.096 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 78.0 t -137.41 143.9 33.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 106.383 -1.71 . . . . 75.409999999999997 106.383 160.852 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.5 HG23 ' CE1' ' A' ' 164' ' ' PHE . 20.0 t -105.21 134.48 46.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 N-CA-C 105.915 -1.883 . . . . 64.540000000000006 105.915 162.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 4.0 t30 50.77 17.02 0.36 Allowed 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 130.197 3.399 . . . . 72.109999999999999 116.359 166.024 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 70.23 25.23 75.92 Favored Glycine 0 CA--C 1.527 0.836 0 CA-C-O 117.231 -1.872 . . . . 73.5 113.659 -171.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 21.6 mtpt -128.72 -37.05 1.79 Allowed 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 119.878 1.839 . . . . 73.510000000000005 114.032 179.202 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' TYR . . . . . 0.424 ' CE1' ' HG3' ' A' ' 14' ' ' GLU . 76.6 m-85 -121.4 108.79 14.1 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 119.708 1.14 . . . . 72.420000000000002 111.557 -168.126 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 18.9 ptt180 -90.56 32.79 0.94 Allowed 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 126.96 2.104 . . . . 74.239999999999995 115.532 -171.318 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' PHE . . . . . 0.5 ' CE1' HG23 ' A' ' 158' ' ' VAL . 4.0 p90 -52.06 155.51 1.86 Allowed 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 122.154 0.978 . . . . 63.229999999999997 110.085 -177.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -160.96 174.66 13.47 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 107.811 -1.181 . . . . 65.400000000000006 107.811 -175.35 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.483 HD12 ' HG3' ' A' ' 154' ' ' PRO . 3.5 mt -46.3 -52.67 3.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 C-N-CA 126.108 1.763 . . . . 71.129999999999995 108.163 161.354 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -78.28 19.72 4.46 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 126.828 2.156 . . . . 33.32 114.621 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 18.8 m -125.27 -48.89 1.7 Allowed 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 119.37 1.585 . . . . 74.510000000000005 109.12 154.393 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -63.2 -34.84 78.52 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-O 118.166 -0.921 . . . . 53.439999999999998 112.909 -170.276 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 117.75 5.5 13.87 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 123.586 0.612 . . . . 72.420000000000002 113.547 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 153.35 174.39 23.6 Favored Glycine 0 CA--C 1.527 0.805 0 CA-C-N 119.22 1.51 . . . . 45.210000000000001 110.543 177.03 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -64.05 -45.18 10.72 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 122.308 2.005 . . . . 63.25 110.826 -173.532 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -66.41 -39.46 89.02 Favored 'General case' 0 N--CA 1.453 -0.304 0 O-C-N 121.269 -0.895 . . . . 75.120000000000005 110.173 177.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -62.58 -27.45 69.2 Favored 'General case' 0 CA--C 1.537 0.466 0 O-C-N 122.306 -0.246 . . . . 71.209999999999994 110.932 175.775 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 24.9 m -61.84 -45.9 91.79 Favored 'General case' 0 CA--C 1.534 0.354 0 O-C-N 120.469 -1.394 . . . . 63.5 109.537 179.646 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 33.2 mt -65.51 -24.38 67.12 Favored 'General case' 0 N--CA 1.466 0.366 0 O-C-N 121.365 -0.834 . . . . 72.329999999999998 112.043 177.699 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.74 -46.18 74.24 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-O 118.796 -0.621 . . . . 71.420000000000002 109.427 169.89 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -76.51 -39.35 53.29 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-O 117.27 -1.348 . . . . 74.209999999999994 110.565 -178.662 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.451 ' HB1' ' CZ2' ' A' ' 50' ' ' TRP . . . -52.65 -49.88 64.32 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 120.015 1.28 . . . . 71.310000000000002 111.754 -172.088 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -66.1 -45.33 81.57 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 125.235 1.414 . . . . 44.240000000000002 110.786 -173.503 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -62.45 -46.88 86.51 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 126.003 1.721 . . . . 74.319999999999993 111.448 176.264 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 83.0 mt -64.32 -38.83 92.44 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 118.487 -0.768 . . . . 74.129999999999995 110.118 -176.298 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 39.5 mt -55.6 -51.5 57.66 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 CA-C-N 119.369 0.986 . . . . 74.299999999999997 108.655 172.333 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 184' ' ' GLU . . . . . 0.406 ' HA ' ' HD3' ' A' ' 187' ' ' ARG . 6.2 tm-20 -67.97 7.4 0.54 Allowed 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 127.378 2.271 . . . . 75.430000000000007 114.414 174.613 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 185' ' ' LYS . . . . . 0.444 ' HE3' ' HA ' ' A' ' 185' ' ' LYS . 0.5 OUTLIER -110.73 -45.29 3.51 Favored 'General case' 0 N--CA 1.454 -0.252 0 O-C-N 120.841 -1.162 . . . . 71.450000000000003 108.823 165.74 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 186' ' ' GLU . . . . . 0.696 ' HA ' ' HB3' ' A' ' 189' ' ' ALA . 26.9 mm-40 -54.66 -38.49 67.0 Favored 'General case' 0 CA--C 1.512 -0.495 0 C-N-CA 126.326 1.85 . . . . 61.240000000000002 115.403 -173.835 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 187' ' ' ARG . . . . . 0.406 ' HD3' ' HA ' ' A' ' 184' ' ' GLU . 0.0 OUTLIER -55.73 -23.41 29.01 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 118.624 -1.23 . . . . 72.109999999999999 114.14 -176.586 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -103.05 -20.29 14.24 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 126.484 1.914 . . . . 74.510000000000005 113.084 175.126 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 189' ' ' ALA . . . . . 0.696 ' HB3' ' HA ' ' A' ' 186' ' ' GLU . . . -83.99 -20.73 32.33 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.785 1.634 . . . . 73.25 112.67 -174.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -151.66 72.66 1.04 Allowed 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.029 1.332 . . . . 42.299999999999997 110.435 173.74 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 4.5 pttt -88.61 53.47 2.72 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 124.51 1.124 . . . . 70.420000000000002 111.983 -175.221 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 24.1 mttt . . . . . 0 C--O 1.248 0.976 0 N-CA-C 106.29 -1.744 . . . . 72.25 106.29 142.934 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.506 -0.505 0 N-CA-C 108.946 -1.662 . . . . 64.510000000000005 108.946 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.412 ' C ' ' H ' ' A' ' 6' ' ' TYR . 1.3 m-20 43.46 66.8 0.74 Allowed 'General case' 0 C--N 1.341 0.203 0 C-N-CA 125.87 1.668 . . . . 70.409999999999997 110.159 155.152 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -75.04 25.18 0.09 Allowed 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.517 1.127 . . . . 74.010000000000005 113.161 -172.386 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.412 ' H ' ' C ' ' A' ' 4' ' ' ASP . 33.1 m-85 -140.53 170.3 16.05 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 128.19 2.596 . . . . 75.340000000000003 108.838 -176.418 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 95.0 m -141.69 137.48 31.76 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 124.932 1.293 . . . . 61.340000000000003 108.269 176.541 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.66 130.62 43.93 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 108.729 -0.841 . . . . 73.329999999999998 108.729 172.69 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 80.07 15.92 77.83 Favored Glycine 0 CA--C 1.525 0.681 0 CA-C-O 119.33 -0.705 . . . . 63.100000000000001 112.966 -174.3 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.1 tpmt? -133.25 -55.99 0.91 Allowed 'General case' 0 CA--C 1.519 -0.242 0 CA-C-N 118.384 1.092 . . . . 65.340000000000003 109.345 -177.146 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.436 ' HB3' HD21 ' A' ' 178' ' ' LEU . 8.1 mp0 -105.42 -21.2 13.27 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 124.388 1.075 . . . . 74.519999999999996 110.642 179.362 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 42.6 p90 -159.44 168.16 26.95 Favored 'General case' 0 C--O 1.234 0.253 0 O-C-N 121.119 -0.988 . . . . 64.120000000000005 110.641 -171.781 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 84.0 t -126.13 111.47 26.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 C-N-CA 124.894 1.277 . . . . 63.0 108.504 178.054 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -78.08 165.61 23.79 Favored 'General case' 0 C--O 1.239 0.5 0 O-C-N 120.871 -1.143 . . . . 64.549999999999997 109.246 169.812 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -133.87 111.41 10.46 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 126.011 1.725 . . . . 73.310000000000002 107.333 -175.728 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 76.3 p -65.24 0.24 1.48 Allowed 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 125.985 1.714 . . . . 45.43 113.26 179.08 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 38.6 m -128.92 73.74 81.4 Favored Pre-proline 0 N--CA 1.439 -1.001 0 N-CA-C 105.397 -2.075 . . . . 55.350000000000001 105.397 -176.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -72.93 177.86 7.18 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 124.211 3.274 . . . . 52.049999999999997 110.922 -170.209 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 6.1 t -140.61 116.67 7.67 Favored Pre-proline 0 CA--C 1.537 0.46 0 C-N-CA 123.321 0.648 . . . . 74.200000000000003 109.442 176.633 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -72.79 -176.36 2.3 Favored 'Trans proline' 0 CA--C 1.537 0.672 0 C-N-CA 123.858 3.038 . . . . 70.219999999999999 110.854 171.011 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.407 HG11 ' CD ' ' A' ' 28' ' ' GLU . 3.5 m -133.85 160.61 41.89 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 N-CA-C 106.016 -1.846 . . . . 44.420000000000002 106.016 176.723 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 3.4 m -47.75 -66.88 0.33 Allowed 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 125.392 1.477 . . . . 63.119999999999997 113.766 166.62 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 11.8 tp60 -128.71 81.25 71.12 Favored Pre-proline 0 N--CA 1.469 0.48 0 C-N-CA 123.9 0.88 . . . . 61.299999999999997 108.718 -169.003 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.507 ' C ' ' H ' ' A' ' 26' ' ' LYS . 36.2 Cg_endo -73.05 -57.51 0.07 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.095 0 CA-C-N 119.122 0.722 . . . . 71.349999999999994 110.314 179.236 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 51.35 -23.34 0.01 OUTLIER Glycine 0 CA--C 1.53 1.019 0 C-N-CA 127.831 2.634 . . . . 31.239999999999998 115.243 -159.566 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.507 ' H ' ' C ' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -140.05 -167.06 2.22 Favored 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 129.548 3.139 . . . . 74.450000000000003 105.483 -161.931 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.53 HD12 ' HB3' ' A' ' 186' ' ' GLU . 30.4 mm -87.75 130.65 37.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 N-CA-C 106.207 -1.775 . . . . 74.209999999999994 106.207 168.515 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.407 ' CD ' HG11 ' A' ' 21' ' ' VAL . 5.0 tp10 -69.71 140.04 53.48 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 105.608 -1.997 . . . . 65.329999999999998 105.608 173.131 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 54.8 t -128.2 134.32 65.21 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 N-CA-C 105.769 -1.937 . . . . 55.420000000000002 105.769 160.463 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 30.1 t -123.14 112.71 34.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 105.95 -1.87 . . . . 74.209999999999994 105.95 172.608 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 62.6 tt0 -72.26 122.01 20.36 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 106.347 -1.723 . . . . 74.540000000000006 106.347 156.716 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.489 HD22 HG21 ' A' ' 150' ' ' VAL . 4.5 mp -109.65 137.91 46.78 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-N 119.212 0.914 . . . . 55.219999999999999 108.919 166.119 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 9.5 p90 -145.66 171.26 14.98 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 122.986 0.514 . . . . 75.239999999999995 110.487 -168.533 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' TRP . . . . . 0.421 ' HB3' HG21 ' A' ' 153' ' ' VAL . 42.2 t90 -156.7 151.57 25.97 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.38 1.472 . . . . 75.329999999999998 109.9 171.942 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 19.4 t80 -45.58 -48.49 14.5 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 127.789 2.436 . . . . 71.209999999999994 114.408 -174.78 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -75.14 -88.59 0.23 Allowed Glycine 0 C--N 1.341 0.806 0 N-CA-C 109.75 -1.34 . . . . 72.400000000000006 109.75 -169.382 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 12.7 t 42.76 72.49 1.13 Allowed Pre-proline 0 CA--C 1.538 0.483 0 C-N-CA 126.44 1.896 . . . . 74.340000000000003 112.955 160.237 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -59.16 -38.83 84.13 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 121.191 1.261 . . . . 52.210000000000001 112.199 -178.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 17.8 m170 -65.79 -30.38 71.02 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 119.142 0.883 . . . . 73.329999999999998 111.031 -179.125 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 82.1 m -62.67 -38.11 89.06 Favored 'General case' 0 C--N 1.343 0.32 0 CA-C-N 118.407 0.549 . . . . 64.129999999999995 110.158 177.853 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 38.6 t80 -62.0 -44.28 97.06 Favored 'General case' 0 C--N 1.339 0.139 0 O-C-N 121.614 -0.679 . . . . 62.409999999999997 110.828 -175.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -56.52 -34.45 67.02 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 118.285 0.493 . . . . 53.32 111.333 178.619 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.46 ' HB2' HD11 ' A' ' 166' ' ' ILE . 6.0 t80 -82.52 -16.0 50.28 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.837 1.655 . . . . 75.319999999999993 113.445 -178.462 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -43.26 -63.48 0.99 Allowed Pre-proline 0 CA--C 1.539 0.554 0 CA-C-N 120.042 1.292 . . . . 75.329999999999998 112.422 -173.218 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -85.79 -7.36 8.46 Favored 'Trans proline' 0 N--CA 1.452 -0.921 0 C-N-CA 121.645 1.563 . . . . 64.530000000000001 114.687 -174.828 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 26.0 m -66.01 -46.84 76.49 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 107.355 -1.35 . . . . 75.040000000000006 107.355 166.204 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 20.5 tt -84.2 -35.31 10.72 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 N-CA-C 113.528 0.936 . . . . 64.299999999999997 113.528 -166.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 42.9 t -48.16 -61.18 3.34 Favored Pre-proline 0 CA--C 1.545 0.779 0 O-C-N 121.237 -0.914 . . . . 73.430000000000007 111.803 178.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -72.5 -6.59 19.33 Favored 'Trans proline' 0 N--CA 1.454 -0.794 0 C-N-CA 122.007 1.805 . . . . 64.420000000000002 113.708 -177.421 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.43 ' CZ2' ' HB1' ' A' ' 179' ' ' ALA . 79.8 t90 -72.25 -62.48 1.42 Allowed 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 120.085 1.312 . . . . 73.329999999999998 107.691 161.185 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 22.4 p -53.79 -33.3 55.55 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 115.035 1.494 . . . . 64.219999999999999 115.035 -169.509 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 58.4 mt-10 -80.45 -24.84 39.29 Favored 'General case' 0 CA--C 1.54 0.572 0 O-C-N 120.663 -1.273 . . . . 70.030000000000001 112.007 -179.678 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 11.1 mptt -96.2 9.26 41.57 Favored 'General case' 0 C--O 1.225 -0.196 0 C-N-CA 124.97 1.308 . . . . 62.350000000000001 112.009 -168.555 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 35.2 mt -62.15 160.14 33.26 Favored Pre-proline 0 C--O 1.242 0.661 0 C-N-CA 129.327 3.051 . . . . 73.109999999999999 113.41 -177.672 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -80.09 170.18 16.75 Favored 'Trans proline' 0 N--CA 1.448 -1.164 0 C-N-CA 124.752 3.634 . . . . 72.129999999999995 110.273 176.759 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -70.1 -5.06 24.24 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 124.112 0.965 . . . . 72.209999999999994 112.919 -179.453 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -104.38 9.61 35.69 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.428 1.091 . . . . 72.340000000000003 111.988 -171.684 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.448 HG21 HD13 ' A' ' 183' ' ' ILE . 93.1 t -120.46 149.52 23.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 N-CA-C 108.166 -1.05 . . . . 73.150000000000006 108.166 -177.772 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 21.9 t-160 -124.88 84.75 2.32 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 128.092 2.557 . . . . 72.420000000000002 105.931 -179.127 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 45.5 t80 -68.26 129.43 39.9 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 108.794 -0.817 . . . . 75.420000000000002 108.794 174.045 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 40.7 t -136.21 155.13 34.41 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.651 0 C-N-CA 126.461 1.904 . . . . 42.119999999999997 106.351 175.634 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 34.6 mtp180 -133.28 123.35 25.34 Favored 'General case' 0 CA--C 1.515 -0.375 0 N-CA-C 105.371 -2.085 . . . . 74.299999999999997 105.371 -176.445 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 78.0 mt -134.62 144.58 51.4 Favored Pre-proline 0 CA--C 1.533 0.307 0 CA-C-N 119.461 1.028 . . . . 71.400000000000006 110.716 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -77.1 129.32 10.42 Favored 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 122.589 2.192 . . . . 53.299999999999997 111.36 177.178 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -69.69 114.53 7.98 Favored 'General case' 0 CA--C 1.537 0.465 0 O-C-N 121.519 -0.738 . . . . 73.0 110.245 174.654 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.49 HD22 ' HA ' ' A' ' 72' ' ' ASN . 14.6 mt -106.62 103.15 12.52 Favored 'General case' 0 N--CA 1.466 0.351 0 O-C-N 121.059 -1.026 . . . . 62.210000000000001 110.247 -178.903 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -133.03 13.35 4.29 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 114.901 1.445 . . . . 73.519999999999996 114.901 -174.375 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -169.47 -116.9 0.39 Allowed Glycine 0 C--N 1.333 0.385 0 CA-C-N 119.603 1.092 . . . . 74.150000000000006 112.382 176.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -114.52 -73.6 0.58 Allowed Glycine 0 C--N 1.334 0.438 0 C-N-CA 126.225 1.869 . . . . 42.210000000000001 108.448 171.048 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 6.4 tp -58.84 -24.77 27.22 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-N 118.248 1.024 . . . . 64.040000000000006 112.164 -174.765 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 10.5 m95 -59.47 -48.8 80.26 Favored 'General case' 0 N--CA 1.455 -0.201 0 O-C-N 121.444 -0.785 . . . . 71.420000000000002 111.547 172.869 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.49 ' HA ' HD22 ' A' ' 66' ' ' LEU . 1.7 p-10 -77.94 -30.64 50.57 Favored 'General case' 0 CA--C 1.509 -0.601 0 CA-C-O 117.663 -1.161 . . . . 74.049999999999997 113.599 177.413 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 74.5 t -57.15 -58.22 6.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 108.824 -0.806 . . . . 73.510000000000005 108.824 172.652 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 37.4 m170 -65.58 -24.18 67.02 Favored 'General case' 0 CA--C 1.528 0.109 0 N-CA-C 112.416 0.525 . . . . 75.219999999999999 112.416 178.782 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -78.96 -18.99 73.77 Favored Glycine 0 N--CA 1.444 -0.804 0 CA-C-O 118.966 -0.908 . . . . 42.409999999999997 111.302 178.473 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.491 HE22 HD12 ' A' ' 134' ' ' ILE . 0.0 OUTLIER -66.71 -55.77 13.6 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 118.275 1.037 . . . . 73.400000000000006 109.606 -160.427 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 3.7 ptm -55.21 -28.78 55.54 Favored 'General case' 0 N--CA 1.454 -0.273 0 O-C-N 124.129 0.893 . . . . 75.430000000000007 113.294 -166.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 29.7 t80 -55.22 -52.06 64.59 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 124.007 0.923 . . . . 74.219999999999999 109.981 176.354 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 37.9 mt -66.54 -43.1 86.03 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 117.979 -1.01 . . . . 75.049999999999997 109.821 179.429 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.74 HG22 HG23 ' A' ' 128' ' ' THR . 0.2 OUTLIER -59.6 -41.67 90.86 Favored 'General case' 0 C--N 1.344 0.354 0 CA-C-N 120.3 1.409 . . . . 55.240000000000002 110.906 -179.31 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.4 -55.45 33.38 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 123.882 0.873 . . . . 62.399999999999999 109.077 -178.484 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -74.74 -14.53 60.73 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 112.505 0.558 . . . . 73.25 112.505 -177.589 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 3.2 t -70.44 -10.22 58.53 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.821 1.249 . . . . 72.319999999999993 112.222 171.384 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 43.4 mtm -100.44 6.9 44.47 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.423 1.089 . . . . 75.329999999999998 112.887 168.165 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 74.15 6.47 74.5 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 125.912 1.72 . . . . 54.130000000000003 113.611 171.163 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 29.2 m -55.34 123.35 6.08 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 C-N-CA 125.3 1.44 . . . . 54.509999999999998 111.401 -167.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -123.28 117.46 25.34 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 106.901 -1.518 . . . . 72.150000000000006 106.901 -165.376 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 52.4 -175.48 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.398 1.479 . . . . 73.510000000000005 113.368 -167.667 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 29.1 t70 62.88 -12.85 0.07 Allowed 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 127.693 2.397 . . . . 74.140000000000001 113.814 -164.838 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.4 p -135.65 133.53 51.66 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 C-N-CA 125.584 1.553 . . . . 42.200000000000003 110.117 178.495 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -178.51 -67.59 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 128.211 2.604 . . . . 71.230000000000004 109.408 166.308 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -63.43 -55.25 25.8 Favored 'General case' 0 CA--C 1.509 -0.615 0 C-N-CA 123.972 0.909 . . . . 75.200000000000003 109.793 -172.346 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -65.45 -14.87 61.89 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-O 118.872 -0.585 . . . . 60.119999999999997 112.003 -168.234 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.9 t -62.26 -76.8 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 N-CA-C 108.515 -0.92 . . . . 71.420000000000002 108.515 164.76 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -51.26 -46.92 62.54 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 126.018 1.727 . . . . 70.340000000000003 112.103 -176.785 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 22.2 mm-40 -60.9 -44.17 97.52 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.514 1.526 . . . . 71.200000000000003 109.242 -175.38 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -74.91 -3.49 32.39 Favored 'General case' 0 CA--C 1.531 0.245 0 O-C-N 120.62 -1.3 . . . . 73.219999999999999 113.158 -179.28 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 72.8 mt -104.18 -54.78 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 N-CA-C 106.554 -1.647 . . . . 74.019999999999996 106.554 177.204 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 90.7 m-70 -80.54 -56.13 4.38 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 123.495 0.718 . . . . 73.219999999999999 112.014 -173.629 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 2.2 mmtp -71.87 -12.95 61.52 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 123.753 0.821 . . . . 74.209999999999994 112.05 -178.355 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -117.07 -31.32 5.4 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.963 0.905 . . . . 74.310000000000002 112.494 -174.621 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 5.2 t60 45.15 61.04 2.7 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 125.903 1.681 . . . . 64.120000000000005 111.209 -176.515 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 7.8 mtpp -76.94 159.45 29.97 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.727 -1.124 . . . . 73.510000000000005 108.454 170.082 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 46.5 tttt -85.82 38.35 0.75 Allowed 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 125.726 1.61 . . . . 61.109999999999999 111.735 -173.736 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 43.3 mt -72.61 51.07 0.26 Allowed 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 128.815 2.846 . . . . 73.420000000000002 112.053 -167.146 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -103.12 3.66 36.14 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 129.463 3.105 . . . . 72.239999999999995 112.21 -177.553 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -134.39 156.03 79.26 Favored Pre-proline 0 N--CA 1.467 0.413 0 CA-C-N 118.556 0.616 . . . . 71.010000000000005 110.66 171.073 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -70.89 -19.84 30.25 Favored 'Trans proline' 0 N--CA 1.449 -1.108 0 C-N-CA 121.658 1.572 . . . . 62.549999999999997 111.889 -177.343 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.7 -62.95 1.48 Allowed 'General case' 0 C--O 1.224 -0.255 0 CA-C-N 119.859 1.209 . . . . 64.310000000000002 108.961 168.11 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -45.79 -56.55 5.2 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 127.229 2.211 . . . . 72.450000000000003 110.413 178.358 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 57.4 mtt -54.91 -50.45 68.77 Favored 'General case' 0 N--CA 1.458 -0.065 0 C-N-CA 123.7 0.8 . . . . 61.130000000000003 111.354 -178.719 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.632 ' HB1' ' HG3' ' A' ' 122' ' ' LYS . . . -77.1 -40.63 45.21 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-O 119.043 -0.504 . . . . 71.439999999999998 111.013 -170.124 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -56.43 -35.61 68.04 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 125.12 1.368 . . . . 73.099999999999994 110.525 174.714 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 82.8 t80 -71.81 -54.08 11.28 Favored 'General case' 0 N--CA 1.44 -0.952 0 C-N-CA 122.969 0.508 . . . . 73.530000000000001 110.2 176.839 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 73.5 mt -69.64 -18.31 63.58 Favored 'General case' 0 CA--C 1.52 -0.178 0 C-N-CA 123.454 0.702 . . . . 61.219999999999999 112.428 -173.136 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -57.17 -16.71 8.54 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.226 1.41 . . . . 41.210000000000001 112.32 -176.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -110.38 8.12 30.58 Favored Glycine 0 CA--C 1.526 0.74 0 C-N-CA 124.94 1.257 . . . . 53.25 113.588 177.073 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 30.9 mmtt -129.09 27.6 5.37 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 119.608 1.704 . . . . 73.25 111.398 -169.096 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 85.56 41.54 7.27 Favored Glycine 0 N--CA 1.447 -0.579 0 CA-C-O 119.199 -0.778 . . . . 75.120000000000005 111.245 178.582 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 95.0 t -135.83 141.91 40.59 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 106.968 -1.493 . . . . 42.009999999999998 106.968 173.345 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 66.2 t0 -97.12 123.62 40.92 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 108.231 -1.025 . . . . 54.329999999999998 108.231 167.618 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.632 ' HG3' ' HB1' ' A' ' 112' ' ' ALA . 0.2 OUTLIER -57.88 -38.97 76.73 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.789 0.835 . . . . 73.329999999999998 109.245 177.071 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -61.87 -41.46 97.88 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 123.638 0.775 . . . . 74.420000000000002 111.225 -177.671 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 21.1 mmtt -79.59 -47.28 15.75 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 108.074 -1.084 . . . . 71.319999999999993 108.074 -176.622 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 80.2 t80 -44.98 -59.3 2.64 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 126.322 1.849 . . . . 73.019999999999996 110.126 -177.301 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 32.4 mt -69.38 -36.32 76.69 Favored 'General case' 0 C--O 1.234 0.245 0 O-C-N 122.107 -0.371 . . . . 73.209999999999994 111.217 -176.399 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 23.2 t -56.05 -47.8 77.22 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 109.442 -0.577 . . . . 72.0 109.442 178.579 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' THR . . . . . 0.74 HG23 HG22 ' A' ' 80' ' ' THR 0.259 15.0 t -77.28 -31.62 54.94 Favored 'General case' 0 CA--C 1.543 0.712 0 C-N-CA 123.116 0.567 . . . . 75.439999999999998 111.543 -179.089 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 76.4 t80 -56.19 -36.49 68.45 Favored 'General case' 0 N--CA 1.471 0.621 0 O-C-N 120.357 -1.465 . . . . 74.400000000000006 111.893 172.561 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 48.0 m-20 -102.97 13.39 34.43 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.085 0.954 . . . . 73.120000000000005 111.216 176.742 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 40.0 t -88.81 163.65 15.58 Favored 'General case' 0 C--O 1.235 0.298 0 O-C-N 120.469 -1.395 . . . . 75.409999999999997 109.263 174.739 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -59.11 -24.96 63.41 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 114.92 -1.036 . . . . 64.409999999999997 110.85 170.328 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -48.91 -63.48 1.08 Allowed 'General case' 0 C--O 1.236 0.387 0 C-N-CA 124.568 1.147 . . . . 72.329999999999998 110.955 176.089 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.51 HD11 ' HA ' ' A' ' 80' ' ' THR . 7.1 mm -58.36 -32.58 45.49 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 N-CA-C 113.532 0.938 . . . . 72.530000000000001 113.532 176.189 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 2.7 tttp -57.7 -35.05 70.1 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 118.844 0.747 . . . . 65.329999999999998 110.151 -178.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -80.13 -37.24 22.3 Favored Glycine 0 C--N 1.34 0.798 0 C-N-CA 124.864 1.221 . . . . 63.520000000000003 111.969 -178.488 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 2.4 mm100 -70.74 -39.8 73.1 Favored 'General case' 0 C--N 1.331 -0.238 0 O-C-N 121.582 -0.952 . . . . 72.030000000000001 109.312 -178.718 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -62.23 -50.09 73.15 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 123.668 0.787 . . . . 75.120000000000005 110.191 176.475 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -63.42 -43.23 98.08 Favored 'General case' 0 CA--C 1.521 -0.151 0 CA-C-O 117.744 -1.122 . . . . 73.510000000000005 111.095 -177.497 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 44.7 mtmt -59.29 -59.67 5.09 Favored 'General case' 0 C--N 1.343 0.31 0 CA-C-O 117.991 -1.004 . . . . 54.420000000000002 108.748 177.548 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -54.35 -35.73 63.07 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 119.852 1.206 . . . . 60.119999999999997 112.012 -179.361 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 35.8 tttt -65.97 -66.44 0.55 Allowed 'General case' 0 C--N 1.342 0.278 0 N-CA-C 108.467 -0.938 . . . . 65.319999999999993 108.467 177.445 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 17.7 ptmt -60.02 -28.14 67.48 Favored 'General case' 0 C--O 1.227 -0.106 0 C-N-CA 123.476 0.71 . . . . 73.25 111.187 -171.749 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 36.2 mt -68.75 -58.58 4.01 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 124.816 1.246 . . . . 65.040000000000006 111.976 173.201 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -55.6 -50.6 69.69 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 118.957 0.799 . . . . 72.310000000000002 110.244 -169.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -58.87 -42.74 90.18 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 113.007 0.743 . . . . 62.340000000000003 113.007 174.882 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -65.84 -26.37 67.63 Favored 'General case' 0 N--CA 1.462 0.155 0 C-N-CA 123.33 0.652 . . . . 75.450000000000003 111.622 -178.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 36.2 m-85 -84.17 20.13 1.67 Allowed 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.3 1.44 . . . . 70.109999999999999 112.125 172.628 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 11.5 mm100 64.35 6.44 3.05 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 127.399 2.279 . . . . 74.140000000000001 115.536 173.706 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.489 HG21 HD22 ' A' ' 32' ' ' LEU . 42.9 t -51.7 -57.27 3.63 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.985 0 C-N-CA 127.639 2.376 . . . . 62.210000000000001 113.858 -164.756 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . 0.281 73.5 p 54.97 -40.05 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 128.912 2.885 . . . . 63.119999999999997 117.365 -165.341 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -150.45 -177.87 24.79 Favored Glycine 0 CA--C 1.521 0.422 0 C-N-CA 125.951 1.739 . . . . 64.140000000000001 110.285 -171.848 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.442 ' HA ' ' C ' ' A' ' 154' ' ' PRO . 17.3 m -133.26 157.33 78.47 Favored Pre-proline 0 C--O 1.239 0.545 0 N-CA-C 108.801 -0.815 . . . . 74.530000000000001 108.801 -178.186 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 154' ' ' PRO . . . . . 0.524 ' HG3' HD12 ' A' ' 166' ' ' ILE . 37.4 Cg_endo -66.74 154.07 83.43 Favored 'Cis proline' 0 N--CA 1.46 -0.489 0 C-N-CA 124.478 -1.051 . . . . 71.420000000000002 112.494 -4.265 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 155' ' ' THR . . . . . 0.444 HG21 HG22 ' A' ' 150' ' ' VAL . 35.3 m -155.06 110.61 3.1 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 105.194 -2.15 . . . . 73.439999999999998 105.194 172.874 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 95.9 mtp -89.5 152.12 21.61 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 107.5 -1.296 . . . . 62.210000000000001 107.5 164.247 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 15.0 t -138.97 139.41 40.48 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.288 0 N-CA-C 108.113 -1.069 . . . . 71.310000000000002 108.113 175.248 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 11.4 t -112.34 124.09 68.7 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 C-N-CA 126.395 1.878 . . . . 75.209999999999994 106.516 176.664 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 1.4 t30 51.0 17.13 0.4 Allowed 'General case' 0 C--O 1.223 -0.308 0 C-N-CA 128.836 2.854 . . . . 72.209999999999994 114.813 170.406 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 58.71 38.99 92.97 Favored Glycine 0 CA--C 1.525 0.66 0 C-N-CA 125.69 1.614 . . . . 35.210000000000001 112.829 -168.539 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 37.6 mttt -132.95 -38.27 0.98 Allowed 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 124.51 1.124 . . . . 74.219999999999999 112.29 178.818 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -116.6 118.24 32.07 Favored 'General case' 0 CA--C 1.517 -0.311 0 N-CA-C 108.284 -1.006 . . . . 71.340000000000003 108.284 -178.597 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 37.3 ttp85 -105.43 123.33 47.7 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 126.536 1.934 . . . . 75.420000000000002 106.972 174.259 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 13.5 p90 -150.23 170.97 17.72 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 107.529 -1.286 . . . . 65.439999999999998 107.529 -176.782 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -178.84 178.77 0.75 Allowed 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.166 -0.679 . . . . 75.299999999999997 109.166 -173.197 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.524 HD12 ' HG3' ' A' ' 154' ' ' PRO . 23.7 mt -47.96 -55.95 2.28 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 C-N-CA 127.733 2.413 . . . . 72.019999999999996 109.044 174.01 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -75.67 8.01 23.15 Favored Glycine 0 CA--C 1.526 0.727 0 C-N-CA 127.028 2.251 . . . . 51.340000000000003 114.794 178.688 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 4.7 m -110.72 -52.25 2.8 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-N 119.507 1.653 . . . . 72.219999999999999 109.886 168.038 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -65.39 -53.11 47.97 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 125.652 1.581 . . . . 62.43 111.598 -178.371 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 142.59 -7.16 2.21 Favored Glycine 0 CA--C 1.528 0.846 0 CA-C-O 119.056 -0.858 . . . . 64.049999999999997 114.41 -174.298 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 155.7 175.72 27.04 Favored Glycine 0 CA--C 1.53 0.983 0 CA-C-N 119.514 1.657 . . . . 44.43 110.149 -175.705 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -61.21 -53.67 2.31 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 122.918 2.412 . . . . 65.219999999999999 111.247 -175.617 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 8.2 mp0 -62.85 -32.89 74.2 Favored 'General case' 0 CA--C 1.536 0.411 0 O-C-N 121.434 -0.791 . . . . 44.32 110.924 179.134 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -66.17 -30.76 71.3 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.218 0.607 . . . . 70.219999999999999 110.131 178.107 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 37.7 m -65.59 -46.21 80.24 Favored 'General case' 0 N--CA 1.455 -0.221 0 O-C-N 121.364 -0.835 . . . . 72.209999999999994 110.453 -173.832 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 64.0 mt -62.89 -28.08 69.8 Favored 'General case' 0 C--O 1.223 -0.306 0 CA-C-N 118.559 0.618 . . . . 73.120000000000005 111.447 -177.027 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 2.6 tttt -53.58 -49.41 67.8 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 124.819 1.248 . . . . 72.010000000000005 109.338 172.45 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.436 HD21 ' HB3' ' A' ' 11' ' ' GLU . 4.1 mm? -67.12 -44.51 79.72 Favored 'General case' 0 CA--C 1.515 -0.392 0 N-CA-C 109.329 -0.619 . . . . 55.399999999999999 109.329 175.655 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.43 ' HB1' ' CZ2' ' A' ' 50' ' ' TRP . . . -56.78 -31.73 64.94 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 118.34 -0.838 . . . . 34.119999999999997 112.71 -174.247 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -84.16 -52.0 6.61 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 126.357 1.863 . . . . 73.340000000000003 108.666 -176.808 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 16.6 t80 -60.84 -45.61 93.8 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 123.896 0.878 . . . . 72.120000000000005 110.998 -175.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 93.1 mt -61.22 -28.66 69.32 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.06 0.944 . . . . 73.140000000000001 112.527 -178.59 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.448 HD13 HG21 ' A' ' 58' ' ' VAL . 44.0 mt -60.3 -52.78 57.36 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 CA-C-N 119.931 1.241 . . . . 61.200000000000003 108.357 173.743 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -66.71 -5.72 12.98 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 126.802 2.041 . . . . 74.040000000000006 112.901 177.514 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -98.12 -23.74 15.6 Favored 'General case' 0 N--CA 1.463 0.21 0 O-C-N 120.868 -1.145 . . . . 74.439999999999998 111.525 173.187 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 186' ' ' GLU . . . . . 0.53 ' HB3' HD12 ' A' ' 27' ' ' ILE . 30.5 mm-40 -96.54 -33.57 11.78 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 123.785 0.834 . . . . 64.340000000000003 112.734 -176.868 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 187' ' ' ARG . . . . . 0.411 ' HE ' HD11 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -51.12 -32.55 23.07 Favored 'General case' 0 N--CA 1.476 0.841 0 O-C-N 120.847 -1.158 . . . . 72.319999999999993 110.522 168.748 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -64.56 -23.22 67.2 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 126.713 2.005 . . . . 33.240000000000002 111.883 179.773 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -58.05 -45.83 86.39 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 109.125 -0.695 . . . . 55.130000000000003 109.125 174.647 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -86.42 -39.12 16.67 Favored 'General case' 0 N--CA 1.456 -0.152 0 O-C-N 121.875 -0.516 . . . . 63.32 110.098 178.254 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 28.2 mttp -138.7 73.12 1.42 Allowed 'General case' 0 N--CA 1.442 -0.837 0 C-N-CA 125.577 1.551 . . . . 63.409999999999997 109.245 -164.028 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 32.3 mtmt . . . . . 0 C--O 1.243 0.752 0 N-CA-C 105.37 -2.085 . . . . 71.319999999999993 105.37 147.142 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.624 0 N-CA-C 108.69 -1.764 . . . . 72.519999999999996 108.69 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 63.99 159.69 0.09 Allowed 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 128.037 2.535 . . . . 75.530000000000001 110.857 -171.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -153.23 15.88 0.54 Allowed 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 114.058 1.133 . . . . 71.549999999999997 114.058 -175.687 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 38.5 m-85 -135.49 160.2 39.2 Favored 'General case' 0 C--O 1.24 0.589 0 C-N-CA 125.1 1.36 . . . . 73.310000000000002 108.884 -173.299 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 88.6 m -125.89 134.78 51.49 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 109.217 -0.66 . . . . 72.540000000000006 109.217 178.062 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.03 144.36 57.33 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 121.837 0.827 . . . . 74.239999999999995 111.077 176.003 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 76.85 -19.61 3.28 Favored Glycine 0 CA--C 1.527 0.807 0 CA-C-O 118.674 -1.07 . . . . 60.32 112.366 -172.324 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 20.3 ttmt -97.43 -84.3 0.38 Allowed 'General case' 0 CA--C 1.511 -0.55 0 CA-C-N 119.116 1.458 . . . . 71.430000000000007 108.007 -177.101 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.443 ' HB3' HD21 ' A' ' 178' ' ' LEU . 5.0 mp0 -64.61 -26.31 68.34 Favored 'General case' 0 N--CA 1.442 -0.854 0 C-N-CA 124.748 1.219 . . . . 53.119999999999997 110.145 -175.19 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 12.7 p90 -163.91 171.8 14.85 Favored 'General case' 0 C--O 1.233 0.206 0 O-C-N 121.091 -1.006 . . . . 71.430000000000007 108.58 -172.809 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 24.4 t -132.34 110.83 16.8 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 C-N-CA 123.614 0.765 . . . . 54.240000000000002 110.035 -177.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -68.75 159.77 31.65 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 124.793 1.237 . . . . 70.420000000000002 109.112 166.514 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -134.08 116.36 15.37 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 124.214 1.005 . . . . 64.109999999999999 108.425 -174.454 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -61.6 -1.1 0.51 Allowed 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 125.805 1.642 . . . . 62.229999999999997 113.908 -177.539 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 48.9 m -133.82 85.57 40.94 Favored Pre-proline 0 CA--C 1.541 0.598 0 C-N-CA 127.583 2.353 . . . . 70.540000000000006 108.284 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -77.54 -178.73 4.81 Favored 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 124.647 3.564 . . . . 71.209999999999994 113.388 -178.372 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 25.9 t -136.55 148.21 62.88 Favored Pre-proline 0 CA--C 1.548 0.875 0 C-N-CA 126.525 1.93 . . . . 65.430000000000007 109.005 -178.115 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -82.19 -178.68 4.2 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 124.567 3.511 . . . . 72.439999999999998 112.572 173.493 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.9 m -131.36 172.18 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 124.975 1.31 . . . . 75.129999999999995 109.513 172.003 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 66.4 m -48.89 -56.15 9.62 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 125.614 1.565 . . . . 73.219999999999999 112.142 176.273 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -144.35 152.08 52.85 Favored Pre-proline 0 C--O 1.239 0.529 0 C-N-CA 125.363 1.465 . . . . 72.310000000000002 108.072 -172.604 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -69.45 178.33 4.49 Favored 'Trans proline' 0 N--CA 1.451 -0.982 0 C-N-CA 122.492 2.128 . . . . 74.540000000000006 109.251 165.63 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.26 -118.87 6.2 Favored Glycine 0 N--CA 1.45 -0.402 0 N-CA-C 106.951 -2.46 . . . . 72.049999999999997 106.951 -166.611 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -61.01 137.55 58.23 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 119.519 1.66 . . . . 71.109999999999999 110.916 -163.225 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 42.1 mm -62.72 138.88 22.02 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 N-CA-C 107.12 -1.437 . . . . 50.049999999999997 107.12 168.113 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.7 124.41 36.69 Favored 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 127.138 2.175 . . . . 73.120000000000005 106.851 -178.668 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.7 t -128.82 102.29 7.8 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.174 0 N-CA-C 106.438 -1.69 . . . . 72.230000000000004 106.438 176.173 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 52.3 t -97.33 114.25 33.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 107.278 -1.378 . . . . 60.119999999999997 107.278 -177.891 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 67.7 tt0 -72.28 134.27 45.47 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 107.6 -1.259 . . . . 51.539999999999999 107.6 152.49 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 5.0 mp -111.36 136.02 51.08 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 107.061 -1.459 . . . . 75.409999999999997 107.061 160.035 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 28.9 p90 -134.28 166.71 22.18 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.229 1.011 . . . . 73.120000000000005 110.642 -177.815 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' TRP . . . . . 0.438 ' HB3' HG21 ' A' ' 153' ' ' VAL . 26.6 t90 -150.36 158.95 44.72 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.724 1.21 . . . . 74.239999999999995 108.888 176.101 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 5.3 m-30 -83.59 51.29 1.97 Allowed 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.427 0.691 . . . . 75.230000000000004 111.302 178.171 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -174.91 18.84 0.05 OUTLIER Glycine 0 N--CA 1.463 0.446 0 O-C-N 120.287 -1.508 . . . . 72.040000000000006 114.273 -174.424 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.532 ' HB3' HG23 ' A' ' 153' ' ' VAL . 20.6 p -118.41 86.28 27.76 Favored Pre-proline 0 N--CA 1.449 -0.513 0 C-N-CA 124.907 1.283 . . . . 73.209999999999994 108.252 -172.756 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -63.15 -11.79 26.86 Favored 'Trans proline' 0 CA--C 1.541 0.874 0 C-N-CA 122.279 1.986 . . . . 74.120000000000005 114.03 -170.63 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 35.3 m170 -73.74 -22.73 59.78 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 119.209 0.913 . . . . 62.409999999999997 112.625 168.908 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 79.1 m -67.53 -65.85 0.64 Allowed 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.564 1.545 . . . . 74.430000000000007 110.67 -173.781 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 14.2 t80 -59.32 -29.23 67.47 Favored 'General case' 0 N--CA 1.467 0.419 0 O-C-N 121.415 -0.803 . . . . 73.209999999999994 112.036 -179.575 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.47 -26.22 68.62 Favored 'General case' 0 CA--C 1.542 0.652 0 O-C-N 121.452 -0.78 . . . . 75.530000000000001 112.615 176.04 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 20.8 t80 -93.97 -18.03 22.32 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 124.999 1.319 . . . . 65.420000000000002 112.426 -173.066 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -38.22 -63.04 0.59 Allowed Pre-proline 0 N--CA 1.472 0.631 0 C-N-CA 125.451 1.5 . . . . 74.549999999999997 112.767 175.079 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -77.23 -11.44 17.6 Favored 'Trans proline' 0 CA--C 1.534 0.524 0 CA-C-N 121.775 1.67 . . . . 72.150000000000006 114.533 -171.103 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.8 m -72.15 -44.97 62.27 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 107.786 -1.19 . . . . 73.219999999999999 107.786 166.727 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 14.3 tt -94.15 -28.65 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 N-CA-C 113.47 0.915 . . . . 74.430000000000007 113.47 -165.339 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 14.1 t -47.88 -60.94 3.5 Favored Pre-proline 0 CA--C 1.544 0.724 0 C-N-CA 124.87 1.268 . . . . 61.399999999999999 110.027 171.822 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_endo -72.28 -7.77 21.54 Favored 'Trans proline' 0 C--N 1.348 0.538 0 CA-C-N 121.555 1.591 . . . . 63.350000000000001 113.34 -175.247 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 82.6 t90 -77.57 -61.11 2.1 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 119.591 1.087 . . . . 73.120000000000005 108.297 165.84 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 47.9 t -60.23 -36.55 77.98 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.156 1.382 . . . . 72.310000000000002 112.593 -169.483 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -75.04 -10.76 59.77 Favored 'General case' 0 CA--C 1.54 0.566 0 O-C-N 120.78 -1.2 . . . . 65.519999999999996 111.922 -177.424 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -111.86 18.82 18.52 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 127.736 2.414 . . . . 73.019999999999996 113.228 -176.212 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 39.1 mt -75.22 156.18 85.8 Favored Pre-proline 0 N--CA 1.448 -0.565 0 C-N-CA 125.044 1.338 . . . . 62.240000000000002 111.424 -177.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -77.78 172.35 15.83 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 124.964 3.776 . . . . 73.150000000000006 111.096 179.045 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -66.12 -2.83 4.57 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 114.501 1.297 . . . . 63.210000000000001 114.501 -178.577 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -102.74 1.69 34.69 Favored 'General case' 0 C--O 1.223 -0.335 0 C-N-CA 125.05 1.34 . . . . 74.349999999999994 112.453 -177.945 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 39.1 t -125.99 131.52 71.67 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 CA-C-N 120.161 1.346 . . . . 70.319999999999993 108.381 -170.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 86.5 t60 -131.67 101.69 5.59 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 125.096 1.358 . . . . 74.310000000000002 109.214 -176.169 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 10.4 t80 -82.66 138.55 34.1 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 126.579 1.951 . . . . 73.549999999999997 109.476 -176.111 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 23.6 t -130.08 154.32 40.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 106.974 -1.491 . . . . 54.119999999999997 106.974 178.514 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 66.5 mtt85 -123.86 129.7 51.42 Favored 'General case' 0 CA--C 1.513 -0.448 0 N-CA-C 105.279 -2.119 . . . . 75.310000000000002 105.279 168.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 47.5 mt -134.24 148.92 69.8 Favored Pre-proline 0 C--N 1.33 -0.256 0 N-CA-C 108.921 -0.77 . . . . 53.100000000000001 108.921 175.354 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -73.8 140.24 28.78 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 122.347 2.031 . . . . 74.400000000000006 110.287 178.024 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -79.1 88.42 4.83 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.883 0.873 . . . . 73.239999999999995 110.549 178.756 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 10.1 mt -87.68 96.73 10.54 Favored 'General case' 0 C--N 1.331 -0.214 0 O-C-N 120.188 -1.57 . . . . 73.420000000000002 109.858 -177.336 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 48.0 m-85 -115.84 36.36 4.05 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 123.929 0.892 . . . . 74.409999999999997 110.958 179.34 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 78.66 -161.47 48.12 Favored Glycine 0 C--N 1.336 0.555 0 N-CA-C 110.004 -1.239 . . . . 63.340000000000003 110.004 -179.307 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 44.82 -131.79 7.78 Favored Glycine 0 CA--C 1.532 1.106 0 C-N-CA 125.355 1.455 . . . . 22.129999999999999 113.106 172.811 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 7.7 tp -80.76 -18.47 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 123.73 0.812 . . . . 73.319999999999993 110.962 174.693 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 8.6 m95 -58.52 -38.4 77.64 Favored 'General case' 0 C--N 1.338 0.097 0 O-C-N 121.226 -0.921 . . . . 72.439999999999998 111.664 -171.528 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -83.04 -28.24 29.74 Favored 'General case' 0 C--O 1.232 0.134 0 N-CA-C 113.647 0.98 . . . . 71.25 113.647 177.044 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 33.3 t -59.66 -52.4 61.49 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 N-CA-C 107.336 -1.357 . . . . 75.120000000000005 107.336 174.613 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 65.6 m170 -75.01 47.82 0.36 Allowed 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 126.968 2.107 . . . . 75.420000000000002 111.261 170.803 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -153.46 -42.17 0.02 OUTLIER Glycine 0 CA--C 1.526 0.734 0 C-N-CA 124.93 1.252 . . . . 75.439999999999998 111.775 177.708 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 37.9 tt0 -61.95 -26.31 68.12 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.421 1.088 . . . . 75.329999999999998 113.783 -168.003 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 1.7 ptt? -71.6 -34.05 69.55 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 120.121 1.328 . . . . 64.310000000000002 112.718 -177.395 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 45.1 t80 -54.81 -51.9 64.36 Favored 'General case' 0 N--CA 1.463 0.209 0 C-N-CA 124.067 0.947 . . . . 74.109999999999999 109.459 -176.034 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 36.7 mt -57.62 -40.47 79.23 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 124.66 1.184 . . . . 55.229999999999997 110.338 178.091 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.679 ' CG2' HG23 ' A' ' 128' ' ' THR . 1.8 m -70.36 -35.02 73.28 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 118.717 0.689 . . . . 65.109999999999999 111.247 -178.833 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -57.52 -56.22 24.66 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 125.073 1.349 . . . . 74.200000000000003 108.452 178.694 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -73.33 -21.16 60.62 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.907 0.883 . . . . 63.5 112.098 -178.308 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 27.8 t -66.1 -3.51 5.64 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 117.621 -1.181 . . . . 60.219999999999999 113.102 175.242 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 44.2 mtm -100.33 -1.95 34.82 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 120.933 1.697 . . . . 62.509999999999998 113.599 169.517 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 74.04 26.64 68.24 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 111.204 -0.758 . . . . 70.409999999999997 111.204 177.195 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.9 m -60.48 153.11 4.96 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 N-CA-C 108.147 -1.057 . . . . 62.030000000000001 108.147 161.705 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -149.95 158.6 44.33 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 107.928 -1.138 . . . . 61.240000000000002 107.928 166.806 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 43.9 m80 45.86 47.08 12.26 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.483 1.513 . . . . 53.340000000000003 111.108 -177.035 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -97.52 5.9 48.9 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 127.654 2.382 . . . . 70.519999999999996 112.491 -170.078 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.5 t 66.65 92.14 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.24 0.577 0 C-N-CA 127.528 2.331 . . . . 72.439999999999998 111.463 -176.539 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 12.4 m-70 -66.58 -32.08 73.19 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 124.3 1.04 . . . . 61.350000000000001 112.856 171.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -62.14 -46.27 89.77 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-O 117.821 -1.085 . . . . 75.099999999999994 112.176 -176.319 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -54.56 -36.4 64.31 Favored 'General case' 0 N--CA 1.457 -0.109 0 CA-C-N 119.159 0.89 . . . . 72.310000000000002 112.382 -175.336 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 58.4 t -58.32 -57.94 8.69 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 C-N-CA 124.091 0.957 . . . . 74.329999999999998 108.921 177.051 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -69.39 -37.98 77.77 Favored 'General case' 0 C--N 1.335 -0.058 0 C-N-CA 123.132 0.573 . . . . 74.530000000000001 112.36 -176.823 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -58.75 -32.61 69.4 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.608 1.563 . . . . 71.230000000000004 110.042 176.367 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -79.61 -20.83 45.91 Favored 'General case' 0 N--CA 1.448 -0.565 0 O-C-N 120.848 -1.157 . . . . 61.210000000000001 111.318 178.788 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 31.8 mt -94.45 -35.72 6.45 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 O-C-N 120.555 -1.341 . . . . 72.120000000000005 109.241 -179.682 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 57.8 m-70 -90.42 -63.64 1.25 Allowed 'General case' 0 C--O 1.233 0.232 0 C-N-CA 124.489 1.116 . . . . 53.539999999999999 110.954 -174.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 7.5 mtmt -68.07 -35.61 78.48 Favored 'General case' 0 N--CA 1.463 0.223 0 O-C-N 121.929 -0.482 . . . . 74.239999999999995 110.583 -176.163 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -99.87 -70.29 0.74 Allowed 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 108.51 -0.922 . . . . 74.230000000000004 108.51 -172.467 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 7.5 t-80 74.6 64.01 0.07 Allowed 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 128.618 2.767 . . . . 73.109999999999999 113.301 -177.743 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 65.2 mttt -76.53 28.97 0.12 Allowed 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 114.755 1.391 . . . . 73.430000000000007 114.755 179.515 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 10.0 tmtt? 46.52 57.91 5.05 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 125.958 1.703 . . . . 72.340000000000003 112.509 176.189 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 44.7 mt -67.46 42.4 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 130.16 3.384 . . . . 72.030000000000001 112.197 179.413 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -88.36 6.44 37.26 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 128.679 2.792 . . . . 53.350000000000001 113.14 -178.563 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -139.7 156.49 71.03 Favored Pre-proline 0 CA--C 1.537 0.479 0 C-N-CA 123.809 0.844 . . . . 73.049999999999997 111.335 178.614 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -64.69 -39.4 26.96 Favored 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 122.579 2.186 . . . . 72.230000000000004 112.386 -179.243 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -59.2 -42.89 92.0 Favored 'General case' 0 C--O 1.225 -0.187 0 CA-C-N 118.09 0.404 . . . . 63.009999999999998 110.177 176.359 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -60.52 -38.31 83.99 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 123.109 0.564 . . . . 64.450000000000003 110.615 -177.0 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 54.2 mtt -68.45 -49.91 56.44 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 123.908 0.883 . . . . 63.299999999999997 110.467 175.173 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -64.75 -47.14 79.29 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 124.811 1.244 . . . . 72.010000000000005 110.783 -171.188 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -62.2 -29.13 70.16 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 126.061 1.744 . . . . 63.229999999999997 112.836 176.602 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 73.0 t80 -76.85 -54.86 6.04 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 109.933 -0.395 . . . . 73.319999999999993 109.933 174.177 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 56.4 mt -68.07 -21.19 65.0 Favored 'General case' 0 CA--C 1.516 -0.345 0 O-C-N 121.809 -0.557 . . . . 70.019999999999996 110.584 -168.698 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -55.03 -13.65 1.23 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.402 0.681 . . . . 72.150000000000006 112.236 169.711 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -88.06 -9.69 70.23 Favored Glycine 0 N--CA 1.433 -1.51 0 CA-C-O 116.97 -2.017 . . . . 53.399999999999999 110.235 179.216 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -130.35 10.94 5.34 Favored 'General case' 0 C--N 1.347 0.466 0 CA-C-N 120.985 2.393 . . . . 72.450000000000003 112.947 -170.137 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 86.83 70.68 1.3 Allowed Glycine 0 N--CA 1.445 -0.731 0 N-CA-C 109.454 -1.458 . . . . 52.420000000000002 109.454 -179.198 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 25.7 t -141.4 129.71 22.83 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.816 0 C-N-CA 127.168 2.187 . . . . 74.120000000000005 107.271 172.788 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 41.2 t0 -89.45 123.16 33.33 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 124.185 0.994 . . . . 73.209999999999994 110.639 178.793 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 11.2 mtmt -59.07 -38.7 80.06 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 124.194 0.998 . . . . 51.049999999999997 111.02 171.192 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 75.7 mm-40 -65.17 -15.22 62.19 Favored 'General case' 0 C--N 1.329 -0.318 0 O-C-N 120.983 -1.073 . . . . 74.310000000000002 112.889 -177.403 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.541 ' O ' HG22 ' A' ' 128' ' ' THR . 9.7 mmtm -117.95 -42.33 2.83 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-O 117.585 -1.198 . . . . 74.120000000000005 110.777 -178.189 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 81.3 t80 -46.65 -65.71 0.52 Allowed 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 125.238 1.415 . . . . 71.099999999999994 111.12 171.89 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 18.0 mt -62.3 -38.38 89.15 Favored 'General case' 0 N--CA 1.465 0.279 0 O-C-N 122.055 -0.403 . . . . 72.340000000000003 110.827 -173.459 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 31.8 t -54.17 -61.76 2.09 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 107.883 -1.154 . . . . 62.329999999999998 107.883 177.178 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' THR . . . . . 0.679 HG23 ' CG2' ' A' ' 80' ' ' THR 0.281 4.8 t -69.41 -30.2 68.1 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 118.268 -0.873 . . . . 62.100000000000001 110.699 -173.541 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 60.8 t80 -56.49 -42.1 77.73 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 119.87 1.214 . . . . 74.200000000000003 111.212 176.209 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -94.7 13.72 23.5 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.906 1.282 . . . . 73.340000000000003 111.854 179.699 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 50.5 m -103.56 161.98 13.43 Favored 'General case' 0 N--CA 1.469 0.504 0 O-C-N 120.618 -1.302 . . . . 51.420000000000002 111.167 176.406 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -63.52 -33.88 76.57 Favored 'General case' 0 C--O 1.225 -0.215 0 C-N-CA 122.628 0.371 . . . . 72.409999999999997 111.944 -171.537 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -50.99 -46.95 61.55 Favored 'General case' 0 CA--C 1.534 0.339 0 O-C-N 121.705 -0.622 . . . . 50.219999999999999 111.98 -175.636 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 48.2 mm -68.53 -33.6 60.89 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-O 118.912 -0.566 . . . . 74.510000000000005 110.01 179.764 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 12.3 tttt -55.05 -38.47 68.04 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 119.453 1.024 . . . . 71.109999999999999 110.45 171.588 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -70.96 -42.44 59.76 Favored Glycine 0 C--N 1.335 0.503 0 N-CA-C 110.603 -0.999 . . . . 64.219999999999999 110.603 -175.117 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -67.11 -43.82 81.48 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 123.946 0.898 . . . . 74.030000000000001 109.833 -179.51 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 86.7 mmm -58.54 -52.59 65.0 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 125.397 1.479 . . . . 64.430000000000007 109.665 175.272 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -63.26 -39.16 93.82 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 120.001 1.273 . . . . 33.439999999999998 112.004 -173.87 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 7.2 mmtt -56.29 -59.77 4.47 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 119.057 0.844 . . . . 54.539999999999999 109.227 170.921 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -53.62 -42.58 67.9 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 118.308 0.504 . . . . 70.409999999999997 110.948 -175.413 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 7.7 tttt -57.99 -60.8 3.16 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 125.532 1.533 . . . . 63.420000000000002 109.872 177.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 2.2 pttt -71.03 -17.62 62.61 Favored 'General case' 0 CA--C 1.529 0.169 0 N-CA-C 112.313 0.486 . . . . 74.150000000000006 112.313 -174.494 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 32.6 mt -73.81 -56.12 5.36 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 124.021 0.928 . . . . 74.540000000000006 111.01 170.305 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -57.16 -43.19 82.29 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 119.049 0.84 . . . . 72.200000000000003 111.577 -171.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 3.8 ppp? -60.62 -44.29 96.49 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 113.146 0.795 . . . . 72.510000000000005 113.146 174.289 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -62.92 -35.75 81.12 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 124.247 1.019 . . . . 75.129999999999995 111.096 179.263 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 31.0 m-85 -74.54 14.37 0.48 Allowed 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.11 1.364 . . . . 73.219999999999999 113.317 177.458 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 57.32 18.65 4.47 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 126.023 1.729 . . . . 54.43 114.112 178.212 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.458 HG13 HG21 ' A' ' 155' ' ' THR . 20.6 t -75.0 137.05 23.8 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 CA-C-N 119.177 0.898 . . . . 72.040000000000006 109.309 -174.815 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -132.42 2.97 3.88 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.524 0.73 . . . . 54.310000000000002 112.191 -172.345 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -173.54 -168.91 35.27 Favored Glycine 0 CA--C 1.527 0.83 0 C-N-CA 127.278 2.371 . . . . 51.219999999999999 110.054 178.228 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.532 HG23 ' HB3' ' A' ' 37' ' ' CYS . 3.5 m -149.04 157.37 40.05 Favored Pre-proline 0 CA--C 1.537 0.476 0 C-N-CA 125.943 1.697 . . . . 61.5 109.092 -175.798 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -62.31 159.79 56.17 Favored 'Cis proline' 0 N--CA 1.454 -0.848 0 C-N-CA 124.527 -1.031 . . . . 73.430000000000007 111.571 -9.837 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' THR . . . . . 0.458 HG21 HG13 ' A' ' 150' ' ' VAL . 7.7 m -155.56 139.71 16.52 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 107.695 -1.224 . . . . 44.350000000000001 107.695 176.174 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 98.8 mtp -119.11 160.26 22.41 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-N 114.666 -1.152 . . . . 74.230000000000004 108.17 170.799 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 39.6 t -139.89 156.01 25.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 106.188 -1.782 . . . . 74.230000000000004 106.188 178.685 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 48.2 t -126.18 120.39 56.67 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 N-CA-C 107.242 -1.392 . . . . 72.209999999999994 107.242 171.033 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 23.2 m-20 51.64 21.87 1.45 Allowed 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 127.794 2.437 . . . . 72.140000000000001 114.405 175.199 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 57.02 32.89 63.15 Favored Glycine 0 CA--C 1.528 0.854 0 CA-C-O 118.239 -1.312 . . . . 62.329999999999998 113.996 -168.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 8.0 mtpt -126.79 -29.94 2.81 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 119.491 1.646 . . . . 73.430000000000007 111.467 -178.437 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -126.07 128.91 48.12 Favored 'General case' 0 CA--C 1.519 -0.225 0 N-CA-C 108.553 -0.906 . . . . 75.340000000000003 108.553 179.221 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 3.7 ttp85 -101.04 132.45 46.46 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 105.673 -1.973 . . . . 74.420000000000002 105.673 171.601 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 13.9 p90 -147.9 161.93 40.32 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.65 -0.871 . . . . 73.109999999999999 108.65 173.276 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -170.47 -171.87 1.15 Allowed 'General case' 0 N--CA 1.474 0.762 0 O-C-N 121.741 -0.6 . . . . 75.239999999999995 111.162 -174.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 12.2 mt -71.72 -26.02 25.29 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 C-N-CA 126.137 1.775 . . . . 72.439999999999998 110.263 -179.168 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -66.16 -54.78 22.16 Favored Glycine 0 N--CA 1.444 -0.811 0 N-CA-C 110.196 -1.161 . . . . 24.030000000000001 110.196 168.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 11.4 m -69.06 -59.17 3.22 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 117.398 0.599 . . . . 63.340000000000003 111.036 -163.219 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.468 ' CB ' HD23 ' A' ' 178' ' ' LEU . . . -67.35 -35.79 80.09 Favored 'General case' 0 CA--C 1.537 0.462 0 O-C-N 122.034 -0.416 . . . . 50.329999999999998 111.862 -167.482 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 140.64 4.09 1.25 Allowed Glycine 0 CA--C 1.531 1.049 0 C-N-CA 125.59 1.567 . . . . 74.230000000000004 115.744 175.362 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 137.36 178.18 15.71 Favored Glycine 0 CA--C 1.531 1.078 0 CA-C-N 119.797 1.798 . . . . 74.420000000000002 109.59 -168.812 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -64.68 -44.48 10.66 Favored 'Trans proline' 0 N--CA 1.459 -0.553 0 C-N-CA 123.243 2.629 . . . . 52.420000000000002 112.006 -166.779 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -56.13 -44.75 79.49 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.363 0.665 . . . . 73.040000000000006 109.968 178.377 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -71.68 -27.53 63.11 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 116.012 -0.54 . . . . 74.430000000000007 110.36 -173.554 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 90.0 m -59.13 -43.56 92.0 Favored 'General case' 0 CA--C 1.533 0.319 0 O-C-N 120.612 -1.305 . . . . 74.129999999999995 110.636 177.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 52.0 mt -64.46 -35.46 81.0 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 119.228 0.922 . . . . 74.420000000000002 110.852 177.85 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 21.2 tttt -55.3 -36.02 65.73 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 124.423 1.089 . . . . 61.399999999999999 110.121 176.196 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.468 HD23 ' CB ' ' A' ' 169' ' ' ALA . 4.6 mm? -79.57 -43.9 22.1 Favored 'General case' 0 CA--C 1.513 -0.47 0 CA-C-O 117.67 -1.157 . . . . 73.120000000000005 110.294 173.432 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -51.33 -43.2 61.68 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 119.459 1.027 . . . . 62.509999999999998 111.979 -177.017 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -82.39 -38.5 24.02 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 123.954 0.902 . . . . 64.450000000000003 109.274 -167.268 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 30.8 t80 -61.07 -55.96 26.52 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 124.442 1.097 . . . . 53.130000000000003 110.535 171.27 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 91.2 mt -61.72 -29.83 70.36 Favored 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 124.09 0.956 . . . . 72.420000000000002 111.83 -173.274 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 30.2 mt -56.47 -60.97 1.37 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.151 0 N-CA-C 108.151 -1.055 . . . . 72.420000000000002 108.151 168.801 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 10.9 tm-20 -52.31 -40.74 62.26 Favored 'General case' 0 N--CA 1.457 -0.113 0 C-N-CA 124.28 1.032 . . . . 74.219999999999999 111.554 -177.551 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 12.7 tptp -58.09 -47.92 81.75 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 123.047 0.539 . . . . 72.430000000000007 111.254 -179.434 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 41.5 mm-40 -74.53 -39.47 62.35 Favored 'General case' 0 C--O 1.223 -0.312 0 C-N-CA 123.082 0.553 . . . . 71.409999999999997 110.865 178.449 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.65 -37.89 89.14 Favored 'General case' 0 C--N 1.331 -0.216 0 O-C-N 120.269 -1.519 . . . . 72.310000000000002 109.253 -175.965 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -60.75 -19.4 58.98 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 125.267 1.427 . . . . 45.009999999999998 111.808 177.288 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -58.48 -29.83 66.52 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 118.667 0.667 . . . . 55.0 111.564 173.872 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -137.85 35.24 2.39 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 111.923 0.342 . . . . 53.310000000000002 111.923 -175.514 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 15.2 tptm -84.74 52.03 2.29 Favored 'General case' 0 CA--C 1.534 0.337 0 O-C-N 121.329 -0.857 . . . . 73.219999999999999 110.462 179.252 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 19.7 pttt . . . . . 0 C--O 1.244 0.809 0 C-N-CA 128.863 2.865 . . . . 74.310000000000002 112.293 175.51 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.527 0 N-CA-C 110.462 -1.055 . . . . 63.439999999999998 110.462 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 74.93 86.03 0.1 Allowed 'General case' 0 C--O 1.232 0.148 0 C-N-CA 126.007 1.723 . . . . 74.420000000000002 109.45 173.795 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -82.69 16.29 2.26 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 126.366 1.866 . . . . 74.230000000000004 114.187 -177.355 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 42.1 m-85 -143.63 164.32 30.75 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 124.431 1.093 . . . . 74.120000000000005 110.5 -165.176 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 57.3 m -133.67 130.53 38.34 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.754 1.221 . . . . 64.109999999999999 108.609 -176.024 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.91 140.89 58.91 Favored 'General case' 0 C--O 1.232 0.162 0 O-C-N 121.636 -0.665 . . . . 63.0 109.732 175.464 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 82.52 -23.19 5.74 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 125.877 1.703 . . . . 44.530000000000001 112.297 -170.461 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 75.1 tttt -96.64 -72.77 0.62 Allowed 'General case' 0 CA--C 1.508 -0.642 0 CA-C-N 118.405 1.103 . . . . 73.0 110.517 -169.761 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.501 ' HB3' HD11 ' A' ' 178' ' ' LEU . 16.5 mp0 -76.3 -23.89 54.36 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 124.639 1.175 . . . . 73.340000000000003 109.702 178.816 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 41.3 p90 -162.19 174.46 12.87 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.699 0.8 . . . . 63.049999999999997 110.717 -171.265 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 59.8 t -131.95 113.74 22.89 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 N-CA-C 108.123 -1.066 . . . . 74.120000000000005 108.123 178.28 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.68 160.51 32.11 Favored 'General case' 0 C--O 1.234 0.283 0 O-C-N 120.602 -1.311 . . . . 72.109999999999999 108.736 163.418 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -134.75 116.75 15.23 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 124.43 1.092 . . . . 73.239999999999995 110.133 -178.312 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 4.3 p -67.39 6.3 0.62 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 127.274 2.23 . . . . 54.350000000000001 113.918 176.664 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 18.6 m -127.12 71.43 75.96 Favored Pre-proline 0 N--CA 1.45 -0.447 0 C-N-CA 126.023 1.729 . . . . 73.200000000000003 108.205 174.796 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -76.69 179.81 6.09 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 124.125 3.216 . . . . 73.329999999999998 112.533 -170.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 88.3 t -140.8 128.2 12.15 Favored Pre-proline 0 CA--C 1.544 0.73 0 C-N-CA 124.284 1.034 . . . . 61.5 110.448 -167.393 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -82.65 178.73 5.87 Favored 'Trans proline' 0 CA--C 1.542 0.897 0 C-N-CA 124.794 3.663 . . . . 62.539999999999999 112.326 176.615 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 28.2 m -134.07 167.29 26.55 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 C-N-CA 124.202 1.001 . . . . 73.310000000000002 112.077 -179.268 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 11.2 t -64.42 -49.29 72.11 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 127.427 2.291 . . . . 60.43 109.568 170.163 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 30.9 tt0 -113.74 80.99 5.39 Favored Pre-proline 0 CA--C 1.541 0.601 0 C-N-CA 124.264 1.026 . . . . 75.510000000000005 110.451 -173.74 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -68.97 97.18 0.56 Allowed 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 123.928 3.086 . . . . 71.25 108.216 174.434 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -175.5 -58.97 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.378 0 N-CA-C 110.715 -0.954 . . . . 42.32 110.715 -175.553 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.46 145.04 28.36 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 107.172 -1.418 . . . . 74.439999999999998 107.172 166.634 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 36.9 mm -66.11 131.74 31.79 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 N-CA-C 105.721 -1.955 . . . . 64.239999999999995 105.721 167.298 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -80.65 142.58 33.84 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 108.699 -0.852 . . . . 72.209999999999994 108.699 171.916 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.442 HG22 HG22 ' A' ' 158' ' ' VAL . 47.1 t -131.57 114.38 25.29 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 N-CA-C 106.391 -1.707 . . . . 71.129999999999995 106.391 161.815 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 4.7 t -92.89 141.85 14.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 106.81 -1.552 . . . . 74.319999999999993 106.81 171.256 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 79.4 tt0 -107.64 106.25 16.51 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 105.217 -2.142 . . . . 70.310000000000002 105.217 156.286 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.0 mp -74.93 155.43 37.45 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 108.624 -0.88 . . . . 71.420000000000002 108.624 165.087 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -140.71 164.02 31.32 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 115.777 -0.647 . . . . 75.409999999999997 112.207 -163.849 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' TRP . . . . . 0.55 ' HB3' HG21 ' A' ' 153' ' ' VAL . 23.6 t90 -159.63 129.76 5.58 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 121.559 0.695 . . . . 71.439999999999998 110.642 158.403 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 11.2 m-30 -45.24 -27.3 0.62 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 126.392 1.877 . . . . 71.530000000000001 114.611 165.045 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -80.77 2.42 79.6 Favored Glycine 0 CA--C 1.531 1.067 0 CA-C-N 119.63 1.105 . . . . 72.140000000000001 114.161 -178.151 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 54.1 t -105.44 86.89 1.86 Allowed Pre-proline 0 CA--C 1.539 0.543 0 C-N-CA 125.71 1.604 . . . . 71.019999999999996 112.72 -165.304 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -63.81 -25.13 68.05 Favored 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 121.862 1.708 . . . . 72.120000000000005 112.95 177.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 13.7 m-70 -61.76 -46.39 89.78 Favored 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 108.365 -0.976 . . . . 75.099999999999994 108.365 173.337 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 87.7 m -60.09 -39.03 84.7 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.83 0.852 . . . . 52.100000000000001 109.037 -170.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 45.7 t80 -51.96 -40.46 60.88 Favored 'General case' 0 C--N 1.344 0.344 0 C-N-CA 125.3 1.44 . . . . 72.120000000000005 110.763 178.316 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.74 -26.25 68.28 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 118.817 -0.611 . . . . 52.149999999999999 112.546 -178.337 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.465 ' CD2' HD11 ' A' ' 166' ' ' ILE . 1.5 t80 -79.3 -25.73 42.37 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-O 117.558 -1.21 . . . . 64.019999999999996 111.741 -176.483 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 28.8 mm-40 -37.64 -69.39 0.19 Allowed Pre-proline 0 N--CA 1.471 0.606 0 C-N-CA 125.379 1.472 . . . . 74.450000000000003 112.829 -171.629 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -68.68 -6.67 18.45 Favored 'Trans proline' 0 CA--C 1.536 0.62 0 CA-C-N 121.98 1.743 . . . . 72.200000000000003 115.696 -172.778 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 60.1 m -85.26 -40.25 16.82 Favored 'General case' 0 CA--C 1.537 0.464 0 O-C-N 121.019 -1.051 . . . . 64.439999999999998 109.293 168.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 21.0 tt -93.51 -26.16 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 CA-C-N 118.575 0.625 . . . . 72.329999999999998 112.467 -171.571 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 19.3 t -53.18 -64.73 1.46 Allowed Pre-proline 0 C--O 1.236 0.385 0 C-N-CA 125.728 1.611 . . . . 70.439999999999998 110.059 172.522 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -63.11 -34.6 68.83 Favored 'Trans proline' 0 N--CA 1.451 -0.971 0 CA-C-N 120.898 1.356 . . . . 75.099999999999994 111.396 -174.142 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 86.7 t90 -54.54 -51.92 63.69 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 124.195 0.998 . . . . 72.239999999999995 110.521 174.242 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 98.7 p -59.25 -38.07 79.15 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 118.428 0.558 . . . . 74.310000000000002 111.84 -176.592 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -71.49 -18.71 62.27 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.691 0.796 . . . . 64.219999999999999 112.116 179.281 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 67.7 mmtt -94.72 -1.89 52.15 Favored 'General case' 0 C--O 1.232 0.164 0 C-N-CA 124.98 1.312 . . . . 62.439999999999998 112.983 179.101 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 36.9 mt -61.16 149.73 81.4 Favored Pre-proline 0 N--CA 1.45 -0.438 0 CA-C-N 119.846 1.203 . . . . 72.140000000000001 111.927 -175.733 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -77.48 165.06 27.87 Favored 'Trans proline' 0 N--CA 1.447 -1.221 0 C-N-CA 123.82 3.013 . . . . 71.219999999999999 111.547 -175.11 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -66.77 12.46 0.07 Allowed 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 127.421 2.288 . . . . 35.340000000000003 115.072 -176.703 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -128.36 14.76 6.65 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.449 1.499 . . . . 74.0 111.211 175.591 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 90.2 t -116.28 155.98 17.56 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 O-C-N 120.64 -1.288 . . . . 71.129999999999995 109.445 177.347 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 16.9 t-160 -132.43 102.84 5.89 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 125.955 1.702 . . . . 72.120000000000005 106.905 168.764 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -89.21 139.04 30.89 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 109.228 -0.656 . . . . 73.530000000000001 109.228 172.861 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 78.2 t -143.8 145.74 21.74 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.102 0 C-N-CA 124.675 1.19 . . . . 72.319999999999993 108.616 -176.317 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 22.2 mtp180 -111.21 119.28 38.39 Favored 'General case' 0 N--CA 1.463 0.193 0 N-CA-C 105.838 -1.912 . . . . 74.430000000000007 105.838 174.156 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 21.0 mt -128.18 147.02 61.74 Favored Pre-proline 0 N--CA 1.473 0.721 0 C-N-CA 123.543 0.737 . . . . 71.030000000000001 111.406 176.788 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -77.38 149.04 27.25 Favored 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 122.639 2.226 . . . . 70.019999999999996 112.206 -178.216 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -95.21 126.03 40.25 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 122.232 1.015 . . . . 73.030000000000001 108.671 174.668 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.461 HD22 ' HE1' ' A' ' 138' ' ' MET . 60.9 mt -113.03 52.26 0.8 Allowed 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 125.927 1.691 . . . . 74.019999999999996 111.583 -165.934 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 50.4 m-85 -83.42 63.89 7.55 Favored 'General case' 0 CA--C 1.54 0.57 0 O-C-N 121.332 -0.855 . . . . 71.230000000000004 111.784 -177.015 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 61.77 6.77 9.73 Favored Glycine 0 N--CA 1.476 1.366 0 N-CA-C 117.428 1.731 . . . . 61.020000000000003 117.428 142.673 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -170.47 103.85 0.2 Allowed Glycine 0 C--O 1.226 -0.406 0 N-CA-C 106.851 -2.5 . . . . 64.519999999999996 106.851 -176.705 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . 0.308 3.6 tp 58.34 -40.38 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 C-N-CA 130.501 3.52 . . . . 70.120000000000005 115.637 -171.063 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 12.5 m95 -49.26 -42.33 40.54 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 126.282 1.833 . . . . 74.450000000000003 111.606 -176.049 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 12.6 p30 -76.74 -28.69 55.87 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 114.284 1.216 . . . . 73.019999999999996 114.284 -178.323 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 86.0 t -70.28 -53.42 23.17 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 N-CA-C 106.347 -1.723 . . . . 74.200000000000003 106.347 174.797 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 40.5 m170 -68.03 39.42 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 128.905 2.882 . . . . 72.219999999999999 113.263 169.509 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -156.47 -46.66 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.424 0 O-C-N 121.204 -0.935 . . . . 72.209999999999994 111.378 177.397 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -50.66 -41.57 55.66 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.136 0.975 . . . . 33.25 112.144 -176.049 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 4.1 ttt -54.1 -35.39 62.07 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.387 1.075 . . . . 75.25 113.462 -175.547 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 39.3 t80 -59.94 -42.38 93.87 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 118.918 0.781 . . . . 74.430000000000007 109.844 -179.102 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 16.3 mt -66.0 -40.51 91.22 Favored 'General case' 0 C--O 1.227 -0.102 0 C-N-CA 125.094 1.358 . . . . 74.329999999999998 109.427 179.59 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.444 HG23 HG23 ' A' ' 128' ' ' THR . 0.2 OUTLIER -63.78 -37.02 85.81 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.666 0.786 . . . . 74.549999999999997 110.833 175.673 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.35 -56.33 15.13 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 124.092 0.957 . . . . 42.130000000000003 109.266 -178.422 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -72.06 -15.51 62.02 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 112.534 0.568 . . . . 42.25 112.534 -178.36 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 38.5 t -60.39 -18.99 54.22 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.521 1.129 . . . . 74.439999999999998 111.409 170.867 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 45.9 mtm -98.81 -13.68 20.01 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 120.282 1.401 . . . . 70.230000000000004 114.421 173.565 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 69.87 31.97 70.04 Favored Glycine 0 CA--C 1.529 0.922 0 CA-C-N 119.105 0.866 . . . . 74.430000000000007 112.655 -179.001 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 20.5 m -52.44 157.07 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 C-N-CA 126.112 1.765 . . . . 65.019999999999996 111.895 175.396 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -147.73 3.6 0.74 Allowed 'General case' 0 CA--C 1.543 0.704 0 O-C-N 121.308 -0.87 . . . . 73.239999999999995 112.672 173.335 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 8.0 m80 -131.54 131.26 43.23 Favored 'General case' 0 CA--C 1.529 0.166 0 O-C-N 120.045 -1.659 . . . . 72.549999999999997 109.782 -170.47 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 11.6 t0 54.05 27.95 8.17 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 128.367 2.667 . . . . 63.520000000000003 114.67 177.627 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 15.5 m -117.38 -164.36 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 C-N-CA 127.969 2.507 . . . . 74.049999999999997 109.543 -179.555 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . 0.257 0.3 OUTLIER 51.98 -85.48 0.01 OUTLIER 'General case' 0 C--O 1.233 0.213 0 C-N-CA 128.73 2.812 . . . . 65.420000000000002 113.052 -173.885 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -58.27 -58.94 6.25 Favored 'General case' 0 CA--C 1.51 -0.577 0 CA-C-N 119.507 1.049 . . . . 71.329999999999998 110.344 -178.549 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -60.36 -19.84 57.19 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 113.189 0.811 . . . . 71.450000000000003 113.189 -175.873 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 17.6 t -71.57 -62.18 1.4 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 N-CA-C 108.375 -0.972 . . . . 75.420000000000002 108.375 172.383 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 41.3 m-85 -64.42 -35.88 82.35 Favored 'General case' 0 C--N 1.338 0.082 0 C-N-CA 124.267 1.027 . . . . 72.400000000000006 111.89 -174.561 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 34.8 mm-40 -57.93 -45.19 86.97 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 125.553 1.541 . . . . 65.530000000000001 109.435 175.725 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -64.28 -19.67 65.56 Favored 'General case' 0 CA--C 1.542 0.645 0 O-C-N 121.574 -0.704 . . . . 64.329999999999998 112.195 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 64.4 mt -101.74 -25.93 3.66 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 C-N-CA 125.679 1.592 . . . . 63.539999999999999 110.298 -173.239 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 83.8 m-70 -117.58 -53.71 2.4 Favored 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 124.323 1.049 . . . . 73.239999999999995 111.835 -174.391 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -72.1 -32.66 67.2 Favored 'General case' 0 N--CA 1.468 0.45 0 O-C-N 121.309 -0.869 . . . . 64.310000000000002 110.949 176.956 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -101.71 -36.32 8.76 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 119.425 1.011 . . . . 54.420000000000002 112.597 177.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 22.7 t-160 44.5 63.62 1.61 Allowed 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.901 1.68 . . . . 74.140000000000001 112.07 -171.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 37.7 mmtt -64.19 170.71 3.49 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.208 1.403 . . . . 65.120000000000005 110.96 171.639 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 63.3 tttt -81.38 30.02 0.35 Allowed 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 125.985 1.714 . . . . 70.239999999999995 112.622 -173.477 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.477 HD23 ' HB3' ' A' ' 110' ' ' GLU . 31.0 mt -71.89 32.08 0.05 Allowed 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 128.8 2.84 . . . . 41.149999999999999 114.452 -165.112 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -78.85 8.37 5.61 Favored 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 126.864 2.066 . . . . 71.409999999999997 114.303 -178.333 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -150.75 156.77 36.15 Favored Pre-proline 0 CA--C 1.534 0.332 0 C-N-CA 124.25 1.02 . . . . 75.209999999999994 109.566 -174.983 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -65.42 -30.23 53.21 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 121.818 1.678 . . . . 61.219999999999999 114.0 -170.823 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -66.26 -53.69 33.86 Favored 'General case' 0 C--O 1.223 -0.31 0 CA-C-O 118.13 -0.938 . . . . 75.439999999999998 109.563 178.004 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.477 ' HB3' HD23 ' A' ' 105' ' ' LEU . 13.5 mm-40 -50.89 -48.19 60.5 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 119.353 0.979 . . . . 73.230000000000004 111.286 178.459 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 59.7 mtt -54.96 -55.19 33.48 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 123.937 0.895 . . . . 44.43 110.173 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.44 ' HB1' ' CG ' ' A' ' 122' ' ' LYS . . . -66.73 -42.61 86.0 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.565 1.146 . . . . 75.450000000000003 110.989 -172.665 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -61.0 -40.06 92.08 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 126.192 1.797 . . . . 74.430000000000007 109.853 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 38.7 t80 -68.81 -50.86 46.65 Favored 'General case' 0 N--CA 1.454 -0.243 0 O-C-N 121.807 -0.558 . . . . 75.420000000000002 109.644 178.193 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 50.7 mt -68.45 -15.94 63.73 Favored 'General case' 0 N--CA 1.452 -0.341 0 O-C-N 121.988 -0.445 . . . . 35.219999999999999 110.323 -172.561 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -54.19 -31.41 52.87 Favored 'General case' 0 CA--C 1.534 0.329 0 O-C-N 121.88 -0.513 . . . . 65.439999999999998 111.987 169.4 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -83.65 1.92 88.07 Favored Glycine 0 CA--C 1.534 1.22 0 CA-C-O 119.113 -0.826 . . . . 74.329999999999998 113.988 173.652 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 13.5 mmtp -131.62 27.31 4.68 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 120.036 1.918 . . . . 44.219999999999999 111.292 -166.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 73.33 36.1 55.77 Favored Glycine 0 CA--C 1.521 0.453 0 CA-C-O 119.825 -0.431 . . . . 71.129999999999995 112.295 173.87 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 31.8 t -126.51 123.11 62.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 N-CA-C 106.704 -1.591 . . . . 65.209999999999994 106.704 178.389 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -69.75 153.56 43.19 Favored 'General case' 0 CA--C 1.537 0.454 0 O-C-N 122.021 -0.424 . . . . 63.130000000000003 111.533 173.78 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.44 ' CG ' ' HB1' ' A' ' 112' ' ' ALA . 6.1 ttpt -83.48 -36.84 23.82 Favored 'General case' 0 N--CA 1.465 0.299 0 O-C-N 120.419 -1.426 . . . . 72.25 110.46 175.492 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 58.0 mt-10 -57.83 -52.86 63.72 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 118.859 0.754 . . . . 74.230000000000004 109.693 -176.504 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 7.6 mmmt -73.32 -38.52 65.78 Favored 'General case' 0 CA--C 1.508 -0.639 0 N-CA-C 108.353 -0.98 . . . . 72.109999999999999 108.353 -167.79 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 61.4 t80 -57.88 -62.49 1.77 Allowed 'General case' 0 N--CA 1.436 -1.174 0 O-C-N 124.732 1.27 . . . . 73.439999999999998 109.13 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 16.0 mt -68.05 -31.15 70.6 Favored 'General case' 0 C--O 1.238 0.485 0 O-C-N 121.985 -0.447 . . . . 75.109999999999999 111.305 -176.77 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 33.2 t -56.15 -59.8 4.41 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 107.4 -1.333 . . . . 41.409999999999997 107.4 175.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' THR . . . . . 0.444 HG23 HG23 ' A' ' 80' ' ' THR . 4.5 t -71.86 -36.18 70.04 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 118.963 -0.541 . . . . 73.239999999999995 109.934 -171.73 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 61.6 t80 -51.62 -43.98 62.74 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.93 1.292 . . . . 73.409999999999997 111.733 176.394 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 54.4 m-20 -104.39 33.61 3.45 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 121.779 -0.576 . . . . 73.400000000000006 110.667 -179.768 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 22.6 t -122.95 165.76 16.18 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.178 1.391 . . . . 62.219999999999999 110.926 177.182 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -57.19 -29.42 63.67 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.168 1.387 . . . . 61.240000000000002 111.517 177.746 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -53.57 -58.89 5.57 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 123.918 0.887 . . . . 61.310000000000002 110.849 177.586 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 38.6 mm -74.17 -28.28 23.07 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-O 118.421 -0.8 . . . . 73.230000000000004 109.89 -176.099 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 7.4 mmtt -53.97 -43.12 69.65 Favored 'General case' 0 C--N 1.34 0.169 0 CA-C-N 119.639 1.108 . . . . 63.509999999999998 110.002 170.815 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -66.76 -20.47 70.35 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 124.389 0.995 . . . . 53.439999999999998 112.944 -177.516 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -90.13 -41.31 11.71 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 117.954 0.877 . . . . 71.140000000000001 110.1 174.342 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' MET . . . . . 0.461 ' HE1' HD22 ' A' ' 66' ' ' LEU . 87.8 mmm -64.39 -35.93 82.48 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 124.825 1.25 . . . . 65.439999999999998 112.3 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -61.31 -51.29 69.48 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 119.039 0.836 . . . . 54.229999999999997 109.804 177.248 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 2.7 mmtt -65.04 -55.45 18.82 Favored 'General case' 0 CA--C 1.514 -0.419 0 C-N-CA 123.932 0.893 . . . . 74.519999999999996 109.275 -176.614 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -55.02 -34.5 63.54 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 119.681 1.128 . . . . 22.239999999999998 111.688 -178.086 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 5.7 tmtt? -77.87 -51.31 10.65 Favored 'General case' 0 C--N 1.346 0.437 0 CA-C-N 119.884 1.22 . . . . 72.430000000000007 111.344 -179.244 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 18.3 ptmt -60.54 -30.63 69.89 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 119.558 1.072 . . . . 65.329999999999998 110.527 178.802 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 48.4 mt -68.86 -56.91 6.46 Favored 'General case' 0 N--CA 1.443 -0.802 0 C-N-CA 123.442 0.697 . . . . 74.109999999999999 110.232 177.384 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -53.93 -41.5 67.77 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 119.887 1.221 . . . . 54.210000000000001 113.32 -173.737 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -65.22 -46.74 79.43 Favored 'General case' 0 N--CA 1.464 0.25 0 O-C-N 122.049 -0.407 . . . . 65.140000000000001 111.932 175.149 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -69.73 -35.04 74.66 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 118.733 0.697 . . . . 72.420000000000002 111.557 -176.409 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -69.48 9.29 0.49 Allowed 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 125.536 1.534 . . . . 71.340000000000003 113.763 171.618 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 10.9 mm100 59.04 24.72 13.02 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 126.005 1.722 . . . . 70.310000000000002 113.16 177.727 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 39.3 t -69.18 150.57 10.51 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 O-C-N 120.643 -1.286 . . . . 62.039999999999999 108.475 -178.197 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -145.98 6.27 1.02 Allowed 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.311 0.644 . . . . 52.219999999999999 111.947 -166.02 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 159.52 -171.99 36.05 Favored Glycine 0 N--CA 1.446 -0.688 0 N-CA-C 109.127 -1.589 . . . . 64.530000000000001 109.127 -166.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.55 HG21 ' HB3' ' A' ' 34' ' ' TRP . 15.3 m -139.72 161.93 53.77 Favored Pre-proline 0 CA--C 1.539 0.531 0 C-N-CA 124.064 0.945 . . . . 74.420000000000002 110.261 176.615 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 154' ' ' PRO . . . . . 0.46 ' C ' ' HA ' ' A' ' 153' ' ' VAL . 20.6 Cg_endo -58.37 156.63 36.13 Favored 'Cis proline' 0 CA--C 1.532 0.384 0 C-N-CA 123.928 -1.28 . . . . 73.299999999999997 111.065 -14.916 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 155' ' ' THR . . . . . 0.444 ' HA ' ' HB3' ' A' ' 165' ' ' ASP . 11.0 m -147.95 109.96 4.53 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.066 -1.087 . . . . 64.310000000000002 108.066 171.255 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 36.2 mmm -89.27 158.73 17.73 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 108.337 -0.986 . . . . 71.349999999999994 108.337 170.833 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 11.5 t -145.19 121.56 3.97 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 N-CA-C 108.575 -0.898 . . . . 73.109999999999999 108.575 174.128 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.566 HG23 ' CE1' ' A' ' 164' ' ' PHE . 77.2 t -91.83 131.51 38.73 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 N-CA-C 108.524 -0.917 . . . . 70.450000000000003 108.524 169.367 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 44.1 t30 48.88 19.45 0.27 Allowed 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 130.082 3.353 . . . . 73.109999999999999 115.323 168.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 69.62 23.75 76.54 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 125.357 1.456 . . . . 35.530000000000001 112.852 -175.858 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 55.9 mttt -131.55 -31.45 1.59 Allowed 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 118.596 1.198 . . . . 52.409999999999997 113.111 -171.285 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 162' ' ' TYR . . . . . 0.521 ' CG ' HD22 ' A' ' 182' ' ' LEU . 96.5 m-85 -125.68 108.08 11.19 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 123.529 0.732 . . . . 62.329999999999998 109.12 -175.532 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 41.7 ttt-85 -90.36 124.12 34.67 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 126.985 2.114 . . . . 72.510000000000005 106.039 174.475 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 164' ' ' PHE . . . . . 0.566 ' CE1' HG23 ' A' ' 158' ' ' VAL . 18.1 p90 -149.42 166.95 27.54 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 107.67 -1.233 . . . . 73.519999999999996 107.67 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 165' ' ' ASP . . . . . 0.444 ' HB3' ' HA ' ' A' ' 155' ' ' THR . 10.4 p-10 178.24 178.07 0.4 Allowed 'General case' 0 CA--C 1.51 -0.562 0 C-N-CA 124.86 1.264 . . . . 75.530000000000001 109.205 -178.666 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.465 HD11 ' CD2' ' A' ' 43' ' ' PHE . 18.2 mt -54.35 -38.49 40.54 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.673 0 C-N-CA 126.405 1.882 . . . . 72.420000000000002 109.834 178.204 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -65.27 -30.96 79.03 Favored Glycine 0 CA--C 1.526 0.764 0 C-N-CA 124.321 0.963 . . . . 42.140000000000001 113.266 175.499 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 51.0 m -84.61 -62.19 1.61 Allowed 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.898 0.879 . . . . 65.519999999999996 110.064 178.148 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -59.0 -32.87 70.08 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 126.583 1.953 . . . . 73.25 112.071 -173.274 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 102.07 2.58 51.7 Favored Glycine 0 CA--C 1.526 0.727 0 CA-C-O 118.656 -1.08 . . . . 34.030000000000001 112.453 178.714 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 169.24 172.66 36.17 Favored Glycine 0 CA--C 1.531 1.041 0 CA-C-N 119.256 1.528 . . . . 53.210000000000001 111.556 175.579 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -66.44 -49.37 1.82 Allowed 'Trans proline' 0 CA--C 1.534 0.502 0 C-N-CA 123.046 2.497 . . . . 74.299999999999997 112.459 -175.357 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -57.09 -43.67 82.43 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 119.406 1.003 . . . . 74.099999999999994 109.865 175.429 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -57.79 -34.88 70.08 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.21 -0.905 . . . . 71.400000000000006 109.958 -178.631 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 48.8 m -67.4 -41.51 84.81 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-O 118.179 -0.915 . . . . 74.25 110.689 -178.377 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 49.7 mt -66.45 -35.64 80.81 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 119.836 1.198 . . . . 54.329999999999998 111.039 176.864 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 10.3 mttt -51.39 -48.56 62.54 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.244 1.418 . . . . 63.240000000000002 110.09 170.881 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.501 HD11 ' HB3' ' A' ' 11' ' ' GLU . 3.2 mm? -67.58 -48.85 65.68 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-O 118.346 -0.835 . . . . 72.109999999999999 110.478 173.833 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -52.91 -37.55 60.86 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 123.375 0.67 . . . . 73.030000000000001 111.977 -172.576 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -81.36 -47.55 13.12 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.659 1.184 . . . . 74.299999999999997 110.657 -173.886 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -56.56 -47.79 78.72 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 108.82 -0.807 . . . . 65.439999999999998 108.82 176.876 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.521 HD22 ' CG ' ' A' ' 162' ' ' TYR . 29.4 mt -63.57 -32.44 73.9 Favored 'General case' 0 CA--C 1.514 -0.438 0 C-N-CA 125.3 1.44 . . . . 61.030000000000001 112.205 -170.672 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 30.0 mt -58.38 -61.49 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 N-CA-C 107.046 -1.465 . . . . 71.019999999999996 107.046 174.058 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -53.05 -37.19 61.38 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 123.869 0.867 . . . . 64.120000000000005 111.691 -179.339 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 185' ' ' LYS . . . . . 0.457 ' HA ' ' HE2' ' A' ' 185' ' ' LYS . 0.0 OUTLIER -54.72 -39.09 67.88 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.547 0.739 . . . . 62.340000000000003 111.046 -176.063 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 63.8 mm-40 -95.14 -33.85 12.49 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 124.133 0.973 . . . . 65.549999999999997 112.135 175.126 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.05 -34.45 74.89 Favored 'General case' 0 CA--C 1.529 0.17 0 O-C-N 120.598 -1.314 . . . . 74.519999999999996 109.908 -179.022 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -67.89 -12.02 59.83 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 124.914 1.286 . . . . 54.210000000000001 112.174 179.385 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -69.84 -14.83 62.94 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 118.758 0.708 . . . . 73.329999999999998 111.825 169.247 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . 54.02 26.85 6.8 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 128.234 2.614 . . . . 73.519999999999996 113.074 175.016 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 3.1 ttpm? 50.61 37.74 17.08 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.254 1.422 . . . . 73.209999999999994 111.818 -173.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 20.1 pttm . . . . . 0 C--O 1.243 0.756 0 CA-C-O 117.06 -1.448 . . . . 72.209999999999994 110.694 179.912 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.631 0 N-CA-C 107.91 -2.076 . . . . 73.5 107.91 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -136.02 134.67 38.75 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-N 118.615 1.207 . . . . 62.200000000000003 110.977 -154.428 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -134.21 11.37 3.86 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 126.278 1.831 . . . . 65.349999999999994 111.546 -170.698 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 -140.02 158.18 44.47 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 124.697 1.199 . . . . 71.439999999999998 108.485 -169.775 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 24.4 m -134.76 138.94 44.77 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 108.777 -0.823 . . . . 71.400000000000006 108.777 -178.577 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -71.14 143.74 50.47 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 109.146 -0.687 . . . . 75.420000000000002 109.146 174.192 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 68.1 14.28 65.78 Favored Glycine 0 CA--C 1.523 0.577 0 CA-C-O 119.315 -0.714 . . . . 32.439999999999998 112.515 -168.054 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 6.7 tttm -130.92 -82.56 0.53 Allowed 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 107.532 -1.285 . . . . 72.409999999999997 107.532 179.69 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.441 ' HB3' HD21 ' A' ' 178' ' ' LEU . 7.5 mp0 -79.44 -24.59 42.35 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 124.587 1.155 . . . . 70.400000000000006 111.361 -178.392 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 41.3 p90 -155.89 174.57 15.13 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 107.329 -1.36 . . . . 64.310000000000002 107.329 -177.075 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 23.0 t -132.29 146.82 32.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 108.474 -0.935 . . . . 74.230000000000004 108.474 -175.446 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -109.22 156.52 19.8 Favored 'General case' 0 N--CA 1.451 -0.409 0 O-C-N 120.894 -1.129 . . . . 75.430000000000007 109.161 166.398 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -126.02 120.22 29.72 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 125.747 1.619 . . . . 72.329999999999998 108.695 -169.338 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.8 m -55.13 -15.53 2.31 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.616 1.567 . . . . 61.350000000000001 114.223 -177.666 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 10.4 p -128.59 84.99 61.51 Favored Pre-proline 0 N--CA 1.445 -0.688 0 CA-C-N 119.164 0.893 . . . . 52.240000000000002 111.55 -179.552 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -73.08 179.79 5.07 Favored 'Trans proline' 0 CA--C 1.542 0.923 0 C-N-CA 124.449 3.432 . . . . 61.439999999999998 113.822 178.19 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 6.7 t -128.94 142.3 44.66 Favored Pre-proline 0 N--CA 1.47 0.564 0 C-N-CA 125.347 1.459 . . . . 70.239999999999995 108.102 173.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -76.73 176.52 10.01 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 123.608 2.872 . . . . 64.519999999999996 111.216 172.042 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.7 m -115.99 179.4 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 C-N-CA 124.017 0.927 . . . . 73.299999999999997 109.418 170.095 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 34.7 t -56.15 -64.03 0.99 Allowed 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 123.82 0.848 . . . . 73.150000000000006 108.906 169.448 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 19.1 mt-30 -150.38 161.23 31.27 Favored Pre-proline 0 C--O 1.237 0.442 0 O-C-N 121.68 -0.638 . . . . 73.329999999999998 110.761 -174.172 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -70.82 166.38 29.11 Favored 'Trans proline' 0 N--CA 1.45 -1.049 0 C-N-CA 122.747 2.298 . . . . 74.040000000000006 109.333 171.531 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 143.04 -86.57 0.18 Allowed Glycine 0 N--CA 1.449 -0.495 0 N-CA-C 108.894 -1.683 . . . . 65.430000000000007 108.894 -175.872 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.29 158.0 15.64 Favored 'General case' 0 N--CA 1.462 0.161 0 N-CA-C 108.616 -0.883 . . . . 74.109999999999999 108.616 -176.616 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 48.0 mm -66.63 154.91 7.61 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 N-CA-C 106.585 -1.635 . . . . 75.349999999999994 106.585 166.801 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -108.59 90.32 3.26 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 107.449 -1.315 . . . . 75.400000000000006 107.449 172.466 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 41.4 t -94.61 119.8 43.11 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.175 0 N-CA-C 106.654 -1.61 . . . . 70.430000000000007 106.654 176.889 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 25.4 t -119.45 110.99 31.2 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 N-CA-C 108.507 -0.923 . . . . 70.540000000000006 108.507 -174.291 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -72.61 126.94 31.1 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 108.046 -1.094 . . . . 71.129999999999995 108.046 154.488 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.5 mp -109.7 139.9 44.2 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 106.634 -1.617 . . . . 75.349999999999994 106.634 151.729 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 9.3 p90 -146.07 168.06 21.85 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 125.323 1.449 . . . . 74.120000000000005 107.974 -173.116 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 24.1 t90 -142.18 151.75 42.49 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 107.664 -1.236 . . . . 64.510000000000005 107.664 -177.146 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -47.15 -31.28 3.42 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.882 1.273 . . . . 74.420000000000002 112.085 166.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -109.5 17.9 30.52 Favored Glycine 0 CA--C 1.527 0.809 0 CA-C-O 117.577 -1.68 . . . . 74.420000000000002 115.138 -159.846 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 23.0 p -104.83 86.33 1.45 Allowed Pre-proline 0 CA--C 1.538 0.516 0 CA-C-N 119.644 1.722 . . . . 71.099999999999994 110.723 -170.434 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -58.51 -27.24 81.58 Favored 'Trans proline' 0 CA--C 1.54 0.776 0 CA-C-N 121.778 1.671 . . . . 52.020000000000003 114.232 -174.833 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 10.9 m170 -59.84 -19.63 52.14 Favored 'General case' 0 CA--C 1.537 0.449 0 O-C-N 121.365 -0.835 . . . . 72.439999999999998 112.592 174.067 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 98.8 m -71.01 -36.07 72.28 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.922 1.289 . . . . 65.129999999999995 110.632 -176.156 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 38.4 m-85 -61.68 -36.48 80.97 Favored 'General case' 0 N--CA 1.471 0.595 0 O-C-N 120.794 -1.191 . . . . 74.120000000000005 111.711 -177.462 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.74 -12.09 43.41 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 124.505 1.122 . . . . 71.329999999999998 112.209 179.299 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 27.1 t80 -126.41 -25.28 3.49 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-O 116.353 -1.784 . . . . 73.109999999999999 112.701 -172.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -45.37 -62.77 1.51 Allowed Pre-proline 0 N--CA 1.473 0.722 0 CA-C-N 121.619 2.009 . . . . 65.299999999999997 113.107 -177.517 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -70.38 -7.81 22.12 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 CA-C-N 121.179 1.457 . . . . 74.230000000000004 114.932 -178.872 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 25.4 m -80.84 -37.53 29.83 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.093 0.957 . . . . 64.109999999999999 110.061 170.295 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 20.6 tt -91.65 -31.62 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 C-N-CA 123.147 0.579 . . . . 74.420000000000002 111.617 -174.394 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 12.5 t -46.93 -62.8 1.71 Allowed Pre-proline 0 CA--C 1.539 0.533 0 CA-C-O 117.975 -1.012 . . . . 54.409999999999997 111.027 174.256 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -66.83 -34.91 29.13 Favored 'Trans proline' 0 N--CA 1.452 -0.939 0 CA-C-N 121.222 1.472 . . . . 54.32 111.027 -176.194 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 91.2 t90 -55.09 -47.32 75.08 Favored 'General case' 0 C--N 1.341 0.217 0 CA-C-N 119.778 1.172 . . . . 74.200000000000003 109.929 174.537 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 49.7 p -59.51 -38.1 80.06 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 122.783 0.433 . . . . 71.150000000000006 111.604 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.4 mt-10 -75.32 -10.55 59.55 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.34 1.456 . . . . 74.150000000000006 112.483 177.506 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 9.7 mmmm -119.44 9.8 11.69 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 126.447 1.899 . . . . 72.349999999999994 112.772 -174.571 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 27.5 mt -65.02 160.6 55.05 Favored Pre-proline 0 CA--C 1.538 0.506 0 C-N-CA 124.402 1.081 . . . . 55.25 111.661 172.501 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -82.66 169.7 13.39 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 124.913 3.742 . . . . 73.219999999999999 111.409 175.088 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -71.83 16.64 0.11 Allowed 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 126.755 2.022 . . . . 74.450000000000003 114.062 -175.304 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -127.09 -4.96 6.19 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 126.601 1.961 . . . . 73.400000000000006 113.074 -179.09 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.466 HG21 HD13 ' A' ' 183' ' ' ILE . 48.5 t -113.68 113.98 45.49 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.307 0 N-CA-C 106.689 -1.597 . . . . 54.439999999999998 106.689 -178.011 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 79.5 t60 -101.3 112.71 25.3 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 107.045 -1.465 . . . . 63.350000000000001 107.045 174.663 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 27.6 t80 -84.6 143.99 28.91 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 114.855 -1.066 . . . . 74.140000000000001 109.16 176.153 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 48.8 t -136.24 141.09 42.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 N-CA-C 106.387 -1.708 . . . . 71.239999999999995 106.387 -177.316 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 60.1 mtm-85 -123.43 113.33 18.65 Favored 'General case' 0 CA--C 1.508 -0.635 0 N-CA-C 104.613 -2.366 . . . . 74.340000000000003 104.613 176.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 5.8 mt -124.67 149.23 61.61 Favored Pre-proline 0 N--CA 1.466 0.326 0 CA-C-N 120.443 1.474 . . . . 54.109999999999999 110.043 174.294 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -67.53 143.43 62.85 Favored 'Trans proline' 0 N--CA 1.45 -1.051 0 C-N-CA 121.123 1.215 . . . . 54.420000000000002 110.743 -177.305 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -79.17 59.19 2.69 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.684 1.594 . . . . 50.310000000000002 111.49 -179.665 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 10.6 mt -74.1 88.13 1.91 Allowed 'General case' 0 C--N 1.328 -0.356 0 O-C-N 120.382 -1.449 . . . . 62.240000000000002 108.502 -176.673 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -141.61 1.98 1.57 Allowed 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 114.352 1.241 . . . . 75.549999999999997 114.352 175.649 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -153.04 179.0 29.82 Favored Glycine 0 C--N 1.333 0.401 0 O-C-N 121.078 -1.014 . . . . 72.049999999999997 113.814 -163.873 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -51.81 -53.56 29.18 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 128.589 2.995 . . . . 65.400000000000006 113.117 -164.289 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 9.8 tp -106.39 -6.85 10.24 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 C-N-CA 124.886 1.274 . . . . 51.32 110.884 173.39 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 8.9 m95 -73.76 -24.7 59.9 Favored 'General case' 0 N--CA 1.448 -0.568 0 O-C-N 120.876 -1.14 . . . . 73.549999999999997 111.495 -171.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -70.38 -46.94 63.04 Favored 'General case' 0 C--O 1.234 0.244 0 O-C-N 121.321 -0.862 . . . . 74.120000000000005 109.299 169.457 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 25.7 t -63.31 -53.13 49.65 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 C-N-CA 122.774 0.43 . . . . 70.299999999999997 110.189 -173.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 38.6 m170 -67.31 1.88 1.95 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.225 1.01 . . . . 54.43 113.185 178.457 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -109.19 -43.5 1.17 Allowed Glycine 0 C--N 1.338 0.669 0 CA-C-N 120.702 1.592 . . . . 63.210000000000001 110.697 -176.596 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -54.37 -36.62 64.07 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 113.391 0.886 . . . . 74.430000000000007 113.391 -170.832 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 5.9 ttt -45.21 -45.79 11.94 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 125.849 1.659 . . . . 64.25 114.434 -179.812 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 34.8 t80 -56.85 -42.34 79.53 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 121.52 0.676 . . . . 62.240000000000002 109.775 -173.904 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 18.2 mt -68.75 -42.11 77.97 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 117.082 -1.437 . . . . 60.43 109.291 178.909 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -56.51 -40.61 75.31 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 121.046 1.748 . . . . 74.530000000000001 110.944 178.255 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.534 HD23 HG21 ' A' ' 86' ' ' VAL . 0.2 OUTLIER -63.07 -59.79 4.32 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 123.686 0.794 . . . . 71.109999999999999 110.219 179.243 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -65.24 -16.37 63.47 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 118.806 0.73 . . . . 73.319999999999993 112.208 -178.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -53.25 -25.74 15.52 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.208 1.003 . . . . 61.109999999999999 111.724 174.355 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 11.6 mtp -107.1 -11.42 15.64 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.429 1.492 . . . . 64.420000000000002 112.05 -172.464 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 63.23 39.32 97.75 Favored Glycine 0 CA--C 1.53 0.973 0 N-CA-C 110.743 -0.943 . . . . 43.43 110.743 -173.7 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.534 HG21 HD23 ' A' ' 81' ' ' LEU . 20.5 m -66.2 161.79 3.18 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 C-N-CA 125.005 1.322 . . . . 54.200000000000003 110.76 167.897 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 51.24 -162.16 0.07 Allowed 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 106.589 -1.634 . . . . 75.340000000000003 106.589 -163.661 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 42.9 m170 -91.18 -85.23 0.24 Allowed 'General case' 0 N--CA 1.465 0.293 0 O-C-N 119.353 -2.092 . . . . 63.32 108.832 164.246 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 41.6 t0 -139.5 43.08 2.01 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-O 122.333 1.064 . . . . 71.430000000000007 109.536 -178.508 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 21.6 m -147.07 161.74 8.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 C-N-CA 128.443 2.697 . . . . 71.519999999999996 107.941 -176.605 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 21.2 p80 -156.04 35.59 0.34 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 122.011 0.91 . . . . 72.219999999999999 113.013 -168.742 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -49.95 -64.45 0.8 Allowed 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 126.286 1.834 . . . . 75.319999999999993 110.768 -173.888 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -60.82 -26.21 67.15 Favored 'General case' 0 N--CA 1.457 -0.119 0 CA-C-O 117.96 -1.019 . . . . 35.329999999999998 113.029 -178.216 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 39.0 t -59.19 -62.67 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.339 0.14 0 N-CA-C 107.683 -1.229 . . . . 61.240000000000002 107.683 178.669 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -61.95 -49.57 75.59 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 123.874 0.87 . . . . 74.099999999999994 110.343 -179.387 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -57.29 -38.36 73.86 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.922 0.889 . . . . 72.099999999999994 110.488 -173.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.427 ' HA ' ' HB2' ' A' ' 101' ' ' GLU . . . -67.88 -43.79 78.55 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-O 122.46 1.124 . . . . 71.510000000000005 111.12 -178.452 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 45.2 mt -71.57 -36.29 59.48 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 N-CA-C 108.207 -1.034 . . . . 75.450000000000003 108.207 -175.371 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 81.1 m-70 -95.68 -74.03 0.57 Allowed 'General case' 0 N--CA 1.446 -0.66 0 O-C-N 121.46 -0.775 . . . . 75.319999999999993 109.936 -171.528 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 22.5 mmtt -64.12 -18.53 64.51 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 125.099 1.36 . . . . 75.209999999999994 112.097 -176.359 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.427 ' HB2' ' HA ' ' A' ' 97' ' ' ALA . 0.4 OUTLIER -108.82 -19.83 13.27 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 113.516 0.932 . . . . 74.200000000000003 113.516 179.243 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 3.9 t60 44.02 57.64 4.08 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 126.389 1.876 . . . . 75.219999999999999 112.059 173.325 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 12.6 mmtm -75.51 160.65 29.95 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.668 1.187 . . . . 65.319999999999993 109.992 178.308 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 32.7 tttt -77.61 29.83 0.16 Allowed 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 127.466 2.307 . . . . 74.239999999999995 113.892 -178.716 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 27.6 mt -74.62 49.88 0.41 Allowed 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 127.489 2.316 . . . . 74.150000000000006 111.734 -169.816 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -90.37 -0.26 57.56 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 128.093 2.557 . . . . 72.299999999999997 112.333 -178.535 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 23.8 p -141.01 153.41 67.18 Favored Pre-proline 0 C--O 1.233 0.23 0 C-N-CA 123.424 0.69 . . . . 63.439999999999998 110.135 173.439 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -63.89 -28.4 67.21 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 122.528 2.152 . . . . 63.509999999999998 112.642 -176.649 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 27.8 mp0 -70.35 -36.71 74.36 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 119.594 1.088 . . . . 70.239999999999995 110.31 177.286 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -73.37 -40.36 64.44 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.847 0.859 . . . . 74.140000000000001 109.544 178.612 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 45.1 mtt -58.47 -61.29 2.7 Favored 'General case' 0 C--N 1.343 0.286 0 C-N-CA 126.044 1.738 . . . . 65.200000000000003 109.935 174.671 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -62.91 -41.26 99.38 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 123.888 0.875 . . . . 71.349999999999994 111.476 -170.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -56.65 -41.91 78.04 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.049 0.452 . . . . 72.049999999999997 111.212 176.199 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' PHE . . . . . 0.407 ' CZ ' ' HB1' ' A' ' 97' ' ' ALA . 80.8 t80 -70.57 -40.69 73.17 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 123.614 0.766 . . . . 71.299999999999997 112.061 -179.173 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 56.1 mt -75.97 -17.02 59.88 Favored 'General case' 0 C--N 1.332 -0.181 0 O-C-N 121.378 -0.826 . . . . 55.229999999999997 111.445 -177.796 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -54.06 -28.33 38.18 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.981 0.912 . . . . 64.239999999999995 111.832 -178.075 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -89.54 -1.68 77.45 Favored Glycine 0 CA--C 1.529 0.94 0 CA-C-O 117.741 -1.589 . . . . 61.210000000000001 115.151 177.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 39.5 mttt -129.33 26.42 5.41 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 120.791 2.295 . . . . 74.150000000000006 112.647 -166.313 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 104.7 3.93 42.91 Favored Glycine 0 CA--C 1.527 0.812 0 C-N-CA 123.542 0.591 . . . . 71.129999999999995 113.463 173.101 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 77.0 t -106.3 165.09 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 C-N-CA 125.277 1.431 . . . . 75.200000000000003 107.899 179.733 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 60.8 t0 -132.87 132.24 41.87 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 105.711 -1.959 . . . . 61.020000000000003 105.711 176.849 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 21.3 mtpt -55.72 -36.03 66.77 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 123.523 0.729 . . . . 71.140000000000001 110.885 176.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -60.2 -50.87 71.96 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 118.875 0.761 . . . . 74.430000000000007 109.874 174.609 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -78.04 -28.03 48.91 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 108.979 -0.749 . . . . 60.299999999999997 108.979 -167.452 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 32.8 t80 -68.66 -69.73 0.31 Allowed 'General case' 0 N--CA 1.437 -1.09 0 C-N-CA 125.434 1.493 . . . . 72.329999999999998 108.845 173.627 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 8.1 mt -68.04 -37.99 81.99 Favored 'General case' 0 CA--C 1.531 0.24 0 O-C-N 121.244 -0.91 . . . . 73.310000000000002 110.348 -163.164 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 3.9 t -66.61 -21.13 66.13 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 118.781 -0.628 . . . . 73.049999999999997 112.232 -175.167 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 3.1 t -98.42 -35.11 10.39 Favored 'General case' 0 C--N 1.342 0.27 0 CA-C-N 119.196 0.907 . . . . 72.140000000000001 110.448 171.113 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 80.2 t80 -49.31 -55.69 11.95 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 119.184 0.902 . . . . 61.409999999999997 110.533 177.344 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 -86.08 55.61 3.61 Favored 'General case' 0 C--O 1.231 0.105 0 N-CA-C 108.714 -0.847 . . . . 53.340000000000003 108.714 174.356 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -157.91 166.53 32.4 Favored 'General case' 0 C--O 1.237 0.396 0 O-C-N 120.93 -1.106 . . . . 60.549999999999997 111.33 -177.973 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -74.6 -29.61 61.37 Favored 'General case' 0 N--CA 1.456 -0.14 0 CA-C-N 115.613 -0.721 . . . . 73.019999999999996 112.836 -162.551 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -56.73 -49.48 75.05 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 119.658 1.117 . . . . 73.340000000000003 110.258 -177.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 35.5 mm -63.02 -39.44 85.23 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.345 0 C-N-CA 125.161 1.384 . . . . 64.340000000000003 109.493 177.857 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 28.0 tttm -55.83 -42.67 76.08 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 118.585 -0.721 . . . . 72.329999999999998 109.562 175.305 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -71.18 -24.95 76.48 Favored Glycine 0 CA--C 1.523 0.559 0 C-N-CA 124.796 1.189 . . . . 70.450000000000003 111.958 -171.525 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -87.61 -50.4 6.53 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 124.347 1.059 . . . . 73.400000000000006 108.39 179.114 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 1.2 ppp? -58.49 -43.11 88.87 Favored 'General case' 0 C--N 1.34 0.161 0 C-N-CA 123.627 0.771 . . . . 74.25 109.737 -176.903 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -60.13 -40.01 88.27 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-O 118.464 -0.779 . . . . 64.230000000000004 112.133 -176.024 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -59.85 -59.38 5.52 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 123.906 0.883 . . . . 62.009999999999998 109.855 173.813 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -54.01 -34.0 58.7 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 118.038 0.381 . . . . 45.100000000000001 111.175 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 49.6 tttt -67.55 -59.67 3.17 Favored 'General case' 0 C--O 1.232 0.149 0 O-C-N 121.322 -0.861 . . . . 75.430000000000007 110.852 177.83 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.45 -24.28 64.7 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 118.452 0.569 . . . . 65.230000000000004 111.566 -174.686 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 32.6 mt -67.33 -53.16 32.05 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 118.52 -0.752 . . . . 75.340000000000003 110.203 170.543 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -53.92 -44.86 70.94 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 118.957 0.799 . . . . 71.420000000000002 112.291 -174.733 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 13.5 ptp -63.48 -46.9 84.03 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 119.423 -0.323 . . . . 53.119999999999997 111.551 176.692 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -58.87 -43.31 90.86 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 118.354 -0.831 . . . . 53.350000000000001 109.481 -179.762 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 18.1 m-85 -66.28 5.4 0.55 Allowed 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 115.078 1.511 . . . . 73.239999999999995 115.078 -175.096 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 59.2 mm-40 62.46 34.31 15.5 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 121.143 1.792 . . . . 71.409999999999997 113.198 176.39 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.818 HG22 ' NH2' ' A' ' 163' ' ' ARG . 57.5 t -80.5 -76.97 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 CA-C-O 118.415 -0.803 . . . . 73.349999999999994 111.18 -165.072 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . 0.26 1.6 p 54.59 -22.45 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 129.293 3.037 . . . . 62.310000000000002 118.18 -179.731 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.45 ' O ' HG13 ' A' ' 153' ' ' VAL . . . -99.45 -179.84 30.89 Favored Glycine 0 CA--C 1.532 1.102 0 CA-C-N 121.6 2.0 . . . . 43.549999999999997 111.807 168.467 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.45 HG13 ' O ' ' A' ' 152' ' ' GLY . 3.1 m -165.2 148.06 6.94 Favored Pre-proline 0 CA--C 1.547 0.865 0 C-N-CA 129.351 3.06 . . . . 75.329999999999998 108.033 167.808 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -67.34 142.35 62.2 Favored 'Cis proline' 0 N--CA 1.452 -0.923 0 CA-C-N 120.006 1.038 . . . . 71.319999999999993 110.543 -5.821 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' THR . . . . . 0.5 ' CG2' ' HE ' ' A' ' 163' ' ' ARG . 25.3 m -147.07 133.4 19.56 Favored 'General case' 0 N--CA 1.447 -0.575 0 N-CA-C 107.979 -1.119 . . . . 65.340000000000003 107.979 -174.253 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 42.6 mmm -111.81 163.69 13.89 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.324 1.45 . . . . 53.009999999999998 109.434 176.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 38.7 t -142.32 151.67 18.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 C-N-CA 125.154 1.382 . . . . 61.210000000000001 107.528 168.744 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 60.5 t -118.61 125.46 74.41 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 C-N-CA 125.802 1.641 . . . . 74.150000000000006 106.966 166.614 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 14.9 m-20 55.15 10.99 0.47 Allowed 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 128.016 2.526 . . . . 65.209999999999994 115.926 172.751 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 82.59 12.57 79.99 Favored Glycine 0 CA--C 1.522 0.524 0 CA-C-O 117.921 -1.488 . . . . 22.199999999999999 113.45 -174.537 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 45.1 mttt -121.67 -52.34 2.02 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-N 119.083 1.441 . . . . 61.340000000000003 111.227 -166.645 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 74.6 m-85 -99.68 122.65 43.0 Favored 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 108.086 -1.079 . . . . 75.340000000000003 108.086 -179.52 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 163' ' ' ARG . . . . . 0.818 ' NH2' HG22 ' A' ' 150' ' ' VAL . 0.1 OUTLIER -92.46 133.42 35.93 Favored 'General case' 0 N--CA 1.446 -0.675 0 C-N-CA 126.888 2.075 . . . . 72.450000000000003 105.496 169.256 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 20.6 p90 -147.93 167.96 23.49 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.062 -1.088 . . . . 62.030000000000001 108.062 168.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -174.65 -179.41 1.49 Allowed 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 123.957 0.903 . . . . 63.539999999999999 108.921 178.191 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 13.5 mt -55.61 -45.07 78.75 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 C-N-CA 126.99 2.116 . . . . 71.140000000000001 108.408 176.022 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -61.69 -39.54 97.56 Favored Glycine 0 C--N 1.338 0.667 0 C-N-CA 124.154 0.883 . . . . 73.5 112.415 178.323 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 16.2 m -74.36 -56.79 4.47 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 118.678 1.239 . . . . 71.049999999999997 110.273 178.565 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -74.15 -33.19 63.43 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 125.201 1.401 . . . . 72.310000000000002 113.626 -163.127 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 147.4 -46.77 0.7 Allowed Glycine 0 CA--C 1.521 0.424 0 O-C-N 123.648 0.593 . . . . 62.299999999999997 112.259 -178.047 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 168.16 -174.19 43.0 Favored Glycine 0 CA--C 1.53 0.972 0 N-CA-C 109.209 -1.557 . . . . 75.219999999999999 109.209 -156.31 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -66.76 -55.59 0.32 Allowed 'Trans proline' 0 N--CA 1.452 -0.958 0 C-N-CA 122.618 2.212 . . . . 73.140000000000001 111.003 -170.319 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -60.46 -41.85 95.0 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 121.838 0.827 . . . . 75.230000000000004 109.58 179.35 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -56.48 -29.87 62.27 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 124.971 1.308 . . . . 71.319999999999993 111.864 179.498 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 89.5 m -67.04 -44.49 80.06 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-O 118.358 -0.829 . . . . 65.329999999999998 109.817 179.411 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 55.9 mt -60.52 -37.82 82.4 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 118.945 0.793 . . . . 74.230000000000004 109.682 175.264 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 8.7 ttpp -52.25 -39.89 60.95 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 117.626 -1.178 . . . . 74.239999999999995 110.326 175.876 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.441 HD21 ' HB3' ' A' ' 11' ' ' GLU . 4.5 mm? -79.16 -43.38 24.08 Favored 'General case' 0 C--N 1.346 0.454 0 CA-C-N 120.601 1.546 . . . . 75.409999999999997 111.869 172.071 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -51.54 -41.86 61.38 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 119.287 0.949 . . . . 45.439999999999998 111.818 -175.906 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -78.37 -38.91 40.74 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 124.801 1.24 . . . . 51.439999999999998 110.613 -172.286 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 24.1 t80 -64.46 -54.6 29.94 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 125.091 1.356 . . . . 62.119999999999997 110.444 174.89 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 87.6 mt -60.98 -23.24 65.2 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.251 1.02 . . . . 72.5 113.294 -174.697 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.466 HD13 HG21 ' A' ' 58' ' ' VAL . 23.7 mt -57.02 -59.89 2.63 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 CA-C-N 119.275 0.943 . . . . 55.530000000000001 108.816 170.339 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 10.6 tm-20 -56.87 -37.58 71.54 Favored 'General case' 0 C--O 1.227 -0.108 0 C-N-CA 124.581 1.152 . . . . 71.530000000000001 110.356 -177.519 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 12.8 tptt -53.14 -41.06 64.73 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 124.292 1.037 . . . . 72.420000000000002 111.863 -179.771 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 32.5 mm-40 -91.67 -41.76 10.55 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.036 0.934 . . . . 71.219999999999999 111.242 178.507 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.38 -35.68 78.16 Favored 'General case' 0 C--O 1.234 0.268 0 O-C-N 120.645 -1.284 . . . . 73.420000000000002 109.952 -175.852 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -58.24 -25.03 61.22 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 125.275 1.43 . . . . 71.109999999999999 112.045 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -59.0 -39.38 81.68 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 124.138 0.975 . . . . 75.349999999999994 110.653 177.546 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -138.91 52.08 1.79 Allowed 'General case' 0 C--O 1.233 0.209 0 C-N-CA 122.84 0.456 . . . . 74.329999999999998 109.915 -172.434 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 15.9 pttm -84.53 31.4 0.52 Allowed 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 125.193 1.397 . . . . 73.299999999999997 113.706 -165.4 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.252 1.204 0 C-N-CA 127.487 2.315 . . . . 74.140000000000001 110.819 -167.794 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.67 0 N-CA-C 109.816 -1.314 . . . . 31.120000000000001 109.816 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 66.08 -68.36 0.13 Allowed 'General case' 0 CA--C 1.503 -0.829 0 C-N-CA 128.641 2.777 . . . . 53.409999999999997 110.909 -173.352 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . 0.336 13.8 m-20 75.99 11.31 3.04 Favored 'General case' 0 N--CA 1.435 -1.21 0 C-N-CA 128.43 2.692 . . . . 73.129999999999995 116.222 168.378 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -142.82 172.2 13.02 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 126.758 2.023 . . . . 74.140000000000001 107.73 173.806 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 61.5 m -140.78 138.0 33.77 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.887 0.875 . . . . 64.420000000000002 109.462 178.8 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.04 144.75 57.07 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 122.132 0.968 . . . . 72.340000000000003 110.272 175.425 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 80.5 -36.75 2.24 Favored Glycine 0 CA--C 1.526 0.776 0 C-N-CA 126.64 2.067 . . . . 63.420000000000002 111.787 -167.762 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -84.0 -76.5 0.29 Allowed 'General case' 0 CA--C 1.515 -0.372 0 C-N-CA 124.774 1.23 . . . . 54.329999999999998 110.134 -165.452 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 15.8 mp0 -78.87 -24.87 44.02 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 124.929 1.292 . . . . 74.0 110.452 178.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 37.9 p90 -160.32 174.41 14.22 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 123.806 0.842 . . . . 74.310000000000002 109.726 -172.89 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 32.8 t -132.48 112.49 19.27 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 C-N-CA 123.797 0.839 . . . . 74.219999999999999 109.13 178.418 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -71.0 154.44 41.81 Favored 'General case' 0 C--O 1.235 0.33 0 O-C-N 120.89 -1.131 . . . . 72.310000000000002 109.155 162.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -124.31 113.85 18.78 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 124.476 1.11 . . . . 54.329999999999998 110.292 -173.907 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 59.3 p -69.66 13.34 0.14 Allowed 'General case' 0 C--O 1.236 0.379 0 C-N-CA 127.177 2.191 . . . . 70.120000000000005 114.278 -175.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 32.1 t -143.28 78.77 14.67 Favored Pre-proline 0 N--CA 1.454 -0.239 0 N-CA-C 108.085 -1.08 . . . . 74.409999999999997 108.085 165.852 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -67.22 -179.92 2.07 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 122.867 2.378 . . . . 64.209999999999994 111.922 -173.239 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 40.6 t -130.71 136.66 29.28 Favored Pre-proline 0 C--O 1.233 0.212 0 N-CA-C 107.073 -1.454 . . . . 72.120000000000005 107.073 179.682 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -79.27 173.71 12.93 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 121.836 1.69 . . . . 72.140000000000001 110.939 176.204 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 20.7 m -122.4 169.49 13.69 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 C-N-CA 125.09 1.356 . . . . 72.430000000000007 109.622 -178.183 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.1 t -47.74 -64.25 0.84 Allowed 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 126.406 1.882 . . . . 63.009999999999998 109.808 176.314 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -147.07 164.58 22.59 Favored Pre-proline 0 C--O 1.237 0.401 0 C-N-CA 123.931 0.893 . . . . 74.310000000000002 109.86 178.168 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_endo -66.3 176.07 4.35 Favored 'Trans proline' 0 N--CA 1.45 -1.04 0 C-N-CA 122.081 1.854 . . . . 64.150000000000006 111.066 163.767 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 129.39 -89.42 0.31 Allowed Glycine 0 N--CA 1.448 -0.559 0 N-CA-C 108.059 -2.016 . . . . 51.329999999999998 108.059 -178.029 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -85.21 163.53 18.64 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 117.919 0.86 . . . . 60.109999999999999 109.322 -179.085 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 46.9 mm -77.13 137.51 22.3 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 N-CA-C 105.204 -2.147 . . . . 73.439999999999998 105.204 158.125 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -99.3 118.0 35.0 Favored 'General case' 0 N--CA 1.445 -0.725 0 N-CA-C 105.859 -1.904 . . . . 72.409999999999997 105.859 -179.442 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 60.2 t -121.64 131.81 72.22 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 N-CA-C 106.723 -1.584 . . . . 74.219999999999999 106.723 -179.091 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 43.2 t -127.09 138.72 54.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 106.241 -1.763 . . . . 72.019999999999996 106.241 -175.22 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -106.32 137.74 43.74 Favored 'General case' 0 C--O 1.239 0.525 0 N-CA-C 106.655 -1.609 . . . . 65.25 106.655 158.828 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 5.3 mp -115.69 137.21 52.31 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 107.455 -1.313 . . . . 74.120000000000005 107.455 163.714 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 31.3 p90 -141.44 169.01 18.41 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 124.122 0.969 . . . . 71.109999999999999 110.034 -172.101 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' TRP . . . . . 0.5 ' HB3' HG21 ' A' ' 153' ' ' VAL . 29.7 t90 -155.11 153.21 30.49 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 123.663 0.785 . . . . 63.109999999999999 109.464 179.313 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 56.2 t80 -44.08 -51.26 8.08 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 129.366 3.067 . . . . 75.430000000000007 113.84 -172.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -72.05 -90.49 0.11 Allowed Glycine 0 C--N 1.339 0.705 0 N-CA-C 110.944 -0.862 . . . . 71.239999999999995 110.944 -171.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 34.4 t 43.51 68.92 2.63 Favored Pre-proline 0 CA--C 1.546 0.797 0 C-N-CA 125.283 1.433 . . . . 74.540000000000006 113.824 163.842 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -63.53 -14.87 45.1 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 122.743 2.295 . . . . 73.310000000000002 114.126 -176.415 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 20.3 m170 -84.24 -22.85 30.68 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 119.856 1.207 . . . . 75.239999999999995 112.537 172.07 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 60.4 m -62.65 -48.73 78.06 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 120.284 1.402 . . . . 72.129999999999995 110.619 -174.105 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 45.4 t80 -61.75 -27.55 68.81 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 120.554 -1.341 . . . . 71.549999999999997 112.23 -175.595 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.26 -6.58 40.81 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.558 0.743 . . . . 73.150000000000006 112.73 177.285 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.403 ' CB ' HD11 ' A' ' 166' ' ' ILE . 26.8 t80 -123.64 -13.93 7.39 Favored 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 126.387 1.875 . . . . 73.129999999999995 111.594 -175.52 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 67.0 tt0 -50.73 -64.64 1.22 Allowed Pre-proline 0 CA--C 1.536 0.433 0 CA-C-N 119.813 1.188 . . . . 72.140000000000001 111.512 -178.725 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -74.96 -4.77 15.91 Favored 'Trans proline' 0 N--CA 1.453 -0.881 0 CA-C-N 120.831 1.333 . . . . 62.039999999999999 114.294 -175.659 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.5 m -70.15 -47.25 62.49 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 107.892 -1.151 . . . . 54.310000000000002 107.892 163.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 19.3 tt -96.8 -28.5 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 N-CA-C 113.704 1.001 . . . . 65.140000000000001 113.704 -165.627 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 74.0 t -54.19 -55.97 31.08 Favored Pre-proline 0 CA--C 1.545 0.772 0 CA-C-N 119.64 1.109 . . . . 75.299999999999997 111.314 173.457 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -68.14 -24.93 37.88 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 CA-C-N 120.85 1.339 . . . . 61.049999999999997 111.794 -179.006 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 77.8 t90 -62.38 -55.18 30.39 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 119.274 0.943 . . . . 75.040000000000006 109.008 170.848 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.5 p -61.01 -41.95 97.52 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 123.704 0.802 . . . . 55.119999999999997 112.555 -173.248 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -62.63 -39.86 95.14 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 119.282 0.946 . . . . 73.109999999999999 110.886 175.619 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 8.0 mptt -90.88 20.06 5.1 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 113.543 0.942 . . . . 74.409999999999997 113.543 -170.618 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 32.1 mt -65.71 164.85 23.23 Favored Pre-proline 0 CA--C 1.543 0.674 0 C-N-CA 126.421 1.888 . . . . 70.310000000000002 111.75 175.081 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -83.7 174.45 8.65 Favored 'Trans proline' 0 N--CA 1.454 -0.838 1 C-N-CA 125.64 4.226 . . . . 61.219999999999999 110.933 174.203 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -71.24 -10.26 59.47 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 113.829 1.048 . . . . 72.409999999999997 113.829 -176.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -103.61 5.79 36.76 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 119.364 0.984 . . . . 72.109999999999999 112.074 -170.794 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 87.6 t -117.42 152.61 19.29 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 C-N-CA 124.9 1.28 . . . . 73.200000000000003 107.793 -178.764 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 22.6 t-160 -136.78 92.91 2.79 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 126.486 1.914 . . . . 64.310000000000002 106.651 178.765 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -79.78 132.67 36.21 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 124.488 1.115 . . . . 74.340000000000003 109.692 173.466 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 23.4 t -136.51 158.62 37.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 C-N-CA 125.453 1.501 . . . . 74.340000000000003 107.76 -179.582 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.405 HH11 ' CG ' ' A' ' 91' ' ' HIS . 55.7 mtp180 -131.41 128.42 39.51 Favored 'General case' 0 CA--C 1.506 -0.718 0 N-CA-C 106.897 -1.52 . . . . 73.409999999999997 106.897 179.487 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 70.1 mt -127.44 153.2 77.29 Favored Pre-proline 0 N--CA 1.464 0.267 0 O-C-N 123.379 0.425 . . . . 73.510000000000005 111.082 173.885 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -75.42 134.14 16.79 Favored 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 122.371 2.047 . . . . 65.219999999999999 111.209 179.019 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -75.0 95.78 3.07 Favored 'General case' 0 CA--C 1.54 0.562 0 O-C-N 121.038 -1.039 . . . . 73.209999999999994 111.598 176.241 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 20.0 mt -88.6 95.38 10.22 Favored 'General case' 0 CA--C 1.541 0.62 0 O-C-N 120.42 -1.425 . . . . 73.530000000000001 111.188 -177.728 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -133.83 5.33 3.63 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 116.027 1.862 . . . . 64.319999999999993 116.027 -173.342 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -154.33 -143.62 3.72 Favored Glycine 0 C--N 1.336 0.573 0 CA-C-N 119.039 0.836 . . . . 50.039999999999999 114.269 -166.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -89.96 -85.58 1.34 Allowed Glycine 0 CA--C 1.524 0.607 0 N-CA-C 106.887 -2.485 . . . . 73.040000000000006 106.887 155.242 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.2 tt -58.61 -25.23 27.73 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 N-CA-C 113.133 0.79 . . . . 70.040000000000006 113.133 -168.861 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' TRP . . . . . 0.401 ' HA ' ' CD1' ' A' ' 34' ' ' TRP . 10.8 m95 -54.55 -40.7 68.96 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 123.891 0.876 . . . . 74.219999999999999 112.214 175.137 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 17.2 p30 -91.73 -27.32 18.12 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 112.892 0.701 . . . . 53.43 112.892 179.034 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 39.4 t -64.71 -41.59 92.64 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-N 118.536 0.607 . . . . 65.230000000000004 109.578 174.095 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 66.6 m170 -79.14 7.08 8.12 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.821 1.248 . . . . 73.200000000000003 112.327 170.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -103.08 -37.55 3.1 Favored Glycine 0 CA--C 1.525 0.69 0 O-C-N 120.989 -1.069 . . . . 75.140000000000001 111.594 -179.548 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -65.12 -25.6 67.83 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 114.456 1.28 . . . . 74.5 114.456 -165.908 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 6.6 ttt -62.95 -43.02 99.94 Favored 'General case' 0 N--CA 1.463 0.191 0 O-C-N 120.926 -1.109 . . . . 62.350000000000001 112.055 -175.262 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -51.29 -52.85 41.38 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 125.011 1.324 . . . . 75.299999999999997 108.367 -176.857 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 13.7 mt -63.37 -39.56 94.87 Favored 'General case' 0 C--O 1.226 -0.182 0 C-N-CA 124.451 1.1 . . . . 70.430000000000007 110.122 -178.296 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.467 HG23 HG23 ' A' ' 128' ' ' THR . 1.4 m -66.71 -38.38 86.6 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 118.873 0.761 . . . . 70.5 109.775 -178.048 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.48 -60.13 4.11 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 124.063 0.945 . . . . 72.099999999999994 108.535 177.478 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -60.84 -25.03 66.34 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 124.166 0.986 . . . . 75.109999999999999 112.686 -177.742 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -62.98 -5.62 3.11 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.885 1.674 . . . . 71.040000000000006 114.566 176.406 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 29.5 mtm -100.2 -1.47 36.43 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 115.047 1.499 . . . . 33.43 115.047 165.843 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 80.41 17.76 72.91 Favored Glycine 0 CA--C 1.529 0.968 0 O-C-N 121.606 -0.684 . . . . 72.299999999999997 112.386 175.474 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 27.5 m -70.92 60.32 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.95 0 C-N-CA 126.907 2.083 . . . . 73.349999999999994 113.008 -178.617 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 57.9 -173.41 0.09 Allowed 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 124.947 1.299 . . . . 62.119999999999997 109.772 -156.003 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 31.7 m80 -142.62 30.44 1.51 Allowed 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 125.365 1.466 . . . . 73.409999999999997 108.81 165.49 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -126.24 -56.82 1.42 Allowed 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.699 1.2 . . . . 64.519999999999996 111.8 -167.188 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.1 p -58.62 126.96 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 C-N-CA 127.029 2.131 . . . . 74.510000000000005 112.054 -175.105 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' HIS . . . . . 0.405 ' CG ' HH11 ' A' ' 62' ' ' ARG . 4.4 p80 -146.22 65.55 1.2 Allowed 'General case' 0 C--O 1.233 0.229 0 CA-C-O 121.943 0.877 . . . . 74.329999999999998 112.643 173.766 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -91.92 -73.54 0.54 Allowed 'General case' 0 C--O 1.224 -0.271 0 N-CA-C 108.639 -0.875 . . . . 72.239999999999995 108.639 161.872 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -65.62 -22.06 66.63 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 114.384 1.253 . . . . 64.120000000000005 114.384 -159.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 56.2 t -62.93 -61.45 1.65 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.189 0 N-CA-C 108.079 -1.082 . . . . 55.420000000000002 108.079 172.02 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -62.84 -42.2 99.64 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 125.29 1.436 . . . . 74.120000000000005 110.636 -178.361 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -71.66 3.66 3.85 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 124.828 1.251 . . . . 65.540000000000006 112.351 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -115.52 5.08 14.35 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 115.658 1.725 . . . . 52.299999999999997 115.658 164.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 13.6 mt -117.21 -51.13 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 CA-C-N 120.476 1.489 . . . . 61.109999999999999 108.732 177.681 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 88.2 m-70 -63.97 -83.04 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 126.025 1.73 . . . . 72.219999999999999 113.231 -179.606 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.64 -16.71 64.3 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 126.711 2.004 . . . . 65.409999999999997 114.606 -177.452 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -97.17 -32.91 11.7 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 124.572 1.149 . . . . 74.430000000000007 111.64 178.875 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 1.8 t-160 50.38 36.37 12.97 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 125.572 1.549 . . . . 75.319999999999993 112.924 173.424 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.453 ' HG2' ' H ' ' A' ' 103' ' ' LYS . 0.1 OUTLIER -71.35 164.76 25.12 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 124.039 0.936 . . . . 73.409999999999997 108.784 168.959 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 10.2 mtpt -61.82 -72.11 0.13 Allowed 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 124.94 1.296 . . . . 73.120000000000005 109.433 172.602 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.418 HD21 ' HE3' ' A' ' 103' ' ' LYS . 77.2 mt 50.91 54.52 11.09 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 124.707 1.203 . . . . 72.040000000000006 111.455 -172.316 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -109.81 1.36 19.27 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.666 1.586 . . . . 65.310000000000002 113.326 -170.231 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -147.22 156.49 46.49 Favored Pre-proline 0 C--O 1.234 0.287 0 C-N-CA 126.948 2.099 . . . . 32.350000000000001 109.63 -167.448 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -70.99 -38.19 5.4 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 122.759 2.306 . . . . 62.119999999999997 110.927 -170.119 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -62.2 -48.93 77.81 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 109.022 -0.732 . . . . 61.039999999999999 109.022 172.037 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -58.45 -39.74 80.7 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 124.853 1.261 . . . . 62.130000000000003 111.737 -171.227 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 59.3 mtm -78.0 -50.23 12.53 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 124.523 1.129 . . . . 54.310000000000002 111.336 174.679 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.403 ' HB1' ' HG3' ' A' ' 122' ' ' LYS . . . -64.42 -39.53 94.02 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 119.05 0.841 . . . . 43.32 110.93 -173.63 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -71.03 -22.5 62.14 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 123.764 0.826 . . . . 73.329999999999998 111.509 -179.516 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 91.4 t80 -73.29 -51.46 17.51 Favored 'General case' 0 N--CA 1.45 -0.473 0 O-C-N 121.495 -0.753 . . . . 64.129999999999995 109.631 170.691 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 68.2 mt -69.83 -17.7 63.4 Favored 'General case' 0 N--CA 1.452 -0.351 0 O-C-N 121.728 -0.608 . . . . 72.129999999999995 111.337 -175.8 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -55.9 -18.09 8.1 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.91 0.884 . . . . 71.510000000000005 111.563 167.468 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -98.51 3.75 59.59 Favored Glycine 0 CA--C 1.527 0.803 0 CA-C-O 117.416 -1.769 . . . . 54.310000000000002 114.835 171.76 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.547 ' HA ' ' HE2' ' A' ' 118' ' ' LYS . 7.7 mmpt? -125.85 13.66 7.96 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 120.654 2.227 . . . . 70.420000000000002 113.123 -169.375 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 87.23 26.62 30.34 Favored Glycine 0 CA--C 1.522 0.517 0 CA-C-N 118.836 0.744 . . . . 61.520000000000003 112.526 -179.818 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 76.2 t -112.07 136.76 47.25 Favored 'Isoleucine or valine' 0 C--O 1.24 0.605 0 C-N-CA 125.648 1.579 . . . . 75.019999999999996 107.186 175.276 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 32.0 t0 -85.53 116.28 23.74 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 108.551 -0.907 . . . . 61.219999999999999 108.551 171.422 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.403 ' HG3' ' HB1' ' A' ' 112' ' ' ALA . 3.1 tttm -52.77 -48.08 67.06 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 125.638 1.575 . . . . 53.329999999999998 109.437 177.746 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -65.6 -22.72 66.7 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 113.078 0.77 . . . . 73.200000000000003 113.078 -175.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 49.4 mmtt -82.9 -50.74 8.29 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 107.673 -1.232 . . . . 64.299999999999997 107.673 175.815 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -49.08 -62.0 1.77 Allowed 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 125.648 1.579 . . . . 74.129999999999995 109.729 -179.14 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 20.5 mt -62.93 -39.27 94.09 Favored 'General case' 0 C--O 1.233 0.213 0 C-N-CA 122.744 0.417 . . . . 52.210000000000001 110.889 -174.419 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 39.5 t -57.17 -50.95 71.23 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 123.145 0.578 . . . . 73.120000000000005 109.919 -177.65 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' THR . . . . . 0.467 HG23 HG23 ' A' ' 80' ' ' THR . 2.6 t -81.35 -33.14 32.61 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 119.184 -0.436 . . . . 72.219999999999999 110.761 -175.453 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 82.3 t80 -50.35 -52.39 37.51 Favored 'General case' 0 C--N 1.344 0.34 0 C-N-CA 124.719 1.207 . . . . 72.219999999999999 109.467 172.199 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -90.39 55.56 3.08 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 124.265 1.026 . . . . 75.400000000000006 109.495 174.703 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 22.7 t -140.64 162.2 35.94 Favored 'General case' 0 C--O 1.234 0.258 0 O-C-N 121.083 -1.011 . . . . 62.25 110.795 172.613 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -58.08 -26.97 63.22 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.733 1.213 . . . . 71.439999999999998 110.673 168.506 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -53.31 -59.27 4.79 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 124.492 1.117 . . . . 63.229999999999997 111.218 179.749 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 41.7 mm -69.06 -26.3 31.89 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 C-N-CA 123.266 0.626 . . . . 63.340000000000003 110.355 178.706 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 17.7 tttt -58.37 -36.32 73.31 Favored 'General case' 0 CA--C 1.522 -0.1 0 O-C-N 121.35 -0.844 . . . . 73.099999999999994 111.008 175.768 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -63.3 -46.1 93.64 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 110.665 -0.974 . . . . 72.340000000000003 110.665 178.822 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -66.04 -44.84 83.47 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 123.196 0.599 . . . . 53.119999999999997 110.008 -179.16 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 94.9 mmm -57.32 -47.84 80.5 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 118.595 -0.717 . . . . 63.020000000000003 109.948 176.231 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -65.87 -40.92 92.07 Favored 'General case' 0 N--CA 1.457 -0.098 0 CA-C-N 119.573 1.079 . . . . 71.109999999999999 112.126 -175.812 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 11.2 mtpt -60.13 -58.13 9.87 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-O 118.242 -0.885 . . . . 74.230000000000004 109.579 176.27 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -53.64 -39.8 65.29 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 119.137 0.88 . . . . 75.430000000000007 110.762 178.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 25.7 ttmt -60.97 -63.07 1.42 Allowed 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.128 0.971 . . . . 64.439999999999998 110.481 178.837 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 16.6 ptmt -64.89 -24.01 67.4 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 123.463 0.705 . . . . 62.219999999999999 111.0 -176.041 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.427 HD23 ' HA ' ' A' ' 144' ' ' LEU . 41.7 mt -75.77 -53.76 8.0 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 118.637 -0.697 . . . . 54.32 111.055 175.554 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -52.57 -54.28 35.02 Favored 'General case' 0 C--O 1.228 -0.04 0 C-N-CA 123.865 0.866 . . . . 53.119999999999997 110.52 -173.626 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 3.9 ppp? -55.37 -47.06 76.38 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 113.23 0.826 . . . . 60.310000000000002 113.23 177.803 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -69.11 -29.85 68.01 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-O 118.093 -0.956 . . . . 64.510000000000005 110.291 -176.157 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 23.5 m-85 -71.81 16.29 0.12 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.241 1.416 . . . . 75.420000000000002 113.431 173.355 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 16.8 mm-40 63.31 17.54 10.33 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.062 1.345 . . . . 74.109999999999999 112.724 174.282 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 59.1 t -65.84 90.88 0.11 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.376 0 C-N-CA 125.712 1.605 . . . . 72.530000000000001 109.379 -174.652 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -95.97 88.59 4.94 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-O 123.137 1.446 . . . . 71.340000000000003 108.237 161.843 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 104.65 -162.5 14.85 Favored Glycine 0 N--CA 1.445 -0.712 0 CA-C-N 112.645 -2.07 . . . . 73.299999999999997 111.818 164.404 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.5 HG21 ' HB3' ' A' ' 34' ' ' TRP . 16.6 m -144.38 155.48 57.5 Favored Pre-proline 0 CA--C 1.539 0.524 0 C-N-CA 126.314 1.846 . . . . 74.150000000000006 107.37 178.092 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_endo -64.76 160.15 70.4 Favored 'Cis proline' 0 CA--C 1.54 0.823 0 C-N-CA 124.195 -1.169 . . . . 75.439999999999998 110.465 -12.093 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 5.4 m -153.42 108.12 3.14 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 123.686 0.795 . . . . 65.209999999999994 109.575 -179.616 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 50.7 mmm -93.87 153.44 18.25 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 124.288 1.035 . . . . 74.230000000000004 109.946 169.665 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 94.2 t -145.21 155.04 13.73 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 C-N-CA 125.102 1.361 . . . . 74.5 107.393 175.785 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 50.6 t -126.25 123.95 64.7 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 C-N-CA 127.783 2.433 . . . . 73.439999999999998 107.164 177.288 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 15.9 m-20 52.23 18.44 0.88 Allowed 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 129.294 3.038 . . . . 70.510000000000005 114.685 174.286 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 62.89 31.34 80.16 Favored Glycine 0 CA--C 1.532 1.152 0 CA-C-O 118.025 -1.431 . . . . 73.239999999999995 113.92 -169.288 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 9.2 mtpt -133.87 -28.15 1.41 Allowed 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 119.863 1.831 . . . . 72.209999999999994 113.334 -175.506 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -125.83 129.05 48.63 Favored 'General case' 0 CA--C 1.512 -0.5 0 N-CA-C 107.7 -1.222 . . . . 72.430000000000007 107.7 177.817 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 2.4 ttp85 -114.73 134.96 54.68 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 127.124 2.169 . . . . 74.409999999999997 105.787 179.781 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 28.2 p90 -151.22 167.26 28.34 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.988 -0.745 . . . . 70.400000000000006 108.988 -179.462 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -176.03 178.25 1.48 Allowed 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.269 1.028 . . . . 74.109999999999999 109.896 -178.175 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.403 HD11 ' CB ' ' A' ' 43' ' ' PHE . 38.1 mt -52.18 -42.23 35.51 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 C-N-CA 126.482 1.913 . . . . 53.130000000000003 110.459 178.914 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -80.25 -21.58 64.68 Favored Glycine 0 CA--C 1.526 0.722 0 CA-C-O 118.646 -1.086 . . . . 72.109999999999999 112.56 -179.407 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 1.1 m -72.83 -63.91 1.07 Allowed 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 119.716 1.758 . . . . 65.129999999999995 107.484 170.359 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -64.33 -38.59 91.56 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 123.907 0.883 . . . . 64.150000000000006 111.065 -168.568 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 121.06 -3.87 11.46 Favored Glycine 0 CA--C 1.525 0.674 0 CA-C-O 118.268 -1.295 . . . . 60.329999999999998 112.872 175.061 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 175.74 172.65 40.75 Favored Glycine 0 CA--C 1.528 0.852 0 CA-C-N 119.364 1.582 . . . . 71.030000000000001 110.231 -175.815 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -65.74 -44.68 7.69 Favored 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 122.524 2.149 . . . . 60.219999999999999 109.82 -177.727 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -63.64 -38.28 90.52 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-O 122.228 1.013 . . . . 74.409999999999997 110.467 -176.927 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -68.0 -29.18 68.13 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 126.291 1.836 . . . . 63.240000000000002 109.433 -176.588 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 35.9 m -64.85 -45.09 87.57 Favored 'General case' 0 CA--C 1.533 0.325 0 O-C-N 121.082 -1.011 . . . . 75.310000000000002 110.069 -176.229 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 46.0 mt -63.97 -32.05 73.45 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 118.799 0.727 . . . . 73.540000000000006 110.784 177.542 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 1.9 ttmt -55.41 -38.89 69.53 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 124.31 1.044 . . . . 64.109999999999999 110.148 175.258 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.433 HD13 ' HA ' ' A' ' 178' ' ' LEU . 4.5 mm? -76.47 -41.58 46.71 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-O 118.136 -0.935 . . . . 74.129999999999995 110.552 174.174 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -52.67 -50.36 63.4 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 119.325 0.966 . . . . 70.310000000000002 112.025 -175.442 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -72.12 -42.19 66.33 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 123.323 0.649 . . . . 53.140000000000001 109.347 -173.144 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 10.9 t80 -63.0 -46.38 87.94 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 124.468 1.107 . . . . 74.019999999999996 111.158 178.255 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 81.3 mt -67.69 -34.17 76.38 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 123.649 0.78 . . . . 73.219999999999999 111.024 -178.381 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 29.5 mt -53.75 -55.82 11.86 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 N-CA-C 107.995 -1.113 . . . . 71.530000000000001 107.995 166.828 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -56.63 -31.91 64.8 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.979 0.912 . . . . 72.349999999999994 112.863 -177.689 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 9.3 tptm -68.83 -48.21 64.1 Favored 'General case' 0 N--CA 1.463 0.209 0 O-C-N 121.401 -0.812 . . . . 63.409999999999997 110.535 -179.305 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 35.6 mm-40 -74.75 -42.47 58.18 Favored 'General case' 0 C--O 1.222 -0.367 0 O-C-N 121.955 -0.466 . . . . 63.200000000000003 111.228 178.508 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.05 -34.28 74.64 Favored 'General case' 0 N--CA 1.465 0.288 0 O-C-N 121.073 -1.017 . . . . 74.430000000000007 110.739 -176.874 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -64.65 -11.83 39.53 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.56 0.744 . . . . 65.049999999999997 112.378 175.355 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -64.09 -25.78 68.25 Favored 'General case' 0 C--O 1.223 -0.316 0 CA-C-N 119.446 1.021 . . . . 31.32 111.65 168.823 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . 58.55 6.58 0.6 Allowed 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 127.107 2.163 . . . . 53.409999999999997 113.877 -177.414 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 50.79 53.89 12.19 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.733 1.613 . . . . 74.439999999999998 111.461 -158.586 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 11.9 pttp . . . . . 0 C--O 1.247 0.966 0 CA-C-O 117.328 -1.32 . . . . 73.439999999999998 109.282 173.554 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.459 0.23 0 N-CA-C 109.235 -1.546 . . . . 62.140000000000001 109.235 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 45.21 73.67 0.15 Allowed 'General case' 0 CA--C 1.515 -0.391 0 C-N-CA 127.148 2.179 . . . . 64.510000000000005 110.316 -175.442 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -73.26 11.95 0.66 Allowed 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 127.096 2.158 . . . . 72.120000000000005 113.025 -179.754 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 14.4 m-85 -146.43 157.74 43.8 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 126.01 1.724 . . . . 75.019999999999996 108.056 -175.19 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.9 m -131.23 132.8 44.89 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 107.671 -1.233 . . . . 73.510000000000005 107.671 -174.328 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -69.61 148.45 49.34 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 108.158 -1.052 . . . . 60.0 108.158 175.869 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 63.69 13.61 52.04 Favored Glycine 0 CA--C 1.535 1.308 0 C-N-CA 124.68 1.134 . . . . 65.340000000000003 113.445 -167.02 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.94 -63.06 0.98 Allowed 'General case' 0 CA--C 1.52 -0.208 0 CA-C-N 119.775 1.788 . . . . 73.540000000000006 107.804 -177.962 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.432 ' HB3' HD21 ' A' ' 178' ' ' LEU . 12.4 mp0 -98.44 -25.91 14.63 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.342 1.457 . . . . 71.109999999999999 110.505 178.109 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 50.6 p90 -154.56 167.12 31.16 Favored 'General case' 0 N--CA 1.467 0.41 0 O-C-N 121.238 -0.914 . . . . 73.319999999999993 111.697 -171.85 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 59.2 t -132.9 115.91 25.37 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 C-N-CA 124.859 1.263 . . . . 74.140000000000001 109.058 -171.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -80.43 167.3 20.35 Favored 'General case' 0 C--O 1.236 0.392 0 O-C-N 119.972 -1.705 . . . . 72.319999999999993 110.478 174.301 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -126.16 124.64 40.96 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 124.237 1.015 . . . . 72.200000000000003 108.88 172.694 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 8.2 m -67.34 -9.45 41.32 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.838 0.855 . . . . 34.109999999999999 113.163 179.296 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 30.2 m -129.32 74.47 80.96 Favored Pre-proline 0 CA--C 1.537 0.454 0 C-N-CA 124.224 1.01 . . . . 52.340000000000003 108.625 -177.009 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -69.56 -179.01 2.53 Favored 'Trans proline' 0 N--CA 1.46 -0.459 0 C-N-CA 125.056 3.837 . . . . 73.299999999999997 112.281 -172.12 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.2 t -128.68 138.93 34.18 Favored Pre-proline 0 CA--C 1.532 0.27 0 C-N-CA 124.672 1.189 . . . . 72.109999999999999 107.93 -174.909 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_endo -73.13 179.1 5.74 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 122.42 2.08 . . . . 72.319999999999993 112.613 176.286 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.4 m -127.46 168.25 20.9 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 C-N-CA 126.826 2.051 . . . . 71.510000000000005 108.945 174.028 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 70.9 m -47.01 -61.84 1.69 Allowed 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 126.795 2.038 . . . . 62.399999999999999 110.508 176.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -145.82 165.38 21.17 Favored Pre-proline 0 C--O 1.238 0.492 0 C-N-CA 127.347 2.259 . . . . 73.030000000000001 105.375 163.079 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -70.88 -164.66 0.15 Allowed 'Trans proline' 0 CA--C 1.541 0.862 0 C-N-CA 122.62 2.213 . . . . 73.219999999999999 110.222 173.325 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 118.1 -112.68 2.45 Favored Glycine 0 N--CA 1.447 -0.627 0 N-CA-C 106.301 -2.72 . . . . 72.450000000000003 106.301 -179.388 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 33.4 mttm -54.46 133.69 45.81 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 124.136 0.974 . . . . 65.450000000000003 108.721 172.177 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.424 HD12 ' HB3' ' A' ' 186' ' ' GLU . 31.8 mm -64.59 140.72 19.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 106.377 -1.712 . . . . 72.409999999999997 106.377 169.541 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -99.21 139.17 35.26 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 107.559 -1.274 . . . . 74.319999999999993 107.559 -177.65 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 56.1 t -128.54 130.43 69.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 105.895 -1.891 . . . . 53.329999999999998 105.895 176.684 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 11.3 t -131.2 108.05 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 N-CA-C 107.417 -1.327 . . . . 63.32 107.417 -172.591 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -69.0 143.34 54.38 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 124.27 1.028 . . . . 64.310000000000002 108.556 162.26 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.521 ' CD2' HG21 ' A' ' 150' ' ' VAL . 5.0 mp -121.75 131.08 53.88 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 108.881 -0.785 . . . . 73.200000000000003 108.881 158.416 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 23.9 p90 -127.33 176.77 7.18 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.477 1.111 . . . . 64.420000000000002 110.469 179.249 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 27.1 t90 -151.0 175.8 11.73 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.082 1.353 . . . . 75.019999999999996 109.559 174.551 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 40.2 t80 -61.5 -73.18 0.1 Allowed 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.616 1.166 . . . . 74.239999999999995 112.876 172.741 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -81.86 52.03 4.53 Favored Glycine 0 C--N 1.339 0.705 0 C-N-CA 124.823 1.201 . . . . 44.399999999999999 110.358 -171.123 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 35.8 t -113.5 84.81 8.25 Favored Pre-proline 0 CA--C 1.538 0.487 0 C-N-CA 127.462 2.305 . . . . 72.439999999999998 106.051 -163.848 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -72.57 168.56 24.08 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 123.314 2.676 . . . . 61.329999999999998 109.217 171.228 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 5.2 m170 63.98 -45.7 0.27 Allowed 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 126.476 1.91 . . . . 73.420000000000002 112.116 -165.007 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 3.8 m -46.74 -53.14 12.43 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 126.745 2.018 . . . . 75.150000000000006 110.604 176.425 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 11.7 t80 -58.92 -49.92 75.99 Favored 'General case' 0 C--N 1.341 0.229 0 C-N-CA 125.361 1.464 . . . . 72.120000000000005 110.894 176.51 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.76 -13.52 61.51 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 112.742 0.645 . . . . 55.020000000000003 112.742 -171.356 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 7.0 t80 -90.71 -16.85 27.76 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 125.714 1.605 . . . . 71.510000000000005 112.073 179.262 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -46.68 -67.27 0.4 Allowed Pre-proline 0 N--CA 1.469 0.485 0 CA-C-N 120.059 1.299 . . . . 73.239999999999995 112.566 -172.81 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -69.02 -9.13 25.52 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 CA-C-N 122.033 1.762 . . . . 75.239999999999995 114.496 -177.759 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.9 m -70.91 -43.18 68.83 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 119.758 1.163 . . . . 65.519999999999996 108.798 167.167 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 21.1 tt -105.2 -28.51 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 N-CA-C 113.825 1.046 . . . . 64.340000000000003 113.825 -164.504 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 27.5 t -46.37 -60.4 3.72 Favored Pre-proline 0 CA--C 1.54 0.559 0 C-N-CA 124.794 1.238 . . . . 61.329999999999998 109.434 173.438 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -61.85 -35.31 79.16 Favored 'Trans proline' 0 N--CA 1.453 -0.883 0 CA-C-N 120.31 1.146 . . . . 64.129999999999995 112.974 -177.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.403 ' CZ2' ' HB1' ' A' ' 179' ' ' ALA . 72.8 t90 -57.24 -51.62 68.61 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.367 0.667 . . . . 74.299999999999997 110.402 179.557 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 29.5 t -58.89 -39.18 80.69 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 121.132 0.491 . . . . 72.019999999999996 110.269 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -68.92 -25.55 64.64 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 121.173 -0.954 . . . . 72.510000000000005 111.407 -177.429 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 14.3 mmtp -96.72 10.08 39.79 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.576 1.15 . . . . 75.430000000000007 112.879 177.477 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 34.9 mt -60.88 151.23 74.44 Favored Pre-proline 0 C--O 1.237 0.395 0 CA-C-N 119.532 1.06 . . . . 75.230000000000004 110.964 174.613 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -76.07 169.69 21.58 Favored 'Trans proline' 0 N--CA 1.445 -1.378 0 C-N-CA 124.065 3.177 . . . . 64.209999999999994 110.485 177.533 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -65.13 -4.19 4.64 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 125.044 1.338 . . . . 74.519999999999996 113.391 173.784 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -100.68 8.4 43.36 Favored 'General case' 0 N--CA 1.463 0.182 0 C-N-CA 125.709 1.603 . . . . 75.209999999999994 110.597 -177.056 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 61.0 t -129.53 160.03 40.93 Favored 'Isoleucine or valine' 0 C--O 1.239 0.542 0 O-C-N 121.214 -0.929 . . . . 51.450000000000003 108.798 -179.651 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 29.2 t60 -132.93 155.39 49.17 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 126.268 1.827 . . . . 52.32 107.249 165.53 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 55.7 t80 -132.5 134.01 44.49 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 108.102 -1.073 . . . . 71.219999999999999 108.102 -175.104 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 47.6 t -135.31 155.38 37.2 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 C-N-CA 126.551 1.941 . . . . 71.129999999999995 107.264 -172.906 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 16.4 mtt85 -133.2 130.32 38.94 Favored 'General case' 0 CA--C 1.513 -0.46 0 N-CA-C 105.197 -2.149 . . . . 72.25 105.197 176.284 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 37.6 mt -135.58 144.74 50.45 Favored Pre-proline 0 N--CA 1.469 0.514 0 CA-C-N 120.113 1.324 . . . . 71.450000000000003 110.082 175.502 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -74.89 157.45 43.21 Favored 'Trans proline' 0 N--CA 1.462 -0.353 0 C-N-CA 122.379 2.053 . . . . 73.209999999999994 110.728 -179.414 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -101.04 94.55 6.05 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 123.984 0.914 . . . . 55.009999999999998 110.12 -175.463 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 22.5 mt -86.43 76.75 9.58 Favored 'General case' 0 CA--C 1.539 0.54 0 O-C-N 120.612 -1.305 . . . . 73.099999999999994 111.869 -172.793 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -82.49 20.2 1.14 Allowed 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 115.129 1.529 . . . . 75.439999999999998 115.129 -176.156 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 89.01 -48.09 3.43 Favored Glycine 0 CA--C 1.525 0.704 0 O-C-N 119.924 -1.735 . . . . 34.530000000000001 112.834 168.214 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -72.55 -152.11 1.58 Allowed Glycine 0 CA--C 1.529 0.958 0 C-N-CA 124.337 0.97 . . . . 71.310000000000002 110.737 174.699 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 7.1 tp -46.75 -30.88 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 C-N-CA 124.1 0.96 . . . . 75.329999999999998 112.055 177.371 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 19.4 m95 -50.31 -27.47 6.23 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 126.069 1.748 . . . . 73.030000000000001 113.391 177.757 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 20.2 m-20 -73.91 -36.42 64.72 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-N 119.576 1.08 . . . . 75.040000000000006 110.496 177.153 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.401 ' C ' ' H ' ' A' ' 75' ' ' GLY . 40.7 t -73.82 -55.19 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 N-CA-C 107.966 -1.124 . . . . 73.310000000000002 107.966 174.839 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 34.9 m170 -65.95 31.92 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 129.534 3.134 . . . . 72.239999999999995 112.175 170.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.401 ' H ' ' C ' ' A' ' 73' ' ' VAL . . . -149.21 -42.55 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 125.353 1.454 . . . . 35.100000000000001 111.191 173.122 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -54.6 -41.84 70.42 Favored 'General case' 0 C--O 1.223 -0.328 0 CA-C-O 117.753 -1.118 . . . . 74.109999999999999 112.439 -175.06 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -44.47 -44.34 8.47 Favored 'General case' 0 CA--C 1.514 -0.407 0 N-CA-C 114.123 1.157 . . . . 71.219999999999999 114.123 -173.303 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 28.8 t80 -61.88 -45.76 92.34 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 118.525 0.602 . . . . 72.540000000000006 110.236 -176.898 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 50.0 mt -61.35 -45.24 95.22 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-O 116.726 -1.606 . . . . 61.329999999999998 109.251 175.415 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -62.41 -45.68 92.03 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 120.652 1.569 . . . . 61.5 110.776 -176.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.82 -60.6 2.99 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 125.998 1.719 . . . . 65.349999999999994 109.469 178.495 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -69.75 -28.92 66.18 Favored 'General case' 0 C--O 1.231 0.095 0 CA-C-O 118.927 -0.558 . . . . 64.230000000000004 111.76 -175.21 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 6.2 t -51.67 -37.16 49.33 Favored 'General case' 0 CA--C 1.52 -0.184 0 C-N-CA 124.343 1.057 . . . . 71.519999999999996 110.712 178.091 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 30.8 mtp -75.84 -22.47 56.23 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-O 118.762 -0.637 . . . . 62.009999999999998 111.696 -170.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 88.39 14.46 61.86 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 123.9 0.762 . . . . 34.140000000000001 112.982 -179.092 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 28.4 m -62.29 130.2 26.41 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 C-N-CA 125.046 1.339 . . . . 71.430000000000007 109.312 179.158 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -123.47 75.88 1.36 Allowed 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 123.577 0.751 . . . . 63.210000000000001 109.021 -165.804 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -79.16 -5.46 54.25 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 117.099 2.259 . . . . 75.230000000000004 117.099 -170.437 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 44.38 51.96 7.51 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 126.331 1.852 . . . . 73.239999999999995 112.109 -176.207 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.5 p -144.95 -47.25 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 CA-C-O 117.474 -1.251 . . . . 44.219999999999999 113.381 176.297 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 44.92 34.78 1.31 Allowed 'General case' 0 N--CA 1.478 0.945 0 CA-C-N 120.607 1.548 . . . . 64.120000000000005 113.138 -176.738 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -136.37 -44.54 0.62 Allowed 'General case' 0 C--O 1.221 -0.421 0 O-C-N 120.815 -1.178 . . . . 64.219999999999999 108.887 172.557 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -61.11 -16.51 44.97 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 114.533 1.308 . . . . 62.140000000000001 114.533 -176.631 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 55.8 t -71.49 -65.63 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 CA-C-O 117.575 -1.203 . . . . 54.43 108.614 166.241 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -54.61 -46.78 73.89 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 120.387 1.449 . . . . 72.120000000000005 111.98 -179.58 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -58.45 -40.49 82.77 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.427 1.491 . . . . 75.430000000000007 110.196 -178.705 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.51 ' HB1' ' CE1' ' A' ' 114' ' ' PHE . . . -74.2 4.53 5.53 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 125.798 1.639 . . . . 64.109999999999999 112.84 -178.641 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 61.7 mt -115.25 -57.12 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.891 0 N-CA-C 104.975 -2.232 . . . . 73.049999999999997 104.975 177.129 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 88.0 m-70 -80.67 -61.24 2.03 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 123.664 0.786 . . . . 75.409999999999997 112.616 -173.178 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -68.34 -21.16 64.75 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 119.063 0.847 . . . . 72.150000000000006 112.209 -177.756 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -94.45 -53.56 3.86 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 124.548 1.139 . . . . 73.439999999999998 108.771 -175.86 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 6.9 t60 58.49 88.0 0.07 Allowed 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.513 1.525 . . . . 64.329999999999998 110.65 -169.792 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 3.3 mmpt? -116.33 13.79 15.62 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.389 1.076 . . . . 72.109999999999999 113.302 -176.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 30.4 tttm 69.87 -64.23 0.36 Allowed 'General case' 0 C--O 1.221 -0.418 0 C-N-CA 128.2 2.6 . . . . 52.439999999999998 109.558 -174.333 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.413 HD22 ' HA ' ' A' ' 111' ' ' MET . 40.6 mt 54.47 44.66 28.48 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.813 1.645 . . . . 72.120000000000005 112.508 177.867 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -94.63 14.54 20.72 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.283 1.433 . . . . 72.329999999999998 114.189 -173.871 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -156.13 155.35 29.01 Favored Pre-proline 0 CA--C 1.535 0.395 0 C-N-CA 127.97 2.508 . . . . 75.219999999999999 107.662 -178.078 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -64.21 -44.99 10.71 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.546 2.164 . . . . 64.140000000000001 109.959 -173.733 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -69.01 -29.38 67.55 Favored 'General case' 0 N--CA 1.438 -1.039 0 C-N-CA 124.189 0.995 . . . . 72.430000000000007 111.15 -174.82 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -54.47 -42.15 70.34 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.95 1.3 . . . . 71.329999999999998 110.356 173.039 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' MET . . . . . 0.413 ' HA ' HD22 ' A' ' 105' ' ' LEU . 2.5 mtt -76.85 -48.53 18.14 Favored 'General case' 0 CA--C 1.512 -0.514 0 C-N-CA 124.193 0.997 . . . . 75.450000000000003 108.92 -178.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.498 ' HB1' ' CG ' ' A' ' 122' ' ' LYS . . . -62.29 -37.16 84.46 Favored 'General case' 0 N--CA 1.447 -0.619 0 O-C-N 123.408 0.443 . . . . 73.439999999999998 111.337 -172.549 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -56.07 -46.85 78.83 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 125.287 1.435 . . . . 53.439999999999998 112.61 172.075 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' PHE . . . . . 0.51 ' CE1' ' HB1' ' A' ' 97' ' ' ALA . 19.0 t80 -74.27 -41.68 60.85 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 123.548 0.739 . . . . 71.299999999999997 111.45 -177.401 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 18.2 mt -76.94 -14.71 59.83 Favored 'General case' 0 C--N 1.332 -0.172 0 O-C-N 121.33 -0.856 . . . . 63.200000000000003 110.4 -176.511 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -48.48 -41.71 30.58 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.805 0.842 . . . . 70.129999999999995 110.127 172.786 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -82.09 10.09 54.67 Favored Glycine 0 CA--C 1.529 0.965 0 CA-C-O 117.975 -1.458 . . . . 75.430000000000007 114.805 177.265 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 23.8 mmtt -127.34 8.77 6.58 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 121.338 2.569 . . . . 72.430000000000007 112.615 -174.412 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 86.87 49.31 4.11 Favored Glycine 0 C--N 1.333 0.392 0 N-CA-C 109.669 -1.372 . . . . 65.219999999999999 109.669 -177.416 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 39.0 t -134.58 132.89 54.72 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 N-CA-C 105.18 -2.156 . . . . 73.140000000000001 105.18 169.845 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -92.27 133.65 35.63 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 123.68 0.792 . . . . 75.239999999999995 110.002 173.855 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.498 ' CG ' ' HB1' ' A' ' 112' ' ' ALA . 17.6 mtpt -64.58 -37.0 86.05 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 118.747 -0.644 . . . . 75.109999999999999 110.386 174.947 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -67.02 -26.82 66.97 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 118.707 0.685 . . . . 65.030000000000001 111.72 178.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 13.0 mttm -77.61 -57.06 4.02 Favored 'General case' 0 CA--C 1.518 -0.27 0 N-CA-C 106.402 -1.703 . . . . 71.530000000000001 106.402 171.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 41.3 t80 -51.86 -59.49 4.26 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 124.808 1.243 . . . . 65.510000000000005 112.174 -166.46 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 19.7 mt -73.54 -33.74 64.86 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 110.275 -0.268 . . . . 52.039999999999999 110.275 -170.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 29.7 m -62.26 -49.44 75.7 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 109.315 -0.624 . . . . 74.329999999999998 109.315 179.122 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 23.9 m -65.71 -41.33 92.44 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 124.553 1.141 . . . . 75.010000000000005 110.22 178.704 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 42.2 t80 -49.19 -48.69 45.05 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 119.691 1.132 . . . . 73.310000000000002 110.82 173.826 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 14.5 m-20 -92.64 38.89 1.02 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.647 0.779 . . . . 72.230000000000004 111.16 -178.121 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 7.7 t -122.86 172.26 8.6 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.403 1.481 . . . . 73.030000000000001 111.653 -177.334 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -67.09 -40.39 86.92 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.824 1.25 . . . . 75.200000000000003 110.52 178.603 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -50.58 -49.85 55.25 Favored 'General case' 0 C--N 1.34 0.166 0 C-N-CA 123.725 0.81 . . . . 63.130000000000003 110.463 -177.503 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 21.5 mm -69.51 -38.85 77.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 C-N-CA 124.218 1.007 . . . . 64.150000000000006 111.269 -178.305 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 1.7 mtmt -55.53 -33.26 63.65 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 124.066 0.947 . . . . 73.540000000000006 110.964 177.841 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -73.23 -48.42 19.44 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 110.831 -0.907 . . . . 43.119999999999997 110.831 178.357 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -63.34 -36.2 82.92 Favored 'General case' 0 CA--C 1.532 0.255 0 O-C-N 121.715 -0.874 . . . . 73.150000000000006 109.587 -177.502 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.32 -34.9 78.71 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-O 117.755 -1.116 . . . . 64.150000000000006 111.483 178.605 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -80.48 -39.84 27.3 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 120.588 1.54 . . . . 73.049999999999997 111.634 175.021 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.92 -59.02 5.67 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 118.864 -0.589 . . . . 74.099999999999994 110.763 179.116 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -58.85 -44.45 91.01 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 118.882 0.765 . . . . 75.409999999999997 109.056 -176.315 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 1.9 tmtt? -50.38 -57.73 7.3 Favored 'General case' 0 CA--C 1.528 0.11 0 C-N-CA 123.996 0.918 . . . . 73.120000000000005 111.139 -179.634 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.94 -35.06 69.51 Favored 'General case' 0 C--O 1.231 0.099 0 CA-C-N 118.834 0.743 . . . . 74.230000000000004 111.384 -175.28 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 37.8 mt -59.0 -49.56 77.44 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 123.577 0.751 . . . . 72.340000000000003 110.646 -177.477 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -54.47 -48.0 72.32 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 119.154 0.888 . . . . 73.120000000000005 111.722 -179.646 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 1.5 mtm -66.63 -34.8 78.68 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 120.332 -0.547 . . . . 64.349999999999994 109.774 -177.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -59.91 -43.86 94.62 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 118.426 0.557 . . . . 63.329999999999998 109.66 176.348 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -70.01 4.98 1.77 Allowed 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 126.183 1.793 . . . . 74.510000000000005 113.492 177.581 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 54.37 36.78 26.2 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 126.936 2.094 . . . . 75.430000000000007 112.124 -175.1 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.521 HG21 ' CD2' ' A' ' 32' ' ' LEU . 89.8 t -69.36 135.05 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 107.674 -1.232 . . . . 71.319999999999993 107.674 172.161 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 5.7 p -129.23 -16.12 4.04 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 126.787 2.035 . . . . 74.340000000000003 110.343 -176.132 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -168.36 -170.88 33.62 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 125.944 1.735 . . . . 61.409999999999997 112.825 -175.5 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 14.8 m -142.46 153.04 61.82 Favored Pre-proline 0 CA--C 1.546 0.819 0 C-N-CA 127.323 2.249 . . . . 75.319999999999993 108.316 175.613 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -63.52 152.71 71.36 Favored 'Cis proline' 0 CA--C 1.537 0.673 0 C-N-CA 124.578 -1.009 . . . . 64.439999999999998 113.145 -6.884 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 59.2 m -145.91 144.26 30.07 Favored 'General case' 0 C--O 1.239 0.547 0 C-N-CA 125.31 1.444 . . . . 73.439999999999998 108.529 175.251 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 19.8 mmm -123.97 158.41 32.12 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 125.774 1.63 . . . . 75.409999999999997 108.209 163.711 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 21.5 t -142.1 136.47 29.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 106.939 -1.504 . . . . 72.519999999999996 106.939 174.536 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.425 HG23 ' CE1' ' A' ' 164' ' ' PHE . 28.9 t -104.01 135.2 42.8 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 N-CA-C 107.098 -1.445 . . . . 72.120000000000005 107.098 168.726 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 1.4 t30 47.12 10.8 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.688 1 C-N-CA 133.111 4.565 . . . . 73.430000000000007 117.541 171.153 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 83.69 20.11 60.48 Favored Glycine 0 CA--C 1.526 0.777 0 CA-C-O 117.806 -1.552 . . . . 33.409999999999997 115.559 -169.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 48.0 mttt -131.81 -41.39 1.04 Allowed 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 119.971 1.885 . . . . 70.409999999999997 114.358 -170.302 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 -112.74 107.51 16.19 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 108.293 -1.003 . . . . 72.099999999999994 108.293 -171.772 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 63.2 ttp85 -88.92 113.41 24.43 Favored 'General case' 0 C--O 1.231 0.109 0 C-N-CA 126.5 1.92 . . . . 73.129999999999995 106.797 175.023 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 164' ' ' PHE . . . . . 0.425 ' CE1' HG23 ' A' ' 158' ' ' VAL . 5.3 p90 -136.51 169.59 17.45 Favored 'General case' 0 C--N 1.319 -0.75 0 O-C-N 120.343 -1.473 . . . . 54.210000000000001 107.186 177.8 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -174.97 -178.78 1.28 Allowed 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 122.548 0.339 . . . . 55.539999999999999 110.129 177.333 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 21.5 mt -46.33 -50.05 5.23 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 C-N-CA 128.555 2.742 . . . . 75.030000000000001 107.728 160.378 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -76.16 16.57 4.51 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 125.847 1.689 . . . . 70.409999999999997 114.392 178.012 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 17.8 m -128.3 -51.13 1.29 Allowed 'General case' 0 C--O 1.224 -0.239 0 CA-C-N 118.795 1.298 . . . . 71.409999999999997 109.705 168.565 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -70.32 -34.65 72.94 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 125.12 1.368 . . . . 64.109999999999999 112.266 -175.253 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 122.58 -5.96 9.87 Favored Glycine 0 C--N 1.341 0.83 0 CA-C-O 118.512 -1.16 . . . . 64.450000000000003 114.793 175.089 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 165.84 174.31 35.21 Favored Glycine 0 CA--C 1.532 1.097 0 CA-C-N 119.745 1.772 . . . . 50.229999999999997 110.003 -175.829 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -64.9 -52.61 1.18 Allowed 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 122.408 2.072 . . . . 71.310000000000002 111.772 -169.889 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -62.29 -28.68 69.9 Favored 'General case' 0 N--CA 1.463 0.223 0 O-C-N 120.965 -1.084 . . . . 73.420000000000002 111.547 178.491 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -67.4 -27.21 66.89 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.141 0.576 . . . . 74.319999999999993 110.366 177.527 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 19.7 m -77.66 -42.9 33.07 Favored 'General case' 0 CA--C 1.53 0.177 0 O-C-N 121.052 -1.03 . . . . 73.430000000000007 110.915 -169.713 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 35.8 mt -63.88 -31.77 73.07 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 118.918 0.781 . . . . 74.219999999999999 111.013 178.683 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 4.8 tttt -48.48 -56.48 8.17 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 126.602 1.961 . . . . 70.420000000000002 108.041 168.847 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.463 HD13 ' HA ' ' A' ' 178' ' ' LEU . 4.1 mm? -65.48 -41.37 93.38 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-O 116.941 -1.504 . . . . 65.340000000000003 111.554 176.534 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.403 ' HB1' ' CZ2' ' A' ' 50' ' ' TRP . . . -53.82 -48.68 69.67 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 120.917 1.689 . . . . 50.039999999999999 111.699 -175.395 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -69.52 -47.09 64.92 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 122.943 0.497 . . . . 63.539999999999999 110.577 -176.072 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -60.47 -42.61 96.59 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 123.565 0.746 . . . . 73.409999999999997 111.285 178.799 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 90.6 mt -67.09 -37.4 83.9 Favored 'General case' 0 C--N 1.332 -0.171 0 O-C-N 120.949 -1.094 . . . . 72.420000000000002 111.221 178.635 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 31.6 mt -58.25 -51.94 65.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 CA-C-N 119.259 0.936 . . . . 70.109999999999999 108.582 172.059 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -52.06 -43.07 63.62 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 124.59 1.156 . . . . 73.230000000000004 109.976 175.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 185' ' ' LYS . . . . . 0.596 ' O ' ' HB2' ' A' ' 189' ' ' ALA . 71.3 tttt -79.66 -0.32 33.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 117.124 -1.417 . . . . 72.140000000000001 113.161 -175.486 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 186' ' ' GLU . . . . . 0.424 ' HB3' HD12 ' A' ' 27' ' ' ILE . 16.0 mm-40 -103.11 -33.33 9.27 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 125.662 1.585 . . . . 70.420000000000002 114.43 178.435 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.39 -55.76 4.98 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 107.372 -1.344 . . . . 73.040000000000006 107.372 -179.222 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -65.27 -20.36 66.38 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.172 -0.922 . . . . 75.430000000000007 111.795 -176.444 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 189' ' ' ALA . . . . . 0.596 ' HB2' ' O ' ' A' ' 185' ' ' LYS . . . -46.69 -35.49 6.11 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 130.127 3.371 . . . . 55.229999999999997 113.706 175.459 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -101.07 13.3 35.63 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.721 1.208 . . . . 63.200000000000003 113.148 -178.818 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 49.3 tttm 56.41 76.93 0.27 Allowed 'General case' 0 C--N 1.343 0.294 0 C-N-CA 126.946 2.098 . . . . 74.299999999999997 109.805 -163.868 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 36.1 mtpt . . . . . 0 C--O 1.254 1.29 0 C-N-CA 126.069 1.748 . . . . 65.0 108.735 -179.24 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.947 0 N-CA-C 111.39 -0.684 . . . . 62.140000000000001 111.39 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 43.83 68.64 0.5 Allowed 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 127.445 2.298 . . . . 71.200000000000003 111.895 168.798 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -75.55 5.6 5.77 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 112.954 -1.93 . . . . 73.099999999999994 114.234 -171.48 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 30.1 m-85 -135.0 165.02 26.31 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 126.066 1.746 . . . . 71.140000000000001 108.04 -171.472 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 13.6 m -130.05 131.66 45.89 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 108.001 -1.111 . . . . 74.439999999999998 108.001 -178.741 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.89 154.02 42.03 Favored 'General case' 0 C--O 1.232 0.158 0 O-C-N 121.093 -1.005 . . . . 73.219999999999999 109.265 173.597 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 71.02 -36.17 0.51 Allowed Glycine 0 CA--C 1.53 1.001 0 C-N-CA 125.723 1.63 . . . . 53.200000000000003 112.859 -163.398 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 4.7 tptt -83.38 -83.37 0.14 Allowed 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 124.783 1.233 . . . . 70.549999999999997 108.993 -173.745 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 23.6 mp0 -73.41 -24.61 60.3 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 125.596 1.558 . . . . 73.230000000000004 110.47 -177.294 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 43.6 p90 -158.7 176.03 12.89 Favored 'General case' 0 N--CA 1.468 0.466 0 O-C-N 121.165 -0.959 . . . . 61.310000000000002 110.728 -173.568 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 62.0 t -134.55 107.63 9.33 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 124.921 1.288 . . . . 74.420000000000002 109.344 -177.283 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -73.23 147.14 44.94 Favored 'General case' 0 N--CA 1.444 -0.744 0 O-C-N 120.942 -1.099 . . . . 72.109999999999999 109.963 166.123 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -111.68 134.67 53.09 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 125.29 1.436 . . . . 73.409999999999997 109.92 -178.579 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 5.4 p -80.69 4.11 19.88 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 125.33 1.452 . . . . 53.130000000000003 114.137 -176.356 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -141.7 83.91 12.62 Favored Pre-proline 0 N--CA 1.45 -0.471 0 N-CA-C 106.781 -1.562 . . . . 70.019999999999996 106.781 173.342 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -70.92 -176.25 1.74 Allowed 'Trans proline' 0 CA--C 1.536 0.598 0 C-N-CA 124.086 3.191 . . . . 73.109999999999999 111.799 -175.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 22.1 t -131.65 137.5 30.52 Favored Pre-proline 0 CA--C 1.536 0.431 0 C-N-CA 123.942 0.897 . . . . 73.010000000000005 108.788 -174.186 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -78.95 176.39 9.89 Favored 'Trans proline' 0 CA--C 1.536 0.584 0 C-N-CA 123.67 2.914 . . . . 71.420000000000002 111.607 176.07 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.6 m -125.29 178.91 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 C-N-CA 125.307 1.443 . . . . 72.129999999999995 109.529 171.575 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 51.3 m -59.11 -58.18 9.79 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 124.537 1.135 . . . . 53.130000000000003 111.276 174.854 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -143.89 154.15 58.28 Favored Pre-proline 0 CA--C 1.536 0.428 0 C-N-CA 123.954 0.902 . . . . 73.120000000000005 109.509 173.751 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -70.29 167.04 26.29 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 123.37 2.713 . . . . 72.409999999999997 111.009 177.136 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 131.72 -96.39 0.33 Allowed Glycine 0 N--CA 1.449 -0.471 0 N-CA-C 109.412 -1.475 . . . . 63.039999999999999 109.412 178.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.39 126.11 29.03 Favored 'General case' 0 CA--C 1.518 -0.268 0 N-CA-C 108.53 -0.915 . . . . 75.409999999999997 108.53 -175.364 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 34.2 mm -61.68 140.17 19.51 Favored 'Isoleucine or valine' 0 C--O 1.24 0.581 0 N-CA-C 107.111 -1.44 . . . . 72.409999999999997 107.111 176.459 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -93.87 153.39 18.28 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 118.296 -1.361 . . . . 73.409999999999997 108.558 -177.135 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 16.1 t -146.31 121.81 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 N-CA-C 105.106 -2.183 . . . . 51.539999999999999 105.106 -177.567 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 57.3 t -123.07 119.47 57.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 106.898 -1.519 . . . . 63.539999999999999 106.898 -175.906 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -80.24 124.01 28.45 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 106.489 -1.671 . . . . 74.150000000000006 106.489 157.6 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.7 mp -110.47 145.24 38.02 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 107.031 -1.47 . . . . 74.319999999999993 107.031 160.022 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 18.5 p90 -154.23 176.93 11.68 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 124.138 0.975 . . . . 70.510000000000005 110.07 -172.833 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' TRP . . . . . 0.51 ' CB ' HG21 ' A' ' 153' ' ' VAL . 30.4 t90 -146.9 176.61 9.77 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 126.445 1.898 . . . . 72.439999999999998 108.268 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 23.7 t80 -56.22 -57.9 10.24 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 125.818 1.647 . . . . 73.219999999999999 111.467 178.778 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -93.4 -76.68 1.34 Allowed Glycine 0 C--N 1.338 0.677 0 N-CA-C 111.125 -0.79 . . . . 54.100000000000001 111.125 -155.763 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . 0.289 10.7 p 42.68 74.97 0.68 Allowed Pre-proline 0 CA--C 1.534 0.352 0 C-N-CA 126.409 1.884 . . . . 61.32 112.45 165.828 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -54.95 -27.43 54.08 Favored 'Trans proline' 0 CA--C 1.537 0.668 0 CA-C-N 121.078 1.421 . . . . 55.520000000000003 113.023 -175.801 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 10.6 m170 -70.34 -37.45 74.67 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.598 1.159 . . . . 73.150000000000006 111.861 175.001 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 18.7 p -67.37 -31.58 71.92 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 119.833 1.197 . . . . 74.540000000000006 111.087 -178.451 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 89.9 t80 -65.97 -26.02 67.37 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.314 1.046 . . . . 73.140000000000001 111.733 176.0 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -74.35 -7.76 53.94 Favored 'General case' 0 CA--C 1.536 0.424 0 O-C-N 120.879 -1.138 . . . . 42.149999999999999 112.15 172.196 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -126.76 -20.34 4.3 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-O 118.023 -0.989 . . . . 63.140000000000001 113.125 -163.511 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . 0.253 0.0 OUTLIER -50.44 -64.28 1.38 Allowed Pre-proline 0 N--CA 1.475 0.794 0 CA-C-N 120.689 1.586 . . . . 72.340000000000003 113.893 -175.551 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -70.52 -9.29 25.52 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 CA-C-N 122.099 1.785 . . . . 72.349999999999994 114.015 -176.732 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 85.4 m -79.87 -36.44 36.61 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 119.564 1.074 . . . . 74.430000000000007 109.671 169.398 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 15.8 tt -85.14 -35.49 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 CA-C-N 119.367 0.985 . . . . 72.129999999999995 111.617 -177.125 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 55.8 t -48.29 -62.65 2.05 Favored Pre-proline 0 CA--C 1.538 0.504 0 CA-C-O 117.413 -1.28 . . . . 73.299999999999997 112.088 -177.094 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -68.11 -29.53 33.15 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 121.428 1.418 . . . . 64.209999999999994 111.32 -176.041 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 77.2 t90 -54.23 -57.79 9.83 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 119.322 0.965 . . . . 72.519999999999996 109.973 177.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.2 -23.39 62.94 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 112.587 0.588 . . . . 72.109999999999999 112.587 -172.572 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 78.0 mt-10 -66.42 -48.19 70.8 Favored 'General case' 0 C--O 1.235 0.301 0 O-C-N 120.926 -1.109 . . . . 71.120000000000005 109.716 169.619 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 30.0 mmmt -74.57 3.6 7.46 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.524 1.53 . . . . 64.439999999999998 112.817 -169.678 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 37.7 mt -59.09 159.45 14.31 Favored Pre-proline 0 CA--C 1.543 0.674 0 C-N-CA 125.363 1.465 . . . . 72.209999999999994 112.129 177.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -87.27 174.0 5.39 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 125.204 3.936 . . . . 70.340000000000003 112.265 178.619 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -66.83 -21.26 66.03 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 114.307 1.225 . . . . 61.020000000000003 114.307 -175.681 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 40.9 m-20 -86.81 6.89 29.4 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.722 1.209 . . . . 71.5 111.146 -175.292 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 46.8 t -129.0 151.76 36.22 Favored 'Isoleucine or valine' 0 C--O 1.24 0.589 0 C-N-CA 125.194 1.398 . . . . 62.009999999999998 108.412 -173.245 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 79.6 t60 -133.96 144.5 48.81 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 125.498 1.519 . . . . 73.299999999999997 107.852 173.574 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 24.7 t80 -128.42 136.82 51.4 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 123.763 0.825 . . . . 74.400000000000006 110.535 -172.774 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 70.9 t -133.64 148.96 30.52 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 C-N-CA 126.253 1.821 . . . . 71.230000000000004 107.935 -174.532 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -123.79 125.31 44.47 Favored 'General case' 0 CA--C 1.512 -0.515 0 N-CA-C 105.615 -1.995 . . . . 71.030000000000001 105.615 172.906 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 20.7 mt -133.43 150.93 76.44 Favored Pre-proline 0 N--CA 1.47 0.539 0 CA-C-N 119.474 1.033 . . . . 60.030000000000001 111.092 176.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -73.63 139.29 27.96 Favored 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 121.64 1.56 . . . . 75.340000000000003 110.578 179.13 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -79.93 79.06 6.51 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.225 1.01 . . . . 53.420000000000002 109.382 173.216 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 48.8 mt -72.76 106.02 4.57 Favored 'General case' 0 C--N 1.329 -0.304 0 O-C-N 120.99 -1.069 . . . . 72.109999999999999 109.363 175.656 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -128.8 28.06 5.4 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.424 1.489 . . . . 71.030000000000001 112.376 178.709 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 76.9 169.78 31.54 Favored Glycine 0 CA--C 1.523 0.589 0 C-N-CA 125.454 1.502 . . . . 72.439999999999998 111.166 -178.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 56.77 -151.04 26.15 Favored Glycine 0 CA--C 1.529 0.937 0 N-CA-C 111.083 -0.807 . . . . 72.040000000000006 111.083 -175.129 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.2 tt -60.47 -21.33 22.84 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 C-N-CA 124.183 0.993 . . . . 72.349999999999994 112.658 -174.879 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' TRP . . . . . 0.435 ' CH2' HG22 ' A' ' 153' ' ' VAL . 23.9 m95 -63.31 -32.1 73.43 Favored 'General case' 0 CA--C 1.53 0.178 0 O-C-N 121.725 -0.609 . . . . 73.129999999999995 110.715 173.998 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -77.49 -43.57 31.74 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-N 118.676 0.671 . . . . 75.510000000000005 110.46 173.683 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 58.7 t -55.29 -58.21 5.12 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 C-N-CA 124.077 0.951 . . . . 74.510000000000005 109.916 -175.258 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 61.5 m170 -69.89 -7.61 41.73 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 118.568 -0.729 . . . . 74.109999999999999 112.042 -178.425 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -93.45 -18.55 38.27 Favored Glycine 0 C--N 1.338 0.652 0 CA-C-N 120.288 1.404 . . . . 73.209999999999994 110.242 -177.449 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -74.76 -36.6 62.57 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 118.58 1.19 . . . . 63.310000000000002 110.97 -173.452 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 34.2 ttp -53.82 -45.28 70.78 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.659 1.583 . . . . 73.129999999999995 113.436 179.839 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 10.7 t80 -57.5 -44.21 84.82 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 109.172 -0.677 . . . . 75.239999999999995 109.172 -177.115 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 24.4 mt -65.94 -44.9 83.71 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-O 117.092 -1.432 . . . . 73.230000000000004 109.53 178.331 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.416 ' HA ' HD11 ' A' ' 134' ' ' ILE . 0.2 OUTLIER -56.42 -41.71 76.83 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 121.165 1.802 . . . . 65.040000000000006 112.318 178.501 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.0 -59.43 4.92 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 124.853 1.261 . . . . 24.219999999999999 109.154 -174.675 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -72.46 -24.37 61.19 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 111.442 0.164 . . . . 73.219999999999999 111.442 -174.382 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.4 t -58.92 -8.5 1.41 Allowed 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.597 1.559 . . . . 73.200000000000003 113.516 176.832 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 6.8 mtp -111.21 -4.3 15.05 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 125.453 1.501 . . . . 72.109999999999999 113.963 -179.415 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 68.38 26.45 74.26 Favored Glycine 0 CA--C 1.528 0.861 0 CA-C-N 118.513 0.597 . . . . 50.409999999999997 112.2 176.16 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 12.9 m -68.45 169.85 1.16 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 C-N-CA 124.155 0.982 . . . . 54.130000000000003 110.816 172.066 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 55.82 -163.76 0.14 Allowed 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.421 1.488 . . . . 72.340000000000003 110.223 -171.505 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 33.8 m170 -107.96 -73.61 0.68 Allowed 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 105.894 -1.891 . . . . 74.129999999999995 105.894 153.579 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -139.66 0.71 1.85 Allowed 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 112.898 0.703 . . . . 75.310000000000002 112.898 -168.918 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.4 p -90.22 159.88 2.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 C-N-CA 125.046 1.338 . . . . 73.150000000000006 110.868 174.67 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 26.5 p80 -147.37 15.51 1.14 Allowed 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 114.865 1.432 . . . . 70.209999999999994 114.865 179.683 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 17.7 m-20 -49.14 -55.88 10.93 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 125.772 1.629 . . . . 70.25 111.448 -175.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -64.89 -27.68 69.03 Favored 'General case' 0 CA--C 1.528 0.102 0 N-CA-C 113.421 0.897 . . . . 71.120000000000005 113.421 -174.043 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 60.0 t -58.45 -58.69 5.51 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 N-CA-C 108.393 -0.965 . . . . 75.510000000000005 108.393 172.914 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 -58.84 -49.9 76.0 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 124.296 1.038 . . . . 74.040000000000006 110.873 179.648 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -71.27 -2.97 17.94 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 126.184 1.793 . . . . 73.439999999999998 112.64 -173.529 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.451 ' HB1' ' CE2' ' A' ' 114' ' ' PHE . . . -96.37 -28.33 14.52 Favored 'General case' 0 N--CA 1.453 -0.28 0 O-C-N 120.84 -1.162 . . . . 73.299999999999997 112.405 169.646 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 12.1 mt -84.65 -58.49 3.46 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.513 0 N-CA-C 106.799 -1.556 . . . . 43.240000000000002 106.799 178.027 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 58.0 m-70 -73.61 -61.43 1.84 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 118.8 0.727 . . . . 63.119999999999997 112.734 -163.739 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.6 -12.1 60.0 Favored 'General case' 0 N--CA 1.473 0.7 0 O-C-N 120.614 -1.304 . . . . 75.329999999999998 114.18 179.42 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -114.46 -27.82 7.41 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 113.888 1.07 . . . . 73.420000000000002 113.888 -171.045 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . 0.272 2.7 m-70 43.72 46.63 6.41 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 127.632 2.373 . . . . 55.229999999999997 112.868 169.387 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.468 ' HA ' ' HE2' ' A' ' 103' ' ' LYS . 7.9 mmpt? -68.37 12.12 0.14 Allowed 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 125.109 1.364 . . . . 64.109999999999999 114.614 178.978 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 4.2 ttpm? 68.14 -52.27 0.53 Allowed 'General case' 0 C--O 1.223 -0.293 0 C-N-CA 129.384 3.074 . . . . 75.230000000000004 111.057 -177.771 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 64.8 mt 51.84 43.96 29.72 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 125.957 1.703 . . . . 75.209999999999994 110.295 171.649 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -84.76 -24.97 28.56 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 124.369 1.067 . . . . 54.109999999999999 112.536 -175.371 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 44.4 p -124.06 160.08 53.71 Favored Pre-proline 0 N--CA 1.463 0.193 0 CA-C-N 119.767 1.167 . . . . 71.120000000000005 111.474 -169.423 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -71.15 -15.91 31.92 Favored 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 121.344 1.363 . . . . 61.310000000000002 112.809 178.273 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.43 -59.91 2.58 Favored 'General case' 0 N--CA 1.462 0.153 0 N-CA-C 107.064 -1.458 . . . . 63.0 107.064 166.458 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -58.52 -42.03 86.79 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 123.928 0.891 . . . . 53.240000000000002 112.09 -170.902 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 41.1 mtt -65.57 -55.75 16.01 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 122.963 0.505 . . . . 73.409999999999997 111.099 175.87 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.401 ' HB1' ' CG ' ' A' ' 122' ' ' LYS . . . -70.86 -40.08 72.54 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 119.45 -0.31 . . . . 75.319999999999993 110.721 -166.121 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -60.79 -38.35 85.03 Favored 'General case' 0 C--N 1.338 0.103 0 C-N-CA 122.84 0.456 . . . . 65.219999999999999 110.638 175.915 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' PHE . . . . . 0.451 ' CE2' ' HB1' ' A' ' 97' ' ' ALA . 82.9 t80 -72.0 -48.19 46.53 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 122.848 0.459 . . . . 72.120000000000005 111.206 -177.359 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 55.7 mt -68.29 -16.79 64.09 Favored 'General case' 0 C--O 1.23 0.049 0 O-C-N 121.49 -0.756 . . . . 54.32 111.219 -174.535 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -52.09 -18.03 1.29 Allowed 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.762 1.225 . . . . 63.439999999999998 112.867 172.856 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -86.37 -12.4 70.16 Favored Glycine 0 CA--C 1.529 0.938 0 O-C-N 120.927 -1.108 . . . . 72.129999999999995 113.148 177.812 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -116.84 6.04 13.09 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 119.485 1.643 . . . . 72.230000000000004 113.544 -161.587 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 87.65 48.92 4.04 Favored Glycine 0 C--N 1.334 0.439 0 N-CA-C 109.754 -1.338 . . . . 71.140000000000001 109.754 -169.681 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 55.9 t -129.81 155.08 41.19 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 N-CA-C 104.794 -2.299 . . . . 65.430000000000007 104.794 165.7 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -127.31 135.3 50.36 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 106.538 -1.653 . . . . 65.439999999999998 106.538 -176.27 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.401 ' CG ' ' HB1' ' A' ' 112' ' ' ALA . 2.5 mtmt -67.39 -42.43 83.35 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 118.817 0.735 . . . . 72.25 111.431 -175.238 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -62.48 -36.22 81.81 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 123.859 0.864 . . . . 74.510000000000005 110.1 -178.563 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 40.8 mttm -73.08 -53.48 10.97 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 106.042 -1.836 . . . . 73.319999999999993 106.042 176.264 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 33.1 t80 -51.98 -60.67 2.92 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 125.246 1.418 . . . . 73.219999999999999 110.874 -172.21 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 11.8 mt -68.67 -37.29 79.51 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 123.063 0.545 . . . . 53.130000000000003 110.191 -170.21 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 11.2 t -65.1 -37.07 86.29 Favored 'General case' 0 CA--C 1.534 0.335 0 O-C-N 122.05 -0.406 . . . . 50.5 109.999 179.685 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 51.6 m -70.02 -40.87 74.97 Favored 'General case' 0 N--CA 1.455 -0.209 0 O-C-N 121.87 -0.519 . . . . 61.310000000000002 111.003 171.664 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 77.5 t80 -54.23 -48.93 70.55 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 119.3 0.954 . . . . 74.439999999999998 109.269 179.454 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 55.3 m-20 -91.46 59.09 3.75 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.905 1.282 . . . . 73.329999999999998 109.74 171.657 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 68.3 p -123.64 163.33 21.26 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-O 121.951 0.881 . . . . 51.030000000000001 111.702 168.197 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -68.44 -32.13 71.94 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.675 0.79 . . . . 60.329999999999998 110.21 172.303 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -56.54 -50.46 71.79 Favored 'General case' 0 C--O 1.234 0.26 0 O-C-N 121.796 -0.565 . . . . 50.119999999999997 110.045 -179.187 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.416 HD11 ' HA ' ' A' ' 80' ' ' THR . 26.5 mm -63.94 -34.18 66.77 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-O 118.407 -0.806 . . . . 72.140000000000001 110.983 177.897 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 54.2 tttt -53.53 -41.76 66.72 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 118.898 0.772 . . . . 65.530000000000001 109.394 174.507 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -71.91 -33.81 62.56 Favored Glycine 0 C--N 1.337 0.61 0 C-N-CA 125.015 1.293 . . . . 33.210000000000001 111.75 -178.806 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 -73.3 -36.58 66.3 Favored 'General case' 0 N--CA 1.452 -0.36 0 O-C-N 121.824 -0.809 . . . . 64.230000000000004 110.503 -178.892 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 14.7 mtp -62.17 -52.01 65.51 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 118.119 0.418 . . . . 74.140000000000001 110.458 173.827 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -65.84 -37.01 85.06 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-O 118.696 -0.669 . . . . 52.240000000000002 111.913 -168.529 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 3.0 mtmt -56.52 -64.09 0.98 Allowed 'General case' 0 C--N 1.341 0.222 0 CA-C-O 118.357 -0.83 . . . . 63.140000000000001 109.041 172.448 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -55.99 -37.91 69.74 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 118.567 0.621 . . . . 73.129999999999995 111.437 -173.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 9.5 tmtt? -55.41 -59.82 4.28 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 124.228 1.011 . . . . 72.239999999999995 110.3 178.092 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 8.6 ptmt -69.67 -31.2 69.13 Favored 'General case' 0 C--N 1.343 0.307 0 CA-C-N 120.158 1.345 . . . . 62.140000000000001 111.974 179.828 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 21.9 mt -60.63 -54.41 45.68 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 118.624 0.647 . . . . 74.409999999999997 109.376 -174.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -54.4 -41.07 68.85 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 122.503 0.321 . . . . 60.420000000000002 111.237 -178.244 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -63.65 -45.71 88.94 Favored 'General case' 0 N--CA 1.461 0.11 0 C-N-CA 123.08 0.552 . . . . 70.230000000000004 111.3 178.239 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -62.33 -39.45 93.11 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 123.442 0.697 . . . . 71.420000000000002 110.11 -178.508 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 34.9 m-85 -75.67 8.0 3.32 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.662 1.185 . . . . 72.209999999999994 113.441 177.405 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 13.3 mt-30 49.93 39.06 17.73 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 126.998 2.119 . . . . 74.219999999999999 112.729 -175.678 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 46.6 t -74.2 138.27 21.49 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 N-CA-C 106.276 -1.75 . . . . 74.310000000000002 106.276 168.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -141.68 4.48 1.73 Allowed 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.873 0.869 . . . . 44.149999999999999 111.607 -178.449 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 177.28 -177.22 48.29 Favored Glycine 0 CA--C 1.524 0.631 0 C-N-CA 126.243 1.877 . . . . 74.129999999999995 108.709 -174.861 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.51 HG21 ' CB ' ' A' ' 34' ' ' TRP . 12.9 m -149.15 149.99 30.89 Favored Pre-proline 0 C--O 1.24 0.586 0 C-N-CA 125.378 1.471 . . . . 75.530000000000001 108.91 -175.471 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -68.98 147.89 83.87 Favored 'Cis proline' 0 CA--C 1.537 0.648 0 O-C-N 122.532 0.754 . . . . 64.219999999999999 112.148 -1.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 62.9 m -150.53 131.57 14.34 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 126.559 1.944 . . . . 64.230000000000004 107.442 179.27 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 93.3 mtp -116.36 163.12 16.49 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 124.153 0.981 . . . . 71.409999999999997 109.615 172.022 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 6.3 t -139.75 143.71 29.89 Favored 'Isoleucine or valine' 0 C--O 1.24 0.595 0 N-CA-C 106.522 -1.659 . . . . 71.140000000000001 106.522 179.041 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.522 HG23 ' CE1' ' A' ' 164' ' ' PHE . 96.8 t -113.29 134.7 55.16 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 C-N-CA 124.929 1.291 . . . . 72.400000000000006 107.545 167.802 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 7.8 t30 49.24 9.34 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 131.63 3.972 . . . . 62.020000000000003 116.344 172.361 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 81.48 19.81 65.53 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 126.124 1.821 . . . . 64.200000000000003 114.306 -171.751 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 24.1 mtpt -137.78 -30.19 0.83 Allowed 'General case' 0 N--CA 1.479 1.002 0 CA-C-N 120.292 2.046 . . . . 63.219999999999999 113.498 -167.541 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -118.7 142.41 47.69 Favored 'General case' 0 CA--C 1.508 -0.662 0 N-CA-C 107.318 -1.364 . . . . 72.109999999999999 107.318 174.524 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 21.7 ttp180 -123.48 144.34 49.59 Favored 'General case' 0 N--CA 1.44 -0.955 0 N-CA-C 104.877 -2.268 . . . . 72.439999999999998 104.877 178.795 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 164' ' ' PHE . . . . . 0.522 ' CE1' HG23 ' A' ' 158' ' ' VAL . 14.1 p90 -154.22 173.32 16.27 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 107.596 -1.261 . . . . 75.400000000000006 107.596 178.749 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -173.42 175.65 3.01 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 107.681 -1.229 . . . . 62.299999999999997 107.681 -177.577 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 23.6 mt -56.23 -44.93 80.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 C-N-CA 126.493 1.917 . . . . 62.549999999999997 108.746 -177.498 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -72.46 -34.92 60.02 Favored Glycine 0 N--CA 1.442 -0.927 0 CA-C-O 117.996 -1.446 . . . . 62.340000000000003 112.093 -175.252 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 72.9 m -69.03 -57.3 5.63 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 118.924 1.362 . . . . 70.109999999999999 109.36 172.442 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -63.21 -44.84 94.19 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 123.1 0.56 . . . . 72.409999999999997 111.322 -169.187 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 141.28 -18.32 2.68 Favored Glycine 0 CA--C 1.523 0.573 0 C-N-CA 123.768 0.699 . . . . 71.420000000000002 114.197 173.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 169.82 169.23 32.8 Favored Glycine 0 CA--C 1.527 0.814 0 N-CA-C 107.19 -2.364 . . . . 41.329999999999998 107.19 -172.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -64.34 -36.11 46.99 Favored 'Trans proline' 0 N--CA 1.459 -0.543 0 C-N-CA 122.643 2.229 . . . . 75.0 111.984 -168.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -56.62 -48.96 76.34 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 123.453 0.701 . . . . 60.310000000000002 110.331 171.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -67.15 -27.6 67.43 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 123.797 0.839 . . . . 75.230000000000004 109.909 -169.078 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -51.29 -48.36 62.29 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 124.143 0.977 . . . . 55.509999999999998 110.197 173.75 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 55.9 mt -65.91 -34.02 77.16 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 117.851 0.296 . . . . 64.129999999999995 111.261 -179.318 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.78 -48.4 75.4 Favored 'General case' 0 N--CA 1.456 -0.165 0 N-CA-C 108.652 -0.87 . . . . 74.219999999999999 108.652 174.662 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.478 HD13 ' HA ' ' A' ' 178' ' ' LEU . 4.3 mm? -66.88 -44.7 80.23 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-O 117.848 -1.072 . . . . 65.519999999999996 110.843 175.954 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -50.38 -50.3 51.91 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 118.967 0.803 . . . . 61.219999999999999 110.329 -178.078 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -72.92 -44.37 61.31 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 123.625 0.77 . . . . 42.450000000000003 109.663 -170.133 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 5.5 t80 -59.76 -47.95 83.63 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 124.312 1.045 . . . . 75.540000000000006 111.894 176.063 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.463 ' HB2' HG21 ' A' ' 158' ' ' VAL . 82.7 mt -63.28 -44.63 94.52 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 108.967 -0.753 . . . . 64.019999999999996 108.967 -174.966 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 65.2 mt -58.14 -45.68 88.53 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 123.236 0.614 . . . . 73.200000000000003 109.43 174.891 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -65.84 -17.57 64.73 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 123.694 0.798 . . . . 63.43 112.571 179.492 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 185' ' ' LYS . . . . . 0.467 ' O ' ' HB2' ' A' ' 189' ' ' ALA . 13.5 tptp -84.23 -57.29 3.23 Favored 'General case' 0 N--CA 1.441 -0.917 0 N-CA-C 106.911 -1.514 . . . . 75.200000000000003 106.911 173.923 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -55.88 -20.19 14.77 Favored 'General case' 0 CA--C 1.513 -0.465 0 C-N-CA 129.856 3.262 . . . . 71.120000000000005 116.245 -167.797 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 2.6 mtm180 -71.88 -68.85 0.43 Allowed 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 117.784 -1.566 . . . . 74.030000000000001 110.629 168.336 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -53.41 -37.05 62.14 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-O 124.02 1.866 . . . . 64.230000000000004 111.076 -173.061 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 189' ' ' ALA . . . . . 0.467 ' HB2' ' O ' ' A' ' 185' ' ' LYS 0.282 . . -43.35 -35.34 1.49 Allowed 'General case' 0 N--CA 1.433 -1.314 1 C-N-CA 133.054 4.542 . . . . 61.219999999999999 113.156 176.145 . . . . . . . . 4 3 . 1 . 016 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -126.94 -17.01 4.99 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 119.459 1.027 . . . . 74.409999999999997 112.609 166.43 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -146.38 83.14 1.61 Allowed 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 128.218 2.607 . . . . 73.340000000000003 107.876 -164.37 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 2.0 ttmt . . . . . 0 C--O 1.252 1.21 0 CA-C-N 114.925 -1.034 . . . . 65.239999999999995 113.316 142.874 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.626 0 N-CA-C 109.832 -1.307 . . . . 73.430000000000007 109.832 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -76.95 139.87 40.29 Favored 'General case' 0 CA--C 1.519 -0.217 0 N-CA-C 109.205 -0.665 . . . . 74.140000000000001 109.205 -176.733 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -117.1 11.49 14.21 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 123.968 0.907 . . . . 72.409999999999997 112.631 178.675 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 -135.89 159.87 40.35 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 125.381 1.472 . . . . 73.200000000000003 109.735 -171.895 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.8 m -136.24 142.07 43.99 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 123.827 0.851 . . . . 72.150000000000006 109.481 176.637 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.33 150.52 34.75 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-N 114.602 -1.181 . . . . 70.200000000000003 111.982 176.691 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 77.51 -42.61 1.99 Allowed Glycine 0 CA--C 1.524 0.608 0 C-N-CA 125.015 1.293 . . . . 61.32 110.594 -171.43 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 12.9 ttpt -79.43 -80.49 0.12 Allowed 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 125.202 1.401 . . . . 65.129999999999995 110.76 -168.702 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 8.1 mp0 -70.97 -21.45 62.32 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 124.707 1.203 . . . . 64.409999999999997 110.865 -175.482 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 31.5 p90 -164.94 172.75 12.41 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 125.302 1.441 . . . . 74.219999999999999 108.817 -173.667 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 57.4 t -130.99 108.54 15.29 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 C-N-CA 125.002 1.321 . . . . 71.150000000000006 108.591 -178.678 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.6 164.13 22.12 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 124.387 1.075 . . . . 42.299999999999997 108.422 165.757 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -135.53 114.39 12.02 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 106.858 -1.534 . . . . 54.409999999999997 106.858 -168.942 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.5 m -56.69 -8.45 0.58 Allowed 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.433 1.493 . . . . 74.540000000000006 114.208 -177.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 50.6 m -135.3 83.3 38.61 Favored Pre-proline 0 CA--C 1.543 0.684 0 C-N-CA 125.016 1.327 . . . . 70.519999999999996 109.504 -179.112 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -74.66 177.82 7.95 Favored 'Trans proline' 0 CA--C 1.539 0.761 1 C-N-CA 125.583 4.189 . . . . 64.010000000000005 114.006 -178.725 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 81.3 t -142.0 147.84 46.24 Favored Pre-proline 0 N--CA 1.475 0.797 0 C-N-CA 127.111 2.164 . . . . 64.239999999999995 108.932 -168.271 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo -90.47 174.95 2.84 Favored 'Trans proline' 0 CA--C 1.536 0.59 0 C-N-CA 123.863 3.042 . . . . 70.319999999999993 113.455 178.096 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 15.5 m -105.85 176.28 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 C-N-CA 125.464 1.506 . . . . 35.210000000000001 109.266 166.343 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 67.1 m -52.5 -51.17 60.78 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 126.686 1.994 . . . . 53.329999999999998 112.351 177.728 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 16.7 mt-30 -149.72 164.17 21.91 Favored Pre-proline 0 CA--C 1.537 0.478 0 C-N-CA 125.1 1.36 . . . . 64.319999999999993 109.516 176.119 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -68.58 135.44 33.42 Favored 'Trans proline' 0 N--CA 1.452 -0.952 0 C-N-CA 122.416 2.077 . . . . 63.350000000000001 108.717 167.449 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 175.19 -125.51 1.09 Allowed Glycine 0 N--CA 1.445 -0.754 0 N-CA-C 106.614 -2.594 . . . . 63.409999999999997 106.614 -171.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.03 152.82 43.16 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 117.938 0.869 . . . . 75.400000000000006 109.786 176.823 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 39.2 mm -59.09 157.93 1.86 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 N-CA-C 106.811 -1.551 . . . . 73.040000000000006 106.811 163.3 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -115.84 122.09 44.35 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 107.093 -1.447 . . . . 70.129999999999995 107.093 174.694 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 36.7 t -114.85 113.14 42.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 N-CA-C 105.949 -1.871 . . . . 71.450000000000003 105.949 171.802 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 16.2 t -101.19 139.38 22.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 107.09 -1.448 . . . . 63.530000000000001 107.09 179.24 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -105.75 138.44 41.94 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 107.872 -1.158 . . . . 71.010000000000005 107.872 154.474 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.0 mp -111.46 148.43 33.15 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 124.549 1.14 . . . . 74.120000000000005 108.8 174.367 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 48.7 p90 -138.35 171.72 13.96 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 123.631 0.772 . . . . 74.450000000000003 112.044 -179.601 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 27.2 t90 -145.48 177.15 9.07 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 127.701 2.401 . . . . 63.530000000000001 107.886 172.393 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 56.1 t80 -72.16 -31.61 66.11 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.524 1.53 . . . . 61.32 114.758 178.434 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -116.69 20.99 11.69 Favored Glycine 0 CA--C 1.526 0.721 0 CA-C-O 118.573 -1.126 . . . . 42.539999999999999 114.228 -161.086 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 21.2 p -106.85 86.77 2.49 Favored Pre-proline 0 CA--C 1.538 0.49 0 C-N-CA 125.81 1.644 . . . . 65.530000000000001 110.309 -169.738 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -52.63 -36.45 71.83 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 122.7 2.267 . . . . 64.230000000000004 113.061 -175.219 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 17.0 m170 -55.27 -29.33 57.92 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 118.214 -0.898 . . . . 70.439999999999998 112.774 176.131 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 80.3 m -63.88 -66.45 0.54 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.555 1.542 . . . . 72.420000000000002 109.772 179.313 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.434 ' HB2' ' CD2' ' A' ' 99' ' ' HIS . 19.2 t80 -59.2 -34.85 72.64 Favored 'General case' 0 N--CA 1.469 0.485 0 O-C-N 121.489 -0.757 . . . . 73.040000000000006 111.907 -178.645 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.58 -28.7 69.53 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 118.633 -0.698 . . . . 71.120000000000005 112.327 179.676 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -93.86 -20.45 20.04 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.985 1.314 . . . . 72.219999999999999 112.126 -174.669 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -42.89 -65.45 0.55 Allowed Pre-proline 0 CA--C 1.542 0.654 0 N-CA-C 114.393 1.257 . . . . 71.430000000000007 114.393 -174.335 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -74.73 -6.65 18.47 Favored 'Trans proline' 0 CA--C 1.534 0.522 0 CA-C-N 122.327 1.867 . . . . 41.039999999999999 114.525 -176.315 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 67.0 m -75.44 -39.81 58.37 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 120.411 1.459 . . . . 42.240000000000002 108.905 163.209 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 14.2 tt -87.19 -34.51 7.57 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 N-CA-C 112.846 0.684 . . . . 71.329999999999998 112.846 -171.215 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 31.4 t -49.72 -57.34 12.52 Favored Pre-proline 0 CA--C 1.537 0.451 0 CA-C-N 119.837 1.199 . . . . 73.209999999999994 111.138 175.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -67.02 -7.41 18.62 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 CA-C-N 121.302 1.501 . . . . 63.409999999999997 114.11 -177.09 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.464 ' CH2' ' HB1' ' A' ' 179' ' ' ALA . 70.9 t90 -80.27 -62.21 1.75 Allowed 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 119.326 0.966 . . . . 72.019999999999996 108.837 164.183 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 5.2 p -68.57 -19.08 64.45 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 113.35 0.87 . . . . 73.420000000000002 113.35 -172.0 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . 0.322 4.9 pt-20 -69.66 -20.78 63.57 Favored 'General case' 0 CA--C 1.556 1.179 0 C-N-CA 124.273 1.029 . . . . 54.240000000000002 110.912 170.976 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 67.2 mmtt -115.89 6.52 14.26 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.633 1.573 . . . . 72.420000000000002 113.256 -170.695 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 51.7 mt -63.43 150.41 89.81 Favored Pre-proline 0 C--O 1.236 0.391 0 CA-C-N 118.702 0.683 . . . . 70.409999999999997 110.021 176.723 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -73.11 177.26 8.02 Favored 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 124.555 3.503 . . . . 72.5 111.701 -176.02 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -74.6 -0.72 18.73 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.175 0.99 . . . . 64.519999999999996 113.475 179.104 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -104.07 -1.38 27.47 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 126.589 1.956 . . . . 73.209999999999994 111.339 -177.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 48.2 t -131.3 154.53 40.74 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 126.303 1.841 . . . . 73.329999999999998 106.708 -179.505 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 48.7 t60 -137.69 157.45 46.44 Favored 'General case' 0 N--CA 1.45 -0.468 0 O-C-N 121.674 -0.641 . . . . 72.099999999999994 109.41 169.344 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 46.3 t80 -124.6 135.16 52.88 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.644 1.178 . . . . 74.299999999999997 110.674 -171.561 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 67.1 t -132.85 137.86 53.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 C-N-CA 124.299 1.04 . . . . 73.230000000000004 108.54 -169.115 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -114.16 121.64 44.37 Favored 'General case' 0 CA--C 1.514 -0.414 0 N-CA-C 106.628 -1.619 . . . . 62.399999999999999 106.628 170.952 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 13.1 mt -136.57 144.79 48.7 Favored Pre-proline 0 CA--C 1.537 0.454 0 CA-C-N 118.607 0.639 . . . . 75.409999999999997 112.304 -177.453 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -77.56 125.61 7.7 Favored 'Trans proline' 0 CA--C 1.534 0.482 0 C-N-CA 122.166 1.911 . . . . 74.439999999999998 112.307 -175.691 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -68.29 112.28 5.08 Favored 'General case' 0 CA--C 1.54 0.567 0 O-C-N 120.741 -1.225 . . . . 64.340000000000003 109.286 167.76 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 8.1 mt -110.41 95.57 5.65 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 106.274 -1.751 . . . . 62.140000000000001 106.274 177.215 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -115.5 16.68 16.58 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 114.861 1.43 . . . . 72.519999999999996 114.861 -172.623 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 93.22 170.99 39.75 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 125.258 1.409 . . . . 35.210000000000001 110.058 -178.566 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 58.41 -153.48 27.76 Favored Glycine 0 CA--C 1.532 1.101 0 N-CA-C 110.246 -1.142 . . . . 64.400000000000006 110.246 -172.533 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 8.8 tp -60.19 -17.27 13.8 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 C-N-CA 123.866 0.866 . . . . 72.409999999999997 112.751 -177.208 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 19.1 m95 -58.52 -35.41 72.22 Favored 'General case' 0 C--N 1.34 0.193 0 O-C-N 121.009 -1.057 . . . . 72.299999999999997 110.847 176.82 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 33.4 m-20 -76.66 -33.33 58.3 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 109.283 -0.636 . . . . 72.310000000000002 109.283 -174.863 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 29.8 t -63.17 -65.64 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 C-N-CA 124.797 1.239 . . . . 61.509999999999998 108.992 172.639 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 46.4 m170 -67.66 -2.4 6.81 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 114.138 1.162 . . . . 74.400000000000006 114.138 -171.543 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -102.04 -27.39 7.0 Favored Glycine 0 C--N 1.336 0.563 0 CA-C-N 120.221 1.373 . . . . 52.109999999999999 110.171 -176.783 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 31.7 mt-30 -56.09 -26.86 51.34 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 118.226 -0.893 . . . . 75.519999999999996 112.527 176.362 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 3.7 ttt -46.78 -62.96 1.15 Allowed 'General case' 0 C--N 1.342 0.246 0 N-CA-C 114.796 1.406 . . . . 43.229999999999997 114.796 -170.81 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -53.06 -45.69 68.21 Favored 'General case' 0 C--N 1.331 -0.211 0 O-C-N 123.779 0.674 . . . . 63.219999999999999 110.045 -176.331 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 28.7 mt -61.87 -39.08 90.64 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-O 116.682 -1.628 . . . . 75.219999999999999 109.67 178.079 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.549 ' HA ' HD11 ' A' ' 134' ' ' ILE . 0.0 OUTLIER -60.62 -49.45 77.49 Favored 'General case' 0 C--N 1.349 0.567 0 CA-C-N 121.625 2.011 . . . . 75.530000000000001 109.538 175.596 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -54.57 -54.02 46.87 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 124.452 1.101 . . . . 72.150000000000006 108.425 -175.002 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -75.1 -14.04 60.54 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 112.885 0.698 . . . . 75.420000000000002 112.885 -178.872 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.402 ' HB3' HG21 ' A' ' 128' ' ' THR . 2.9 t -61.37 -33.97 74.53 Favored 'General case' 0 C--O 1.236 0.379 0 O-C-N 121.431 -0.793 . . . . 74.400000000000006 110.809 173.969 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 47.5 mtp -77.66 -21.11 52.66 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 123.602 0.761 . . . . 53.240000000000002 111.914 -171.164 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 68.76 63.77 3.35 Favored Glycine 0 C--N 1.335 0.511 0 N-CA-C 107.296 -2.322 . . . . 72.209999999999994 107.296 -164.326 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 17.3 m -74.83 154.4 6.48 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 N-CA-C 109.467 -0.568 . . . . 74.049999999999997 109.467 167.158 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 59.7 mt-10 -58.56 -64.91 0.76 Allowed 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.001 0.52 . . . . 73.319999999999993 109.948 -175.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -171.31 -178.69 2.44 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.696 1.598 . . . . 71.340000000000003 109.714 155.628 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -150.95 154.14 36.56 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 127.21 2.204 . . . . 51.130000000000003 107.573 179.41 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 38.5 t -78.15 -4.31 6.56 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.824 0 O-C-N 120.706 -1.246 . . . . 73.439999999999998 112.298 -173.213 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 11.3 m170 54.76 56.41 6.74 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.995 1.718 . . . . 74.299999999999997 111.024 -174.906 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -152.04 -48.92 0.11 Allowed 'General case' 0 CA--C 1.513 -0.477 0 C-N-CA 124.257 1.023 . . . . 75.329999999999998 110.745 -178.077 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -57.59 -32.27 67.0 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 124.041 0.936 . . . . 42.420000000000002 111.112 179.222 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 21.7 t -53.64 -68.15 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 C-N-CA 125.691 1.596 . . . . 65.140000000000001 109.658 169.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -70.65 -32.5 69.81 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 119.961 1.255 . . . . 71.239999999999995 112.978 -174.273 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -60.44 -33.27 72.3 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.119 0.968 . . . . 73.299999999999997 109.266 173.238 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.451 ' HA ' ' HB2' ' A' ' 101' ' ' GLU . . . -72.88 -52.75 13.49 Favored 'General case' 0 N--CA 1.446 -0.656 0 O-C-N 120.413 -1.429 . . . . 75.030000000000001 109.312 174.909 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 40.8 mt -61.9 -44.56 99.05 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-O 118.244 -0.884 . . . . 72.299999999999997 109.72 -171.414 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' HIS . . . . . 0.434 ' CD2' ' HB2' ' A' ' 41' ' ' TYR . 48.6 m-70 -81.54 -72.68 0.42 Allowed 'General case' 0 CA--C 1.52 -0.189 0 C-N-CA 124.694 1.198 . . . . 70.510000000000005 111.065 -179.414 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 8.9 mtmt -65.8 -28.2 68.83 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-N 118.319 0.509 . . . . 74.510000000000005 111.307 -168.223 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.451 ' HB2' ' HA ' ' A' ' 97' ' ' ALA . 0.0 OUTLIER -103.79 -31.13 9.97 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 122.792 0.437 . . . . 74.040000000000006 111.028 -170.526 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 4.0 t60 43.83 70.06 0.35 Allowed 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 127.509 2.323 . . . . 75.209999999999994 112.126 172.671 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 21.0 mtpt -96.44 19.09 12.66 Favored 'General case' 0 N--CA 1.467 0.38 0 O-C-N 121.716 -0.615 . . . . 71.120000000000005 111.805 -172.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 12.9 ttpt 46.5 57.77 5.16 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 127.75 2.42 . . . . 74.430000000000007 111.971 176.563 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.496 ' HA ' ' HB3' ' A' ' 110' ' ' GLU . 52.6 mt -73.98 43.28 0.16 Allowed 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 130.428 3.491 . . . . 74.129999999999995 112.193 -176.74 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -82.94 1.43 39.69 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 127.582 2.353 . . . . 55.119999999999997 113.464 -177.211 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 32.9 p -144.11 161.7 43.95 Favored Pre-proline 0 C--O 1.239 0.523 0 C-N-CA 123.726 0.81 . . . . 74.530000000000001 109.916 -172.743 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.43 -13.99 20.37 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 122.471 2.114 . . . . 65.209999999999994 113.445 -179.765 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -63.96 -60.98 2.58 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 107.888 -1.152 . . . . 74.349999999999994 107.888 163.596 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.496 ' HB3' ' HA ' ' A' ' 105' ' ' LEU . 0.1 OUTLIER -61.59 -46.23 90.72 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-O 119.066 -0.492 . . . . 53.229999999999997 111.492 -166.974 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 14.3 mtt -59.89 -42.45 93.81 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 118.427 0.558 . . . . 72.530000000000001 110.998 179.749 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -72.26 -47.49 49.85 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 109.455 -0.572 . . . . 73.329999999999998 109.455 -171.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -66.02 -24.11 66.69 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 118.888 0.767 . . . . 75.219999999999999 112.183 178.104 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' PHE . . . . . 0.525 ' CZ ' ' HE3' ' A' ' 118' ' ' LYS . 9.3 t80 -68.19 -60.4 2.5 Favored 'General case' 0 C--O 1.234 0.257 0 O-C-N 121.488 -0.758 . . . . 73.129999999999995 109.682 173.17 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 82.0 mt -65.56 -26.21 67.77 Favored 'General case' 0 N--CA 1.456 -0.127 0 C-N-CA 123.648 0.779 . . . . 45.43 110.424 -177.917 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -57.44 -39.47 76.34 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 119.189 0.904 . . . . 33.520000000000003 109.332 177.39 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -60.56 -8.52 9.82 Favored Glycine 0 CA--C 1.531 1.036 0 CA-C-O 116.981 -2.011 . . . . 22.510000000000002 114.176 172.291 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.525 ' HE3' ' CZ ' ' A' ' 114' ' ' PHE . 0.5 OUTLIER -131.85 21.65 4.58 Favored 'General case' 0 C--N 1.347 0.491 0 CA-C-N 121.324 2.562 . . . . 65.439999999999998 111.671 -175.469 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 82.22 60.3 2.16 Favored Glycine 0 C--N 1.333 0.396 0 N-CA-C 109.713 -1.355 . . . . 70.200000000000003 109.713 171.04 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 28.3 t -135.97 121.12 27.9 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 C-N-CA 125.361 1.464 . . . . 70.409999999999997 107.114 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 52.9 t0 -66.18 116.34 7.15 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 124.149 0.979 . . . . 63.109999999999999 110.364 -179.854 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 7.2 ttmt -61.57 -41.31 97.22 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 124.502 1.121 . . . . 54.439999999999998 109.442 177.578 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -63.39 -36.75 84.75 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 119.118 -0.468 . . . . 63.119999999999997 111.603 -175.078 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 15.7 mmtp -80.97 -37.58 29.07 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-O 118.493 -0.765 . . . . 63.229999999999997 109.181 176.925 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 82.7 t80 -54.3 -60.33 3.49 Favored 'General case' 0 N--CA 1.445 -0.68 0 O-C-N 123.805 0.691 . . . . 73.129999999999995 110.389 -177.459 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 20.1 mt -66.46 -40.78 89.6 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 123.271 0.629 . . . . 55.329999999999998 110.569 -175.462 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 34.2 t -56.18 -48.47 76.28 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 123.802 0.841 . . . . 70.450000000000003 109.629 -178.304 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' THR . . . . . 0.44 HG23 HG22 ' A' ' 80' ' ' THR . 1.3 t -80.42 -30.98 37.7 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-O 119.196 -0.431 . . . . 64.329999999999998 110.192 -175.647 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 58.5 t80 -55.53 -50.75 69.19 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 119.161 0.891 . . . . 52.299999999999997 110.362 174.665 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -95.78 47.84 1.12 Allowed 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 124.065 0.946 . . . . 72.109999999999999 109.23 177.867 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 37.5 t -128.42 165.44 20.63 Favored 'General case' 0 C--O 1.238 0.474 0 O-C-N 120.998 -1.064 . . . . 65.140000000000001 109.642 173.903 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -58.99 -25.76 63.92 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 115.426 -0.806 . . . . 71.25 110.82 163.692 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -48.46 -54.66 13.37 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 124.45 1.1 . . . . 62.219999999999999 111.32 178.85 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.549 HD11 ' HA ' ' A' ' 80' ' ' THR . 11.8 mm -65.37 -42.95 94.81 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.392 0 N-CA-C 113.339 0.866 . . . . 74.310000000000002 113.339 170.751 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 14.2 tttt -54.02 -36.95 63.57 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 118.866 -0.588 . . . . 71.409999999999997 109.746 -175.667 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -82.89 -8.55 85.68 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 126.443 1.973 . . . . 41.039999999999999 113.273 -174.303 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -100.91 -52.99 3.16 Favored 'General case' 0 C--O 1.227 -0.102 0 N-CA-C 107.397 -1.335 . . . . 62.119999999999997 107.397 171.611 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' MET . . . . . 0.438 ' HE3' ' HB2' ' A' ' 138' ' ' MET . 2.6 ptm -53.85 -37.6 63.8 Favored 'General case' 0 C--O 1.223 -0.313 0 C-N-CA 123.989 0.915 . . . . 65.030000000000001 111.682 -175.184 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -49.72 -44.98 48.64 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.124 0.97 . . . . 73.319999999999993 113.13 178.488 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -68.76 -61.65 1.72 Allowed 'General case' 0 CA--C 1.519 -0.228 0 C-N-CA 125.922 1.689 . . . . 61.130000000000003 107.188 -176.537 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -44.23 -42.97 6.92 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.713 1.605 . . . . 62.0 111.777 177.331 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -64.97 -58.64 5.59 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 124.925 1.29 . . . . 72.409999999999997 111.428 -177.138 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.49 -37.46 86.88 Favored 'General case' 0 C--N 1.342 0.272 0 CA-C-N 119.733 1.152 . . . . 70.310000000000002 110.626 -179.211 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 51.0 mt -56.83 -43.16 80.8 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 123.859 0.863 . . . . 75.019999999999996 110.236 178.477 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -58.35 -46.26 86.6 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 119.153 0.888 . . . . 72.439999999999998 110.611 -177.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -67.96 -34.87 77.38 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 123.527 0.731 . . . . 74.140000000000001 110.721 -178.949 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -59.22 -52.59 65.01 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 107.76 -1.2 . . . . 72.129999999999995 107.76 175.914 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 -69.87 16.56 0.06 Allowed 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 126.208 1.803 . . . . 74.340000000000003 115.698 -174.838 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 57.93 17.51 4.37 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 126.572 1.949 . . . . 73.530000000000001 114.162 175.031 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 30.1 t -69.64 132.99 32.61 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 N-CA-C 108.4 -0.963 . . . . 74.099999999999994 108.4 -176.553 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -130.13 -4.0 4.46 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 124.58 1.152 . . . . 71.310000000000002 113.07 -177.452 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -169.1 -174.82 37.95 Favored Glycine 0 CA--C 1.526 0.75 0 C-N-CA 126.283 1.896 . . . . 54.229999999999997 110.064 174.291 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.416 ' HA ' ' C ' ' A' ' 154' ' ' PRO . 4.8 m -143.21 159.47 55.51 Favored Pre-proline 0 CA--C 1.537 0.474 0 C-N-CA 125.99 1.716 . . . . 74.230000000000004 109.871 -172.04 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 154' ' ' PRO . . . . . 0.416 ' C ' ' HA ' ' A' ' 153' ' ' VAL . 27.8 Cg_endo -61.45 162.57 42.49 Favored 'Cis proline' 0 N--CA 1.455 -0.792 0 C-N-CA 124.647 -0.98 . . . . 64.400000000000006 111.206 -11.319 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 6.5 m -156.97 138.64 14.13 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 107.026 -1.472 . . . . 40.530000000000001 107.026 176.82 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 98.8 mtp -114.11 158.11 21.7 Favored 'General case' 0 N--CA 1.438 -1.064 0 N-CA-C 108.067 -1.086 . . . . 71.019999999999996 108.067 171.689 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 37.6 t -140.77 134.04 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 N-CA-C 106.148 -1.797 . . . . 63.200000000000003 106.148 177.59 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.405 HG23 ' CE1' ' A' ' 164' ' ' PHE . 13.1 t -102.24 119.44 50.55 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.9 0 N-CA-C 105.92 -1.881 . . . . 72.420000000000002 105.92 171.951 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 15.4 t30 56.01 24.28 7.59 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 128.512 2.725 . . . . 62.229999999999997 114.285 158.807 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 61.64 30.84 75.87 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 127.287 2.375 . . . . 54.25 113.823 -172.86 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 42.6 mttt -131.81 -34.79 1.29 Allowed 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 119.427 1.614 . . . . 74.230000000000004 113.344 -175.686 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -124.33 128.24 48.8 Favored 'General case' 0 CA--C 1.512 -0.512 0 N-CA-C 108.941 -0.763 . . . . 75.310000000000002 108.941 -179.797 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 26.5 ttp85 -107.72 136.62 47.16 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 105.141 -2.17 . . . . 64.340000000000003 105.141 174.123 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 164' ' ' PHE . . . . . 0.405 ' CE1' HG23 ' A' ' 158' ' ' VAL . 9.8 p90 -150.51 170.1 19.91 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 107.705 -1.22 . . . . 73.409999999999997 107.705 178.102 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 165' ' ' ASP . . . . . 0.422 ' H ' ' HB2' ' A' ' 168' ' ' SER . 9.7 p30 -167.65 177.47 5.84 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 108.81 -0.811 . . . . 74.450000000000003 108.81 -178.923 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 16.5 mt -58.94 -40.85 81.41 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 C-N-CA 124.942 1.297 . . . . 65.239999999999995 108.615 -174.913 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -74.62 -39.29 41.38 Favored Glycine 0 N--CA 1.447 -0.602 0 CA-C-O 118.851 -0.972 . . . . 64.219999999999999 111.626 -178.898 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 168' ' ' SER . . . . . 0.422 ' HB2' ' H ' ' A' ' 165' ' ' ASP . 2.6 m -57.97 -59.45 5.25 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 124.462 1.105 . . . . 72.230000000000004 109.695 174.607 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -61.82 -51.11 69.6 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 109.718 -0.475 . . . . 72.299999999999997 109.718 -176.366 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 132.63 4.14 3.55 Favored Glycine 0 CA--C 1.528 0.896 0 CA-C-O 119.137 -0.813 . . . . 53.439999999999998 113.855 177.024 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 164.36 163.65 17.87 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 108.445 -1.862 . . . . 71.540000000000006 108.445 -174.768 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -66.06 -43.86 8.33 Favored 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 122.474 2.116 . . . . 71.329999999999998 110.079 -173.495 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -54.1 -38.61 65.55 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 125.199 1.399 . . . . 72.340000000000003 111.766 173.038 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -76.1 -26.25 56.25 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.432 1.093 . . . . 74.129999999999995 109.511 -173.142 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -56.64 -48.3 77.85 Favored 'General case' 0 CA--C 1.528 0.106 0 C-N-CA 123.997 0.919 . . . . 73.099999999999994 109.696 177.196 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 61.8 mt -62.05 -34.23 75.87 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 118.127 0.421 . . . . 62.030000000000001 110.777 179.052 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -54.6 -42.33 71.0 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 123.496 0.718 . . . . 72.540000000000006 110.289 175.877 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.414 ' HA ' HD13 ' A' ' 178' ' ' LEU . 4.4 mm? -73.25 -46.11 51.97 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-O 118.008 -0.996 . . . . 74.439999999999998 110.237 173.357 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.464 ' HB1' ' CH2' ' A' ' 50' ' ' TRP . . . -55.18 -34.94 64.28 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 118.843 0.747 . . . . 72.430000000000007 112.11 -174.047 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -94.24 -32.11 13.81 Favored 'General case' 0 C--N 1.333 -0.147 0 C-N-CA 124.859 1.264 . . . . 75.329999999999998 110.059 -167.401 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 35.5 t80 -64.69 -58.28 6.72 Favored 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 123.991 0.916 . . . . 73.319999999999993 110.497 167.521 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 56.1 mt -58.01 -35.77 71.71 Favored 'General case' 0 C--O 1.224 -0.268 0 C-N-CA 124.825 1.25 . . . . 73.140000000000001 112.294 -164.641 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 38.1 mt -45.09 -52.8 1.79 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 C-N-CA 124.279 1.031 . . . . 72.209999999999994 109.974 173.223 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -58.16 -34.53 70.4 Favored 'General case' 0 N--CA 1.447 -0.596 0 O-C-N 121.213 -0.929 . . . . 75.209999999999994 111.534 -177.751 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.3 -32.77 68.77 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 123.71 0.804 . . . . 54.450000000000003 110.934 -178.34 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -93.1 -43.87 8.66 Favored 'General case' 0 C--O 1.224 -0.256 0 CA-C-N 119.954 1.252 . . . . 64.439999999999998 112.298 168.957 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.54 -34.24 68.94 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 125.5 1.52 . . . . 61.530000000000001 110.308 -172.335 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -60.35 -22.08 62.85 Favored 'General case' 0 C--N 1.339 0.147 0 C-N-CA 124.776 1.23 . . . . 75.129999999999995 111.933 178.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -55.67 -38.26 69.37 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 123.609 0.764 . . . . 63.409999999999997 110.535 173.314 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -80.84 -21.34 40.86 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 113.557 0.947 . . . . 23.210000000000001 113.557 178.166 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 62.1 tttt 44.62 58.41 3.9 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.232 1.813 . . . . 42.350000000000001 112.55 -177.434 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.02 0 C-N-CA 123.957 0.903 . . . . 74.409999999999997 109.976 176.045 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.476 0 N-CA-C 110.241 -1.144 . . . . 53.409999999999997 110.241 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 49.2 68.56 0.7 Allowed 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 127.108 2.163 . . . . 74.230000000000004 110.313 175.507 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -81.69 11.14 5.05 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 113.735 -1.575 . . . . 71.420000000000002 114.565 -159.884 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 36.1 m-85 -134.65 175.56 9.44 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 126.696 1.998 . . . . 72.439999999999998 108.89 -172.757 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 31.9 m -137.13 136.95 38.72 Favored 'General case' 0 CA--C 1.535 0.387 0 O-C-N 119.972 -1.705 . . . . 65.230000000000004 110.679 172.251 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -68.6 153.13 44.36 Favored 'General case' 0 C--N 1.342 0.271 0 CA-C-O 121.709 0.766 . . . . 61.130000000000003 109.043 178.162 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 75.58 -31.7 1.21 Allowed Glycine 0 CA--C 1.53 0.988 0 C-N-CA 124.134 0.873 . . . . 50.310000000000002 111.309 -165.113 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 38.5 tttt -95.43 -84.26 0.34 Allowed 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 118.946 1.373 . . . . 74.420000000000002 110.264 -170.027 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -68.6 -25.17 64.73 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.794 1.637 . . . . 65.5 110.655 -178.523 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 31.9 p90 -162.09 170.27 19.48 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 107.35 -1.352 . . . . 74.439999999999998 107.35 -173.822 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 13.7 t -134.63 108.24 10.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 107.958 -1.127 . . . . 62.229999999999997 107.958 -178.426 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -63.56 152.57 38.32 Favored 'General case' 0 N--CA 1.44 -0.928 0 O-C-N 121.178 -0.951 . . . . 74.219999999999999 108.968 164.102 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -120.13 107.08 12.6 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 125.565 1.546 . . . . 75.310000000000002 109.535 179.734 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 70.3 m -67.02 21.06 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.864 1.666 . . . . 43.329999999999998 114.193 173.889 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 4.4 t -132.3 81.92 59.45 Favored Pre-proline 0 CA--C 1.53 0.195 0 N-CA-C 106.674 -1.602 . . . . 62.240000000000002 106.674 153.616 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -72.25 178.58 5.89 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 123.031 2.487 . . . . 72.230000000000004 111.139 -175.64 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 39.4 t -137.48 142.06 35.89 Favored Pre-proline 0 CA--C 1.539 0.538 0 N-CA-C 109.15 -0.685 . . . . 73.120000000000005 109.15 -170.468 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -79.36 178.55 7.29 Favored 'Trans proline' 0 CA--C 1.536 0.599 0 C-N-CA 123.739 2.959 . . . . 53.43 111.733 172.684 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 16.2 m -131.91 172.43 16.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 126.079 1.752 . . . . 74.530000000000001 109.735 179.084 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 13.1 t -53.86 -58.74 6.15 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.831 1.253 . . . . 74.239999999999995 110.625 173.584 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -144.78 164.97 24.67 Favored Pre-proline 0 CA--C 1.531 0.234 0 O-C-N 121.301 -0.874 . . . . 74.5 111.342 173.788 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -80.52 -172.88 1.64 Allowed 'Trans proline' 0 N--CA 1.452 -0.966 0 C-N-CA 123.219 2.613 . . . . 63.299999999999997 110.995 170.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 104.68 -86.67 0.52 Allowed Glycine 0 N--CA 1.451 -0.321 0 N-CA-C 106.832 -2.507 . . . . 71.140000000000001 106.832 179.168 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 67.0 mttt -68.06 149.16 50.01 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-O 121.511 0.672 . . . . 71.109999999999999 109.281 170.87 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 29.8 mm -80.01 141.56 15.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 107.663 -1.236 . . . . 54.32 107.663 168.51 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -87.96 132.43 34.24 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 106.493 -1.669 . . . . 64.019999999999996 106.493 173.147 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 46.4 t -131.2 136.22 58.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 N-CA-C 106.181 -1.785 . . . . 55.420000000000002 106.181 169.605 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 23.5 t -135.34 123.29 38.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 N-CA-C 108.005 -1.109 . . . . 61.509999999999998 108.005 -171.006 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -91.09 145.2 24.88 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 124.948 1.299 . . . . 73.540000000000006 108.847 166.101 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.41 HD22 HG11 ' A' ' 150' ' ' VAL . 5.5 mp -125.31 137.63 54.07 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.572 1.549 . . . . 64.200000000000003 107.744 168.002 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 30.9 p90 -141.78 172.67 12.37 Favored 'General case' 0 CA--C 1.549 0.918 0 N-CA-C 113.616 0.969 . . . . 71.129999999999995 113.616 -173.277 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 27.8 t90 -156.44 150.23 24.9 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.489 1.115 . . . . 65.439999999999998 111.806 -178.218 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -60.47 -9.17 3.32 Favored 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 114.843 1.423 . . . . 72.129999999999995 114.843 -179.842 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -123.84 19.0 7.48 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 125.447 1.499 . . . . 54.240000000000002 114.25 -169.337 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.413 ' HB3' HG23 ' A' ' 153' ' ' VAL . 22.4 p -104.26 86.7 1.4 Allowed Pre-proline 0 CA--C 1.536 0.431 0 CA-C-N 119.782 1.791 . . . . 44.009999999999998 110.744 -175.248 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -52.47 -35.83 67.57 Favored 'Trans proline' 0 CA--C 1.534 0.476 0 C-N-CA 122.769 2.313 . . . . 74.230000000000004 113.334 -177.242 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 11.5 m170 -64.74 -24.55 67.6 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 118.341 -0.838 . . . . 74.400000000000006 112.063 -178.882 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 83.6 m -59.39 -53.94 52.45 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.33 1.052 . . . . 62.100000000000001 109.144 175.198 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 59.9 t80 -56.78 -40.44 75.88 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 119.253 0.933 . . . . 72.239999999999995 111.041 -176.163 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -70.16 2.37 3.74 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 113.303 0.853 . . . . 75.430000000000007 113.303 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -125.71 -29.9 3.1 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 127.602 2.361 . . . . 72.209999999999994 111.261 179.163 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -37.5 -62.13 0.65 Allowed Pre-proline 0 CA--C 1.544 0.735 0 C-N-CA 126.401 1.88 . . . . 62.200000000000003 113.708 -174.667 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -79.52 -10.68 14.53 Favored 'Trans proline' 0 N--CA 1.454 -0.818 0 CA-C-N 121.191 1.461 . . . . 72.129999999999995 114.937 -175.746 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 51.1 m -70.87 -41.27 71.59 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 119.605 1.093 . . . . 74.319999999999993 109.335 164.715 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 17.3 tt -81.84 -42.64 19.32 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 CA-C-O 118.136 -0.935 . . . . 62.409999999999997 111.926 -169.705 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 79.5 t -44.84 -60.22 3.3 Favored Pre-proline 0 CA--C 1.544 0.716 0 CA-C-N 120.012 1.278 . . . . 74.25 112.803 177.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -73.79 -15.0 24.16 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 122.284 1.989 . . . . 72.409999999999997 112.112 -174.377 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 76.0 t90 -64.53 -61.59 2.12 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 119.73 1.15 . . . . 71.329999999999998 108.498 163.147 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -63.96 -34.53 78.2 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 113.008 0.744 . . . . 54.350000000000001 113.008 -171.97 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -59.13 -36.5 75.32 Favored 'General case' 0 C--O 1.237 0.441 0 O-C-N 121.389 -0.819 . . . . 51.299999999999997 110.908 175.16 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 29.9 mmmt -93.98 10.01 35.23 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.879 1.271 . . . . 61.039999999999999 111.863 -170.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 23.1 mt -61.6 157.54 46.72 Favored Pre-proline 0 CA--C 1.54 0.564 0 CA-C-N 119.5 1.045 . . . . 72.439999999999998 112.811 -178.082 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -77.98 178.05 8.06 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 124.991 3.794 . . . . 65.5 111.695 178.246 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -74.45 -0.2 16.69 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.032 1.333 . . . . 75.040000000000006 114.437 -174.302 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -126.22 18.75 7.65 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.782 1.233 . . . . 32.219999999999999 110.726 -172.853 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 42.5 t -124.82 139.18 51.76 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 N-CA-C 108.063 -1.088 . . . . 53.530000000000001 108.063 170.161 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 82.7 t60 -113.59 153.25 29.14 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 125.6 1.56 . . . . 70.329999999999998 106.908 166.33 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.472 ' CE2' ' HD2' ' A' ' 62' ' ' ARG . 24.2 t80 -136.57 141.5 43.33 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 108.63 -0.878 . . . . 70.140000000000001 108.63 -178.833 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 60.2 t -134.38 147.19 30.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 C-N-CA 126.622 1.969 . . . . 61.299999999999997 107.253 -170.796 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.472 ' HD2' ' CE2' ' A' ' 60' ' ' PHE . 0.0 OUTLIER -126.79 121.73 32.78 Favored 'General case' 0 CA--C 1.516 -0.358 0 N-CA-C 104.35 -2.463 . . . . 73.030000000000001 104.35 176.298 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 32.7 mt -127.09 151.97 75.08 Favored Pre-proline 0 N--CA 1.467 0.386 0 CA-C-N 118.961 0.8 . . . . 50.030000000000001 111.112 177.905 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -72.57 130.56 16.15 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 122.194 1.929 . . . . 62.520000000000003 109.828 178.003 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -75.48 100.8 4.62 Favored 'General case' 0 CA--C 1.536 0.409 0 O-C-N 121.42 -0.8 . . . . 45.420000000000002 109.006 176.389 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 42.8 mt -95.43 78.43 3.41 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.657 1.583 . . . . 52.32 111.548 -174.442 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -110.38 12.97 22.96 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 114.275 1.213 . . . . 73.140000000000001 114.275 -169.535 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 108.95 152.06 14.91 Favored Glycine 0 CA--C 1.518 0.275 0 C-N-CA 125.259 1.409 . . . . 52.109999999999999 110.626 173.721 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 52.82 -139.57 32.12 Favored Glycine 0 CA--C 1.521 0.439 0 C-N-CA 123.641 0.639 . . . . 13.24 111.952 -173.552 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 5.5 tp -58.62 -20.87 17.31 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 C-N-CA 124.963 1.305 . . . . 71.140000000000001 112.507 -168.874 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 23.6 m95 -57.3 -38.26 73.72 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.898 0.879 . . . . 73.209999999999994 110.92 173.449 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 14.0 m-80 -74.8 -43.46 54.63 Favored 'General case' 0 C--N 1.339 0.147 0 O-C-N 121.804 -0.56 . . . . 61.210000000000001 111.794 175.356 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 61.3 t -57.67 -54.57 29.71 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 C-N-CA 124.31 1.044 . . . . 73.109999999999999 108.588 -177.176 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 57.5 m170 -79.4 24.67 0.34 Allowed 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.662 1.585 . . . . 72.120000000000005 111.546 175.605 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -114.85 -33.53 1.68 Allowed Glycine 0 CA--C 1.524 0.637 0 C-N-CA 125.573 1.559 . . . . 64.230000000000004 111.69 170.722 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 31.6 mt-30 -63.29 -31.62 72.82 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 118.402 -0.808 . . . . 72.329999999999998 112.771 -179.111 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 16.7 ttp -60.42 -50.71 72.51 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-N 119.754 1.161 . . . . 73.239999999999995 111.535 -174.842 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 17.5 t80 -53.78 -50.9 65.07 Favored 'General case' 0 CA--C 1.53 0.178 0 O-C-N 123.72 0.638 . . . . 75.420000000000002 109.933 -179.63 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 76.0 mt -61.11 -36.73 80.49 Favored 'General case' 0 C--O 1.222 -0.378 0 CA-C-O 117.774 -1.108 . . . . 72.510000000000005 111.155 177.401 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.422 ' HA ' HD11 ' A' ' 134' ' ' ILE . 1.5 m -66.89 -35.26 79.61 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 120.622 1.556 . . . . 74.150000000000006 111.09 178.23 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.19 -56.83 16.74 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 107.544 -1.28 . . . . 73.420000000000002 107.544 178.085 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -66.29 -25.29 66.79 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.2 1.4 . . . . 60.399999999999999 112.744 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 16.1 t -73.07 -6.8 47.99 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.37 1.468 . . . . 71.120000000000005 113.442 -175.738 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 9.8 mtm -84.23 -6.8 59.45 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 119.998 1.272 . . . . 53.520000000000003 112.893 162.329 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 81.6 28.54 42.82 Favored Glycine 0 CA--C 1.519 0.33 0 C-N-CA 124.81 1.195 . . . . 50.420000000000002 110.601 177.763 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 26.2 m -86.04 123.18 39.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 107.012 -1.477 . . . . 72.510000000000005 107.012 171.873 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 47.8 tt0 -75.7 -59.31 2.81 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 107.251 -1.389 . . . . 71.109999999999999 107.251 171.419 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER 51.39 -172.01 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 126.993 2.117 . . . . 71.150000000000006 113.433 -173.511 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -154.69 -176.04 5.72 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 126.198 1.799 . . . . 75.319999999999993 107.686 -177.71 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 15.6 m 45.31 54.47 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 C-N-CA 126.881 2.073 . . . . 74.519999999999996 113.103 168.621 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 24.1 p-80 -72.42 31.62 0.06 Allowed 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 126.919 2.088 . . . . 74.129999999999995 114.54 -176.843 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.401 ' HA ' ' CD2' ' A' ' 95' ' ' PHE . 1.0 OUTLIER -63.72 -56.93 11.87 Favored 'General case' 0 C--O 1.217 -0.609 0 C-N-CA 125.584 1.554 . . . . 75.329999999999998 112.214 176.664 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -61.45 -20.03 62.66 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 120.602 1.546 . . . . 53.240000000000002 113.011 -177.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 3.8 t -62.76 -67.06 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-N 119.275 0.943 . . . . 73.140000000000001 108.51 161.581 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.401 ' CD2' ' HA ' ' A' ' 92' ' ' ASN . 0.1 OUTLIER -60.78 -48.68 80.69 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 107.744 -1.206 . . . . 73.430000000000007 107.744 -167.163 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.414 ' CD ' ' HE2' ' A' ' 100' ' ' LYS . 4.1 mm-40 -51.89 -33.66 37.72 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 128.006 2.522 . . . . 75.329999999999998 110.368 -176.024 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.447 ' HA ' ' HB2' ' A' ' 101' ' ' GLU . . . -79.56 -13.81 59.28 Favored 'General case' 0 N--CA 1.444 -0.746 0 O-C-N 120.621 -1.3 . . . . 73.340000000000003 113.215 -172.177 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 14.3 mt -114.01 -49.33 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 N-CA-C 106.008 -1.849 . . . . 60.420000000000002 106.008 -175.561 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 76.8 m80 -76.08 -40.27 53.48 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 124.22 1.008 . . . . 74.25 112.564 -176.864 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.414 ' HE2' ' CD ' ' A' ' 96' ' ' GLU . 25.5 mtmt -93.59 -37.8 11.69 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 120.431 1.469 . . . . 75.010000000000005 111.69 172.179 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.447 ' HB2' ' HA ' ' A' ' 97' ' ' ALA . 27.5 mt-10 -122.55 32.47 5.75 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 113.214 0.82 . . . . 70.219999999999999 113.214 -160.264 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 41.2 t-80 -41.88 97.67 0.01 OUTLIER 'General case' 0 C--O 1.241 0.639 0 C-N-CA 129.472 3.109 . . . . 65.030000000000001 112.432 -172.67 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.09 27.61 1.58 Allowed 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 126.133 1.773 . . . . 71.049999999999997 112.036 175.841 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 2.7 tttp 65.4 -61.53 0.24 Allowed 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 128.72 2.808 . . . . 72.409999999999997 112.004 -175.184 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 87.7 mt 74.96 17.03 2.81 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 127.532 2.333 . . . . 75.099999999999994 113.696 174.475 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -85.14 33.71 0.55 Allowed 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.018 1.327 . . . . 74.109999999999999 112.703 -174.76 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -152.29 158.21 33.63 Favored Pre-proline 0 C--O 1.237 0.412 0 C-N-CA 124.425 1.09 . . . . 73.439999999999998 108.974 167.256 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -64.99 -41.47 17.1 Favored 'Trans proline' 0 N--CA 1.451 -0.975 0 C-N-CA 122.147 1.898 . . . . 63.520000000000003 111.331 177.463 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -58.76 -47.21 85.48 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 118.746 0.703 . . . . 64.25 110.03 176.175 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -62.7 -31.67 72.62 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 123.362 0.665 . . . . 72.340000000000003 111.473 -176.076 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 74.1 mtm -81.06 -35.76 31.36 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 118.475 -0.774 . . . . 75.209999999999994 112.5 173.22 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -77.66 -47.95 17.99 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 119.29 0.95 . . . . 55.439999999999998 111.449 -172.486 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -58.05 -31.83 67.42 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 125.477 1.511 . . . . 52.43 111.866 -172.86 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 38.4 t80 -75.08 -48.2 25.04 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 123.851 0.86 . . . . 72.25 112.22 174.653 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 88.4 mt -65.63 -25.07 67.21 Favored 'General case' 0 N--CA 1.455 -0.186 0 O-C-N 121.333 -0.854 . . . . 62.0 110.489 -176.018 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -53.4 -23.88 10.94 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.975 0.91 . . . . 72.540000000000006 112.579 171.446 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -84.09 -15.5 69.5 Favored Glycine 0 CA--C 1.53 0.971 0 C-N-CA 124.258 0.932 . . . . 72.209999999999994 114.272 174.483 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 45.5 mmtt -129.03 39.79 3.73 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 120.294 2.047 . . . . 74.439999999999998 110.691 -162.072 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 74.34 39.75 42.44 Favored Glycine 0 N--CA 1.448 -0.529 0 N-CA-C 110.989 -0.845 . . . . 75.230000000000004 110.989 170.076 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 89.2 t -128.56 143.88 39.7 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 N-CA-C 106.068 -1.827 . . . . 74.409999999999997 106.068 172.138 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 16.0 t0 -95.64 129.15 42.93 Favored 'General case' 0 C--N 1.331 -0.212 0 O-C-N 121.909 -0.495 . . . . 61.32 109.67 177.484 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -67.57 -46.96 71.18 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 123.268 0.627 . . . . 73.510000000000005 110.405 -177.265 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -57.31 -37.67 72.85 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 117.731 0.241 . . . . 72.319999999999993 110.993 -174.4 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 16.3 mmtp -97.17 -29.21 13.72 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-O 117.227 -1.368 . . . . 70.0 108.756 -169.097 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 89.6 t80 -51.71 -60.42 3.18 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 119.164 0.893 . . . . 72.099999999999994 109.391 165.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 7.1 mt -65.49 -42.81 91.76 Favored 'General case' 0 C--O 1.234 0.253 0 O-C-N 121.875 -0.516 . . . . 71.420000000000002 110.693 -170.718 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 2.5 m -58.04 -56.02 27.39 Favored 'General case' 0 C--O 1.223 -0.321 0 CA-C-O 118.321 -0.847 . . . . 74.349999999999994 109.007 176.052 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 28.8 m -59.68 -39.68 85.31 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.749 0.82 . . . . 62.119999999999997 111.215 -175.617 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -57.2 -46.81 82.54 Favored 'General case' 0 C--O 1.236 0.357 0 O-C-N 121.353 -0.842 . . . . 72.510000000000005 109.576 175.55 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -89.26 30.48 0.97 Allowed 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.309 1.044 . . . . 75.129999999999995 111.983 175.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 72.7 m -110.89 150.62 28.92 Favored 'General case' 0 C--O 1.236 0.363 0 O-C-N 120.699 -1.251 . . . . 73.010000000000005 109.926 171.814 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -59.91 -22.9 63.01 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.407 1.083 . . . . 73.329999999999998 111.616 175.098 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -44.87 -55.76 5.14 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 125.345 1.458 . . . . 71.519999999999996 111.955 172.59 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.422 HD11 ' HA ' ' A' ' 80' ' ' THR . 45.4 mm -66.73 -34.87 72.88 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.253 0 C-N-CA 123.104 0.562 . . . . 71.25 109.806 -178.551 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 25.8 tttm -57.35 -39.46 75.97 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 118.717 -0.658 . . . . 72.010000000000005 110.501 179.681 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -69.79 -27.67 72.94 Favored Glycine 0 CA--C 1.523 0.572 0 C-N-CA 124.075 0.845 . . . . 53.530000000000001 111.98 -176.379 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -80.31 -48.56 12.81 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 108.502 -0.925 . . . . 70.209999999999994 108.502 175.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 91.6 mmm -54.16 -45.84 72.16 Favored 'General case' 0 C--N 1.339 0.119 0 C-N-CA 125.305 1.442 . . . . 70.310000000000002 111.118 -178.697 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -63.86 -44.77 92.11 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 119.087 0.858 . . . . 65.439999999999998 111.687 -176.03 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 33.4 mttt -60.77 -61.47 2.56 Favored 'General case' 0 C--N 1.341 0.219 0 N-CA-C 108.922 -0.77 . . . . 71.150000000000006 108.922 171.641 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -47.41 -40.98 19.13 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.283 1.033 . . . . 45.229999999999997 111.564 -175.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -59.21 -64.92 0.77 Allowed 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 124.171 0.989 . . . . 63.509999999999998 108.823 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.85 -23.03 65.97 Favored 'General case' 0 N--CA 1.461 0.097 0 CA-C-O 118.278 -0.868 . . . . 74.120000000000005 112.723 -175.401 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 55.9 mt -59.73 -50.28 74.44 Favored 'General case' 0 C--O 1.227 -0.122 0 CA-C-N 118.972 0.805 . . . . 65.420000000000002 109.662 173.618 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -63.88 -32.86 74.52 Favored 'General case' 0 CA--C 1.537 0.476 0 O-C-N 121.908 -0.495 . . . . 62.229999999999997 111.307 -172.66 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' MET . . . . . 0.406 ' H ' ' HG2' ' A' ' 146' ' ' MET . 11.3 mmt -62.36 -45.44 93.17 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 125.502 1.521 . . . . 63.299999999999997 110.381 174.811 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -58.24 -47.2 84.27 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 109.017 -0.734 . . . . 75.230000000000004 109.017 -177.438 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 31.8 m-85 -68.85 5.31 1.15 Allowed 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 126.417 1.887 . . . . 72.540000000000006 114.674 -176.297 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 62.6 mt-30 54.04 28.88 9.34 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 126.234 1.814 . . . . 64.209999999999994 112.363 -179.272 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.412 HG13 HG21 ' A' ' 155' ' ' THR . 44.3 t -78.53 135.95 24.93 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 N-CA-C 107.424 -1.325 . . . . 74.109999999999999 107.424 176.142 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -142.66 14.96 1.96 Allowed 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 121.501 0.667 . . . . 72.230000000000004 111.397 -176.873 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -173.76 177.27 46.14 Favored Glycine 0 CA--C 1.52 0.398 0 C-N-CA 125.939 1.733 . . . . 63.43 110.144 174.503 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.416 ' HA ' ' C ' ' A' ' 154' ' ' PRO . 12.4 m -141.14 150.89 60.31 Favored Pre-proline 0 CA--C 1.539 0.523 0 C-N-CA 124.337 1.055 . . . . 73.200000000000003 109.793 179.365 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 154' ' ' PRO . . . . . 0.416 ' C ' ' HA ' ' A' ' 153' ' ' VAL . 38.8 Cg_endo -68.91 150.18 87.56 Favored 'Cis proline' 0 N--CA 1.459 -0.526 0 C-N-CA 125.067 -0.805 . . . . 61.109999999999999 112.072 -1.005 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 155' ' ' THR . . . . . 0.412 HG21 HG13 ' A' ' 150' ' ' VAL . 51.6 m -148.33 117.32 6.77 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.738 1.615 . . . . 71.409999999999997 107.197 175.461 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 96.4 mtp -94.69 158.84 15.34 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 108.38 -0.97 . . . . 64.109999999999999 108.38 167.188 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 38.2 t -140.42 138.27 36.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 106.459 -1.682 . . . . 70.340000000000003 106.459 171.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.597 HG23 ' CE1' ' A' ' 164' ' ' PHE . 95.3 t -103.53 132.32 50.13 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 N-CA-C 107.606 -1.257 . . . . 63.219999999999999 107.606 168.132 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 4.9 t30 48.79 23.63 0.7 Allowed 'General case' 0 C--N 1.331 -0.231 1 C-N-CA 132.159 4.184 . . . . 64.109999999999999 115.963 167.041 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 70.12 24.4 76.58 Favored Glycine 0 CA--C 1.527 0.792 0 C-N-CA 126.209 1.862 . . . . 63.130000000000003 114.498 -175.182 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 48.7 mttp -137.02 -28.54 0.94 Allowed 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 120.202 2.001 . . . . 74.230000000000004 113.996 -171.669 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -125.04 105.83 9.48 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 108.466 -0.939 . . . . 54.439999999999998 108.466 -175.001 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 32.5 ttp85 -83.03 136.73 34.39 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 105.166 -2.161 . . . . 71.209999999999994 105.166 171.331 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 164' ' ' PHE . . . . . 0.597 ' CE1' HG23 ' A' ' 158' ' ' VAL . 15.3 p90 -152.32 170.03 21.05 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 107.845 -1.169 . . . . 62.399999999999999 107.845 174.93 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -179.52 178.98 0.63 Allowed 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 123.877 0.871 . . . . 73.140000000000001 109.177 179.764 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.416 HG23 ' HA2' ' A' ' 171' ' ' GLY . 29.5 mt -45.37 -52.78 2.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 C-N-CA 129.217 3.007 . . . . 72.319999999999993 109.71 174.429 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -75.41 -21.22 77.9 Favored Glycine 0 C--N 1.338 0.639 0 CA-C-O 119.435 -0.647 . . . . 54.409999999999997 113.443 -176.737 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 14.4 m -75.19 -68.23 0.58 Allowed 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 118.492 1.146 . . . . 63.200000000000003 108.084 169.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.514 ' HB1' HD23 ' A' ' 178' ' ' LEU . . . -75.0 -31.33 61.39 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-O 117.415 -1.279 . . . . 45.140000000000001 113.443 -162.223 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 134.78 5.39 2.5 Favored Glycine 0 CA--C 1.533 1.201 0 N-CA-C 117.171 1.628 . . . . 62.030000000000001 117.171 174.265 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 171' ' ' GLY . . . . . 0.416 ' HA2' HG23 ' A' ' 166' ' ' ILE . . . 126.42 167.95 12.51 Favored Glycine 0 CA--C 1.529 0.953 0 CA-C-N 119.446 1.623 . . . . 73.310000000000002 110.378 -173.914 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -61.44 -40.47 47.93 Favored 'Trans proline' 0 CA--C 1.534 0.502 0 C-N-CA 123.059 2.506 . . . . 51.310000000000002 113.736 -156.294 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -65.93 -33.2 75.29 Favored 'General case' 0 CA--C 1.532 0.283 0 O-C-N 121.206 -0.934 . . . . 70.430000000000007 111.379 177.816 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -72.44 -25.99 61.66 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 123.274 0.63 . . . . 73.030000000000001 110.515 176.61 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 6.6 m -63.84 -47.44 80.76 Favored 'General case' 0 C--O 1.233 0.195 0 O-C-N 120.867 -1.146 . . . . 75.049999999999997 108.443 -178.152 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 59.9 mt -62.79 -33.26 74.83 Favored 'General case' 0 C--O 1.224 -0.258 0 CA-C-O 119.484 -0.293 . . . . 74.299999999999997 110.788 175.633 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 14.0 tptt -54.23 -36.75 63.87 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-O 118.939 -0.553 . . . . 65.200000000000003 111.089 176.132 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.514 HD23 ' HB1' ' A' ' 169' ' ' ALA . 4.6 mm? -80.09 -44.85 19.28 Favored 'General case' 0 CA--C 1.509 -0.63 0 CA-C-O 117.665 -1.16 . . . . 75.409999999999997 110.077 175.262 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -50.43 -42.41 53.89 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 119.251 0.932 . . . . 73.439999999999998 111.169 -179.327 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -82.19 -33.3 29.49 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 124.693 1.197 . . . . 74.120000000000005 109.827 -165.415 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 19.2 t80 -69.79 -51.06 37.08 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.892 1.277 . . . . 73.230000000000004 110.496 170.8 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 62.5 mt -61.32 -27.96 68.87 Favored 'General case' 0 N--CA 1.462 0.133 0 C-N-CA 125.274 1.429 . . . . 74.450000000000003 112.871 -174.924 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 24.4 mt -56.61 -63.11 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 N-CA-C 108.178 -1.045 . . . . 65.319999999999993 108.178 171.539 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 7.8 tm-20 -60.36 -33.38 72.36 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.646 1.179 . . . . 72.239999999999995 111.324 -173.81 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 43.6 tptt -48.72 -57.99 5.46 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 124.344 1.058 . . . . 65.340000000000003 109.971 173.765 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 25.0 mm-40 -77.07 -34.55 57.01 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 123.504 0.721 . . . . 74.120000000000005 111.715 -178.419 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.75 -36.87 83.46 Favored 'General case' 0 N--CA 1.462 0.155 0 O-C-N 120.959 -1.088 . . . . 60.130000000000003 109.99 -174.92 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -62.81 -14.07 41.01 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.103 0.961 . . . . 71.0 112.065 177.883 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -61.13 -28.14 68.89 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 118.886 0.766 . . . . 73.25 111.575 169.926 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . 59.41 14.68 3.92 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 127.251 2.22 . . . . 74.409999999999997 113.527 169.828 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . 0.264 0.0 OUTLIER 57.24 24.98 10.52 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 126.266 1.826 . . . . 72.549999999999997 114.381 -169.284 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.172 0 C-N-CA 124.588 1.155 . . . . 75.530000000000001 110.327 177.905 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.176 0 N-CA-C 109.412 -1.475 . . . . 63.210000000000001 109.412 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.86 147.34 51.85 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 119.387 1.593 . . . . 75.510000000000005 110.723 176.879 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -142.85 8.02 1.67 Allowed 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 124.527 1.131 . . . . 72.319999999999993 111.752 -173.413 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 -145.97 157.77 43.88 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 125.016 1.327 . . . . 75.129999999999995 109.383 -170.451 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 51.1 m -134.06 141.26 47.12 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-O 121.692 0.758 . . . . 74.430000000000007 109.698 -179.115 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.43 144.28 57.29 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 124.12 0.968 . . . . 50.229999999999997 110.021 -178.779 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 79.1 -46.07 2.9 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 126.059 1.79 . . . . 71.129999999999995 111.099 -170.196 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 9.2 tptp -67.14 -70.42 0.25 Allowed 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 125.467 1.507 . . . . 72.530000000000001 109.748 -172.842 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.432 ' HB3' HD21 ' A' ' 178' ' ' LEU . 11.2 mp0 -88.24 -27.49 21.73 Favored 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 123.46 0.704 . . . . 71.430000000000007 110.735 -176.829 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 39.7 p90 -156.12 177.11 11.8 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 121.087 -1.008 . . . . 74.310000000000002 110.267 -171.462 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 17.7 t -134.1 112.73 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 N-CA-C 108.577 -0.897 . . . . 73.319999999999993 108.577 -175.266 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.32 163.66 26.09 Favored 'General case' 0 C--N 1.329 -0.314 0 O-C-N 120.652 -1.28 . . . . 75.109999999999999 109.01 164.459 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -132.01 113.52 13.49 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 123.959 0.904 . . . . 53.219999999999999 109.107 -176.241 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.9 m -61.16 -10.49 6.55 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 114.657 1.355 . . . . 45.530000000000001 114.657 -179.095 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 15.7 m -117.86 79.88 13.86 Favored Pre-proline 0 N--CA 1.448 -0.57 0 CA-C-N 119.834 1.197 . . . . 71.200000000000003 108.312 171.581 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_endo -69.06 174.79 8.4 Favored 'Trans proline' 0 N--CA 1.451 -1.012 0 C-N-CA 122.566 2.178 . . . . 72.530000000000001 111.336 175.175 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 50.5 t -143.22 134.76 12.84 Favored Pre-proline 0 C--N 1.33 -0.271 0 N-CA-C 106.203 -1.777 . . . . 51.030000000000001 106.203 -176.437 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -75.37 173.86 13.79 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 121.067 1.178 . . . . 63.299999999999997 110.56 176.934 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 16.3 m -116.2 165.19 11.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 C-N-CA 124.864 1.266 . . . . 63.509999999999998 108.87 175.006 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 3.4 m -48.75 -53.77 17.69 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 124.823 1.249 . . . . 71.430000000000007 112.418 174.742 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 2.2 pm0 -147.45 159.56 41.37 Favored Pre-proline 0 N--CA 1.449 -0.496 0 CA-C-N 120.413 1.46 . . . . 72.030000000000001 111.045 177.84 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -65.09 -177.07 0.54 Allowed 'Trans proline' 0 CA--C 1.544 1.021 0 C-N-CA 123.902 3.068 . . . . 74.329999999999998 111.135 166.218 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 119.97 -80.3 0.32 Allowed Glycine 0 CA--C 1.525 0.692 0 C-N-CA 125.211 1.386 . . . . 52.210000000000001 111.34 174.358 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -109.04 144.72 36.69 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 124.192 0.997 . . . . 71.319999999999993 109.232 179.122 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 47.2 mm -59.26 146.74 8.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 C-N-CA 124.481 1.112 . . . . 73.340000000000003 108.484 175.397 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -107.71 90.16 3.22 Favored 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 105.872 -1.899 . . . . 75.310000000000002 105.872 175.907 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 47.8 t -84.22 125.36 40.23 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.174 0 N-CA-C 105.505 -2.035 . . . . 72.530000000000001 105.505 170.946 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 41.9 t -119.35 113.39 41.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 N-CA-C 107.291 -1.374 . . . . 72.209999999999994 107.291 -175.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -72.01 131.6 43.13 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 107.83 -1.174 . . . . 54.439999999999998 107.83 156.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.1 mp -119.68 130.59 55.12 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 106.826 -1.546 . . . . 70.340000000000003 106.826 165.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 6.1 p90 -142.75 170.35 15.87 Favored 'General case' 0 C--O 1.237 0.416 0 O-C-N 123.9 0.75 . . . . 74.530000000000001 112.639 -170.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' TRP . . . . . 0.458 ' HB3' HG21 ' A' ' 153' ' ' VAL . 27.4 t90 -142.44 149.02 38.73 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 127.224 2.21 . . . . 62.310000000000002 108.344 -178.291 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 9.3 p90 -60.67 -20.11 60.1 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 115.905 1.817 . . . . 71.129999999999995 115.905 -172.178 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -100.69 -89.13 2.04 Favored Glycine 0 N--CA 1.449 -0.498 0 N-CA-C 106.931 -2.468 . . . . 54.450000000000003 106.931 -176.418 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 30.8 t 44.8 80.64 0.28 Allowed Pre-proline 0 CA--C 1.538 0.483 0 C-N-CA 126.172 1.789 . . . . 71.230000000000004 112.491 175.748 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -59.76 -21.36 63.12 Favored 'Trans proline' 0 CA--C 1.536 0.595 0 C-N-CA 121.993 1.795 . . . . 63.340000000000003 113.493 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 18.6 m170 -82.39 -39.37 22.79 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.757 1.223 . . . . 73.109999999999999 111.047 179.638 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 74.5 m -58.21 -43.25 87.58 Favored 'General case' 0 N--CA 1.462 0.143 0 C-N-CA 124.949 1.3 . . . . 63.119999999999997 111.271 -175.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 68.5 t80 -61.39 -27.84 68.82 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.819 0.848 . . . . 73.329999999999998 111.207 178.153 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -77.89 10.76 2.58 Favored 'General case' 0 CA--C 1.544 0.719 0 O-C-N 120.598 -1.314 . . . . 65.310000000000002 112.88 174.606 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 10.9 t80 -138.43 -23.63 0.98 Allowed 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 125.796 1.639 . . . . 74.540000000000006 111.994 174.731 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -35.12 -66.14 0.25 Allowed Pre-proline 0 CA--C 1.541 0.622 0 C-N-CA 127.074 2.15 . . . . 71.400000000000006 112.594 176.592 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -72.07 -11.36 27.13 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 CA-C-N 120.907 1.36 . . . . 72.540000000000006 114.476 -173.297 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 82.0 m -82.15 -35.65 28.22 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 119.469 1.031 . . . . 71.400000000000006 110.072 172.947 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 18.7 tt -90.46 -26.03 5.33 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 O-C-N 121.989 -0.445 . . . . 73.530000000000001 111.994 -173.274 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 14.5 t -52.15 -65.1 1.12 Allowed Pre-proline 0 CA--C 1.543 0.685 0 C-N-CA 124.668 1.187 . . . . 72.25 111.214 172.773 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -71.98 -13.71 29.04 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 CA-C-N 121.522 1.579 . . . . 62.210000000000001 112.613 -174.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 70.8 t90 -68.03 -58.46 4.46 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 119.115 0.871 . . . . 71.230000000000004 109.331 168.738 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 7.2 p -62.22 -34.64 76.87 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.306 0.643 . . . . 73.329999999999998 112.476 -169.671 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -59.5 -49.49 77.58 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 118.749 0.704 . . . . 73.450000000000003 110.655 177.349 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.14 18.4 1.39 Allowed 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 124.643 1.177 . . . . 74.519999999999996 113.17 -174.162 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 26.3 mt -63.39 153.34 82.71 Favored Pre-proline 0 N--CA 1.449 -0.506 0 CA-C-N 118.476 0.58 . . . . 73.340000000000003 110.803 175.011 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -80.11 166.2 20.95 Favored 'Trans proline' 0 N--CA 1.446 -1.283 0 C-N-CA 124.679 3.586 . . . . 71.310000000000002 111.025 -179.747 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -65.46 -7.9 16.46 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 114.793 1.405 . . . . 71.530000000000001 114.793 -175.2 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -104.65 8.18 35.14 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 125.454 1.502 . . . . 74.230000000000004 111.62 -177.572 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 67.1 t -120.67 152.24 23.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 106.418 -1.697 . . . . 61.420000000000002 106.418 177.674 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 16.9 t60 -134.25 124.88 26.64 Favored 'General case' 0 N--CA 1.439 -1.014 0 N-CA-C 108.036 -1.098 . . . . 74.209999999999994 108.036 166.408 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 29.4 t80 -84.68 140.15 31.52 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 107.004 -1.48 . . . . 60.149999999999999 107.004 173.233 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 88.7 t -133.34 150.36 32.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 C-N-CA 126.693 1.997 . . . . 64.230000000000004 106.128 178.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 18.3 mtt180 -131.23 120.81 23.77 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 106.127 -1.805 . . . . 74.230000000000004 106.127 179.166 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 40.3 mt -127.56 151.01 74.47 Favored Pre-proline 0 N--CA 1.473 0.691 0 CA-C-N 120.369 1.441 . . . . 71.209999999999994 110.618 173.225 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -71.89 131.24 17.97 Favored 'Trans proline' 0 N--CA 1.453 -0.901 0 C-N-CA 122.357 2.038 . . . . 72.140000000000001 110.064 176.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -77.38 81.75 3.85 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 123.758 0.823 . . . . 70.420000000000002 110.717 177.208 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 33.6 mt -77.25 95.36 4.31 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.002 0.921 . . . . 73.319999999999993 109.313 -177.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 37.4 m-85 -123.49 20.05 9.59 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.158 0.983 . . . . 71.420000000000002 112.343 -177.596 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 85.79 -174.55 48.15 Favored Glycine 0 C--N 1.336 0.553 0 N-CA-C 110.702 -0.959 . . . . 70.010000000000005 110.702 -178.84 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 44.88 71.37 0.48 Allowed Glycine 0 CA--C 1.526 0.731 0 C-N-CA 125.308 1.432 . . . . 55.140000000000001 113.914 166.297 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . 0.256 5.5 tp 58.23 -19.85 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.739 0 C-N-CA 130.288 3.435 . . . . 73.109999999999999 115.671 -176.58 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 10.6 m95 -56.85 -39.77 74.89 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 121.277 1.853 . . . . 62.43 110.302 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 25.1 p30 -73.88 -43.67 57.8 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 125.357 1.463 . . . . 54.130000000000003 113.395 -177.77 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 78.9 t -56.5 -49.26 78.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 N-CA-C 108.906 -0.776 . . . . 62.200000000000003 108.906 177.345 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 43.8 m170 -72.19 -2.6 19.37 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 114.473 1.286 . . . . 73.329999999999998 114.473 179.125 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -107.02 -21.6 8.02 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 124.921 1.248 . . . . 74.019999999999996 112.475 177.517 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 54.4 tt0 -64.26 -30.93 71.96 Favored 'General case' 0 CA--C 1.539 0.527 0 O-C-N 121.716 -0.873 . . . . 75.120000000000005 111.682 -175.699 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -67.52 -37.52 82.89 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 126.004 1.721 . . . . 72.239999999999995 112.613 -174.495 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 26.6 t80 -64.11 -48.47 76.0 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-N 119.647 1.112 . . . . 72.430000000000007 109.018 -171.688 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 54.8 mt -56.87 -36.41 70.05 Favored 'General case' 0 C--O 1.223 -0.341 0 C-N-CA 124.228 1.011 . . . . 71.349999999999994 110.101 173.483 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.15 -44.25 76.46 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 119.764 1.165 . . . . 64.120000000000005 111.382 178.103 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -53.22 -58.62 6.42 Favored 'General case' 0 CA--C 1.529 0.14 0 N-CA-C 107.561 -1.274 . . . . 62.530000000000001 107.561 -178.749 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -67.62 -23.15 65.33 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 111.968 0.358 . . . . 72.400000000000006 111.968 -176.544 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 17.4 t -62.16 -25.53 67.82 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-O 118.485 -0.769 . . . . 54.109999999999999 112.783 178.033 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 3.2 ptp -103.1 -11.09 18.34 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 119.762 1.165 . . . . 61.229999999999997 113.372 172.666 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 120.58 -52.05 0.75 Allowed Glycine 0 CA--C 1.523 0.574 0 C-N-CA 125.557 1.551 . . . . 64.409999999999997 112.748 163.314 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 35.9 m 45.58 18.58 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 C-N-CA 129.227 3.011 . . . . 74.219999999999999 116.974 173.156 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 3.1 pm0 -43.39 102.95 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 126.615 1.966 . . . . 73.5 112.18 -163.421 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 32.3 t-80 -108.65 -16.45 14.19 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.031 1.332 . . . . 73.540000000000006 111.129 -173.434 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 64.72 10.83 6.32 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 126.423 1.889 . . . . 65.409999999999997 114.525 176.855 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 10.7 p -157.79 -25.56 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.852 0 N-CA-C 115.046 1.498 . . . . 70.120000000000005 115.046 178.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 73.7 m-70 60.4 -5.07 0.1 Allowed 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 117.308 2.336 . . . . 71.420000000000002 117.308 177.647 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 9.0 m-20 -57.68 -46.25 84.56 Favored 'General case' 0 C--O 1.221 -0.428 0 CA-C-N 120.137 1.335 . . . . 65.109999999999999 113.085 -173.114 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -61.55 -25.84 67.57 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 119.768 1.167 . . . . 74.430000000000007 113.202 -173.354 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 82.4 t -59.11 -61.37 1.46 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 N-CA-C 107.627 -1.249 . . . . 65.329999999999998 107.627 169.369 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -61.22 -47.56 85.55 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.106 0.962 . . . . 61.030000000000001 111.05 -176.586 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -72.13 2.41 5.89 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.659 1.984 . . . . 72.409999999999997 112.124 -173.331 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -117.23 3.32 12.63 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 124.96 1.304 . . . . 63.32 112.282 171.08 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.475 HG12 HD12 ' A' ' 105' ' ' LEU . 83.8 mt -124.15 -60.94 1.81 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.373 0 N-CA-C 106.096 -1.816 . . . . 63.140000000000001 106.096 -175.595 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 83.3 m-70 -59.79 -64.87 0.79 Allowed 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 125.0 1.32 . . . . 74.230000000000004 111.237 -179.662 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 4.6 ptmt -82.41 -7.03 59.64 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 114.693 1.368 . . . . 75.340000000000003 114.693 -175.167 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -114.91 -37.5 4.16 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 113.665 0.987 . . . . 74.129999999999995 113.665 -173.085 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 12.1 t-160 45.63 53.06 8.92 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 127.695 2.398 . . . . 74.430000000000007 113.162 -178.355 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . 0.289 0.0 OUTLIER -70.71 12.97 0.21 Allowed 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 115.308 1.595 . . . . 71.319999999999993 115.308 172.966 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 26.2 ttmt 45.43 61.48 2.57 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 128.676 2.79 . . . . 61.210000000000001 110.863 171.806 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.475 HD12 HG12 ' A' ' 98' ' ' ILE . 63.1 mt -76.44 60.75 1.63 Allowed 'General case' 0 C--N 1.315 -0.93 0 C-N-CA 128.895 2.878 . . . . 54.350000000000001 107.181 177.643 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -103.03 -12.16 17.63 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 127.928 2.491 . . . . 75.140000000000001 111.11 -176.028 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -114.27 154.09 46.36 Favored Pre-proline 0 C--O 1.236 0.393 0 C-N-CA 124.967 1.307 . . . . 60.530000000000001 108.163 177.091 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -67.72 -36.35 19.18 Favored 'Trans proline' 0 N--CA 1.45 -1.067 0 C-N-CA 121.226 1.284 . . . . 73.510000000000005 110.73 -177.159 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -55.63 -55.18 35.09 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 123.559 0.743 . . . . 75.430000000000007 110.161 174.077 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -57.54 -50.86 71.71 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 125.053 1.341 . . . . 73.239999999999995 109.801 -175.597 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 51.2 mtt -55.82 -53.71 53.39 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 123.958 0.903 . . . . 72.439999999999998 111.355 178.51 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.609 ' HB1' ' HG2' ' A' ' 122' ' ' LYS . . . -71.75 -36.95 70.57 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 124.288 1.035 . . . . 71.230000000000004 110.597 -168.573 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -62.4 -42.59 99.55 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 118.699 0.682 . . . . 74.129999999999995 111.723 174.882 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 8.9 t80 -61.28 -51.48 68.75 Favored 'General case' 0 N--CA 1.455 -0.192 0 O-C-N 121.4 -0.813 . . . . 75.129999999999995 110.534 177.577 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 58.3 mt -70.55 -22.88 62.55 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 110.075 -0.342 . . . . 75.400000000000006 110.075 -175.647 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -58.21 -36.02 72.51 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 118.85 0.75 . . . . 63.530000000000001 109.431 171.893 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -71.81 -4.74 59.29 Favored Glycine 0 N--CA 1.442 -0.918 0 CA-C-O 116.459 -2.3 . . . . 34.340000000000003 115.034 170.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.505 ' HA ' ' HE2' ' A' ' 118' ' ' LYS . 5.7 mmpt? -116.74 -9.13 11.32 Favored 'General case' 0 C--N 1.348 0.537 0 CA-C-N 122.553 3.176 . . . . 71.239999999999995 114.245 -171.996 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 97.0 59.02 1.01 Allowed Glycine 0 N--CA 1.452 -0.234 0 N-CA-C 108.486 -1.845 . . . . 53.439999999999998 108.486 -168.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 53.7 t -142.31 153.05 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 C-N-CA 129.372 3.069 . . . . 63.509999999999998 104.089 167.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 41.6 t0 -111.67 128.91 56.21 Favored 'General case' 0 C--N 1.331 -0.221 0 O-C-N 121.116 -0.99 . . . . 64.140000000000001 108.746 -177.903 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.609 ' HG2' ' HB1' ' A' ' 112' ' ' ALA . 14.2 mtpt -60.75 -31.35 70.69 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 119.277 0.944 . . . . 74.230000000000004 110.374 172.991 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -59.81 -20.93 59.86 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 119.844 1.202 . . . . 65.25 112.214 173.66 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 65.0 mmtt -113.3 -33.11 6.06 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-N 119.8 1.182 . . . . 72.319999999999993 112.057 -175.76 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -62.64 -56.41 18.01 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 118.814 0.734 . . . . 72.329999999999998 109.926 -178.268 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 9.9 mt -72.76 -46.5 53.05 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.861 0.839 . . . . 74.049999999999997 111.173 -163.182 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 21.0 p -53.61 -41.79 67.03 Favored 'General case' 0 N--CA 1.444 -0.736 0 C-N-CA 125.511 1.525 . . . . 73.450000000000003 108.822 177.412 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 40.9 m -76.48 -41.39 47.36 Favored 'General case' 0 C--O 1.222 -0.356 0 N-CA-C 108.322 -0.992 . . . . 61.409999999999997 108.322 -176.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 61.6 t80 -56.57 -32.27 65.02 Favored 'General case' 0 C--O 1.235 0.337 0 O-C-N 120.709 -1.245 . . . . 72.519999999999996 110.878 178.153 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -105.17 26.4 9.38 Favored 'General case' 0 C--O 1.243 0.714 0 N-CA-C 113.432 0.901 . . . . 73.129999999999995 113.432 175.485 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 11.1 p -99.68 157.02 16.77 Favored 'General case' 0 C--O 1.234 0.275 0 O-C-N 120.919 -1.113 . . . . 74.049999999999997 111.317 175.726 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -67.19 -27.59 67.39 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 115.538 -0.755 . . . . 74.439999999999998 111.921 -175.637 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -55.09 -47.0 75.52 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 121.524 0.678 . . . . 72.239999999999995 110.324 175.734 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 32.8 mm -64.08 -37.72 80.57 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 C-N-CA 123.787 0.835 . . . . 72.5 109.149 179.4 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 10.5 mttt -58.31 -35.23 71.54 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 119.64 1.109 . . . . 75.310000000000002 110.591 172.393 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -73.51 -40.21 47.98 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 109.816 -1.314 . . . . 50.350000000000001 109.816 -173.769 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 2.3 mm100 -68.98 -43.1 75.61 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 123.391 0.676 . . . . 72.129999999999995 109.824 178.361 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 45.4 mtp -60.54 -42.76 97.19 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-O 117.495 -1.241 . . . . 64.25 111.478 177.15 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -62.8 -39.99 95.98 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 120.638 1.563 . . . . 74.450000000000003 110.839 -178.432 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 9.3 mmtt -59.62 -65.48 0.67 Allowed 'General case' 0 N--CA 1.463 0.176 0 C-N-CA 123.803 0.841 . . . . 73.230000000000004 110.316 170.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -57.92 -34.84 70.28 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 119.472 1.033 . . . . 73.200000000000003 111.257 -171.195 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 14.2 tmtt? -61.62 -61.55 2.44 Favored 'General case' 0 CA--C 1.518 -0.25 0 C-N-CA 124.895 1.278 . . . . 65.140000000000001 110.172 176.744 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.08 -25.98 68.35 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 119.74 1.154 . . . . 71.209999999999994 110.903 -178.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 25.4 mt -69.62 -54.24 14.92 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 118.429 -0.796 . . . . 75.209999999999994 111.712 -176.378 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -58.75 -49.32 78.08 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 118.873 0.76 . . . . 75.230000000000004 111.196 -169.445 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -61.03 -40.39 93.4 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 123.527 0.731 . . . . 73.120000000000005 112.515 175.742 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -67.3 -36.42 81.46 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 118.278 -0.868 . . . . 42.329999999999998 110.019 -179.526 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -67.78 14.14 0.06 Allowed 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.824 1.65 . . . . 64.209999999999994 113.359 175.891 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 54.29 21.52 3.19 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 127.12 2.168 . . . . 73.129999999999995 113.839 -179.023 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.449 HG13 HG21 ' A' ' 155' ' ' THR . 44.4 t -71.47 142.04 15.97 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 N-CA-C 108.576 -0.898 . . . . 62.030000000000001 108.576 179.4 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -112.64 -14.09 13.2 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 124.662 1.185 . . . . 60.140000000000001 112.717 -176.112 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 167.49 -160.16 33.71 Favored Glycine 0 N--CA 1.446 -0.699 0 N-CA-C 108.119 -1.992 . . . . 42.32 108.119 -165.398 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.458 HG21 ' HB3' ' A' ' 34' ' ' TRP . 31.0 m -138.69 157.31 72.18 Favored Pre-proline 0 CA--C 1.536 0.425 0 C-N-CA 124.345 1.058 . . . . 65.209999999999994 109.741 -178.185 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_endo -66.59 156.9 81.91 Favored 'Cis proline' 0 N--CA 1.459 -0.552 0 C-N-CA 124.738 -0.943 . . . . 74.430000000000007 111.621 -7.063 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' THR . . . . . 0.449 HG21 HG13 ' A' ' 150' ' ' VAL . 5.6 m -156.86 138.37 13.99 Favored 'General case' 0 N--CA 1.466 0.339 0 O-C-N 121.102 -0.999 . . . . 74.010000000000005 109.239 171.96 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 92.1 mtp -112.32 148.64 33.79 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 125.148 1.379 . . . . 54.409999999999997 109.164 171.605 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 26.7 t -137.09 151.8 27.48 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 C-N-CA 124.623 1.169 . . . . 63.119999999999997 108.027 176.667 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 39.9 t -130.2 123.5 56.04 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 C-N-CA 126.053 1.741 . . . . 73.310000000000002 106.819 -178.351 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 16.6 m-20 50.01 21.15 0.68 Allowed 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 127.805 2.442 . . . . 65.25 114.973 173.937 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 51.74 45.17 55.17 Favored Glycine 0 CA--C 1.531 1.07 0 CA-C-O 117.697 -1.613 . . . . 60.149999999999999 112.924 -165.419 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 12.1 mtpp -139.44 -33.98 0.59 Allowed 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 119.595 1.697 . . . . 63.119999999999997 113.056 178.348 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -121.81 148.25 44.92 Favored 'General case' 0 CA--C 1.506 -0.729 0 N-CA-C 108.154 -1.054 . . . . 74.099999999999994 108.154 176.809 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 48.8 ttp85 -136.4 139.39 42.42 Favored 'General case' 0 N--CA 1.442 -0.857 0 N-CA-C 106.268 -1.753 . . . . 73.230000000000004 106.268 179.426 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 22.9 p90 -154.94 174.59 14.92 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 108.255 -1.017 . . . . 74.030000000000001 108.255 -179.364 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -177.41 173.73 1.67 Allowed 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 107.736 -1.209 . . . . 64.329999999999998 107.736 -176.59 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.42 HG13 ' H ' ' A' ' 166' ' ' ILE . 17.8 mt -45.4 -50.13 3.25 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 C-N-CA 127.964 2.506 . . . . 55.32 108.408 162.462 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -73.86 9.5 8.72 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 126.433 1.968 . . . . 30.329999999999998 114.699 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 22.6 m -120.51 -54.15 2.08 Favored 'General case' 0 N--CA 1.458 -0.047 0 CA-C-N 119.198 1.499 . . . . 71.239999999999995 109.764 163.387 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -61.25 -53.1 61.14 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.511 1.125 . . . . 62.409999999999997 110.78 -172.571 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 146.02 -17.42 1.75 Allowed Glycine 0 CA--C 1.523 0.553 0 CA-C-O 119.614 -0.548 . . . . 73.340000000000003 113.764 178.417 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 169.47 176.37 39.3 Favored Glycine 0 CA--C 1.528 0.872 0 N-CA-C 108.885 -1.686 . . . . 42.140000000000001 108.885 -169.332 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -63.9 -52.48 1.71 Allowed 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 123.072 2.515 . . . . 73.230000000000004 111.611 -175.177 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -59.8 -39.74 86.0 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 119.295 0.952 . . . . 74.239999999999995 109.732 178.053 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -60.77 -32.65 71.96 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.523 0.729 . . . . 74.420000000000002 110.494 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 26.6 m -65.63 -43.68 88.77 Favored 'General case' 0 N--CA 1.453 -0.282 0 O-C-N 120.716 -1.24 . . . . 45.329999999999998 109.617 179.083 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 48.0 mt -66.46 -28.24 68.44 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 118.891 0.768 . . . . 72.329999999999998 111.354 176.139 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 10.1 tptt -51.29 -49.23 61.67 Favored 'General case' 0 C--O 1.232 0.182 0 N-CA-C 109.005 -0.739 . . . . 73.010000000000005 109.005 169.48 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.467 HD13 ' HA ' ' A' ' 178' ' ' LEU . 4.4 mm? -74.46 -38.79 62.85 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-O 119.012 -0.518 . . . . 61.229999999999997 111.54 -178.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.08 -43.94 87.29 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 118.005 0.366 . . . . 34.219999999999999 111.099 -176.625 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -74.04 -28.52 61.46 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 123.244 0.618 . . . . 64.019999999999996 110.58 -174.471 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 9.9 t80 -74.08 -57.0 4.26 Favored 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 125.053 1.341 . . . . 74.439999999999998 110.425 178.454 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 77.8 mt -61.95 -24.7 67.16 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 124.997 1.319 . . . . 74.319999999999993 112.955 -171.552 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 35.6 mt -53.3 -54.94 15.06 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 C-N-CA 123.348 0.659 . . . . 72.209999999999994 109.36 170.014 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -66.07 -38.23 87.8 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 118.342 0.519 . . . . 65.209999999999994 111.229 -177.073 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 185' ' ' LYS . . . . . 0.45 ' HE3' ' HA ' ' A' ' 185' ' ' LYS . 0.1 OUTLIER -52.4 -46.44 66.29 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 124.325 1.05 . . . . 75.010000000000005 110.182 -176.723 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -74.64 -51.83 13.37 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 123.087 0.555 . . . . 65.25 112.082 173.237 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 3.2 tpm_? -48.07 -45.31 32.36 Favored 'General case' 0 CA--C 1.516 -0.357 0 C-N-CA 124.82 1.248 . . . . 71.420000000000002 112.086 -175.422 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -58.79 -20.27 48.47 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 125.696 1.598 . . . . 72.549999999999997 111.746 -174.566 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -59.47 -39.41 83.6 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 124.031 0.932 . . . . 74.540000000000006 111.254 172.651 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -132.98 42.74 3.03 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 126.318 1.847 . . . . 42.530000000000001 109.588 -168.855 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 40.2 tttm -134.51 85.82 2.22 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 102.583 -3.117 . . . . 24.239999999999998 102.583 174.816 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 55.0 mttt . . . . . 0 C--O 1.257 1.497 0 N-CA-C 107.557 -1.275 . . . . 73.540000000000006 107.557 -171.625 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.665 0 N-CA-C 108.852 -1.699 . . . . 54.439999999999998 108.852 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -76.27 -53.54 8.08 Favored 'General case' 0 CA--C 1.502 -0.888 0 C-N-CA 122.907 0.483 . . . . 60.520000000000003 111.011 -170.178 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 76.38 10.46 2.95 Favored 'General case' 0 N--CA 1.442 -0.852 0 C-N-CA 130.078 3.351 . . . . 64.219999999999999 115.556 -172.133 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 29.7 m-85 -139.83 178.1 7.48 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 126.648 1.979 . . . . 73.230000000000004 108.305 179.383 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 95.0 m -144.3 143.88 31.2 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 108.287 -1.005 . . . . 75.230000000000004 108.287 166.238 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.64 152.27 45.69 Favored 'General case' 0 C--O 1.227 -0.123 0 O-C-N 121.393 -0.817 . . . . 74.019999999999996 108.838 172.386 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 70.33 -44.37 0.58 Allowed Glycine 0 CA--C 1.534 1.224 0 C-N-CA 125.504 1.525 . . . . 30.199999999999999 112.287 -162.36 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.5 tptm -70.21 -58.57 3.63 Favored 'General case' 0 CA--C 1.519 -0.222 0 C-N-CA 126.295 1.838 . . . . 72.409999999999997 111.165 -169.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -113.78 -23.42 9.68 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 126.04 1.736 . . . . 73.530000000000001 109.965 -172.056 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 42.4 p90 -157.22 173.38 17.05 Favored 'General case' 0 N--CA 1.47 0.525 0 O-C-N 120.96 -1.088 . . . . 74.129999999999995 109.586 -176.147 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 24.9 t -135.52 117.89 21.77 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 C-N-CA 123.437 0.695 . . . . 74.530000000000001 109.193 -174.576 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.9 162.54 28.04 Favored 'General case' 0 CA--C 1.537 0.446 0 O-C-N 121.189 -0.945 . . . . 44.520000000000003 109.055 167.953 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -136.18 108.28 7.21 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 126.679 1.992 . . . . 71.409999999999997 108.294 -167.52 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.8 p -63.27 -0.46 0.82 Allowed 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 115.493 1.664 . . . . 74.439999999999998 115.493 -176.229 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 49.0 m -131.0 76.41 76.98 Favored Pre-proline 0 N--CA 1.451 -0.389 0 CA-C-N 119.841 1.201 . . . . 72.109999999999999 109.428 174.036 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -65.97 176.64 3.58 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 123.894 3.063 . . . . 63.130000000000003 112.688 -176.487 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 40.2 t -133.81 136.03 25.81 Favored Pre-proline 0 CA--C 1.537 0.443 0 C-N-CA 125.539 1.536 . . . . 73.530000000000001 108.336 -169.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -76.24 178.45 7.48 Favored 'Trans proline' 0 CA--C 1.534 0.509 0 C-N-CA 123.491 2.794 . . . . 60.039999999999999 111.443 176.894 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 27.9 m -132.85 174.1 13.81 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 C-N-CA 125.336 1.454 . . . . 54.049999999999997 109.674 170.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 73.9 m -58.45 -51.36 70.15 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 126.33 1.852 . . . . 64.219999999999999 112.335 175.002 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 41.7 tt0 -143.16 145.29 32.06 Favored Pre-proline 0 CA--C 1.534 0.361 0 C-N-CA 124.278 1.031 . . . . 73.549999999999997 108.733 -177.819 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -74.54 90.91 1.0 Allowed 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 123.158 2.572 . . . . 70.209999999999994 109.202 165.2 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -137.12 -94.9 0.38 Allowed Glycine 0 C--N 1.336 0.542 0 O-C-N 121.497 -0.752 . . . . 73.120000000000005 111.304 -172.387 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 12.7 mptt -80.02 159.95 26.03 Favored 'General case' 0 C--O 1.227 -0.13 0 N-CA-C 107.693 -1.225 . . . . 73.010000000000005 107.693 170.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 49.2 mm -70.46 130.46 34.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 106.135 -1.802 . . . . 65.140000000000001 106.135 167.227 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -83.8 130.48 34.94 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 106.203 -1.777 . . . . 64.299999999999997 106.203 173.422 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 13.9 t -119.42 144.17 28.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 105.813 -1.921 . . . . 63.109999999999999 105.813 166.049 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 37.8 t -133.98 101.65 3.94 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.137 0 N-CA-C 106.512 -1.662 . . . . 73.340000000000003 106.512 -174.225 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -76.17 137.33 39.99 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 106.143 -1.799 . . . . 73.340000000000003 106.143 161.115 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.4 mp -120.93 134.19 55.29 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 105.494 -2.039 . . . . 62.240000000000002 105.494 163.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 42.6 p90 -134.76 172.77 12.5 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 123.552 0.741 . . . . 73.319999999999993 110.962 -177.379 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' TRP . . . . . 0.611 ' CB ' HG21 ' A' ' 153' ' ' VAL . 22.9 t90 -148.55 167.68 24.77 Favored 'General case' 0 N--CA 1.463 0.209 0 C-N-CA 125.225 1.41 . . . . 72.040000000000006 108.644 178.405 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 17.6 t80 -67.34 -43.98 80.19 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.865 0.866 . . . . 65.299999999999997 112.026 172.253 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -95.71 22.79 37.26 Favored Glycine 0 CA--C 1.527 0.79 0 CA-C-O 119.026 -0.875 . . . . 44.130000000000003 113.954 -163.479 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.521 ' HB3' HG23 ' A' ' 153' ' ' VAL . 22.0 p -105.08 86.11 1.46 Allowed Pre-proline 0 CA--C 1.532 0.274 0 CA-C-N 118.843 1.321 . . . . 63.149999999999999 109.372 -177.906 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_endo -56.96 -24.97 60.07 Favored 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 122.325 2.016 . . . . 71.239999999999995 113.133 -177.093 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 15.6 m170 -68.11 -26.03 65.6 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 119.028 0.831 . . . . 73.310000000000002 111.037 178.243 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 84.6 m -65.29 -32.81 74.66 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.814 0.846 . . . . 61.229999999999997 109.48 -174.168 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -63.78 -46.35 85.6 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 125.657 1.583 . . . . 75.519999999999996 110.687 -178.793 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -53.58 -33.82 56.18 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 122.6 0.36 . . . . 71.109999999999999 110.467 178.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.452 ' HB2' HD11 ' A' ' 166' ' ' ILE . 2.4 t80 -87.78 -37.45 16.59 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-O 116.171 -1.871 . . . . 70.150000000000006 113.002 -175.233 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -39.23 -63.78 0.59 Allowed Pre-proline 0 N--CA 1.477 0.885 0 CA-C-N 120.724 1.602 . . . . 75.329999999999998 113.712 -168.378 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -71.95 -8.97 23.95 Favored 'Trans proline' 0 CA--C 1.535 0.525 0 CA-C-N 121.885 1.709 . . . . 70.340000000000003 114.726 -177.338 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.9 m -76.01 -44.11 41.01 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 108.311 -0.996 . . . . 75.420000000000002 108.311 167.128 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 14.5 tt -85.89 -35.93 9.99 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 CA-C-O 118.541 -0.742 . . . . 75.409999999999997 112.01 -169.402 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 68.9 t -49.79 -59.97 5.89 Favored Pre-proline 0 CA--C 1.541 0.621 0 CA-C-N 120.358 1.435 . . . . 63.340000000000003 111.479 176.847 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -70.12 -20.6 32.91 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 121.332 1.355 . . . . 65.400000000000006 112.16 -174.874 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 81.9 t90 -61.01 -54.28 46.83 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 117.559 -1.21 . . . . 73.129999999999995 111.204 175.392 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.2 t -57.99 -40.7 81.37 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 120.646 1.566 . . . . 62.149999999999999 111.132 -179.118 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -62.8 -31.56 72.58 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 121.36 0.6 . . . . 74.329999999999998 110.5 -178.75 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -104.96 39.68 1.66 Allowed 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 126.175 1.79 . . . . 65.219999999999999 112.653 178.135 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 19.2 mt -89.51 160.26 42.34 Favored Pre-proline 0 C--O 1.238 0.454 0 C-N-CA 126.855 2.062 . . . . 62.399999999999999 109.995 165.389 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -78.99 175.85 10.49 Favored 'Trans proline' 0 N--CA 1.451 -0.989 0 C-N-CA 124.772 3.648 . . . . 34.43 112.015 175.312 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -72.35 -4.82 32.16 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 114.537 1.31 . . . . 72.030000000000001 114.537 -173.646 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -111.32 5.49 19.83 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 126.681 1.992 . . . . 75.329999999999998 111.907 -173.423 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 34.8 t -119.98 156.56 22.69 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 C-N-CA 124.658 1.183 . . . . 71.340000000000003 108.377 177.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 83.0 t60 -147.79 116.48 6.7 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.251 1.82 . . . . 74.219999999999999 108.694 -178.081 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -93.54 131.4 38.81 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 124.908 1.283 . . . . 73.430000000000007 109.801 -177.914 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 43.8 t -119.98 146.61 24.52 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 C-N-CA 124.703 1.201 . . . . 71.319999999999993 108.049 178.627 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 17.4 mtm180 -123.75 132.47 53.81 Favored 'General case' 0 CA--C 1.504 -0.794 0 N-CA-C 107.565 -1.272 . . . . 71.109999999999999 107.565 168.658 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 26.7 mt -141.76 153.64 64.9 Favored Pre-proline 0 C--N 1.321 -0.649 0 C-N-CA 124.388 1.075 . . . . 60.210000000000001 108.61 -179.513 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -73.39 154.64 50.91 Favored 'Trans proline' 0 N--CA 1.446 -1.278 0 C-N-CA 121.328 1.352 . . . . 71.430000000000007 111.772 178.365 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -97.96 72.89 2.23 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 125.521 1.528 . . . . 61.520000000000003 107.847 179.736 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 84.3 mt -74.31 78.73 1.84 Allowed 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.374 1.069 . . . . 75.25 111.238 -170.497 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -112.95 54.33 0.73 Allowed 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 125.242 1.417 . . . . 74.420000000000002 110.886 -176.409 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 60.17 173.5 0.83 Allowed Glycine 0 CA--C 1.529 0.928 0 C-N-CA 126.914 2.197 . . . . 61.229999999999997 114.615 178.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 53.0 -147.8 14.88 Favored Glycine 0 CA--C 1.53 1.015 0 O-C-N 121.282 -1.128 . . . . 75.219999999999999 111.193 -179.444 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -64.53 -10.95 9.71 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 O-C-N 122.01 -0.7 . . . . 74.219999999999999 112.886 179.518 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' TRP . . . . . 0.455 ' CH2' HG22 ' A' ' 153' ' ' VAL . 34.6 m95 -70.55 -28.53 64.99 Favored 'General case' 0 C--N 1.341 0.201 0 CA-C-N 119.9 1.227 . . . . 74.510000000000005 110.775 171.524 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -72.02 -45.46 60.8 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 119.103 -1.039 . . . . 72.450000000000003 109.449 166.373 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 75.6 t -64.17 -55.65 20.77 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 N-CA-C 111.917 0.339 . . . . 64.239999999999995 111.917 -167.876 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 28.3 m170 -70.72 6.98 1.24 Allowed 'General case' 0 CA--C 1.535 0.386 0 O-C-N 121.529 -0.732 . . . . 74.219999999999999 112.468 179.573 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -102.69 -33.71 4.33 Favored Glycine 0 N--CA 1.439 -1.128 0 CA-C-O 118.63 -1.094 . . . . 55.0 111.36 173.36 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . 0.417 0.0 OUTLIER -71.25 -36.56 71.83 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 118.951 1.376 . . . . 73.450000000000003 112.146 -166.029 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -53.82 -45.32 70.81 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-O 116.192 -1.861 . . . . 73.140000000000001 113.253 175.819 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 50.1 t80 -45.96 -52.2 12.06 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 125.736 1.614 . . . . 74.049999999999997 109.668 -177.126 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 18.1 mt -60.34 -44.06 95.88 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 126.605 1.962 . . . . 70.439999999999998 110.555 -177.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -64.51 -40.38 95.53 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 119.283 0.947 . . . . 64.209999999999994 110.872 -178.648 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.38 -51.22 70.84 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 107.903 -1.147 . . . . 64.329999999999998 107.903 -176.011 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -69.34 -27.24 65.18 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.067 0.947 . . . . 73.400000000000006 111.495 178.221 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 4.0 t -63.07 -16.68 60.71 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.368 1.067 . . . . 61.219999999999999 113.181 176.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 13.6 mtp -92.64 -4.18 53.74 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 124.013 0.925 . . . . 74.120000000000005 112.531 173.906 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 74.91 9.73 83.57 Favored Glycine 0 CA--C 1.524 0.615 0 C-N-CA 125.454 1.502 . . . . 51.25 112.341 173.403 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 30.8 m -53.71 117.18 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 C-N-CA 124.245 1.018 . . . . 75.540000000000006 110.648 -173.712 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -53.27 -63.6 1.1 Allowed 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.913 1.285 . . . . 75.109999999999999 110.301 -169.821 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . 0.275 2.1 m170 43.58 54.09 5.56 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 127.323 2.249 . . . . 62.119999999999997 113.504 167.045 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -65.03 67.04 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 127.868 2.467 . . . . 54.130000000000003 110.11 169.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 69.1 t -153.49 -56.75 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 C-N-CA 130.221 3.409 . . . . 64.040000000000006 106.501 -175.721 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . 0.258 0.2 OUTLIER 44.25 29.85 0.4 Allowed 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 127.659 2.384 . . . . 73.310000000000002 115.477 171.652 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -137.42 -33.79 0.72 Allowed 'General case' 0 C--O 1.22 -0.46 0 C-N-CA 125.417 1.487 . . . . 71.409999999999997 109.642 -178.208 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -56.5 -35.51 68.11 Favored 'General case' 0 C--O 1.227 -0.129 0 CA-C-N 119.412 1.006 . . . . 62.420000000000002 110.974 177.858 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 37.3 t -54.17 -63.18 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-O 117.767 -1.111 . . . . 74.219999999999999 109.296 167.899 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -60.16 -41.44 92.81 Favored 'General case' 0 CA--C 1.548 0.875 0 CA-C-N 121.349 1.886 . . . . 62.340000000000003 109.273 -174.279 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -74.97 4.54 6.41 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 129.291 3.036 . . . . 71.109999999999999 111.568 -176.11 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.401 ' HB1' ' CZ ' ' A' ' 114' ' ' PHE . . . -111.27 -3.16 15.44 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 125.184 1.393 . . . . 33.420000000000002 113.251 169.614 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 8.1 mt -126.28 -44.62 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 107.873 -1.158 . . . . 70.109999999999999 107.873 -172.916 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 85.2 m-70 -70.53 -65.13 0.77 Allowed 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 123.316 0.646 . . . . 73.219999999999999 111.38 177.42 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.84 -20.51 38.84 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 115.044 1.498 . . . . 64.230000000000004 115.044 -176.316 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -81.68 -39.89 23.64 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.294 -1.002 . . . . 74.140000000000001 108.294 173.817 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 4.0 t60 52.06 64.55 1.8 Allowed 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.168 1.387 . . . . 74.030000000000001 108.783 -174.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 3.7 mmpt? -92.32 147.34 22.99 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 124.352 1.061 . . . . 74.510000000000005 108.578 171.717 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 27.9 tttp -84.35 55.41 3.35 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 127.181 2.192 . . . . 54.439999999999998 110.14 -178.144 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 95.7 mt -75.89 34.16 0.12 Allowed 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 127.758 2.423 . . . . 74.430000000000007 111.599 -176.387 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -70.8 11.73 0.35 Allowed 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 127.001 2.12 . . . . 65.409999999999997 114.373 -165.486 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -147.98 161.39 34.91 Favored Pre-proline 0 N--CA 1.47 0.57 0 C-N-CA 126.551 1.94 . . . . 63.420000000000002 111.091 179.344 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -56.76 -48.34 19.11 Favored 'Trans proline' 0 CA--C 1.51 -0.681 0 C-N-CA 123.738 2.958 . . . . 75.310000000000002 111.981 177.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -60.04 -34.3 73.2 Favored 'General case' 0 N--CA 1.44 -0.97 0 C-N-CA 125.484 1.513 . . . . 70.450000000000003 111.336 -175.303 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -71.4 -48.23 51.13 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 126.059 1.744 . . . . 74.099999999999994 109.592 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 71.1 mtm -59.82 -49.77 76.42 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 123.814 0.846 . . . . 64.239999999999995 109.558 175.891 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -62.4 -43.88 97.76 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 125.409 1.484 . . . . 64.140000000000001 111.135 -177.012 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -53.01 -41.97 65.16 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 123.792 0.837 . . . . 71.319999999999993 111.303 177.295 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' PHE . . . . . 0.401 ' CZ ' ' HB1' ' A' ' 97' ' ' ALA . 93.6 t80 -76.43 -46.82 25.4 Favored 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 124.26 1.024 . . . . 63.310000000000002 109.551 -174.486 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 25.9 mt -65.38 -29.97 70.74 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.514 1.126 . . . . 74.299999999999997 110.252 -178.354 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -53.98 -31.58 51.28 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.806 0.842 . . . . 53.219999999999999 111.361 178.584 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -94.77 12.42 68.65 Favored Glycine 0 CA--C 1.527 0.785 0 CA-C-O 117.406 -1.774 . . . . 62.200000000000003 113.907 176.744 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 7.8 mmtm -132.46 11.33 4.48 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 120.097 1.949 . . . . 72.319999999999993 111.835 -173.229 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 97.77 42.09 3.19 Favored Glycine 0 N--CA 1.463 0.475 0 CA-C-N 119.769 1.168 . . . . 43.310000000000002 111.863 177.578 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 46.8 t -136.85 158.82 37.11 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 C-N-CA 127.101 2.16 . . . . 71.209999999999994 105.474 172.641 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -116.27 126.94 54.26 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 108.856 -0.794 . . . . 65.319999999999993 108.856 174.006 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 1.7 mtpm? -56.13 -37.0 68.87 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 123.169 0.588 . . . . 72.019999999999996 110.393 171.883 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -64.11 -14.92 58.16 Favored 'General case' 0 C--O 1.226 -0.165 0 C-N-CA 124.931 1.292 . . . . 62.100000000000001 111.992 -178.905 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 14.6 mmtp -114.66 -33.46 5.51 Favored 'General case' 0 C--O 1.225 -0.196 0 C-N-CA 124.367 1.067 . . . . 75.540000000000006 111.837 178.438 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 12.8 t80 -54.82 -61.39 2.34 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 123.632 0.773 . . . . 71.010000000000005 109.353 175.306 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 32.3 mt -73.88 -37.12 64.81 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 121.663 0.744 . . . . 72.239999999999995 110.798 -161.522 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 18.8 p -66.92 -21.35 65.99 Favored 'General case' 0 N--CA 1.442 -0.856 0 C-N-CA 125.204 1.401 . . . . 75.420000000000002 111.757 179.57 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 34.0 m -97.98 -31.74 12.01 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.181 0.992 . . . . 73.430000000000007 109.867 174.846 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 45.4 t80 -57.83 -56.33 23.33 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 124.624 1.17 . . . . 75.120000000000005 110.219 177.008 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 -89.47 56.89 3.75 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 108.002 -1.11 . . . . 71.0 108.002 173.871 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -134.96 160.24 38.94 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 124.061 0.944 . . . . 74.049999999999997 110.424 172.336 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -55.28 -28.09 51.04 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.68 1.592 . . . . 72.129999999999995 112.654 -179.114 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -45.32 -67.13 0.31 Allowed 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 125.691 1.597 . . . . 73.409999999999997 108.728 171.535 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 24.7 mm -61.28 -40.24 85.36 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 CA-C-O 117.524 -1.227 . . . . 73.019999999999996 111.295 -178.288 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 18.4 mtpp -54.74 -38.34 67.02 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 120.537 1.517 . . . . 75.230000000000004 110.137 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -78.22 -43.57 13.04 Favored Glycine 0 N--CA 1.442 -0.94 0 N-CA-C 110.589 -1.005 . . . . 63.32 110.589 -177.137 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 9.2 mt-30 -62.12 -39.57 92.98 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 123.15 0.58 . . . . 70.450000000000003 109.688 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 1.7 mtp -56.42 -57.59 11.63 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 124.673 1.189 . . . . 51.520000000000003 109.28 173.594 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -70.82 -31.2 67.85 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 118.898 -1.121 . . . . 73.219999999999999 112.227 -168.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 4.5 mttt -63.2 -59.18 5.09 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 123.88 0.872 . . . . 71.230000000000004 110.814 170.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -58.13 -35.58 71.7 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 119.459 1.027 . . . . 75.349999999999994 110.807 179.683 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 10.0 tmtt? -61.11 -53.2 60.08 Favored 'General case' 0 N--CA 1.456 -0.139 0 O-C-N 120.437 -1.415 . . . . 73.420000000000002 110.557 177.798 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.02 -25.11 64.33 Favored 'General case' 0 C--O 1.221 -0.396 0 CA-C-N 120.096 1.316 . . . . 74.209999999999994 111.874 176.756 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.427 HD23 ' HA ' ' A' ' 144' ' ' LEU . 30.0 mt -70.68 -59.27 2.92 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 119.57 1.077 . . . . 72.510000000000005 110.991 -178.759 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -55.42 -44.68 76.49 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 118.412 0.551 . . . . 74.030000000000001 111.176 -170.642 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 4.1 ppp? -64.49 -41.75 96.27 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 113.574 0.953 . . . . 74.239999999999995 113.574 176.394 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -64.62 -29.81 70.82 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 116.374 -1.774 . . . . 64.129999999999995 110.869 -178.375 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -80.0 11.77 3.17 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 127.787 2.435 . . . . 73.109999999999999 113.369 176.688 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 21.4 mt-30 59.67 18.63 7.34 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 127.51 2.324 . . . . 75.219999999999999 115.039 -177.332 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 40.2 t -73.43 141.45 16.27 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 O-C-N 121.12 -0.988 . . . . 60.5 108.919 -179.461 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -135.91 3.26 2.93 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.032 0.933 . . . . 64.109999999999999 113.078 -177.557 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -174.33 -173.93 40.72 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 108.711 -1.756 . . . . 52.310000000000002 108.711 -179.164 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.611 HG21 ' CB ' ' A' ' 34' ' ' TRP . 6.4 m -139.41 154.16 71.45 Favored Pre-proline 0 CA--C 1.535 0.398 0 C-N-CA 125.794 1.638 . . . . 74.540000000000006 109.349 176.597 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 154' ' ' PRO . . . . . 0.474 ' HG3' HD12 ' A' ' 166' ' ' ILE . 35.7 Cg_endo -65.03 160.04 72.13 Favored 'Cis proline' 0 CA--C 1.533 0.431 0 C-N-CA 125.317 -0.701 . . . . 71.319999999999993 113.793 -2.269 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 17.7 m -157.81 141.66 15.75 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 124.816 1.246 . . . . 61.200000000000003 108.367 173.594 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 19.2 mmm -123.5 155.88 36.69 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 125.968 1.707 . . . . 74.299999999999997 108.512 167.341 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 6.1 t -135.26 153.77 34.5 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 N-CA-C 106.946 -1.502 . . . . 33.43 106.946 174.43 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 58.5 t -126.45 123.86 64.21 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 C-N-CA 126.439 1.896 . . . . 61.43 106.995 173.931 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 1.2 t30 54.56 16.7 1.41 Allowed 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 129.472 3.109 . . . . 72.209999999999994 115.898 166.697 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 74.37 28.43 63.83 Favored Glycine 0 CA--C 1.523 0.572 0 C-N-CA 128.866 3.127 . . . . 74.430000000000007 113.205 -176.131 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 33.5 mttt -139.33 -31.26 0.7 Allowed 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 114.848 1.425 . . . . 45.409999999999997 114.848 -166.268 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -125.13 138.51 54.16 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 107.91 -1.144 . . . . 72.0 107.91 177.861 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 71.0 ttt-85 -122.6 141.57 51.57 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 105.381 -2.081 . . . . 72.329999999999998 105.381 178.126 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 11.4 p90 -153.9 170.66 20.49 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 107.097 -1.446 . . . . 74.010000000000005 107.097 -179.243 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -173.97 -178.99 1.62 Allowed 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 123.822 0.849 . . . . 61.549999999999997 109.103 178.643 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.474 HD12 ' HG3' ' A' ' 154' ' ' PRO . 15.6 mt -52.0 -48.36 40.93 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 C-N-CA 126.245 1.818 . . . . 60.240000000000002 109.324 176.085 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -71.65 -34.36 63.02 Favored Glycine 0 CA--C 1.525 0.676 0 CA-C-O 118.744 -1.031 . . . . 70.120000000000005 113.009 179.302 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 3.5 m -65.21 -55.79 16.51 Favored 'General case' 0 C--O 1.227 -0.09 0 CA-C-N 119.649 1.724 . . . . 45.009999999999998 109.523 174.021 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -67.29 -49.53 63.86 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 124.507 1.123 . . . . 72.310000000000002 111.111 -171.03 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 124.43 5.13 7.32 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 125.069 1.319 . . . . 65.109999999999999 113.921 -176.633 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 162.04 173.63 30.94 Favored Glycine 0 CA--C 1.528 0.874 0 CA-C-N 118.839 1.319 . . . . 70.25 111.014 175.726 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -66.62 -47.66 2.73 Favored 'Trans proline' 0 CA--C 1.532 0.416 0 C-N-CA 122.785 2.323 . . . . 74.439999999999998 111.157 -175.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -54.01 -46.6 71.85 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.143 0.977 . . . . 74.230000000000004 110.16 172.528 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -65.33 -26.48 68.06 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.684 0.794 . . . . 70.519999999999996 110.403 -176.808 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 25.0 m -65.83 -40.82 92.16 Favored 'General case' 0 CA--C 1.533 0.3 0 O-C-N 120.663 -1.273 . . . . 70.450000000000003 109.524 178.908 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 37.7 mt -66.62 -29.72 69.82 Favored 'General case' 0 C--N 1.342 0.249 0 CA-C-N 119.507 1.049 . . . . 51.109999999999999 111.132 175.919 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.65 -47.78 66.86 Favored 'General case' 0 C--N 1.339 0.145 0 C-N-CA 124.093 0.957 . . . . 74.129999999999995 109.208 171.241 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.423 HD13 ' HA ' ' A' ' 178' ' ' LEU . 4.4 mm? -72.75 -42.1 64.41 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-O 118.33 -0.843 . . . . 74.040000000000006 110.845 178.713 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -53.18 -48.01 68.37 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 118.699 0.681 . . . . 72.409999999999997 111.788 -173.385 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -75.8 -34.53 60.18 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 123.01 0.524 . . . . 73.299999999999997 110.752 -172.13 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -66.2 -48.36 70.87 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 124.83 1.252 . . . . 63.009999999999998 111.087 174.206 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 68.7 mt -65.52 -32.69 74.42 Favored 'General case' 0 N--CA 1.457 -0.077 0 C-N-CA 124.312 1.045 . . . . 62.340000000000003 111.155 -177.248 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 29.0 mt -50.39 -57.85 2.15 Favored 'Isoleucine or valine' 0 C--N 1.34 0.179 0 CA-C-O 117.976 -1.011 . . . . 74.409999999999997 108.781 168.177 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -57.74 -37.04 72.89 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 119.813 1.188 . . . . 62.149999999999999 111.552 -176.87 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 22.6 tptt -56.54 -38.97 72.61 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.466 0.706 . . . . 75.109999999999999 111.469 -175.72 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 51.3 mm-40 -90.98 -42.88 10.3 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 123.741 0.816 . . . . 44.340000000000003 111.665 176.561 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.95 -37.65 77.25 Favored 'General case' 0 C--N 1.333 -0.128 0 O-C-N 120.76 -1.212 . . . . 72.140000000000001 110.175 -177.033 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -57.09 -27.34 61.67 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 124.834 1.253 . . . . 71.430000000000007 111.584 178.82 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -57.01 -24.52 54.26 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 123.261 0.624 . . . . 65.430000000000007 112.043 175.746 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -124.86 21.38 8.28 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 128.508 2.723 . . . . 63.219999999999999 111.886 -174.632 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 5.7 tttt -123.12 34.86 5.01 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 119.333 0.97 . . . . 65.349999999999994 112.44 -170.429 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . 0.264 7.3 pttm . . . . . 0 C--O 1.248 0.995 0 N-CA-C 105.877 -1.898 . . . . 75.120000000000005 105.877 168.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 . . . . . 0 N--CA 1.464 0.245 0 CA-C-O 121.732 0.777 . . . . 75.04 110.504 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -128.33 4.91 5.73 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 113.883 1.068 . . . . 74.15 113.883 -161.647 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 16.1 m-85 -140.95 161.86 36.83 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 125.332 1.453 . . . . 71.33 108.234 -170.165 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 24.6 m -133.73 141.94 47.74 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.123 0.569 . . . . 73.33 109.564 -177.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -70.37 152.96 43.53 Favored 'General case' 0 C--O 1.235 0.316 0 O-C-N 121.477 -0.764 . . . . 75.21 109.423 173.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 73.28 -41.35 0.92 Allowed Glycine 0 CA--C 1.531 1.049 0 C-N-CA 125.877 1.703 . . . . 45.03 111.626 -164.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 17.6 tptt -74.89 -85.16 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 126.631 1.972 . . . . 54.14 110.612 -174.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.7 mp0 -77.82 -25.03 48.58 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 125.343 1.457 . . . . 73.04 110.075 -174.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 41.2 p90 -161.17 178.01 9.69 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 123.885 0.874 . . . . 70.35 109.719 -173.121 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 79.2 t -132.47 109.28 14.58 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 C-N-CA 125.074 1.35 . . . . 74.11 108.179 -179.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.22 162.63 24.56 Favored 'General case' 0 C--O 1.235 0.317 0 O-C-N 120.815 -1.178 . . . . 70.21 108.24 158.327 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -140.88 118.34 11.49 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 124.049 0.94 . . . . 72.13 109.584 -172.069 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.2 m -71.11 7.9 1.11 Allowed 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.99 1.316 . . . . 64.54 113.025 -174.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 33.0 m -134.47 82.13 46.85 Favored Pre-proline 0 N--CA 1.449 -0.505 0 C-N-CA 125.592 1.557 . . . . 74.23 109.224 173.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -75.16 -174.85 2.11 Favored 'Trans proline' 0 CA--C 1.544 1.005 0 C-N-CA 124.966 3.778 . . . . 41.33 114.011 -174.005 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 10.8 t -141.92 143.27 27.82 Favored Pre-proline 0 CA--C 1.545 0.788 0 C-N-CA 125.872 1.669 . . . . 71.22 109.339 168.015 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -90.05 178.87 2.14 Favored 'Trans proline' 0 CA--C 1.543 0.956 1 C-N-CA 125.777 4.318 . . . . 71.21 113.068 170.025 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 4.6 m -112.85 -177.7 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 C-N-CA 126.085 1.754 . . . . 72.24 110.327 171.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 12.6 t -63.12 -38.29 90.57 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 125.941 1.696 . . . . 72.21 112.05 172.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -153.53 143.49 15.34 Favored Pre-proline 0 N--CA 1.45 -0.457 0 CA-C-O 117.532 -1.223 . . . . 72.03 107.72 -179.424 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -72.62 178.0 6.82 Favored 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 122.437 2.091 . . . . 71.21 111.118 173.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 133.46 -95.85 0.29 Allowed Glycine 0 C--N 1.332 0.318 0 N-CA-C 108.456 -1.858 . . . . 73.43 108.456 174.071 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.642 ' HE3' ' H ' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -70.28 137.73 50.97 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 107.461 -1.311 . . . . 73.34 107.461 176.592 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 33.6 mm -67.69 133.32 31.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 106.79 -1.559 . . . . 60.2 106.79 175.021 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -83.95 143.65 29.69 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.283 -0.636 . . . . 62.4 109.283 176.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 25.7 t -133.68 109.53 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.225 0 N-CA-C 106.381 -1.711 . . . . 63.44 106.381 171.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 58.6 t -96.56 115.06 34.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 N-CA-C 106.104 -1.813 . . . . 71.02 106.104 179.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -76.45 134.99 39.4 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 107.937 -1.134 . . . . 71.43 107.937 157.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.744 HD22 HG21 ' A' ' 150' ' ' VAL . 3.3 mp -125.95 123.23 38.09 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 125.661 1.584 . . . . 73.31 108.011 170.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 15.9 p90 -138.94 176.71 8.46 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.376 1.071 . . . . 64.34 110.816 -170.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 25.0 t90 -147.1 172.12 14.25 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.997 1.319 . . . . 75.51 107.857 177.054 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 19.7 t80 -56.01 -41.0 74.22 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 126.374 1.869 . . . . 45.12 113.129 173.115 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -92.99 -106.87 1.76 Allowed Glycine 0 N--CA 1.449 -0.483 0 N-CA-C 107.965 -2.054 . . . . 74.01 107.965 -168.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 21.1 p 44.22 72.34 1.23 Allowed Pre-proline 0 C--O 1.221 -0.419 0 C-N-CA 125.373 1.469 . . . . 65.12 112.03 175.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -58.93 -24.9 75.02 Favored 'Trans proline' 0 CA--C 1.539 0.739 0 CA-C-N 121.596 1.606 . . . . 71.53 113.419 -171.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 19.7 m170 -71.98 -33.03 67.82 Favored 'General case' 0 CA--C 1.549 0.926 0 CA-C-O 118.059 -0.972 . . . . 73.45 112.512 172.125 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 15.9 p -65.85 -38.33 88.57 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 120.746 1.612 . . . . 73.14 110.793 -179.166 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 34.8 t80 -64.56 -31.32 72.49 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 123.199 0.6 . . . . 72.25 111.657 176.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.9 -3.99 25.64 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 112.597 0.591 . . . . 71.42 112.597 174.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 26.1 t80 -117.45 -21.33 8.69 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 125.358 1.463 . . . . 74.22 111.982 -176.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -46.33 -63.52 1.29 Allowed Pre-proline 0 N--CA 1.474 0.762 0 CA-C-N 120.446 1.475 . . . . 73.43 112.432 178.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -71.93 -6.77 19.78 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 CA-C-N 121.856 1.698 . . . . 72.35 114.084 -175.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.0 m -78.95 -42.83 25.92 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.172 1.389 . . . . 71.23 108.535 169.379 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 20.2 tt -89.84 -36.48 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 O-C-N 121.5 -0.75 . . . . 73.21 112.035 -171.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 54.2 t -50.69 -54.24 38.12 Favored Pre-proline 0 CA--C 1.54 0.565 0 C-N-CA 124.787 1.235 . . . . 62.41 111.591 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -68.73 -36.34 14.3 Favored 'Trans proline' 0 N--CA 1.454 -0.852 0 CA-C-N 121.098 1.428 . . . . 55.45 111.416 178.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.505 ' CH2' ' HB1' ' A' ' 179' ' ' ALA . 79.2 t90 -54.75 -51.05 66.9 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 118.801 0.728 . . . . 72.31 109.486 177.326 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -63.16 -37.39 87.04 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 117.857 0.299 . . . . 61.45 111.292 -175.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -62.59 -48.69 78.31 Favored 'General case' 0 N--CA 1.453 -0.299 0 O-C-N 121.58 -0.7 . . . . 75.14 109.255 179.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.54 18.24 2.37 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.84 0.856 . . . . 64.01 113.087 -173.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 19.7 mt -65.02 156.34 80.88 Favored Pre-proline 0 N--CA 1.451 -0.381 0 C-N-CA 123.483 0.713 . . . . 62.31 110.355 174.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -76.06 177.13 9.14 Favored 'Trans proline' 0 N--CA 1.452 -0.917 0 C-N-CA 124.648 3.566 . . . . 71.14 111.164 177.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -67.32 -7.99 28.87 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.535 1.134 . . . . 54.3 113.371 -178.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -107.29 1.77 24.09 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 119.804 1.184 . . . . 71.42 112.369 -168.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 40.7 t -125.66 137.52 57.41 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 N-CA-C 107.835 -1.172 . . . . 74.4 107.835 -172.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 67.2 t60 -127.5 99.94 5.81 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 124.687 1.195 . . . . 72.13 109.227 -177.064 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 35.0 t80 -80.51 142.15 34.47 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 114.389 -1.278 . . . . 61.33 110.863 176.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 32.6 t -135.08 154.57 36.41 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 C-N-CA 126.573 1.949 . . . . 73.24 106.85 178.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 9.6 mtm180 -132.11 120.18 21.98 Favored 'General case' 0 CA--C 1.516 -0.341 0 C-N-CA 124.364 1.066 . . . . 62.3 108.479 175.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 28.9 mt -132.33 153.28 81.18 Favored Pre-proline 0 C--N 1.33 -0.279 0 O-C-N 121.903 -0.498 . . . . 75.51 110.614 -177.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -81.71 144.97 14.22 Favored 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 123.455 2.77 . . . . 73.32 112.149 -178.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -90.91 74.42 6.47 Favored 'General case' 0 CA--C 1.528 0.122 0 C-N-CA 124.221 1.008 . . . . 62.53 109.338 -171.104 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 15.7 mt -74.32 86.84 1.99 Allowed 'General case' 0 CA--C 1.543 0.683 0 O-C-N 121.226 -0.921 . . . . 64.14 110.96 -170.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -105.87 24.76 11.82 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.495 1.118 . . . . 70.43 112.414 -178.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 89.14 171.28 45.53 Favored Glycine 0 CA--C 1.528 0.854 0 N-CA-C 110.215 -1.154 . . . . 64.22 110.215 -175.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 46.5 -146.49 3.27 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 124.117 0.865 . . . . 73.24 113.249 177.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 6.7 tp -63.92 -18.57 22.77 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 C-N-CA 123.288 0.635 . . . . 72.54 112.544 -172.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 9.4 m95 -62.16 -44.36 96.79 Favored 'General case' 0 C--N 1.344 0.362 0 CA-C-N 119.537 1.062 . . . . 71.02 109.537 176.316 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 4.3 p30 -77.08 -39.44 49.74 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 117.858 -1.067 . . . . 71.23 111.884 178.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 56.1 t -55.83 -52.03 53.47 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-N 119.153 0.888 . . . . 72.22 109.811 -178.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 34.0 m170 -63.64 -31.94 73.26 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 118.691 -0.671 . . . . 65.23 112.808 -176.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -87.98 -12.08 66.59 Favored Glycine 0 C--N 1.335 0.515 0 CA-C-N 119.701 1.137 . . . . 33.04 111.706 -175.143 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -60.97 -43.77 98.31 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 123.662 0.785 . . . . 75.04 110.667 -173.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 3.7 ppp? -50.22 -32.96 17.9 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 125.318 1.447 . . . . 64.51 114.155 177.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -59.92 -49.52 77.37 Favored 'General case' 0 N--CA 1.458 -0.072 0 C-N-CA 125.181 1.392 . . . . 74.43 108.421 -175.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 29.2 mt -66.26 -36.54 83.27 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 124.486 1.114 . . . . 74.31 109.732 179.244 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.02 -46.86 82.6 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 120.006 1.275 . . . . 74.03 110.801 176.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.31 -50.79 64.22 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 125.878 1.671 . . . . 71.41 107.961 -175.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -62.12 -46.31 89.61 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.516 1.126 . . . . 73.22 111.52 174.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 7.1 t -53.3 -32.89 50.98 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 126.102 1.761 . . . . 65.41 113.941 -172.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . 0.456 ' HE3' HG13 ' A' ' 120' ' ' VAL . 8.1 ptp . . . . . 0 N--CA 1.467 0.416 0 N-CA-C 114.16 1.17 . . . . 70.42 114.16 179.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.342 0 N-CA-C 113.059 0.763 . . . . 60.44 113.059 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 66.9 t -51.61 -70.6 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 C-N-CA 128.369 2.668 . . . . 61.23 111.063 160.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -54.27 -43.07 70.7 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 125.948 1.699 . . . . 72.43 110.977 176.058 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -83.63 14.86 3.5 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 126.018 1.727 . . . . 73.15 110.846 -174.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -114.76 -19.85 10.87 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 126.081 1.752 . . . . 71.1 114.604 157.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 36.9 mt -80.5 -66.71 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 N-CA-C 108.373 -0.973 . . . . 73.32 108.373 175.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -78.45 -66.96 0.79 Allowed 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 114.038 1.125 . . . . 71.13 114.038 -163.14 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 29.8 mtpt -50.3 -53.19 30.47 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 125.36 1.464 . . . . 63.11 109.996 177.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 22.4 mm-40 -75.68 -28.11 58.54 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 125.609 1.563 . . . . 64.34 109.426 -168.067 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 22.3 t-160 64.86 26.57 12.89 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 126.217 1.807 . . . . 61.05 111.358 174.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 28.2 mmtp -70.61 140.23 51.59 Favored 'General case' 0 C--N 1.342 0.251 0 O-C-N 121.1 -1.0 . . . . 75.01 109.665 177.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 19.8 tttt -56.97 -51.03 70.84 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 125.277 1.431 . . . . 73.32 111.313 -171.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 50.2 mt 47.86 35.14 4.5 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.363 1.465 . . . . 74.33 112.496 173.082 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -94.11 -7.16 43.25 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 113.941 1.089 . . . . 55.24 113.941 -169.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 17.3 p -135.98 155.23 77.86 Favored Pre-proline 0 C--O 1.235 0.308 0 CA-C-N 119.242 0.928 . . . . 71.11 109.639 -177.15 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -63.14 -33.61 72.03 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 122.088 1.858 . . . . 72.01 111.843 -178.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -66.32 -23.88 66.44 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 118.467 0.576 . . . . 74.5 111.974 176.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -81.77 -44.79 16.53 Favored 'General case' 0 CA--C 1.528 0.111 0 C-N-CA 123.57 0.748 . . . . 73.33 109.851 175.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 44.4 mtt -66.11 -54.55 24.24 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 123.628 0.771 . . . . 61.53 109.162 -175.11 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.489 ' HB2' ' CD1' ' A' ' 125' ' ' PHE . . . -68.18 -29.91 68.89 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 119.073 -0.489 . . . . 55.15 111.518 -173.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -62.21 -48.61 79.25 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 123.524 0.73 . . . . 71.33 110.464 169.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 86.8 t80 -62.4 -42.52 99.49 Favored 'General case' 0 N--CA 1.447 -0.592 0 O-C-N 122.21 -0.306 . . . . 75.41 111.725 -179.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 35.3 mt -80.89 -11.59 59.56 Favored 'General case' 0 N--CA 1.451 -0.408 0 O-C-N 121.339 -0.851 . . . . 51.21 111.071 -172.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -54.51 -37.65 65.59 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 118.082 0.401 . . . . 61.35 110.506 178.058 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -84.53 8.97 66.25 Favored Glycine 0 CA--C 1.528 0.857 0 C-N-CA 124.928 1.251 . . . . 53.25 114.818 175.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 52.4 mmtt -133.74 45.01 2.7 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-N 119.485 1.643 . . . . 65.13 110.256 -169.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 63.25 22.84 65.72 Favored Glycine 0 CA--C 1.53 1.022 0 CA-C-O 118.6 -1.111 . . . . 62.24 113.503 170.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.456 HG13 ' HE3' ' A' ' 84' ' ' MET . 41.9 t -114.17 151.89 15.91 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 C-N-CA 127.528 2.331 . . . . 75.41 106.335 173.368 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -115.67 140.56 49.08 Favored 'General case' 0 C--O 1.235 0.33 0 O-C-N 121.963 -0.461 . . . . 74.43 110.322 172.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 10.8 mttt -62.69 -39.97 95.67 Favored 'General case' 0 CA--C 1.527 0.061 0 CA-C-O 118.42 -0.8 . . . . 63.11 110.519 178.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 59.2 mt-10 -50.99 -52.39 43.25 Favored 'General case' 0 N--CA 1.457 -0.124 0 CA-C-N 118.888 0.767 . . . . 64.12 109.954 176.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 88.1 mttt -79.53 -42.14 25.8 Favored 'General case' 0 CA--C 1.515 -0.399 0 N-CA-C 107.075 -1.454 . . . . 61.54 107.075 -166.27 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.489 ' CD1' ' HB2' ' A' ' 112' ' ' ALA . 62.4 t80 -55.78 -60.32 3.62 Favored 'General case' 0 N--CA 1.443 -0.821 0 C-N-CA 123.798 0.839 . . . . 72.01 109.357 179.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 47.8 mt -67.2 -37.81 84.28 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-O 118.953 -0.546 . . . . 73.03 110.799 -172.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 2.9 t -64.73 -41.77 95.7 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 119.42 1.009 . . . . 72.53 110.127 -176.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 3.4 t -80.23 -31.77 38.53 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 118.839 0.745 . . . . 71.01 111.069 -179.011 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 91.0 t80 -53.45 -52.93 57.87 Favored 'General case' 0 C--O 1.234 0.268 0 O-C-N 121.294 -0.879 . . . . 63.5 109.369 170.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -86.58 56.5 4.03 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 125.205 1.402 . . . . 74.44 109.033 176.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 14.9 t -136.26 168.5 19.29 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 124.037 0.935 . . . . 74.25 110.549 176.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -69.34 -27.16 65.11 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.249 0.62 . . . . 65.11 110.053 167.288 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -51.73 -53.73 36.14 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 124.209 1.003 . . . . 71.21 111.005 -178.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.4 HD13 ' HA ' ' A' ' 134' ' ' ILE . 14.3 mm -65.17 -36.56 78.05 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 CA-C-O 118.763 -0.637 . . . . 74.35 110.853 177.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 22.4 mttt -57.88 -38.3 75.52 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 119.511 1.05 . . . . 75.42 110.369 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -72.2 -17.73 77.57 Favored Glycine 0 CA--C 1.528 0.86 0 N-CA-C 111.842 -0.503 . . . . 72.4 111.842 -177.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 6.9 mt-30 -88.98 -42.77 11.58 Favored 'General case' 0 N--CA 1.453 -0.276 0 O-C-N 121.542 -0.975 . . . . 61.41 110.514 174.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 91.7 mmm -58.37 -52.58 65.01 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 108.636 -0.876 . . . . 74.2 108.636 -178.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -65.85 -30.46 71.08 Favored 'General case' 0 CA--C 1.535 0.365 0 CA-C-N 119.112 0.869 . . . . 71.13 112.509 -172.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 13.5 mmtt -63.3 -68.54 0.33 Allowed 'General case' 0 C--O 1.227 -0.083 0 C-N-CA 126.081 1.752 . . . . 73.32 109.606 171.074 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -54.73 -36.27 64.59 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 119.218 0.917 . . . . 62.23 111.208 -174.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -54.57 -66.14 0.45 Allowed 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 126.374 1.87 . . . . 70.21 110.949 172.176 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.69 -31.51 72.23 Favored 'General case' 0 N--CA 1.466 0.33 0 O-C-N 121.433 -0.792 . . . . 64.22 111.142 -174.233 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 49.2 mt -60.11 -54.29 47.67 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 123.968 0.907 . . . . 65.21 109.778 178.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -54.13 -42.14 69.17 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 118.842 0.746 . . . . 74.22 111.341 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -64.25 -43.51 94.68 Favored 'General case' 0 C--O 1.235 0.336 0 O-C-N 121.499 -0.751 . . . . 73.24 111.229 178.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -63.35 -40.17 96.55 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 123.72 0.808 . . . . 73.43 110.383 -179.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 52.8 m-85 -72.78 11.92 0.59 Allowed 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 114.181 1.178 . . . . 74.23 114.181 -178.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 55.59 27.81 11.0 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.295 1.438 . . . . 75.15 113.347 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.744 HG21 HD22 ' A' ' 32' ' ' LEU . 40.8 t -64.02 -47.78 88.89 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 C-N-CA 124.995 1.318 . . . . 74.51 112.791 -168.317 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 82.0 p 55.0 -54.51 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 128.713 2.805 . . . . 74.43 114.82 -166.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -146.94 -166.76 12.55 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 127.161 2.315 . . . . 45.44 110.506 -173.28 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 29.1 m -143.83 155.12 59.54 Favored Pre-proline 0 C--O 1.239 0.551 0 C-N-CA 125.47 1.508 . . . . 73.31 108.779 -172.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -68.81 145.38 77.12 Favored 'Cis proline' 0 C--N 1.345 0.359 0 C-N-CA 125.055 -0.81 . . . . 74.02 113.918 0.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 37.8 m -149.43 127.94 12.31 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 125.431 1.493 . . . . 51.33 107.533 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 20.2 mmm -115.26 148.46 39.13 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 125.561 1.544 . . . . 74.23 107.916 172.126 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 49.9 t -138.96 115.38 10.09 Favored 'Isoleucine or valine' 0 C--O 1.238 0.482 0 N-CA-C 109.571 -0.529 . . . . 75.04 109.571 -177.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.569 HG23 ' CE1' ' A' ' 164' ' ' PHE . 95.2 t -84.48 127.23 40.03 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 N-CA-C 107.764 -1.198 . . . . 72.22 107.764 170.477 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 6.1 t30 49.34 26.15 1.5 Allowed 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 130.128 3.371 . . . . 65.52 115.243 165.306 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 56.8 28.77 57.71 Favored Glycine 0 CA--C 1.527 0.825 0 C-N-CA 126.311 1.91 . . . . 34.44 114.172 -172.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 6.1 mtpt -131.72 -22.33 2.4 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 120.08 1.94 . . . . 73.11 112.916 -179.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -128.08 126.75 41.81 Favored 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 107.954 -1.128 . . . . 75.44 107.954 179.125 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 9.2 ttp85 -109.27 134.29 51.96 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 127.187 2.195 . . . . 70.1 105.643 176.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . 0.569 ' CE1' HG23 ' A' ' 158' ' ' VAL . 11.8 p90 -152.26 167.55 28.25 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.675 -0.861 . . . . 74.33 108.675 -178.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -175.9 177.8 1.59 Allowed 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.655 1.182 . . . . 72.34 109.903 -179.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 10.8 mt -47.1 -47.7 8.72 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.131 0 C-N-CA 127.145 2.178 . . . . 55.31 109.394 176.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -80.86 -8.89 86.97 Favored Glycine 0 N--CA 1.448 -0.556 0 CA-C-O 118.092 -1.393 . . . . 52.45 113.715 -177.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 1.2 m -82.94 -65.79 0.97 Allowed 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 119.743 1.771 . . . . 63.43 107.504 164.032 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -59.51 -54.85 41.8 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 124.388 1.075 . . . . 65.25 109.774 -168.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 140.58 -8.45 2.84 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 124.764 1.173 . . . . 72.01 114.106 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 171.38 167.08 31.13 Favored Glycine 0 CA--C 1.526 0.73 0 CA-C-N 119.598 1.699 . . . . 63.41 109.401 -174.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_endo -64.5 -45.36 9.28 Favored 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 122.902 2.401 . . . . 72.12 111.518 -173.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -65.12 -25.55 67.81 Favored 'General case' 0 CA--C 1.537 0.445 0 O-C-N 121.32 -0.862 . . . . 63.41 111.536 174.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -77.07 -28.28 54.6 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.745 0.818 . . . . 72.01 111.021 177.147 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 93.4 m -60.12 -45.51 92.75 Favored 'General case' 0 N--CA 1.464 0.235 0 O-C-N 120.581 -1.324 . . . . 51.1 109.854 178.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 52.5 mt -62.09 -31.83 72.31 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 118.028 0.376 . . . . 73.23 110.622 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 14.2 ttpt -55.8 -40.16 72.31 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 124.131 0.973 . . . . 71.51 110.07 174.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -75.05 -44.82 45.47 Favored 'General case' 0 CA--C 1.509 -0.614 0 CA-C-O 117.876 -1.059 . . . . 73.3 111.196 173.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.505 ' HB1' ' CH2' ' A' ' 50' ' ' TRP . . . -51.66 -47.45 63.8 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 119.048 0.84 . . . . 62.42 111.75 -172.019 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -68.91 -47.48 65.71 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.209 1.004 . . . . 72.02 110.524 -175.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -55.17 -49.35 72.08 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 125.301 1.441 . . . . 73.41 111.164 175.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 77.5 mt -66.11 -34.78 78.83 Favored 'General case' 0 C--O 1.232 0.14 0 C-N-CA 124.617 1.167 . . . . 71.4 111.583 -178.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 28.8 mt -60.5 -54.52 33.95 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.143 0 N-CA-C 107.845 -1.169 . . . . 64.44 107.845 173.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -53.36 -42.33 66.72 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 119.271 0.941 . . . . 73.33 111.042 -179.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 42.9 tptt -59.96 -37.0 78.32 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 126.296 1.838 . . . . 53.31 111.881 -177.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 34.7 mm-40 -90.44 -31.34 16.85 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.562 1.145 . . . . 75.21 111.784 177.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . 0.567 ' HA ' ' HE ' ' A' ' 187' ' ' ARG . 1.4 tpm_? -61.18 -37.96 84.81 Favored 'General case' 0 CA--C 1.514 -0.419 0 O-C-N 120.439 -1.413 . . . . 74.42 110.071 178.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.273 0 C-N-CA 127.856 2.462 . . . . 61.4 110.975 173.477 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 . . . . . 0 N--CA 1.456 -0.153 0 CA-C-O 122.606 1.193 . . . . 75.31 111.234 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -131.66 6.86 4.41 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.455 1.102 . . . . 73.21 111.866 -177.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 34.0 m-85 -130.35 160.62 33.42 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 124.104 0.962 . . . . 44.54 110.006 -169.104 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 59.7 m -137.07 133.27 35.22 Favored 'General case' 0 C--O 1.239 0.541 0 N-CA-C 107.04 -1.467 . . . . 75.24 107.04 179.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.26 146.62 54.71 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 109.101 -0.703 . . . . 74.32 109.101 174.003 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 79.92 -35.13 2.11 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 126.332 1.92 . . . . 51.33 112.081 -170.023 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 21.4 tptt -77.54 -63.92 1.27 Allowed 'General case' 0 CA--C 1.518 -0.279 0 C-N-CA 124.687 1.195 . . . . 74.24 110.456 -176.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -98.16 -26.15 14.66 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 125.002 1.321 . . . . 41.12 109.362 -171.171 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 45.0 p90 -157.96 174.96 14.46 Favored 'General case' 0 N--CA 1.468 0.429 0 O-C-N 121.55 -0.719 . . . . 72.53 110.625 -172.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 48.7 t -132.72 106.9 11.25 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 N-CA-C 107.548 -1.279 . . . . 65.32 107.548 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 13.4 tt0 -64.81 147.94 52.24 Favored 'General case' 0 N--CA 1.445 -0.693 0 O-C-N 120.111 -1.618 . . . . 71.34 109.209 165.419 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -110.55 103.96 12.62 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.252 -1.34 . . . . 75.13 110.005 -178.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 79.6 p -65.0 5.85 0.3 Allowed 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 114.521 1.304 . . . . 41.51 114.521 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 8.8 t -128.37 85.28 60.85 Favored Pre-proline 0 N--CA 1.449 -0.479 0 N-CA-C 105.975 -1.861 . . . . 61.22 105.975 159.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -72.34 178.91 5.55 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 123.608 2.872 . . . . 62.42 111.097 -176.157 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 10.9 t -142.99 137.47 14.95 Favored Pre-proline 0 CA--C 1.539 0.521 0 C-N-CA 124.029 0.932 . . . . 64.21 109.186 -176.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -79.37 -178.52 4.66 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 C-N-CA 124.53 3.487 . . . . 75.22 111.703 175.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 29.6 m -132.29 166.23 29.77 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 125.798 1.639 . . . . 74.15 109.009 168.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 5.2 m -44.92 -49.66 10.91 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 127.138 2.175 . . . . 62.33 113.304 178.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 36.4 tt0 -145.62 144.38 22.45 Favored Pre-proline 0 CA--C 1.539 0.521 0 C-N-CA 124.588 1.155 . . . . 72.44 108.766 176.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -70.55 -167.49 0.26 Allowed 'Trans proline' 0 CA--C 1.544 0.976 0 C-N-CA 123.452 2.768 . . . . 65.53 110.455 164.142 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 120.26 -65.35 0.44 Allowed Glycine 0 C--N 1.333 0.395 0 N-CA-C 109.007 -1.637 . . . . 64.12 109.007 177.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -103.55 146.7 28.16 Favored 'General case' 0 C--O 1.232 0.132 0 C-N-CA 125.352 1.461 . . . . 53.43 108.899 170.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 49.5 mm -68.69 139.68 20.18 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 N-CA-C 106.247 -1.76 . . . . 64.43 106.247 173.266 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -94.81 104.14 16.04 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 106.913 -1.514 . . . . 51.01 106.913 175.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 55.2 t -102.99 128.53 55.82 Favored 'Isoleucine or valine' 0 C--O 1.231 0.089 0 N-CA-C 106.482 -1.673 . . . . 60.53 106.482 173.118 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 17.6 t -133.73 118.99 31.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 N-CA-C 107.717 -1.216 . . . . 61.22 107.717 -173.434 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -87.86 144.77 26.41 Favored 'General case' 0 C--O 1.238 0.478 0 N-CA-C 107.737 -1.208 . . . . 74.32 107.737 160.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.9 mp -124.34 125.06 43.71 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 125.042 1.337 . . . . 73.54 108.235 174.386 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -115.11 175.95 5.28 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.564 0.746 . . . . 72.34 112.717 -169.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . 0.501 ' CB ' HG21 ' A' ' 153' ' ' VAL . 25.3 t90 -148.29 -178.54 6.36 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 126.526 1.93 . . . . 73.22 108.235 168.279 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.419 ' CG ' HG21 ' A' ' 98' ' ' ILE . 4.0 m-30 -104.86 4.3 31.92 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 126.912 2.085 . . . . 64.53 112.377 179.403 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -129.6 18.74 5.39 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 124.689 1.137 . . . . 63.22 111.242 -178.265 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.553 ' HB3' HG23 ' A' ' 153' ' ' VAL . 21.9 p -105.03 85.59 1.3 Allowed Pre-proline 0 N--CA 1.449 -0.511 0 C-N-CA 125.11 1.364 . . . . 72.54 108.587 -177.146 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -59.82 -24.93 77.76 Favored 'Trans proline' 0 CA--C 1.535 0.558 0 CA-C-N 120.833 1.333 . . . . 60.25 112.291 -175.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 14.1 m170 -74.57 -15.31 60.85 Favored 'General case' 0 CA--C 1.538 0.489 0 O-C-N 121.233 -0.917 . . . . 74.14 112.403 178.039 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 71.5 m -62.25 -43.61 98.43 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 119.356 0.98 . . . . 33.11 108.815 167.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -57.28 -44.84 84.38 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 125.125 1.37 . . . . 74.13 111.013 175.292 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.37 -10.49 11.46 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 114.005 1.113 . . . . 62.32 114.005 -179.269 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.437 ' HB2' HD11 ' A' ' 166' ' ' ILE . 6.2 t80 -119.51 -25.54 5.99 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-O 117.221 -1.371 . . . . 73.33 112.537 -169.096 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -37.86 -67.5 0.25 Allowed Pre-proline 0 N--CA 1.472 0.659 0 C-N-CA 125.902 1.681 . . . . 74.11 113.378 179.078 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -70.84 -5.48 16.99 Favored 'Trans proline' 0 CA--C 1.537 0.639 0 CA-C-N 121.249 1.482 . . . . 74.13 114.067 -173.017 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.9 m -103.75 4.47 35.27 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 128.501 2.72 . . . . 72.31 110.647 177.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 16.8 tt -131.32 -30.52 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-N 120.406 1.457 . . . . 71.53 111.74 171.271 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 18.3 t -45.69 -64.87 0.77 Allowed Pre-proline 0 CA--C 1.537 0.464 0 C-N-CA 125.096 1.358 . . . . 74.33 110.168 173.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -69.33 -28.86 26.82 Favored 'Trans proline' 0 N--CA 1.451 -0.972 0 CA-C-N 120.791 1.318 . . . . 73.13 111.029 -172.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.489 ' CH2' ' HB1' ' A' ' 179' ' ' ALA . 70.7 t90 -59.2 -53.29 60.0 Favored 'General case' 0 C--N 1.341 0.198 0 CA-C-N 119.093 0.861 . . . . 74.11 109.581 174.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 90.6 p -58.77 -39.75 81.95 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 122.244 0.218 . . . . 61.12 111.07 -176.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -70.93 -12.94 61.83 Favored 'General case' 0 CA--C 1.54 0.587 0 O-C-N 121.154 -0.966 . . . . 73.25 112.874 178.153 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 68.4 mmtt -103.76 -2.03 27.05 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 125.771 1.628 . . . . 60.32 114.154 175.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 18.4 mt -54.93 147.68 31.74 Favored Pre-proline 0 N--CA 1.452 -0.327 0 CA-C-N 119.714 1.143 . . . . 42.35 110.997 -178.394 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -74.46 164.89 32.95 Favored 'Trans proline' 0 N--CA 1.439 -1.696 0 C-N-CA 123.346 2.698 . . . . 54.03 109.82 -176.161 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -65.43 1.02 1.26 Allowed 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.03 1.332 . . . . 64.33 114.009 178.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -98.73 0.09 43.83 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 127.965 2.506 . . . . 54.54 112.107 -179.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 57.5 t -131.81 157.09 43.08 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 C-N-CA 124.518 1.127 . . . . 75.52 108.569 -169.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 78.9 t60 -132.64 138.89 47.51 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 107.499 -1.297 . . . . 72.21 107.499 162.061 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 73.4 t80 -106.0 144.13 33.15 Favored 'General case' 0 CA--C 1.519 -0.224 0 N-CA-C 107.915 -1.143 . . . . 65.34 107.915 179.095 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 48.6 t -136.86 148.83 26.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 N-CA-C 108.239 -1.022 . . . . 73.12 108.239 178.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 23.1 mtt180 -115.47 128.08 55.77 Favored 'General case' 0 CA--C 1.513 -0.467 0 N-CA-C 105.867 -1.901 . . . . 73.25 105.867 165.409 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 23.5 mt -128.41 149.95 73.0 Favored Pre-proline 0 N--CA 1.467 0.391 0 CA-C-N 118.616 0.644 . . . . 73.25 111.173 170.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -78.29 129.62 9.62 Favored 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 122.482 2.122 . . . . 60.42 111.363 178.058 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -76.74 120.33 21.76 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.971 1.308 . . . . 62.32 110.179 174.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 47.7 mt -107.62 56.93 0.63 Allowed 'General case' 0 C--O 1.232 0.146 0 O-C-N 121.026 -1.046 . . . . 72.32 113.456 -167.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -77.33 53.26 1.01 Allowed 'General case' 0 CA--C 1.548 0.869 0 N-CA-C 113.456 0.91 . . . . 72.11 113.456 -176.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 80.29 -54.28 4.52 Favored Glycine 0 CA--C 1.53 1.02 0 C-N-CA 126.693 2.092 . . . . 61.43 114.486 155.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -82.52 -150.98 9.27 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 125.639 1.59 . . . . 62.21 110.377 172.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 9.7 tp -50.29 -19.88 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 C-N-CA 126.648 1.979 . . . . 72.22 113.604 -172.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 28.1 m95 -49.42 -52.93 25.53 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 125.484 1.513 . . . . 75.14 112.16 173.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 20.0 p30 -75.22 -29.58 60.31 Favored 'General case' 0 CA--C 1.522 -0.118 0 N-CA-C 112.288 0.477 . . . . 62.11 112.288 -178.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 81.5 t -61.32 -50.48 80.26 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.33 0 N-CA-C 107.809 -1.182 . . . . 73.55 107.809 174.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 60.8 m170 -70.44 14.63 0.12 Allowed 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 125.714 1.605 . . . . 72.22 113.004 173.122 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -129.58 -33.37 0.53 Allowed Glycine 0 CA--C 1.528 0.845 0 O-C-N 119.914 -1.741 . . . . 53.45 113.352 -173.086 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -64.71 -36.42 84.23 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 117.961 0.88 . . . . 63.13 111.073 -176.285 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -60.1 -45.04 94.28 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-O 116.37 -1.776 . . . . 71.22 112.126 179.644 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 25.9 t80 -52.22 -48.99 64.81 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 120.33 1.423 . . . . 54.51 109.935 -176.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 13.3 mt -67.04 -37.49 84.2 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 118.234 -0.889 . . . . 64.21 109.486 -178.03 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.3 m -63.74 -39.57 94.62 Favored 'General case' 0 C--N 1.342 0.253 0 CA-C-N 119.756 1.162 . . . . 72.22 111.407 174.169 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -60.4 -54.02 50.59 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 125.44 1.496 . . . . 65.53 107.035 -179.447 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -63.69 -31.41 72.57 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 112.592 0.59 . . . . 71.11 112.592 178.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.9 t -54.5 -19.15 5.25 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 118.003 -0.998 . . . . 71.33 112.288 171.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 9.1 mtp . . . . . 0 N--CA 1.453 -0.312 0 N-CA-C 115.33 1.604 . . . . 75.34 115.33 -174.818 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 0.351 0 N-CA-C 112.971 0.73 . . . . 54.41 112.971 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 70.2 t -54.58 -61.58 0.96 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.841 0 C-N-CA 123.925 0.89 . . . . 60.23 111.157 171.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -71.99 -35.23 69.41 Favored 'General case' 0 N--CA 1.473 0.693 0 O-C-N 119.966 -1.709 . . . . 75.53 111.785 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -67.73 -12.31 60.25 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.003 0.921 . . . . 72.41 111.46 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -84.46 -16.57 42.07 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.259 1.024 . . . . 73.11 111.547 173.092 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.616 HD13 HD12 ' A' ' 105' ' ' LEU . 10.0 mm -96.16 -37.14 7.04 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 C-N-CA 124.546 1.138 . . . . 72.32 110.243 -176.438 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 88.1 m-70 -103.74 -64.78 1.06 Allowed 'General case' 0 C--O 1.233 0.21 0 C-N-CA 122.838 0.455 . . . . 73.44 110.667 -169.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 21.3 mtpt -63.26 -15.94 58.72 Favored 'General case' 0 N--CA 1.464 0.27 0 O-C-N 121.876 -0.515 . . . . 64.42 111.309 177.247 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -123.83 -58.41 1.58 Allowed 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.565 1.146 . . . . 73.41 112.4 -173.015 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 2.4 t60 63.94 62.53 0.88 Allowed 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.749 1.62 . . . . 71.32 112.448 -176.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 7.8 mmmt -77.91 22.51 0.28 Allowed 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 127.628 2.371 . . . . 72.43 113.916 -178.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 18.0 ttpp 46.53 40.29 8.02 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 126.309 1.844 . . . . 62.11 111.669 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.616 HD12 HD13 ' A' ' 98' ' ' ILE . 40.3 mt -72.67 59.51 0.46 Allowed 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 129.61 3.164 . . . . 63.12 109.313 178.482 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -106.42 10.98 31.32 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 128.386 2.674 . . . . 42.25 111.429 -172.252 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -150.75 157.4 35.97 Favored Pre-proline 0 C--N 1.328 -0.335 0 C-N-CA 124.645 1.178 . . . . 74.41 109.497 -175.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -66.14 -42.43 10.8 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 121.905 1.737 . . . . 71.42 109.973 -175.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -55.98 -53.56 55.38 Favored 'General case' 0 N--CA 1.437 -1.098 0 C-N-CA 124.011 0.924 . . . . 71.34 111.86 173.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 24.0 tp10 -62.35 -41.19 98.39 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 118.206 0.457 . . . . 71.33 109.988 -175.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 38.5 mtt -60.65 -51.05 71.05 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 123.056 0.542 . . . . 63.52 110.335 175.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.432 ' HB1' ' HG3' ' A' ' 122' ' ' LYS . . . -61.71 -44.0 97.76 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 124.678 1.191 . . . . 62.34 110.329 -177.28 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -66.57 -4.93 9.66 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.624 1.57 . . . . 75.53 112.414 177.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -95.54 -54.76 3.26 Favored 'General case' 0 C--O 1.234 0.266 0 O-C-N 120.061 -1.649 . . . . 55.04 109.669 163.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 33.7 mt -65.37 -15.4 62.53 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 124.123 0.969 . . . . 62.22 112.066 -172.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -57.92 -16.81 13.35 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.078 0.951 . . . . 60.13 111.805 172.394 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -105.84 8.07 42.43 Favored Glycine 0 CA--C 1.531 1.043 0 C-N-CA 125.304 1.431 . . . . 60.53 114.43 171.013 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 30.1 mmtm -134.88 42.05 2.82 Favored 'General case' 0 C--O 1.225 -0.221 0 CA-C-N 119.751 1.776 . . . . 51.25 109.046 -172.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 70.49 42.09 64.85 Favored Glycine 0 C--N 1.336 0.541 0 N-CA-C 111.901 -0.48 . . . . 74.11 111.901 169.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 65.9 t -134.0 115.18 20.73 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 CA-C-O 122.601 1.191 . . . . 51.33 108.869 178.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 49.9 t0 -67.99 123.69 21.33 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 115.164 -0.926 . . . . 75.33 109.926 166.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.432 ' HG3' ' HB1' ' A' ' 112' ' ' ALA . 5.2 ttmt -62.51 -35.35 79.11 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 122.895 0.478 . . . . 75.15 110.233 175.088 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 61.7 mm-40 -64.76 -22.03 66.89 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 123.548 0.739 . . . . 71.43 111.69 179.135 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 67.9 mmtt -91.25 -53.28 4.42 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 107.937 -1.134 . . . . 75.41 107.937 176.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -47.39 -69.45 0.13 Allowed 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 126.348 1.859 . . . . 75.12 111.399 -175.381 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 15.5 mt -63.51 -41.45 98.51 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 118.655 0.661 . . . . 62.32 110.409 -167.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 35.3 t -59.87 -54.2 49.0 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 125.368 1.467 . . . . 74.14 109.549 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 30.2 m -64.57 -40.02 94.8 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.426 1.09 . . . . 62.24 109.72 -175.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -57.03 -47.48 80.81 Favored 'General case' 0 C--O 1.231 0.108 0 C-N-CA 124.293 1.037 . . . . 71.14 108.952 176.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -84.7 29.43 0.61 Allowed 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 126.685 1.994 . . . . 62.41 111.771 -177.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 3.2 t -115.14 165.92 12.39 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 124.573 1.149 . . . . 64.14 111.072 -171.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -59.77 -33.38 71.62 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.509 1.124 . . . . 65.41 110.769 170.294 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -52.84 -54.56 32.58 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 124.562 1.145 . . . . 71.11 111.258 -176.13 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 48.3 mm -74.92 -25.82 18.87 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 CA-C-O 119.226 -0.416 . . . . 73.21 110.393 -175.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 12.8 tttt -53.78 -41.42 67.2 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 124.386 1.074 . . . . 63.41 109.813 170.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -67.99 -22.33 74.0 Favored Glycine 0 CA--C 1.528 0.854 0 C-N-CA 124.205 0.907 . . . . 64.41 113.549 -178.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -88.85 -43.22 11.37 Favored 'General case' 0 N--CA 1.455 -0.182 0 O-C-N 121.421 -1.046 . . . . 72.34 109.357 174.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 4.2 mtp -57.38 -41.53 80.39 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 112.836 0.68 . . . . 72.42 112.836 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 22.9 pt-20 -60.28 -49.28 78.23 Favored 'General case' 0 C--O 1.233 0.205 0 O-C-N 121.95 -0.469 . . . . 73.35 111.171 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 76.1 mttt -60.64 -59.11 5.92 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 124.12 0.968 . . . . 61.24 108.603 178.285 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -53.13 -41.41 65.05 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 118.87 -0.586 . . . . 64.13 111.522 -174.121 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 26.8 ttmt -64.83 -59.9 3.68 Favored 'General case' 0 C--N 1.344 0.334 0 CA-C-N 119.015 0.825 . . . . 73.52 109.932 -179.365 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.39 -28.91 70.11 Favored 'General case' 0 C--N 1.343 0.308 0 CA-C-N 118.612 0.642 . . . . 61.52 110.746 -174.056 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 52.1 mt -68.52 -52.16 35.11 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-O 118.675 -0.679 . . . . 71.32 110.606 177.429 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -55.78 -50.42 70.51 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 118.97 0.804 . . . . 73.43 111.437 -175.093 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -59.13 -47.59 84.73 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 118.938 -0.554 . . . . 61.14 111.776 176.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -71.42 -21.25 62.01 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 119.303 0.956 . . . . 65.12 111.589 -174.292 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 21.5 m-85 -77.93 10.84 2.54 Favored 'General case' 0 CA--C 1.541 0.609 0 O-C-N 121.002 -1.061 . . . . 75.24 112.564 170.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 53.62 34.05 17.85 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 126.778 2.031 . . . . 72.42 112.534 -177.145 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 34.8 t -75.72 141.85 15.26 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 N-CA-C 107.415 -1.328 . . . . 42.04 107.415 174.184 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -135.69 -4.02 2.29 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 124.452 1.101 . . . . 61.52 112.621 170.619 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -160.48 177.54 36.86 Favored Glycine 0 N--CA 1.448 -0.501 0 N-CA-C 109.843 -1.303 . . . . 60.54 109.843 -176.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.553 HG23 ' HB3' ' A' ' 37' ' ' CYS . 23.7 m -145.26 149.22 40.69 Favored Pre-proline 0 C--O 1.238 0.487 0 C-N-CA 124.336 1.054 . . . . 65.44 108.974 -179.439 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . 0.425 ' C ' ' HA ' ' A' ' 153' ' ' VAL . 41.0 Cg_endo -67.64 153.87 86.52 Favored 'Cis proline' 0 C--O 1.237 0.447 0 C-N-CA 125.195 -0.752 . . . . 64.31 112.728 0.325 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 55.0 m -150.7 127.54 11.0 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 125.305 1.442 . . . . 71.32 107.367 177.357 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 91.1 mtp -105.42 157.85 17.06 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-O 122.171 0.986 . . . . 73.53 109.161 168.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 21.4 t -141.01 149.64 20.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 106.858 -1.534 . . . . 63.23 106.858 177.085 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 41.4 t -122.62 123.56 68.69 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 C-N-CA 125.958 1.703 . . . . 65.22 106.648 172.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 56.48 16.51 2.52 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 127.37 2.268 . . . . 63.32 114.782 167.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 60.81 33.89 84.86 Favored Glycine 0 CA--C 1.528 0.889 0 CA-C-O 118.205 -1.331 . . . . 52.05 113.867 -169.117 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 61.9 mttt -132.04 -33.31 1.35 Allowed 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 119.457 1.629 . . . . 72.54 113.262 -177.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -122.63 122.61 39.23 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 107.444 -1.317 . . . . 73.41 107.444 -178.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 35.9 ttp180 -103.33 137.73 41.06 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 104.805 -2.295 . . . . 71.43 104.805 170.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 21.1 p90 -152.65 162.24 41.51 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 107.075 -1.454 . . . . 73.25 107.075 176.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -171.08 176.55 3.96 Favored 'General case' 0 CA--C 1.514 -0.426 0 N-CA-C 109.235 -0.654 . . . . 60.52 109.235 -178.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.437 HD11 ' HB2' ' A' ' 43' ' ' PHE . 40.5 mt -47.78 -49.45 10.55 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 C-N-CA 126.881 2.072 . . . . 73.51 110.34 -177.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -84.51 0.14 89.28 Favored Glycine 0 CA--C 1.522 0.525 0 CA-C-O 118.788 -1.007 . . . . 41.22 113.767 -177.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 10.5 m -90.85 -66.27 0.94 Allowed 'General case' 0 N--CA 1.456 -0.157 0 CA-C-N 119.872 1.836 . . . . 73.15 107.179 161.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.6 ' HB1' HD23 ' A' ' 178' ' ' LEU . . . -70.13 -30.5 67.7 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-O 117.446 -1.264 . . . . 72.42 113.154 -161.276 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 129.86 22.09 1.18 Allowed Glycine 0 CA--C 1.538 1.51 0 N-CA-C 116.247 1.259 . . . . 62.41 116.247 171.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 113.12 164.28 15.89 Favored Glycine 0 CA--C 1.532 1.113 0 CA-C-N 120.028 1.914 . . . . 33.1 110.249 -176.36 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -63.23 -32.06 73.89 Favored 'Trans proline' 0 CA--C 1.536 0.622 0 CA-C-N 120.53 2.165 . . . . 43.33 113.816 -156.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 80.9 mt-10 -71.64 -29.94 65.2 Favored 'General case' 0 C--O 1.232 0.184 0 O-C-N 121.004 -1.06 . . . . 52.42 111.559 176.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -72.99 -24.79 60.81 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 122.773 0.429 . . . . 64.33 110.613 173.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 3.1 m -65.24 -45.57 84.08 Favored 'General case' 0 C--O 1.233 0.217 0 O-C-N 121.014 -1.054 . . . . 62.54 109.296 -175.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 39.8 mt -60.56 -33.42 72.67 Favored 'General case' 0 C--O 1.225 -0.213 0 CA-C-N 118.235 0.47 . . . . 54.21 111.206 175.214 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 10.3 tttt -58.05 -35.14 70.9 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-O 118.091 -0.956 . . . . 73.53 110.207 179.075 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.6 HD23 ' HB1' ' A' ' 169' ' ' ALA . 4.5 mm? -78.94 -44.89 21.6 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-N 119.359 0.982 . . . . 75.32 110.299 171.371 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.489 ' HB1' ' CH2' ' A' ' 50' ' ' TRP . . . -55.38 -31.49 61.85 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 118.604 0.638 . . . . 65.41 112.649 -175.652 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -90.61 -44.41 9.55 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 124.699 1.199 . . . . 42.43 109.41 -171.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 25.5 t80 -61.18 -49.21 78.12 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 121.382 0.611 . . . . 72.22 110.604 175.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 89.7 mt -63.07 -21.29 66.07 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 123.879 0.871 . . . . 71.24 112.491 -174.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 28.4 mt -57.36 -59.32 3.37 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.306 0 N-CA-C 107.395 -1.335 . . . . 72.14 107.395 168.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -56.52 -38.55 71.98 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 120.083 1.311 . . . . 73.42 111.618 -177.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 2.7 tmtt? -59.39 -39.82 84.6 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.249 0.619 . . . . 73.34 110.457 -178.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -89.05 -31.14 18.2 Favored 'General case' 0 CA--C 1.517 -0.301 0 O-C-N 121.424 -0.798 . . . . 71.35 112.75 177.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -60.55 -35.89 77.14 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.741 0.781 . . . . 74.25 111.039 -177.537 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.491 0 C-N-CA 123.719 0.808 . . . . 52.41 112.636 176.761 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.449 -0.478 0 N-CA-C 107.3 -1.37 . . . . 61.45 107.3 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 27.3 t0 -141.9 15.41 2.11 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 125.991 1.716 . . . . 71.32 110.023 -178.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 -155.34 153.22 30.17 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 126.581 1.953 . . . . 74.41 108.086 -173.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 74.7 m -128.25 144.59 51.14 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 121.337 0.589 . . . . 74.2 110.02 -172.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -70.1 144.42 52.1 Favored 'General case' 0 N--CA 1.456 -0.127 0 O-C-N 121.375 -0.828 . . . . 52.24 109.196 -179.056 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 67.44 -15.17 0.44 Allowed Glycine 0 CA--C 1.532 1.14 0 C-N-CA 126.05 1.786 . . . . 63.14 113.45 -167.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -94.54 -60.25 1.75 Allowed 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 125.218 1.407 . . . . 64.23 107.594 -171.104 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -106.57 -25.59 11.75 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 126.423 1.889 . . . . 75.01 110.18 -177.167 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 41.1 p90 -153.48 170.15 21.45 Favored 'General case' 0 C--N 1.332 -0.164 0 O-C-N 120.895 -1.128 . . . . 75.02 110.266 -171.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 26.8 t -128.93 103.42 9.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 107.158 -1.423 . . . . 54.24 107.158 -176.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -80.78 169.85 17.06 Favored 'General case' 0 C--O 1.237 0.446 0 O-C-N 119.243 -2.161 . . . . 54.43 109.672 174.705 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -127.59 110.88 13.14 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 107.543 -1.28 . . . . 75.22 107.543 -177.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -60.33 -14.27 17.51 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.824 1.649 . . . . 72.41 112.814 175.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 4.0 p -109.52 85.06 3.44 Favored Pre-proline 0 N--CA 1.451 -0.39 0 N-CA-C 107.618 -1.253 . . . . 74.35 107.618 166.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -67.52 179.35 2.6 Favored 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 122.479 2.119 . . . . 74.23 111.038 178.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 31.0 t -134.47 139.57 33.1 Favored Pre-proline 0 CA--C 1.536 0.425 0 N-CA-C 107.55 -1.278 . . . . 62.52 107.55 -178.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -75.58 177.25 8.92 Favored 'Trans proline' 0 CA--C 1.536 0.588 0 C-N-CA 122.937 2.425 . . . . 73.41 110.577 173.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 35.4 m -139.86 166.85 20.01 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 C-N-CA 123.426 0.69 . . . . 60.3 110.859 179.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 3.4 t -54.43 -60.1 3.8 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 126.26 1.824 . . . . 71.43 110.027 172.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 4.1 tp-100 -120.71 84.97 38.23 Favored Pre-proline 0 N--CA 1.454 -0.243 0 C-N-CA 125.335 1.454 . . . . 73.21 108.316 -163.155 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -67.75 -8.71 23.22 Favored 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 122.18 1.92 . . . . 75.3 112.183 177.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -61.21 -25.59 64.83 Favored Glycine 0 CA--C 1.53 1.022 0 O-C-N 120.848 -1.157 . . . . 65.23 112.118 168.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 56.2 mttm -125.66 150.87 47.24 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-N 119.391 1.595 . . . . 73.03 109.39 -179.157 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 51.2 mm -78.09 127.62 38.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 106.28 -1.748 . . . . 55.32 106.28 177.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -91.24 118.71 30.71 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 107.716 -1.216 . . . . 64.03 107.716 -174.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 42.1 t -120.42 115.94 48.67 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 N-CA-C 106.985 -1.487 . . . . 64.32 106.985 -178.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 16.8 t -124.48 103.59 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 N-CA-C 107.642 -1.244 . . . . 71.14 107.642 -163.299 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -67.67 135.83 53.4 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 125.48 1.512 . . . . 74.31 108.594 164.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.0 mp -119.85 125.61 48.94 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 124.741 1.216 . . . . 75.25 107.72 160.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -130.77 164.27 25.49 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.086 0.954 . . . . 65.23 111.222 -174.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 25.9 t90 -143.27 142.58 31.41 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.163 0.985 . . . . 74.42 109.975 177.257 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 5.7 m-30 -61.57 -25.5 67.36 Favored 'General case' 0 CA--C 1.533 0.309 0 O-C-N 121.757 -0.59 . . . . 74.41 111.505 175.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -91.57 19.9 44.87 Favored Glycine 0 CA--C 1.53 1.026 0 CA-C-O 118.53 -1.15 . . . . 73.44 113.255 -179.349 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 46.1 t -104.46 85.66 1.18 Allowed Pre-proline 0 CA--C 1.541 0.606 0 C-N-CA 125.281 1.432 . . . . 60.51 110.719 -173.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_endo -67.17 5.28 0.89 Allowed 'Trans proline' 0 CA--C 1.536 0.619 0 C-N-CA 124.672 3.581 . . . . 72.22 114.606 179.164 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 22.9 m170 -107.11 -20.02 13.43 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 126.27 1.828 . . . . 64.11 111.546 175.193 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 94.4 m -78.82 -34.55 45.15 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.602 0.761 . . . . 74.54 110.901 -175.238 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 14.1 t80 -55.91 -41.4 74.49 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 124.917 1.287 . . . . 72.1 110.575 178.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -45.39 -51.7 10.94 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 125.766 1.626 . . . . 64.42 110.859 179.302 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -84.39 -21.23 30.89 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 125.791 1.636 . . . . 75.23 112.695 -167.075 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 59.0 mm-40 -45.15 -62.59 1.58 Allowed Pre-proline 0 N--CA 1.469 0.505 0 CA-C-N 120.001 1.273 . . . . 61.54 112.562 -176.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -71.11 -5.13 16.3 Favored 'Trans proline' 0 CA--C 1.538 0.724 0 C-N-CA 121.839 1.693 . . . . 60.34 114.455 -178.032 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 74.7 m -87.74 -34.69 18.26 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 119.643 1.11 . . . . 75.3 109.561 168.22 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 19.2 tt -92.78 -29.05 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 CA-C-N 119.708 1.14 . . . . 63.12 112.189 -174.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 38.6 t -49.19 -62.92 1.94 Allowed Pre-proline 0 CA--C 1.536 0.437 0 CA-C-O 117.797 -1.097 . . . . 75.51 109.943 170.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -66.3 -25.38 49.6 Favored 'Trans proline' 0 N--CA 1.451 -0.973 0 CA-C-N 120.737 1.299 . . . . 75.14 112.591 -173.298 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.407 ' CZ2' HD21 ' A' ' 54' ' ' LEU . 58.4 t90 -65.88 -54.92 20.34 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 123.564 0.746 . . . . 61.53 110.406 173.345 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 88.8 p -57.61 -38.66 75.3 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.187 0.595 . . . . 63.31 112.24 -170.363 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 72.2 mt-10 -59.13 -36.84 75.9 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.796 1.238 . . . . 75.14 111.291 177.208 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 4.7 mmmm -92.51 2.82 56.46 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 125.35 1.46 . . . . 74.53 112.019 -167.094 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.407 HD21 ' CZ2' ' A' ' 50' ' ' TRP . 33.7 mt -62.06 155.98 61.01 Favored Pre-proline 0 C--O 1.239 0.502 0 C-N-CA 125.558 1.543 . . . . 71.23 112.122 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -81.4 171.57 13.5 Favored 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 125.143 3.895 . . . . 72.44 112.452 -177.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -69.12 -2.34 9.99 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 126.513 1.925 . . . . 73.51 115.28 -177.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -115.79 0.24 13.11 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.756 1.222 . . . . 74.22 111.939 -178.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 86.1 t -96.71 150.6 4.36 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 N-CA-C 107.751 -1.203 . . . . 73.01 107.751 168.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 33.8 t60 -129.94 99.6 5.16 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 124.983 1.313 . . . . 71.45 107.829 165.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 51.4 t80 -77.21 145.23 37.73 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 114.9 -1.046 . . . . 75.25 109.606 178.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 21.6 t -142.09 157.04 19.93 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 C-N-CA 125.998 1.719 . . . . 74.03 107.695 -177.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 57.7 mtt180 -130.56 131.74 45.19 Favored 'General case' 0 N--CA 1.462 0.144 0 N-CA-C 107.793 -1.188 . . . . 74.03 107.793 163.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 37.3 mt -133.63 157.35 78.17 Favored Pre-proline 0 N--CA 1.468 0.438 0 C-N-CA 124.532 1.133 . . . . 71.0 108.935 176.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -74.85 164.72 32.94 Favored 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 121.381 1.388 . . . . 74.2 111.289 177.608 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -111.45 112.6 24.46 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 125.777 1.631 . . . . 75.11 107.53 -177.03 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 26.8 mt -115.68 60.29 0.71 Allowed 'General case' 0 C--O 1.234 0.274 0 O-C-N 121.489 -0.757 . . . . 73.14 112.602 -161.093 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -65.53 -14.83 61.89 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 114.613 1.338 . . . . 72.02 114.613 -171.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 122.65 -37.78 2.73 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 125.329 1.442 . . . . 64.25 111.763 175.291 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -77.96 -157.77 10.03 Favored Glycine 0 CA--C 1.527 0.787 0 C-N-CA 124.383 0.992 . . . . 75.53 110.844 172.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 6.3 tp -45.11 -24.28 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 127.996 2.519 . . . . 74.11 113.396 179.288 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 37.6 m95 -44.19 -50.72 8.62 Favored 'General case' 0 N--CA 1.441 -0.899 0 C-N-CA 126.657 1.983 . . . . 73.12 111.277 172.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 26.4 p30 -77.71 -29.27 51.21 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 113.852 1.056 . . . . 73.03 113.852 -179.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 73.8 t -60.89 -50.0 82.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 108.757 -0.831 . . . . 72.31 108.757 174.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 55.9 m170 -72.29 -0.65 12.78 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.034 1.734 . . . . 73.24 112.538 171.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -100.51 -14.56 32.14 Favored Glycine 0 CA--C 1.525 0.661 0 CA-C-N 120.205 1.366 . . . . 72.14 112.309 -175.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -96.63 -27.13 14.94 Favored 'General case' 0 N--CA 1.45 -0.473 0 O-C-N 121.792 -0.828 . . . . 60.43 112.102 -159.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -65.11 -42.37 94.02 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-O 116.833 -1.556 . . . . 73.03 111.244 -177.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 7.7 t80 -52.21 -56.13 16.66 Favored 'General case' 0 C--N 1.34 0.194 0 CA-C-N 119.466 1.03 . . . . 74.24 109.01 -176.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 44.5 mt -64.89 -32.07 73.61 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 116.497 -1.716 . . . . 71.52 111.247 -177.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.688 ' CG2' HG23 ' A' ' 128' ' ' THR . 1.3 m -70.3 -38.18 74.93 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 120.77 1.623 . . . . 75.32 111.356 177.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.7 -54.25 47.56 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 124.395 1.078 . . . . 71.22 109.211 175.338 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -56.21 -37.69 70.0 Favored 'General case' 0 C--O 1.226 -0.154 0 C-N-CA 125.139 1.375 . . . . 73.33 110.485 177.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -50.95 -20.31 1.3 Allowed 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.538 1.535 . . . . 54.52 113.769 176.443 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 53.6 mtm . . . . . 0 N--CA 1.466 0.368 0 CA-C-N 120.422 1.465 . . . . 72.2 113.992 176.593 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.187 0 CA-C-O 118.761 -0.638 . . . . 74.21 111.152 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 4.1 t -57.43 -51.27 71.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 CA-C-N 119.551 1.068 . . . . 53.21 110.83 -179.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -65.18 -52.84 52.48 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 123.686 0.794 . . . . 75.21 109.256 175.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -58.02 -26.89 62.99 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.605 1.562 . . . . 73.21 110.978 -172.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.44 ' HA ' ' HB2' ' A' ' 101' ' ' GLU . . . -72.91 -16.03 61.57 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 125.822 1.649 . . . . 54.4 113.572 -179.383 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 19.4 mt -92.61 -43.1 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 N-CA-C 107.353 -1.351 . . . . 64.43 107.353 174.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 30.5 p80 -102.86 -64.11 1.1 Allowed 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 113.54 0.941 . . . . 71.33 113.54 -166.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 29.6 mtpt -68.14 -16.06 63.84 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 119.916 1.235 . . . . 65.43 111.783 176.13 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.44 ' HB2' ' HA ' ' A' ' 97' ' ' ALA . 20.9 mt-10 -99.48 -23.32 15.14 Favored 'General case' 0 C--N 1.331 -0.212 0 O-C-N 120.834 -1.166 . . . . 70.51 111.92 171.498 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 7.2 t60 57.4 84.6 0.09 Allowed 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.629 1.572 . . . . 72.2 112.497 172.202 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 8.3 mmtp -136.71 152.23 50.13 Favored 'General case' 0 CA--C 1.52 -0.193 0 C-N-CA 124.187 0.995 . . . . 65.02 111.193 -169.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 9.3 ttmm -71.18 -51.19 26.23 Favored 'General case' 0 C--O 1.224 -0.253 0 N-CA-C 109.261 -0.644 . . . . 73.54 109.261 -177.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 77.9 mt 50.54 32.17 6.39 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.893 1.277 . . . . 62.1 113.514 179.053 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -86.81 8.67 21.82 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 114.768 1.395 . . . . 73.22 114.768 -167.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -143.34 157.84 58.97 Favored Pre-proline 0 N--CA 1.471 0.605 0 O-C-N 120.846 -1.159 . . . . 53.41 109.392 -172.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -58.77 -42.68 50.79 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 121.905 1.736 . . . . 70.35 111.738 -177.151 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -63.05 -53.45 53.62 Favored 'General case' 0 N--CA 1.442 -0.86 0 O-C-N 124.342 1.026 . . . . 73.32 110.486 -178.25 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 44.3 tp10 -58.11 -33.61 69.31 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.362 0.665 . . . . 70.24 111.04 -172.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 69.1 mtm -72.68 -56.86 4.66 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 118.149 -0.929 . . . . 72.32 111.595 169.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -59.63 -49.87 76.06 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 124.764 1.226 . . . . 72.31 112.529 -171.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -68.08 -36.7 80.25 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 124.62 1.168 . . . . 73.3 111.591 -170.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . 0.465 ' CZ ' ' HE3' ' A' ' 118' ' ' LYS . 84.8 t80 -58.06 -38.93 77.27 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.229 0.612 . . . . 70.22 110.878 171.416 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 14.0 mt -77.66 -19.18 55.84 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 123.924 0.89 . . . . 72.12 110.278 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.4 -20.06 58.26 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 121.149 -0.969 . . . . 71.44 111.249 173.239 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -97.06 -6.5 57.86 Favored Glycine 0 CA--C 1.528 0.888 0 CA-C-O 118.877 -0.957 . . . . 64.02 114.112 169.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.465 ' HE3' ' CZ ' ' A' ' 114' ' ' PHE . 48.2 mttm -125.27 61.91 1.19 Allowed 'General case' 0 N--CA 1.456 -0.134 0 CA-C-N 119.938 1.869 . . . . 74.2 108.406 -175.083 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 71.69 18.48 77.34 Favored Glycine 0 CA--C 1.525 0.661 0 CA-C-O 119.021 -0.877 . . . . 65.44 114.646 161.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 28.3 t -125.89 139.88 50.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 C-N-CA 125.707 1.603 . . . . 62.53 108.04 -176.608 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 65.5 t0 -85.68 121.2 28.01 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 107.712 -1.218 . . . . 54.31 107.712 167.409 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 15.3 ttpt -57.32 -35.62 70.09 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 124.053 0.941 . . . . 75.33 110.394 176.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -65.68 -39.6 91.47 Favored 'General case' 0 N--CA 1.454 -0.26 0 O-C-N 121.491 -0.756 . . . . 64.32 111.566 178.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.457 ' O ' HG22 ' A' ' 128' ' ' THR . 46.0 mttm -75.68 -44.25 43.2 Favored 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 106.819 -1.548 . . . . 74.22 106.819 -173.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -49.02 -68.06 0.21 Allowed 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 125.605 1.562 . . . . 72.45 110.579 174.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 18.3 mt -65.33 -32.59 74.32 Favored 'General case' 0 C--O 1.234 0.253 0 O-C-N 121.379 -0.825 . . . . 72.2 111.155 -170.433 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 35.7 t -56.98 -58.26 8.92 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 107.637 -1.245 . . . . 75.1 107.637 177.017 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . 0.688 HG23 ' CG2' ' A' ' 80' ' ' THR 0.341 10.1 t -71.79 -30.13 65.2 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 119.919 -0.712 . . . . 74.12 110.864 -175.32 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 31.1 t80 -54.65 -35.36 63.4 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 120.646 -1.283 . . . . 74.45 111.085 174.228 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -102.72 18.14 22.12 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.618 1.167 . . . . 34.1 112.744 179.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 28.8 m -104.53 160.99 14.49 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 125.652 1.581 . . . . 73.3 111.926 176.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -59.9 -25.97 65.54 Favored 'General case' 0 CA--C 1.532 0.288 0 O-C-N 122.143 -0.348 . . . . 51.02 111.058 171.051 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -50.01 -28.75 7.42 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 125.386 1.474 . . . . 52.3 113.304 173.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.501 HD11 ' HA ' ' A' ' 80' ' ' THR . 5.5 mm -101.64 -36.06 4.49 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 C-N-CA 125.159 1.384 . . . . 74.42 110.671 176.366 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 35.3 tttm -53.91 -39.06 65.47 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 124.073 0.949 . . . . 75.43 110.463 174.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -72.55 -16.05 77.57 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 125.152 1.358 . . . . 51.14 111.916 -170.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -99.1 -39.22 8.6 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 123.393 0.677 . . . . 73.03 109.494 176.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 75.6 mmm -58.47 -37.83 76.32 Favored 'General case' 0 C--N 1.342 0.257 0 N-CA-C 109.77 -0.456 . . . . 64.14 109.77 177.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -59.66 -51.53 69.41 Favored 'General case' 0 CA--C 1.535 0.374 0 O-C-N 121.303 -0.873 . . . . 71.4 110.737 173.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 4.3 mmtp -61.98 -58.14 9.01 Favored 'General case' 0 C--N 1.344 0.327 0 CA-C-O 117.987 -1.006 . . . . 73.21 111.47 -175.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -59.5 -30.75 68.79 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 119.474 1.034 . . . . 51.2 110.671 -176.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 2.2 tmpt? -66.16 -58.87 4.48 Favored 'General case' 0 C--N 1.344 0.357 0 O-C-N 121.035 -1.04 . . . . 73.21 109.99 176.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 15.2 ptpt -62.61 -37.82 87.78 Favored 'General case' 0 C--N 1.341 0.22 0 CA-C-O 118.611 -0.709 . . . . 73.44 109.499 -173.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 35.7 mt -57.89 -59.77 4.73 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.467 1.107 . . . . 64.44 110.984 175.363 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -56.01 -40.61 73.63 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 119.03 0.832 . . . . 75.23 111.765 -175.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -63.25 -50.52 69.84 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 109.918 -0.401 . . . . 74.33 109.918 175.503 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -69.67 -22.44 63.44 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-O 118.572 -0.727 . . . . 72.13 112.4 -172.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -73.98 -8.27 55.49 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 125.37 1.468 . . . . 72.52 113.864 171.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 52.61 72.66 0.39 Allowed 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 124.793 1.237 . . . . 75.31 110.919 -167.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 47.4 t -101.63 145.83 10.93 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 N-CA-C 107.457 -1.312 . . . . 71.22 107.457 166.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -123.27 -13.89 7.58 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 123.629 0.772 . . . . 70.5 112.787 172.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -159.35 -163.7 13.59 Favored Glycine 0 C--N 1.334 0.431 0 O-C-N 121.047 -1.033 . . . . 75.32 113.213 179.051 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.451 ' HA ' ' C ' ' A' ' 154' ' ' PRO . 15.4 m -144.11 146.78 35.1 Favored Pre-proline 0 C--N 1.328 -0.335 0 C-N-CA 126.102 1.761 . . . . 65.44 107.086 173.055 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . 0.451 ' C ' ' HA ' ' A' ' 153' ' ' VAL . 60.8 Cg_endo -67.31 150.95 83.68 Favored 'Cis proline' 0 N--CA 1.46 -0.479 0 C-N-CA 125.2 -0.75 . . . . 64.42 112.149 1.524 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 85.8 m -151.15 127.75 10.81 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 105.769 -1.937 . . . . 42.51 105.769 174.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 14.6 mmm -110.81 150.81 28.6 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 106.569 -1.641 . . . . 72.14 106.569 165.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 46.6 t -129.11 128.91 67.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 107.114 -1.439 . . . . 73.21 107.114 171.301 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.503 HG23 ' CE1' ' A' ' 164' ' ' PHE . 77.4 t -93.1 123.04 45.06 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 N-CA-C 107.48 -1.304 . . . . 62.23 107.48 164.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 2.7 t30 64.58 11.74 6.92 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 129.114 2.966 . . . . 60.54 115.52 159.242 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 71.19 23.33 78.19 Favored Glycine 0 CA--C 1.526 0.742 0 CA-C-O 117.711 -1.605 . . . . 74.42 112.973 -170.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 35.9 mttt -133.58 -30.18 1.3 Allowed 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 120.043 1.921 . . . . 65.42 112.402 -175.473 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 80.3 m-85 -124.34 115.01 20.31 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 118.943 -0.551 . . . . 74.5 110.864 -179.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 6.3 ptt180 -96.01 141.41 29.45 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 106.685 -1.598 . . . . 61.25 106.685 171.171 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . 0.503 ' CE1' HG23 ' A' ' 158' ' ' VAL . 15.1 p90 -151.71 164.84 36.08 Favored 'General case' 0 C--N 1.309 -1.154 0 O-C-N 120.721 -1.237 . . . . 73.04 108.376 176.635 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -168.19 169.12 11.19 Favored 'General case' 0 CA--C 1.513 -0.445 0 CA-C-N 116.001 -0.545 . . . . 73.21 109.611 -174.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.442 HD12 ' HG3' ' A' ' 154' ' ' PRO . 42.0 mt -51.73 -47.79 38.57 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 C-N-CA 125.41 1.484 . . . . 62.32 109.702 -175.115 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -84.13 -4.65 88.16 Favored Glycine 0 CA--C 1.527 0.791 0 CA-C-O 117.701 -1.611 . . . . 64.44 113.38 -176.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 52.1 m -87.24 -56.31 3.42 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 121.224 2.512 . . . . 71.44 108.249 163.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.75 ' HB1' HD23 ' A' ' 178' ' ' LEU . . . -79.0 -28.02 43.36 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-O 116.9 -1.524 . . . . 71.34 113.969 -165.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 154.12 -46.7 0.54 Allowed Glycine 0 CA--C 1.527 0.793 0 CA-C-N 121.343 1.883 . . . . 42.11 115.457 176.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 154.26 167.13 15.83 Favored Glycine 0 CA--C 1.534 1.224 0 N-CA-C 108.159 -1.977 . . . . 64.14 108.159 -153.145 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -67.69 -23.48 42.35 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 CA-C-N 120.525 2.163 . . . . 31.23 113.294 -164.182 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -70.0 -46.4 65.22 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 123.013 1.387 . . . . 65.43 109.557 174.072 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -66.97 -21.51 65.96 Favored 'General case' 0 N--CA 1.445 -0.675 0 C-N-CA 126.622 1.969 . . . . 74.44 111.344 -175.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 3.2 m -70.6 -43.76 68.68 Favored 'General case' 0 CA--C 1.529 0.16 0 O-C-N 121.126 -0.984 . . . . 72.15 109.162 -177.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 53.4 mt -62.84 -33.27 74.9 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 118.288 0.495 . . . . 73.35 110.799 177.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 7.5 tttt -52.58 -51.42 59.88 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 125.099 1.36 . . . . 74.34 109.33 173.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.75 HD23 ' HB1' ' A' ' 169' ' ' ALA . 4.3 mm? -68.78 -39.89 79.96 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-O 118.287 -0.864 . . . . 54.4 110.846 175.265 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -55.8 -49.04 74.28 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 119.215 0.916 . . . . 75.12 111.201 -174.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -72.88 -43.13 62.9 Favored 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 122.76 0.424 . . . . 71.05 110.333 -172.246 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 15.9 t80 -60.45 -52.33 65.67 Favored 'General case' 0 N--CA 1.44 -0.946 0 C-N-CA 124.736 1.214 . . . . 74.33 110.048 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . 0.501 ' HB2' HG21 ' A' ' 158' ' ' VAL . 95.9 mt -62.63 -34.8 77.78 Favored 'General case' 0 C--O 1.233 0.213 0 C-N-CA 123.206 0.602 . . . . 71.05 110.768 -178.41 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 38.1 mt -60.8 -61.96 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 N-CA-C 108.419 -0.956 . . . . 73.41 108.419 173.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -56.98 -32.79 66.44 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 124.491 1.117 . . . . 65.25 111.509 -173.384 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 79.3 tttt -58.51 -66.93 0.41 Allowed 'General case' 0 C--O 1.232 0.156 0 C-N-CA 125.425 1.49 . . . . 74.25 110.571 171.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 43.0 mm-40 -65.38 -19.34 65.9 Favored 'General case' 0 N--CA 1.446 -0.625 0 O-C-N 121.03 -1.044 . . . . 73.01 113.258 -177.441 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.94 -44.79 63.04 Favored 'General case' 0 CA--C 1.533 0.319 0 O-C-N 120.974 -1.079 . . . . 74.03 109.327 169.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.133 0 C-N-CA 124.214 1.005 . . . . 73.3 110.73 -177.648 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 . . . . . 0 CA--C 1.512 -0.483 0 N-CA-C 106.969 -1.493 . . . . 74.53 106.969 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -81.55 8.92 8.43 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-N 112.757 -2.02 . . . . 50.41 114.835 -161.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 42.7 m-85 -134.18 167.03 21.41 Favored 'General case' 0 N--CA 1.442 -0.854 0 C-N-CA 124.803 1.241 . . . . 75.35 108.641 -164.015 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 94.2 m -134.2 141.24 46.97 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 108.451 -0.944 . . . . 63.55 108.451 173.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -70.28 143.58 52.03 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-O 122.069 0.938 . . . . 63.53 110.055 175.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 61.46 16.0 48.28 Favored Glycine 0 CA--C 1.529 0.917 0 C-N-CA 124.898 1.237 . . . . 51.44 112.762 -166.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 8.1 ttmt -118.4 -85.23 0.65 Allowed 'General case' 0 CA--C 1.517 -0.31 0 N-CA-C 105.879 -1.897 . . . . 61.43 105.879 172.047 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.434 ' HB3' HD11 ' A' ' 178' ' ' LEU . 38.4 mp0 -75.6 -21.97 57.32 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 118.675 0.67 . . . . 73.45 112.462 -179.505 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 47.9 p90 -159.78 176.0 12.47 Favored 'General case' 0 CA--C 1.52 -0.179 0 O-C-N 121.477 -0.765 . . . . 64.1 110.726 -170.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 44.3 t -140.68 96.05 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 N-CA-C 108.534 -0.913 . . . . 70.01 108.534 -170.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.39 146.18 27.81 Favored 'General case' 0 C--O 1.237 0.402 0 O-C-N 121.089 -1.007 . . . . 60.31 110.677 177.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -100.68 146.46 27.17 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 114.467 -1.242 . . . . 74.32 108.192 -170.675 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.8 p -81.85 -23.77 36.2 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 125.569 1.547 . . . . 54.11 111.12 179.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 69.3 m -115.27 84.32 11.35 Favored Pre-proline 0 N--CA 1.455 -0.18 0 C-N-CA 124.783 1.233 . . . . 75.0 109.587 -178.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -75.01 174.75 12.25 Favored 'Trans proline' 0 N--CA 1.451 -0.995 0 C-N-CA 122.113 1.875 . . . . 75.4 112.288 -178.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 20.7 t -130.2 130.46 23.06 Favored Pre-proline 0 CA--C 1.534 0.342 0 CA-C-N 114.937 -1.029 . . . . 44.41 108.714 -173.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -76.73 175.91 10.78 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 124.277 3.318 . . . . 72.1 112.865 178.04 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 19.4 m -120.25 168.56 12.48 Favored 'Isoleucine or valine' 0 C--O 1.24 0.567 0 C-N-CA 126.366 1.866 . . . . 75.22 110.264 173.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 38.9 m -54.91 -53.01 61.02 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 126.664 1.986 . . . . 74.13 110.777 174.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 3.5 mm-40 -141.58 144.27 32.74 Favored Pre-proline 0 N--CA 1.451 -0.392 0 N-CA-C 106.564 -1.643 . . . . 74.23 106.564 178.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -71.51 165.01 33.81 Favored 'Trans proline' 0 N--CA 1.447 -1.224 0 C-N-CA 121.269 1.313 . . . . 64.15 109.156 162.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 159.57 -35.04 0.47 Allowed Glycine 0 CA--C 1.519 0.329 0 CA-C-O 119.547 -0.585 . . . . 63.34 112.784 167.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -129.71 163.58 25.85 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.581 1.553 . . . . 75.33 109.707 162.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.435 HD12 ' HB3' ' A' ' 186' ' ' GLU . 28.2 mm -66.31 126.34 25.46 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 N-CA-C 106.467 -1.679 . . . . 50.41 106.467 168.43 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -89.3 123.45 33.5 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 125.992 1.717 . . . . 72.53 106.762 -176.66 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 28.3 t -123.73 135.29 63.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 108.002 -1.11 . . . . 73.45 108.002 -179.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 40.3 t -126.76 125.9 67.72 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.177 0 N-CA-C 108.262 -1.014 . . . . 53.15 108.262 -175.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -87.46 134.91 33.53 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 125.164 1.386 . . . . 72.31 107.769 162.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.2 mp -122.23 123.5 41.61 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 124.715 1.206 . . . . 73.53 108.354 165.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -131.8 171.59 13.33 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.754 1.622 . . . . 72.01 110.979 -169.452 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 27.3 t90 -147.22 168.92 20.49 Favored 'General case' 0 CA--C 1.537 0.452 0 O-C-N 120.86 -1.15 . . . . 74.03 109.46 168.038 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 14.6 t80 -60.77 -53.51 56.5 Favored 'General case' 0 N--CA 1.461 0.076 0 C-N-CA 126.062 1.745 . . . . 74.12 111.425 174.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -68.66 -84.41 0.13 Allowed Glycine 0 C--N 1.336 0.575 0 N-CA-C 110.697 -0.961 . . . . 55.44 110.697 -159.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 14.5 t 42.54 71.93 1.27 Allowed Pre-proline 0 CA--C 1.533 0.289 0 C-N-CA 125.961 1.704 . . . . 53.24 113.415 149.163 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -67.3 3.42 1.7 Allowed 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 122.264 1.976 . . . . 72.42 113.71 -176.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 18.7 m170 -108.66 -28.98 8.96 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 119.857 1.208 . . . . 71.33 111.978 173.062 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 85.7 m -60.27 -46.32 90.24 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 119.545 1.066 . . . . 33.24 109.754 -175.118 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 32.7 t80 -66.62 -22.13 66.12 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 121.085 -1.009 . . . . 73.24 112.187 -178.329 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -74.64 -3.54 31.85 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 120.931 -1.106 . . . . 34.34 112.782 175.023 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.425 ' CG ' HD11 ' A' ' 166' ' ' ILE . 15.6 t80 -121.82 -25.14 5.08 Favored 'General case' 0 C--O 1.226 -0.171 0 C-N-CA 125.372 1.469 . . . . 65.0 112.511 -168.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 56.9 mm-40 -42.39 -63.23 0.96 Allowed Pre-proline 0 CA--C 1.539 0.553 0 C-N-CA 124.253 1.021 . . . . 73.04 112.403 -177.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -73.3 -8.73 22.34 Favored 'Trans proline' 0 N--CA 1.46 -0.445 0 CA-C-N 122.535 1.941 . . . . 74.1 114.966 -177.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.4 m -70.8 -44.91 65.63 Favored 'General case' 0 CA--C 1.543 0.708 0 O-C-N 121.034 -1.042 . . . . 74.33 108.525 166.293 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 12.9 tt -94.78 -36.02 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 C-N-CA 123.86 0.864 . . . . 73.41 112.418 -165.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 41.9 t -46.8 -58.85 6.09 Favored Pre-proline 0 CA--C 1.538 0.493 0 C-N-CA 125.691 1.596 . . . . 74.53 110.443 176.001 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -72.53 -25.51 17.72 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 121.646 1.564 . . . . 71.54 112.929 -178.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.457 ' CG ' HD22 ' A' ' 176' ' ' LEU . 79.6 t90 -60.24 -52.01 67.11 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 119.757 1.162 . . . . 74.4 109.014 173.315 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.2 t -55.88 -42.8 76.46 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.321 0.648 . . . . 64.2 110.522 177.209 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 90.0 mt-10 -64.05 -10.34 21.52 Favored 'General case' 0 N--CA 1.468 0.474 0 O-C-N 121.207 -0.933 . . . . 62.03 113.352 -179.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 19.3 mmmt -122.49 8.48 9.58 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 126.116 1.767 . . . . 74.13 112.277 -171.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 25.2 mt -64.73 153.59 87.39 Favored Pre-proline 0 C--O 1.24 0.566 0 C-N-CA 125.029 1.331 . . . . 74.41 111.177 177.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -74.54 167.25 27.56 Favored 'Trans proline' 0 N--CA 1.448 -1.154 0 C-N-CA 124.658 3.572 . . . . 73.05 110.494 179.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -73.12 -2.19 20.45 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.385 1.474 . . . . 73.43 113.349 -175.419 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -101.75 8.29 41.55 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.01 1.324 . . . . 64.04 111.15 177.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 60.8 t -124.58 155.13 32.47 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 C-N-CA 124.521 1.128 . . . . 64.32 108.766 -177.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 63.9 t60 -139.27 123.72 18.26 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 126.903 2.081 . . . . 72.02 106.333 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 47.4 t80 -107.97 139.4 42.65 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 108.079 -1.082 . . . . 60.03 108.079 -176.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 25.9 t -135.2 153.75 34.61 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 N-CA-C 105.511 -2.033 . . . . 75.23 105.511 -177.48 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -127.86 140.16 52.19 Favored 'General case' 0 CA--C 1.512 -0.512 0 N-CA-C 105.341 -2.096 . . . . 75.3 105.341 167.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 97.5 mt -138.54 144.46 42.45 Favored Pre-proline 0 C--N 1.326 -0.416 0 N-CA-C 108.829 -0.804 . . . . 71.42 108.829 174.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -71.6 148.25 53.05 Favored 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 121.526 1.484 . . . . 72.45 110.913 178.098 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -93.28 86.53 5.34 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 124.962 1.305 . . . . 74.53 108.362 -178.019 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 46.8 mt -80.86 65.45 6.01 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 121.006 -1.059 . . . . 65.13 112.601 -169.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 13.0 m-85 -80.02 27.2 0.32 Allowed 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 115.111 1.523 . . . . 64.12 115.111 -168.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 66.54 -168.32 35.48 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 109.217 -1.553 . . . . 63.2 109.217 -166.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 56.15 -151.03 23.03 Favored Glycine 0 CA--C 1.526 0.747 0 CA-C-N 117.848 0.824 . . . . 64.25 111.34 178.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 9.6 tp -70.45 -12.04 15.65 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 N-CA-C 112.471 0.545 . . . . 74.2 112.471 173.162 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 9.4 m95 -64.42 -36.16 83.24 Favored 'General case' 0 C--O 1.224 -0.266 0 O-C-N 120.004 -1.685 . . . . 62.51 112.178 -171.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 11.5 p30 -76.54 -28.34 56.27 Favored 'General case' 0 CA--C 1.518 -0.254 0 N-CA-C 113.051 0.76 . . . . 73.43 113.051 177.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 94.2 t -65.61 -51.69 59.79 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 N-CA-C 107.21 -1.404 . . . . 63.23 107.21 172.281 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 59.0 m170 -79.1 54.18 1.58 Allowed 'General case' 0 C--O 1.239 0.505 0 C-N-CA 125.493 1.517 . . . . 72.23 111.446 172.497 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -164.82 -29.28 0.02 OUTLIER Glycine 0 N--CA 1.445 -0.752 0 CA-C-N 115.485 -0.78 . . . . 62.32 112.717 156.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -62.32 -25.78 68.07 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 119.314 1.557 . . . . 64.33 114.045 -173.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 40.3 ttp -53.3 -40.12 64.53 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 124.358 1.063 . . . . 52.02 112.546 -177.404 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -58.47 -47.1 85.15 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 125.074 1.349 . . . . 72.12 108.523 178.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 15.5 mt -68.81 -34.69 75.93 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-O 116.487 -1.721 . . . . 72.11 111.095 -178.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.642 HG22 HG23 ' A' ' 128' ' ' THR . 0.0 OUTLIER -63.73 -45.12 91.33 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 121.761 2.073 . . . . 75.13 111.335 174.509 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -52.53 -60.6 3.04 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.454 1.102 . . . . 62.4 108.723 -176.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -67.19 -27.56 67.37 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.26 1.024 . . . . 71.44 110.043 -174.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.0 t -51.68 -39.86 59.04 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 124.52 1.128 . . . . 45.31 111.621 176.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 44.7 mtm . . . . . 0 CA--C 1.534 0.327 0 CA-C-N 118.761 0.71 . . . . 64.31 112.439 -176.979 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.545 0.752 0 N-CA-C 114.986 1.476 . . . . 71.25 114.986 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 25.6 t -73.36 -66.43 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 CA-C-N 119.895 1.225 . . . . 63.13 108.805 167.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -60.0 -36.98 78.35 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.261 1.025 . . . . 71.04 110.776 -175.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -60.15 -35.55 75.57 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 125.382 1.473 . . . . 62.52 110.745 176.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.428 ' HB2' ' CZ ' ' A' ' 114' ' ' PHE . . . -65.22 -22.18 66.85 Favored 'General case' 0 CA--C 1.534 0.338 0 O-C-N 121.163 -0.961 . . . . 63.13 112.053 176.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 55.5 mt -87.34 -60.01 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.884 0 N-CA-C 105.883 -1.895 . . . . 51.23 105.883 178.106 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 31.6 p80 -92.55 -53.64 4.11 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 115.379 1.622 . . . . 72.15 115.379 -168.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 34.2 mmtt -62.64 -20.4 64.75 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.238 1.015 . . . . 70.1 111.742 175.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -117.19 -26.2 6.86 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 118.053 -0.975 . . . . 70.42 113.148 -171.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 1.9 t-160 53.46 42.97 31.91 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.275 1.43 . . . . 72.1 111.994 178.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 25.4 mmtp -74.79 157.52 35.03 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 120.941 -1.099 . . . . 75.33 110.218 175.353 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 11.0 tttt -80.17 36.47 0.35 Allowed 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 127.872 2.469 . . . . 62.13 111.748 -173.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.403 ' HA ' ' HB3' ' A' ' 110' ' ' GLU . 24.7 mt -64.54 32.82 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 130.452 3.501 . . . . 71.54 115.182 -174.72 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -79.8 13.09 2.29 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 129.636 3.174 . . . . 60.04 113.14 178.562 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -148.04 158.53 41.74 Favored Pre-proline 0 N--CA 1.463 0.221 0 CA-C-N 119.21 0.914 . . . . 75.4 111.852 -179.628 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -67.93 -19.55 46.09 Favored 'Trans proline' 0 N--CA 1.455 -0.773 0 C-N-CA 123.225 2.617 . . . . 62.31 112.106 174.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -60.39 -71.19 0.14 Allowed 'General case' 0 C--O 1.22 -0.497 0 N-CA-C 107.398 -1.334 . . . . 73.03 107.398 167.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.403 ' HB3' ' HA ' ' A' ' 105' ' ' LEU . 3.7 mm-40 -51.51 -42.61 61.83 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 124.289 1.036 . . . . 73.51 112.395 -176.599 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 48.0 mtt -58.72 -57.15 14.28 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 109.67 -0.493 . . . . 74.24 109.67 179.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.508 ' HB1' ' HG3' ' A' ' 122' ' ' LYS . . . -65.73 -37.33 86.1 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 119.536 -0.269 . . . . 65.15 111.111 -177.627 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -60.63 -48.77 80.31 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 127.533 2.333 . . . . 72.13 110.341 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . 0.428 ' CZ ' ' HB2' ' A' ' 97' ' ' ALA . 81.4 t80 -65.72 -47.81 74.06 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 123.666 0.787 . . . . 75.12 110.698 177.109 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 66.9 mt -75.15 -13.06 60.43 Favored 'General case' 0 N--CA 1.457 -0.101 0 CA-C-O 119.051 -0.5 . . . . 74.54 111.76 -173.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -49.11 -53.58 20.05 Favored 'General case' 0 CA--C 1.52 -0.178 0 C-N-CA 125.099 1.36 . . . . 70.25 109.882 -174.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -72.21 7.2 8.41 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 125.453 1.501 . . . . 65.54 115.571 178.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 20.3 mttm -125.43 25.94 6.94 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 120.788 2.294 . . . . 63.25 111.57 -170.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 74.46 40.82 38.53 Favored Glycine 0 C--N 1.334 0.448 0 N-CA-C 111.142 -0.783 . . . . 74.4 111.142 -179.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 58.4 t -131.0 111.61 20.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 N-CA-C 107.147 -1.427 . . . . 64.11 107.147 173.363 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -70.57 136.54 49.34 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 123.993 0.917 . . . . 50.21 111.47 173.191 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.508 ' HG3' ' HB1' ' A' ' 112' ' ' ALA . 26.9 tttt -64.74 -48.25 75.27 Favored 'General case' 0 CA--C 1.516 -0.362 0 N-CA-C 109.762 -0.458 . . . . 74.33 109.762 -176.618 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 60.1 mm-40 -63.85 -39.19 93.63 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 122.775 0.43 . . . . 71.24 110.237 -174.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 3.9 mtpm? -75.62 -38.77 58.71 Favored 'General case' 0 CA--C 1.515 -0.376 0 N-CA-C 108.282 -1.007 . . . . 62.31 108.282 -177.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 87.4 t80 -57.76 -60.5 3.6 Favored 'General case' 0 N--CA 1.44 -0.925 0 O-C-N 123.794 0.684 . . . . 72.52 110.294 178.234 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 15.7 mt -65.61 -37.27 86.13 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-O 118.937 -0.554 . . . . 74.41 109.754 -175.108 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 45.6 t -60.14 -51.85 67.86 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 108.582 -0.896 . . . . 72.52 108.582 177.094 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . 0.642 HG23 HG22 ' A' ' 80' ' ' THR 0.278 1.3 t -69.12 -33.12 72.97 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 119.454 1.025 . . . . 72.14 109.873 -173.792 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 53.2 t80 -51.1 -48.56 61.65 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.361 1.465 . . . . 73.51 110.664 170.14 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -95.14 17.63 13.77 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 113.213 0.82 . . . . 72.43 113.213 -179.074 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 58.0 m -107.67 172.47 6.81 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 119.772 1.169 . . . . 74.44 111.694 179.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -63.84 -23.84 67.51 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 115.92 -0.582 . . . . 75.5 112.338 -174.724 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -53.58 -59.87 4.04 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.671 1.189 . . . . 65.14 110.032 176.006 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.49 HD11 ' HA ' ' A' ' 80' ' ' THR . 14.2 mm -67.1 -26.21 35.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 C-N-CA 123.032 0.533 . . . . 73.04 111.605 -179.239 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 6.8 tttp -55.48 -45.45 76.99 Favored 'General case' 0 N--CA 1.464 0.225 0 O-C-N 120.938 -1.101 . . . . 72.23 109.639 171.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -72.76 -10.91 77.45 Favored Glycine 0 CA--C 1.524 0.63 0 C-N-CA 123.475 0.559 . . . . 72.22 112.009 -172.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 7.5 mm100 -108.66 -38.52 5.63 Favored 'General case' 0 N--CA 1.44 -0.938 0 C-N-CA 126.332 1.853 . . . . 65.04 109.357 -171.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -62.98 -41.91 99.69 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 118.368 -0.825 . . . . 71.11 110.332 174.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -67.71 -44.66 77.17 Favored 'General case' 0 CA--C 1.535 0.365 0 CA-C-N 119.137 0.881 . . . . 73.35 110.266 178.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 3.1 ttmt -63.23 -56.13 19.15 Favored 'General case' 0 N--CA 1.449 -0.475 0 O-C-N 121.034 -1.041 . . . . 74.23 111.164 -174.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -59.64 -33.27 71.31 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 118.029 0.377 . . . . 65.31 110.661 -176.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 2.0 tmtm? -60.1 -60.54 3.66 Favored 'General case' 0 CA--C 1.531 0.245 0 O-C-N 121.269 -0.894 . . . . 71.44 110.925 172.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.44 -18.79 63.0 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 119.265 0.939 . . . . 54.14 112.039 -173.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 45.4 mt -69.5 -54.55 13.64 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 123.96 0.904 . . . . 73.45 110.338 172.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -53.58 -47.37 70.2 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 119.558 1.072 . . . . 71.31 112.588 -174.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -62.33 -45.13 94.6 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 112.704 0.631 . . . . 65.44 112.704 175.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -63.21 -35.65 81.01 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 118.496 0.589 . . . . 74.34 109.88 -179.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 -74.19 9.2 1.72 Allowed 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 114.014 1.116 . . . . 71.14 114.014 173.029 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 60.86 19.5 9.76 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 126.294 1.838 . . . . 73.44 112.649 176.063 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 25.8 t -75.16 141.14 16.31 Favored 'Isoleucine or valine' 0 C--O 1.24 0.58 0 N-CA-C 107.996 -1.113 . . . . 52.3 107.996 -177.042 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -141.49 0.5 1.48 Allowed 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 118.846 -0.597 . . . . 75.33 112.408 173.409 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -160.12 167.96 35.63 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 108.6 -1.8 . . . . 72.33 108.6 170.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 30.0 m -123.88 156.03 66.08 Favored Pre-proline 0 C--O 1.238 0.473 0 C-N-CA 125.697 1.599 . . . . 71.23 107.614 176.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . 0.417 ' HG3' HD12 ' A' ' 166' ' ' ILE . 94.8 Cg_endo -67.33 157.92 83.53 Favored 'Cis proline' 0 N--CA 1.46 -0.447 0 O-C-N 122.607 0.793 . . . . 73.41 113.323 -2.083 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 5.1 m -154.86 136.93 14.69 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 107.989 -1.115 . . . . 74.32 107.989 171.014 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 91.8 mtp -111.13 152.92 26.44 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 107.135 -1.432 . . . . 61.24 107.135 169.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 41.0 t -138.98 128.66 31.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 N-CA-C 107.92 -1.141 . . . . 73.43 107.92 178.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 42.7 t -104.03 130.71 54.23 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 C-N-CA 124.371 1.069 . . . . 61.23 108.634 173.013 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 45.29 23.53 0.12 Allowed 'General case' 0 N--CA 1.464 0.264 1 C-N-CA 131.728 4.011 . . . . 61.33 114.374 177.278 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 59.41 31.33 69.91 Favored Glycine 0 CA--C 1.531 1.091 0 CA-C-O 117.69 -1.616 . . . . 52.43 113.882 -170.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 10.5 mtpt -131.27 -30.56 1.72 Allowed 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 119.622 1.711 . . . . 72.32 113.386 -177.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -122.16 118.59 29.0 Favored 'General case' 0 CA--C 1.519 -0.235 0 N-CA-C 107.907 -1.146 . . . . 74.24 107.907 -174.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 36.2 ttp85 -100.49 135.8 41.36 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 105.04 -2.207 . . . . 72.02 105.04 175.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 18.1 p90 -154.07 166.5 32.84 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 108.346 -0.983 . . . . 73.13 108.346 172.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -170.94 178.56 3.39 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.998 0.428 . . . . 75.15 110.77 -175.346 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.425 HD11 ' CG ' ' A' ' 43' ' ' PHE . 43.3 mt -55.89 -45.06 79.74 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 C-N-CA 124.904 1.282 . . . . 64.12 108.799 -179.406 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -88.32 29.4 5.68 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 126.481 1.991 . . . . 75.13 113.155 174.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 19.0 p -119.99 -51.16 2.24 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 107.482 -1.303 . . . . 74.14 107.482 156.315 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.414 ' HB2' HD23 ' A' ' 178' ' ' LEU . . . -66.52 -39.55 88.7 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 125.097 1.359 . . . . 64.21 112.319 -175.042 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 110.61 11.56 19.05 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 124.103 0.859 . . . . 64.34 113.48 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 159.99 170.4 24.53 Favored Glycine 0 CA--C 1.524 0.598 0 CA-C-N 119.469 1.634 . . . . 62.04 110.525 175.02 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -66.44 -42.36 10.05 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 122.019 1.813 . . . . 74.14 110.762 -175.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -70.1 -34.33 73.0 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 109.166 -0.679 . . . . 62.23 109.166 -177.488 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 41.7 mm-40 -67.37 -28.9 68.33 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.544 1.538 . . . . 73.11 110.472 174.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 23.6 m -66.0 -40.72 91.39 Favored 'General case' 0 CA--C 1.531 0.212 0 O-C-N 120.467 -1.396 . . . . 73.03 108.844 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . 0.457 HD22 ' CG ' ' A' ' 50' ' ' TRP . 61.1 mt -66.36 -24.48 66.51 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 119.343 0.974 . . . . 71.24 112.423 177.65 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 9.4 mttt -56.58 -54.25 48.09 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 108.564 -0.902 . . . . 74.02 108.564 168.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.434 HD11 ' HB3' ' A' ' 11' ' ' GLU . 2.9 mm? -68.14 -43.62 77.92 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 120.326 -0.549 . . . . 55.53 109.931 -178.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.42 -26.98 63.89 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 124.247 1.019 . . . . 70.24 112.864 -174.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . 0.406 ' HA ' HD12 ' A' ' 183' ' ' ILE . 15.8 t70 -100.69 -32.57 10.66 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 123.769 0.827 . . . . 44.51 111.474 -173.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 33.7 t80 -62.45 -52.01 65.24 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 124.178 0.991 . . . . 71.41 109.906 170.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 48.9 mt -55.39 -32.54 62.72 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 124.304 1.042 . . . . 73.22 112.164 -176.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.406 HD12 ' HA ' ' A' ' 180' ' ' ASP . 81.3 mt -54.19 -62.73 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.309 0 N-CA-C 107.857 -1.164 . . . . 44.15 107.857 174.401 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 -61.53 -37.43 83.75 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 121.193 0.52 . . . . 73.12 111.56 -171.188 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -58.14 -52.21 66.5 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.106 0.963 . . . . 43.41 109.875 179.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . 0.435 ' HB3' HD12 ' A' ' 27' ' ' ILE . 3.2 mm-40 -68.06 -42.53 80.34 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-O 121.603 0.716 . . . . 74.3 112.586 174.581 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 5.5 tpm_? -53.61 -46.72 70.53 Favored 'General case' 0 CA--C 1.516 -0.334 0 C-N-CA 125.188 1.395 . . . . 75.45 110.326 -175.09 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.286 0 C-N-CA 125.201 1.401 . . . . 63.01 112.159 -177.733 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 . . . . . 0 N--CA 1.458 -0.055 0 CA-C-O 123.108 1.433 . . . . 74.31 110.049 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -69.33 8.33 0.62 Allowed 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 125.262 1.425 . . . . 72.14 113.524 177.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -138.6 167.53 21.74 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 126.603 1.961 . . . . 64.32 108.944 -171.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 59.3 m -133.99 133.32 41.17 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 107.213 -1.402 . . . . 74.43 107.213 176.034 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -69.37 137.78 53.13 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 108.166 -1.05 . . . . 52.53 108.166 168.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 72.47 24.78 75.68 Favored Glycine 0 CA--C 1.528 0.867 0 N-CA-C 111.251 -0.74 . . . . 61.43 111.251 -167.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 18.4 tttm -140.4 -85.02 0.21 Allowed 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 106.81 -1.552 . . . . 74.45 106.81 171.044 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.494 ' HB3' HD21 ' A' ' 178' ' ' LEU . 13.3 mm-40 -72.92 -23.93 60.76 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 124.588 1.155 . . . . 72.41 111.044 -177.262 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 44.8 p90 -157.74 167.51 29.84 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 123.508 0.723 . . . . 62.11 109.468 -171.45 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 93.5 t -133.99 119.71 32.99 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 C-N-CA 124.321 1.048 . . . . 75.42 109.089 -179.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.91 161.42 30.15 Favored 'General case' 0 C--N 1.328 -0.351 0 O-C-N 120.19 -1.568 . . . . 63.2 109.633 172.307 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -119.53 108.12 14.13 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 124.022 0.929 . . . . 72.02 108.988 177.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.8 m -61.9 -5.64 2.23 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 124.864 1.266 . . . . 74.51 113.946 -178.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -121.02 84.6 39.54 Favored Pre-proline 0 N--CA 1.449 -0.483 0 N-CA-C 106.334 -1.728 . . . . 73.44 106.334 167.298 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -67.19 177.62 3.62 Favored 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 123.084 2.523 . . . . 74.33 111.129 179.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 36.4 t -136.8 139.67 29.61 Favored Pre-proline 0 C--N 1.327 -0.371 0 C-N-CA 124.552 1.141 . . . . 72.32 108.085 -166.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -76.14 177.78 8.32 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 123.0 2.466 . . . . 62.41 112.356 175.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 4.0 m -126.83 -174.61 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 C-N-CA 126.952 2.101 . . . . 73.12 108.301 177.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -66.18 -41.59 90.04 Favored 'General case' 0 CA--C 1.538 0.517 0 O-C-N 121.51 -0.744 . . . . 44.11 109.752 176.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 -168.12 166.04 7.52 Favored Pre-proline 0 CA--C 1.539 0.535 0 C-N-CA 127.63 2.372 . . . . 60.21 108.325 -179.127 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -61.25 167.25 9.64 Favored 'Trans proline' 0 CA--C 1.543 0.952 0 C-N-CA 122.051 1.834 . . . . 71.43 110.681 162.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 137.05 -64.08 0.57 Allowed Glycine 0 C--N 1.338 0.64 0 O-C-N 121.296 -0.877 . . . . 53.12 112.509 170.146 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.447 ' HE2' ' N ' ' A' ' 26' ' ' LYS . 0.2 OUTLIER -113.43 144.16 43.27 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 118.966 1.383 . . . . 74.25 107.756 176.389 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 45.4 mm -67.54 129.66 32.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 104.991 -2.226 . . . . 72.54 104.991 170.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -90.47 138.57 31.44 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 107.322 -1.362 . . . . 72.42 107.322 177.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 58.5 t -129.43 116.47 39.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 106.414 -1.699 . . . . 71.14 106.414 175.114 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 23.4 t -106.58 112.35 39.27 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 N-CA-C 107.891 -1.151 . . . . 72.21 107.891 -175.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -77.53 130.3 36.78 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 107.843 -1.169 . . . . 61.24 107.843 159.076 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.743 HD22 HG21 ' A' ' 150' ' ' VAL . 5.3 mp -114.68 130.75 56.86 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 124.236 1.014 . . . . 71.0 108.587 164.406 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 33.4 p90 -134.17 168.58 18.59 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.608 0.763 . . . . 75.1 111.255 -172.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 25.2 t90 -147.96 168.45 22.26 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 126.597 1.959 . . . . 75.05 107.691 173.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 2.1 m-30 -81.41 -41.13 22.36 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 109.181 -0.674 . . . . 74.23 109.181 179.301 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -76.5 21.64 2.35 Favored Glycine 0 CA--C 1.532 1.105 0 C-N-CA 124.81 1.195 . . . . 60.23 114.089 -175.547 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 51.8 t -105.0 87.23 1.79 Allowed Pre-proline 0 CA--C 1.537 0.475 0 C-N-CA 126.752 2.021 . . . . 71.5 110.391 -170.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -54.11 -42.61 65.59 Favored 'Trans proline' 0 CA--C 1.534 0.514 0 C-N-CA 122.387 2.058 . . . . 54.44 113.284 177.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 26.7 m170 -72.87 -24.16 60.82 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 119.227 0.922 . . . . 70.2 111.734 -172.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 99.6 m -62.57 -39.25 93.09 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.846 0.858 . . . . 60.25 110.56 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 21.8 t80 -62.67 -45.94 90.5 Favored 'General case' 0 C--N 1.341 0.229 0 C-N-CA 123.616 0.766 . . . . 72.21 111.061 -176.245 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.61 -9.97 31.61 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 112.695 0.628 . . . . 74.2 112.695 -176.056 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.437 ' HB2' HD11 ' A' ' 166' ' ' ILE . 2.6 t80 -97.97 -22.61 16.2 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 124.97 1.308 . . . . 71.43 111.267 178.013 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -44.81 -64.83 0.74 Allowed Pre-proline 0 CA--C 1.54 0.57 0 C-N-CA 125.007 1.323 . . . . 71.2 112.47 -172.069 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -69.96 -4.91 15.11 Favored 'Trans proline' 0 N--CA 1.459 -0.509 0 C-N-CA 122.1 1.867 . . . . 64.24 115.547 -176.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.8 m -87.12 -41.11 14.04 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 108.529 -0.915 . . . . 72.53 108.529 171.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 19.0 tt -84.62 -29.35 6.87 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 O-C-N 121.586 -0.696 . . . . 72.01 111.422 -174.011 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 34.8 t -48.88 -66.32 0.61 Allowed Pre-proline 0 CA--C 1.534 0.339 0 CA-C-O 117.428 -1.272 . . . . 71.43 110.84 172.126 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -58.86 -41.45 62.42 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 121.67 1.58 . . . . 75.05 110.125 -175.206 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 61.6 t90 -52.71 -57.33 10.45 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 118.519 0.599 . . . . 74.14 110.473 177.095 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 78.1 p -59.96 -34.61 73.49 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.272 0.629 . . . . 73.05 112.483 -177.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -78.67 -16.77 56.9 Favored 'General case' 0 CA--C 1.533 0.317 0 O-C-N 121.303 -0.873 . . . . 62.11 112.835 178.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 42.2 mmtm -106.04 2.16 27.04 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 126.089 1.756 . . . . 74.44 112.662 -178.078 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 37.2 mt -57.7 148.73 55.88 Favored Pre-proline 0 C--O 1.236 0.37 0 C-N-CA 124.397 1.079 . . . . 74.41 110.741 177.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -77.55 170.93 18.41 Favored 'Trans proline' 0 N--CA 1.443 -1.451 0 C-N-CA 124.015 3.143 . . . . 54.45 111.014 178.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -67.84 3.4 1.51 Allowed 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 115.075 1.509 . . . . 74.12 115.075 -170.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -118.56 1.42 11.7 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 126.94 2.096 . . . . 43.24 112.568 -177.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 23.1 t -120.19 123.29 70.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 CA-C-N 119.369 0.986 . . . . 51.0 109.569 -179.014 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 80.1 t60 -115.05 107.63 15.6 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 126.155 1.782 . . . . 75.43 109.663 -174.317 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 26.5 t80 -78.34 139.63 38.81 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.688 1.195 . . . . 64.14 110.762 179.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 88.8 t -131.51 146.61 33.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 C-N-CA 127.698 2.399 . . . . 75.55 106.681 -178.132 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 29.7 mtt-85 -131.63 120.03 22.25 Favored 'General case' 0 CA--C 1.508 -0.669 0 N-CA-C 106.929 -1.508 . . . . 65.03 106.929 -177.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 75.2 mt -129.93 148.68 70.57 Favored Pre-proline 0 C--N 1.325 -0.464 0 O-C-N 123.419 0.45 . . . . 74.14 112.187 179.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -75.87 134.77 16.77 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 122.8 2.333 . . . . 71.22 110.457 177.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -75.97 108.7 9.03 Favored 'General case' 0 CA--C 1.535 0.395 0 O-C-N 121.477 -0.764 . . . . 71.02 109.059 170.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 49.5 mt -103.03 94.19 5.42 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 127.165 2.186 . . . . 72.14 108.548 -179.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -130.8 43.53 3.09 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 119.221 0.918 . . . . 64.45 112.21 -175.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.452 ' H ' ' ND2' ' A' ' 72' ' ' ASN . . . 74.63 164.23 11.35 Favored Glycine 0 CA--C 1.522 0.525 0 C-N-CA 124.767 1.175 . . . . 74.51 112.358 175.41 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 52.33 -144.11 20.45 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.416 -1.073 . . . . 73.32 110.416 -175.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 4.8 tp -64.4 -15.12 16.9 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 CA-C-O 118.093 -0.955 . . . . 73.24 111.431 -172.279 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 19.7 m95 -59.81 -33.59 71.93 Favored 'General case' 0 C--N 1.342 0.275 0 CA-C-N 120.732 1.605 . . . . 73.25 111.139 173.126 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.452 ' ND2' ' H ' ' A' ' 68' ' ' GLY . 7.3 m-80 -80.52 -32.32 36.9 Favored 'General case' 0 C--N 1.339 0.147 0 CA-C-N 118.766 0.712 . . . . 73.32 111.708 177.137 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 70.5 t -68.44 -58.83 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 N-CA-C 108.512 -0.922 . . . . 72.35 108.512 178.159 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 52.1 m170 -72.14 47.21 0.15 Allowed 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 126.625 1.97 . . . . 74.24 109.578 167.113 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -164.49 1.24 0.05 OUTLIER Glycine 0 CA--C 1.527 0.818 0 C-N-CA 127.055 2.264 . . . . 55.53 113.28 -176.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -108.2 -24.13 11.65 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 120.78 2.29 . . . . 63.11 113.23 -174.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 3.0 ptt? -85.14 -23.45 28.41 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 114.361 1.245 . . . . 74.22 114.361 -170.194 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 29.5 t80 -56.58 -48.68 76.87 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 119.861 1.21 . . . . 74.4 107.94 176.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 35.1 mt -60.84 -46.85 88.95 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 114.846 -1.07 . . . . 72.35 109.672 178.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.586 HG22 HG23 ' A' ' 128' ' ' THR . 0.2 OUTLIER -61.72 -41.94 98.29 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 119.503 1.047 . . . . 51.42 111.525 -179.837 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -54.53 -53.24 57.04 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 123.99 0.916 . . . . 74.42 108.993 -177.31 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -76.54 -24.85 53.64 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 124.645 1.178 . . . . 71.02 112.212 -176.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 7.7 t -55.11 -11.71 0.76 Allowed 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.629 1.572 . . . . 72.13 113.46 172.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 9.1 mtp . . . . . 0 C--O 1.225 -0.213 0 C-N-CA 124.165 0.986 . . . . 75.52 112.799 177.745 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.135 0 N-CA-C 111.53 0.196 . . . . 61.45 111.53 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 82.7 t -62.0 -35.19 67.03 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.379 0 N-CA-C 109.468 -0.567 . . . . 75.42 109.468 175.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -80.44 -46.97 15.07 Favored 'General case' 0 CA--C 1.527 0.062 0 CA-C-N 119.738 1.154 . . . . 73.51 109.908 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.413 ' OE1' ' HE3' ' A' ' 100' ' ' LYS . 13.4 mm-40 -50.99 -38.13 49.15 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.715 1.606 . . . . 73.31 110.251 178.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.4 ' HA ' ' HB2' ' A' ' 101' ' ' GLU . . . -75.56 -14.71 60.41 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.75 1.22 . . . . 64.33 113.826 -174.659 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.424 HG21 HD13 ' A' ' 98' ' ' ILE . 51.9 mt -121.01 -24.45 2.79 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 C-N-CA 125.123 1.369 . . . . 45.45 109.307 -169.721 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -100.16 -68.3 0.82 Allowed 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 124.977 1.311 . . . . 73.12 108.419 176.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.413 ' HE3' ' OE1' ' A' ' 96' ' ' GLU . 0.1 OUTLIER -65.96 -32.9 74.66 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 119.601 1.091 . . . . 71.32 110.985 -177.456 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.4 ' HB2' ' HA ' ' A' ' 97' ' ' ALA . 20.3 mt-10 -112.98 -21.11 11.28 Favored 'General case' 0 CA--C 1.528 0.101 0 N-CA-C 113.53 0.937 . . . . 72.1 113.53 -170.508 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 3.2 t60 45.08 62.98 1.9 Allowed 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 125.726 1.611 . . . . 63.53 114.644 175.06 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 19.3 mmtp -77.78 158.95 29.33 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.634 1.174 . . . . 63.31 111.794 174.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 28.7 tttt -93.27 45.87 1.19 Allowed 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 125.089 1.356 . . . . 75.52 112.381 -172.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 53.6 mt -69.0 51.76 0.08 Allowed 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 131.387 3.875 . . . . 72.12 111.475 -179.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -98.37 1.5 47.0 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 126.232 1.813 . . . . 71.4 111.924 -177.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -131.52 150.62 76.87 Favored Pre-proline 0 N--CA 1.467 0.388 0 C-N-CA 124.128 0.971 . . . . 65.24 109.936 -178.483 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_exo -59.62 -42.59 45.77 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 121.675 1.583 . . . . 64.21 110.782 -176.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 10.5 mp0 -61.35 -38.08 85.65 Favored 'General case' 0 N--CA 1.438 -1.065 0 C-N-CA 124.447 1.099 . . . . 74.14 110.623 -179.078 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -71.42 -47.05 58.37 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 125.591 1.557 . . . . 71.0 110.369 -176.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 58.2 mtt -58.56 -55.63 32.61 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 124.609 1.164 . . . . 71.54 109.154 174.108 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -64.28 -31.12 72.2 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.825 1.25 . . . . 74.42 111.559 -175.18 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -63.6 -46.68 84.7 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 119.478 1.036 . . . . 74.33 110.955 173.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 72.0 t80 -65.71 -44.32 86.45 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 121.866 0.841 . . . . 75.14 109.972 177.403 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.447 HD23 ' HA ' ' A' ' 115' ' ' LEU . 53.0 mt -69.27 -23.94 63.9 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 124.459 1.104 . . . . 75.45 111.481 -176.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.81 -13.92 18.4 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 122.902 0.481 . . . . 74.14 112.2 176.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -110.93 3.2 28.72 Favored Glycine 0 CA--C 1.526 0.755 0 C-N-CA 124.705 1.145 . . . . 63.23 114.046 170.292 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -135.42 51.31 2.08 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 119.383 1.592 . . . . 73.2 108.847 -171.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 92.56 13.85 56.35 Favored Glycine 0 CA--C 1.526 0.756 0 O-C-N 124.149 0.905 . . . . 43.13 114.395 162.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 99.1 t -129.99 165.06 31.07 Favored 'Isoleucine or valine' 0 C--O 1.231 0.116 0 CA-C-N 118.317 1.058 . . . . 64.31 109.35 -167.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 45.2 t0 -129.27 130.86 46.74 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 107.36 -1.348 . . . . 74.34 107.36 174.202 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 3.3 mttp -57.23 -36.98 71.59 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 119.075 0.852 . . . . 71.03 110.571 174.103 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -61.05 -24.16 65.99 Favored 'General case' 0 C--O 1.231 0.098 0 C-N-CA 124.173 0.989 . . . . 74.11 112.209 176.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 88.2 mttt -102.31 -49.37 3.91 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 119.97 1.259 . . . . 63.13 108.465 -177.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 68.4 t80 -48.92 -61.96 1.78 Allowed 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 126.331 1.852 . . . . 72.12 111.953 -178.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 15.9 mt -66.66 -31.63 72.42 Favored 'General case' 0 CA--C 1.534 0.352 0 O-C-N 121.486 -0.759 . . . . 75.2 110.475 -172.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 34.3 t -61.57 -50.4 72.79 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 124.299 1.04 . . . . 54.23 109.128 179.017 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . 0.586 HG23 HG22 ' A' ' 80' ' ' THR 0.272 0.0 OUTLIER -70.15 -34.76 73.43 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 119.164 0.893 . . . . 71.21 110.332 178.264 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 49.2 t80 -54.96 -55.29 32.36 Favored 'General case' 0 CA--C 1.529 0.17 0 O-C-N 121.592 -0.693 . . . . 74.42 110.422 179.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 -94.16 49.66 1.33 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.4 0.68 . . . . 74.22 109.294 176.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -123.2 164.15 19.26 Favored 'General case' 0 C--O 1.241 0.626 0 C-N-CA 125.626 1.57 . . . . 51.14 109.322 170.678 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.17 -30.96 70.72 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-O 119.293 -0.384 . . . . 74.05 110.464 178.446 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -45.3 -66.92 0.33 Allowed 'General case' 0 C--O 1.234 0.264 0 C-N-CA 124.97 1.308 . . . . 70.35 110.959 176.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 8.0 mm -64.54 -32.82 59.39 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 CA-C-O 118.56 -0.733 . . . . 75.03 111.21 -178.134 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 10.5 mttp -57.87 -35.35 70.84 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 119.1 0.863 . . . . 72.4 110.617 174.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -82.65 -31.78 29.09 Favored Glycine 0 C--N 1.339 0.695 0 CA-C-O 122.583 1.101 . . . . 72.44 110.696 -175.112 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 2.8 mm100 -74.51 -39.86 62.14 Favored 'General case' 0 N--CA 1.45 -0.46 0 O-C-N 121.539 -0.977 . . . . 75.54 109.835 -176.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 9.3 mtp -60.63 -51.26 70.15 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 119.069 -0.491 . . . . 65.21 110.379 174.102 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -63.64 -29.16 70.44 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 118.86 0.754 . . . . 73.41 112.435 -174.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 14.7 mtmt -61.47 -75.15 0.07 Allowed 'General case' 0 CA--C 1.522 -0.102 0 N-CA-C 107.86 -1.163 . . . . 74.11 107.86 165.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -49.12 -35.07 15.44 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.228 1.011 . . . . 74.43 112.619 -169.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 9.9 tmtt? -58.02 -46.94 84.48 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 126.301 1.84 . . . . 72.21 112.366 177.357 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 9.5 ptpp? -77.79 -33.44 52.59 Favored 'General case' 0 C--N 1.34 0.176 0 CA-C-N 120.824 1.647 . . . . 62.34 111.199 173.573 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 41.5 mt -59.35 -46.21 89.27 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 119.032 0.833 . . . . 71.24 109.973 -174.151 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -58.67 -37.03 75.12 Favored 'General case' 0 CA--C 1.534 0.349 0 O-C-N 121.814 -0.554 . . . . 60.53 111.592 -178.357 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 1.1 mtm -76.8 -31.85 57.25 Favored 'General case' 0 C--O 1.23 0.044 0 O-C-N 122.138 -0.352 . . . . 64.32 110.857 179.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -56.46 -46.24 80.47 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 108.82 -0.808 . . . . 75.45 108.82 172.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 35.8 m-85 -76.74 10.16 2.38 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 114.175 1.176 . . . . 75.24 114.175 177.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 59.1 23.47 11.69 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 127.562 2.345 . . . . 54.12 113.98 176.004 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.814 HG22 HG21 ' A' ' 155' ' ' THR . 66.4 t -67.05 133.97 30.76 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 C-N-CA 124.031 0.932 . . . . 71.2 108.653 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -130.49 -5.65 4.21 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 125.244 1.418 . . . . 75.32 113.132 -177.641 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 170.98 139.51 2.78 Favored Glycine 0 N--CA 1.448 -0.541 0 N-CA-C 107.666 -2.173 . . . . 64.24 107.666 174.174 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.429 ' HA ' ' C ' ' A' ' 154' ' ' PRO . 17.2 m -83.37 152.72 64.84 Favored Pre-proline 0 CA--C 1.534 0.364 0 C-N-CA 124.559 1.144 . . . . 70.44 109.647 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . 0.486 ' HG3' HD12 ' A' ' 166' ' ' ILE . 53.7 Cg_endo -70.74 157.71 94.59 Favored 'Cis proline' 0 CA--C 1.531 0.359 0 C-N-CA 125.15 -0.771 . . . . 75.35 113.623 3.405 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . 0.814 HG21 HG22 ' A' ' 150' ' ' VAL . 36.5 m -157.13 115.17 3.19 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 107.461 -1.311 . . . . 71.01 107.461 175.338 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 93.7 mtp -96.3 158.24 15.53 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 108.705 -0.85 . . . . 75.53 108.705 164.01 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 5.2 t -136.48 138.47 46.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 106.586 -1.635 . . . . 74.13 106.586 174.365 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.54 HG23 ' CE1' ' A' ' 164' ' ' PHE . 51.2 t -103.18 125.22 57.66 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 N-CA-C 106.734 -1.58 . . . . 74.21 106.734 164.184 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 9.4 t30 52.98 21.54 2.08 Favored 'General case' 0 N--CA 1.462 0.153 0 C-N-CA 130.89 3.676 . . . . 72.15 115.521 162.112 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 73.34 22.62 78.57 Favored Glycine 0 CA--C 1.526 0.72 0 CA-C-O 117.69 -1.617 . . . . 51.21 114.068 -176.415 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 10.4 mtpt -134.18 -24.4 1.64 Allowed 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 120.248 2.024 . . . . 72.41 113.122 -174.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -128.2 120.2 26.78 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 124.179 0.991 . . . . 74.12 109.033 -173.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 41.5 ttp85 -102.56 126.83 49.76 Favored 'General case' 0 CA--C 1.52 -0.178 0 C-N-CA 126.117 1.767 . . . . 71.23 107.886 174.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . 0.54 ' CE1' HG23 ' A' ' 158' ' ' VAL . 13.4 p90 -145.28 174.0 11.48 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 107.277 -1.379 . . . . 73.53 107.277 177.375 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 174.89 -175.25 0.08 Allowed 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 125.437 1.495 . . . . 63.41 108.595 176.423 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.486 HD12 ' HG3' ' A' ' 154' ' ' PRO . 6.5 mt -45.58 -52.27 2.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 C-N-CA 129.901 3.281 . . . . 63.2 108.574 172.624 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -75.61 19.28 2.6 Favored Glycine 0 CA--C 1.524 0.641 0 C-N-CA 128.062 2.744 . . . . 74.12 114.911 176.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 19.2 m -129.27 -50.1 1.19 Allowed 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 119.315 1.557 . . . . 62.1 110.847 157.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -71.16 -19.56 62.4 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.691 0.797 . . . . 72.44 111.944 -174.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 103.44 4.14 46.83 Favored Glycine 0 CA--C 1.525 0.66 0 O-C-N 120.624 -1.298 . . . . 62.35 113.296 175.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . 0.438 ' HA2' HG23 ' A' ' 166' ' ' ILE . . . 154.03 177.06 27.07 Favored Glycine 0 CA--C 1.53 0.981 0 CA-C-N 119.239 1.52 . . . . 63.53 111.268 172.339 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -65.07 -37.51 32.55 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 122.851 2.367 . . . . 65.23 113.38 -169.318 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -69.37 -42.32 75.37 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 119.454 1.025 . . . . 74.51 108.413 -178.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 51.2 mm-40 -66.03 -26.89 67.73 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.685 1.194 . . . . 64.43 110.235 179.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 46.0 m -64.36 -41.34 96.77 Favored 'General case' 0 CA--C 1.534 0.354 0 O-C-N 120.075 -1.641 . . . . 64.54 110.638 -178.276 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 36.9 mt -65.88 -32.04 73.32 Favored 'General case' 0 C--N 1.341 0.203 0 CA-C-N 119.061 0.846 . . . . 72.12 110.532 175.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.03 -39.8 69.53 Favored 'General case' 0 CA--C 1.522 -0.127 0 C-N-CA 124.903 1.281 . . . . 70.23 109.535 174.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.494 HD21 ' HB3' ' A' ' 11' ' ' GLU . 4.5 mm? -78.21 -41.48 34.33 Favored 'General case' 0 CA--C 1.505 -0.763 0 CA-C-O 117.638 -1.172 . . . . 70.1 111.076 173.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -55.63 -45.97 77.49 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 119.52 1.055 . . . . 55.35 109.889 -172.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.93 -37.6 55.01 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 125.204 1.401 . . . . 55.53 109.519 -167.643 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 12.9 t80 -67.78 -47.8 68.13 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.512 1.125 . . . . 65.33 111.253 173.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 78.8 mt -63.33 -35.88 81.85 Favored 'General case' 0 C--O 1.232 0.169 0 C-N-CA 123.889 0.876 . . . . 64.44 110.83 -176.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 34.7 mt -53.31 -54.61 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 CA-C-O 118.338 -0.839 . . . . 73.32 109.181 170.275 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -55.92 -41.78 75.08 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 119.554 1.07 . . . . 73.13 111.553 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.86 -55.72 27.34 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 125.157 1.383 . . . . 74.45 108.267 -179.363 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 26.4 mm-40 -71.38 -32.74 68.82 Favored 'General case' 0 C--O 1.225 -0.186 0 C-N-CA 124.514 1.125 . . . . 73.34 113.094 -178.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.91 -24.52 62.46 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 120.762 -1.211 . . . . 44.41 111.719 -178.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 0.259 0 C-N-CA 123.302 0.641 . . . . 71.12 111.928 171.725 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 . . . . . 0 N--CA 1.445 -0.691 0 N-CA-C 103.341 -2.837 . . . . 65.51 103.341 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -143.03 6.87 1.58 Allowed 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.527 0.679 . . . . 61.43 111.723 -166.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 -132.87 178.96 6.47 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.561 1.144 . . . . 71.34 109.619 -168.422 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.0 m -148.05 141.93 25.78 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.588 1.555 . . . . 71.03 109.467 175.313 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.98 137.28 56.4 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 124.338 1.055 . . . . 72.33 110.043 178.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.7 -17.4 15.54 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 125.959 1.742 . . . . 21.53 112.76 -171.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 4.4 ttmt -92.86 -86.47 0.25 Allowed 'General case' 0 CA--C 1.519 -0.218 0 CA-C-N 119.028 1.414 . . . . 63.11 107.783 -176.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.422 ' HB3' HD21 ' A' ' 178' ' ' LEU . 0.4 OUTLIER -77.53 -21.34 52.77 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.627 0.771 . . . . 63.21 110.364 -175.354 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 14.0 p90 -161.51 175.95 11.59 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.784 1.234 . . . . 64.11 109.296 -175.196 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 41.3 t -135.05 154.41 36.21 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.811 0 C-N-CA 126.377 1.871 . . . . 63.5 108.321 -175.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -103.88 170.59 7.84 Favored 'General case' 0 CA--C 1.521 -0.164 0 O-C-N 119.649 -1.907 . . . . 51.35 109.63 166.209 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -128.56 113.22 15.18 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 106.956 -1.498 . . . . 73.33 106.956 169.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.4 m -58.43 -15.06 9.27 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 117.129 -1.415 . . . . 73.21 113.744 176.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.6 m -107.96 75.91 0.56 Allowed Pre-proline 0 C--N 1.343 0.307 0 CA-C-N 120.526 1.512 . . . . 41.54 110.179 169.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -71.54 174.46 10.92 Favored 'Trans proline' 0 N--CA 1.444 -1.386 0 C-N-CA 123.19 2.594 . . . . 70.12 110.241 178.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 64.7 t -139.26 125.76 12.51 Favored Pre-proline 0 C--N 1.323 -0.583 0 N-CA-C 107.042 -1.466 . . . . 53.22 107.042 -165.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -73.78 174.84 11.62 Favored 'Trans proline' 0 N--CA 1.453 -0.892 0 C-N-CA 122.646 2.231 . . . . 75.54 110.897 178.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 34.0 m -139.39 -174.03 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 C-N-CA 124.645 1.178 . . . . 64.33 109.404 178.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 15.2 t -48.19 -68.89 0.14 Allowed 'General case' 0 N--CA 1.442 -0.852 0 C-N-CA 128.17 2.588 . . . . 73.35 110.458 172.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -152.94 163.47 23.4 Favored Pre-proline 0 CA--C 1.534 0.354 0 C-N-CA 124.399 1.08 . . . . 52.32 110.297 174.36 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -78.79 -7.1 15.51 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 124.058 3.172 . . . . 64.32 113.095 177.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -58.15 -37.29 85.85 Favored Glycine 0 C--N 1.338 0.667 0 C-N-CA 125.537 1.541 . . . . 71.11 113.605 -170.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 28.2 mttp -119.32 124.58 46.99 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 126.388 1.875 . . . . 73.23 106.087 165.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 44.7 mm -54.98 136.26 17.23 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 N-CA-C 106.931 -1.507 . . . . 51.12 106.931 168.2 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -104.4 93.12 4.63 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 106.425 -1.695 . . . . 71.45 106.425 -176.112 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 26.6 t -88.31 135.86 24.62 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 N-CA-C 106.624 -1.621 . . . . 74.51 106.624 174.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 33.6 t -129.31 135.84 60.83 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 N-CA-C 107.243 -1.392 . . . . 61.21 107.243 -176.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 15.9 tm-20 -114.0 140.57 48.32 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 125.133 1.373 . . . . 72.01 107.699 167.063 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.4 mp -130.76 114.72 15.7 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 124.615 1.166 . . . . 70.54 108.466 -179.54 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 18.9 p90 -107.36 174.85 5.7 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 124.603 1.161 . . . . 74.3 111.931 -176.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 22.6 t90 -145.34 162.01 38.27 Favored 'General case' 0 C--O 1.225 -0.219 0 C-N-CA 125.068 1.347 . . . . 72.5 107.999 162.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 59.8 t80 -56.7 -42.43 79.1 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 126.062 1.745 . . . . 75.52 112.121 172.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -95.39 29.73 9.2 Favored Glycine 0 CA--C 1.531 1.089 0 O-C-N 120.938 -1.101 . . . . 61.34 113.665 -168.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 23.3 t -106.03 81.87 0.82 Allowed Pre-proline 0 CA--C 1.537 0.472 0 C-N-CA 130.474 3.51 . . . . 74.24 111.528 -173.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -79.14 62.02 8.35 Favored 'Trans proline' 0 CA--C 1.544 1.023 0 C-N-CA 121.694 1.596 . . . . 74.24 111.482 -177.457 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 -160.35 -49.99 0.05 OUTLIER 'General case' 0 C--O 1.226 -0.182 0 C-N-CA 126.123 1.769 . . . . 74.42 109.095 -178.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 1.1 p -61.52 -37.36 83.45 Favored 'General case' 0 CA--C 1.548 0.872 0 CA-C-O 121.769 0.795 . . . . 74.13 110.339 -173.036 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -61.76 -29.15 69.94 Favored 'General case' 0 N--CA 1.468 0.465 0 O-C-N 120.084 -1.635 . . . . 73.22 112.87 176.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -78.01 3.61 14.34 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.903 1.281 . . . . 51.35 111.107 177.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 24.4 t80 -125.49 -27.78 3.39 Favored 'General case' 0 C--O 1.223 -0.308 0 C-N-CA 126.781 2.033 . . . . 72.2 111.0 178.161 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -39.51 -65.76 0.39 Allowed Pre-proline 0 CA--C 1.544 0.712 0 CA-C-N 120.286 1.403 . . . . 74.44 114.638 -177.128 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -75.89 -9.05 19.43 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 CA-C-N 122.17 1.811 . . . . 73.24 114.185 -178.116 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 4.2 m -68.44 -42.68 78.51 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 108.45 -0.944 . . . . 73.13 108.45 164.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 19.9 tt -88.21 -34.55 7.23 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 N-CA-C 112.762 0.652 . . . . 73.03 112.762 -172.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 16.2 t -44.73 -54.72 12.14 Favored Pre-proline 0 CA--C 1.549 0.936 0 C-N-CA 124.409 1.084 . . . . 44.13 113.464 176.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -74.07 -21.35 18.23 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 121.905 1.737 . . . . 70.43 112.356 -178.136 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 86.3 t90 -66.15 -51.61 56.21 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 118.679 0.672 . . . . 72.12 109.75 170.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 5.1 p -67.05 -24.14 65.96 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 119.075 0.852 . . . . 73.42 112.277 -175.142 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 73.6 mt-10 -59.9 -54.7 43.08 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 120.793 -1.192 . . . . 74.11 110.302 168.451 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 54.5 mmtt -76.68 6.73 5.49 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 125.316 1.446 . . . . 50.15 113.555 -168.278 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 36.6 mt -62.28 157.15 56.29 Favored Pre-proline 0 N--CA 1.448 -0.574 0 C-N-CA 122.986 0.514 . . . . 54.03 111.268 178.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -77.72 174.88 11.93 Favored 'Trans proline' 0 N--CA 1.449 -1.117 0 C-N-CA 124.809 3.673 . . . . 63.41 110.296 173.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -71.26 -5.74 34.47 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.636 0.774 . . . . 73.12 112.888 177.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -95.66 7.88 45.03 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 123.856 0.862 . . . . 60.15 109.847 -176.205 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 22.6 t -138.76 152.75 24.8 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 N-CA-C 107.628 -1.249 . . . . 70.33 107.628 -176.046 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 41.3 t60 -137.47 162.1 34.59 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 107.332 -1.359 . . . . 54.35 107.332 165.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 35.1 t80 -125.99 137.74 53.69 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 124.237 1.015 . . . . 73.52 108.493 -173.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 52.8 t -132.44 147.84 31.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 107.421 -1.325 . . . . 63.13 107.421 -175.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 44.0 mtm180 -124.21 136.0 53.85 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 107.236 -1.394 . . . . 71.33 107.236 163.365 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 92.8 mt -129.7 144.91 54.84 Favored Pre-proline 0 C--N 1.328 -0.361 0 O-C-N 123.654 0.596 . . . . 53.01 109.96 172.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -73.9 143.83 33.65 Favored 'Trans proline' 0 N--CA 1.451 -0.984 0 C-N-CA 120.756 0.971 . . . . 75.13 109.835 175.269 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -89.28 106.31 18.36 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 126.297 1.839 . . . . 55.42 107.841 174.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 57.8 mt -102.83 60.09 0.79 Allowed 'General case' 0 C--O 1.237 0.417 0 C-N-CA 125.343 1.457 . . . . 73.34 111.491 -168.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 -88.15 -6.54 57.82 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 114.569 1.322 . . . . 71.11 114.569 -164.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 106.58 -173.22 19.26 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 108.548 -1.821 . . . . 34.21 108.548 -175.152 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.489 ' O ' HG22 ' A' ' 70' ' ' ILE . . . 44.39 64.79 1.91 Allowed Glycine 0 CA--C 1.528 0.904 0 CA-C-O 117.929 -1.484 . . . . 64.33 112.444 173.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.489 HG22 ' O ' ' A' ' 69' ' ' GLY 0.276 2.8 tt 64.96 -15.97 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 131.153 3.781 . . . . 74.53 116.192 -176.486 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 10.4 m95 -57.01 -36.83 70.86 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 121.185 1.811 . . . . 65.2 112.311 -174.256 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -73.02 -40.25 65.31 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-O 118.693 -0.67 . . . . 63.2 112.4 -178.078 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 92.3 t -57.92 -51.67 67.71 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 C-N-CA 123.605 0.762 . . . . 70.42 109.474 -175.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 65.4 m170 -69.23 -0.69 6.45 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.541 1.136 . . . . 65.11 113.259 178.049 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -101.19 -47.85 1.52 Allowed Glycine 0 CA--C 1.526 0.761 0 N-CA-C 109.852 -1.299 . . . . 50.13 109.852 174.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -53.28 -34.02 55.56 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 127.383 2.273 . . . . 75.24 114.684 -164.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -57.98 -42.91 86.08 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-O 117.742 -1.123 . . . . 63.12 112.443 178.469 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -55.4 -54.1 47.9 Favored 'General case' 0 CA--C 1.526 0.042 0 N-CA-C 108.639 -0.875 . . . . 74.31 108.639 -175.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 15.7 mt -55.74 -37.56 68.64 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.664 1.186 . . . . 64.21 110.982 177.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.456 ' HA ' HD11 ' A' ' 134' ' ' ILE . 1.3 m -73.39 -39.76 64.86 Favored 'General case' 0 C--N 1.343 0.324 0 CA-C-N 119.498 1.044 . . . . 72.23 110.588 -177.691 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 1.2 tt -56.3 -51.1 69.46 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 125.219 1.407 . . . . 64.52 108.054 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -62.19 -29.66 70.53 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.694 1.198 . . . . 73.02 110.757 177.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 10.4 t -65.17 -30.66 71.59 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.873 0.869 . . . . 75.12 111.351 -171.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 16.6 mtm . . . . . 0 N--CA 1.468 0.443 0 CA-C-N 119.682 1.128 . . . . 63.11 112.861 173.344 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.321 0 N-CA-C 113.722 1.008 . . . . 44.53 113.722 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 74.9 t -60.81 -69.37 0.18 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.322 0 C-N-CA 124.897 1.279 . . . . 72.43 108.587 170.039 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -60.4 -47.7 84.94 Favored 'General case' 0 CA--C 1.521 -0.165 0 C-N-CA 123.666 0.786 . . . . 74.45 109.814 -175.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -59.61 -26.93 65.86 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 124.198 0.999 . . . . 61.31 111.038 -176.287 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -88.56 -8.96 53.87 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 112.928 0.714 . . . . 43.34 112.928 -179.342 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 14.7 mm -73.27 -60.65 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 N-CA-C 106.053 -1.832 . . . . 74.41 106.053 154.256 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 35.0 p80 -88.27 -70.41 0.64 Allowed 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 114.325 1.231 . . . . 74.12 114.325 -152.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 25.5 mttp -58.76 -31.3 68.23 Favored 'General case' 0 N--CA 1.463 0.19 0 C-N-CA 123.954 0.901 . . . . 53.1 110.74 177.008 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -69.58 -38.47 77.39 Favored 'General case' 0 N--CA 1.452 -0.34 0 O-C-N 121.814 -0.554 . . . . 64.31 110.602 176.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 3.4 t-160 48.77 92.45 0.02 OUTLIER 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 129.578 3.151 . . . . 63.12 110.891 -164.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.529 ' HE3' ' CE1' ' A' ' 114' ' ' PHE . 0.2 OUTLIER -132.85 147.28 52.3 Favored 'General case' 0 CA--C 1.515 -0.392 0 C-N-CA 123.374 0.67 . . . . 72.25 110.667 170.722 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 3.9 ttmt -79.48 95.47 5.82 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 106.249 -1.76 . . . . 73.01 106.249 -175.189 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 90.0 mt -121.07 46.18 2.1 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 126.379 1.872 . . . . 73.53 110.645 -177.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -80.05 8.08 7.83 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 115.025 1.491 . . . . 72.32 115.025 -174.617 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -153.13 153.86 30.13 Favored Pre-proline 0 C--N 1.326 -0.421 0 C-N-CA 124.737 1.215 . . . . 72.03 109.056 -163.201 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_endo -65.29 -42.84 12.27 Favored 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 122.421 2.081 . . . . 75.54 110.759 -170.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -64.61 -36.79 85.4 Favored 'General case' 0 N--CA 1.444 -0.738 0 C-N-CA 124.209 1.004 . . . . 72.32 111.449 -177.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -65.74 -52.9 47.45 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 125.8 1.64 . . . . 71.34 110.192 175.065 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 49.6 mtm -59.3 -43.51 92.6 Favored 'General case' 0 CA--C 1.529 0.164 0 O-C-N 121.804 -0.56 . . . . 74.45 110.616 178.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.406 ' HB1' ' CG ' ' A' ' 122' ' ' LYS . . . -61.46 -52.24 65.36 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 124.195 0.998 . . . . 64.32 109.676 177.575 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -50.81 -46.48 59.86 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 125.371 1.469 . . . . 73.1 110.696 -179.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . 0.529 ' CE1' ' HE3' ' A' ' 103' ' ' LYS . 57.5 t80 -61.15 -41.75 97.32 Favored 'General case' 0 N--CA 1.449 -0.497 0 O-C-N 121.768 -0.582 . . . . 74.44 112.217 -178.001 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 36.7 mt -83.28 -16.53 45.94 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 123.782 0.833 . . . . 75.43 111.144 -174.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -72.53 66.61 0.71 Allowed 'General case' 0 C--O 1.234 0.267 0 C-N-CA 127.539 2.336 . . . . 64.23 110.891 -171.049 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -178.4 -37.81 0.06 OUTLIER Glycine 0 N--CA 1.442 -0.95 0 C-N-CA 127.557 2.503 . . . . 35.41 109.941 -177.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 1.7 ptpt -86.32 3.12 44.76 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 119.428 1.614 . . . . 74.0 114.111 -163.186 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 118.36 -2.77 16.1 Favored Glycine 0 N--CA 1.449 -0.499 0 CA-C-O 118.694 -1.059 . . . . 61.25 111.135 -167.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 42.5 t -96.7 149.48 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.948 0 N-CA-C 103.642 -2.725 . . . . 74.24 103.642 169.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -124.34 143.35 50.63 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 106.942 -1.503 . . . . 62.1 106.942 169.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.406 ' CG ' ' HB1' ' A' ' 112' ' ' ALA . 24.4 mtpt -55.8 -48.86 74.64 Favored 'General case' 0 CA--C 1.516 -0.327 0 CA-C-O 118.56 -0.733 . . . . 65.41 109.285 178.494 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -55.01 -35.91 64.9 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 118.71 0.687 . . . . 70.33 111.779 -177.108 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 27.8 mmmt -94.99 -29.54 14.58 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 123.537 0.735 . . . . 74.1 109.392 -165.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 82.1 t80 -66.55 -64.57 0.83 Allowed 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 127.2 2.2 . . . . 73.32 109.413 169.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 12.8 mt -58.27 -43.75 88.08 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.236 1.014 . . . . 71.1 109.939 -170.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 22.7 t -52.68 -26.49 14.03 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 126.294 1.838 . . . . 54.34 113.176 -179.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . 0.416 HG23 HG23 ' A' ' 80' ' ' THR 0.278 1.4 t -116.73 -23.55 8.09 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 119.363 0.983 . . . . 70.33 110.712 -176.262 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . 0.429 ' HA ' HG13 ' A' ' 134' ' ' ILE . 27.9 t80 -53.59 -52.57 59.35 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.721 1.208 . . . . 73.11 108.84 166.2 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 18.0 m-80 -91.98 38.85 1.0 Allowed 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 124.551 1.141 . . . . 74.51 110.574 -177.016 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 3.2 t -140.06 169.95 16.75 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 114.627 1.343 . . . . 53.52 114.627 178.187 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -52.98 -30.6 35.93 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 126.802 2.041 . . . . 73.52 111.133 -179.458 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -52.33 -63.73 1.05 Allowed 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 125.351 1.461 . . . . 74.33 110.824 173.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.456 HD11 ' HA ' ' A' ' 80' ' ' THR . 11.5 mm -63.55 -27.37 42.83 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.141 0 O-C-N 121.452 -0.78 . . . . 75.41 112.298 176.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.09 -40.44 73.64 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 119.604 1.093 . . . . 70.12 109.708 173.275 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -64.84 -26.63 71.31 Favored Glycine 0 CA--C 1.532 1.114 0 C-N-CA 124.569 1.08 . . . . 61.52 112.744 177.295 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 6.9 mt-30 -85.42 -45.31 11.98 Favored 'General case' 0 C--O 1.235 0.291 0 O-C-N 120.943 -1.328 . . . . 60.41 110.287 179.239 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 82.4 mmm -61.84 -31.45 71.7 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 123.645 0.778 . . . . 71.02 110.764 179.275 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -64.73 -51.84 60.25 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 119.502 1.046 . . . . 71.51 111.321 175.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 5.8 mttm -62.82 -57.57 10.42 Favored 'General case' 0 CA--C 1.512 -0.497 0 C-N-CA 123.761 0.824 . . . . 64.34 109.29 -175.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -52.95 -40.52 63.73 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 119.494 -0.289 . . . . 72.45 110.883 -176.4 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.68 -62.14 2.02 Favored 'General case' 0 C--N 1.343 0.292 0 CA-C-N 118.7 0.682 . . . . 73.53 110.007 174.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 8.0 ptmt -68.52 -16.55 63.92 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 113.019 0.748 . . . . 72.23 113.019 -169.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 65.9 mt -69.47 -59.65 2.84 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 123.687 0.795 . . . . 74.15 110.104 168.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -54.51 -43.72 72.1 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 118.736 0.698 . . . . 73.04 112.531 -173.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 2.1 ptm -63.21 -44.4 95.43 Favored 'General case' 0 N--CA 1.468 0.458 0 O-C-N 121.677 -0.639 . . . . 75.4 112.377 175.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -64.11 -40.82 97.03 Favored 'General case' 0 CA--C 1.536 0.433 0 O-C-N 121.893 -0.505 . . . . 75.43 109.739 -178.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 21.5 m-85 -70.42 9.0 0.68 Allowed 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 126.944 2.098 . . . . 65.23 113.426 173.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 58.3 mt-30 53.76 35.54 21.65 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 126.612 1.965 . . . . 75.12 114.046 178.415 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.437 HG22 HG21 ' A' ' 155' ' ' THR . 43.4 t -77.68 89.21 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 O-C-N 120.698 -1.251 . . . . 72.2 108.602 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -82.34 -12.13 58.16 Favored 'General case' 0 N--CA 1.469 0.496 0 O-C-N 120.586 -1.321 . . . . 60.12 113.458 177.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -171.18 -171.64 36.59 Favored Glycine 0 CA--C 1.524 0.639 0 C-N-CA 125.216 1.389 . . . . 73.53 109.65 -173.066 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.438 ' HA ' ' C ' ' A' ' 154' ' ' PRO . 29.0 m -137.92 158.38 71.48 Favored Pre-proline 0 CA--C 1.544 0.72 0 C-N-CA 124.756 1.222 . . . . 45.54 109.155 178.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . 0.438 ' C ' ' HA ' ' A' ' 153' ' ' VAL . 31.4 Cg_endo -62.49 152.17 65.46 Favored 'Cis proline' 0 N--CA 1.452 -0.969 0 C-N-CA 123.569 -1.429 . . . . 74.0 112.788 -10.221 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . 0.437 HG21 HG22 ' A' ' 150' ' ' VAL . 77.6 m -141.07 127.08 19.39 Favored 'General case' 0 N--CA 1.443 -0.805 0 C-N-CA 126.457 1.903 . . . . 74.44 107.013 170.041 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 33.1 mmm -107.08 160.27 15.68 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 124.908 1.283 . . . . 65.01 107.57 159.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 6.3 t -142.02 148.29 20.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 106.955 -1.498 . . . . 74.41 106.955 177.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.504 HG23 ' CE1' ' A' ' 164' ' ' PHE . 58.8 t -121.36 126.0 74.39 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 N-CA-C 106.314 -1.735 . . . . 63.24 106.314 168.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 55.25 17.82 2.21 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 127.339 2.256 . . . . 65.12 115.006 171.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 58.41 31.37 66.32 Favored Glycine 0 CA--C 1.53 0.969 0 CA-C-O 117.926 -1.485 . . . . 72.35 112.791 -168.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 1.2 mtpm? -126.38 -42.88 1.8 Allowed 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 119.656 1.728 . . . . 73.34 111.779 -177.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -111.65 147.34 35.73 Favored 'General case' 0 CA--C 1.511 -0.551 0 N-CA-C 106.941 -1.503 . . . . 74.2 106.941 179.11 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 41.4 ttp85 -125.01 135.87 53.18 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 105.601 -2.0 . . . . 72.31 105.601 175.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . 0.504 ' CE1' HG23 ' A' ' 158' ' ' VAL . 7.4 p90 -153.54 171.41 18.78 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 107.295 -1.372 . . . . 72.22 107.295 -178.578 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 174.97 176.33 0.17 Allowed 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 123.726 0.81 . . . . 64.22 108.915 -178.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 38.7 mt -57.14 -35.2 47.41 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 C-N-CA 128.266 2.626 . . . . 72.41 110.268 -173.271 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -86.62 -3.55 83.73 Favored Glycine 0 CA--C 1.525 0.687 0 CA-C-O 117.617 -1.657 . . . . 41.42 113.278 -177.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 19.4 m -105.72 -54.59 2.46 Favored 'General case' 0 C--N 1.342 0.248 0 CA-C-N 119.04 1.42 . . . . 75.11 108.86 168.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -60.74 -29.14 69.2 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 125.234 1.414 . . . . 44.21 112.4 -179.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 98.43 8.59 54.65 Favored Glycine 0 CA--C 1.527 0.841 0 CA-C-O 119.115 -0.825 . . . . 73.05 113.712 175.396 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 163.68 171.42 29.9 Favored Glycine 0 CA--C 1.527 0.827 0 CA-C-N 119.543 1.671 . . . . 72.52 111.781 177.299 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -69.37 -44.34 2.41 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 122.097 1.864 . . . . 60.24 111.129 -175.197 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -68.6 -34.45 75.8 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 118.913 0.779 . . . . 71.21 109.473 179.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -62.8 -33.27 74.86 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 123.226 0.611 . . . . 75.02 109.828 176.181 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 37.1 m -65.41 -40.55 93.52 Favored 'General case' 0 CA--C 1.534 0.358 0 O-C-N 120.924 -1.11 . . . . 65.42 109.332 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 58.7 mt -64.55 -36.46 84.28 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 119.644 1.111 . . . . 70.13 110.647 175.009 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 27.0 tttt -50.93 -51.76 49.0 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.176 0.991 . . . . 55.43 108.904 172.344 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.428 HD13 ' HA ' ' A' ' 178' ' ' LEU . 4.2 mm? -67.67 -40.85 84.45 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-O 118.415 -0.803 . . . . 52.53 111.143 177.56 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -56.59 -41.59 77.24 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 119.05 0.841 . . . . 52.21 111.347 -174.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -85.93 -36.75 19.68 Favored 'General case' 0 CA--C 1.511 -0.532 0 N-CA-C 109.171 -0.677 . . . . 74.2 109.171 -168.271 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -59.3 -54.17 49.85 Favored 'General case' 0 N--CA 1.438 -1.059 0 N-CA-C 109.064 -0.717 . . . . 74.32 109.064 170.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 90.9 mt -61.93 -32.04 72.41 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-O 118.271 -0.871 . . . . 73.34 112.47 -175.135 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 26.6 mt -51.16 -65.97 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.212 0 CA-C-N 119.211 0.914 . . . . 72.11 109.352 166.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 9.8 tm-20 -69.76 -20.09 63.5 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.984 0.913 . . . . 64.42 112.101 -171.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.24 -52.95 60.09 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 124.962 1.305 . . . . 64.34 109.05 168.551 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 42.2 mm-40 -74.99 -39.7 61.1 Favored 'General case' 0 C--N 1.334 -0.104 0 C-N-CA 123.578 0.751 . . . . 72.44 111.891 -176.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.14 -36.03 74.53 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 124.023 0.929 . . . . 75.41 109.767 -177.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.381 0 C-N-CA 124.273 1.029 . . . . 55.31 112.417 177.981 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.234 0.288 0 N-CA-C 108.155 -1.054 . . . . 53.11 108.155 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -117.83 10.99 13.4 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 113.172 0.805 . . . . 71.31 113.172 -171.214 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -141.55 164.15 30.99 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 125.558 1.543 . . . . 75.41 107.705 -173.356 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 29.4 m -133.04 130.98 40.11 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.14 -0.689 . . . . 72.03 109.14 -176.046 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.36 124.18 21.57 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 108.061 -1.089 . . . . 61.11 108.061 176.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 101.1 -38.49 3.12 Favored Glycine 0 CA--C 1.527 0.832 0 C-N-CA 128.556 2.979 . . . . 71.12 111.393 -173.303 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 8.4 tptp -75.21 -67.3 0.67 Allowed 'General case' 0 C--O 1.226 -0.163 0 C-N-CA 126.364 1.866 . . . . 73.15 109.442 -175.15 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 5.3 mp0 -93.28 -28.65 16.09 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 126.229 1.812 . . . . 71.23 109.691 -173.237 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 55.2 p90 -152.54 167.26 29.41 Favored 'General case' 0 N--CA 1.469 0.523 0 O-C-N 121.012 -1.055 . . . . 73.52 110.73 -171.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 93.4 t -133.51 117.01 26.09 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-N 119.661 1.119 . . . . 74.33 109.716 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -71.71 166.75 21.3 Favored 'General case' 0 N--CA 1.447 -0.614 0 O-C-N 121.085 -1.009 . . . . 73.11 110.727 174.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -126.68 104.48 8.11 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 124.803 1.241 . . . . 63.42 108.207 173.055 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 44.2 p -67.52 -6.39 19.55 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 124.068 0.947 . . . . 70.01 112.425 176.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 70.0 m -104.86 80.51 0.49 Allowed Pre-proline 0 N--CA 1.451 -0.396 0 N-CA-C 107.006 -1.479 . . . . 64.33 107.006 160.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -70.95 -179.48 3.48 Favored 'Trans proline' 0 N--CA 1.452 -0.969 0 C-N-CA 123.224 2.616 . . . . 60.23 110.519 -177.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 11.8 t -140.21 136.18 16.76 Favored Pre-proline 0 CA--C 1.534 0.361 0 N-CA-C 108.365 -0.976 . . . . 72.42 108.365 178.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -76.53 174.68 12.43 Favored 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 122.603 2.202 . . . . 53.32 111.413 172.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.4 m -112.18 -174.91 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 125.906 1.682 . . . . 63.04 109.539 179.184 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 21.4 m -67.01 -51.84 49.99 Favored 'General case' 0 N--CA 1.45 -0.465 0 O-C-N 121.318 -0.864 . . . . 75.2 109.484 170.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -146.41 161.03 40.26 Favored Pre-proline 0 N--CA 1.446 -0.63 0 C-N-CA 124.176 0.99 . . . . 73.33 109.636 177.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -69.28 -164.58 0.12 Allowed 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 124.358 3.372 . . . . 74.12 111.726 170.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.74 -110.11 3.96 Favored Glycine 0 N--CA 1.448 -0.531 0 N-CA-C 107.457 -2.257 . . . . 64.41 107.457 179.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 8.3 mttp -63.53 135.33 56.78 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 109.639 -0.504 . . . . 42.25 109.639 -178.258 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 38.6 mm -62.3 144.08 14.63 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 N-CA-C 107.423 -1.325 . . . . 73.14 107.423 170.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -101.75 118.62 37.31 Favored 'General case' 0 N--CA 1.458 -0.038 0 N-CA-C 107.564 -1.272 . . . . 74.1 107.564 -177.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 48.8 t -108.77 134.82 49.51 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 N-CA-C 107.716 -1.216 . . . . 43.44 107.716 171.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 6.8 t -132.83 111.05 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 C-N-CA 123.842 0.857 . . . . 72.44 109.814 -174.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 -65.82 127.98 34.16 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 125.255 1.422 . . . . 72.02 108.916 162.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.6 mp -102.45 148.68 25.21 Favored 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 107.596 -1.261 . . . . 53.35 107.596 155.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 37.7 p90 -141.94 170.76 15.12 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 118.848 0.749 . . . . 71.0 111.554 173.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 28.1 t90 -156.41 158.43 37.31 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.889 1.276 . . . . 72.3 110.041 172.323 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 7.4 t80 -70.68 -15.52 62.72 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 113.444 0.905 . . . . 74.41 113.444 -177.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -104.84 12.58 49.83 Favored Glycine 0 CA--C 1.522 0.47 0 CA-C-O 117.554 -1.692 . . . . 74.15 113.067 -175.002 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 24.8 p -112.95 85.3 7.7 Favored Pre-proline 0 CA--C 1.538 0.486 0 CA-C-N 119.938 1.869 . . . . 72.1 108.53 -178.122 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_endo -59.38 -26.31 81.48 Favored 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 121.735 1.623 . . . . 72.15 113.187 -177.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 29.1 m170 -68.27 -23.16 64.74 Favored 'General case' 0 CA--C 1.535 0.379 0 O-C-N 121.346 -0.846 . . . . 71.04 110.89 178.063 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 73.4 m -60.04 -48.06 83.26 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.022 0.929 . . . . 73.03 108.499 171.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 27.1 t80 -63.38 -46.05 88.29 Favored 'General case' 0 N--CA 1.467 0.419 0 O-C-N 120.892 -1.13 . . . . 73.51 111.46 175.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -55.99 -34.9 66.19 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 118.416 0.553 . . . . 52.33 111.737 -176.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -71.23 -23.04 61.93 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 127.174 2.19 . . . . 71.42 113.697 178.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -48.75 -67.05 0.46 Allowed Pre-proline 0 CA--C 1.541 0.614 0 C-N-CA 124.222 1.009 . . . . 61.11 113.21 -165.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -70.93 -6.82 20.03 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 CA-C-N 122.081 1.779 . . . . 72.52 114.636 -177.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.4 m -69.38 -47.4 64.35 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 119.432 1.014 . . . . 72.44 108.318 164.316 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 16.7 tt -94.5 -32.64 4.69 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 C-N-CA 123.814 0.846 . . . . 73.14 112.733 -165.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 22.8 t -49.54 -61.85 3.09 Favored Pre-proline 0 CA--C 1.542 0.646 0 C-N-CA 124.849 1.26 . . . . 75.13 110.551 178.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -64.08 -34.37 58.41 Favored 'Trans proline' 0 N--CA 1.454 -0.795 0 CA-C-N 120.454 1.198 . . . . 75.42 112.329 179.137 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.457 ' CZ2' HD21 ' A' ' 54' ' ' LEU . 72.7 t90 -59.73 -50.57 73.33 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 119.768 1.167 . . . . 73.43 110.679 177.594 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 42.0 t -59.57 -44.9 93.16 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 123.947 0.899 . . . . 25.23 108.97 -176.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 57.5 mt-10 -61.99 -35.61 79.02 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 121.162 -0.961 . . . . 71.1 110.737 178.168 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 70.4 mmtt -77.19 -2.96 37.15 Favored 'General case' 0 C--O 1.237 0.432 0 O-C-N 120.42 -1.425 . . . . 74.1 114.482 177.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.457 HD21 ' CZ2' ' A' ' 50' ' ' TRP . 26.8 mt -54.57 147.21 30.81 Favored Pre-proline 0 C--O 1.237 0.414 0 CA-C-N 120.405 1.457 . . . . 73.04 111.588 -177.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -74.28 164.95 33.0 Favored 'Trans proline' 0 N--CA 1.445 -1.34 0 C-N-CA 124.035 3.157 . . . . 52.44 110.602 -176.062 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -66.23 -4.65 8.13 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 125.753 1.621 . . . . 34.15 115.025 -171.509 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 -118.52 22.71 11.93 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.646 1.579 . . . . 62.5 110.744 179.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 57.8 t -121.61 160.18 23.34 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 N-CA-C 107.531 -1.285 . . . . 73.44 107.531 167.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 75.3 t60 -137.27 152.7 50.09 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 125.766 1.626 . . . . 73.14 107.3 167.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 57.5 t80 -130.79 137.37 49.41 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 123.787 0.835 . . . . 73.45 108.849 -171.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 47.4 t -134.07 155.35 39.42 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 C-N-CA 126.426 1.89 . . . . 73.01 106.906 -173.056 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 4.0 mpt_? -127.07 134.89 50.19 Favored 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 104.364 -2.458 . . . . 74.54 104.364 166.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 68.0 mt -131.85 148.79 71.33 Favored Pre-proline 0 N--CA 1.465 0.293 0 CA-C-N 119.51 1.05 . . . . 74.54 108.629 170.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -69.11 141.78 48.9 Favored 'Trans proline' 0 N--CA 1.451 -1.016 0 C-N-CA 121.421 1.414 . . . . 71.21 110.409 171.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -91.46 67.32 5.6 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 124.535 1.134 . . . . 72.11 108.44 -176.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 54.9 mt -64.8 65.94 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 127.538 2.335 . . . . 74.24 112.724 -171.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -98.2 48.66 1.0 Allowed 'General case' 0 C--O 1.237 0.416 0 C-N-CA 125.229 1.412 . . . . 73.35 111.437 -170.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 67.48 167.83 3.62 Favored Glycine 0 CA--C 1.531 1.034 0 C-N-CA 124.218 0.913 . . . . 74.14 112.11 -177.27 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 50.94 -143.22 14.85 Favored Glycine 0 CA--C 1.526 0.736 0 O-C-N 122.091 -0.653 . . . . 41.52 113.121 176.34 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 4.9 tp -63.63 -11.77 9.58 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 C-N-CA 123.955 0.902 . . . . 73.31 111.547 -173.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 18.4 m95 -73.81 -33.45 64.18 Favored 'General case' 0 CA--C 1.531 0.243 0 O-C-N 120.661 -1.274 . . . . 72.24 110.909 175.2 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -64.78 -44.06 91.22 Favored 'General case' 0 C--O 1.236 0.382 0 O-C-N 121.33 -0.856 . . . . 65.34 109.834 168.072 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 91.5 t -62.78 -53.99 39.66 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 N-CA-C 109.169 -0.678 . . . . 60.2 109.169 -173.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 19.3 m170 -88.96 51.15 2.09 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.864 1.266 . . . . 72.41 109.455 173.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -140.71 -55.53 0.04 OUTLIER Glycine 0 N--CA 1.443 -0.891 0 C-N-CA 124.75 1.167 . . . . 34.54 110.224 167.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.519 ' OE1' HD12 ' A' ' 134' ' ' ILE . 0.0 OUTLIER -55.94 -28.75 58.36 Favored 'General case' 0 CA--C 1.554 1.109 0 N-CA-C 114.617 1.34 . . . . 62.54 114.617 -166.223 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 34.8 ttp -58.22 -38.14 76.23 Favored 'General case' 0 N--CA 1.469 0.489 0 O-C-N 119.299 -2.126 . . . . 74.3 112.119 -176.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 27.9 t80 -56.12 -50.28 71.55 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 123.774 0.83 . . . . 63.41 109.5 -179.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 42.3 mt -66.1 -42.43 89.28 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-O 117.495 -1.241 . . . . 74.53 109.825 179.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.669 ' HA ' HD11 ' A' ' 134' ' ' ILE . 0.2 OUTLIER -58.39 -42.36 86.93 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 120.317 1.417 . . . . 71.22 110.623 -178.192 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -54.94 -52.13 63.95 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 125.131 1.372 . . . . 65.24 108.813 -174.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -78.79 -25.37 44.29 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.415 0.686 . . . . 74.32 111.505 -177.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 12.6 t -62.49 -33.42 74.84 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 125.124 1.37 . . . . 74.11 111.387 176.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . 0.41 ' SD ' ' HA ' ' A' ' 125' ' ' PHE . 30.6 mtp . . . . . 0 C--O 1.236 0.382 0 C-N-CA 125.718 1.607 . . . . 71.54 111.616 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 0.262 0 CA-C-O 117.748 -1.12 . . . . 64.14 112.869 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 57.9 t -45.06 -65.32 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 124.845 1.258 . . . . 63.45 110.987 166.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -57.87 -46.34 85.01 Favored 'General case' 0 C--O 1.226 -0.146 0 CA-C-N 118.583 0.629 . . . . 75.32 110.722 178.289 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -59.27 -37.54 77.89 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.499 0.72 . . . . 73.25 110.637 -174.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.473 ' HB1' ' CE2' ' A' ' 114' ' ' PHE . . . -68.51 -31.72 71.17 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 124.791 1.236 . . . . 44.11 113.016 178.248 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 55.9 mt -78.75 -57.25 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 N-CA-C 105.897 -1.89 . . . . 60.45 105.897 -179.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 85.2 m-70 -74.13 -72.26 0.29 Allowed 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 127.032 2.133 . . . . 73.44 112.031 -172.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 43.5 mttt -65.68 -30.68 71.4 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 119.396 0.998 . . . . 74.32 112.063 -173.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -93.58 -26.76 16.97 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 118.427 0.558 . . . . 72.24 110.788 -173.481 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 49.29 53.2 13.05 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 126.029 1.732 . . . . 74.23 113.766 175.671 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 2.5 mmpt? -85.23 22.33 1.5 Allowed 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.955 1.302 . . . . 60.33 114.401 -173.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 12.2 ttmt 70.29 -69.66 0.17 Allowed 'General case' 0 C--O 1.222 -0.342 0 C-N-CA 128.151 2.58 . . . . 72.44 109.873 -179.33 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.431 ' H ' ' HG2' ' A' ' 110' ' ' GLU . 39.3 mt 63.08 28.93 16.25 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 127.176 2.19 . . . . 75.23 112.342 175.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -79.3 -10.08 59.73 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 115.142 1.534 . . . . 65.33 115.142 -175.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 24.8 p -137.13 159.43 69.86 Favored Pre-proline 0 C--O 1.236 0.39 0 O-C-N 120.932 -1.105 . . . . 40.32 109.08 -177.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -61.55 -34.84 84.34 Favored 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 122.04 1.827 . . . . 73.23 110.607 177.008 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -63.83 -40.28 96.23 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 123.404 0.681 . . . . 74.22 112.216 176.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.431 ' HG2' ' H ' ' A' ' 105' ' ' LEU . 6.9 tp10 -65.01 -48.37 74.19 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.696 0.798 . . . . 72.41 110.123 177.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 57.8 mtt -63.54 -50.46 69.47 Favored 'General case' 0 C--O 1.231 0.09 0 C-N-CA 123.893 0.877 . . . . 75.13 110.773 -179.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.434 ' HB1' ' CG ' ' A' ' 122' ' ' LYS . . . -71.46 -39.46 70.94 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-O 118.414 -0.803 . . . . 62.34 110.234 -170.438 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -61.62 -28.46 69.38 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 119.288 0.949 . . . . 64.43 112.293 176.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . 0.473 ' CE2' ' HB1' ' A' ' 97' ' ' ALA . 86.1 t80 -75.25 -58.76 3.08 Favored 'General case' 0 N--CA 1.443 -0.806 0 O-C-N 121.827 -0.546 . . . . 73.12 110.176 175.047 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 53.8 mt -66.59 -22.48 66.13 Favored 'General case' 0 CA--C 1.532 0.261 0 O-C-N 121.748 -0.595 . . . . 72.11 110.756 -173.37 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -55.93 -17.53 6.78 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 125.215 1.406 . . . . 63.14 112.719 175.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -90.98 -5.83 67.65 Favored Glycine 0 CA--C 1.524 0.625 0 CA-C-O 118.079 -1.4 . . . . 71.44 114.51 174.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 17.2 mmtt -134.79 29.92 3.45 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 120.217 2.009 . . . . 72.45 111.749 -156.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 83.82 29.86 30.81 Favored Glycine 0 CA--C 1.52 0.405 0 N-CA-C 111.558 -0.617 . . . . 64.3 111.558 175.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 87.7 t -123.87 119.15 56.21 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 N-CA-C 107.126 -1.435 . . . . 74.14 107.126 175.404 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 66.3 t0 -70.25 124.37 23.96 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-O 121.185 0.517 . . . . 64.43 109.745 172.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.434 ' CG ' ' HB1' ' A' ' 112' ' ' ALA . 9.5 ttpt -60.15 -40.3 89.41 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 124.128 0.971 . . . . 73.05 110.206 176.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -68.07 -27.25 66.33 Favored 'General case' 0 C--O 1.236 0.347 0 O-C-N 121.489 -0.757 . . . . 71.35 111.325 -177.103 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 52.2 mttm -77.71 -48.13 17.44 Favored 'General case' 0 CA--C 1.509 -0.611 0 N-CA-C 107.217 -1.401 . . . . 71.12 107.217 177.036 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.421 ' CD1' ' HB2' ' A' ' 112' ' ' ALA . 34.0 t80 -44.81 -64.87 0.61 Allowed 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 124.751 1.22 . . . . 71.14 110.592 177.26 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 22.3 mt -68.69 -40.57 79.98 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 119.22 -0.419 . . . . 64.05 110.552 -170.05 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 46.6 t -58.33 -56.73 18.28 Favored 'General case' 0 C--N 1.341 0.209 0 N-CA-C 108.059 -1.089 . . . . 75.25 108.059 -179.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 55.2 m -62.03 -43.3 99.13 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 123.808 0.843 . . . . 33.4 110.325 -176.077 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 45.5 t80 -51.46 -45.86 62.86 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 123.838 0.855 . . . . 72.43 110.591 177.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -98.05 35.06 1.8 Allowed 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.456 1.102 . . . . 60.41 111.155 178.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -120.03 155.84 32.1 Favored 'General case' 0 C--O 1.235 0.316 0 O-C-N 120.929 -1.107 . . . . 74.01 109.807 174.617 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -64.79 -22.3 66.96 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.654 0.782 . . . . 74.41 111.293 174.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -53.95 -29.11 41.27 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 125.173 1.389 . . . . 73.32 113.17 173.333 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.669 HD11 ' HA ' ' A' ' 80' ' ' THR . 11.2 mm -77.23 -39.4 28.48 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.484 0 C-N-CA 123.829 0.852 . . . . 74.2 113.149 169.263 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 9.9 tttp -58.89 -34.61 71.86 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 118.309 -0.853 . . . . 65.24 110.002 -170.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -67.81 -23.4 74.12 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 123.915 0.769 . . . . 53.32 112.952 -178.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -91.28 -45.51 8.57 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 121.923 0.868 . . . . 72.02 108.974 178.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 5.2 ttm -62.17 -40.27 95.46 Favored 'General case' 0 N--CA 1.426 -1.647 0 C-N-CA 126.293 1.837 . . . . 74.0 110.142 -177.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 21.8 pt-20 -69.44 -37.51 77.42 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 120.042 1.292 . . . . 73.2 112.531 -177.04 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 10.2 mmtt -62.59 -59.4 4.98 Favored 'General case' 0 C--O 1.225 -0.23 0 N-CA-C 107.402 -1.333 . . . . 74.42 107.402 171.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -54.78 -43.3 72.68 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 119.56 1.073 . . . . 55.45 111.707 -175.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 11.6 tmtt? -49.77 -64.25 0.87 Allowed 'General case' 0 CA--C 1.518 -0.283 0 C-N-CA 125.167 1.387 . . . . 74.45 110.272 174.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.2 -29.82 64.34 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 120.031 -0.668 . . . . 65.34 110.972 -170.616 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 38.0 mt -61.5 -53.3 58.23 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 123.843 0.857 . . . . 74.44 110.383 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -57.67 -40.76 80.11 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 118.823 0.738 . . . . 53.42 110.814 -175.01 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -64.97 -48.11 75.18 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.769 0.828 . . . . 73.22 110.635 177.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -68.91 -28.97 67.15 Favored 'General case' 0 CA--C 1.533 0.297 0 O-C-N 121.791 -0.568 . . . . 53.14 111.27 -175.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -71.57 7.88 1.29 Allowed 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 125.057 1.343 . . . . 73.22 112.976 171.03 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 57.53 28.42 15.54 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 127.522 2.329 . . . . 74.15 113.335 177.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 15.5 t -77.31 141.55 15.43 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 O-C-N 120.865 -1.147 . . . . 75.33 108.057 -179.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -142.14 10.87 1.95 Allowed 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 121.618 0.723 . . . . 72.23 112.248 179.636 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -171.64 178.98 43.66 Favored Glycine 0 N--CA 1.442 -0.933 0 N-CA-C 108.301 -1.92 . . . . 62.22 108.301 172.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.457 ' HA ' ' C ' ' A' ' 154' ' ' PRO . 0.8 OUTLIER -145.51 147.2 32.51 Favored Pre-proline 0 C--N 1.32 -0.681 0 C-N-CA 126.66 1.984 . . . . 62.12 106.082 -175.155 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . 0.544 ' HG3' HD12 ' A' ' 166' ' ' ILE . 37.6 Cg_endo -65.59 157.67 77.33 Favored 'Cis proline' 0 CA--C 1.531 0.351 0 N-CA-C 114.74 1.015 . . . . 74.33 114.74 3.217 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 18.1 m -158.92 141.05 13.82 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 124.758 1.223 . . . . 73.22 109.227 172.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 98.5 mtp -113.38 156.04 24.15 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 126.529 1.932 . . . . 61.45 107.947 165.192 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 40.6 t -135.42 144.19 34.72 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.36 0 N-CA-C 106.898 -1.519 . . . . 72.43 106.898 172.569 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 6.0 t -113.81 124.1 70.12 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 N-CA-C 105.828 -1.916 . . . . 74.31 105.828 172.218 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 48.9 22.58 0.58 Allowed 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 129.948 3.299 . . . . 62.02 115.927 165.305 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 59.67 36.21 88.84 Favored Glycine 0 CA--C 1.527 0.835 0 CA-C-O 118.335 -1.258 . . . . 64.11 114.223 -169.018 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 32.1 mttm -128.37 -44.39 1.4 Allowed 'General case' 0 C--O 1.233 0.222 0 CA-C-N 119.269 1.534 . . . . 63.43 111.887 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -116.84 120.29 38.05 Favored 'General case' 0 C--N 1.332 -0.174 0 O-C-N 122.194 -0.316 . . . . 60.05 110.767 -174.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 35.8 ttp85 -98.75 126.58 44.41 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 106.752 -1.573 . . . . 64.23 106.752 171.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 7.8 p90 -145.36 163.42 34.63 Favored 'General case' 0 C--N 1.316 -0.872 0 O-C-N 120.829 -1.169 . . . . 74.2 108.438 177.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -173.33 173.1 3.61 Favored 'General case' 0 CA--C 1.516 -0.357 0 N-CA-C 109.786 -0.45 . . . . 63.32 109.786 -172.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.544 HD12 ' HG3' ' A' ' 154' ' ' PRO . 9.1 mt -52.48 -47.99 46.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 C-N-CA 127.648 2.379 . . . . 70.53 109.959 -175.644 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -83.54 3.98 83.31 Favored Glycine 0 CA--C 1.526 0.752 0 CA-C-O 117.9 -1.5 . . . . 71.23 114.027 179.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -102.39 -53.73 2.83 Favored 'General case' 0 C--O 1.226 -0.174 0 CA-C-N 120.518 2.159 . . . . 54.44 107.771 166.634 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -60.0 -52.62 64.6 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 123.872 0.869 . . . . 73.21 110.75 -178.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 129.76 8.59 3.41 Favored Glycine 0 CA--C 1.526 0.724 0 CA-C-O 119.092 -0.838 . . . . 61.14 113.882 -176.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 154.96 174.38 24.82 Favored Glycine 0 CA--C 1.528 0.895 0 CA-C-N 119.192 1.496 . . . . 41.21 110.496 178.208 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -62.48 -49.39 5.89 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 122.67 2.247 . . . . 65.23 111.136 -175.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -67.96 -37.34 81.45 Favored 'General case' 0 CA--C 1.53 0.182 0 O-C-N 121.305 -0.872 . . . . 74.22 110.013 -177.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -59.35 -29.93 68.02 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.204 0.601 . . . . 71.41 110.862 175.491 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 30.5 m -66.74 -41.91 87.1 Favored 'General case' 0 CA--C 1.529 0.172 0 O-C-N 120.698 -1.251 . . . . 74.21 109.361 178.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 44.6 mt -63.87 -36.33 83.58 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 118.928 0.786 . . . . 65.53 110.458 174.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -54.39 -44.74 72.55 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 118.219 -0.896 . . . . 73.5 109.585 173.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.448 HD13 ' HA ' ' A' ' 178' ' ' LEU . 4.2 mm? -68.66 -43.39 76.29 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-O 117.711 -1.138 . . . . 73.51 111.867 173.061 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -52.46 -49.81 63.92 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 119.458 1.026 . . . . 70.15 111.367 -170.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -70.68 -36.95 73.58 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 124.103 0.961 . . . . 72.31 111.055 -171.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -68.07 -48.22 66.15 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 126.213 1.805 . . . . 72.43 111.412 177.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 85.1 mt -61.92 -44.03 97.62 Favored 'General case' 0 CA--C 1.527 0.076 0 C-N-CA 123.673 0.789 . . . . 52.31 110.225 -176.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 56.8 mt -51.78 -51.16 29.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 C-N-CA 124.479 1.112 . . . . 72.15 109.387 174.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 14.9 tm-20 -61.18 -27.23 68.27 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 124.512 1.125 . . . . 74.43 112.419 -178.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . 0.472 ' HA ' ' HE3' ' A' ' 185' ' ' LYS . 0.3 OUTLIER -61.7 -60.73 3.23 Favored 'General case' 0 C--O 1.232 0.162 0 N-CA-C 107.833 -1.173 . . . . 51.34 107.833 176.602 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 66.8 mt-10 -67.41 -34.82 78.04 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 125.781 1.632 . . . . 72.15 111.594 -173.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.93 -21.43 64.76 Favored 'General case' 0 N--CA 1.462 0.173 0 O-C-N 120.776 -1.202 . . . . 73.11 111.911 -177.59 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.357 0 C-N-CA 122.979 0.511 . . . . 52.43 111.955 173.535 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 . . . . . 0 CA--C 1.524 -0.035 0 N-CA-C 109.234 -0.654 . . . . 74.11 109.234 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -142.28 9.37 1.86 Allowed 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.029 0.932 . . . . 73.31 112.593 -175.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 34.7 m-85 -142.02 167.16 22.79 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 124.755 1.222 . . . . 75.51 109.687 -170.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 18.9 m -130.87 133.63 46.07 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.697 1.199 . . . . 73.14 109.691 175.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.03 128.7 36.84 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 124.709 1.204 . . . . 70.13 109.98 173.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 71.52 24.33 76.96 Favored Glycine 0 CA--C 1.531 1.037 0 CA-C-O 118.721 -1.044 . . . . 63.24 111.946 -170.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 3.9 ttmt -127.39 -85.77 0.59 Allowed 'General case' 0 CA--C 1.518 -0.263 0 C-N-CA 125.119 1.368 . . . . 51.54 107.866 165.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.491 ' HB3' HD11 ' A' ' 178' ' ' LEU . 36.9 mp0 -64.31 -23.24 67.23 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 123.484 0.713 . . . . 74.11 110.824 -179.758 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 46.0 p90 -162.98 -178.53 6.14 Favored 'General case' 0 N--CA 1.462 0.174 0 O-C-N 121.731 -0.606 . . . . 54.45 111.88 -169.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 85.1 t -140.0 111.95 4.91 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 C-N-CA 125.428 1.491 . . . . 70.45 109.116 -178.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -75.7 163.42 27.31 Favored 'General case' 0 C--O 1.234 0.289 0 O-C-N 119.997 -1.689 . . . . 64.24 109.162 162.498 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -123.77 129.76 51.57 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 124.958 1.303 . . . . 72.12 108.657 -176.514 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 57.1 p -59.79 -27.54 66.65 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-O 118.228 -0.891 . . . . 74.0 112.363 -178.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 9.3 p -114.65 84.19 9.8 Favored Pre-proline 0 N--CA 1.452 -0.345 0 CA-C-N 119.068 0.849 . . . . 72.51 110.507 -175.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -70.75 175.19 9.27 Favored 'Trans proline' 0 N--CA 1.451 -1.01 0 C-N-CA 122.897 2.398 . . . . 64.15 110.915 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 24.6 t -139.18 136.46 18.12 Favored Pre-proline 0 CA--C 1.542 0.644 0 C-N-CA 123.674 0.79 . . . . 74.22 109.122 -167.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -73.05 176.93 8.42 Favored 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 123.917 3.078 . . . . 74.31 112.949 175.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 15.4 m -137.02 164.71 29.53 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 C-N-CA 124.601 1.16 . . . . 75.43 112.63 -167.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 13.4 t -58.49 -30.4 66.98 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 126.769 2.028 . . . . 72.54 112.965 175.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -155.58 86.06 3.29 Favored Pre-proline 0 N--CA 1.446 -0.657 0 CA-C-N 119.636 1.107 . . . . 73.14 109.425 -170.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -65.28 86.8 0.19 Allowed 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 122.224 1.949 . . . . 74.21 108.991 172.186 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -174.25 -41.8 0.05 OUTLIER Glycine 0 CA--C 1.525 0.714 0 CA-C-O 118.846 -0.975 . . . . 73.11 112.296 -165.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 9.5 mptt -108.06 152.19 24.84 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 106.759 -1.571 . . . . 73.11 106.759 160.011 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 32.6 mm -57.81 148.39 5.53 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 N-CA-C 105.868 -1.901 . . . . 63.34 105.868 162.121 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -117.55 117.47 29.51 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 106.958 -1.497 . . . . 72.21 106.958 -178.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 43.1 t -116.61 129.79 72.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 N-CA-C 107.327 -1.361 . . . . 74.12 107.327 179.409 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 4.8 t -118.9 134.37 62.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 106.143 -1.799 . . . . 74.53 106.143 179.427 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -107.89 101.8 11.04 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 104.631 -2.359 . . . . 60.51 104.631 162.031 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.441 HD22 HG21 ' A' ' 150' ' ' VAL . 5.4 mp -82.98 118.67 23.65 Favored 'General case' 0 CA--C 1.522 -0.114 0 N-CA-C 106.917 -1.512 . . . . 72.45 106.917 177.178 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 49.4 p90 -124.22 168.39 13.0 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.163 0.585 . . . . 71.22 112.045 -171.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . 0.493 ' HB3' HG21 ' A' ' 153' ' ' VAL . 22.6 t90 -146.14 143.43 29.32 Favored 'General case' 0 C--N 1.343 0.312 0 C-N-CA 125.142 1.377 . . . . 75.2 109.238 174.614 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 5.4 t80 -49.15 -42.15 38.7 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 126.739 2.016 . . . . 75.21 112.571 171.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -83.57 15.61 34.9 Favored Glycine 0 CA--C 1.525 0.7 0 CA-C-O 119.163 -0.799 . . . . 64.12 113.017 -171.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 53.5 t -105.12 85.62 1.34 Allowed Pre-proline 0 N--CA 1.447 -0.613 0 C-N-CA 126.322 1.849 . . . . 51.02 108.148 178.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -61.44 -32.68 88.92 Favored 'Trans proline' 0 CA--C 1.534 0.5 0 C-N-CA 122.085 1.856 . . . . 70.12 110.279 177.198 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 5.4 m170 -53.44 -48.72 68.55 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 126.201 1.8 . . . . 64.23 110.134 175.258 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 84.1 m -59.57 -38.07 80.17 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.008 0.923 . . . . 73.42 109.555 -168.102 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 38.5 t80 -62.74 -23.45 67.19 Favored 'General case' 0 N--CA 1.47 0.55 0 O-C-N 120.892 -1.13 . . . . 73.34 112.559 179.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -55.96 -40.32 73.07 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 118.983 0.81 . . . . 74.41 110.043 172.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -85.44 -21.66 28.65 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 125.833 1.653 . . . . 62.23 112.681 -168.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -38.93 -67.08 0.28 Allowed Pre-proline 0 N--CA 1.478 0.937 0 C-N-CA 125.348 1.459 . . . . 73.02 112.662 -176.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -73.95 -10.29 22.88 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 CA-C-N 121.803 1.68 . . . . 71.1 114.406 -174.351 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.8 m -72.32 -45.21 60.92 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 107.975 -1.12 . . . . 75.11 107.975 166.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 20.2 tt -92.28 -36.54 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 N-CA-C 113.207 0.817 . . . . 73.42 113.207 -167.376 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 29.3 t -43.5 -60.48 2.51 Favored Pre-proline 0 CA--C 1.543 0.686 0 C-N-CA 125.31 1.444 . . . . 64.15 110.962 175.135 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -69.62 -29.93 23.73 Favored 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 121.725 1.617 . . . . 74.42 112.011 -177.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.49 ' CZ2' ' HB1' ' A' ' 179' ' ' ALA . 72.5 t90 -57.44 -49.75 75.23 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 119.074 0.852 . . . . 75.22 109.209 175.764 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 44.2 t -61.73 -37.08 82.9 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 122.942 0.497 . . . . 61.12 110.636 178.099 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -59.6 -44.66 93.32 Favored 'General case' 0 CA--C 1.533 0.324 0 O-C-N 120.757 -1.214 . . . . 64.15 110.979 176.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -85.99 4.99 35.37 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 119.197 0.908 . . . . 74.04 113.179 -173.486 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 60.7 mt -58.6 148.72 65.34 Favored Pre-proline 0 N--CA 1.447 -0.612 0 N-CA-C 109.785 -0.45 . . . . 73.43 109.785 173.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -70.69 174.45 10.3 Favored 'Trans proline' 0 N--CA 1.447 -1.252 0 C-N-CA 123.982 3.121 . . . . 64.2 110.623 -178.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -67.68 0.95 2.76 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.986 1.314 . . . . 62.23 114.093 178.253 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -117.88 4.08 12.19 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 125.598 1.559 . . . . 65.33 111.916 -170.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 59.5 t -126.4 138.03 55.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 N-CA-C 105.721 -1.955 . . . . 62.25 105.721 179.243 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 3.2 p-80 -126.74 147.14 50.0 Favored 'General case' 0 N--CA 1.444 -0.768 0 C-N-CA 123.827 0.851 . . . . 41.14 109.13 179.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 28.1 t80 -110.96 140.5 45.41 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 124.199 1.0 . . . . 71.11 108.661 -173.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 82.4 t -133.71 113.54 18.66 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.441 0 N-CA-C 108.283 -1.006 . . . . 73.4 108.283 -170.011 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 29.1 mtm180 -101.07 114.96 29.39 Favored 'General case' 0 CA--C 1.506 -0.716 0 N-CA-C 105.84 -1.911 . . . . 64.52 105.84 -175.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 79.1 mt -130.36 145.58 58.02 Favored Pre-proline 0 C--N 1.328 -0.365 0 C-N-CA 123.177 0.591 . . . . 72.31 109.679 175.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -76.65 134.92 15.61 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 122.829 2.353 . . . . 74.03 110.474 172.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -77.11 95.03 4.14 Favored 'General case' 0 CA--C 1.539 0.533 0 O-C-N 121.55 -0.719 . . . . 53.01 110.035 178.058 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 29.6 mt -88.63 75.09 8.33 Favored 'General case' 0 CA--C 1.539 0.553 0 O-C-N 120.057 -1.652 . . . . 75.23 111.372 -172.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -87.0 30.28 0.77 Allowed 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 113.947 1.091 . . . . 75.12 113.947 -175.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 72.31 -165.01 54.42 Favored Glycine 0 CA--C 1.527 0.826 0 N-CA-C 108.341 -1.904 . . . . 51.32 108.341 -168.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 56.34 -156.47 11.64 Favored Glycine 0 CA--C 1.529 0.95 0 CA-C-N 117.891 0.846 . . . . 75.03 113.601 172.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 9.5 tp -61.67 -20.98 24.49 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 C-N-CA 123.481 0.712 . . . . 74.51 112.219 172.182 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 11.9 m95 -59.3 -42.07 90.49 Favored 'General case' 0 C--N 1.343 0.313 0 CA-C-N 120.097 1.317 . . . . 73.35 110.798 -171.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 12.1 p30 -79.93 -28.15 39.75 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 112.979 0.733 . . . . 62.21 112.979 178.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 92.4 t -63.12 -45.99 97.18 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 N-CA-C 108.089 -1.078 . . . . 54.31 108.089 175.055 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 64.2 m170 -76.61 15.13 0.67 Allowed 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 124.759 1.224 . . . . 71.44 112.644 169.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -123.73 -22.48 2.23 Favored Glycine 0 CA--C 1.532 1.141 0 CA-C-N 120.358 1.436 . . . . 53.14 114.182 178.144 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 33.7 tt0 -72.92 -28.98 62.78 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 118.286 1.043 . . . . 65.21 111.553 -172.146 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 6.5 ttp -61.52 -47.79 83.99 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-O 117.512 -1.232 . . . . 73.23 111.724 -177.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 13.7 t80 -52.62 -52.91 53.28 Favored 'General case' 0 N--CA 1.462 0.138 0 N-CA-C 108.813 -0.81 . . . . 74.25 108.813 -176.315 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 47.3 mt -56.61 -44.22 80.93 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 114.829 -1.078 . . . . 71.02 109.993 177.014 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.685 ' HA ' HD11 ' A' ' 134' ' ' ILE . 2.5 m -62.94 -40.92 99.1 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 120.353 1.433 . . . . 73.05 112.087 -174.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -55.88 -54.14 48.26 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.897 0.879 . . . . 61.53 108.76 176.584 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -74.36 -10.71 59.85 Favored 'General case' 0 CA--C 1.543 0.68 0 O-C-N 121.407 -0.808 . . . . 75.44 111.5 -176.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 9.3 t -88.29 -20.03 25.97 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 126.496 1.918 . . . . 71.41 113.578 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 8.5 ptp . . . . . 0 N--CA 1.466 0.334 0 O-C-N 120.89 -1.132 . . . . 74.21 110.072 157.904 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.297 0 N-CA-C 111.65 0.241 . . . . 73.23 111.65 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 48.5 t -53.42 -61.98 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 C-N-CA 124.159 0.983 . . . . 73.3 108.552 171.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.403 ' CD2' ' CD2' ' A' ' 99' ' ' HIS . 4.8 t80 -69.1 -41.95 76.76 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 119.174 -0.441 . . . . 55.13 110.716 -175.142 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -52.86 -39.66 62.75 Favored 'General case' 0 C--O 1.233 0.21 0 C-N-CA 124.671 1.188 . . . . 75.31 111.024 -178.334 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -63.76 -27.53 69.26 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 124.022 0.929 . . . . 72.23 111.055 -176.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 52.2 mt -85.45 -60.51 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.933 0 C-N-CA 125.97 1.708 . . . . 75.15 107.299 176.12 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . 0.403 ' CD2' ' CD2' ' A' ' 95' ' ' PHE . 20.7 p80 -76.18 -57.17 4.02 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 119.719 1.145 . . . . 51.11 113.256 -169.016 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -83.07 -33.15 26.48 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-N 118.404 0.547 . . . . 71.12 110.989 -171.187 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -97.51 -30.77 12.69 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 124.145 0.978 . . . . 75.31 111.091 -171.06 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 5.2 t-160 45.08 88.53 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 127.901 2.48 . . . . 74.1 112.885 176.056 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.488 ' HE2' ' CE1' ' A' ' 114' ' ' PHE . 0.0 OUTLIER -106.38 155.31 19.68 Favored 'General case' 0 CA--C 1.507 -0.7 0 CA-C-O 121.579 0.704 . . . . 73.52 111.128 164.429 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 5.2 ttmt -58.03 101.97 0.09 Allowed 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 106.698 -1.593 . . . . 65.4 106.698 165.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 93.0 mt -130.42 70.1 1.45 Allowed 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 126.934 2.094 . . . . 72.32 108.701 178.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -114.86 1.67 14.13 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.463 1.105 . . . . 62.43 112.619 -175.523 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -138.63 152.57 71.11 Favored Pre-proline 0 CA--C 1.531 0.249 0 C-N-CA 125.342 1.457 . . . . 75.24 109.209 -175.197 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -65.15 -34.02 47.56 Favored 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 121.395 1.396 . . . . 71.33 110.473 -179.424 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -64.37 -21.02 66.5 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 118.536 0.607 . . . . 73.31 112.343 174.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -84.06 -55.06 4.41 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 107.894 -1.15 . . . . 74.45 107.894 177.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 3.9 mpp? -58.21 -51.78 68.33 Favored 'General case' 0 C--N 1.34 0.187 0 C-N-CA 123.213 0.605 . . . . 73.1 111.135 179.374 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.612 ' HB1' ' HG2' ' A' ' 122' ' ' LYS . . . -67.28 -41.45 85.45 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 118.3 -0.857 . . . . 53.43 110.319 -173.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -57.8 -46.98 83.88 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 118.831 0.741 . . . . 74.34 110.006 174.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . 0.488 ' CE1' ' HE2' ' A' ' 103' ' ' LYS . 84.7 t80 -60.48 -46.9 88.39 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 118.015 0.37 . . . . 43.3 110.817 -176.561 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 46.0 mt -75.62 -17.98 59.84 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 119.356 -0.354 . . . . 52.04 111.007 -176.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.18 -9.85 2.41 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.481 1.512 . . . . 41.24 114.115 -179.096 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -121.34 15.37 9.29 Favored Glycine 0 CA--C 1.533 1.194 0 C-N-CA 126.666 2.079 . . . . 75.22 112.808 176.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 2.8 mmpt? -135.01 25.87 3.59 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.905 1.282 . . . . 75.21 110.891 -172.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 94.13 20.69 29.73 Favored Glycine 0 CA--C 1.524 0.617 0 C-N-CA 124.08 0.848 . . . . 64.22 113.529 172.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 94.0 t -132.98 130.01 58.13 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 C-N-CA 124.675 1.19 . . . . 74.13 107.817 -169.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -98.98 134.06 42.36 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 112.251 0.463 . . . . 73.12 112.251 -176.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.612 ' HG2' ' HB1' ' A' ' 112' ' ' ALA . 39.6 mtpt -60.74 -35.07 75.45 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 118.491 -0.766 . . . . 74.34 110.017 176.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -55.87 -46.51 78.24 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 119.086 0.857 . . . . 53.11 110.479 176.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 25.8 mmtt -78.27 -46.27 20.68 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 106.724 -1.584 . . . . 72.23 106.724 -174.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.51 ' CD2' ' HB2' ' A' ' 112' ' ' ALA . 47.6 t80 -54.06 -65.15 0.62 Allowed 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 125.455 1.502 . . . . 72.4 111.391 -176.504 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 9.3 mt -70.45 -33.76 71.68 Favored 'General case' 0 N--CA 1.467 0.418 0 O-C-N 121.146 -0.971 . . . . 55.4 111.06 -166.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 17.1 t -58.02 -57.8 11.21 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 107.198 -1.408 . . . . 62.13 107.198 172.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 38.4 m -62.85 -39.81 95.52 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-O 118.987 -0.53 . . . . 74.31 110.238 -175.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 54.7 t80 -56.42 -41.79 76.97 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 119.975 1.262 . . . . 73.54 110.064 -179.046 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 33.7 m-80 -84.43 -10.78 57.22 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 124.367 1.067 . . . . 74.21 113.745 -179.382 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 4.3 m -86.73 154.93 20.58 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 126.125 1.77 . . . . 71.43 112.645 -169.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -63.01 -29.83 71.13 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 114.171 1.174 . . . . 75.31 114.171 -171.541 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -57.21 -43.99 83.26 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 120.297 1.408 . . . . 54.33 111.231 -177.287 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.685 HD11 ' HA ' ' A' ' 80' ' ' THR . 4.6 mm -58.48 -43.86 87.73 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.496 0 C-N-CA 126.394 1.878 . . . . 72.12 110.721 174.098 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 17.3 tttm -51.82 -37.49 51.99 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.941 0.896 . . . . 61.23 109.161 174.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -71.95 -40.13 57.78 Favored Glycine 0 CA--C 1.527 0.787 0 C-N-CA 124.634 1.111 . . . . 72.33 111.599 179.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -72.22 -34.37 68.29 Favored 'General case' 0 C--N 1.329 -0.311 0 O-C-N 120.906 -1.349 . . . . 72.1 110.551 -179.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 55.1 mtp -65.06 -51.29 62.33 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 124.599 1.16 . . . . 71.21 109.395 176.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -55.88 -38.78 70.62 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 119.298 0.953 . . . . 74.42 110.926 -172.519 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 21.6 mtmt -66.67 -61.6 1.88 Allowed 'General case' 0 C--N 1.342 0.255 0 CA-C-O 117.703 -1.141 . . . . 61.32 110.911 176.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -52.31 -39.13 60.16 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 120.834 1.652 . . . . 54.52 111.298 -177.226 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 11.0 tttt -62.49 -54.46 39.68 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 125.514 1.526 . . . . 54.51 112.454 178.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.01 -30.61 67.97 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 119.824 1.193 . . . . 72.1 110.623 179.166 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 40.3 mt -60.2 -47.25 86.76 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-O 118.932 -0.556 . . . . 72.1 110.558 -177.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -54.76 -45.93 74.28 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 118.016 0.371 . . . . 72.04 111.56 -177.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 13.2 ptp -70.57 -42.05 71.6 Favored 'General case' 0 CA--C 1.523 -0.079 0 N-CA-C 112.117 0.414 . . . . 55.21 112.117 -179.172 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -60.59 -38.53 84.96 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 123.747 0.819 . . . . 52.1 109.126 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 23.4 m-85 -76.47 6.16 6.17 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 114.12 1.155 . . . . 72.12 114.12 175.527 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 54.2 mt-30 57.63 36.19 26.46 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 127.073 2.149 . . . . 71.34 112.829 -179.22 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.441 HG21 HD22 ' A' ' 32' ' ' LEU . 36.1 t -82.94 145.87 7.85 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 N-CA-C 108.072 -1.084 . . . . 71.14 108.072 171.762 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -140.18 -7.79 1.18 Allowed 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 124.53 1.132 . . . . 64.23 112.642 173.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -154.43 -176.77 27.1 Favored Glycine 0 CA--C 1.52 0.396 0 N-CA-C 108.601 -1.8 . . . . 73.13 108.601 -178.209 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.493 HG21 ' HB3' ' A' ' 34' ' ' TRP . 31.4 m -137.49 158.37 72.18 Favored Pre-proline 0 CA--C 1.54 0.563 0 N-CA-C 108.628 -0.879 . . . . 71.44 108.628 174.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . 0.413 ' C ' ' HA ' ' A' ' 153' ' ' VAL . 61.5 Cg_endo -63.05 160.56 59.06 Favored 'Cis proline' 0 N--CA 1.455 -0.771 0 C-N-CA 123.252 -1.562 . . . . 75.51 112.055 -12.026 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . 0.424 HG21 HG22 ' A' ' 150' ' ' VAL . 9.4 m -159.04 111.05 2.16 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 105.537 -2.023 . . . . 71.55 105.537 174.332 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 92.7 mtp -84.39 155.61 22.21 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 108.579 -0.897 . . . . 71.05 108.579 165.143 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 10.0 t -138.48 150.71 24.16 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 N-CA-C 106.82 -1.548 . . . . 75.24 106.82 174.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 55.2 t -134.98 123.79 41.49 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 N-CA-C 105.908 -1.886 . . . . 73.04 105.908 -178.133 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 9.3 m-20 52.33 13.1 0.27 Allowed 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 129.814 3.246 . . . . 74.2 114.598 178.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 59.17 42.31 97.09 Favored Glycine 0 CA--C 1.527 0.785 0 CA-C-O 118.612 -1.105 . . . . 75.44 111.826 -166.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 13.5 mtpp -133.19 -38.85 0.94 Allowed 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 125.119 1.367 . . . . 63.23 111.219 -177.23 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -116.29 154.2 30.59 Favored 'General case' 0 CA--C 1.502 -0.901 0 N-CA-C 108.409 -0.96 . . . . 70.32 108.409 177.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 28.4 ttp85 -132.7 135.11 45.58 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 105.034 -2.21 . . . . 65.24 105.034 174.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 45.5 p90 -149.77 173.26 13.92 Favored 'General case' 0 C--N 1.324 -0.543 0 O-C-N 121.465 -0.772 . . . . 74.32 109.123 169.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -167.5 174.24 8.03 Favored 'General case' 0 CA--C 1.515 -0.367 0 N-CA-C 109.76 -0.459 . . . . 43.3 109.76 178.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 14.7 mt -51.77 -51.27 28.47 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 C-N-CA 125.917 1.687 . . . . 71.5 110.33 -179.183 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -76.09 -20.7 77.23 Favored Glycine 0 CA--C 1.527 0.8 0 CA-C-O 118.096 -1.391 . . . . 70.31 113.467 -178.072 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 66.6 m -70.18 -64.25 0.93 Allowed 'General case' 0 C--O 1.235 0.33 0 CA-C-N 120.011 1.906 . . . . 71.05 108.407 168.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -55.76 -48.74 74.76 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 127.354 2.261 . . . . 71.43 111.943 -174.04 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 130.89 -6.49 5.78 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 124.532 1.063 . . . . 74.3 114.303 178.197 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 165.59 169.67 29.51 Favored Glycine 0 CA--C 1.526 0.758 0 CA-C-N 119.218 1.509 . . . . 52.44 110.413 178.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -61.07 -43.43 29.89 Favored 'Trans proline' 0 N--CA 1.461 -0.439 0 C-N-CA 123.047 2.498 . . . . 74.21 111.351 -174.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 -60.32 -44.43 95.48 Favored 'General case' 0 CA--C 1.536 0.424 0 O-C-N 121.468 -0.77 . . . . 71.31 110.474 176.332 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -66.5 -23.94 66.33 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.511 1.125 . . . . 74.44 110.648 -177.527 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 28.3 m -66.58 -44.31 82.6 Favored 'General case' 0 N--CA 1.455 -0.19 0 O-C-N 121.056 -1.027 . . . . 74.52 109.668 179.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 54.9 mt -68.15 -23.51 64.88 Favored 'General case' 0 C--N 1.341 0.217 0 CA-C-N 118.702 0.683 . . . . 74.15 111.938 179.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.12 -54.9 37.36 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 108.245 -1.02 . . . . 50.44 108.245 168.577 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.491 HD11 ' HB3' ' A' ' 11' ' ' GLU . 3.0 mm? -64.74 -44.69 89.33 Favored 'General case' 0 CA--C 1.515 -0.383 0 N-CA-C 110.016 -0.365 . . . . 70.31 110.016 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.49 ' HB1' ' CZ2' ' A' ' 50' ' ' TRP . . . -54.86 -34.38 62.86 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 112.538 0.57 . . . . 73.12 112.538 -175.018 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -94.61 -36.55 11.74 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 123.475 0.71 . . . . 54.32 110.929 -170.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 37.9 t80 -57.25 -53.45 57.99 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.757 0.823 . . . . 74.21 109.65 171.156 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 26.5 mt -55.75 -46.8 77.75 Favored 'General case' 0 CA--C 1.516 -0.329 0 C-N-CA 124.43 1.092 . . . . 72.43 111.403 -177.154 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 46.2 mt -48.46 -58.65 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.139 0 N-CA-C 109.025 -0.731 . . . . 71.11 109.025 176.378 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 6.9 tm-20 -65.1 -26.64 68.3 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 119.254 0.934 . . . . 73.31 111.882 -176.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 3.7 tmtm? -64.9 -58.28 6.59 Favored 'General case' 0 C--O 1.234 0.282 0 O-C-N 120.645 -1.284 . . . . 62.42 109.634 172.018 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -60.54 -40.8 92.85 Favored 'General case' 0 N--CA 1.438 -1.04 0 C-N-CA 125.525 1.53 . . . . 75.22 112.077 -177.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.68 -43.37 80.31 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 125.859 1.664 . . . . 44.21 110.299 179.428 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.451 0 CA-C-N 119.884 1.22 . . . . 72.43 111.202 -174.708 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . 0.27 0.0 OUTLIER . . . . . 0 N--CA 1.471 0.59 0 CA-C-O 120.561 0.22 . . . . 63.34 110.598 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -152.93 14.48 0.54 Allowed 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.123 0.969 . . . . 74.23 112.127 175.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 25.5 m-85 -146.6 160.72 41.81 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 123.932 0.893 . . . . 74.41 110.275 -167.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 31.5 m -128.78 136.59 50.74 Favored 'General case' 0 C--O 1.238 0.461 0 O-C-N 121.418 -0.801 . . . . 62.31 108.846 -177.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -70.99 149.99 46.1 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 122.119 0.961 . . . . 43.34 109.1 174.229 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 62.32 12.04 36.6 Favored Glycine 0 CA--C 1.533 1.208 0 CA-C-O 118.556 -1.136 . . . . 73.54 112.582 -167.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.8 tptt -126.97 -84.24 0.61 Allowed 'General case' 0 C--N 1.339 0.131 0 CA-C-N 119.885 1.842 . . . . 74.42 107.346 -178.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.6 mp0 -74.52 -26.82 60.23 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 125.477 1.511 . . . . 74.43 110.372 179.441 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 34.3 p90 -158.61 174.86 14.41 Favored 'General case' 0 N--CA 1.456 -0.131 0 O-C-N 121.18 -0.95 . . . . 74.11 109.451 -175.223 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 24.7 t -135.76 128.56 47.07 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.107 0 C-N-CA 124.418 1.087 . . . . 52.23 108.196 -179.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.424 ' HG3' ' CE1' ' A' ' 162' ' ' TYR . 0.7 OUTLIER -87.74 169.28 12.23 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.211 1.404 . . . . 74.53 110.782 165.204 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -136.38 122.48 20.29 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 124.641 1.176 . . . . 74.11 111.054 177.037 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.6 p -63.13 -0.07 0.69 Allowed 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 128.657 2.783 . . . . 74.14 114.693 179.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 74.1 m -137.7 78.87 35.82 Favored Pre-proline 0 N--CA 1.447 -0.592 0 N-CA-C 107.546 -1.279 . . . . 73.25 107.546 173.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -68.97 179.6 3.17 Favored 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 123.339 2.692 . . . . 74.52 111.818 -176.39 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 40.4 t -126.84 136.97 29.57 Favored Pre-proline 0 CA--C 1.536 0.407 0 N-CA-C 108.503 -0.925 . . . . 70.35 108.503 -169.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -78.18 -179.09 5.13 Favored 'Trans proline' 0 CA--C 1.537 0.635 0 C-N-CA 122.882 2.388 . . . . 72.25 111.861 178.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 3.7 m -131.96 179.78 4.07 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 C-N-CA 127.294 2.237 . . . . 53.02 109.504 176.306 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 47.3 t -64.15 -70.58 0.21 Allowed 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 124.879 1.272 . . . . 53.25 108.324 168.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 57.2 tp60 -116.54 143.03 30.49 Favored Pre-proline 0 N--CA 1.45 -0.443 0 N-CA-C 105.543 -2.021 . . . . 62.11 105.543 -176.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -86.21 -164.13 0.21 Allowed 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 123.699 2.932 . . . . 73.42 110.306 176.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 94.3 -77.84 0.97 Allowed Glycine 0 N--CA 1.444 -0.771 0 N-CA-C 108.889 -1.684 . . . . 74.3 108.889 174.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 87.2 mttt -62.98 136.56 57.91 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 107.919 -1.141 . . . . 55.31 107.919 178.271 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.446 HD12 ' HB3' ' A' ' 186' ' ' GLU . 25.8 mm -73.78 124.66 31.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 106.134 -1.802 . . . . 74.45 106.134 176.117 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -73.76 146.93 43.94 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.104 -1.073 . . . . 75.31 108.104 175.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 60.1 t -133.35 135.6 55.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 106.382 -1.71 . . . . 72.23 106.382 164.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 60.9 t -130.38 101.28 5.65 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 N-CA-C 106.4 -1.704 . . . . 62.03 106.4 -169.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -72.04 133.64 45.39 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 107.679 -1.23 . . . . 71.53 107.679 164.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.1 mp -119.71 126.87 52.13 Favored 'General case' 0 C--O 1.231 0.109 0 N-CA-C 108.536 -0.912 . . . . 74.32 108.536 167.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 21.6 p90 -135.3 163.59 29.66 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 124.649 1.18 . . . . 70.04 111.131 -171.007 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . 0.449 ' HB3' HG21 ' A' ' 153' ' ' VAL . 34.2 t90 -143.44 157.75 44.2 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 124.647 1.179 . . . . 73.24 107.948 173.672 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 31.3 t80 -46.23 -57.88 4.16 Favored 'General case' 0 N--CA 1.444 -0.745 0 C-N-CA 128.063 2.545 . . . . 75.34 113.707 -177.11 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -75.46 -83.68 0.41 Allowed Glycine 0 N--CA 1.444 -0.767 0 N-CA-C 108.548 -1.821 . . . . 72.1 108.548 -170.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 9.1 t 42.63 65.53 5.1 Favored Pre-proline 0 CA--C 1.541 0.62 0 C-N-CA 126.032 1.733 . . . . 63.41 112.752 164.128 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -62.57 -20.12 69.81 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 122.413 2.076 . . . . 74.24 112.471 -175.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 15.1 m-70 -83.95 -21.4 31.8 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 117.732 -1.128 . . . . 74.41 113.938 172.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 99.0 m -68.16 -41.87 80.9 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 119.931 1.241 . . . . 74.52 109.56 175.141 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 19.1 t80 -54.06 -42.81 69.68 Favored 'General case' 0 C--N 1.341 0.202 0 C-N-CA 124.155 0.982 . . . . 75.14 110.804 -174.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -51.68 -43.87 62.88 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.815 0.846 . . . . 71.13 111.909 -179.094 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -76.84 -24.59 52.7 Favored 'General case' 0 C--O 1.225 -0.231 0 CA-C-O 117.061 -1.447 . . . . 71.35 112.725 -171.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -44.45 -67.79 0.33 Allowed Pre-proline 0 CA--C 1.543 0.68 0 CA-C-N 120.421 1.464 . . . . 75.13 113.677 -170.037 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -70.92 -4.62 15.17 Favored 'Trans proline' 0 CA--C 1.536 0.611 0 C-N-CA 121.801 1.667 . . . . 54.05 112.815 -175.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -96.52 -0.8 48.38 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 127.181 2.192 . . . . 55.1 111.151 173.461 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 20.6 tt -126.93 -28.38 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 CA-C-N 120.885 1.675 . . . . 74.01 112.978 171.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 54.6 t -50.92 -60.14 6.14 Favored Pre-proline 0 CA--C 1.538 0.493 0 CA-C-N 119.612 1.096 . . . . 73.51 110.974 178.14 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -69.16 -32.51 20.93 Favored 'Trans proline' 0 N--CA 1.451 -0.998 0 CA-C-N 121.07 1.418 . . . . 43.34 111.067 -175.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.451 ' CZ2' ' HB1' ' A' ' 179' ' ' ALA . 83.4 t90 -53.38 -53.41 51.51 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 119.842 1.201 . . . . 73.3 110.242 173.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 21.5 t -60.48 -37.42 81.0 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.676 0.79 . . . . 73.55 111.288 -177.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -61.66 -45.82 92.41 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 119.32 0.963 . . . . 63.43 110.88 173.083 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 2.6 mptp? -83.49 7.93 15.51 Favored 'General case' 0 C--O 1.234 0.261 0 O-C-N 120.625 -1.297 . . . . 73.42 113.544 -169.081 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 35.2 mt -61.59 157.49 47.01 Favored Pre-proline 0 CA--C 1.537 0.471 0 C-N-CA 125.198 1.399 . . . . 70.32 111.784 179.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -74.85 167.98 25.87 Favored 'Trans proline' 0 N--CA 1.451 -0.993 0 C-N-CA 124.752 3.635 . . . . 73.13 110.548 172.123 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -77.69 -4.95 48.75 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.755 0.822 . . . . 55.33 113.133 178.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -94.43 7.04 46.91 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 119.272 0.942 . . . . 72.42 110.647 177.408 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 96.8 t -126.55 138.0 56.06 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 N-CA-C 106.715 -1.587 . . . . 64.52 106.715 -177.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 68.5 t60 -123.48 108.84 13.11 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 124.9 1.28 . . . . 72.34 108.747 -178.004 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 51.8 t80 -87.81 137.55 32.24 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 123.788 0.835 . . . . 72.34 109.528 -178.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 47.7 t -136.28 150.18 27.66 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 C-N-CA 126.215 1.806 . . . . 74.02 107.409 -174.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 30.4 mtp180 -132.72 126.08 31.69 Favored 'General case' 0 C--O 1.232 0.166 0 N-CA-C 106.885 -1.524 . . . . 72.22 106.885 -176.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 86.8 mt -138.47 144.82 44.11 Favored Pre-proline 0 N--CA 1.467 0.402 0 C-N-CA 124.141 0.976 . . . . 62.33 109.587 -178.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -74.79 152.82 42.37 Favored 'Trans proline' 0 N--CA 1.456 -0.735 0 C-N-CA 122.14 1.893 . . . . 73.44 111.672 177.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -89.48 107.21 18.94 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 125.237 1.415 . . . . 61.04 109.09 177.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.442 HD13 ' HE3' ' A' ' 138' ' ' MET . 39.8 mt -105.71 78.59 1.36 Allowed 'General case' 0 C--O 1.236 0.356 0 C-N-CA 125.151 1.381 . . . . 61.11 108.103 -173.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -121.96 59.95 0.99 Allowed 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 124.706 1.202 . . . . 62.34 110.197 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 68.85 164.74 3.58 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 125.983 1.754 . . . . 71.32 114.174 167.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 48.72 -142.7 8.6 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 124.252 0.929 . . . . 74.11 111.276 -175.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -56.7 -17.29 4.83 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 C-N-CA 124.71 1.204 . . . . 63.1 113.524 -175.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 13.3 m95 -60.97 -42.85 99.1 Favored 'General case' 0 C--N 1.341 0.211 0 O-C-N 120.442 -1.411 . . . . 75.24 109.959 178.435 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 7.5 m-80 -72.21 -17.97 61.88 Favored 'General case' 0 CA--C 1.527 0.095 0 O-C-N 121.566 -0.709 . . . . 74.31 112.512 176.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 64.8 t -92.53 -13.25 8.76 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 C-N-CA 123.786 0.834 . . . . 74.4 111.605 -173.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 52.0 m170 -115.45 4.49 14.3 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.342 1.057 . . . . 74.14 111.924 172.141 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -102.93 -41.73 2.22 Favored Glycine 0 N--CA 1.448 -0.526 0 N-CA-C 109.518 -1.433 . . . . 43.41 109.518 -176.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . 0.268 1.3 pm0 -49.12 -43.86 41.85 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 125.16 1.384 . . . . 75.13 113.027 -179.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 5.1 ppp? -54.35 -37.16 64.61 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 114.154 1.168 . . . . 64.13 114.154 -172.276 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 39.4 t80 -56.49 -43.07 79.34 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 122.835 1.302 . . . . 74.14 109.049 -172.2 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 12.9 mt -68.87 -34.8 76.05 Favored 'General case' 0 N--CA 1.442 -0.867 0 C-N-CA 125.991 1.716 . . . . 75.15 110.729 -177.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.75 HG22 HG23 ' A' ' 128' ' ' THR . 0.0 OUTLIER -68.53 -50.99 47.8 Favored 'General case' 0 C--N 1.344 0.356 0 CA-C-N 121.125 1.784 . . . . 71.5 110.182 176.026 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.464 HD21 HD22 ' A' ' 115' ' ' LEU . 0.7 OUTLIER -51.09 -52.96 38.42 Favored 'General case' 0 CA--C 1.535 0.376 0 O-C-N 123.968 0.793 . . . . 75.13 109.459 -177.543 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -65.12 -28.14 69.22 Favored 'General case' 0 N--CA 1.465 0.289 0 O-C-N 121.517 -0.739 . . . . 35.13 112.866 -179.408 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 8.5 t -69.63 -19.76 63.62 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 118.09 -0.957 . . . . 64.51 111.682 -175.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 4.9 ptp . . . . . 0 N--CA 1.471 0.617 0 CA-C-N 121.116 1.78 . . . . 74.22 112.364 170.794 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.478 0 CA-C-O 118.65 -0.691 . . . . 60.13 111.663 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 57.3 t -60.05 -65.08 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 CA-C-N 119.997 1.271 . . . . 65.34 108.258 164.182 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -51.4 -49.36 61.72 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 125.114 1.366 . . . . 74.1 112.086 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.418 ' OE1' ' HE3' ' A' ' 100' ' ' LYS . 3.5 mm-40 -62.04 -13.8 29.64 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 126.825 2.05 . . . . 71.55 112.442 -178.272 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.451 ' HB1' ' CZ ' ' A' ' 114' ' ' PHE . . . -108.0 1.51 22.55 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 125.638 1.575 . . . . 74.33 111.024 178.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 28.3 mt -110.74 -58.1 3.78 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.286 0 N-CA-C 107.741 -1.207 . . . . 72.11 107.741 172.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 80.3 m-70 -66.37 -60.7 2.51 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 119.051 0.841 . . . . 73.24 111.09 -177.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.418 ' HE3' ' OE1' ' A' ' 96' ' ' GLU . 0.6 OUTLIER -68.17 -30.0 69.01 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 118.999 0.818 . . . . 75.54 110.646 -174.06 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -98.38 -36.89 9.83 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 123.84 0.856 . . . . 70.24 111.715 -168.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 5.0 t-160 44.26 57.31 4.37 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 128.713 2.805 . . . . 72.22 112.778 178.004 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -64.88 -173.37 0.11 Allowed 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.897 1.679 . . . . 71.14 111.756 170.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 18.8 ttmm -109.49 54.3 0.66 Allowed 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 126.447 1.899 . . . . 72.32 110.415 175.09 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 24.8 mt -75.39 58.32 0.98 Allowed 'General case' 0 C--N 1.322 -0.587 0 C-N-CA 127.479 2.311 . . . . 72.23 108.452 179.323 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -114.6 -2.36 13.12 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 127.832 2.453 . . . . 74.15 111.346 -171.307 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 45.1 p -135.4 151.28 74.5 Favored Pre-proline 0 C--O 1.232 0.14 0 C-N-CA 124.729 1.212 . . . . 51.23 108.715 179.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -66.59 -23.83 49.17 Favored 'Trans proline' 0 N--CA 1.459 -0.5 0 C-N-CA 121.888 1.725 . . . . 71.41 111.955 179.01 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -58.27 -60.32 3.94 Favored 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 124.71 1.204 . . . . 75.11 110.479 167.034 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 19.5 tp10 -66.49 -40.07 89.09 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 120.978 -0.289 . . . . 53.45 110.842 -174.06 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 3.6 mtt -67.01 -47.06 72.62 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 120.722 -0.391 . . . . 74.45 111.447 -175.007 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -63.28 -48.35 78.49 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 118.94 -0.552 . . . . 54.22 110.59 -177.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -70.96 -5.42 30.83 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 118.847 0.748 . . . . 53.12 112.928 -178.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . 0.451 ' CZ ' ' HB1' ' A' ' 97' ' ' ALA . 87.0 t80 -100.18 -35.22 9.73 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 124.626 1.17 . . . . 63.05 112.38 176.528 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.464 HD22 HD21 ' A' ' 81' ' ' LEU . 76.9 mt -83.22 -17.75 41.66 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 123.134 0.574 . . . . 72.33 111.166 175.502 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -52.17 -30.31 26.33 Favored 'General case' 0 CA--C 1.528 0.115 0 C-N-CA 125.765 1.626 . . . . 73.3 112.657 -175.375 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -93.28 -2.0 66.3 Favored Glycine 0 N--CA 1.441 -1.01 0 CA-C-O 118.473 -1.182 . . . . 73.05 112.312 -175.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.12 39.46 3.11 Favored 'General case' 0 C--N 1.342 0.242 0 CA-C-N 119.134 1.467 . . . . 72.21 111.273 -163.569 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 90.45 11.57 62.32 Favored Glycine 0 CA--C 1.527 0.785 0 CA-C-O 118.541 -1.144 . . . . 51.42 113.849 169.319 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 30.7 t -113.36 128.92 69.94 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 C-N-CA 125.643 1.577 . . . . 73.03 107.237 175.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -99.16 141.13 32.32 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 122.884 0.474 . . . . 54.24 111.811 173.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 5.1 mtmt -66.15 -33.82 76.64 Favored 'General case' 0 CA--C 1.537 0.449 0 O-C-N 121.501 -0.749 . . . . 74.24 111.423 178.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -64.9 -33.61 76.43 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 125.116 1.367 . . . . 75.05 111.323 178.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 7.2 mmtp -79.55 -50.77 10.22 Favored 'General case' 0 C--O 1.23 0.066 0 N-CA-C 107.888 -1.153 . . . . 61.03 107.888 172.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 52.0 t80 -53.39 -67.47 0.25 Allowed 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.831 1.252 . . . . 72.52 113.332 -165.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 25.4 mt -62.79 -38.84 92.25 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 122.738 0.415 . . . . 65.11 111.228 -165.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 22.5 t -57.43 -46.5 83.48 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 124.16 0.984 . . . . 72.35 111.295 -176.31 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . 0.75 HG23 HG22 ' A' ' 80' ' ' THR . 9.9 t -80.73 -33.66 35.02 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 110.355 -0.239 . . . . 73.24 110.355 178.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 76.8 t80 -55.62 -38.28 69.29 Favored 'General case' 0 C--O 1.237 0.396 0 O-C-N 121.266 -0.896 . . . . 70.21 111.138 176.091 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -91.99 16.83 10.31 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.428 1.491 . . . . 75.04 112.082 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 2.2 p -106.48 171.89 7.11 Favored 'General case' 0 C--O 1.24 0.589 0 CA-C-N 119.804 1.183 . . . . 71.24 111.895 -175.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -67.2 -17.78 64.97 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 123.883 0.873 . . . . 74.0 112.081 172.34 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -57.9 -56.31 23.62 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 119.106 0.866 . . . . 74.21 109.29 178.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 13.7 mm -59.39 -41.33 84.07 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.134 0 CA-C-O 119.169 -0.443 . . . . 63.25 110.583 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 13.0 mttt -57.31 -35.14 69.46 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 119.31 0.959 . . . . 71.22 111.637 175.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -81.61 -22.38 60.21 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 125.071 1.32 . . . . 64.35 113.009 -178.183 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -82.39 -39.6 22.46 Favored 'General case' 0 CA--C 1.535 0.399 0 O-C-N 121.382 -1.069 . . . . 74.12 110.097 173.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . 0.442 ' HE3' HD13 ' A' ' 66' ' ' LEU . 92.8 mmm -61.26 -41.19 96.5 Favored 'General case' 0 C--O 1.231 0.099 0 C-N-CA 124.105 0.962 . . . . 62.3 111.169 -179.767 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -57.13 -43.13 82.12 Favored 'General case' 0 CA--C 1.535 0.4 0 O-C-N 121.032 -1.043 . . . . 52.13 111.375 178.199 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 13.3 mtmt -60.29 -66.06 0.58 Allowed 'General case' 0 C--N 1.342 0.272 0 CA-C-N 118.549 0.613 . . . . 75.04 110.518 176.216 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -59.94 -26.97 66.39 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 119.027 0.83 . . . . 75.3 111.64 -170.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.55 -56.11 8.26 Favored 'General case' 0 C--N 1.34 0.158 0 O-C-N 121.368 -0.832 . . . . 74.3 110.509 176.411 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.55 -32.7 73.66 Favored 'General case' 0 C--N 1.342 0.26 0 CA-C-N 119.172 0.896 . . . . 64.1 110.365 -177.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 42.1 mt -59.67 -54.97 40.17 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 118.007 -0.997 . . . . 73.42 110.288 179.263 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -54.66 -37.44 65.72 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 119.616 1.098 . . . . 74.21 112.166 -178.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -73.25 -42.7 62.23 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 122.903 0.481 . . . . 53.14 110.777 -179.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -59.83 -44.95 93.8 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 123.605 0.762 . . . . 31.14 109.099 175.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 15.9 m-85 -63.0 -7.35 5.12 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.242 1.417 . . . . 73.41 113.337 177.151 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 61.7 mt-30 56.21 47.56 19.13 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 127.208 2.203 . . . . 75.23 111.01 -174.07 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 95.3 t -82.72 141.54 14.82 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 O-C-N 120.665 -1.272 . . . . 34.25 108.196 178.216 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 11.7 p -104.93 -19.75 13.76 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 124.178 0.991 . . . . 73.42 113.092 -174.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 179.12 -148.08 8.04 Favored Glycine 0 N--CA 1.452 -0.275 0 N-CA-C 108.81 -1.716 . . . . 61.33 108.81 -170.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.449 HG21 ' HB3' ' A' ' 34' ' ' TRP . 22.3 m -147.09 153.93 45.81 Favored Pre-proline 0 C--O 1.243 0.738 0 C-N-CA 127.115 2.166 . . . . 74.23 106.717 167.46 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . 0.483 ' HG3' HD12 ' A' ' 166' ' ' ILE . 98.2 Cg_endo -66.9 158.24 81.64 Favored 'Cis proline' 0 N--CA 1.458 -0.587 0 C-N-CA 124.132 -1.195 . . . . 64.33 112.154 -3.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 97.8 m -156.82 146.46 20.69 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 106.391 -1.707 . . . . 55.11 106.391 172.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 28.7 mmm -114.78 165.48 12.78 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 106.689 -1.596 . . . . 60.33 106.689 161.096 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 78.0 t -137.41 143.9 33.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 106.383 -1.71 . . . . 75.41 106.383 160.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.5 HG23 ' CE1' ' A' ' 164' ' ' PHE . 20.0 t -105.21 134.48 46.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 N-CA-C 105.915 -1.883 . . . . 64.54 105.915 162.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 4.0 t30 50.77 17.02 0.36 Allowed 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 130.197 3.399 . . . . 72.11 116.359 166.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 70.23 25.23 75.92 Favored Glycine 0 CA--C 1.527 0.836 0 CA-C-O 117.231 -1.872 . . . . 73.5 113.659 -171.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 21.6 mtpt -128.72 -37.05 1.79 Allowed 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 119.878 1.839 . . . . 73.51 114.032 179.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . 0.424 ' CE1' ' HG3' ' A' ' 14' ' ' GLU . 76.6 m-85 -121.4 108.79 14.1 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 119.708 1.14 . . . . 72.42 111.557 -168.126 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 18.9 ptt180 -90.56 32.79 0.94 Allowed 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 126.96 2.104 . . . . 74.24 115.532 -171.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . 0.5 ' CE1' HG23 ' A' ' 158' ' ' VAL . 4.0 p90 -52.06 155.51 1.86 Allowed 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 122.154 0.978 . . . . 63.23 110.085 -177.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -160.96 174.66 13.47 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 107.811 -1.181 . . . . 65.4 107.811 -175.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.483 HD12 ' HG3' ' A' ' 154' ' ' PRO . 3.5 mt -46.3 -52.67 3.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 C-N-CA 126.108 1.763 . . . . 71.13 108.163 161.354 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -78.28 19.72 4.46 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 126.828 2.156 . . . . 33.32 114.621 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 18.8 m -125.27 -48.89 1.7 Allowed 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 119.37 1.585 . . . . 74.51 109.12 154.393 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -63.2 -34.84 78.52 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-O 118.166 -0.921 . . . . 53.44 112.909 -170.276 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 117.75 5.5 13.87 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 123.586 0.612 . . . . 72.42 113.547 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 153.35 174.39 23.6 Favored Glycine 0 CA--C 1.527 0.805 0 CA-C-N 119.22 1.51 . . . . 45.21 110.543 177.03 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -64.05 -45.18 10.72 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 122.308 2.005 . . . . 63.25 110.826 -173.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -66.41 -39.46 89.02 Favored 'General case' 0 N--CA 1.453 -0.304 0 O-C-N 121.269 -0.895 . . . . 75.12 110.173 177.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -62.58 -27.45 69.2 Favored 'General case' 0 CA--C 1.537 0.466 0 O-C-N 122.306 -0.246 . . . . 71.21 110.932 175.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 24.9 m -61.84 -45.9 91.79 Favored 'General case' 0 CA--C 1.534 0.354 0 O-C-N 120.469 -1.394 . . . . 63.5 109.537 179.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 33.2 mt -65.51 -24.38 67.12 Favored 'General case' 0 N--CA 1.466 0.366 0 O-C-N 121.365 -0.834 . . . . 72.33 112.043 177.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.74 -46.18 74.24 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-O 118.796 -0.621 . . . . 71.42 109.427 169.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -76.51 -39.35 53.29 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-O 117.27 -1.348 . . . . 74.21 110.565 -178.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.451 ' HB1' ' CZ2' ' A' ' 50' ' ' TRP . . . -52.65 -49.88 64.32 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 120.015 1.28 . . . . 71.31 111.754 -172.088 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -66.1 -45.33 81.57 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 125.235 1.414 . . . . 44.24 110.786 -173.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -62.45 -46.88 86.51 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 126.003 1.721 . . . . 74.32 111.448 176.264 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 83.0 mt -64.32 -38.83 92.44 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 118.487 -0.768 . . . . 74.13 110.118 -176.298 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 39.5 mt -55.6 -51.5 57.66 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 CA-C-N 119.369 0.986 . . . . 74.3 108.655 172.333 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . 0.406 ' HA ' ' HD3' ' A' ' 187' ' ' ARG . 6.2 tm-20 -67.97 7.4 0.54 Allowed 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 127.378 2.271 . . . . 75.43 114.414 174.613 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . 0.444 ' HA ' ' HE3' ' A' ' 185' ' ' LYS . 0.5 OUTLIER -110.73 -45.29 3.51 Favored 'General case' 0 N--CA 1.454 -0.252 0 O-C-N 120.841 -1.162 . . . . 71.45 108.823 165.74 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . 0.446 ' HB3' HD12 ' A' ' 27' ' ' ILE . 26.9 mm-40 -54.66 -38.49 67.0 Favored 'General case' 0 CA--C 1.512 -0.495 0 C-N-CA 126.326 1.85 . . . . 61.24 115.403 -173.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . 0.406 ' HD3' ' HA ' ' A' ' 184' ' ' GLU . 0.0 OUTLIER -55.73 -23.41 29.01 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 118.624 -1.23 . . . . 72.11 114.14 -176.586 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.238 0.463 0 C-N-CA 126.484 1.914 . . . . 74.51 113.084 175.126 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . 0.412 ' C ' ' H ' ' A' ' 6' ' ' TYR . 1.3 m-20 . . . . . 0 CA--C 1.53 0.189 0 N-CA-C 110.159 -0.312 . . . . 70.41 110.159 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -75.04 25.18 0.09 Allowed 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.517 1.127 . . . . 74.01 113.161 -172.386 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.412 ' H ' ' C ' ' A' ' 4' ' ' ASP . 33.1 m-85 -140.53 170.3 16.05 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 128.19 2.596 . . . . 75.34 108.838 -176.418 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 95.0 m -141.69 137.48 31.76 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 124.932 1.293 . . . . 61.34 108.269 176.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.66 130.62 43.93 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 108.729 -0.841 . . . . 73.33 108.729 172.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 80.07 15.92 77.83 Favored Glycine 0 CA--C 1.525 0.681 0 CA-C-O 119.33 -0.705 . . . . 63.1 112.966 -174.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.1 tpmt? -133.25 -55.99 0.91 Allowed 'General case' 0 CA--C 1.519 -0.242 0 CA-C-N 118.384 1.092 . . . . 65.34 109.345 -177.146 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.436 ' HB3' HD21 ' A' ' 178' ' ' LEU . 8.1 mp0 -105.42 -21.2 13.27 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 124.388 1.075 . . . . 74.52 110.642 179.362 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 42.6 p90 -159.44 168.16 26.95 Favored 'General case' 0 C--O 1.234 0.253 0 O-C-N 121.119 -0.988 . . . . 64.12 110.641 -171.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 84.0 t -126.13 111.47 26.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 C-N-CA 124.894 1.277 . . . . 63.0 108.504 178.054 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -78.08 165.61 23.79 Favored 'General case' 0 C--O 1.239 0.5 0 O-C-N 120.871 -1.143 . . . . 64.55 109.246 169.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -133.87 111.41 10.46 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 126.011 1.725 . . . . 73.31 107.333 -175.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 76.3 p -65.24 0.24 1.48 Allowed 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 125.985 1.714 . . . . 45.43 113.26 179.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 38.6 m -128.92 73.74 81.4 Favored Pre-proline 0 N--CA 1.439 -1.001 0 N-CA-C 105.397 -2.075 . . . . 55.35 105.397 -176.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -72.93 177.86 7.18 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 124.211 3.274 . . . . 52.05 110.922 -170.209 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 6.1 t -140.61 116.67 7.67 Favored Pre-proline 0 CA--C 1.537 0.46 0 C-N-CA 123.321 0.648 . . . . 74.2 109.442 176.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -72.79 -176.36 2.3 Favored 'Trans proline' 0 CA--C 1.537 0.672 0 C-N-CA 123.858 3.038 . . . . 70.22 110.854 171.011 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.407 HG11 ' CD ' ' A' ' 28' ' ' GLU . 3.5 m -133.85 160.61 41.89 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 N-CA-C 106.016 -1.846 . . . . 44.42 106.016 176.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 3.4 m -47.75 -66.88 0.33 Allowed 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 125.392 1.477 . . . . 63.12 113.766 166.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 11.8 tp60 -128.71 81.25 71.12 Favored Pre-proline 0 N--CA 1.469 0.48 0 C-N-CA 123.9 0.88 . . . . 61.3 108.718 -169.003 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.507 ' C ' ' H ' ' A' ' 26' ' ' LYS . 36.2 Cg_endo -73.05 -57.51 0.07 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.095 0 CA-C-N 119.122 0.722 . . . . 71.35 110.314 179.236 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 51.35 -23.34 0.01 OUTLIER Glycine 0 CA--C 1.53 1.019 0 C-N-CA 127.831 2.634 . . . . 31.24 115.243 -159.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.507 ' H ' ' C ' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -140.05 -167.06 2.22 Favored 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 129.548 3.139 . . . . 74.45 105.483 -161.931 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.53 HD12 ' HB3' ' A' ' 186' ' ' GLU . 30.4 mm -87.75 130.65 37.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 N-CA-C 106.207 -1.775 . . . . 74.21 106.207 168.515 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.407 ' CD ' HG11 ' A' ' 21' ' ' VAL . 5.0 tp10 -69.71 140.04 53.48 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 105.608 -1.997 . . . . 65.33 105.608 173.131 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 54.8 t -128.2 134.32 65.21 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 N-CA-C 105.769 -1.937 . . . . 55.42 105.769 160.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 30.1 t -123.14 112.71 34.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 105.95 -1.87 . . . . 74.21 105.95 172.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 62.6 tt0 -72.26 122.01 20.36 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 106.347 -1.723 . . . . 74.54 106.347 156.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.489 HD22 HG21 ' A' ' 150' ' ' VAL . 4.5 mp -109.65 137.91 46.78 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-N 119.212 0.914 . . . . 55.22 108.919 166.119 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 9.5 p90 -145.66 171.26 14.98 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 122.986 0.514 . . . . 75.24 110.487 -168.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . 0.421 ' HB3' HG21 ' A' ' 153' ' ' VAL . 42.2 t90 -156.7 151.57 25.97 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.38 1.472 . . . . 75.33 109.9 171.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 19.4 t80 -45.58 -48.49 14.5 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 127.789 2.436 . . . . 71.21 114.408 -174.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -75.14 -88.59 0.23 Allowed Glycine 0 C--N 1.341 0.806 0 N-CA-C 109.75 -1.34 . . . . 72.4 109.75 -169.382 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 12.7 t 42.76 72.49 1.13 Allowed Pre-proline 0 CA--C 1.538 0.483 0 C-N-CA 126.44 1.896 . . . . 74.34 112.955 160.237 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -59.16 -38.83 84.13 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 121.191 1.261 . . . . 52.21 112.199 -178.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 17.8 m170 -65.79 -30.38 71.02 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 119.142 0.883 . . . . 73.33 111.031 -179.125 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 82.1 m -62.67 -38.11 89.06 Favored 'General case' 0 C--N 1.343 0.32 0 CA-C-N 118.407 0.549 . . . . 64.13 110.158 177.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 38.6 t80 -62.0 -44.28 97.06 Favored 'General case' 0 C--N 1.339 0.139 0 O-C-N 121.614 -0.679 . . . . 62.41 110.828 -175.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -56.52 -34.45 67.02 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 118.285 0.493 . . . . 53.32 111.333 178.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.46 ' HB2' HD11 ' A' ' 166' ' ' ILE . 6.0 t80 -82.52 -16.0 50.28 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.837 1.655 . . . . 75.32 113.445 -178.462 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -43.26 -63.48 0.99 Allowed Pre-proline 0 CA--C 1.539 0.554 0 CA-C-N 120.042 1.292 . . . . 75.33 112.422 -173.218 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -85.79 -7.36 8.46 Favored 'Trans proline' 0 N--CA 1.452 -0.921 0 C-N-CA 121.645 1.563 . . . . 64.53 114.687 -174.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 26.0 m -66.01 -46.84 76.49 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 107.355 -1.35 . . . . 75.04 107.355 166.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 20.5 tt -84.2 -35.31 10.72 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 N-CA-C 113.528 0.936 . . . . 64.3 113.528 -166.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 42.9 t -48.16 -61.18 3.34 Favored Pre-proline 0 CA--C 1.545 0.779 0 O-C-N 121.237 -0.914 . . . . 73.43 111.803 178.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -72.5 -6.59 19.33 Favored 'Trans proline' 0 N--CA 1.454 -0.794 0 C-N-CA 122.007 1.805 . . . . 64.42 113.708 -177.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.43 ' CZ2' ' HB1' ' A' ' 179' ' ' ALA . 79.8 t90 -72.25 -62.48 1.42 Allowed 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 120.085 1.312 . . . . 73.33 107.691 161.185 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 22.4 p -53.79 -33.3 55.55 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 115.035 1.494 . . . . 64.22 115.035 -169.509 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 58.4 mt-10 -80.45 -24.84 39.29 Favored 'General case' 0 CA--C 1.54 0.572 0 O-C-N 120.663 -1.273 . . . . 70.03 112.007 -179.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 11.1 mptt -96.2 9.26 41.57 Favored 'General case' 0 C--O 1.225 -0.196 0 C-N-CA 124.97 1.308 . . . . 62.35 112.009 -168.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 35.2 mt -62.15 160.14 33.26 Favored Pre-proline 0 C--O 1.242 0.661 0 C-N-CA 129.327 3.051 . . . . 73.11 113.41 -177.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -80.09 170.18 16.75 Favored 'Trans proline' 0 N--CA 1.448 -1.164 0 C-N-CA 124.752 3.634 . . . . 72.13 110.273 176.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -70.1 -5.06 24.24 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 124.112 0.965 . . . . 72.21 112.919 -179.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -104.38 9.61 35.69 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.428 1.091 . . . . 72.34 111.988 -171.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.448 HG21 HD13 ' A' ' 183' ' ' ILE . 93.1 t -120.46 149.52 23.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 N-CA-C 108.166 -1.05 . . . . 73.15 108.166 -177.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 21.9 t-160 -124.88 84.75 2.32 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 128.092 2.557 . . . . 72.42 105.931 -179.127 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 45.5 t80 -68.26 129.43 39.9 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 108.794 -0.817 . . . . 75.42 108.794 174.045 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 40.7 t -136.21 155.13 34.41 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.651 0 C-N-CA 126.461 1.904 . . . . 42.12 106.351 175.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 34.6 mtp180 -133.28 123.35 25.34 Favored 'General case' 0 CA--C 1.515 -0.375 0 N-CA-C 105.371 -2.085 . . . . 74.3 105.371 -176.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 78.0 mt -134.62 144.58 51.4 Favored Pre-proline 0 CA--C 1.533 0.307 0 CA-C-N 119.461 1.028 . . . . 71.4 110.716 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -77.1 129.32 10.42 Favored 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 122.589 2.192 . . . . 53.3 111.36 177.178 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -69.69 114.53 7.98 Favored 'General case' 0 CA--C 1.537 0.465 0 O-C-N 121.519 -0.738 . . . . 73.0 110.245 174.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.49 HD22 ' HA ' ' A' ' 72' ' ' ASN . 14.6 mt -106.62 103.15 12.52 Favored 'General case' 0 N--CA 1.466 0.351 0 O-C-N 121.059 -1.026 . . . . 62.21 110.247 -178.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -133.03 13.35 4.29 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 114.901 1.445 . . . . 73.52 114.901 -174.375 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -169.47 -116.9 0.39 Allowed Glycine 0 C--N 1.333 0.385 0 CA-C-N 119.603 1.092 . . . . 74.15 112.382 176.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -114.52 -73.6 0.58 Allowed Glycine 0 C--N 1.334 0.438 0 C-N-CA 126.225 1.869 . . . . 42.21 108.448 171.048 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 6.4 tp -58.84 -24.77 27.22 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-N 118.248 1.024 . . . . 64.04 112.164 -174.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 10.5 m95 -59.47 -48.8 80.26 Favored 'General case' 0 N--CA 1.455 -0.201 0 O-C-N 121.444 -0.785 . . . . 71.42 111.547 172.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.49 ' HA ' HD22 ' A' ' 66' ' ' LEU . 11.7 p30 -77.94 -30.64 50.57 Favored 'General case' 0 CA--C 1.509 -0.601 0 CA-C-O 117.663 -1.161 . . . . 74.05 113.599 177.413 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 74.5 t -57.15 -58.22 6.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 108.824 -0.806 . . . . 73.51 108.824 172.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 37.4 m170 -65.58 -24.18 67.02 Favored 'General case' 0 CA--C 1.528 0.109 0 N-CA-C 112.416 0.525 . . . . 75.22 112.416 178.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -78.96 -18.99 73.77 Favored Glycine 0 N--CA 1.444 -0.804 0 CA-C-O 118.966 -0.908 . . . . 42.41 111.302 178.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.491 HE22 HD12 ' A' ' 134' ' ' ILE . 0.0 OUTLIER -66.71 -55.77 13.6 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 118.275 1.037 . . . . 73.4 109.606 -160.427 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 3.7 ptm -55.21 -28.78 55.54 Favored 'General case' 0 N--CA 1.454 -0.273 0 O-C-N 124.129 0.893 . . . . 75.43 113.294 -166.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 29.7 t80 -55.22 -52.06 64.59 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 124.007 0.923 . . . . 74.22 109.981 176.354 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 37.9 mt -66.54 -43.1 86.03 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 117.979 -1.01 . . . . 75.05 109.821 179.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.74 HG22 HG23 ' A' ' 128' ' ' THR . 0.2 OUTLIER -59.6 -41.67 90.86 Favored 'General case' 0 C--N 1.344 0.354 0 CA-C-N 120.3 1.409 . . . . 55.24 110.906 -179.31 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.4 -55.45 33.38 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 123.882 0.873 . . . . 62.4 109.077 -178.484 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -74.74 -14.53 60.73 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 112.505 0.558 . . . . 73.25 112.505 -177.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 3.2 t -70.44 -10.22 58.53 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.821 1.249 . . . . 72.32 112.222 171.384 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 43.4 mtm . . . . . 0 CA--C 1.535 0.386 0 C-N-CA 124.423 1.089 . . . . 75.33 112.887 168.165 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.445 0 CA-C-O 118.872 -0.585 . . . . 60.12 112.003 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.9 t -62.26 -76.8 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 N-CA-C 108.515 -0.92 . . . . 71.42 108.515 164.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -51.26 -46.92 62.54 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 126.018 1.727 . . . . 70.34 112.103 -176.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 22.2 mm-40 -60.9 -44.17 97.52 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.514 1.526 . . . . 71.2 109.242 -175.38 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -74.91 -3.49 32.39 Favored 'General case' 0 CA--C 1.531 0.245 0 O-C-N 120.62 -1.3 . . . . 73.22 113.158 -179.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 72.8 mt -104.18 -54.78 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 N-CA-C 106.554 -1.647 . . . . 74.02 106.554 177.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 90.7 m-70 -80.54 -56.13 4.38 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 123.495 0.718 . . . . 73.22 112.014 -173.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 2.2 mmtp -71.87 -12.95 61.52 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 123.753 0.821 . . . . 74.21 112.05 -178.355 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -117.07 -31.32 5.4 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.963 0.905 . . . . 74.31 112.494 -174.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 5.2 t60 45.15 61.04 2.7 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 125.903 1.681 . . . . 64.12 111.209 -176.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 7.8 mtpp -76.94 159.45 29.97 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.727 -1.124 . . . . 73.51 108.454 170.082 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 46.5 tttt -85.82 38.35 0.75 Allowed 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 125.726 1.61 . . . . 61.11 111.735 -173.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 43.3 mt -72.61 51.07 0.26 Allowed 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 128.815 2.846 . . . . 73.42 112.053 -167.146 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -103.12 3.66 36.14 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 129.463 3.105 . . . . 72.24 112.21 -177.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -134.39 156.03 79.26 Favored Pre-proline 0 N--CA 1.467 0.413 0 CA-C-N 118.556 0.616 . . . . 71.01 110.66 171.073 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -70.89 -19.84 30.25 Favored 'Trans proline' 0 N--CA 1.449 -1.108 0 C-N-CA 121.658 1.572 . . . . 62.55 111.889 -177.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.7 -62.95 1.48 Allowed 'General case' 0 C--O 1.224 -0.255 0 CA-C-N 119.859 1.209 . . . . 64.31 108.961 168.11 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -45.79 -56.55 5.2 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 127.229 2.211 . . . . 72.45 110.413 178.358 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 57.4 mtt -54.91 -50.45 68.77 Favored 'General case' 0 N--CA 1.458 -0.065 0 C-N-CA 123.7 0.8 . . . . 61.13 111.354 -178.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.632 ' HB1' ' HG3' ' A' ' 122' ' ' LYS . . . -77.1 -40.63 45.21 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-O 119.043 -0.504 . . . . 71.44 111.013 -170.124 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -56.43 -35.61 68.04 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 125.12 1.368 . . . . 73.1 110.525 174.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 82.8 t80 -71.81 -54.08 11.28 Favored 'General case' 0 N--CA 1.44 -0.952 0 C-N-CA 122.969 0.508 . . . . 73.53 110.2 176.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 73.5 mt -69.64 -18.31 63.58 Favored 'General case' 0 CA--C 1.52 -0.178 0 C-N-CA 123.454 0.702 . . . . 61.22 112.428 -173.136 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -57.17 -16.71 8.54 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.226 1.41 . . . . 41.21 112.32 -176.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -110.38 8.12 30.58 Favored Glycine 0 CA--C 1.526 0.74 0 C-N-CA 124.94 1.257 . . . . 53.25 113.588 177.073 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 30.9 mmtt -129.09 27.6 5.37 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 119.608 1.704 . . . . 73.25 111.398 -169.096 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 85.56 41.54 7.27 Favored Glycine 0 N--CA 1.447 -0.579 0 CA-C-O 119.199 -0.778 . . . . 75.12 111.245 178.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 95.0 t -135.83 141.91 40.59 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 106.968 -1.493 . . . . 42.01 106.968 173.345 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 66.2 t0 -97.12 123.62 40.92 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 108.231 -1.025 . . . . 54.33 108.231 167.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.632 ' HG3' ' HB1' ' A' ' 112' ' ' ALA . 0.2 OUTLIER -57.88 -38.97 76.73 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.789 0.835 . . . . 73.33 109.245 177.071 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -61.87 -41.46 97.88 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 123.638 0.775 . . . . 74.42 111.225 -177.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 21.1 mmtt -79.59 -47.28 15.75 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 108.074 -1.084 . . . . 71.32 108.074 -176.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 80.2 t80 -44.98 -59.3 2.64 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 126.322 1.849 . . . . 73.02 110.126 -177.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 32.4 mt -69.38 -36.32 76.69 Favored 'General case' 0 C--O 1.234 0.245 0 O-C-N 122.107 -0.371 . . . . 73.21 111.217 -176.399 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 23.2 t -56.05 -47.8 77.22 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 109.442 -0.577 . . . . 72.0 109.442 178.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . 0.74 HG23 HG22 ' A' ' 80' ' ' THR 0.259 15.0 t -77.28 -31.62 54.94 Favored 'General case' 0 CA--C 1.543 0.712 0 C-N-CA 123.116 0.567 . . . . 75.44 111.543 -179.089 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 76.4 t80 -56.19 -36.49 68.45 Favored 'General case' 0 N--CA 1.471 0.621 0 O-C-N 120.357 -1.465 . . . . 74.4 111.893 172.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 48.0 m-20 -102.97 13.39 34.43 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.085 0.954 . . . . 73.12 111.216 176.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 40.0 t -88.81 163.65 15.58 Favored 'General case' 0 C--O 1.235 0.298 0 O-C-N 120.469 -1.395 . . . . 75.41 109.263 174.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -59.11 -24.96 63.41 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 114.92 -1.036 . . . . 64.41 110.85 170.328 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -48.91 -63.48 1.08 Allowed 'General case' 0 C--O 1.236 0.387 0 C-N-CA 124.568 1.147 . . . . 72.33 110.955 176.089 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.51 HD11 ' HA ' ' A' ' 80' ' ' THR . 7.1 mm -58.36 -32.58 45.49 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 N-CA-C 113.532 0.938 . . . . 72.53 113.532 176.189 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 2.7 tttp -57.7 -35.05 70.1 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 118.844 0.747 . . . . 65.33 110.151 -178.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -80.13 -37.24 22.3 Favored Glycine 0 C--N 1.34 0.798 0 C-N-CA 124.864 1.221 . . . . 63.52 111.969 -178.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 2.4 mm100 -70.74 -39.8 73.1 Favored 'General case' 0 C--N 1.331 -0.238 0 O-C-N 121.582 -0.952 . . . . 72.03 109.312 -178.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -62.23 -50.09 73.15 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 123.668 0.787 . . . . 75.12 110.191 176.475 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -63.42 -43.23 98.08 Favored 'General case' 0 CA--C 1.521 -0.151 0 CA-C-O 117.744 -1.122 . . . . 73.51 111.095 -177.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 44.7 mtmt -59.29 -59.67 5.09 Favored 'General case' 0 C--N 1.343 0.31 0 CA-C-O 117.991 -1.004 . . . . 54.42 108.748 177.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -54.35 -35.73 63.07 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 119.852 1.206 . . . . 60.12 112.012 -179.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 35.8 tttt -65.97 -66.44 0.55 Allowed 'General case' 0 C--N 1.342 0.278 0 N-CA-C 108.467 -0.938 . . . . 65.32 108.467 177.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 17.7 ptmt -60.02 -28.14 67.48 Favored 'General case' 0 C--O 1.227 -0.106 0 C-N-CA 123.476 0.71 . . . . 73.25 111.187 -171.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 36.2 mt -68.75 -58.58 4.01 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 124.816 1.246 . . . . 65.04 111.976 173.201 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -55.6 -50.6 69.69 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 118.957 0.799 . . . . 72.31 110.244 -169.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -58.87 -42.74 90.18 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 113.007 0.743 . . . . 62.34 113.007 174.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -65.84 -26.37 67.63 Favored 'General case' 0 N--CA 1.462 0.155 0 C-N-CA 123.33 0.652 . . . . 75.45 111.622 -178.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 36.2 m-85 -84.17 20.13 1.67 Allowed 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.3 1.44 . . . . 70.11 112.125 172.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 11.5 mm100 64.35 6.44 3.05 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 127.399 2.279 . . . . 74.14 115.536 173.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.489 HG21 HD22 ' A' ' 32' ' ' LEU . 42.9 t -51.7 -57.27 3.63 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.985 0 C-N-CA 127.639 2.376 . . . . 62.21 113.858 -164.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . 0.281 73.5 p 54.97 -40.05 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 128.912 2.885 . . . . 63.12 117.365 -165.341 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -150.45 -177.87 24.79 Favored Glycine 0 CA--C 1.521 0.422 0 C-N-CA 125.951 1.739 . . . . 64.14 110.285 -171.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.442 ' HA ' ' C ' ' A' ' 154' ' ' PRO . 17.3 m -133.26 157.33 78.47 Favored Pre-proline 0 C--O 1.239 0.545 0 N-CA-C 108.801 -0.815 . . . . 74.53 108.801 -178.186 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . 0.524 ' HG3' HD12 ' A' ' 166' ' ' ILE . 37.4 Cg_endo -66.74 154.07 83.43 Favored 'Cis proline' 0 N--CA 1.46 -0.489 0 C-N-CA 124.478 -1.051 . . . . 71.42 112.494 -4.265 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . 0.444 HG21 HG22 ' A' ' 150' ' ' VAL . 35.3 m -155.06 110.61 3.1 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 105.194 -2.15 . . . . 73.44 105.194 172.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 95.9 mtp -89.5 152.12 21.61 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 107.5 -1.296 . . . . 62.21 107.5 164.247 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 15.0 t -138.97 139.41 40.48 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.288 0 N-CA-C 108.113 -1.069 . . . . 71.31 108.113 175.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 11.4 t -112.34 124.09 68.7 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 C-N-CA 126.395 1.878 . . . . 75.21 106.516 176.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 1.4 t30 51.0 17.13 0.4 Allowed 'General case' 0 C--O 1.223 -0.308 0 C-N-CA 128.836 2.854 . . . . 72.21 114.813 170.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 58.71 38.99 92.97 Favored Glycine 0 CA--C 1.525 0.66 0 C-N-CA 125.69 1.614 . . . . 35.21 112.829 -168.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 37.6 mttt -132.95 -38.27 0.98 Allowed 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 124.51 1.124 . . . . 74.22 112.29 178.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -116.6 118.24 32.07 Favored 'General case' 0 CA--C 1.517 -0.311 0 N-CA-C 108.284 -1.006 . . . . 71.34 108.284 -178.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 37.3 ttp85 -105.43 123.33 47.7 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 126.536 1.934 . . . . 75.42 106.972 174.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 13.5 p90 -150.23 170.97 17.72 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 107.529 -1.286 . . . . 65.44 107.529 -176.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -178.84 178.77 0.75 Allowed 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.166 -0.679 . . . . 75.3 109.166 -173.197 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.524 HD12 ' HG3' ' A' ' 154' ' ' PRO . 23.7 mt -47.96 -55.95 2.28 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 C-N-CA 127.733 2.413 . . . . 72.02 109.044 174.01 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -75.67 8.01 23.15 Favored Glycine 0 CA--C 1.526 0.727 0 C-N-CA 127.028 2.251 . . . . 51.34 114.794 178.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 4.7 m -110.72 -52.25 2.8 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-N 119.507 1.653 . . . . 72.22 109.886 168.038 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -65.39 -53.11 47.97 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 125.652 1.581 . . . . 62.43 111.598 -178.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 142.59 -7.16 2.21 Favored Glycine 0 CA--C 1.528 0.846 0 CA-C-O 119.056 -0.858 . . . . 64.05 114.41 -174.298 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 155.7 175.72 27.04 Favored Glycine 0 CA--C 1.53 0.983 0 CA-C-N 119.514 1.657 . . . . 44.43 110.149 -175.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -61.21 -53.67 2.31 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 122.918 2.412 . . . . 65.22 111.247 -175.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 8.2 mp0 -62.85 -32.89 74.2 Favored 'General case' 0 CA--C 1.536 0.411 0 O-C-N 121.434 -0.791 . . . . 44.32 110.924 179.134 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -66.17 -30.76 71.3 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.218 0.607 . . . . 70.22 110.131 178.107 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 37.7 m -65.59 -46.21 80.24 Favored 'General case' 0 N--CA 1.455 -0.221 0 O-C-N 121.364 -0.835 . . . . 72.21 110.453 -173.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 64.0 mt -62.89 -28.08 69.8 Favored 'General case' 0 C--O 1.223 -0.306 0 CA-C-N 118.559 0.618 . . . . 73.12 111.447 -177.027 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 2.6 tttt -53.58 -49.41 67.8 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 124.819 1.248 . . . . 72.01 109.338 172.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.436 HD21 ' HB3' ' A' ' 11' ' ' GLU . 4.1 mm? -67.12 -44.51 79.72 Favored 'General case' 0 CA--C 1.515 -0.392 0 N-CA-C 109.329 -0.619 . . . . 55.4 109.329 175.655 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.43 ' HB1' ' CZ2' ' A' ' 50' ' ' TRP . . . -56.78 -31.73 64.94 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 118.34 -0.838 . . . . 34.12 112.71 -174.247 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -84.16 -52.0 6.61 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 126.357 1.863 . . . . 73.34 108.666 -176.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 16.6 t80 -60.84 -45.61 93.8 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 123.896 0.878 . . . . 72.12 110.998 -175.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 93.1 mt -61.22 -28.66 69.32 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.06 0.944 . . . . 73.14 112.527 -178.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.448 HD13 HG21 ' A' ' 58' ' ' VAL . 44.0 mt -60.3 -52.78 57.36 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 CA-C-N 119.931 1.241 . . . . 61.2 108.357 173.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -66.71 -5.72 12.98 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 126.802 2.041 . . . . 74.04 112.901 177.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -98.12 -23.74 15.6 Favored 'General case' 0 N--CA 1.463 0.21 0 O-C-N 120.868 -1.145 . . . . 74.44 111.525 173.187 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . 0.53 ' HB3' HD12 ' A' ' 27' ' ' ILE . 30.5 mm-40 -96.54 -33.57 11.78 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 123.785 0.834 . . . . 64.34 112.734 -176.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . 0.411 ' HE ' HD11 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -51.12 -32.55 23.07 Favored 'General case' 0 N--CA 1.476 0.841 0 O-C-N 120.847 -1.158 . . . . 72.32 110.522 168.748 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.478 0 C-N-CA 126.713 2.005 . . . . 33.24 111.883 179.773 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 . . . . . 0 CA--C 1.532 0.28 0 CA-C-O 121.083 0.468 . . . . 75.53 110.857 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -153.23 15.88 0.54 Allowed 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 114.058 1.133 . . . . 71.55 114.058 -175.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 38.5 m-85 -135.49 160.2 39.2 Favored 'General case' 0 C--O 1.24 0.589 0 C-N-CA 125.1 1.36 . . . . 73.31 108.884 -173.299 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 88.6 m -125.89 134.78 51.49 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 109.217 -0.66 . . . . 72.54 109.217 178.062 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.03 144.36 57.33 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 121.837 0.827 . . . . 74.24 111.077 176.003 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 76.85 -19.61 3.28 Favored Glycine 0 CA--C 1.527 0.807 0 CA-C-O 118.674 -1.07 . . . . 60.32 112.366 -172.324 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 20.3 ttmt -97.43 -84.3 0.38 Allowed 'General case' 0 CA--C 1.511 -0.55 0 CA-C-N 119.116 1.458 . . . . 71.43 108.007 -177.101 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.443 ' HB3' HD21 ' A' ' 178' ' ' LEU . 5.0 mp0 -64.61 -26.31 68.34 Favored 'General case' 0 N--CA 1.442 -0.854 0 C-N-CA 124.748 1.219 . . . . 53.12 110.145 -175.19 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 12.7 p90 -163.91 171.8 14.85 Favored 'General case' 0 C--O 1.233 0.206 0 O-C-N 121.091 -1.006 . . . . 71.43 108.58 -172.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 24.4 t -132.34 110.83 16.8 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 C-N-CA 123.614 0.765 . . . . 54.24 110.035 -177.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -68.75 159.77 31.65 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 124.793 1.237 . . . . 70.42 109.112 166.514 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -134.08 116.36 15.37 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 124.214 1.005 . . . . 64.11 108.425 -174.454 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -61.6 -1.1 0.51 Allowed 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 125.805 1.642 . . . . 62.23 113.908 -177.539 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 48.9 m -133.82 85.57 40.94 Favored Pre-proline 0 CA--C 1.541 0.598 0 C-N-CA 127.583 2.353 . . . . 70.54 108.284 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -77.54 -178.73 4.81 Favored 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 124.647 3.564 . . . . 71.21 113.388 -178.372 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 25.9 t -136.55 148.21 62.88 Favored Pre-proline 0 CA--C 1.548 0.875 0 C-N-CA 126.525 1.93 . . . . 65.43 109.005 -178.115 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -82.19 -178.68 4.2 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 124.567 3.511 . . . . 72.44 112.572 173.493 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.9 m -131.36 172.18 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 124.975 1.31 . . . . 75.13 109.513 172.003 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 66.4 m -48.89 -56.15 9.62 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 125.614 1.565 . . . . 73.22 112.142 176.273 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -144.35 152.08 52.85 Favored Pre-proline 0 C--O 1.239 0.529 0 C-N-CA 125.363 1.465 . . . . 72.31 108.072 -172.604 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -69.45 178.33 4.49 Favored 'Trans proline' 0 N--CA 1.451 -0.982 0 C-N-CA 122.492 2.128 . . . . 74.54 109.251 165.63 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.26 -118.87 6.2 Favored Glycine 0 N--CA 1.45 -0.402 0 N-CA-C 106.951 -2.46 . . . . 72.05 106.951 -166.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -61.01 137.55 58.23 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 119.519 1.66 . . . . 71.11 110.916 -163.225 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 42.1 mm -62.72 138.88 22.02 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 N-CA-C 107.12 -1.437 . . . . 50.05 107.12 168.113 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.7 124.41 36.69 Favored 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 127.138 2.175 . . . . 73.12 106.851 -178.668 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.7 t -128.82 102.29 7.8 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.174 0 N-CA-C 106.438 -1.69 . . . . 72.23 106.438 176.173 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 52.3 t -97.33 114.25 33.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 107.278 -1.378 . . . . 60.12 107.278 -177.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 67.7 tt0 -72.28 134.27 45.47 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 107.6 -1.259 . . . . 51.54 107.6 152.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 5.0 mp -111.36 136.02 51.08 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 107.061 -1.459 . . . . 75.41 107.061 160.035 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 28.9 p90 -134.28 166.71 22.18 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.229 1.011 . . . . 73.12 110.642 -177.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . 0.438 ' HB3' HG21 ' A' ' 153' ' ' VAL . 26.6 t90 -150.36 158.95 44.72 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.724 1.21 . . . . 74.24 108.888 176.101 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 5.3 m-30 -83.59 51.29 1.97 Allowed 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.427 0.691 . . . . 75.23 111.302 178.171 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -174.91 18.84 0.05 OUTLIER Glycine 0 N--CA 1.463 0.446 0 O-C-N 120.287 -1.508 . . . . 72.04 114.273 -174.424 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.532 ' HB3' HG23 ' A' ' 153' ' ' VAL . 20.6 p -118.41 86.28 27.76 Favored Pre-proline 0 N--CA 1.449 -0.513 0 C-N-CA 124.907 1.283 . . . . 73.21 108.252 -172.756 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -63.15 -11.79 26.86 Favored 'Trans proline' 0 CA--C 1.541 0.874 0 C-N-CA 122.279 1.986 . . . . 74.12 114.03 -170.63 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 35.3 m170 -73.74 -22.73 59.78 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 119.209 0.913 . . . . 62.41 112.625 168.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 79.1 m -67.53 -65.85 0.64 Allowed 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.564 1.545 . . . . 74.43 110.67 -173.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 14.2 t80 -59.32 -29.23 67.47 Favored 'General case' 0 N--CA 1.467 0.419 0 O-C-N 121.415 -0.803 . . . . 73.21 112.036 -179.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.47 -26.22 68.62 Favored 'General case' 0 CA--C 1.542 0.652 0 O-C-N 121.452 -0.78 . . . . 75.53 112.615 176.04 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 20.8 t80 -93.97 -18.03 22.32 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 124.999 1.319 . . . . 65.42 112.426 -173.066 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -38.22 -63.04 0.59 Allowed Pre-proline 0 N--CA 1.472 0.631 0 C-N-CA 125.451 1.5 . . . . 74.55 112.767 175.079 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -77.23 -11.44 17.6 Favored 'Trans proline' 0 CA--C 1.534 0.524 0 CA-C-N 121.775 1.67 . . . . 72.15 114.533 -171.103 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.8 m -72.15 -44.97 62.27 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 107.786 -1.19 . . . . 73.22 107.786 166.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 14.3 tt -94.15 -28.65 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 N-CA-C 113.47 0.915 . . . . 74.43 113.47 -165.339 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 14.1 t -47.88 -60.94 3.5 Favored Pre-proline 0 CA--C 1.544 0.724 0 C-N-CA 124.87 1.268 . . . . 61.4 110.027 171.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_endo -72.28 -7.77 21.54 Favored 'Trans proline' 0 C--N 1.348 0.538 0 CA-C-N 121.555 1.591 . . . . 63.35 113.34 -175.247 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 82.6 t90 -77.57 -61.11 2.1 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 119.591 1.087 . . . . 73.12 108.297 165.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 47.9 t -60.23 -36.55 77.98 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.156 1.382 . . . . 72.31 112.593 -169.483 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -75.04 -10.76 59.77 Favored 'General case' 0 CA--C 1.54 0.566 0 O-C-N 120.78 -1.2 . . . . 65.52 111.922 -177.424 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -111.86 18.82 18.52 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 127.736 2.414 . . . . 73.02 113.228 -176.212 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 39.1 mt -75.22 156.18 85.8 Favored Pre-proline 0 N--CA 1.448 -0.565 0 C-N-CA 125.044 1.338 . . . . 62.24 111.424 -177.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -77.78 172.35 15.83 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 124.964 3.776 . . . . 73.15 111.096 179.045 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -66.12 -2.83 4.57 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 114.501 1.297 . . . . 63.21 114.501 -178.577 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -102.74 1.69 34.69 Favored 'General case' 0 C--O 1.223 -0.335 0 C-N-CA 125.05 1.34 . . . . 74.35 112.453 -177.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 39.1 t -125.99 131.52 71.67 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 CA-C-N 120.161 1.346 . . . . 70.32 108.381 -170.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 86.5 t60 -131.67 101.69 5.59 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 125.096 1.358 . . . . 74.31 109.214 -176.169 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 10.4 t80 -82.66 138.55 34.1 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 126.579 1.951 . . . . 73.55 109.476 -176.111 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 23.6 t -130.08 154.32 40.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 106.974 -1.491 . . . . 54.12 106.974 178.514 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 66.5 mtt85 -123.86 129.7 51.42 Favored 'General case' 0 CA--C 1.513 -0.448 0 N-CA-C 105.279 -2.119 . . . . 75.31 105.279 168.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 47.5 mt -134.24 148.92 69.8 Favored Pre-proline 0 C--N 1.33 -0.256 0 N-CA-C 108.921 -0.77 . . . . 53.1 108.921 175.354 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -73.8 140.24 28.78 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 122.347 2.031 . . . . 74.4 110.287 178.024 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -79.1 88.42 4.83 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.883 0.873 . . . . 73.24 110.549 178.756 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 10.1 mt -87.68 96.73 10.54 Favored 'General case' 0 C--N 1.331 -0.214 0 O-C-N 120.188 -1.57 . . . . 73.42 109.858 -177.336 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 48.0 m-85 -115.84 36.36 4.05 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 123.929 0.892 . . . . 74.41 110.958 179.34 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 78.66 -161.47 48.12 Favored Glycine 0 C--N 1.336 0.555 0 N-CA-C 110.004 -1.239 . . . . 63.34 110.004 -179.307 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 44.82 -131.79 7.78 Favored Glycine 0 CA--C 1.532 1.106 0 C-N-CA 125.355 1.455 . . . . 22.13 113.106 172.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 7.7 tp -80.76 -18.47 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 123.73 0.812 . . . . 73.32 110.962 174.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 8.6 m95 -58.52 -38.4 77.64 Favored 'General case' 0 C--N 1.338 0.097 0 O-C-N 121.226 -0.921 . . . . 72.44 111.664 -171.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -83.04 -28.24 29.74 Favored 'General case' 0 C--O 1.232 0.134 0 N-CA-C 113.647 0.98 . . . . 71.25 113.647 177.044 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 33.3 t -59.66 -52.4 61.49 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 N-CA-C 107.336 -1.357 . . . . 75.12 107.336 174.613 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 65.6 m170 -75.01 47.82 0.36 Allowed 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 126.968 2.107 . . . . 75.42 111.261 170.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -153.46 -42.17 0.02 OUTLIER Glycine 0 CA--C 1.526 0.734 0 C-N-CA 124.93 1.252 . . . . 75.44 111.775 177.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 37.9 tt0 -61.95 -26.31 68.12 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.421 1.088 . . . . 75.33 113.783 -168.003 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 1.7 ptt? -71.6 -34.05 69.55 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 120.121 1.328 . . . . 64.31 112.718 -177.395 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 45.1 t80 -54.81 -51.9 64.36 Favored 'General case' 0 N--CA 1.463 0.209 0 C-N-CA 124.067 0.947 . . . . 74.11 109.459 -176.034 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 36.7 mt -57.62 -40.47 79.23 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 124.66 1.184 . . . . 55.23 110.338 178.091 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.679 ' CG2' HG23 ' A' ' 128' ' ' THR . 1.8 m -70.36 -35.02 73.28 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 118.717 0.689 . . . . 65.11 111.247 -178.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -57.52 -56.22 24.66 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 125.073 1.349 . . . . 74.2 108.452 178.694 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -73.33 -21.16 60.62 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.907 0.883 . . . . 63.5 112.098 -178.308 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 27.8 t -66.1 -3.51 5.64 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 117.621 -1.181 . . . . 60.22 113.102 175.242 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 44.2 mtm . . . . . 0 N--CA 1.464 0.235 0 CA-C-N 120.933 1.697 . . . . 62.51 113.599 169.517 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.109 0 CA-C-O 118.946 -0.549 . . . . 72.31 112.382 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 58.4 t -58.32 -57.94 8.69 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 C-N-CA 124.091 0.957 . . . . 74.33 108.921 177.051 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -69.39 -37.98 77.77 Favored 'General case' 0 C--N 1.335 -0.058 0 C-N-CA 123.132 0.573 . . . . 74.53 112.36 -176.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -58.75 -32.61 69.4 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.608 1.563 . . . . 71.23 110.042 176.367 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -79.61 -20.83 45.91 Favored 'General case' 0 N--CA 1.448 -0.565 0 O-C-N 120.848 -1.157 . . . . 61.21 111.318 178.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 31.8 mt -94.45 -35.72 6.45 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 O-C-N 120.555 -1.341 . . . . 72.12 109.241 -179.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 57.8 m-70 -90.42 -63.64 1.25 Allowed 'General case' 0 C--O 1.233 0.232 0 C-N-CA 124.489 1.116 . . . . 53.54 110.954 -174.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 7.5 mtmt -68.07 -35.61 78.48 Favored 'General case' 0 N--CA 1.463 0.223 0 O-C-N 121.929 -0.482 . . . . 74.24 110.583 -176.163 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -99.87 -70.29 0.74 Allowed 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 108.51 -0.922 . . . . 74.23 108.51 -172.467 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 7.5 t-80 74.6 64.01 0.07 Allowed 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 128.618 2.767 . . . . 73.11 113.301 -177.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 65.2 mttt -76.53 28.97 0.12 Allowed 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 114.755 1.391 . . . . 73.43 114.755 179.515 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 10.0 tmtt? 46.52 57.91 5.05 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 125.958 1.703 . . . . 72.34 112.509 176.189 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 44.7 mt -67.46 42.4 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 130.16 3.384 . . . . 72.03 112.197 179.413 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -88.36 6.44 37.26 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 128.679 2.792 . . . . 53.35 113.14 -178.563 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -139.7 156.49 71.03 Favored Pre-proline 0 CA--C 1.537 0.479 0 C-N-CA 123.809 0.844 . . . . 73.05 111.335 178.614 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -64.69 -39.4 26.96 Favored 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 122.579 2.186 . . . . 72.23 112.386 -179.243 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -59.2 -42.89 92.0 Favored 'General case' 0 C--O 1.225 -0.187 0 CA-C-N 118.09 0.404 . . . . 63.01 110.177 176.359 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -60.52 -38.31 83.99 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 123.109 0.564 . . . . 64.45 110.615 -177.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 54.2 mtt -68.45 -49.91 56.44 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 123.908 0.883 . . . . 63.3 110.467 175.173 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -64.75 -47.14 79.29 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 124.811 1.244 . . . . 72.01 110.783 -171.188 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -62.2 -29.13 70.16 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 126.061 1.744 . . . . 63.23 112.836 176.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 73.0 t80 -76.85 -54.86 6.04 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 109.933 -0.395 . . . . 73.32 109.933 174.177 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 56.4 mt -68.07 -21.19 65.0 Favored 'General case' 0 CA--C 1.516 -0.345 0 O-C-N 121.809 -0.557 . . . . 70.02 110.584 -168.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -55.03 -13.65 1.23 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.402 0.681 . . . . 72.15 112.236 169.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -88.06 -9.69 70.23 Favored Glycine 0 N--CA 1.433 -1.51 0 CA-C-O 116.97 -2.017 . . . . 53.4 110.235 179.216 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -130.35 10.94 5.34 Favored 'General case' 0 C--N 1.347 0.466 0 CA-C-N 120.985 2.393 . . . . 72.45 112.947 -170.137 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 86.83 70.68 1.3 Allowed Glycine 0 N--CA 1.445 -0.731 0 N-CA-C 109.454 -1.458 . . . . 52.42 109.454 -179.198 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 25.7 t -141.4 129.71 22.83 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.816 0 C-N-CA 127.168 2.187 . . . . 74.12 107.271 172.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 41.2 t0 -89.45 123.16 33.33 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 124.185 0.994 . . . . 73.21 110.639 178.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 11.2 mtmt -59.07 -38.7 80.06 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 124.194 0.998 . . . . 51.05 111.02 171.192 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 75.7 mm-40 -65.17 -15.22 62.19 Favored 'General case' 0 C--N 1.329 -0.318 0 O-C-N 120.983 -1.073 . . . . 74.31 112.889 -177.403 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.541 ' O ' HG22 ' A' ' 128' ' ' THR . 9.7 mmtm -117.95 -42.33 2.83 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-O 117.585 -1.198 . . . . 74.12 110.777 -178.189 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 81.3 t80 -46.65 -65.71 0.52 Allowed 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 125.238 1.415 . . . . 71.1 111.12 171.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 18.0 mt -62.3 -38.38 89.15 Favored 'General case' 0 N--CA 1.465 0.279 0 O-C-N 122.055 -0.403 . . . . 72.34 110.827 -173.459 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 31.8 t -54.17 -61.76 2.09 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 107.883 -1.154 . . . . 62.33 107.883 177.178 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . 0.679 HG23 ' CG2' ' A' ' 80' ' ' THR 0.281 4.8 t -69.41 -30.2 68.1 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 118.268 -0.873 . . . . 62.1 110.699 -173.541 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 60.8 t80 -56.49 -42.1 77.73 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 119.87 1.214 . . . . 74.2 111.212 176.209 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -94.7 13.72 23.5 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.906 1.282 . . . . 73.34 111.854 179.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 50.5 m -103.56 161.98 13.43 Favored 'General case' 0 N--CA 1.469 0.504 0 O-C-N 120.618 -1.302 . . . . 51.42 111.167 176.406 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -63.52 -33.88 76.57 Favored 'General case' 0 C--O 1.225 -0.215 0 C-N-CA 122.628 0.371 . . . . 72.41 111.944 -171.537 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -50.99 -46.95 61.55 Favored 'General case' 0 CA--C 1.534 0.339 0 O-C-N 121.705 -0.622 . . . . 50.22 111.98 -175.636 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 48.2 mm -68.53 -33.6 60.89 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-O 118.912 -0.566 . . . . 74.51 110.01 179.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 12.3 tttt -55.05 -38.47 68.04 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 119.453 1.024 . . . . 71.11 110.45 171.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -70.96 -42.44 59.76 Favored Glycine 0 C--N 1.335 0.503 0 N-CA-C 110.603 -0.999 . . . . 64.22 110.603 -175.117 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -67.11 -43.82 81.48 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 123.946 0.898 . . . . 74.03 109.833 -179.51 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 86.7 mmm -58.54 -52.59 65.0 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 125.397 1.479 . . . . 64.43 109.665 175.272 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -63.26 -39.16 93.82 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 120.001 1.273 . . . . 33.44 112.004 -173.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 7.2 mmtt -56.29 -59.77 4.47 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 119.057 0.844 . . . . 54.54 109.227 170.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -53.62 -42.58 67.9 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 118.308 0.504 . . . . 70.41 110.948 -175.413 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 7.7 tttt -57.99 -60.8 3.16 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 125.532 1.533 . . . . 63.42 109.872 177.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 2.2 pttt -71.03 -17.62 62.61 Favored 'General case' 0 CA--C 1.529 0.169 0 N-CA-C 112.313 0.486 . . . . 74.15 112.313 -174.494 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 32.6 mt -73.81 -56.12 5.36 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 124.021 0.928 . . . . 74.54 111.01 170.305 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -57.16 -43.19 82.29 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 119.049 0.84 . . . . 72.2 111.577 -171.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 3.8 ppp? -60.62 -44.29 96.49 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 113.146 0.795 . . . . 72.51 113.146 174.289 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -62.92 -35.75 81.12 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 124.247 1.019 . . . . 75.13 111.096 179.263 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 31.0 m-85 -74.54 14.37 0.48 Allowed 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.11 1.364 . . . . 73.22 113.317 177.458 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 57.32 18.65 4.47 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 126.023 1.729 . . . . 54.43 114.112 178.212 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.458 HG13 HG21 ' A' ' 155' ' ' THR . 20.6 t -75.0 137.05 23.8 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 CA-C-N 119.177 0.898 . . . . 72.04 109.309 -174.815 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -132.42 2.97 3.88 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.524 0.73 . . . . 54.31 112.191 -172.345 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -173.54 -168.91 35.27 Favored Glycine 0 CA--C 1.527 0.83 0 C-N-CA 127.278 2.371 . . . . 51.22 110.054 178.228 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.532 HG23 ' HB3' ' A' ' 37' ' ' CYS . 3.5 m -149.04 157.37 40.05 Favored Pre-proline 0 CA--C 1.537 0.476 0 C-N-CA 125.943 1.697 . . . . 61.5 109.092 -175.798 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -62.31 159.79 56.17 Favored 'Cis proline' 0 N--CA 1.454 -0.848 0 C-N-CA 124.527 -1.031 . . . . 73.43 111.571 -9.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . 0.458 HG21 HG13 ' A' ' 150' ' ' VAL . 7.7 m -155.56 139.71 16.52 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 107.695 -1.224 . . . . 44.35 107.695 176.174 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 98.8 mtp -119.11 160.26 22.41 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-N 114.666 -1.152 . . . . 74.23 108.17 170.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 39.6 t -139.89 156.01 25.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 106.188 -1.782 . . . . 74.23 106.188 178.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 48.2 t -126.18 120.39 56.67 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 N-CA-C 107.242 -1.392 . . . . 72.21 107.242 171.033 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 23.2 m-20 51.64 21.87 1.45 Allowed 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 127.794 2.437 . . . . 72.14 114.405 175.199 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 57.02 32.89 63.15 Favored Glycine 0 CA--C 1.528 0.854 0 CA-C-O 118.239 -1.312 . . . . 62.33 113.996 -168.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 8.0 mtpt -126.79 -29.94 2.81 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 119.491 1.646 . . . . 73.43 111.467 -178.437 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -126.07 128.91 48.12 Favored 'General case' 0 CA--C 1.519 -0.225 0 N-CA-C 108.553 -0.906 . . . . 75.34 108.553 179.221 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 3.7 ttp85 -101.04 132.45 46.46 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 105.673 -1.973 . . . . 74.42 105.673 171.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 13.9 p90 -147.9 161.93 40.32 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.65 -0.871 . . . . 73.11 108.65 173.276 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -170.47 -171.87 1.15 Allowed 'General case' 0 N--CA 1.474 0.762 0 O-C-N 121.741 -0.6 . . . . 75.24 111.162 -174.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 12.2 mt -71.72 -26.02 25.29 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 C-N-CA 126.137 1.775 . . . . 72.44 110.263 -179.168 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -66.16 -54.78 22.16 Favored Glycine 0 N--CA 1.444 -0.811 0 N-CA-C 110.196 -1.161 . . . . 24.03 110.196 168.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 11.4 m -69.06 -59.17 3.22 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 117.398 0.599 . . . . 63.34 111.036 -163.219 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.468 ' CB ' HD23 ' A' ' 178' ' ' LEU . . . -67.35 -35.79 80.09 Favored 'General case' 0 CA--C 1.537 0.462 0 O-C-N 122.034 -0.416 . . . . 50.33 111.862 -167.482 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 140.64 4.09 1.25 Allowed Glycine 0 CA--C 1.531 1.049 0 C-N-CA 125.59 1.567 . . . . 74.23 115.744 175.362 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 137.36 178.18 15.71 Favored Glycine 0 CA--C 1.531 1.078 0 CA-C-N 119.797 1.798 . . . . 74.42 109.59 -168.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -64.68 -44.48 10.66 Favored 'Trans proline' 0 N--CA 1.459 -0.553 0 C-N-CA 123.243 2.629 . . . . 52.42 112.006 -166.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -56.13 -44.75 79.49 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.363 0.665 . . . . 73.04 109.968 178.377 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -71.68 -27.53 63.11 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 116.012 -0.54 . . . . 74.43 110.36 -173.554 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 90.0 m -59.13 -43.56 92.0 Favored 'General case' 0 CA--C 1.533 0.319 0 O-C-N 120.612 -1.305 . . . . 74.13 110.636 177.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 52.0 mt -64.46 -35.46 81.0 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 119.228 0.922 . . . . 74.42 110.852 177.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 21.2 tttt -55.3 -36.02 65.73 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 124.423 1.089 . . . . 61.4 110.121 176.196 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.468 HD23 ' CB ' ' A' ' 169' ' ' ALA . 4.6 mm? -79.57 -43.9 22.1 Favored 'General case' 0 CA--C 1.513 -0.47 0 CA-C-O 117.67 -1.157 . . . . 73.12 110.294 173.432 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -51.33 -43.2 61.68 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 119.459 1.027 . . . . 62.51 111.979 -177.017 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -82.39 -38.5 24.02 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 123.954 0.902 . . . . 64.45 109.274 -167.268 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 30.8 t80 -61.07 -55.96 26.52 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 124.442 1.097 . . . . 53.13 110.535 171.27 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 91.2 mt -61.72 -29.83 70.36 Favored 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 124.09 0.956 . . . . 72.42 111.83 -173.274 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 30.2 mt -56.47 -60.97 1.37 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.151 0 N-CA-C 108.151 -1.055 . . . . 72.42 108.151 168.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 10.9 tm-20 -52.31 -40.74 62.26 Favored 'General case' 0 N--CA 1.457 -0.113 0 C-N-CA 124.28 1.032 . . . . 74.22 111.554 -177.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 12.7 tptp -58.09 -47.92 81.75 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 123.047 0.539 . . . . 72.43 111.254 -179.434 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 41.5 mm-40 -74.53 -39.47 62.35 Favored 'General case' 0 C--O 1.223 -0.312 0 C-N-CA 123.082 0.553 . . . . 71.41 110.865 178.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.65 -37.89 89.14 Favored 'General case' 0 C--N 1.331 -0.216 0 O-C-N 120.269 -1.519 . . . . 72.31 109.253 -175.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.255 0 C-N-CA 125.267 1.427 . . . . 45.01 111.808 177.288 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 . . . . . 0 C--O 1.232 0.148 0 CA-C-O 122.509 1.147 . . . . 74.42 109.45 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -82.69 16.29 2.26 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 126.366 1.866 . . . . 74.23 114.187 -177.355 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 42.1 m-85 -143.63 164.32 30.75 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 124.431 1.093 . . . . 74.12 110.5 -165.176 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 57.3 m -133.67 130.53 38.34 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.754 1.221 . . . . 64.11 108.609 -176.024 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.91 140.89 58.91 Favored 'General case' 0 C--O 1.232 0.162 0 O-C-N 121.636 -0.665 . . . . 63.0 109.732 175.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 82.52 -23.19 5.74 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 125.877 1.703 . . . . 44.53 112.297 -170.461 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 75.1 tttt -96.64 -72.77 0.62 Allowed 'General case' 0 CA--C 1.508 -0.642 0 CA-C-N 118.405 1.103 . . . . 73.0 110.517 -169.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.501 ' HB3' HD11 ' A' ' 178' ' ' LEU . 16.5 mp0 -76.3 -23.89 54.36 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 124.639 1.175 . . . . 73.34 109.702 178.816 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 41.3 p90 -162.19 174.46 12.87 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.699 0.8 . . . . 63.05 110.717 -171.265 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 59.8 t -131.95 113.74 22.89 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 N-CA-C 108.123 -1.066 . . . . 74.12 108.123 178.28 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.68 160.51 32.11 Favored 'General case' 0 C--O 1.234 0.283 0 O-C-N 120.602 -1.311 . . . . 72.11 108.736 163.418 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -134.75 116.75 15.23 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 124.43 1.092 . . . . 73.24 110.133 -178.312 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 4.3 p -67.39 6.3 0.62 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 127.274 2.23 . . . . 54.35 113.918 176.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 18.6 m -127.12 71.43 75.96 Favored Pre-proline 0 N--CA 1.45 -0.447 0 C-N-CA 126.023 1.729 . . . . 73.2 108.205 174.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -76.69 179.81 6.09 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 124.125 3.216 . . . . 73.33 112.533 -170.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 88.3 t -140.8 128.2 12.15 Favored Pre-proline 0 CA--C 1.544 0.73 0 C-N-CA 124.284 1.034 . . . . 61.5 110.448 -167.393 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -82.65 178.73 5.87 Favored 'Trans proline' 0 CA--C 1.542 0.897 0 C-N-CA 124.794 3.663 . . . . 62.54 112.326 176.615 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 28.2 m -134.07 167.29 26.55 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 C-N-CA 124.202 1.001 . . . . 73.31 112.077 -179.268 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 11.2 t -64.42 -49.29 72.11 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 127.427 2.291 . . . . 60.43 109.568 170.163 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 30.9 tt0 -113.74 80.99 5.39 Favored Pre-proline 0 CA--C 1.541 0.601 0 C-N-CA 124.264 1.026 . . . . 75.51 110.451 -173.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -68.97 97.18 0.56 Allowed 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 123.928 3.086 . . . . 71.25 108.216 174.434 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -175.5 -58.97 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.378 0 N-CA-C 110.715 -0.954 . . . . 42.32 110.715 -175.553 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.46 145.04 28.36 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 107.172 -1.418 . . . . 74.44 107.172 166.634 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 36.9 mm -66.11 131.74 31.79 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 N-CA-C 105.721 -1.955 . . . . 64.24 105.721 167.298 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -80.65 142.58 33.84 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 108.699 -0.852 . . . . 72.21 108.699 171.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.442 HG22 HG22 ' A' ' 158' ' ' VAL . 47.1 t -131.57 114.38 25.29 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 N-CA-C 106.391 -1.707 . . . . 71.13 106.391 161.815 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 4.7 t -92.89 141.85 14.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 106.81 -1.552 . . . . 74.32 106.81 171.256 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 79.4 tt0 -107.64 106.25 16.51 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 105.217 -2.142 . . . . 70.31 105.217 156.286 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.0 mp -74.93 155.43 37.45 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 108.624 -0.88 . . . . 71.42 108.624 165.087 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -140.71 164.02 31.32 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 115.777 -0.647 . . . . 75.41 112.207 -163.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . 0.55 ' HB3' HG21 ' A' ' 153' ' ' VAL . 23.6 t90 -159.63 129.76 5.58 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 121.559 0.695 . . . . 71.44 110.642 158.403 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 11.2 m-30 -45.24 -27.3 0.62 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 126.392 1.877 . . . . 71.53 114.611 165.045 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -80.77 2.42 79.6 Favored Glycine 0 CA--C 1.531 1.067 0 CA-C-N 119.63 1.105 . . . . 72.14 114.161 -178.151 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 54.1 t -105.44 86.89 1.86 Allowed Pre-proline 0 CA--C 1.539 0.543 0 C-N-CA 125.71 1.604 . . . . 71.02 112.72 -165.304 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -63.81 -25.13 68.05 Favored 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 121.862 1.708 . . . . 72.12 112.95 177.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 13.7 m-70 -61.76 -46.39 89.78 Favored 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 108.365 -0.976 . . . . 75.1 108.365 173.337 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 87.7 m -60.09 -39.03 84.7 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.83 0.852 . . . . 52.1 109.037 -170.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 45.7 t80 -51.96 -40.46 60.88 Favored 'General case' 0 C--N 1.344 0.344 0 C-N-CA 125.3 1.44 . . . . 72.12 110.763 178.316 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.74 -26.25 68.28 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 118.817 -0.611 . . . . 52.15 112.546 -178.337 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.465 ' CD2' HD11 ' A' ' 166' ' ' ILE . 1.5 t80 -79.3 -25.73 42.37 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-O 117.558 -1.21 . . . . 64.02 111.741 -176.483 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 28.8 mm-40 -37.64 -69.39 0.19 Allowed Pre-proline 0 N--CA 1.471 0.606 0 C-N-CA 125.379 1.472 . . . . 74.45 112.829 -171.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -68.68 -6.67 18.45 Favored 'Trans proline' 0 CA--C 1.536 0.62 0 CA-C-N 121.98 1.743 . . . . 72.2 115.696 -172.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 60.1 m -85.26 -40.25 16.82 Favored 'General case' 0 CA--C 1.537 0.464 0 O-C-N 121.019 -1.051 . . . . 64.44 109.293 168.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 21.0 tt -93.51 -26.16 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 CA-C-N 118.575 0.625 . . . . 72.33 112.467 -171.571 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 19.3 t -53.18 -64.73 1.46 Allowed Pre-proline 0 C--O 1.236 0.385 0 C-N-CA 125.728 1.611 . . . . 70.44 110.059 172.522 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -63.11 -34.6 68.83 Favored 'Trans proline' 0 N--CA 1.451 -0.971 0 CA-C-N 120.898 1.356 . . . . 75.1 111.396 -174.142 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 86.7 t90 -54.54 -51.92 63.69 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 124.195 0.998 . . . . 72.24 110.521 174.242 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 98.7 p -59.25 -38.07 79.15 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 118.428 0.558 . . . . 74.31 111.84 -176.592 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -71.49 -18.71 62.27 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.691 0.796 . . . . 64.22 112.116 179.281 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 67.7 mmtt -94.72 -1.89 52.15 Favored 'General case' 0 C--O 1.232 0.164 0 C-N-CA 124.98 1.312 . . . . 62.44 112.983 179.101 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 36.9 mt -61.16 149.73 81.4 Favored Pre-proline 0 N--CA 1.45 -0.438 0 CA-C-N 119.846 1.203 . . . . 72.14 111.927 -175.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -77.48 165.06 27.87 Favored 'Trans proline' 0 N--CA 1.447 -1.221 0 C-N-CA 123.82 3.013 . . . . 71.22 111.547 -175.11 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -66.77 12.46 0.07 Allowed 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 127.421 2.288 . . . . 35.34 115.072 -176.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -128.36 14.76 6.65 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.449 1.499 . . . . 74.0 111.211 175.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 90.2 t -116.28 155.98 17.56 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 O-C-N 120.64 -1.288 . . . . 71.13 109.445 177.347 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 16.9 t-160 -132.43 102.84 5.89 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 125.955 1.702 . . . . 72.12 106.905 168.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -89.21 139.04 30.89 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 109.228 -0.656 . . . . 73.53 109.228 172.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 78.2 t -143.8 145.74 21.74 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.102 0 C-N-CA 124.675 1.19 . . . . 72.32 108.616 -176.317 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 22.2 mtp180 -111.21 119.28 38.39 Favored 'General case' 0 N--CA 1.463 0.193 0 N-CA-C 105.838 -1.912 . . . . 74.43 105.838 174.156 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 21.0 mt -128.18 147.02 61.74 Favored Pre-proline 0 N--CA 1.473 0.721 0 C-N-CA 123.543 0.737 . . . . 71.03 111.406 176.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -77.38 149.04 27.25 Favored 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 122.639 2.226 . . . . 70.02 112.206 -178.216 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -95.21 126.03 40.25 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 122.232 1.015 . . . . 73.03 108.671 174.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.461 HD22 ' HE1' ' A' ' 138' ' ' MET . 60.9 mt -113.03 52.26 0.8 Allowed 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 125.927 1.691 . . . . 74.02 111.583 -165.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 50.4 m-85 -83.42 63.89 7.55 Favored 'General case' 0 CA--C 1.54 0.57 0 O-C-N 121.332 -0.855 . . . . 71.23 111.784 -177.015 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 61.77 6.77 9.73 Favored Glycine 0 N--CA 1.476 1.366 0 N-CA-C 117.428 1.731 . . . . 61.02 117.428 142.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -170.47 103.85 0.2 Allowed Glycine 0 C--O 1.226 -0.406 0 N-CA-C 106.851 -2.5 . . . . 64.52 106.851 -176.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . 0.308 3.6 tp 58.34 -40.38 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 C-N-CA 130.501 3.52 . . . . 70.12 115.637 -171.063 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 12.5 m95 -49.26 -42.33 40.54 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 126.282 1.833 . . . . 74.45 111.606 -176.049 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 12.6 p30 -76.74 -28.69 55.87 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 114.284 1.216 . . . . 73.02 114.284 -178.323 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 86.0 t -70.28 -53.42 23.17 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 N-CA-C 106.347 -1.723 . . . . 74.2 106.347 174.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 40.5 m170 -68.03 39.42 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 128.905 2.882 . . . . 72.22 113.263 169.509 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -156.47 -46.66 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.424 0 O-C-N 121.204 -0.935 . . . . 72.21 111.378 177.397 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -50.66 -41.57 55.66 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.136 0.975 . . . . 33.25 112.144 -176.049 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 4.1 ttt -54.1 -35.39 62.07 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.387 1.075 . . . . 75.25 113.462 -175.547 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 39.3 t80 -59.94 -42.38 93.87 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 118.918 0.781 . . . . 74.43 109.844 -179.102 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 16.3 mt -66.0 -40.51 91.22 Favored 'General case' 0 C--O 1.227 -0.102 0 C-N-CA 125.094 1.358 . . . . 74.33 109.427 179.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.444 HG23 HG23 ' A' ' 128' ' ' THR . 0.2 OUTLIER -63.78 -37.02 85.81 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.666 0.786 . . . . 74.55 110.833 175.673 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.35 -56.33 15.13 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 124.092 0.957 . . . . 42.13 109.266 -178.422 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -72.06 -15.51 62.02 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 112.534 0.568 . . . . 42.25 112.534 -178.36 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 38.5 t -60.39 -18.99 54.22 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.521 1.129 . . . . 74.44 111.409 170.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 45.9 mtm . . . . . 0 N--CA 1.47 0.537 0 CA-C-N 120.282 1.401 . . . . 70.23 114.421 173.565 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 0.532 0 N-CA-C 113.189 0.811 . . . . 71.45 113.189 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 17.6 t -71.57 -62.18 1.4 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 N-CA-C 108.375 -0.972 . . . . 75.42 108.375 172.383 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 41.3 m-85 -64.42 -35.88 82.35 Favored 'General case' 0 C--N 1.338 0.082 0 C-N-CA 124.267 1.027 . . . . 72.4 111.89 -174.561 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 34.8 mm-40 -57.93 -45.19 86.97 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 125.553 1.541 . . . . 65.53 109.435 175.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -64.28 -19.67 65.56 Favored 'General case' 0 CA--C 1.542 0.645 0 O-C-N 121.574 -0.704 . . . . 64.33 112.195 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 64.4 mt -101.74 -25.93 3.66 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 C-N-CA 125.679 1.592 . . . . 63.54 110.298 -173.239 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 83.8 m-70 -117.58 -53.71 2.4 Favored 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 124.323 1.049 . . . . 73.24 111.835 -174.391 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -72.1 -32.66 67.2 Favored 'General case' 0 N--CA 1.468 0.45 0 O-C-N 121.309 -0.869 . . . . 64.31 110.949 176.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -101.71 -36.32 8.76 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 119.425 1.011 . . . . 54.42 112.597 177.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 22.7 t-160 44.5 63.62 1.61 Allowed 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.901 1.68 . . . . 74.14 112.07 -171.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 37.7 mmtt -64.19 170.71 3.49 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.208 1.403 . . . . 65.12 110.96 171.639 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 63.3 tttt -81.38 30.02 0.35 Allowed 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 125.985 1.714 . . . . 70.24 112.622 -173.477 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.477 HD23 ' HB3' ' A' ' 110' ' ' GLU . 31.0 mt -71.89 32.08 0.05 Allowed 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 128.8 2.84 . . . . 41.15 114.452 -165.112 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -78.85 8.37 5.61 Favored 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 126.864 2.066 . . . . 71.41 114.303 -178.333 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -150.75 156.77 36.15 Favored Pre-proline 0 CA--C 1.534 0.332 0 C-N-CA 124.25 1.02 . . . . 75.21 109.566 -174.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -65.42 -30.23 53.21 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 121.818 1.678 . . . . 61.22 114.0 -170.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -66.26 -53.69 33.86 Favored 'General case' 0 C--O 1.223 -0.31 0 CA-C-O 118.13 -0.938 . . . . 75.44 109.563 178.004 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.477 ' HB3' HD23 ' A' ' 105' ' ' LEU . 13.5 mm-40 -50.89 -48.19 60.5 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 119.353 0.979 . . . . 73.23 111.286 178.459 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 59.7 mtt -54.96 -55.19 33.48 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 123.937 0.895 . . . . 44.43 110.173 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.44 ' HB1' ' CG ' ' A' ' 122' ' ' LYS . . . -66.73 -42.61 86.0 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.565 1.146 . . . . 75.45 110.989 -172.665 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -61.0 -40.06 92.08 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 126.192 1.797 . . . . 74.43 109.853 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 38.7 t80 -68.81 -50.86 46.65 Favored 'General case' 0 N--CA 1.454 -0.243 0 O-C-N 121.807 -0.558 . . . . 75.42 109.644 178.193 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 50.7 mt -68.45 -15.94 63.73 Favored 'General case' 0 N--CA 1.452 -0.341 0 O-C-N 121.988 -0.445 . . . . 35.22 110.323 -172.561 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -54.19 -31.41 52.87 Favored 'General case' 0 CA--C 1.534 0.329 0 O-C-N 121.88 -0.513 . . . . 65.44 111.987 169.4 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -83.65 1.92 88.07 Favored Glycine 0 CA--C 1.534 1.22 0 CA-C-O 119.113 -0.826 . . . . 74.33 113.988 173.652 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 13.5 mmtp -131.62 27.31 4.68 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 120.036 1.918 . . . . 44.22 111.292 -166.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 73.33 36.1 55.77 Favored Glycine 0 CA--C 1.521 0.453 0 CA-C-O 119.825 -0.431 . . . . 71.13 112.295 173.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 31.8 t -126.51 123.11 62.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 N-CA-C 106.704 -1.591 . . . . 65.21 106.704 178.389 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -69.75 153.56 43.19 Favored 'General case' 0 CA--C 1.537 0.454 0 O-C-N 122.021 -0.424 . . . . 63.13 111.533 173.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.44 ' CG ' ' HB1' ' A' ' 112' ' ' ALA . 6.1 ttpt -83.48 -36.84 23.82 Favored 'General case' 0 N--CA 1.465 0.299 0 O-C-N 120.419 -1.426 . . . . 72.25 110.46 175.492 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 58.0 mt-10 -57.83 -52.86 63.72 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 118.859 0.754 . . . . 74.23 109.693 -176.504 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 7.6 mmmt -73.32 -38.52 65.78 Favored 'General case' 0 CA--C 1.508 -0.639 0 N-CA-C 108.353 -0.98 . . . . 72.11 108.353 -167.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 61.4 t80 -57.88 -62.49 1.77 Allowed 'General case' 0 N--CA 1.436 -1.174 0 O-C-N 124.732 1.27 . . . . 73.44 109.13 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 16.0 mt -68.05 -31.15 70.6 Favored 'General case' 0 C--O 1.238 0.485 0 O-C-N 121.985 -0.447 . . . . 75.11 111.305 -176.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 33.2 t -56.15 -59.8 4.41 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 107.4 -1.333 . . . . 41.41 107.4 175.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . 0.444 HG23 HG23 ' A' ' 80' ' ' THR . 4.5 t -71.86 -36.18 70.04 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 118.963 -0.541 . . . . 73.24 109.934 -171.73 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 61.6 t80 -51.62 -43.98 62.74 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.93 1.292 . . . . 73.41 111.733 176.394 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 54.4 m-20 -104.39 33.61 3.45 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 121.779 -0.576 . . . . 73.4 110.667 -179.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 22.6 t -122.95 165.76 16.18 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.178 1.391 . . . . 62.22 110.926 177.182 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -57.19 -29.42 63.67 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.168 1.387 . . . . 61.24 111.517 177.746 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -53.57 -58.89 5.57 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 123.918 0.887 . . . . 61.31 110.849 177.586 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 38.6 mm -74.17 -28.28 23.07 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-O 118.421 -0.8 . . . . 73.23 109.89 -176.099 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 7.4 mmtt -53.97 -43.12 69.65 Favored 'General case' 0 C--N 1.34 0.169 0 CA-C-N 119.639 1.108 . . . . 63.51 110.002 170.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -66.76 -20.47 70.35 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 124.389 0.995 . . . . 53.44 112.944 -177.516 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -90.13 -41.31 11.71 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 117.954 0.877 . . . . 71.14 110.1 174.342 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . 0.461 ' HE1' HD22 ' A' ' 66' ' ' LEU . 87.8 mmm -64.39 -35.93 82.48 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 124.825 1.25 . . . . 65.44 112.3 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -61.31 -51.29 69.48 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 119.039 0.836 . . . . 54.23 109.804 177.248 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 2.7 mmtt -65.04 -55.45 18.82 Favored 'General case' 0 CA--C 1.514 -0.419 0 C-N-CA 123.932 0.893 . . . . 74.52 109.275 -176.614 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -55.02 -34.5 63.54 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 119.681 1.128 . . . . 22.24 111.688 -178.086 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 5.7 tmtt? -77.87 -51.31 10.65 Favored 'General case' 0 C--N 1.346 0.437 0 CA-C-N 119.884 1.22 . . . . 72.43 111.344 -179.244 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 18.3 ptmt -60.54 -30.63 69.89 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 119.558 1.072 . . . . 65.33 110.527 178.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 48.4 mt -68.86 -56.91 6.46 Favored 'General case' 0 N--CA 1.443 -0.802 0 C-N-CA 123.442 0.697 . . . . 74.11 110.232 177.384 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -53.93 -41.5 67.77 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 119.887 1.221 . . . . 54.21 113.32 -173.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -65.22 -46.74 79.43 Favored 'General case' 0 N--CA 1.464 0.25 0 O-C-N 122.049 -0.407 . . . . 65.14 111.932 175.149 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -69.73 -35.04 74.66 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 118.733 0.697 . . . . 72.42 111.557 -176.409 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -69.48 9.29 0.49 Allowed 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 125.536 1.534 . . . . 71.34 113.763 171.618 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 10.9 mm100 59.04 24.72 13.02 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 126.005 1.722 . . . . 70.31 113.16 177.727 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 39.3 t -69.18 150.57 10.51 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 O-C-N 120.643 -1.286 . . . . 62.04 108.475 -178.197 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -145.98 6.27 1.02 Allowed 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.311 0.644 . . . . 52.22 111.947 -166.02 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 159.52 -171.99 36.05 Favored Glycine 0 N--CA 1.446 -0.688 0 N-CA-C 109.127 -1.589 . . . . 64.53 109.127 -166.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.55 HG21 ' HB3' ' A' ' 34' ' ' TRP . 15.3 m -139.72 161.93 53.77 Favored Pre-proline 0 CA--C 1.539 0.531 0 C-N-CA 124.064 0.945 . . . . 74.42 110.261 176.615 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . 0.46 ' C ' ' HA ' ' A' ' 153' ' ' VAL . 20.6 Cg_endo -58.37 156.63 36.13 Favored 'Cis proline' 0 CA--C 1.532 0.384 0 C-N-CA 123.928 -1.28 . . . . 73.3 111.065 -14.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . 0.444 ' HA ' ' HB3' ' A' ' 165' ' ' ASP . 11.0 m -147.95 109.96 4.53 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.066 -1.087 . . . . 64.31 108.066 171.255 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 36.2 mmm -89.27 158.73 17.73 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 108.337 -0.986 . . . . 71.35 108.337 170.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 11.5 t -145.19 121.56 3.97 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 N-CA-C 108.575 -0.898 . . . . 73.11 108.575 174.128 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.566 HG23 ' CE1' ' A' ' 164' ' ' PHE . 77.2 t -91.83 131.51 38.73 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 N-CA-C 108.524 -0.917 . . . . 70.45 108.524 169.367 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 44.1 t30 48.88 19.45 0.27 Allowed 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 130.082 3.353 . . . . 73.11 115.323 168.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 69.62 23.75 76.54 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 125.357 1.456 . . . . 35.53 112.852 -175.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 55.9 mttt -131.55 -31.45 1.59 Allowed 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 118.596 1.198 . . . . 52.41 113.111 -171.285 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . 0.521 ' CG ' HD22 ' A' ' 182' ' ' LEU . 96.5 m-85 -125.68 108.08 11.19 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 123.529 0.732 . . . . 62.33 109.12 -175.532 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 41.7 ttt-85 -90.36 124.12 34.67 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 126.985 2.114 . . . . 72.51 106.039 174.475 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . 0.566 ' CE1' HG23 ' A' ' 158' ' ' VAL . 18.1 p90 -149.42 166.95 27.54 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 107.67 -1.233 . . . . 73.52 107.67 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . 0.444 ' HB3' ' HA ' ' A' ' 155' ' ' THR . 10.4 p-10 178.24 178.07 0.4 Allowed 'General case' 0 CA--C 1.51 -0.562 0 C-N-CA 124.86 1.264 . . . . 75.53 109.205 -178.666 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.465 HD11 ' CD2' ' A' ' 43' ' ' PHE . 18.2 mt -54.35 -38.49 40.54 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.673 0 C-N-CA 126.405 1.882 . . . . 72.42 109.834 178.204 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -65.27 -30.96 79.03 Favored Glycine 0 CA--C 1.526 0.764 0 C-N-CA 124.321 0.963 . . . . 42.14 113.266 175.499 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 51.0 m -84.61 -62.19 1.61 Allowed 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.898 0.879 . . . . 65.52 110.064 178.148 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -59.0 -32.87 70.08 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 126.583 1.953 . . . . 73.25 112.071 -173.274 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 102.07 2.58 51.7 Favored Glycine 0 CA--C 1.526 0.727 0 CA-C-O 118.656 -1.08 . . . . 34.03 112.453 178.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 169.24 172.66 36.17 Favored Glycine 0 CA--C 1.531 1.041 0 CA-C-N 119.256 1.528 . . . . 53.21 111.556 175.579 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -66.44 -49.37 1.82 Allowed 'Trans proline' 0 CA--C 1.534 0.502 0 C-N-CA 123.046 2.497 . . . . 74.3 112.459 -175.357 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -57.09 -43.67 82.43 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 119.406 1.003 . . . . 74.1 109.865 175.429 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -57.79 -34.88 70.08 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.21 -0.905 . . . . 71.4 109.958 -178.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 48.8 m -67.4 -41.51 84.81 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-O 118.179 -0.915 . . . . 74.25 110.689 -178.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 49.7 mt -66.45 -35.64 80.81 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 119.836 1.198 . . . . 54.33 111.039 176.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 10.3 mttt -51.39 -48.56 62.54 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.244 1.418 . . . . 63.24 110.09 170.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.501 HD11 ' HB3' ' A' ' 11' ' ' GLU . 3.2 mm? -67.58 -48.85 65.68 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-O 118.346 -0.835 . . . . 72.11 110.478 173.833 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -52.91 -37.55 60.86 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 123.375 0.67 . . . . 73.03 111.977 -172.576 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -81.36 -47.55 13.12 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.659 1.184 . . . . 74.3 110.657 -173.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -56.56 -47.79 78.72 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 108.82 -0.807 . . . . 65.44 108.82 176.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . 0.521 HD22 ' CG ' ' A' ' 162' ' ' TYR . 29.4 mt -63.57 -32.44 73.9 Favored 'General case' 0 CA--C 1.514 -0.438 0 C-N-CA 125.3 1.44 . . . . 61.03 112.205 -170.672 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 30.0 mt -58.38 -61.49 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 N-CA-C 107.046 -1.465 . . . . 71.02 107.046 174.058 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -53.05 -37.19 61.38 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 123.869 0.867 . . . . 64.12 111.691 -179.339 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . 0.457 ' HA ' ' HE2' ' A' ' 185' ' ' LYS . 0.0 OUTLIER -54.72 -39.09 67.88 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.547 0.739 . . . . 62.34 111.046 -176.063 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 63.8 mm-40 -95.14 -33.85 12.49 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 124.133 0.973 . . . . 65.55 112.135 175.126 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.05 -34.45 74.89 Favored 'General case' 0 CA--C 1.529 0.17 0 O-C-N 120.598 -1.314 . . . . 74.52 109.908 -179.022 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.237 0.427 0 C-N-CA 124.914 1.286 . . . . 54.21 112.174 179.385 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 . . . . . 0 CA--C 1.514 -0.43 0 CA-C-O 120.788 0.327 . . . . 62.2 110.977 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -134.21 11.37 3.86 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 126.278 1.831 . . . . 65.35 111.546 -170.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 -140.02 158.18 44.47 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 124.697 1.199 . . . . 71.44 108.485 -169.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 24.4 m -134.76 138.94 44.77 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 108.777 -0.823 . . . . 71.4 108.777 -178.577 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -71.14 143.74 50.47 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 109.146 -0.687 . . . . 75.42 109.146 174.192 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 68.1 14.28 65.78 Favored Glycine 0 CA--C 1.523 0.577 0 CA-C-O 119.315 -0.714 . . . . 32.44 112.515 -168.054 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 6.7 tttm -130.92 -82.56 0.53 Allowed 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 107.532 -1.285 . . . . 72.41 107.532 179.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.441 ' HB3' HD21 ' A' ' 178' ' ' LEU . 7.5 mp0 -79.44 -24.59 42.35 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 124.587 1.155 . . . . 70.4 111.361 -178.392 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 41.3 p90 -155.89 174.57 15.13 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 107.329 -1.36 . . . . 64.31 107.329 -177.075 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 23.0 t -132.29 146.82 32.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 108.474 -0.935 . . . . 74.23 108.474 -175.446 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -109.22 156.52 19.8 Favored 'General case' 0 N--CA 1.451 -0.409 0 O-C-N 120.894 -1.129 . . . . 75.43 109.161 166.398 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -126.02 120.22 29.72 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 125.747 1.619 . . . . 72.33 108.695 -169.338 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.8 m -55.13 -15.53 2.31 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.616 1.567 . . . . 61.35 114.223 -177.666 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 10.4 p -128.59 84.99 61.51 Favored Pre-proline 0 N--CA 1.445 -0.688 0 CA-C-N 119.164 0.893 . . . . 52.24 111.55 -179.552 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -73.08 179.79 5.07 Favored 'Trans proline' 0 CA--C 1.542 0.923 0 C-N-CA 124.449 3.432 . . . . 61.44 113.822 178.19 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 6.7 t -128.94 142.3 44.66 Favored Pre-proline 0 N--CA 1.47 0.564 0 C-N-CA 125.347 1.459 . . . . 70.24 108.102 173.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -76.73 176.52 10.01 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 123.608 2.872 . . . . 64.52 111.216 172.042 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.7 m -115.99 179.4 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 C-N-CA 124.017 0.927 . . . . 73.3 109.418 170.095 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 34.7 t -56.15 -64.03 0.99 Allowed 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 123.82 0.848 . . . . 73.15 108.906 169.448 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 19.1 mt-30 -150.38 161.23 31.27 Favored Pre-proline 0 C--O 1.237 0.442 0 O-C-N 121.68 -0.638 . . . . 73.33 110.761 -174.172 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -70.82 166.38 29.11 Favored 'Trans proline' 0 N--CA 1.45 -1.049 0 C-N-CA 122.747 2.298 . . . . 74.04 109.333 171.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 143.04 -86.57 0.18 Allowed Glycine 0 N--CA 1.449 -0.495 0 N-CA-C 108.894 -1.683 . . . . 65.43 108.894 -175.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.29 158.0 15.64 Favored 'General case' 0 N--CA 1.462 0.161 0 N-CA-C 108.616 -0.883 . . . . 74.11 108.616 -176.616 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 48.0 mm -66.63 154.91 7.61 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 N-CA-C 106.585 -1.635 . . . . 75.35 106.585 166.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -108.59 90.32 3.26 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 107.449 -1.315 . . . . 75.4 107.449 172.466 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 41.4 t -94.61 119.8 43.11 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.175 0 N-CA-C 106.654 -1.61 . . . . 70.43 106.654 176.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 25.4 t -119.45 110.99 31.2 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 N-CA-C 108.507 -0.923 . . . . 70.54 108.507 -174.291 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -72.61 126.94 31.1 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 108.046 -1.094 . . . . 71.13 108.046 154.488 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.5 mp -109.7 139.9 44.2 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 106.634 -1.617 . . . . 75.35 106.634 151.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 9.3 p90 -146.07 168.06 21.85 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 125.323 1.449 . . . . 74.12 107.974 -173.116 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 24.1 t90 -142.18 151.75 42.49 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 107.664 -1.236 . . . . 64.51 107.664 -177.146 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -47.15 -31.28 3.42 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.882 1.273 . . . . 74.42 112.085 166.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -109.5 17.9 30.52 Favored Glycine 0 CA--C 1.527 0.809 0 CA-C-O 117.577 -1.68 . . . . 74.42 115.138 -159.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 23.0 p -104.83 86.33 1.45 Allowed Pre-proline 0 CA--C 1.538 0.516 0 CA-C-N 119.644 1.722 . . . . 71.1 110.723 -170.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -58.51 -27.24 81.58 Favored 'Trans proline' 0 CA--C 1.54 0.776 0 CA-C-N 121.778 1.671 . . . . 52.02 114.232 -174.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 10.9 m170 -59.84 -19.63 52.14 Favored 'General case' 0 CA--C 1.537 0.449 0 O-C-N 121.365 -0.835 . . . . 72.44 112.592 174.067 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 98.8 m -71.01 -36.07 72.28 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.922 1.289 . . . . 65.13 110.632 -176.156 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 38.4 m-85 -61.68 -36.48 80.97 Favored 'General case' 0 N--CA 1.471 0.595 0 O-C-N 120.794 -1.191 . . . . 74.12 111.711 -177.462 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.74 -12.09 43.41 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 124.505 1.122 . . . . 71.33 112.209 179.299 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 27.1 t80 -126.41 -25.28 3.49 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-O 116.353 -1.784 . . . . 73.11 112.701 -172.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -45.37 -62.77 1.51 Allowed Pre-proline 0 N--CA 1.473 0.722 0 CA-C-N 121.619 2.009 . . . . 65.3 113.107 -177.517 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -70.38 -7.81 22.12 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 CA-C-N 121.179 1.457 . . . . 74.23 114.932 -178.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 25.4 m -80.84 -37.53 29.83 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.093 0.957 . . . . 64.11 110.061 170.295 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 20.6 tt -91.65 -31.62 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 C-N-CA 123.147 0.579 . . . . 74.42 111.617 -174.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 12.5 t -46.93 -62.8 1.71 Allowed Pre-proline 0 CA--C 1.539 0.533 0 CA-C-O 117.975 -1.012 . . . . 54.41 111.027 174.256 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -66.83 -34.91 29.13 Favored 'Trans proline' 0 N--CA 1.452 -0.939 0 CA-C-N 121.222 1.472 . . . . 54.32 111.027 -176.194 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 91.2 t90 -55.09 -47.32 75.08 Favored 'General case' 0 C--N 1.341 0.217 0 CA-C-N 119.778 1.172 . . . . 74.2 109.929 174.537 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 49.7 p -59.51 -38.1 80.06 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 122.783 0.433 . . . . 71.15 111.604 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.4 mt-10 -75.32 -10.55 59.55 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.34 1.456 . . . . 74.15 112.483 177.506 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 9.7 mmmm -119.44 9.8 11.69 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 126.447 1.899 . . . . 72.35 112.772 -174.571 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 27.5 mt -65.02 160.6 55.05 Favored Pre-proline 0 CA--C 1.538 0.506 0 C-N-CA 124.402 1.081 . . . . 55.25 111.661 172.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -82.66 169.7 13.39 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 124.913 3.742 . . . . 73.22 111.409 175.088 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -71.83 16.64 0.11 Allowed 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 126.755 2.022 . . . . 74.45 114.062 -175.304 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -127.09 -4.96 6.19 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 126.601 1.961 . . . . 73.4 113.074 -179.09 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.466 HG21 HD13 ' A' ' 183' ' ' ILE . 48.5 t -113.68 113.98 45.49 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.307 0 N-CA-C 106.689 -1.597 . . . . 54.44 106.689 -178.011 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 79.5 t60 -101.3 112.71 25.3 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 107.045 -1.465 . . . . 63.35 107.045 174.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 27.6 t80 -84.6 143.99 28.91 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 114.855 -1.066 . . . . 74.14 109.16 176.153 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 48.8 t -136.24 141.09 42.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 N-CA-C 106.387 -1.708 . . . . 71.24 106.387 -177.316 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 60.1 mtm-85 -123.43 113.33 18.65 Favored 'General case' 0 CA--C 1.508 -0.635 0 N-CA-C 104.613 -2.366 . . . . 74.34 104.613 176.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 5.8 mt -124.67 149.23 61.61 Favored Pre-proline 0 N--CA 1.466 0.326 0 CA-C-N 120.443 1.474 . . . . 54.11 110.043 174.294 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -67.53 143.43 62.85 Favored 'Trans proline' 0 N--CA 1.45 -1.051 0 C-N-CA 121.123 1.215 . . . . 54.42 110.743 -177.305 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -79.17 59.19 2.69 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.684 1.594 . . . . 50.31 111.49 -179.665 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 10.6 mt -74.1 88.13 1.91 Allowed 'General case' 0 C--N 1.328 -0.356 0 O-C-N 120.382 -1.449 . . . . 62.24 108.502 -176.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -141.61 1.98 1.57 Allowed 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 114.352 1.241 . . . . 75.55 114.352 175.649 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -153.04 179.0 29.82 Favored Glycine 0 C--N 1.333 0.401 0 O-C-N 121.078 -1.014 . . . . 72.05 113.814 -163.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -51.81 -53.56 29.18 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 128.589 2.995 . . . . 65.4 113.117 -164.289 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 9.8 tp -106.39 -6.85 10.24 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 C-N-CA 124.886 1.274 . . . . 51.32 110.884 173.39 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 8.9 m95 -73.76 -24.7 59.9 Favored 'General case' 0 N--CA 1.448 -0.568 0 O-C-N 120.876 -1.14 . . . . 73.55 111.495 -171.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -70.38 -46.94 63.04 Favored 'General case' 0 C--O 1.234 0.244 0 O-C-N 121.321 -0.862 . . . . 74.12 109.299 169.457 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 25.7 t -63.31 -53.13 49.65 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 C-N-CA 122.774 0.43 . . . . 70.3 110.189 -173.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 38.6 m170 -67.31 1.88 1.95 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.225 1.01 . . . . 54.43 113.185 178.457 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -109.19 -43.5 1.17 Allowed Glycine 0 C--N 1.338 0.669 0 CA-C-N 120.702 1.592 . . . . 63.21 110.697 -176.596 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -54.37 -36.62 64.07 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 113.391 0.886 . . . . 74.43 113.391 -170.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 5.9 ttt -45.21 -45.79 11.94 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 125.849 1.659 . . . . 64.25 114.434 -179.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 34.8 t80 -56.85 -42.34 79.53 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 121.52 0.676 . . . . 62.24 109.775 -173.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 18.2 mt -68.75 -42.11 77.97 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 117.082 -1.437 . . . . 60.43 109.291 178.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -56.51 -40.61 75.31 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 121.046 1.748 . . . . 74.53 110.944 178.255 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.07 -59.79 4.32 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 123.686 0.794 . . . . 71.11 110.219 179.243 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -65.24 -16.37 63.47 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 118.806 0.73 . . . . 73.32 112.208 -178.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -53.25 -25.74 15.52 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.208 1.003 . . . . 61.11 111.724 174.355 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 11.6 mtp . . . . . 0 CA--C 1.531 0.243 0 C-N-CA 125.429 1.492 . . . . 64.42 112.05 -172.464 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.119 0 CA-C-O 117.96 -1.019 . . . . 35.33 113.029 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 39.0 t -59.19 -62.67 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.339 0.14 0 N-CA-C 107.683 -1.229 . . . . 61.24 107.683 178.669 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -61.95 -49.57 75.59 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 123.874 0.87 . . . . 74.1 110.343 -179.387 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -57.29 -38.36 73.86 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.922 0.889 . . . . 72.1 110.488 -173.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.427 ' HA ' ' HB2' ' A' ' 101' ' ' GLU . . . -67.88 -43.79 78.55 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-O 122.46 1.124 . . . . 71.51 111.12 -178.452 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 45.2 mt -71.57 -36.29 59.48 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 N-CA-C 108.207 -1.034 . . . . 75.45 108.207 -175.371 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 81.1 m-70 -95.68 -74.03 0.57 Allowed 'General case' 0 N--CA 1.446 -0.66 0 O-C-N 121.46 -0.775 . . . . 75.32 109.936 -171.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 22.5 mmtt -64.12 -18.53 64.51 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 125.099 1.36 . . . . 75.21 112.097 -176.359 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.427 ' HB2' ' HA ' ' A' ' 97' ' ' ALA . 0.4 OUTLIER -108.82 -19.83 13.27 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 113.516 0.932 . . . . 74.2 113.516 179.243 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 3.9 t60 44.02 57.64 4.08 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 126.389 1.876 . . . . 75.22 112.059 173.325 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 12.6 mmtm -75.51 160.65 29.95 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.668 1.187 . . . . 65.32 109.992 178.308 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 32.7 tttt -77.61 29.83 0.16 Allowed 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 127.466 2.307 . . . . 74.24 113.892 -178.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 27.6 mt -74.62 49.88 0.41 Allowed 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 127.489 2.316 . . . . 74.15 111.734 -169.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -90.37 -0.26 57.56 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 128.093 2.557 . . . . 72.3 112.333 -178.535 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 23.8 p -141.01 153.41 67.18 Favored Pre-proline 0 C--O 1.233 0.23 0 C-N-CA 123.424 0.69 . . . . 63.44 110.135 173.439 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -63.89 -28.4 67.21 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 122.528 2.152 . . . . 63.51 112.642 -176.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 27.8 mp0 -70.35 -36.71 74.36 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 119.594 1.088 . . . . 70.24 110.31 177.286 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -73.37 -40.36 64.44 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.847 0.859 . . . . 74.14 109.544 178.612 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 45.1 mtt -58.47 -61.29 2.7 Favored 'General case' 0 C--N 1.343 0.286 0 C-N-CA 126.044 1.738 . . . . 65.2 109.935 174.671 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -62.91 -41.26 99.38 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 123.888 0.875 . . . . 71.35 111.476 -170.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -56.65 -41.91 78.04 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.049 0.452 . . . . 72.05 111.212 176.199 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . 0.407 ' CZ ' ' HB1' ' A' ' 97' ' ' ALA . 80.8 t80 -70.57 -40.69 73.17 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 123.614 0.766 . . . . 71.3 112.061 -179.173 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 56.1 mt -75.97 -17.02 59.88 Favored 'General case' 0 C--N 1.332 -0.181 0 O-C-N 121.378 -0.826 . . . . 55.23 111.445 -177.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -54.06 -28.33 38.18 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.981 0.912 . . . . 64.24 111.832 -178.075 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -89.54 -1.68 77.45 Favored Glycine 0 CA--C 1.529 0.94 0 CA-C-O 117.741 -1.589 . . . . 61.21 115.151 177.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 39.5 mttt -129.33 26.42 5.41 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 120.791 2.295 . . . . 74.15 112.647 -166.313 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 104.7 3.93 42.91 Favored Glycine 0 CA--C 1.527 0.812 0 C-N-CA 123.542 0.591 . . . . 71.13 113.463 173.101 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 77.0 t -106.3 165.09 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 C-N-CA 125.277 1.431 . . . . 75.2 107.899 179.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 60.8 t0 -132.87 132.24 41.87 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 105.711 -1.959 . . . . 61.02 105.711 176.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 21.3 mtpt -55.72 -36.03 66.77 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 123.523 0.729 . . . . 71.14 110.885 176.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -60.2 -50.87 71.96 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 118.875 0.761 . . . . 74.43 109.874 174.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -78.04 -28.03 48.91 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 108.979 -0.749 . . . . 60.3 108.979 -167.452 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 32.8 t80 -68.66 -69.73 0.31 Allowed 'General case' 0 N--CA 1.437 -1.09 0 C-N-CA 125.434 1.493 . . . . 72.33 108.845 173.627 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 8.1 mt -68.04 -37.99 81.99 Favored 'General case' 0 CA--C 1.531 0.24 0 O-C-N 121.244 -0.91 . . . . 73.31 110.348 -163.164 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 3.9 t -66.61 -21.13 66.13 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 118.781 -0.628 . . . . 73.05 112.232 -175.167 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 3.1 t -98.42 -35.11 10.39 Favored 'General case' 0 C--N 1.342 0.27 0 CA-C-N 119.196 0.907 . . . . 72.14 110.448 171.113 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 80.2 t80 -49.31 -55.69 11.95 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 119.184 0.902 . . . . 61.41 110.533 177.344 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 -86.08 55.61 3.61 Favored 'General case' 0 C--O 1.231 0.105 0 N-CA-C 108.714 -0.847 . . . . 53.34 108.714 174.356 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -157.91 166.53 32.4 Favored 'General case' 0 C--O 1.237 0.396 0 O-C-N 120.93 -1.106 . . . . 60.55 111.33 -177.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -74.6 -29.61 61.37 Favored 'General case' 0 N--CA 1.456 -0.14 0 CA-C-N 115.613 -0.721 . . . . 73.02 112.836 -162.551 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -56.73 -49.48 75.05 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 119.658 1.117 . . . . 73.34 110.258 -177.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 35.5 mm -63.02 -39.44 85.23 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.345 0 C-N-CA 125.161 1.384 . . . . 64.34 109.493 177.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 28.0 tttm -55.83 -42.67 76.08 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 118.585 -0.721 . . . . 72.33 109.562 175.305 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -71.18 -24.95 76.48 Favored Glycine 0 CA--C 1.523 0.559 0 C-N-CA 124.796 1.189 . . . . 70.45 111.958 -171.525 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -87.61 -50.4 6.53 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 124.347 1.059 . . . . 73.4 108.39 179.114 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 1.2 ppp? -58.49 -43.11 88.87 Favored 'General case' 0 C--N 1.34 0.161 0 C-N-CA 123.627 0.771 . . . . 74.25 109.737 -176.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -60.13 -40.01 88.27 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-O 118.464 -0.779 . . . . 64.23 112.133 -176.024 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -59.85 -59.38 5.52 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 123.906 0.883 . . . . 62.01 109.855 173.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -54.01 -34.0 58.7 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 118.038 0.381 . . . . 45.1 111.175 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 49.6 tttt -67.55 -59.67 3.17 Favored 'General case' 0 C--O 1.232 0.149 0 O-C-N 121.322 -0.861 . . . . 75.43 110.852 177.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.45 -24.28 64.7 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 118.452 0.569 . . . . 65.23 111.566 -174.686 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 32.6 mt -67.33 -53.16 32.05 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 118.52 -0.752 . . . . 75.34 110.203 170.543 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -53.92 -44.86 70.94 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 118.957 0.799 . . . . 71.42 112.291 -174.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 13.5 ptp -63.48 -46.9 84.03 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 119.423 -0.323 . . . . 53.12 111.551 176.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -58.87 -43.31 90.86 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 118.354 -0.831 . . . . 53.35 109.481 -179.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 18.1 m-85 -66.28 5.4 0.55 Allowed 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 115.078 1.511 . . . . 73.24 115.078 -175.096 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 59.2 mm-40 62.46 34.31 15.5 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 121.143 1.792 . . . . 71.41 113.198 176.39 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.818 HG22 ' NH2' ' A' ' 163' ' ' ARG . 57.5 t -80.5 -76.97 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 CA-C-O 118.415 -0.803 . . . . 73.35 111.18 -165.072 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . 0.26 1.6 p 54.59 -22.45 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 129.293 3.037 . . . . 62.31 118.18 -179.731 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.45 ' O ' HG13 ' A' ' 153' ' ' VAL . . . -99.45 -179.84 30.89 Favored Glycine 0 CA--C 1.532 1.102 0 CA-C-N 121.6 2.0 . . . . 43.55 111.807 168.467 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.45 HG13 ' O ' ' A' ' 152' ' ' GLY . 3.1 m -165.2 148.06 6.94 Favored Pre-proline 0 CA--C 1.547 0.865 0 C-N-CA 129.351 3.06 . . . . 75.33 108.033 167.808 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -67.34 142.35 62.2 Favored 'Cis proline' 0 N--CA 1.452 -0.923 0 CA-C-N 120.006 1.038 . . . . 71.32 110.543 -5.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . 0.5 ' CG2' ' HE ' ' A' ' 163' ' ' ARG . 25.3 m -147.07 133.4 19.56 Favored 'General case' 0 N--CA 1.447 -0.575 0 N-CA-C 107.979 -1.119 . . . . 65.34 107.979 -174.253 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 42.6 mmm -111.81 163.69 13.89 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.324 1.45 . . . . 53.01 109.434 176.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 38.7 t -142.32 151.67 18.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 C-N-CA 125.154 1.382 . . . . 61.21 107.528 168.744 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 60.5 t -118.61 125.46 74.41 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 C-N-CA 125.802 1.641 . . . . 74.15 106.966 166.614 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 14.9 m-20 55.15 10.99 0.47 Allowed 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 128.016 2.526 . . . . 65.21 115.926 172.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 82.59 12.57 79.99 Favored Glycine 0 CA--C 1.522 0.524 0 CA-C-O 117.921 -1.488 . . . . 22.2 113.45 -174.537 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 45.1 mttt -121.67 -52.34 2.02 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-N 119.083 1.441 . . . . 61.34 111.227 -166.645 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 74.6 m-85 -99.68 122.65 43.0 Favored 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 108.086 -1.079 . . . . 75.34 108.086 -179.52 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . 0.818 ' NH2' HG22 ' A' ' 150' ' ' VAL . 0.1 OUTLIER -92.46 133.42 35.93 Favored 'General case' 0 N--CA 1.446 -0.675 0 C-N-CA 126.888 2.075 . . . . 72.45 105.496 169.256 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 20.6 p90 -147.93 167.96 23.49 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.062 -1.088 . . . . 62.03 108.062 168.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -174.65 -179.41 1.49 Allowed 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 123.957 0.903 . . . . 63.54 108.921 178.191 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 13.5 mt -55.61 -45.07 78.75 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 C-N-CA 126.99 2.116 . . . . 71.14 108.408 176.022 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -61.69 -39.54 97.56 Favored Glycine 0 C--N 1.338 0.667 0 C-N-CA 124.154 0.883 . . . . 73.5 112.415 178.323 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 16.2 m -74.36 -56.79 4.47 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 118.678 1.239 . . . . 71.05 110.273 178.565 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -74.15 -33.19 63.43 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 125.201 1.401 . . . . 72.31 113.626 -163.127 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 147.4 -46.77 0.7 Allowed Glycine 0 CA--C 1.521 0.424 0 O-C-N 123.648 0.593 . . . . 62.3 112.259 -178.047 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 168.16 -174.19 43.0 Favored Glycine 0 CA--C 1.53 0.972 0 N-CA-C 109.209 -1.557 . . . . 75.22 109.209 -156.31 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -66.76 -55.59 0.32 Allowed 'Trans proline' 0 N--CA 1.452 -0.958 0 C-N-CA 122.618 2.212 . . . . 73.14 111.003 -170.319 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -60.46 -41.85 95.0 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 121.838 0.827 . . . . 75.23 109.58 179.35 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -56.48 -29.87 62.27 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 124.971 1.308 . . . . 71.32 111.864 179.498 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 89.5 m -67.04 -44.49 80.06 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-O 118.358 -0.829 . . . . 65.33 109.817 179.411 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 55.9 mt -60.52 -37.82 82.4 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 118.945 0.793 . . . . 74.23 109.682 175.264 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 8.7 ttpp -52.25 -39.89 60.95 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 117.626 -1.178 . . . . 74.24 110.326 175.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.441 HD21 ' HB3' ' A' ' 11' ' ' GLU . 4.5 mm? -79.16 -43.38 24.08 Favored 'General case' 0 C--N 1.346 0.454 0 CA-C-N 120.601 1.546 . . . . 75.41 111.869 172.071 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -51.54 -41.86 61.38 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 119.287 0.949 . . . . 45.44 111.818 -175.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -78.37 -38.91 40.74 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 124.801 1.24 . . . . 51.44 110.613 -172.286 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 24.1 t80 -64.46 -54.6 29.94 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 125.091 1.356 . . . . 62.12 110.444 174.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 87.6 mt -60.98 -23.24 65.2 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.251 1.02 . . . . 72.5 113.294 -174.697 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.466 HD13 HG21 ' A' ' 58' ' ' VAL . 23.7 mt -57.02 -59.89 2.63 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 CA-C-N 119.275 0.943 . . . . 55.53 108.816 170.339 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 10.6 tm-20 -56.87 -37.58 71.54 Favored 'General case' 0 C--O 1.227 -0.108 0 C-N-CA 124.581 1.152 . . . . 71.53 110.356 -177.519 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 12.8 tptt -53.14 -41.06 64.73 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 124.292 1.037 . . . . 72.42 111.863 -179.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 32.5 mm-40 -91.67 -41.76 10.55 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.036 0.934 . . . . 71.22 111.242 178.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.38 -35.68 78.16 Favored 'General case' 0 C--O 1.234 0.268 0 O-C-N 120.645 -1.284 . . . . 73.42 109.952 -175.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.237 0.423 0 C-N-CA 125.275 1.43 . . . . 71.11 112.045 -179.927 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 . . . . . 0 CA--C 1.503 -0.829 0 CA-C-O 119.552 -0.261 . . . . 53.41 110.909 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . 0.336 13.8 m-20 75.99 11.31 3.04 Favored 'General case' 0 N--CA 1.435 -1.21 0 C-N-CA 128.43 2.692 . . . . 73.13 116.222 168.378 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -142.82 172.2 13.02 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 126.758 2.023 . . . . 74.14 107.73 173.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 61.5 m -140.78 138.0 33.77 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.887 0.875 . . . . 64.42 109.462 178.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.04 144.75 57.07 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 122.132 0.968 . . . . 72.34 110.272 175.425 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 80.5 -36.75 2.24 Favored Glycine 0 CA--C 1.526 0.776 0 C-N-CA 126.64 2.067 . . . . 63.42 111.787 -167.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -84.0 -76.5 0.29 Allowed 'General case' 0 CA--C 1.515 -0.372 0 C-N-CA 124.774 1.23 . . . . 54.33 110.134 -165.452 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 15.8 mp0 -78.87 -24.87 44.02 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 124.929 1.292 . . . . 74.0 110.452 178.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 37.9 p90 -160.32 174.41 14.22 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 123.806 0.842 . . . . 74.31 109.726 -172.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 32.8 t -132.48 112.49 19.27 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 C-N-CA 123.797 0.839 . . . . 74.22 109.13 178.418 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -71.0 154.44 41.81 Favored 'General case' 0 C--O 1.235 0.33 0 O-C-N 120.89 -1.131 . . . . 72.31 109.155 162.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -124.31 113.85 18.78 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 124.476 1.11 . . . . 54.33 110.292 -173.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 59.3 p -69.66 13.34 0.14 Allowed 'General case' 0 C--O 1.236 0.379 0 C-N-CA 127.177 2.191 . . . . 70.12 114.278 -175.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 32.1 t -143.28 78.77 14.67 Favored Pre-proline 0 N--CA 1.454 -0.239 0 N-CA-C 108.085 -1.08 . . . . 74.41 108.085 165.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -67.22 -179.92 2.07 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 122.867 2.378 . . . . 64.21 111.922 -173.239 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 40.6 t -130.71 136.66 29.28 Favored Pre-proline 0 C--O 1.233 0.212 0 N-CA-C 107.073 -1.454 . . . . 72.12 107.073 179.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -79.27 173.71 12.93 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 121.836 1.69 . . . . 72.14 110.939 176.204 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 20.7 m -122.4 169.49 13.69 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 C-N-CA 125.09 1.356 . . . . 72.43 109.622 -178.183 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.1 t -47.74 -64.25 0.84 Allowed 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 126.406 1.882 . . . . 63.01 109.808 176.314 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -147.07 164.58 22.59 Favored Pre-proline 0 C--O 1.237 0.401 0 C-N-CA 123.931 0.893 . . . . 74.31 109.86 178.168 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_endo -66.3 176.07 4.35 Favored 'Trans proline' 0 N--CA 1.45 -1.04 0 C-N-CA 122.081 1.854 . . . . 64.15 111.066 163.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 129.39 -89.42 0.31 Allowed Glycine 0 N--CA 1.448 -0.559 0 N-CA-C 108.059 -2.016 . . . . 51.33 108.059 -178.029 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -85.21 163.53 18.64 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 117.919 0.86 . . . . 60.11 109.322 -179.085 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 46.9 mm -77.13 137.51 22.3 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 N-CA-C 105.204 -2.147 . . . . 73.44 105.204 158.125 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -99.3 118.0 35.0 Favored 'General case' 0 N--CA 1.445 -0.725 0 N-CA-C 105.859 -1.904 . . . . 72.41 105.859 -179.442 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 60.2 t -121.64 131.81 72.22 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 N-CA-C 106.723 -1.584 . . . . 74.22 106.723 -179.091 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 43.2 t -127.09 138.72 54.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 106.241 -1.763 . . . . 72.02 106.241 -175.22 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -106.32 137.74 43.74 Favored 'General case' 0 C--O 1.239 0.525 0 N-CA-C 106.655 -1.609 . . . . 65.25 106.655 158.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 5.3 mp -115.69 137.21 52.31 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 107.455 -1.313 . . . . 74.12 107.455 163.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 31.3 p90 -141.44 169.01 18.41 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 124.122 0.969 . . . . 71.11 110.034 -172.101 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . 0.5 ' HB3' HG21 ' A' ' 153' ' ' VAL . 29.7 t90 -155.11 153.21 30.49 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 123.663 0.785 . . . . 63.11 109.464 179.313 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 56.2 t80 -44.08 -51.26 8.08 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 129.366 3.067 . . . . 75.43 113.84 -172.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -72.05 -90.49 0.11 Allowed Glycine 0 C--N 1.339 0.705 0 N-CA-C 110.944 -0.862 . . . . 71.24 110.944 -171.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 34.4 t 43.51 68.92 2.63 Favored Pre-proline 0 CA--C 1.546 0.797 0 C-N-CA 125.283 1.433 . . . . 74.54 113.824 163.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -63.53 -14.87 45.1 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 122.743 2.295 . . . . 73.31 114.126 -176.415 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 20.3 m170 -84.24 -22.85 30.68 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 119.856 1.207 . . . . 75.24 112.537 172.07 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 60.4 m -62.65 -48.73 78.06 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 120.284 1.402 . . . . 72.13 110.619 -174.105 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 45.4 t80 -61.75 -27.55 68.81 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 120.554 -1.341 . . . . 71.55 112.23 -175.595 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.26 -6.58 40.81 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.558 0.743 . . . . 73.15 112.73 177.285 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.403 ' CB ' HD11 ' A' ' 166' ' ' ILE . 26.8 t80 -123.64 -13.93 7.39 Favored 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 126.387 1.875 . . . . 73.13 111.594 -175.52 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 67.0 tt0 -50.73 -64.64 1.22 Allowed Pre-proline 0 CA--C 1.536 0.433 0 CA-C-N 119.813 1.188 . . . . 72.14 111.512 -178.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -74.96 -4.77 15.91 Favored 'Trans proline' 0 N--CA 1.453 -0.881 0 CA-C-N 120.831 1.333 . . . . 62.04 114.294 -175.659 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.5 m -70.15 -47.25 62.49 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 107.892 -1.151 . . . . 54.31 107.892 163.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 19.3 tt -96.8 -28.5 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 N-CA-C 113.704 1.001 . . . . 65.14 113.704 -165.627 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 74.0 t -54.19 -55.97 31.08 Favored Pre-proline 0 CA--C 1.545 0.772 0 CA-C-N 119.64 1.109 . . . . 75.3 111.314 173.457 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -68.14 -24.93 37.88 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 CA-C-N 120.85 1.339 . . . . 61.05 111.794 -179.006 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 77.8 t90 -62.38 -55.18 30.39 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 119.274 0.943 . . . . 75.04 109.008 170.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.5 p -61.01 -41.95 97.52 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 123.704 0.802 . . . . 55.12 112.555 -173.248 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -62.63 -39.86 95.14 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 119.282 0.946 . . . . 73.11 110.886 175.619 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 8.0 mptt -90.88 20.06 5.1 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 113.543 0.942 . . . . 74.41 113.543 -170.618 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 32.1 mt -65.71 164.85 23.23 Favored Pre-proline 0 CA--C 1.543 0.674 0 C-N-CA 126.421 1.888 . . . . 70.31 111.75 175.081 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -83.7 174.45 8.65 Favored 'Trans proline' 0 N--CA 1.454 -0.838 1 C-N-CA 125.64 4.226 . . . . 61.22 110.933 174.203 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -71.24 -10.26 59.47 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 113.829 1.048 . . . . 72.41 113.829 -176.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -103.61 5.79 36.76 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 119.364 0.984 . . . . 72.11 112.074 -170.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 87.6 t -117.42 152.61 19.29 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 C-N-CA 124.9 1.28 . . . . 73.2 107.793 -178.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 22.6 t-160 -136.78 92.91 2.79 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 126.486 1.914 . . . . 64.31 106.651 178.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -79.78 132.67 36.21 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 124.488 1.115 . . . . 74.34 109.692 173.466 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 23.4 t -136.51 158.62 37.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 C-N-CA 125.453 1.501 . . . . 74.34 107.76 -179.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 55.7 mtp180 -131.41 128.42 39.51 Favored 'General case' 0 CA--C 1.506 -0.718 0 N-CA-C 106.897 -1.52 . . . . 73.41 106.897 179.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 70.1 mt -127.44 153.2 77.29 Favored Pre-proline 0 N--CA 1.464 0.267 0 O-C-N 123.379 0.425 . . . . 73.51 111.082 173.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -75.42 134.14 16.79 Favored 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 122.371 2.047 . . . . 65.22 111.209 179.019 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -75.0 95.78 3.07 Favored 'General case' 0 CA--C 1.54 0.562 0 O-C-N 121.038 -1.039 . . . . 73.21 111.598 176.241 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 20.0 mt -88.6 95.38 10.22 Favored 'General case' 0 CA--C 1.541 0.62 0 O-C-N 120.42 -1.425 . . . . 73.53 111.188 -177.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -133.83 5.33 3.63 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 116.027 1.862 . . . . 64.32 116.027 -173.342 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -154.33 -143.62 3.72 Favored Glycine 0 C--N 1.336 0.573 0 CA-C-N 119.039 0.836 . . . . 50.04 114.269 -166.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -89.96 -85.58 1.34 Allowed Glycine 0 CA--C 1.524 0.607 0 N-CA-C 106.887 -2.485 . . . . 73.04 106.887 155.242 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.2 tt -58.61 -25.23 27.73 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 N-CA-C 113.133 0.79 . . . . 70.04 113.133 -168.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . 0.401 ' HA ' ' CD1' ' A' ' 34' ' ' TRP . 10.8 m95 -54.55 -40.7 68.96 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 123.891 0.876 . . . . 74.22 112.214 175.137 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 17.2 p30 -91.73 -27.32 18.12 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 112.892 0.701 . . . . 53.43 112.892 179.034 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 39.4 t -64.71 -41.59 92.64 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-N 118.536 0.607 . . . . 65.23 109.578 174.095 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 66.6 m170 -79.14 7.08 8.12 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.821 1.248 . . . . 73.2 112.327 170.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -103.08 -37.55 3.1 Favored Glycine 0 CA--C 1.525 0.69 0 O-C-N 120.989 -1.069 . . . . 75.14 111.594 -179.548 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -65.12 -25.6 67.83 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 114.456 1.28 . . . . 74.5 114.456 -165.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 6.6 ttt -62.95 -43.02 99.94 Favored 'General case' 0 N--CA 1.463 0.191 0 O-C-N 120.926 -1.109 . . . . 62.35 112.055 -175.262 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -51.29 -52.85 41.38 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 125.011 1.324 . . . . 75.3 108.367 -176.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 13.7 mt -63.37 -39.56 94.87 Favored 'General case' 0 C--O 1.226 -0.182 0 C-N-CA 124.451 1.1 . . . . 70.43 110.122 -178.296 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.467 HG23 HG23 ' A' ' 128' ' ' THR . 1.4 m -66.71 -38.38 86.6 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 118.873 0.761 . . . . 70.5 109.775 -178.048 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.48 -60.13 4.11 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 124.063 0.945 . . . . 72.1 108.535 177.478 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -60.84 -25.03 66.34 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 124.166 0.986 . . . . 75.11 112.686 -177.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -62.98 -5.62 3.11 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.885 1.674 . . . . 71.04 114.566 176.406 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 29.5 mtm . . . . . 0 N--CA 1.473 0.685 0 N-CA-C 115.047 1.499 . . . . 33.43 115.047 165.843 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.294 0 N-CA-C 114.384 1.253 . . . . 64.12 114.384 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 56.2 t -62.93 -61.45 1.65 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.189 0 N-CA-C 108.079 -1.082 . . . . 55.42 108.079 172.02 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -62.84 -42.2 99.64 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 125.29 1.436 . . . . 74.12 110.636 -178.361 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -71.66 3.66 3.85 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 124.828 1.251 . . . . 65.54 112.351 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -115.52 5.08 14.35 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 115.658 1.725 . . . . 52.3 115.658 164.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 13.6 mt -117.21 -51.13 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 CA-C-N 120.476 1.489 . . . . 61.11 108.732 177.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 88.2 m-70 -63.97 -83.04 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 126.025 1.73 . . . . 72.22 113.231 -179.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.64 -16.71 64.3 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 126.711 2.004 . . . . 65.41 114.606 -177.452 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -97.17 -32.91 11.7 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 124.572 1.149 . . . . 74.43 111.64 178.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 1.8 t-160 50.38 36.37 12.97 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 125.572 1.549 . . . . 75.32 112.924 173.424 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.453 ' HG2' ' H ' ' A' ' 103' ' ' LYS . 0.1 OUTLIER -71.35 164.76 25.12 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 124.039 0.936 . . . . 73.41 108.784 168.959 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 10.2 mtpt -61.82 -72.11 0.13 Allowed 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 124.94 1.296 . . . . 73.12 109.433 172.602 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.418 HD21 ' HE3' ' A' ' 103' ' ' LYS . 77.2 mt 50.91 54.52 11.09 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 124.707 1.203 . . . . 72.04 111.455 -172.316 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -109.81 1.36 19.27 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.666 1.586 . . . . 65.31 113.326 -170.231 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -147.22 156.49 46.49 Favored Pre-proline 0 C--O 1.234 0.287 0 C-N-CA 126.948 2.099 . . . . 32.35 109.63 -167.448 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -70.99 -38.19 5.4 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 122.759 2.306 . . . . 62.12 110.927 -170.119 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -62.2 -48.93 77.81 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 109.022 -0.732 . . . . 61.04 109.022 172.037 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -58.45 -39.74 80.7 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 124.853 1.261 . . . . 62.13 111.737 -171.227 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 59.3 mtm -78.0 -50.23 12.53 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 124.523 1.129 . . . . 54.31 111.336 174.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.403 ' HB1' ' HG3' ' A' ' 122' ' ' LYS . . . -64.42 -39.53 94.02 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 119.05 0.841 . . . . 43.32 110.93 -173.63 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -71.03 -22.5 62.14 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 123.764 0.826 . . . . 73.33 111.509 -179.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 91.4 t80 -73.29 -51.46 17.51 Favored 'General case' 0 N--CA 1.45 -0.473 0 O-C-N 121.495 -0.753 . . . . 64.13 109.631 170.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 68.2 mt -69.83 -17.7 63.4 Favored 'General case' 0 N--CA 1.452 -0.351 0 O-C-N 121.728 -0.608 . . . . 72.13 111.337 -175.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -55.9 -18.09 8.1 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.91 0.884 . . . . 71.51 111.563 167.468 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -98.51 3.75 59.59 Favored Glycine 0 CA--C 1.527 0.803 0 CA-C-O 117.416 -1.769 . . . . 54.31 114.835 171.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.547 ' HA ' ' HE2' ' A' ' 118' ' ' LYS . 7.7 mmpt? -125.85 13.66 7.96 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 120.654 2.227 . . . . 70.42 113.123 -169.375 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 87.23 26.62 30.34 Favored Glycine 0 CA--C 1.522 0.517 0 CA-C-N 118.836 0.744 . . . . 61.52 112.526 -179.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 76.2 t -112.07 136.76 47.25 Favored 'Isoleucine or valine' 0 C--O 1.24 0.605 0 C-N-CA 125.648 1.579 . . . . 75.02 107.186 175.276 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 32.0 t0 -85.53 116.28 23.74 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 108.551 -0.907 . . . . 61.22 108.551 171.422 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.403 ' HG3' ' HB1' ' A' ' 112' ' ' ALA . 3.1 tttm -52.77 -48.08 67.06 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 125.638 1.575 . . . . 53.33 109.437 177.746 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -65.6 -22.72 66.7 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 113.078 0.77 . . . . 73.2 113.078 -175.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 49.4 mmtt -82.9 -50.74 8.29 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 107.673 -1.232 . . . . 64.3 107.673 175.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -49.08 -62.0 1.77 Allowed 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 125.648 1.579 . . . . 74.13 109.729 -179.14 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 20.5 mt -62.93 -39.27 94.09 Favored 'General case' 0 C--O 1.233 0.213 0 C-N-CA 122.744 0.417 . . . . 52.21 110.889 -174.419 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 39.5 t -57.17 -50.95 71.23 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 123.145 0.578 . . . . 73.12 109.919 -177.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . 0.467 HG23 HG23 ' A' ' 80' ' ' THR . 2.6 t -81.35 -33.14 32.61 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 119.184 -0.436 . . . . 72.22 110.761 -175.453 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 82.3 t80 -50.35 -52.39 37.51 Favored 'General case' 0 C--N 1.344 0.34 0 C-N-CA 124.719 1.207 . . . . 72.22 109.467 172.199 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -90.39 55.56 3.08 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 124.265 1.026 . . . . 75.4 109.495 174.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 22.7 t -140.64 162.2 35.94 Favored 'General case' 0 C--O 1.234 0.258 0 O-C-N 121.083 -1.011 . . . . 62.25 110.795 172.613 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -58.08 -26.97 63.22 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.733 1.213 . . . . 71.44 110.673 168.506 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -53.31 -59.27 4.79 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 124.492 1.117 . . . . 63.23 111.218 179.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 41.7 mm -69.06 -26.3 31.89 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 C-N-CA 123.266 0.626 . . . . 63.34 110.355 178.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 17.7 tttt -58.37 -36.32 73.31 Favored 'General case' 0 CA--C 1.522 -0.1 0 O-C-N 121.35 -0.844 . . . . 73.1 111.008 175.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -63.3 -46.1 93.64 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 110.665 -0.974 . . . . 72.34 110.665 178.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -66.04 -44.84 83.47 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 123.196 0.599 . . . . 53.12 110.008 -179.16 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 94.9 mmm -57.32 -47.84 80.5 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 118.595 -0.717 . . . . 63.02 109.948 176.231 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -65.87 -40.92 92.07 Favored 'General case' 0 N--CA 1.457 -0.098 0 CA-C-N 119.573 1.079 . . . . 71.11 112.126 -175.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 11.2 mtpt -60.13 -58.13 9.87 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-O 118.242 -0.885 . . . . 74.23 109.579 176.27 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -53.64 -39.8 65.29 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 119.137 0.88 . . . . 75.43 110.762 178.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 25.7 ttmt -60.97 -63.07 1.42 Allowed 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.128 0.971 . . . . 64.44 110.481 178.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 16.6 ptmt -64.89 -24.01 67.4 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 123.463 0.705 . . . . 62.22 111.0 -176.041 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.427 HD23 ' HA ' ' A' ' 144' ' ' LEU . 41.7 mt -75.77 -53.76 8.0 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 118.637 -0.697 . . . . 54.32 111.055 175.554 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -52.57 -54.28 35.02 Favored 'General case' 0 C--O 1.228 -0.04 0 C-N-CA 123.865 0.866 . . . . 53.12 110.52 -173.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 3.9 ppp? -55.37 -47.06 76.38 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 113.23 0.826 . . . . 60.31 113.23 177.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -69.11 -29.85 68.01 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-O 118.093 -0.956 . . . . 64.51 110.291 -176.157 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 23.5 m-85 -71.81 16.29 0.12 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.241 1.416 . . . . 75.42 113.431 173.355 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 16.8 mm-40 63.31 17.54 10.33 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.062 1.345 . . . . 74.11 112.724 174.282 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 59.1 t -65.84 90.88 0.11 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.376 0 C-N-CA 125.712 1.605 . . . . 72.53 109.379 -174.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -95.97 88.59 4.94 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-O 123.137 1.446 . . . . 71.34 108.237 161.843 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 104.65 -162.5 14.85 Favored Glycine 0 N--CA 1.445 -0.712 0 CA-C-N 112.645 -2.07 . . . . 73.3 111.818 164.404 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.5 HG21 ' HB3' ' A' ' 34' ' ' TRP . 16.6 m -144.38 155.48 57.5 Favored Pre-proline 0 CA--C 1.539 0.524 0 C-N-CA 126.314 1.846 . . . . 74.15 107.37 178.092 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_endo -64.76 160.15 70.4 Favored 'Cis proline' 0 CA--C 1.54 0.823 0 C-N-CA 124.195 -1.169 . . . . 75.44 110.465 -12.093 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 5.4 m -153.42 108.12 3.14 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 123.686 0.795 . . . . 65.21 109.575 -179.616 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 50.7 mmm -93.87 153.44 18.25 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 124.288 1.035 . . . . 74.23 109.946 169.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 94.2 t -145.21 155.04 13.73 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 C-N-CA 125.102 1.361 . . . . 74.5 107.393 175.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 50.6 t -126.25 123.95 64.7 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 C-N-CA 127.783 2.433 . . . . 73.44 107.164 177.288 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 15.9 m-20 52.23 18.44 0.88 Allowed 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 129.294 3.038 . . . . 70.51 114.685 174.286 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 62.89 31.34 80.16 Favored Glycine 0 CA--C 1.532 1.152 0 CA-C-O 118.025 -1.431 . . . . 73.24 113.92 -169.288 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 9.2 mtpt -133.87 -28.15 1.41 Allowed 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 119.863 1.831 . . . . 72.21 113.334 -175.506 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -125.83 129.05 48.63 Favored 'General case' 0 CA--C 1.512 -0.5 0 N-CA-C 107.7 -1.222 . . . . 72.43 107.7 177.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 2.4 ttp85 -114.73 134.96 54.68 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 127.124 2.169 . . . . 74.41 105.787 179.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 28.2 p90 -151.22 167.26 28.34 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.988 -0.745 . . . . 70.4 108.988 -179.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -176.03 178.25 1.48 Allowed 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.269 1.028 . . . . 74.11 109.896 -178.175 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.403 HD11 ' CB ' ' A' ' 43' ' ' PHE . 38.1 mt -52.18 -42.23 35.51 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 C-N-CA 126.482 1.913 . . . . 53.13 110.459 178.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -80.25 -21.58 64.68 Favored Glycine 0 CA--C 1.526 0.722 0 CA-C-O 118.646 -1.086 . . . . 72.11 112.56 -179.407 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 1.1 m -72.83 -63.91 1.07 Allowed 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 119.716 1.758 . . . . 65.13 107.484 170.359 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -64.33 -38.59 91.56 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 123.907 0.883 . . . . 64.15 111.065 -168.568 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 121.06 -3.87 11.46 Favored Glycine 0 CA--C 1.525 0.674 0 CA-C-O 118.268 -1.295 . . . . 60.33 112.872 175.061 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 175.74 172.65 40.75 Favored Glycine 0 CA--C 1.528 0.852 0 CA-C-N 119.364 1.582 . . . . 71.03 110.231 -175.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -65.74 -44.68 7.69 Favored 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 122.524 2.149 . . . . 60.22 109.82 -177.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -63.64 -38.28 90.52 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-O 122.228 1.013 . . . . 74.41 110.467 -176.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -68.0 -29.18 68.13 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 126.291 1.836 . . . . 63.24 109.433 -176.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 35.9 m -64.85 -45.09 87.57 Favored 'General case' 0 CA--C 1.533 0.325 0 O-C-N 121.082 -1.011 . . . . 75.31 110.069 -176.229 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 46.0 mt -63.97 -32.05 73.45 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 118.799 0.727 . . . . 73.54 110.784 177.542 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 1.9 ttmt -55.41 -38.89 69.53 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 124.31 1.044 . . . . 64.11 110.148 175.258 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.433 HD13 ' HA ' ' A' ' 178' ' ' LEU . 4.5 mm? -76.47 -41.58 46.71 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-O 118.136 -0.935 . . . . 74.13 110.552 174.174 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -52.67 -50.36 63.4 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 119.325 0.966 . . . . 70.31 112.025 -175.442 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -72.12 -42.19 66.33 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 123.323 0.649 . . . . 53.14 109.347 -173.144 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 10.9 t80 -63.0 -46.38 87.94 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 124.468 1.107 . . . . 74.02 111.158 178.255 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 81.3 mt -67.69 -34.17 76.38 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 123.649 0.78 . . . . 73.22 111.024 -178.381 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 29.5 mt -53.75 -55.82 11.86 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 N-CA-C 107.995 -1.113 . . . . 71.53 107.995 166.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -56.63 -31.91 64.8 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.979 0.912 . . . . 72.35 112.863 -177.689 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 9.3 tptm -68.83 -48.21 64.1 Favored 'General case' 0 N--CA 1.463 0.209 0 O-C-N 121.401 -0.812 . . . . 63.41 110.535 -179.305 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 35.6 mm-40 -74.75 -42.47 58.18 Favored 'General case' 0 C--O 1.222 -0.367 0 O-C-N 121.955 -0.466 . . . . 63.2 111.228 178.508 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.05 -34.28 74.64 Favored 'General case' 0 N--CA 1.465 0.288 0 O-C-N 121.073 -1.017 . . . . 74.43 110.739 -176.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.368 0 C-N-CA 123.56 0.744 . . . . 65.05 112.378 175.355 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.515 -0.391 0 CA-C-O 123.479 1.609 . . . . 64.51 110.316 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -73.26 11.95 0.66 Allowed 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 127.096 2.158 . . . . 72.12 113.025 -179.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 14.4 m-85 -146.43 157.74 43.8 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 126.01 1.724 . . . . 75.02 108.056 -175.19 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.9 m -131.23 132.8 44.89 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 107.671 -1.233 . . . . 73.51 107.671 -174.328 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -69.61 148.45 49.34 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 108.158 -1.052 . . . . 60.0 108.158 175.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 63.69 13.61 52.04 Favored Glycine 0 CA--C 1.535 1.308 0 C-N-CA 124.68 1.134 . . . . 65.34 113.445 -167.02 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.94 -63.06 0.98 Allowed 'General case' 0 CA--C 1.52 -0.208 0 CA-C-N 119.775 1.788 . . . . 73.54 107.804 -177.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.432 ' HB3' HD21 ' A' ' 178' ' ' LEU . 12.4 mp0 -98.44 -25.91 14.63 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.342 1.457 . . . . 71.11 110.505 178.109 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 50.6 p90 -154.56 167.12 31.16 Favored 'General case' 0 N--CA 1.467 0.41 0 O-C-N 121.238 -0.914 . . . . 73.32 111.697 -171.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 59.2 t -132.9 115.91 25.37 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 C-N-CA 124.859 1.263 . . . . 74.14 109.058 -171.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -80.43 167.3 20.35 Favored 'General case' 0 C--O 1.236 0.392 0 O-C-N 119.972 -1.705 . . . . 72.32 110.478 174.301 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -126.16 124.64 40.96 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 124.237 1.015 . . . . 72.2 108.88 172.694 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 8.2 m -67.34 -9.45 41.32 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.838 0.855 . . . . 34.11 113.163 179.296 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 30.2 m -129.32 74.47 80.96 Favored Pre-proline 0 CA--C 1.537 0.454 0 C-N-CA 124.224 1.01 . . . . 52.34 108.625 -177.009 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -69.56 -179.01 2.53 Favored 'Trans proline' 0 N--CA 1.46 -0.459 0 C-N-CA 125.056 3.837 . . . . 73.3 112.281 -172.12 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.2 t -128.68 138.93 34.18 Favored Pre-proline 0 CA--C 1.532 0.27 0 C-N-CA 124.672 1.189 . . . . 72.11 107.93 -174.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_endo -73.13 179.1 5.74 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 122.42 2.08 . . . . 72.32 112.613 176.286 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.4 m -127.46 168.25 20.9 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 C-N-CA 126.826 2.051 . . . . 71.51 108.945 174.028 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 70.9 m -47.01 -61.84 1.69 Allowed 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 126.795 2.038 . . . . 62.4 110.508 176.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -145.82 165.38 21.17 Favored Pre-proline 0 C--O 1.238 0.492 0 C-N-CA 127.347 2.259 . . . . 73.03 105.375 163.079 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -70.88 -164.66 0.15 Allowed 'Trans proline' 0 CA--C 1.541 0.862 0 C-N-CA 122.62 2.213 . . . . 73.22 110.222 173.325 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 118.1 -112.68 2.45 Favored Glycine 0 N--CA 1.447 -0.627 0 N-CA-C 106.301 -2.72 . . . . 72.45 106.301 -179.388 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 33.4 mttm -54.46 133.69 45.81 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 124.136 0.974 . . . . 65.45 108.721 172.177 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.424 HD12 ' HB3' ' A' ' 186' ' ' GLU . 31.8 mm -64.59 140.72 19.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 106.377 -1.712 . . . . 72.41 106.377 169.541 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -99.21 139.17 35.26 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 107.559 -1.274 . . . . 74.32 107.559 -177.65 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 56.1 t -128.54 130.43 69.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 105.895 -1.891 . . . . 53.33 105.895 176.684 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 11.3 t -131.2 108.05 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 N-CA-C 107.417 -1.327 . . . . 63.32 107.417 -172.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -69.0 143.34 54.38 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 124.27 1.028 . . . . 64.31 108.556 162.26 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.521 ' CD2' HG21 ' A' ' 150' ' ' VAL . 5.0 mp -121.75 131.08 53.88 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 108.881 -0.785 . . . . 73.2 108.881 158.416 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 23.9 p90 -127.33 176.77 7.18 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.477 1.111 . . . . 64.42 110.469 179.249 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 27.1 t90 -151.0 175.8 11.73 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.082 1.353 . . . . 75.02 109.559 174.551 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 40.2 t80 -61.5 -73.18 0.1 Allowed 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.616 1.166 . . . . 74.24 112.876 172.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -81.86 52.03 4.53 Favored Glycine 0 C--N 1.339 0.705 0 C-N-CA 124.823 1.201 . . . . 44.4 110.358 -171.123 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 35.8 t -113.5 84.81 8.25 Favored Pre-proline 0 CA--C 1.538 0.487 0 C-N-CA 127.462 2.305 . . . . 72.44 106.051 -163.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -72.57 168.56 24.08 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 123.314 2.676 . . . . 61.33 109.217 171.228 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 5.2 m170 63.98 -45.7 0.27 Allowed 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 126.476 1.91 . . . . 73.42 112.116 -165.007 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 3.8 m -46.74 -53.14 12.43 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 126.745 2.018 . . . . 75.15 110.604 176.425 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 11.7 t80 -58.92 -49.92 75.99 Favored 'General case' 0 C--N 1.341 0.229 0 C-N-CA 125.361 1.464 . . . . 72.12 110.894 176.51 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.76 -13.52 61.51 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 112.742 0.645 . . . . 55.02 112.742 -171.356 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 7.0 t80 -90.71 -16.85 27.76 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 125.714 1.605 . . . . 71.51 112.073 179.262 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -46.68 -67.27 0.4 Allowed Pre-proline 0 N--CA 1.469 0.485 0 CA-C-N 120.059 1.299 . . . . 73.24 112.566 -172.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -69.02 -9.13 25.52 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 CA-C-N 122.033 1.762 . . . . 75.24 114.496 -177.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.9 m -70.91 -43.18 68.83 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 119.758 1.163 . . . . 65.52 108.798 167.167 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 21.1 tt -105.2 -28.51 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 N-CA-C 113.825 1.046 . . . . 64.34 113.825 -164.504 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 27.5 t -46.37 -60.4 3.72 Favored Pre-proline 0 CA--C 1.54 0.559 0 C-N-CA 124.794 1.238 . . . . 61.33 109.434 173.438 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -61.85 -35.31 79.16 Favored 'Trans proline' 0 N--CA 1.453 -0.883 0 CA-C-N 120.31 1.146 . . . . 64.13 112.974 -177.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.403 ' CZ2' ' HB1' ' A' ' 179' ' ' ALA . 72.8 t90 -57.24 -51.62 68.61 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.367 0.667 . . . . 74.3 110.402 179.557 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 29.5 t -58.89 -39.18 80.69 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 121.132 0.491 . . . . 72.02 110.269 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -68.92 -25.55 64.64 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 121.173 -0.954 . . . . 72.51 111.407 -177.429 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 14.3 mmtp -96.72 10.08 39.79 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.576 1.15 . . . . 75.43 112.879 177.477 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 34.9 mt -60.88 151.23 74.44 Favored Pre-proline 0 C--O 1.237 0.395 0 CA-C-N 119.532 1.06 . . . . 75.23 110.964 174.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -76.07 169.69 21.58 Favored 'Trans proline' 0 N--CA 1.445 -1.378 0 C-N-CA 124.065 3.177 . . . . 64.21 110.485 177.533 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -65.13 -4.19 4.64 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 125.044 1.338 . . . . 74.52 113.391 173.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -100.68 8.4 43.36 Favored 'General case' 0 N--CA 1.463 0.182 0 C-N-CA 125.709 1.603 . . . . 75.21 110.597 -177.056 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 61.0 t -129.53 160.03 40.93 Favored 'Isoleucine or valine' 0 C--O 1.239 0.542 0 O-C-N 121.214 -0.929 . . . . 51.45 108.798 -179.651 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 29.2 t60 -132.93 155.39 49.17 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 126.268 1.827 . . . . 52.32 107.249 165.53 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 55.7 t80 -132.5 134.01 44.49 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 108.102 -1.073 . . . . 71.22 108.102 -175.104 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 47.6 t -135.31 155.38 37.2 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 C-N-CA 126.551 1.941 . . . . 71.13 107.264 -172.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 16.4 mtt85 -133.2 130.32 38.94 Favored 'General case' 0 CA--C 1.513 -0.46 0 N-CA-C 105.197 -2.149 . . . . 72.25 105.197 176.284 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 37.6 mt -135.58 144.74 50.45 Favored Pre-proline 0 N--CA 1.469 0.514 0 CA-C-N 120.113 1.324 . . . . 71.45 110.082 175.502 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -74.89 157.45 43.21 Favored 'Trans proline' 0 N--CA 1.462 -0.353 0 C-N-CA 122.379 2.053 . . . . 73.21 110.728 -179.414 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -101.04 94.55 6.05 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 123.984 0.914 . . . . 55.01 110.12 -175.463 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 22.5 mt -86.43 76.75 9.58 Favored 'General case' 0 CA--C 1.539 0.54 0 O-C-N 120.612 -1.305 . . . . 73.1 111.869 -172.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -82.49 20.2 1.14 Allowed 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 115.129 1.529 . . . . 75.44 115.129 -176.156 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 89.01 -48.09 3.43 Favored Glycine 0 CA--C 1.525 0.704 0 O-C-N 119.924 -1.735 . . . . 34.53 112.834 168.214 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -72.55 -152.11 1.58 Allowed Glycine 0 CA--C 1.529 0.958 0 C-N-CA 124.337 0.97 . . . . 71.31 110.737 174.699 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 7.1 tp -46.75 -30.88 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 C-N-CA 124.1 0.96 . . . . 75.33 112.055 177.371 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 19.4 m95 -50.31 -27.47 6.23 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 126.069 1.748 . . . . 73.03 113.391 177.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 20.2 m-20 -73.91 -36.42 64.72 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-N 119.576 1.08 . . . . 75.04 110.496 177.153 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.401 ' C ' ' H ' ' A' ' 75' ' ' GLY . 40.7 t -73.82 -55.19 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 N-CA-C 107.966 -1.124 . . . . 73.31 107.966 174.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 34.9 m170 -65.95 31.92 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 129.534 3.134 . . . . 72.24 112.175 170.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.401 ' H ' ' C ' ' A' ' 73' ' ' VAL . . . -149.21 -42.55 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 125.353 1.454 . . . . 35.1 111.191 173.122 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -54.6 -41.84 70.42 Favored 'General case' 0 C--O 1.223 -0.328 0 CA-C-O 117.753 -1.118 . . . . 74.11 112.439 -175.06 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -44.47 -44.34 8.47 Favored 'General case' 0 CA--C 1.514 -0.407 0 N-CA-C 114.123 1.157 . . . . 71.22 114.123 -173.303 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 28.8 t80 -61.88 -45.76 92.34 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 118.525 0.602 . . . . 72.54 110.236 -176.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 50.0 mt -61.35 -45.24 95.22 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-O 116.726 -1.606 . . . . 61.33 109.251 175.415 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -62.41 -45.68 92.03 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 120.652 1.569 . . . . 61.5 110.776 -176.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.82 -60.6 2.99 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 125.998 1.719 . . . . 65.35 109.469 178.495 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -69.75 -28.92 66.18 Favored 'General case' 0 C--O 1.231 0.095 0 CA-C-O 118.927 -0.558 . . . . 64.23 111.76 -175.21 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 6.2 t -51.67 -37.16 49.33 Favored 'General case' 0 CA--C 1.52 -0.184 0 C-N-CA 124.343 1.057 . . . . 71.52 110.712 178.091 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 30.8 mtp . . . . . 0 N--CA 1.448 -0.562 0 CA-C-O 118.762 -0.637 . . . . 62.01 111.696 -170.913 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.387 0 N-CA-C 114.533 1.308 . . . . 62.14 114.533 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 55.8 t -71.49 -65.63 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 CA-C-O 117.575 -1.203 . . . . 54.43 108.614 166.241 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -54.61 -46.78 73.89 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 120.387 1.449 . . . . 72.12 111.98 -179.58 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -58.45 -40.49 82.77 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.427 1.491 . . . . 75.43 110.196 -178.705 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.51 ' HB1' ' CE1' ' A' ' 114' ' ' PHE . . . -74.2 4.53 5.53 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 125.798 1.639 . . . . 64.11 112.84 -178.641 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 61.7 mt -115.25 -57.12 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.891 0 N-CA-C 104.975 -2.232 . . . . 73.05 104.975 177.129 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 88.0 m-70 -80.67 -61.24 2.03 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 123.664 0.786 . . . . 75.41 112.616 -173.178 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -68.34 -21.16 64.75 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 119.063 0.847 . . . . 72.15 112.209 -177.756 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -94.45 -53.56 3.86 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 124.548 1.139 . . . . 73.44 108.771 -175.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 6.9 t60 58.49 88.0 0.07 Allowed 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.513 1.525 . . . . 64.33 110.65 -169.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 3.3 mmpt? -116.33 13.79 15.62 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.389 1.076 . . . . 72.11 113.302 -176.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 30.4 tttm 69.87 -64.23 0.36 Allowed 'General case' 0 C--O 1.221 -0.418 0 C-N-CA 128.2 2.6 . . . . 52.44 109.558 -174.333 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.413 HD22 ' HA ' ' A' ' 111' ' ' MET . 40.6 mt 54.47 44.66 28.48 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.813 1.645 . . . . 72.12 112.508 177.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -94.63 14.54 20.72 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.283 1.433 . . . . 72.33 114.189 -173.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -156.13 155.35 29.01 Favored Pre-proline 0 CA--C 1.535 0.395 0 C-N-CA 127.97 2.508 . . . . 75.22 107.662 -178.078 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -64.21 -44.99 10.71 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.546 2.164 . . . . 64.14 109.959 -173.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -69.01 -29.38 67.55 Favored 'General case' 0 N--CA 1.438 -1.039 0 C-N-CA 124.189 0.995 . . . . 72.43 111.15 -174.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -54.47 -42.15 70.34 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.95 1.3 . . . . 71.33 110.356 173.039 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . 0.413 ' HA ' HD22 ' A' ' 105' ' ' LEU . 2.5 mtt -76.85 -48.53 18.14 Favored 'General case' 0 CA--C 1.512 -0.514 0 C-N-CA 124.193 0.997 . . . . 75.45 108.92 -178.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.498 ' HB1' ' CG ' ' A' ' 122' ' ' LYS . . . -62.29 -37.16 84.46 Favored 'General case' 0 N--CA 1.447 -0.619 0 O-C-N 123.408 0.443 . . . . 73.44 111.337 -172.549 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -56.07 -46.85 78.83 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 125.287 1.435 . . . . 53.44 112.61 172.075 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . 0.51 ' CE1' ' HB1' ' A' ' 97' ' ' ALA . 19.0 t80 -74.27 -41.68 60.85 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 123.548 0.739 . . . . 71.3 111.45 -177.401 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 18.2 mt -76.94 -14.71 59.83 Favored 'General case' 0 C--N 1.332 -0.172 0 O-C-N 121.33 -0.856 . . . . 63.2 110.4 -176.511 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -48.48 -41.71 30.58 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.805 0.842 . . . . 70.13 110.127 172.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -82.09 10.09 54.67 Favored Glycine 0 CA--C 1.529 0.965 0 CA-C-O 117.975 -1.458 . . . . 75.43 114.805 177.265 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 23.8 mmtt -127.34 8.77 6.58 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 121.338 2.569 . . . . 72.43 112.615 -174.412 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 86.87 49.31 4.11 Favored Glycine 0 C--N 1.333 0.392 0 N-CA-C 109.669 -1.372 . . . . 65.22 109.669 -177.416 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 39.0 t -134.58 132.89 54.72 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 N-CA-C 105.18 -2.156 . . . . 73.14 105.18 169.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -92.27 133.65 35.63 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 123.68 0.792 . . . . 75.24 110.002 173.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.498 ' CG ' ' HB1' ' A' ' 112' ' ' ALA . 17.6 mtpt -64.58 -37.0 86.05 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 118.747 -0.644 . . . . 75.11 110.386 174.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -67.02 -26.82 66.97 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 118.707 0.685 . . . . 65.03 111.72 178.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 13.0 mttm -77.61 -57.06 4.02 Favored 'General case' 0 CA--C 1.518 -0.27 0 N-CA-C 106.402 -1.703 . . . . 71.53 106.402 171.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 41.3 t80 -51.86 -59.49 4.26 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 124.808 1.243 . . . . 65.51 112.174 -166.46 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 19.7 mt -73.54 -33.74 64.86 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 110.275 -0.268 . . . . 52.04 110.275 -170.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 29.7 m -62.26 -49.44 75.7 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 109.315 -0.624 . . . . 74.33 109.315 179.122 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 23.9 m -65.71 -41.33 92.44 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 124.553 1.141 . . . . 75.01 110.22 178.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 42.2 t80 -49.19 -48.69 45.05 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 119.691 1.132 . . . . 73.31 110.82 173.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 14.5 m-20 -92.64 38.89 1.02 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.647 0.779 . . . . 72.23 111.16 -178.121 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 7.7 t -122.86 172.26 8.6 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.403 1.481 . . . . 73.03 111.653 -177.334 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -67.09 -40.39 86.92 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.824 1.25 . . . . 75.2 110.52 178.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -50.58 -49.85 55.25 Favored 'General case' 0 C--N 1.34 0.166 0 C-N-CA 123.725 0.81 . . . . 63.13 110.463 -177.503 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 21.5 mm -69.51 -38.85 77.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 C-N-CA 124.218 1.007 . . . . 64.15 111.269 -178.305 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 1.7 mtmt -55.53 -33.26 63.65 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 124.066 0.947 . . . . 73.54 110.964 177.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -73.23 -48.42 19.44 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 110.831 -0.907 . . . . 43.12 110.831 178.357 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -63.34 -36.2 82.92 Favored 'General case' 0 CA--C 1.532 0.255 0 O-C-N 121.715 -0.874 . . . . 73.15 109.587 -177.502 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.32 -34.9 78.71 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-O 117.755 -1.116 . . . . 64.15 111.483 178.605 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -80.48 -39.84 27.3 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 120.588 1.54 . . . . 73.05 111.634 175.021 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.92 -59.02 5.67 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 118.864 -0.589 . . . . 74.1 110.763 179.116 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -58.85 -44.45 91.01 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 118.882 0.765 . . . . 75.41 109.056 -176.315 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 1.9 tmtt? -50.38 -57.73 7.3 Favored 'General case' 0 CA--C 1.528 0.11 0 C-N-CA 123.996 0.918 . . . . 73.12 111.139 -179.634 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.94 -35.06 69.51 Favored 'General case' 0 C--O 1.231 0.099 0 CA-C-N 118.834 0.743 . . . . 74.23 111.384 -175.28 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 37.8 mt -59.0 -49.56 77.44 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 123.577 0.751 . . . . 72.34 110.646 -177.477 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -54.47 -48.0 72.32 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 119.154 0.888 . . . . 73.12 111.722 -179.646 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 1.5 mtm -66.63 -34.8 78.68 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 120.332 -0.547 . . . . 64.35 109.774 -177.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -59.91 -43.86 94.62 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 118.426 0.557 . . . . 63.33 109.66 176.348 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -70.01 4.98 1.77 Allowed 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 126.183 1.793 . . . . 74.51 113.492 177.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 54.37 36.78 26.2 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 126.936 2.094 . . . . 75.43 112.124 -175.1 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.521 HG21 ' CD2' ' A' ' 32' ' ' LEU . 89.8 t -69.36 135.05 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 107.674 -1.232 . . . . 71.32 107.674 172.161 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 5.7 p -129.23 -16.12 4.04 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 126.787 2.035 . . . . 74.34 110.343 -176.132 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -168.36 -170.88 33.62 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 125.944 1.735 . . . . 61.41 112.825 -175.5 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 14.8 m -142.46 153.04 61.82 Favored Pre-proline 0 CA--C 1.546 0.819 0 C-N-CA 127.323 2.249 . . . . 75.32 108.316 175.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -63.52 152.71 71.36 Favored 'Cis proline' 0 CA--C 1.537 0.673 0 C-N-CA 124.578 -1.009 . . . . 64.44 113.145 -6.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 59.2 m -145.91 144.26 30.07 Favored 'General case' 0 C--O 1.239 0.547 0 C-N-CA 125.31 1.444 . . . . 73.44 108.529 175.251 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 19.8 mmm -123.97 158.41 32.12 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 125.774 1.63 . . . . 75.41 108.209 163.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 21.5 t -142.1 136.47 29.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 106.939 -1.504 . . . . 72.52 106.939 174.536 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.425 HG23 ' CE1' ' A' ' 164' ' ' PHE . 28.9 t -104.01 135.2 42.8 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 N-CA-C 107.098 -1.445 . . . . 72.12 107.098 168.726 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 1.4 t30 47.12 10.8 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.688 1 C-N-CA 133.111 4.565 . . . . 73.43 117.541 171.153 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 83.69 20.11 60.48 Favored Glycine 0 CA--C 1.526 0.777 0 CA-C-O 117.806 -1.552 . . . . 33.41 115.559 -169.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 48.0 mttt -131.81 -41.39 1.04 Allowed 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 119.971 1.885 . . . . 70.41 114.358 -170.302 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 -112.74 107.51 16.19 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 108.293 -1.003 . . . . 72.1 108.293 -171.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 63.2 ttp85 -88.92 113.41 24.43 Favored 'General case' 0 C--O 1.231 0.109 0 C-N-CA 126.5 1.92 . . . . 73.13 106.797 175.023 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . 0.425 ' CE1' HG23 ' A' ' 158' ' ' VAL . 5.3 p90 -136.51 169.59 17.45 Favored 'General case' 0 C--N 1.319 -0.75 0 O-C-N 120.343 -1.473 . . . . 54.21 107.186 177.8 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -174.97 -178.78 1.28 Allowed 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 122.548 0.339 . . . . 55.54 110.129 177.333 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 21.5 mt -46.33 -50.05 5.23 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 C-N-CA 128.555 2.742 . . . . 75.03 107.728 160.378 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -76.16 16.57 4.51 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 125.847 1.689 . . . . 70.41 114.392 178.012 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 17.8 m -128.3 -51.13 1.29 Allowed 'General case' 0 C--O 1.224 -0.239 0 CA-C-N 118.795 1.298 . . . . 71.41 109.705 168.565 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -70.32 -34.65 72.94 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 125.12 1.368 . . . . 64.11 112.266 -175.253 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 122.58 -5.96 9.87 Favored Glycine 0 C--N 1.341 0.83 0 CA-C-O 118.512 -1.16 . . . . 64.45 114.793 175.089 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 165.84 174.31 35.21 Favored Glycine 0 CA--C 1.532 1.097 0 CA-C-N 119.745 1.772 . . . . 50.23 110.003 -175.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -64.9 -52.61 1.18 Allowed 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 122.408 2.072 . . . . 71.31 111.772 -169.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -62.29 -28.68 69.9 Favored 'General case' 0 N--CA 1.463 0.223 0 O-C-N 120.965 -1.084 . . . . 73.42 111.547 178.491 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -67.4 -27.21 66.89 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.141 0.576 . . . . 74.32 110.366 177.527 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 19.7 m -77.66 -42.9 33.07 Favored 'General case' 0 CA--C 1.53 0.177 0 O-C-N 121.052 -1.03 . . . . 73.43 110.915 -169.713 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 35.8 mt -63.88 -31.77 73.07 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 118.918 0.781 . . . . 74.22 111.013 178.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 4.8 tttt -48.48 -56.48 8.17 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 126.602 1.961 . . . . 70.42 108.041 168.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.463 HD13 ' HA ' ' A' ' 178' ' ' LEU . 4.1 mm? -65.48 -41.37 93.38 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-O 116.941 -1.504 . . . . 65.34 111.554 176.534 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.403 ' HB1' ' CZ2' ' A' ' 50' ' ' TRP . . . -53.82 -48.68 69.67 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 120.917 1.689 . . . . 50.04 111.699 -175.395 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -69.52 -47.09 64.92 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 122.943 0.497 . . . . 63.54 110.577 -176.072 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -60.47 -42.61 96.59 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 123.565 0.746 . . . . 73.41 111.285 178.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 90.6 mt -67.09 -37.4 83.9 Favored 'General case' 0 C--N 1.332 -0.171 0 O-C-N 120.949 -1.094 . . . . 72.42 111.221 178.635 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 31.6 mt -58.25 -51.94 65.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 CA-C-N 119.259 0.936 . . . . 70.11 108.582 172.059 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -52.06 -43.07 63.62 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 124.59 1.156 . . . . 73.23 109.976 175.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 71.3 tttt -79.66 -0.32 33.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 117.124 -1.417 . . . . 72.14 113.161 -175.486 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . 0.424 ' HB3' HD12 ' A' ' 27' ' ' ILE . 16.0 mm-40 -103.11 -33.33 9.27 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 125.662 1.585 . . . . 70.42 114.43 178.435 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.39 -55.76 4.98 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 107.372 -1.344 . . . . 73.04 107.372 -179.222 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.403 0 CA-C-N 115.172 -0.922 . . . . 75.43 111.795 -176.444 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 . . . . . 0 N--CA 1.471 0.576 0 CA-C-O 123.399 1.571 . . . . 71.2 111.895 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -75.55 5.6 5.77 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 112.954 -1.93 . . . . 73.1 114.234 -171.48 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 30.1 m-85 -135.0 165.02 26.31 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 126.066 1.746 . . . . 71.14 108.04 -171.472 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 13.6 m -130.05 131.66 45.89 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 108.001 -1.111 . . . . 74.44 108.001 -178.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.89 154.02 42.03 Favored 'General case' 0 C--O 1.232 0.158 0 O-C-N 121.093 -1.005 . . . . 73.22 109.265 173.597 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 71.02 -36.17 0.51 Allowed Glycine 0 CA--C 1.53 1.001 0 C-N-CA 125.723 1.63 . . . . 53.2 112.859 -163.398 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 4.7 tptt -83.38 -83.37 0.14 Allowed 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 124.783 1.233 . . . . 70.55 108.993 -173.745 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 23.6 mp0 -73.41 -24.61 60.3 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 125.596 1.558 . . . . 73.23 110.47 -177.294 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 43.6 p90 -158.7 176.03 12.89 Favored 'General case' 0 N--CA 1.468 0.466 0 O-C-N 121.165 -0.959 . . . . 61.31 110.728 -173.568 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 62.0 t -134.55 107.63 9.33 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 124.921 1.288 . . . . 74.42 109.344 -177.283 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -73.23 147.14 44.94 Favored 'General case' 0 N--CA 1.444 -0.744 0 O-C-N 120.942 -1.099 . . . . 72.11 109.963 166.123 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -111.68 134.67 53.09 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 125.29 1.436 . . . . 73.41 109.92 -178.579 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 5.4 p -80.69 4.11 19.88 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 125.33 1.452 . . . . 53.13 114.137 -176.356 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -141.7 83.91 12.62 Favored Pre-proline 0 N--CA 1.45 -0.471 0 N-CA-C 106.781 -1.562 . . . . 70.02 106.781 173.342 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -70.92 -176.25 1.74 Allowed 'Trans proline' 0 CA--C 1.536 0.598 0 C-N-CA 124.086 3.191 . . . . 73.11 111.799 -175.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 22.1 t -131.65 137.5 30.52 Favored Pre-proline 0 CA--C 1.536 0.431 0 C-N-CA 123.942 0.897 . . . . 73.01 108.788 -174.186 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -78.95 176.39 9.89 Favored 'Trans proline' 0 CA--C 1.536 0.584 0 C-N-CA 123.67 2.914 . . . . 71.42 111.607 176.07 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.6 m -125.29 178.91 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 C-N-CA 125.307 1.443 . . . . 72.13 109.529 171.575 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 51.3 m -59.11 -58.18 9.79 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 124.537 1.135 . . . . 53.13 111.276 174.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -143.89 154.15 58.28 Favored Pre-proline 0 CA--C 1.536 0.428 0 C-N-CA 123.954 0.902 . . . . 73.12 109.509 173.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -70.29 167.04 26.29 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 123.37 2.713 . . . . 72.41 111.009 177.136 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 131.72 -96.39 0.33 Allowed Glycine 0 N--CA 1.449 -0.471 0 N-CA-C 109.412 -1.475 . . . . 63.04 109.412 178.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.39 126.11 29.03 Favored 'General case' 0 CA--C 1.518 -0.268 0 N-CA-C 108.53 -0.915 . . . . 75.41 108.53 -175.364 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 34.2 mm -61.68 140.17 19.51 Favored 'Isoleucine or valine' 0 C--O 1.24 0.581 0 N-CA-C 107.111 -1.44 . . . . 72.41 107.111 176.459 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -93.87 153.39 18.28 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 118.296 -1.361 . . . . 73.41 108.558 -177.135 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 16.1 t -146.31 121.81 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 N-CA-C 105.106 -2.183 . . . . 51.54 105.106 -177.567 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 57.3 t -123.07 119.47 57.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 106.898 -1.519 . . . . 63.54 106.898 -175.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -80.24 124.01 28.45 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 106.489 -1.671 . . . . 74.15 106.489 157.6 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.7 mp -110.47 145.24 38.02 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 107.031 -1.47 . . . . 74.32 107.031 160.022 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 18.5 p90 -154.23 176.93 11.68 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 124.138 0.975 . . . . 70.51 110.07 -172.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . 0.51 ' CB ' HG21 ' A' ' 153' ' ' VAL . 30.4 t90 -146.9 176.61 9.77 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 126.445 1.898 . . . . 72.44 108.268 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 23.7 t80 -56.22 -57.9 10.24 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 125.818 1.647 . . . . 73.22 111.467 178.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -93.4 -76.68 1.34 Allowed Glycine 0 C--N 1.338 0.677 0 N-CA-C 111.125 -0.79 . . . . 54.1 111.125 -155.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . 0.289 10.7 p 42.68 74.97 0.68 Allowed Pre-proline 0 CA--C 1.534 0.352 0 C-N-CA 126.409 1.884 . . . . 61.32 112.45 165.828 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -54.95 -27.43 54.08 Favored 'Trans proline' 0 CA--C 1.537 0.668 0 CA-C-N 121.078 1.421 . . . . 55.52 113.023 -175.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 10.6 m170 -70.34 -37.45 74.67 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.598 1.159 . . . . 73.15 111.861 175.001 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 18.7 p -67.37 -31.58 71.92 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 119.833 1.197 . . . . 74.54 111.087 -178.451 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 89.9 t80 -65.97 -26.02 67.37 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.314 1.046 . . . . 73.14 111.733 176.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -74.35 -7.76 53.94 Favored 'General case' 0 CA--C 1.536 0.424 0 O-C-N 120.879 -1.138 . . . . 42.15 112.15 172.196 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -126.76 -20.34 4.3 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-O 118.023 -0.989 . . . . 63.14 113.125 -163.511 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . 0.253 0.0 OUTLIER -50.44 -64.28 1.38 Allowed Pre-proline 0 N--CA 1.475 0.794 0 CA-C-N 120.689 1.586 . . . . 72.34 113.893 -175.551 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -70.52 -9.29 25.52 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 CA-C-N 122.099 1.785 . . . . 72.35 114.015 -176.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 85.4 m -79.87 -36.44 36.61 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 119.564 1.074 . . . . 74.43 109.671 169.398 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 15.8 tt -85.14 -35.49 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 CA-C-N 119.367 0.985 . . . . 72.13 111.617 -177.125 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 55.8 t -48.29 -62.65 2.05 Favored Pre-proline 0 CA--C 1.538 0.504 0 CA-C-O 117.413 -1.28 . . . . 73.3 112.088 -177.094 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -68.11 -29.53 33.15 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 121.428 1.418 . . . . 64.21 111.32 -176.041 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 77.2 t90 -54.23 -57.79 9.83 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 119.322 0.965 . . . . 72.52 109.973 177.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.2 -23.39 62.94 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 112.587 0.588 . . . . 72.11 112.587 -172.572 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 78.0 mt-10 -66.42 -48.19 70.8 Favored 'General case' 0 C--O 1.235 0.301 0 O-C-N 120.926 -1.109 . . . . 71.12 109.716 169.619 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 30.0 mmmt -74.57 3.6 7.46 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.524 1.53 . . . . 64.44 112.817 -169.678 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 37.7 mt -59.09 159.45 14.31 Favored Pre-proline 0 CA--C 1.543 0.674 0 C-N-CA 125.363 1.465 . . . . 72.21 112.129 177.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -87.27 174.0 5.39 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 125.204 3.936 . . . . 70.34 112.265 178.619 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -66.83 -21.26 66.03 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 114.307 1.225 . . . . 61.02 114.307 -175.681 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 40.9 m-20 -86.81 6.89 29.4 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.722 1.209 . . . . 71.5 111.146 -175.292 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 46.8 t -129.0 151.76 36.22 Favored 'Isoleucine or valine' 0 C--O 1.24 0.589 0 C-N-CA 125.194 1.398 . . . . 62.01 108.412 -173.245 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 79.6 t60 -133.96 144.5 48.81 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 125.498 1.519 . . . . 73.3 107.852 173.574 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 24.7 t80 -128.42 136.82 51.4 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 123.763 0.825 . . . . 74.4 110.535 -172.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 70.9 t -133.64 148.96 30.52 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 C-N-CA 126.253 1.821 . . . . 71.23 107.935 -174.532 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -123.79 125.31 44.47 Favored 'General case' 0 CA--C 1.512 -0.515 0 N-CA-C 105.615 -1.995 . . . . 71.03 105.615 172.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 20.7 mt -133.43 150.93 76.44 Favored Pre-proline 0 N--CA 1.47 0.539 0 CA-C-N 119.474 1.033 . . . . 60.03 111.092 176.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -73.63 139.29 27.96 Favored 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 121.64 1.56 . . . . 75.34 110.578 179.13 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -79.93 79.06 6.51 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.225 1.01 . . . . 53.42 109.382 173.216 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 48.8 mt -72.76 106.02 4.57 Favored 'General case' 0 C--N 1.329 -0.304 0 O-C-N 120.99 -1.069 . . . . 72.11 109.363 175.656 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -128.8 28.06 5.4 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.424 1.489 . . . . 71.03 112.376 178.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 76.9 169.78 31.54 Favored Glycine 0 CA--C 1.523 0.589 0 C-N-CA 125.454 1.502 . . . . 72.44 111.166 -178.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 56.77 -151.04 26.15 Favored Glycine 0 CA--C 1.529 0.937 0 N-CA-C 111.083 -0.807 . . . . 72.04 111.083 -175.129 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.2 tt -60.47 -21.33 22.84 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 C-N-CA 124.183 0.993 . . . . 72.35 112.658 -174.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . 0.435 ' CH2' HG22 ' A' ' 153' ' ' VAL . 23.9 m95 -63.31 -32.1 73.43 Favored 'General case' 0 CA--C 1.53 0.178 0 O-C-N 121.725 -0.609 . . . . 73.13 110.715 173.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -77.49 -43.57 31.74 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-N 118.676 0.671 . . . . 75.51 110.46 173.683 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 58.7 t -55.29 -58.21 5.12 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 C-N-CA 124.077 0.951 . . . . 74.51 109.916 -175.258 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 61.5 m170 -69.89 -7.61 41.73 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 118.568 -0.729 . . . . 74.11 112.042 -178.425 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -93.45 -18.55 38.27 Favored Glycine 0 C--N 1.338 0.652 0 CA-C-N 120.288 1.404 . . . . 73.21 110.242 -177.449 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -74.76 -36.6 62.57 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 118.58 1.19 . . . . 63.31 110.97 -173.452 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 34.2 ttp -53.82 -45.28 70.78 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.659 1.583 . . . . 73.13 113.436 179.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 10.7 t80 -57.5 -44.21 84.82 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 109.172 -0.677 . . . . 75.24 109.172 -177.115 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 24.4 mt -65.94 -44.9 83.71 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-O 117.092 -1.432 . . . . 73.23 109.53 178.331 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.416 ' HA ' HD11 ' A' ' 134' ' ' ILE . 0.2 OUTLIER -56.42 -41.71 76.83 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 121.165 1.802 . . . . 65.04 112.318 178.501 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.0 -59.43 4.92 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 124.853 1.261 . . . . 24.22 109.154 -174.675 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -72.46 -24.37 61.19 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 111.442 0.164 . . . . 73.22 111.442 -174.382 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.4 t -58.92 -8.5 1.41 Allowed 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.597 1.559 . . . . 73.2 113.516 176.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 6.8 mtp . . . . . 0 C--O 1.233 0.22 0 C-N-CA 125.453 1.501 . . . . 72.11 113.963 -179.415 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.102 0 N-CA-C 113.421 0.897 . . . . 71.12 113.421 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 60.0 t -58.45 -58.69 5.51 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 N-CA-C 108.393 -0.965 . . . . 75.51 108.393 172.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 -58.84 -49.9 76.0 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 124.296 1.038 . . . . 74.04 110.873 179.648 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -71.27 -2.97 17.94 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 126.184 1.793 . . . . 73.44 112.64 -173.529 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.451 ' HB1' ' CE2' ' A' ' 114' ' ' PHE . . . -96.37 -28.33 14.52 Favored 'General case' 0 N--CA 1.453 -0.28 0 O-C-N 120.84 -1.162 . . . . 73.3 112.405 169.646 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 12.1 mt -84.65 -58.49 3.46 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.513 0 N-CA-C 106.799 -1.556 . . . . 43.24 106.799 178.027 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 58.0 m-70 -73.61 -61.43 1.84 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 118.8 0.727 . . . . 63.12 112.734 -163.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.6 -12.1 60.0 Favored 'General case' 0 N--CA 1.473 0.7 0 O-C-N 120.614 -1.304 . . . . 75.33 114.18 179.42 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -114.46 -27.82 7.41 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 113.888 1.07 . . . . 73.42 113.888 -171.045 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . 0.272 5.1 m170 43.72 46.63 6.41 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 127.632 2.373 . . . . 55.23 112.868 169.387 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.468 ' HE2' ' HA ' ' A' ' 103' ' ' LYS . 7.9 mmpt? -68.37 12.12 0.14 Allowed 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 125.109 1.364 . . . . 64.11 114.614 178.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 4.2 ttpm? 68.14 -52.27 0.53 Allowed 'General case' 0 C--O 1.223 -0.293 0 C-N-CA 129.384 3.074 . . . . 75.23 111.057 -177.771 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 64.8 mt 51.84 43.96 29.72 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 125.957 1.703 . . . . 75.21 110.295 171.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -84.76 -24.97 28.56 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 124.369 1.067 . . . . 54.11 112.536 -175.371 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 44.4 p -124.06 160.08 53.71 Favored Pre-proline 0 N--CA 1.463 0.193 0 CA-C-N 119.767 1.167 . . . . 71.12 111.474 -169.423 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -71.15 -15.91 31.92 Favored 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 121.344 1.363 . . . . 61.31 112.809 178.273 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.43 -59.91 2.58 Favored 'General case' 0 N--CA 1.462 0.153 0 N-CA-C 107.064 -1.458 . . . . 63.0 107.064 166.458 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -58.52 -42.03 86.79 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 123.928 0.891 . . . . 53.24 112.09 -170.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 41.1 mtt -65.57 -55.75 16.01 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 122.963 0.505 . . . . 73.41 111.099 175.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.401 ' HB1' ' CG ' ' A' ' 122' ' ' LYS . . . -70.86 -40.08 72.54 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 119.45 -0.31 . . . . 75.32 110.721 -166.121 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -60.79 -38.35 85.03 Favored 'General case' 0 C--N 1.338 0.103 0 C-N-CA 122.84 0.456 . . . . 65.22 110.638 175.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . 0.451 ' CE2' ' HB1' ' A' ' 97' ' ' ALA . 82.9 t80 -72.0 -48.19 46.53 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 122.848 0.459 . . . . 72.12 111.206 -177.359 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 55.7 mt -68.29 -16.79 64.09 Favored 'General case' 0 C--O 1.23 0.049 0 O-C-N 121.49 -0.756 . . . . 54.32 111.219 -174.535 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -52.09 -18.03 1.29 Allowed 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.762 1.225 . . . . 63.44 112.867 172.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -86.37 -12.4 70.16 Favored Glycine 0 CA--C 1.529 0.938 0 O-C-N 120.927 -1.108 . . . . 72.13 113.148 177.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -116.84 6.04 13.09 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 119.485 1.643 . . . . 72.23 113.544 -161.587 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 87.65 48.92 4.04 Favored Glycine 0 C--N 1.334 0.439 0 N-CA-C 109.754 -1.338 . . . . 71.14 109.754 -169.681 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 55.9 t -129.81 155.08 41.19 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 N-CA-C 104.794 -2.299 . . . . 65.43 104.794 165.7 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -127.31 135.3 50.36 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 106.538 -1.653 . . . . 65.44 106.538 -176.27 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.401 ' CG ' ' HB1' ' A' ' 112' ' ' ALA . 2.5 mtmt -67.39 -42.43 83.35 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 118.817 0.735 . . . . 72.25 111.431 -175.238 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -62.48 -36.22 81.81 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 123.859 0.864 . . . . 74.51 110.1 -178.563 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 40.8 mttm -73.08 -53.48 10.97 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 106.042 -1.836 . . . . 73.32 106.042 176.264 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 33.1 t80 -51.98 -60.67 2.92 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 125.246 1.418 . . . . 73.22 110.874 -172.21 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 11.8 mt -68.67 -37.29 79.51 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 123.063 0.545 . . . . 53.13 110.191 -170.21 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 11.2 t -65.1 -37.07 86.29 Favored 'General case' 0 CA--C 1.534 0.335 0 O-C-N 122.05 -0.406 . . . . 50.5 109.999 179.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 51.6 m -70.02 -40.87 74.97 Favored 'General case' 0 N--CA 1.455 -0.209 0 O-C-N 121.87 -0.519 . . . . 61.31 111.003 171.664 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 77.5 t80 -54.23 -48.93 70.55 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 119.3 0.954 . . . . 74.44 109.269 179.454 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 55.3 m-20 -91.46 59.09 3.75 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.905 1.282 . . . . 73.33 109.74 171.657 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 68.3 p -123.64 163.33 21.26 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-O 121.951 0.881 . . . . 51.03 111.702 168.197 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -68.44 -32.13 71.94 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.675 0.79 . . . . 60.33 110.21 172.303 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -56.54 -50.46 71.79 Favored 'General case' 0 C--O 1.234 0.26 0 O-C-N 121.796 -0.565 . . . . 50.12 110.045 -179.187 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.416 HD11 ' HA ' ' A' ' 80' ' ' THR . 26.5 mm -63.94 -34.18 66.77 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-O 118.407 -0.806 . . . . 72.14 110.983 177.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 54.2 tttt -53.53 -41.76 66.72 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 118.898 0.772 . . . . 65.53 109.394 174.507 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -71.91 -33.81 62.56 Favored Glycine 0 C--N 1.337 0.61 0 C-N-CA 125.015 1.293 . . . . 33.21 111.75 -178.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 -73.3 -36.58 66.3 Favored 'General case' 0 N--CA 1.452 -0.36 0 O-C-N 121.824 -0.809 . . . . 64.23 110.503 -178.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 14.7 mtp -62.17 -52.01 65.51 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 118.119 0.418 . . . . 74.14 110.458 173.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -65.84 -37.01 85.06 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-O 118.696 -0.669 . . . . 52.24 111.913 -168.529 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 3.0 mtmt -56.52 -64.09 0.98 Allowed 'General case' 0 C--N 1.341 0.222 0 CA-C-O 118.357 -0.83 . . . . 63.14 109.041 172.448 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -55.99 -37.91 69.74 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 118.567 0.621 . . . . 73.13 111.437 -173.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 9.5 tmtt? -55.41 -59.82 4.28 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 124.228 1.011 . . . . 72.24 110.3 178.092 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 8.6 ptmt -69.67 -31.2 69.13 Favored 'General case' 0 C--N 1.343 0.307 0 CA-C-N 120.158 1.345 . . . . 62.14 111.974 179.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 21.9 mt -60.63 -54.41 45.68 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 118.624 0.647 . . . . 74.41 109.376 -174.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -54.4 -41.07 68.85 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 122.503 0.321 . . . . 60.42 111.237 -178.244 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -63.65 -45.71 88.94 Favored 'General case' 0 N--CA 1.461 0.11 0 C-N-CA 123.08 0.552 . . . . 70.23 111.3 178.239 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -62.33 -39.45 93.11 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 123.442 0.697 . . . . 71.42 110.11 -178.508 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 34.9 m-85 -75.67 8.0 3.32 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.662 1.185 . . . . 72.21 113.441 177.405 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 13.3 mt-30 49.93 39.06 17.73 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 126.998 2.119 . . . . 74.22 112.729 -175.678 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 46.6 t -74.2 138.27 21.49 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 N-CA-C 106.276 -1.75 . . . . 74.31 106.276 168.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -141.68 4.48 1.73 Allowed 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.873 0.869 . . . . 44.15 111.607 -178.449 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 177.28 -177.22 48.29 Favored Glycine 0 CA--C 1.524 0.631 0 C-N-CA 126.243 1.877 . . . . 74.13 108.709 -174.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.51 HG21 ' CB ' ' A' ' 34' ' ' TRP . 12.9 m -149.15 149.99 30.89 Favored Pre-proline 0 C--O 1.24 0.586 0 C-N-CA 125.378 1.471 . . . . 75.53 108.91 -175.471 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -68.98 147.89 83.87 Favored 'Cis proline' 0 CA--C 1.537 0.648 0 O-C-N 122.532 0.754 . . . . 64.22 112.148 -1.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 62.9 m -150.53 131.57 14.34 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 126.559 1.944 . . . . 64.23 107.442 179.27 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 93.3 mtp -116.36 163.12 16.49 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 124.153 0.981 . . . . 71.41 109.615 172.022 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 6.3 t -139.75 143.71 29.89 Favored 'Isoleucine or valine' 0 C--O 1.24 0.595 0 N-CA-C 106.522 -1.659 . . . . 71.14 106.522 179.041 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.522 HG23 ' CE1' ' A' ' 164' ' ' PHE . 96.8 t -113.29 134.7 55.16 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 C-N-CA 124.929 1.291 . . . . 72.4 107.545 167.802 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 7.8 t30 49.24 9.34 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 131.63 3.972 . . . . 62.02 116.344 172.361 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 81.48 19.81 65.53 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 126.124 1.821 . . . . 64.2 114.306 -171.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 24.1 mtpt -137.78 -30.19 0.83 Allowed 'General case' 0 N--CA 1.479 1.002 0 CA-C-N 120.292 2.046 . . . . 63.22 113.498 -167.541 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -118.7 142.41 47.69 Favored 'General case' 0 CA--C 1.508 -0.662 0 N-CA-C 107.318 -1.364 . . . . 72.11 107.318 174.524 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 21.7 ttp180 -123.48 144.34 49.59 Favored 'General case' 0 N--CA 1.44 -0.955 0 N-CA-C 104.877 -2.268 . . . . 72.44 104.877 178.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . 0.522 ' CE1' HG23 ' A' ' 158' ' ' VAL . 14.1 p90 -154.22 173.32 16.27 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 107.596 -1.261 . . . . 75.4 107.596 178.749 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -173.42 175.65 3.01 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 107.681 -1.229 . . . . 62.3 107.681 -177.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 23.6 mt -56.23 -44.93 80.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 C-N-CA 126.493 1.917 . . . . 62.55 108.746 -177.498 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -72.46 -34.92 60.02 Favored Glycine 0 N--CA 1.442 -0.927 0 CA-C-O 117.996 -1.446 . . . . 62.34 112.093 -175.252 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 72.9 m -69.03 -57.3 5.63 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 118.924 1.362 . . . . 70.11 109.36 172.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -63.21 -44.84 94.19 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 123.1 0.56 . . . . 72.41 111.322 -169.187 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 141.28 -18.32 2.68 Favored Glycine 0 CA--C 1.523 0.573 0 C-N-CA 123.768 0.699 . . . . 71.42 114.197 173.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 169.82 169.23 32.8 Favored Glycine 0 CA--C 1.527 0.814 0 N-CA-C 107.19 -2.364 . . . . 41.33 107.19 -172.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -64.34 -36.11 46.99 Favored 'Trans proline' 0 N--CA 1.459 -0.543 0 C-N-CA 122.643 2.229 . . . . 75.0 111.984 -168.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -56.62 -48.96 76.34 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 123.453 0.701 . . . . 60.31 110.331 171.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -67.15 -27.6 67.43 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 123.797 0.839 . . . . 75.23 109.909 -169.078 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -51.29 -48.36 62.29 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 124.143 0.977 . . . . 55.51 110.197 173.75 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 55.9 mt -65.91 -34.02 77.16 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 117.851 0.296 . . . . 64.13 111.261 -179.318 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.78 -48.4 75.4 Favored 'General case' 0 N--CA 1.456 -0.165 0 N-CA-C 108.652 -0.87 . . . . 74.22 108.652 174.662 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.478 HD13 ' HA ' ' A' ' 178' ' ' LEU . 4.3 mm? -66.88 -44.7 80.23 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-O 117.848 -1.072 . . . . 65.52 110.843 175.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -50.38 -50.3 51.91 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 118.967 0.803 . . . . 61.22 110.329 -178.078 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -72.92 -44.37 61.31 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 123.625 0.77 . . . . 42.45 109.663 -170.133 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 5.5 t80 -59.76 -47.95 83.63 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 124.312 1.045 . . . . 75.54 111.894 176.063 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . 0.463 ' HB2' HG21 ' A' ' 158' ' ' VAL . 82.7 mt -63.28 -44.63 94.52 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 108.967 -0.753 . . . . 64.02 108.967 -174.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 65.2 mt -58.14 -45.68 88.53 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 123.236 0.614 . . . . 73.2 109.43 174.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -65.84 -17.57 64.73 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 123.694 0.798 . . . . 63.43 112.571 179.492 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 13.5 tptp -84.23 -57.29 3.23 Favored 'General case' 0 N--CA 1.441 -0.917 0 N-CA-C 106.911 -1.514 . . . . 75.2 106.911 173.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -55.88 -20.19 14.77 Favored 'General case' 0 CA--C 1.513 -0.465 0 C-N-CA 129.856 3.262 . . . . 71.12 116.245 -167.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 2.6 mtm180 -71.88 -68.85 0.43 Allowed 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 117.784 -1.566 . . . . 74.03 110.629 168.336 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.471 0 CA-C-O 124.02 1.866 . . . . 64.23 111.076 -173.061 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 . . . . . 0 CA--C 1.519 -0.217 0 N-CA-C 109.205 -0.665 . . . . 74.14 109.205 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -117.1 11.49 14.21 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 123.968 0.907 . . . . 72.41 112.631 178.675 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 -135.89 159.87 40.35 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 125.381 1.472 . . . . 73.2 109.735 -171.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.8 m -136.24 142.07 43.99 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 123.827 0.851 . . . . 72.15 109.481 176.637 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.33 150.52 34.75 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-N 114.602 -1.181 . . . . 70.2 111.982 176.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 77.51 -42.61 1.99 Allowed Glycine 0 CA--C 1.524 0.608 0 C-N-CA 125.015 1.293 . . . . 61.32 110.594 -171.43 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 12.9 ttpt -79.43 -80.49 0.12 Allowed 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 125.202 1.401 . . . . 65.13 110.76 -168.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 8.1 mp0 -70.97 -21.45 62.32 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 124.707 1.203 . . . . 64.41 110.865 -175.482 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 31.5 p90 -164.94 172.75 12.41 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 125.302 1.441 . . . . 74.22 108.817 -173.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 57.4 t -130.99 108.54 15.29 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 C-N-CA 125.002 1.321 . . . . 71.15 108.591 -178.678 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.6 164.13 22.12 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 124.387 1.075 . . . . 42.3 108.422 165.757 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -135.53 114.39 12.02 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 106.858 -1.534 . . . . 54.41 106.858 -168.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.5 m -56.69 -8.45 0.58 Allowed 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.433 1.493 . . . . 74.54 114.208 -177.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 50.6 m -135.3 83.3 38.61 Favored Pre-proline 0 CA--C 1.543 0.684 0 C-N-CA 125.016 1.327 . . . . 70.52 109.504 -179.112 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -74.66 177.82 7.95 Favored 'Trans proline' 0 CA--C 1.539 0.761 1 C-N-CA 125.583 4.189 . . . . 64.01 114.006 -178.725 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 81.3 t -142.0 147.84 46.24 Favored Pre-proline 0 N--CA 1.475 0.797 0 C-N-CA 127.111 2.164 . . . . 64.24 108.932 -168.271 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo -90.47 174.95 2.84 Favored 'Trans proline' 0 CA--C 1.536 0.59 0 C-N-CA 123.863 3.042 . . . . 70.32 113.455 178.096 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 15.5 m -105.85 176.28 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 C-N-CA 125.464 1.506 . . . . 35.21 109.266 166.343 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 67.1 m -52.5 -51.17 60.78 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 126.686 1.994 . . . . 53.33 112.351 177.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 16.7 mt-30 -149.72 164.17 21.91 Favored Pre-proline 0 CA--C 1.537 0.478 0 C-N-CA 125.1 1.36 . . . . 64.32 109.516 176.119 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -68.58 135.44 33.42 Favored 'Trans proline' 0 N--CA 1.452 -0.952 0 C-N-CA 122.416 2.077 . . . . 63.35 108.717 167.449 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 175.19 -125.51 1.09 Allowed Glycine 0 N--CA 1.445 -0.754 0 N-CA-C 106.614 -2.594 . . . . 63.41 106.614 -171.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.03 152.82 43.16 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 117.938 0.869 . . . . 75.4 109.786 176.823 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 39.2 mm -59.09 157.93 1.86 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 N-CA-C 106.811 -1.551 . . . . 73.04 106.811 163.3 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -115.84 122.09 44.35 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 107.093 -1.447 . . . . 70.13 107.093 174.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 36.7 t -114.85 113.14 42.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 N-CA-C 105.949 -1.871 . . . . 71.45 105.949 171.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 16.2 t -101.19 139.38 22.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 107.09 -1.448 . . . . 63.53 107.09 179.24 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -105.75 138.44 41.94 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 107.872 -1.158 . . . . 71.01 107.872 154.474 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.0 mp -111.46 148.43 33.15 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 124.549 1.14 . . . . 74.12 108.8 174.367 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 48.7 p90 -138.35 171.72 13.96 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 123.631 0.772 . . . . 74.45 112.044 -179.601 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 27.2 t90 -145.48 177.15 9.07 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 127.701 2.401 . . . . 63.53 107.886 172.393 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 56.1 t80 -72.16 -31.61 66.11 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.524 1.53 . . . . 61.32 114.758 178.434 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -116.69 20.99 11.69 Favored Glycine 0 CA--C 1.526 0.721 0 CA-C-O 118.573 -1.126 . . . . 42.54 114.228 -161.086 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 21.2 p -106.85 86.77 2.49 Favored Pre-proline 0 CA--C 1.538 0.49 0 C-N-CA 125.81 1.644 . . . . 65.53 110.309 -169.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -52.63 -36.45 71.83 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 122.7 2.267 . . . . 64.23 113.061 -175.219 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 17.0 m170 -55.27 -29.33 57.92 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 118.214 -0.898 . . . . 70.44 112.774 176.131 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 80.3 m -63.88 -66.45 0.54 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.555 1.542 . . . . 72.42 109.772 179.313 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.434 ' HB2' ' CD2' ' A' ' 99' ' ' HIS . 19.2 t80 -59.2 -34.85 72.64 Favored 'General case' 0 N--CA 1.469 0.485 0 O-C-N 121.489 -0.757 . . . . 73.04 111.907 -178.645 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.58 -28.7 69.53 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 118.633 -0.698 . . . . 71.12 112.327 179.676 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -93.86 -20.45 20.04 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.985 1.314 . . . . 72.22 112.126 -174.669 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -42.89 -65.45 0.55 Allowed Pre-proline 0 CA--C 1.542 0.654 0 N-CA-C 114.393 1.257 . . . . 71.43 114.393 -174.335 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -74.73 -6.65 18.47 Favored 'Trans proline' 0 CA--C 1.534 0.522 0 CA-C-N 122.327 1.867 . . . . 41.04 114.525 -176.315 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 67.0 m -75.44 -39.81 58.37 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 120.411 1.459 . . . . 42.24 108.905 163.209 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 14.2 tt -87.19 -34.51 7.57 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 N-CA-C 112.846 0.684 . . . . 71.33 112.846 -171.215 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 31.4 t -49.72 -57.34 12.52 Favored Pre-proline 0 CA--C 1.537 0.451 0 CA-C-N 119.837 1.199 . . . . 73.21 111.138 175.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -67.02 -7.41 18.62 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 CA-C-N 121.302 1.501 . . . . 63.41 114.11 -177.09 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.464 ' CH2' ' HB1' ' A' ' 179' ' ' ALA . 70.9 t90 -80.27 -62.21 1.75 Allowed 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 119.326 0.966 . . . . 72.02 108.837 164.183 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 5.2 p -68.57 -19.08 64.45 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 113.35 0.87 . . . . 73.42 113.35 -172.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . 0.322 4.9 pt-20 -69.66 -20.78 63.57 Favored 'General case' 0 CA--C 1.556 1.179 0 C-N-CA 124.273 1.029 . . . . 54.24 110.912 170.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 67.2 mmtt -115.89 6.52 14.26 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.633 1.573 . . . . 72.42 113.256 -170.695 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 51.7 mt -63.43 150.41 89.81 Favored Pre-proline 0 C--O 1.236 0.391 0 CA-C-N 118.702 0.683 . . . . 70.41 110.021 176.723 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -73.11 177.26 8.02 Favored 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 124.555 3.503 . . . . 72.5 111.701 -176.02 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -74.6 -0.72 18.73 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.175 0.99 . . . . 64.52 113.475 179.104 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -104.07 -1.38 27.47 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 126.589 1.956 . . . . 73.21 111.339 -177.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 48.2 t -131.3 154.53 40.74 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 126.303 1.841 . . . . 73.33 106.708 -179.505 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 48.7 t60 -137.69 157.45 46.44 Favored 'General case' 0 N--CA 1.45 -0.468 0 O-C-N 121.674 -0.641 . . . . 72.1 109.41 169.344 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 46.3 t80 -124.6 135.16 52.88 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.644 1.178 . . . . 74.3 110.674 -171.561 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 67.1 t -132.85 137.86 53.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 C-N-CA 124.299 1.04 . . . . 73.23 108.54 -169.115 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -114.16 121.64 44.37 Favored 'General case' 0 CA--C 1.514 -0.414 0 N-CA-C 106.628 -1.619 . . . . 62.4 106.628 170.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 13.1 mt -136.57 144.79 48.7 Favored Pre-proline 0 CA--C 1.537 0.454 0 CA-C-N 118.607 0.639 . . . . 75.41 112.304 -177.453 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -77.56 125.61 7.7 Favored 'Trans proline' 0 CA--C 1.534 0.482 0 C-N-CA 122.166 1.911 . . . . 74.44 112.307 -175.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -68.29 112.28 5.08 Favored 'General case' 0 CA--C 1.54 0.567 0 O-C-N 120.741 -1.225 . . . . 64.34 109.286 167.76 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 8.1 mt -110.41 95.57 5.65 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 106.274 -1.751 . . . . 62.14 106.274 177.215 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -115.5 16.68 16.58 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 114.861 1.43 . . . . 72.52 114.861 -172.623 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 93.22 170.99 39.75 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 125.258 1.409 . . . . 35.21 110.058 -178.566 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 58.41 -153.48 27.76 Favored Glycine 0 CA--C 1.532 1.101 0 N-CA-C 110.246 -1.142 . . . . 64.4 110.246 -172.533 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 8.8 tp -60.19 -17.27 13.8 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 C-N-CA 123.866 0.866 . . . . 72.41 112.751 -177.208 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 19.1 m95 -58.52 -35.41 72.22 Favored 'General case' 0 C--N 1.34 0.193 0 O-C-N 121.009 -1.057 . . . . 72.3 110.847 176.82 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 33.4 m-20 -76.66 -33.33 58.3 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 109.283 -0.636 . . . . 72.31 109.283 -174.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 29.8 t -63.17 -65.64 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 C-N-CA 124.797 1.239 . . . . 61.51 108.992 172.639 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 46.4 m170 -67.66 -2.4 6.81 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 114.138 1.162 . . . . 74.4 114.138 -171.543 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -102.04 -27.39 7.0 Favored Glycine 0 C--N 1.336 0.563 0 CA-C-N 120.221 1.373 . . . . 52.11 110.171 -176.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 31.7 mt-30 -56.09 -26.86 51.34 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 118.226 -0.893 . . . . 75.52 112.527 176.362 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 3.7 ttt -46.78 -62.96 1.15 Allowed 'General case' 0 C--N 1.342 0.246 0 N-CA-C 114.796 1.406 . . . . 43.23 114.796 -170.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -53.06 -45.69 68.21 Favored 'General case' 0 C--N 1.331 -0.211 0 O-C-N 123.779 0.674 . . . . 63.22 110.045 -176.331 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 28.7 mt -61.87 -39.08 90.64 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-O 116.682 -1.628 . . . . 75.22 109.67 178.079 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.549 ' HA ' HD11 ' A' ' 134' ' ' ILE . 0.0 OUTLIER -60.62 -49.45 77.49 Favored 'General case' 0 C--N 1.349 0.567 0 CA-C-N 121.625 2.011 . . . . 75.53 109.538 175.596 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -54.57 -54.02 46.87 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 124.452 1.101 . . . . 72.15 108.425 -175.002 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -75.1 -14.04 60.54 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 112.885 0.698 . . . . 75.42 112.885 -178.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.402 ' HB3' HG21 ' A' ' 128' ' ' THR . 2.9 t -61.37 -33.97 74.53 Favored 'General case' 0 C--O 1.236 0.379 0 O-C-N 121.431 -0.793 . . . . 74.4 110.809 173.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 47.5 mtp . . . . . 0 N--CA 1.447 -0.591 0 C-N-CA 123.602 0.761 . . . . 53.24 111.914 -171.164 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.135 0 CA-C-O 119.229 -0.415 . . . . 42.42 111.112 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 21.7 t -53.64 -68.15 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 C-N-CA 125.691 1.596 . . . . 65.14 109.658 169.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -70.65 -32.5 69.81 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 119.961 1.255 . . . . 71.24 112.978 -174.273 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -60.44 -33.27 72.3 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.119 0.968 . . . . 73.3 109.266 173.238 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.451 ' HA ' ' HB2' ' A' ' 101' ' ' GLU . . . -72.88 -52.75 13.49 Favored 'General case' 0 N--CA 1.446 -0.656 0 O-C-N 120.413 -1.429 . . . . 75.03 109.312 174.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 40.8 mt -61.9 -44.56 99.05 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-O 118.244 -0.884 . . . . 72.3 109.72 -171.414 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . 0.434 ' CD2' ' HB2' ' A' ' 41' ' ' TYR . 48.6 m-70 -81.54 -72.68 0.42 Allowed 'General case' 0 CA--C 1.52 -0.189 0 C-N-CA 124.694 1.198 . . . . 70.51 111.065 -179.414 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 8.9 mtmt -65.8 -28.2 68.83 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-N 118.319 0.509 . . . . 74.51 111.307 -168.223 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.451 ' HB2' ' HA ' ' A' ' 97' ' ' ALA . 0.0 OUTLIER -103.79 -31.13 9.97 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 122.792 0.437 . . . . 74.04 111.028 -170.526 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 4.0 t60 43.83 70.06 0.35 Allowed 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 127.509 2.323 . . . . 75.21 112.126 172.671 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 21.0 mtpt -96.44 19.09 12.66 Favored 'General case' 0 N--CA 1.467 0.38 0 O-C-N 121.716 -0.615 . . . . 71.12 111.805 -172.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 12.9 ttpt 46.5 57.77 5.16 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 127.75 2.42 . . . . 74.43 111.971 176.563 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.496 ' HA ' ' HB3' ' A' ' 110' ' ' GLU . 52.6 mt -73.98 43.28 0.16 Allowed 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 130.428 3.491 . . . . 74.13 112.193 -176.74 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -82.94 1.43 39.69 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 127.582 2.353 . . . . 55.12 113.464 -177.211 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 32.9 p -144.11 161.7 43.95 Favored Pre-proline 0 C--O 1.239 0.523 0 C-N-CA 123.726 0.81 . . . . 74.53 109.916 -172.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.43 -13.99 20.37 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 122.471 2.114 . . . . 65.21 113.445 -179.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -63.96 -60.98 2.58 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 107.888 -1.152 . . . . 74.35 107.888 163.596 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.496 ' HB3' ' HA ' ' A' ' 105' ' ' LEU . 0.1 OUTLIER -61.59 -46.23 90.72 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-O 119.066 -0.492 . . . . 53.23 111.492 -166.974 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 14.3 mtt -59.89 -42.45 93.81 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 118.427 0.558 . . . . 72.53 110.998 179.749 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -72.26 -47.49 49.85 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 109.455 -0.572 . . . . 73.33 109.455 -171.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -66.02 -24.11 66.69 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 118.888 0.767 . . . . 75.22 112.183 178.104 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . 0.525 ' CZ ' ' HE3' ' A' ' 118' ' ' LYS . 9.3 t80 -68.19 -60.4 2.5 Favored 'General case' 0 C--O 1.234 0.257 0 O-C-N 121.488 -0.758 . . . . 73.13 109.682 173.17 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 82.0 mt -65.56 -26.21 67.77 Favored 'General case' 0 N--CA 1.456 -0.127 0 C-N-CA 123.648 0.779 . . . . 45.43 110.424 -177.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -57.44 -39.47 76.34 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 119.189 0.904 . . . . 33.52 109.332 177.39 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -60.56 -8.52 9.82 Favored Glycine 0 CA--C 1.531 1.036 0 CA-C-O 116.981 -2.011 . . . . 22.51 114.176 172.291 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.525 ' HE3' ' CZ ' ' A' ' 114' ' ' PHE . 0.5 OUTLIER -131.85 21.65 4.58 Favored 'General case' 0 C--N 1.347 0.491 0 CA-C-N 121.324 2.562 . . . . 65.44 111.671 -175.469 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 82.22 60.3 2.16 Favored Glycine 0 C--N 1.333 0.396 0 N-CA-C 109.713 -1.355 . . . . 70.2 109.713 171.04 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 28.3 t -135.97 121.12 27.9 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 C-N-CA 125.361 1.464 . . . . 70.41 107.114 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 52.9 t0 -66.18 116.34 7.15 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 124.149 0.979 . . . . 63.11 110.364 -179.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 7.2 ttmt -61.57 -41.31 97.22 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 124.502 1.121 . . . . 54.44 109.442 177.578 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -63.39 -36.75 84.75 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 119.118 -0.468 . . . . 63.12 111.603 -175.078 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 15.7 mmtp -80.97 -37.58 29.07 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-O 118.493 -0.765 . . . . 63.23 109.181 176.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 82.7 t80 -54.3 -60.33 3.49 Favored 'General case' 0 N--CA 1.445 -0.68 0 O-C-N 123.805 0.691 . . . . 73.13 110.389 -177.459 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 20.1 mt -66.46 -40.78 89.6 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 123.271 0.629 . . . . 55.33 110.569 -175.462 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 34.2 t -56.18 -48.47 76.28 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 123.802 0.841 . . . . 70.45 109.629 -178.304 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . 0.44 HG23 HG22 ' A' ' 80' ' ' THR . 1.3 t -80.42 -30.98 37.7 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-O 119.196 -0.431 . . . . 64.33 110.192 -175.647 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 58.5 t80 -55.53 -50.75 69.19 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 119.161 0.891 . . . . 52.3 110.362 174.665 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -95.78 47.84 1.12 Allowed 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 124.065 0.946 . . . . 72.11 109.23 177.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 37.5 t -128.42 165.44 20.63 Favored 'General case' 0 C--O 1.238 0.474 0 O-C-N 120.998 -1.064 . . . . 65.14 109.642 173.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -58.99 -25.76 63.92 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 115.426 -0.806 . . . . 71.25 110.82 163.692 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -48.46 -54.66 13.37 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 124.45 1.1 . . . . 62.22 111.32 178.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.549 HD11 ' HA ' ' A' ' 80' ' ' THR . 11.8 mm -65.37 -42.95 94.81 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.392 0 N-CA-C 113.339 0.866 . . . . 74.31 113.339 170.751 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 14.2 tttt -54.02 -36.95 63.57 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 118.866 -0.588 . . . . 71.41 109.746 -175.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -82.89 -8.55 85.68 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 126.443 1.973 . . . . 41.04 113.273 -174.303 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -100.91 -52.99 3.16 Favored 'General case' 0 C--O 1.227 -0.102 0 N-CA-C 107.397 -1.335 . . . . 62.12 107.397 171.611 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . 0.438 ' HE3' ' HB2' ' A' ' 138' ' ' MET . 2.6 ptm -53.85 -37.6 63.8 Favored 'General case' 0 C--O 1.223 -0.313 0 C-N-CA 123.989 0.915 . . . . 65.03 111.682 -175.184 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -49.72 -44.98 48.64 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.124 0.97 . . . . 73.32 113.13 178.488 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -68.76 -61.65 1.72 Allowed 'General case' 0 CA--C 1.519 -0.228 0 C-N-CA 125.922 1.689 . . . . 61.13 107.188 -176.537 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -44.23 -42.97 6.92 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.713 1.605 . . . . 62.0 111.777 177.331 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -64.97 -58.64 5.59 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 124.925 1.29 . . . . 72.41 111.428 -177.138 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.49 -37.46 86.88 Favored 'General case' 0 C--N 1.342 0.272 0 CA-C-N 119.733 1.152 . . . . 70.31 110.626 -179.211 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 51.0 mt -56.83 -43.16 80.8 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 123.859 0.863 . . . . 75.02 110.236 178.477 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -58.35 -46.26 86.6 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 119.153 0.888 . . . . 72.44 110.611 -177.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -67.96 -34.87 77.38 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 123.527 0.731 . . . . 74.14 110.721 -178.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -59.22 -52.59 65.01 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 107.76 -1.2 . . . . 72.13 107.76 175.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 -69.87 16.56 0.06 Allowed 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 126.208 1.803 . . . . 74.34 115.698 -174.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 57.93 17.51 4.37 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 126.572 1.949 . . . . 73.53 114.162 175.031 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 30.1 t -69.64 132.99 32.61 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 N-CA-C 108.4 -0.963 . . . . 74.1 108.4 -176.553 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -130.13 -4.0 4.46 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 124.58 1.152 . . . . 71.31 113.07 -177.452 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -169.1 -174.82 37.95 Favored Glycine 0 CA--C 1.526 0.75 0 C-N-CA 126.283 1.896 . . . . 54.23 110.064 174.291 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.416 ' HA ' ' C ' ' A' ' 154' ' ' PRO . 4.8 m -143.21 159.47 55.51 Favored Pre-proline 0 CA--C 1.537 0.474 0 C-N-CA 125.99 1.716 . . . . 74.23 109.871 -172.04 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . 0.416 ' C ' ' HA ' ' A' ' 153' ' ' VAL . 27.8 Cg_endo -61.45 162.57 42.49 Favored 'Cis proline' 0 N--CA 1.455 -0.792 0 C-N-CA 124.647 -0.98 . . . . 64.4 111.206 -11.319 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 6.5 m -156.97 138.64 14.13 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 107.026 -1.472 . . . . 40.53 107.026 176.82 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 98.8 mtp -114.11 158.11 21.7 Favored 'General case' 0 N--CA 1.438 -1.064 0 N-CA-C 108.067 -1.086 . . . . 71.02 108.067 171.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 37.6 t -140.77 134.04 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 N-CA-C 106.148 -1.797 . . . . 63.2 106.148 177.59 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.405 HG23 ' CE1' ' A' ' 164' ' ' PHE . 13.1 t -102.24 119.44 50.55 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.9 0 N-CA-C 105.92 -1.881 . . . . 72.42 105.92 171.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 15.4 t30 56.01 24.28 7.59 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 128.512 2.725 . . . . 62.23 114.285 158.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 61.64 30.84 75.87 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 127.287 2.375 . . . . 54.25 113.823 -172.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 42.6 mttt -131.81 -34.79 1.29 Allowed 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 119.427 1.614 . . . . 74.23 113.344 -175.686 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -124.33 128.24 48.8 Favored 'General case' 0 CA--C 1.512 -0.512 0 N-CA-C 108.941 -0.763 . . . . 75.31 108.941 -179.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 26.5 ttp85 -107.72 136.62 47.16 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 105.141 -2.17 . . . . 64.34 105.141 174.123 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . 0.405 ' CE1' HG23 ' A' ' 158' ' ' VAL . 9.8 p90 -150.51 170.1 19.91 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 107.705 -1.22 . . . . 73.41 107.705 178.102 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . 0.422 ' H ' ' HB2' ' A' ' 168' ' ' SER . 9.7 p30 -167.65 177.47 5.84 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 108.81 -0.811 . . . . 74.45 108.81 -178.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 16.5 mt -58.94 -40.85 81.41 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 C-N-CA 124.942 1.297 . . . . 65.24 108.615 -174.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -74.62 -39.29 41.38 Favored Glycine 0 N--CA 1.447 -0.602 0 CA-C-O 118.851 -0.972 . . . . 64.22 111.626 -178.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . 0.422 ' HB2' ' H ' ' A' ' 165' ' ' ASP . 2.6 m -57.97 -59.45 5.25 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 124.462 1.105 . . . . 72.23 109.695 174.607 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -61.82 -51.11 69.6 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 109.718 -0.475 . . . . 72.3 109.718 -176.366 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 132.63 4.14 3.55 Favored Glycine 0 CA--C 1.528 0.896 0 CA-C-O 119.137 -0.813 . . . . 53.44 113.855 177.024 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 164.36 163.65 17.87 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 108.445 -1.862 . . . . 71.54 108.445 -174.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -66.06 -43.86 8.33 Favored 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 122.474 2.116 . . . . 71.33 110.079 -173.495 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -54.1 -38.61 65.55 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 125.199 1.399 . . . . 72.34 111.766 173.038 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -76.1 -26.25 56.25 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.432 1.093 . . . . 74.13 109.511 -173.142 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -56.64 -48.3 77.85 Favored 'General case' 0 CA--C 1.528 0.106 0 C-N-CA 123.997 0.919 . . . . 73.1 109.696 177.196 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 61.8 mt -62.05 -34.23 75.87 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 118.127 0.421 . . . . 62.03 110.777 179.052 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -54.6 -42.33 71.0 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 123.496 0.718 . . . . 72.54 110.289 175.877 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.414 ' HA ' HD13 ' A' ' 178' ' ' LEU . 4.4 mm? -73.25 -46.11 51.97 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-O 118.008 -0.996 . . . . 74.44 110.237 173.357 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.464 ' HB1' ' CH2' ' A' ' 50' ' ' TRP . . . -55.18 -34.94 64.28 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 118.843 0.747 . . . . 72.43 112.11 -174.047 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -94.24 -32.11 13.81 Favored 'General case' 0 C--N 1.333 -0.147 0 C-N-CA 124.859 1.264 . . . . 75.33 110.059 -167.401 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 35.5 t80 -64.69 -58.28 6.72 Favored 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 123.991 0.916 . . . . 73.32 110.497 167.521 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 56.1 mt -58.01 -35.77 71.71 Favored 'General case' 0 C--O 1.224 -0.268 0 C-N-CA 124.825 1.25 . . . . 73.14 112.294 -164.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 38.1 mt -45.09 -52.8 1.79 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 C-N-CA 124.279 1.031 . . . . 72.21 109.974 173.223 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -58.16 -34.53 70.4 Favored 'General case' 0 N--CA 1.447 -0.596 0 O-C-N 121.213 -0.929 . . . . 75.21 111.534 -177.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.3 -32.77 68.77 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 123.71 0.804 . . . . 54.45 110.934 -178.34 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -93.1 -43.87 8.66 Favored 'General case' 0 C--O 1.224 -0.256 0 CA-C-N 119.954 1.252 . . . . 64.44 112.298 168.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.54 -34.24 68.94 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 125.5 1.52 . . . . 61.53 110.308 -172.335 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.339 0.147 0 C-N-CA 124.776 1.23 . . . . 75.13 111.933 178.931 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 . . . . . 0 N--CA 1.466 0.368 0 CA-C-O 123.603 1.668 . . . . 74.23 110.313 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -81.69 11.14 5.05 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 113.735 -1.575 . . . . 71.42 114.565 -159.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 36.1 m-85 -134.65 175.56 9.44 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 126.696 1.998 . . . . 72.44 108.89 -172.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 31.9 m -137.13 136.95 38.72 Favored 'General case' 0 CA--C 1.535 0.387 0 O-C-N 119.972 -1.705 . . . . 65.23 110.679 172.251 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -68.6 153.13 44.36 Favored 'General case' 0 C--N 1.342 0.271 0 CA-C-O 121.709 0.766 . . . . 61.13 109.043 178.162 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 75.58 -31.7 1.21 Allowed Glycine 0 CA--C 1.53 0.988 0 C-N-CA 124.134 0.873 . . . . 50.31 111.309 -165.113 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 38.5 tttt -95.43 -84.26 0.34 Allowed 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 118.946 1.373 . . . . 74.42 110.264 -170.027 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -68.6 -25.17 64.73 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.794 1.637 . . . . 65.5 110.655 -178.523 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 31.9 p90 -162.09 170.27 19.48 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 107.35 -1.352 . . . . 74.44 107.35 -173.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 13.7 t -134.63 108.24 10.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 107.958 -1.127 . . . . 62.23 107.958 -178.426 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -63.56 152.57 38.32 Favored 'General case' 0 N--CA 1.44 -0.928 0 O-C-N 121.178 -0.951 . . . . 74.22 108.968 164.102 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -120.13 107.08 12.6 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 125.565 1.546 . . . . 75.31 109.535 179.734 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 70.3 m -67.02 21.06 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.864 1.666 . . . . 43.33 114.193 173.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 4.4 t -132.3 81.92 59.45 Favored Pre-proline 0 CA--C 1.53 0.195 0 N-CA-C 106.674 -1.602 . . . . 62.24 106.674 153.616 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -72.25 178.58 5.89 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 123.031 2.487 . . . . 72.23 111.139 -175.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 39.4 t -137.48 142.06 35.89 Favored Pre-proline 0 CA--C 1.539 0.538 0 N-CA-C 109.15 -0.685 . . . . 73.12 109.15 -170.468 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -79.36 178.55 7.29 Favored 'Trans proline' 0 CA--C 1.536 0.599 0 C-N-CA 123.739 2.959 . . . . 53.43 111.733 172.684 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 16.2 m -131.91 172.43 16.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 126.079 1.752 . . . . 74.53 109.735 179.084 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 13.1 t -53.86 -58.74 6.15 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.831 1.253 . . . . 74.24 110.625 173.584 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -144.78 164.97 24.67 Favored Pre-proline 0 CA--C 1.531 0.234 0 O-C-N 121.301 -0.874 . . . . 74.5 111.342 173.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -80.52 -172.88 1.64 Allowed 'Trans proline' 0 N--CA 1.452 -0.966 0 C-N-CA 123.219 2.613 . . . . 63.3 110.995 170.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 104.68 -86.67 0.52 Allowed Glycine 0 N--CA 1.451 -0.321 0 N-CA-C 106.832 -2.507 . . . . 71.14 106.832 179.168 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 67.0 mttt -68.06 149.16 50.01 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-O 121.511 0.672 . . . . 71.11 109.281 170.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 29.8 mm -80.01 141.56 15.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 107.663 -1.236 . . . . 54.32 107.663 168.51 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -87.96 132.43 34.24 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 106.493 -1.669 . . . . 64.02 106.493 173.147 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 46.4 t -131.2 136.22 58.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 N-CA-C 106.181 -1.785 . . . . 55.42 106.181 169.605 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 23.5 t -135.34 123.29 38.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 N-CA-C 108.005 -1.109 . . . . 61.51 108.005 -171.006 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -91.09 145.2 24.88 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 124.948 1.299 . . . . 73.54 108.847 166.101 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.41 HD22 HG11 ' A' ' 150' ' ' VAL . 5.5 mp -125.31 137.63 54.07 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.572 1.549 . . . . 64.2 107.744 168.002 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 30.9 p90 -141.78 172.67 12.37 Favored 'General case' 0 CA--C 1.549 0.918 0 N-CA-C 113.616 0.969 . . . . 71.13 113.616 -173.277 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 27.8 t90 -156.44 150.23 24.9 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.489 1.115 . . . . 65.44 111.806 -178.218 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -60.47 -9.17 3.32 Favored 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 114.843 1.423 . . . . 72.13 114.843 -179.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -123.84 19.0 7.48 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 125.447 1.499 . . . . 54.24 114.25 -169.337 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.413 ' HB3' HG23 ' A' ' 153' ' ' VAL . 22.4 p -104.26 86.7 1.4 Allowed Pre-proline 0 CA--C 1.536 0.431 0 CA-C-N 119.782 1.791 . . . . 44.01 110.744 -175.248 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -52.47 -35.83 67.57 Favored 'Trans proline' 0 CA--C 1.534 0.476 0 C-N-CA 122.769 2.313 . . . . 74.23 113.334 -177.242 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 11.5 m170 -64.74 -24.55 67.6 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 118.341 -0.838 . . . . 74.4 112.063 -178.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 83.6 m -59.39 -53.94 52.45 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.33 1.052 . . . . 62.1 109.144 175.198 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 59.9 t80 -56.78 -40.44 75.88 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 119.253 0.933 . . . . 72.24 111.041 -176.163 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -70.16 2.37 3.74 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 113.303 0.853 . . . . 75.43 113.303 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -125.71 -29.9 3.1 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 127.602 2.361 . . . . 72.21 111.261 179.163 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -37.5 -62.13 0.65 Allowed Pre-proline 0 CA--C 1.544 0.735 0 C-N-CA 126.401 1.88 . . . . 62.2 113.708 -174.667 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -79.52 -10.68 14.53 Favored 'Trans proline' 0 N--CA 1.454 -0.818 0 CA-C-N 121.191 1.461 . . . . 72.13 114.937 -175.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 51.1 m -70.87 -41.27 71.59 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 119.605 1.093 . . . . 74.32 109.335 164.715 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 17.3 tt -81.84 -42.64 19.32 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 CA-C-O 118.136 -0.935 . . . . 62.41 111.926 -169.705 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 79.5 t -44.84 -60.22 3.3 Favored Pre-proline 0 CA--C 1.544 0.716 0 CA-C-N 120.012 1.278 . . . . 74.25 112.803 177.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -73.79 -15.0 24.16 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 122.284 1.989 . . . . 72.41 112.112 -174.377 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 76.0 t90 -64.53 -61.59 2.12 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 119.73 1.15 . . . . 71.33 108.498 163.147 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -63.96 -34.53 78.2 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 113.008 0.744 . . . . 54.35 113.008 -171.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -59.13 -36.5 75.32 Favored 'General case' 0 C--O 1.237 0.441 0 O-C-N 121.389 -0.819 . . . . 51.3 110.908 175.16 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 29.9 mmmt -93.98 10.01 35.23 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.879 1.271 . . . . 61.04 111.863 -170.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 23.1 mt -61.6 157.54 46.72 Favored Pre-proline 0 CA--C 1.54 0.564 0 CA-C-N 119.5 1.045 . . . . 72.44 112.811 -178.082 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -77.98 178.05 8.06 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 124.991 3.794 . . . . 65.5 111.695 178.246 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -74.45 -0.2 16.69 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.032 1.333 . . . . 75.04 114.437 -174.302 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -126.22 18.75 7.65 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.782 1.233 . . . . 32.22 110.726 -172.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 42.5 t -124.82 139.18 51.76 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 N-CA-C 108.063 -1.088 . . . . 53.53 108.063 170.161 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 82.7 t60 -113.59 153.25 29.14 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 125.6 1.56 . . . . 70.33 106.908 166.33 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.472 ' CE2' ' HD2' ' A' ' 62' ' ' ARG . 24.2 t80 -136.57 141.5 43.33 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 108.63 -0.878 . . . . 70.14 108.63 -178.833 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 60.2 t -134.38 147.19 30.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 C-N-CA 126.622 1.969 . . . . 61.3 107.253 -170.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.472 ' HD2' ' CE2' ' A' ' 60' ' ' PHE . 0.0 OUTLIER -126.79 121.73 32.78 Favored 'General case' 0 CA--C 1.516 -0.358 0 N-CA-C 104.35 -2.463 . . . . 73.03 104.35 176.298 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 32.7 mt -127.09 151.97 75.08 Favored Pre-proline 0 N--CA 1.467 0.386 0 CA-C-N 118.961 0.8 . . . . 50.03 111.112 177.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -72.57 130.56 16.15 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 122.194 1.929 . . . . 62.52 109.828 178.003 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -75.48 100.8 4.62 Favored 'General case' 0 CA--C 1.536 0.409 0 O-C-N 121.42 -0.8 . . . . 45.42 109.006 176.389 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 42.8 mt -95.43 78.43 3.41 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.657 1.583 . . . . 52.32 111.548 -174.442 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -110.38 12.97 22.96 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 114.275 1.213 . . . . 73.14 114.275 -169.535 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 108.95 152.06 14.91 Favored Glycine 0 CA--C 1.518 0.275 0 C-N-CA 125.259 1.409 . . . . 52.11 110.626 173.721 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 52.82 -139.57 32.12 Favored Glycine 0 CA--C 1.521 0.439 0 C-N-CA 123.641 0.639 . . . . 13.24 111.952 -173.552 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 5.5 tp -58.62 -20.87 17.31 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 C-N-CA 124.963 1.305 . . . . 71.14 112.507 -168.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 23.6 m95 -57.3 -38.26 73.72 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.898 0.879 . . . . 73.21 110.92 173.449 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 14.0 m-80 -74.8 -43.46 54.63 Favored 'General case' 0 C--N 1.339 0.147 0 O-C-N 121.804 -0.56 . . . . 61.21 111.794 175.356 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 61.3 t -57.67 -54.57 29.71 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 C-N-CA 124.31 1.044 . . . . 73.11 108.588 -177.176 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 57.5 m170 -79.4 24.67 0.34 Allowed 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.662 1.585 . . . . 72.12 111.546 175.605 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -114.85 -33.53 1.68 Allowed Glycine 0 CA--C 1.524 0.637 0 C-N-CA 125.573 1.559 . . . . 64.23 111.69 170.722 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 31.6 mt-30 -63.29 -31.62 72.82 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 118.402 -0.808 . . . . 72.33 112.771 -179.111 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 16.7 ttp -60.42 -50.71 72.51 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-N 119.754 1.161 . . . . 73.24 111.535 -174.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 17.5 t80 -53.78 -50.9 65.07 Favored 'General case' 0 CA--C 1.53 0.178 0 O-C-N 123.72 0.638 . . . . 75.42 109.933 -179.63 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 76.0 mt -61.11 -36.73 80.49 Favored 'General case' 0 C--O 1.222 -0.378 0 CA-C-O 117.774 -1.108 . . . . 72.51 111.155 177.401 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.422 ' HA ' HD11 ' A' ' 134' ' ' ILE . 1.5 m -66.89 -35.26 79.61 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 120.622 1.556 . . . . 74.15 111.09 178.23 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.19 -56.83 16.74 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 107.544 -1.28 . . . . 73.42 107.544 178.085 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -66.29 -25.29 66.79 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.2 1.4 . . . . 60.4 112.744 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 16.1 t -73.07 -6.8 47.99 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.37 1.468 . . . . 71.12 113.442 -175.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 9.8 mtm . . . . . 0 N--CA 1.467 0.42 0 CA-C-N 119.998 1.272 . . . . 53.52 112.893 162.329 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 0.305 0 N-CA-C 113.011 0.745 . . . . 53.24 113.011 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 3.8 t -62.76 -67.06 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-N 119.275 0.943 . . . . 73.14 108.51 161.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -60.78 -48.68 80.69 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 107.744 -1.206 . . . . 73.43 107.744 -167.163 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.414 ' CD ' ' HE2' ' A' ' 100' ' ' LYS . 4.1 mm-40 -51.89 -33.66 37.72 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 128.006 2.522 . . . . 75.33 110.368 -176.024 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.447 ' HA ' ' HB2' ' A' ' 101' ' ' GLU . . . -79.56 -13.81 59.28 Favored 'General case' 0 N--CA 1.444 -0.746 0 O-C-N 120.621 -1.3 . . . . 73.34 113.215 -172.177 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 14.3 mt -114.01 -49.33 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 N-CA-C 106.008 -1.849 . . . . 60.42 106.008 -175.561 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 61.5 m-70 -76.08 -40.27 53.48 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 124.22 1.008 . . . . 74.25 112.564 -176.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.414 ' HE2' ' CD ' ' A' ' 96' ' ' GLU . 25.5 mtmt -93.59 -37.8 11.69 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 120.431 1.469 . . . . 75.01 111.69 172.179 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.447 ' HB2' ' HA ' ' A' ' 97' ' ' ALA . 27.5 mt-10 -122.55 32.47 5.75 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 113.214 0.82 . . . . 70.22 113.214 -160.264 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 41.2 t-80 -41.88 97.67 0.01 OUTLIER 'General case' 0 C--O 1.241 0.639 0 C-N-CA 129.472 3.109 . . . . 65.03 112.432 -172.67 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.09 27.61 1.58 Allowed 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 126.133 1.773 . . . . 71.05 112.036 175.841 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 2.7 tttp 65.4 -61.53 0.24 Allowed 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 128.72 2.808 . . . . 72.41 112.004 -175.184 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 87.7 mt 74.96 17.03 2.81 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 127.532 2.333 . . . . 75.1 113.696 174.475 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -85.14 33.71 0.55 Allowed 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.018 1.327 . . . . 74.11 112.703 -174.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -152.29 158.21 33.63 Favored Pre-proline 0 C--O 1.237 0.412 0 C-N-CA 124.425 1.09 . . . . 73.44 108.974 167.256 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -64.99 -41.47 17.1 Favored 'Trans proline' 0 N--CA 1.451 -0.975 0 C-N-CA 122.147 1.898 . . . . 63.52 111.331 177.463 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -58.76 -47.21 85.48 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 118.746 0.703 . . . . 64.25 110.03 176.175 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -62.7 -31.67 72.62 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 123.362 0.665 . . . . 72.34 111.473 -176.076 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 74.1 mtm -81.06 -35.76 31.36 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 118.475 -0.774 . . . . 75.21 112.5 173.22 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -77.66 -47.95 17.99 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 119.29 0.95 . . . . 55.44 111.449 -172.486 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -58.05 -31.83 67.42 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 125.477 1.511 . . . . 52.43 111.866 -172.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 38.4 t80 -75.08 -48.2 25.04 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 123.851 0.86 . . . . 72.25 112.22 174.653 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 88.4 mt -65.63 -25.07 67.21 Favored 'General case' 0 N--CA 1.455 -0.186 0 O-C-N 121.333 -0.854 . . . . 62.0 110.489 -176.018 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -53.4 -23.88 10.94 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.975 0.91 . . . . 72.54 112.579 171.446 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -84.09 -15.5 69.5 Favored Glycine 0 CA--C 1.53 0.971 0 C-N-CA 124.258 0.932 . . . . 72.21 114.272 174.483 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 45.5 mmtt -129.03 39.79 3.73 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 120.294 2.047 . . . . 74.44 110.691 -162.072 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 74.34 39.75 42.44 Favored Glycine 0 N--CA 1.448 -0.529 0 N-CA-C 110.989 -0.845 . . . . 75.23 110.989 170.076 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 89.2 t -128.56 143.88 39.7 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 N-CA-C 106.068 -1.827 . . . . 74.41 106.068 172.138 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 16.0 t0 -95.64 129.15 42.93 Favored 'General case' 0 C--N 1.331 -0.212 0 O-C-N 121.909 -0.495 . . . . 61.32 109.67 177.484 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -67.57 -46.96 71.18 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 123.268 0.627 . . . . 73.51 110.405 -177.265 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -57.31 -37.67 72.85 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 117.731 0.241 . . . . 72.32 110.993 -174.4 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 16.3 mmtp -97.17 -29.21 13.72 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-O 117.227 -1.368 . . . . 70.0 108.756 -169.097 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 89.6 t80 -51.71 -60.42 3.18 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 119.164 0.893 . . . . 72.1 109.391 165.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 7.1 mt -65.49 -42.81 91.76 Favored 'General case' 0 C--O 1.234 0.253 0 O-C-N 121.875 -0.516 . . . . 71.42 110.693 -170.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 2.5 m -58.04 -56.02 27.39 Favored 'General case' 0 C--O 1.223 -0.321 0 CA-C-O 118.321 -0.847 . . . . 74.35 109.007 176.052 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 28.8 m -59.68 -39.68 85.31 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.749 0.82 . . . . 62.12 111.215 -175.617 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -57.2 -46.81 82.54 Favored 'General case' 0 C--O 1.236 0.357 0 O-C-N 121.353 -0.842 . . . . 72.51 109.576 175.55 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -89.26 30.48 0.97 Allowed 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.309 1.044 . . . . 75.13 111.983 175.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 72.7 m -110.89 150.62 28.92 Favored 'General case' 0 C--O 1.236 0.363 0 O-C-N 120.699 -1.251 . . . . 73.01 109.926 171.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -59.91 -22.9 63.01 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.407 1.083 . . . . 73.33 111.616 175.098 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -44.87 -55.76 5.14 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 125.345 1.458 . . . . 71.52 111.955 172.59 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.422 HD11 ' HA ' ' A' ' 80' ' ' THR . 45.4 mm -66.73 -34.87 72.88 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.253 0 C-N-CA 123.104 0.562 . . . . 71.25 109.806 -178.551 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 25.8 tttm -57.35 -39.46 75.97 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 118.717 -0.658 . . . . 72.01 110.501 179.681 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -69.79 -27.67 72.94 Favored Glycine 0 CA--C 1.523 0.572 0 C-N-CA 124.075 0.845 . . . . 53.53 111.98 -176.379 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -80.31 -48.56 12.81 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 108.502 -0.925 . . . . 70.21 108.502 175.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 91.6 mmm -54.16 -45.84 72.16 Favored 'General case' 0 C--N 1.339 0.119 0 C-N-CA 125.305 1.442 . . . . 70.31 111.118 -178.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -63.86 -44.77 92.11 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 119.087 0.858 . . . . 65.44 111.687 -176.03 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 33.4 mttt -60.77 -61.47 2.56 Favored 'General case' 0 C--N 1.341 0.219 0 N-CA-C 108.922 -0.77 . . . . 71.15 108.922 171.641 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -47.41 -40.98 19.13 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.283 1.033 . . . . 45.23 111.564 -175.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -59.21 -64.92 0.77 Allowed 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 124.171 0.989 . . . . 63.51 108.823 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.85 -23.03 65.97 Favored 'General case' 0 N--CA 1.461 0.097 0 CA-C-O 118.278 -0.868 . . . . 74.12 112.723 -175.401 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 55.9 mt -59.73 -50.28 74.44 Favored 'General case' 0 C--O 1.227 -0.122 0 CA-C-N 118.972 0.805 . . . . 65.42 109.662 173.618 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -63.88 -32.86 74.52 Favored 'General case' 0 CA--C 1.537 0.476 0 O-C-N 121.908 -0.495 . . . . 62.23 111.307 -172.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' MET . . . . . 0.406 ' H ' ' HG2' ' A' ' 146' ' ' MET . 11.3 mmt -62.36 -45.44 93.17 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 125.502 1.521 . . . . 63.3 110.381 174.811 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -58.24 -47.2 84.27 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 109.017 -0.734 . . . . 75.23 109.017 -177.438 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 31.8 m-85 -68.85 5.31 1.15 Allowed 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 126.417 1.887 . . . . 72.54 114.674 -176.297 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 62.6 mt-30 54.04 28.88 9.34 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 126.234 1.814 . . . . 64.21 112.363 -179.272 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.412 HG13 HG21 ' A' ' 155' ' ' THR . 44.3 t -78.53 135.95 24.93 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 N-CA-C 107.424 -1.325 . . . . 74.11 107.424 176.142 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -142.66 14.96 1.96 Allowed 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 121.501 0.667 . . . . 72.23 111.397 -176.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -173.76 177.27 46.14 Favored Glycine 0 CA--C 1.52 0.398 0 C-N-CA 125.939 1.733 . . . . 63.43 110.144 174.503 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.416 ' HA ' ' C ' ' A' ' 154' ' ' PRO . 12.4 m -141.14 150.89 60.31 Favored Pre-proline 0 CA--C 1.539 0.523 0 C-N-CA 124.337 1.055 . . . . 73.2 109.793 179.365 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . 0.416 ' C ' ' HA ' ' A' ' 153' ' ' VAL . 38.8 Cg_endo -68.91 150.18 87.56 Favored 'Cis proline' 0 N--CA 1.459 -0.526 0 C-N-CA 125.067 -0.805 . . . . 61.11 112.072 -1.005 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . 0.412 HG21 HG13 ' A' ' 150' ' ' VAL . 51.6 m -148.33 117.32 6.77 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.738 1.615 . . . . 71.41 107.197 175.461 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 96.4 mtp -94.69 158.84 15.34 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 108.38 -0.97 . . . . 64.11 108.38 167.188 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 38.2 t -140.42 138.27 36.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 106.459 -1.682 . . . . 70.34 106.459 171.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.597 HG23 ' CE1' ' A' ' 164' ' ' PHE . 95.3 t -103.53 132.32 50.13 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 N-CA-C 107.606 -1.257 . . . . 63.22 107.606 168.132 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 4.9 t30 48.79 23.63 0.7 Allowed 'General case' 0 C--N 1.331 -0.231 1 C-N-CA 132.159 4.184 . . . . 64.11 115.963 167.041 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 70.12 24.4 76.58 Favored Glycine 0 CA--C 1.527 0.792 0 C-N-CA 126.209 1.862 . . . . 63.13 114.498 -175.182 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 48.7 mttp -137.02 -28.54 0.94 Allowed 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 120.202 2.001 . . . . 74.23 113.996 -171.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -125.04 105.83 9.48 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 108.466 -0.939 . . . . 54.44 108.466 -175.001 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 32.5 ttp85 -83.03 136.73 34.39 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 105.166 -2.161 . . . . 71.21 105.166 171.331 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . 0.597 ' CE1' HG23 ' A' ' 158' ' ' VAL . 15.3 p90 -152.32 170.03 21.05 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 107.845 -1.169 . . . . 62.4 107.845 174.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -179.52 178.98 0.63 Allowed 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 123.877 0.871 . . . . 73.14 109.177 179.764 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.416 HG23 ' HA2' ' A' ' 171' ' ' GLY . 29.5 mt -45.37 -52.78 2.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 C-N-CA 129.217 3.007 . . . . 72.32 109.71 174.429 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -75.41 -21.22 77.9 Favored Glycine 0 C--N 1.338 0.639 0 CA-C-O 119.435 -0.647 . . . . 54.41 113.443 -176.737 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 14.4 m -75.19 -68.23 0.58 Allowed 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 118.492 1.146 . . . . 63.2 108.084 169.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.514 ' HB1' HD23 ' A' ' 178' ' ' LEU . . . -75.0 -31.33 61.39 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-O 117.415 -1.279 . . . . 45.14 113.443 -162.223 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 134.78 5.39 2.5 Favored Glycine 0 CA--C 1.533 1.201 0 N-CA-C 117.171 1.628 . . . . 62.03 117.171 174.265 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . 0.416 ' HA2' HG23 ' A' ' 166' ' ' ILE . . . 126.42 167.95 12.51 Favored Glycine 0 CA--C 1.529 0.953 0 CA-C-N 119.446 1.623 . . . . 73.31 110.378 -173.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -61.44 -40.47 47.93 Favored 'Trans proline' 0 CA--C 1.534 0.502 0 C-N-CA 123.059 2.506 . . . . 51.31 113.736 -156.294 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -65.93 -33.2 75.29 Favored 'General case' 0 CA--C 1.532 0.283 0 O-C-N 121.206 -0.934 . . . . 70.43 111.379 177.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -72.44 -25.99 61.66 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 123.274 0.63 . . . . 73.03 110.515 176.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 6.6 m -63.84 -47.44 80.76 Favored 'General case' 0 C--O 1.233 0.195 0 O-C-N 120.867 -1.146 . . . . 75.05 108.443 -178.152 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 59.9 mt -62.79 -33.26 74.83 Favored 'General case' 0 C--O 1.224 -0.258 0 CA-C-O 119.484 -0.293 . . . . 74.3 110.788 175.633 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 14.0 tptt -54.23 -36.75 63.87 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-O 118.939 -0.553 . . . . 65.2 111.089 176.132 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.514 HD23 ' HB1' ' A' ' 169' ' ' ALA . 4.6 mm? -80.09 -44.85 19.28 Favored 'General case' 0 CA--C 1.509 -0.63 0 CA-C-O 117.665 -1.16 . . . . 75.41 110.077 175.262 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -50.43 -42.41 53.89 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 119.251 0.932 . . . . 73.44 111.169 -179.327 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -82.19 -33.3 29.49 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 124.693 1.197 . . . . 74.12 109.827 -165.415 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 19.2 t80 -69.79 -51.06 37.08 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.892 1.277 . . . . 73.23 110.496 170.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 62.5 mt -61.32 -27.96 68.87 Favored 'General case' 0 N--CA 1.462 0.133 0 C-N-CA 125.274 1.429 . . . . 74.45 112.871 -174.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 24.4 mt -56.61 -63.11 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 N-CA-C 108.178 -1.045 . . . . 65.32 108.178 171.539 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 7.8 tm-20 -60.36 -33.38 72.36 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.646 1.179 . . . . 72.24 111.324 -173.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 43.6 tptt -48.72 -57.99 5.46 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 124.344 1.058 . . . . 65.34 109.971 173.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 25.0 mm-40 -77.07 -34.55 57.01 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 123.504 0.721 . . . . 74.12 111.715 -178.419 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.75 -36.87 83.46 Favored 'General case' 0 N--CA 1.462 0.155 0 O-C-N 120.959 -1.088 . . . . 60.13 109.99 -174.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.369 0 C-N-CA 124.103 0.961 . . . . 71.0 112.065 177.883 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.235 0.302 0 CA-C-O 120.951 0.405 . . . . 75.51 110.723 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -142.85 8.02 1.67 Allowed 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 124.527 1.131 . . . . 72.32 111.752 -173.413 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 -145.97 157.77 43.88 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 125.016 1.327 . . . . 75.13 109.383 -170.451 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 51.1 m -134.06 141.26 47.12 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-O 121.692 0.758 . . . . 74.43 109.698 -179.115 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.43 144.28 57.29 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 124.12 0.968 . . . . 50.23 110.021 -178.779 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 79.1 -46.07 2.9 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 126.059 1.79 . . . . 71.13 111.099 -170.196 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 9.2 tptp -67.14 -70.42 0.25 Allowed 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 125.467 1.507 . . . . 72.53 109.748 -172.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.432 ' HB3' HD21 ' A' ' 178' ' ' LEU . 11.2 mp0 -88.24 -27.49 21.73 Favored 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 123.46 0.704 . . . . 71.43 110.735 -176.829 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 39.7 p90 -156.12 177.11 11.8 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 121.087 -1.008 . . . . 74.31 110.267 -171.462 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 17.7 t -134.1 112.73 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 N-CA-C 108.577 -0.897 . . . . 73.32 108.577 -175.266 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.32 163.66 26.09 Favored 'General case' 0 C--N 1.329 -0.314 0 O-C-N 120.652 -1.28 . . . . 75.11 109.01 164.459 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -132.01 113.52 13.49 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 123.959 0.904 . . . . 53.22 109.107 -176.241 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.9 m -61.16 -10.49 6.55 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 114.657 1.355 . . . . 45.53 114.657 -179.095 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 15.7 m -117.86 79.88 13.86 Favored Pre-proline 0 N--CA 1.448 -0.57 0 CA-C-N 119.834 1.197 . . . . 71.2 108.312 171.581 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_endo -69.06 174.79 8.4 Favored 'Trans proline' 0 N--CA 1.451 -1.012 0 C-N-CA 122.566 2.178 . . . . 72.53 111.336 175.175 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 50.5 t -143.22 134.76 12.84 Favored Pre-proline 0 C--N 1.33 -0.271 0 N-CA-C 106.203 -1.777 . . . . 51.03 106.203 -176.437 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -75.37 173.86 13.79 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 121.067 1.178 . . . . 63.3 110.56 176.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 16.3 m -116.2 165.19 11.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 C-N-CA 124.864 1.266 . . . . 63.51 108.87 175.006 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 3.4 m -48.75 -53.77 17.69 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 124.823 1.249 . . . . 71.43 112.418 174.742 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 2.2 pm0 -147.45 159.56 41.37 Favored Pre-proline 0 N--CA 1.449 -0.496 0 CA-C-N 120.413 1.46 . . . . 72.03 111.045 177.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -65.09 -177.07 0.54 Allowed 'Trans proline' 0 CA--C 1.544 1.021 0 C-N-CA 123.902 3.068 . . . . 74.33 111.135 166.218 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 119.97 -80.3 0.32 Allowed Glycine 0 CA--C 1.525 0.692 0 C-N-CA 125.211 1.386 . . . . 52.21 111.34 174.358 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -109.04 144.72 36.69 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 124.192 0.997 . . . . 71.32 109.232 179.122 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 47.2 mm -59.26 146.74 8.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 C-N-CA 124.481 1.112 . . . . 73.34 108.484 175.397 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -107.71 90.16 3.22 Favored 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 105.872 -1.899 . . . . 75.31 105.872 175.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 47.8 t -84.22 125.36 40.23 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.174 0 N-CA-C 105.505 -2.035 . . . . 72.53 105.505 170.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 41.9 t -119.35 113.39 41.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 N-CA-C 107.291 -1.374 . . . . 72.21 107.291 -175.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -72.01 131.6 43.13 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 107.83 -1.174 . . . . 54.44 107.83 156.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.1 mp -119.68 130.59 55.12 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 106.826 -1.546 . . . . 70.34 106.826 165.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 6.1 p90 -142.75 170.35 15.87 Favored 'General case' 0 C--O 1.237 0.416 0 O-C-N 123.9 0.75 . . . . 74.53 112.639 -170.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . 0.458 ' HB3' HG21 ' A' ' 153' ' ' VAL . 27.4 t90 -142.44 149.02 38.73 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 127.224 2.21 . . . . 62.31 108.344 -178.291 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 9.3 p90 -60.67 -20.11 60.1 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 115.905 1.817 . . . . 71.13 115.905 -172.178 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -100.69 -89.13 2.04 Favored Glycine 0 N--CA 1.449 -0.498 0 N-CA-C 106.931 -2.468 . . . . 54.45 106.931 -176.418 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 30.8 t 44.8 80.64 0.28 Allowed Pre-proline 0 CA--C 1.538 0.483 0 C-N-CA 126.172 1.789 . . . . 71.23 112.491 175.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -59.76 -21.36 63.12 Favored 'Trans proline' 0 CA--C 1.536 0.595 0 C-N-CA 121.993 1.795 . . . . 63.34 113.493 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 18.6 m170 -82.39 -39.37 22.79 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.757 1.223 . . . . 73.11 111.047 179.638 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 74.5 m -58.21 -43.25 87.58 Favored 'General case' 0 N--CA 1.462 0.143 0 C-N-CA 124.949 1.3 . . . . 63.12 111.271 -175.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 68.5 t80 -61.39 -27.84 68.82 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.819 0.848 . . . . 73.33 111.207 178.153 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -77.89 10.76 2.58 Favored 'General case' 0 CA--C 1.544 0.719 0 O-C-N 120.598 -1.314 . . . . 65.31 112.88 174.606 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 10.9 t80 -138.43 -23.63 0.98 Allowed 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 125.796 1.639 . . . . 74.54 111.994 174.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -35.12 -66.14 0.25 Allowed Pre-proline 0 CA--C 1.541 0.622 0 C-N-CA 127.074 2.15 . . . . 71.4 112.594 176.592 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -72.07 -11.36 27.13 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 CA-C-N 120.907 1.36 . . . . 72.54 114.476 -173.297 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 82.0 m -82.15 -35.65 28.22 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 119.469 1.031 . . . . 71.4 110.072 172.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 18.7 tt -90.46 -26.03 5.33 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 O-C-N 121.989 -0.445 . . . . 73.53 111.994 -173.274 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 14.5 t -52.15 -65.1 1.12 Allowed Pre-proline 0 CA--C 1.543 0.685 0 C-N-CA 124.668 1.187 . . . . 72.25 111.214 172.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -71.98 -13.71 29.04 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 CA-C-N 121.522 1.579 . . . . 62.21 112.613 -174.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 70.8 t90 -68.03 -58.46 4.46 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 119.115 0.871 . . . . 71.23 109.331 168.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 7.2 p -62.22 -34.64 76.87 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.306 0.643 . . . . 73.33 112.476 -169.671 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -59.5 -49.49 77.58 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 118.749 0.704 . . . . 73.45 110.655 177.349 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.14 18.4 1.39 Allowed 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 124.643 1.177 . . . . 74.52 113.17 -174.162 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 26.3 mt -63.39 153.34 82.71 Favored Pre-proline 0 N--CA 1.449 -0.506 0 CA-C-N 118.476 0.58 . . . . 73.34 110.803 175.011 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -80.11 166.2 20.95 Favored 'Trans proline' 0 N--CA 1.446 -1.283 0 C-N-CA 124.679 3.586 . . . . 71.31 111.025 -179.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -65.46 -7.9 16.46 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 114.793 1.405 . . . . 71.53 114.793 -175.2 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -104.65 8.18 35.14 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 125.454 1.502 . . . . 74.23 111.62 -177.572 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 67.1 t -120.67 152.24 23.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 106.418 -1.697 . . . . 61.42 106.418 177.674 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 16.9 t60 -134.25 124.88 26.64 Favored 'General case' 0 N--CA 1.439 -1.014 0 N-CA-C 108.036 -1.098 . . . . 74.21 108.036 166.408 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 29.4 t80 -84.68 140.15 31.52 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 107.004 -1.48 . . . . 60.15 107.004 173.233 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 88.7 t -133.34 150.36 32.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 C-N-CA 126.693 1.997 . . . . 64.23 106.128 178.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 18.3 mtt180 -131.23 120.81 23.77 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 106.127 -1.805 . . . . 74.23 106.127 179.166 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 40.3 mt -127.56 151.01 74.47 Favored Pre-proline 0 N--CA 1.473 0.691 0 CA-C-N 120.369 1.441 . . . . 71.21 110.618 173.225 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -71.89 131.24 17.97 Favored 'Trans proline' 0 N--CA 1.453 -0.901 0 C-N-CA 122.357 2.038 . . . . 72.14 110.064 176.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -77.38 81.75 3.85 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 123.758 0.823 . . . . 70.42 110.717 177.208 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 33.6 mt -77.25 95.36 4.31 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.002 0.921 . . . . 73.32 109.313 -177.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 37.4 m-85 -123.49 20.05 9.59 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.158 0.983 . . . . 71.42 112.343 -177.596 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 85.79 -174.55 48.15 Favored Glycine 0 C--N 1.336 0.553 0 N-CA-C 110.702 -0.959 . . . . 70.01 110.702 -178.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 44.88 71.37 0.48 Allowed Glycine 0 CA--C 1.526 0.731 0 C-N-CA 125.308 1.432 . . . . 55.14 113.914 166.297 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . 0.256 5.5 tp 58.23 -19.85 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.739 0 C-N-CA 130.288 3.435 . . . . 73.11 115.671 -176.58 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 10.6 m95 -56.85 -39.77 74.89 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 121.277 1.853 . . . . 62.43 110.302 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 25.1 p30 -73.88 -43.67 57.8 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 125.357 1.463 . . . . 54.13 113.395 -177.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 78.9 t -56.5 -49.26 78.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 N-CA-C 108.906 -0.776 . . . . 62.2 108.906 177.345 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 43.8 m170 -72.19 -2.6 19.37 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 114.473 1.286 . . . . 73.33 114.473 179.125 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -107.02 -21.6 8.02 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 124.921 1.248 . . . . 74.02 112.475 177.517 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 54.4 tt0 -64.26 -30.93 71.96 Favored 'General case' 0 CA--C 1.539 0.527 0 O-C-N 121.716 -0.873 . . . . 75.12 111.682 -175.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -67.52 -37.52 82.89 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 126.004 1.721 . . . . 72.24 112.613 -174.495 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 26.6 t80 -64.11 -48.47 76.0 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-N 119.647 1.112 . . . . 72.43 109.018 -171.688 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 54.8 mt -56.87 -36.41 70.05 Favored 'General case' 0 C--O 1.223 -0.341 0 C-N-CA 124.228 1.011 . . . . 71.35 110.101 173.483 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.15 -44.25 76.46 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 119.764 1.165 . . . . 64.12 111.382 178.103 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -53.22 -58.62 6.42 Favored 'General case' 0 CA--C 1.529 0.14 0 N-CA-C 107.561 -1.274 . . . . 62.53 107.561 -178.749 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -67.62 -23.15 65.33 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 111.968 0.358 . . . . 72.4 111.968 -176.544 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 17.4 t -62.16 -25.53 67.82 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-O 118.485 -0.769 . . . . 54.11 112.783 178.033 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 3.2 ptp . . . . . 0 N--CA 1.467 0.415 0 CA-C-N 119.762 1.165 . . . . 61.23 113.372 172.666 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 0.261 0 N-CA-C 113.202 0.816 . . . . 74.43 113.202 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 82.4 t -59.11 -61.37 1.46 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 N-CA-C 107.627 -1.249 . . . . 65.33 107.627 169.369 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -61.22 -47.56 85.55 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.106 0.962 . . . . 61.03 111.05 -176.586 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -72.13 2.41 5.89 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.659 1.984 . . . . 72.41 112.124 -173.331 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -117.23 3.32 12.63 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 124.96 1.304 . . . . 63.32 112.282 171.08 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.475 HG12 HD12 ' A' ' 105' ' ' LEU . 83.8 mt -124.15 -60.94 1.81 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.373 0 N-CA-C 106.096 -1.816 . . . . 63.14 106.096 -175.595 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 83.3 m-70 -59.79 -64.87 0.79 Allowed 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 125.0 1.32 . . . . 74.23 111.237 -179.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 4.6 ptmt -82.41 -7.03 59.64 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 114.693 1.368 . . . . 75.34 114.693 -175.167 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -114.91 -37.5 4.16 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 113.665 0.987 . . . . 74.13 113.665 -173.085 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 12.1 t-160 45.63 53.06 8.92 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 127.695 2.398 . . . . 74.43 113.162 -178.355 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . 0.289 0.0 OUTLIER -70.71 12.97 0.21 Allowed 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 115.308 1.595 . . . . 71.32 115.308 172.966 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 26.2 ttmt 45.43 61.48 2.57 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 128.676 2.79 . . . . 61.21 110.863 171.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.475 HD12 HG12 ' A' ' 98' ' ' ILE . 63.1 mt -76.44 60.75 1.63 Allowed 'General case' 0 C--N 1.315 -0.93 0 C-N-CA 128.895 2.878 . . . . 54.35 107.181 177.643 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -103.03 -12.16 17.63 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 127.928 2.491 . . . . 75.14 111.11 -176.028 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -114.27 154.09 46.36 Favored Pre-proline 0 C--O 1.236 0.393 0 C-N-CA 124.967 1.307 . . . . 60.53 108.163 177.091 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -67.72 -36.35 19.18 Favored 'Trans proline' 0 N--CA 1.45 -1.067 0 C-N-CA 121.226 1.284 . . . . 73.51 110.73 -177.159 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -55.63 -55.18 35.09 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 123.559 0.743 . . . . 75.43 110.161 174.077 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -57.54 -50.86 71.71 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 125.053 1.341 . . . . 73.24 109.801 -175.597 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 51.2 mtt -55.82 -53.71 53.39 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 123.958 0.903 . . . . 72.44 111.355 178.51 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.609 ' HB1' ' HG2' ' A' ' 122' ' ' LYS . . . -71.75 -36.95 70.57 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 124.288 1.035 . . . . 71.23 110.597 -168.573 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -62.4 -42.59 99.55 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 118.699 0.682 . . . . 74.13 111.723 174.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 8.9 t80 -61.28 -51.48 68.75 Favored 'General case' 0 N--CA 1.455 -0.192 0 O-C-N 121.4 -0.813 . . . . 75.13 110.534 177.577 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 58.3 mt -70.55 -22.88 62.55 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 110.075 -0.342 . . . . 75.4 110.075 -175.647 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -58.21 -36.02 72.51 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 118.85 0.75 . . . . 63.53 109.431 171.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -71.81 -4.74 59.29 Favored Glycine 0 N--CA 1.442 -0.918 0 CA-C-O 116.459 -2.3 . . . . 34.34 115.034 170.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.505 ' HA ' ' HE2' ' A' ' 118' ' ' LYS . 5.7 mmpt? -116.74 -9.13 11.32 Favored 'General case' 0 C--N 1.348 0.537 0 CA-C-N 122.553 3.176 . . . . 71.24 114.245 -171.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 97.0 59.02 1.01 Allowed Glycine 0 N--CA 1.452 -0.234 0 N-CA-C 108.486 -1.845 . . . . 53.44 108.486 -168.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 53.7 t -142.31 153.05 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 C-N-CA 129.372 3.069 . . . . 63.51 104.089 167.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 41.6 t0 -111.67 128.91 56.21 Favored 'General case' 0 C--N 1.331 -0.221 0 O-C-N 121.116 -0.99 . . . . 64.14 108.746 -177.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.609 ' HG2' ' HB1' ' A' ' 112' ' ' ALA . 14.2 mtpt -60.75 -31.35 70.69 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 119.277 0.944 . . . . 74.23 110.374 172.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -59.81 -20.93 59.86 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 119.844 1.202 . . . . 65.25 112.214 173.66 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 65.0 mmtt -113.3 -33.11 6.06 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-N 119.8 1.182 . . . . 72.32 112.057 -175.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -62.64 -56.41 18.01 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 118.814 0.734 . . . . 72.33 109.926 -178.268 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 9.9 mt -72.76 -46.5 53.05 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.861 0.839 . . . . 74.05 111.173 -163.182 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 21.0 p -53.61 -41.79 67.03 Favored 'General case' 0 N--CA 1.444 -0.736 0 C-N-CA 125.511 1.525 . . . . 73.45 108.822 177.412 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 40.9 m -76.48 -41.39 47.36 Favored 'General case' 0 C--O 1.222 -0.356 0 N-CA-C 108.322 -0.992 . . . . 61.41 108.322 -176.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 61.6 t80 -56.57 -32.27 65.02 Favored 'General case' 0 C--O 1.235 0.337 0 O-C-N 120.709 -1.245 . . . . 72.52 110.878 178.153 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -105.17 26.4 9.38 Favored 'General case' 0 C--O 1.243 0.714 0 N-CA-C 113.432 0.901 . . . . 73.13 113.432 175.485 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 11.1 p -99.68 157.02 16.77 Favored 'General case' 0 C--O 1.234 0.275 0 O-C-N 120.919 -1.113 . . . . 74.05 111.317 175.726 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -67.19 -27.59 67.39 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 115.538 -0.755 . . . . 74.44 111.921 -175.637 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -55.09 -47.0 75.52 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 121.524 0.678 . . . . 72.24 110.324 175.734 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 32.8 mm -64.08 -37.72 80.57 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 C-N-CA 123.787 0.835 . . . . 72.5 109.149 179.4 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 10.5 mttt -58.31 -35.23 71.54 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 119.64 1.109 . . . . 75.31 110.591 172.393 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -73.51 -40.21 47.98 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 109.816 -1.314 . . . . 50.35 109.816 -173.769 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 2.3 mm100 -68.98 -43.1 75.61 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 123.391 0.676 . . . . 72.13 109.824 178.361 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 45.4 mtp -60.54 -42.76 97.19 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-O 117.495 -1.241 . . . . 64.25 111.478 177.15 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -62.8 -39.99 95.98 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 120.638 1.563 . . . . 74.45 110.839 -178.432 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 9.3 mmtt -59.62 -65.48 0.67 Allowed 'General case' 0 N--CA 1.463 0.176 0 C-N-CA 123.803 0.841 . . . . 73.23 110.316 170.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -57.92 -34.84 70.28 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 119.472 1.033 . . . . 73.2 111.257 -171.195 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 14.2 tmtt? -61.62 -61.55 2.44 Favored 'General case' 0 CA--C 1.518 -0.25 0 C-N-CA 124.895 1.278 . . . . 65.14 110.172 176.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.08 -25.98 68.35 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 119.74 1.154 . . . . 71.21 110.903 -178.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 25.4 mt -69.62 -54.24 14.92 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 118.429 -0.796 . . . . 75.21 111.712 -176.378 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -58.75 -49.32 78.08 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 118.873 0.76 . . . . 75.23 111.196 -169.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -61.03 -40.39 93.4 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 123.527 0.731 . . . . 73.12 112.515 175.742 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -67.3 -36.42 81.46 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 118.278 -0.868 . . . . 42.33 110.019 -179.526 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -67.78 14.14 0.06 Allowed 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.824 1.65 . . . . 64.21 113.359 175.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 54.29 21.52 3.19 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 127.12 2.168 . . . . 73.13 113.839 -179.023 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.449 HG13 HG21 ' A' ' 155' ' ' THR . 44.4 t -71.47 142.04 15.97 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 N-CA-C 108.576 -0.898 . . . . 62.03 108.576 179.4 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -112.64 -14.09 13.2 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 124.662 1.185 . . . . 60.14 112.717 -176.112 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 167.49 -160.16 33.71 Favored Glycine 0 N--CA 1.446 -0.699 0 N-CA-C 108.119 -1.992 . . . . 42.32 108.119 -165.398 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.458 HG21 ' HB3' ' A' ' 34' ' ' TRP . 31.0 m -138.69 157.31 72.18 Favored Pre-proline 0 CA--C 1.536 0.425 0 C-N-CA 124.345 1.058 . . . . 65.21 109.741 -178.185 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_endo -66.59 156.9 81.91 Favored 'Cis proline' 0 N--CA 1.459 -0.552 0 C-N-CA 124.738 -0.943 . . . . 74.43 111.621 -7.063 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . 0.449 HG21 HG13 ' A' ' 150' ' ' VAL . 5.6 m -156.86 138.37 13.99 Favored 'General case' 0 N--CA 1.466 0.339 0 O-C-N 121.102 -0.999 . . . . 74.01 109.239 171.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 92.1 mtp -112.32 148.64 33.79 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 125.148 1.379 . . . . 54.41 109.164 171.605 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 26.7 t -137.09 151.8 27.48 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 C-N-CA 124.623 1.169 . . . . 63.12 108.027 176.667 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 39.9 t -130.2 123.5 56.04 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 C-N-CA 126.053 1.741 . . . . 73.31 106.819 -178.351 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 16.6 m-20 50.01 21.15 0.68 Allowed 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 127.805 2.442 . . . . 65.25 114.973 173.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 51.74 45.17 55.17 Favored Glycine 0 CA--C 1.531 1.07 0 CA-C-O 117.697 -1.613 . . . . 60.15 112.924 -165.419 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 12.1 mtpp -139.44 -33.98 0.59 Allowed 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 119.595 1.697 . . . . 63.12 113.056 178.348 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -121.81 148.25 44.92 Favored 'General case' 0 CA--C 1.506 -0.729 0 N-CA-C 108.154 -1.054 . . . . 74.1 108.154 176.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 48.8 ttp85 -136.4 139.39 42.42 Favored 'General case' 0 N--CA 1.442 -0.857 0 N-CA-C 106.268 -1.753 . . . . 73.23 106.268 179.426 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 22.9 p90 -154.94 174.59 14.92 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 108.255 -1.017 . . . . 74.03 108.255 -179.364 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -177.41 173.73 1.67 Allowed 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 107.736 -1.209 . . . . 64.33 107.736 -176.59 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.42 HG13 ' H ' ' A' ' 166' ' ' ILE . 17.8 mt -45.4 -50.13 3.25 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 C-N-CA 127.964 2.506 . . . . 55.32 108.408 162.462 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -73.86 9.5 8.72 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 126.433 1.968 . . . . 30.33 114.699 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 22.6 m -120.51 -54.15 2.08 Favored 'General case' 0 N--CA 1.458 -0.047 0 CA-C-N 119.198 1.499 . . . . 71.24 109.764 163.387 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -61.25 -53.1 61.14 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.511 1.125 . . . . 62.41 110.78 -172.571 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 146.02 -17.42 1.75 Allowed Glycine 0 CA--C 1.523 0.553 0 CA-C-O 119.614 -0.548 . . . . 73.34 113.764 178.417 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 169.47 176.37 39.3 Favored Glycine 0 CA--C 1.528 0.872 0 N-CA-C 108.885 -1.686 . . . . 42.14 108.885 -169.332 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -63.9 -52.48 1.71 Allowed 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 123.072 2.515 . . . . 73.23 111.611 -175.177 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -59.8 -39.74 86.0 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 119.295 0.952 . . . . 74.24 109.732 178.053 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -60.77 -32.65 71.96 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.523 0.729 . . . . 74.42 110.494 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 26.6 m -65.63 -43.68 88.77 Favored 'General case' 0 N--CA 1.453 -0.282 0 O-C-N 120.716 -1.24 . . . . 45.33 109.617 179.083 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 48.0 mt -66.46 -28.24 68.44 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 118.891 0.768 . . . . 72.33 111.354 176.139 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 10.1 tptt -51.29 -49.23 61.67 Favored 'General case' 0 C--O 1.232 0.182 0 N-CA-C 109.005 -0.739 . . . . 73.01 109.005 169.48 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.467 HD13 ' HA ' ' A' ' 178' ' ' LEU . 4.4 mm? -74.46 -38.79 62.85 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-O 119.012 -0.518 . . . . 61.23 111.54 -178.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.08 -43.94 87.29 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 118.005 0.366 . . . . 34.22 111.099 -176.625 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -74.04 -28.52 61.46 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 123.244 0.618 . . . . 64.02 110.58 -174.471 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 9.9 t80 -74.08 -57.0 4.26 Favored 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 125.053 1.341 . . . . 74.44 110.425 178.454 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 77.8 mt -61.95 -24.7 67.16 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 124.997 1.319 . . . . 74.32 112.955 -171.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 35.6 mt -53.3 -54.94 15.06 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 C-N-CA 123.348 0.659 . . . . 72.21 109.36 170.014 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -66.07 -38.23 87.8 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 118.342 0.519 . . . . 65.21 111.229 -177.073 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . 0.45 ' HA ' ' HE3' ' A' ' 185' ' ' LYS . 0.1 OUTLIER -52.4 -46.44 66.29 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 124.325 1.05 . . . . 75.01 110.182 -176.723 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -74.64 -51.83 13.37 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 123.087 0.555 . . . . 65.25 112.082 173.237 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 3.2 tpm_? -48.07 -45.31 32.36 Favored 'General case' 0 CA--C 1.516 -0.357 0 C-N-CA 124.82 1.248 . . . . 71.42 112.086 -175.422 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.353 0 C-N-CA 125.696 1.598 . . . . 72.55 111.746 -174.566 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 . . . . . 0 CA--C 1.502 -0.888 0 CA-C-O 120.931 0.396 . . . . 60.52 111.011 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 76.38 10.46 2.95 Favored 'General case' 0 N--CA 1.442 -0.852 0 C-N-CA 130.078 3.351 . . . . 64.22 115.556 -172.133 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 29.7 m-85 -139.83 178.1 7.48 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 126.648 1.979 . . . . 73.23 108.305 179.383 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 95.0 m -144.3 143.88 31.2 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 108.287 -1.005 . . . . 75.23 108.287 166.238 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.64 152.27 45.69 Favored 'General case' 0 C--O 1.227 -0.123 0 O-C-N 121.393 -0.817 . . . . 74.02 108.838 172.386 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 70.33 -44.37 0.58 Allowed Glycine 0 CA--C 1.534 1.224 0 C-N-CA 125.504 1.525 . . . . 30.2 112.287 -162.36 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.5 tptm -70.21 -58.57 3.63 Favored 'General case' 0 CA--C 1.519 -0.222 0 C-N-CA 126.295 1.838 . . . . 72.41 111.165 -169.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -113.78 -23.42 9.68 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 126.04 1.736 . . . . 73.53 109.965 -172.056 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 42.4 p90 -157.22 173.38 17.05 Favored 'General case' 0 N--CA 1.47 0.525 0 O-C-N 120.96 -1.088 . . . . 74.13 109.586 -176.147 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 24.9 t -135.52 117.89 21.77 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 C-N-CA 123.437 0.695 . . . . 74.53 109.193 -174.576 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.9 162.54 28.04 Favored 'General case' 0 CA--C 1.537 0.446 0 O-C-N 121.189 -0.945 . . . . 44.52 109.055 167.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -136.18 108.28 7.21 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 126.679 1.992 . . . . 71.41 108.294 -167.52 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.8 p -63.27 -0.46 0.82 Allowed 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 115.493 1.664 . . . . 74.44 115.493 -176.229 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 49.0 m -131.0 76.41 76.98 Favored Pre-proline 0 N--CA 1.451 -0.389 0 CA-C-N 119.841 1.201 . . . . 72.11 109.428 174.036 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -65.97 176.64 3.58 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 123.894 3.063 . . . . 63.13 112.688 -176.487 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 40.2 t -133.81 136.03 25.81 Favored Pre-proline 0 CA--C 1.537 0.443 0 C-N-CA 125.539 1.536 . . . . 73.53 108.336 -169.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -76.24 178.45 7.48 Favored 'Trans proline' 0 CA--C 1.534 0.509 0 C-N-CA 123.491 2.794 . . . . 60.04 111.443 176.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 27.9 m -132.85 174.1 13.81 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 C-N-CA 125.336 1.454 . . . . 54.05 109.674 170.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 73.9 m -58.45 -51.36 70.15 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 126.33 1.852 . . . . 64.22 112.335 175.002 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 41.7 tt0 -143.16 145.29 32.06 Favored Pre-proline 0 CA--C 1.534 0.361 0 C-N-CA 124.278 1.031 . . . . 73.55 108.733 -177.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -74.54 90.91 1.0 Allowed 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 123.158 2.572 . . . . 70.21 109.202 165.2 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -137.12 -94.9 0.38 Allowed Glycine 0 C--N 1.336 0.542 0 O-C-N 121.497 -0.752 . . . . 73.12 111.304 -172.387 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 12.7 mptt -80.02 159.95 26.03 Favored 'General case' 0 C--O 1.227 -0.13 0 N-CA-C 107.693 -1.225 . . . . 73.01 107.693 170.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 49.2 mm -70.46 130.46 34.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 106.135 -1.802 . . . . 65.14 106.135 167.227 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -83.8 130.48 34.94 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 106.203 -1.777 . . . . 64.3 106.203 173.422 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 13.9 t -119.42 144.17 28.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 105.813 -1.921 . . . . 63.11 105.813 166.049 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 37.8 t -133.98 101.65 3.94 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.137 0 N-CA-C 106.512 -1.662 . . . . 73.34 106.512 -174.225 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -76.17 137.33 39.99 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 106.143 -1.799 . . . . 73.34 106.143 161.115 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.4 mp -120.93 134.19 55.29 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 105.494 -2.039 . . . . 62.24 105.494 163.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 42.6 p90 -134.76 172.77 12.5 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 123.552 0.741 . . . . 73.32 110.962 -177.379 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . 0.611 ' CB ' HG21 ' A' ' 153' ' ' VAL . 22.9 t90 -148.55 167.68 24.77 Favored 'General case' 0 N--CA 1.463 0.209 0 C-N-CA 125.225 1.41 . . . . 72.04 108.644 178.405 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 17.6 t80 -67.34 -43.98 80.19 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.865 0.866 . . . . 65.3 112.026 172.253 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -95.71 22.79 37.26 Favored Glycine 0 CA--C 1.527 0.79 0 CA-C-O 119.026 -0.875 . . . . 44.13 113.954 -163.479 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.521 ' HB3' HG23 ' A' ' 153' ' ' VAL . 22.0 p -105.08 86.11 1.46 Allowed Pre-proline 0 CA--C 1.532 0.274 0 CA-C-N 118.843 1.321 . . . . 63.15 109.372 -177.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_endo -56.96 -24.97 60.07 Favored 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 122.325 2.016 . . . . 71.24 113.133 -177.093 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 15.6 m170 -68.11 -26.03 65.6 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 119.028 0.831 . . . . 73.31 111.037 178.243 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 84.6 m -65.29 -32.81 74.66 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.814 0.846 . . . . 61.23 109.48 -174.168 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -63.78 -46.35 85.6 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 125.657 1.583 . . . . 75.52 110.687 -178.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -53.58 -33.82 56.18 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 122.6 0.36 . . . . 71.11 110.467 178.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.452 ' HB2' HD11 ' A' ' 166' ' ' ILE . 2.4 t80 -87.78 -37.45 16.59 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-O 116.171 -1.871 . . . . 70.15 113.002 -175.233 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -39.23 -63.78 0.59 Allowed Pre-proline 0 N--CA 1.477 0.885 0 CA-C-N 120.724 1.602 . . . . 75.33 113.712 -168.378 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -71.95 -8.97 23.95 Favored 'Trans proline' 0 CA--C 1.535 0.525 0 CA-C-N 121.885 1.709 . . . . 70.34 114.726 -177.338 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.9 m -76.01 -44.11 41.01 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 108.311 -0.996 . . . . 75.42 108.311 167.128 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 14.5 tt -85.89 -35.93 9.99 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 CA-C-O 118.541 -0.742 . . . . 75.41 112.01 -169.402 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 68.9 t -49.79 -59.97 5.89 Favored Pre-proline 0 CA--C 1.541 0.621 0 CA-C-N 120.358 1.435 . . . . 63.34 111.479 176.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -70.12 -20.6 32.91 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 121.332 1.355 . . . . 65.4 112.16 -174.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 81.9 t90 -61.01 -54.28 46.83 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 117.559 -1.21 . . . . 73.13 111.204 175.392 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.2 t -57.99 -40.7 81.37 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 120.646 1.566 . . . . 62.15 111.132 -179.118 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -62.8 -31.56 72.58 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 121.36 0.6 . . . . 74.33 110.5 -178.75 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -104.96 39.68 1.66 Allowed 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 126.175 1.79 . . . . 65.22 112.653 178.135 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 19.2 mt -89.51 160.26 42.34 Favored Pre-proline 0 C--O 1.238 0.454 0 C-N-CA 126.855 2.062 . . . . 62.4 109.995 165.389 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -78.99 175.85 10.49 Favored 'Trans proline' 0 N--CA 1.451 -0.989 0 C-N-CA 124.772 3.648 . . . . 34.43 112.015 175.312 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -72.35 -4.82 32.16 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 114.537 1.31 . . . . 72.03 114.537 -173.646 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -111.32 5.49 19.83 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 126.681 1.992 . . . . 75.33 111.907 -173.423 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 34.8 t -119.98 156.56 22.69 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 C-N-CA 124.658 1.183 . . . . 71.34 108.377 177.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 83.0 t60 -147.79 116.48 6.7 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.251 1.82 . . . . 74.22 108.694 -178.081 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -93.54 131.4 38.81 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 124.908 1.283 . . . . 73.43 109.801 -177.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 43.8 t -119.98 146.61 24.52 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 C-N-CA 124.703 1.201 . . . . 71.32 108.049 178.627 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 17.4 mtm180 -123.75 132.47 53.81 Favored 'General case' 0 CA--C 1.504 -0.794 0 N-CA-C 107.565 -1.272 . . . . 71.11 107.565 168.658 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 26.7 mt -141.76 153.64 64.9 Favored Pre-proline 0 C--N 1.321 -0.649 0 C-N-CA 124.388 1.075 . . . . 60.21 108.61 -179.513 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -73.39 154.64 50.91 Favored 'Trans proline' 0 N--CA 1.446 -1.278 0 C-N-CA 121.328 1.352 . . . . 71.43 111.772 178.365 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -97.96 72.89 2.23 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 125.521 1.528 . . . . 61.52 107.847 179.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 84.3 mt -74.31 78.73 1.84 Allowed 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.374 1.069 . . . . 75.25 111.238 -170.497 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -112.95 54.33 0.73 Allowed 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 125.242 1.417 . . . . 74.42 110.886 -176.409 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 60.17 173.5 0.83 Allowed Glycine 0 CA--C 1.529 0.928 0 C-N-CA 126.914 2.197 . . . . 61.23 114.615 178.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 53.0 -147.8 14.88 Favored Glycine 0 CA--C 1.53 1.015 0 O-C-N 121.282 -1.128 . . . . 75.22 111.193 -179.444 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -64.53 -10.95 9.71 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 O-C-N 122.01 -0.7 . . . . 74.22 112.886 179.518 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . 0.455 ' CH2' HG22 ' A' ' 153' ' ' VAL . 34.6 m95 -70.55 -28.53 64.99 Favored 'General case' 0 C--N 1.341 0.201 0 CA-C-N 119.9 1.227 . . . . 74.51 110.775 171.524 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -72.02 -45.46 60.8 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 119.103 -1.039 . . . . 72.45 109.449 166.373 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.43 ' HA ' ' NE2' ' A' ' 76' ' ' GLN . 75.6 t -64.17 -55.65 20.77 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 N-CA-C 111.917 0.339 . . . . 64.24 111.917 -167.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 28.3 m170 -70.72 6.98 1.24 Allowed 'General case' 0 CA--C 1.535 0.386 0 O-C-N 121.529 -0.732 . . . . 74.22 112.468 179.573 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -102.69 -33.71 4.33 Favored Glycine 0 N--CA 1.439 -1.128 0 CA-C-O 118.63 -1.094 . . . . 55.0 111.36 173.36 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.43 ' NE2' ' HA ' ' A' ' 73' ' ' VAL 0.417 0.0 OUTLIER -71.25 -36.56 71.83 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 118.951 1.376 . . . . 73.45 112.146 -166.029 . . . . . . . . 4 4 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -53.82 -45.32 70.81 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-O 116.192 -1.861 . . . . 73.14 113.253 175.819 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 50.1 t80 -45.96 -52.2 12.06 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 125.736 1.614 . . . . 74.05 109.668 -177.126 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 18.1 mt -60.34 -44.06 95.88 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 126.605 1.962 . . . . 70.44 110.555 -177.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -64.51 -40.38 95.53 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 119.283 0.947 . . . . 64.21 110.872 -178.648 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.38 -51.22 70.84 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 107.903 -1.147 . . . . 64.33 107.903 -176.011 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -69.34 -27.24 65.18 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.067 0.947 . . . . 73.4 111.495 178.221 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 4.0 t -63.07 -16.68 60.71 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.368 1.067 . . . . 61.22 113.181 176.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 13.6 mtp . . . . . 0 C--O 1.233 0.225 0 C-N-CA 124.013 0.925 . . . . 74.12 112.531 173.906 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.227 -0.129 0 CA-C-O 119.209 -0.424 . . . . 62.42 110.974 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 37.3 t -54.17 -63.18 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-O 117.767 -1.111 . . . . 74.22 109.296 167.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -60.16 -41.44 92.81 Favored 'General case' 0 CA--C 1.548 0.875 0 CA-C-N 121.349 1.886 . . . . 62.34 109.273 -174.279 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -74.97 4.54 6.41 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 129.291 3.036 . . . . 71.11 111.568 -176.11 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.401 ' HB1' ' CZ ' ' A' ' 114' ' ' PHE . . . -111.27 -3.16 15.44 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 125.184 1.393 . . . . 33.42 113.251 169.614 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 8.1 mt -126.28 -44.62 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 107.873 -1.158 . . . . 70.11 107.873 -172.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 85.2 m-70 -70.53 -65.13 0.77 Allowed 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 123.316 0.646 . . . . 73.22 111.38 177.42 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.84 -20.51 38.84 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 115.044 1.498 . . . . 64.23 115.044 -176.316 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -81.68 -39.89 23.64 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.294 -1.002 . . . . 74.14 108.294 173.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 4.0 t60 52.06 64.55 1.8 Allowed 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.168 1.387 . . . . 74.03 108.783 -174.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 3.7 mmpt? -92.32 147.34 22.99 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 124.352 1.061 . . . . 74.51 108.578 171.717 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 27.9 tttp -84.35 55.41 3.35 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 127.181 2.192 . . . . 54.44 110.14 -178.144 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 95.7 mt -75.89 34.16 0.12 Allowed 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 127.758 2.423 . . . . 74.43 111.599 -176.387 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -70.8 11.73 0.35 Allowed 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 127.001 2.12 . . . . 65.41 114.373 -165.486 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -147.98 161.39 34.91 Favored Pre-proline 0 N--CA 1.47 0.57 0 C-N-CA 126.551 1.94 . . . . 63.42 111.091 179.344 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -56.76 -48.34 19.11 Favored 'Trans proline' 0 CA--C 1.51 -0.681 0 C-N-CA 123.738 2.958 . . . . 75.31 111.981 177.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -60.04 -34.3 73.2 Favored 'General case' 0 N--CA 1.44 -0.97 0 C-N-CA 125.484 1.513 . . . . 70.45 111.336 -175.303 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -71.4 -48.23 51.13 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 126.059 1.744 . . . . 74.1 109.592 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 71.1 mtm -59.82 -49.77 76.42 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 123.814 0.846 . . . . 64.24 109.558 175.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -62.4 -43.88 97.76 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 125.409 1.484 . . . . 64.14 111.135 -177.012 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -53.01 -41.97 65.16 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 123.792 0.837 . . . . 71.32 111.303 177.295 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . 0.401 ' CZ ' ' HB1' ' A' ' 97' ' ' ALA . 93.6 t80 -76.43 -46.82 25.4 Favored 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 124.26 1.024 . . . . 63.31 109.551 -174.486 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 25.9 mt -65.38 -29.97 70.74 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.514 1.126 . . . . 74.3 110.252 -178.354 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -53.98 -31.58 51.28 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.806 0.842 . . . . 53.22 111.361 178.584 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -94.77 12.42 68.65 Favored Glycine 0 CA--C 1.527 0.785 0 CA-C-O 117.406 -1.774 . . . . 62.2 113.907 176.744 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 7.8 mmtm -132.46 11.33 4.48 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 120.097 1.949 . . . . 72.32 111.835 -173.229 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 97.77 42.09 3.19 Favored Glycine 0 N--CA 1.463 0.475 0 CA-C-N 119.769 1.168 . . . . 43.31 111.863 177.578 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 46.8 t -136.85 158.82 37.11 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 C-N-CA 127.101 2.16 . . . . 71.21 105.474 172.641 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -116.27 126.94 54.26 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 108.856 -0.794 . . . . 65.32 108.856 174.006 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 1.7 mtpm? -56.13 -37.0 68.87 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 123.169 0.588 . . . . 72.02 110.393 171.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -64.11 -14.92 58.16 Favored 'General case' 0 C--O 1.226 -0.165 0 C-N-CA 124.931 1.292 . . . . 62.1 111.992 -178.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 14.6 mmtp -114.66 -33.46 5.51 Favored 'General case' 0 C--O 1.225 -0.196 0 C-N-CA 124.367 1.067 . . . . 75.54 111.837 178.438 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 12.8 t80 -54.82 -61.39 2.34 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 123.632 0.773 . . . . 71.01 109.353 175.306 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 32.3 mt -73.88 -37.12 64.81 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 121.663 0.744 . . . . 72.24 110.798 -161.522 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 18.8 p -66.92 -21.35 65.99 Favored 'General case' 0 N--CA 1.442 -0.856 0 C-N-CA 125.204 1.401 . . . . 75.42 111.757 179.57 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 34.0 m -97.98 -31.74 12.01 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.181 0.992 . . . . 73.43 109.867 174.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 45.4 t80 -57.83 -56.33 23.33 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 124.624 1.17 . . . . 75.12 110.219 177.008 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 -89.47 56.89 3.75 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 108.002 -1.11 . . . . 71.0 108.002 173.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -134.96 160.24 38.94 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 124.061 0.944 . . . . 74.05 110.424 172.336 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -55.28 -28.09 51.04 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.68 1.592 . . . . 72.13 112.654 -179.114 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -45.32 -67.13 0.31 Allowed 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 125.691 1.597 . . . . 73.41 108.728 171.535 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 24.7 mm -61.28 -40.24 85.36 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 CA-C-O 117.524 -1.227 . . . . 73.02 111.295 -178.288 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 18.4 mtpp -54.74 -38.34 67.02 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 120.537 1.517 . . . . 75.23 110.137 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -78.22 -43.57 13.04 Favored Glycine 0 N--CA 1.442 -0.94 0 N-CA-C 110.589 -1.005 . . . . 63.32 110.589 -177.137 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 9.2 mt-30 -62.12 -39.57 92.98 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 123.15 0.58 . . . . 70.45 109.688 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 1.7 mtp -56.42 -57.59 11.63 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 124.673 1.189 . . . . 51.52 109.28 173.594 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -70.82 -31.2 67.85 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 118.898 -1.121 . . . . 73.22 112.227 -168.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 4.5 mttt -63.2 -59.18 5.09 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 123.88 0.872 . . . . 71.23 110.814 170.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -58.13 -35.58 71.7 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 119.459 1.027 . . . . 75.35 110.807 179.683 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 10.0 tmtt? -61.11 -53.2 60.08 Favored 'General case' 0 N--CA 1.456 -0.139 0 O-C-N 120.437 -1.415 . . . . 73.42 110.557 177.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.02 -25.11 64.33 Favored 'General case' 0 C--O 1.221 -0.396 0 CA-C-N 120.096 1.316 . . . . 74.21 111.874 176.756 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.427 HD23 ' HA ' ' A' ' 144' ' ' LEU . 30.0 mt -70.68 -59.27 2.92 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 119.57 1.077 . . . . 72.51 110.991 -178.759 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -55.42 -44.68 76.49 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 118.412 0.551 . . . . 74.03 111.176 -170.642 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 4.1 ppp? -64.49 -41.75 96.27 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 113.574 0.953 . . . . 74.24 113.574 176.394 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -64.62 -29.81 70.82 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 116.374 -1.774 . . . . 64.13 110.869 -178.375 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -80.0 11.77 3.17 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 127.787 2.435 . . . . 73.11 113.369 176.688 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 21.4 mt-30 59.67 18.63 7.34 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 127.51 2.324 . . . . 75.22 115.039 -177.332 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 40.2 t -73.43 141.45 16.27 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 O-C-N 121.12 -0.988 . . . . 60.5 108.919 -179.461 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -135.91 3.26 2.93 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.032 0.933 . . . . 64.11 113.078 -177.557 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -174.33 -173.93 40.72 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 108.711 -1.756 . . . . 52.31 108.711 -179.164 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.611 HG21 ' CB ' ' A' ' 34' ' ' TRP . 6.4 m -139.41 154.16 71.45 Favored Pre-proline 0 CA--C 1.535 0.398 0 C-N-CA 125.794 1.638 . . . . 74.54 109.349 176.597 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . 0.474 ' HG3' HD12 ' A' ' 166' ' ' ILE . 35.7 Cg_endo -65.03 160.04 72.13 Favored 'Cis proline' 0 CA--C 1.533 0.431 0 C-N-CA 125.317 -0.701 . . . . 71.32 113.793 -2.269 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 17.7 m -157.81 141.66 15.75 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 124.816 1.246 . . . . 61.2 108.367 173.594 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 19.2 mmm -123.5 155.88 36.69 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 125.968 1.707 . . . . 74.3 108.512 167.341 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 6.1 t -135.26 153.77 34.5 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 N-CA-C 106.946 -1.502 . . . . 33.43 106.946 174.43 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 58.5 t -126.45 123.86 64.21 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 C-N-CA 126.439 1.896 . . . . 61.43 106.995 173.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 1.2 t30 54.56 16.7 1.41 Allowed 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 129.472 3.109 . . . . 72.21 115.898 166.697 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 74.37 28.43 63.83 Favored Glycine 0 CA--C 1.523 0.572 0 C-N-CA 128.866 3.127 . . . . 74.43 113.205 -176.131 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 33.5 mttt -139.33 -31.26 0.7 Allowed 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 114.848 1.425 . . . . 45.41 114.848 -166.268 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -125.13 138.51 54.16 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 107.91 -1.144 . . . . 72.0 107.91 177.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 71.0 ttt-85 -122.6 141.57 51.57 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 105.381 -2.081 . . . . 72.33 105.381 178.126 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 11.4 p90 -153.9 170.66 20.49 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 107.097 -1.446 . . . . 74.01 107.097 -179.243 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -173.97 -178.99 1.62 Allowed 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 123.822 0.849 . . . . 61.55 109.103 178.643 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.474 HD12 ' HG3' ' A' ' 154' ' ' PRO . 15.6 mt -52.0 -48.36 40.93 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 C-N-CA 126.245 1.818 . . . . 60.24 109.324 176.085 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -71.65 -34.36 63.02 Favored Glycine 0 CA--C 1.525 0.676 0 CA-C-O 118.744 -1.031 . . . . 70.12 113.009 179.302 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 3.5 m -65.21 -55.79 16.51 Favored 'General case' 0 C--O 1.227 -0.09 0 CA-C-N 119.649 1.724 . . . . 45.01 109.523 174.021 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -67.29 -49.53 63.86 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 124.507 1.123 . . . . 72.31 111.111 -171.03 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 124.43 5.13 7.32 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 125.069 1.319 . . . . 65.11 113.921 -176.633 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 162.04 173.63 30.94 Favored Glycine 0 CA--C 1.528 0.874 0 CA-C-N 118.839 1.319 . . . . 70.25 111.014 175.726 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -66.62 -47.66 2.73 Favored 'Trans proline' 0 CA--C 1.532 0.416 0 C-N-CA 122.785 2.323 . . . . 74.44 111.157 -175.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -54.01 -46.6 71.85 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.143 0.977 . . . . 74.23 110.16 172.528 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -65.33 -26.48 68.06 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.684 0.794 . . . . 70.52 110.403 -176.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 25.0 m -65.83 -40.82 92.16 Favored 'General case' 0 CA--C 1.533 0.3 0 O-C-N 120.663 -1.273 . . . . 70.45 109.524 178.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 37.7 mt -66.62 -29.72 69.82 Favored 'General case' 0 C--N 1.342 0.249 0 CA-C-N 119.507 1.049 . . . . 51.11 111.132 175.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.65 -47.78 66.86 Favored 'General case' 0 C--N 1.339 0.145 0 C-N-CA 124.093 0.957 . . . . 74.13 109.208 171.241 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.423 HD13 ' HA ' ' A' ' 178' ' ' LEU . 4.4 mm? -72.75 -42.1 64.41 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-O 118.33 -0.843 . . . . 74.04 110.845 178.713 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -53.18 -48.01 68.37 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 118.699 0.681 . . . . 72.41 111.788 -173.385 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -75.8 -34.53 60.18 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 123.01 0.524 . . . . 73.3 110.752 -172.13 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -66.2 -48.36 70.87 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 124.83 1.252 . . . . 63.01 111.087 174.206 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 68.7 mt -65.52 -32.69 74.42 Favored 'General case' 0 N--CA 1.457 -0.077 0 C-N-CA 124.312 1.045 . . . . 62.34 111.155 -177.248 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 29.0 mt -50.39 -57.85 2.15 Favored 'Isoleucine or valine' 0 C--N 1.34 0.179 0 CA-C-O 117.976 -1.011 . . . . 74.41 108.781 168.177 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -57.74 -37.04 72.89 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 119.813 1.188 . . . . 62.15 111.552 -176.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 22.6 tptt -56.54 -38.97 72.61 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.466 0.706 . . . . 75.11 111.469 -175.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 51.3 mm-40 -90.98 -42.88 10.3 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 123.741 0.816 . . . . 44.34 111.665 176.561 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.95 -37.65 77.25 Favored 'General case' 0 C--N 1.333 -0.128 0 O-C-N 120.76 -1.212 . . . . 72.14 110.175 -177.033 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.432 0 C-N-CA 124.834 1.253 . . . . 71.43 111.584 178.82 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.927 0 N-CA-C 109.08 -1.608 . . . . 54.31 109.08 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 70.77 120.7 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 128.065 2.546 . . . . 75.04 110.504 170.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -128.33 4.91 5.73 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 113.883 1.068 . . . . 74.15 113.883 -161.647 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 16.1 m-85 -140.95 161.86 36.83 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 125.332 1.453 . . . . 71.33 108.234 -170.165 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 24.6 m -133.73 141.94 47.74 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.123 0.569 . . . . 73.33 109.564 -177.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -70.37 152.96 43.53 Favored 'General case' 0 C--O 1.235 0.316 0 O-C-N 121.477 -0.764 . . . . 75.21 109.423 173.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 73.28 -41.35 0.92 Allowed Glycine 0 CA--C 1.531 1.049 0 C-N-CA 125.877 1.703 . . . . 45.03 111.626 -164.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 17.6 tptt -74.89 -85.16 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 126.631 1.972 . . . . 54.14 110.612 -174.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.7 mp0 -77.82 -25.03 48.58 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 125.343 1.457 . . . . 73.04 110.075 -174.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 41.2 p90 -161.17 178.01 9.69 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 123.885 0.874 . . . . 70.35 109.719 -173.121 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 79.2 t -132.47 109.28 14.58 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 C-N-CA 125.074 1.35 . . . . 74.11 108.179 -179.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.22 162.63 24.56 Favored 'General case' 0 C--O 1.235 0.317 0 O-C-N 120.815 -1.178 . . . . 70.21 108.24 158.327 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -140.88 118.34 11.49 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 124.049 0.94 . . . . 72.13 109.584 -172.069 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.2 m -71.11 7.9 1.11 Allowed 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.99 1.316 . . . . 64.54 113.025 -174.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 33.0 m -134.47 82.13 46.85 Favored Pre-proline 0 N--CA 1.449 -0.505 0 C-N-CA 125.592 1.557 . . . . 74.23 109.224 173.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -75.16 -174.85 2.11 Favored 'Trans proline' 0 CA--C 1.544 1.005 0 C-N-CA 124.966 3.778 . . . . 41.33 114.011 -174.005 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 10.8 t -141.92 143.27 27.82 Favored Pre-proline 0 CA--C 1.545 0.788 0 C-N-CA 125.872 1.669 . . . . 71.22 109.339 168.015 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -90.05 178.87 2.14 Favored 'Trans proline' 0 CA--C 1.543 0.956 1 C-N-CA 125.777 4.318 . . . . 71.21 113.068 170.025 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 4.6 m -112.85 -177.7 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 C-N-CA 126.085 1.754 . . . . 72.24 110.327 171.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 12.6 t -63.12 -38.29 90.57 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 125.941 1.696 . . . . 72.21 112.05 172.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -153.53 143.49 15.34 Favored Pre-proline 0 N--CA 1.45 -0.457 0 CA-C-O 117.532 -1.223 . . . . 72.03 107.72 -179.424 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -72.62 178.0 6.82 Favored 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 122.437 2.091 . . . . 71.21 111.118 173.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 133.46 -95.85 0.29 Allowed Glycine 0 C--N 1.332 0.318 0 N-CA-C 108.456 -1.858 . . . . 73.43 108.456 174.071 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.642 ' HE3' ' H ' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -70.28 137.73 50.97 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 107.461 -1.311 . . . . 73.34 107.461 176.592 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 33.6 mm -67.69 133.32 31.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 106.79 -1.559 . . . . 60.2 106.79 175.021 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -83.95 143.65 29.69 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.283 -0.636 . . . . 62.4 109.283 176.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 25.7 t -133.68 109.53 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.225 0 N-CA-C 106.381 -1.711 . . . . 63.44 106.381 171.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 58.6 t -96.56 115.06 34.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 N-CA-C 106.104 -1.813 . . . . 71.02 106.104 179.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -76.45 134.99 39.4 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 107.937 -1.134 . . . . 71.43 107.937 157.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.744 HD22 HG21 ' A' ' 150' ' ' VAL . 3.3 mp -125.95 123.23 38.09 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 125.661 1.584 . . . . 73.31 108.011 170.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 15.9 p90 -138.94 176.71 8.46 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.376 1.071 . . . . 64.34 110.816 -170.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 25.0 t90 -147.1 172.12 14.25 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.997 1.319 . . . . 75.51 107.857 177.054 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 19.7 t80 -56.01 -41.0 74.22 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 126.374 1.869 . . . . 45.12 113.129 173.115 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -92.99 -106.87 1.76 Allowed Glycine 0 N--CA 1.449 -0.483 0 N-CA-C 107.965 -2.054 . . . . 74.01 107.965 -168.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 21.1 p 44.22 72.34 1.23 Allowed Pre-proline 0 C--O 1.221 -0.419 0 C-N-CA 125.373 1.469 . . . . 65.12 112.03 175.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -58.93 -24.9 75.02 Favored 'Trans proline' 0 CA--C 1.539 0.739 0 CA-C-N 121.596 1.606 . . . . 71.53 113.419 -171.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 19.7 m170 -71.98 -33.03 67.82 Favored 'General case' 0 CA--C 1.549 0.926 0 CA-C-O 118.059 -0.972 . . . . 73.45 112.512 172.125 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 15.9 p -65.85 -38.33 88.57 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 120.746 1.612 . . . . 73.14 110.793 -179.166 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 34.8 t80 -64.56 -31.32 72.49 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 123.199 0.6 . . . . 72.25 111.657 176.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.9 -3.99 25.64 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 112.597 0.591 . . . . 71.42 112.597 174.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 26.1 t80 -117.45 -21.33 8.69 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 125.358 1.463 . . . . 74.22 111.982 -176.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -46.33 -63.52 1.29 Allowed Pre-proline 0 N--CA 1.474 0.762 0 CA-C-N 120.446 1.475 . . . . 73.43 112.432 178.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -71.93 -6.77 19.78 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 CA-C-N 121.856 1.698 . . . . 72.35 114.084 -175.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.0 m -78.95 -42.83 25.92 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.172 1.389 . . . . 71.23 108.535 169.379 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 20.2 tt -89.84 -36.48 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 O-C-N 121.5 -0.75 . . . . 73.21 112.035 -171.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 54.2 t -50.69 -54.24 38.12 Favored Pre-proline 0 CA--C 1.54 0.565 0 C-N-CA 124.787 1.235 . . . . 62.41 111.591 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -68.73 -36.34 14.3 Favored 'Trans proline' 0 N--CA 1.454 -0.852 0 CA-C-N 121.098 1.428 . . . . 55.45 111.416 178.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.505 ' CH2' ' HB1' ' A' ' 179' ' ' ALA . 79.2 t90 -54.75 -51.05 66.9 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 118.801 0.728 . . . . 72.31 109.486 177.326 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -63.16 -37.39 87.04 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 117.857 0.299 . . . . 61.45 111.292 -175.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -62.59 -48.69 78.31 Favored 'General case' 0 N--CA 1.453 -0.299 0 O-C-N 121.58 -0.7 . . . . 75.14 109.255 179.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.54 18.24 2.37 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.84 0.856 . . . . 64.01 113.087 -173.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 19.7 mt -65.02 156.34 80.88 Favored Pre-proline 0 N--CA 1.451 -0.381 0 C-N-CA 123.483 0.713 . . . . 62.31 110.355 174.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -76.06 177.13 9.14 Favored 'Trans proline' 0 N--CA 1.452 -0.917 0 C-N-CA 124.648 3.566 . . . . 71.14 111.164 177.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -67.32 -7.99 28.87 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.535 1.134 . . . . 54.3 113.371 -178.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -107.29 1.77 24.09 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 119.804 1.184 . . . . 71.42 112.369 -168.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 40.7 t -125.66 137.52 57.41 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 N-CA-C 107.835 -1.172 . . . . 74.4 107.835 -172.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 67.2 t60 -127.5 99.94 5.81 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 124.687 1.195 . . . . 72.13 109.227 -177.064 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 35.0 t80 -80.51 142.15 34.47 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 114.389 -1.278 . . . . 61.33 110.863 176.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 32.6 t -135.08 154.57 36.41 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 C-N-CA 126.573 1.949 . . . . 73.24 106.85 178.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 9.6 mtm180 -132.11 120.18 21.98 Favored 'General case' 0 CA--C 1.516 -0.341 0 C-N-CA 124.364 1.066 . . . . 62.3 108.479 175.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 28.9 mt -132.33 153.28 81.18 Favored Pre-proline 0 C--N 1.33 -0.279 0 O-C-N 121.903 -0.498 . . . . 75.51 110.614 -177.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -81.71 144.97 14.22 Favored 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 123.455 2.77 . . . . 73.32 112.149 -178.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -90.91 74.42 6.47 Favored 'General case' 0 CA--C 1.528 0.122 0 C-N-CA 124.221 1.008 . . . . 62.53 109.338 -171.104 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 15.7 mt -74.32 86.84 1.99 Allowed 'General case' 0 CA--C 1.543 0.683 0 O-C-N 121.226 -0.921 . . . . 64.14 110.96 -170.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -105.87 24.76 11.82 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.495 1.118 . . . . 70.43 112.414 -178.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 89.14 171.28 45.53 Favored Glycine 0 CA--C 1.528 0.854 0 N-CA-C 110.215 -1.154 . . . . 64.22 110.215 -175.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 46.5 -146.49 3.27 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 124.117 0.865 . . . . 73.24 113.249 177.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 6.7 tp -63.92 -18.57 22.77 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 C-N-CA 123.288 0.635 . . . . 72.54 112.544 -172.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 9.4 m95 -62.16 -44.36 96.79 Favored 'General case' 0 C--N 1.344 0.362 0 CA-C-N 119.537 1.062 . . . . 71.02 109.537 176.316 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 4.3 p30 -77.08 -39.44 49.74 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 117.858 -1.067 . . . . 71.23 111.884 178.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 56.1 t -55.83 -52.03 53.47 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-N 119.153 0.888 . . . . 72.22 109.811 -178.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 34.0 m170 -63.64 -31.94 73.26 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 118.691 -0.671 . . . . 65.23 112.808 -176.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -87.98 -12.08 66.59 Favored Glycine 0 C--N 1.335 0.515 0 CA-C-N 119.701 1.137 . . . . 33.04 111.706 -175.143 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -60.97 -43.77 98.31 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 123.662 0.785 . . . . 75.04 110.667 -173.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 3.7 ppp? -50.22 -32.96 17.9 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 125.318 1.447 . . . . 64.51 114.155 177.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -59.92 -49.52 77.37 Favored 'General case' 0 N--CA 1.458 -0.072 0 C-N-CA 125.181 1.392 . . . . 74.43 108.421 -175.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 29.2 mt -66.26 -36.54 83.27 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 124.486 1.114 . . . . 74.31 109.732 179.244 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.02 -46.86 82.6 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 120.006 1.275 . . . . 74.03 110.801 176.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.31 -50.79 64.22 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 125.878 1.671 . . . . 71.41 107.961 -175.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -62.12 -46.31 89.61 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.516 1.126 . . . . 73.22 111.52 174.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 7.1 t -53.3 -32.89 50.98 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 126.102 1.761 . . . . 65.41 113.941 -172.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . 0.456 ' HE3' HG13 ' A' ' 120' ' ' VAL . 8.1 ptp -81.39 -10.84 59.44 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 114.16 1.17 . . . . 70.42 114.16 179.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 93.92 50.72 2.23 Favored Glycine 0 CA--C 1.524 0.607 0 C-N-CA 126.137 1.827 . . . . 63.41 111.862 170.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 18.1 m -66.17 129.96 31.04 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 CA-C-N 118.683 1.241 . . . . 72.43 109.309 176.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -80.55 50.34 1.29 Allowed 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.014 1.326 . . . . 73.4 111.328 -179.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 37.1 m-70 57.81 36.04 26.04 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 127.034 2.134 . . . . 72.44 111.813 -176.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -60.18 103.65 0.25 Allowed 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.418 1.487 . . . . 72.41 108.567 174.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.3 t 44.02 71.91 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.809 0 C-N-CA 128.37 2.668 . . . . 70.52 113.848 166.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 12.5 t-80 -61.15 -34.98 75.87 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.594 1.158 . . . . 74.12 113.971 -177.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -61.61 -46.12 91.19 Favored 'General case' 0 CA--C 1.51 -0.582 0 C-N-CA 123.628 0.771 . . . . 71.34 111.636 177.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -66.92 -19.12 65.67 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 113.059 0.763 . . . . 60.44 113.059 -162.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 66.9 t -51.61 -70.6 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 C-N-CA 128.369 2.668 . . . . 61.23 111.063 160.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -54.27 -43.07 70.7 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 125.948 1.699 . . . . 72.43 110.977 176.058 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -83.63 14.86 3.5 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 126.018 1.727 . . . . 73.15 110.846 -174.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -114.76 -19.85 10.87 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 126.081 1.752 . . . . 71.1 114.604 157.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 36.9 mt -80.5 -66.71 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 N-CA-C 108.373 -0.973 . . . . 73.32 108.373 175.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -78.45 -66.96 0.79 Allowed 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 114.038 1.125 . . . . 71.13 114.038 -163.14 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 29.8 mtpt -50.3 -53.19 30.47 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 125.36 1.464 . . . . 63.11 109.996 177.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 22.4 mm-40 -75.68 -28.11 58.54 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 125.609 1.563 . . . . 64.34 109.426 -168.067 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 22.3 t-160 64.86 26.57 12.89 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 126.217 1.807 . . . . 61.05 111.358 174.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 28.2 mmtp -70.61 140.23 51.59 Favored 'General case' 0 C--N 1.342 0.251 0 O-C-N 121.1 -1.0 . . . . 75.01 109.665 177.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 19.8 tttt -56.97 -51.03 70.84 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 125.277 1.431 . . . . 73.32 111.313 -171.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 50.2 mt 47.86 35.14 4.5 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.363 1.465 . . . . 74.33 112.496 173.082 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -94.11 -7.16 43.25 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 113.941 1.089 . . . . 55.24 113.941 -169.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 17.3 p -135.98 155.23 77.86 Favored Pre-proline 0 C--O 1.235 0.308 0 CA-C-N 119.242 0.928 . . . . 71.11 109.639 -177.15 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -63.14 -33.61 72.03 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 122.088 1.858 . . . . 72.01 111.843 -178.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -66.32 -23.88 66.44 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 118.467 0.576 . . . . 74.5 111.974 176.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -81.77 -44.79 16.53 Favored 'General case' 0 CA--C 1.528 0.111 0 C-N-CA 123.57 0.748 . . . . 73.33 109.851 175.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 44.4 mtt -66.11 -54.55 24.24 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 123.628 0.771 . . . . 61.53 109.162 -175.11 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.489 ' HB2' ' CD1' ' A' ' 125' ' ' PHE . . . -68.18 -29.91 68.89 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 119.073 -0.489 . . . . 55.15 111.518 -173.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -62.21 -48.61 79.25 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 123.524 0.73 . . . . 71.33 110.464 169.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 86.8 t80 -62.4 -42.52 99.49 Favored 'General case' 0 N--CA 1.447 -0.592 0 O-C-N 122.21 -0.306 . . . . 75.41 111.725 -179.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 35.3 mt -80.89 -11.59 59.56 Favored 'General case' 0 N--CA 1.451 -0.408 0 O-C-N 121.339 -0.851 . . . . 51.21 111.071 -172.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -54.51 -37.65 65.59 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 118.082 0.401 . . . . 61.35 110.506 178.058 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -84.53 8.97 66.25 Favored Glycine 0 CA--C 1.528 0.857 0 C-N-CA 124.928 1.251 . . . . 53.25 114.818 175.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 52.4 mmtt -133.74 45.01 2.7 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-N 119.485 1.643 . . . . 65.13 110.256 -169.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 63.25 22.84 65.72 Favored Glycine 0 CA--C 1.53 1.022 0 CA-C-O 118.6 -1.111 . . . . 62.24 113.503 170.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.456 HG13 ' HE3' ' A' ' 84' ' ' MET . 41.9 t -114.17 151.89 15.91 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 C-N-CA 127.528 2.331 . . . . 75.41 106.335 173.368 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -115.67 140.56 49.08 Favored 'General case' 0 C--O 1.235 0.33 0 O-C-N 121.963 -0.461 . . . . 74.43 110.322 172.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 10.8 mttt -62.69 -39.97 95.67 Favored 'General case' 0 CA--C 1.527 0.061 0 CA-C-O 118.42 -0.8 . . . . 63.11 110.519 178.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 59.2 mt-10 -50.99 -52.39 43.25 Favored 'General case' 0 N--CA 1.457 -0.124 0 CA-C-N 118.888 0.767 . . . . 64.12 109.954 176.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 88.1 mttt -79.53 -42.14 25.8 Favored 'General case' 0 CA--C 1.515 -0.399 0 N-CA-C 107.075 -1.454 . . . . 61.54 107.075 -166.27 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.489 ' CD1' ' HB2' ' A' ' 112' ' ' ALA . 62.4 t80 -55.78 -60.32 3.62 Favored 'General case' 0 N--CA 1.443 -0.821 0 C-N-CA 123.798 0.839 . . . . 72.01 109.357 179.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 47.8 mt -67.2 -37.81 84.28 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-O 118.953 -0.546 . . . . 73.03 110.799 -172.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 2.9 t -64.73 -41.77 95.7 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 119.42 1.009 . . . . 72.53 110.127 -176.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 3.4 t -80.23 -31.77 38.53 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 118.839 0.745 . . . . 71.01 111.069 -179.011 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 91.0 t80 -53.45 -52.93 57.87 Favored 'General case' 0 C--O 1.234 0.268 0 O-C-N 121.294 -0.879 . . . . 63.5 109.369 170.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -86.58 56.5 4.03 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 125.205 1.402 . . . . 74.44 109.033 176.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 14.9 t -136.26 168.5 19.29 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 124.037 0.935 . . . . 74.25 110.549 176.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -69.34 -27.16 65.11 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.249 0.62 . . . . 65.11 110.053 167.288 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -51.73 -53.73 36.14 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 124.209 1.003 . . . . 71.21 111.005 -178.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.4 HD13 ' HA ' ' A' ' 134' ' ' ILE . 14.3 mm -65.17 -36.56 78.05 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 CA-C-O 118.763 -0.637 . . . . 74.35 110.853 177.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 22.4 mttt -57.88 -38.3 75.52 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 119.511 1.05 . . . . 75.42 110.369 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -72.2 -17.73 77.57 Favored Glycine 0 CA--C 1.528 0.86 0 N-CA-C 111.842 -0.503 . . . . 72.4 111.842 -177.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 6.9 mt-30 -88.98 -42.77 11.58 Favored 'General case' 0 N--CA 1.453 -0.276 0 O-C-N 121.542 -0.975 . . . . 61.41 110.514 174.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 91.7 mmm -58.37 -52.58 65.01 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 108.636 -0.876 . . . . 74.2 108.636 -178.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -65.85 -30.46 71.08 Favored 'General case' 0 CA--C 1.535 0.365 0 CA-C-N 119.112 0.869 . . . . 71.13 112.509 -172.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 13.5 mmtt -63.3 -68.54 0.33 Allowed 'General case' 0 C--O 1.227 -0.083 0 C-N-CA 126.081 1.752 . . . . 73.32 109.606 171.074 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -54.73 -36.27 64.59 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 119.218 0.917 . . . . 62.23 111.208 -174.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -54.57 -66.14 0.45 Allowed 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 126.374 1.87 . . . . 70.21 110.949 172.176 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.69 -31.51 72.23 Favored 'General case' 0 N--CA 1.466 0.33 0 O-C-N 121.433 -0.792 . . . . 64.22 111.142 -174.233 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 49.2 mt -60.11 -54.29 47.67 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 123.968 0.907 . . . . 65.21 109.778 178.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -54.13 -42.14 69.17 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 118.842 0.746 . . . . 74.22 111.341 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -64.25 -43.51 94.68 Favored 'General case' 0 C--O 1.235 0.336 0 O-C-N 121.499 -0.751 . . . . 73.24 111.229 178.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -63.35 -40.17 96.55 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 123.72 0.808 . . . . 73.43 110.383 -179.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 52.8 m-85 -72.78 11.92 0.59 Allowed 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 114.181 1.178 . . . . 74.23 114.181 -178.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 55.59 27.81 11.0 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.295 1.438 . . . . 75.15 113.347 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.744 HG21 HD22 ' A' ' 32' ' ' LEU . 40.8 t -64.02 -47.78 88.89 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 C-N-CA 124.995 1.318 . . . . 74.51 112.791 -168.317 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 82.0 p 55.0 -54.51 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 128.713 2.805 . . . . 74.43 114.82 -166.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -146.94 -166.76 12.55 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 127.161 2.315 . . . . 45.44 110.506 -173.28 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 29.1 m -143.83 155.12 59.54 Favored Pre-proline 0 C--O 1.239 0.551 0 C-N-CA 125.47 1.508 . . . . 73.31 108.779 -172.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -68.81 145.38 77.12 Favored 'Cis proline' 0 C--N 1.345 0.359 0 C-N-CA 125.055 -0.81 . . . . 74.02 113.918 0.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 37.8 m -149.43 127.94 12.31 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 125.431 1.493 . . . . 51.33 107.533 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 20.2 mmm -115.26 148.46 39.13 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 125.561 1.544 . . . . 74.23 107.916 172.126 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 49.9 t -138.96 115.38 10.09 Favored 'Isoleucine or valine' 0 C--O 1.238 0.482 0 N-CA-C 109.571 -0.529 . . . . 75.04 109.571 -177.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.569 HG23 ' CE1' ' A' ' 164' ' ' PHE . 95.2 t -84.48 127.23 40.03 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 N-CA-C 107.764 -1.198 . . . . 72.22 107.764 170.477 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 6.1 t30 49.34 26.15 1.5 Allowed 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 130.128 3.371 . . . . 65.52 115.243 165.306 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 56.8 28.77 57.71 Favored Glycine 0 CA--C 1.527 0.825 0 C-N-CA 126.311 1.91 . . . . 34.44 114.172 -172.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 6.1 mtpt -131.72 -22.33 2.4 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 120.08 1.94 . . . . 73.11 112.916 -179.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -128.08 126.75 41.81 Favored 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 107.954 -1.128 . . . . 75.44 107.954 179.125 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 9.2 ttp85 -109.27 134.29 51.96 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 127.187 2.195 . . . . 70.1 105.643 176.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . 0.569 ' CE1' HG23 ' A' ' 158' ' ' VAL . 11.8 p90 -152.26 167.55 28.25 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.675 -0.861 . . . . 74.33 108.675 -178.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -175.9 177.8 1.59 Allowed 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.655 1.182 . . . . 72.34 109.903 -179.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 10.8 mt -47.1 -47.7 8.72 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.131 0 C-N-CA 127.145 2.178 . . . . 55.31 109.394 176.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -80.86 -8.89 86.97 Favored Glycine 0 N--CA 1.448 -0.556 0 CA-C-O 118.092 -1.393 . . . . 52.45 113.715 -177.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 1.2 m -82.94 -65.79 0.97 Allowed 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 119.743 1.771 . . . . 63.43 107.504 164.032 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -59.51 -54.85 41.8 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 124.388 1.075 . . . . 65.25 109.774 -168.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 140.58 -8.45 2.84 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 124.764 1.173 . . . . 72.01 114.106 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 171.38 167.08 31.13 Favored Glycine 0 CA--C 1.526 0.73 0 CA-C-N 119.598 1.699 . . . . 63.41 109.401 -174.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_endo -64.5 -45.36 9.28 Favored 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 122.902 2.401 . . . . 72.12 111.518 -173.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -65.12 -25.55 67.81 Favored 'General case' 0 CA--C 1.537 0.445 0 O-C-N 121.32 -0.862 . . . . 63.41 111.536 174.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -77.07 -28.28 54.6 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.745 0.818 . . . . 72.01 111.021 177.147 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 93.4 m -60.12 -45.51 92.75 Favored 'General case' 0 N--CA 1.464 0.235 0 O-C-N 120.581 -1.324 . . . . 51.1 109.854 178.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 52.5 mt -62.09 -31.83 72.31 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 118.028 0.376 . . . . 73.23 110.622 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 14.2 ttpt -55.8 -40.16 72.31 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 124.131 0.973 . . . . 71.51 110.07 174.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -75.05 -44.82 45.47 Favored 'General case' 0 CA--C 1.509 -0.614 0 CA-C-O 117.876 -1.059 . . . . 73.3 111.196 173.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.505 ' HB1' ' CH2' ' A' ' 50' ' ' TRP . . . -51.66 -47.45 63.8 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 119.048 0.84 . . . . 62.42 111.75 -172.019 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -68.91 -47.48 65.71 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.209 1.004 . . . . 72.02 110.524 -175.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -55.17 -49.35 72.08 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 125.301 1.441 . . . . 73.41 111.164 175.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 77.5 mt -66.11 -34.78 78.83 Favored 'General case' 0 C--O 1.232 0.14 0 C-N-CA 124.617 1.167 . . . . 71.4 111.583 -178.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 28.8 mt -60.5 -54.52 33.95 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.143 0 N-CA-C 107.845 -1.169 . . . . 64.44 107.845 173.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -53.36 -42.33 66.72 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 119.271 0.941 . . . . 73.33 111.042 -179.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 42.9 tptt -59.96 -37.0 78.32 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 126.296 1.838 . . . . 53.31 111.881 -177.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 34.7 mm-40 -90.44 -31.34 16.85 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.562 1.145 . . . . 75.21 111.784 177.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . 0.567 ' HA ' ' HE ' ' A' ' 187' ' ' ARG . 1.4 tpm_? -61.18 -37.96 84.81 Favored 'General case' 0 CA--C 1.514 -0.419 0 O-C-N 120.439 -1.413 . . . . 74.42 110.071 178.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -49.31 -36.29 20.55 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 127.856 2.462 . . . . 61.4 110.975 173.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -56.86 -34.67 68.06 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-O 118.896 -0.574 . . . . 55.1 110.777 -175.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -134.32 57.49 1.8 Allowed 'General case' 0 C--O 1.235 0.291 0 CA-C-N 118.213 0.46 . . . . 23.12 110.914 -178.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 59.3 tttt -115.13 38.29 3.24 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 127.05 2.14 . . . . 73.23 111.638 -170.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 5.6 tttp . . . . . 0 C--O 1.246 0.884 0 CA-C-O 116.641 -1.647 . . . . 73.54 112.357 -168.775 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.658 0 N-CA-C 107.852 -2.099 . . . . 60.13 107.852 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 75.74 135.48 0.06 Allowed 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 127.898 2.479 . . . . 75.31 111.234 165.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -131.66 6.86 4.41 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.455 1.102 . . . . 73.21 111.866 -177.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 34.0 m-85 -130.35 160.62 33.42 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 124.104 0.962 . . . . 44.54 110.006 -169.104 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 59.7 m -137.07 133.27 35.22 Favored 'General case' 0 C--O 1.239 0.541 0 N-CA-C 107.04 -1.467 . . . . 75.24 107.04 179.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.26 146.62 54.71 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 109.101 -0.703 . . . . 74.32 109.101 174.003 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 79.92 -35.13 2.11 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 126.332 1.92 . . . . 51.33 112.081 -170.023 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 21.4 tptt -77.54 -63.92 1.27 Allowed 'General case' 0 CA--C 1.518 -0.279 0 C-N-CA 124.687 1.195 . . . . 74.24 110.456 -176.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -98.16 -26.15 14.66 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 125.002 1.321 . . . . 41.12 109.362 -171.171 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 45.0 p90 -157.96 174.96 14.46 Favored 'General case' 0 N--CA 1.468 0.429 0 O-C-N 121.55 -0.719 . . . . 72.53 110.625 -172.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 48.7 t -132.72 106.9 11.25 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 N-CA-C 107.548 -1.279 . . . . 65.32 107.548 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 13.4 tt0 -64.81 147.94 52.24 Favored 'General case' 0 N--CA 1.445 -0.693 0 O-C-N 120.111 -1.618 . . . . 71.34 109.209 165.419 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -110.55 103.96 12.62 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.252 -1.34 . . . . 75.13 110.005 -178.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 79.6 p -65.0 5.85 0.3 Allowed 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 114.521 1.304 . . . . 41.51 114.521 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 8.8 t -128.37 85.28 60.85 Favored Pre-proline 0 N--CA 1.449 -0.479 0 N-CA-C 105.975 -1.861 . . . . 61.22 105.975 159.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -72.34 178.91 5.55 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 123.608 2.872 . . . . 62.42 111.097 -176.157 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 10.9 t -142.99 137.47 14.95 Favored Pre-proline 0 CA--C 1.539 0.521 0 C-N-CA 124.029 0.932 . . . . 64.21 109.186 -176.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -79.37 -178.52 4.66 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 C-N-CA 124.53 3.487 . . . . 75.22 111.703 175.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 29.6 m -132.29 166.23 29.77 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 125.798 1.639 . . . . 74.15 109.009 168.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 5.2 m -44.92 -49.66 10.91 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 127.138 2.175 . . . . 62.33 113.304 178.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 36.4 tt0 -145.62 144.38 22.45 Favored Pre-proline 0 CA--C 1.539 0.521 0 C-N-CA 124.588 1.155 . . . . 72.44 108.766 176.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -70.55 -167.49 0.26 Allowed 'Trans proline' 0 CA--C 1.544 0.976 0 C-N-CA 123.452 2.768 . . . . 65.53 110.455 164.142 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 120.26 -65.35 0.44 Allowed Glycine 0 C--N 1.333 0.395 0 N-CA-C 109.007 -1.637 . . . . 64.12 109.007 177.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -103.55 146.7 28.16 Favored 'General case' 0 C--O 1.232 0.132 0 C-N-CA 125.352 1.461 . . . . 53.43 108.899 170.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 49.5 mm -68.69 139.68 20.18 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 N-CA-C 106.247 -1.76 . . . . 64.43 106.247 173.266 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -94.81 104.14 16.04 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 106.913 -1.514 . . . . 51.01 106.913 175.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 55.2 t -102.99 128.53 55.82 Favored 'Isoleucine or valine' 0 C--O 1.231 0.089 0 N-CA-C 106.482 -1.673 . . . . 60.53 106.482 173.118 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 17.6 t -133.73 118.99 31.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 N-CA-C 107.717 -1.216 . . . . 61.22 107.717 -173.434 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -87.86 144.77 26.41 Favored 'General case' 0 C--O 1.238 0.478 0 N-CA-C 107.737 -1.208 . . . . 74.32 107.737 160.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.9 mp -124.34 125.06 43.71 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 125.042 1.337 . . . . 73.54 108.235 174.386 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -115.11 175.95 5.28 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.564 0.746 . . . . 72.34 112.717 -169.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . 0.501 ' CB ' HG21 ' A' ' 153' ' ' VAL . 25.3 t90 -148.29 -178.54 6.36 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 126.526 1.93 . . . . 73.22 108.235 168.279 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.419 ' CG ' HG21 ' A' ' 98' ' ' ILE . 4.0 m-30 -104.86 4.3 31.92 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 126.912 2.085 . . . . 64.53 112.377 179.403 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -129.6 18.74 5.39 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 124.689 1.137 . . . . 63.22 111.242 -178.265 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.553 ' HB3' HG23 ' A' ' 153' ' ' VAL . 21.9 p -105.03 85.59 1.3 Allowed Pre-proline 0 N--CA 1.449 -0.511 0 C-N-CA 125.11 1.364 . . . . 72.54 108.587 -177.146 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -59.82 -24.93 77.76 Favored 'Trans proline' 0 CA--C 1.535 0.558 0 CA-C-N 120.833 1.333 . . . . 60.25 112.291 -175.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 14.1 m170 -74.57 -15.31 60.85 Favored 'General case' 0 CA--C 1.538 0.489 0 O-C-N 121.233 -0.917 . . . . 74.14 112.403 178.039 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 71.5 m -62.25 -43.61 98.43 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 119.356 0.98 . . . . 33.11 108.815 167.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -57.28 -44.84 84.38 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 125.125 1.37 . . . . 74.13 111.013 175.292 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.37 -10.49 11.46 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 114.005 1.113 . . . . 62.32 114.005 -179.269 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.437 ' HB2' HD11 ' A' ' 166' ' ' ILE . 6.2 t80 -119.51 -25.54 5.99 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-O 117.221 -1.371 . . . . 73.33 112.537 -169.096 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -37.86 -67.5 0.25 Allowed Pre-proline 0 N--CA 1.472 0.659 0 C-N-CA 125.902 1.681 . . . . 74.11 113.378 179.078 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -70.84 -5.48 16.99 Favored 'Trans proline' 0 CA--C 1.537 0.639 0 CA-C-N 121.249 1.482 . . . . 74.13 114.067 -173.017 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.9 m -103.75 4.47 35.27 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 128.501 2.72 . . . . 72.31 110.647 177.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 16.8 tt -131.32 -30.52 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-N 120.406 1.457 . . . . 71.53 111.74 171.271 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 18.3 t -45.69 -64.87 0.77 Allowed Pre-proline 0 CA--C 1.537 0.464 0 C-N-CA 125.096 1.358 . . . . 74.33 110.168 173.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -69.33 -28.86 26.82 Favored 'Trans proline' 0 N--CA 1.451 -0.972 0 CA-C-N 120.791 1.318 . . . . 73.13 111.029 -172.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.489 ' CH2' ' HB1' ' A' ' 179' ' ' ALA . 70.7 t90 -59.2 -53.29 60.0 Favored 'General case' 0 C--N 1.341 0.198 0 CA-C-N 119.093 0.861 . . . . 74.11 109.581 174.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 90.6 p -58.77 -39.75 81.95 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 122.244 0.218 . . . . 61.12 111.07 -176.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -70.93 -12.94 61.83 Favored 'General case' 0 CA--C 1.54 0.587 0 O-C-N 121.154 -0.966 . . . . 73.25 112.874 178.153 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 68.4 mmtt -103.76 -2.03 27.05 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 125.771 1.628 . . . . 60.32 114.154 175.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 18.4 mt -54.93 147.68 31.74 Favored Pre-proline 0 N--CA 1.452 -0.327 0 CA-C-N 119.714 1.143 . . . . 42.35 110.997 -178.394 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -74.46 164.89 32.95 Favored 'Trans proline' 0 N--CA 1.439 -1.696 0 C-N-CA 123.346 2.698 . . . . 54.03 109.82 -176.161 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -65.43 1.02 1.26 Allowed 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.03 1.332 . . . . 64.33 114.009 178.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -98.73 0.09 43.83 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 127.965 2.506 . . . . 54.54 112.107 -179.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 57.5 t -131.81 157.09 43.08 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 C-N-CA 124.518 1.127 . . . . 75.52 108.569 -169.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 78.9 t60 -132.64 138.89 47.51 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 107.499 -1.297 . . . . 72.21 107.499 162.061 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 73.4 t80 -106.0 144.13 33.15 Favored 'General case' 0 CA--C 1.519 -0.224 0 N-CA-C 107.915 -1.143 . . . . 65.34 107.915 179.095 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 48.6 t -136.86 148.83 26.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 N-CA-C 108.239 -1.022 . . . . 73.12 108.239 178.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 23.1 mtt180 -115.47 128.08 55.77 Favored 'General case' 0 CA--C 1.513 -0.467 0 N-CA-C 105.867 -1.901 . . . . 73.25 105.867 165.409 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 23.5 mt -128.41 149.95 73.0 Favored Pre-proline 0 N--CA 1.467 0.391 0 CA-C-N 118.616 0.644 . . . . 73.25 111.173 170.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -78.29 129.62 9.62 Favored 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 122.482 2.122 . . . . 60.42 111.363 178.058 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -76.74 120.33 21.76 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.971 1.308 . . . . 62.32 110.179 174.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 47.7 mt -107.62 56.93 0.63 Allowed 'General case' 0 C--O 1.232 0.146 0 O-C-N 121.026 -1.046 . . . . 72.32 113.456 -167.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -77.33 53.26 1.01 Allowed 'General case' 0 CA--C 1.548 0.869 0 N-CA-C 113.456 0.91 . . . . 72.11 113.456 -176.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 80.29 -54.28 4.52 Favored Glycine 0 CA--C 1.53 1.02 0 C-N-CA 126.693 2.092 . . . . 61.43 114.486 155.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -82.52 -150.98 9.27 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 125.639 1.59 . . . . 62.21 110.377 172.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 9.7 tp -50.29 -19.88 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 C-N-CA 126.648 1.979 . . . . 72.22 113.604 -172.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 28.1 m95 -49.42 -52.93 25.53 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 125.484 1.513 . . . . 75.14 112.16 173.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 20.0 p30 -75.22 -29.58 60.31 Favored 'General case' 0 CA--C 1.522 -0.118 0 N-CA-C 112.288 0.477 . . . . 62.11 112.288 -178.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 81.5 t -61.32 -50.48 80.26 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.33 0 N-CA-C 107.809 -1.182 . . . . 73.55 107.809 174.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 60.8 m170 -70.44 14.63 0.12 Allowed 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 125.714 1.605 . . . . 72.22 113.004 173.122 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -129.58 -33.37 0.53 Allowed Glycine 0 CA--C 1.528 0.845 0 O-C-N 119.914 -1.741 . . . . 53.45 113.352 -173.086 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -64.71 -36.42 84.23 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 117.961 0.88 . . . . 63.13 111.073 -176.285 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -60.1 -45.04 94.28 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-O 116.37 -1.776 . . . . 71.22 112.126 179.644 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 25.9 t80 -52.22 -48.99 64.81 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 120.33 1.423 . . . . 54.51 109.935 -176.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 13.3 mt -67.04 -37.49 84.2 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 118.234 -0.889 . . . . 64.21 109.486 -178.03 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.3 m -63.74 -39.57 94.62 Favored 'General case' 0 C--N 1.342 0.253 0 CA-C-N 119.756 1.162 . . . . 72.22 111.407 174.169 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.414 HD22 HG23 ' A' ' 86' ' ' VAL . 0.4 OUTLIER -60.4 -54.02 50.59 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 125.44 1.496 . . . . 65.53 107.035 -179.447 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.422 ' HA ' ' CG1' ' A' ' 86' ' ' VAL . 3.2 mt-10 -63.69 -31.41 72.57 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 112.592 0.59 . . . . 71.11 112.592 178.316 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.9 t -54.5 -19.15 5.25 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 118.003 -0.998 . . . . 71.33 112.288 171.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 9.1 mtp -107.25 -9.69 16.02 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 115.33 1.604 . . . . 75.34 115.33 -174.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 105.7 -11.5 46.07 Favored Glycine 0 CA--C 1.525 0.717 0 CA-C-O 118.116 -1.38 . . . . 43.23 113.025 175.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.422 ' CG1' ' HA ' ' A' ' 82' ' ' GLU . 6.2 p 44.13 82.37 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 C-N-CA 125.904 1.682 . . . . 40.34 115.02 151.134 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -46.83 117.59 1.73 Allowed 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 126.166 1.786 . . . . 73.33 110.225 177.436 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 20.2 m-70 -59.41 -24.72 63.7 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 116.079 -0.509 . . . . 63.54 110.979 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -60.56 -10.49 5.17 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.603 1.161 . . . . 51.34 113.271 176.341 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 33.2 m -121.69 2.67 6.38 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 CA-C-N 120.773 1.624 . . . . 41.44 113.438 178.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -57.65 -20.8 35.95 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 115.52 1.674 . . . . 71.54 115.52 -172.203 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -86.61 -56.04 3.6 Favored 'General case' 0 CA--C 1.513 -0.472 0 C-N-CA 124.37 1.068 . . . . 75.41 109.432 172.092 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -49.69 -30.96 10.08 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.433 1.093 . . . . 54.41 112.971 -171.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 70.2 t -54.58 -61.58 0.96 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.841 0 C-N-CA 123.925 0.89 . . . . 60.23 111.157 171.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -71.99 -35.23 69.41 Favored 'General case' 0 N--CA 1.473 0.693 0 O-C-N 119.966 -1.709 . . . . 75.53 111.785 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -67.73 -12.31 60.25 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.003 0.921 . . . . 72.41 111.46 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -84.46 -16.57 42.07 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.259 1.024 . . . . 73.11 111.547 173.092 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.616 HD13 HD12 ' A' ' 105' ' ' LEU . 10.0 mm -96.16 -37.14 7.04 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 C-N-CA 124.546 1.138 . . . . 72.32 110.243 -176.438 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 88.1 m-70 -103.74 -64.78 1.06 Allowed 'General case' 0 C--O 1.233 0.21 0 C-N-CA 122.838 0.455 . . . . 73.44 110.667 -169.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 21.3 mtpt -63.26 -15.94 58.72 Favored 'General case' 0 N--CA 1.464 0.27 0 O-C-N 121.876 -0.515 . . . . 64.42 111.309 177.247 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -123.83 -58.41 1.58 Allowed 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.565 1.146 . . . . 73.41 112.4 -173.015 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 2.4 t60 63.94 62.53 0.88 Allowed 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.749 1.62 . . . . 71.32 112.448 -176.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 7.8 mmmt -77.91 22.51 0.28 Allowed 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 127.628 2.371 . . . . 72.43 113.916 -178.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 18.0 ttpp 46.53 40.29 8.02 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 126.309 1.844 . . . . 62.11 111.669 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.616 HD12 HD13 ' A' ' 98' ' ' ILE . 40.3 mt -72.67 59.51 0.46 Allowed 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 129.61 3.164 . . . . 63.12 109.313 178.482 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -106.42 10.98 31.32 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 128.386 2.674 . . . . 42.25 111.429 -172.252 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -150.75 157.4 35.97 Favored Pre-proline 0 C--N 1.328 -0.335 0 C-N-CA 124.645 1.178 . . . . 74.41 109.497 -175.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -66.14 -42.43 10.8 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 121.905 1.737 . . . . 71.42 109.973 -175.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -55.98 -53.56 55.38 Favored 'General case' 0 N--CA 1.437 -1.098 0 C-N-CA 124.011 0.924 . . . . 71.34 111.86 173.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 24.0 tp10 -62.35 -41.19 98.39 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 118.206 0.457 . . . . 71.33 109.988 -175.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 38.5 mtt -60.65 -51.05 71.05 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 123.056 0.542 . . . . 63.52 110.335 175.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.432 ' HB1' ' HG3' ' A' ' 122' ' ' LYS . . . -61.71 -44.0 97.76 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 124.678 1.191 . . . . 62.34 110.329 -177.28 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -66.57 -4.93 9.66 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.624 1.57 . . . . 75.53 112.414 177.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -95.54 -54.76 3.26 Favored 'General case' 0 C--O 1.234 0.266 0 O-C-N 120.061 -1.649 . . . . 55.04 109.669 163.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 33.7 mt -65.37 -15.4 62.53 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 124.123 0.969 . . . . 62.22 112.066 -172.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -57.92 -16.81 13.35 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.078 0.951 . . . . 60.13 111.805 172.394 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -105.84 8.07 42.43 Favored Glycine 0 CA--C 1.531 1.043 0 C-N-CA 125.304 1.431 . . . . 60.53 114.43 171.013 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 30.1 mmtm -134.88 42.05 2.82 Favored 'General case' 0 C--O 1.225 -0.221 0 CA-C-N 119.751 1.776 . . . . 51.25 109.046 -172.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 70.49 42.09 64.85 Favored Glycine 0 C--N 1.336 0.541 0 N-CA-C 111.901 -0.48 . . . . 74.11 111.901 169.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 65.9 t -134.0 115.18 20.73 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 CA-C-O 122.601 1.191 . . . . 51.33 108.869 178.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 49.9 t0 -67.99 123.69 21.33 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 115.164 -0.926 . . . . 75.33 109.926 166.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.432 ' HG3' ' HB1' ' A' ' 112' ' ' ALA . 5.2 ttmt -62.51 -35.35 79.11 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 122.895 0.478 . . . . 75.15 110.233 175.088 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 61.7 mm-40 -64.76 -22.03 66.89 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 123.548 0.739 . . . . 71.43 111.69 179.135 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 67.9 mmtt -91.25 -53.28 4.42 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 107.937 -1.134 . . . . 75.41 107.937 176.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -47.39 -69.45 0.13 Allowed 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 126.348 1.859 . . . . 75.12 111.399 -175.381 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 15.5 mt -63.51 -41.45 98.51 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 118.655 0.661 . . . . 62.32 110.409 -167.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 35.3 t -59.87 -54.2 49.0 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 125.368 1.467 . . . . 74.14 109.549 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 30.2 m -64.57 -40.02 94.8 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.426 1.09 . . . . 62.24 109.72 -175.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -57.03 -47.48 80.81 Favored 'General case' 0 C--O 1.231 0.108 0 C-N-CA 124.293 1.037 . . . . 71.14 108.952 176.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -84.7 29.43 0.61 Allowed 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 126.685 1.994 . . . . 62.41 111.771 -177.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 3.2 t -115.14 165.92 12.39 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 124.573 1.149 . . . . 64.14 111.072 -171.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -59.77 -33.38 71.62 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.509 1.124 . . . . 65.41 110.769 170.294 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -52.84 -54.56 32.58 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 124.562 1.145 . . . . 71.11 111.258 -176.13 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 48.3 mm -74.92 -25.82 18.87 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 CA-C-O 119.226 -0.416 . . . . 73.21 110.393 -175.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 12.8 tttt -53.78 -41.42 67.2 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 124.386 1.074 . . . . 63.41 109.813 170.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -67.99 -22.33 74.0 Favored Glycine 0 CA--C 1.528 0.854 0 C-N-CA 124.205 0.907 . . . . 64.41 113.549 -178.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -88.85 -43.22 11.37 Favored 'General case' 0 N--CA 1.455 -0.182 0 O-C-N 121.421 -1.046 . . . . 72.34 109.357 174.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 4.2 mtp -57.38 -41.53 80.39 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 112.836 0.68 . . . . 72.42 112.836 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 22.9 pt-20 -60.28 -49.28 78.23 Favored 'General case' 0 C--O 1.233 0.205 0 O-C-N 121.95 -0.469 . . . . 73.35 111.171 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 76.1 mttt -60.64 -59.11 5.92 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 124.12 0.968 . . . . 61.24 108.603 178.285 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -53.13 -41.41 65.05 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 118.87 -0.586 . . . . 64.13 111.522 -174.121 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 26.8 ttmt -64.83 -59.9 3.68 Favored 'General case' 0 C--N 1.344 0.334 0 CA-C-N 119.015 0.825 . . . . 73.52 109.932 -179.365 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.39 -28.91 70.11 Favored 'General case' 0 C--N 1.343 0.308 0 CA-C-N 118.612 0.642 . . . . 61.52 110.746 -174.056 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 52.1 mt -68.52 -52.16 35.11 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-O 118.675 -0.679 . . . . 71.32 110.606 177.429 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -55.78 -50.42 70.51 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 118.97 0.804 . . . . 73.43 111.437 -175.093 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -59.13 -47.59 84.73 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 118.938 -0.554 . . . . 61.14 111.776 176.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -71.42 -21.25 62.01 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 119.303 0.956 . . . . 65.12 111.589 -174.292 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 21.5 m-85 -77.93 10.84 2.54 Favored 'General case' 0 CA--C 1.541 0.609 0 O-C-N 121.002 -1.061 . . . . 75.24 112.564 170.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 53.62 34.05 17.85 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 126.778 2.031 . . . . 72.42 112.534 -177.145 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 34.8 t -75.72 141.85 15.26 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 N-CA-C 107.415 -1.328 . . . . 42.04 107.415 174.184 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -135.69 -4.02 2.29 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 124.452 1.101 . . . . 61.52 112.621 170.619 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -160.48 177.54 36.86 Favored Glycine 0 N--CA 1.448 -0.501 0 N-CA-C 109.843 -1.303 . . . . 60.54 109.843 -176.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.553 HG23 ' HB3' ' A' ' 37' ' ' CYS . 23.7 m -145.26 149.22 40.69 Favored Pre-proline 0 C--O 1.238 0.487 0 C-N-CA 124.336 1.054 . . . . 65.44 108.974 -179.439 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . 0.425 ' C ' ' HA ' ' A' ' 153' ' ' VAL . 41.0 Cg_endo -67.64 153.87 86.52 Favored 'Cis proline' 0 C--O 1.237 0.447 0 C-N-CA 125.195 -0.752 . . . . 64.31 112.728 0.325 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 55.0 m -150.7 127.54 11.0 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 125.305 1.442 . . . . 71.32 107.367 177.357 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 91.1 mtp -105.42 157.85 17.06 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-O 122.171 0.986 . . . . 73.53 109.161 168.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 21.4 t -141.01 149.64 20.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 106.858 -1.534 . . . . 63.23 106.858 177.085 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 41.4 t -122.62 123.56 68.69 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 C-N-CA 125.958 1.703 . . . . 65.22 106.648 172.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 56.48 16.51 2.52 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 127.37 2.268 . . . . 63.32 114.782 167.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 60.81 33.89 84.86 Favored Glycine 0 CA--C 1.528 0.889 0 CA-C-O 118.205 -1.331 . . . . 52.05 113.867 -169.117 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 61.9 mttt -132.04 -33.31 1.35 Allowed 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 119.457 1.629 . . . . 72.54 113.262 -177.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -122.63 122.61 39.23 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 107.444 -1.317 . . . . 73.41 107.444 -178.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 35.9 ttp180 -103.33 137.73 41.06 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 104.805 -2.295 . . . . 71.43 104.805 170.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 21.1 p90 -152.65 162.24 41.51 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 107.075 -1.454 . . . . 73.25 107.075 176.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -171.08 176.55 3.96 Favored 'General case' 0 CA--C 1.514 -0.426 0 N-CA-C 109.235 -0.654 . . . . 60.52 109.235 -178.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.437 HD11 ' HB2' ' A' ' 43' ' ' PHE . 40.5 mt -47.78 -49.45 10.55 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 C-N-CA 126.881 2.072 . . . . 73.51 110.34 -177.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -84.51 0.14 89.28 Favored Glycine 0 CA--C 1.522 0.525 0 CA-C-O 118.788 -1.007 . . . . 41.22 113.767 -177.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 10.5 m -90.85 -66.27 0.94 Allowed 'General case' 0 N--CA 1.456 -0.157 0 CA-C-N 119.872 1.836 . . . . 73.15 107.179 161.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.6 ' HB1' HD23 ' A' ' 178' ' ' LEU . . . -70.13 -30.5 67.7 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-O 117.446 -1.264 . . . . 72.42 113.154 -161.276 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 129.86 22.09 1.18 Allowed Glycine 0 CA--C 1.538 1.51 0 N-CA-C 116.247 1.259 . . . . 62.41 116.247 171.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 113.12 164.28 15.89 Favored Glycine 0 CA--C 1.532 1.113 0 CA-C-N 120.028 1.914 . . . . 33.1 110.249 -176.36 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -63.23 -32.06 73.89 Favored 'Trans proline' 0 CA--C 1.536 0.622 0 CA-C-N 120.53 2.165 . . . . 43.33 113.816 -156.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 80.9 mt-10 -71.64 -29.94 65.2 Favored 'General case' 0 C--O 1.232 0.184 0 O-C-N 121.004 -1.06 . . . . 52.42 111.559 176.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -72.99 -24.79 60.81 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 122.773 0.429 . . . . 64.33 110.613 173.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 3.1 m -65.24 -45.57 84.08 Favored 'General case' 0 C--O 1.233 0.217 0 O-C-N 121.014 -1.054 . . . . 62.54 109.296 -175.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 39.8 mt -60.56 -33.42 72.67 Favored 'General case' 0 C--O 1.225 -0.213 0 CA-C-N 118.235 0.47 . . . . 54.21 111.206 175.214 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 10.3 tttt -58.05 -35.14 70.9 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-O 118.091 -0.956 . . . . 73.53 110.207 179.075 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.6 HD23 ' HB1' ' A' ' 169' ' ' ALA . 4.5 mm? -78.94 -44.89 21.6 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-N 119.359 0.982 . . . . 75.32 110.299 171.371 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.489 ' HB1' ' CH2' ' A' ' 50' ' ' TRP . . . -55.38 -31.49 61.85 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 118.604 0.638 . . . . 65.41 112.649 -175.652 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -90.61 -44.41 9.55 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 124.699 1.199 . . . . 42.43 109.41 -171.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 25.5 t80 -61.18 -49.21 78.12 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 121.382 0.611 . . . . 72.22 110.604 175.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 89.7 mt -63.07 -21.29 66.07 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 123.879 0.871 . . . . 71.24 112.491 -174.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 28.4 mt -57.36 -59.32 3.37 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.306 0 N-CA-C 107.395 -1.335 . . . . 72.14 107.395 168.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -56.52 -38.55 71.98 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 120.083 1.311 . . . . 73.42 111.618 -177.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 2.7 tmtt? -59.39 -39.82 84.6 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.249 0.619 . . . . 73.34 110.457 -178.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -89.05 -31.14 18.2 Favored 'General case' 0 CA--C 1.517 -0.301 0 O-C-N 121.424 -0.798 . . . . 71.35 112.75 177.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -60.55 -35.89 77.14 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.741 0.781 . . . . 74.25 111.039 -177.537 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -69.42 -10.09 56.44 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 123.719 0.808 . . . . 52.41 112.636 176.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -64.65 -47.26 79.14 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 119.921 1.237 . . . . 54.01 109.765 169.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -75.75 -39.29 57.42 Favored 'General case' 0 CA--C 1.528 0.101 0 O-C-N 123.684 0.615 . . . . 55.42 110.233 176.065 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 53.74 78.06 0.16 Allowed 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 126.391 1.877 . . . . 73.53 111.114 -177.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.245 0.834 0 C-N-CA 125.526 1.53 . . . . 64.13 110.696 -173.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.508 -0.356 0 N-CA-C 109.129 -1.588 . . . . 63.34 109.129 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -138.04 152.23 48.63 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 107.3 -1.37 . . . . 61.45 107.3 151.16 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 27.3 t0 -141.9 15.41 2.11 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 125.991 1.716 . . . . 71.32 110.023 -178.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 -155.34 153.22 30.17 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 126.581 1.953 . . . . 74.41 108.086 -173.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 74.7 m -128.25 144.59 51.14 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 121.337 0.589 . . . . 74.2 110.02 -172.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -70.1 144.42 52.1 Favored 'General case' 0 N--CA 1.456 -0.127 0 O-C-N 121.375 -0.828 . . . . 52.24 109.196 -179.056 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 67.44 -15.17 0.44 Allowed Glycine 0 CA--C 1.532 1.14 0 C-N-CA 126.05 1.786 . . . . 63.14 113.45 -167.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -94.54 -60.25 1.75 Allowed 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 125.218 1.407 . . . . 64.23 107.594 -171.104 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -106.57 -25.59 11.75 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 126.423 1.889 . . . . 75.01 110.18 -177.167 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 41.1 p90 -153.48 170.15 21.45 Favored 'General case' 0 C--N 1.332 -0.164 0 O-C-N 120.895 -1.128 . . . . 75.02 110.266 -171.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 26.8 t -128.93 103.42 9.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 107.158 -1.423 . . . . 54.24 107.158 -176.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -80.78 169.85 17.06 Favored 'General case' 0 C--O 1.237 0.446 0 O-C-N 119.243 -2.161 . . . . 54.43 109.672 174.705 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -127.59 110.88 13.14 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 107.543 -1.28 . . . . 75.22 107.543 -177.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -60.33 -14.27 17.51 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.824 1.649 . . . . 72.41 112.814 175.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 4.0 p -109.52 85.06 3.44 Favored Pre-proline 0 N--CA 1.451 -0.39 0 N-CA-C 107.618 -1.253 . . . . 74.35 107.618 166.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -67.52 179.35 2.6 Favored 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 122.479 2.119 . . . . 74.23 111.038 178.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 31.0 t -134.47 139.57 33.1 Favored Pre-proline 0 CA--C 1.536 0.425 0 N-CA-C 107.55 -1.278 . . . . 62.52 107.55 -178.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -75.58 177.25 8.92 Favored 'Trans proline' 0 CA--C 1.536 0.588 0 C-N-CA 122.937 2.425 . . . . 73.41 110.577 173.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 35.4 m -139.86 166.85 20.01 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 C-N-CA 123.426 0.69 . . . . 60.3 110.859 179.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 3.4 t -54.43 -60.1 3.8 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 126.26 1.824 . . . . 71.43 110.027 172.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 4.1 tp-100 -120.71 84.97 38.23 Favored Pre-proline 0 N--CA 1.454 -0.243 0 C-N-CA 125.335 1.454 . . . . 73.21 108.316 -163.155 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -67.75 -8.71 23.22 Favored 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 122.18 1.92 . . . . 75.3 112.183 177.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -61.21 -25.59 64.83 Favored Glycine 0 CA--C 1.53 1.022 0 O-C-N 120.848 -1.157 . . . . 65.23 112.118 168.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 56.2 mttm -125.66 150.87 47.24 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-N 119.391 1.595 . . . . 73.03 109.39 -179.157 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 51.2 mm -78.09 127.62 38.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 106.28 -1.748 . . . . 55.32 106.28 177.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -91.24 118.71 30.71 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 107.716 -1.216 . . . . 64.03 107.716 -174.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 42.1 t -120.42 115.94 48.67 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 N-CA-C 106.985 -1.487 . . . . 64.32 106.985 -178.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 16.8 t -124.48 103.59 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 N-CA-C 107.642 -1.244 . . . . 71.14 107.642 -163.299 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -67.67 135.83 53.4 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 125.48 1.512 . . . . 74.31 108.594 164.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.0 mp -119.85 125.61 48.94 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 124.741 1.216 . . . . 75.25 107.72 160.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -130.77 164.27 25.49 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.086 0.954 . . . . 65.23 111.222 -174.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 25.9 t90 -143.27 142.58 31.41 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.163 0.985 . . . . 74.42 109.975 177.257 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 5.7 m-30 -61.57 -25.5 67.36 Favored 'General case' 0 CA--C 1.533 0.309 0 O-C-N 121.757 -0.59 . . . . 74.41 111.505 175.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -91.57 19.9 44.87 Favored Glycine 0 CA--C 1.53 1.026 0 CA-C-O 118.53 -1.15 . . . . 73.44 113.255 -179.349 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 46.1 t -104.46 85.66 1.18 Allowed Pre-proline 0 CA--C 1.541 0.606 0 C-N-CA 125.281 1.432 . . . . 60.51 110.719 -173.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_endo -67.17 5.28 0.89 Allowed 'Trans proline' 0 CA--C 1.536 0.619 0 C-N-CA 124.672 3.581 . . . . 72.22 114.606 179.164 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 22.9 m170 -107.11 -20.02 13.43 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 126.27 1.828 . . . . 64.11 111.546 175.193 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 94.4 m -78.82 -34.55 45.15 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.602 0.761 . . . . 74.54 110.901 -175.238 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 14.1 t80 -55.91 -41.4 74.49 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 124.917 1.287 . . . . 72.1 110.575 178.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -45.39 -51.7 10.94 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 125.766 1.626 . . . . 64.42 110.859 179.302 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -84.39 -21.23 30.89 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 125.791 1.636 . . . . 75.23 112.695 -167.075 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 59.0 mm-40 -45.15 -62.59 1.58 Allowed Pre-proline 0 N--CA 1.469 0.505 0 CA-C-N 120.001 1.273 . . . . 61.54 112.562 -176.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -71.11 -5.13 16.3 Favored 'Trans proline' 0 CA--C 1.538 0.724 0 C-N-CA 121.839 1.693 . . . . 60.34 114.455 -178.032 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 74.7 m -87.74 -34.69 18.26 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 119.643 1.11 . . . . 75.3 109.561 168.22 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 19.2 tt -92.78 -29.05 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 CA-C-N 119.708 1.14 . . . . 63.12 112.189 -174.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 38.6 t -49.19 -62.92 1.94 Allowed Pre-proline 0 CA--C 1.536 0.437 0 CA-C-O 117.797 -1.097 . . . . 75.51 109.943 170.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -66.3 -25.38 49.6 Favored 'Trans proline' 0 N--CA 1.451 -0.973 0 CA-C-N 120.737 1.299 . . . . 75.14 112.591 -173.298 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.407 ' CZ2' HD21 ' A' ' 54' ' ' LEU . 58.4 t90 -65.88 -54.92 20.34 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 123.564 0.746 . . . . 61.53 110.406 173.345 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 88.8 p -57.61 -38.66 75.3 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.187 0.595 . . . . 63.31 112.24 -170.363 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 72.2 mt-10 -59.13 -36.84 75.9 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.796 1.238 . . . . 75.14 111.291 177.208 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 4.7 mmmm -92.51 2.82 56.46 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 125.35 1.46 . . . . 74.53 112.019 -167.094 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.407 HD21 ' CZ2' ' A' ' 50' ' ' TRP . 33.7 mt -62.06 155.98 61.01 Favored Pre-proline 0 C--O 1.239 0.502 0 C-N-CA 125.558 1.543 . . . . 71.23 112.122 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -81.4 171.57 13.5 Favored 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 125.143 3.895 . . . . 72.44 112.452 -177.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -69.12 -2.34 9.99 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 126.513 1.925 . . . . 73.51 115.28 -177.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -115.79 0.24 13.11 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.756 1.222 . . . . 74.22 111.939 -178.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 86.1 t -96.71 150.6 4.36 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 N-CA-C 107.751 -1.203 . . . . 73.01 107.751 168.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 33.8 t60 -129.94 99.6 5.16 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 124.983 1.313 . . . . 71.45 107.829 165.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 51.4 t80 -77.21 145.23 37.73 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 114.9 -1.046 . . . . 75.25 109.606 178.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 21.6 t -142.09 157.04 19.93 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 C-N-CA 125.998 1.719 . . . . 74.03 107.695 -177.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 57.7 mtt180 -130.56 131.74 45.19 Favored 'General case' 0 N--CA 1.462 0.144 0 N-CA-C 107.793 -1.188 . . . . 74.03 107.793 163.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 37.3 mt -133.63 157.35 78.17 Favored Pre-proline 0 N--CA 1.468 0.438 0 C-N-CA 124.532 1.133 . . . . 71.0 108.935 176.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -74.85 164.72 32.94 Favored 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 121.381 1.388 . . . . 74.2 111.289 177.608 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -111.45 112.6 24.46 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 125.777 1.631 . . . . 75.11 107.53 -177.03 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 26.8 mt -115.68 60.29 0.71 Allowed 'General case' 0 C--O 1.234 0.274 0 O-C-N 121.489 -0.757 . . . . 73.14 112.602 -161.093 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -65.53 -14.83 61.89 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 114.613 1.338 . . . . 72.02 114.613 -171.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 122.65 -37.78 2.73 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 125.329 1.442 . . . . 64.25 111.763 175.291 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -77.96 -157.77 10.03 Favored Glycine 0 CA--C 1.527 0.787 0 C-N-CA 124.383 0.992 . . . . 75.53 110.844 172.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 6.3 tp -45.11 -24.28 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 127.996 2.519 . . . . 74.11 113.396 179.288 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 37.6 m95 -44.19 -50.72 8.62 Favored 'General case' 0 N--CA 1.441 -0.899 0 C-N-CA 126.657 1.983 . . . . 73.12 111.277 172.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 26.4 p30 -77.71 -29.27 51.21 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 113.852 1.056 . . . . 73.03 113.852 -179.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 73.8 t -60.89 -50.0 82.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 108.757 -0.831 . . . . 72.31 108.757 174.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 55.9 m170 -72.29 -0.65 12.78 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.034 1.734 . . . . 73.24 112.538 171.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -100.51 -14.56 32.14 Favored Glycine 0 CA--C 1.525 0.661 0 CA-C-N 120.205 1.366 . . . . 72.14 112.309 -175.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -96.63 -27.13 14.94 Favored 'General case' 0 N--CA 1.45 -0.473 0 O-C-N 121.792 -0.828 . . . . 60.43 112.102 -159.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -65.11 -42.37 94.02 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-O 116.833 -1.556 . . . . 73.03 111.244 -177.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 7.7 t80 -52.21 -56.13 16.66 Favored 'General case' 0 C--N 1.34 0.194 0 CA-C-N 119.466 1.03 . . . . 74.24 109.01 -176.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 44.5 mt -64.89 -32.07 73.61 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 116.497 -1.716 . . . . 71.52 111.247 -177.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.688 ' CG2' HG23 ' A' ' 128' ' ' THR . 1.3 m -70.3 -38.18 74.93 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 120.77 1.623 . . . . 75.32 111.356 177.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.7 -54.25 47.56 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 124.395 1.078 . . . . 71.22 109.211 175.338 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -56.21 -37.69 70.0 Favored 'General case' 0 C--O 1.226 -0.154 0 C-N-CA 125.139 1.375 . . . . 73.33 110.485 177.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -50.95 -20.31 1.3 Allowed 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.538 1.535 . . . . 54.52 113.769 176.443 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 53.6 mtm -99.78 -7.92 24.86 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 120.422 1.465 . . . . 72.2 113.992 176.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 68.6 46.4 62.17 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 109.804 -1.318 . . . . 75.14 109.804 -178.469 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 10.8 m -58.6 93.8 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 C-N-CA 125.102 1.361 . . . . 70.24 111.904 178.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -84.82 14.0 5.26 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.065 1.346 . . . . 70.33 111.997 -176.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 14.8 m-70 -79.07 52.89 1.34 Allowed 'General case' 0 C--O 1.238 0.495 0 C-N-CA 127.271 2.229 . . . . 72.44 111.916 -172.276 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 66.78 179.29 0.22 Allowed 'General case' 0 C--O 1.239 0.548 0 C-N-CA 128.743 2.817 . . . . 64.05 111.521 -171.021 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.2 p -61.27 155.94 3.89 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 C-N-CA 123.524 0.73 . . . . 74.42 109.255 -176.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 1.5 p80 -75.51 35.79 0.12 Allowed 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 114.191 1.182 . . . . 73.12 114.191 -175.272 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -56.41 -66.97 0.35 Allowed 'General case' 0 CA--C 1.515 -0.391 0 C-N-CA 125.044 1.338 . . . . 74.24 109.373 178.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -52.92 -36.74 59.97 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 118.761 -0.638 . . . . 74.21 111.152 -178.345 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 4.1 t -57.43 -51.27 71.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 CA-C-N 119.551 1.068 . . . . 53.21 110.83 -179.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -65.18 -52.84 52.48 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 123.686 0.794 . . . . 75.21 109.256 175.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -58.02 -26.89 62.99 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.605 1.562 . . . . 73.21 110.978 -172.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.44 ' HA ' ' HB2' ' A' ' 101' ' ' GLU . . . -72.91 -16.03 61.57 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 125.822 1.649 . . . . 54.4 113.572 -179.383 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 19.4 mt -92.61 -43.1 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 N-CA-C 107.353 -1.351 . . . . 64.43 107.353 174.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 30.5 p80 -102.86 -64.11 1.1 Allowed 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 113.54 0.941 . . . . 71.33 113.54 -166.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 29.6 mtpt -68.14 -16.06 63.84 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 119.916 1.235 . . . . 65.43 111.783 176.13 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.44 ' HB2' ' HA ' ' A' ' 97' ' ' ALA . 20.9 mt-10 -99.48 -23.32 15.14 Favored 'General case' 0 C--N 1.331 -0.212 0 O-C-N 120.834 -1.166 . . . . 70.51 111.92 171.498 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 7.2 t60 57.4 84.6 0.09 Allowed 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.629 1.572 . . . . 72.2 112.497 172.202 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 8.3 mmtp -136.71 152.23 50.13 Favored 'General case' 0 CA--C 1.52 -0.193 0 C-N-CA 124.187 0.995 . . . . 65.02 111.193 -169.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 9.3 ttmm -71.18 -51.19 26.23 Favored 'General case' 0 C--O 1.224 -0.253 0 N-CA-C 109.261 -0.644 . . . . 73.54 109.261 -177.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 77.9 mt 50.54 32.17 6.39 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.893 1.277 . . . . 62.1 113.514 179.053 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -86.81 8.67 21.82 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 114.768 1.395 . . . . 73.22 114.768 -167.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -143.34 157.84 58.97 Favored Pre-proline 0 N--CA 1.471 0.605 0 O-C-N 120.846 -1.159 . . . . 53.41 109.392 -172.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -58.77 -42.68 50.79 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 121.905 1.736 . . . . 70.35 111.738 -177.151 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -63.05 -53.45 53.62 Favored 'General case' 0 N--CA 1.442 -0.86 0 O-C-N 124.342 1.026 . . . . 73.32 110.486 -178.25 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 44.3 tp10 -58.11 -33.61 69.31 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.362 0.665 . . . . 70.24 111.04 -172.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 69.1 mtm -72.68 -56.86 4.66 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 118.149 -0.929 . . . . 72.32 111.595 169.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -59.63 -49.87 76.06 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 124.764 1.226 . . . . 72.31 112.529 -171.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -68.08 -36.7 80.25 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 124.62 1.168 . . . . 73.3 111.591 -170.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . 0.465 ' CZ ' ' HE3' ' A' ' 118' ' ' LYS . 84.8 t80 -58.06 -38.93 77.27 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.229 0.612 . . . . 70.22 110.878 171.416 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 14.0 mt -77.66 -19.18 55.84 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 123.924 0.89 . . . . 72.12 110.278 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.4 -20.06 58.26 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 121.149 -0.969 . . . . 71.44 111.249 173.239 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -97.06 -6.5 57.86 Favored Glycine 0 CA--C 1.528 0.888 0 CA-C-O 118.877 -0.957 . . . . 64.02 114.112 169.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.465 ' HE3' ' CZ ' ' A' ' 114' ' ' PHE . 48.2 mttm -125.27 61.91 1.19 Allowed 'General case' 0 N--CA 1.456 -0.134 0 CA-C-N 119.938 1.869 . . . . 74.2 108.406 -175.083 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 71.69 18.48 77.34 Favored Glycine 0 CA--C 1.525 0.661 0 CA-C-O 119.021 -0.877 . . . . 65.44 114.646 161.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 28.3 t -125.89 139.88 50.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 C-N-CA 125.707 1.603 . . . . 62.53 108.04 -176.608 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 65.5 t0 -85.68 121.2 28.01 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 107.712 -1.218 . . . . 54.31 107.712 167.409 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 15.3 ttpt -57.32 -35.62 70.09 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 124.053 0.941 . . . . 75.33 110.394 176.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -65.68 -39.6 91.47 Favored 'General case' 0 N--CA 1.454 -0.26 0 O-C-N 121.491 -0.756 . . . . 64.32 111.566 178.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.457 ' O ' HG22 ' A' ' 128' ' ' THR . 46.0 mttm -75.68 -44.25 43.2 Favored 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 106.819 -1.548 . . . . 74.22 106.819 -173.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -49.02 -68.06 0.21 Allowed 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 125.605 1.562 . . . . 72.45 110.579 174.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 18.3 mt -65.33 -32.59 74.32 Favored 'General case' 0 C--O 1.234 0.253 0 O-C-N 121.379 -0.825 . . . . 72.2 111.155 -170.433 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 35.7 t -56.98 -58.26 8.92 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 107.637 -1.245 . . . . 75.1 107.637 177.017 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . 0.688 HG23 ' CG2' ' A' ' 80' ' ' THR 0.341 10.1 t -71.79 -30.13 65.2 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 119.919 -0.712 . . . . 74.12 110.864 -175.32 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 31.1 t80 -54.65 -35.36 63.4 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 120.646 -1.283 . . . . 74.45 111.085 174.228 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -102.72 18.14 22.12 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.618 1.167 . . . . 34.1 112.744 179.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 28.8 m -104.53 160.99 14.49 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 125.652 1.581 . . . . 73.3 111.926 176.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -59.9 -25.97 65.54 Favored 'General case' 0 CA--C 1.532 0.288 0 O-C-N 122.143 -0.348 . . . . 51.02 111.058 171.051 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -50.01 -28.75 7.42 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 125.386 1.474 . . . . 52.3 113.304 173.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.501 HD11 ' HA ' ' A' ' 80' ' ' THR . 5.5 mm -101.64 -36.06 4.49 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 C-N-CA 125.159 1.384 . . . . 74.42 110.671 176.366 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 35.3 tttm -53.91 -39.06 65.47 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 124.073 0.949 . . . . 75.43 110.463 174.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -72.55 -16.05 77.57 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 125.152 1.358 . . . . 51.14 111.916 -170.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -99.1 -39.22 8.6 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 123.393 0.677 . . . . 73.03 109.494 176.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 75.6 mmm -58.47 -37.83 76.32 Favored 'General case' 0 C--N 1.342 0.257 0 N-CA-C 109.77 -0.456 . . . . 64.14 109.77 177.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -59.66 -51.53 69.41 Favored 'General case' 0 CA--C 1.535 0.374 0 O-C-N 121.303 -0.873 . . . . 71.4 110.737 173.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 4.3 mmtp -61.98 -58.14 9.01 Favored 'General case' 0 C--N 1.344 0.327 0 CA-C-O 117.987 -1.006 . . . . 73.21 111.47 -175.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -59.5 -30.75 68.79 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 119.474 1.034 . . . . 51.2 110.671 -176.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 2.2 tmpt? -66.16 -58.87 4.48 Favored 'General case' 0 C--N 1.344 0.357 0 O-C-N 121.035 -1.04 . . . . 73.21 109.99 176.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 15.2 ptpt -62.61 -37.82 87.78 Favored 'General case' 0 C--N 1.341 0.22 0 CA-C-O 118.611 -0.709 . . . . 73.44 109.499 -173.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 35.7 mt -57.89 -59.77 4.73 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.467 1.107 . . . . 64.44 110.984 175.363 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -56.01 -40.61 73.63 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 119.03 0.832 . . . . 75.23 111.765 -175.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -63.25 -50.52 69.84 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 109.918 -0.401 . . . . 74.33 109.918 175.503 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -69.67 -22.44 63.44 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-O 118.572 -0.727 . . . . 72.13 112.4 -172.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -73.98 -8.27 55.49 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 125.37 1.468 . . . . 72.52 113.864 171.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 52.61 72.66 0.39 Allowed 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 124.793 1.237 . . . . 75.31 110.919 -167.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 47.4 t -101.63 145.83 10.93 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 N-CA-C 107.457 -1.312 . . . . 71.22 107.457 166.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -123.27 -13.89 7.58 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 123.629 0.772 . . . . 70.5 112.787 172.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -159.35 -163.7 13.59 Favored Glycine 0 C--N 1.334 0.431 0 O-C-N 121.047 -1.033 . . . . 75.32 113.213 179.051 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.451 ' HA ' ' C ' ' A' ' 154' ' ' PRO . 15.4 m -144.11 146.78 35.1 Favored Pre-proline 0 C--N 1.328 -0.335 0 C-N-CA 126.102 1.761 . . . . 65.44 107.086 173.055 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . 0.451 ' C ' ' HA ' ' A' ' 153' ' ' VAL . 60.8 Cg_endo -67.31 150.95 83.68 Favored 'Cis proline' 0 N--CA 1.46 -0.479 0 C-N-CA 125.2 -0.75 . . . . 64.42 112.149 1.524 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 85.8 m -151.15 127.75 10.81 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 105.769 -1.937 . . . . 42.51 105.769 174.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 14.6 mmm -110.81 150.81 28.6 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 106.569 -1.641 . . . . 72.14 106.569 165.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 46.6 t -129.11 128.91 67.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 107.114 -1.439 . . . . 73.21 107.114 171.301 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.503 HG23 ' CE1' ' A' ' 164' ' ' PHE . 77.4 t -93.1 123.04 45.06 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 N-CA-C 107.48 -1.304 . . . . 62.23 107.48 164.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 2.7 t30 64.58 11.74 6.92 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 129.114 2.966 . . . . 60.54 115.52 159.242 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 71.19 23.33 78.19 Favored Glycine 0 CA--C 1.526 0.742 0 CA-C-O 117.711 -1.605 . . . . 74.42 112.973 -170.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 35.9 mttt -133.58 -30.18 1.3 Allowed 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 120.043 1.921 . . . . 65.42 112.402 -175.473 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 80.3 m-85 -124.34 115.01 20.31 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 118.943 -0.551 . . . . 74.5 110.864 -179.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 6.3 ptt180 -96.01 141.41 29.45 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 106.685 -1.598 . . . . 61.25 106.685 171.171 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . 0.503 ' CE1' HG23 ' A' ' 158' ' ' VAL . 15.1 p90 -151.71 164.84 36.08 Favored 'General case' 0 C--N 1.309 -1.154 0 O-C-N 120.721 -1.237 . . . . 73.04 108.376 176.635 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -168.19 169.12 11.19 Favored 'General case' 0 CA--C 1.513 -0.445 0 CA-C-N 116.001 -0.545 . . . . 73.21 109.611 -174.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.442 HD12 ' HG3' ' A' ' 154' ' ' PRO . 42.0 mt -51.73 -47.79 38.57 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 C-N-CA 125.41 1.484 . . . . 62.32 109.702 -175.115 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -84.13 -4.65 88.16 Favored Glycine 0 CA--C 1.527 0.791 0 CA-C-O 117.701 -1.611 . . . . 64.44 113.38 -176.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 52.1 m -87.24 -56.31 3.42 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 121.224 2.512 . . . . 71.44 108.249 163.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.75 ' HB1' HD23 ' A' ' 178' ' ' LEU . . . -79.0 -28.02 43.36 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-O 116.9 -1.524 . . . . 71.34 113.969 -165.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 154.12 -46.7 0.54 Allowed Glycine 0 CA--C 1.527 0.793 0 CA-C-N 121.343 1.883 . . . . 42.11 115.457 176.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 154.26 167.13 15.83 Favored Glycine 0 CA--C 1.534 1.224 0 N-CA-C 108.159 -1.977 . . . . 64.14 108.159 -153.145 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -67.69 -23.48 42.35 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 CA-C-N 120.525 2.163 . . . . 31.23 113.294 -164.182 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -70.0 -46.4 65.22 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 123.013 1.387 . . . . 65.43 109.557 174.072 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -66.97 -21.51 65.96 Favored 'General case' 0 N--CA 1.445 -0.675 0 C-N-CA 126.622 1.969 . . . . 74.44 111.344 -175.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 3.2 m -70.6 -43.76 68.68 Favored 'General case' 0 CA--C 1.529 0.16 0 O-C-N 121.126 -0.984 . . . . 72.15 109.162 -177.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 53.4 mt -62.84 -33.27 74.9 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 118.288 0.495 . . . . 73.35 110.799 177.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 7.5 tttt -52.58 -51.42 59.88 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 125.099 1.36 . . . . 74.34 109.33 173.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.75 HD23 ' HB1' ' A' ' 169' ' ' ALA . 4.3 mm? -68.78 -39.89 79.96 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-O 118.287 -0.864 . . . . 54.4 110.846 175.265 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -55.8 -49.04 74.28 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 119.215 0.916 . . . . 75.12 111.201 -174.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -72.88 -43.13 62.9 Favored 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 122.76 0.424 . . . . 71.05 110.333 -172.246 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 15.9 t80 -60.45 -52.33 65.67 Favored 'General case' 0 N--CA 1.44 -0.946 0 C-N-CA 124.736 1.214 . . . . 74.33 110.048 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.501 ' HB2' HG21 ' A' ' 158' ' ' VAL . 95.9 mt -62.63 -34.8 77.78 Favored 'General case' 0 C--O 1.233 0.213 0 C-N-CA 123.206 0.602 . . . . 71.05 110.768 -178.41 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 38.1 mt -60.8 -61.96 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 N-CA-C 108.419 -0.956 . . . . 73.41 108.419 173.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -56.98 -32.79 66.44 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 124.491 1.117 . . . . 65.25 111.509 -173.384 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 79.3 tttt -58.51 -66.93 0.41 Allowed 'General case' 0 C--O 1.232 0.156 0 C-N-CA 125.425 1.49 . . . . 74.25 110.571 171.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 43.0 mm-40 -65.38 -19.34 65.9 Favored 'General case' 0 N--CA 1.446 -0.625 0 O-C-N 121.03 -1.044 . . . . 73.01 113.258 -177.441 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.94 -44.79 63.04 Favored 'General case' 0 CA--C 1.533 0.319 0 O-C-N 120.974 -1.079 . . . . 74.03 109.327 169.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -56.2 -32.57 64.51 Favored 'General case' 0 C--O 1.232 0.133 0 C-N-CA 124.214 1.005 . . . . 73.3 110.73 -177.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -51.91 -28.02 14.93 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.336 1.054 . . . . 63.44 113.483 178.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -133.44 40.36 3.16 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 118.978 0.808 . . . . 74.11 111.5 174.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 25.4 tttp -130.45 33.68 4.26 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.559 1.543 . . . . 74.13 109.937 176.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 6.2 mtpm? . . . . . 0 C--O 1.25 1.102 0 C-N-CA 127.016 2.126 . . . . 64.12 108.616 -162.364 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.984 0 N-CA-C 108.441 -1.864 . . . . 73.41 108.441 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -108.53 69.17 0.71 Allowed 'General case' 0 CA--C 1.512 -0.483 0 N-CA-C 106.969 -1.493 . . . . 74.53 106.969 -146.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -81.55 8.92 8.43 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-N 112.757 -2.02 . . . . 50.41 114.835 -161.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 42.7 m-85 -134.18 167.03 21.41 Favored 'General case' 0 N--CA 1.442 -0.854 0 C-N-CA 124.803 1.241 . . . . 75.35 108.641 -164.015 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 94.2 m -134.2 141.24 46.97 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 108.451 -0.944 . . . . 63.55 108.451 173.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -70.28 143.58 52.03 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-O 122.069 0.938 . . . . 63.53 110.055 175.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 61.46 16.0 48.28 Favored Glycine 0 CA--C 1.529 0.917 0 C-N-CA 124.898 1.237 . . . . 51.44 112.762 -166.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 8.1 ttmt -118.4 -85.23 0.65 Allowed 'General case' 0 CA--C 1.517 -0.31 0 N-CA-C 105.879 -1.897 . . . . 61.43 105.879 172.047 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.434 ' HB3' HD11 ' A' ' 178' ' ' LEU . 38.4 mp0 -75.6 -21.97 57.32 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 118.675 0.67 . . . . 73.45 112.462 -179.505 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 47.9 p90 -159.78 176.0 12.47 Favored 'General case' 0 CA--C 1.52 -0.179 0 O-C-N 121.477 -0.765 . . . . 64.1 110.726 -170.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 44.3 t -140.68 96.05 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 N-CA-C 108.534 -0.913 . . . . 70.01 108.534 -170.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.39 146.18 27.81 Favored 'General case' 0 C--O 1.237 0.402 0 O-C-N 121.089 -1.007 . . . . 60.31 110.677 177.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -100.68 146.46 27.17 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 114.467 -1.242 . . . . 74.32 108.192 -170.675 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.8 p -81.85 -23.77 36.2 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 125.569 1.547 . . . . 54.11 111.12 179.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 69.3 m -115.27 84.32 11.35 Favored Pre-proline 0 N--CA 1.455 -0.18 0 C-N-CA 124.783 1.233 . . . . 75.0 109.587 -178.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -75.01 174.75 12.25 Favored 'Trans proline' 0 N--CA 1.451 -0.995 0 C-N-CA 122.113 1.875 . . . . 75.4 112.288 -178.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 20.7 t -130.2 130.46 23.06 Favored Pre-proline 0 CA--C 1.534 0.342 0 CA-C-N 114.937 -1.029 . . . . 44.41 108.714 -173.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -76.73 175.91 10.78 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 124.277 3.318 . . . . 72.1 112.865 178.04 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 19.4 m -120.25 168.56 12.48 Favored 'Isoleucine or valine' 0 C--O 1.24 0.567 0 C-N-CA 126.366 1.866 . . . . 75.22 110.264 173.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 38.9 m -54.91 -53.01 61.02 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 126.664 1.986 . . . . 74.13 110.777 174.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 3.5 mm-40 -141.58 144.27 32.74 Favored Pre-proline 0 N--CA 1.451 -0.392 0 N-CA-C 106.564 -1.643 . . . . 74.23 106.564 178.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -71.51 165.01 33.81 Favored 'Trans proline' 0 N--CA 1.447 -1.224 0 C-N-CA 121.269 1.313 . . . . 64.15 109.156 162.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 159.57 -35.04 0.47 Allowed Glycine 0 CA--C 1.519 0.329 0 CA-C-O 119.547 -0.585 . . . . 63.34 112.784 167.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -129.71 163.58 25.85 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.581 1.553 . . . . 75.33 109.707 162.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.435 HD12 ' HB3' ' A' ' 186' ' ' GLU . 28.2 mm -66.31 126.34 25.46 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 N-CA-C 106.467 -1.679 . . . . 50.41 106.467 168.43 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -89.3 123.45 33.5 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 125.992 1.717 . . . . 72.53 106.762 -176.66 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 28.3 t -123.73 135.29 63.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 108.002 -1.11 . . . . 73.45 108.002 -179.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 40.3 t -126.76 125.9 67.72 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.177 0 N-CA-C 108.262 -1.014 . . . . 53.15 108.262 -175.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -87.46 134.91 33.53 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 125.164 1.386 . . . . 72.31 107.769 162.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.2 mp -122.23 123.5 41.61 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 124.715 1.206 . . . . 73.53 108.354 165.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -131.8 171.59 13.33 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.754 1.622 . . . . 72.01 110.979 -169.452 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 27.3 t90 -147.22 168.92 20.49 Favored 'General case' 0 CA--C 1.537 0.452 0 O-C-N 120.86 -1.15 . . . . 74.03 109.46 168.038 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 14.6 t80 -60.77 -53.51 56.5 Favored 'General case' 0 N--CA 1.461 0.076 0 C-N-CA 126.062 1.745 . . . . 74.12 111.425 174.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -68.66 -84.41 0.13 Allowed Glycine 0 C--N 1.336 0.575 0 N-CA-C 110.697 -0.961 . . . . 55.44 110.697 -159.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 14.5 t 42.54 71.93 1.27 Allowed Pre-proline 0 CA--C 1.533 0.289 0 C-N-CA 125.961 1.704 . . . . 53.24 113.415 149.163 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -67.3 3.42 1.7 Allowed 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 122.264 1.976 . . . . 72.42 113.71 -176.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 18.7 m170 -108.66 -28.98 8.96 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 119.857 1.208 . . . . 71.33 111.978 173.062 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 85.7 m -60.27 -46.32 90.24 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 119.545 1.066 . . . . 33.24 109.754 -175.118 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 32.7 t80 -66.62 -22.13 66.12 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 121.085 -1.009 . . . . 73.24 112.187 -178.329 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -74.64 -3.54 31.85 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 120.931 -1.106 . . . . 34.34 112.782 175.023 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.425 ' CG ' HD11 ' A' ' 166' ' ' ILE . 15.6 t80 -121.82 -25.14 5.08 Favored 'General case' 0 C--O 1.226 -0.171 0 C-N-CA 125.372 1.469 . . . . 65.0 112.511 -168.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 56.9 mm-40 -42.39 -63.23 0.96 Allowed Pre-proline 0 CA--C 1.539 0.553 0 C-N-CA 124.253 1.021 . . . . 73.04 112.403 -177.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -73.3 -8.73 22.34 Favored 'Trans proline' 0 N--CA 1.46 -0.445 0 CA-C-N 122.535 1.941 . . . . 74.1 114.966 -177.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.4 m -70.8 -44.91 65.63 Favored 'General case' 0 CA--C 1.543 0.708 0 O-C-N 121.034 -1.042 . . . . 74.33 108.525 166.293 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 12.9 tt -94.78 -36.02 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 C-N-CA 123.86 0.864 . . . . 73.41 112.418 -165.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 41.9 t -46.8 -58.85 6.09 Favored Pre-proline 0 CA--C 1.538 0.493 0 C-N-CA 125.691 1.596 . . . . 74.53 110.443 176.001 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -72.53 -25.51 17.72 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 121.646 1.564 . . . . 71.54 112.929 -178.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.457 ' CG ' HD22 ' A' ' 176' ' ' LEU . 79.6 t90 -60.24 -52.01 67.11 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 119.757 1.162 . . . . 74.4 109.014 173.315 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.2 t -55.88 -42.8 76.46 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.321 0.648 . . . . 64.2 110.522 177.209 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 90.0 mt-10 -64.05 -10.34 21.52 Favored 'General case' 0 N--CA 1.468 0.474 0 O-C-N 121.207 -0.933 . . . . 62.03 113.352 -179.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 19.3 mmmt -122.49 8.48 9.58 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 126.116 1.767 . . . . 74.13 112.277 -171.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 25.2 mt -64.73 153.59 87.39 Favored Pre-proline 0 C--O 1.24 0.566 0 C-N-CA 125.029 1.331 . . . . 74.41 111.177 177.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -74.54 167.25 27.56 Favored 'Trans proline' 0 N--CA 1.448 -1.154 0 C-N-CA 124.658 3.572 . . . . 73.05 110.494 179.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -73.12 -2.19 20.45 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.385 1.474 . . . . 73.43 113.349 -175.419 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -101.75 8.29 41.55 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.01 1.324 . . . . 64.04 111.15 177.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 60.8 t -124.58 155.13 32.47 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 C-N-CA 124.521 1.128 . . . . 64.32 108.766 -177.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 63.9 t60 -139.27 123.72 18.26 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 126.903 2.081 . . . . 72.02 106.333 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 47.4 t80 -107.97 139.4 42.65 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 108.079 -1.082 . . . . 60.03 108.079 -176.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 25.9 t -135.2 153.75 34.61 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 N-CA-C 105.511 -2.033 . . . . 75.23 105.511 -177.48 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -127.86 140.16 52.19 Favored 'General case' 0 CA--C 1.512 -0.512 0 N-CA-C 105.341 -2.096 . . . . 75.3 105.341 167.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 97.5 mt -138.54 144.46 42.45 Favored Pre-proline 0 C--N 1.326 -0.416 0 N-CA-C 108.829 -0.804 . . . . 71.42 108.829 174.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -71.6 148.25 53.05 Favored 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 121.526 1.484 . . . . 72.45 110.913 178.098 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -93.28 86.53 5.34 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 124.962 1.305 . . . . 74.53 108.362 -178.019 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 46.8 mt -80.86 65.45 6.01 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 121.006 -1.059 . . . . 65.13 112.601 -169.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 13.0 m-85 -80.02 27.2 0.32 Allowed 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 115.111 1.523 . . . . 64.12 115.111 -168.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 66.54 -168.32 35.48 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 109.217 -1.553 . . . . 63.2 109.217 -166.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 56.15 -151.03 23.03 Favored Glycine 0 CA--C 1.526 0.747 0 CA-C-N 117.848 0.824 . . . . 64.25 111.34 178.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 9.6 tp -70.45 -12.04 15.65 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 N-CA-C 112.471 0.545 . . . . 74.2 112.471 173.162 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 9.4 m95 -64.42 -36.16 83.24 Favored 'General case' 0 C--O 1.224 -0.266 0 O-C-N 120.004 -1.685 . . . . 62.51 112.178 -171.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 11.5 p30 -76.54 -28.34 56.27 Favored 'General case' 0 CA--C 1.518 -0.254 0 N-CA-C 113.051 0.76 . . . . 73.43 113.051 177.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 94.2 t -65.61 -51.69 59.79 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 N-CA-C 107.21 -1.404 . . . . 63.23 107.21 172.281 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 59.0 m170 -79.1 54.18 1.58 Allowed 'General case' 0 C--O 1.239 0.505 0 C-N-CA 125.493 1.517 . . . . 72.23 111.446 172.497 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -164.82 -29.28 0.02 OUTLIER Glycine 0 N--CA 1.445 -0.752 0 CA-C-N 115.485 -0.78 . . . . 62.32 112.717 156.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -62.32 -25.78 68.07 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 119.314 1.557 . . . . 64.33 114.045 -173.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 40.3 ttp -53.3 -40.12 64.53 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 124.358 1.063 . . . . 52.02 112.546 -177.404 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -58.47 -47.1 85.15 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 125.074 1.349 . . . . 72.12 108.523 178.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 15.5 mt -68.81 -34.69 75.93 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-O 116.487 -1.721 . . . . 72.11 111.095 -178.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.642 HG22 HG23 ' A' ' 128' ' ' THR . 0.0 OUTLIER -63.73 -45.12 91.33 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 121.761 2.073 . . . . 75.13 111.335 174.509 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -52.53 -60.6 3.04 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.454 1.102 . . . . 62.4 108.723 -176.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -67.19 -27.56 67.37 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.26 1.024 . . . . 71.44 110.043 -174.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.0 t -51.68 -39.86 59.04 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 124.52 1.128 . . . . 45.31 111.621 176.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 44.7 mtm -71.53 -11.6 60.95 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 118.761 0.71 . . . . 64.31 112.439 -176.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 81.8 25.4 53.19 Favored Glycine 0 CA--C 1.527 0.831 0 CA-C-N 118.862 0.756 . . . . 71.1 112.402 -178.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 17.4 m -49.79 153.31 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 C-N-CA 125.632 1.573 . . . . 74.45 112.111 173.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -132.05 23.15 4.53 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 126.513 1.925 . . . . 62.14 111.458 -176.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 3.2 t-160 -55.09 121.1 8.02 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 125.592 1.557 . . . . 72.11 107.554 170.023 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.74 121.26 15.57 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 108.728 -0.841 . . . . 75.25 108.728 -179.121 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 70.8 t 62.13 167.44 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.081 0 C-N-CA 125.218 1.407 . . . . 60.02 112.057 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 53.1 p-80 -132.07 9.45 4.48 Favored 'General case' 0 N--CA 1.465 0.289 0 O-C-N 120.131 -1.606 . . . . 64.52 114.911 -167.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -50.73 -60.89 2.58 Favored 'General case' 0 C--O 1.217 -0.645 0 C-N-CA 124.938 1.295 . . . . 73.24 109.016 177.183 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -56.52 -17.56 8.79 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 120.874 1.67 . . . . 71.25 114.986 -174.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 25.6 t -73.36 -66.43 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 CA-C-N 119.895 1.225 . . . . 63.13 108.805 167.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -60.0 -36.98 78.35 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.261 1.025 . . . . 71.04 110.776 -175.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -60.15 -35.55 75.57 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 125.382 1.473 . . . . 62.52 110.745 176.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.428 ' HB2' ' CZ ' ' A' ' 114' ' ' PHE . . . -65.22 -22.18 66.85 Favored 'General case' 0 CA--C 1.534 0.338 0 O-C-N 121.163 -0.961 . . . . 63.13 112.053 176.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 55.5 mt -87.34 -60.01 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.884 0 N-CA-C 105.883 -1.895 . . . . 51.23 105.883 178.106 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 31.6 p80 -92.55 -53.64 4.11 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 115.379 1.622 . . . . 72.15 115.379 -168.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 34.2 mmtt -62.64 -20.4 64.75 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.238 1.015 . . . . 70.1 111.742 175.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -117.19 -26.2 6.86 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 118.053 -0.975 . . . . 70.42 113.148 -171.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 1.9 t-160 53.46 42.97 31.91 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.275 1.43 . . . . 72.1 111.994 178.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 25.4 mmtp -74.79 157.52 35.03 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 120.941 -1.099 . . . . 75.33 110.218 175.353 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 11.0 tttt -80.17 36.47 0.35 Allowed 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 127.872 2.469 . . . . 62.13 111.748 -173.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.403 ' HA ' ' HB3' ' A' ' 110' ' ' GLU . 24.7 mt -64.54 32.82 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 130.452 3.501 . . . . 71.54 115.182 -174.72 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -79.8 13.09 2.29 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 129.636 3.174 . . . . 60.04 113.14 178.562 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -148.04 158.53 41.74 Favored Pre-proline 0 N--CA 1.463 0.221 0 CA-C-N 119.21 0.914 . . . . 75.4 111.852 -179.628 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -67.93 -19.55 46.09 Favored 'Trans proline' 0 N--CA 1.455 -0.773 0 C-N-CA 123.225 2.617 . . . . 62.31 112.106 174.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -60.39 -71.19 0.14 Allowed 'General case' 0 C--O 1.22 -0.497 0 N-CA-C 107.398 -1.334 . . . . 73.03 107.398 167.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.403 ' HB3' ' HA ' ' A' ' 105' ' ' LEU . 3.7 mm-40 -51.51 -42.61 61.83 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 124.289 1.036 . . . . 73.51 112.395 -176.599 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 48.0 mtt -58.72 -57.15 14.28 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 109.67 -0.493 . . . . 74.24 109.67 179.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.508 ' HB1' ' HG3' ' A' ' 122' ' ' LYS . . . -65.73 -37.33 86.1 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 119.536 -0.269 . . . . 65.15 111.111 -177.627 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -60.63 -48.77 80.31 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 127.533 2.333 . . . . 72.13 110.341 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . 0.428 ' CZ ' ' HB2' ' A' ' 97' ' ' ALA . 81.4 t80 -65.72 -47.81 74.06 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 123.666 0.787 . . . . 75.12 110.698 177.109 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 66.9 mt -75.15 -13.06 60.43 Favored 'General case' 0 N--CA 1.457 -0.101 0 CA-C-O 119.051 -0.5 . . . . 74.54 111.76 -173.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -49.11 -53.58 20.05 Favored 'General case' 0 CA--C 1.52 -0.178 0 C-N-CA 125.099 1.36 . . . . 70.25 109.882 -174.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -72.21 7.2 8.41 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 125.453 1.501 . . . . 65.54 115.571 178.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 20.3 mttm -125.43 25.94 6.94 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 120.788 2.294 . . . . 63.25 111.57 -170.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 74.46 40.82 38.53 Favored Glycine 0 C--N 1.334 0.448 0 N-CA-C 111.142 -0.783 . . . . 74.4 111.142 -179.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 58.4 t -131.0 111.61 20.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 N-CA-C 107.147 -1.427 . . . . 64.11 107.147 173.363 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -70.57 136.54 49.34 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 123.993 0.917 . . . . 50.21 111.47 173.191 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.508 ' HG3' ' HB1' ' A' ' 112' ' ' ALA . 26.9 tttt -64.74 -48.25 75.27 Favored 'General case' 0 CA--C 1.516 -0.362 0 N-CA-C 109.762 -0.458 . . . . 74.33 109.762 -176.618 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 60.1 mm-40 -63.85 -39.19 93.63 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 122.775 0.43 . . . . 71.24 110.237 -174.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 3.9 mtpm? -75.62 -38.77 58.71 Favored 'General case' 0 CA--C 1.515 -0.376 0 N-CA-C 108.282 -1.007 . . . . 62.31 108.282 -177.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 87.4 t80 -57.76 -60.5 3.6 Favored 'General case' 0 N--CA 1.44 -0.925 0 O-C-N 123.794 0.684 . . . . 72.52 110.294 178.234 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 15.7 mt -65.61 -37.27 86.13 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-O 118.937 -0.554 . . . . 74.41 109.754 -175.108 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 45.6 t -60.14 -51.85 67.86 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 108.582 -0.896 . . . . 72.52 108.582 177.094 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . 0.642 HG23 HG22 ' A' ' 80' ' ' THR 0.278 1.3 t -69.12 -33.12 72.97 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 119.454 1.025 . . . . 72.14 109.873 -173.792 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 53.2 t80 -51.1 -48.56 61.65 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.361 1.465 . . . . 73.51 110.664 170.14 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -95.14 17.63 13.77 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 113.213 0.82 . . . . 72.43 113.213 -179.074 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 58.0 m -107.67 172.47 6.81 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 119.772 1.169 . . . . 74.44 111.694 179.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -63.84 -23.84 67.51 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 115.92 -0.582 . . . . 75.5 112.338 -174.724 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -53.58 -59.87 4.04 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.671 1.189 . . . . 65.14 110.032 176.006 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.49 HD11 ' HA ' ' A' ' 80' ' ' THR . 14.2 mm -67.1 -26.21 35.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 C-N-CA 123.032 0.533 . . . . 73.04 111.605 -179.239 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 6.8 tttp -55.48 -45.45 76.99 Favored 'General case' 0 N--CA 1.464 0.225 0 O-C-N 120.938 -1.101 . . . . 72.23 109.639 171.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -72.76 -10.91 77.45 Favored Glycine 0 CA--C 1.524 0.63 0 C-N-CA 123.475 0.559 . . . . 72.22 112.009 -172.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 7.5 mm100 -108.66 -38.52 5.63 Favored 'General case' 0 N--CA 1.44 -0.938 0 C-N-CA 126.332 1.853 . . . . 65.04 109.357 -171.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -62.98 -41.91 99.69 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 118.368 -0.825 . . . . 71.11 110.332 174.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -67.71 -44.66 77.17 Favored 'General case' 0 CA--C 1.535 0.365 0 CA-C-N 119.137 0.881 . . . . 73.35 110.266 178.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 3.1 ttmt -63.23 -56.13 19.15 Favored 'General case' 0 N--CA 1.449 -0.475 0 O-C-N 121.034 -1.041 . . . . 74.23 111.164 -174.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -59.64 -33.27 71.31 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 118.029 0.377 . . . . 65.31 110.661 -176.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 2.0 tmtm? -60.1 -60.54 3.66 Favored 'General case' 0 CA--C 1.531 0.245 0 O-C-N 121.269 -0.894 . . . . 71.44 110.925 172.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.44 -18.79 63.0 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 119.265 0.939 . . . . 54.14 112.039 -173.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 45.4 mt -69.5 -54.55 13.64 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 123.96 0.904 . . . . 73.45 110.338 172.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -53.58 -47.37 70.2 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 119.558 1.072 . . . . 71.31 112.588 -174.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -62.33 -45.13 94.6 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 112.704 0.631 . . . . 65.44 112.704 175.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -63.21 -35.65 81.01 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 118.496 0.589 . . . . 74.34 109.88 -179.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 -74.19 9.2 1.72 Allowed 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 114.014 1.116 . . . . 71.14 114.014 173.029 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 60.86 19.5 9.76 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 126.294 1.838 . . . . 73.44 112.649 176.063 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 25.8 t -75.16 141.14 16.31 Favored 'Isoleucine or valine' 0 C--O 1.24 0.58 0 N-CA-C 107.996 -1.113 . . . . 52.3 107.996 -177.042 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -141.49 0.5 1.48 Allowed 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 118.846 -0.597 . . . . 75.33 112.408 173.409 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -160.12 167.96 35.63 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 108.6 -1.8 . . . . 72.33 108.6 170.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 30.0 m -123.88 156.03 66.08 Favored Pre-proline 0 C--O 1.238 0.473 0 C-N-CA 125.697 1.599 . . . . 71.23 107.614 176.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . 0.417 ' HG3' HD12 ' A' ' 166' ' ' ILE . 94.8 Cg_endo -67.33 157.92 83.53 Favored 'Cis proline' 0 N--CA 1.46 -0.447 0 O-C-N 122.607 0.793 . . . . 73.41 113.323 -2.083 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 5.1 m -154.86 136.93 14.69 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 107.989 -1.115 . . . . 74.32 107.989 171.014 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 91.8 mtp -111.13 152.92 26.44 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 107.135 -1.432 . . . . 61.24 107.135 169.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 41.0 t -138.98 128.66 31.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 N-CA-C 107.92 -1.141 . . . . 73.43 107.92 178.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 42.7 t -104.03 130.71 54.23 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 C-N-CA 124.371 1.069 . . . . 61.23 108.634 173.013 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 45.29 23.53 0.12 Allowed 'General case' 0 N--CA 1.464 0.264 1 C-N-CA 131.728 4.011 . . . . 61.33 114.374 177.278 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 59.41 31.33 69.91 Favored Glycine 0 CA--C 1.531 1.091 0 CA-C-O 117.69 -1.616 . . . . 52.43 113.882 -170.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 10.5 mtpt -131.27 -30.56 1.72 Allowed 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 119.622 1.711 . . . . 72.32 113.386 -177.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -122.16 118.59 29.0 Favored 'General case' 0 CA--C 1.519 -0.235 0 N-CA-C 107.907 -1.146 . . . . 74.24 107.907 -174.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 36.2 ttp85 -100.49 135.8 41.36 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 105.04 -2.207 . . . . 72.02 105.04 175.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 18.1 p90 -154.07 166.5 32.84 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 108.346 -0.983 . . . . 73.13 108.346 172.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -170.94 178.56 3.39 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.998 0.428 . . . . 75.15 110.77 -175.346 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.425 HD11 ' CG ' ' A' ' 43' ' ' PHE . 43.3 mt -55.89 -45.06 79.74 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 C-N-CA 124.904 1.282 . . . . 64.12 108.799 -179.406 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -88.32 29.4 5.68 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 126.481 1.991 . . . . 75.13 113.155 174.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 19.0 p -119.99 -51.16 2.24 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 107.482 -1.303 . . . . 74.14 107.482 156.315 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.414 ' HB2' HD23 ' A' ' 178' ' ' LEU . . . -66.52 -39.55 88.7 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 125.097 1.359 . . . . 64.21 112.319 -175.042 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 110.61 11.56 19.05 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 124.103 0.859 . . . . 64.34 113.48 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 159.99 170.4 24.53 Favored Glycine 0 CA--C 1.524 0.598 0 CA-C-N 119.469 1.634 . . . . 62.04 110.525 175.02 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -66.44 -42.36 10.05 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 122.019 1.813 . . . . 74.14 110.762 -175.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -70.1 -34.33 73.0 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 109.166 -0.679 . . . . 62.23 109.166 -177.488 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 41.7 mm-40 -67.37 -28.9 68.33 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.544 1.538 . . . . 73.11 110.472 174.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 23.6 m -66.0 -40.72 91.39 Favored 'General case' 0 CA--C 1.531 0.212 0 O-C-N 120.467 -1.396 . . . . 73.03 108.844 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . 0.457 HD22 ' CG ' ' A' ' 50' ' ' TRP . 61.1 mt -66.36 -24.48 66.51 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 119.343 0.974 . . . . 71.24 112.423 177.65 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 9.4 mttt -56.58 -54.25 48.09 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 108.564 -0.902 . . . . 74.02 108.564 168.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.434 HD11 ' HB3' ' A' ' 11' ' ' GLU . 2.9 mm? -68.14 -43.62 77.92 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 120.326 -0.549 . . . . 55.53 109.931 -178.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.42 -26.98 63.89 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 124.247 1.019 . . . . 70.24 112.864 -174.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . 0.406 ' HA ' HD12 ' A' ' 183' ' ' ILE . 15.8 t70 -100.69 -32.57 10.66 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 123.769 0.827 . . . . 44.51 111.474 -173.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 33.7 t80 -62.45 -52.01 65.24 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 124.178 0.991 . . . . 71.41 109.906 170.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 48.9 mt -55.39 -32.54 62.72 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 124.304 1.042 . . . . 73.22 112.164 -176.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.406 HD12 ' HA ' ' A' ' 180' ' ' ASP . 81.3 mt -54.19 -62.73 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.309 0 N-CA-C 107.857 -1.164 . . . . 44.15 107.857 174.401 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 -61.53 -37.43 83.75 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 121.193 0.52 . . . . 73.12 111.56 -171.188 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -58.14 -52.21 66.5 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.106 0.963 . . . . 43.41 109.875 179.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . 0.435 ' HB3' HD12 ' A' ' 27' ' ' ILE . 3.2 mm-40 -68.06 -42.53 80.34 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-O 121.603 0.716 . . . . 74.3 112.586 174.581 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 5.5 tpm_? -53.61 -46.72 70.53 Favored 'General case' 0 CA--C 1.516 -0.334 0 C-N-CA 125.188 1.395 . . . . 75.45 110.326 -175.09 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -61.35 -15.8 39.73 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 125.201 1.401 . . . . 63.01 112.159 -177.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -62.89 -26.02 68.59 Favored 'General case' 0 CA--C 1.535 0.384 0 O-C-N 121.394 -0.816 . . . . 42.21 112.247 171.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . 55.24 69.12 0.77 Allowed 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 127.351 2.26 . . . . 51.35 109.606 176.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 48.2 tttm -83.5 31.27 0.46 Allowed 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 123.82 0.848 . . . . 73.12 110.866 -168.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 17.2 pttp . . . . . 0 C--O 1.247 0.958 0 C-N-CA 126.171 1.789 . . . . 54.1 110.179 178.113 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.526 0 N-CA-C 107.974 -2.05 . . . . 73.01 107.974 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 49.39 79.4 0.08 Allowed 'General case' 0 N--CA 1.458 -0.055 0 C-N-CA 125.607 1.563 . . . . 74.31 110.049 -164.402 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -69.33 8.33 0.62 Allowed 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 125.262 1.425 . . . . 72.14 113.524 177.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -138.6 167.53 21.74 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 126.603 1.961 . . . . 64.32 108.944 -171.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 59.3 m -133.99 133.32 41.17 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 107.213 -1.402 . . . . 74.43 107.213 176.034 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -69.37 137.78 53.13 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 108.166 -1.05 . . . . 52.53 108.166 168.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 72.47 24.78 75.68 Favored Glycine 0 CA--C 1.528 0.867 0 N-CA-C 111.251 -0.74 . . . . 61.43 111.251 -167.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 18.4 tttm -140.4 -85.02 0.21 Allowed 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 106.81 -1.552 . . . . 74.45 106.81 171.044 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.494 ' HB3' HD21 ' A' ' 178' ' ' LEU . 13.3 mm-40 -72.92 -23.93 60.76 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 124.588 1.155 . . . . 72.41 111.044 -177.262 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 44.8 p90 -157.74 167.51 29.84 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 123.508 0.723 . . . . 62.11 109.468 -171.45 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 93.5 t -133.99 119.71 32.99 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 C-N-CA 124.321 1.048 . . . . 75.42 109.089 -179.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.91 161.42 30.15 Favored 'General case' 0 C--N 1.328 -0.351 0 O-C-N 120.19 -1.568 . . . . 63.2 109.633 172.307 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -119.53 108.12 14.13 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 124.022 0.929 . . . . 72.02 108.988 177.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.8 m -61.9 -5.64 2.23 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 124.864 1.266 . . . . 74.51 113.946 -178.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -121.02 84.6 39.54 Favored Pre-proline 0 N--CA 1.449 -0.483 0 N-CA-C 106.334 -1.728 . . . . 73.44 106.334 167.298 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -67.19 177.62 3.62 Favored 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 123.084 2.523 . . . . 74.33 111.129 179.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 36.4 t -136.8 139.67 29.61 Favored Pre-proline 0 C--N 1.327 -0.371 0 C-N-CA 124.552 1.141 . . . . 72.32 108.085 -166.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -76.14 177.78 8.32 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 123.0 2.466 . . . . 62.41 112.356 175.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 4.0 m -126.83 -174.61 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 C-N-CA 126.952 2.101 . . . . 73.12 108.301 177.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -66.18 -41.59 90.04 Favored 'General case' 0 CA--C 1.538 0.517 0 O-C-N 121.51 -0.744 . . . . 44.11 109.752 176.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 -168.12 166.04 7.52 Favored Pre-proline 0 CA--C 1.539 0.535 0 C-N-CA 127.63 2.372 . . . . 60.21 108.325 -179.127 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -61.25 167.25 9.64 Favored 'Trans proline' 0 CA--C 1.543 0.952 0 C-N-CA 122.051 1.834 . . . . 71.43 110.681 162.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 137.05 -64.08 0.57 Allowed Glycine 0 C--N 1.338 0.64 0 O-C-N 121.296 -0.877 . . . . 53.12 112.509 170.146 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.447 ' HE2' ' N ' ' A' ' 26' ' ' LYS . 0.2 OUTLIER -113.43 144.16 43.27 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 118.966 1.383 . . . . 74.25 107.756 176.389 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 45.4 mm -67.54 129.66 32.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 104.991 -2.226 . . . . 72.54 104.991 170.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -90.47 138.57 31.44 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 107.322 -1.362 . . . . 72.42 107.322 177.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 58.5 t -129.43 116.47 39.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 106.414 -1.699 . . . . 71.14 106.414 175.114 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 23.4 t -106.58 112.35 39.27 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 N-CA-C 107.891 -1.151 . . . . 72.21 107.891 -175.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -77.53 130.3 36.78 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 107.843 -1.169 . . . . 61.24 107.843 159.076 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.743 HD22 HG21 ' A' ' 150' ' ' VAL . 5.3 mp -114.68 130.75 56.86 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 124.236 1.014 . . . . 71.0 108.587 164.406 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 33.4 p90 -134.17 168.58 18.59 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.608 0.763 . . . . 75.1 111.255 -172.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 25.2 t90 -147.96 168.45 22.26 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 126.597 1.959 . . . . 75.05 107.691 173.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 2.1 m-30 -81.41 -41.13 22.36 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 109.181 -0.674 . . . . 74.23 109.181 179.301 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -76.5 21.64 2.35 Favored Glycine 0 CA--C 1.532 1.105 0 C-N-CA 124.81 1.195 . . . . 60.23 114.089 -175.547 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 51.8 t -105.0 87.23 1.79 Allowed Pre-proline 0 CA--C 1.537 0.475 0 C-N-CA 126.752 2.021 . . . . 71.5 110.391 -170.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -54.11 -42.61 65.59 Favored 'Trans proline' 0 CA--C 1.534 0.514 0 C-N-CA 122.387 2.058 . . . . 54.44 113.284 177.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 26.7 m170 -72.87 -24.16 60.82 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 119.227 0.922 . . . . 70.2 111.734 -172.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 99.6 m -62.57 -39.25 93.09 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.846 0.858 . . . . 60.25 110.56 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 21.8 t80 -62.67 -45.94 90.5 Favored 'General case' 0 C--N 1.341 0.229 0 C-N-CA 123.616 0.766 . . . . 72.21 111.061 -176.245 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.61 -9.97 31.61 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 112.695 0.628 . . . . 74.2 112.695 -176.056 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.437 ' HB2' HD11 ' A' ' 166' ' ' ILE . 2.6 t80 -97.97 -22.61 16.2 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 124.97 1.308 . . . . 71.43 111.267 178.013 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -44.81 -64.83 0.74 Allowed Pre-proline 0 CA--C 1.54 0.57 0 C-N-CA 125.007 1.323 . . . . 71.2 112.47 -172.069 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -69.96 -4.91 15.11 Favored 'Trans proline' 0 N--CA 1.459 -0.509 0 C-N-CA 122.1 1.867 . . . . 64.24 115.547 -176.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.8 m -87.12 -41.11 14.04 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 108.529 -0.915 . . . . 72.53 108.529 171.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 19.0 tt -84.62 -29.35 6.87 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 O-C-N 121.586 -0.696 . . . . 72.01 111.422 -174.011 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 34.8 t -48.88 -66.32 0.61 Allowed Pre-proline 0 CA--C 1.534 0.339 0 CA-C-O 117.428 -1.272 . . . . 71.43 110.84 172.126 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -58.86 -41.45 62.42 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 121.67 1.58 . . . . 75.05 110.125 -175.206 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 61.6 t90 -52.71 -57.33 10.45 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 118.519 0.599 . . . . 74.14 110.473 177.095 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 78.1 p -59.96 -34.61 73.49 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.272 0.629 . . . . 73.05 112.483 -177.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -78.67 -16.77 56.9 Favored 'General case' 0 CA--C 1.533 0.317 0 O-C-N 121.303 -0.873 . . . . 62.11 112.835 178.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 42.2 mmtm -106.04 2.16 27.04 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 126.089 1.756 . . . . 74.44 112.662 -178.078 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 37.2 mt -57.7 148.73 55.88 Favored Pre-proline 0 C--O 1.236 0.37 0 C-N-CA 124.397 1.079 . . . . 74.41 110.741 177.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -77.55 170.93 18.41 Favored 'Trans proline' 0 N--CA 1.443 -1.451 0 C-N-CA 124.015 3.143 . . . . 54.45 111.014 178.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -67.84 3.4 1.51 Allowed 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 115.075 1.509 . . . . 74.12 115.075 -170.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -118.56 1.42 11.7 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 126.94 2.096 . . . . 43.24 112.568 -177.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 23.1 t -120.19 123.29 70.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 CA-C-N 119.369 0.986 . . . . 51.0 109.569 -179.014 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 80.1 t60 -115.05 107.63 15.6 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 126.155 1.782 . . . . 75.43 109.663 -174.317 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 26.5 t80 -78.34 139.63 38.81 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.688 1.195 . . . . 64.14 110.762 179.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 88.8 t -131.51 146.61 33.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 C-N-CA 127.698 2.399 . . . . 75.55 106.681 -178.132 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 29.7 mtt-85 -131.63 120.03 22.25 Favored 'General case' 0 CA--C 1.508 -0.669 0 N-CA-C 106.929 -1.508 . . . . 65.03 106.929 -177.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 75.2 mt -129.93 148.68 70.57 Favored Pre-proline 0 C--N 1.325 -0.464 0 O-C-N 123.419 0.45 . . . . 74.14 112.187 179.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -75.87 134.77 16.77 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 122.8 2.333 . . . . 71.22 110.457 177.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -75.97 108.7 9.03 Favored 'General case' 0 CA--C 1.535 0.395 0 O-C-N 121.477 -0.764 . . . . 71.02 109.059 170.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 49.5 mt -103.03 94.19 5.42 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 127.165 2.186 . . . . 72.14 108.548 -179.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -130.8 43.53 3.09 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 119.221 0.918 . . . . 64.45 112.21 -175.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.452 ' H ' ' ND2' ' A' ' 72' ' ' ASN . . . 74.63 164.23 11.35 Favored Glycine 0 CA--C 1.522 0.525 0 C-N-CA 124.767 1.175 . . . . 74.51 112.358 175.41 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 52.33 -144.11 20.45 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.416 -1.073 . . . . 73.32 110.416 -175.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 4.8 tp -64.4 -15.12 16.9 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 CA-C-O 118.093 -0.955 . . . . 73.24 111.431 -172.279 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 19.7 m95 -59.81 -33.59 71.93 Favored 'General case' 0 C--N 1.342 0.275 0 CA-C-N 120.732 1.605 . . . . 73.25 111.139 173.126 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.452 ' ND2' ' H ' ' A' ' 68' ' ' GLY . 7.3 m-80 -80.52 -32.32 36.9 Favored 'General case' 0 C--N 1.339 0.147 0 CA-C-N 118.766 0.712 . . . . 73.32 111.708 177.137 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 70.5 t -68.44 -58.83 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 N-CA-C 108.512 -0.922 . . . . 72.35 108.512 178.159 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 52.1 m170 -72.14 47.21 0.15 Allowed 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 126.625 1.97 . . . . 74.24 109.578 167.113 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -164.49 1.24 0.05 OUTLIER Glycine 0 CA--C 1.527 0.818 0 C-N-CA 127.055 2.264 . . . . 55.53 113.28 -176.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -108.2 -24.13 11.65 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 120.78 2.29 . . . . 63.11 113.23 -174.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 3.0 ptt? -85.14 -23.45 28.41 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 114.361 1.245 . . . . 74.22 114.361 -170.194 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 29.5 t80 -56.58 -48.68 76.87 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 119.861 1.21 . . . . 74.4 107.94 176.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 35.1 mt -60.84 -46.85 88.95 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 114.846 -1.07 . . . . 72.35 109.672 178.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.586 HG22 HG23 ' A' ' 128' ' ' THR . 0.2 OUTLIER -61.72 -41.94 98.29 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 119.503 1.047 . . . . 51.42 111.525 -179.837 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -54.53 -53.24 57.04 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 123.99 0.916 . . . . 74.42 108.993 -177.31 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -76.54 -24.85 53.64 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 124.645 1.178 . . . . 71.02 112.212 -176.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 7.7 t -55.11 -11.71 0.76 Allowed 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.629 1.572 . . . . 72.13 113.46 172.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 9.1 mtp -110.25 -10.53 14.62 Favored 'General case' 0 C--O 1.225 -0.213 0 C-N-CA 124.165 0.986 . . . . 75.52 112.799 177.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 64.73 37.42 94.33 Favored Glycine 0 CA--C 1.527 0.821 0 CA-C-N 119.926 1.239 . . . . 61.22 111.234 -176.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 27.1 m -57.33 -41.36 78.19 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 C-N-CA 123.496 0.718 . . . . 62.52 111.11 175.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 51.48 75.25 0.21 Allowed 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 126.449 1.9 . . . . 72.45 110.293 173.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 54.7 m170 -71.02 -72.11 0.23 Allowed 'General case' 0 N--CA 1.465 0.285 0 O-C-N 121.574 -0.704 . . . . 72.3 109.581 -174.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 14.5 t0 -174.74 -67.1 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 128.059 2.543 . . . . 51.33 105.041 167.004 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 15.0 m -140.42 157.98 24.77 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 C-N-CA 124.126 0.971 . . . . 63.34 112.127 -173.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 32.5 m80 -73.94 100.66 3.59 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 125.907 1.683 . . . . 74.23 108.423 171.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -139.78 -69.14 0.41 Allowed 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 125.884 1.674 . . . . 75.41 107.55 176.222 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -66.08 -36.83 84.26 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 123.335 0.654 . . . . 61.45 111.53 -166.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 82.7 t -62.0 -35.19 67.03 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.379 0 N-CA-C 109.468 -0.567 . . . . 75.42 109.468 175.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -80.44 -46.97 15.07 Favored 'General case' 0 CA--C 1.527 0.062 0 CA-C-N 119.738 1.154 . . . . 73.51 109.908 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.413 ' OE1' ' HE3' ' A' ' 100' ' ' LYS . 13.4 mm-40 -50.99 -38.13 49.15 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.715 1.606 . . . . 73.31 110.251 178.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.4 ' HA ' ' HB2' ' A' ' 101' ' ' GLU . . . -75.56 -14.71 60.41 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.75 1.22 . . . . 64.33 113.826 -174.659 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.424 HG21 HD13 ' A' ' 98' ' ' ILE . 51.9 mt -121.01 -24.45 2.79 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 C-N-CA 125.123 1.369 . . . . 45.45 109.307 -169.721 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -100.16 -68.3 0.82 Allowed 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 124.977 1.311 . . . . 73.12 108.419 176.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.413 ' HE3' ' OE1' ' A' ' 96' ' ' GLU . 0.1 OUTLIER -65.96 -32.9 74.66 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 119.601 1.091 . . . . 71.32 110.985 -177.456 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.4 ' HB2' ' HA ' ' A' ' 97' ' ' ALA . 20.3 mt-10 -112.98 -21.11 11.28 Favored 'General case' 0 CA--C 1.528 0.101 0 N-CA-C 113.53 0.937 . . . . 72.1 113.53 -170.508 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 3.2 t60 45.08 62.98 1.9 Allowed 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 125.726 1.611 . . . . 63.53 114.644 175.06 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 19.3 mmtp -77.78 158.95 29.33 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.634 1.174 . . . . 63.31 111.794 174.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 28.7 tttt -93.27 45.87 1.19 Allowed 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 125.089 1.356 . . . . 75.52 112.381 -172.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 53.6 mt -69.0 51.76 0.08 Allowed 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 131.387 3.875 . . . . 72.12 111.475 -179.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -98.37 1.5 47.0 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 126.232 1.813 . . . . 71.4 111.924 -177.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -131.52 150.62 76.87 Favored Pre-proline 0 N--CA 1.467 0.388 0 C-N-CA 124.128 0.971 . . . . 65.24 109.936 -178.483 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_exo -59.62 -42.59 45.77 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 121.675 1.583 . . . . 64.21 110.782 -176.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 10.5 mp0 -61.35 -38.08 85.65 Favored 'General case' 0 N--CA 1.438 -1.065 0 C-N-CA 124.447 1.099 . . . . 74.14 110.623 -179.078 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -71.42 -47.05 58.37 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 125.591 1.557 . . . . 71.0 110.369 -176.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 58.2 mtt -58.56 -55.63 32.61 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 124.609 1.164 . . . . 71.54 109.154 174.108 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -64.28 -31.12 72.2 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.825 1.25 . . . . 74.42 111.559 -175.18 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -63.6 -46.68 84.7 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 119.478 1.036 . . . . 74.33 110.955 173.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 72.0 t80 -65.71 -44.32 86.45 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 121.866 0.841 . . . . 75.14 109.972 177.403 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.447 HD23 ' HA ' ' A' ' 115' ' ' LEU . 53.0 mt -69.27 -23.94 63.9 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 124.459 1.104 . . . . 75.45 111.481 -176.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.81 -13.92 18.4 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 122.902 0.481 . . . . 74.14 112.2 176.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -110.93 3.2 28.72 Favored Glycine 0 CA--C 1.526 0.755 0 C-N-CA 124.705 1.145 . . . . 63.23 114.046 170.292 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -135.42 51.31 2.08 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 119.383 1.592 . . . . 73.2 108.847 -171.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 92.56 13.85 56.35 Favored Glycine 0 CA--C 1.526 0.756 0 O-C-N 124.149 0.905 . . . . 43.13 114.395 162.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 99.1 t -129.99 165.06 31.07 Favored 'Isoleucine or valine' 0 C--O 1.231 0.116 0 CA-C-N 118.317 1.058 . . . . 64.31 109.35 -167.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 45.2 t0 -129.27 130.86 46.74 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 107.36 -1.348 . . . . 74.34 107.36 174.202 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 3.3 mttp -57.23 -36.98 71.59 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 119.075 0.852 . . . . 71.03 110.571 174.103 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -61.05 -24.16 65.99 Favored 'General case' 0 C--O 1.231 0.098 0 C-N-CA 124.173 0.989 . . . . 74.11 112.209 176.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 88.2 mttt -102.31 -49.37 3.91 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 119.97 1.259 . . . . 63.13 108.465 -177.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 68.4 t80 -48.92 -61.96 1.78 Allowed 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 126.331 1.852 . . . . 72.12 111.953 -178.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 15.9 mt -66.66 -31.63 72.42 Favored 'General case' 0 CA--C 1.534 0.352 0 O-C-N 121.486 -0.759 . . . . 75.2 110.475 -172.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 34.3 t -61.57 -50.4 72.79 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 124.299 1.04 . . . . 54.23 109.128 179.017 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . 0.586 HG23 HG22 ' A' ' 80' ' ' THR 0.272 0.0 OUTLIER -70.15 -34.76 73.43 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 119.164 0.893 . . . . 71.21 110.332 178.264 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 49.2 t80 -54.96 -55.29 32.36 Favored 'General case' 0 CA--C 1.529 0.17 0 O-C-N 121.592 -0.693 . . . . 74.42 110.422 179.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 -94.16 49.66 1.33 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.4 0.68 . . . . 74.22 109.294 176.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -123.2 164.15 19.26 Favored 'General case' 0 C--O 1.241 0.626 0 C-N-CA 125.626 1.57 . . . . 51.14 109.322 170.678 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.17 -30.96 70.72 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-O 119.293 -0.384 . . . . 74.05 110.464 178.446 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -45.3 -66.92 0.33 Allowed 'General case' 0 C--O 1.234 0.264 0 C-N-CA 124.97 1.308 . . . . 70.35 110.959 176.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 8.0 mm -64.54 -32.82 59.39 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 CA-C-O 118.56 -0.733 . . . . 75.03 111.21 -178.134 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 10.5 mttp -57.87 -35.35 70.84 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 119.1 0.863 . . . . 72.4 110.617 174.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -82.65 -31.78 29.09 Favored Glycine 0 C--N 1.339 0.695 0 CA-C-O 122.583 1.101 . . . . 72.44 110.696 -175.112 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 2.8 mm100 -74.51 -39.86 62.14 Favored 'General case' 0 N--CA 1.45 -0.46 0 O-C-N 121.539 -0.977 . . . . 75.54 109.835 -176.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 9.3 mtp -60.63 -51.26 70.15 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 119.069 -0.491 . . . . 65.21 110.379 174.102 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -63.64 -29.16 70.44 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 118.86 0.754 . . . . 73.41 112.435 -174.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 14.7 mtmt -61.47 -75.15 0.07 Allowed 'General case' 0 CA--C 1.522 -0.102 0 N-CA-C 107.86 -1.163 . . . . 74.11 107.86 165.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -49.12 -35.07 15.44 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.228 1.011 . . . . 74.43 112.619 -169.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 9.9 tmtt? -58.02 -46.94 84.48 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 126.301 1.84 . . . . 72.21 112.366 177.357 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 9.5 ptpp? -77.79 -33.44 52.59 Favored 'General case' 0 C--N 1.34 0.176 0 CA-C-N 120.824 1.647 . . . . 62.34 111.199 173.573 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 41.5 mt -59.35 -46.21 89.27 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 119.032 0.833 . . . . 71.24 109.973 -174.151 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -58.67 -37.03 75.12 Favored 'General case' 0 CA--C 1.534 0.349 0 O-C-N 121.814 -0.554 . . . . 60.53 111.592 -178.357 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 1.1 mtm -76.8 -31.85 57.25 Favored 'General case' 0 C--O 1.23 0.044 0 O-C-N 122.138 -0.352 . . . . 64.32 110.857 179.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -56.46 -46.24 80.47 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 108.82 -0.808 . . . . 75.45 108.82 172.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 35.8 m-85 -76.74 10.16 2.38 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 114.175 1.176 . . . . 75.24 114.175 177.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 59.1 23.47 11.69 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 127.562 2.345 . . . . 54.12 113.98 176.004 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.814 HG22 HG21 ' A' ' 155' ' ' THR . 66.4 t -67.05 133.97 30.76 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 C-N-CA 124.031 0.932 . . . . 71.2 108.653 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -130.49 -5.65 4.21 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 125.244 1.418 . . . . 75.32 113.132 -177.641 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 170.98 139.51 2.78 Favored Glycine 0 N--CA 1.448 -0.541 0 N-CA-C 107.666 -2.173 . . . . 64.24 107.666 174.174 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.429 ' HA ' ' C ' ' A' ' 154' ' ' PRO . 17.2 m -83.37 152.72 64.84 Favored Pre-proline 0 CA--C 1.534 0.364 0 C-N-CA 124.559 1.144 . . . . 70.44 109.647 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . 0.486 ' HG3' HD12 ' A' ' 166' ' ' ILE . 53.7 Cg_endo -70.74 157.71 94.59 Favored 'Cis proline' 0 CA--C 1.531 0.359 0 C-N-CA 125.15 -0.771 . . . . 75.35 113.623 3.405 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . 0.814 HG21 HG22 ' A' ' 150' ' ' VAL . 36.5 m -157.13 115.17 3.19 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 107.461 -1.311 . . . . 71.01 107.461 175.338 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 93.7 mtp -96.3 158.24 15.53 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 108.705 -0.85 . . . . 75.53 108.705 164.01 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 5.2 t -136.48 138.47 46.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 106.586 -1.635 . . . . 74.13 106.586 174.365 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.54 HG23 ' CE1' ' A' ' 164' ' ' PHE . 51.2 t -103.18 125.22 57.66 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 N-CA-C 106.734 -1.58 . . . . 74.21 106.734 164.184 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 9.4 t30 52.98 21.54 2.08 Favored 'General case' 0 N--CA 1.462 0.153 0 C-N-CA 130.89 3.676 . . . . 72.15 115.521 162.112 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 73.34 22.62 78.57 Favored Glycine 0 CA--C 1.526 0.72 0 CA-C-O 117.69 -1.617 . . . . 51.21 114.068 -176.415 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 10.4 mtpt -134.18 -24.4 1.64 Allowed 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 120.248 2.024 . . . . 72.41 113.122 -174.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -128.2 120.2 26.78 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 124.179 0.991 . . . . 74.12 109.033 -173.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 41.5 ttp85 -102.56 126.83 49.76 Favored 'General case' 0 CA--C 1.52 -0.178 0 C-N-CA 126.117 1.767 . . . . 71.23 107.886 174.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . 0.54 ' CE1' HG23 ' A' ' 158' ' ' VAL . 13.4 p90 -145.28 174.0 11.48 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 107.277 -1.379 . . . . 73.53 107.277 177.375 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 174.89 -175.25 0.08 Allowed 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 125.437 1.495 . . . . 63.41 108.595 176.423 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.486 HD12 ' HG3' ' A' ' 154' ' ' PRO . 6.5 mt -45.58 -52.27 2.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 C-N-CA 129.901 3.281 . . . . 63.2 108.574 172.624 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -75.61 19.28 2.6 Favored Glycine 0 CA--C 1.524 0.641 0 C-N-CA 128.062 2.744 . . . . 74.12 114.911 176.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 19.2 m -129.27 -50.1 1.19 Allowed 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 119.315 1.557 . . . . 62.1 110.847 157.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -71.16 -19.56 62.4 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.691 0.797 . . . . 72.44 111.944 -174.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 103.44 4.14 46.83 Favored Glycine 0 CA--C 1.525 0.66 0 O-C-N 120.624 -1.298 . . . . 62.35 113.296 175.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . 0.438 ' HA2' HG23 ' A' ' 166' ' ' ILE . . . 154.03 177.06 27.07 Favored Glycine 0 CA--C 1.53 0.981 0 CA-C-N 119.239 1.52 . . . . 63.53 111.268 172.339 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -65.07 -37.51 32.55 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 122.851 2.367 . . . . 65.23 113.38 -169.318 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -69.37 -42.32 75.37 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 119.454 1.025 . . . . 74.51 108.413 -178.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 51.2 mm-40 -66.03 -26.89 67.73 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.685 1.194 . . . . 64.43 110.235 179.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 46.0 m -64.36 -41.34 96.77 Favored 'General case' 0 CA--C 1.534 0.354 0 O-C-N 120.075 -1.641 . . . . 64.54 110.638 -178.276 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 36.9 mt -65.88 -32.04 73.32 Favored 'General case' 0 C--N 1.341 0.203 0 CA-C-N 119.061 0.846 . . . . 72.12 110.532 175.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.03 -39.8 69.53 Favored 'General case' 0 CA--C 1.522 -0.127 0 C-N-CA 124.903 1.281 . . . . 70.23 109.535 174.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.494 HD21 ' HB3' ' A' ' 11' ' ' GLU . 4.5 mm? -78.21 -41.48 34.33 Favored 'General case' 0 CA--C 1.505 -0.763 0 CA-C-O 117.638 -1.172 . . . . 70.1 111.076 173.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -55.63 -45.97 77.49 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 119.52 1.055 . . . . 55.35 109.889 -172.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.93 -37.6 55.01 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 125.204 1.401 . . . . 55.53 109.519 -167.643 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 12.9 t80 -67.78 -47.8 68.13 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.512 1.125 . . . . 65.33 111.253 173.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 78.8 mt -63.33 -35.88 81.85 Favored 'General case' 0 C--O 1.232 0.169 0 C-N-CA 123.889 0.876 . . . . 64.44 110.83 -176.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 34.7 mt -53.31 -54.61 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 CA-C-O 118.338 -0.839 . . . . 73.32 109.181 170.275 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -55.92 -41.78 75.08 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 119.554 1.07 . . . . 73.13 111.553 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.86 -55.72 27.34 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 125.157 1.383 . . . . 74.45 108.267 -179.363 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 26.4 mm-40 -71.38 -32.74 68.82 Favored 'General case' 0 C--O 1.225 -0.186 0 C-N-CA 124.514 1.125 . . . . 73.34 113.094 -178.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.91 -24.52 62.46 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 120.762 -1.211 . . . . 44.41 111.719 -178.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -59.11 -23.75 62.38 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.302 0.641 . . . . 71.12 111.928 171.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -54.68 -22.06 12.6 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.327 1.051 . . . . 73.3 112.463 169.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -119.04 -7.96 10.28 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 113.721 1.008 . . . . 61.44 113.721 168.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 23.3 ttmt -101.03 51.1 0.86 Allowed 'General case' 0 CA--C 1.536 0.419 0 O-C-N 120.513 -1.367 . . . . 74.12 110.698 -172.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.159 0 C-N-CA 127.694 2.398 . . . . 73.42 111.981 177.199 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.929 0 N-CA-C 108.668 -1.773 . . . . 73.24 108.668 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 178.19 142.18 0.1 Allowed 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 129.118 2.967 . . . . 65.51 103.341 -159.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -143.03 6.87 1.58 Allowed 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.527 0.679 . . . . 61.43 111.723 -166.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 -132.87 178.96 6.47 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.561 1.144 . . . . 71.34 109.619 -168.422 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.0 m -148.05 141.93 25.78 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.588 1.555 . . . . 71.03 109.467 175.313 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.98 137.28 56.4 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 124.338 1.055 . . . . 72.33 110.043 178.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.7 -17.4 15.54 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 125.959 1.742 . . . . 21.53 112.76 -171.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 4.4 ttmt -92.86 -86.47 0.25 Allowed 'General case' 0 CA--C 1.519 -0.218 0 CA-C-N 119.028 1.414 . . . . 63.11 107.783 -176.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.422 ' HB3' HD21 ' A' ' 178' ' ' LEU . 0.4 OUTLIER -77.53 -21.34 52.77 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.627 0.771 . . . . 63.21 110.364 -175.354 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 14.0 p90 -161.51 175.95 11.59 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.784 1.234 . . . . 64.11 109.296 -175.196 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 41.3 t -135.05 154.41 36.21 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.811 0 C-N-CA 126.377 1.871 . . . . 63.5 108.321 -175.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -103.88 170.59 7.84 Favored 'General case' 0 CA--C 1.521 -0.164 0 O-C-N 119.649 -1.907 . . . . 51.35 109.63 166.209 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -128.56 113.22 15.18 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 106.956 -1.498 . . . . 73.33 106.956 169.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.4 m -58.43 -15.06 9.27 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 117.129 -1.415 . . . . 73.21 113.744 176.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.6 m -107.96 75.91 0.56 Allowed Pre-proline 0 C--N 1.343 0.307 0 CA-C-N 120.526 1.512 . . . . 41.54 110.179 169.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -71.54 174.46 10.92 Favored 'Trans proline' 0 N--CA 1.444 -1.386 0 C-N-CA 123.19 2.594 . . . . 70.12 110.241 178.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 64.7 t -139.26 125.76 12.51 Favored Pre-proline 0 C--N 1.323 -0.583 0 N-CA-C 107.042 -1.466 . . . . 53.22 107.042 -165.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -73.78 174.84 11.62 Favored 'Trans proline' 0 N--CA 1.453 -0.892 0 C-N-CA 122.646 2.231 . . . . 75.54 110.897 178.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 34.0 m -139.39 -174.03 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 C-N-CA 124.645 1.178 . . . . 64.33 109.404 178.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 15.2 t -48.19 -68.89 0.14 Allowed 'General case' 0 N--CA 1.442 -0.852 0 C-N-CA 128.17 2.588 . . . . 73.35 110.458 172.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -152.94 163.47 23.4 Favored Pre-proline 0 CA--C 1.534 0.354 0 C-N-CA 124.399 1.08 . . . . 52.32 110.297 174.36 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -78.79 -7.1 15.51 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 124.058 3.172 . . . . 64.32 113.095 177.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -58.15 -37.29 85.85 Favored Glycine 0 C--N 1.338 0.667 0 C-N-CA 125.537 1.541 . . . . 71.11 113.605 -170.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 28.2 mttp -119.32 124.58 46.99 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 126.388 1.875 . . . . 73.23 106.087 165.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 44.7 mm -54.98 136.26 17.23 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 N-CA-C 106.931 -1.507 . . . . 51.12 106.931 168.2 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -104.4 93.12 4.63 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 106.425 -1.695 . . . . 71.45 106.425 -176.112 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 26.6 t -88.31 135.86 24.62 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 N-CA-C 106.624 -1.621 . . . . 74.51 106.624 174.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 33.6 t -129.31 135.84 60.83 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 N-CA-C 107.243 -1.392 . . . . 61.21 107.243 -176.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 15.9 tm-20 -114.0 140.57 48.32 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 125.133 1.373 . . . . 72.01 107.699 167.063 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.4 mp -130.76 114.72 15.7 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 124.615 1.166 . . . . 70.54 108.466 -179.54 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 18.9 p90 -107.36 174.85 5.7 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 124.603 1.161 . . . . 74.3 111.931 -176.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 22.6 t90 -145.34 162.01 38.27 Favored 'General case' 0 C--O 1.225 -0.219 0 C-N-CA 125.068 1.347 . . . . 72.5 107.999 162.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 59.8 t80 -56.7 -42.43 79.1 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 126.062 1.745 . . . . 75.52 112.121 172.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -95.39 29.73 9.2 Favored Glycine 0 CA--C 1.531 1.089 0 O-C-N 120.938 -1.101 . . . . 61.34 113.665 -168.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 23.3 t -106.03 81.87 0.82 Allowed Pre-proline 0 CA--C 1.537 0.472 0 C-N-CA 130.474 3.51 . . . . 74.24 111.528 -173.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -79.14 62.02 8.35 Favored 'Trans proline' 0 CA--C 1.544 1.023 0 C-N-CA 121.694 1.596 . . . . 74.24 111.482 -177.457 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 -160.35 -49.99 0.05 OUTLIER 'General case' 0 C--O 1.226 -0.182 0 C-N-CA 126.123 1.769 . . . . 74.42 109.095 -178.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 1.1 p -61.52 -37.36 83.45 Favored 'General case' 0 CA--C 1.548 0.872 0 CA-C-O 121.769 0.795 . . . . 74.13 110.339 -173.036 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -61.76 -29.15 69.94 Favored 'General case' 0 N--CA 1.468 0.465 0 O-C-N 120.084 -1.635 . . . . 73.22 112.87 176.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -78.01 3.61 14.34 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.903 1.281 . . . . 51.35 111.107 177.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 24.4 t80 -125.49 -27.78 3.39 Favored 'General case' 0 C--O 1.223 -0.308 0 C-N-CA 126.781 2.033 . . . . 72.2 111.0 178.161 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -39.51 -65.76 0.39 Allowed Pre-proline 0 CA--C 1.544 0.712 0 CA-C-N 120.286 1.403 . . . . 74.44 114.638 -177.128 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -75.89 -9.05 19.43 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 CA-C-N 122.17 1.811 . . . . 73.24 114.185 -178.116 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 4.2 m -68.44 -42.68 78.51 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 108.45 -0.944 . . . . 73.13 108.45 164.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 19.9 tt -88.21 -34.55 7.23 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 N-CA-C 112.762 0.652 . . . . 73.03 112.762 -172.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 16.2 t -44.73 -54.72 12.14 Favored Pre-proline 0 CA--C 1.549 0.936 0 C-N-CA 124.409 1.084 . . . . 44.13 113.464 176.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -74.07 -21.35 18.23 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 121.905 1.737 . . . . 70.43 112.356 -178.136 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 86.3 t90 -66.15 -51.61 56.21 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 118.679 0.672 . . . . 72.12 109.75 170.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 5.1 p -67.05 -24.14 65.96 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 119.075 0.852 . . . . 73.42 112.277 -175.142 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 73.6 mt-10 -59.9 -54.7 43.08 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 120.793 -1.192 . . . . 74.11 110.302 168.451 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 54.5 mmtt -76.68 6.73 5.49 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 125.316 1.446 . . . . 50.15 113.555 -168.278 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 36.6 mt -62.28 157.15 56.29 Favored Pre-proline 0 N--CA 1.448 -0.574 0 C-N-CA 122.986 0.514 . . . . 54.03 111.268 178.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -77.72 174.88 11.93 Favored 'Trans proline' 0 N--CA 1.449 -1.117 0 C-N-CA 124.809 3.673 . . . . 63.41 110.296 173.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -71.26 -5.74 34.47 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.636 0.774 . . . . 73.12 112.888 177.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -95.66 7.88 45.03 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 123.856 0.862 . . . . 60.15 109.847 -176.205 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 22.6 t -138.76 152.75 24.8 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 N-CA-C 107.628 -1.249 . . . . 70.33 107.628 -176.046 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 41.3 t60 -137.47 162.1 34.59 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 107.332 -1.359 . . . . 54.35 107.332 165.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 35.1 t80 -125.99 137.74 53.69 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 124.237 1.015 . . . . 73.52 108.493 -173.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 52.8 t -132.44 147.84 31.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 107.421 -1.325 . . . . 63.13 107.421 -175.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 44.0 mtm180 -124.21 136.0 53.85 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 107.236 -1.394 . . . . 71.33 107.236 163.365 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 92.8 mt -129.7 144.91 54.84 Favored Pre-proline 0 C--N 1.328 -0.361 0 O-C-N 123.654 0.596 . . . . 53.01 109.96 172.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -73.9 143.83 33.65 Favored 'Trans proline' 0 N--CA 1.451 -0.984 0 C-N-CA 120.756 0.971 . . . . 75.13 109.835 175.269 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -89.28 106.31 18.36 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 126.297 1.839 . . . . 55.42 107.841 174.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 57.8 mt -102.83 60.09 0.79 Allowed 'General case' 0 C--O 1.237 0.417 0 C-N-CA 125.343 1.457 . . . . 73.34 111.491 -168.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 -88.15 -6.54 57.82 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 114.569 1.322 . . . . 71.11 114.569 -164.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 106.58 -173.22 19.26 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 108.548 -1.821 . . . . 34.21 108.548 -175.152 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.489 ' O ' HG22 ' A' ' 70' ' ' ILE . . . 44.39 64.79 1.91 Allowed Glycine 0 CA--C 1.528 0.904 0 CA-C-O 117.929 -1.484 . . . . 64.33 112.444 173.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.489 HG22 ' O ' ' A' ' 69' ' ' GLY 0.276 2.8 tt 64.96 -15.97 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 131.153 3.781 . . . . 74.53 116.192 -176.486 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 10.4 m95 -57.01 -36.83 70.86 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 121.185 1.811 . . . . 65.2 112.311 -174.256 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -73.02 -40.25 65.31 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-O 118.693 -0.67 . . . . 63.2 112.4 -178.078 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 92.3 t -57.92 -51.67 67.71 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 C-N-CA 123.605 0.762 . . . . 70.42 109.474 -175.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 65.4 m170 -69.23 -0.69 6.45 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.541 1.136 . . . . 65.11 113.259 178.049 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -101.19 -47.85 1.52 Allowed Glycine 0 CA--C 1.526 0.761 0 N-CA-C 109.852 -1.299 . . . . 50.13 109.852 174.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -53.28 -34.02 55.56 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 127.383 2.273 . . . . 75.24 114.684 -164.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -57.98 -42.91 86.08 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-O 117.742 -1.123 . . . . 63.12 112.443 178.469 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -55.4 -54.1 47.9 Favored 'General case' 0 CA--C 1.526 0.042 0 N-CA-C 108.639 -0.875 . . . . 74.31 108.639 -175.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 15.7 mt -55.74 -37.56 68.64 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.664 1.186 . . . . 64.21 110.982 177.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.456 ' HA ' HD11 ' A' ' 134' ' ' ILE . 1.3 m -73.39 -39.76 64.86 Favored 'General case' 0 C--N 1.343 0.324 0 CA-C-N 119.498 1.044 . . . . 72.23 110.588 -177.691 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 1.2 tt -56.3 -51.1 69.46 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 125.219 1.407 . . . . 64.52 108.054 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -62.19 -29.66 70.53 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.694 1.198 . . . . 73.02 110.757 177.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 10.4 t -65.17 -30.66 71.59 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.873 0.869 . . . . 75.12 111.351 -171.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 16.6 mtm -69.23 -13.91 62.67 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 119.682 1.128 . . . . 63.11 112.861 173.344 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 67.47 44.8 82.55 Favored Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 110.127 -1.189 . . . . 71.21 110.127 -170.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 27.7 m -57.22 -35.28 48.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 CA-C-O 118.839 -0.6 . . . . 72.22 111.264 171.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 44.73 67.38 0.71 Allowed 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 126.421 1.888 . . . . 63.5 110.807 -179.175 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 9.6 t-80 -87.08 152.08 22.67 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 114.45 -1.25 . . . . 55.42 109.926 -168.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -47.2 -52.93 14.43 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 125.998 1.719 . . . . 70.54 113.365 -170.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 21.2 m -142.0 160.49 20.55 Favored 'Isoleucine or valine' 0 C--O 1.243 0.711 0 C-N-CA 125.993 1.717 . . . . 54.43 107.504 167.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 25.0 m170 -97.26 5.79 49.43 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.114 0.966 . . . . 71.32 112.93 -176.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -54.06 -59.23 4.92 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 125.629 1.572 . . . . 74.22 110.166 179.162 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -61.78 -22.74 65.68 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 113.722 1.008 . . . . 44.53 113.722 -166.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 74.9 t -60.81 -69.37 0.18 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.322 0 C-N-CA 124.897 1.279 . . . . 72.43 108.587 170.039 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -60.4 -47.7 84.94 Favored 'General case' 0 CA--C 1.521 -0.165 0 C-N-CA 123.666 0.786 . . . . 74.45 109.814 -175.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -59.61 -26.93 65.86 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 124.198 0.999 . . . . 61.31 111.038 -176.287 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -88.56 -8.96 53.87 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 112.928 0.714 . . . . 43.34 112.928 -179.342 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 14.7 mm -73.27 -60.65 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 N-CA-C 106.053 -1.832 . . . . 74.41 106.053 154.256 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 35.0 p80 -88.27 -70.41 0.64 Allowed 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 114.325 1.231 . . . . 74.12 114.325 -152.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 25.5 mttp -58.76 -31.3 68.23 Favored 'General case' 0 N--CA 1.463 0.19 0 C-N-CA 123.954 0.901 . . . . 53.1 110.74 177.008 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -69.58 -38.47 77.39 Favored 'General case' 0 N--CA 1.452 -0.34 0 O-C-N 121.814 -0.554 . . . . 64.31 110.602 176.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 3.4 t-160 48.77 92.45 0.02 OUTLIER 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 129.578 3.151 . . . . 63.12 110.891 -164.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.529 ' HE3' ' CE1' ' A' ' 114' ' ' PHE . 0.2 OUTLIER -132.85 147.28 52.3 Favored 'General case' 0 CA--C 1.515 -0.392 0 C-N-CA 123.374 0.67 . . . . 72.25 110.667 170.722 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 3.9 ttmt -79.48 95.47 5.82 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 106.249 -1.76 . . . . 73.01 106.249 -175.189 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 90.0 mt -121.07 46.18 2.1 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 126.379 1.872 . . . . 73.53 110.645 -177.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -80.05 8.08 7.83 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 115.025 1.491 . . . . 72.32 115.025 -174.617 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -153.13 153.86 30.13 Favored Pre-proline 0 C--N 1.326 -0.421 0 C-N-CA 124.737 1.215 . . . . 72.03 109.056 -163.201 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_endo -65.29 -42.84 12.27 Favored 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 122.421 2.081 . . . . 75.54 110.759 -170.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -64.61 -36.79 85.4 Favored 'General case' 0 N--CA 1.444 -0.738 0 C-N-CA 124.209 1.004 . . . . 72.32 111.449 -177.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -65.74 -52.9 47.45 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 125.8 1.64 . . . . 71.34 110.192 175.065 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 49.6 mtm -59.3 -43.51 92.6 Favored 'General case' 0 CA--C 1.529 0.164 0 O-C-N 121.804 -0.56 . . . . 74.45 110.616 178.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.406 ' HB1' ' CG ' ' A' ' 122' ' ' LYS . . . -61.46 -52.24 65.36 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 124.195 0.998 . . . . 64.32 109.676 177.575 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -50.81 -46.48 59.86 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 125.371 1.469 . . . . 73.1 110.696 -179.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . 0.529 ' CE1' ' HE3' ' A' ' 103' ' ' LYS . 57.5 t80 -61.15 -41.75 97.32 Favored 'General case' 0 N--CA 1.449 -0.497 0 O-C-N 121.768 -0.582 . . . . 74.44 112.217 -178.001 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 36.7 mt -83.28 -16.53 45.94 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 123.782 0.833 . . . . 75.43 111.144 -174.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -72.53 66.61 0.71 Allowed 'General case' 0 C--O 1.234 0.267 0 C-N-CA 127.539 2.336 . . . . 64.23 110.891 -171.049 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -178.4 -37.81 0.06 OUTLIER Glycine 0 N--CA 1.442 -0.95 0 C-N-CA 127.557 2.503 . . . . 35.41 109.941 -177.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 1.7 ptpt -86.32 3.12 44.76 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 119.428 1.614 . . . . 74.0 114.111 -163.186 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 118.36 -2.77 16.1 Favored Glycine 0 N--CA 1.449 -0.499 0 CA-C-O 118.694 -1.059 . . . . 61.25 111.135 -167.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 42.5 t -96.7 149.48 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.948 0 N-CA-C 103.642 -2.725 . . . . 74.24 103.642 169.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -124.34 143.35 50.63 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 106.942 -1.503 . . . . 62.1 106.942 169.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.406 ' CG ' ' HB1' ' A' ' 112' ' ' ALA . 24.4 mtpt -55.8 -48.86 74.64 Favored 'General case' 0 CA--C 1.516 -0.327 0 CA-C-O 118.56 -0.733 . . . . 65.41 109.285 178.494 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -55.01 -35.91 64.9 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 118.71 0.687 . . . . 70.33 111.779 -177.108 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 27.8 mmmt -94.99 -29.54 14.58 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 123.537 0.735 . . . . 74.1 109.392 -165.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 82.1 t80 -66.55 -64.57 0.83 Allowed 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 127.2 2.2 . . . . 73.32 109.413 169.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 12.8 mt -58.27 -43.75 88.08 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.236 1.014 . . . . 71.1 109.939 -170.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 22.7 t -52.68 -26.49 14.03 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 126.294 1.838 . . . . 54.34 113.176 -179.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . 0.416 HG23 HG23 ' A' ' 80' ' ' THR 0.278 1.4 t -116.73 -23.55 8.09 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 119.363 0.983 . . . . 70.33 110.712 -176.262 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . 0.429 ' HA ' HG13 ' A' ' 134' ' ' ILE . 27.9 t80 -53.59 -52.57 59.35 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.721 1.208 . . . . 73.11 108.84 166.2 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 18.0 m-80 -91.98 38.85 1.0 Allowed 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 124.551 1.141 . . . . 74.51 110.574 -177.016 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 3.2 t -140.06 169.95 16.75 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 114.627 1.343 . . . . 53.52 114.627 178.187 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -52.98 -30.6 35.93 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 126.802 2.041 . . . . 73.52 111.133 -179.458 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -52.33 -63.73 1.05 Allowed 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 125.351 1.461 . . . . 74.33 110.824 173.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.456 HD11 ' HA ' ' A' ' 80' ' ' THR . 11.5 mm -63.55 -27.37 42.83 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.141 0 O-C-N 121.452 -0.78 . . . . 75.41 112.298 176.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.09 -40.44 73.64 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 119.604 1.093 . . . . 70.12 109.708 173.275 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -64.84 -26.63 71.31 Favored Glycine 0 CA--C 1.532 1.114 0 C-N-CA 124.569 1.08 . . . . 61.52 112.744 177.295 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 6.9 mt-30 -85.42 -45.31 11.98 Favored 'General case' 0 C--O 1.235 0.291 0 O-C-N 120.943 -1.328 . . . . 60.41 110.287 179.239 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 82.4 mmm -61.84 -31.45 71.7 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 123.645 0.778 . . . . 71.02 110.764 179.275 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -64.73 -51.84 60.25 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 119.502 1.046 . . . . 71.51 111.321 175.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 5.8 mttm -62.82 -57.57 10.42 Favored 'General case' 0 CA--C 1.512 -0.497 0 C-N-CA 123.761 0.824 . . . . 64.34 109.29 -175.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -52.95 -40.52 63.73 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 119.494 -0.289 . . . . 72.45 110.883 -176.4 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.68 -62.14 2.02 Favored 'General case' 0 C--N 1.343 0.292 0 CA-C-N 118.7 0.682 . . . . 73.53 110.007 174.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 8.0 ptmt -68.52 -16.55 63.92 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 113.019 0.748 . . . . 72.23 113.019 -169.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 65.9 mt -69.47 -59.65 2.84 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 123.687 0.795 . . . . 74.15 110.104 168.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -54.51 -43.72 72.1 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 118.736 0.698 . . . . 73.04 112.531 -173.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 2.1 ptm -63.21 -44.4 95.43 Favored 'General case' 0 N--CA 1.468 0.458 0 O-C-N 121.677 -0.639 . . . . 75.4 112.377 175.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -64.11 -40.82 97.03 Favored 'General case' 0 CA--C 1.536 0.433 0 O-C-N 121.893 -0.505 . . . . 75.43 109.739 -178.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 21.5 m-85 -70.42 9.0 0.68 Allowed 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 126.944 2.098 . . . . 65.23 113.426 173.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 58.3 mt-30 53.76 35.54 21.65 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 126.612 1.965 . . . . 75.12 114.046 178.415 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.437 HG22 HG21 ' A' ' 155' ' ' THR . 43.4 t -77.68 89.21 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 O-C-N 120.698 -1.251 . . . . 72.2 108.602 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -82.34 -12.13 58.16 Favored 'General case' 0 N--CA 1.469 0.496 0 O-C-N 120.586 -1.321 . . . . 60.12 113.458 177.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -171.18 -171.64 36.59 Favored Glycine 0 CA--C 1.524 0.639 0 C-N-CA 125.216 1.389 . . . . 73.53 109.65 -173.066 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.438 ' HA ' ' C ' ' A' ' 154' ' ' PRO . 29.0 m -137.92 158.38 71.48 Favored Pre-proline 0 CA--C 1.544 0.72 0 C-N-CA 124.756 1.222 . . . . 45.54 109.155 178.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . 0.438 ' C ' ' HA ' ' A' ' 153' ' ' VAL . 31.4 Cg_endo -62.49 152.17 65.46 Favored 'Cis proline' 0 N--CA 1.452 -0.969 0 C-N-CA 123.569 -1.429 . . . . 74.0 112.788 -10.221 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . 0.437 HG21 HG22 ' A' ' 150' ' ' VAL . 77.6 m -141.07 127.08 19.39 Favored 'General case' 0 N--CA 1.443 -0.805 0 C-N-CA 126.457 1.903 . . . . 74.44 107.013 170.041 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 33.1 mmm -107.08 160.27 15.68 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 124.908 1.283 . . . . 65.01 107.57 159.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 6.3 t -142.02 148.29 20.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 106.955 -1.498 . . . . 74.41 106.955 177.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.504 HG23 ' CE1' ' A' ' 164' ' ' PHE . 58.8 t -121.36 126.0 74.39 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 N-CA-C 106.314 -1.735 . . . . 63.24 106.314 168.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 55.25 17.82 2.21 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 127.339 2.256 . . . . 65.12 115.006 171.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 58.41 31.37 66.32 Favored Glycine 0 CA--C 1.53 0.969 0 CA-C-O 117.926 -1.485 . . . . 72.35 112.791 -168.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 1.2 mtpm? -126.38 -42.88 1.8 Allowed 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 119.656 1.728 . . . . 73.34 111.779 -177.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -111.65 147.34 35.73 Favored 'General case' 0 CA--C 1.511 -0.551 0 N-CA-C 106.941 -1.503 . . . . 74.2 106.941 179.11 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 41.4 ttp85 -125.01 135.87 53.18 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 105.601 -2.0 . . . . 72.31 105.601 175.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . 0.504 ' CE1' HG23 ' A' ' 158' ' ' VAL . 7.4 p90 -153.54 171.41 18.78 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 107.295 -1.372 . . . . 72.22 107.295 -178.578 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 174.97 176.33 0.17 Allowed 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 123.726 0.81 . . . . 64.22 108.915 -178.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 38.7 mt -57.14 -35.2 47.41 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 C-N-CA 128.266 2.626 . . . . 72.41 110.268 -173.271 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -86.62 -3.55 83.73 Favored Glycine 0 CA--C 1.525 0.687 0 CA-C-O 117.617 -1.657 . . . . 41.42 113.278 -177.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 19.4 m -105.72 -54.59 2.46 Favored 'General case' 0 C--N 1.342 0.248 0 CA-C-N 119.04 1.42 . . . . 75.11 108.86 168.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -60.74 -29.14 69.2 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 125.234 1.414 . . . . 44.21 112.4 -179.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 98.43 8.59 54.65 Favored Glycine 0 CA--C 1.527 0.841 0 CA-C-O 119.115 -0.825 . . . . 73.05 113.712 175.396 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 163.68 171.42 29.9 Favored Glycine 0 CA--C 1.527 0.827 0 CA-C-N 119.543 1.671 . . . . 72.52 111.781 177.299 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -69.37 -44.34 2.41 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 122.097 1.864 . . . . 60.24 111.129 -175.197 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -68.6 -34.45 75.8 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 118.913 0.779 . . . . 71.21 109.473 179.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -62.8 -33.27 74.86 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 123.226 0.611 . . . . 75.02 109.828 176.181 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 37.1 m -65.41 -40.55 93.52 Favored 'General case' 0 CA--C 1.534 0.358 0 O-C-N 120.924 -1.11 . . . . 65.42 109.332 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 58.7 mt -64.55 -36.46 84.28 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 119.644 1.111 . . . . 70.13 110.647 175.009 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 27.0 tttt -50.93 -51.76 49.0 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.176 0.991 . . . . 55.43 108.904 172.344 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.428 HD13 ' HA ' ' A' ' 178' ' ' LEU . 4.2 mm? -67.67 -40.85 84.45 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-O 118.415 -0.803 . . . . 52.53 111.143 177.56 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -56.59 -41.59 77.24 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 119.05 0.841 . . . . 52.21 111.347 -174.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -85.93 -36.75 19.68 Favored 'General case' 0 CA--C 1.511 -0.532 0 N-CA-C 109.171 -0.677 . . . . 74.2 109.171 -168.271 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -59.3 -54.17 49.85 Favored 'General case' 0 N--CA 1.438 -1.059 0 N-CA-C 109.064 -0.717 . . . . 74.32 109.064 170.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 90.9 mt -61.93 -32.04 72.41 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-O 118.271 -0.871 . . . . 73.34 112.47 -175.135 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 26.6 mt -51.16 -65.97 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.212 0 CA-C-N 119.211 0.914 . . . . 72.11 109.352 166.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 9.8 tm-20 -69.76 -20.09 63.5 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.984 0.913 . . . . 64.42 112.101 -171.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.24 -52.95 60.09 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 124.962 1.305 . . . . 64.34 109.05 168.551 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 42.2 mm-40 -74.99 -39.7 61.1 Favored 'General case' 0 C--N 1.334 -0.104 0 C-N-CA 123.578 0.751 . . . . 72.44 111.891 -176.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.14 -36.03 74.53 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 124.023 0.929 . . . . 75.41 109.767 -177.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -61.7 -16.18 46.86 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.273 1.029 . . . . 55.31 112.417 177.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -65.52 -35.48 80.98 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 119.168 0.894 . . . . 63.0 111.533 173.065 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -118.04 -18.09 9.5 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 113.922 1.082 . . . . 65.12 113.922 -173.01 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 36.6 tttt 44.83 80.16 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 126.804 2.042 . . . . 61.5 113.213 168.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 8.6 mmtt . . . . . 0 C--O 1.25 1.081 0 C-N-CA 125.694 1.598 . . . . 73.34 111.525 166.39 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.812 0 N-CA-C 108.608 -1.797 . . . . 60.11 108.608 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -86.25 131.99 34.1 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 124.538 1.135 . . . . 53.11 108.155 -174.404 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -117.83 10.99 13.4 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 113.172 0.805 . . . . 71.31 113.172 -171.214 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -141.55 164.15 30.99 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 125.558 1.543 . . . . 75.41 107.705 -173.356 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 29.4 m -133.04 130.98 40.11 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.14 -0.689 . . . . 72.03 109.14 -176.046 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.36 124.18 21.57 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 108.061 -1.089 . . . . 61.11 108.061 176.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 101.1 -38.49 3.12 Favored Glycine 0 CA--C 1.527 0.832 0 C-N-CA 128.556 2.979 . . . . 71.12 111.393 -173.303 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 8.4 tptp -75.21 -67.3 0.67 Allowed 'General case' 0 C--O 1.226 -0.163 0 C-N-CA 126.364 1.866 . . . . 73.15 109.442 -175.15 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 5.3 mp0 -93.28 -28.65 16.09 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 126.229 1.812 . . . . 71.23 109.691 -173.237 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 55.2 p90 -152.54 167.26 29.41 Favored 'General case' 0 N--CA 1.469 0.523 0 O-C-N 121.012 -1.055 . . . . 73.52 110.73 -171.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 93.4 t -133.51 117.01 26.09 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-N 119.661 1.119 . . . . 74.33 109.716 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -71.71 166.75 21.3 Favored 'General case' 0 N--CA 1.447 -0.614 0 O-C-N 121.085 -1.009 . . . . 73.11 110.727 174.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -126.68 104.48 8.11 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 124.803 1.241 . . . . 63.42 108.207 173.055 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 44.2 p -67.52 -6.39 19.55 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 124.068 0.947 . . . . 70.01 112.425 176.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 70.0 m -104.86 80.51 0.49 Allowed Pre-proline 0 N--CA 1.451 -0.396 0 N-CA-C 107.006 -1.479 . . . . 64.33 107.006 160.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -70.95 -179.48 3.48 Favored 'Trans proline' 0 N--CA 1.452 -0.969 0 C-N-CA 123.224 2.616 . . . . 60.23 110.519 -177.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 11.8 t -140.21 136.18 16.76 Favored Pre-proline 0 CA--C 1.534 0.361 0 N-CA-C 108.365 -0.976 . . . . 72.42 108.365 178.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -76.53 174.68 12.43 Favored 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 122.603 2.202 . . . . 53.32 111.413 172.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.4 m -112.18 -174.91 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 125.906 1.682 . . . . 63.04 109.539 179.184 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 21.4 m -67.01 -51.84 49.99 Favored 'General case' 0 N--CA 1.45 -0.465 0 O-C-N 121.318 -0.864 . . . . 75.2 109.484 170.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -146.41 161.03 40.26 Favored Pre-proline 0 N--CA 1.446 -0.63 0 C-N-CA 124.176 0.99 . . . . 73.33 109.636 177.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -69.28 -164.58 0.12 Allowed 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 124.358 3.372 . . . . 74.12 111.726 170.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.74 -110.11 3.96 Favored Glycine 0 N--CA 1.448 -0.531 0 N-CA-C 107.457 -2.257 . . . . 64.41 107.457 179.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 8.3 mttp -63.53 135.33 56.78 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 109.639 -0.504 . . . . 42.25 109.639 -178.258 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 38.6 mm -62.3 144.08 14.63 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 N-CA-C 107.423 -1.325 . . . . 73.14 107.423 170.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -101.75 118.62 37.31 Favored 'General case' 0 N--CA 1.458 -0.038 0 N-CA-C 107.564 -1.272 . . . . 74.1 107.564 -177.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 48.8 t -108.77 134.82 49.51 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 N-CA-C 107.716 -1.216 . . . . 43.44 107.716 171.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 6.8 t -132.83 111.05 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 C-N-CA 123.842 0.857 . . . . 72.44 109.814 -174.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 -65.82 127.98 34.16 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 125.255 1.422 . . . . 72.02 108.916 162.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.6 mp -102.45 148.68 25.21 Favored 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 107.596 -1.261 . . . . 53.35 107.596 155.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 37.7 p90 -141.94 170.76 15.12 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 118.848 0.749 . . . . 71.0 111.554 173.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 28.1 t90 -156.41 158.43 37.31 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.889 1.276 . . . . 72.3 110.041 172.323 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 7.4 t80 -70.68 -15.52 62.72 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 113.444 0.905 . . . . 74.41 113.444 -177.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -104.84 12.58 49.83 Favored Glycine 0 CA--C 1.522 0.47 0 CA-C-O 117.554 -1.692 . . . . 74.15 113.067 -175.002 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 24.8 p -112.95 85.3 7.7 Favored Pre-proline 0 CA--C 1.538 0.486 0 CA-C-N 119.938 1.869 . . . . 72.1 108.53 -178.122 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_endo -59.38 -26.31 81.48 Favored 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 121.735 1.623 . . . . 72.15 113.187 -177.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 29.1 m170 -68.27 -23.16 64.74 Favored 'General case' 0 CA--C 1.535 0.379 0 O-C-N 121.346 -0.846 . . . . 71.04 110.89 178.063 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 73.4 m -60.04 -48.06 83.26 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.022 0.929 . . . . 73.03 108.499 171.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 27.1 t80 -63.38 -46.05 88.29 Favored 'General case' 0 N--CA 1.467 0.419 0 O-C-N 120.892 -1.13 . . . . 73.51 111.46 175.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -55.99 -34.9 66.19 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 118.416 0.553 . . . . 52.33 111.737 -176.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -71.23 -23.04 61.93 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 127.174 2.19 . . . . 71.42 113.697 178.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -48.75 -67.05 0.46 Allowed Pre-proline 0 CA--C 1.541 0.614 0 C-N-CA 124.222 1.009 . . . . 61.11 113.21 -165.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -70.93 -6.82 20.03 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 CA-C-N 122.081 1.779 . . . . 72.52 114.636 -177.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.4 m -69.38 -47.4 64.35 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 119.432 1.014 . . . . 72.44 108.318 164.316 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 16.7 tt -94.5 -32.64 4.69 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 C-N-CA 123.814 0.846 . . . . 73.14 112.733 -165.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 22.8 t -49.54 -61.85 3.09 Favored Pre-proline 0 CA--C 1.542 0.646 0 C-N-CA 124.849 1.26 . . . . 75.13 110.551 178.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -64.08 -34.37 58.41 Favored 'Trans proline' 0 N--CA 1.454 -0.795 0 CA-C-N 120.454 1.198 . . . . 75.42 112.329 179.137 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.457 ' CZ2' HD21 ' A' ' 54' ' ' LEU . 72.7 t90 -59.73 -50.57 73.33 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 119.768 1.167 . . . . 73.43 110.679 177.594 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 42.0 t -59.57 -44.9 93.16 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 123.947 0.899 . . . . 25.23 108.97 -176.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 57.5 mt-10 -61.99 -35.61 79.02 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 121.162 -0.961 . . . . 71.1 110.737 178.168 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 70.4 mmtt -77.19 -2.96 37.15 Favored 'General case' 0 C--O 1.237 0.432 0 O-C-N 120.42 -1.425 . . . . 74.1 114.482 177.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.457 HD21 ' CZ2' ' A' ' 50' ' ' TRP . 26.8 mt -54.57 147.21 30.81 Favored Pre-proline 0 C--O 1.237 0.414 0 CA-C-N 120.405 1.457 . . . . 73.04 111.588 -177.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -74.28 164.95 33.0 Favored 'Trans proline' 0 N--CA 1.445 -1.34 0 C-N-CA 124.035 3.157 . . . . 52.44 110.602 -176.062 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -66.23 -4.65 8.13 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 125.753 1.621 . . . . 34.15 115.025 -171.509 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 -118.52 22.71 11.93 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.646 1.579 . . . . 62.5 110.744 179.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 57.8 t -121.61 160.18 23.34 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 N-CA-C 107.531 -1.285 . . . . 73.44 107.531 167.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 75.3 t60 -137.27 152.7 50.09 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 125.766 1.626 . . . . 73.14 107.3 167.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 57.5 t80 -130.79 137.37 49.41 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 123.787 0.835 . . . . 73.45 108.849 -171.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 47.4 t -134.07 155.35 39.42 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 C-N-CA 126.426 1.89 . . . . 73.01 106.906 -173.056 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 4.0 mpt_? -127.07 134.89 50.19 Favored 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 104.364 -2.458 . . . . 74.54 104.364 166.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 68.0 mt -131.85 148.79 71.33 Favored Pre-proline 0 N--CA 1.465 0.293 0 CA-C-N 119.51 1.05 . . . . 74.54 108.629 170.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -69.11 141.78 48.9 Favored 'Trans proline' 0 N--CA 1.451 -1.016 0 C-N-CA 121.421 1.414 . . . . 71.21 110.409 171.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -91.46 67.32 5.6 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 124.535 1.134 . . . . 72.11 108.44 -176.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 54.9 mt -64.8 65.94 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 127.538 2.335 . . . . 74.24 112.724 -171.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -98.2 48.66 1.0 Allowed 'General case' 0 C--O 1.237 0.416 0 C-N-CA 125.229 1.412 . . . . 73.35 111.437 -170.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 67.48 167.83 3.62 Favored Glycine 0 CA--C 1.531 1.034 0 C-N-CA 124.218 0.913 . . . . 74.14 112.11 -177.27 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 50.94 -143.22 14.85 Favored Glycine 0 CA--C 1.526 0.736 0 O-C-N 122.091 -0.653 . . . . 41.52 113.121 176.34 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 4.9 tp -63.63 -11.77 9.58 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 C-N-CA 123.955 0.902 . . . . 73.31 111.547 -173.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 18.4 m95 -73.81 -33.45 64.18 Favored 'General case' 0 CA--C 1.531 0.243 0 O-C-N 120.661 -1.274 . . . . 72.24 110.909 175.2 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -64.78 -44.06 91.22 Favored 'General case' 0 C--O 1.236 0.382 0 O-C-N 121.33 -0.856 . . . . 65.34 109.834 168.072 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 91.5 t -62.78 -53.99 39.66 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 N-CA-C 109.169 -0.678 . . . . 60.2 109.169 -173.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 19.3 m170 -88.96 51.15 2.09 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.864 1.266 . . . . 72.41 109.455 173.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -140.71 -55.53 0.04 OUTLIER Glycine 0 N--CA 1.443 -0.891 0 C-N-CA 124.75 1.167 . . . . 34.54 110.224 167.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.519 ' OE1' HD12 ' A' ' 134' ' ' ILE . 0.0 OUTLIER -55.94 -28.75 58.36 Favored 'General case' 0 CA--C 1.554 1.109 0 N-CA-C 114.617 1.34 . . . . 62.54 114.617 -166.223 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 34.8 ttp -58.22 -38.14 76.23 Favored 'General case' 0 N--CA 1.469 0.489 0 O-C-N 119.299 -2.126 . . . . 74.3 112.119 -176.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 27.9 t80 -56.12 -50.28 71.55 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 123.774 0.83 . . . . 63.41 109.5 -179.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 42.3 mt -66.1 -42.43 89.28 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-O 117.495 -1.241 . . . . 74.53 109.825 179.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.669 ' HA ' HD11 ' A' ' 134' ' ' ILE . 0.2 OUTLIER -58.39 -42.36 86.93 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 120.317 1.417 . . . . 71.22 110.623 -178.192 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -54.94 -52.13 63.95 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 125.131 1.372 . . . . 65.24 108.813 -174.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -78.79 -25.37 44.29 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.415 0.686 . . . . 74.32 111.505 -177.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 12.6 t -62.49 -33.42 74.84 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 125.124 1.37 . . . . 74.11 111.387 176.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . 0.41 ' SD ' ' HA ' ' A' ' 125' ' ' PHE . 30.6 mtp -81.11 -7.87 59.65 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 125.718 1.607 . . . . 71.54 111.616 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 58.53 36.06 83.16 Favored Glycine 0 C--N 1.336 0.565 0 C-N-CA 125.284 1.421 . . . . 61.11 110.803 177.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.4 m -57.78 135.84 21.54 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 N-CA-C 108.691 -0.855 . . . . 63.13 108.691 177.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -72.53 175.61 6.15 Favored 'General case' 0 C--O 1.244 0.777 0 N-CA-C 109.133 -0.691 . . . . 74.24 109.133 176.105 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 75.57 163.1 0.25 Allowed 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 127.91 2.484 . . . . 75.45 110.067 -177.444 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -127.46 33.87 4.78 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 125.249 1.42 . . . . 62.21 109.156 -158.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.9 t -85.26 43.77 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.946 0 C-N-CA 125.208 1.403 . . . . 70.12 110.895 -167.311 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 11.0 p-80 -58.21 -12.25 3.42 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 128.787 2.835 . . . . 54.54 116.254 -174.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -91.46 -47.16 7.59 Favored 'General case' 0 CA--C 1.515 -0.391 0 O-C-N 121.25 -0.906 . . . . 75.11 109.64 173.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -53.6 -36.42 61.95 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-O 117.748 -1.12 . . . . 64.14 112.869 -176.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 57.9 t -45.06 -65.32 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 124.845 1.258 . . . . 63.45 110.987 166.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -57.87 -46.34 85.01 Favored 'General case' 0 C--O 1.226 -0.146 0 CA-C-N 118.583 0.629 . . . . 75.32 110.722 178.289 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -59.27 -37.54 77.89 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.499 0.72 . . . . 73.25 110.637 -174.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.473 ' HB1' ' CE2' ' A' ' 114' ' ' PHE . . . -68.51 -31.72 71.17 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 124.791 1.236 . . . . 44.11 113.016 178.248 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 55.9 mt -78.75 -57.25 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 N-CA-C 105.897 -1.89 . . . . 60.45 105.897 -179.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 85.2 m-70 -74.13 -72.26 0.29 Allowed 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 127.032 2.133 . . . . 73.44 112.031 -172.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 43.5 mttt -65.68 -30.68 71.4 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 119.396 0.998 . . . . 74.32 112.063 -173.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -93.58 -26.76 16.97 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 118.427 0.558 . . . . 72.24 110.788 -173.481 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 49.29 53.2 13.05 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 126.029 1.732 . . . . 74.23 113.766 175.671 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 2.5 mmpt? -85.23 22.33 1.5 Allowed 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.955 1.302 . . . . 60.33 114.401 -173.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 12.2 ttmt 70.29 -69.66 0.17 Allowed 'General case' 0 C--O 1.222 -0.342 0 C-N-CA 128.151 2.58 . . . . 72.44 109.873 -179.33 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.431 ' H ' ' HG2' ' A' ' 110' ' ' GLU . 39.3 mt 63.08 28.93 16.25 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 127.176 2.19 . . . . 75.23 112.342 175.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -79.3 -10.08 59.73 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 115.142 1.534 . . . . 65.33 115.142 -175.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 24.8 p -137.13 159.43 69.86 Favored Pre-proline 0 C--O 1.236 0.39 0 O-C-N 120.932 -1.105 . . . . 40.32 109.08 -177.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -61.55 -34.84 84.34 Favored 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 122.04 1.827 . . . . 73.23 110.607 177.008 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -63.83 -40.28 96.23 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 123.404 0.681 . . . . 74.22 112.216 176.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.431 ' HG2' ' H ' ' A' ' 105' ' ' LEU . 6.9 tp10 -65.01 -48.37 74.19 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.696 0.798 . . . . 72.41 110.123 177.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 57.8 mtt -63.54 -50.46 69.47 Favored 'General case' 0 C--O 1.231 0.09 0 C-N-CA 123.893 0.877 . . . . 75.13 110.773 -179.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.434 ' HB1' ' CG ' ' A' ' 122' ' ' LYS . . . -71.46 -39.46 70.94 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-O 118.414 -0.803 . . . . 62.34 110.234 -170.438 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -61.62 -28.46 69.38 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 119.288 0.949 . . . . 64.43 112.293 176.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . 0.473 ' CE2' ' HB1' ' A' ' 97' ' ' ALA . 86.1 t80 -75.25 -58.76 3.08 Favored 'General case' 0 N--CA 1.443 -0.806 0 O-C-N 121.827 -0.546 . . . . 73.12 110.176 175.047 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 53.8 mt -66.59 -22.48 66.13 Favored 'General case' 0 CA--C 1.532 0.261 0 O-C-N 121.748 -0.595 . . . . 72.11 110.756 -173.37 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -55.93 -17.53 6.78 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 125.215 1.406 . . . . 63.14 112.719 175.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -90.98 -5.83 67.65 Favored Glycine 0 CA--C 1.524 0.625 0 CA-C-O 118.079 -1.4 . . . . 71.44 114.51 174.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 17.2 mmtt -134.79 29.92 3.45 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 120.217 2.009 . . . . 72.45 111.749 -156.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 83.82 29.86 30.81 Favored Glycine 0 CA--C 1.52 0.405 0 N-CA-C 111.558 -0.617 . . . . 64.3 111.558 175.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 87.7 t -123.87 119.15 56.21 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 N-CA-C 107.126 -1.435 . . . . 74.14 107.126 175.404 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 66.3 t0 -70.25 124.37 23.96 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-O 121.185 0.517 . . . . 64.43 109.745 172.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.434 ' CG ' ' HB1' ' A' ' 112' ' ' ALA . 9.5 ttpt -60.15 -40.3 89.41 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 124.128 0.971 . . . . 73.05 110.206 176.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -68.07 -27.25 66.33 Favored 'General case' 0 C--O 1.236 0.347 0 O-C-N 121.489 -0.757 . . . . 71.35 111.325 -177.103 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 52.2 mttm -77.71 -48.13 17.44 Favored 'General case' 0 CA--C 1.509 -0.611 0 N-CA-C 107.217 -1.401 . . . . 71.12 107.217 177.036 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.421 ' CD1' ' HB2' ' A' ' 112' ' ' ALA . 34.0 t80 -44.81 -64.87 0.61 Allowed 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 124.751 1.22 . . . . 71.14 110.592 177.26 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 22.3 mt -68.69 -40.57 79.98 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 119.22 -0.419 . . . . 64.05 110.552 -170.05 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 46.6 t -58.33 -56.73 18.28 Favored 'General case' 0 C--N 1.341 0.209 0 N-CA-C 108.059 -1.089 . . . . 75.25 108.059 -179.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 55.2 m -62.03 -43.3 99.13 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 123.808 0.843 . . . . 33.4 110.325 -176.077 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 45.5 t80 -51.46 -45.86 62.86 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 123.838 0.855 . . . . 72.43 110.591 177.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -98.05 35.06 1.8 Allowed 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.456 1.102 . . . . 60.41 111.155 178.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -120.03 155.84 32.1 Favored 'General case' 0 C--O 1.235 0.316 0 O-C-N 120.929 -1.107 . . . . 74.01 109.807 174.617 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -64.79 -22.3 66.96 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.654 0.782 . . . . 74.41 111.293 174.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -53.95 -29.11 41.27 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 125.173 1.389 . . . . 73.32 113.17 173.333 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.669 HD11 ' HA ' ' A' ' 80' ' ' THR . 11.2 mm -77.23 -39.4 28.48 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.484 0 C-N-CA 123.829 0.852 . . . . 74.2 113.149 169.263 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 9.9 tttp -58.89 -34.61 71.86 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 118.309 -0.853 . . . . 65.24 110.002 -170.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -67.81 -23.4 74.12 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 123.915 0.769 . . . . 53.32 112.952 -178.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -91.28 -45.51 8.57 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 121.923 0.868 . . . . 72.02 108.974 178.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 5.2 ttm -62.17 -40.27 95.46 Favored 'General case' 0 N--CA 1.426 -1.647 0 C-N-CA 126.293 1.837 . . . . 74.0 110.142 -177.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 21.8 pt-20 -69.44 -37.51 77.42 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 120.042 1.292 . . . . 73.2 112.531 -177.04 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 10.2 mmtt -62.59 -59.4 4.98 Favored 'General case' 0 C--O 1.225 -0.23 0 N-CA-C 107.402 -1.333 . . . . 74.42 107.402 171.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -54.78 -43.3 72.68 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 119.56 1.073 . . . . 55.45 111.707 -175.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 11.6 tmtt? -49.77 -64.25 0.87 Allowed 'General case' 0 CA--C 1.518 -0.283 0 C-N-CA 125.167 1.387 . . . . 74.45 110.272 174.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.2 -29.82 64.34 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 120.031 -0.668 . . . . 65.34 110.972 -170.616 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 38.0 mt -61.5 -53.3 58.23 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 123.843 0.857 . . . . 74.44 110.383 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -57.67 -40.76 80.11 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 118.823 0.738 . . . . 53.42 110.814 -175.01 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -64.97 -48.11 75.18 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.769 0.828 . . . . 73.22 110.635 177.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -68.91 -28.97 67.15 Favored 'General case' 0 CA--C 1.533 0.297 0 O-C-N 121.791 -0.568 . . . . 53.14 111.27 -175.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -71.57 7.88 1.29 Allowed 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 125.057 1.343 . . . . 73.22 112.976 171.03 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 57.53 28.42 15.54 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 127.522 2.329 . . . . 74.15 113.335 177.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 15.5 t -77.31 141.55 15.43 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 O-C-N 120.865 -1.147 . . . . 75.33 108.057 -179.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -142.14 10.87 1.95 Allowed 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 121.618 0.723 . . . . 72.23 112.248 179.636 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -171.64 178.98 43.66 Favored Glycine 0 N--CA 1.442 -0.933 0 N-CA-C 108.301 -1.92 . . . . 62.22 108.301 172.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.457 ' HA ' ' C ' ' A' ' 154' ' ' PRO . 0.8 OUTLIER -145.51 147.2 32.51 Favored Pre-proline 0 C--N 1.32 -0.681 0 C-N-CA 126.66 1.984 . . . . 62.12 106.082 -175.155 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . 0.544 ' HG3' HD12 ' A' ' 166' ' ' ILE . 37.6 Cg_endo -65.59 157.67 77.33 Favored 'Cis proline' 0 CA--C 1.531 0.351 0 N-CA-C 114.74 1.015 . . . . 74.33 114.74 3.217 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 18.1 m -158.92 141.05 13.82 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 124.758 1.223 . . . . 73.22 109.227 172.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 98.5 mtp -113.38 156.04 24.15 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 126.529 1.932 . . . . 61.45 107.947 165.192 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 40.6 t -135.42 144.19 34.72 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.36 0 N-CA-C 106.898 -1.519 . . . . 72.43 106.898 172.569 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 6.0 t -113.81 124.1 70.12 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 N-CA-C 105.828 -1.916 . . . . 74.31 105.828 172.218 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 48.9 22.58 0.58 Allowed 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 129.948 3.299 . . . . 62.02 115.927 165.305 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 59.67 36.21 88.84 Favored Glycine 0 CA--C 1.527 0.835 0 CA-C-O 118.335 -1.258 . . . . 64.11 114.223 -169.018 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 32.1 mttm -128.37 -44.39 1.4 Allowed 'General case' 0 C--O 1.233 0.222 0 CA-C-N 119.269 1.534 . . . . 63.43 111.887 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -116.84 120.29 38.05 Favored 'General case' 0 C--N 1.332 -0.174 0 O-C-N 122.194 -0.316 . . . . 60.05 110.767 -174.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 35.8 ttp85 -98.75 126.58 44.41 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 106.752 -1.573 . . . . 64.23 106.752 171.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 7.8 p90 -145.36 163.42 34.63 Favored 'General case' 0 C--N 1.316 -0.872 0 O-C-N 120.829 -1.169 . . . . 74.2 108.438 177.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -173.33 173.1 3.61 Favored 'General case' 0 CA--C 1.516 -0.357 0 N-CA-C 109.786 -0.45 . . . . 63.32 109.786 -172.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.544 HD12 ' HG3' ' A' ' 154' ' ' PRO . 9.1 mt -52.48 -47.99 46.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 C-N-CA 127.648 2.379 . . . . 70.53 109.959 -175.644 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -83.54 3.98 83.31 Favored Glycine 0 CA--C 1.526 0.752 0 CA-C-O 117.9 -1.5 . . . . 71.23 114.027 179.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -102.39 -53.73 2.83 Favored 'General case' 0 C--O 1.226 -0.174 0 CA-C-N 120.518 2.159 . . . . 54.44 107.771 166.634 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -60.0 -52.62 64.6 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 123.872 0.869 . . . . 73.21 110.75 -178.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 129.76 8.59 3.41 Favored Glycine 0 CA--C 1.526 0.724 0 CA-C-O 119.092 -0.838 . . . . 61.14 113.882 -176.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 154.96 174.38 24.82 Favored Glycine 0 CA--C 1.528 0.895 0 CA-C-N 119.192 1.496 . . . . 41.21 110.496 178.208 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -62.48 -49.39 5.89 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 122.67 2.247 . . . . 65.23 111.136 -175.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -67.96 -37.34 81.45 Favored 'General case' 0 CA--C 1.53 0.182 0 O-C-N 121.305 -0.872 . . . . 74.22 110.013 -177.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -59.35 -29.93 68.02 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.204 0.601 . . . . 71.41 110.862 175.491 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 30.5 m -66.74 -41.91 87.1 Favored 'General case' 0 CA--C 1.529 0.172 0 O-C-N 120.698 -1.251 . . . . 74.21 109.361 178.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 44.6 mt -63.87 -36.33 83.58 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 118.928 0.786 . . . . 65.53 110.458 174.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -54.39 -44.74 72.55 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 118.219 -0.896 . . . . 73.5 109.585 173.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.448 HD13 ' HA ' ' A' ' 178' ' ' LEU . 4.2 mm? -68.66 -43.39 76.29 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-O 117.711 -1.138 . . . . 73.51 111.867 173.061 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -52.46 -49.81 63.92 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 119.458 1.026 . . . . 70.15 111.367 -170.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -70.68 -36.95 73.58 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 124.103 0.961 . . . . 72.31 111.055 -171.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -68.07 -48.22 66.15 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 126.213 1.805 . . . . 72.43 111.412 177.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 85.1 mt -61.92 -44.03 97.62 Favored 'General case' 0 CA--C 1.527 0.076 0 C-N-CA 123.673 0.789 . . . . 52.31 110.225 -176.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 56.8 mt -51.78 -51.16 29.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 C-N-CA 124.479 1.112 . . . . 72.15 109.387 174.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 14.9 tm-20 -61.18 -27.23 68.27 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 124.512 1.125 . . . . 74.43 112.419 -178.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . 0.472 ' HA ' ' HE3' ' A' ' 185' ' ' LYS . 0.3 OUTLIER -61.7 -60.73 3.23 Favored 'General case' 0 C--O 1.232 0.162 0 N-CA-C 107.833 -1.173 . . . . 51.34 107.833 176.602 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 66.8 mt-10 -67.41 -34.82 78.04 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 125.781 1.632 . . . . 72.15 111.594 -173.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.93 -21.43 64.76 Favored 'General case' 0 N--CA 1.462 0.173 0 O-C-N 120.776 -1.202 . . . . 73.11 111.911 -177.59 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -60.66 -24.39 65.55 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 122.979 0.511 . . . . 52.43 111.955 173.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -65.43 -18.11 65.06 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 118.69 0.677 . . . . 63.13 112.197 174.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -129.61 15.65 5.95 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.631 1.573 . . . . 75.14 112.225 -176.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 14.3 tptt 46.9 83.52 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 127.053 2.141 . . . . 72.23 112.669 -172.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 8.0 mttp . . . . . 0 C--O 1.251 1.148 0 C-N-CA 128.899 2.88 . . . . 72.2 115.39 162.668 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.672 0 N-CA-C 108.69 -1.764 . . . . 71.43 108.69 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -62.87 138.24 58.48 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 123.531 0.732 . . . . 74.11 109.234 -175.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -142.28 9.37 1.86 Allowed 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.029 0.932 . . . . 73.31 112.593 -175.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 34.7 m-85 -142.02 167.16 22.79 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 124.755 1.222 . . . . 75.51 109.687 -170.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 18.9 m -130.87 133.63 46.07 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.697 1.199 . . . . 73.14 109.691 175.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.03 128.7 36.84 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 124.709 1.204 . . . . 70.13 109.98 173.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 71.52 24.33 76.96 Favored Glycine 0 CA--C 1.531 1.037 0 CA-C-O 118.721 -1.044 . . . . 63.24 111.946 -170.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 3.9 ttmt -127.39 -85.77 0.59 Allowed 'General case' 0 CA--C 1.518 -0.263 0 C-N-CA 125.119 1.368 . . . . 51.54 107.866 165.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.491 ' HB3' HD11 ' A' ' 178' ' ' LEU . 36.9 mp0 -64.31 -23.24 67.23 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 123.484 0.713 . . . . 74.11 110.824 -179.758 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 46.0 p90 -162.98 -178.53 6.14 Favored 'General case' 0 N--CA 1.462 0.174 0 O-C-N 121.731 -0.606 . . . . 54.45 111.88 -169.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 85.1 t -140.0 111.95 4.91 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 C-N-CA 125.428 1.491 . . . . 70.45 109.116 -178.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -75.7 163.42 27.31 Favored 'General case' 0 C--O 1.234 0.289 0 O-C-N 119.997 -1.689 . . . . 64.24 109.162 162.498 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -123.77 129.76 51.57 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 124.958 1.303 . . . . 72.12 108.657 -176.514 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 57.1 p -59.79 -27.54 66.65 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-O 118.228 -0.891 . . . . 74.0 112.363 -178.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 9.3 p -114.65 84.19 9.8 Favored Pre-proline 0 N--CA 1.452 -0.345 0 CA-C-N 119.068 0.849 . . . . 72.51 110.507 -175.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -70.75 175.19 9.27 Favored 'Trans proline' 0 N--CA 1.451 -1.01 0 C-N-CA 122.897 2.398 . . . . 64.15 110.915 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 24.6 t -139.18 136.46 18.12 Favored Pre-proline 0 CA--C 1.542 0.644 0 C-N-CA 123.674 0.79 . . . . 74.22 109.122 -167.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -73.05 176.93 8.42 Favored 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 123.917 3.078 . . . . 74.31 112.949 175.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 15.4 m -137.02 164.71 29.53 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 C-N-CA 124.601 1.16 . . . . 75.43 112.63 -167.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 13.4 t -58.49 -30.4 66.98 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 126.769 2.028 . . . . 72.54 112.965 175.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -155.58 86.06 3.29 Favored Pre-proline 0 N--CA 1.446 -0.657 0 CA-C-N 119.636 1.107 . . . . 73.14 109.425 -170.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -65.28 86.8 0.19 Allowed 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 122.224 1.949 . . . . 74.21 108.991 172.186 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -174.25 -41.8 0.05 OUTLIER Glycine 0 CA--C 1.525 0.714 0 CA-C-O 118.846 -0.975 . . . . 73.11 112.296 -165.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 9.5 mptt -108.06 152.19 24.84 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 106.759 -1.571 . . . . 73.11 106.759 160.011 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 32.6 mm -57.81 148.39 5.53 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 N-CA-C 105.868 -1.901 . . . . 63.34 105.868 162.121 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -117.55 117.47 29.51 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 106.958 -1.497 . . . . 72.21 106.958 -178.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 43.1 t -116.61 129.79 72.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 N-CA-C 107.327 -1.361 . . . . 74.12 107.327 179.409 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 4.8 t -118.9 134.37 62.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 106.143 -1.799 . . . . 74.53 106.143 179.427 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -107.89 101.8 11.04 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 104.631 -2.359 . . . . 60.51 104.631 162.031 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.441 HD22 HG21 ' A' ' 150' ' ' VAL . 5.4 mp -82.98 118.67 23.65 Favored 'General case' 0 CA--C 1.522 -0.114 0 N-CA-C 106.917 -1.512 . . . . 72.45 106.917 177.178 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 49.4 p90 -124.22 168.39 13.0 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.163 0.585 . . . . 71.22 112.045 -171.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . 0.493 ' HB3' HG21 ' A' ' 153' ' ' VAL . 22.6 t90 -146.14 143.43 29.32 Favored 'General case' 0 C--N 1.343 0.312 0 C-N-CA 125.142 1.377 . . . . 75.2 109.238 174.614 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 5.4 t80 -49.15 -42.15 38.7 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 126.739 2.016 . . . . 75.21 112.571 171.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -83.57 15.61 34.9 Favored Glycine 0 CA--C 1.525 0.7 0 CA-C-O 119.163 -0.799 . . . . 64.12 113.017 -171.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 53.5 t -105.12 85.62 1.34 Allowed Pre-proline 0 N--CA 1.447 -0.613 0 C-N-CA 126.322 1.849 . . . . 51.02 108.148 178.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -61.44 -32.68 88.92 Favored 'Trans proline' 0 CA--C 1.534 0.5 0 C-N-CA 122.085 1.856 . . . . 70.12 110.279 177.198 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 5.4 m170 -53.44 -48.72 68.55 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 126.201 1.8 . . . . 64.23 110.134 175.258 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 84.1 m -59.57 -38.07 80.17 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.008 0.923 . . . . 73.42 109.555 -168.102 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 38.5 t80 -62.74 -23.45 67.19 Favored 'General case' 0 N--CA 1.47 0.55 0 O-C-N 120.892 -1.13 . . . . 73.34 112.559 179.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -55.96 -40.32 73.07 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 118.983 0.81 . . . . 74.41 110.043 172.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -85.44 -21.66 28.65 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 125.833 1.653 . . . . 62.23 112.681 -168.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -38.93 -67.08 0.28 Allowed Pre-proline 0 N--CA 1.478 0.937 0 C-N-CA 125.348 1.459 . . . . 73.02 112.662 -176.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -73.95 -10.29 22.88 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 CA-C-N 121.803 1.68 . . . . 71.1 114.406 -174.351 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.8 m -72.32 -45.21 60.92 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 107.975 -1.12 . . . . 75.11 107.975 166.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 20.2 tt -92.28 -36.54 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 N-CA-C 113.207 0.817 . . . . 73.42 113.207 -167.376 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 29.3 t -43.5 -60.48 2.51 Favored Pre-proline 0 CA--C 1.543 0.686 0 C-N-CA 125.31 1.444 . . . . 64.15 110.962 175.135 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -69.62 -29.93 23.73 Favored 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 121.725 1.617 . . . . 74.42 112.011 -177.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.49 ' CZ2' ' HB1' ' A' ' 179' ' ' ALA . 72.5 t90 -57.44 -49.75 75.23 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 119.074 0.852 . . . . 75.22 109.209 175.764 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 44.2 t -61.73 -37.08 82.9 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 122.942 0.497 . . . . 61.12 110.636 178.099 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -59.6 -44.66 93.32 Favored 'General case' 0 CA--C 1.533 0.324 0 O-C-N 120.757 -1.214 . . . . 64.15 110.979 176.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -85.99 4.99 35.37 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 119.197 0.908 . . . . 74.04 113.179 -173.486 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 60.7 mt -58.6 148.72 65.34 Favored Pre-proline 0 N--CA 1.447 -0.612 0 N-CA-C 109.785 -0.45 . . . . 73.43 109.785 173.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -70.69 174.45 10.3 Favored 'Trans proline' 0 N--CA 1.447 -1.252 0 C-N-CA 123.982 3.121 . . . . 64.2 110.623 -178.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -67.68 0.95 2.76 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.986 1.314 . . . . 62.23 114.093 178.253 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -117.88 4.08 12.19 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 125.598 1.559 . . . . 65.33 111.916 -170.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 59.5 t -126.4 138.03 55.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 N-CA-C 105.721 -1.955 . . . . 62.25 105.721 179.243 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 3.2 p-80 -126.74 147.14 50.0 Favored 'General case' 0 N--CA 1.444 -0.768 0 C-N-CA 123.827 0.851 . . . . 41.14 109.13 179.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 28.1 t80 -110.96 140.5 45.41 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 124.199 1.0 . . . . 71.11 108.661 -173.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 82.4 t -133.71 113.54 18.66 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.441 0 N-CA-C 108.283 -1.006 . . . . 73.4 108.283 -170.011 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 29.1 mtm180 -101.07 114.96 29.39 Favored 'General case' 0 CA--C 1.506 -0.716 0 N-CA-C 105.84 -1.911 . . . . 64.52 105.84 -175.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 79.1 mt -130.36 145.58 58.02 Favored Pre-proline 0 C--N 1.328 -0.365 0 C-N-CA 123.177 0.591 . . . . 72.31 109.679 175.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -76.65 134.92 15.61 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 122.829 2.353 . . . . 74.03 110.474 172.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -77.11 95.03 4.14 Favored 'General case' 0 CA--C 1.539 0.533 0 O-C-N 121.55 -0.719 . . . . 53.01 110.035 178.058 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 29.6 mt -88.63 75.09 8.33 Favored 'General case' 0 CA--C 1.539 0.553 0 O-C-N 120.057 -1.652 . . . . 75.23 111.372 -172.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -87.0 30.28 0.77 Allowed 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 113.947 1.091 . . . . 75.12 113.947 -175.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 72.31 -165.01 54.42 Favored Glycine 0 CA--C 1.527 0.826 0 N-CA-C 108.341 -1.904 . . . . 51.32 108.341 -168.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 56.34 -156.47 11.64 Favored Glycine 0 CA--C 1.529 0.95 0 CA-C-N 117.891 0.846 . . . . 75.03 113.601 172.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 9.5 tp -61.67 -20.98 24.49 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 C-N-CA 123.481 0.712 . . . . 74.51 112.219 172.182 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 11.9 m95 -59.3 -42.07 90.49 Favored 'General case' 0 C--N 1.343 0.313 0 CA-C-N 120.097 1.317 . . . . 73.35 110.798 -171.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 12.1 p30 -79.93 -28.15 39.75 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 112.979 0.733 . . . . 62.21 112.979 178.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 92.4 t -63.12 -45.99 97.18 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 N-CA-C 108.089 -1.078 . . . . 54.31 108.089 175.055 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 64.2 m170 -76.61 15.13 0.67 Allowed 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 124.759 1.224 . . . . 71.44 112.644 169.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -123.73 -22.48 2.23 Favored Glycine 0 CA--C 1.532 1.141 0 CA-C-N 120.358 1.436 . . . . 53.14 114.182 178.144 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 33.7 tt0 -72.92 -28.98 62.78 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 118.286 1.043 . . . . 65.21 111.553 -172.146 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 6.5 ttp -61.52 -47.79 83.99 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-O 117.512 -1.232 . . . . 73.23 111.724 -177.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 13.7 t80 -52.62 -52.91 53.28 Favored 'General case' 0 N--CA 1.462 0.138 0 N-CA-C 108.813 -0.81 . . . . 74.25 108.813 -176.315 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 47.3 mt -56.61 -44.22 80.93 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 114.829 -1.078 . . . . 71.02 109.993 177.014 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.685 ' HA ' HD11 ' A' ' 134' ' ' ILE . 2.5 m -62.94 -40.92 99.1 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 120.353 1.433 . . . . 73.05 112.087 -174.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -55.88 -54.14 48.26 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.897 0.879 . . . . 61.53 108.76 176.584 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -74.36 -10.71 59.85 Favored 'General case' 0 CA--C 1.543 0.68 0 O-C-N 121.407 -0.808 . . . . 75.44 111.5 -176.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 9.3 t -88.29 -20.03 25.97 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 126.496 1.918 . . . . 71.41 113.578 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 8.5 ptp -81.66 -21.65 38.0 Favored 'General case' 0 N--CA 1.466 0.334 0 O-C-N 120.89 -1.132 . . . . 74.21 110.072 157.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 80.82 56.13 3.17 Favored Glycine 0 C--N 1.332 0.317 0 N-CA-C 109.373 -1.491 . . . . 63.31 109.373 179.472 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 5.5 m -53.5 125.71 8.32 Favored 'Isoleucine or valine' 0 C--O 1.239 0.511 0 CA-C-O 121.407 0.622 . . . . 72.54 109.837 178.015 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -131.2 29.54 4.63 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 124.909 1.284 . . . . 72.31 110.146 -175.102 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 18.6 t-160 -153.7 79.96 1.15 Allowed 'General case' 0 CA--C 1.536 0.416 0 O-C-N 121.439 -0.788 . . . . 72.42 109.088 168.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -162.85 179.57 7.52 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.078 0.551 . . . . 60.23 111.238 173.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 9.3 p -97.36 -10.16 8.88 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 C-N-CA 126.201 1.8 . . . . 73.22 111.251 173.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 13.8 m-70 49.1 52.39 14.46 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.301 1.44 . . . . 60.3 110.696 -174.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -143.99 -45.71 0.27 Allowed 'General case' 0 CA--C 1.515 -0.399 0 C-N-CA 123.558 0.743 . . . . 61.12 110.757 176.495 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -61.82 -29.57 70.25 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 118.028 0.376 . . . . 73.23 111.65 -176.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 48.5 t -53.42 -61.98 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 C-N-CA 124.159 0.983 . . . . 73.3 108.552 171.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.403 ' CD2' ' CD2' ' A' ' 99' ' ' HIS . 4.8 t80 -69.1 -41.95 76.76 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 119.174 -0.441 . . . . 55.13 110.716 -175.142 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -52.86 -39.66 62.75 Favored 'General case' 0 C--O 1.233 0.21 0 C-N-CA 124.671 1.188 . . . . 75.31 111.024 -178.334 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -63.76 -27.53 69.26 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 124.022 0.929 . . . . 72.23 111.055 -176.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 52.2 mt -85.45 -60.51 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.933 0 C-N-CA 125.97 1.708 . . . . 75.15 107.299 176.12 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . 0.403 ' CD2' ' CD2' ' A' ' 95' ' ' PHE . 20.7 p80 -76.18 -57.17 4.02 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 119.719 1.145 . . . . 51.11 113.256 -169.016 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -83.07 -33.15 26.48 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-N 118.404 0.547 . . . . 71.12 110.989 -171.187 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -97.51 -30.77 12.69 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 124.145 0.978 . . . . 75.31 111.091 -171.06 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 5.2 t-160 45.08 88.53 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 127.901 2.48 . . . . 74.1 112.885 176.056 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.488 ' HE2' ' CE1' ' A' ' 114' ' ' PHE . 0.0 OUTLIER -106.38 155.31 19.68 Favored 'General case' 0 CA--C 1.507 -0.7 0 CA-C-O 121.579 0.704 . . . . 73.52 111.128 164.429 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 5.2 ttmt -58.03 101.97 0.09 Allowed 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 106.698 -1.593 . . . . 65.4 106.698 165.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 93.0 mt -130.42 70.1 1.45 Allowed 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 126.934 2.094 . . . . 72.32 108.701 178.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -114.86 1.67 14.13 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.463 1.105 . . . . 62.43 112.619 -175.523 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -138.63 152.57 71.11 Favored Pre-proline 0 CA--C 1.531 0.249 0 C-N-CA 125.342 1.457 . . . . 75.24 109.209 -175.197 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -65.15 -34.02 47.56 Favored 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 121.395 1.396 . . . . 71.33 110.473 -179.424 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -64.37 -21.02 66.5 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 118.536 0.607 . . . . 73.31 112.343 174.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -84.06 -55.06 4.41 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 107.894 -1.15 . . . . 74.45 107.894 177.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 3.9 mpp? -58.21 -51.78 68.33 Favored 'General case' 0 C--N 1.34 0.187 0 C-N-CA 123.213 0.605 . . . . 73.1 111.135 179.374 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.612 ' HB1' ' HG2' ' A' ' 122' ' ' LYS . . . -67.28 -41.45 85.45 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 118.3 -0.857 . . . . 53.43 110.319 -173.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -57.8 -46.98 83.88 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 118.831 0.741 . . . . 74.34 110.006 174.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . 0.488 ' CE1' ' HE2' ' A' ' 103' ' ' LYS . 84.7 t80 -60.48 -46.9 88.39 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 118.015 0.37 . . . . 43.3 110.817 -176.561 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 46.0 mt -75.62 -17.98 59.84 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 119.356 -0.354 . . . . 52.04 111.007 -176.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.18 -9.85 2.41 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.481 1.512 . . . . 41.24 114.115 -179.096 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -121.34 15.37 9.29 Favored Glycine 0 CA--C 1.533 1.194 0 C-N-CA 126.666 2.079 . . . . 75.22 112.808 176.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 2.8 mmpt? -135.01 25.87 3.59 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.905 1.282 . . . . 75.21 110.891 -172.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 94.13 20.69 29.73 Favored Glycine 0 CA--C 1.524 0.617 0 C-N-CA 124.08 0.848 . . . . 64.22 113.529 172.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 94.0 t -132.98 130.01 58.13 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 C-N-CA 124.675 1.19 . . . . 74.13 107.817 -169.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -98.98 134.06 42.36 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 112.251 0.463 . . . . 73.12 112.251 -176.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.612 ' HG2' ' HB1' ' A' ' 112' ' ' ALA . 39.6 mtpt -60.74 -35.07 75.45 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 118.491 -0.766 . . . . 74.34 110.017 176.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -55.87 -46.51 78.24 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 119.086 0.857 . . . . 53.11 110.479 176.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 25.8 mmtt -78.27 -46.27 20.68 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 106.724 -1.584 . . . . 72.23 106.724 -174.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.51 ' CD2' ' HB2' ' A' ' 112' ' ' ALA . 47.6 t80 -54.06 -65.15 0.62 Allowed 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 125.455 1.502 . . . . 72.4 111.391 -176.504 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 9.3 mt -70.45 -33.76 71.68 Favored 'General case' 0 N--CA 1.467 0.418 0 O-C-N 121.146 -0.971 . . . . 55.4 111.06 -166.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 17.1 t -58.02 -57.8 11.21 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 107.198 -1.408 . . . . 62.13 107.198 172.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 38.4 m -62.85 -39.81 95.52 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-O 118.987 -0.53 . . . . 74.31 110.238 -175.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 54.7 t80 -56.42 -41.79 76.97 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 119.975 1.262 . . . . 73.54 110.064 -179.046 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 33.7 m-80 -84.43 -10.78 57.22 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 124.367 1.067 . . . . 74.21 113.745 -179.382 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 4.3 m -86.73 154.93 20.58 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 126.125 1.77 . . . . 71.43 112.645 -169.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -63.01 -29.83 71.13 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 114.171 1.174 . . . . 75.31 114.171 -171.541 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -57.21 -43.99 83.26 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 120.297 1.408 . . . . 54.33 111.231 -177.287 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.685 HD11 ' HA ' ' A' ' 80' ' ' THR . 4.6 mm -58.48 -43.86 87.73 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.496 0 C-N-CA 126.394 1.878 . . . . 72.12 110.721 174.098 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 17.3 tttm -51.82 -37.49 51.99 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.941 0.896 . . . . 61.23 109.161 174.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -71.95 -40.13 57.78 Favored Glycine 0 CA--C 1.527 0.787 0 C-N-CA 124.634 1.111 . . . . 72.33 111.599 179.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -72.22 -34.37 68.29 Favored 'General case' 0 C--N 1.329 -0.311 0 O-C-N 120.906 -1.349 . . . . 72.1 110.551 -179.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 55.1 mtp -65.06 -51.29 62.33 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 124.599 1.16 . . . . 71.21 109.395 176.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -55.88 -38.78 70.62 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 119.298 0.953 . . . . 74.42 110.926 -172.519 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 21.6 mtmt -66.67 -61.6 1.88 Allowed 'General case' 0 C--N 1.342 0.255 0 CA-C-O 117.703 -1.141 . . . . 61.32 110.911 176.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -52.31 -39.13 60.16 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 120.834 1.652 . . . . 54.52 111.298 -177.226 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 11.0 tttt -62.49 -54.46 39.68 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 125.514 1.526 . . . . 54.51 112.454 178.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.01 -30.61 67.97 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 119.824 1.193 . . . . 72.1 110.623 179.166 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 40.3 mt -60.2 -47.25 86.76 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-O 118.932 -0.556 . . . . 72.1 110.558 -177.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -54.76 -45.93 74.28 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 118.016 0.371 . . . . 72.04 111.56 -177.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 13.2 ptp -70.57 -42.05 71.6 Favored 'General case' 0 CA--C 1.523 -0.079 0 N-CA-C 112.117 0.414 . . . . 55.21 112.117 -179.172 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -60.59 -38.53 84.96 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 123.747 0.819 . . . . 52.1 109.126 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 23.4 m-85 -76.47 6.16 6.17 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 114.12 1.155 . . . . 72.12 114.12 175.527 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 54.2 mt-30 57.63 36.19 26.46 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 127.073 2.149 . . . . 71.34 112.829 -179.22 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.441 HG21 HD22 ' A' ' 32' ' ' LEU . 36.1 t -82.94 145.87 7.85 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 N-CA-C 108.072 -1.084 . . . . 71.14 108.072 171.762 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -140.18 -7.79 1.18 Allowed 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 124.53 1.132 . . . . 64.23 112.642 173.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -154.43 -176.77 27.1 Favored Glycine 0 CA--C 1.52 0.396 0 N-CA-C 108.601 -1.8 . . . . 73.13 108.601 -178.209 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.493 HG21 ' HB3' ' A' ' 34' ' ' TRP . 31.4 m -137.49 158.37 72.18 Favored Pre-proline 0 CA--C 1.54 0.563 0 N-CA-C 108.628 -0.879 . . . . 71.44 108.628 174.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . 0.413 ' C ' ' HA ' ' A' ' 153' ' ' VAL . 61.5 Cg_endo -63.05 160.56 59.06 Favored 'Cis proline' 0 N--CA 1.455 -0.771 0 C-N-CA 123.252 -1.562 . . . . 75.51 112.055 -12.026 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . 0.424 HG21 HG22 ' A' ' 150' ' ' VAL . 9.4 m -159.04 111.05 2.16 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 105.537 -2.023 . . . . 71.55 105.537 174.332 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 92.7 mtp -84.39 155.61 22.21 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 108.579 -0.897 . . . . 71.05 108.579 165.143 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 10.0 t -138.48 150.71 24.16 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 N-CA-C 106.82 -1.548 . . . . 75.24 106.82 174.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 55.2 t -134.98 123.79 41.49 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 N-CA-C 105.908 -1.886 . . . . 73.04 105.908 -178.133 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 9.3 m-20 52.33 13.1 0.27 Allowed 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 129.814 3.246 . . . . 74.2 114.598 178.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 59.17 42.31 97.09 Favored Glycine 0 CA--C 1.527 0.785 0 CA-C-O 118.612 -1.105 . . . . 75.44 111.826 -166.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 13.5 mtpp -133.19 -38.85 0.94 Allowed 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 125.119 1.367 . . . . 63.23 111.219 -177.23 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -116.29 154.2 30.59 Favored 'General case' 0 CA--C 1.502 -0.901 0 N-CA-C 108.409 -0.96 . . . . 70.32 108.409 177.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 28.4 ttp85 -132.7 135.11 45.58 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 105.034 -2.21 . . . . 65.24 105.034 174.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 45.5 p90 -149.77 173.26 13.92 Favored 'General case' 0 C--N 1.324 -0.543 0 O-C-N 121.465 -0.772 . . . . 74.32 109.123 169.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -167.5 174.24 8.03 Favored 'General case' 0 CA--C 1.515 -0.367 0 N-CA-C 109.76 -0.459 . . . . 43.3 109.76 178.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 14.7 mt -51.77 -51.27 28.47 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 C-N-CA 125.917 1.687 . . . . 71.5 110.33 -179.183 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -76.09 -20.7 77.23 Favored Glycine 0 CA--C 1.527 0.8 0 CA-C-O 118.096 -1.391 . . . . 70.31 113.467 -178.072 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 66.6 m -70.18 -64.25 0.93 Allowed 'General case' 0 C--O 1.235 0.33 0 CA-C-N 120.011 1.906 . . . . 71.05 108.407 168.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -55.76 -48.74 74.76 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 127.354 2.261 . . . . 71.43 111.943 -174.04 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 130.89 -6.49 5.78 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 124.532 1.063 . . . . 74.3 114.303 178.197 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 165.59 169.67 29.51 Favored Glycine 0 CA--C 1.526 0.758 0 CA-C-N 119.218 1.509 . . . . 52.44 110.413 178.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -61.07 -43.43 29.89 Favored 'Trans proline' 0 N--CA 1.461 -0.439 0 C-N-CA 123.047 2.498 . . . . 74.21 111.351 -174.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 -60.32 -44.43 95.48 Favored 'General case' 0 CA--C 1.536 0.424 0 O-C-N 121.468 -0.77 . . . . 71.31 110.474 176.332 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -66.5 -23.94 66.33 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.511 1.125 . . . . 74.44 110.648 -177.527 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 28.3 m -66.58 -44.31 82.6 Favored 'General case' 0 N--CA 1.455 -0.19 0 O-C-N 121.056 -1.027 . . . . 74.52 109.668 179.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 54.9 mt -68.15 -23.51 64.88 Favored 'General case' 0 C--N 1.341 0.217 0 CA-C-N 118.702 0.683 . . . . 74.15 111.938 179.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.12 -54.9 37.36 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 108.245 -1.02 . . . . 50.44 108.245 168.577 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.491 HD11 ' HB3' ' A' ' 11' ' ' GLU . 3.0 mm? -64.74 -44.69 89.33 Favored 'General case' 0 CA--C 1.515 -0.383 0 N-CA-C 110.016 -0.365 . . . . 70.31 110.016 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.49 ' HB1' ' CZ2' ' A' ' 50' ' ' TRP . . . -54.86 -34.38 62.86 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 112.538 0.57 . . . . 73.12 112.538 -175.018 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -94.61 -36.55 11.74 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 123.475 0.71 . . . . 54.32 110.929 -170.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 37.9 t80 -57.25 -53.45 57.99 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.757 0.823 . . . . 74.21 109.65 171.156 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 26.5 mt -55.75 -46.8 77.75 Favored 'General case' 0 CA--C 1.516 -0.329 0 C-N-CA 124.43 1.092 . . . . 72.43 111.403 -177.154 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 46.2 mt -48.46 -58.65 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.139 0 N-CA-C 109.025 -0.731 . . . . 71.11 109.025 176.378 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 6.9 tm-20 -65.1 -26.64 68.3 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 119.254 0.934 . . . . 73.31 111.882 -176.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 3.7 tmtm? -64.9 -58.28 6.59 Favored 'General case' 0 C--O 1.234 0.282 0 O-C-N 120.645 -1.284 . . . . 62.42 109.634 172.018 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -60.54 -40.8 92.85 Favored 'General case' 0 N--CA 1.438 -1.04 0 C-N-CA 125.525 1.53 . . . . 75.22 112.077 -177.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.68 -43.37 80.31 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 125.859 1.664 . . . . 44.21 110.299 179.428 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -57.49 -29.52 64.35 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 119.884 1.22 . . . . 72.43 111.202 -174.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -53.2 -29.45 32.16 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.06 0.944 . . . . 61.43 113.39 174.079 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -147.98 50.49 1.04 Allowed 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 125.797 1.639 . . . . 43.44 109.894 -174.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 49.9 tttt -84.26 44.4 1.02 Allowed 'General case' 0 N--CA 1.476 0.851 0 O-C-N 120.934 -1.104 . . . . 74.13 109.237 -178.25 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.097 0 C-N-CA 127.038 2.135 . . . . 63.42 112.292 -161.287 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.934 0 N-CA-C 108.599 -1.8 . . . . 45.1 108.599 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . 0.27 0.0 OUTLIER 59.4 164.03 0.05 OUTLIER 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.148 0.579 . . . . 63.34 110.598 -135.492 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -152.93 14.48 0.54 Allowed 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.123 0.969 . . . . 74.23 112.127 175.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 25.5 m-85 -146.6 160.72 41.81 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 123.932 0.893 . . . . 74.41 110.275 -167.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 31.5 m -128.78 136.59 50.74 Favored 'General case' 0 C--O 1.238 0.461 0 O-C-N 121.418 -0.801 . . . . 62.31 108.846 -177.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -70.99 149.99 46.1 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 122.119 0.961 . . . . 43.34 109.1 174.229 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 62.32 12.04 36.6 Favored Glycine 0 CA--C 1.533 1.208 0 CA-C-O 118.556 -1.136 . . . . 73.54 112.582 -167.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.8 tptt -126.97 -84.24 0.61 Allowed 'General case' 0 C--N 1.339 0.131 0 CA-C-N 119.885 1.842 . . . . 74.42 107.346 -178.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.6 mp0 -74.52 -26.82 60.23 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 125.477 1.511 . . . . 74.43 110.372 179.441 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 34.3 p90 -158.61 174.86 14.41 Favored 'General case' 0 N--CA 1.456 -0.131 0 O-C-N 121.18 -0.95 . . . . 74.11 109.451 -175.223 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 24.7 t -135.76 128.56 47.07 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.107 0 C-N-CA 124.418 1.087 . . . . 52.23 108.196 -179.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.424 ' HG3' ' CE1' ' A' ' 162' ' ' TYR . 0.7 OUTLIER -87.74 169.28 12.23 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.211 1.404 . . . . 74.53 110.782 165.204 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -136.38 122.48 20.29 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 124.641 1.176 . . . . 74.11 111.054 177.037 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.6 p -63.13 -0.07 0.69 Allowed 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 128.657 2.783 . . . . 74.14 114.693 179.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 74.1 m -137.7 78.87 35.82 Favored Pre-proline 0 N--CA 1.447 -0.592 0 N-CA-C 107.546 -1.279 . . . . 73.25 107.546 173.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -68.97 179.6 3.17 Favored 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 123.339 2.692 . . . . 74.52 111.818 -176.39 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 40.4 t -126.84 136.97 29.57 Favored Pre-proline 0 CA--C 1.536 0.407 0 N-CA-C 108.503 -0.925 . . . . 70.35 108.503 -169.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -78.18 -179.09 5.13 Favored 'Trans proline' 0 CA--C 1.537 0.635 0 C-N-CA 122.882 2.388 . . . . 72.25 111.861 178.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 3.7 m -131.96 179.78 4.07 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 C-N-CA 127.294 2.237 . . . . 53.02 109.504 176.306 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 47.3 t -64.15 -70.58 0.21 Allowed 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 124.879 1.272 . . . . 53.25 108.324 168.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 57.2 tp60 -116.54 143.03 30.49 Favored Pre-proline 0 N--CA 1.45 -0.443 0 N-CA-C 105.543 -2.021 . . . . 62.11 105.543 -176.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -86.21 -164.13 0.21 Allowed 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 123.699 2.932 . . . . 73.42 110.306 176.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 94.3 -77.84 0.97 Allowed Glycine 0 N--CA 1.444 -0.771 0 N-CA-C 108.889 -1.684 . . . . 74.3 108.889 174.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 87.2 mttt -62.98 136.56 57.91 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 107.919 -1.141 . . . . 55.31 107.919 178.271 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.446 HD12 ' HB3' ' A' ' 186' ' ' GLU . 25.8 mm -73.78 124.66 31.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 106.134 -1.802 . . . . 74.45 106.134 176.117 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -73.76 146.93 43.94 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.104 -1.073 . . . . 75.31 108.104 175.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 60.1 t -133.35 135.6 55.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 106.382 -1.71 . . . . 72.23 106.382 164.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 60.9 t -130.38 101.28 5.65 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 N-CA-C 106.4 -1.704 . . . . 62.03 106.4 -169.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -72.04 133.64 45.39 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 107.679 -1.23 . . . . 71.53 107.679 164.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.1 mp -119.71 126.87 52.13 Favored 'General case' 0 C--O 1.231 0.109 0 N-CA-C 108.536 -0.912 . . . . 74.32 108.536 167.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 21.6 p90 -135.3 163.59 29.66 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 124.649 1.18 . . . . 70.04 111.131 -171.007 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . 0.449 ' HB3' HG21 ' A' ' 153' ' ' VAL . 34.2 t90 -143.44 157.75 44.2 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 124.647 1.179 . . . . 73.24 107.948 173.672 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 31.3 t80 -46.23 -57.88 4.16 Favored 'General case' 0 N--CA 1.444 -0.745 0 C-N-CA 128.063 2.545 . . . . 75.34 113.707 -177.11 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -75.46 -83.68 0.41 Allowed Glycine 0 N--CA 1.444 -0.767 0 N-CA-C 108.548 -1.821 . . . . 72.1 108.548 -170.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 9.1 t 42.63 65.53 5.1 Favored Pre-proline 0 CA--C 1.541 0.62 0 C-N-CA 126.032 1.733 . . . . 63.41 112.752 164.128 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -62.57 -20.12 69.81 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 122.413 2.076 . . . . 74.24 112.471 -175.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 15.1 m-70 -83.95 -21.4 31.8 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 117.732 -1.128 . . . . 74.41 113.938 172.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 99.0 m -68.16 -41.87 80.9 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 119.931 1.241 . . . . 74.52 109.56 175.141 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 19.1 t80 -54.06 -42.81 69.68 Favored 'General case' 0 C--N 1.341 0.202 0 C-N-CA 124.155 0.982 . . . . 75.14 110.804 -174.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -51.68 -43.87 62.88 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.815 0.846 . . . . 71.13 111.909 -179.094 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -76.84 -24.59 52.7 Favored 'General case' 0 C--O 1.225 -0.231 0 CA-C-O 117.061 -1.447 . . . . 71.35 112.725 -171.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -44.45 -67.79 0.33 Allowed Pre-proline 0 CA--C 1.543 0.68 0 CA-C-N 120.421 1.464 . . . . 75.13 113.677 -170.037 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -70.92 -4.62 15.17 Favored 'Trans proline' 0 CA--C 1.536 0.611 0 C-N-CA 121.801 1.667 . . . . 54.05 112.815 -175.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -96.52 -0.8 48.38 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 127.181 2.192 . . . . 55.1 111.151 173.461 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 20.6 tt -126.93 -28.38 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 CA-C-N 120.885 1.675 . . . . 74.01 112.978 171.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 54.6 t -50.92 -60.14 6.14 Favored Pre-proline 0 CA--C 1.538 0.493 0 CA-C-N 119.612 1.096 . . . . 73.51 110.974 178.14 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -69.16 -32.51 20.93 Favored 'Trans proline' 0 N--CA 1.451 -0.998 0 CA-C-N 121.07 1.418 . . . . 43.34 111.067 -175.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.451 ' CZ2' ' HB1' ' A' ' 179' ' ' ALA . 83.4 t90 -53.38 -53.41 51.51 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 119.842 1.201 . . . . 73.3 110.242 173.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 21.5 t -60.48 -37.42 81.0 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.676 0.79 . . . . 73.55 111.288 -177.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -61.66 -45.82 92.41 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 119.32 0.963 . . . . 63.43 110.88 173.083 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 2.6 mptp? -83.49 7.93 15.51 Favored 'General case' 0 C--O 1.234 0.261 0 O-C-N 120.625 -1.297 . . . . 73.42 113.544 -169.081 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 35.2 mt -61.59 157.49 47.01 Favored Pre-proline 0 CA--C 1.537 0.471 0 C-N-CA 125.198 1.399 . . . . 70.32 111.784 179.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -74.85 167.98 25.87 Favored 'Trans proline' 0 N--CA 1.451 -0.993 0 C-N-CA 124.752 3.635 . . . . 73.13 110.548 172.123 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -77.69 -4.95 48.75 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.755 0.822 . . . . 55.33 113.133 178.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -94.43 7.04 46.91 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 119.272 0.942 . . . . 72.42 110.647 177.408 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 96.8 t -126.55 138.0 56.06 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 N-CA-C 106.715 -1.587 . . . . 64.52 106.715 -177.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 68.5 t60 -123.48 108.84 13.11 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 124.9 1.28 . . . . 72.34 108.747 -178.004 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 51.8 t80 -87.81 137.55 32.24 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 123.788 0.835 . . . . 72.34 109.528 -178.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 47.7 t -136.28 150.18 27.66 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 C-N-CA 126.215 1.806 . . . . 74.02 107.409 -174.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 30.4 mtp180 -132.72 126.08 31.69 Favored 'General case' 0 C--O 1.232 0.166 0 N-CA-C 106.885 -1.524 . . . . 72.22 106.885 -176.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 86.8 mt -138.47 144.82 44.11 Favored Pre-proline 0 N--CA 1.467 0.402 0 C-N-CA 124.141 0.976 . . . . 62.33 109.587 -178.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -74.79 152.82 42.37 Favored 'Trans proline' 0 N--CA 1.456 -0.735 0 C-N-CA 122.14 1.893 . . . . 73.44 111.672 177.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -89.48 107.21 18.94 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 125.237 1.415 . . . . 61.04 109.09 177.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.442 HD13 ' HE3' ' A' ' 138' ' ' MET . 39.8 mt -105.71 78.59 1.36 Allowed 'General case' 0 C--O 1.236 0.356 0 C-N-CA 125.151 1.381 . . . . 61.11 108.103 -173.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -121.96 59.95 0.99 Allowed 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 124.706 1.202 . . . . 62.34 110.197 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 68.85 164.74 3.58 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 125.983 1.754 . . . . 71.32 114.174 167.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 48.72 -142.7 8.6 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 124.252 0.929 . . . . 74.11 111.276 -175.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -56.7 -17.29 4.83 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 C-N-CA 124.71 1.204 . . . . 63.1 113.524 -175.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 13.3 m95 -60.97 -42.85 99.1 Favored 'General case' 0 C--N 1.341 0.211 0 O-C-N 120.442 -1.411 . . . . 75.24 109.959 178.435 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 7.5 m-80 -72.21 -17.97 61.88 Favored 'General case' 0 CA--C 1.527 0.095 0 O-C-N 121.566 -0.709 . . . . 74.31 112.512 176.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 64.8 t -92.53 -13.25 8.76 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 C-N-CA 123.786 0.834 . . . . 74.4 111.605 -173.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 52.0 m170 -115.45 4.49 14.3 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.342 1.057 . . . . 74.14 111.924 172.141 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -102.93 -41.73 2.22 Favored Glycine 0 N--CA 1.448 -0.526 0 N-CA-C 109.518 -1.433 . . . . 43.41 109.518 -176.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . 0.268 1.3 pm0 -49.12 -43.86 41.85 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 125.16 1.384 . . . . 75.13 113.027 -179.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 5.1 ppp? -54.35 -37.16 64.61 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 114.154 1.168 . . . . 64.13 114.154 -172.276 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 39.4 t80 -56.49 -43.07 79.34 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 122.835 1.302 . . . . 74.14 109.049 -172.2 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 12.9 mt -68.87 -34.8 76.05 Favored 'General case' 0 N--CA 1.442 -0.867 0 C-N-CA 125.991 1.716 . . . . 75.15 110.729 -177.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.75 HG22 HG23 ' A' ' 128' ' ' THR . 0.0 OUTLIER -68.53 -50.99 47.8 Favored 'General case' 0 C--N 1.344 0.356 0 CA-C-N 121.125 1.784 . . . . 71.5 110.182 176.026 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.464 HD21 HD22 ' A' ' 115' ' ' LEU . 0.7 OUTLIER -51.09 -52.96 38.42 Favored 'General case' 0 CA--C 1.535 0.376 0 O-C-N 123.968 0.793 . . . . 75.13 109.459 -177.543 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -65.12 -28.14 69.22 Favored 'General case' 0 N--CA 1.465 0.289 0 O-C-N 121.517 -0.739 . . . . 35.13 112.866 -179.408 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 8.5 t -69.63 -19.76 63.62 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 118.09 -0.957 . . . . 64.51 111.682 -175.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 4.9 ptp -93.6 -16.97 23.82 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 121.116 1.78 . . . . 74.22 112.364 170.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 79.7 63.46 2.0 Favored Glycine 0 CA--C 1.522 0.47 0 N-CA-C 109.153 -1.579 . . . . 22.44 109.153 -179.26 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 4.4 m -58.27 107.72 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 C-N-CA 124.336 1.054 . . . . 71.12 109.761 178.508 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -92.13 172.06 8.68 Favored 'General case' 0 C--O 1.237 0.446 0 O-C-N 121.363 -0.835 . . . . 75.1 109.143 170.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 6.8 t-160 76.15 19.98 1.71 Allowed 'General case' 0 C--O 1.242 0.692 0 C-N-CA 127.485 2.314 . . . . 74.05 113.545 176.562 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -153.9 154.83 34.58 Favored 'General case' 0 CA--C 1.546 0.815 0 O-C-N 120.968 -1.083 . . . . 73.42 108.988 154.181 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.0 t -77.18 29.07 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 127.761 2.424 . . . . 73.14 112.481 -174.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 71.9 m80 50.0 48.55 21.76 Favored 'General case' 0 CA--C 1.544 0.749 0 O-C-N 120.401 -1.437 . . . . 53.22 109.832 -168.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -130.23 -48.78 1.1 Allowed 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 128.092 2.557 . . . . 61.1 109.055 -178.005 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -68.34 -22.35 64.69 Favored 'General case' 0 N--CA 1.449 -0.478 0 O-C-N 121.471 -0.768 . . . . 60.13 111.663 -174.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 57.3 t -60.05 -65.08 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 CA-C-N 119.997 1.271 . . . . 65.34 108.258 164.182 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -51.4 -49.36 61.72 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 125.114 1.366 . . . . 74.1 112.086 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.418 ' OE1' ' HE3' ' A' ' 100' ' ' LYS . 3.5 mm-40 -62.04 -13.8 29.64 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 126.825 2.05 . . . . 71.55 112.442 -178.272 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.451 ' HB1' ' CZ ' ' A' ' 114' ' ' PHE . . . -108.0 1.51 22.55 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 125.638 1.575 . . . . 74.33 111.024 178.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 28.3 mt -110.74 -58.1 3.78 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.286 0 N-CA-C 107.741 -1.207 . . . . 72.11 107.741 172.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 80.3 m-70 -66.37 -60.7 2.51 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 119.051 0.841 . . . . 73.24 111.09 -177.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.418 ' HE3' ' OE1' ' A' ' 96' ' ' GLU . 0.6 OUTLIER -68.17 -30.0 69.01 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 118.999 0.818 . . . . 75.54 110.646 -174.06 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -98.38 -36.89 9.83 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 123.84 0.856 . . . . 70.24 111.715 -168.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 5.0 t-160 44.26 57.31 4.37 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 128.713 2.805 . . . . 72.22 112.778 178.004 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -64.88 -173.37 0.11 Allowed 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.897 1.679 . . . . 71.14 111.756 170.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 18.8 ttmm -109.49 54.3 0.66 Allowed 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 126.447 1.899 . . . . 72.32 110.415 175.09 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 24.8 mt -75.39 58.32 0.98 Allowed 'General case' 0 C--N 1.322 -0.587 0 C-N-CA 127.479 2.311 . . . . 72.23 108.452 179.323 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -114.6 -2.36 13.12 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 127.832 2.453 . . . . 74.15 111.346 -171.307 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 45.1 p -135.4 151.28 74.5 Favored Pre-proline 0 C--O 1.232 0.14 0 C-N-CA 124.729 1.212 . . . . 51.23 108.715 179.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -66.59 -23.83 49.17 Favored 'Trans proline' 0 N--CA 1.459 -0.5 0 C-N-CA 121.888 1.725 . . . . 71.41 111.955 179.01 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -58.27 -60.32 3.94 Favored 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 124.71 1.204 . . . . 75.11 110.479 167.034 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 19.5 tp10 -66.49 -40.07 89.09 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 120.978 -0.289 . . . . 53.45 110.842 -174.06 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 3.6 mtt -67.01 -47.06 72.62 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 120.722 -0.391 . . . . 74.45 111.447 -175.007 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -63.28 -48.35 78.49 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 118.94 -0.552 . . . . 54.22 110.59 -177.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -70.96 -5.42 30.83 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 118.847 0.748 . . . . 53.12 112.928 -178.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . 0.451 ' CZ ' ' HB1' ' A' ' 97' ' ' ALA . 87.0 t80 -100.18 -35.22 9.73 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 124.626 1.17 . . . . 63.05 112.38 176.528 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.464 HD22 HD21 ' A' ' 81' ' ' LEU . 76.9 mt -83.22 -17.75 41.66 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 123.134 0.574 . . . . 72.33 111.166 175.502 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -52.17 -30.31 26.33 Favored 'General case' 0 CA--C 1.528 0.115 0 C-N-CA 125.765 1.626 . . . . 73.3 112.657 -175.375 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -93.28 -2.0 66.3 Favored Glycine 0 N--CA 1.441 -1.01 0 CA-C-O 118.473 -1.182 . . . . 73.05 112.312 -175.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.12 39.46 3.11 Favored 'General case' 0 C--N 1.342 0.242 0 CA-C-N 119.134 1.467 . . . . 72.21 111.273 -163.569 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 90.45 11.57 62.32 Favored Glycine 0 CA--C 1.527 0.785 0 CA-C-O 118.541 -1.144 . . . . 51.42 113.849 169.319 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 30.7 t -113.36 128.92 69.94 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 C-N-CA 125.643 1.577 . . . . 73.03 107.237 175.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -99.16 141.13 32.32 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 122.884 0.474 . . . . 54.24 111.811 173.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 5.1 mtmt -66.15 -33.82 76.64 Favored 'General case' 0 CA--C 1.537 0.449 0 O-C-N 121.501 -0.749 . . . . 74.24 111.423 178.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -64.9 -33.61 76.43 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 125.116 1.367 . . . . 75.05 111.323 178.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 7.2 mmtp -79.55 -50.77 10.22 Favored 'General case' 0 C--O 1.23 0.066 0 N-CA-C 107.888 -1.153 . . . . 61.03 107.888 172.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 52.0 t80 -53.39 -67.47 0.25 Allowed 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.831 1.252 . . . . 72.52 113.332 -165.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 25.4 mt -62.79 -38.84 92.25 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 122.738 0.415 . . . . 65.11 111.228 -165.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 22.5 t -57.43 -46.5 83.48 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 124.16 0.984 . . . . 72.35 111.295 -176.31 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . 0.75 HG23 HG22 ' A' ' 80' ' ' THR . 9.9 t -80.73 -33.66 35.02 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 110.355 -0.239 . . . . 73.24 110.355 178.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 76.8 t80 -55.62 -38.28 69.29 Favored 'General case' 0 C--O 1.237 0.396 0 O-C-N 121.266 -0.896 . . . . 70.21 111.138 176.091 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -91.99 16.83 10.31 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.428 1.491 . . . . 75.04 112.082 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 2.2 p -106.48 171.89 7.11 Favored 'General case' 0 C--O 1.24 0.589 0 CA-C-N 119.804 1.183 . . . . 71.24 111.895 -175.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -67.2 -17.78 64.97 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 123.883 0.873 . . . . 74.0 112.081 172.34 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -57.9 -56.31 23.62 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 119.106 0.866 . . . . 74.21 109.29 178.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 13.7 mm -59.39 -41.33 84.07 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.134 0 CA-C-O 119.169 -0.443 . . . . 63.25 110.583 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 13.0 mttt -57.31 -35.14 69.46 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 119.31 0.959 . . . . 71.22 111.637 175.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -81.61 -22.38 60.21 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 125.071 1.32 . . . . 64.35 113.009 -178.183 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -82.39 -39.6 22.46 Favored 'General case' 0 CA--C 1.535 0.399 0 O-C-N 121.382 -1.069 . . . . 74.12 110.097 173.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . 0.442 ' HE3' HD13 ' A' ' 66' ' ' LEU . 92.8 mmm -61.26 -41.19 96.5 Favored 'General case' 0 C--O 1.231 0.099 0 C-N-CA 124.105 0.962 . . . . 62.3 111.169 -179.767 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -57.13 -43.13 82.12 Favored 'General case' 0 CA--C 1.535 0.4 0 O-C-N 121.032 -1.043 . . . . 52.13 111.375 178.199 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 13.3 mtmt -60.29 -66.06 0.58 Allowed 'General case' 0 C--N 1.342 0.272 0 CA-C-N 118.549 0.613 . . . . 75.04 110.518 176.216 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -59.94 -26.97 66.39 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 119.027 0.83 . . . . 75.3 111.64 -170.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.55 -56.11 8.26 Favored 'General case' 0 C--N 1.34 0.158 0 O-C-N 121.368 -0.832 . . . . 74.3 110.509 176.411 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.55 -32.7 73.66 Favored 'General case' 0 C--N 1.342 0.26 0 CA-C-N 119.172 0.896 . . . . 64.1 110.365 -177.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 42.1 mt -59.67 -54.97 40.17 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 118.007 -0.997 . . . . 73.42 110.288 179.263 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -54.66 -37.44 65.72 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 119.616 1.098 . . . . 74.21 112.166 -178.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -73.25 -42.7 62.23 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 122.903 0.481 . . . . 53.14 110.777 -179.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -59.83 -44.95 93.8 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 123.605 0.762 . . . . 31.14 109.099 175.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 15.9 m-85 -63.0 -7.35 5.12 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.242 1.417 . . . . 73.41 113.337 177.151 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 61.7 mt-30 56.21 47.56 19.13 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 127.208 2.203 . . . . 75.23 111.01 -174.07 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 95.3 t -82.72 141.54 14.82 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 O-C-N 120.665 -1.272 . . . . 34.25 108.196 178.216 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 11.7 p -104.93 -19.75 13.76 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 124.178 0.991 . . . . 73.42 113.092 -174.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 179.12 -148.08 8.04 Favored Glycine 0 N--CA 1.452 -0.275 0 N-CA-C 108.81 -1.716 . . . . 61.33 108.81 -170.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.449 HG21 ' HB3' ' A' ' 34' ' ' TRP . 22.3 m -147.09 153.93 45.81 Favored Pre-proline 0 C--O 1.243 0.738 0 C-N-CA 127.115 2.166 . . . . 74.23 106.717 167.46 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . 0.483 ' HG3' HD12 ' A' ' 166' ' ' ILE . 98.2 Cg_endo -66.9 158.24 81.64 Favored 'Cis proline' 0 N--CA 1.458 -0.587 0 C-N-CA 124.132 -1.195 . . . . 64.33 112.154 -3.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 97.8 m -156.82 146.46 20.69 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 106.391 -1.707 . . . . 55.11 106.391 172.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 28.7 mmm -114.78 165.48 12.78 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 106.689 -1.596 . . . . 60.33 106.689 161.096 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 78.0 t -137.41 143.9 33.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 106.383 -1.71 . . . . 75.41 106.383 160.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.5 HG23 ' CE1' ' A' ' 164' ' ' PHE . 20.0 t -105.21 134.48 46.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 N-CA-C 105.915 -1.883 . . . . 64.54 105.915 162.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 4.0 t30 50.77 17.02 0.36 Allowed 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 130.197 3.399 . . . . 72.11 116.359 166.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 70.23 25.23 75.92 Favored Glycine 0 CA--C 1.527 0.836 0 CA-C-O 117.231 -1.872 . . . . 73.5 113.659 -171.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 21.6 mtpt -128.72 -37.05 1.79 Allowed 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 119.878 1.839 . . . . 73.51 114.032 179.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . 0.424 ' CE1' ' HG3' ' A' ' 14' ' ' GLU . 76.6 m-85 -121.4 108.79 14.1 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 119.708 1.14 . . . . 72.42 111.557 -168.126 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 18.9 ptt180 -90.56 32.79 0.94 Allowed 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 126.96 2.104 . . . . 74.24 115.532 -171.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . 0.5 ' CE1' HG23 ' A' ' 158' ' ' VAL . 4.0 p90 -52.06 155.51 1.86 Allowed 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 122.154 0.978 . . . . 63.23 110.085 -177.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -160.96 174.66 13.47 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 107.811 -1.181 . . . . 65.4 107.811 -175.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.483 HD12 ' HG3' ' A' ' 154' ' ' PRO . 3.5 mt -46.3 -52.67 3.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 C-N-CA 126.108 1.763 . . . . 71.13 108.163 161.354 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -78.28 19.72 4.46 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 126.828 2.156 . . . . 33.32 114.621 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 18.8 m -125.27 -48.89 1.7 Allowed 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 119.37 1.585 . . . . 74.51 109.12 154.393 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -63.2 -34.84 78.52 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-O 118.166 -0.921 . . . . 53.44 112.909 -170.276 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 117.75 5.5 13.87 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 123.586 0.612 . . . . 72.42 113.547 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 153.35 174.39 23.6 Favored Glycine 0 CA--C 1.527 0.805 0 CA-C-N 119.22 1.51 . . . . 45.21 110.543 177.03 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -64.05 -45.18 10.72 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 122.308 2.005 . . . . 63.25 110.826 -173.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -66.41 -39.46 89.02 Favored 'General case' 0 N--CA 1.453 -0.304 0 O-C-N 121.269 -0.895 . . . . 75.12 110.173 177.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -62.58 -27.45 69.2 Favored 'General case' 0 CA--C 1.537 0.466 0 O-C-N 122.306 -0.246 . . . . 71.21 110.932 175.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 24.9 m -61.84 -45.9 91.79 Favored 'General case' 0 CA--C 1.534 0.354 0 O-C-N 120.469 -1.394 . . . . 63.5 109.537 179.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 33.2 mt -65.51 -24.38 67.12 Favored 'General case' 0 N--CA 1.466 0.366 0 O-C-N 121.365 -0.834 . . . . 72.33 112.043 177.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.74 -46.18 74.24 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-O 118.796 -0.621 . . . . 71.42 109.427 169.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -76.51 -39.35 53.29 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-O 117.27 -1.348 . . . . 74.21 110.565 -178.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.451 ' HB1' ' CZ2' ' A' ' 50' ' ' TRP . . . -52.65 -49.88 64.32 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 120.015 1.28 . . . . 71.31 111.754 -172.088 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -66.1 -45.33 81.57 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 125.235 1.414 . . . . 44.24 110.786 -173.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -62.45 -46.88 86.51 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 126.003 1.721 . . . . 74.32 111.448 176.264 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 83.0 mt -64.32 -38.83 92.44 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 118.487 -0.768 . . . . 74.13 110.118 -176.298 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 39.5 mt -55.6 -51.5 57.66 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 CA-C-N 119.369 0.986 . . . . 74.3 108.655 172.333 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . 0.406 ' HA ' ' HD3' ' A' ' 187' ' ' ARG . 6.2 tm-20 -67.97 7.4 0.54 Allowed 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 127.378 2.271 . . . . 75.43 114.414 174.613 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . 0.444 ' HA ' ' HE3' ' A' ' 185' ' ' LYS . 0.5 OUTLIER -110.73 -45.29 3.51 Favored 'General case' 0 N--CA 1.454 -0.252 0 O-C-N 120.841 -1.162 . . . . 71.45 108.823 165.74 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . 0.696 ' HA ' ' HB3' ' A' ' 189' ' ' ALA . 26.9 mm-40 -54.66 -38.49 67.0 Favored 'General case' 0 CA--C 1.512 -0.495 0 C-N-CA 126.326 1.85 . . . . 61.24 115.403 -173.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . 0.406 ' HD3' ' HA ' ' A' ' 184' ' ' GLU . 0.0 OUTLIER -55.73 -23.41 29.01 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 118.624 -1.23 . . . . 72.11 114.14 -176.586 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -103.05 -20.29 14.24 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 126.484 1.914 . . . . 74.51 113.084 175.126 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . 0.696 ' HB3' ' HA ' ' A' ' 186' ' ' GLU . . . -83.99 -20.73 32.33 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.785 1.634 . . . . 73.25 112.67 -174.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -151.66 72.66 1.04 Allowed 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.029 1.332 . . . . 42.3 110.435 173.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 4.5 pttt -88.61 53.47 2.72 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 124.51 1.124 . . . . 70.42 111.983 -175.221 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 24.1 mttt . . . . . 0 C--O 1.248 0.976 0 N-CA-C 106.29 -1.744 . . . . 72.25 106.29 142.934 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.506 -0.505 0 N-CA-C 108.946 -1.662 . . . . 64.51 108.946 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.412 ' C ' ' H ' ' A' ' 6' ' ' TYR . 1.3 m-20 43.46 66.8 0.74 Allowed 'General case' 0 C--N 1.341 0.203 0 C-N-CA 125.87 1.668 . . . . 70.41 110.159 155.152 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -75.04 25.18 0.09 Allowed 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.517 1.127 . . . . 74.01 113.161 -172.386 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.412 ' H ' ' C ' ' A' ' 4' ' ' ASP . 33.1 m-85 -140.53 170.3 16.05 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 128.19 2.596 . . . . 75.34 108.838 -176.418 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 95.0 m -141.69 137.48 31.76 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 124.932 1.293 . . . . 61.34 108.269 176.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.66 130.62 43.93 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 108.729 -0.841 . . . . 73.33 108.729 172.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 80.07 15.92 77.83 Favored Glycine 0 CA--C 1.525 0.681 0 CA-C-O 119.33 -0.705 . . . . 63.1 112.966 -174.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.1 tpmt? -133.25 -55.99 0.91 Allowed 'General case' 0 CA--C 1.519 -0.242 0 CA-C-N 118.384 1.092 . . . . 65.34 109.345 -177.146 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.436 ' HB3' HD21 ' A' ' 178' ' ' LEU . 8.1 mp0 -105.42 -21.2 13.27 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 124.388 1.075 . . . . 74.52 110.642 179.362 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 42.6 p90 -159.44 168.16 26.95 Favored 'General case' 0 C--O 1.234 0.253 0 O-C-N 121.119 -0.988 . . . . 64.12 110.641 -171.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 84.0 t -126.13 111.47 26.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 C-N-CA 124.894 1.277 . . . . 63.0 108.504 178.054 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -78.08 165.61 23.79 Favored 'General case' 0 C--O 1.239 0.5 0 O-C-N 120.871 -1.143 . . . . 64.55 109.246 169.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -133.87 111.41 10.46 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 126.011 1.725 . . . . 73.31 107.333 -175.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 76.3 p -65.24 0.24 1.48 Allowed 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 125.985 1.714 . . . . 45.43 113.26 179.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 38.6 m -128.92 73.74 81.4 Favored Pre-proline 0 N--CA 1.439 -1.001 0 N-CA-C 105.397 -2.075 . . . . 55.35 105.397 -176.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -72.93 177.86 7.18 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 124.211 3.274 . . . . 52.05 110.922 -170.209 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 6.1 t -140.61 116.67 7.67 Favored Pre-proline 0 CA--C 1.537 0.46 0 C-N-CA 123.321 0.648 . . . . 74.2 109.442 176.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -72.79 -176.36 2.3 Favored 'Trans proline' 0 CA--C 1.537 0.672 0 C-N-CA 123.858 3.038 . . . . 70.22 110.854 171.011 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.407 HG11 ' CD ' ' A' ' 28' ' ' GLU . 3.5 m -133.85 160.61 41.89 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 N-CA-C 106.016 -1.846 . . . . 44.42 106.016 176.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 3.4 m -47.75 -66.88 0.33 Allowed 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 125.392 1.477 . . . . 63.12 113.766 166.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 11.8 tp60 -128.71 81.25 71.12 Favored Pre-proline 0 N--CA 1.469 0.48 0 C-N-CA 123.9 0.88 . . . . 61.3 108.718 -169.003 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.507 ' C ' ' H ' ' A' ' 26' ' ' LYS . 36.2 Cg_endo -73.05 -57.51 0.07 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.095 0 CA-C-N 119.122 0.722 . . . . 71.35 110.314 179.236 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 51.35 -23.34 0.01 OUTLIER Glycine 0 CA--C 1.53 1.019 0 C-N-CA 127.831 2.634 . . . . 31.24 115.243 -159.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.507 ' H ' ' C ' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -140.05 -167.06 2.22 Favored 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 129.548 3.139 . . . . 74.45 105.483 -161.931 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.53 HD12 ' HB3' ' A' ' 186' ' ' GLU . 30.4 mm -87.75 130.65 37.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 N-CA-C 106.207 -1.775 . . . . 74.21 106.207 168.515 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.407 ' CD ' HG11 ' A' ' 21' ' ' VAL . 5.0 tp10 -69.71 140.04 53.48 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 105.608 -1.997 . . . . 65.33 105.608 173.131 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 54.8 t -128.2 134.32 65.21 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 N-CA-C 105.769 -1.937 . . . . 55.42 105.769 160.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 30.1 t -123.14 112.71 34.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 105.95 -1.87 . . . . 74.21 105.95 172.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 62.6 tt0 -72.26 122.01 20.36 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 106.347 -1.723 . . . . 74.54 106.347 156.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.489 HD22 HG21 ' A' ' 150' ' ' VAL . 4.5 mp -109.65 137.91 46.78 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-N 119.212 0.914 . . . . 55.22 108.919 166.119 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 9.5 p90 -145.66 171.26 14.98 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 122.986 0.514 . . . . 75.24 110.487 -168.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . 0.421 ' HB3' HG21 ' A' ' 153' ' ' VAL . 42.2 t90 -156.7 151.57 25.97 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.38 1.472 . . . . 75.33 109.9 171.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 19.4 t80 -45.58 -48.49 14.5 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 127.789 2.436 . . . . 71.21 114.408 -174.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -75.14 -88.59 0.23 Allowed Glycine 0 C--N 1.341 0.806 0 N-CA-C 109.75 -1.34 . . . . 72.4 109.75 -169.382 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 12.7 t 42.76 72.49 1.13 Allowed Pre-proline 0 CA--C 1.538 0.483 0 C-N-CA 126.44 1.896 . . . . 74.34 112.955 160.237 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -59.16 -38.83 84.13 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 121.191 1.261 . . . . 52.21 112.199 -178.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 17.8 m170 -65.79 -30.38 71.02 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 119.142 0.883 . . . . 73.33 111.031 -179.125 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 82.1 m -62.67 -38.11 89.06 Favored 'General case' 0 C--N 1.343 0.32 0 CA-C-N 118.407 0.549 . . . . 64.13 110.158 177.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 38.6 t80 -62.0 -44.28 97.06 Favored 'General case' 0 C--N 1.339 0.139 0 O-C-N 121.614 -0.679 . . . . 62.41 110.828 -175.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -56.52 -34.45 67.02 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 118.285 0.493 . . . . 53.32 111.333 178.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.46 ' HB2' HD11 ' A' ' 166' ' ' ILE . 6.0 t80 -82.52 -16.0 50.28 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.837 1.655 . . . . 75.32 113.445 -178.462 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -43.26 -63.48 0.99 Allowed Pre-proline 0 CA--C 1.539 0.554 0 CA-C-N 120.042 1.292 . . . . 75.33 112.422 -173.218 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -85.79 -7.36 8.46 Favored 'Trans proline' 0 N--CA 1.452 -0.921 0 C-N-CA 121.645 1.563 . . . . 64.53 114.687 -174.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 26.0 m -66.01 -46.84 76.49 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 107.355 -1.35 . . . . 75.04 107.355 166.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 20.5 tt -84.2 -35.31 10.72 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 N-CA-C 113.528 0.936 . . . . 64.3 113.528 -166.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 42.9 t -48.16 -61.18 3.34 Favored Pre-proline 0 CA--C 1.545 0.779 0 O-C-N 121.237 -0.914 . . . . 73.43 111.803 178.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -72.5 -6.59 19.33 Favored 'Trans proline' 0 N--CA 1.454 -0.794 0 C-N-CA 122.007 1.805 . . . . 64.42 113.708 -177.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.43 ' CZ2' ' HB1' ' A' ' 179' ' ' ALA . 79.8 t90 -72.25 -62.48 1.42 Allowed 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 120.085 1.312 . . . . 73.33 107.691 161.185 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 22.4 p -53.79 -33.3 55.55 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 115.035 1.494 . . . . 64.22 115.035 -169.509 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 58.4 mt-10 -80.45 -24.84 39.29 Favored 'General case' 0 CA--C 1.54 0.572 0 O-C-N 120.663 -1.273 . . . . 70.03 112.007 -179.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 11.1 mptt -96.2 9.26 41.57 Favored 'General case' 0 C--O 1.225 -0.196 0 C-N-CA 124.97 1.308 . . . . 62.35 112.009 -168.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 35.2 mt -62.15 160.14 33.26 Favored Pre-proline 0 C--O 1.242 0.661 0 C-N-CA 129.327 3.051 . . . . 73.11 113.41 -177.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -80.09 170.18 16.75 Favored 'Trans proline' 0 N--CA 1.448 -1.164 0 C-N-CA 124.752 3.634 . . . . 72.13 110.273 176.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -70.1 -5.06 24.24 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 124.112 0.965 . . . . 72.21 112.919 -179.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -104.38 9.61 35.69 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.428 1.091 . . . . 72.34 111.988 -171.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.448 HG21 HD13 ' A' ' 183' ' ' ILE . 93.1 t -120.46 149.52 23.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 N-CA-C 108.166 -1.05 . . . . 73.15 108.166 -177.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 21.9 t-160 -124.88 84.75 2.32 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 128.092 2.557 . . . . 72.42 105.931 -179.127 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 45.5 t80 -68.26 129.43 39.9 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 108.794 -0.817 . . . . 75.42 108.794 174.045 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 40.7 t -136.21 155.13 34.41 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.651 0 C-N-CA 126.461 1.904 . . . . 42.12 106.351 175.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 34.6 mtp180 -133.28 123.35 25.34 Favored 'General case' 0 CA--C 1.515 -0.375 0 N-CA-C 105.371 -2.085 . . . . 74.3 105.371 -176.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 78.0 mt -134.62 144.58 51.4 Favored Pre-proline 0 CA--C 1.533 0.307 0 CA-C-N 119.461 1.028 . . . . 71.4 110.716 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -77.1 129.32 10.42 Favored 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 122.589 2.192 . . . . 53.3 111.36 177.178 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -69.69 114.53 7.98 Favored 'General case' 0 CA--C 1.537 0.465 0 O-C-N 121.519 -0.738 . . . . 73.0 110.245 174.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.49 HD22 ' HA ' ' A' ' 72' ' ' ASN . 14.6 mt -106.62 103.15 12.52 Favored 'General case' 0 N--CA 1.466 0.351 0 O-C-N 121.059 -1.026 . . . . 62.21 110.247 -178.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -133.03 13.35 4.29 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 114.901 1.445 . . . . 73.52 114.901 -174.375 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -169.47 -116.9 0.39 Allowed Glycine 0 C--N 1.333 0.385 0 CA-C-N 119.603 1.092 . . . . 74.15 112.382 176.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -114.52 -73.6 0.58 Allowed Glycine 0 C--N 1.334 0.438 0 C-N-CA 126.225 1.869 . . . . 42.21 108.448 171.048 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 6.4 tp -58.84 -24.77 27.22 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-N 118.248 1.024 . . . . 64.04 112.164 -174.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 10.5 m95 -59.47 -48.8 80.26 Favored 'General case' 0 N--CA 1.455 -0.201 0 O-C-N 121.444 -0.785 . . . . 71.42 111.547 172.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.49 ' HA ' HD22 ' A' ' 66' ' ' LEU . 11.7 p30 -77.94 -30.64 50.57 Favored 'General case' 0 CA--C 1.509 -0.601 0 CA-C-O 117.663 -1.161 . . . . 74.05 113.599 177.413 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 74.5 t -57.15 -58.22 6.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 108.824 -0.806 . . . . 73.51 108.824 172.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 37.4 m170 -65.58 -24.18 67.02 Favored 'General case' 0 CA--C 1.528 0.109 0 N-CA-C 112.416 0.525 . . . . 75.22 112.416 178.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -78.96 -18.99 73.77 Favored Glycine 0 N--CA 1.444 -0.804 0 CA-C-O 118.966 -0.908 . . . . 42.41 111.302 178.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.491 HE22 HD12 ' A' ' 134' ' ' ILE . 0.0 OUTLIER -66.71 -55.77 13.6 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 118.275 1.037 . . . . 73.4 109.606 -160.427 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 3.7 ptm -55.21 -28.78 55.54 Favored 'General case' 0 N--CA 1.454 -0.273 0 O-C-N 124.129 0.893 . . . . 75.43 113.294 -166.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 29.7 t80 -55.22 -52.06 64.59 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 124.007 0.923 . . . . 74.22 109.981 176.354 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 37.9 mt -66.54 -43.1 86.03 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 117.979 -1.01 . . . . 75.05 109.821 179.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.74 HG22 HG23 ' A' ' 128' ' ' THR . 0.2 OUTLIER -59.6 -41.67 90.86 Favored 'General case' 0 C--N 1.344 0.354 0 CA-C-N 120.3 1.409 . . . . 55.24 110.906 -179.31 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.4 -55.45 33.38 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 123.882 0.873 . . . . 62.4 109.077 -178.484 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -74.74 -14.53 60.73 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 112.505 0.558 . . . . 73.25 112.505 -177.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 3.2 t -70.44 -10.22 58.53 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.821 1.249 . . . . 72.32 112.222 171.384 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 43.4 mtm -100.44 6.9 44.47 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.423 1.089 . . . . 75.33 112.887 168.165 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 74.15 6.47 74.5 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 125.912 1.72 . . . . 54.13 113.611 171.163 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 29.2 m -55.34 123.35 6.08 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 C-N-CA 125.3 1.44 . . . . 54.51 111.401 -167.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -123.28 117.46 25.34 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 106.901 -1.518 . . . . 72.15 106.901 -165.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 52.4 -175.48 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.398 1.479 . . . . 73.51 113.368 -167.667 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 29.1 t70 62.88 -12.85 0.07 Allowed 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 127.693 2.397 . . . . 74.14 113.814 -164.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.4 p -135.65 133.53 51.66 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 C-N-CA 125.584 1.553 . . . . 42.2 110.117 178.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -178.51 -67.59 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 128.211 2.604 . . . . 71.23 109.408 166.308 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -63.43 -55.25 25.8 Favored 'General case' 0 CA--C 1.509 -0.615 0 C-N-CA 123.972 0.909 . . . . 75.2 109.793 -172.346 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -65.45 -14.87 61.89 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-O 118.872 -0.585 . . . . 60.12 112.003 -168.234 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.9 t -62.26 -76.8 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 N-CA-C 108.515 -0.92 . . . . 71.42 108.515 164.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -51.26 -46.92 62.54 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 126.018 1.727 . . . . 70.34 112.103 -176.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 22.2 mm-40 -60.9 -44.17 97.52 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.514 1.526 . . . . 71.2 109.242 -175.38 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -74.91 -3.49 32.39 Favored 'General case' 0 CA--C 1.531 0.245 0 O-C-N 120.62 -1.3 . . . . 73.22 113.158 -179.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 72.8 mt -104.18 -54.78 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 N-CA-C 106.554 -1.647 . . . . 74.02 106.554 177.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 90.7 m-70 -80.54 -56.13 4.38 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 123.495 0.718 . . . . 73.22 112.014 -173.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 2.2 mmtp -71.87 -12.95 61.52 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 123.753 0.821 . . . . 74.21 112.05 -178.355 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -117.07 -31.32 5.4 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.963 0.905 . . . . 74.31 112.494 -174.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 5.2 t60 45.15 61.04 2.7 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 125.903 1.681 . . . . 64.12 111.209 -176.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 7.8 mtpp -76.94 159.45 29.97 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.727 -1.124 . . . . 73.51 108.454 170.082 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 46.5 tttt -85.82 38.35 0.75 Allowed 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 125.726 1.61 . . . . 61.11 111.735 -173.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 43.3 mt -72.61 51.07 0.26 Allowed 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 128.815 2.846 . . . . 73.42 112.053 -167.146 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -103.12 3.66 36.14 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 129.463 3.105 . . . . 72.24 112.21 -177.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -134.39 156.03 79.26 Favored Pre-proline 0 N--CA 1.467 0.413 0 CA-C-N 118.556 0.616 . . . . 71.01 110.66 171.073 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -70.89 -19.84 30.25 Favored 'Trans proline' 0 N--CA 1.449 -1.108 0 C-N-CA 121.658 1.572 . . . . 62.55 111.889 -177.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.7 -62.95 1.48 Allowed 'General case' 0 C--O 1.224 -0.255 0 CA-C-N 119.859 1.209 . . . . 64.31 108.961 168.11 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -45.79 -56.55 5.2 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 127.229 2.211 . . . . 72.45 110.413 178.358 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 57.4 mtt -54.91 -50.45 68.77 Favored 'General case' 0 N--CA 1.458 -0.065 0 C-N-CA 123.7 0.8 . . . . 61.13 111.354 -178.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.632 ' HB1' ' HG3' ' A' ' 122' ' ' LYS . . . -77.1 -40.63 45.21 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-O 119.043 -0.504 . . . . 71.44 111.013 -170.124 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -56.43 -35.61 68.04 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 125.12 1.368 . . . . 73.1 110.525 174.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 82.8 t80 -71.81 -54.08 11.28 Favored 'General case' 0 N--CA 1.44 -0.952 0 C-N-CA 122.969 0.508 . . . . 73.53 110.2 176.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 73.5 mt -69.64 -18.31 63.58 Favored 'General case' 0 CA--C 1.52 -0.178 0 C-N-CA 123.454 0.702 . . . . 61.22 112.428 -173.136 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -57.17 -16.71 8.54 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.226 1.41 . . . . 41.21 112.32 -176.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -110.38 8.12 30.58 Favored Glycine 0 CA--C 1.526 0.74 0 C-N-CA 124.94 1.257 . . . . 53.25 113.588 177.073 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 30.9 mmtt -129.09 27.6 5.37 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 119.608 1.704 . . . . 73.25 111.398 -169.096 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 85.56 41.54 7.27 Favored Glycine 0 N--CA 1.447 -0.579 0 CA-C-O 119.199 -0.778 . . . . 75.12 111.245 178.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 95.0 t -135.83 141.91 40.59 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 106.968 -1.493 . . . . 42.01 106.968 173.345 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 66.2 t0 -97.12 123.62 40.92 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 108.231 -1.025 . . . . 54.33 108.231 167.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.632 ' HG3' ' HB1' ' A' ' 112' ' ' ALA . 0.2 OUTLIER -57.88 -38.97 76.73 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.789 0.835 . . . . 73.33 109.245 177.071 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -61.87 -41.46 97.88 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 123.638 0.775 . . . . 74.42 111.225 -177.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 21.1 mmtt -79.59 -47.28 15.75 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 108.074 -1.084 . . . . 71.32 108.074 -176.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 80.2 t80 -44.98 -59.3 2.64 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 126.322 1.849 . . . . 73.02 110.126 -177.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 32.4 mt -69.38 -36.32 76.69 Favored 'General case' 0 C--O 1.234 0.245 0 O-C-N 122.107 -0.371 . . . . 73.21 111.217 -176.399 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 23.2 t -56.05 -47.8 77.22 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 109.442 -0.577 . . . . 72.0 109.442 178.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . 0.74 HG23 HG22 ' A' ' 80' ' ' THR 0.259 15.0 t -77.28 -31.62 54.94 Favored 'General case' 0 CA--C 1.543 0.712 0 C-N-CA 123.116 0.567 . . . . 75.44 111.543 -179.089 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 76.4 t80 -56.19 -36.49 68.45 Favored 'General case' 0 N--CA 1.471 0.621 0 O-C-N 120.357 -1.465 . . . . 74.4 111.893 172.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 48.0 m-20 -102.97 13.39 34.43 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.085 0.954 . . . . 73.12 111.216 176.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 40.0 t -88.81 163.65 15.58 Favored 'General case' 0 C--O 1.235 0.298 0 O-C-N 120.469 -1.395 . . . . 75.41 109.263 174.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -59.11 -24.96 63.41 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 114.92 -1.036 . . . . 64.41 110.85 170.328 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -48.91 -63.48 1.08 Allowed 'General case' 0 C--O 1.236 0.387 0 C-N-CA 124.568 1.147 . . . . 72.33 110.955 176.089 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.51 HD11 ' HA ' ' A' ' 80' ' ' THR . 7.1 mm -58.36 -32.58 45.49 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 N-CA-C 113.532 0.938 . . . . 72.53 113.532 176.189 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 2.7 tttp -57.7 -35.05 70.1 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 118.844 0.747 . . . . 65.33 110.151 -178.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -80.13 -37.24 22.3 Favored Glycine 0 C--N 1.34 0.798 0 C-N-CA 124.864 1.221 . . . . 63.52 111.969 -178.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 2.4 mm100 -70.74 -39.8 73.1 Favored 'General case' 0 C--N 1.331 -0.238 0 O-C-N 121.582 -0.952 . . . . 72.03 109.312 -178.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -62.23 -50.09 73.15 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 123.668 0.787 . . . . 75.12 110.191 176.475 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -63.42 -43.23 98.08 Favored 'General case' 0 CA--C 1.521 -0.151 0 CA-C-O 117.744 -1.122 . . . . 73.51 111.095 -177.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 44.7 mtmt -59.29 -59.67 5.09 Favored 'General case' 0 C--N 1.343 0.31 0 CA-C-O 117.991 -1.004 . . . . 54.42 108.748 177.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -54.35 -35.73 63.07 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 119.852 1.206 . . . . 60.12 112.012 -179.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 35.8 tttt -65.97 -66.44 0.55 Allowed 'General case' 0 C--N 1.342 0.278 0 N-CA-C 108.467 -0.938 . . . . 65.32 108.467 177.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 17.7 ptmt -60.02 -28.14 67.48 Favored 'General case' 0 C--O 1.227 -0.106 0 C-N-CA 123.476 0.71 . . . . 73.25 111.187 -171.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 36.2 mt -68.75 -58.58 4.01 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 124.816 1.246 . . . . 65.04 111.976 173.201 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -55.6 -50.6 69.69 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 118.957 0.799 . . . . 72.31 110.244 -169.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -58.87 -42.74 90.18 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 113.007 0.743 . . . . 62.34 113.007 174.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -65.84 -26.37 67.63 Favored 'General case' 0 N--CA 1.462 0.155 0 C-N-CA 123.33 0.652 . . . . 75.45 111.622 -178.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 36.2 m-85 -84.17 20.13 1.67 Allowed 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.3 1.44 . . . . 70.11 112.125 172.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 11.5 mm100 64.35 6.44 3.05 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 127.399 2.279 . . . . 74.14 115.536 173.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.489 HG21 HD22 ' A' ' 32' ' ' LEU . 42.9 t -51.7 -57.27 3.63 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.985 0 C-N-CA 127.639 2.376 . . . . 62.21 113.858 -164.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . 0.281 73.5 p 54.97 -40.05 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 128.912 2.885 . . . . 63.12 117.365 -165.341 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -150.45 -177.87 24.79 Favored Glycine 0 CA--C 1.521 0.422 0 C-N-CA 125.951 1.739 . . . . 64.14 110.285 -171.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.442 ' HA ' ' C ' ' A' ' 154' ' ' PRO . 17.3 m -133.26 157.33 78.47 Favored Pre-proline 0 C--O 1.239 0.545 0 N-CA-C 108.801 -0.815 . . . . 74.53 108.801 -178.186 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . 0.524 ' HG3' HD12 ' A' ' 166' ' ' ILE . 37.4 Cg_endo -66.74 154.07 83.43 Favored 'Cis proline' 0 N--CA 1.46 -0.489 0 C-N-CA 124.478 -1.051 . . . . 71.42 112.494 -4.265 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . 0.444 HG21 HG22 ' A' ' 150' ' ' VAL . 35.3 m -155.06 110.61 3.1 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 105.194 -2.15 . . . . 73.44 105.194 172.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 95.9 mtp -89.5 152.12 21.61 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 107.5 -1.296 . . . . 62.21 107.5 164.247 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 15.0 t -138.97 139.41 40.48 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.288 0 N-CA-C 108.113 -1.069 . . . . 71.31 108.113 175.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 11.4 t -112.34 124.09 68.7 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 C-N-CA 126.395 1.878 . . . . 75.21 106.516 176.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 1.4 t30 51.0 17.13 0.4 Allowed 'General case' 0 C--O 1.223 -0.308 0 C-N-CA 128.836 2.854 . . . . 72.21 114.813 170.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 58.71 38.99 92.97 Favored Glycine 0 CA--C 1.525 0.66 0 C-N-CA 125.69 1.614 . . . . 35.21 112.829 -168.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 37.6 mttt -132.95 -38.27 0.98 Allowed 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 124.51 1.124 . . . . 74.22 112.29 178.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -116.6 118.24 32.07 Favored 'General case' 0 CA--C 1.517 -0.311 0 N-CA-C 108.284 -1.006 . . . . 71.34 108.284 -178.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 37.3 ttp85 -105.43 123.33 47.7 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 126.536 1.934 . . . . 75.42 106.972 174.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 13.5 p90 -150.23 170.97 17.72 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 107.529 -1.286 . . . . 65.44 107.529 -176.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -178.84 178.77 0.75 Allowed 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.166 -0.679 . . . . 75.3 109.166 -173.197 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.524 HD12 ' HG3' ' A' ' 154' ' ' PRO . 23.7 mt -47.96 -55.95 2.28 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 C-N-CA 127.733 2.413 . . . . 72.02 109.044 174.01 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -75.67 8.01 23.15 Favored Glycine 0 CA--C 1.526 0.727 0 C-N-CA 127.028 2.251 . . . . 51.34 114.794 178.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 4.7 m -110.72 -52.25 2.8 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-N 119.507 1.653 . . . . 72.22 109.886 168.038 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -65.39 -53.11 47.97 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 125.652 1.581 . . . . 62.43 111.598 -178.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 142.59 -7.16 2.21 Favored Glycine 0 CA--C 1.528 0.846 0 CA-C-O 119.056 -0.858 . . . . 64.05 114.41 -174.298 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 155.7 175.72 27.04 Favored Glycine 0 CA--C 1.53 0.983 0 CA-C-N 119.514 1.657 . . . . 44.43 110.149 -175.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -61.21 -53.67 2.31 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 122.918 2.412 . . . . 65.22 111.247 -175.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 8.2 mp0 -62.85 -32.89 74.2 Favored 'General case' 0 CA--C 1.536 0.411 0 O-C-N 121.434 -0.791 . . . . 44.32 110.924 179.134 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -66.17 -30.76 71.3 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.218 0.607 . . . . 70.22 110.131 178.107 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 37.7 m -65.59 -46.21 80.24 Favored 'General case' 0 N--CA 1.455 -0.221 0 O-C-N 121.364 -0.835 . . . . 72.21 110.453 -173.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 64.0 mt -62.89 -28.08 69.8 Favored 'General case' 0 C--O 1.223 -0.306 0 CA-C-N 118.559 0.618 . . . . 73.12 111.447 -177.027 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 2.6 tttt -53.58 -49.41 67.8 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 124.819 1.248 . . . . 72.01 109.338 172.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.436 HD21 ' HB3' ' A' ' 11' ' ' GLU . 4.1 mm? -67.12 -44.51 79.72 Favored 'General case' 0 CA--C 1.515 -0.392 0 N-CA-C 109.329 -0.619 . . . . 55.4 109.329 175.655 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.43 ' HB1' ' CZ2' ' A' ' 50' ' ' TRP . . . -56.78 -31.73 64.94 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 118.34 -0.838 . . . . 34.12 112.71 -174.247 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -84.16 -52.0 6.61 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 126.357 1.863 . . . . 73.34 108.666 -176.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 16.6 t80 -60.84 -45.61 93.8 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 123.896 0.878 . . . . 72.12 110.998 -175.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 93.1 mt -61.22 -28.66 69.32 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.06 0.944 . . . . 73.14 112.527 -178.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.448 HD13 HG21 ' A' ' 58' ' ' VAL . 44.0 mt -60.3 -52.78 57.36 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 CA-C-N 119.931 1.241 . . . . 61.2 108.357 173.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -66.71 -5.72 12.98 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 126.802 2.041 . . . . 74.04 112.901 177.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -98.12 -23.74 15.6 Favored 'General case' 0 N--CA 1.463 0.21 0 O-C-N 120.868 -1.145 . . . . 74.44 111.525 173.187 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . 0.53 ' HB3' HD12 ' A' ' 27' ' ' ILE . 30.5 mm-40 -96.54 -33.57 11.78 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 123.785 0.834 . . . . 64.34 112.734 -176.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . 0.411 ' HE ' HD11 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -51.12 -32.55 23.07 Favored 'General case' 0 N--CA 1.476 0.841 0 O-C-N 120.847 -1.158 . . . . 72.32 110.522 168.748 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -64.56 -23.22 67.2 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 126.713 2.005 . . . . 33.24 111.883 179.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -58.05 -45.83 86.39 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 109.125 -0.695 . . . . 55.13 109.125 174.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -86.42 -39.12 16.67 Favored 'General case' 0 N--CA 1.456 -0.152 0 O-C-N 121.875 -0.516 . . . . 63.32 110.098 178.254 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 28.2 mttp -138.7 73.12 1.42 Allowed 'General case' 0 N--CA 1.442 -0.837 0 C-N-CA 125.577 1.551 . . . . 63.41 109.245 -164.028 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 32.3 mtmt . . . . . 0 C--O 1.243 0.752 0 N-CA-C 105.37 -2.085 . . . . 71.32 105.37 147.142 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.624 0 N-CA-C 108.69 -1.764 . . . . 72.52 108.69 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 63.99 159.69 0.09 Allowed 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 128.037 2.535 . . . . 75.53 110.857 -171.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -153.23 15.88 0.54 Allowed 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 114.058 1.133 . . . . 71.55 114.058 -175.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 38.5 m-85 -135.49 160.2 39.2 Favored 'General case' 0 C--O 1.24 0.589 0 C-N-CA 125.1 1.36 . . . . 73.31 108.884 -173.299 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 88.6 m -125.89 134.78 51.49 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 109.217 -0.66 . . . . 72.54 109.217 178.062 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.03 144.36 57.33 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 121.837 0.827 . . . . 74.24 111.077 176.003 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 76.85 -19.61 3.28 Favored Glycine 0 CA--C 1.527 0.807 0 CA-C-O 118.674 -1.07 . . . . 60.32 112.366 -172.324 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 20.3 ttmt -97.43 -84.3 0.38 Allowed 'General case' 0 CA--C 1.511 -0.55 0 CA-C-N 119.116 1.458 . . . . 71.43 108.007 -177.101 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.443 ' HB3' HD21 ' A' ' 178' ' ' LEU . 5.0 mp0 -64.61 -26.31 68.34 Favored 'General case' 0 N--CA 1.442 -0.854 0 C-N-CA 124.748 1.219 . . . . 53.12 110.145 -175.19 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 12.7 p90 -163.91 171.8 14.85 Favored 'General case' 0 C--O 1.233 0.206 0 O-C-N 121.091 -1.006 . . . . 71.43 108.58 -172.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 24.4 t -132.34 110.83 16.8 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 C-N-CA 123.614 0.765 . . . . 54.24 110.035 -177.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -68.75 159.77 31.65 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 124.793 1.237 . . . . 70.42 109.112 166.514 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -134.08 116.36 15.37 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 124.214 1.005 . . . . 64.11 108.425 -174.454 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -61.6 -1.1 0.51 Allowed 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 125.805 1.642 . . . . 62.23 113.908 -177.539 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 48.9 m -133.82 85.57 40.94 Favored Pre-proline 0 CA--C 1.541 0.598 0 C-N-CA 127.583 2.353 . . . . 70.54 108.284 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -77.54 -178.73 4.81 Favored 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 124.647 3.564 . . . . 71.21 113.388 -178.372 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 25.9 t -136.55 148.21 62.88 Favored Pre-proline 0 CA--C 1.548 0.875 0 C-N-CA 126.525 1.93 . . . . 65.43 109.005 -178.115 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -82.19 -178.68 4.2 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 124.567 3.511 . . . . 72.44 112.572 173.493 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.9 m -131.36 172.18 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 124.975 1.31 . . . . 75.13 109.513 172.003 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 66.4 m -48.89 -56.15 9.62 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 125.614 1.565 . . . . 73.22 112.142 176.273 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -144.35 152.08 52.85 Favored Pre-proline 0 C--O 1.239 0.529 0 C-N-CA 125.363 1.465 . . . . 72.31 108.072 -172.604 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -69.45 178.33 4.49 Favored 'Trans proline' 0 N--CA 1.451 -0.982 0 C-N-CA 122.492 2.128 . . . . 74.54 109.251 165.63 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.26 -118.87 6.2 Favored Glycine 0 N--CA 1.45 -0.402 0 N-CA-C 106.951 -2.46 . . . . 72.05 106.951 -166.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -61.01 137.55 58.23 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 119.519 1.66 . . . . 71.11 110.916 -163.225 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 42.1 mm -62.72 138.88 22.02 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 N-CA-C 107.12 -1.437 . . . . 50.05 107.12 168.113 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.7 124.41 36.69 Favored 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 127.138 2.175 . . . . 73.12 106.851 -178.668 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.7 t -128.82 102.29 7.8 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.174 0 N-CA-C 106.438 -1.69 . . . . 72.23 106.438 176.173 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 52.3 t -97.33 114.25 33.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 107.278 -1.378 . . . . 60.12 107.278 -177.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 67.7 tt0 -72.28 134.27 45.47 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 107.6 -1.259 . . . . 51.54 107.6 152.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 5.0 mp -111.36 136.02 51.08 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 107.061 -1.459 . . . . 75.41 107.061 160.035 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 28.9 p90 -134.28 166.71 22.18 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.229 1.011 . . . . 73.12 110.642 -177.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . 0.438 ' HB3' HG21 ' A' ' 153' ' ' VAL . 26.6 t90 -150.36 158.95 44.72 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.724 1.21 . . . . 74.24 108.888 176.101 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 5.3 m-30 -83.59 51.29 1.97 Allowed 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.427 0.691 . . . . 75.23 111.302 178.171 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -174.91 18.84 0.05 OUTLIER Glycine 0 N--CA 1.463 0.446 0 O-C-N 120.287 -1.508 . . . . 72.04 114.273 -174.424 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.532 ' HB3' HG23 ' A' ' 153' ' ' VAL . 20.6 p -118.41 86.28 27.76 Favored Pre-proline 0 N--CA 1.449 -0.513 0 C-N-CA 124.907 1.283 . . . . 73.21 108.252 -172.756 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -63.15 -11.79 26.86 Favored 'Trans proline' 0 CA--C 1.541 0.874 0 C-N-CA 122.279 1.986 . . . . 74.12 114.03 -170.63 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 35.3 m170 -73.74 -22.73 59.78 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 119.209 0.913 . . . . 62.41 112.625 168.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 79.1 m -67.53 -65.85 0.64 Allowed 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.564 1.545 . . . . 74.43 110.67 -173.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 14.2 t80 -59.32 -29.23 67.47 Favored 'General case' 0 N--CA 1.467 0.419 0 O-C-N 121.415 -0.803 . . . . 73.21 112.036 -179.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.47 -26.22 68.62 Favored 'General case' 0 CA--C 1.542 0.652 0 O-C-N 121.452 -0.78 . . . . 75.53 112.615 176.04 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 20.8 t80 -93.97 -18.03 22.32 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 124.999 1.319 . . . . 65.42 112.426 -173.066 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -38.22 -63.04 0.59 Allowed Pre-proline 0 N--CA 1.472 0.631 0 C-N-CA 125.451 1.5 . . . . 74.55 112.767 175.079 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -77.23 -11.44 17.6 Favored 'Trans proline' 0 CA--C 1.534 0.524 0 CA-C-N 121.775 1.67 . . . . 72.15 114.533 -171.103 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.8 m -72.15 -44.97 62.27 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 107.786 -1.19 . . . . 73.22 107.786 166.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 14.3 tt -94.15 -28.65 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 N-CA-C 113.47 0.915 . . . . 74.43 113.47 -165.339 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 14.1 t -47.88 -60.94 3.5 Favored Pre-proline 0 CA--C 1.544 0.724 0 C-N-CA 124.87 1.268 . . . . 61.4 110.027 171.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_endo -72.28 -7.77 21.54 Favored 'Trans proline' 0 C--N 1.348 0.538 0 CA-C-N 121.555 1.591 . . . . 63.35 113.34 -175.247 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 82.6 t90 -77.57 -61.11 2.1 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 119.591 1.087 . . . . 73.12 108.297 165.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 47.9 t -60.23 -36.55 77.98 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.156 1.382 . . . . 72.31 112.593 -169.483 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -75.04 -10.76 59.77 Favored 'General case' 0 CA--C 1.54 0.566 0 O-C-N 120.78 -1.2 . . . . 65.52 111.922 -177.424 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -111.86 18.82 18.52 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 127.736 2.414 . . . . 73.02 113.228 -176.212 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 39.1 mt -75.22 156.18 85.8 Favored Pre-proline 0 N--CA 1.448 -0.565 0 C-N-CA 125.044 1.338 . . . . 62.24 111.424 -177.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -77.78 172.35 15.83 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 124.964 3.776 . . . . 73.15 111.096 179.045 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -66.12 -2.83 4.57 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 114.501 1.297 . . . . 63.21 114.501 -178.577 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -102.74 1.69 34.69 Favored 'General case' 0 C--O 1.223 -0.335 0 C-N-CA 125.05 1.34 . . . . 74.35 112.453 -177.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 39.1 t -125.99 131.52 71.67 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 CA-C-N 120.161 1.346 . . . . 70.32 108.381 -170.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 86.5 t60 -131.67 101.69 5.59 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 125.096 1.358 . . . . 74.31 109.214 -176.169 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 10.4 t80 -82.66 138.55 34.1 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 126.579 1.951 . . . . 73.55 109.476 -176.111 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 23.6 t -130.08 154.32 40.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 106.974 -1.491 . . . . 54.12 106.974 178.514 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 66.5 mtt85 -123.86 129.7 51.42 Favored 'General case' 0 CA--C 1.513 -0.448 0 N-CA-C 105.279 -2.119 . . . . 75.31 105.279 168.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 47.5 mt -134.24 148.92 69.8 Favored Pre-proline 0 C--N 1.33 -0.256 0 N-CA-C 108.921 -0.77 . . . . 53.1 108.921 175.354 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -73.8 140.24 28.78 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 122.347 2.031 . . . . 74.4 110.287 178.024 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -79.1 88.42 4.83 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.883 0.873 . . . . 73.24 110.549 178.756 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 10.1 mt -87.68 96.73 10.54 Favored 'General case' 0 C--N 1.331 -0.214 0 O-C-N 120.188 -1.57 . . . . 73.42 109.858 -177.336 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 48.0 m-85 -115.84 36.36 4.05 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 123.929 0.892 . . . . 74.41 110.958 179.34 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 78.66 -161.47 48.12 Favored Glycine 0 C--N 1.336 0.555 0 N-CA-C 110.004 -1.239 . . . . 63.34 110.004 -179.307 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 44.82 -131.79 7.78 Favored Glycine 0 CA--C 1.532 1.106 0 C-N-CA 125.355 1.455 . . . . 22.13 113.106 172.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 7.7 tp -80.76 -18.47 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 123.73 0.812 . . . . 73.32 110.962 174.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 8.6 m95 -58.52 -38.4 77.64 Favored 'General case' 0 C--N 1.338 0.097 0 O-C-N 121.226 -0.921 . . . . 72.44 111.664 -171.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -83.04 -28.24 29.74 Favored 'General case' 0 C--O 1.232 0.134 0 N-CA-C 113.647 0.98 . . . . 71.25 113.647 177.044 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 33.3 t -59.66 -52.4 61.49 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 N-CA-C 107.336 -1.357 . . . . 75.12 107.336 174.613 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 65.6 m170 -75.01 47.82 0.36 Allowed 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 126.968 2.107 . . . . 75.42 111.261 170.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -153.46 -42.17 0.02 OUTLIER Glycine 0 CA--C 1.526 0.734 0 C-N-CA 124.93 1.252 . . . . 75.44 111.775 177.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 37.9 tt0 -61.95 -26.31 68.12 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.421 1.088 . . . . 75.33 113.783 -168.003 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 1.7 ptt? -71.6 -34.05 69.55 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 120.121 1.328 . . . . 64.31 112.718 -177.395 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 45.1 t80 -54.81 -51.9 64.36 Favored 'General case' 0 N--CA 1.463 0.209 0 C-N-CA 124.067 0.947 . . . . 74.11 109.459 -176.034 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 36.7 mt -57.62 -40.47 79.23 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 124.66 1.184 . . . . 55.23 110.338 178.091 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.679 ' CG2' HG23 ' A' ' 128' ' ' THR . 1.8 m -70.36 -35.02 73.28 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 118.717 0.689 . . . . 65.11 111.247 -178.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -57.52 -56.22 24.66 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 125.073 1.349 . . . . 74.2 108.452 178.694 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -73.33 -21.16 60.62 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.907 0.883 . . . . 63.5 112.098 -178.308 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 27.8 t -66.1 -3.51 5.64 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 117.621 -1.181 . . . . 60.22 113.102 175.242 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 44.2 mtm -100.33 -1.95 34.82 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 120.933 1.697 . . . . 62.51 113.599 169.517 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 74.04 26.64 68.24 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 111.204 -0.758 . . . . 70.41 111.204 177.195 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.9 m -60.48 153.11 4.96 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 N-CA-C 108.147 -1.057 . . . . 62.03 108.147 161.705 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -149.95 158.6 44.33 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 107.928 -1.138 . . . . 61.24 107.928 166.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 43.9 m80 45.86 47.08 12.26 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.483 1.513 . . . . 53.34 111.108 -177.035 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -97.52 5.9 48.9 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 127.654 2.382 . . . . 70.52 112.491 -170.078 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.5 t 66.65 92.14 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.24 0.577 0 C-N-CA 127.528 2.331 . . . . 72.44 111.463 -176.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 12.4 m-70 -66.58 -32.08 73.19 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 124.3 1.04 . . . . 61.35 112.856 171.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -62.14 -46.27 89.77 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-O 117.821 -1.085 . . . . 75.1 112.176 -176.319 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -54.56 -36.4 64.31 Favored 'General case' 0 N--CA 1.457 -0.109 0 CA-C-N 119.159 0.89 . . . . 72.31 112.382 -175.336 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 58.4 t -58.32 -57.94 8.69 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 C-N-CA 124.091 0.957 . . . . 74.33 108.921 177.051 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -69.39 -37.98 77.77 Favored 'General case' 0 C--N 1.335 -0.058 0 C-N-CA 123.132 0.573 . . . . 74.53 112.36 -176.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -58.75 -32.61 69.4 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.608 1.563 . . . . 71.23 110.042 176.367 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -79.61 -20.83 45.91 Favored 'General case' 0 N--CA 1.448 -0.565 0 O-C-N 120.848 -1.157 . . . . 61.21 111.318 178.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 31.8 mt -94.45 -35.72 6.45 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 O-C-N 120.555 -1.341 . . . . 72.12 109.241 -179.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 57.8 m-70 -90.42 -63.64 1.25 Allowed 'General case' 0 C--O 1.233 0.232 0 C-N-CA 124.489 1.116 . . . . 53.54 110.954 -174.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 7.5 mtmt -68.07 -35.61 78.48 Favored 'General case' 0 N--CA 1.463 0.223 0 O-C-N 121.929 -0.482 . . . . 74.24 110.583 -176.163 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -99.87 -70.29 0.74 Allowed 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 108.51 -0.922 . . . . 74.23 108.51 -172.467 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 7.5 t-80 74.6 64.01 0.07 Allowed 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 128.618 2.767 . . . . 73.11 113.301 -177.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 65.2 mttt -76.53 28.97 0.12 Allowed 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 114.755 1.391 . . . . 73.43 114.755 179.515 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 10.0 tmtt? 46.52 57.91 5.05 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 125.958 1.703 . . . . 72.34 112.509 176.189 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 44.7 mt -67.46 42.4 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 130.16 3.384 . . . . 72.03 112.197 179.413 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -88.36 6.44 37.26 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 128.679 2.792 . . . . 53.35 113.14 -178.563 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -139.7 156.49 71.03 Favored Pre-proline 0 CA--C 1.537 0.479 0 C-N-CA 123.809 0.844 . . . . 73.05 111.335 178.614 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -64.69 -39.4 26.96 Favored 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 122.579 2.186 . . . . 72.23 112.386 -179.243 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -59.2 -42.89 92.0 Favored 'General case' 0 C--O 1.225 -0.187 0 CA-C-N 118.09 0.404 . . . . 63.01 110.177 176.359 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -60.52 -38.31 83.99 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 123.109 0.564 . . . . 64.45 110.615 -177.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 54.2 mtt -68.45 -49.91 56.44 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 123.908 0.883 . . . . 63.3 110.467 175.173 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -64.75 -47.14 79.29 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 124.811 1.244 . . . . 72.01 110.783 -171.188 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -62.2 -29.13 70.16 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 126.061 1.744 . . . . 63.23 112.836 176.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 73.0 t80 -76.85 -54.86 6.04 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 109.933 -0.395 . . . . 73.32 109.933 174.177 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 56.4 mt -68.07 -21.19 65.0 Favored 'General case' 0 CA--C 1.516 -0.345 0 O-C-N 121.809 -0.557 . . . . 70.02 110.584 -168.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -55.03 -13.65 1.23 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.402 0.681 . . . . 72.15 112.236 169.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -88.06 -9.69 70.23 Favored Glycine 0 N--CA 1.433 -1.51 0 CA-C-O 116.97 -2.017 . . . . 53.4 110.235 179.216 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -130.35 10.94 5.34 Favored 'General case' 0 C--N 1.347 0.466 0 CA-C-N 120.985 2.393 . . . . 72.45 112.947 -170.137 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 86.83 70.68 1.3 Allowed Glycine 0 N--CA 1.445 -0.731 0 N-CA-C 109.454 -1.458 . . . . 52.42 109.454 -179.198 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 25.7 t -141.4 129.71 22.83 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.816 0 C-N-CA 127.168 2.187 . . . . 74.12 107.271 172.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 41.2 t0 -89.45 123.16 33.33 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 124.185 0.994 . . . . 73.21 110.639 178.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 11.2 mtmt -59.07 -38.7 80.06 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 124.194 0.998 . . . . 51.05 111.02 171.192 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 75.7 mm-40 -65.17 -15.22 62.19 Favored 'General case' 0 C--N 1.329 -0.318 0 O-C-N 120.983 -1.073 . . . . 74.31 112.889 -177.403 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.541 ' O ' HG22 ' A' ' 128' ' ' THR . 9.7 mmtm -117.95 -42.33 2.83 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-O 117.585 -1.198 . . . . 74.12 110.777 -178.189 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 81.3 t80 -46.65 -65.71 0.52 Allowed 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 125.238 1.415 . . . . 71.1 111.12 171.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 18.0 mt -62.3 -38.38 89.15 Favored 'General case' 0 N--CA 1.465 0.279 0 O-C-N 122.055 -0.403 . . . . 72.34 110.827 -173.459 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 31.8 t -54.17 -61.76 2.09 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 107.883 -1.154 . . . . 62.33 107.883 177.178 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . 0.679 HG23 ' CG2' ' A' ' 80' ' ' THR 0.281 4.8 t -69.41 -30.2 68.1 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 118.268 -0.873 . . . . 62.1 110.699 -173.541 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 60.8 t80 -56.49 -42.1 77.73 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 119.87 1.214 . . . . 74.2 111.212 176.209 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -94.7 13.72 23.5 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.906 1.282 . . . . 73.34 111.854 179.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 50.5 m -103.56 161.98 13.43 Favored 'General case' 0 N--CA 1.469 0.504 0 O-C-N 120.618 -1.302 . . . . 51.42 111.167 176.406 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -63.52 -33.88 76.57 Favored 'General case' 0 C--O 1.225 -0.215 0 C-N-CA 122.628 0.371 . . . . 72.41 111.944 -171.537 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -50.99 -46.95 61.55 Favored 'General case' 0 CA--C 1.534 0.339 0 O-C-N 121.705 -0.622 . . . . 50.22 111.98 -175.636 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 48.2 mm -68.53 -33.6 60.89 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-O 118.912 -0.566 . . . . 74.51 110.01 179.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 12.3 tttt -55.05 -38.47 68.04 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 119.453 1.024 . . . . 71.11 110.45 171.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -70.96 -42.44 59.76 Favored Glycine 0 C--N 1.335 0.503 0 N-CA-C 110.603 -0.999 . . . . 64.22 110.603 -175.117 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -67.11 -43.82 81.48 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 123.946 0.898 . . . . 74.03 109.833 -179.51 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 86.7 mmm -58.54 -52.59 65.0 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 125.397 1.479 . . . . 64.43 109.665 175.272 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -63.26 -39.16 93.82 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 120.001 1.273 . . . . 33.44 112.004 -173.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 7.2 mmtt -56.29 -59.77 4.47 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 119.057 0.844 . . . . 54.54 109.227 170.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -53.62 -42.58 67.9 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 118.308 0.504 . . . . 70.41 110.948 -175.413 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 7.7 tttt -57.99 -60.8 3.16 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 125.532 1.533 . . . . 63.42 109.872 177.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 2.2 pttt -71.03 -17.62 62.61 Favored 'General case' 0 CA--C 1.529 0.169 0 N-CA-C 112.313 0.486 . . . . 74.15 112.313 -174.494 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 32.6 mt -73.81 -56.12 5.36 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 124.021 0.928 . . . . 74.54 111.01 170.305 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -57.16 -43.19 82.29 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 119.049 0.84 . . . . 72.2 111.577 -171.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 3.8 ppp? -60.62 -44.29 96.49 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 113.146 0.795 . . . . 72.51 113.146 174.289 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -62.92 -35.75 81.12 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 124.247 1.019 . . . . 75.13 111.096 179.263 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 31.0 m-85 -74.54 14.37 0.48 Allowed 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.11 1.364 . . . . 73.22 113.317 177.458 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 57.32 18.65 4.47 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 126.023 1.729 . . . . 54.43 114.112 178.212 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.458 HG13 HG21 ' A' ' 155' ' ' THR . 20.6 t -75.0 137.05 23.8 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 CA-C-N 119.177 0.898 . . . . 72.04 109.309 -174.815 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -132.42 2.97 3.88 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.524 0.73 . . . . 54.31 112.191 -172.345 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -173.54 -168.91 35.27 Favored Glycine 0 CA--C 1.527 0.83 0 C-N-CA 127.278 2.371 . . . . 51.22 110.054 178.228 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.532 HG23 ' HB3' ' A' ' 37' ' ' CYS . 3.5 m -149.04 157.37 40.05 Favored Pre-proline 0 CA--C 1.537 0.476 0 C-N-CA 125.943 1.697 . . . . 61.5 109.092 -175.798 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -62.31 159.79 56.17 Favored 'Cis proline' 0 N--CA 1.454 -0.848 0 C-N-CA 124.527 -1.031 . . . . 73.43 111.571 -9.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . 0.458 HG21 HG13 ' A' ' 150' ' ' VAL . 7.7 m -155.56 139.71 16.52 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 107.695 -1.224 . . . . 44.35 107.695 176.174 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 98.8 mtp -119.11 160.26 22.41 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-N 114.666 -1.152 . . . . 74.23 108.17 170.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 39.6 t -139.89 156.01 25.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 106.188 -1.782 . . . . 74.23 106.188 178.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 48.2 t -126.18 120.39 56.67 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 N-CA-C 107.242 -1.392 . . . . 72.21 107.242 171.033 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 23.2 m-20 51.64 21.87 1.45 Allowed 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 127.794 2.437 . . . . 72.14 114.405 175.199 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 57.02 32.89 63.15 Favored Glycine 0 CA--C 1.528 0.854 0 CA-C-O 118.239 -1.312 . . . . 62.33 113.996 -168.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 8.0 mtpt -126.79 -29.94 2.81 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 119.491 1.646 . . . . 73.43 111.467 -178.437 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -126.07 128.91 48.12 Favored 'General case' 0 CA--C 1.519 -0.225 0 N-CA-C 108.553 -0.906 . . . . 75.34 108.553 179.221 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 3.7 ttp85 -101.04 132.45 46.46 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 105.673 -1.973 . . . . 74.42 105.673 171.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 13.9 p90 -147.9 161.93 40.32 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.65 -0.871 . . . . 73.11 108.65 173.276 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -170.47 -171.87 1.15 Allowed 'General case' 0 N--CA 1.474 0.762 0 O-C-N 121.741 -0.6 . . . . 75.24 111.162 -174.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 12.2 mt -71.72 -26.02 25.29 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 C-N-CA 126.137 1.775 . . . . 72.44 110.263 -179.168 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -66.16 -54.78 22.16 Favored Glycine 0 N--CA 1.444 -0.811 0 N-CA-C 110.196 -1.161 . . . . 24.03 110.196 168.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 11.4 m -69.06 -59.17 3.22 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 117.398 0.599 . . . . 63.34 111.036 -163.219 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.468 ' CB ' HD23 ' A' ' 178' ' ' LEU . . . -67.35 -35.79 80.09 Favored 'General case' 0 CA--C 1.537 0.462 0 O-C-N 122.034 -0.416 . . . . 50.33 111.862 -167.482 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 140.64 4.09 1.25 Allowed Glycine 0 CA--C 1.531 1.049 0 C-N-CA 125.59 1.567 . . . . 74.23 115.744 175.362 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 137.36 178.18 15.71 Favored Glycine 0 CA--C 1.531 1.078 0 CA-C-N 119.797 1.798 . . . . 74.42 109.59 -168.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -64.68 -44.48 10.66 Favored 'Trans proline' 0 N--CA 1.459 -0.553 0 C-N-CA 123.243 2.629 . . . . 52.42 112.006 -166.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -56.13 -44.75 79.49 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.363 0.665 . . . . 73.04 109.968 178.377 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -71.68 -27.53 63.11 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 116.012 -0.54 . . . . 74.43 110.36 -173.554 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 90.0 m -59.13 -43.56 92.0 Favored 'General case' 0 CA--C 1.533 0.319 0 O-C-N 120.612 -1.305 . . . . 74.13 110.636 177.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 52.0 mt -64.46 -35.46 81.0 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 119.228 0.922 . . . . 74.42 110.852 177.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 21.2 tttt -55.3 -36.02 65.73 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 124.423 1.089 . . . . 61.4 110.121 176.196 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.468 HD23 ' CB ' ' A' ' 169' ' ' ALA . 4.6 mm? -79.57 -43.9 22.1 Favored 'General case' 0 CA--C 1.513 -0.47 0 CA-C-O 117.67 -1.157 . . . . 73.12 110.294 173.432 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -51.33 -43.2 61.68 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 119.459 1.027 . . . . 62.51 111.979 -177.017 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -82.39 -38.5 24.02 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 123.954 0.902 . . . . 64.45 109.274 -167.268 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 30.8 t80 -61.07 -55.96 26.52 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 124.442 1.097 . . . . 53.13 110.535 171.27 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 91.2 mt -61.72 -29.83 70.36 Favored 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 124.09 0.956 . . . . 72.42 111.83 -173.274 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 30.2 mt -56.47 -60.97 1.37 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.151 0 N-CA-C 108.151 -1.055 . . . . 72.42 108.151 168.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 10.9 tm-20 -52.31 -40.74 62.26 Favored 'General case' 0 N--CA 1.457 -0.113 0 C-N-CA 124.28 1.032 . . . . 74.22 111.554 -177.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 12.7 tptp -58.09 -47.92 81.75 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 123.047 0.539 . . . . 72.43 111.254 -179.434 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 41.5 mm-40 -74.53 -39.47 62.35 Favored 'General case' 0 C--O 1.223 -0.312 0 C-N-CA 123.082 0.553 . . . . 71.41 110.865 178.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.65 -37.89 89.14 Favored 'General case' 0 C--N 1.331 -0.216 0 O-C-N 120.269 -1.519 . . . . 72.31 109.253 -175.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -60.75 -19.4 58.98 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 125.267 1.427 . . . . 45.01 111.808 177.288 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -58.48 -29.83 66.52 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 118.667 0.667 . . . . 55.0 111.564 173.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -137.85 35.24 2.39 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 111.923 0.342 . . . . 53.31 111.923 -175.514 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 15.2 tptm -84.74 52.03 2.29 Favored 'General case' 0 CA--C 1.534 0.337 0 O-C-N 121.329 -0.857 . . . . 73.22 110.462 179.252 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 19.7 pttt . . . . . 0 C--O 1.244 0.809 0 C-N-CA 128.863 2.865 . . . . 74.31 112.293 175.51 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.527 0 N-CA-C 110.462 -1.055 . . . . 63.44 110.462 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 74.93 86.03 0.1 Allowed 'General case' 0 C--O 1.232 0.148 0 C-N-CA 126.007 1.723 . . . . 74.42 109.45 173.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -82.69 16.29 2.26 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 126.366 1.866 . . . . 74.23 114.187 -177.355 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 42.1 m-85 -143.63 164.32 30.75 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 124.431 1.093 . . . . 74.12 110.5 -165.176 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 57.3 m -133.67 130.53 38.34 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.754 1.221 . . . . 64.11 108.609 -176.024 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.91 140.89 58.91 Favored 'General case' 0 C--O 1.232 0.162 0 O-C-N 121.636 -0.665 . . . . 63.0 109.732 175.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 82.52 -23.19 5.74 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 125.877 1.703 . . . . 44.53 112.297 -170.461 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 75.1 tttt -96.64 -72.77 0.62 Allowed 'General case' 0 CA--C 1.508 -0.642 0 CA-C-N 118.405 1.103 . . . . 73.0 110.517 -169.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.501 ' HB3' HD11 ' A' ' 178' ' ' LEU . 16.5 mp0 -76.3 -23.89 54.36 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 124.639 1.175 . . . . 73.34 109.702 178.816 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 41.3 p90 -162.19 174.46 12.87 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.699 0.8 . . . . 63.05 110.717 -171.265 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 59.8 t -131.95 113.74 22.89 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 N-CA-C 108.123 -1.066 . . . . 74.12 108.123 178.28 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.68 160.51 32.11 Favored 'General case' 0 C--O 1.234 0.283 0 O-C-N 120.602 -1.311 . . . . 72.11 108.736 163.418 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -134.75 116.75 15.23 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 124.43 1.092 . . . . 73.24 110.133 -178.312 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 4.3 p -67.39 6.3 0.62 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 127.274 2.23 . . . . 54.35 113.918 176.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 18.6 m -127.12 71.43 75.96 Favored Pre-proline 0 N--CA 1.45 -0.447 0 C-N-CA 126.023 1.729 . . . . 73.2 108.205 174.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -76.69 179.81 6.09 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 124.125 3.216 . . . . 73.33 112.533 -170.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 88.3 t -140.8 128.2 12.15 Favored Pre-proline 0 CA--C 1.544 0.73 0 C-N-CA 124.284 1.034 . . . . 61.5 110.448 -167.393 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -82.65 178.73 5.87 Favored 'Trans proline' 0 CA--C 1.542 0.897 0 C-N-CA 124.794 3.663 . . . . 62.54 112.326 176.615 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 28.2 m -134.07 167.29 26.55 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 C-N-CA 124.202 1.001 . . . . 73.31 112.077 -179.268 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 11.2 t -64.42 -49.29 72.11 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 127.427 2.291 . . . . 60.43 109.568 170.163 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 30.9 tt0 -113.74 80.99 5.39 Favored Pre-proline 0 CA--C 1.541 0.601 0 C-N-CA 124.264 1.026 . . . . 75.51 110.451 -173.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -68.97 97.18 0.56 Allowed 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 123.928 3.086 . . . . 71.25 108.216 174.434 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -175.5 -58.97 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.378 0 N-CA-C 110.715 -0.954 . . . . 42.32 110.715 -175.553 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.46 145.04 28.36 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 107.172 -1.418 . . . . 74.44 107.172 166.634 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 36.9 mm -66.11 131.74 31.79 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 N-CA-C 105.721 -1.955 . . . . 64.24 105.721 167.298 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -80.65 142.58 33.84 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 108.699 -0.852 . . . . 72.21 108.699 171.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.442 HG22 HG22 ' A' ' 158' ' ' VAL . 47.1 t -131.57 114.38 25.29 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 N-CA-C 106.391 -1.707 . . . . 71.13 106.391 161.815 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 4.7 t -92.89 141.85 14.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 106.81 -1.552 . . . . 74.32 106.81 171.256 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 79.4 tt0 -107.64 106.25 16.51 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 105.217 -2.142 . . . . 70.31 105.217 156.286 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.0 mp -74.93 155.43 37.45 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 108.624 -0.88 . . . . 71.42 108.624 165.087 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -140.71 164.02 31.32 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 115.777 -0.647 . . . . 75.41 112.207 -163.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . 0.55 ' HB3' HG21 ' A' ' 153' ' ' VAL . 23.6 t90 -159.63 129.76 5.58 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 121.559 0.695 . . . . 71.44 110.642 158.403 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 11.2 m-30 -45.24 -27.3 0.62 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 126.392 1.877 . . . . 71.53 114.611 165.045 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -80.77 2.42 79.6 Favored Glycine 0 CA--C 1.531 1.067 0 CA-C-N 119.63 1.105 . . . . 72.14 114.161 -178.151 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 54.1 t -105.44 86.89 1.86 Allowed Pre-proline 0 CA--C 1.539 0.543 0 C-N-CA 125.71 1.604 . . . . 71.02 112.72 -165.304 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -63.81 -25.13 68.05 Favored 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 121.862 1.708 . . . . 72.12 112.95 177.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 13.7 m-70 -61.76 -46.39 89.78 Favored 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 108.365 -0.976 . . . . 75.1 108.365 173.337 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 87.7 m -60.09 -39.03 84.7 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.83 0.852 . . . . 52.1 109.037 -170.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 45.7 t80 -51.96 -40.46 60.88 Favored 'General case' 0 C--N 1.344 0.344 0 C-N-CA 125.3 1.44 . . . . 72.12 110.763 178.316 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.74 -26.25 68.28 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 118.817 -0.611 . . . . 52.15 112.546 -178.337 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.465 ' CD2' HD11 ' A' ' 166' ' ' ILE . 1.5 t80 -79.3 -25.73 42.37 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-O 117.558 -1.21 . . . . 64.02 111.741 -176.483 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 28.8 mm-40 -37.64 -69.39 0.19 Allowed Pre-proline 0 N--CA 1.471 0.606 0 C-N-CA 125.379 1.472 . . . . 74.45 112.829 -171.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -68.68 -6.67 18.45 Favored 'Trans proline' 0 CA--C 1.536 0.62 0 CA-C-N 121.98 1.743 . . . . 72.2 115.696 -172.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 60.1 m -85.26 -40.25 16.82 Favored 'General case' 0 CA--C 1.537 0.464 0 O-C-N 121.019 -1.051 . . . . 64.44 109.293 168.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 21.0 tt -93.51 -26.16 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 CA-C-N 118.575 0.625 . . . . 72.33 112.467 -171.571 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 19.3 t -53.18 -64.73 1.46 Allowed Pre-proline 0 C--O 1.236 0.385 0 C-N-CA 125.728 1.611 . . . . 70.44 110.059 172.522 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -63.11 -34.6 68.83 Favored 'Trans proline' 0 N--CA 1.451 -0.971 0 CA-C-N 120.898 1.356 . . . . 75.1 111.396 -174.142 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 86.7 t90 -54.54 -51.92 63.69 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 124.195 0.998 . . . . 72.24 110.521 174.242 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 98.7 p -59.25 -38.07 79.15 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 118.428 0.558 . . . . 74.31 111.84 -176.592 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -71.49 -18.71 62.27 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.691 0.796 . . . . 64.22 112.116 179.281 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 67.7 mmtt -94.72 -1.89 52.15 Favored 'General case' 0 C--O 1.232 0.164 0 C-N-CA 124.98 1.312 . . . . 62.44 112.983 179.101 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 36.9 mt -61.16 149.73 81.4 Favored Pre-proline 0 N--CA 1.45 -0.438 0 CA-C-N 119.846 1.203 . . . . 72.14 111.927 -175.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -77.48 165.06 27.87 Favored 'Trans proline' 0 N--CA 1.447 -1.221 0 C-N-CA 123.82 3.013 . . . . 71.22 111.547 -175.11 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -66.77 12.46 0.07 Allowed 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 127.421 2.288 . . . . 35.34 115.072 -176.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -128.36 14.76 6.65 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.449 1.499 . . . . 74.0 111.211 175.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 90.2 t -116.28 155.98 17.56 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 O-C-N 120.64 -1.288 . . . . 71.13 109.445 177.347 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 16.9 t-160 -132.43 102.84 5.89 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 125.955 1.702 . . . . 72.12 106.905 168.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -89.21 139.04 30.89 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 109.228 -0.656 . . . . 73.53 109.228 172.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 78.2 t -143.8 145.74 21.74 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.102 0 C-N-CA 124.675 1.19 . . . . 72.32 108.616 -176.317 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 22.2 mtp180 -111.21 119.28 38.39 Favored 'General case' 0 N--CA 1.463 0.193 0 N-CA-C 105.838 -1.912 . . . . 74.43 105.838 174.156 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 21.0 mt -128.18 147.02 61.74 Favored Pre-proline 0 N--CA 1.473 0.721 0 C-N-CA 123.543 0.737 . . . . 71.03 111.406 176.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -77.38 149.04 27.25 Favored 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 122.639 2.226 . . . . 70.02 112.206 -178.216 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -95.21 126.03 40.25 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 122.232 1.015 . . . . 73.03 108.671 174.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.461 HD22 ' HE1' ' A' ' 138' ' ' MET . 60.9 mt -113.03 52.26 0.8 Allowed 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 125.927 1.691 . . . . 74.02 111.583 -165.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 50.4 m-85 -83.42 63.89 7.55 Favored 'General case' 0 CA--C 1.54 0.57 0 O-C-N 121.332 -0.855 . . . . 71.23 111.784 -177.015 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 61.77 6.77 9.73 Favored Glycine 0 N--CA 1.476 1.366 0 N-CA-C 117.428 1.731 . . . . 61.02 117.428 142.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -170.47 103.85 0.2 Allowed Glycine 0 C--O 1.226 -0.406 0 N-CA-C 106.851 -2.5 . . . . 64.52 106.851 -176.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . 0.308 3.6 tp 58.34 -40.38 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 C-N-CA 130.501 3.52 . . . . 70.12 115.637 -171.063 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 12.5 m95 -49.26 -42.33 40.54 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 126.282 1.833 . . . . 74.45 111.606 -176.049 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 12.6 p30 -76.74 -28.69 55.87 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 114.284 1.216 . . . . 73.02 114.284 -178.323 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 86.0 t -70.28 -53.42 23.17 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 N-CA-C 106.347 -1.723 . . . . 74.2 106.347 174.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 40.5 m170 -68.03 39.42 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 128.905 2.882 . . . . 72.22 113.263 169.509 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -156.47 -46.66 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.424 0 O-C-N 121.204 -0.935 . . . . 72.21 111.378 177.397 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -50.66 -41.57 55.66 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.136 0.975 . . . . 33.25 112.144 -176.049 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 4.1 ttt -54.1 -35.39 62.07 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.387 1.075 . . . . 75.25 113.462 -175.547 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 39.3 t80 -59.94 -42.38 93.87 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 118.918 0.781 . . . . 74.43 109.844 -179.102 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 16.3 mt -66.0 -40.51 91.22 Favored 'General case' 0 C--O 1.227 -0.102 0 C-N-CA 125.094 1.358 . . . . 74.33 109.427 179.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.444 HG23 HG23 ' A' ' 128' ' ' THR . 0.2 OUTLIER -63.78 -37.02 85.81 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.666 0.786 . . . . 74.55 110.833 175.673 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.35 -56.33 15.13 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 124.092 0.957 . . . . 42.13 109.266 -178.422 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -72.06 -15.51 62.02 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 112.534 0.568 . . . . 42.25 112.534 -178.36 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 38.5 t -60.39 -18.99 54.22 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.521 1.129 . . . . 74.44 111.409 170.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 45.9 mtm -98.81 -13.68 20.01 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 120.282 1.401 . . . . 70.23 114.421 173.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 69.87 31.97 70.04 Favored Glycine 0 CA--C 1.529 0.922 0 CA-C-N 119.105 0.866 . . . . 74.43 112.655 -179.001 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 20.5 m -52.44 157.07 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 C-N-CA 126.112 1.765 . . . . 65.02 111.895 175.396 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -147.73 3.6 0.74 Allowed 'General case' 0 CA--C 1.543 0.704 0 O-C-N 121.308 -0.87 . . . . 73.24 112.672 173.335 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 8.0 m80 -131.54 131.26 43.23 Favored 'General case' 0 CA--C 1.529 0.166 0 O-C-N 120.045 -1.659 . . . . 72.55 109.782 -170.47 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 11.6 t0 54.05 27.95 8.17 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 128.367 2.667 . . . . 63.52 114.67 177.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 15.5 m -117.38 -164.36 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 C-N-CA 127.969 2.507 . . . . 74.05 109.543 -179.555 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . 0.257 0.3 OUTLIER 51.98 -85.48 0.01 OUTLIER 'General case' 0 C--O 1.233 0.213 0 C-N-CA 128.73 2.812 . . . . 65.42 113.052 -173.885 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -58.27 -58.94 6.25 Favored 'General case' 0 CA--C 1.51 -0.577 0 CA-C-N 119.507 1.049 . . . . 71.33 110.344 -178.549 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -60.36 -19.84 57.19 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 113.189 0.811 . . . . 71.45 113.189 -175.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 17.6 t -71.57 -62.18 1.4 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 N-CA-C 108.375 -0.972 . . . . 75.42 108.375 172.383 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 41.3 m-85 -64.42 -35.88 82.35 Favored 'General case' 0 C--N 1.338 0.082 0 C-N-CA 124.267 1.027 . . . . 72.4 111.89 -174.561 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 34.8 mm-40 -57.93 -45.19 86.97 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 125.553 1.541 . . . . 65.53 109.435 175.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -64.28 -19.67 65.56 Favored 'General case' 0 CA--C 1.542 0.645 0 O-C-N 121.574 -0.704 . . . . 64.33 112.195 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 64.4 mt -101.74 -25.93 3.66 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 C-N-CA 125.679 1.592 . . . . 63.54 110.298 -173.239 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 83.8 m-70 -117.58 -53.71 2.4 Favored 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 124.323 1.049 . . . . 73.24 111.835 -174.391 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -72.1 -32.66 67.2 Favored 'General case' 0 N--CA 1.468 0.45 0 O-C-N 121.309 -0.869 . . . . 64.31 110.949 176.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -101.71 -36.32 8.76 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 119.425 1.011 . . . . 54.42 112.597 177.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 22.7 t-160 44.5 63.62 1.61 Allowed 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.901 1.68 . . . . 74.14 112.07 -171.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 37.7 mmtt -64.19 170.71 3.49 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.208 1.403 . . . . 65.12 110.96 171.639 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 63.3 tttt -81.38 30.02 0.35 Allowed 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 125.985 1.714 . . . . 70.24 112.622 -173.477 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.477 HD23 ' HB3' ' A' ' 110' ' ' GLU . 31.0 mt -71.89 32.08 0.05 Allowed 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 128.8 2.84 . . . . 41.15 114.452 -165.112 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -78.85 8.37 5.61 Favored 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 126.864 2.066 . . . . 71.41 114.303 -178.333 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -150.75 156.77 36.15 Favored Pre-proline 0 CA--C 1.534 0.332 0 C-N-CA 124.25 1.02 . . . . 75.21 109.566 -174.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -65.42 -30.23 53.21 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 121.818 1.678 . . . . 61.22 114.0 -170.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -66.26 -53.69 33.86 Favored 'General case' 0 C--O 1.223 -0.31 0 CA-C-O 118.13 -0.938 . . . . 75.44 109.563 178.004 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.477 ' HB3' HD23 ' A' ' 105' ' ' LEU . 13.5 mm-40 -50.89 -48.19 60.5 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 119.353 0.979 . . . . 73.23 111.286 178.459 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 59.7 mtt -54.96 -55.19 33.48 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 123.937 0.895 . . . . 44.43 110.173 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.44 ' HB1' ' CG ' ' A' ' 122' ' ' LYS . . . -66.73 -42.61 86.0 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.565 1.146 . . . . 75.45 110.989 -172.665 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -61.0 -40.06 92.08 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 126.192 1.797 . . . . 74.43 109.853 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 38.7 t80 -68.81 -50.86 46.65 Favored 'General case' 0 N--CA 1.454 -0.243 0 O-C-N 121.807 -0.558 . . . . 75.42 109.644 178.193 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 50.7 mt -68.45 -15.94 63.73 Favored 'General case' 0 N--CA 1.452 -0.341 0 O-C-N 121.988 -0.445 . . . . 35.22 110.323 -172.561 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -54.19 -31.41 52.87 Favored 'General case' 0 CA--C 1.534 0.329 0 O-C-N 121.88 -0.513 . . . . 65.44 111.987 169.4 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -83.65 1.92 88.07 Favored Glycine 0 CA--C 1.534 1.22 0 CA-C-O 119.113 -0.826 . . . . 74.33 113.988 173.652 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 13.5 mmtp -131.62 27.31 4.68 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 120.036 1.918 . . . . 44.22 111.292 -166.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 73.33 36.1 55.77 Favored Glycine 0 CA--C 1.521 0.453 0 CA-C-O 119.825 -0.431 . . . . 71.13 112.295 173.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 31.8 t -126.51 123.11 62.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 N-CA-C 106.704 -1.591 . . . . 65.21 106.704 178.389 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -69.75 153.56 43.19 Favored 'General case' 0 CA--C 1.537 0.454 0 O-C-N 122.021 -0.424 . . . . 63.13 111.533 173.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.44 ' CG ' ' HB1' ' A' ' 112' ' ' ALA . 6.1 ttpt -83.48 -36.84 23.82 Favored 'General case' 0 N--CA 1.465 0.299 0 O-C-N 120.419 -1.426 . . . . 72.25 110.46 175.492 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 58.0 mt-10 -57.83 -52.86 63.72 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 118.859 0.754 . . . . 74.23 109.693 -176.504 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 7.6 mmmt -73.32 -38.52 65.78 Favored 'General case' 0 CA--C 1.508 -0.639 0 N-CA-C 108.353 -0.98 . . . . 72.11 108.353 -167.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 61.4 t80 -57.88 -62.49 1.77 Allowed 'General case' 0 N--CA 1.436 -1.174 0 O-C-N 124.732 1.27 . . . . 73.44 109.13 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 16.0 mt -68.05 -31.15 70.6 Favored 'General case' 0 C--O 1.238 0.485 0 O-C-N 121.985 -0.447 . . . . 75.11 111.305 -176.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 33.2 t -56.15 -59.8 4.41 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 107.4 -1.333 . . . . 41.41 107.4 175.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . 0.444 HG23 HG23 ' A' ' 80' ' ' THR . 4.5 t -71.86 -36.18 70.04 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 118.963 -0.541 . . . . 73.24 109.934 -171.73 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 61.6 t80 -51.62 -43.98 62.74 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.93 1.292 . . . . 73.41 111.733 176.394 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 54.4 m-20 -104.39 33.61 3.45 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 121.779 -0.576 . . . . 73.4 110.667 -179.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 22.6 t -122.95 165.76 16.18 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.178 1.391 . . . . 62.22 110.926 177.182 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -57.19 -29.42 63.67 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.168 1.387 . . . . 61.24 111.517 177.746 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -53.57 -58.89 5.57 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 123.918 0.887 . . . . 61.31 110.849 177.586 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 38.6 mm -74.17 -28.28 23.07 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-O 118.421 -0.8 . . . . 73.23 109.89 -176.099 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 7.4 mmtt -53.97 -43.12 69.65 Favored 'General case' 0 C--N 1.34 0.169 0 CA-C-N 119.639 1.108 . . . . 63.51 110.002 170.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -66.76 -20.47 70.35 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 124.389 0.995 . . . . 53.44 112.944 -177.516 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -90.13 -41.31 11.71 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 117.954 0.877 . . . . 71.14 110.1 174.342 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . 0.461 ' HE1' HD22 ' A' ' 66' ' ' LEU . 87.8 mmm -64.39 -35.93 82.48 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 124.825 1.25 . . . . 65.44 112.3 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -61.31 -51.29 69.48 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 119.039 0.836 . . . . 54.23 109.804 177.248 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 2.7 mmtt -65.04 -55.45 18.82 Favored 'General case' 0 CA--C 1.514 -0.419 0 C-N-CA 123.932 0.893 . . . . 74.52 109.275 -176.614 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -55.02 -34.5 63.54 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 119.681 1.128 . . . . 22.24 111.688 -178.086 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 5.7 tmtt? -77.87 -51.31 10.65 Favored 'General case' 0 C--N 1.346 0.437 0 CA-C-N 119.884 1.22 . . . . 72.43 111.344 -179.244 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 18.3 ptmt -60.54 -30.63 69.89 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 119.558 1.072 . . . . 65.33 110.527 178.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 48.4 mt -68.86 -56.91 6.46 Favored 'General case' 0 N--CA 1.443 -0.802 0 C-N-CA 123.442 0.697 . . . . 74.11 110.232 177.384 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -53.93 -41.5 67.77 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 119.887 1.221 . . . . 54.21 113.32 -173.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -65.22 -46.74 79.43 Favored 'General case' 0 N--CA 1.464 0.25 0 O-C-N 122.049 -0.407 . . . . 65.14 111.932 175.149 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -69.73 -35.04 74.66 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 118.733 0.697 . . . . 72.42 111.557 -176.409 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -69.48 9.29 0.49 Allowed 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 125.536 1.534 . . . . 71.34 113.763 171.618 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 10.9 mm100 59.04 24.72 13.02 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 126.005 1.722 . . . . 70.31 113.16 177.727 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 39.3 t -69.18 150.57 10.51 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 O-C-N 120.643 -1.286 . . . . 62.04 108.475 -178.197 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -145.98 6.27 1.02 Allowed 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.311 0.644 . . . . 52.22 111.947 -166.02 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 159.52 -171.99 36.05 Favored Glycine 0 N--CA 1.446 -0.688 0 N-CA-C 109.127 -1.589 . . . . 64.53 109.127 -166.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.55 HG21 ' HB3' ' A' ' 34' ' ' TRP . 15.3 m -139.72 161.93 53.77 Favored Pre-proline 0 CA--C 1.539 0.531 0 C-N-CA 124.064 0.945 . . . . 74.42 110.261 176.615 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . 0.46 ' C ' ' HA ' ' A' ' 153' ' ' VAL . 20.6 Cg_endo -58.37 156.63 36.13 Favored 'Cis proline' 0 CA--C 1.532 0.384 0 C-N-CA 123.928 -1.28 . . . . 73.3 111.065 -14.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . 0.444 ' HA ' ' HB3' ' A' ' 165' ' ' ASP . 11.0 m -147.95 109.96 4.53 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.066 -1.087 . . . . 64.31 108.066 171.255 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 36.2 mmm -89.27 158.73 17.73 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 108.337 -0.986 . . . . 71.35 108.337 170.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 11.5 t -145.19 121.56 3.97 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 N-CA-C 108.575 -0.898 . . . . 73.11 108.575 174.128 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.566 HG23 ' CE1' ' A' ' 164' ' ' PHE . 77.2 t -91.83 131.51 38.73 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 N-CA-C 108.524 -0.917 . . . . 70.45 108.524 169.367 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 44.1 t30 48.88 19.45 0.27 Allowed 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 130.082 3.353 . . . . 73.11 115.323 168.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 69.62 23.75 76.54 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 125.357 1.456 . . . . 35.53 112.852 -175.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 55.9 mttt -131.55 -31.45 1.59 Allowed 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 118.596 1.198 . . . . 52.41 113.111 -171.285 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . 0.521 ' CG ' HD22 ' A' ' 182' ' ' LEU . 96.5 m-85 -125.68 108.08 11.19 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 123.529 0.732 . . . . 62.33 109.12 -175.532 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 41.7 ttt-85 -90.36 124.12 34.67 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 126.985 2.114 . . . . 72.51 106.039 174.475 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . 0.566 ' CE1' HG23 ' A' ' 158' ' ' VAL . 18.1 p90 -149.42 166.95 27.54 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 107.67 -1.233 . . . . 73.52 107.67 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . 0.444 ' HB3' ' HA ' ' A' ' 155' ' ' THR . 10.4 p-10 178.24 178.07 0.4 Allowed 'General case' 0 CA--C 1.51 -0.562 0 C-N-CA 124.86 1.264 . . . . 75.53 109.205 -178.666 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.465 HD11 ' CD2' ' A' ' 43' ' ' PHE . 18.2 mt -54.35 -38.49 40.54 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.673 0 C-N-CA 126.405 1.882 . . . . 72.42 109.834 178.204 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -65.27 -30.96 79.03 Favored Glycine 0 CA--C 1.526 0.764 0 C-N-CA 124.321 0.963 . . . . 42.14 113.266 175.499 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 51.0 m -84.61 -62.19 1.61 Allowed 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.898 0.879 . . . . 65.52 110.064 178.148 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -59.0 -32.87 70.08 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 126.583 1.953 . . . . 73.25 112.071 -173.274 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 102.07 2.58 51.7 Favored Glycine 0 CA--C 1.526 0.727 0 CA-C-O 118.656 -1.08 . . . . 34.03 112.453 178.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 169.24 172.66 36.17 Favored Glycine 0 CA--C 1.531 1.041 0 CA-C-N 119.256 1.528 . . . . 53.21 111.556 175.579 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -66.44 -49.37 1.82 Allowed 'Trans proline' 0 CA--C 1.534 0.502 0 C-N-CA 123.046 2.497 . . . . 74.3 112.459 -175.357 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -57.09 -43.67 82.43 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 119.406 1.003 . . . . 74.1 109.865 175.429 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -57.79 -34.88 70.08 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.21 -0.905 . . . . 71.4 109.958 -178.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 48.8 m -67.4 -41.51 84.81 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-O 118.179 -0.915 . . . . 74.25 110.689 -178.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 49.7 mt -66.45 -35.64 80.81 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 119.836 1.198 . . . . 54.33 111.039 176.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 10.3 mttt -51.39 -48.56 62.54 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.244 1.418 . . . . 63.24 110.09 170.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.501 HD11 ' HB3' ' A' ' 11' ' ' GLU . 3.2 mm? -67.58 -48.85 65.68 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-O 118.346 -0.835 . . . . 72.11 110.478 173.833 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -52.91 -37.55 60.86 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 123.375 0.67 . . . . 73.03 111.977 -172.576 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -81.36 -47.55 13.12 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.659 1.184 . . . . 74.3 110.657 -173.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -56.56 -47.79 78.72 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 108.82 -0.807 . . . . 65.44 108.82 176.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.521 HD22 ' CG ' ' A' ' 162' ' ' TYR . 29.4 mt -63.57 -32.44 73.9 Favored 'General case' 0 CA--C 1.514 -0.438 0 C-N-CA 125.3 1.44 . . . . 61.03 112.205 -170.672 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 30.0 mt -58.38 -61.49 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 N-CA-C 107.046 -1.465 . . . . 71.02 107.046 174.058 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -53.05 -37.19 61.38 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 123.869 0.867 . . . . 64.12 111.691 -179.339 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . 0.457 ' HA ' ' HE2' ' A' ' 185' ' ' LYS . 0.0 OUTLIER -54.72 -39.09 67.88 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.547 0.739 . . . . 62.34 111.046 -176.063 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 63.8 mm-40 -95.14 -33.85 12.49 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 124.133 0.973 . . . . 65.55 112.135 175.126 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.05 -34.45 74.89 Favored 'General case' 0 CA--C 1.529 0.17 0 O-C-N 120.598 -1.314 . . . . 74.52 109.908 -179.022 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -67.89 -12.02 59.83 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 124.914 1.286 . . . . 54.21 112.174 179.385 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -69.84 -14.83 62.94 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 118.758 0.708 . . . . 73.33 111.825 169.247 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . 54.02 26.85 6.8 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 128.234 2.614 . . . . 73.52 113.074 175.016 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 3.1 ttpm? 50.61 37.74 17.08 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.254 1.422 . . . . 73.21 111.818 -173.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 20.1 pttm . . . . . 0 C--O 1.243 0.756 0 CA-C-O 117.06 -1.448 . . . . 72.21 110.694 179.912 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.631 0 N-CA-C 107.91 -2.076 . . . . 73.5 107.91 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -136.02 134.67 38.75 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-N 118.615 1.207 . . . . 62.2 110.977 -154.428 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -134.21 11.37 3.86 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 126.278 1.831 . . . . 65.35 111.546 -170.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 -140.02 158.18 44.47 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 124.697 1.199 . . . . 71.44 108.485 -169.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 24.4 m -134.76 138.94 44.77 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 108.777 -0.823 . . . . 71.4 108.777 -178.577 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -71.14 143.74 50.47 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 109.146 -0.687 . . . . 75.42 109.146 174.192 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 68.1 14.28 65.78 Favored Glycine 0 CA--C 1.523 0.577 0 CA-C-O 119.315 -0.714 . . . . 32.44 112.515 -168.054 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 6.7 tttm -130.92 -82.56 0.53 Allowed 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 107.532 -1.285 . . . . 72.41 107.532 179.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.441 ' HB3' HD21 ' A' ' 178' ' ' LEU . 7.5 mp0 -79.44 -24.59 42.35 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 124.587 1.155 . . . . 70.4 111.361 -178.392 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 41.3 p90 -155.89 174.57 15.13 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 107.329 -1.36 . . . . 64.31 107.329 -177.075 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 23.0 t -132.29 146.82 32.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 108.474 -0.935 . . . . 74.23 108.474 -175.446 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -109.22 156.52 19.8 Favored 'General case' 0 N--CA 1.451 -0.409 0 O-C-N 120.894 -1.129 . . . . 75.43 109.161 166.398 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -126.02 120.22 29.72 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 125.747 1.619 . . . . 72.33 108.695 -169.338 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.8 m -55.13 -15.53 2.31 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.616 1.567 . . . . 61.35 114.223 -177.666 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 10.4 p -128.59 84.99 61.51 Favored Pre-proline 0 N--CA 1.445 -0.688 0 CA-C-N 119.164 0.893 . . . . 52.24 111.55 -179.552 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -73.08 179.79 5.07 Favored 'Trans proline' 0 CA--C 1.542 0.923 0 C-N-CA 124.449 3.432 . . . . 61.44 113.822 178.19 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 6.7 t -128.94 142.3 44.66 Favored Pre-proline 0 N--CA 1.47 0.564 0 C-N-CA 125.347 1.459 . . . . 70.24 108.102 173.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -76.73 176.52 10.01 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 123.608 2.872 . . . . 64.52 111.216 172.042 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.7 m -115.99 179.4 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 C-N-CA 124.017 0.927 . . . . 73.3 109.418 170.095 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 34.7 t -56.15 -64.03 0.99 Allowed 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 123.82 0.848 . . . . 73.15 108.906 169.448 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 19.1 mt-30 -150.38 161.23 31.27 Favored Pre-proline 0 C--O 1.237 0.442 0 O-C-N 121.68 -0.638 . . . . 73.33 110.761 -174.172 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -70.82 166.38 29.11 Favored 'Trans proline' 0 N--CA 1.45 -1.049 0 C-N-CA 122.747 2.298 . . . . 74.04 109.333 171.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 143.04 -86.57 0.18 Allowed Glycine 0 N--CA 1.449 -0.495 0 N-CA-C 108.894 -1.683 . . . . 65.43 108.894 -175.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.29 158.0 15.64 Favored 'General case' 0 N--CA 1.462 0.161 0 N-CA-C 108.616 -0.883 . . . . 74.11 108.616 -176.616 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 48.0 mm -66.63 154.91 7.61 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 N-CA-C 106.585 -1.635 . . . . 75.35 106.585 166.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -108.59 90.32 3.26 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 107.449 -1.315 . . . . 75.4 107.449 172.466 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 41.4 t -94.61 119.8 43.11 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.175 0 N-CA-C 106.654 -1.61 . . . . 70.43 106.654 176.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 25.4 t -119.45 110.99 31.2 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 N-CA-C 108.507 -0.923 . . . . 70.54 108.507 -174.291 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -72.61 126.94 31.1 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 108.046 -1.094 . . . . 71.13 108.046 154.488 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.5 mp -109.7 139.9 44.2 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 106.634 -1.617 . . . . 75.35 106.634 151.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 9.3 p90 -146.07 168.06 21.85 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 125.323 1.449 . . . . 74.12 107.974 -173.116 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 24.1 t90 -142.18 151.75 42.49 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 107.664 -1.236 . . . . 64.51 107.664 -177.146 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -47.15 -31.28 3.42 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.882 1.273 . . . . 74.42 112.085 166.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -109.5 17.9 30.52 Favored Glycine 0 CA--C 1.527 0.809 0 CA-C-O 117.577 -1.68 . . . . 74.42 115.138 -159.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 23.0 p -104.83 86.33 1.45 Allowed Pre-proline 0 CA--C 1.538 0.516 0 CA-C-N 119.644 1.722 . . . . 71.1 110.723 -170.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -58.51 -27.24 81.58 Favored 'Trans proline' 0 CA--C 1.54 0.776 0 CA-C-N 121.778 1.671 . . . . 52.02 114.232 -174.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 10.9 m170 -59.84 -19.63 52.14 Favored 'General case' 0 CA--C 1.537 0.449 0 O-C-N 121.365 -0.835 . . . . 72.44 112.592 174.067 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 98.8 m -71.01 -36.07 72.28 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.922 1.289 . . . . 65.13 110.632 -176.156 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 38.4 m-85 -61.68 -36.48 80.97 Favored 'General case' 0 N--CA 1.471 0.595 0 O-C-N 120.794 -1.191 . . . . 74.12 111.711 -177.462 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.74 -12.09 43.41 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 124.505 1.122 . . . . 71.33 112.209 179.299 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 27.1 t80 -126.41 -25.28 3.49 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-O 116.353 -1.784 . . . . 73.11 112.701 -172.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -45.37 -62.77 1.51 Allowed Pre-proline 0 N--CA 1.473 0.722 0 CA-C-N 121.619 2.009 . . . . 65.3 113.107 -177.517 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -70.38 -7.81 22.12 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 CA-C-N 121.179 1.457 . . . . 74.23 114.932 -178.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 25.4 m -80.84 -37.53 29.83 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.093 0.957 . . . . 64.11 110.061 170.295 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 20.6 tt -91.65 -31.62 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 C-N-CA 123.147 0.579 . . . . 74.42 111.617 -174.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 12.5 t -46.93 -62.8 1.71 Allowed Pre-proline 0 CA--C 1.539 0.533 0 CA-C-O 117.975 -1.012 . . . . 54.41 111.027 174.256 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -66.83 -34.91 29.13 Favored 'Trans proline' 0 N--CA 1.452 -0.939 0 CA-C-N 121.222 1.472 . . . . 54.32 111.027 -176.194 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 91.2 t90 -55.09 -47.32 75.08 Favored 'General case' 0 C--N 1.341 0.217 0 CA-C-N 119.778 1.172 . . . . 74.2 109.929 174.537 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 49.7 p -59.51 -38.1 80.06 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 122.783 0.433 . . . . 71.15 111.604 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.4 mt-10 -75.32 -10.55 59.55 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.34 1.456 . . . . 74.15 112.483 177.506 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 9.7 mmmm -119.44 9.8 11.69 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 126.447 1.899 . . . . 72.35 112.772 -174.571 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 27.5 mt -65.02 160.6 55.05 Favored Pre-proline 0 CA--C 1.538 0.506 0 C-N-CA 124.402 1.081 . . . . 55.25 111.661 172.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -82.66 169.7 13.39 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 124.913 3.742 . . . . 73.22 111.409 175.088 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -71.83 16.64 0.11 Allowed 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 126.755 2.022 . . . . 74.45 114.062 -175.304 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -127.09 -4.96 6.19 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 126.601 1.961 . . . . 73.4 113.074 -179.09 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.466 HG21 HD13 ' A' ' 183' ' ' ILE . 48.5 t -113.68 113.98 45.49 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.307 0 N-CA-C 106.689 -1.597 . . . . 54.44 106.689 -178.011 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 79.5 t60 -101.3 112.71 25.3 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 107.045 -1.465 . . . . 63.35 107.045 174.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 27.6 t80 -84.6 143.99 28.91 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 114.855 -1.066 . . . . 74.14 109.16 176.153 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 48.8 t -136.24 141.09 42.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 N-CA-C 106.387 -1.708 . . . . 71.24 106.387 -177.316 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 60.1 mtm-85 -123.43 113.33 18.65 Favored 'General case' 0 CA--C 1.508 -0.635 0 N-CA-C 104.613 -2.366 . . . . 74.34 104.613 176.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 5.8 mt -124.67 149.23 61.61 Favored Pre-proline 0 N--CA 1.466 0.326 0 CA-C-N 120.443 1.474 . . . . 54.11 110.043 174.294 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -67.53 143.43 62.85 Favored 'Trans proline' 0 N--CA 1.45 -1.051 0 C-N-CA 121.123 1.215 . . . . 54.42 110.743 -177.305 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -79.17 59.19 2.69 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.684 1.594 . . . . 50.31 111.49 -179.665 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 10.6 mt -74.1 88.13 1.91 Allowed 'General case' 0 C--N 1.328 -0.356 0 O-C-N 120.382 -1.449 . . . . 62.24 108.502 -176.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -141.61 1.98 1.57 Allowed 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 114.352 1.241 . . . . 75.55 114.352 175.649 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -153.04 179.0 29.82 Favored Glycine 0 C--N 1.333 0.401 0 O-C-N 121.078 -1.014 . . . . 72.05 113.814 -163.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -51.81 -53.56 29.18 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 128.589 2.995 . . . . 65.4 113.117 -164.289 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 9.8 tp -106.39 -6.85 10.24 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 C-N-CA 124.886 1.274 . . . . 51.32 110.884 173.39 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 8.9 m95 -73.76 -24.7 59.9 Favored 'General case' 0 N--CA 1.448 -0.568 0 O-C-N 120.876 -1.14 . . . . 73.55 111.495 -171.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -70.38 -46.94 63.04 Favored 'General case' 0 C--O 1.234 0.244 0 O-C-N 121.321 -0.862 . . . . 74.12 109.299 169.457 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 25.7 t -63.31 -53.13 49.65 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 C-N-CA 122.774 0.43 . . . . 70.3 110.189 -173.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 38.6 m170 -67.31 1.88 1.95 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.225 1.01 . . . . 54.43 113.185 178.457 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -109.19 -43.5 1.17 Allowed Glycine 0 C--N 1.338 0.669 0 CA-C-N 120.702 1.592 . . . . 63.21 110.697 -176.596 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -54.37 -36.62 64.07 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 113.391 0.886 . . . . 74.43 113.391 -170.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 5.9 ttt -45.21 -45.79 11.94 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 125.849 1.659 . . . . 64.25 114.434 -179.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 34.8 t80 -56.85 -42.34 79.53 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 121.52 0.676 . . . . 62.24 109.775 -173.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 18.2 mt -68.75 -42.11 77.97 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 117.082 -1.437 . . . . 60.43 109.291 178.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -56.51 -40.61 75.31 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 121.046 1.748 . . . . 74.53 110.944 178.255 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.534 HD23 HG21 ' A' ' 86' ' ' VAL . 0.2 OUTLIER -63.07 -59.79 4.32 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 123.686 0.794 . . . . 71.11 110.219 179.243 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -65.24 -16.37 63.47 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 118.806 0.73 . . . . 73.32 112.208 -178.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -53.25 -25.74 15.52 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.208 1.003 . . . . 61.11 111.724 174.355 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 11.6 mtp -107.1 -11.42 15.64 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.429 1.492 . . . . 64.42 112.05 -172.464 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 63.23 39.32 97.75 Favored Glycine 0 CA--C 1.53 0.973 0 N-CA-C 110.743 -0.943 . . . . 43.43 110.743 -173.7 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.534 HG21 HD23 ' A' ' 81' ' ' LEU . 20.5 m -66.2 161.79 3.18 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 C-N-CA 125.005 1.322 . . . . 54.2 110.76 167.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 51.24 -162.16 0.07 Allowed 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 106.589 -1.634 . . . . 75.34 106.589 -163.661 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 42.9 m170 -91.18 -85.23 0.24 Allowed 'General case' 0 N--CA 1.465 0.293 0 O-C-N 119.353 -2.092 . . . . 63.32 108.832 164.246 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 41.6 t0 -139.5 43.08 2.01 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-O 122.333 1.064 . . . . 71.43 109.536 -178.508 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 21.6 m -147.07 161.74 8.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 C-N-CA 128.443 2.697 . . . . 71.52 107.941 -176.605 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 21.2 p80 -156.04 35.59 0.34 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 122.011 0.91 . . . . 72.22 113.013 -168.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -49.95 -64.45 0.8 Allowed 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 126.286 1.834 . . . . 75.32 110.768 -173.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -60.82 -26.21 67.15 Favored 'General case' 0 N--CA 1.457 -0.119 0 CA-C-O 117.96 -1.019 . . . . 35.33 113.029 -178.216 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 39.0 t -59.19 -62.67 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.339 0.14 0 N-CA-C 107.683 -1.229 . . . . 61.24 107.683 178.669 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -61.95 -49.57 75.59 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 123.874 0.87 . . . . 74.1 110.343 -179.387 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -57.29 -38.36 73.86 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.922 0.889 . . . . 72.1 110.488 -173.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.427 ' HA ' ' HB2' ' A' ' 101' ' ' GLU . . . -67.88 -43.79 78.55 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-O 122.46 1.124 . . . . 71.51 111.12 -178.452 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 45.2 mt -71.57 -36.29 59.48 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 N-CA-C 108.207 -1.034 . . . . 75.45 108.207 -175.371 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 81.1 m-70 -95.68 -74.03 0.57 Allowed 'General case' 0 N--CA 1.446 -0.66 0 O-C-N 121.46 -0.775 . . . . 75.32 109.936 -171.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 22.5 mmtt -64.12 -18.53 64.51 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 125.099 1.36 . . . . 75.21 112.097 -176.359 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.427 ' HB2' ' HA ' ' A' ' 97' ' ' ALA . 0.4 OUTLIER -108.82 -19.83 13.27 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 113.516 0.932 . . . . 74.2 113.516 179.243 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 3.9 t60 44.02 57.64 4.08 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 126.389 1.876 . . . . 75.22 112.059 173.325 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 12.6 mmtm -75.51 160.65 29.95 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.668 1.187 . . . . 65.32 109.992 178.308 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 32.7 tttt -77.61 29.83 0.16 Allowed 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 127.466 2.307 . . . . 74.24 113.892 -178.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 27.6 mt -74.62 49.88 0.41 Allowed 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 127.489 2.316 . . . . 74.15 111.734 -169.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -90.37 -0.26 57.56 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 128.093 2.557 . . . . 72.3 112.333 -178.535 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 23.8 p -141.01 153.41 67.18 Favored Pre-proline 0 C--O 1.233 0.23 0 C-N-CA 123.424 0.69 . . . . 63.44 110.135 173.439 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -63.89 -28.4 67.21 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 122.528 2.152 . . . . 63.51 112.642 -176.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 27.8 mp0 -70.35 -36.71 74.36 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 119.594 1.088 . . . . 70.24 110.31 177.286 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -73.37 -40.36 64.44 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.847 0.859 . . . . 74.14 109.544 178.612 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 45.1 mtt -58.47 -61.29 2.7 Favored 'General case' 0 C--N 1.343 0.286 0 C-N-CA 126.044 1.738 . . . . 65.2 109.935 174.671 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -62.91 -41.26 99.38 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 123.888 0.875 . . . . 71.35 111.476 -170.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -56.65 -41.91 78.04 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.049 0.452 . . . . 72.05 111.212 176.199 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . 0.407 ' CZ ' ' HB1' ' A' ' 97' ' ' ALA . 80.8 t80 -70.57 -40.69 73.17 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 123.614 0.766 . . . . 71.3 112.061 -179.173 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 56.1 mt -75.97 -17.02 59.88 Favored 'General case' 0 C--N 1.332 -0.181 0 O-C-N 121.378 -0.826 . . . . 55.23 111.445 -177.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -54.06 -28.33 38.18 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.981 0.912 . . . . 64.24 111.832 -178.075 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -89.54 -1.68 77.45 Favored Glycine 0 CA--C 1.529 0.94 0 CA-C-O 117.741 -1.589 . . . . 61.21 115.151 177.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 39.5 mttt -129.33 26.42 5.41 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 120.791 2.295 . . . . 74.15 112.647 -166.313 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 104.7 3.93 42.91 Favored Glycine 0 CA--C 1.527 0.812 0 C-N-CA 123.542 0.591 . . . . 71.13 113.463 173.101 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 77.0 t -106.3 165.09 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 C-N-CA 125.277 1.431 . . . . 75.2 107.899 179.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 60.8 t0 -132.87 132.24 41.87 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 105.711 -1.959 . . . . 61.02 105.711 176.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 21.3 mtpt -55.72 -36.03 66.77 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 123.523 0.729 . . . . 71.14 110.885 176.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -60.2 -50.87 71.96 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 118.875 0.761 . . . . 74.43 109.874 174.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -78.04 -28.03 48.91 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 108.979 -0.749 . . . . 60.3 108.979 -167.452 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 32.8 t80 -68.66 -69.73 0.31 Allowed 'General case' 0 N--CA 1.437 -1.09 0 C-N-CA 125.434 1.493 . . . . 72.33 108.845 173.627 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 8.1 mt -68.04 -37.99 81.99 Favored 'General case' 0 CA--C 1.531 0.24 0 O-C-N 121.244 -0.91 . . . . 73.31 110.348 -163.164 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 3.9 t -66.61 -21.13 66.13 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 118.781 -0.628 . . . . 73.05 112.232 -175.167 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 3.1 t -98.42 -35.11 10.39 Favored 'General case' 0 C--N 1.342 0.27 0 CA-C-N 119.196 0.907 . . . . 72.14 110.448 171.113 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 80.2 t80 -49.31 -55.69 11.95 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 119.184 0.902 . . . . 61.41 110.533 177.344 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 -86.08 55.61 3.61 Favored 'General case' 0 C--O 1.231 0.105 0 N-CA-C 108.714 -0.847 . . . . 53.34 108.714 174.356 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -157.91 166.53 32.4 Favored 'General case' 0 C--O 1.237 0.396 0 O-C-N 120.93 -1.106 . . . . 60.55 111.33 -177.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -74.6 -29.61 61.37 Favored 'General case' 0 N--CA 1.456 -0.14 0 CA-C-N 115.613 -0.721 . . . . 73.02 112.836 -162.551 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -56.73 -49.48 75.05 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 119.658 1.117 . . . . 73.34 110.258 -177.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 35.5 mm -63.02 -39.44 85.23 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.345 0 C-N-CA 125.161 1.384 . . . . 64.34 109.493 177.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 28.0 tttm -55.83 -42.67 76.08 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 118.585 -0.721 . . . . 72.33 109.562 175.305 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -71.18 -24.95 76.48 Favored Glycine 0 CA--C 1.523 0.559 0 C-N-CA 124.796 1.189 . . . . 70.45 111.958 -171.525 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -87.61 -50.4 6.53 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 124.347 1.059 . . . . 73.4 108.39 179.114 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 1.2 ppp? -58.49 -43.11 88.87 Favored 'General case' 0 C--N 1.34 0.161 0 C-N-CA 123.627 0.771 . . . . 74.25 109.737 -176.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -60.13 -40.01 88.27 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-O 118.464 -0.779 . . . . 64.23 112.133 -176.024 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -59.85 -59.38 5.52 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 123.906 0.883 . . . . 62.01 109.855 173.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -54.01 -34.0 58.7 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 118.038 0.381 . . . . 45.1 111.175 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 49.6 tttt -67.55 -59.67 3.17 Favored 'General case' 0 C--O 1.232 0.149 0 O-C-N 121.322 -0.861 . . . . 75.43 110.852 177.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.45 -24.28 64.7 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 118.452 0.569 . . . . 65.23 111.566 -174.686 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 32.6 mt -67.33 -53.16 32.05 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 118.52 -0.752 . . . . 75.34 110.203 170.543 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -53.92 -44.86 70.94 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 118.957 0.799 . . . . 71.42 112.291 -174.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 13.5 ptp -63.48 -46.9 84.03 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 119.423 -0.323 . . . . 53.12 111.551 176.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -58.87 -43.31 90.86 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 118.354 -0.831 . . . . 53.35 109.481 -179.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 18.1 m-85 -66.28 5.4 0.55 Allowed 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 115.078 1.511 . . . . 73.24 115.078 -175.096 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 59.2 mm-40 62.46 34.31 15.5 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 121.143 1.792 . . . . 71.41 113.198 176.39 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.818 HG22 ' NH2' ' A' ' 163' ' ' ARG . 57.5 t -80.5 -76.97 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 CA-C-O 118.415 -0.803 . . . . 73.35 111.18 -165.072 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . 0.26 1.6 p 54.59 -22.45 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 129.293 3.037 . . . . 62.31 118.18 -179.731 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.45 ' O ' HG13 ' A' ' 153' ' ' VAL . . . -99.45 -179.84 30.89 Favored Glycine 0 CA--C 1.532 1.102 0 CA-C-N 121.6 2.0 . . . . 43.55 111.807 168.467 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.45 HG13 ' O ' ' A' ' 152' ' ' GLY . 3.1 m -165.2 148.06 6.94 Favored Pre-proline 0 CA--C 1.547 0.865 0 C-N-CA 129.351 3.06 . . . . 75.33 108.033 167.808 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -67.34 142.35 62.2 Favored 'Cis proline' 0 N--CA 1.452 -0.923 0 CA-C-N 120.006 1.038 . . . . 71.32 110.543 -5.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . 0.5 ' CG2' ' HE ' ' A' ' 163' ' ' ARG . 25.3 m -147.07 133.4 19.56 Favored 'General case' 0 N--CA 1.447 -0.575 0 N-CA-C 107.979 -1.119 . . . . 65.34 107.979 -174.253 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 42.6 mmm -111.81 163.69 13.89 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.324 1.45 . . . . 53.01 109.434 176.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 38.7 t -142.32 151.67 18.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 C-N-CA 125.154 1.382 . . . . 61.21 107.528 168.744 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 60.5 t -118.61 125.46 74.41 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 C-N-CA 125.802 1.641 . . . . 74.15 106.966 166.614 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 14.9 m-20 55.15 10.99 0.47 Allowed 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 128.016 2.526 . . . . 65.21 115.926 172.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 82.59 12.57 79.99 Favored Glycine 0 CA--C 1.522 0.524 0 CA-C-O 117.921 -1.488 . . . . 22.2 113.45 -174.537 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 45.1 mttt -121.67 -52.34 2.02 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-N 119.083 1.441 . . . . 61.34 111.227 -166.645 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 74.6 m-85 -99.68 122.65 43.0 Favored 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 108.086 -1.079 . . . . 75.34 108.086 -179.52 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . 0.818 ' NH2' HG22 ' A' ' 150' ' ' VAL . 0.1 OUTLIER -92.46 133.42 35.93 Favored 'General case' 0 N--CA 1.446 -0.675 0 C-N-CA 126.888 2.075 . . . . 72.45 105.496 169.256 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 20.6 p90 -147.93 167.96 23.49 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.062 -1.088 . . . . 62.03 108.062 168.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -174.65 -179.41 1.49 Allowed 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 123.957 0.903 . . . . 63.54 108.921 178.191 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 13.5 mt -55.61 -45.07 78.75 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 C-N-CA 126.99 2.116 . . . . 71.14 108.408 176.022 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -61.69 -39.54 97.56 Favored Glycine 0 C--N 1.338 0.667 0 C-N-CA 124.154 0.883 . . . . 73.5 112.415 178.323 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 16.2 m -74.36 -56.79 4.47 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 118.678 1.239 . . . . 71.05 110.273 178.565 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -74.15 -33.19 63.43 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 125.201 1.401 . . . . 72.31 113.626 -163.127 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 147.4 -46.77 0.7 Allowed Glycine 0 CA--C 1.521 0.424 0 O-C-N 123.648 0.593 . . . . 62.3 112.259 -178.047 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 168.16 -174.19 43.0 Favored Glycine 0 CA--C 1.53 0.972 0 N-CA-C 109.209 -1.557 . . . . 75.22 109.209 -156.31 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -66.76 -55.59 0.32 Allowed 'Trans proline' 0 N--CA 1.452 -0.958 0 C-N-CA 122.618 2.212 . . . . 73.14 111.003 -170.319 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -60.46 -41.85 95.0 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 121.838 0.827 . . . . 75.23 109.58 179.35 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -56.48 -29.87 62.27 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 124.971 1.308 . . . . 71.32 111.864 179.498 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 89.5 m -67.04 -44.49 80.06 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-O 118.358 -0.829 . . . . 65.33 109.817 179.411 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 55.9 mt -60.52 -37.82 82.4 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 118.945 0.793 . . . . 74.23 109.682 175.264 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 8.7 ttpp -52.25 -39.89 60.95 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 117.626 -1.178 . . . . 74.24 110.326 175.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.441 HD21 ' HB3' ' A' ' 11' ' ' GLU . 4.5 mm? -79.16 -43.38 24.08 Favored 'General case' 0 C--N 1.346 0.454 0 CA-C-N 120.601 1.546 . . . . 75.41 111.869 172.071 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -51.54 -41.86 61.38 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 119.287 0.949 . . . . 45.44 111.818 -175.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -78.37 -38.91 40.74 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 124.801 1.24 . . . . 51.44 110.613 -172.286 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 24.1 t80 -64.46 -54.6 29.94 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 125.091 1.356 . . . . 62.12 110.444 174.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 87.6 mt -60.98 -23.24 65.2 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.251 1.02 . . . . 72.5 113.294 -174.697 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.466 HD13 HG21 ' A' ' 58' ' ' VAL . 23.7 mt -57.02 -59.89 2.63 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 CA-C-N 119.275 0.943 . . . . 55.53 108.816 170.339 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 10.6 tm-20 -56.87 -37.58 71.54 Favored 'General case' 0 C--O 1.227 -0.108 0 C-N-CA 124.581 1.152 . . . . 71.53 110.356 -177.519 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 12.8 tptt -53.14 -41.06 64.73 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 124.292 1.037 . . . . 72.42 111.863 -179.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 32.5 mm-40 -91.67 -41.76 10.55 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.036 0.934 . . . . 71.22 111.242 178.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.38 -35.68 78.16 Favored 'General case' 0 C--O 1.234 0.268 0 O-C-N 120.645 -1.284 . . . . 73.42 109.952 -175.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -58.24 -25.03 61.22 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 125.275 1.43 . . . . 71.11 112.045 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -59.0 -39.38 81.68 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 124.138 0.975 . . . . 75.35 110.653 177.546 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -138.91 52.08 1.79 Allowed 'General case' 0 C--O 1.233 0.209 0 C-N-CA 122.84 0.456 . . . . 74.33 109.915 -172.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 15.9 pttm -84.53 31.4 0.52 Allowed 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 125.193 1.397 . . . . 73.3 113.706 -165.4 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.252 1.204 0 C-N-CA 127.487 2.315 . . . . 74.14 110.819 -167.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.67 0 N-CA-C 109.816 -1.314 . . . . 31.12 109.816 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 66.08 -68.36 0.13 Allowed 'General case' 0 CA--C 1.503 -0.829 0 C-N-CA 128.641 2.777 . . . . 53.41 110.909 -173.352 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . 0.336 13.8 m-20 75.99 11.31 3.04 Favored 'General case' 0 N--CA 1.435 -1.21 0 C-N-CA 128.43 2.692 . . . . 73.13 116.222 168.378 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -142.82 172.2 13.02 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 126.758 2.023 . . . . 74.14 107.73 173.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 61.5 m -140.78 138.0 33.77 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.887 0.875 . . . . 64.42 109.462 178.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.04 144.75 57.07 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 122.132 0.968 . . . . 72.34 110.272 175.425 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 80.5 -36.75 2.24 Favored Glycine 0 CA--C 1.526 0.776 0 C-N-CA 126.64 2.067 . . . . 63.42 111.787 -167.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -84.0 -76.5 0.29 Allowed 'General case' 0 CA--C 1.515 -0.372 0 C-N-CA 124.774 1.23 . . . . 54.33 110.134 -165.452 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 15.8 mp0 -78.87 -24.87 44.02 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 124.929 1.292 . . . . 74.0 110.452 178.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 37.9 p90 -160.32 174.41 14.22 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 123.806 0.842 . . . . 74.31 109.726 -172.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 32.8 t -132.48 112.49 19.27 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 C-N-CA 123.797 0.839 . . . . 74.22 109.13 178.418 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -71.0 154.44 41.81 Favored 'General case' 0 C--O 1.235 0.33 0 O-C-N 120.89 -1.131 . . . . 72.31 109.155 162.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -124.31 113.85 18.78 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 124.476 1.11 . . . . 54.33 110.292 -173.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 59.3 p -69.66 13.34 0.14 Allowed 'General case' 0 C--O 1.236 0.379 0 C-N-CA 127.177 2.191 . . . . 70.12 114.278 -175.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 32.1 t -143.28 78.77 14.67 Favored Pre-proline 0 N--CA 1.454 -0.239 0 N-CA-C 108.085 -1.08 . . . . 74.41 108.085 165.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -67.22 -179.92 2.07 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 122.867 2.378 . . . . 64.21 111.922 -173.239 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 40.6 t -130.71 136.66 29.28 Favored Pre-proline 0 C--O 1.233 0.212 0 N-CA-C 107.073 -1.454 . . . . 72.12 107.073 179.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -79.27 173.71 12.93 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 121.836 1.69 . . . . 72.14 110.939 176.204 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 20.7 m -122.4 169.49 13.69 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 C-N-CA 125.09 1.356 . . . . 72.43 109.622 -178.183 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.1 t -47.74 -64.25 0.84 Allowed 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 126.406 1.882 . . . . 63.01 109.808 176.314 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -147.07 164.58 22.59 Favored Pre-proline 0 C--O 1.237 0.401 0 C-N-CA 123.931 0.893 . . . . 74.31 109.86 178.168 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_endo -66.3 176.07 4.35 Favored 'Trans proline' 0 N--CA 1.45 -1.04 0 C-N-CA 122.081 1.854 . . . . 64.15 111.066 163.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 129.39 -89.42 0.31 Allowed Glycine 0 N--CA 1.448 -0.559 0 N-CA-C 108.059 -2.016 . . . . 51.33 108.059 -178.029 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -85.21 163.53 18.64 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 117.919 0.86 . . . . 60.11 109.322 -179.085 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 46.9 mm -77.13 137.51 22.3 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 N-CA-C 105.204 -2.147 . . . . 73.44 105.204 158.125 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -99.3 118.0 35.0 Favored 'General case' 0 N--CA 1.445 -0.725 0 N-CA-C 105.859 -1.904 . . . . 72.41 105.859 -179.442 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 60.2 t -121.64 131.81 72.22 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 N-CA-C 106.723 -1.584 . . . . 74.22 106.723 -179.091 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 43.2 t -127.09 138.72 54.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 106.241 -1.763 . . . . 72.02 106.241 -175.22 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -106.32 137.74 43.74 Favored 'General case' 0 C--O 1.239 0.525 0 N-CA-C 106.655 -1.609 . . . . 65.25 106.655 158.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 5.3 mp -115.69 137.21 52.31 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 107.455 -1.313 . . . . 74.12 107.455 163.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 31.3 p90 -141.44 169.01 18.41 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 124.122 0.969 . . . . 71.11 110.034 -172.101 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . 0.5 ' HB3' HG21 ' A' ' 153' ' ' VAL . 29.7 t90 -155.11 153.21 30.49 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 123.663 0.785 . . . . 63.11 109.464 179.313 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 56.2 t80 -44.08 -51.26 8.08 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 129.366 3.067 . . . . 75.43 113.84 -172.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -72.05 -90.49 0.11 Allowed Glycine 0 C--N 1.339 0.705 0 N-CA-C 110.944 -0.862 . . . . 71.24 110.944 -171.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 34.4 t 43.51 68.92 2.63 Favored Pre-proline 0 CA--C 1.546 0.797 0 C-N-CA 125.283 1.433 . . . . 74.54 113.824 163.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -63.53 -14.87 45.1 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 122.743 2.295 . . . . 73.31 114.126 -176.415 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 20.3 m170 -84.24 -22.85 30.68 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 119.856 1.207 . . . . 75.24 112.537 172.07 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 60.4 m -62.65 -48.73 78.06 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 120.284 1.402 . . . . 72.13 110.619 -174.105 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 45.4 t80 -61.75 -27.55 68.81 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 120.554 -1.341 . . . . 71.55 112.23 -175.595 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.26 -6.58 40.81 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.558 0.743 . . . . 73.15 112.73 177.285 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.403 ' CB ' HD11 ' A' ' 166' ' ' ILE . 26.8 t80 -123.64 -13.93 7.39 Favored 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 126.387 1.875 . . . . 73.13 111.594 -175.52 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 67.0 tt0 -50.73 -64.64 1.22 Allowed Pre-proline 0 CA--C 1.536 0.433 0 CA-C-N 119.813 1.188 . . . . 72.14 111.512 -178.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -74.96 -4.77 15.91 Favored 'Trans proline' 0 N--CA 1.453 -0.881 0 CA-C-N 120.831 1.333 . . . . 62.04 114.294 -175.659 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.5 m -70.15 -47.25 62.49 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 107.892 -1.151 . . . . 54.31 107.892 163.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 19.3 tt -96.8 -28.5 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 N-CA-C 113.704 1.001 . . . . 65.14 113.704 -165.627 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 74.0 t -54.19 -55.97 31.08 Favored Pre-proline 0 CA--C 1.545 0.772 0 CA-C-N 119.64 1.109 . . . . 75.3 111.314 173.457 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -68.14 -24.93 37.88 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 CA-C-N 120.85 1.339 . . . . 61.05 111.794 -179.006 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 77.8 t90 -62.38 -55.18 30.39 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 119.274 0.943 . . . . 75.04 109.008 170.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.5 p -61.01 -41.95 97.52 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 123.704 0.802 . . . . 55.12 112.555 -173.248 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -62.63 -39.86 95.14 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 119.282 0.946 . . . . 73.11 110.886 175.619 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 8.0 mptt -90.88 20.06 5.1 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 113.543 0.942 . . . . 74.41 113.543 -170.618 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 32.1 mt -65.71 164.85 23.23 Favored Pre-proline 0 CA--C 1.543 0.674 0 C-N-CA 126.421 1.888 . . . . 70.31 111.75 175.081 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -83.7 174.45 8.65 Favored 'Trans proline' 0 N--CA 1.454 -0.838 1 C-N-CA 125.64 4.226 . . . . 61.22 110.933 174.203 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -71.24 -10.26 59.47 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 113.829 1.048 . . . . 72.41 113.829 -176.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -103.61 5.79 36.76 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 119.364 0.984 . . . . 72.11 112.074 -170.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 87.6 t -117.42 152.61 19.29 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 C-N-CA 124.9 1.28 . . . . 73.2 107.793 -178.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 22.6 t-160 -136.78 92.91 2.79 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 126.486 1.914 . . . . 64.31 106.651 178.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -79.78 132.67 36.21 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 124.488 1.115 . . . . 74.34 109.692 173.466 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 23.4 t -136.51 158.62 37.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 C-N-CA 125.453 1.501 . . . . 74.34 107.76 -179.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.405 HH11 ' CG ' ' A' ' 91' ' ' HIS . 55.7 mtp180 -131.41 128.42 39.51 Favored 'General case' 0 CA--C 1.506 -0.718 0 N-CA-C 106.897 -1.52 . . . . 73.41 106.897 179.487 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 70.1 mt -127.44 153.2 77.29 Favored Pre-proline 0 N--CA 1.464 0.267 0 O-C-N 123.379 0.425 . . . . 73.51 111.082 173.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -75.42 134.14 16.79 Favored 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 122.371 2.047 . . . . 65.22 111.209 179.019 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -75.0 95.78 3.07 Favored 'General case' 0 CA--C 1.54 0.562 0 O-C-N 121.038 -1.039 . . . . 73.21 111.598 176.241 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 20.0 mt -88.6 95.38 10.22 Favored 'General case' 0 CA--C 1.541 0.62 0 O-C-N 120.42 -1.425 . . . . 73.53 111.188 -177.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -133.83 5.33 3.63 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 116.027 1.862 . . . . 64.32 116.027 -173.342 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -154.33 -143.62 3.72 Favored Glycine 0 C--N 1.336 0.573 0 CA-C-N 119.039 0.836 . . . . 50.04 114.269 -166.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -89.96 -85.58 1.34 Allowed Glycine 0 CA--C 1.524 0.607 0 N-CA-C 106.887 -2.485 . . . . 73.04 106.887 155.242 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.2 tt -58.61 -25.23 27.73 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 N-CA-C 113.133 0.79 . . . . 70.04 113.133 -168.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . 0.401 ' HA ' ' CD1' ' A' ' 34' ' ' TRP . 10.8 m95 -54.55 -40.7 68.96 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 123.891 0.876 . . . . 74.22 112.214 175.137 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 17.2 p30 -91.73 -27.32 18.12 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 112.892 0.701 . . . . 53.43 112.892 179.034 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 39.4 t -64.71 -41.59 92.64 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-N 118.536 0.607 . . . . 65.23 109.578 174.095 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 66.6 m170 -79.14 7.08 8.12 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.821 1.248 . . . . 73.2 112.327 170.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -103.08 -37.55 3.1 Favored Glycine 0 CA--C 1.525 0.69 0 O-C-N 120.989 -1.069 . . . . 75.14 111.594 -179.548 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -65.12 -25.6 67.83 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 114.456 1.28 . . . . 74.5 114.456 -165.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 6.6 ttt -62.95 -43.02 99.94 Favored 'General case' 0 N--CA 1.463 0.191 0 O-C-N 120.926 -1.109 . . . . 62.35 112.055 -175.262 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -51.29 -52.85 41.38 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 125.011 1.324 . . . . 75.3 108.367 -176.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 13.7 mt -63.37 -39.56 94.87 Favored 'General case' 0 C--O 1.226 -0.182 0 C-N-CA 124.451 1.1 . . . . 70.43 110.122 -178.296 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.467 HG23 HG23 ' A' ' 128' ' ' THR . 1.4 m -66.71 -38.38 86.6 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 118.873 0.761 . . . . 70.5 109.775 -178.048 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.48 -60.13 4.11 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 124.063 0.945 . . . . 72.1 108.535 177.478 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -60.84 -25.03 66.34 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 124.166 0.986 . . . . 75.11 112.686 -177.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -62.98 -5.62 3.11 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.885 1.674 . . . . 71.04 114.566 176.406 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 29.5 mtm -100.2 -1.47 36.43 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 115.047 1.499 . . . . 33.43 115.047 165.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 80.41 17.76 72.91 Favored Glycine 0 CA--C 1.529 0.968 0 O-C-N 121.606 -0.684 . . . . 72.3 112.386 175.474 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 27.5 m -70.92 60.32 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.95 0 C-N-CA 126.907 2.083 . . . . 73.35 113.008 -178.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 57.9 -173.41 0.09 Allowed 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 124.947 1.299 . . . . 62.12 109.772 -156.003 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 31.7 m80 -142.62 30.44 1.51 Allowed 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 125.365 1.466 . . . . 73.41 108.81 165.49 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -126.24 -56.82 1.42 Allowed 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.699 1.2 . . . . 64.52 111.8 -167.188 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.1 p -58.62 126.96 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 C-N-CA 127.029 2.131 . . . . 74.51 112.054 -175.105 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . 0.405 ' CG ' HH11 ' A' ' 62' ' ' ARG . 4.4 p80 -146.22 65.55 1.2 Allowed 'General case' 0 C--O 1.233 0.229 0 CA-C-O 121.943 0.877 . . . . 74.33 112.643 173.766 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -91.92 -73.54 0.54 Allowed 'General case' 0 C--O 1.224 -0.271 0 N-CA-C 108.639 -0.875 . . . . 72.24 108.639 161.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -65.62 -22.06 66.63 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 114.384 1.253 . . . . 64.12 114.384 -159.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 56.2 t -62.93 -61.45 1.65 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.189 0 N-CA-C 108.079 -1.082 . . . . 55.42 108.079 172.02 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -62.84 -42.2 99.64 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 125.29 1.436 . . . . 74.12 110.636 -178.361 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -71.66 3.66 3.85 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 124.828 1.251 . . . . 65.54 112.351 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -115.52 5.08 14.35 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 115.658 1.725 . . . . 52.3 115.658 164.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 13.6 mt -117.21 -51.13 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 CA-C-N 120.476 1.489 . . . . 61.11 108.732 177.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 88.2 m-70 -63.97 -83.04 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 126.025 1.73 . . . . 72.22 113.231 -179.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.64 -16.71 64.3 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 126.711 2.004 . . . . 65.41 114.606 -177.452 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -97.17 -32.91 11.7 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 124.572 1.149 . . . . 74.43 111.64 178.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 1.8 t-160 50.38 36.37 12.97 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 125.572 1.549 . . . . 75.32 112.924 173.424 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.453 ' HG2' ' H ' ' A' ' 103' ' ' LYS . 0.1 OUTLIER -71.35 164.76 25.12 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 124.039 0.936 . . . . 73.41 108.784 168.959 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 10.2 mtpt -61.82 -72.11 0.13 Allowed 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 124.94 1.296 . . . . 73.12 109.433 172.602 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.418 HD21 ' HE3' ' A' ' 103' ' ' LYS . 77.2 mt 50.91 54.52 11.09 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 124.707 1.203 . . . . 72.04 111.455 -172.316 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -109.81 1.36 19.27 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.666 1.586 . . . . 65.31 113.326 -170.231 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -147.22 156.49 46.49 Favored Pre-proline 0 C--O 1.234 0.287 0 C-N-CA 126.948 2.099 . . . . 32.35 109.63 -167.448 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -70.99 -38.19 5.4 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 122.759 2.306 . . . . 62.12 110.927 -170.119 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -62.2 -48.93 77.81 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 109.022 -0.732 . . . . 61.04 109.022 172.037 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -58.45 -39.74 80.7 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 124.853 1.261 . . . . 62.13 111.737 -171.227 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 59.3 mtm -78.0 -50.23 12.53 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 124.523 1.129 . . . . 54.31 111.336 174.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.403 ' HB1' ' HG3' ' A' ' 122' ' ' LYS . . . -64.42 -39.53 94.02 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 119.05 0.841 . . . . 43.32 110.93 -173.63 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -71.03 -22.5 62.14 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 123.764 0.826 . . . . 73.33 111.509 -179.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 91.4 t80 -73.29 -51.46 17.51 Favored 'General case' 0 N--CA 1.45 -0.473 0 O-C-N 121.495 -0.753 . . . . 64.13 109.631 170.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 68.2 mt -69.83 -17.7 63.4 Favored 'General case' 0 N--CA 1.452 -0.351 0 O-C-N 121.728 -0.608 . . . . 72.13 111.337 -175.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -55.9 -18.09 8.1 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.91 0.884 . . . . 71.51 111.563 167.468 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -98.51 3.75 59.59 Favored Glycine 0 CA--C 1.527 0.803 0 CA-C-O 117.416 -1.769 . . . . 54.31 114.835 171.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.547 ' HA ' ' HE2' ' A' ' 118' ' ' LYS . 7.7 mmpt? -125.85 13.66 7.96 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 120.654 2.227 . . . . 70.42 113.123 -169.375 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 87.23 26.62 30.34 Favored Glycine 0 CA--C 1.522 0.517 0 CA-C-N 118.836 0.744 . . . . 61.52 112.526 -179.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 76.2 t -112.07 136.76 47.25 Favored 'Isoleucine or valine' 0 C--O 1.24 0.605 0 C-N-CA 125.648 1.579 . . . . 75.02 107.186 175.276 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 32.0 t0 -85.53 116.28 23.74 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 108.551 -0.907 . . . . 61.22 108.551 171.422 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.403 ' HG3' ' HB1' ' A' ' 112' ' ' ALA . 3.1 tttm -52.77 -48.08 67.06 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 125.638 1.575 . . . . 53.33 109.437 177.746 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -65.6 -22.72 66.7 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 113.078 0.77 . . . . 73.2 113.078 -175.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 49.4 mmtt -82.9 -50.74 8.29 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 107.673 -1.232 . . . . 64.3 107.673 175.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -49.08 -62.0 1.77 Allowed 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 125.648 1.579 . . . . 74.13 109.729 -179.14 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 20.5 mt -62.93 -39.27 94.09 Favored 'General case' 0 C--O 1.233 0.213 0 C-N-CA 122.744 0.417 . . . . 52.21 110.889 -174.419 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 39.5 t -57.17 -50.95 71.23 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 123.145 0.578 . . . . 73.12 109.919 -177.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . 0.467 HG23 HG23 ' A' ' 80' ' ' THR . 2.6 t -81.35 -33.14 32.61 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 119.184 -0.436 . . . . 72.22 110.761 -175.453 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 82.3 t80 -50.35 -52.39 37.51 Favored 'General case' 0 C--N 1.344 0.34 0 C-N-CA 124.719 1.207 . . . . 72.22 109.467 172.199 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -90.39 55.56 3.08 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 124.265 1.026 . . . . 75.4 109.495 174.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 22.7 t -140.64 162.2 35.94 Favored 'General case' 0 C--O 1.234 0.258 0 O-C-N 121.083 -1.011 . . . . 62.25 110.795 172.613 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -58.08 -26.97 63.22 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.733 1.213 . . . . 71.44 110.673 168.506 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -53.31 -59.27 4.79 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 124.492 1.117 . . . . 63.23 111.218 179.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 41.7 mm -69.06 -26.3 31.89 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 C-N-CA 123.266 0.626 . . . . 63.34 110.355 178.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 17.7 tttt -58.37 -36.32 73.31 Favored 'General case' 0 CA--C 1.522 -0.1 0 O-C-N 121.35 -0.844 . . . . 73.1 111.008 175.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -63.3 -46.1 93.64 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 110.665 -0.974 . . . . 72.34 110.665 178.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -66.04 -44.84 83.47 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 123.196 0.599 . . . . 53.12 110.008 -179.16 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 94.9 mmm -57.32 -47.84 80.5 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 118.595 -0.717 . . . . 63.02 109.948 176.231 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -65.87 -40.92 92.07 Favored 'General case' 0 N--CA 1.457 -0.098 0 CA-C-N 119.573 1.079 . . . . 71.11 112.126 -175.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 11.2 mtpt -60.13 -58.13 9.87 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-O 118.242 -0.885 . . . . 74.23 109.579 176.27 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -53.64 -39.8 65.29 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 119.137 0.88 . . . . 75.43 110.762 178.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 25.7 ttmt -60.97 -63.07 1.42 Allowed 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.128 0.971 . . . . 64.44 110.481 178.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 16.6 ptmt -64.89 -24.01 67.4 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 123.463 0.705 . . . . 62.22 111.0 -176.041 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.427 HD23 ' HA ' ' A' ' 144' ' ' LEU . 41.7 mt -75.77 -53.76 8.0 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 118.637 -0.697 . . . . 54.32 111.055 175.554 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -52.57 -54.28 35.02 Favored 'General case' 0 C--O 1.228 -0.04 0 C-N-CA 123.865 0.866 . . . . 53.12 110.52 -173.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 3.9 ppp? -55.37 -47.06 76.38 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 113.23 0.826 . . . . 60.31 113.23 177.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -69.11 -29.85 68.01 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-O 118.093 -0.956 . . . . 64.51 110.291 -176.157 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 23.5 m-85 -71.81 16.29 0.12 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.241 1.416 . . . . 75.42 113.431 173.355 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 16.8 mm-40 63.31 17.54 10.33 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.062 1.345 . . . . 74.11 112.724 174.282 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 59.1 t -65.84 90.88 0.11 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.376 0 C-N-CA 125.712 1.605 . . . . 72.53 109.379 -174.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -95.97 88.59 4.94 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-O 123.137 1.446 . . . . 71.34 108.237 161.843 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 104.65 -162.5 14.85 Favored Glycine 0 N--CA 1.445 -0.712 0 CA-C-N 112.645 -2.07 . . . . 73.3 111.818 164.404 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.5 HG21 ' HB3' ' A' ' 34' ' ' TRP . 16.6 m -144.38 155.48 57.5 Favored Pre-proline 0 CA--C 1.539 0.524 0 C-N-CA 126.314 1.846 . . . . 74.15 107.37 178.092 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_endo -64.76 160.15 70.4 Favored 'Cis proline' 0 CA--C 1.54 0.823 0 C-N-CA 124.195 -1.169 . . . . 75.44 110.465 -12.093 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 5.4 m -153.42 108.12 3.14 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 123.686 0.795 . . . . 65.21 109.575 -179.616 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 50.7 mmm -93.87 153.44 18.25 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 124.288 1.035 . . . . 74.23 109.946 169.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 94.2 t -145.21 155.04 13.73 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 C-N-CA 125.102 1.361 . . . . 74.5 107.393 175.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 50.6 t -126.25 123.95 64.7 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 C-N-CA 127.783 2.433 . . . . 73.44 107.164 177.288 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 15.9 m-20 52.23 18.44 0.88 Allowed 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 129.294 3.038 . . . . 70.51 114.685 174.286 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 62.89 31.34 80.16 Favored Glycine 0 CA--C 1.532 1.152 0 CA-C-O 118.025 -1.431 . . . . 73.24 113.92 -169.288 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 9.2 mtpt -133.87 -28.15 1.41 Allowed 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 119.863 1.831 . . . . 72.21 113.334 -175.506 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -125.83 129.05 48.63 Favored 'General case' 0 CA--C 1.512 -0.5 0 N-CA-C 107.7 -1.222 . . . . 72.43 107.7 177.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 2.4 ttp85 -114.73 134.96 54.68 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 127.124 2.169 . . . . 74.41 105.787 179.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 28.2 p90 -151.22 167.26 28.34 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.988 -0.745 . . . . 70.4 108.988 -179.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -176.03 178.25 1.48 Allowed 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.269 1.028 . . . . 74.11 109.896 -178.175 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.403 HD11 ' CB ' ' A' ' 43' ' ' PHE . 38.1 mt -52.18 -42.23 35.51 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 C-N-CA 126.482 1.913 . . . . 53.13 110.459 178.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -80.25 -21.58 64.68 Favored Glycine 0 CA--C 1.526 0.722 0 CA-C-O 118.646 -1.086 . . . . 72.11 112.56 -179.407 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 1.1 m -72.83 -63.91 1.07 Allowed 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 119.716 1.758 . . . . 65.13 107.484 170.359 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -64.33 -38.59 91.56 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 123.907 0.883 . . . . 64.15 111.065 -168.568 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 121.06 -3.87 11.46 Favored Glycine 0 CA--C 1.525 0.674 0 CA-C-O 118.268 -1.295 . . . . 60.33 112.872 175.061 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 175.74 172.65 40.75 Favored Glycine 0 CA--C 1.528 0.852 0 CA-C-N 119.364 1.582 . . . . 71.03 110.231 -175.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -65.74 -44.68 7.69 Favored 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 122.524 2.149 . . . . 60.22 109.82 -177.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -63.64 -38.28 90.52 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-O 122.228 1.013 . . . . 74.41 110.467 -176.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -68.0 -29.18 68.13 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 126.291 1.836 . . . . 63.24 109.433 -176.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 35.9 m -64.85 -45.09 87.57 Favored 'General case' 0 CA--C 1.533 0.325 0 O-C-N 121.082 -1.011 . . . . 75.31 110.069 -176.229 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 46.0 mt -63.97 -32.05 73.45 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 118.799 0.727 . . . . 73.54 110.784 177.542 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 1.9 ttmt -55.41 -38.89 69.53 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 124.31 1.044 . . . . 64.11 110.148 175.258 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.433 HD13 ' HA ' ' A' ' 178' ' ' LEU . 4.5 mm? -76.47 -41.58 46.71 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-O 118.136 -0.935 . . . . 74.13 110.552 174.174 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -52.67 -50.36 63.4 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 119.325 0.966 . . . . 70.31 112.025 -175.442 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -72.12 -42.19 66.33 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 123.323 0.649 . . . . 53.14 109.347 -173.144 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 10.9 t80 -63.0 -46.38 87.94 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 124.468 1.107 . . . . 74.02 111.158 178.255 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 81.3 mt -67.69 -34.17 76.38 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 123.649 0.78 . . . . 73.22 111.024 -178.381 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 29.5 mt -53.75 -55.82 11.86 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 N-CA-C 107.995 -1.113 . . . . 71.53 107.995 166.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -56.63 -31.91 64.8 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.979 0.912 . . . . 72.35 112.863 -177.689 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 9.3 tptm -68.83 -48.21 64.1 Favored 'General case' 0 N--CA 1.463 0.209 0 O-C-N 121.401 -0.812 . . . . 63.41 110.535 -179.305 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 35.6 mm-40 -74.75 -42.47 58.18 Favored 'General case' 0 C--O 1.222 -0.367 0 O-C-N 121.955 -0.466 . . . . 63.2 111.228 178.508 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.05 -34.28 74.64 Favored 'General case' 0 N--CA 1.465 0.288 0 O-C-N 121.073 -1.017 . . . . 74.43 110.739 -176.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -64.65 -11.83 39.53 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.56 0.744 . . . . 65.05 112.378 175.355 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -64.09 -25.78 68.25 Favored 'General case' 0 C--O 1.223 -0.316 0 CA-C-N 119.446 1.021 . . . . 31.32 111.65 168.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . 58.55 6.58 0.6 Allowed 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 127.107 2.163 . . . . 53.41 113.877 -177.414 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 50.79 53.89 12.19 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.733 1.613 . . . . 74.44 111.461 -158.586 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 11.9 pttp . . . . . 0 C--O 1.247 0.966 0 CA-C-O 117.328 -1.32 . . . . 73.44 109.282 173.554 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.459 0.23 0 N-CA-C 109.235 -1.546 . . . . 62.14 109.235 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 45.21 73.67 0.15 Allowed 'General case' 0 CA--C 1.515 -0.391 0 C-N-CA 127.148 2.179 . . . . 64.51 110.316 -175.442 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -73.26 11.95 0.66 Allowed 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 127.096 2.158 . . . . 72.12 113.025 -179.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 14.4 m-85 -146.43 157.74 43.8 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 126.01 1.724 . . . . 75.02 108.056 -175.19 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.9 m -131.23 132.8 44.89 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 107.671 -1.233 . . . . 73.51 107.671 -174.328 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -69.61 148.45 49.34 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 108.158 -1.052 . . . . 60.0 108.158 175.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 63.69 13.61 52.04 Favored Glycine 0 CA--C 1.535 1.308 0 C-N-CA 124.68 1.134 . . . . 65.34 113.445 -167.02 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.94 -63.06 0.98 Allowed 'General case' 0 CA--C 1.52 -0.208 0 CA-C-N 119.775 1.788 . . . . 73.54 107.804 -177.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.432 ' HB3' HD21 ' A' ' 178' ' ' LEU . 12.4 mp0 -98.44 -25.91 14.63 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.342 1.457 . . . . 71.11 110.505 178.109 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 50.6 p90 -154.56 167.12 31.16 Favored 'General case' 0 N--CA 1.467 0.41 0 O-C-N 121.238 -0.914 . . . . 73.32 111.697 -171.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 59.2 t -132.9 115.91 25.37 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 C-N-CA 124.859 1.263 . . . . 74.14 109.058 -171.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -80.43 167.3 20.35 Favored 'General case' 0 C--O 1.236 0.392 0 O-C-N 119.972 -1.705 . . . . 72.32 110.478 174.301 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -126.16 124.64 40.96 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 124.237 1.015 . . . . 72.2 108.88 172.694 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 8.2 m -67.34 -9.45 41.32 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.838 0.855 . . . . 34.11 113.163 179.296 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 30.2 m -129.32 74.47 80.96 Favored Pre-proline 0 CA--C 1.537 0.454 0 C-N-CA 124.224 1.01 . . . . 52.34 108.625 -177.009 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -69.56 -179.01 2.53 Favored 'Trans proline' 0 N--CA 1.46 -0.459 0 C-N-CA 125.056 3.837 . . . . 73.3 112.281 -172.12 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.2 t -128.68 138.93 34.18 Favored Pre-proline 0 CA--C 1.532 0.27 0 C-N-CA 124.672 1.189 . . . . 72.11 107.93 -174.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_endo -73.13 179.1 5.74 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 122.42 2.08 . . . . 72.32 112.613 176.286 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.4 m -127.46 168.25 20.9 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 C-N-CA 126.826 2.051 . . . . 71.51 108.945 174.028 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 70.9 m -47.01 -61.84 1.69 Allowed 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 126.795 2.038 . . . . 62.4 110.508 176.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -145.82 165.38 21.17 Favored Pre-proline 0 C--O 1.238 0.492 0 C-N-CA 127.347 2.259 . . . . 73.03 105.375 163.079 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -70.88 -164.66 0.15 Allowed 'Trans proline' 0 CA--C 1.541 0.862 0 C-N-CA 122.62 2.213 . . . . 73.22 110.222 173.325 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 118.1 -112.68 2.45 Favored Glycine 0 N--CA 1.447 -0.627 0 N-CA-C 106.301 -2.72 . . . . 72.45 106.301 -179.388 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 33.4 mttm -54.46 133.69 45.81 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 124.136 0.974 . . . . 65.45 108.721 172.177 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.424 HD12 ' HB3' ' A' ' 186' ' ' GLU . 31.8 mm -64.59 140.72 19.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 106.377 -1.712 . . . . 72.41 106.377 169.541 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -99.21 139.17 35.26 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 107.559 -1.274 . . . . 74.32 107.559 -177.65 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 56.1 t -128.54 130.43 69.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 105.895 -1.891 . . . . 53.33 105.895 176.684 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 11.3 t -131.2 108.05 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 N-CA-C 107.417 -1.327 . . . . 63.32 107.417 -172.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -69.0 143.34 54.38 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 124.27 1.028 . . . . 64.31 108.556 162.26 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.521 ' CD2' HG21 ' A' ' 150' ' ' VAL . 5.0 mp -121.75 131.08 53.88 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 108.881 -0.785 . . . . 73.2 108.881 158.416 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 23.9 p90 -127.33 176.77 7.18 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.477 1.111 . . . . 64.42 110.469 179.249 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 27.1 t90 -151.0 175.8 11.73 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.082 1.353 . . . . 75.02 109.559 174.551 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 40.2 t80 -61.5 -73.18 0.1 Allowed 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.616 1.166 . . . . 74.24 112.876 172.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -81.86 52.03 4.53 Favored Glycine 0 C--N 1.339 0.705 0 C-N-CA 124.823 1.201 . . . . 44.4 110.358 -171.123 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 35.8 t -113.5 84.81 8.25 Favored Pre-proline 0 CA--C 1.538 0.487 0 C-N-CA 127.462 2.305 . . . . 72.44 106.051 -163.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -72.57 168.56 24.08 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 123.314 2.676 . . . . 61.33 109.217 171.228 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 5.2 m170 63.98 -45.7 0.27 Allowed 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 126.476 1.91 . . . . 73.42 112.116 -165.007 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 3.8 m -46.74 -53.14 12.43 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 126.745 2.018 . . . . 75.15 110.604 176.425 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 11.7 t80 -58.92 -49.92 75.99 Favored 'General case' 0 C--N 1.341 0.229 0 C-N-CA 125.361 1.464 . . . . 72.12 110.894 176.51 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.76 -13.52 61.51 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 112.742 0.645 . . . . 55.02 112.742 -171.356 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 7.0 t80 -90.71 -16.85 27.76 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 125.714 1.605 . . . . 71.51 112.073 179.262 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -46.68 -67.27 0.4 Allowed Pre-proline 0 N--CA 1.469 0.485 0 CA-C-N 120.059 1.299 . . . . 73.24 112.566 -172.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -69.02 -9.13 25.52 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 CA-C-N 122.033 1.762 . . . . 75.24 114.496 -177.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.9 m -70.91 -43.18 68.83 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 119.758 1.163 . . . . 65.52 108.798 167.167 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 21.1 tt -105.2 -28.51 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 N-CA-C 113.825 1.046 . . . . 64.34 113.825 -164.504 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 27.5 t -46.37 -60.4 3.72 Favored Pre-proline 0 CA--C 1.54 0.559 0 C-N-CA 124.794 1.238 . . . . 61.33 109.434 173.438 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -61.85 -35.31 79.16 Favored 'Trans proline' 0 N--CA 1.453 -0.883 0 CA-C-N 120.31 1.146 . . . . 64.13 112.974 -177.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.403 ' CZ2' ' HB1' ' A' ' 179' ' ' ALA . 72.8 t90 -57.24 -51.62 68.61 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.367 0.667 . . . . 74.3 110.402 179.557 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 29.5 t -58.89 -39.18 80.69 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 121.132 0.491 . . . . 72.02 110.269 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -68.92 -25.55 64.64 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 121.173 -0.954 . . . . 72.51 111.407 -177.429 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 14.3 mmtp -96.72 10.08 39.79 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.576 1.15 . . . . 75.43 112.879 177.477 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 34.9 mt -60.88 151.23 74.44 Favored Pre-proline 0 C--O 1.237 0.395 0 CA-C-N 119.532 1.06 . . . . 75.23 110.964 174.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -76.07 169.69 21.58 Favored 'Trans proline' 0 N--CA 1.445 -1.378 0 C-N-CA 124.065 3.177 . . . . 64.21 110.485 177.533 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -65.13 -4.19 4.64 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 125.044 1.338 . . . . 74.52 113.391 173.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -100.68 8.4 43.36 Favored 'General case' 0 N--CA 1.463 0.182 0 C-N-CA 125.709 1.603 . . . . 75.21 110.597 -177.056 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 61.0 t -129.53 160.03 40.93 Favored 'Isoleucine or valine' 0 C--O 1.239 0.542 0 O-C-N 121.214 -0.929 . . . . 51.45 108.798 -179.651 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 29.2 t60 -132.93 155.39 49.17 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 126.268 1.827 . . . . 52.32 107.249 165.53 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 55.7 t80 -132.5 134.01 44.49 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 108.102 -1.073 . . . . 71.22 108.102 -175.104 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 47.6 t -135.31 155.38 37.2 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 C-N-CA 126.551 1.941 . . . . 71.13 107.264 -172.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 16.4 mtt85 -133.2 130.32 38.94 Favored 'General case' 0 CA--C 1.513 -0.46 0 N-CA-C 105.197 -2.149 . . . . 72.25 105.197 176.284 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 37.6 mt -135.58 144.74 50.45 Favored Pre-proline 0 N--CA 1.469 0.514 0 CA-C-N 120.113 1.324 . . . . 71.45 110.082 175.502 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -74.89 157.45 43.21 Favored 'Trans proline' 0 N--CA 1.462 -0.353 0 C-N-CA 122.379 2.053 . . . . 73.21 110.728 -179.414 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -101.04 94.55 6.05 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 123.984 0.914 . . . . 55.01 110.12 -175.463 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 22.5 mt -86.43 76.75 9.58 Favored 'General case' 0 CA--C 1.539 0.54 0 O-C-N 120.612 -1.305 . . . . 73.1 111.869 -172.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -82.49 20.2 1.14 Allowed 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 115.129 1.529 . . . . 75.44 115.129 -176.156 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 89.01 -48.09 3.43 Favored Glycine 0 CA--C 1.525 0.704 0 O-C-N 119.924 -1.735 . . . . 34.53 112.834 168.214 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -72.55 -152.11 1.58 Allowed Glycine 0 CA--C 1.529 0.958 0 C-N-CA 124.337 0.97 . . . . 71.31 110.737 174.699 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 7.1 tp -46.75 -30.88 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 C-N-CA 124.1 0.96 . . . . 75.33 112.055 177.371 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 19.4 m95 -50.31 -27.47 6.23 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 126.069 1.748 . . . . 73.03 113.391 177.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 20.2 m-20 -73.91 -36.42 64.72 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-N 119.576 1.08 . . . . 75.04 110.496 177.153 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.401 ' C ' ' H ' ' A' ' 75' ' ' GLY . 40.7 t -73.82 -55.19 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 N-CA-C 107.966 -1.124 . . . . 73.31 107.966 174.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 34.9 m170 -65.95 31.92 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 129.534 3.134 . . . . 72.24 112.175 170.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.401 ' H ' ' C ' ' A' ' 73' ' ' VAL . . . -149.21 -42.55 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 125.353 1.454 . . . . 35.1 111.191 173.122 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -54.6 -41.84 70.42 Favored 'General case' 0 C--O 1.223 -0.328 0 CA-C-O 117.753 -1.118 . . . . 74.11 112.439 -175.06 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -44.47 -44.34 8.47 Favored 'General case' 0 CA--C 1.514 -0.407 0 N-CA-C 114.123 1.157 . . . . 71.22 114.123 -173.303 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 28.8 t80 -61.88 -45.76 92.34 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 118.525 0.602 . . . . 72.54 110.236 -176.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 50.0 mt -61.35 -45.24 95.22 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-O 116.726 -1.606 . . . . 61.33 109.251 175.415 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -62.41 -45.68 92.03 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 120.652 1.569 . . . . 61.5 110.776 -176.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.82 -60.6 2.99 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 125.998 1.719 . . . . 65.35 109.469 178.495 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -69.75 -28.92 66.18 Favored 'General case' 0 C--O 1.231 0.095 0 CA-C-O 118.927 -0.558 . . . . 64.23 111.76 -175.21 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 6.2 t -51.67 -37.16 49.33 Favored 'General case' 0 CA--C 1.52 -0.184 0 C-N-CA 124.343 1.057 . . . . 71.52 110.712 178.091 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 30.8 mtp -75.84 -22.47 56.23 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-O 118.762 -0.637 . . . . 62.01 111.696 -170.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 88.39 14.46 61.86 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 123.9 0.762 . . . . 34.14 112.982 -179.092 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 28.4 m -62.29 130.2 26.41 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 C-N-CA 125.046 1.339 . . . . 71.43 109.312 179.158 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -123.47 75.88 1.36 Allowed 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 123.577 0.751 . . . . 63.21 109.021 -165.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -79.16 -5.46 54.25 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 117.099 2.259 . . . . 75.23 117.099 -170.437 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 44.38 51.96 7.51 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 126.331 1.852 . . . . 73.24 112.109 -176.207 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.5 p -144.95 -47.25 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 CA-C-O 117.474 -1.251 . . . . 44.22 113.381 176.297 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 44.92 34.78 1.31 Allowed 'General case' 0 N--CA 1.478 0.945 0 CA-C-N 120.607 1.548 . . . . 64.12 113.138 -176.738 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -136.37 -44.54 0.62 Allowed 'General case' 0 C--O 1.221 -0.421 0 O-C-N 120.815 -1.178 . . . . 64.22 108.887 172.557 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -61.11 -16.51 44.97 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 114.533 1.308 . . . . 62.14 114.533 -176.631 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 55.8 t -71.49 -65.63 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 CA-C-O 117.575 -1.203 . . . . 54.43 108.614 166.241 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -54.61 -46.78 73.89 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 120.387 1.449 . . . . 72.12 111.98 -179.58 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -58.45 -40.49 82.77 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.427 1.491 . . . . 75.43 110.196 -178.705 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.51 ' HB1' ' CE1' ' A' ' 114' ' ' PHE . . . -74.2 4.53 5.53 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 125.798 1.639 . . . . 64.11 112.84 -178.641 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 61.7 mt -115.25 -57.12 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.891 0 N-CA-C 104.975 -2.232 . . . . 73.05 104.975 177.129 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 88.0 m-70 -80.67 -61.24 2.03 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 123.664 0.786 . . . . 75.41 112.616 -173.178 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -68.34 -21.16 64.75 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 119.063 0.847 . . . . 72.15 112.209 -177.756 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -94.45 -53.56 3.86 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 124.548 1.139 . . . . 73.44 108.771 -175.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 6.9 t60 58.49 88.0 0.07 Allowed 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.513 1.525 . . . . 64.33 110.65 -169.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 3.3 mmpt? -116.33 13.79 15.62 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.389 1.076 . . . . 72.11 113.302 -176.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 30.4 tttm 69.87 -64.23 0.36 Allowed 'General case' 0 C--O 1.221 -0.418 0 C-N-CA 128.2 2.6 . . . . 52.44 109.558 -174.333 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.413 HD22 ' HA ' ' A' ' 111' ' ' MET . 40.6 mt 54.47 44.66 28.48 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.813 1.645 . . . . 72.12 112.508 177.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -94.63 14.54 20.72 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.283 1.433 . . . . 72.33 114.189 -173.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -156.13 155.35 29.01 Favored Pre-proline 0 CA--C 1.535 0.395 0 C-N-CA 127.97 2.508 . . . . 75.22 107.662 -178.078 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -64.21 -44.99 10.71 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.546 2.164 . . . . 64.14 109.959 -173.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -69.01 -29.38 67.55 Favored 'General case' 0 N--CA 1.438 -1.039 0 C-N-CA 124.189 0.995 . . . . 72.43 111.15 -174.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -54.47 -42.15 70.34 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.95 1.3 . . . . 71.33 110.356 173.039 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . 0.413 ' HA ' HD22 ' A' ' 105' ' ' LEU . 2.5 mtt -76.85 -48.53 18.14 Favored 'General case' 0 CA--C 1.512 -0.514 0 C-N-CA 124.193 0.997 . . . . 75.45 108.92 -178.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.498 ' HB1' ' CG ' ' A' ' 122' ' ' LYS . . . -62.29 -37.16 84.46 Favored 'General case' 0 N--CA 1.447 -0.619 0 O-C-N 123.408 0.443 . . . . 73.44 111.337 -172.549 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -56.07 -46.85 78.83 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 125.287 1.435 . . . . 53.44 112.61 172.075 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . 0.51 ' CE1' ' HB1' ' A' ' 97' ' ' ALA . 19.0 t80 -74.27 -41.68 60.85 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 123.548 0.739 . . . . 71.3 111.45 -177.401 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 18.2 mt -76.94 -14.71 59.83 Favored 'General case' 0 C--N 1.332 -0.172 0 O-C-N 121.33 -0.856 . . . . 63.2 110.4 -176.511 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -48.48 -41.71 30.58 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.805 0.842 . . . . 70.13 110.127 172.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -82.09 10.09 54.67 Favored Glycine 0 CA--C 1.529 0.965 0 CA-C-O 117.975 -1.458 . . . . 75.43 114.805 177.265 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 23.8 mmtt -127.34 8.77 6.58 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 121.338 2.569 . . . . 72.43 112.615 -174.412 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 86.87 49.31 4.11 Favored Glycine 0 C--N 1.333 0.392 0 N-CA-C 109.669 -1.372 . . . . 65.22 109.669 -177.416 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 39.0 t -134.58 132.89 54.72 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 N-CA-C 105.18 -2.156 . . . . 73.14 105.18 169.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -92.27 133.65 35.63 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 123.68 0.792 . . . . 75.24 110.002 173.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.498 ' CG ' ' HB1' ' A' ' 112' ' ' ALA . 17.6 mtpt -64.58 -37.0 86.05 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 118.747 -0.644 . . . . 75.11 110.386 174.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -67.02 -26.82 66.97 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 118.707 0.685 . . . . 65.03 111.72 178.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 13.0 mttm -77.61 -57.06 4.02 Favored 'General case' 0 CA--C 1.518 -0.27 0 N-CA-C 106.402 -1.703 . . . . 71.53 106.402 171.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 41.3 t80 -51.86 -59.49 4.26 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 124.808 1.243 . . . . 65.51 112.174 -166.46 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 19.7 mt -73.54 -33.74 64.86 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 110.275 -0.268 . . . . 52.04 110.275 -170.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 29.7 m -62.26 -49.44 75.7 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 109.315 -0.624 . . . . 74.33 109.315 179.122 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 23.9 m -65.71 -41.33 92.44 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 124.553 1.141 . . . . 75.01 110.22 178.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 42.2 t80 -49.19 -48.69 45.05 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 119.691 1.132 . . . . 73.31 110.82 173.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 14.5 m-20 -92.64 38.89 1.02 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.647 0.779 . . . . 72.23 111.16 -178.121 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 7.7 t -122.86 172.26 8.6 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.403 1.481 . . . . 73.03 111.653 -177.334 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -67.09 -40.39 86.92 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.824 1.25 . . . . 75.2 110.52 178.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -50.58 -49.85 55.25 Favored 'General case' 0 C--N 1.34 0.166 0 C-N-CA 123.725 0.81 . . . . 63.13 110.463 -177.503 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 21.5 mm -69.51 -38.85 77.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 C-N-CA 124.218 1.007 . . . . 64.15 111.269 -178.305 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 1.7 mtmt -55.53 -33.26 63.65 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 124.066 0.947 . . . . 73.54 110.964 177.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -73.23 -48.42 19.44 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 110.831 -0.907 . . . . 43.12 110.831 178.357 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -63.34 -36.2 82.92 Favored 'General case' 0 CA--C 1.532 0.255 0 O-C-N 121.715 -0.874 . . . . 73.15 109.587 -177.502 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.32 -34.9 78.71 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-O 117.755 -1.116 . . . . 64.15 111.483 178.605 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -80.48 -39.84 27.3 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 120.588 1.54 . . . . 73.05 111.634 175.021 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.92 -59.02 5.67 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 118.864 -0.589 . . . . 74.1 110.763 179.116 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -58.85 -44.45 91.01 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 118.882 0.765 . . . . 75.41 109.056 -176.315 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 1.9 tmtt? -50.38 -57.73 7.3 Favored 'General case' 0 CA--C 1.528 0.11 0 C-N-CA 123.996 0.918 . . . . 73.12 111.139 -179.634 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.94 -35.06 69.51 Favored 'General case' 0 C--O 1.231 0.099 0 CA-C-N 118.834 0.743 . . . . 74.23 111.384 -175.28 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 37.8 mt -59.0 -49.56 77.44 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 123.577 0.751 . . . . 72.34 110.646 -177.477 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -54.47 -48.0 72.32 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 119.154 0.888 . . . . 73.12 111.722 -179.646 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 1.5 mtm -66.63 -34.8 78.68 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 120.332 -0.547 . . . . 64.35 109.774 -177.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -59.91 -43.86 94.62 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 118.426 0.557 . . . . 63.33 109.66 176.348 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -70.01 4.98 1.77 Allowed 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 126.183 1.793 . . . . 74.51 113.492 177.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 54.37 36.78 26.2 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 126.936 2.094 . . . . 75.43 112.124 -175.1 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.521 HG21 ' CD2' ' A' ' 32' ' ' LEU . 89.8 t -69.36 135.05 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 107.674 -1.232 . . . . 71.32 107.674 172.161 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 5.7 p -129.23 -16.12 4.04 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 126.787 2.035 . . . . 74.34 110.343 -176.132 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -168.36 -170.88 33.62 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 125.944 1.735 . . . . 61.41 112.825 -175.5 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 14.8 m -142.46 153.04 61.82 Favored Pre-proline 0 CA--C 1.546 0.819 0 C-N-CA 127.323 2.249 . . . . 75.32 108.316 175.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -63.52 152.71 71.36 Favored 'Cis proline' 0 CA--C 1.537 0.673 0 C-N-CA 124.578 -1.009 . . . . 64.44 113.145 -6.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 59.2 m -145.91 144.26 30.07 Favored 'General case' 0 C--O 1.239 0.547 0 C-N-CA 125.31 1.444 . . . . 73.44 108.529 175.251 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 19.8 mmm -123.97 158.41 32.12 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 125.774 1.63 . . . . 75.41 108.209 163.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 21.5 t -142.1 136.47 29.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 106.939 -1.504 . . . . 72.52 106.939 174.536 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.425 HG23 ' CE1' ' A' ' 164' ' ' PHE . 28.9 t -104.01 135.2 42.8 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 N-CA-C 107.098 -1.445 . . . . 72.12 107.098 168.726 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 1.4 t30 47.12 10.8 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.688 1 C-N-CA 133.111 4.565 . . . . 73.43 117.541 171.153 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 83.69 20.11 60.48 Favored Glycine 0 CA--C 1.526 0.777 0 CA-C-O 117.806 -1.552 . . . . 33.41 115.559 -169.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 48.0 mttt -131.81 -41.39 1.04 Allowed 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 119.971 1.885 . . . . 70.41 114.358 -170.302 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 -112.74 107.51 16.19 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 108.293 -1.003 . . . . 72.1 108.293 -171.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 63.2 ttp85 -88.92 113.41 24.43 Favored 'General case' 0 C--O 1.231 0.109 0 C-N-CA 126.5 1.92 . . . . 73.13 106.797 175.023 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . 0.425 ' CE1' HG23 ' A' ' 158' ' ' VAL . 5.3 p90 -136.51 169.59 17.45 Favored 'General case' 0 C--N 1.319 -0.75 0 O-C-N 120.343 -1.473 . . . . 54.21 107.186 177.8 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -174.97 -178.78 1.28 Allowed 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 122.548 0.339 . . . . 55.54 110.129 177.333 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 21.5 mt -46.33 -50.05 5.23 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 C-N-CA 128.555 2.742 . . . . 75.03 107.728 160.378 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -76.16 16.57 4.51 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 125.847 1.689 . . . . 70.41 114.392 178.012 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 17.8 m -128.3 -51.13 1.29 Allowed 'General case' 0 C--O 1.224 -0.239 0 CA-C-N 118.795 1.298 . . . . 71.41 109.705 168.565 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -70.32 -34.65 72.94 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 125.12 1.368 . . . . 64.11 112.266 -175.253 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 122.58 -5.96 9.87 Favored Glycine 0 C--N 1.341 0.83 0 CA-C-O 118.512 -1.16 . . . . 64.45 114.793 175.089 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 165.84 174.31 35.21 Favored Glycine 0 CA--C 1.532 1.097 0 CA-C-N 119.745 1.772 . . . . 50.23 110.003 -175.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -64.9 -52.61 1.18 Allowed 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 122.408 2.072 . . . . 71.31 111.772 -169.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -62.29 -28.68 69.9 Favored 'General case' 0 N--CA 1.463 0.223 0 O-C-N 120.965 -1.084 . . . . 73.42 111.547 178.491 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -67.4 -27.21 66.89 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.141 0.576 . . . . 74.32 110.366 177.527 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 19.7 m -77.66 -42.9 33.07 Favored 'General case' 0 CA--C 1.53 0.177 0 O-C-N 121.052 -1.03 . . . . 73.43 110.915 -169.713 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 35.8 mt -63.88 -31.77 73.07 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 118.918 0.781 . . . . 74.22 111.013 178.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 4.8 tttt -48.48 -56.48 8.17 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 126.602 1.961 . . . . 70.42 108.041 168.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.463 HD13 ' HA ' ' A' ' 178' ' ' LEU . 4.1 mm? -65.48 -41.37 93.38 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-O 116.941 -1.504 . . . . 65.34 111.554 176.534 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.403 ' HB1' ' CZ2' ' A' ' 50' ' ' TRP . . . -53.82 -48.68 69.67 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 120.917 1.689 . . . . 50.04 111.699 -175.395 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -69.52 -47.09 64.92 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 122.943 0.497 . . . . 63.54 110.577 -176.072 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -60.47 -42.61 96.59 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 123.565 0.746 . . . . 73.41 111.285 178.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 90.6 mt -67.09 -37.4 83.9 Favored 'General case' 0 C--N 1.332 -0.171 0 O-C-N 120.949 -1.094 . . . . 72.42 111.221 178.635 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 31.6 mt -58.25 -51.94 65.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 CA-C-N 119.259 0.936 . . . . 70.11 108.582 172.059 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -52.06 -43.07 63.62 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 124.59 1.156 . . . . 73.23 109.976 175.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . 0.596 ' O ' ' HB2' ' A' ' 189' ' ' ALA . 71.3 tttt -79.66 -0.32 33.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 117.124 -1.417 . . . . 72.14 113.161 -175.486 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . 0.424 ' HB3' HD12 ' A' ' 27' ' ' ILE . 16.0 mm-40 -103.11 -33.33 9.27 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 125.662 1.585 . . . . 70.42 114.43 178.435 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.39 -55.76 4.98 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 107.372 -1.344 . . . . 73.04 107.372 -179.222 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -65.27 -20.36 66.38 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.172 -0.922 . . . . 75.43 111.795 -176.444 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . 0.596 ' HB2' ' O ' ' A' ' 185' ' ' LYS . . . -46.69 -35.49 6.11 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 130.127 3.371 . . . . 55.23 113.706 175.459 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -101.07 13.3 35.63 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.721 1.208 . . . . 63.2 113.148 -178.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 49.3 tttm 56.41 76.93 0.27 Allowed 'General case' 0 C--N 1.343 0.294 0 C-N-CA 126.946 2.098 . . . . 74.3 109.805 -163.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 36.1 mtpt . . . . . 0 C--O 1.254 1.29 0 C-N-CA 126.069 1.748 . . . . 65.0 108.735 -179.24 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.947 0 N-CA-C 111.39 -0.684 . . . . 62.14 111.39 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 43.83 68.64 0.5 Allowed 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 127.445 2.298 . . . . 71.2 111.895 168.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -75.55 5.6 5.77 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 112.954 -1.93 . . . . 73.1 114.234 -171.48 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 30.1 m-85 -135.0 165.02 26.31 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 126.066 1.746 . . . . 71.14 108.04 -171.472 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 13.6 m -130.05 131.66 45.89 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 108.001 -1.111 . . . . 74.44 108.001 -178.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.89 154.02 42.03 Favored 'General case' 0 C--O 1.232 0.158 0 O-C-N 121.093 -1.005 . . . . 73.22 109.265 173.597 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 71.02 -36.17 0.51 Allowed Glycine 0 CA--C 1.53 1.001 0 C-N-CA 125.723 1.63 . . . . 53.2 112.859 -163.398 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 4.7 tptt -83.38 -83.37 0.14 Allowed 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 124.783 1.233 . . . . 70.55 108.993 -173.745 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 23.6 mp0 -73.41 -24.61 60.3 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 125.596 1.558 . . . . 73.23 110.47 -177.294 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 43.6 p90 -158.7 176.03 12.89 Favored 'General case' 0 N--CA 1.468 0.466 0 O-C-N 121.165 -0.959 . . . . 61.31 110.728 -173.568 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 62.0 t -134.55 107.63 9.33 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 124.921 1.288 . . . . 74.42 109.344 -177.283 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -73.23 147.14 44.94 Favored 'General case' 0 N--CA 1.444 -0.744 0 O-C-N 120.942 -1.099 . . . . 72.11 109.963 166.123 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -111.68 134.67 53.09 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 125.29 1.436 . . . . 73.41 109.92 -178.579 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 5.4 p -80.69 4.11 19.88 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 125.33 1.452 . . . . 53.13 114.137 -176.356 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -141.7 83.91 12.62 Favored Pre-proline 0 N--CA 1.45 -0.471 0 N-CA-C 106.781 -1.562 . . . . 70.02 106.781 173.342 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -70.92 -176.25 1.74 Allowed 'Trans proline' 0 CA--C 1.536 0.598 0 C-N-CA 124.086 3.191 . . . . 73.11 111.799 -175.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 22.1 t -131.65 137.5 30.52 Favored Pre-proline 0 CA--C 1.536 0.431 0 C-N-CA 123.942 0.897 . . . . 73.01 108.788 -174.186 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -78.95 176.39 9.89 Favored 'Trans proline' 0 CA--C 1.536 0.584 0 C-N-CA 123.67 2.914 . . . . 71.42 111.607 176.07 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.6 m -125.29 178.91 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 C-N-CA 125.307 1.443 . . . . 72.13 109.529 171.575 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 51.3 m -59.11 -58.18 9.79 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 124.537 1.135 . . . . 53.13 111.276 174.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -143.89 154.15 58.28 Favored Pre-proline 0 CA--C 1.536 0.428 0 C-N-CA 123.954 0.902 . . . . 73.12 109.509 173.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -70.29 167.04 26.29 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 123.37 2.713 . . . . 72.41 111.009 177.136 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 131.72 -96.39 0.33 Allowed Glycine 0 N--CA 1.449 -0.471 0 N-CA-C 109.412 -1.475 . . . . 63.04 109.412 178.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.39 126.11 29.03 Favored 'General case' 0 CA--C 1.518 -0.268 0 N-CA-C 108.53 -0.915 . . . . 75.41 108.53 -175.364 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 34.2 mm -61.68 140.17 19.51 Favored 'Isoleucine or valine' 0 C--O 1.24 0.581 0 N-CA-C 107.111 -1.44 . . . . 72.41 107.111 176.459 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -93.87 153.39 18.28 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 118.296 -1.361 . . . . 73.41 108.558 -177.135 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 16.1 t -146.31 121.81 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 N-CA-C 105.106 -2.183 . . . . 51.54 105.106 -177.567 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 57.3 t -123.07 119.47 57.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 106.898 -1.519 . . . . 63.54 106.898 -175.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -80.24 124.01 28.45 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 106.489 -1.671 . . . . 74.15 106.489 157.6 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.7 mp -110.47 145.24 38.02 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 107.031 -1.47 . . . . 74.32 107.031 160.022 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 18.5 p90 -154.23 176.93 11.68 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 124.138 0.975 . . . . 70.51 110.07 -172.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . 0.51 ' CB ' HG21 ' A' ' 153' ' ' VAL . 30.4 t90 -146.9 176.61 9.77 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 126.445 1.898 . . . . 72.44 108.268 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 23.7 t80 -56.22 -57.9 10.24 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 125.818 1.647 . . . . 73.22 111.467 178.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -93.4 -76.68 1.34 Allowed Glycine 0 C--N 1.338 0.677 0 N-CA-C 111.125 -0.79 . . . . 54.1 111.125 -155.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . 0.289 10.7 p 42.68 74.97 0.68 Allowed Pre-proline 0 CA--C 1.534 0.352 0 C-N-CA 126.409 1.884 . . . . 61.32 112.45 165.828 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -54.95 -27.43 54.08 Favored 'Trans proline' 0 CA--C 1.537 0.668 0 CA-C-N 121.078 1.421 . . . . 55.52 113.023 -175.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 10.6 m170 -70.34 -37.45 74.67 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.598 1.159 . . . . 73.15 111.861 175.001 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 18.7 p -67.37 -31.58 71.92 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 119.833 1.197 . . . . 74.54 111.087 -178.451 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 89.9 t80 -65.97 -26.02 67.37 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.314 1.046 . . . . 73.14 111.733 176.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -74.35 -7.76 53.94 Favored 'General case' 0 CA--C 1.536 0.424 0 O-C-N 120.879 -1.138 . . . . 42.15 112.15 172.196 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -126.76 -20.34 4.3 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-O 118.023 -0.989 . . . . 63.14 113.125 -163.511 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . 0.253 0.0 OUTLIER -50.44 -64.28 1.38 Allowed Pre-proline 0 N--CA 1.475 0.794 0 CA-C-N 120.689 1.586 . . . . 72.34 113.893 -175.551 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -70.52 -9.29 25.52 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 CA-C-N 122.099 1.785 . . . . 72.35 114.015 -176.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 85.4 m -79.87 -36.44 36.61 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 119.564 1.074 . . . . 74.43 109.671 169.398 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 15.8 tt -85.14 -35.49 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 CA-C-N 119.367 0.985 . . . . 72.13 111.617 -177.125 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 55.8 t -48.29 -62.65 2.05 Favored Pre-proline 0 CA--C 1.538 0.504 0 CA-C-O 117.413 -1.28 . . . . 73.3 112.088 -177.094 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -68.11 -29.53 33.15 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 121.428 1.418 . . . . 64.21 111.32 -176.041 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 77.2 t90 -54.23 -57.79 9.83 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 119.322 0.965 . . . . 72.52 109.973 177.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.2 -23.39 62.94 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 112.587 0.588 . . . . 72.11 112.587 -172.572 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 78.0 mt-10 -66.42 -48.19 70.8 Favored 'General case' 0 C--O 1.235 0.301 0 O-C-N 120.926 -1.109 . . . . 71.12 109.716 169.619 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 30.0 mmmt -74.57 3.6 7.46 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.524 1.53 . . . . 64.44 112.817 -169.678 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 37.7 mt -59.09 159.45 14.31 Favored Pre-proline 0 CA--C 1.543 0.674 0 C-N-CA 125.363 1.465 . . . . 72.21 112.129 177.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -87.27 174.0 5.39 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 125.204 3.936 . . . . 70.34 112.265 178.619 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -66.83 -21.26 66.03 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 114.307 1.225 . . . . 61.02 114.307 -175.681 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 40.9 m-20 -86.81 6.89 29.4 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.722 1.209 . . . . 71.5 111.146 -175.292 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 46.8 t -129.0 151.76 36.22 Favored 'Isoleucine or valine' 0 C--O 1.24 0.589 0 C-N-CA 125.194 1.398 . . . . 62.01 108.412 -173.245 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 79.6 t60 -133.96 144.5 48.81 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 125.498 1.519 . . . . 73.3 107.852 173.574 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 24.7 t80 -128.42 136.82 51.4 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 123.763 0.825 . . . . 74.4 110.535 -172.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 70.9 t -133.64 148.96 30.52 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 C-N-CA 126.253 1.821 . . . . 71.23 107.935 -174.532 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -123.79 125.31 44.47 Favored 'General case' 0 CA--C 1.512 -0.515 0 N-CA-C 105.615 -1.995 . . . . 71.03 105.615 172.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 20.7 mt -133.43 150.93 76.44 Favored Pre-proline 0 N--CA 1.47 0.539 0 CA-C-N 119.474 1.033 . . . . 60.03 111.092 176.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -73.63 139.29 27.96 Favored 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 121.64 1.56 . . . . 75.34 110.578 179.13 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -79.93 79.06 6.51 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.225 1.01 . . . . 53.42 109.382 173.216 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 48.8 mt -72.76 106.02 4.57 Favored 'General case' 0 C--N 1.329 -0.304 0 O-C-N 120.99 -1.069 . . . . 72.11 109.363 175.656 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -128.8 28.06 5.4 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.424 1.489 . . . . 71.03 112.376 178.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 76.9 169.78 31.54 Favored Glycine 0 CA--C 1.523 0.589 0 C-N-CA 125.454 1.502 . . . . 72.44 111.166 -178.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 56.77 -151.04 26.15 Favored Glycine 0 CA--C 1.529 0.937 0 N-CA-C 111.083 -0.807 . . . . 72.04 111.083 -175.129 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.2 tt -60.47 -21.33 22.84 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 C-N-CA 124.183 0.993 . . . . 72.35 112.658 -174.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . 0.435 ' CH2' HG22 ' A' ' 153' ' ' VAL . 23.9 m95 -63.31 -32.1 73.43 Favored 'General case' 0 CA--C 1.53 0.178 0 O-C-N 121.725 -0.609 . . . . 73.13 110.715 173.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -77.49 -43.57 31.74 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-N 118.676 0.671 . . . . 75.51 110.46 173.683 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 58.7 t -55.29 -58.21 5.12 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 C-N-CA 124.077 0.951 . . . . 74.51 109.916 -175.258 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 61.5 m170 -69.89 -7.61 41.73 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 118.568 -0.729 . . . . 74.11 112.042 -178.425 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -93.45 -18.55 38.27 Favored Glycine 0 C--N 1.338 0.652 0 CA-C-N 120.288 1.404 . . . . 73.21 110.242 -177.449 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -74.76 -36.6 62.57 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 118.58 1.19 . . . . 63.31 110.97 -173.452 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 34.2 ttp -53.82 -45.28 70.78 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.659 1.583 . . . . 73.13 113.436 179.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 10.7 t80 -57.5 -44.21 84.82 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 109.172 -0.677 . . . . 75.24 109.172 -177.115 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 24.4 mt -65.94 -44.9 83.71 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-O 117.092 -1.432 . . . . 73.23 109.53 178.331 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.416 ' HA ' HD11 ' A' ' 134' ' ' ILE . 0.2 OUTLIER -56.42 -41.71 76.83 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 121.165 1.802 . . . . 65.04 112.318 178.501 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.0 -59.43 4.92 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 124.853 1.261 . . . . 24.22 109.154 -174.675 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -72.46 -24.37 61.19 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 111.442 0.164 . . . . 73.22 111.442 -174.382 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.4 t -58.92 -8.5 1.41 Allowed 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.597 1.559 . . . . 73.2 113.516 176.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 6.8 mtp -111.21 -4.3 15.05 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 125.453 1.501 . . . . 72.11 113.963 -179.415 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 68.38 26.45 74.26 Favored Glycine 0 CA--C 1.528 0.861 0 CA-C-N 118.513 0.597 . . . . 50.41 112.2 176.16 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 12.9 m -68.45 169.85 1.16 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 C-N-CA 124.155 0.982 . . . . 54.13 110.816 172.066 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 55.82 -163.76 0.14 Allowed 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.421 1.488 . . . . 72.34 110.223 -171.505 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 33.8 m170 -107.96 -73.61 0.68 Allowed 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 105.894 -1.891 . . . . 74.13 105.894 153.579 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -139.66 0.71 1.85 Allowed 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 112.898 0.703 . . . . 75.31 112.898 -168.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.4 p -90.22 159.88 2.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 C-N-CA 125.046 1.338 . . . . 73.15 110.868 174.67 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 26.5 p80 -147.37 15.51 1.14 Allowed 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 114.865 1.432 . . . . 70.21 114.865 179.683 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -49.14 -55.88 10.93 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 125.772 1.629 . . . . 70.25 111.448 -175.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -64.89 -27.68 69.03 Favored 'General case' 0 CA--C 1.528 0.102 0 N-CA-C 113.421 0.897 . . . . 71.12 113.421 -174.043 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 60.0 t -58.45 -58.69 5.51 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 N-CA-C 108.393 -0.965 . . . . 75.51 108.393 172.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 -58.84 -49.9 76.0 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 124.296 1.038 . . . . 74.04 110.873 179.648 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -71.27 -2.97 17.94 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 126.184 1.793 . . . . 73.44 112.64 -173.529 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.451 ' HB1' ' CE2' ' A' ' 114' ' ' PHE . . . -96.37 -28.33 14.52 Favored 'General case' 0 N--CA 1.453 -0.28 0 O-C-N 120.84 -1.162 . . . . 73.3 112.405 169.646 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 12.1 mt -84.65 -58.49 3.46 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.513 0 N-CA-C 106.799 -1.556 . . . . 43.24 106.799 178.027 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 58.0 m-70 -73.61 -61.43 1.84 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 118.8 0.727 . . . . 63.12 112.734 -163.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.6 -12.1 60.0 Favored 'General case' 0 N--CA 1.473 0.7 0 O-C-N 120.614 -1.304 . . . . 75.33 114.18 179.42 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -114.46 -27.82 7.41 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 113.888 1.07 . . . . 73.42 113.888 -171.045 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . 0.272 5.1 m170 43.72 46.63 6.41 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 127.632 2.373 . . . . 55.23 112.868 169.387 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.468 ' HE2' ' HA ' ' A' ' 103' ' ' LYS . 7.9 mmpt? -68.37 12.12 0.14 Allowed 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 125.109 1.364 . . . . 64.11 114.614 178.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 4.2 ttpm? 68.14 -52.27 0.53 Allowed 'General case' 0 C--O 1.223 -0.293 0 C-N-CA 129.384 3.074 . . . . 75.23 111.057 -177.771 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 64.8 mt 51.84 43.96 29.72 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 125.957 1.703 . . . . 75.21 110.295 171.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -84.76 -24.97 28.56 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 124.369 1.067 . . . . 54.11 112.536 -175.371 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 44.4 p -124.06 160.08 53.71 Favored Pre-proline 0 N--CA 1.463 0.193 0 CA-C-N 119.767 1.167 . . . . 71.12 111.474 -169.423 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -71.15 -15.91 31.92 Favored 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 121.344 1.363 . . . . 61.31 112.809 178.273 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.43 -59.91 2.58 Favored 'General case' 0 N--CA 1.462 0.153 0 N-CA-C 107.064 -1.458 . . . . 63.0 107.064 166.458 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -58.52 -42.03 86.79 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 123.928 0.891 . . . . 53.24 112.09 -170.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 41.1 mtt -65.57 -55.75 16.01 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 122.963 0.505 . . . . 73.41 111.099 175.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.401 ' HB1' ' CG ' ' A' ' 122' ' ' LYS . . . -70.86 -40.08 72.54 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 119.45 -0.31 . . . . 75.32 110.721 -166.121 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -60.79 -38.35 85.03 Favored 'General case' 0 C--N 1.338 0.103 0 C-N-CA 122.84 0.456 . . . . 65.22 110.638 175.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . 0.451 ' CE2' ' HB1' ' A' ' 97' ' ' ALA . 82.9 t80 -72.0 -48.19 46.53 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 122.848 0.459 . . . . 72.12 111.206 -177.359 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 55.7 mt -68.29 -16.79 64.09 Favored 'General case' 0 C--O 1.23 0.049 0 O-C-N 121.49 -0.756 . . . . 54.32 111.219 -174.535 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -52.09 -18.03 1.29 Allowed 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.762 1.225 . . . . 63.44 112.867 172.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -86.37 -12.4 70.16 Favored Glycine 0 CA--C 1.529 0.938 0 O-C-N 120.927 -1.108 . . . . 72.13 113.148 177.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -116.84 6.04 13.09 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 119.485 1.643 . . . . 72.23 113.544 -161.587 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 87.65 48.92 4.04 Favored Glycine 0 C--N 1.334 0.439 0 N-CA-C 109.754 -1.338 . . . . 71.14 109.754 -169.681 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 55.9 t -129.81 155.08 41.19 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 N-CA-C 104.794 -2.299 . . . . 65.43 104.794 165.7 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -127.31 135.3 50.36 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 106.538 -1.653 . . . . 65.44 106.538 -176.27 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.401 ' CG ' ' HB1' ' A' ' 112' ' ' ALA . 2.5 mtmt -67.39 -42.43 83.35 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 118.817 0.735 . . . . 72.25 111.431 -175.238 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -62.48 -36.22 81.81 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 123.859 0.864 . . . . 74.51 110.1 -178.563 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 40.8 mttm -73.08 -53.48 10.97 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 106.042 -1.836 . . . . 73.32 106.042 176.264 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 33.1 t80 -51.98 -60.67 2.92 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 125.246 1.418 . . . . 73.22 110.874 -172.21 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 11.8 mt -68.67 -37.29 79.51 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 123.063 0.545 . . . . 53.13 110.191 -170.21 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 11.2 t -65.1 -37.07 86.29 Favored 'General case' 0 CA--C 1.534 0.335 0 O-C-N 122.05 -0.406 . . . . 50.5 109.999 179.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 51.6 m -70.02 -40.87 74.97 Favored 'General case' 0 N--CA 1.455 -0.209 0 O-C-N 121.87 -0.519 . . . . 61.31 111.003 171.664 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 77.5 t80 -54.23 -48.93 70.55 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 119.3 0.954 . . . . 74.44 109.269 179.454 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 55.3 m-20 -91.46 59.09 3.75 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.905 1.282 . . . . 73.33 109.74 171.657 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 68.3 p -123.64 163.33 21.26 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-O 121.951 0.881 . . . . 51.03 111.702 168.197 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -68.44 -32.13 71.94 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.675 0.79 . . . . 60.33 110.21 172.303 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -56.54 -50.46 71.79 Favored 'General case' 0 C--O 1.234 0.26 0 O-C-N 121.796 -0.565 . . . . 50.12 110.045 -179.187 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.416 HD11 ' HA ' ' A' ' 80' ' ' THR . 26.5 mm -63.94 -34.18 66.77 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-O 118.407 -0.806 . . . . 72.14 110.983 177.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 54.2 tttt -53.53 -41.76 66.72 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 118.898 0.772 . . . . 65.53 109.394 174.507 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -71.91 -33.81 62.56 Favored Glycine 0 C--N 1.337 0.61 0 C-N-CA 125.015 1.293 . . . . 33.21 111.75 -178.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 -73.3 -36.58 66.3 Favored 'General case' 0 N--CA 1.452 -0.36 0 O-C-N 121.824 -0.809 . . . . 64.23 110.503 -178.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 14.7 mtp -62.17 -52.01 65.51 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 118.119 0.418 . . . . 74.14 110.458 173.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -65.84 -37.01 85.06 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-O 118.696 -0.669 . . . . 52.24 111.913 -168.529 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 3.0 mtmt -56.52 -64.09 0.98 Allowed 'General case' 0 C--N 1.341 0.222 0 CA-C-O 118.357 -0.83 . . . . 63.14 109.041 172.448 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -55.99 -37.91 69.74 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 118.567 0.621 . . . . 73.13 111.437 -173.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 9.5 tmtt? -55.41 -59.82 4.28 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 124.228 1.011 . . . . 72.24 110.3 178.092 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 8.6 ptmt -69.67 -31.2 69.13 Favored 'General case' 0 C--N 1.343 0.307 0 CA-C-N 120.158 1.345 . . . . 62.14 111.974 179.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 21.9 mt -60.63 -54.41 45.68 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 118.624 0.647 . . . . 74.41 109.376 -174.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -54.4 -41.07 68.85 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 122.503 0.321 . . . . 60.42 111.237 -178.244 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -63.65 -45.71 88.94 Favored 'General case' 0 N--CA 1.461 0.11 0 C-N-CA 123.08 0.552 . . . . 70.23 111.3 178.239 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -62.33 -39.45 93.11 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 123.442 0.697 . . . . 71.42 110.11 -178.508 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 34.9 m-85 -75.67 8.0 3.32 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.662 1.185 . . . . 72.21 113.441 177.405 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 13.3 mt-30 49.93 39.06 17.73 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 126.998 2.119 . . . . 74.22 112.729 -175.678 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 46.6 t -74.2 138.27 21.49 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 N-CA-C 106.276 -1.75 . . . . 74.31 106.276 168.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -141.68 4.48 1.73 Allowed 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.873 0.869 . . . . 44.15 111.607 -178.449 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 177.28 -177.22 48.29 Favored Glycine 0 CA--C 1.524 0.631 0 C-N-CA 126.243 1.877 . . . . 74.13 108.709 -174.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.51 HG21 ' CB ' ' A' ' 34' ' ' TRP . 12.9 m -149.15 149.99 30.89 Favored Pre-proline 0 C--O 1.24 0.586 0 C-N-CA 125.378 1.471 . . . . 75.53 108.91 -175.471 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -68.98 147.89 83.87 Favored 'Cis proline' 0 CA--C 1.537 0.648 0 O-C-N 122.532 0.754 . . . . 64.22 112.148 -1.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 62.9 m -150.53 131.57 14.34 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 126.559 1.944 . . . . 64.23 107.442 179.27 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 93.3 mtp -116.36 163.12 16.49 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 124.153 0.981 . . . . 71.41 109.615 172.022 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 6.3 t -139.75 143.71 29.89 Favored 'Isoleucine or valine' 0 C--O 1.24 0.595 0 N-CA-C 106.522 -1.659 . . . . 71.14 106.522 179.041 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.522 HG23 ' CE1' ' A' ' 164' ' ' PHE . 96.8 t -113.29 134.7 55.16 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 C-N-CA 124.929 1.291 . . . . 72.4 107.545 167.802 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 7.8 t30 49.24 9.34 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 131.63 3.972 . . . . 62.02 116.344 172.361 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 81.48 19.81 65.53 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 126.124 1.821 . . . . 64.2 114.306 -171.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 24.1 mtpt -137.78 -30.19 0.83 Allowed 'General case' 0 N--CA 1.479 1.002 0 CA-C-N 120.292 2.046 . . . . 63.22 113.498 -167.541 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -118.7 142.41 47.69 Favored 'General case' 0 CA--C 1.508 -0.662 0 N-CA-C 107.318 -1.364 . . . . 72.11 107.318 174.524 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 21.7 ttp180 -123.48 144.34 49.59 Favored 'General case' 0 N--CA 1.44 -0.955 0 N-CA-C 104.877 -2.268 . . . . 72.44 104.877 178.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . 0.522 ' CE1' HG23 ' A' ' 158' ' ' VAL . 14.1 p90 -154.22 173.32 16.27 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 107.596 -1.261 . . . . 75.4 107.596 178.749 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -173.42 175.65 3.01 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 107.681 -1.229 . . . . 62.3 107.681 -177.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 23.6 mt -56.23 -44.93 80.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 C-N-CA 126.493 1.917 . . . . 62.55 108.746 -177.498 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -72.46 -34.92 60.02 Favored Glycine 0 N--CA 1.442 -0.927 0 CA-C-O 117.996 -1.446 . . . . 62.34 112.093 -175.252 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 72.9 m -69.03 -57.3 5.63 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 118.924 1.362 . . . . 70.11 109.36 172.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -63.21 -44.84 94.19 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 123.1 0.56 . . . . 72.41 111.322 -169.187 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 141.28 -18.32 2.68 Favored Glycine 0 CA--C 1.523 0.573 0 C-N-CA 123.768 0.699 . . . . 71.42 114.197 173.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 169.82 169.23 32.8 Favored Glycine 0 CA--C 1.527 0.814 0 N-CA-C 107.19 -2.364 . . . . 41.33 107.19 -172.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -64.34 -36.11 46.99 Favored 'Trans proline' 0 N--CA 1.459 -0.543 0 C-N-CA 122.643 2.229 . . . . 75.0 111.984 -168.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -56.62 -48.96 76.34 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 123.453 0.701 . . . . 60.31 110.331 171.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -67.15 -27.6 67.43 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 123.797 0.839 . . . . 75.23 109.909 -169.078 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -51.29 -48.36 62.29 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 124.143 0.977 . . . . 55.51 110.197 173.75 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 55.9 mt -65.91 -34.02 77.16 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 117.851 0.296 . . . . 64.13 111.261 -179.318 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.78 -48.4 75.4 Favored 'General case' 0 N--CA 1.456 -0.165 0 N-CA-C 108.652 -0.87 . . . . 74.22 108.652 174.662 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.478 HD13 ' HA ' ' A' ' 178' ' ' LEU . 4.3 mm? -66.88 -44.7 80.23 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-O 117.848 -1.072 . . . . 65.52 110.843 175.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -50.38 -50.3 51.91 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 118.967 0.803 . . . . 61.22 110.329 -178.078 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -72.92 -44.37 61.31 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 123.625 0.77 . . . . 42.45 109.663 -170.133 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 5.5 t80 -59.76 -47.95 83.63 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 124.312 1.045 . . . . 75.54 111.894 176.063 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.463 ' HB2' HG21 ' A' ' 158' ' ' VAL . 82.7 mt -63.28 -44.63 94.52 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 108.967 -0.753 . . . . 64.02 108.967 -174.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 65.2 mt -58.14 -45.68 88.53 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 123.236 0.614 . . . . 73.2 109.43 174.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -65.84 -17.57 64.73 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 123.694 0.798 . . . . 63.43 112.571 179.492 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . 0.467 ' O ' ' HB2' ' A' ' 189' ' ' ALA . 13.5 tptp -84.23 -57.29 3.23 Favored 'General case' 0 N--CA 1.441 -0.917 0 N-CA-C 106.911 -1.514 . . . . 75.2 106.911 173.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -55.88 -20.19 14.77 Favored 'General case' 0 CA--C 1.513 -0.465 0 C-N-CA 129.856 3.262 . . . . 71.12 116.245 -167.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 2.6 mtm180 -71.88 -68.85 0.43 Allowed 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 117.784 -1.566 . . . . 74.03 110.629 168.336 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -53.41 -37.05 62.14 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-O 124.02 1.866 . . . . 64.23 111.076 -173.061 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . 0.467 ' HB2' ' O ' ' A' ' 185' ' ' LYS 0.282 . . -43.35 -35.34 1.49 Allowed 'General case' 0 N--CA 1.433 -1.314 1 C-N-CA 133.054 4.542 . . . . 61.22 113.156 176.145 . . . . . . . . 4 3 . 1 . 016 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -126.94 -17.01 4.99 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 119.459 1.027 . . . . 74.41 112.609 166.43 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -146.38 83.14 1.61 Allowed 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 128.218 2.607 . . . . 73.34 107.876 -164.37 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 2.0 ttmt . . . . . 0 C--O 1.252 1.21 0 CA-C-N 114.925 -1.034 . . . . 65.24 113.316 142.874 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.626 0 N-CA-C 109.832 -1.307 . . . . 73.43 109.832 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -76.95 139.87 40.29 Favored 'General case' 0 CA--C 1.519 -0.217 0 N-CA-C 109.205 -0.665 . . . . 74.14 109.205 -176.733 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -117.1 11.49 14.21 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 123.968 0.907 . . . . 72.41 112.631 178.675 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 -135.89 159.87 40.35 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 125.381 1.472 . . . . 73.2 109.735 -171.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.8 m -136.24 142.07 43.99 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 123.827 0.851 . . . . 72.15 109.481 176.637 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.33 150.52 34.75 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-N 114.602 -1.181 . . . . 70.2 111.982 176.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 77.51 -42.61 1.99 Allowed Glycine 0 CA--C 1.524 0.608 0 C-N-CA 125.015 1.293 . . . . 61.32 110.594 -171.43 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 12.9 ttpt -79.43 -80.49 0.12 Allowed 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 125.202 1.401 . . . . 65.13 110.76 -168.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 8.1 mp0 -70.97 -21.45 62.32 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 124.707 1.203 . . . . 64.41 110.865 -175.482 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 31.5 p90 -164.94 172.75 12.41 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 125.302 1.441 . . . . 74.22 108.817 -173.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 57.4 t -130.99 108.54 15.29 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 C-N-CA 125.002 1.321 . . . . 71.15 108.591 -178.678 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.6 164.13 22.12 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 124.387 1.075 . . . . 42.3 108.422 165.757 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -135.53 114.39 12.02 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 106.858 -1.534 . . . . 54.41 106.858 -168.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.5 m -56.69 -8.45 0.58 Allowed 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.433 1.493 . . . . 74.54 114.208 -177.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 50.6 m -135.3 83.3 38.61 Favored Pre-proline 0 CA--C 1.543 0.684 0 C-N-CA 125.016 1.327 . . . . 70.52 109.504 -179.112 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -74.66 177.82 7.95 Favored 'Trans proline' 0 CA--C 1.539 0.761 1 C-N-CA 125.583 4.189 . . . . 64.01 114.006 -178.725 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 81.3 t -142.0 147.84 46.24 Favored Pre-proline 0 N--CA 1.475 0.797 0 C-N-CA 127.111 2.164 . . . . 64.24 108.932 -168.271 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo -90.47 174.95 2.84 Favored 'Trans proline' 0 CA--C 1.536 0.59 0 C-N-CA 123.863 3.042 . . . . 70.32 113.455 178.096 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 15.5 m -105.85 176.28 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 C-N-CA 125.464 1.506 . . . . 35.21 109.266 166.343 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 67.1 m -52.5 -51.17 60.78 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 126.686 1.994 . . . . 53.33 112.351 177.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 16.7 mt-30 -149.72 164.17 21.91 Favored Pre-proline 0 CA--C 1.537 0.478 0 C-N-CA 125.1 1.36 . . . . 64.32 109.516 176.119 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -68.58 135.44 33.42 Favored 'Trans proline' 0 N--CA 1.452 -0.952 0 C-N-CA 122.416 2.077 . . . . 63.35 108.717 167.449 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 175.19 -125.51 1.09 Allowed Glycine 0 N--CA 1.445 -0.754 0 N-CA-C 106.614 -2.594 . . . . 63.41 106.614 -171.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.03 152.82 43.16 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 117.938 0.869 . . . . 75.4 109.786 176.823 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 39.2 mm -59.09 157.93 1.86 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 N-CA-C 106.811 -1.551 . . . . 73.04 106.811 163.3 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -115.84 122.09 44.35 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 107.093 -1.447 . . . . 70.13 107.093 174.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 36.7 t -114.85 113.14 42.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 N-CA-C 105.949 -1.871 . . . . 71.45 105.949 171.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 16.2 t -101.19 139.38 22.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 107.09 -1.448 . . . . 63.53 107.09 179.24 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -105.75 138.44 41.94 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 107.872 -1.158 . . . . 71.01 107.872 154.474 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.0 mp -111.46 148.43 33.15 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 124.549 1.14 . . . . 74.12 108.8 174.367 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 48.7 p90 -138.35 171.72 13.96 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 123.631 0.772 . . . . 74.45 112.044 -179.601 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 27.2 t90 -145.48 177.15 9.07 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 127.701 2.401 . . . . 63.53 107.886 172.393 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 56.1 t80 -72.16 -31.61 66.11 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.524 1.53 . . . . 61.32 114.758 178.434 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -116.69 20.99 11.69 Favored Glycine 0 CA--C 1.526 0.721 0 CA-C-O 118.573 -1.126 . . . . 42.54 114.228 -161.086 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 21.2 p -106.85 86.77 2.49 Favored Pre-proline 0 CA--C 1.538 0.49 0 C-N-CA 125.81 1.644 . . . . 65.53 110.309 -169.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -52.63 -36.45 71.83 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 122.7 2.267 . . . . 64.23 113.061 -175.219 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 17.0 m170 -55.27 -29.33 57.92 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 118.214 -0.898 . . . . 70.44 112.774 176.131 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 80.3 m -63.88 -66.45 0.54 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.555 1.542 . . . . 72.42 109.772 179.313 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.434 ' HB2' ' CD2' ' A' ' 99' ' ' HIS . 19.2 t80 -59.2 -34.85 72.64 Favored 'General case' 0 N--CA 1.469 0.485 0 O-C-N 121.489 -0.757 . . . . 73.04 111.907 -178.645 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.58 -28.7 69.53 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 118.633 -0.698 . . . . 71.12 112.327 179.676 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -93.86 -20.45 20.04 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.985 1.314 . . . . 72.22 112.126 -174.669 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -42.89 -65.45 0.55 Allowed Pre-proline 0 CA--C 1.542 0.654 0 N-CA-C 114.393 1.257 . . . . 71.43 114.393 -174.335 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -74.73 -6.65 18.47 Favored 'Trans proline' 0 CA--C 1.534 0.522 0 CA-C-N 122.327 1.867 . . . . 41.04 114.525 -176.315 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 67.0 m -75.44 -39.81 58.37 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 120.411 1.459 . . . . 42.24 108.905 163.209 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 14.2 tt -87.19 -34.51 7.57 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 N-CA-C 112.846 0.684 . . . . 71.33 112.846 -171.215 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 31.4 t -49.72 -57.34 12.52 Favored Pre-proline 0 CA--C 1.537 0.451 0 CA-C-N 119.837 1.199 . . . . 73.21 111.138 175.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -67.02 -7.41 18.62 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 CA-C-N 121.302 1.501 . . . . 63.41 114.11 -177.09 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.464 ' CH2' ' HB1' ' A' ' 179' ' ' ALA . 70.9 t90 -80.27 -62.21 1.75 Allowed 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 119.326 0.966 . . . . 72.02 108.837 164.183 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 5.2 p -68.57 -19.08 64.45 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 113.35 0.87 . . . . 73.42 113.35 -172.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . 0.322 4.9 pt-20 -69.66 -20.78 63.57 Favored 'General case' 0 CA--C 1.556 1.179 0 C-N-CA 124.273 1.029 . . . . 54.24 110.912 170.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 67.2 mmtt -115.89 6.52 14.26 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.633 1.573 . . . . 72.42 113.256 -170.695 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 51.7 mt -63.43 150.41 89.81 Favored Pre-proline 0 C--O 1.236 0.391 0 CA-C-N 118.702 0.683 . . . . 70.41 110.021 176.723 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -73.11 177.26 8.02 Favored 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 124.555 3.503 . . . . 72.5 111.701 -176.02 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -74.6 -0.72 18.73 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.175 0.99 . . . . 64.52 113.475 179.104 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -104.07 -1.38 27.47 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 126.589 1.956 . . . . 73.21 111.339 -177.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 48.2 t -131.3 154.53 40.74 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 126.303 1.841 . . . . 73.33 106.708 -179.505 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 48.7 t60 -137.69 157.45 46.44 Favored 'General case' 0 N--CA 1.45 -0.468 0 O-C-N 121.674 -0.641 . . . . 72.1 109.41 169.344 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 46.3 t80 -124.6 135.16 52.88 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.644 1.178 . . . . 74.3 110.674 -171.561 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 67.1 t -132.85 137.86 53.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 C-N-CA 124.299 1.04 . . . . 73.23 108.54 -169.115 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -114.16 121.64 44.37 Favored 'General case' 0 CA--C 1.514 -0.414 0 N-CA-C 106.628 -1.619 . . . . 62.4 106.628 170.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 13.1 mt -136.57 144.79 48.7 Favored Pre-proline 0 CA--C 1.537 0.454 0 CA-C-N 118.607 0.639 . . . . 75.41 112.304 -177.453 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -77.56 125.61 7.7 Favored 'Trans proline' 0 CA--C 1.534 0.482 0 C-N-CA 122.166 1.911 . . . . 74.44 112.307 -175.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -68.29 112.28 5.08 Favored 'General case' 0 CA--C 1.54 0.567 0 O-C-N 120.741 -1.225 . . . . 64.34 109.286 167.76 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 8.1 mt -110.41 95.57 5.65 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 106.274 -1.751 . . . . 62.14 106.274 177.215 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -115.5 16.68 16.58 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 114.861 1.43 . . . . 72.52 114.861 -172.623 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 93.22 170.99 39.75 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 125.258 1.409 . . . . 35.21 110.058 -178.566 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 58.41 -153.48 27.76 Favored Glycine 0 CA--C 1.532 1.101 0 N-CA-C 110.246 -1.142 . . . . 64.4 110.246 -172.533 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 8.8 tp -60.19 -17.27 13.8 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 C-N-CA 123.866 0.866 . . . . 72.41 112.751 -177.208 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 19.1 m95 -58.52 -35.41 72.22 Favored 'General case' 0 C--N 1.34 0.193 0 O-C-N 121.009 -1.057 . . . . 72.3 110.847 176.82 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 33.4 m-20 -76.66 -33.33 58.3 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 109.283 -0.636 . . . . 72.31 109.283 -174.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 29.8 t -63.17 -65.64 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 C-N-CA 124.797 1.239 . . . . 61.51 108.992 172.639 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 46.4 m170 -67.66 -2.4 6.81 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 114.138 1.162 . . . . 74.4 114.138 -171.543 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -102.04 -27.39 7.0 Favored Glycine 0 C--N 1.336 0.563 0 CA-C-N 120.221 1.373 . . . . 52.11 110.171 -176.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 31.7 mt-30 -56.09 -26.86 51.34 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 118.226 -0.893 . . . . 75.52 112.527 176.362 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 3.7 ttt -46.78 -62.96 1.15 Allowed 'General case' 0 C--N 1.342 0.246 0 N-CA-C 114.796 1.406 . . . . 43.23 114.796 -170.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -53.06 -45.69 68.21 Favored 'General case' 0 C--N 1.331 -0.211 0 O-C-N 123.779 0.674 . . . . 63.22 110.045 -176.331 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 28.7 mt -61.87 -39.08 90.64 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-O 116.682 -1.628 . . . . 75.22 109.67 178.079 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.549 ' HA ' HD11 ' A' ' 134' ' ' ILE . 0.0 OUTLIER -60.62 -49.45 77.49 Favored 'General case' 0 C--N 1.349 0.567 0 CA-C-N 121.625 2.011 . . . . 75.53 109.538 175.596 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -54.57 -54.02 46.87 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 124.452 1.101 . . . . 72.15 108.425 -175.002 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -75.1 -14.04 60.54 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 112.885 0.698 . . . . 75.42 112.885 -178.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.402 ' HB3' HG21 ' A' ' 128' ' ' THR . 2.9 t -61.37 -33.97 74.53 Favored 'General case' 0 C--O 1.236 0.379 0 O-C-N 121.431 -0.793 . . . . 74.4 110.809 173.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 47.5 mtp -77.66 -21.11 52.66 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 123.602 0.761 . . . . 53.24 111.914 -171.164 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 68.76 63.77 3.35 Favored Glycine 0 C--N 1.335 0.511 0 N-CA-C 107.296 -2.322 . . . . 72.21 107.296 -164.326 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 17.3 m -74.83 154.4 6.48 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 N-CA-C 109.467 -0.568 . . . . 74.05 109.467 167.158 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 59.7 mt-10 -58.56 -64.91 0.76 Allowed 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.001 0.52 . . . . 73.32 109.948 -175.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -171.31 -178.69 2.44 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.696 1.598 . . . . 71.34 109.714 155.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -150.95 154.14 36.56 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 127.21 2.204 . . . . 51.13 107.573 179.41 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 38.5 t -78.15 -4.31 6.56 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.824 0 O-C-N 120.706 -1.246 . . . . 73.44 112.298 -173.213 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 11.3 m170 54.76 56.41 6.74 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.995 1.718 . . . . 74.3 111.024 -174.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -152.04 -48.92 0.11 Allowed 'General case' 0 CA--C 1.513 -0.477 0 C-N-CA 124.257 1.023 . . . . 75.33 110.745 -178.077 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -57.59 -32.27 67.0 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 124.041 0.936 . . . . 42.42 111.112 179.222 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 21.7 t -53.64 -68.15 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 C-N-CA 125.691 1.596 . . . . 65.14 109.658 169.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -70.65 -32.5 69.81 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 119.961 1.255 . . . . 71.24 112.978 -174.273 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -60.44 -33.27 72.3 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.119 0.968 . . . . 73.3 109.266 173.238 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.451 ' HA ' ' HB2' ' A' ' 101' ' ' GLU . . . -72.88 -52.75 13.49 Favored 'General case' 0 N--CA 1.446 -0.656 0 O-C-N 120.413 -1.429 . . . . 75.03 109.312 174.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 40.8 mt -61.9 -44.56 99.05 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-O 118.244 -0.884 . . . . 72.3 109.72 -171.414 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . 0.434 ' CD2' ' HB2' ' A' ' 41' ' ' TYR . 48.6 m-70 -81.54 -72.68 0.42 Allowed 'General case' 0 CA--C 1.52 -0.189 0 C-N-CA 124.694 1.198 . . . . 70.51 111.065 -179.414 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 8.9 mtmt -65.8 -28.2 68.83 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-N 118.319 0.509 . . . . 74.51 111.307 -168.223 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.451 ' HB2' ' HA ' ' A' ' 97' ' ' ALA . 0.0 OUTLIER -103.79 -31.13 9.97 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 122.792 0.437 . . . . 74.04 111.028 -170.526 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 4.0 t60 43.83 70.06 0.35 Allowed 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 127.509 2.323 . . . . 75.21 112.126 172.671 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 21.0 mtpt -96.44 19.09 12.66 Favored 'General case' 0 N--CA 1.467 0.38 0 O-C-N 121.716 -0.615 . . . . 71.12 111.805 -172.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 12.9 ttpt 46.5 57.77 5.16 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 127.75 2.42 . . . . 74.43 111.971 176.563 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.496 ' HA ' ' HB3' ' A' ' 110' ' ' GLU . 52.6 mt -73.98 43.28 0.16 Allowed 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 130.428 3.491 . . . . 74.13 112.193 -176.74 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -82.94 1.43 39.69 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 127.582 2.353 . . . . 55.12 113.464 -177.211 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 32.9 p -144.11 161.7 43.95 Favored Pre-proline 0 C--O 1.239 0.523 0 C-N-CA 123.726 0.81 . . . . 74.53 109.916 -172.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.43 -13.99 20.37 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 122.471 2.114 . . . . 65.21 113.445 -179.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -63.96 -60.98 2.58 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 107.888 -1.152 . . . . 74.35 107.888 163.596 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.496 ' HB3' ' HA ' ' A' ' 105' ' ' LEU . 0.1 OUTLIER -61.59 -46.23 90.72 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-O 119.066 -0.492 . . . . 53.23 111.492 -166.974 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 14.3 mtt -59.89 -42.45 93.81 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 118.427 0.558 . . . . 72.53 110.998 179.749 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -72.26 -47.49 49.85 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 109.455 -0.572 . . . . 73.33 109.455 -171.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -66.02 -24.11 66.69 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 118.888 0.767 . . . . 75.22 112.183 178.104 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . 0.525 ' CZ ' ' HE3' ' A' ' 118' ' ' LYS . 9.3 t80 -68.19 -60.4 2.5 Favored 'General case' 0 C--O 1.234 0.257 0 O-C-N 121.488 -0.758 . . . . 73.13 109.682 173.17 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 82.0 mt -65.56 -26.21 67.77 Favored 'General case' 0 N--CA 1.456 -0.127 0 C-N-CA 123.648 0.779 . . . . 45.43 110.424 -177.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -57.44 -39.47 76.34 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 119.189 0.904 . . . . 33.52 109.332 177.39 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -60.56 -8.52 9.82 Favored Glycine 0 CA--C 1.531 1.036 0 CA-C-O 116.981 -2.011 . . . . 22.51 114.176 172.291 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.525 ' HE3' ' CZ ' ' A' ' 114' ' ' PHE . 0.5 OUTLIER -131.85 21.65 4.58 Favored 'General case' 0 C--N 1.347 0.491 0 CA-C-N 121.324 2.562 . . . . 65.44 111.671 -175.469 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 82.22 60.3 2.16 Favored Glycine 0 C--N 1.333 0.396 0 N-CA-C 109.713 -1.355 . . . . 70.2 109.713 171.04 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 28.3 t -135.97 121.12 27.9 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 C-N-CA 125.361 1.464 . . . . 70.41 107.114 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 52.9 t0 -66.18 116.34 7.15 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 124.149 0.979 . . . . 63.11 110.364 -179.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 7.2 ttmt -61.57 -41.31 97.22 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 124.502 1.121 . . . . 54.44 109.442 177.578 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -63.39 -36.75 84.75 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 119.118 -0.468 . . . . 63.12 111.603 -175.078 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 15.7 mmtp -80.97 -37.58 29.07 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-O 118.493 -0.765 . . . . 63.23 109.181 176.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 82.7 t80 -54.3 -60.33 3.49 Favored 'General case' 0 N--CA 1.445 -0.68 0 O-C-N 123.805 0.691 . . . . 73.13 110.389 -177.459 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 20.1 mt -66.46 -40.78 89.6 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 123.271 0.629 . . . . 55.33 110.569 -175.462 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 34.2 t -56.18 -48.47 76.28 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 123.802 0.841 . . . . 70.45 109.629 -178.304 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . 0.44 HG23 HG22 ' A' ' 80' ' ' THR . 1.3 t -80.42 -30.98 37.7 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-O 119.196 -0.431 . . . . 64.33 110.192 -175.647 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 58.5 t80 -55.53 -50.75 69.19 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 119.161 0.891 . . . . 52.3 110.362 174.665 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -95.78 47.84 1.12 Allowed 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 124.065 0.946 . . . . 72.11 109.23 177.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 37.5 t -128.42 165.44 20.63 Favored 'General case' 0 C--O 1.238 0.474 0 O-C-N 120.998 -1.064 . . . . 65.14 109.642 173.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -58.99 -25.76 63.92 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 115.426 -0.806 . . . . 71.25 110.82 163.692 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -48.46 -54.66 13.37 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 124.45 1.1 . . . . 62.22 111.32 178.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.549 HD11 ' HA ' ' A' ' 80' ' ' THR . 11.8 mm -65.37 -42.95 94.81 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.392 0 N-CA-C 113.339 0.866 . . . . 74.31 113.339 170.751 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 14.2 tttt -54.02 -36.95 63.57 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 118.866 -0.588 . . . . 71.41 109.746 -175.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -82.89 -8.55 85.68 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 126.443 1.973 . . . . 41.04 113.273 -174.303 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -100.91 -52.99 3.16 Favored 'General case' 0 C--O 1.227 -0.102 0 N-CA-C 107.397 -1.335 . . . . 62.12 107.397 171.611 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . 0.438 ' HE3' ' HB2' ' A' ' 138' ' ' MET . 2.6 ptm -53.85 -37.6 63.8 Favored 'General case' 0 C--O 1.223 -0.313 0 C-N-CA 123.989 0.915 . . . . 65.03 111.682 -175.184 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -49.72 -44.98 48.64 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.124 0.97 . . . . 73.32 113.13 178.488 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -68.76 -61.65 1.72 Allowed 'General case' 0 CA--C 1.519 -0.228 0 C-N-CA 125.922 1.689 . . . . 61.13 107.188 -176.537 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -44.23 -42.97 6.92 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.713 1.605 . . . . 62.0 111.777 177.331 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -64.97 -58.64 5.59 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 124.925 1.29 . . . . 72.41 111.428 -177.138 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.49 -37.46 86.88 Favored 'General case' 0 C--N 1.342 0.272 0 CA-C-N 119.733 1.152 . . . . 70.31 110.626 -179.211 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 51.0 mt -56.83 -43.16 80.8 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 123.859 0.863 . . . . 75.02 110.236 178.477 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -58.35 -46.26 86.6 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 119.153 0.888 . . . . 72.44 110.611 -177.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -67.96 -34.87 77.38 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 123.527 0.731 . . . . 74.14 110.721 -178.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -59.22 -52.59 65.01 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 107.76 -1.2 . . . . 72.13 107.76 175.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 -69.87 16.56 0.06 Allowed 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 126.208 1.803 . . . . 74.34 115.698 -174.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 57.93 17.51 4.37 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 126.572 1.949 . . . . 73.53 114.162 175.031 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 30.1 t -69.64 132.99 32.61 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 N-CA-C 108.4 -0.963 . . . . 74.1 108.4 -176.553 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -130.13 -4.0 4.46 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 124.58 1.152 . . . . 71.31 113.07 -177.452 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -169.1 -174.82 37.95 Favored Glycine 0 CA--C 1.526 0.75 0 C-N-CA 126.283 1.896 . . . . 54.23 110.064 174.291 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.416 ' HA ' ' C ' ' A' ' 154' ' ' PRO . 4.8 m -143.21 159.47 55.51 Favored Pre-proline 0 CA--C 1.537 0.474 0 C-N-CA 125.99 1.716 . . . . 74.23 109.871 -172.04 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . 0.416 ' C ' ' HA ' ' A' ' 153' ' ' VAL . 27.8 Cg_endo -61.45 162.57 42.49 Favored 'Cis proline' 0 N--CA 1.455 -0.792 0 C-N-CA 124.647 -0.98 . . . . 64.4 111.206 -11.319 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 6.5 m -156.97 138.64 14.13 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 107.026 -1.472 . . . . 40.53 107.026 176.82 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 98.8 mtp -114.11 158.11 21.7 Favored 'General case' 0 N--CA 1.438 -1.064 0 N-CA-C 108.067 -1.086 . . . . 71.02 108.067 171.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 37.6 t -140.77 134.04 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 N-CA-C 106.148 -1.797 . . . . 63.2 106.148 177.59 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.405 HG23 ' CE1' ' A' ' 164' ' ' PHE . 13.1 t -102.24 119.44 50.55 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.9 0 N-CA-C 105.92 -1.881 . . . . 72.42 105.92 171.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 15.4 t30 56.01 24.28 7.59 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 128.512 2.725 . . . . 62.23 114.285 158.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 61.64 30.84 75.87 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 127.287 2.375 . . . . 54.25 113.823 -172.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 42.6 mttt -131.81 -34.79 1.29 Allowed 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 119.427 1.614 . . . . 74.23 113.344 -175.686 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -124.33 128.24 48.8 Favored 'General case' 0 CA--C 1.512 -0.512 0 N-CA-C 108.941 -0.763 . . . . 75.31 108.941 -179.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 26.5 ttp85 -107.72 136.62 47.16 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 105.141 -2.17 . . . . 64.34 105.141 174.123 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . 0.405 ' CE1' HG23 ' A' ' 158' ' ' VAL . 9.8 p90 -150.51 170.1 19.91 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 107.705 -1.22 . . . . 73.41 107.705 178.102 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . 0.422 ' H ' ' HB2' ' A' ' 168' ' ' SER . 9.7 p30 -167.65 177.47 5.84 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 108.81 -0.811 . . . . 74.45 108.81 -178.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 16.5 mt -58.94 -40.85 81.41 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 C-N-CA 124.942 1.297 . . . . 65.24 108.615 -174.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -74.62 -39.29 41.38 Favored Glycine 0 N--CA 1.447 -0.602 0 CA-C-O 118.851 -0.972 . . . . 64.22 111.626 -178.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . 0.422 ' HB2' ' H ' ' A' ' 165' ' ' ASP . 2.6 m -57.97 -59.45 5.25 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 124.462 1.105 . . . . 72.23 109.695 174.607 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -61.82 -51.11 69.6 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 109.718 -0.475 . . . . 72.3 109.718 -176.366 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 132.63 4.14 3.55 Favored Glycine 0 CA--C 1.528 0.896 0 CA-C-O 119.137 -0.813 . . . . 53.44 113.855 177.024 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 164.36 163.65 17.87 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 108.445 -1.862 . . . . 71.54 108.445 -174.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -66.06 -43.86 8.33 Favored 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 122.474 2.116 . . . . 71.33 110.079 -173.495 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -54.1 -38.61 65.55 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 125.199 1.399 . . . . 72.34 111.766 173.038 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -76.1 -26.25 56.25 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.432 1.093 . . . . 74.13 109.511 -173.142 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -56.64 -48.3 77.85 Favored 'General case' 0 CA--C 1.528 0.106 0 C-N-CA 123.997 0.919 . . . . 73.1 109.696 177.196 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 61.8 mt -62.05 -34.23 75.87 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 118.127 0.421 . . . . 62.03 110.777 179.052 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -54.6 -42.33 71.0 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 123.496 0.718 . . . . 72.54 110.289 175.877 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.414 ' HA ' HD13 ' A' ' 178' ' ' LEU . 4.4 mm? -73.25 -46.11 51.97 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-O 118.008 -0.996 . . . . 74.44 110.237 173.357 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.464 ' HB1' ' CH2' ' A' ' 50' ' ' TRP . . . -55.18 -34.94 64.28 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 118.843 0.747 . . . . 72.43 112.11 -174.047 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -94.24 -32.11 13.81 Favored 'General case' 0 C--N 1.333 -0.147 0 C-N-CA 124.859 1.264 . . . . 75.33 110.059 -167.401 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 35.5 t80 -64.69 -58.28 6.72 Favored 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 123.991 0.916 . . . . 73.32 110.497 167.521 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 56.1 mt -58.01 -35.77 71.71 Favored 'General case' 0 C--O 1.224 -0.268 0 C-N-CA 124.825 1.25 . . . . 73.14 112.294 -164.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 38.1 mt -45.09 -52.8 1.79 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 C-N-CA 124.279 1.031 . . . . 72.21 109.974 173.223 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -58.16 -34.53 70.4 Favored 'General case' 0 N--CA 1.447 -0.596 0 O-C-N 121.213 -0.929 . . . . 75.21 111.534 -177.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.3 -32.77 68.77 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 123.71 0.804 . . . . 54.45 110.934 -178.34 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -93.1 -43.87 8.66 Favored 'General case' 0 C--O 1.224 -0.256 0 CA-C-N 119.954 1.252 . . . . 64.44 112.298 168.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.54 -34.24 68.94 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 125.5 1.52 . . . . 61.53 110.308 -172.335 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -60.35 -22.08 62.85 Favored 'General case' 0 C--N 1.339 0.147 0 C-N-CA 124.776 1.23 . . . . 75.13 111.933 178.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -55.67 -38.26 69.37 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 123.609 0.764 . . . . 63.41 110.535 173.314 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -80.84 -21.34 40.86 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 113.557 0.947 . . . . 23.21 113.557 178.166 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 62.1 tttt 44.62 58.41 3.9 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.232 1.813 . . . . 42.35 112.55 -177.434 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.02 0 C-N-CA 123.957 0.903 . . . . 74.41 109.976 176.045 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.476 0 N-CA-C 110.241 -1.144 . . . . 53.41 110.241 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 49.2 68.56 0.7 Allowed 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 127.108 2.163 . . . . 74.23 110.313 175.507 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -81.69 11.14 5.05 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 113.735 -1.575 . . . . 71.42 114.565 -159.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 36.1 m-85 -134.65 175.56 9.44 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 126.696 1.998 . . . . 72.44 108.89 -172.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 31.9 m -137.13 136.95 38.72 Favored 'General case' 0 CA--C 1.535 0.387 0 O-C-N 119.972 -1.705 . . . . 65.23 110.679 172.251 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -68.6 153.13 44.36 Favored 'General case' 0 C--N 1.342 0.271 0 CA-C-O 121.709 0.766 . . . . 61.13 109.043 178.162 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 75.58 -31.7 1.21 Allowed Glycine 0 CA--C 1.53 0.988 0 C-N-CA 124.134 0.873 . . . . 50.31 111.309 -165.113 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 38.5 tttt -95.43 -84.26 0.34 Allowed 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 118.946 1.373 . . . . 74.42 110.264 -170.027 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -68.6 -25.17 64.73 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.794 1.637 . . . . 65.5 110.655 -178.523 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 31.9 p90 -162.09 170.27 19.48 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 107.35 -1.352 . . . . 74.44 107.35 -173.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 13.7 t -134.63 108.24 10.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 107.958 -1.127 . . . . 62.23 107.958 -178.426 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -63.56 152.57 38.32 Favored 'General case' 0 N--CA 1.44 -0.928 0 O-C-N 121.178 -0.951 . . . . 74.22 108.968 164.102 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -120.13 107.08 12.6 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 125.565 1.546 . . . . 75.31 109.535 179.734 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 70.3 m -67.02 21.06 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.864 1.666 . . . . 43.33 114.193 173.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 4.4 t -132.3 81.92 59.45 Favored Pre-proline 0 CA--C 1.53 0.195 0 N-CA-C 106.674 -1.602 . . . . 62.24 106.674 153.616 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -72.25 178.58 5.89 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 123.031 2.487 . . . . 72.23 111.139 -175.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 39.4 t -137.48 142.06 35.89 Favored Pre-proline 0 CA--C 1.539 0.538 0 N-CA-C 109.15 -0.685 . . . . 73.12 109.15 -170.468 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -79.36 178.55 7.29 Favored 'Trans proline' 0 CA--C 1.536 0.599 0 C-N-CA 123.739 2.959 . . . . 53.43 111.733 172.684 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 16.2 m -131.91 172.43 16.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 126.079 1.752 . . . . 74.53 109.735 179.084 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 13.1 t -53.86 -58.74 6.15 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.831 1.253 . . . . 74.24 110.625 173.584 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -144.78 164.97 24.67 Favored Pre-proline 0 CA--C 1.531 0.234 0 O-C-N 121.301 -0.874 . . . . 74.5 111.342 173.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -80.52 -172.88 1.64 Allowed 'Trans proline' 0 N--CA 1.452 -0.966 0 C-N-CA 123.219 2.613 . . . . 63.3 110.995 170.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 104.68 -86.67 0.52 Allowed Glycine 0 N--CA 1.451 -0.321 0 N-CA-C 106.832 -2.507 . . . . 71.14 106.832 179.168 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 67.0 mttt -68.06 149.16 50.01 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-O 121.511 0.672 . . . . 71.11 109.281 170.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 29.8 mm -80.01 141.56 15.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 107.663 -1.236 . . . . 54.32 107.663 168.51 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -87.96 132.43 34.24 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 106.493 -1.669 . . . . 64.02 106.493 173.147 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 46.4 t -131.2 136.22 58.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 N-CA-C 106.181 -1.785 . . . . 55.42 106.181 169.605 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 23.5 t -135.34 123.29 38.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 N-CA-C 108.005 -1.109 . . . . 61.51 108.005 -171.006 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -91.09 145.2 24.88 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 124.948 1.299 . . . . 73.54 108.847 166.101 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.41 HD22 HG11 ' A' ' 150' ' ' VAL . 5.5 mp -125.31 137.63 54.07 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.572 1.549 . . . . 64.2 107.744 168.002 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 30.9 p90 -141.78 172.67 12.37 Favored 'General case' 0 CA--C 1.549 0.918 0 N-CA-C 113.616 0.969 . . . . 71.13 113.616 -173.277 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 27.8 t90 -156.44 150.23 24.9 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.489 1.115 . . . . 65.44 111.806 -178.218 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -60.47 -9.17 3.32 Favored 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 114.843 1.423 . . . . 72.13 114.843 -179.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -123.84 19.0 7.48 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 125.447 1.499 . . . . 54.24 114.25 -169.337 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.413 ' HB3' HG23 ' A' ' 153' ' ' VAL . 22.4 p -104.26 86.7 1.4 Allowed Pre-proline 0 CA--C 1.536 0.431 0 CA-C-N 119.782 1.791 . . . . 44.01 110.744 -175.248 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -52.47 -35.83 67.57 Favored 'Trans proline' 0 CA--C 1.534 0.476 0 C-N-CA 122.769 2.313 . . . . 74.23 113.334 -177.242 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 11.5 m170 -64.74 -24.55 67.6 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 118.341 -0.838 . . . . 74.4 112.063 -178.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 83.6 m -59.39 -53.94 52.45 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.33 1.052 . . . . 62.1 109.144 175.198 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 59.9 t80 -56.78 -40.44 75.88 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 119.253 0.933 . . . . 72.24 111.041 -176.163 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -70.16 2.37 3.74 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 113.303 0.853 . . . . 75.43 113.303 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -125.71 -29.9 3.1 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 127.602 2.361 . . . . 72.21 111.261 179.163 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -37.5 -62.13 0.65 Allowed Pre-proline 0 CA--C 1.544 0.735 0 C-N-CA 126.401 1.88 . . . . 62.2 113.708 -174.667 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -79.52 -10.68 14.53 Favored 'Trans proline' 0 N--CA 1.454 -0.818 0 CA-C-N 121.191 1.461 . . . . 72.13 114.937 -175.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 51.1 m -70.87 -41.27 71.59 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 119.605 1.093 . . . . 74.32 109.335 164.715 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 17.3 tt -81.84 -42.64 19.32 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 CA-C-O 118.136 -0.935 . . . . 62.41 111.926 -169.705 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 79.5 t -44.84 -60.22 3.3 Favored Pre-proline 0 CA--C 1.544 0.716 0 CA-C-N 120.012 1.278 . . . . 74.25 112.803 177.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -73.79 -15.0 24.16 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 122.284 1.989 . . . . 72.41 112.112 -174.377 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 76.0 t90 -64.53 -61.59 2.12 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 119.73 1.15 . . . . 71.33 108.498 163.147 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -63.96 -34.53 78.2 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 113.008 0.744 . . . . 54.35 113.008 -171.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -59.13 -36.5 75.32 Favored 'General case' 0 C--O 1.237 0.441 0 O-C-N 121.389 -0.819 . . . . 51.3 110.908 175.16 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 29.9 mmmt -93.98 10.01 35.23 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.879 1.271 . . . . 61.04 111.863 -170.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 23.1 mt -61.6 157.54 46.72 Favored Pre-proline 0 CA--C 1.54 0.564 0 CA-C-N 119.5 1.045 . . . . 72.44 112.811 -178.082 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -77.98 178.05 8.06 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 124.991 3.794 . . . . 65.5 111.695 178.246 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -74.45 -0.2 16.69 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.032 1.333 . . . . 75.04 114.437 -174.302 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -126.22 18.75 7.65 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.782 1.233 . . . . 32.22 110.726 -172.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 42.5 t -124.82 139.18 51.76 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 N-CA-C 108.063 -1.088 . . . . 53.53 108.063 170.161 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 82.7 t60 -113.59 153.25 29.14 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 125.6 1.56 . . . . 70.33 106.908 166.33 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.472 ' CE2' ' HD2' ' A' ' 62' ' ' ARG . 24.2 t80 -136.57 141.5 43.33 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 108.63 -0.878 . . . . 70.14 108.63 -178.833 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 60.2 t -134.38 147.19 30.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 C-N-CA 126.622 1.969 . . . . 61.3 107.253 -170.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.472 ' HD2' ' CE2' ' A' ' 60' ' ' PHE . 0.0 OUTLIER -126.79 121.73 32.78 Favored 'General case' 0 CA--C 1.516 -0.358 0 N-CA-C 104.35 -2.463 . . . . 73.03 104.35 176.298 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 32.7 mt -127.09 151.97 75.08 Favored Pre-proline 0 N--CA 1.467 0.386 0 CA-C-N 118.961 0.8 . . . . 50.03 111.112 177.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -72.57 130.56 16.15 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 122.194 1.929 . . . . 62.52 109.828 178.003 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -75.48 100.8 4.62 Favored 'General case' 0 CA--C 1.536 0.409 0 O-C-N 121.42 -0.8 . . . . 45.42 109.006 176.389 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 42.8 mt -95.43 78.43 3.41 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.657 1.583 . . . . 52.32 111.548 -174.442 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -110.38 12.97 22.96 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 114.275 1.213 . . . . 73.14 114.275 -169.535 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 108.95 152.06 14.91 Favored Glycine 0 CA--C 1.518 0.275 0 C-N-CA 125.259 1.409 . . . . 52.11 110.626 173.721 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 52.82 -139.57 32.12 Favored Glycine 0 CA--C 1.521 0.439 0 C-N-CA 123.641 0.639 . . . . 13.24 111.952 -173.552 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 5.5 tp -58.62 -20.87 17.31 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 C-N-CA 124.963 1.305 . . . . 71.14 112.507 -168.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 23.6 m95 -57.3 -38.26 73.72 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.898 0.879 . . . . 73.21 110.92 173.449 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 14.0 m-80 -74.8 -43.46 54.63 Favored 'General case' 0 C--N 1.339 0.147 0 O-C-N 121.804 -0.56 . . . . 61.21 111.794 175.356 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 61.3 t -57.67 -54.57 29.71 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 C-N-CA 124.31 1.044 . . . . 73.11 108.588 -177.176 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 57.5 m170 -79.4 24.67 0.34 Allowed 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.662 1.585 . . . . 72.12 111.546 175.605 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -114.85 -33.53 1.68 Allowed Glycine 0 CA--C 1.524 0.637 0 C-N-CA 125.573 1.559 . . . . 64.23 111.69 170.722 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 31.6 mt-30 -63.29 -31.62 72.82 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 118.402 -0.808 . . . . 72.33 112.771 -179.111 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 16.7 ttp -60.42 -50.71 72.51 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-N 119.754 1.161 . . . . 73.24 111.535 -174.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 17.5 t80 -53.78 -50.9 65.07 Favored 'General case' 0 CA--C 1.53 0.178 0 O-C-N 123.72 0.638 . . . . 75.42 109.933 -179.63 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 76.0 mt -61.11 -36.73 80.49 Favored 'General case' 0 C--O 1.222 -0.378 0 CA-C-O 117.774 -1.108 . . . . 72.51 111.155 177.401 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.422 ' HA ' HD11 ' A' ' 134' ' ' ILE . 1.5 m -66.89 -35.26 79.61 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 120.622 1.556 . . . . 74.15 111.09 178.23 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.19 -56.83 16.74 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 107.544 -1.28 . . . . 73.42 107.544 178.085 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -66.29 -25.29 66.79 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.2 1.4 . . . . 60.4 112.744 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 16.1 t -73.07 -6.8 47.99 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.37 1.468 . . . . 71.12 113.442 -175.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 9.8 mtm -84.23 -6.8 59.45 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 119.998 1.272 . . . . 53.52 112.893 162.329 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 81.6 28.54 42.82 Favored Glycine 0 CA--C 1.519 0.33 0 C-N-CA 124.81 1.195 . . . . 50.42 110.601 177.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 26.2 m -86.04 123.18 39.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 107.012 -1.477 . . . . 72.51 107.012 171.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 47.8 tt0 -75.7 -59.31 2.81 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 107.251 -1.389 . . . . 71.11 107.251 171.419 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER 51.39 -172.01 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 126.993 2.117 . . . . 71.15 113.433 -173.511 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -154.69 -176.04 5.72 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 126.198 1.799 . . . . 75.32 107.686 -177.71 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 15.6 m 45.31 54.47 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 C-N-CA 126.881 2.073 . . . . 74.52 113.103 168.621 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 24.1 p-80 -72.42 31.62 0.06 Allowed 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 126.919 2.088 . . . . 74.13 114.54 -176.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.401 ' HA ' ' CD2' ' A' ' 95' ' ' PHE . 1.0 OUTLIER -63.72 -56.93 11.87 Favored 'General case' 0 C--O 1.217 -0.609 0 C-N-CA 125.584 1.554 . . . . 75.33 112.214 176.664 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -61.45 -20.03 62.66 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 120.602 1.546 . . . . 53.24 113.011 -177.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 3.8 t -62.76 -67.06 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-N 119.275 0.943 . . . . 73.14 108.51 161.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.401 ' CD2' ' HA ' ' A' ' 92' ' ' ASN . 0.1 OUTLIER -60.78 -48.68 80.69 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 107.744 -1.206 . . . . 73.43 107.744 -167.163 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.414 ' CD ' ' HE2' ' A' ' 100' ' ' LYS . 4.1 mm-40 -51.89 -33.66 37.72 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 128.006 2.522 . . . . 75.33 110.368 -176.024 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.447 ' HA ' ' HB2' ' A' ' 101' ' ' GLU . . . -79.56 -13.81 59.28 Favored 'General case' 0 N--CA 1.444 -0.746 0 O-C-N 120.621 -1.3 . . . . 73.34 113.215 -172.177 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 14.3 mt -114.01 -49.33 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 N-CA-C 106.008 -1.849 . . . . 60.42 106.008 -175.561 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 61.5 m-70 -76.08 -40.27 53.48 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 124.22 1.008 . . . . 74.25 112.564 -176.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.414 ' HE2' ' CD ' ' A' ' 96' ' ' GLU . 25.5 mtmt -93.59 -37.8 11.69 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 120.431 1.469 . . . . 75.01 111.69 172.179 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.447 ' HB2' ' HA ' ' A' ' 97' ' ' ALA . 27.5 mt-10 -122.55 32.47 5.75 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 113.214 0.82 . . . . 70.22 113.214 -160.264 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 41.2 t-80 -41.88 97.67 0.01 OUTLIER 'General case' 0 C--O 1.241 0.639 0 C-N-CA 129.472 3.109 . . . . 65.03 112.432 -172.67 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.09 27.61 1.58 Allowed 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 126.133 1.773 . . . . 71.05 112.036 175.841 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 2.7 tttp 65.4 -61.53 0.24 Allowed 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 128.72 2.808 . . . . 72.41 112.004 -175.184 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 87.7 mt 74.96 17.03 2.81 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 127.532 2.333 . . . . 75.1 113.696 174.475 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -85.14 33.71 0.55 Allowed 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.018 1.327 . . . . 74.11 112.703 -174.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -152.29 158.21 33.63 Favored Pre-proline 0 C--O 1.237 0.412 0 C-N-CA 124.425 1.09 . . . . 73.44 108.974 167.256 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -64.99 -41.47 17.1 Favored 'Trans proline' 0 N--CA 1.451 -0.975 0 C-N-CA 122.147 1.898 . . . . 63.52 111.331 177.463 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -58.76 -47.21 85.48 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 118.746 0.703 . . . . 64.25 110.03 176.175 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -62.7 -31.67 72.62 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 123.362 0.665 . . . . 72.34 111.473 -176.076 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 74.1 mtm -81.06 -35.76 31.36 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 118.475 -0.774 . . . . 75.21 112.5 173.22 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -77.66 -47.95 17.99 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 119.29 0.95 . . . . 55.44 111.449 -172.486 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -58.05 -31.83 67.42 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 125.477 1.511 . . . . 52.43 111.866 -172.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 38.4 t80 -75.08 -48.2 25.04 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 123.851 0.86 . . . . 72.25 112.22 174.653 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 88.4 mt -65.63 -25.07 67.21 Favored 'General case' 0 N--CA 1.455 -0.186 0 O-C-N 121.333 -0.854 . . . . 62.0 110.489 -176.018 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -53.4 -23.88 10.94 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.975 0.91 . . . . 72.54 112.579 171.446 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -84.09 -15.5 69.5 Favored Glycine 0 CA--C 1.53 0.971 0 C-N-CA 124.258 0.932 . . . . 72.21 114.272 174.483 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 45.5 mmtt -129.03 39.79 3.73 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 120.294 2.047 . . . . 74.44 110.691 -162.072 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 74.34 39.75 42.44 Favored Glycine 0 N--CA 1.448 -0.529 0 N-CA-C 110.989 -0.845 . . . . 75.23 110.989 170.076 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 89.2 t -128.56 143.88 39.7 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 N-CA-C 106.068 -1.827 . . . . 74.41 106.068 172.138 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 16.0 t0 -95.64 129.15 42.93 Favored 'General case' 0 C--N 1.331 -0.212 0 O-C-N 121.909 -0.495 . . . . 61.32 109.67 177.484 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -67.57 -46.96 71.18 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 123.268 0.627 . . . . 73.51 110.405 -177.265 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -57.31 -37.67 72.85 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 117.731 0.241 . . . . 72.32 110.993 -174.4 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 16.3 mmtp -97.17 -29.21 13.72 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-O 117.227 -1.368 . . . . 70.0 108.756 -169.097 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 89.6 t80 -51.71 -60.42 3.18 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 119.164 0.893 . . . . 72.1 109.391 165.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 7.1 mt -65.49 -42.81 91.76 Favored 'General case' 0 C--O 1.234 0.253 0 O-C-N 121.875 -0.516 . . . . 71.42 110.693 -170.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 2.5 m -58.04 -56.02 27.39 Favored 'General case' 0 C--O 1.223 -0.321 0 CA-C-O 118.321 -0.847 . . . . 74.35 109.007 176.052 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 28.8 m -59.68 -39.68 85.31 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.749 0.82 . . . . 62.12 111.215 -175.617 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -57.2 -46.81 82.54 Favored 'General case' 0 C--O 1.236 0.357 0 O-C-N 121.353 -0.842 . . . . 72.51 109.576 175.55 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -89.26 30.48 0.97 Allowed 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.309 1.044 . . . . 75.13 111.983 175.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 72.7 m -110.89 150.62 28.92 Favored 'General case' 0 C--O 1.236 0.363 0 O-C-N 120.699 -1.251 . . . . 73.01 109.926 171.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -59.91 -22.9 63.01 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.407 1.083 . . . . 73.33 111.616 175.098 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -44.87 -55.76 5.14 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 125.345 1.458 . . . . 71.52 111.955 172.59 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.422 HD11 ' HA ' ' A' ' 80' ' ' THR . 45.4 mm -66.73 -34.87 72.88 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.253 0 C-N-CA 123.104 0.562 . . . . 71.25 109.806 -178.551 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 25.8 tttm -57.35 -39.46 75.97 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 118.717 -0.658 . . . . 72.01 110.501 179.681 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -69.79 -27.67 72.94 Favored Glycine 0 CA--C 1.523 0.572 0 C-N-CA 124.075 0.845 . . . . 53.53 111.98 -176.379 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -80.31 -48.56 12.81 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 108.502 -0.925 . . . . 70.21 108.502 175.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 91.6 mmm -54.16 -45.84 72.16 Favored 'General case' 0 C--N 1.339 0.119 0 C-N-CA 125.305 1.442 . . . . 70.31 111.118 -178.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -63.86 -44.77 92.11 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 119.087 0.858 . . . . 65.44 111.687 -176.03 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 33.4 mttt -60.77 -61.47 2.56 Favored 'General case' 0 C--N 1.341 0.219 0 N-CA-C 108.922 -0.77 . . . . 71.15 108.922 171.641 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -47.41 -40.98 19.13 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.283 1.033 . . . . 45.23 111.564 -175.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -59.21 -64.92 0.77 Allowed 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 124.171 0.989 . . . . 63.51 108.823 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.85 -23.03 65.97 Favored 'General case' 0 N--CA 1.461 0.097 0 CA-C-O 118.278 -0.868 . . . . 74.12 112.723 -175.401 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 55.9 mt -59.73 -50.28 74.44 Favored 'General case' 0 C--O 1.227 -0.122 0 CA-C-N 118.972 0.805 . . . . 65.42 109.662 173.618 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -63.88 -32.86 74.52 Favored 'General case' 0 CA--C 1.537 0.476 0 O-C-N 121.908 -0.495 . . . . 62.23 111.307 -172.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' MET . . . . . 0.406 ' H ' ' HG2' ' A' ' 146' ' ' MET . 11.3 mmt -62.36 -45.44 93.17 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 125.502 1.521 . . . . 63.3 110.381 174.811 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -58.24 -47.2 84.27 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 109.017 -0.734 . . . . 75.23 109.017 -177.438 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 31.8 m-85 -68.85 5.31 1.15 Allowed 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 126.417 1.887 . . . . 72.54 114.674 -176.297 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 62.6 mt-30 54.04 28.88 9.34 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 126.234 1.814 . . . . 64.21 112.363 -179.272 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.412 HG13 HG21 ' A' ' 155' ' ' THR . 44.3 t -78.53 135.95 24.93 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 N-CA-C 107.424 -1.325 . . . . 74.11 107.424 176.142 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -142.66 14.96 1.96 Allowed 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 121.501 0.667 . . . . 72.23 111.397 -176.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -173.76 177.27 46.14 Favored Glycine 0 CA--C 1.52 0.398 0 C-N-CA 125.939 1.733 . . . . 63.43 110.144 174.503 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.416 ' HA ' ' C ' ' A' ' 154' ' ' PRO . 12.4 m -141.14 150.89 60.31 Favored Pre-proline 0 CA--C 1.539 0.523 0 C-N-CA 124.337 1.055 . . . . 73.2 109.793 179.365 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . 0.416 ' C ' ' HA ' ' A' ' 153' ' ' VAL . 38.8 Cg_endo -68.91 150.18 87.56 Favored 'Cis proline' 0 N--CA 1.459 -0.526 0 C-N-CA 125.067 -0.805 . . . . 61.11 112.072 -1.005 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . 0.412 HG21 HG13 ' A' ' 150' ' ' VAL . 51.6 m -148.33 117.32 6.77 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.738 1.615 . . . . 71.41 107.197 175.461 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 96.4 mtp -94.69 158.84 15.34 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 108.38 -0.97 . . . . 64.11 108.38 167.188 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 38.2 t -140.42 138.27 36.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 106.459 -1.682 . . . . 70.34 106.459 171.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.597 HG23 ' CE1' ' A' ' 164' ' ' PHE . 95.3 t -103.53 132.32 50.13 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 N-CA-C 107.606 -1.257 . . . . 63.22 107.606 168.132 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 4.9 t30 48.79 23.63 0.7 Allowed 'General case' 0 C--N 1.331 -0.231 1 C-N-CA 132.159 4.184 . . . . 64.11 115.963 167.041 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 70.12 24.4 76.58 Favored Glycine 0 CA--C 1.527 0.792 0 C-N-CA 126.209 1.862 . . . . 63.13 114.498 -175.182 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 48.7 mttp -137.02 -28.54 0.94 Allowed 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 120.202 2.001 . . . . 74.23 113.996 -171.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -125.04 105.83 9.48 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 108.466 -0.939 . . . . 54.44 108.466 -175.001 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 32.5 ttp85 -83.03 136.73 34.39 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 105.166 -2.161 . . . . 71.21 105.166 171.331 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . 0.597 ' CE1' HG23 ' A' ' 158' ' ' VAL . 15.3 p90 -152.32 170.03 21.05 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 107.845 -1.169 . . . . 62.4 107.845 174.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -179.52 178.98 0.63 Allowed 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 123.877 0.871 . . . . 73.14 109.177 179.764 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.416 HG23 ' HA2' ' A' ' 171' ' ' GLY . 29.5 mt -45.37 -52.78 2.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 C-N-CA 129.217 3.007 . . . . 72.32 109.71 174.429 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -75.41 -21.22 77.9 Favored Glycine 0 C--N 1.338 0.639 0 CA-C-O 119.435 -0.647 . . . . 54.41 113.443 -176.737 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 14.4 m -75.19 -68.23 0.58 Allowed 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 118.492 1.146 . . . . 63.2 108.084 169.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.514 ' HB1' HD23 ' A' ' 178' ' ' LEU . . . -75.0 -31.33 61.39 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-O 117.415 -1.279 . . . . 45.14 113.443 -162.223 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 134.78 5.39 2.5 Favored Glycine 0 CA--C 1.533 1.201 0 N-CA-C 117.171 1.628 . . . . 62.03 117.171 174.265 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . 0.416 ' HA2' HG23 ' A' ' 166' ' ' ILE . . . 126.42 167.95 12.51 Favored Glycine 0 CA--C 1.529 0.953 0 CA-C-N 119.446 1.623 . . . . 73.31 110.378 -173.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -61.44 -40.47 47.93 Favored 'Trans proline' 0 CA--C 1.534 0.502 0 C-N-CA 123.059 2.506 . . . . 51.31 113.736 -156.294 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -65.93 -33.2 75.29 Favored 'General case' 0 CA--C 1.532 0.283 0 O-C-N 121.206 -0.934 . . . . 70.43 111.379 177.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -72.44 -25.99 61.66 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 123.274 0.63 . . . . 73.03 110.515 176.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 6.6 m -63.84 -47.44 80.76 Favored 'General case' 0 C--O 1.233 0.195 0 O-C-N 120.867 -1.146 . . . . 75.05 108.443 -178.152 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 59.9 mt -62.79 -33.26 74.83 Favored 'General case' 0 C--O 1.224 -0.258 0 CA-C-O 119.484 -0.293 . . . . 74.3 110.788 175.633 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 14.0 tptt -54.23 -36.75 63.87 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-O 118.939 -0.553 . . . . 65.2 111.089 176.132 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.514 HD23 ' HB1' ' A' ' 169' ' ' ALA . 4.6 mm? -80.09 -44.85 19.28 Favored 'General case' 0 CA--C 1.509 -0.63 0 CA-C-O 117.665 -1.16 . . . . 75.41 110.077 175.262 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -50.43 -42.41 53.89 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 119.251 0.932 . . . . 73.44 111.169 -179.327 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -82.19 -33.3 29.49 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 124.693 1.197 . . . . 74.12 109.827 -165.415 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 19.2 t80 -69.79 -51.06 37.08 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.892 1.277 . . . . 73.23 110.496 170.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 62.5 mt -61.32 -27.96 68.87 Favored 'General case' 0 N--CA 1.462 0.133 0 C-N-CA 125.274 1.429 . . . . 74.45 112.871 -174.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 24.4 mt -56.61 -63.11 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 N-CA-C 108.178 -1.045 . . . . 65.32 108.178 171.539 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 7.8 tm-20 -60.36 -33.38 72.36 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.646 1.179 . . . . 72.24 111.324 -173.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 43.6 tptt -48.72 -57.99 5.46 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 124.344 1.058 . . . . 65.34 109.971 173.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 25.0 mm-40 -77.07 -34.55 57.01 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 123.504 0.721 . . . . 74.12 111.715 -178.419 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.75 -36.87 83.46 Favored 'General case' 0 N--CA 1.462 0.155 0 O-C-N 120.959 -1.088 . . . . 60.13 109.99 -174.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -62.81 -14.07 41.01 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.103 0.961 . . . . 71.0 112.065 177.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -61.13 -28.14 68.89 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 118.886 0.766 . . . . 73.25 111.575 169.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . 59.41 14.68 3.92 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 127.251 2.22 . . . . 74.41 113.527 169.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . 0.264 0.0 OUTLIER 57.24 24.98 10.52 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 126.266 1.826 . . . . 72.55 114.381 -169.284 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.172 0 C-N-CA 124.588 1.155 . . . . 75.53 110.327 177.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.176 0 N-CA-C 109.412 -1.475 . . . . 63.21 109.412 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.86 147.34 51.85 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 119.387 1.593 . . . . 75.51 110.723 176.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -142.85 8.02 1.67 Allowed 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 124.527 1.131 . . . . 72.32 111.752 -173.413 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 -145.97 157.77 43.88 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 125.016 1.327 . . . . 75.13 109.383 -170.451 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 51.1 m -134.06 141.26 47.12 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-O 121.692 0.758 . . . . 74.43 109.698 -179.115 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.43 144.28 57.29 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 124.12 0.968 . . . . 50.23 110.021 -178.779 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 79.1 -46.07 2.9 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 126.059 1.79 . . . . 71.13 111.099 -170.196 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 9.2 tptp -67.14 -70.42 0.25 Allowed 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 125.467 1.507 . . . . 72.53 109.748 -172.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.432 ' HB3' HD21 ' A' ' 178' ' ' LEU . 11.2 mp0 -88.24 -27.49 21.73 Favored 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 123.46 0.704 . . . . 71.43 110.735 -176.829 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 39.7 p90 -156.12 177.11 11.8 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 121.087 -1.008 . . . . 74.31 110.267 -171.462 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 17.7 t -134.1 112.73 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 N-CA-C 108.577 -0.897 . . . . 73.32 108.577 -175.266 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.32 163.66 26.09 Favored 'General case' 0 C--N 1.329 -0.314 0 O-C-N 120.652 -1.28 . . . . 75.11 109.01 164.459 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -132.01 113.52 13.49 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 123.959 0.904 . . . . 53.22 109.107 -176.241 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.9 m -61.16 -10.49 6.55 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 114.657 1.355 . . . . 45.53 114.657 -179.095 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 15.7 m -117.86 79.88 13.86 Favored Pre-proline 0 N--CA 1.448 -0.57 0 CA-C-N 119.834 1.197 . . . . 71.2 108.312 171.581 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_endo -69.06 174.79 8.4 Favored 'Trans proline' 0 N--CA 1.451 -1.012 0 C-N-CA 122.566 2.178 . . . . 72.53 111.336 175.175 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 50.5 t -143.22 134.76 12.84 Favored Pre-proline 0 C--N 1.33 -0.271 0 N-CA-C 106.203 -1.777 . . . . 51.03 106.203 -176.437 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -75.37 173.86 13.79 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 121.067 1.178 . . . . 63.3 110.56 176.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 16.3 m -116.2 165.19 11.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 C-N-CA 124.864 1.266 . . . . 63.51 108.87 175.006 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 3.4 m -48.75 -53.77 17.69 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 124.823 1.249 . . . . 71.43 112.418 174.742 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 2.2 pm0 -147.45 159.56 41.37 Favored Pre-proline 0 N--CA 1.449 -0.496 0 CA-C-N 120.413 1.46 . . . . 72.03 111.045 177.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -65.09 -177.07 0.54 Allowed 'Trans proline' 0 CA--C 1.544 1.021 0 C-N-CA 123.902 3.068 . . . . 74.33 111.135 166.218 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 119.97 -80.3 0.32 Allowed Glycine 0 CA--C 1.525 0.692 0 C-N-CA 125.211 1.386 . . . . 52.21 111.34 174.358 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -109.04 144.72 36.69 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 124.192 0.997 . . . . 71.32 109.232 179.122 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 47.2 mm -59.26 146.74 8.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 C-N-CA 124.481 1.112 . . . . 73.34 108.484 175.397 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -107.71 90.16 3.22 Favored 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 105.872 -1.899 . . . . 75.31 105.872 175.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 47.8 t -84.22 125.36 40.23 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.174 0 N-CA-C 105.505 -2.035 . . . . 72.53 105.505 170.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 41.9 t -119.35 113.39 41.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 N-CA-C 107.291 -1.374 . . . . 72.21 107.291 -175.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -72.01 131.6 43.13 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 107.83 -1.174 . . . . 54.44 107.83 156.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.1 mp -119.68 130.59 55.12 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 106.826 -1.546 . . . . 70.34 106.826 165.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 6.1 p90 -142.75 170.35 15.87 Favored 'General case' 0 C--O 1.237 0.416 0 O-C-N 123.9 0.75 . . . . 74.53 112.639 -170.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . 0.458 ' HB3' HG21 ' A' ' 153' ' ' VAL . 27.4 t90 -142.44 149.02 38.73 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 127.224 2.21 . . . . 62.31 108.344 -178.291 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 9.3 p90 -60.67 -20.11 60.1 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 115.905 1.817 . . . . 71.13 115.905 -172.178 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -100.69 -89.13 2.04 Favored Glycine 0 N--CA 1.449 -0.498 0 N-CA-C 106.931 -2.468 . . . . 54.45 106.931 -176.418 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 30.8 t 44.8 80.64 0.28 Allowed Pre-proline 0 CA--C 1.538 0.483 0 C-N-CA 126.172 1.789 . . . . 71.23 112.491 175.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -59.76 -21.36 63.12 Favored 'Trans proline' 0 CA--C 1.536 0.595 0 C-N-CA 121.993 1.795 . . . . 63.34 113.493 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 18.6 m170 -82.39 -39.37 22.79 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.757 1.223 . . . . 73.11 111.047 179.638 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 74.5 m -58.21 -43.25 87.58 Favored 'General case' 0 N--CA 1.462 0.143 0 C-N-CA 124.949 1.3 . . . . 63.12 111.271 -175.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 68.5 t80 -61.39 -27.84 68.82 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.819 0.848 . . . . 73.33 111.207 178.153 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -77.89 10.76 2.58 Favored 'General case' 0 CA--C 1.544 0.719 0 O-C-N 120.598 -1.314 . . . . 65.31 112.88 174.606 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 10.9 t80 -138.43 -23.63 0.98 Allowed 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 125.796 1.639 . . . . 74.54 111.994 174.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -35.12 -66.14 0.25 Allowed Pre-proline 0 CA--C 1.541 0.622 0 C-N-CA 127.074 2.15 . . . . 71.4 112.594 176.592 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -72.07 -11.36 27.13 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 CA-C-N 120.907 1.36 . . . . 72.54 114.476 -173.297 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 82.0 m -82.15 -35.65 28.22 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 119.469 1.031 . . . . 71.4 110.072 172.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 18.7 tt -90.46 -26.03 5.33 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 O-C-N 121.989 -0.445 . . . . 73.53 111.994 -173.274 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 14.5 t -52.15 -65.1 1.12 Allowed Pre-proline 0 CA--C 1.543 0.685 0 C-N-CA 124.668 1.187 . . . . 72.25 111.214 172.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -71.98 -13.71 29.04 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 CA-C-N 121.522 1.579 . . . . 62.21 112.613 -174.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 70.8 t90 -68.03 -58.46 4.46 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 119.115 0.871 . . . . 71.23 109.331 168.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 7.2 p -62.22 -34.64 76.87 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.306 0.643 . . . . 73.33 112.476 -169.671 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -59.5 -49.49 77.58 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 118.749 0.704 . . . . 73.45 110.655 177.349 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.14 18.4 1.39 Allowed 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 124.643 1.177 . . . . 74.52 113.17 -174.162 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 26.3 mt -63.39 153.34 82.71 Favored Pre-proline 0 N--CA 1.449 -0.506 0 CA-C-N 118.476 0.58 . . . . 73.34 110.803 175.011 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -80.11 166.2 20.95 Favored 'Trans proline' 0 N--CA 1.446 -1.283 0 C-N-CA 124.679 3.586 . . . . 71.31 111.025 -179.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -65.46 -7.9 16.46 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 114.793 1.405 . . . . 71.53 114.793 -175.2 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -104.65 8.18 35.14 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 125.454 1.502 . . . . 74.23 111.62 -177.572 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 67.1 t -120.67 152.24 23.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 106.418 -1.697 . . . . 61.42 106.418 177.674 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 16.9 t60 -134.25 124.88 26.64 Favored 'General case' 0 N--CA 1.439 -1.014 0 N-CA-C 108.036 -1.098 . . . . 74.21 108.036 166.408 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 29.4 t80 -84.68 140.15 31.52 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 107.004 -1.48 . . . . 60.15 107.004 173.233 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 88.7 t -133.34 150.36 32.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 C-N-CA 126.693 1.997 . . . . 64.23 106.128 178.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 18.3 mtt180 -131.23 120.81 23.77 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 106.127 -1.805 . . . . 74.23 106.127 179.166 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 40.3 mt -127.56 151.01 74.47 Favored Pre-proline 0 N--CA 1.473 0.691 0 CA-C-N 120.369 1.441 . . . . 71.21 110.618 173.225 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -71.89 131.24 17.97 Favored 'Trans proline' 0 N--CA 1.453 -0.901 0 C-N-CA 122.357 2.038 . . . . 72.14 110.064 176.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -77.38 81.75 3.85 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 123.758 0.823 . . . . 70.42 110.717 177.208 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 33.6 mt -77.25 95.36 4.31 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.002 0.921 . . . . 73.32 109.313 -177.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 37.4 m-85 -123.49 20.05 9.59 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.158 0.983 . . . . 71.42 112.343 -177.596 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 85.79 -174.55 48.15 Favored Glycine 0 C--N 1.336 0.553 0 N-CA-C 110.702 -0.959 . . . . 70.01 110.702 -178.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 44.88 71.37 0.48 Allowed Glycine 0 CA--C 1.526 0.731 0 C-N-CA 125.308 1.432 . . . . 55.14 113.914 166.297 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . 0.256 5.5 tp 58.23 -19.85 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.739 0 C-N-CA 130.288 3.435 . . . . 73.11 115.671 -176.58 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 10.6 m95 -56.85 -39.77 74.89 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 121.277 1.853 . . . . 62.43 110.302 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 25.1 p30 -73.88 -43.67 57.8 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 125.357 1.463 . . . . 54.13 113.395 -177.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 78.9 t -56.5 -49.26 78.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 N-CA-C 108.906 -0.776 . . . . 62.2 108.906 177.345 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 43.8 m170 -72.19 -2.6 19.37 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 114.473 1.286 . . . . 73.33 114.473 179.125 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -107.02 -21.6 8.02 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 124.921 1.248 . . . . 74.02 112.475 177.517 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 54.4 tt0 -64.26 -30.93 71.96 Favored 'General case' 0 CA--C 1.539 0.527 0 O-C-N 121.716 -0.873 . . . . 75.12 111.682 -175.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -67.52 -37.52 82.89 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 126.004 1.721 . . . . 72.24 112.613 -174.495 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 26.6 t80 -64.11 -48.47 76.0 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-N 119.647 1.112 . . . . 72.43 109.018 -171.688 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 54.8 mt -56.87 -36.41 70.05 Favored 'General case' 0 C--O 1.223 -0.341 0 C-N-CA 124.228 1.011 . . . . 71.35 110.101 173.483 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.15 -44.25 76.46 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 119.764 1.165 . . . . 64.12 111.382 178.103 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -53.22 -58.62 6.42 Favored 'General case' 0 CA--C 1.529 0.14 0 N-CA-C 107.561 -1.274 . . . . 62.53 107.561 -178.749 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -67.62 -23.15 65.33 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 111.968 0.358 . . . . 72.4 111.968 -176.544 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 17.4 t -62.16 -25.53 67.82 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-O 118.485 -0.769 . . . . 54.11 112.783 178.033 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 3.2 ptp -103.1 -11.09 18.34 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 119.762 1.165 . . . . 61.23 113.372 172.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 120.58 -52.05 0.75 Allowed Glycine 0 CA--C 1.523 0.574 0 C-N-CA 125.557 1.551 . . . . 64.41 112.748 163.314 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 35.9 m 45.58 18.58 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 C-N-CA 129.227 3.011 . . . . 74.22 116.974 173.156 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 3.1 pm0 -43.39 102.95 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 126.615 1.966 . . . . 73.5 112.18 -163.421 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 32.3 t-80 -108.65 -16.45 14.19 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.031 1.332 . . . . 73.54 111.129 -173.434 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 64.72 10.83 6.32 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 126.423 1.889 . . . . 65.41 114.525 176.855 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 10.7 p -157.79 -25.56 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.852 0 N-CA-C 115.046 1.498 . . . . 70.12 115.046 178.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 73.7 m-70 60.4 -5.07 0.1 Allowed 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 117.308 2.336 . . . . 71.42 117.308 177.647 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -57.68 -46.25 84.56 Favored 'General case' 0 C--O 1.221 -0.428 0 CA-C-N 120.137 1.335 . . . . 65.11 113.085 -173.114 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -61.55 -25.84 67.57 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 119.768 1.167 . . . . 74.43 113.202 -173.354 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 82.4 t -59.11 -61.37 1.46 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 N-CA-C 107.627 -1.249 . . . . 65.33 107.627 169.369 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -61.22 -47.56 85.55 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.106 0.962 . . . . 61.03 111.05 -176.586 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -72.13 2.41 5.89 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.659 1.984 . . . . 72.41 112.124 -173.331 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -117.23 3.32 12.63 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 124.96 1.304 . . . . 63.32 112.282 171.08 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.475 HG12 HD12 ' A' ' 105' ' ' LEU . 83.8 mt -124.15 -60.94 1.81 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.373 0 N-CA-C 106.096 -1.816 . . . . 63.14 106.096 -175.595 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 83.3 m-70 -59.79 -64.87 0.79 Allowed 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 125.0 1.32 . . . . 74.23 111.237 -179.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 4.6 ptmt -82.41 -7.03 59.64 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 114.693 1.368 . . . . 75.34 114.693 -175.167 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -114.91 -37.5 4.16 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 113.665 0.987 . . . . 74.13 113.665 -173.085 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 12.1 t-160 45.63 53.06 8.92 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 127.695 2.398 . . . . 74.43 113.162 -178.355 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . 0.289 0.0 OUTLIER -70.71 12.97 0.21 Allowed 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 115.308 1.595 . . . . 71.32 115.308 172.966 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 26.2 ttmt 45.43 61.48 2.57 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 128.676 2.79 . . . . 61.21 110.863 171.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.475 HD12 HG12 ' A' ' 98' ' ' ILE . 63.1 mt -76.44 60.75 1.63 Allowed 'General case' 0 C--N 1.315 -0.93 0 C-N-CA 128.895 2.878 . . . . 54.35 107.181 177.643 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -103.03 -12.16 17.63 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 127.928 2.491 . . . . 75.14 111.11 -176.028 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -114.27 154.09 46.36 Favored Pre-proline 0 C--O 1.236 0.393 0 C-N-CA 124.967 1.307 . . . . 60.53 108.163 177.091 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -67.72 -36.35 19.18 Favored 'Trans proline' 0 N--CA 1.45 -1.067 0 C-N-CA 121.226 1.284 . . . . 73.51 110.73 -177.159 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -55.63 -55.18 35.09 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 123.559 0.743 . . . . 75.43 110.161 174.077 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -57.54 -50.86 71.71 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 125.053 1.341 . . . . 73.24 109.801 -175.597 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 51.2 mtt -55.82 -53.71 53.39 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 123.958 0.903 . . . . 72.44 111.355 178.51 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.609 ' HB1' ' HG2' ' A' ' 122' ' ' LYS . . . -71.75 -36.95 70.57 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 124.288 1.035 . . . . 71.23 110.597 -168.573 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -62.4 -42.59 99.55 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 118.699 0.682 . . . . 74.13 111.723 174.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 8.9 t80 -61.28 -51.48 68.75 Favored 'General case' 0 N--CA 1.455 -0.192 0 O-C-N 121.4 -0.813 . . . . 75.13 110.534 177.577 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 58.3 mt -70.55 -22.88 62.55 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 110.075 -0.342 . . . . 75.4 110.075 -175.647 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -58.21 -36.02 72.51 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 118.85 0.75 . . . . 63.53 109.431 171.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -71.81 -4.74 59.29 Favored Glycine 0 N--CA 1.442 -0.918 0 CA-C-O 116.459 -2.3 . . . . 34.34 115.034 170.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.505 ' HA ' ' HE2' ' A' ' 118' ' ' LYS . 5.7 mmpt? -116.74 -9.13 11.32 Favored 'General case' 0 C--N 1.348 0.537 0 CA-C-N 122.553 3.176 . . . . 71.24 114.245 -171.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 97.0 59.02 1.01 Allowed Glycine 0 N--CA 1.452 -0.234 0 N-CA-C 108.486 -1.845 . . . . 53.44 108.486 -168.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 53.7 t -142.31 153.05 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 C-N-CA 129.372 3.069 . . . . 63.51 104.089 167.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 41.6 t0 -111.67 128.91 56.21 Favored 'General case' 0 C--N 1.331 -0.221 0 O-C-N 121.116 -0.99 . . . . 64.14 108.746 -177.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.609 ' HG2' ' HB1' ' A' ' 112' ' ' ALA . 14.2 mtpt -60.75 -31.35 70.69 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 119.277 0.944 . . . . 74.23 110.374 172.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -59.81 -20.93 59.86 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 119.844 1.202 . . . . 65.25 112.214 173.66 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 65.0 mmtt -113.3 -33.11 6.06 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-N 119.8 1.182 . . . . 72.32 112.057 -175.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -62.64 -56.41 18.01 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 118.814 0.734 . . . . 72.33 109.926 -178.268 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 9.9 mt -72.76 -46.5 53.05 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.861 0.839 . . . . 74.05 111.173 -163.182 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 21.0 p -53.61 -41.79 67.03 Favored 'General case' 0 N--CA 1.444 -0.736 0 C-N-CA 125.511 1.525 . . . . 73.45 108.822 177.412 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 40.9 m -76.48 -41.39 47.36 Favored 'General case' 0 C--O 1.222 -0.356 0 N-CA-C 108.322 -0.992 . . . . 61.41 108.322 -176.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 61.6 t80 -56.57 -32.27 65.02 Favored 'General case' 0 C--O 1.235 0.337 0 O-C-N 120.709 -1.245 . . . . 72.52 110.878 178.153 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -105.17 26.4 9.38 Favored 'General case' 0 C--O 1.243 0.714 0 N-CA-C 113.432 0.901 . . . . 73.13 113.432 175.485 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 11.1 p -99.68 157.02 16.77 Favored 'General case' 0 C--O 1.234 0.275 0 O-C-N 120.919 -1.113 . . . . 74.05 111.317 175.726 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -67.19 -27.59 67.39 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 115.538 -0.755 . . . . 74.44 111.921 -175.637 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -55.09 -47.0 75.52 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 121.524 0.678 . . . . 72.24 110.324 175.734 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 32.8 mm -64.08 -37.72 80.57 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 C-N-CA 123.787 0.835 . . . . 72.5 109.149 179.4 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 10.5 mttt -58.31 -35.23 71.54 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 119.64 1.109 . . . . 75.31 110.591 172.393 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -73.51 -40.21 47.98 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 109.816 -1.314 . . . . 50.35 109.816 -173.769 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 2.3 mm100 -68.98 -43.1 75.61 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 123.391 0.676 . . . . 72.13 109.824 178.361 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 45.4 mtp -60.54 -42.76 97.19 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-O 117.495 -1.241 . . . . 64.25 111.478 177.15 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -62.8 -39.99 95.98 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 120.638 1.563 . . . . 74.45 110.839 -178.432 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 9.3 mmtt -59.62 -65.48 0.67 Allowed 'General case' 0 N--CA 1.463 0.176 0 C-N-CA 123.803 0.841 . . . . 73.23 110.316 170.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -57.92 -34.84 70.28 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 119.472 1.033 . . . . 73.2 111.257 -171.195 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 14.2 tmtt? -61.62 -61.55 2.44 Favored 'General case' 0 CA--C 1.518 -0.25 0 C-N-CA 124.895 1.278 . . . . 65.14 110.172 176.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.08 -25.98 68.35 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 119.74 1.154 . . . . 71.21 110.903 -178.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 25.4 mt -69.62 -54.24 14.92 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 118.429 -0.796 . . . . 75.21 111.712 -176.378 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -58.75 -49.32 78.08 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 118.873 0.76 . . . . 75.23 111.196 -169.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -61.03 -40.39 93.4 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 123.527 0.731 . . . . 73.12 112.515 175.742 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -67.3 -36.42 81.46 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 118.278 -0.868 . . . . 42.33 110.019 -179.526 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -67.78 14.14 0.06 Allowed 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.824 1.65 . . . . 64.21 113.359 175.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 54.29 21.52 3.19 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 127.12 2.168 . . . . 73.13 113.839 -179.023 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.449 HG13 HG21 ' A' ' 155' ' ' THR . 44.4 t -71.47 142.04 15.97 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 N-CA-C 108.576 -0.898 . . . . 62.03 108.576 179.4 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -112.64 -14.09 13.2 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 124.662 1.185 . . . . 60.14 112.717 -176.112 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 167.49 -160.16 33.71 Favored Glycine 0 N--CA 1.446 -0.699 0 N-CA-C 108.119 -1.992 . . . . 42.32 108.119 -165.398 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.458 HG21 ' HB3' ' A' ' 34' ' ' TRP . 31.0 m -138.69 157.31 72.18 Favored Pre-proline 0 CA--C 1.536 0.425 0 C-N-CA 124.345 1.058 . . . . 65.21 109.741 -178.185 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_endo -66.59 156.9 81.91 Favored 'Cis proline' 0 N--CA 1.459 -0.552 0 C-N-CA 124.738 -0.943 . . . . 74.43 111.621 -7.063 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . 0.449 HG21 HG13 ' A' ' 150' ' ' VAL . 5.6 m -156.86 138.37 13.99 Favored 'General case' 0 N--CA 1.466 0.339 0 O-C-N 121.102 -0.999 . . . . 74.01 109.239 171.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 92.1 mtp -112.32 148.64 33.79 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 125.148 1.379 . . . . 54.41 109.164 171.605 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 26.7 t -137.09 151.8 27.48 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 C-N-CA 124.623 1.169 . . . . 63.12 108.027 176.667 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 39.9 t -130.2 123.5 56.04 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 C-N-CA 126.053 1.741 . . . . 73.31 106.819 -178.351 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 16.6 m-20 50.01 21.15 0.68 Allowed 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 127.805 2.442 . . . . 65.25 114.973 173.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 51.74 45.17 55.17 Favored Glycine 0 CA--C 1.531 1.07 0 CA-C-O 117.697 -1.613 . . . . 60.15 112.924 -165.419 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 12.1 mtpp -139.44 -33.98 0.59 Allowed 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 119.595 1.697 . . . . 63.12 113.056 178.348 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -121.81 148.25 44.92 Favored 'General case' 0 CA--C 1.506 -0.729 0 N-CA-C 108.154 -1.054 . . . . 74.1 108.154 176.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 48.8 ttp85 -136.4 139.39 42.42 Favored 'General case' 0 N--CA 1.442 -0.857 0 N-CA-C 106.268 -1.753 . . . . 73.23 106.268 179.426 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 22.9 p90 -154.94 174.59 14.92 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 108.255 -1.017 . . . . 74.03 108.255 -179.364 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -177.41 173.73 1.67 Allowed 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 107.736 -1.209 . . . . 64.33 107.736 -176.59 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.42 HG13 ' H ' ' A' ' 166' ' ' ILE . 17.8 mt -45.4 -50.13 3.25 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 C-N-CA 127.964 2.506 . . . . 55.32 108.408 162.462 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -73.86 9.5 8.72 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 126.433 1.968 . . . . 30.33 114.699 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 22.6 m -120.51 -54.15 2.08 Favored 'General case' 0 N--CA 1.458 -0.047 0 CA-C-N 119.198 1.499 . . . . 71.24 109.764 163.387 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -61.25 -53.1 61.14 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.511 1.125 . . . . 62.41 110.78 -172.571 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 146.02 -17.42 1.75 Allowed Glycine 0 CA--C 1.523 0.553 0 CA-C-O 119.614 -0.548 . . . . 73.34 113.764 178.417 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 169.47 176.37 39.3 Favored Glycine 0 CA--C 1.528 0.872 0 N-CA-C 108.885 -1.686 . . . . 42.14 108.885 -169.332 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -63.9 -52.48 1.71 Allowed 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 123.072 2.515 . . . . 73.23 111.611 -175.177 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -59.8 -39.74 86.0 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 119.295 0.952 . . . . 74.24 109.732 178.053 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -60.77 -32.65 71.96 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.523 0.729 . . . . 74.42 110.494 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 26.6 m -65.63 -43.68 88.77 Favored 'General case' 0 N--CA 1.453 -0.282 0 O-C-N 120.716 -1.24 . . . . 45.33 109.617 179.083 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 48.0 mt -66.46 -28.24 68.44 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 118.891 0.768 . . . . 72.33 111.354 176.139 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 10.1 tptt -51.29 -49.23 61.67 Favored 'General case' 0 C--O 1.232 0.182 0 N-CA-C 109.005 -0.739 . . . . 73.01 109.005 169.48 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.467 HD13 ' HA ' ' A' ' 178' ' ' LEU . 4.4 mm? -74.46 -38.79 62.85 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-O 119.012 -0.518 . . . . 61.23 111.54 -178.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.08 -43.94 87.29 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 118.005 0.366 . . . . 34.22 111.099 -176.625 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -74.04 -28.52 61.46 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 123.244 0.618 . . . . 64.02 110.58 -174.471 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 9.9 t80 -74.08 -57.0 4.26 Favored 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 125.053 1.341 . . . . 74.44 110.425 178.454 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 77.8 mt -61.95 -24.7 67.16 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 124.997 1.319 . . . . 74.32 112.955 -171.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 35.6 mt -53.3 -54.94 15.06 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 C-N-CA 123.348 0.659 . . . . 72.21 109.36 170.014 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -66.07 -38.23 87.8 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 118.342 0.519 . . . . 65.21 111.229 -177.073 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . 0.45 ' HA ' ' HE3' ' A' ' 185' ' ' LYS . 0.1 OUTLIER -52.4 -46.44 66.29 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 124.325 1.05 . . . . 75.01 110.182 -176.723 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -74.64 -51.83 13.37 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 123.087 0.555 . . . . 65.25 112.082 173.237 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 3.2 tpm_? -48.07 -45.31 32.36 Favored 'General case' 0 CA--C 1.516 -0.357 0 C-N-CA 124.82 1.248 . . . . 71.42 112.086 -175.422 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -58.79 -20.27 48.47 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 125.696 1.598 . . . . 72.55 111.746 -174.566 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -59.47 -39.41 83.6 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 124.031 0.932 . . . . 74.54 111.254 172.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -132.98 42.74 3.03 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 126.318 1.847 . . . . 42.53 109.588 -168.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 40.2 tttm -134.51 85.82 2.22 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 102.583 -3.117 . . . . 24.24 102.583 174.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 55.0 mttt . . . . . 0 C--O 1.257 1.497 0 N-CA-C 107.557 -1.275 . . . . 73.54 107.557 -171.625 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.665 0 N-CA-C 108.852 -1.699 . . . . 54.44 108.852 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -76.27 -53.54 8.08 Favored 'General case' 0 CA--C 1.502 -0.888 0 C-N-CA 122.907 0.483 . . . . 60.52 111.011 -170.178 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 76.38 10.46 2.95 Favored 'General case' 0 N--CA 1.442 -0.852 0 C-N-CA 130.078 3.351 . . . . 64.22 115.556 -172.133 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 29.7 m-85 -139.83 178.1 7.48 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 126.648 1.979 . . . . 73.23 108.305 179.383 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 95.0 m -144.3 143.88 31.2 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 108.287 -1.005 . . . . 75.23 108.287 166.238 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.64 152.27 45.69 Favored 'General case' 0 C--O 1.227 -0.123 0 O-C-N 121.393 -0.817 . . . . 74.02 108.838 172.386 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 70.33 -44.37 0.58 Allowed Glycine 0 CA--C 1.534 1.224 0 C-N-CA 125.504 1.525 . . . . 30.2 112.287 -162.36 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.5 tptm -70.21 -58.57 3.63 Favored 'General case' 0 CA--C 1.519 -0.222 0 C-N-CA 126.295 1.838 . . . . 72.41 111.165 -169.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -113.78 -23.42 9.68 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 126.04 1.736 . . . . 73.53 109.965 -172.056 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 42.4 p90 -157.22 173.38 17.05 Favored 'General case' 0 N--CA 1.47 0.525 0 O-C-N 120.96 -1.088 . . . . 74.13 109.586 -176.147 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 24.9 t -135.52 117.89 21.77 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 C-N-CA 123.437 0.695 . . . . 74.53 109.193 -174.576 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.9 162.54 28.04 Favored 'General case' 0 CA--C 1.537 0.446 0 O-C-N 121.189 -0.945 . . . . 44.52 109.055 167.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -136.18 108.28 7.21 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 126.679 1.992 . . . . 71.41 108.294 -167.52 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.8 p -63.27 -0.46 0.82 Allowed 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 115.493 1.664 . . . . 74.44 115.493 -176.229 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 49.0 m -131.0 76.41 76.98 Favored Pre-proline 0 N--CA 1.451 -0.389 0 CA-C-N 119.841 1.201 . . . . 72.11 109.428 174.036 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -65.97 176.64 3.58 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 123.894 3.063 . . . . 63.13 112.688 -176.487 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 40.2 t -133.81 136.03 25.81 Favored Pre-proline 0 CA--C 1.537 0.443 0 C-N-CA 125.539 1.536 . . . . 73.53 108.336 -169.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -76.24 178.45 7.48 Favored 'Trans proline' 0 CA--C 1.534 0.509 0 C-N-CA 123.491 2.794 . . . . 60.04 111.443 176.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 27.9 m -132.85 174.1 13.81 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 C-N-CA 125.336 1.454 . . . . 54.05 109.674 170.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 73.9 m -58.45 -51.36 70.15 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 126.33 1.852 . . . . 64.22 112.335 175.002 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 41.7 tt0 -143.16 145.29 32.06 Favored Pre-proline 0 CA--C 1.534 0.361 0 C-N-CA 124.278 1.031 . . . . 73.55 108.733 -177.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -74.54 90.91 1.0 Allowed 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 123.158 2.572 . . . . 70.21 109.202 165.2 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -137.12 -94.9 0.38 Allowed Glycine 0 C--N 1.336 0.542 0 O-C-N 121.497 -0.752 . . . . 73.12 111.304 -172.387 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 12.7 mptt -80.02 159.95 26.03 Favored 'General case' 0 C--O 1.227 -0.13 0 N-CA-C 107.693 -1.225 . . . . 73.01 107.693 170.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 49.2 mm -70.46 130.46 34.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 106.135 -1.802 . . . . 65.14 106.135 167.227 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -83.8 130.48 34.94 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 106.203 -1.777 . . . . 64.3 106.203 173.422 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 13.9 t -119.42 144.17 28.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 105.813 -1.921 . . . . 63.11 105.813 166.049 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 37.8 t -133.98 101.65 3.94 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.137 0 N-CA-C 106.512 -1.662 . . . . 73.34 106.512 -174.225 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -76.17 137.33 39.99 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 106.143 -1.799 . . . . 73.34 106.143 161.115 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.4 mp -120.93 134.19 55.29 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 105.494 -2.039 . . . . 62.24 105.494 163.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 42.6 p90 -134.76 172.77 12.5 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 123.552 0.741 . . . . 73.32 110.962 -177.379 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . 0.611 ' CB ' HG21 ' A' ' 153' ' ' VAL . 22.9 t90 -148.55 167.68 24.77 Favored 'General case' 0 N--CA 1.463 0.209 0 C-N-CA 125.225 1.41 . . . . 72.04 108.644 178.405 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 17.6 t80 -67.34 -43.98 80.19 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.865 0.866 . . . . 65.3 112.026 172.253 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -95.71 22.79 37.26 Favored Glycine 0 CA--C 1.527 0.79 0 CA-C-O 119.026 -0.875 . . . . 44.13 113.954 -163.479 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.521 ' HB3' HG23 ' A' ' 153' ' ' VAL . 22.0 p -105.08 86.11 1.46 Allowed Pre-proline 0 CA--C 1.532 0.274 0 CA-C-N 118.843 1.321 . . . . 63.15 109.372 -177.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_endo -56.96 -24.97 60.07 Favored 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 122.325 2.016 . . . . 71.24 113.133 -177.093 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 15.6 m170 -68.11 -26.03 65.6 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 119.028 0.831 . . . . 73.31 111.037 178.243 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 84.6 m -65.29 -32.81 74.66 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.814 0.846 . . . . 61.23 109.48 -174.168 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -63.78 -46.35 85.6 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 125.657 1.583 . . . . 75.52 110.687 -178.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -53.58 -33.82 56.18 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 122.6 0.36 . . . . 71.11 110.467 178.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.452 ' HB2' HD11 ' A' ' 166' ' ' ILE . 2.4 t80 -87.78 -37.45 16.59 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-O 116.171 -1.871 . . . . 70.15 113.002 -175.233 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -39.23 -63.78 0.59 Allowed Pre-proline 0 N--CA 1.477 0.885 0 CA-C-N 120.724 1.602 . . . . 75.33 113.712 -168.378 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -71.95 -8.97 23.95 Favored 'Trans proline' 0 CA--C 1.535 0.525 0 CA-C-N 121.885 1.709 . . . . 70.34 114.726 -177.338 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.9 m -76.01 -44.11 41.01 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 108.311 -0.996 . . . . 75.42 108.311 167.128 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 14.5 tt -85.89 -35.93 9.99 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 CA-C-O 118.541 -0.742 . . . . 75.41 112.01 -169.402 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.617 HG21 HD21 ' A' ' 92' ' ' ASN . 68.9 t -49.79 -59.97 5.89 Favored Pre-proline 0 CA--C 1.541 0.621 0 CA-C-N 120.358 1.435 . . . . 63.34 111.479 176.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -70.12 -20.6 32.91 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 121.332 1.355 . . . . 65.4 112.16 -174.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 81.9 t90 -61.01 -54.28 46.83 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 117.559 -1.21 . . . . 73.13 111.204 175.392 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.2 t -57.99 -40.7 81.37 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 120.646 1.566 . . . . 62.15 111.132 -179.118 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -62.8 -31.56 72.58 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 121.36 0.6 . . . . 74.33 110.5 -178.75 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -104.96 39.68 1.66 Allowed 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 126.175 1.79 . . . . 65.22 112.653 178.135 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 19.2 mt -89.51 160.26 42.34 Favored Pre-proline 0 C--O 1.238 0.454 0 C-N-CA 126.855 2.062 . . . . 62.4 109.995 165.389 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -78.99 175.85 10.49 Favored 'Trans proline' 0 N--CA 1.451 -0.989 0 C-N-CA 124.772 3.648 . . . . 34.43 112.015 175.312 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -72.35 -4.82 32.16 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 114.537 1.31 . . . . 72.03 114.537 -173.646 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -111.32 5.49 19.83 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 126.681 1.992 . . . . 75.33 111.907 -173.423 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 34.8 t -119.98 156.56 22.69 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 C-N-CA 124.658 1.183 . . . . 71.34 108.377 177.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 83.0 t60 -147.79 116.48 6.7 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.251 1.82 . . . . 74.22 108.694 -178.081 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -93.54 131.4 38.81 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 124.908 1.283 . . . . 73.43 109.801 -177.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 43.8 t -119.98 146.61 24.52 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 C-N-CA 124.703 1.201 . . . . 71.32 108.049 178.627 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 17.4 mtm180 -123.75 132.47 53.81 Favored 'General case' 0 CA--C 1.504 -0.794 0 N-CA-C 107.565 -1.272 . . . . 71.11 107.565 168.658 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 26.7 mt -141.76 153.64 64.9 Favored Pre-proline 0 C--N 1.321 -0.649 0 C-N-CA 124.388 1.075 . . . . 60.21 108.61 -179.513 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -73.39 154.64 50.91 Favored 'Trans proline' 0 N--CA 1.446 -1.278 0 C-N-CA 121.328 1.352 . . . . 71.43 111.772 178.365 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -97.96 72.89 2.23 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 125.521 1.528 . . . . 61.52 107.847 179.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 84.3 mt -74.31 78.73 1.84 Allowed 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.374 1.069 . . . . 75.25 111.238 -170.497 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -112.95 54.33 0.73 Allowed 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 125.242 1.417 . . . . 74.42 110.886 -176.409 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 60.17 173.5 0.83 Allowed Glycine 0 CA--C 1.529 0.928 0 C-N-CA 126.914 2.197 . . . . 61.23 114.615 178.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 53.0 -147.8 14.88 Favored Glycine 0 CA--C 1.53 1.015 0 O-C-N 121.282 -1.128 . . . . 75.22 111.193 -179.444 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -64.53 -10.95 9.71 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 O-C-N 122.01 -0.7 . . . . 74.22 112.886 179.518 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . 0.455 ' CH2' HG22 ' A' ' 153' ' ' VAL . 34.6 m95 -70.55 -28.53 64.99 Favored 'General case' 0 C--N 1.341 0.201 0 CA-C-N 119.9 1.227 . . . . 74.51 110.775 171.524 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -72.02 -45.46 60.8 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 119.103 -1.039 . . . . 72.45 109.449 166.373 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.43 ' HA ' ' NE2' ' A' ' 76' ' ' GLN . 75.6 t -64.17 -55.65 20.77 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 N-CA-C 111.917 0.339 . . . . 64.24 111.917 -167.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 28.3 m170 -70.72 6.98 1.24 Allowed 'General case' 0 CA--C 1.535 0.386 0 O-C-N 121.529 -0.732 . . . . 74.22 112.468 179.573 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -102.69 -33.71 4.33 Favored Glycine 0 N--CA 1.439 -1.128 0 CA-C-O 118.63 -1.094 . . . . 55.0 111.36 173.36 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.43 ' NE2' ' HA ' ' A' ' 73' ' ' VAL 0.417 0.0 OUTLIER -71.25 -36.56 71.83 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 118.951 1.376 . . . . 73.45 112.146 -166.029 . . . . . . . . 4 4 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -53.82 -45.32 70.81 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-O 116.192 -1.861 . . . . 73.14 113.253 175.819 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 50.1 t80 -45.96 -52.2 12.06 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 125.736 1.614 . . . . 74.05 109.668 -177.126 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 18.1 mt -60.34 -44.06 95.88 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 126.605 1.962 . . . . 70.44 110.555 -177.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -64.51 -40.38 95.53 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 119.283 0.947 . . . . 64.21 110.872 -178.648 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.38 -51.22 70.84 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 107.903 -1.147 . . . . 64.33 107.903 -176.011 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -69.34 -27.24 65.18 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.067 0.947 . . . . 73.4 111.495 178.221 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 4.0 t -63.07 -16.68 60.71 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.368 1.067 . . . . 61.22 113.181 176.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 13.6 mtp -92.64 -4.18 53.74 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 124.013 0.925 . . . . 74.12 112.531 173.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 74.91 9.73 83.57 Favored Glycine 0 CA--C 1.524 0.615 0 C-N-CA 125.454 1.502 . . . . 51.25 112.341 173.403 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 30.8 m -53.71 117.18 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 C-N-CA 124.245 1.018 . . . . 75.54 110.648 -173.712 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -53.27 -63.6 1.1 Allowed 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.913 1.285 . . . . 75.11 110.301 -169.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . 0.275 2.1 m170 43.58 54.09 5.56 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 127.323 2.249 . . . . 62.12 113.504 167.045 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -65.03 67.04 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 127.868 2.467 . . . . 54.13 110.11 169.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 69.1 t -153.49 -56.75 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 C-N-CA 130.221 3.409 . . . . 64.04 106.501 -175.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . 0.258 0.2 OUTLIER 44.25 29.85 0.4 Allowed 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 127.659 2.384 . . . . 73.31 115.477 171.652 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.617 HD21 HG21 ' A' ' 48' ' ' VAL . 0.5 OUTLIER -137.42 -33.79 0.72 Allowed 'General case' 0 C--O 1.22 -0.46 0 C-N-CA 125.417 1.487 . . . . 71.41 109.642 -178.208 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -56.5 -35.51 68.11 Favored 'General case' 0 C--O 1.227 -0.129 0 CA-C-N 119.412 1.006 . . . . 62.42 110.974 177.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 37.3 t -54.17 -63.18 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-O 117.767 -1.111 . . . . 74.22 109.296 167.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -60.16 -41.44 92.81 Favored 'General case' 0 CA--C 1.548 0.875 0 CA-C-N 121.349 1.886 . . . . 62.34 109.273 -174.279 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -74.97 4.54 6.41 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 129.291 3.036 . . . . 71.11 111.568 -176.11 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.401 ' HB1' ' CZ ' ' A' ' 114' ' ' PHE . . . -111.27 -3.16 15.44 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 125.184 1.393 . . . . 33.42 113.251 169.614 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 8.1 mt -126.28 -44.62 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 107.873 -1.158 . . . . 70.11 107.873 -172.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 85.2 m-70 -70.53 -65.13 0.77 Allowed 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 123.316 0.646 . . . . 73.22 111.38 177.42 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.84 -20.51 38.84 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 115.044 1.498 . . . . 64.23 115.044 -176.316 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -81.68 -39.89 23.64 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.294 -1.002 . . . . 74.14 108.294 173.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 4.0 t60 52.06 64.55 1.8 Allowed 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.168 1.387 . . . . 74.03 108.783 -174.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 3.7 mmpt? -92.32 147.34 22.99 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 124.352 1.061 . . . . 74.51 108.578 171.717 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 27.9 tttp -84.35 55.41 3.35 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 127.181 2.192 . . . . 54.44 110.14 -178.144 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 95.7 mt -75.89 34.16 0.12 Allowed 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 127.758 2.423 . . . . 74.43 111.599 -176.387 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -70.8 11.73 0.35 Allowed 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 127.001 2.12 . . . . 65.41 114.373 -165.486 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -147.98 161.39 34.91 Favored Pre-proline 0 N--CA 1.47 0.57 0 C-N-CA 126.551 1.94 . . . . 63.42 111.091 179.344 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -56.76 -48.34 19.11 Favored 'Trans proline' 0 CA--C 1.51 -0.681 0 C-N-CA 123.738 2.958 . . . . 75.31 111.981 177.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -60.04 -34.3 73.2 Favored 'General case' 0 N--CA 1.44 -0.97 0 C-N-CA 125.484 1.513 . . . . 70.45 111.336 -175.303 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -71.4 -48.23 51.13 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 126.059 1.744 . . . . 74.1 109.592 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 71.1 mtm -59.82 -49.77 76.42 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 123.814 0.846 . . . . 64.24 109.558 175.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -62.4 -43.88 97.76 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 125.409 1.484 . . . . 64.14 111.135 -177.012 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -53.01 -41.97 65.16 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 123.792 0.837 . . . . 71.32 111.303 177.295 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . 0.401 ' CZ ' ' HB1' ' A' ' 97' ' ' ALA . 93.6 t80 -76.43 -46.82 25.4 Favored 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 124.26 1.024 . . . . 63.31 109.551 -174.486 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 25.9 mt -65.38 -29.97 70.74 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.514 1.126 . . . . 74.3 110.252 -178.354 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -53.98 -31.58 51.28 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.806 0.842 . . . . 53.22 111.361 178.584 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -94.77 12.42 68.65 Favored Glycine 0 CA--C 1.527 0.785 0 CA-C-O 117.406 -1.774 . . . . 62.2 113.907 176.744 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 7.8 mmtm -132.46 11.33 4.48 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 120.097 1.949 . . . . 72.32 111.835 -173.229 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 97.77 42.09 3.19 Favored Glycine 0 N--CA 1.463 0.475 0 CA-C-N 119.769 1.168 . . . . 43.31 111.863 177.578 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 46.8 t -136.85 158.82 37.11 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 C-N-CA 127.101 2.16 . . . . 71.21 105.474 172.641 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -116.27 126.94 54.26 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 108.856 -0.794 . . . . 65.32 108.856 174.006 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 1.7 mtpm? -56.13 -37.0 68.87 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 123.169 0.588 . . . . 72.02 110.393 171.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -64.11 -14.92 58.16 Favored 'General case' 0 C--O 1.226 -0.165 0 C-N-CA 124.931 1.292 . . . . 62.1 111.992 -178.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 14.6 mmtp -114.66 -33.46 5.51 Favored 'General case' 0 C--O 1.225 -0.196 0 C-N-CA 124.367 1.067 . . . . 75.54 111.837 178.438 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 12.8 t80 -54.82 -61.39 2.34 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 123.632 0.773 . . . . 71.01 109.353 175.306 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 32.3 mt -73.88 -37.12 64.81 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 121.663 0.744 . . . . 72.24 110.798 -161.522 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 18.8 p -66.92 -21.35 65.99 Favored 'General case' 0 N--CA 1.442 -0.856 0 C-N-CA 125.204 1.401 . . . . 75.42 111.757 179.57 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 34.0 m -97.98 -31.74 12.01 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.181 0.992 . . . . 73.43 109.867 174.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 45.4 t80 -57.83 -56.33 23.33 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 124.624 1.17 . . . . 75.12 110.219 177.008 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 -89.47 56.89 3.75 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 108.002 -1.11 . . . . 71.0 108.002 173.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -134.96 160.24 38.94 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 124.061 0.944 . . . . 74.05 110.424 172.336 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -55.28 -28.09 51.04 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.68 1.592 . . . . 72.13 112.654 -179.114 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -45.32 -67.13 0.31 Allowed 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 125.691 1.597 . . . . 73.41 108.728 171.535 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 24.7 mm -61.28 -40.24 85.36 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 CA-C-O 117.524 -1.227 . . . . 73.02 111.295 -178.288 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 18.4 mtpp -54.74 -38.34 67.02 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 120.537 1.517 . . . . 75.23 110.137 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -78.22 -43.57 13.04 Favored Glycine 0 N--CA 1.442 -0.94 0 N-CA-C 110.589 -1.005 . . . . 63.32 110.589 -177.137 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 9.2 mt-30 -62.12 -39.57 92.98 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 123.15 0.58 . . . . 70.45 109.688 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 1.7 mtp -56.42 -57.59 11.63 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 124.673 1.189 . . . . 51.52 109.28 173.594 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -70.82 -31.2 67.85 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 118.898 -1.121 . . . . 73.22 112.227 -168.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 4.5 mttt -63.2 -59.18 5.09 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 123.88 0.872 . . . . 71.23 110.814 170.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -58.13 -35.58 71.7 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 119.459 1.027 . . . . 75.35 110.807 179.683 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 10.0 tmtt? -61.11 -53.2 60.08 Favored 'General case' 0 N--CA 1.456 -0.139 0 O-C-N 120.437 -1.415 . . . . 73.42 110.557 177.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.02 -25.11 64.33 Favored 'General case' 0 C--O 1.221 -0.396 0 CA-C-N 120.096 1.316 . . . . 74.21 111.874 176.756 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.427 HD23 ' HA ' ' A' ' 144' ' ' LEU . 30.0 mt -70.68 -59.27 2.92 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 119.57 1.077 . . . . 72.51 110.991 -178.759 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -55.42 -44.68 76.49 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 118.412 0.551 . . . . 74.03 111.176 -170.642 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 4.1 ppp? -64.49 -41.75 96.27 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 113.574 0.953 . . . . 74.24 113.574 176.394 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -64.62 -29.81 70.82 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 116.374 -1.774 . . . . 64.13 110.869 -178.375 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -80.0 11.77 3.17 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 127.787 2.435 . . . . 73.11 113.369 176.688 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 21.4 mt-30 59.67 18.63 7.34 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 127.51 2.324 . . . . 75.22 115.039 -177.332 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 40.2 t -73.43 141.45 16.27 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 O-C-N 121.12 -0.988 . . . . 60.5 108.919 -179.461 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -135.91 3.26 2.93 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.032 0.933 . . . . 64.11 113.078 -177.557 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -174.33 -173.93 40.72 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 108.711 -1.756 . . . . 52.31 108.711 -179.164 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.611 HG21 ' CB ' ' A' ' 34' ' ' TRP . 6.4 m -139.41 154.16 71.45 Favored Pre-proline 0 CA--C 1.535 0.398 0 C-N-CA 125.794 1.638 . . . . 74.54 109.349 176.597 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . 0.474 ' HG3' HD12 ' A' ' 166' ' ' ILE . 35.7 Cg_endo -65.03 160.04 72.13 Favored 'Cis proline' 0 CA--C 1.533 0.431 0 C-N-CA 125.317 -0.701 . . . . 71.32 113.793 -2.269 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 17.7 m -157.81 141.66 15.75 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 124.816 1.246 . . . . 61.2 108.367 173.594 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 19.2 mmm -123.5 155.88 36.69 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 125.968 1.707 . . . . 74.3 108.512 167.341 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 6.1 t -135.26 153.77 34.5 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 N-CA-C 106.946 -1.502 . . . . 33.43 106.946 174.43 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 58.5 t -126.45 123.86 64.21 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 C-N-CA 126.439 1.896 . . . . 61.43 106.995 173.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 1.2 t30 54.56 16.7 1.41 Allowed 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 129.472 3.109 . . . . 72.21 115.898 166.697 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 74.37 28.43 63.83 Favored Glycine 0 CA--C 1.523 0.572 0 C-N-CA 128.866 3.127 . . . . 74.43 113.205 -176.131 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 33.5 mttt -139.33 -31.26 0.7 Allowed 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 114.848 1.425 . . . . 45.41 114.848 -166.268 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -125.13 138.51 54.16 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 107.91 -1.144 . . . . 72.0 107.91 177.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 71.0 ttt-85 -122.6 141.57 51.57 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 105.381 -2.081 . . . . 72.33 105.381 178.126 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 11.4 p90 -153.9 170.66 20.49 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 107.097 -1.446 . . . . 74.01 107.097 -179.243 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -173.97 -178.99 1.62 Allowed 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 123.822 0.849 . . . . 61.55 109.103 178.643 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.474 HD12 ' HG3' ' A' ' 154' ' ' PRO . 15.6 mt -52.0 -48.36 40.93 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 C-N-CA 126.245 1.818 . . . . 60.24 109.324 176.085 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -71.65 -34.36 63.02 Favored Glycine 0 CA--C 1.525 0.676 0 CA-C-O 118.744 -1.031 . . . . 70.12 113.009 179.302 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 3.5 m -65.21 -55.79 16.51 Favored 'General case' 0 C--O 1.227 -0.09 0 CA-C-N 119.649 1.724 . . . . 45.01 109.523 174.021 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -67.29 -49.53 63.86 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 124.507 1.123 . . . . 72.31 111.111 -171.03 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 124.43 5.13 7.32 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 125.069 1.319 . . . . 65.11 113.921 -176.633 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 162.04 173.63 30.94 Favored Glycine 0 CA--C 1.528 0.874 0 CA-C-N 118.839 1.319 . . . . 70.25 111.014 175.726 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -66.62 -47.66 2.73 Favored 'Trans proline' 0 CA--C 1.532 0.416 0 C-N-CA 122.785 2.323 . . . . 74.44 111.157 -175.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -54.01 -46.6 71.85 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.143 0.977 . . . . 74.23 110.16 172.528 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -65.33 -26.48 68.06 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.684 0.794 . . . . 70.52 110.403 -176.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 25.0 m -65.83 -40.82 92.16 Favored 'General case' 0 CA--C 1.533 0.3 0 O-C-N 120.663 -1.273 . . . . 70.45 109.524 178.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 37.7 mt -66.62 -29.72 69.82 Favored 'General case' 0 C--N 1.342 0.249 0 CA-C-N 119.507 1.049 . . . . 51.11 111.132 175.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.65 -47.78 66.86 Favored 'General case' 0 C--N 1.339 0.145 0 C-N-CA 124.093 0.957 . . . . 74.13 109.208 171.241 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.423 HD13 ' HA ' ' A' ' 178' ' ' LEU . 4.4 mm? -72.75 -42.1 64.41 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-O 118.33 -0.843 . . . . 74.04 110.845 178.713 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -53.18 -48.01 68.37 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 118.699 0.681 . . . . 72.41 111.788 -173.385 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -75.8 -34.53 60.18 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 123.01 0.524 . . . . 73.3 110.752 -172.13 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -66.2 -48.36 70.87 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 124.83 1.252 . . . . 63.01 111.087 174.206 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 68.7 mt -65.52 -32.69 74.42 Favored 'General case' 0 N--CA 1.457 -0.077 0 C-N-CA 124.312 1.045 . . . . 62.34 111.155 -177.248 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 29.0 mt -50.39 -57.85 2.15 Favored 'Isoleucine or valine' 0 C--N 1.34 0.179 0 CA-C-O 117.976 -1.011 . . . . 74.41 108.781 168.177 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -57.74 -37.04 72.89 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 119.813 1.188 . . . . 62.15 111.552 -176.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 22.6 tptt -56.54 -38.97 72.61 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.466 0.706 . . . . 75.11 111.469 -175.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 51.3 mm-40 -90.98 -42.88 10.3 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 123.741 0.816 . . . . 44.34 111.665 176.561 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.95 -37.65 77.25 Favored 'General case' 0 C--N 1.333 -0.128 0 O-C-N 120.76 -1.212 . . . . 72.14 110.175 -177.033 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -57.09 -27.34 61.67 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 124.834 1.253 . . . . 71.43 111.584 178.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -57.01 -24.52 54.26 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 123.261 0.624 . . . . 65.43 112.043 175.746 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -124.86 21.38 8.28 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 128.508 2.723 . . . . 63.22 111.886 -174.632 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 5.7 tttt -123.12 34.86 5.01 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 119.333 0.97 . . . . 65.35 112.44 -170.429 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . 0.264 7.3 pttm . . . . . 0 C--O 1.248 0.995 0 N-CA-C 105.877 -1.898 . . . . 75.12 105.877 168.266 . . . . . . . . 1 1 . 1 stop_ save_